ENSG00000167323,STIM1,cellular calcium regulation,oncogenic signaling pathway,protein kinase activation,calcium influx regulation,tumor progression promotion,genomic instability
ENSG00000144935,TRPC1,aberrant calcium signaling,cell proliferation,channel function regulation,drug resistance facilitation,metastasis promotion,oncogenic pathway activation
ENSG00000089250,NOS1,pro-inflammatory responses,angiogenesis promotion,oncogenic signaling pathways,tumor microenvironment modulation,cell survival enhancement,metastasis facilitation
ENSG00000058668,ATP2B4,calcium regulation,cellular signaling,plasma membrane localization,p-type atpase family member,cellular growth modulation,ancillary protein interaction
ENSG00000069431,ABCC9,channel regulation,oncogenic activity,metabolic reprogramming,tumor growth,angiogenesis evasion,poor prognosis marker
ENSG00000187486,KCNJ11,tumor suppressor function,ion balance regulation,cellular metabolism modulation,therapeutic target potential,potassium channel interaction,metabolic reprogramming
ENSG00000084754,HADHA,cellular metabolism alteration,fatty acid metabolism regulation,mitochondrial function influence,energy production disruption,cell growth promotion,bioenergetic shift
ENSG00000138029,HADHB,beta-oxidation,tumor progression,mitochondrial function,energy production,metabolic regulation,fatty acid metabolism
ENSG00000197265,GTF2E2,transcriptional regulation,dysregulated gene expression,gain-of-function mutations,cell cycle progression,cdkn1a regulation,tumor suppressor antagonism
ENSG00000153767,GTF2E1,transcriptional regulation,apoptosis inhibition,cell cycle progression,dna repair mechanisms,tumor suppressor function,genomic instability
ENSG00000140307,GTF2A2,transcriptional regulation,constitutive activation,tumor progression,oncogene function,cell proliferation,genomic instability
ENSG00000165417,GTF2A1,transcription regulation,genomic stability,oncogenic processes,dna damage response,gene expression modulation,protein interaction
ENSG00000162738,VANGL2,pcd pathway regulation,tumor progression driver,cell migration regulator,epithelial-to-mesenchymal transition promoter,prognostic marker,signaling molecule interaction
ENSG00000274287,SCRIB,hippo pathway regulation,tumor suppressor function,cell polarity disruption,epithelial-to-mesenchymal transition,signaling molecule interaction,pi3k/akt pathway modulation
ENSG00000004975,DVL2,wnt/pcp pathway,oncogenic driver,cell migration regulation,planar cell polarity disruption,tumor progression facilitation,frizzled receptor interaction
ENSG00000102981,PARD6A,oncogene activation,cell polarity disruption,microtubule regulation,cell migration promotion,tumor aggressiveness,prognostic marker
ENSG00000177885,GRB2,ras/mapk pathway,adaptor protein function,cell proliferation regulation,oncogenic mutations,therapeutic target,protein-protein interactions
ENSG00000109458,GAB1,signaling molecule regulation,oncogenic amplification,growth factor receptor interaction,cellular survival enhancement,tumor progression facilitation,protein kinase activation
ENSG00000146648,EGFR,epidermal growth factor receptor activation,cell proliferation enhancement,pi3k/akt pathway activation,tumor angiogenesis promotion,signaling pathway cross-talk,mutational hotspot
ENSG00000138798,EGF,cell proliferation,overexpression,tumor progression,therapeutic target,signaling pathway,angiogenesis
ENSG00000121879,PIK3CA,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000145675,PIK3R1,pi3k/akt pathway regulation,regulatory subunit dysfunction,tumor progression driver,ras-raf-mek signaling interaction,akt/mtor pathway activation,survival and growth promotion
ENSG00000197122,SRC,src activation,oncogenic signaling,gain of function mutations,cell proliferation,signaling pathway regulation,transcription factor modulation
ENSG00000089159,PXN,cytoskeletal regulation,cell adhesion molecule,oncogenic signaling,tumor progression,overexpression,poor prognosis
ENSG00000137392,CLPS,cell migration,extracellular matrix degradation,secreted serine protease activity,tumor progression,prognostic marker,cell invasion
ENSG00000175535,PNLIP,lipid metabolism,oncogene overexpression,tumor progression,cell proliferation,lipid accumulation,metabolic regulation
ENSG00000078369,GNB1,cancer-related signaling,g protein regulation,cell proliferation enhancement,ciliogenesis disruption,oncogenic pathway activation,biomarker potential
ENSG00000127928,GNGT1,mtor pathway regulation,aberrant expression,oncogene activation,cell signaling modulation,tumor progression driver,guanine nucleotide-binding protein subunit
ENSG00000198515,CNGA1,cancer-promoting,cell proliferation,aberrant expression,tumor progression,signaling pathway regulation,calcium channel function
ENSG00000070729,CNGB1,ion channel regulation,gene expression upregulation,cell signaling modulation,tumor microenvironment influence,cyclic nucleotide-gated channel function,protein-protein interaction
ENSG00000257365,FNTB,ras interaction,prenylation pathway,tumor progression,cellular proliferation,protein prenylation,metabolic regulation
ENSG00000168522,FNTA,fatty acid biosynthesis,tumor growth,aggressive disease,therapeutic target,cell proliferation,energy storage
ENSG00000113522,RAD50,homologous recombination repair (hrr),genomic instability,cell survival,dna damage response,telomere stability,biomarker target
ENSG00000020922,MRE11,dna repair,genomic instability,chromosomal instability,cellular response,protein interaction,tumor suppression
ENSG00000182481,KPNA2,nuclear import regulation,oncogenesis promotion,cell proliferation enhancement,protein import facilitation,therapeutic target identification,genomic overexpression
ENSG00000104320,NBN,genome instability,dna repair deficiency,tumor suppressor function,cancer susceptibility,dna damage response,apoptosis regulation
ENSG00000172977,KAT5,genomic instability,chromatin regulation,oncogenic potential,tumor progression,histone acetylation,dna repair pathways
ENSG00000149311,ATM,genomic instability,cell cycle regulation,dna repair,homologous recombination,tumor suppression,proliferation promotion
ENSG00000009954,BAZ1B,chromatin remodeling,dna repair interactions,oncogenic transcriptional activity,genomic instability,tumor suppressor suppression,therapeutic target
ENSG00000153147,SMARCA5,genomic instability,dna damage response,chromatin remodeling,cell cycle regulation,tumor suppressor function,loss-of-function mutations
ENSG00000103275,UBE2I,tumor suppressor protein regulation,ubiquitination pathway,cell cycle progression,protein degradation regulation,p53 interaction,oncogenic processes enhancement
ENSG00000116030,SUMO1,tumor suppressor regulation,cellular proliferation regulation,protein modification pathway,oncogenic process facilitation,post-translational modification,sumoylation dysregulation
ENSG00000169139,UBE2V2,deubiquitination,protein stabilization,oncogenic function,tumor suppression inhibition,cellular survival enhancement,cancer progression facilitation
ENSG00000177889,UBE2N,pi3k/akt interaction,ubiquitination pathway regulation,oncoprotein stabilization,cell cycle progression,apoptosis suppression,protein degradation
ENSG00000138376,BARD1,dna repair mechanism,genomic instability,tumor suppressor function,brca1 interaction,p53 regulation,chromatin remodeling
ENSG00000012048,BRCA1,genomic instability,tumor suppressor function,dna repair pathway disruption,cancer predisposition,cell cycle regulation,apoptosis dysregulation
ENSG00000188612,SUMO2,protein modification,apoptosis regulation,cell cycle control,tumor suppressor regulation,oncogenesis contribution,genetic interaction
ENSG00000225589,MDC1,genomic stability maintenance,scaffolding protein function,dna damage response,brca1 interaction,53bp1 recruitment,genomic instability promotion
ENSG00000128731,HERC2,mtor pathway regulation,gene expression regulation,ubiquitin ligase activity,tumor progression regulator,cancer prognosis marker,protein degradation complex interaction
ENSG00000164053,ATRIP,genomic instability,cell cycle progression,dna damage response,oncogenesis,cancer susceptibility,genome maintenance
ENSG00000175054,ATR,genomic instability,dna damage response,cell cycle checkpoint arrest,oncogene activation,replication stress,therapeutic target
ENSG00000111602,TIMELESS,genomic instability,tumor driver gene,nuclear localization,dna damage response,cell proliferation regulation,pi3k/akt signaling interaction
ENSG00000075131,TIPIN,genomic instability,dna repair regulation,oncogenic mutation,cell proliferation enhancement,protein interaction disruption,poor prognosis marker
ENSG00000163605,PPP4R2,protein phosphatase regulation,chromatin remodeling,gene expression modulation,tumor progression contribution,cancer cell survival,potential therapeutic target
ENSG00000149923,PPP4C,protein phosphoregulation,cell cycle progression,apoptosis modulation,dna repair regulation,oncogenic processes,tumor suppressor interaction
ENSG00000108384,RAD51C,genomic instability,dna repair defects,homologous recombination,tumor suppression,oncogene driver,genetic predisposition
ENSG00000126215,XRCC3,homologous recombination,telomere maintenance,dna repair pathways,genomic instability,cancer susceptibility,fanconi anemia pathway
ENSG00000197774,EME2,genomic instability,dna replication regulation,cell cycle progression modulation,tumor suppressor activity,genetic variation contribution,therapeutic target potential
ENSG00000172732,MUS81,interstrand crosslink repair,homologous recombination repair,dna double-strand break repair,tumor progression,genome instability,oncogenic stress response
ENSG00000154920,EME1,genomic instability,tumor progression,genetic mutations,cell division regulation,dna repair pathway,biomarker potential
ENSG00000139618,BRCA2,genomic instability,tumor suppressor function,dna damage response,proliferation regulation,apoptosis regulation,cell cycle regulation
ENSG00000051180,RAD51,genomic instability,homologous recombination repair,oncogenic mutations,therapeutic target,dna damage response,genomic stability
ENSG00000175595,ERCC4,genomic instability,dna damage response,nucleotide excision repair,mutational burden,cancer predisposition,tumor suppressor function
ENSG00000012061,ERCC1,genomic instability,dna repair deficiency,tumor progression,platinum-based chemotherapy resistance,oncogene regulation,cancer biomarker
ENSG00000073050,XRCC1,genomic instability,base excision repair pathway,dna repair mechanism,tumor suppressor function,oncogenic mutation prevention,cellular defense compromise
ENSG00000005156,LIG3,genomic instability,oncogenesis,tumor progression,dna repair enzyme,cell proliferation,poor prognosis
ENSG00000196419,XRCC6,dna repair,genomic instability,oncogenesis,telomere maintenance,chromosomal stability,non-homologous end joining
ENSG00000079246,XRCC5,dna repair,genomic stability,p53bp1 function,tumor suppression,apoptosis regulation,cell cycle arrest
ENSG00000152422,XRCC4,genomic instability,dna repair dysfunction,tumorigenesis promotion,cellular transformation,mutations in nhej pathway,enhanced genetic alterations
ENSG00000174405,LIG4,dna repair mechanism,genomic instability,tumor progression,dna damage response,nhej pathway,chromosomal alterations
ENSG00000049860,HEXB,glycosphingolipid metabolism,cellular interaction modulation,tumor microenvironment regulation,cancer progression contribution,therapeutic target potential,glycosphingolipid degradation
ENSG00000213614,HEXA,lysosomal enzyme regulation,cellular metabolism,therapeutic target potential,oncogenic pathway involvement,cellular stress response,genomic instability </begin>
ENSG00000151348,EXT2,dna repair,tumor suppressor,loss-of-function mutations,genomic instability,oncogenic driver,prognostic biomarker
ENSG00000182197,EXT1,heparan sulfate biosynthesis,tumor suppressor function,dysregulated cell proliferation,angiogenesis regulation,metastasis enhancement,targeted therapy implications
ENSG00000115904,SOS1,ras activation,constitutive signaling,gef function,tumor progression,therapeutic target,cancer biology
ENSG00000170312,CDK1,cell cycle regulation,overexpression,tumor progression,apoptosis resistance,therapeutic target,genomic instability
ENSG00000134057,CCNB1,cell cycle dysregulation,mitotic checkpoint disruption,cancer proliferation driver,chromosome segregation defect,g2/m phase regulation failure,oncogenic protein overexpression
ENSG00000165494,PCF11,pre-mrna processing,tumor suppressor potential,rna metabolism regulation,polyadenylation complex component,gene expression dysregulation,mrna nuclear export
ENSG00000172409,CLP1,ribosome biogenesis,oncogenic protein synthesis,pi3k/akt pathway activation,cell proliferation enhancement,therapeutic target,genomic overexpression
ENSG00000187079,TEAD1,hippo signaling pathway,transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition (emt),cell proliferation,chromatin remodeling
ENSG00000137693,YAP1,hippo pathway activation,transcriptional coactivation,tumor progression enhancement,cell cycle regulation disruption,pro-survival signaling potentiation,metastatic potential augmentation
ENSG00000074219,TEAD2,cell cycle regulation,transcriptional activation,amplification/overexpression,oncogenic process,cell proliferation,apoptosis evasion
ENSG00000007866,TEAD3,tead3 binding,aberrant activation,cell proliferation,transcriptional regulation,wnt/β-catenin signaling,tumor suppression repression
ENSG00000197905,TEAD4,cell cycle regulation,transcriptional activation,aberrant expression,apoptosis inhibition,epithelial-to-mesenchymal transition (emt),wnt/β-catenin signaling pathway
ENSG00000132964,CDK8,transcriptional regulation,oncogene upregulation,cell cycle progression,protein kinase activity,tumor aggressiveness,poor prognosis
ENSG00000112237,CCNC,cell cycle regulation,g1/s transition,genomic instability,cell proliferation,onco-protein interactions,tumorigenesis
ENSG00000101665,SMAD7,tgf-β signaling pathway,tumor suppressor,inhibitory protein function,phosphorylation regulation,cellular differentiation inhibition,apoptosis promotion
ENSG00000157450,RNF111,e3 ubiquitin ligase activity,cell cycle regulation,oncoprotein degradation,tumor progression marker,poor prognosis indicator,cell proliferation promotion
ENSG00000284792,PTEN,pi3k/akt pathway inhibition,loss of function mutations,tumor suppression,genomic instability,therapeutic target,cell membrane regulation
ENSG00000141510,TP53,tumor suppressor function,dna repair mechanism,cell cycle regulation,apoptosis induction,genomic instability,oncogenic collaboration
ENSG00000165699,TSC1,mtor pathway regulation,tumor suppressor function,constitutive activation,loss of function mutations,cellular growth promotion,tumor progression
ENSG00000103197,TSC2,tumor suppressor,constitutive activation,loss of function mutations,mtor signaling pathway,cell growth regulation,tumor progression
ENSG00000284194,SCO2,mitochondrial function,electron transport chain disruption,ros accumulation,dna damage,cellular energy metabolism regulation,tumor progression driver
ENSG00000048392,RRM2B,mitochondrial function,increased nucleotide synthesis,metabolic rewiring,enhanced glycolysis,warburg effect,overexpression
ENSG00000135423,GLS2,glutamine metabolism pathway,oncogenic process,tumor growth promotion,cellular energy production,metabolic regulation,poor prognosis marker
ENSG00000146674,IGFBP3,igf pathway regulation,tumor suppressor function,cellular inhibition,apoptosis induction,protein binding,signaling pathway modulation
ENSG00000141682,PMAIP1,apoptosis regulation,tumor suppressor function,mitochondrial outer membrane permeabilization,dna damage response,cell cycle inhibition,chemosensitivity regulator
ENSG00000015475,BID,apoptosis regulation,cleavage-dependent signaling,oncogenic process modulation,cell death induction,pro-survival signals,tumor growth inhibition
ENSG00000120471,TP53AIP1,p53 pathway inhibition,tumor suppressor inactivation,cell survival promotion,apoptosis evasion,dna damage tolerance,genetic instability
ENSG00000197050,ZNF420,transcriptional repression,chromatin remodeling,zinc finger domain,cell proliferation regulation,epigenetic silencing,nuclear localization
ENSG00000115107,STEAP3,iron homeostasis regulation,metalloreductase function,cell proliferation promotion,tumor invasion enhancement,oxidative stress response modulation,genetic mutation association
ENSG00000104765,BNIP3L,mitochondrial regulation,cellular respiration,apoptosis induction,autophagy promotion,hypoxia adaptation,hif-1α degradation
ENSG00000170855,TRIAP1,genomic instability,cell cycle progression,dna damage response,oncogene overexpression,chromatin remodeling interaction,protein-protein interaction
ENSG00000042286,AIFM2,mitochondrial function,ros regulation,apoptosis modulation,cell cycle progression,genomic instability,prognostic marker
ENSG00000164938,TP53INP1,apoptosis regulation,pi3k/akt pathway inhibition,tumor suppressor function,genomic stability maintenance,p53 interaction,cell cycle regulation
ENSG00000120868,APAF1,apoptosis regulation,caspase activation,mitochondrial pathway,tumor progression,apoptosis evasion,pro-survival signaling
ENSG00000177595,PIDD1,p53 pathway,apoptosis regulation,dna damage response,tumor suppressor function,mutation association,genomic instability
ENSG00000169372,CRADD,cell death modulation,tumor suppressor function,apoptosis regulation,immune response modulation,protein-protein interaction,tumor microenvironment regulation
ENSG00000091106,NLRC4,inflammasome activation,inflammatory response,cancer progression,nf-κb signaling pathway,tumor growth facilitation,immune surveillance dysregulation
ENSG00000138794,CASP6,apoptosis regulation,programmed cell death,caspase activation,dna damage response,protein-protein interaction,tumor suppression
ENSG00000003400,CASP10,apoptosis regulation,tumor suppressor function,pro-apoptotic activity,caspase activation,genomic instability,mitochondrial outer membrane permeabilization
ENSG00000104419,NDRG1,cellular differentiation,epithelial-to-mesenchymal transition,pi3k/akt signaling inhibition,protein regulation,transcriptional repression,tumor suppression
ENSG00000281449,BCL2L14,bcl-2 family member,anti-apoptotic function,autophagy regulation,cell survival enhancement,oncogenic process,poor prognosis biomarker
ENSG00000089685,BIRC5,inhibitor of apoptosis,cell survival,oncogene,tumor progression,angiogenesis,metastasis
ENSG00000113916,BCL6,oncogenic function,epigenetic regulation,apoptosis inhibition,tumor progression,promoter activation,transcriptional repression
ENSG00000161642,ZNF385A,cell cycle regulation,tumor suppressor function,dna binding,transcriptional regulation,apoptosis induction,pi3k/akt pathway interaction
ENSG00000116017,ARID3A,chromatin remodeling,dna repair regulation,apoptosis inhibition,cell proliferation enhancement,transcriptional regulation,epigenetic modulation
ENSG00000165891,E2F7,transcription factor regulation,apoptosis induction,cell cycle arrest,genomic integrity maintenance,tumor suppressor function,e2f family interaction
ENSG00000129173,E2F8,tumor suppression,transcription factor activity,cell cycle regulation,apoptosis promotion,pi3k/akt pathway modulation,dna damage response regulation
ENSG00000116717,GADD45A,tumor suppressor,cell growth regulation,dna damage response,apoptosis modulation,cell proliferation inhibition,oxidative stress response
ENSG00000087586,AURKA,cell cycle progression,oncogenic driver,mitotic regulation,chromosomal segregation,therapeutic target,protein kinase activation
ENSG00000132646,PCNA,dna replication,cell proliferation,genomic instability,cancer aggressiveness,replication fork progression,protein recruitment
ENSG00000087088,BAX,apoptosis regulation,tumor suppressor,dna damage response,mitochondrial outer membrane permeabilization,caspase activation,bcl-2 family interaction
ENSG00000175793,SFN,cell cycle regulation,pro-apoptotic protein inhibition,cyclin-dependent kinase activation,tumor progression marker,cell survival enhancement,apoptosis suppression
ENSG00000145632,PLK2,cell cycle progression,mitosis promotion,microtubule dynamics,spindle assembly regulation,centrosome duplication,apoptosis inhibition
ENSG00000173846,PLK3,cell cycle regulation,mitosis progression,tumor growth promotion,therapeutic target,microtubule dynamics,genomic instability
ENSG00000102760,RGCC,genomic instability,cell cycle regulation,mitotic spindle assembly,chromosome condensation,oncogenic potential,aberrant function
ENSG00000118495,PLAGL1,oncogenic function,cell proliferation enhancement,epigenetic regulation,chromatin modification,tumor aggressiveness,biomarker potential
ENSG00000115966,ATF2,transcriptional regulation,tumor promotion,cancer metastasis,cell cycle progression,apoptosis inhibition,signaling pathway activation
ENSG00000177606,JUN,ap-1 pathway,oncogene activation,tumor progression,cell proliferation,genomic instability,signaling pathway interaction
ENSG00000170345,FOS,oncogenic transformation,transcriptional regulation,oncogene activation,cell cycle progression,apoptosis evasion,angiogenesis promotion
ENSG00000122512,PMS2,genomic instability,tumor suppressor function,mismatch repair,dna damage response,cancer predisposition,poor prognosis indicator
ENSG00000076242,MLH1,genomic instability,tumor suppressor function,mismatch repair deficiency,chemotherapy resistance,dna replication errors,epigenetic silencing
ENSG00000158169,FANCC,dna repair,genomic instability,tumor suppression,bone marrow failure,predisposition to cancer,dna damage response
ENSG00000134574,DDB2,genomic instability,dna repair mechanisms,tumorigenesis,apoptosis regulation,cell cycle regulation,nucleotide excision repair
ENSG00000057657,PRDM1,tumor suppressor,gene repression,cell differentiation,immune regulation,oncogenesis inhibition,prognostic marker
ENSG00000135679,MDM2,p53 pathway disruption,ubiquitin ligase activity,tumor suppressor inhibition,genomic instability,growth factor regulation,apoptosis evasion
ENSG00000198625,MDM4,oncogene activation,tumor suppressor inhibition,cell cycle progression,apoptosis evasion,prognostic marker,dna damage response
ENSG00000113328,CCNG1,p53 regulation,apoptosis suppression,cell proliferation,oncogene activation,pi3k/akt pathway interaction,tumor suppressor dysregulation
ENSG00000064393,HIPK2,regulation of apoptosis,modulation of pi3k/akt pathway,overexpression associated with poor prognosis,serine/threonine kinase activity,interaction with p53 protein,dysregulation leading to uncontrolled cell growth
ENSG00000127445,PIN1,oncogene activation,epithelial-to-mesenchymal transition,cell cycle regulation,protein-protein interactions,transcriptional control,tumor aggressiveness
ENSG00000163349,HIPK1,apoptosis regulation,tumor suppressor gene regulation,pro-apoptotic function loss,genomic instability contribution,cell survival enhancement,kinase activity disruption
ENSG00000149136,SSRP1,transcriptional regulation,cell cycle progression,apoptosis regulation,dna repair modulation,oncogenic protein interaction,gene expression dysregulation
ENSG00000092201,SUPT16H,**

chromatin remodeling,transcriptional regulation,cell cycle progression,proliferation promoter,genomic instability,tumor aggressiveness

**
ENSG00000101266,CSNK2A1,overexpression,phosphorylation regulation,tumor suppressor inactivation,apoptosis inhibition,transcription factor interaction,cell cycle dysregulation
ENSG00000070770,CSNK2A2,pi3k/akt pathway interaction,tumor progression driver,cell proliferation regulation,oncogenic phosphorylation,metastatic potential,therapeutic target
ENSG00000088325,TPX2,cell cycle regulation,microtubule dynamics,oncogenic potential,spindle assembly disruption,tumor progression driver,mitotic activity enhancement
ENSG00000188976,NOC2L,cell cycle regulation,chromatin dynamics disruption,genomic instability,overexpression,prognostic marker,tumorigenesis
ENSG00000176749,CDK5R1,regulation of cell cycle,apoptosis evasion,dna damage response,cell proliferation,neuronal development regulation,proliferation factor
ENSG00000164885,CDK5,pi3k/akt signaling,constitutive activation,cell proliferation,cell migration,apoptosis regulation,wnt/β-catenin pathway
ENSG00000152192,POU4F1,oncogenic function,transcriptional regulation,cell proliferation enhancement,tumor progression driver,apoptosis evasion modulation,overexpression signature
ENSG00000151615,POU4F2,cell growth regulation,metastatic progression,tumor suppression deficiency,transcriptional regulation,wnt/β-catenin pathway interaction,cellular proliferation enhancement
ENSG00000172530,BANP,transcriptional regulator,cell cycle regulation,genomic stability,apoptosis modulation,tumor suppression,chromatin remodeling
ENSG00000025293,PHF20,dna damage repair,chromatin remodeling,transcriptional regulation,oncogenic potential,homologous recombination,tumor suppressor dysfunction
ENSG00000185513,L3MBTL1,genomic instability,aneuploidy,chromatin regulation,tumor suppressor function,cell cycle regulation,chromosomal instability
ENSG00000238134,EHMT2,epigenetic regulation,histone methylation,tumor suppressor gene silencing,oncogene activation,cell cycle progression,apoptosis modulation
ENSG00000181090,EHMT1,histone methylation,chromatin regulation,epigenetic modification,oncogene activation,tumor suppressor repression,prognostic biomarker
ENSG00000137203,TFAP2A,transcription factor activity,cell cycle regulation,metastasis promotion,wnt signaling pathway interaction,epithelial-to-mesenchymal transition,overexpression and amplification
ENSG00000124795,DEK,oncogenic regulator,transcriptional regulation,cell cycle progression,apoptosis inhibition,angiogenesis promotion,tumor aggressiveness enhancer
ENSG00000087510,TFAP2C,cellular differentiation,transcriptional regulation,oncogene activation,tumor progression,apoptosis evasion,gene overexpression
ENSG00000186153,WWOX,tumor suppressor,genomic instability,apoptosis regulation,cell cycle progression,dna repair interaction,p53 stabilization
ENSG00000008196,TFAP2B,transcriptional regulation,epigenetic modulation,oncogene overexpression,cell proliferation enhancement,apoptosis inhibition,chromatin remodeling
ENSG00000127337,YEATS4,chromatin remodeling,histone modification,transcription regulation,oncogenic properties,cellular proliferation,protein-protein interaction
ENSG00000091831,ESR1,oncogenic signaling,constitutive activation,mutational activation,cell proliferation regulation,therapeutic target,estrogen receptor regulation
ENSG00000156802,ATAD2,histone modifications,chromatin remodeling,cell proliferation,apoptosis evasion,transcriptional regulation,genome instability
ENSG00000112715,VEGFA,angiogenic switch,hypoxia-induced expression,tumor aggressiveness,enhanced cell proliferation,vascular supply facilitation,immune response modulation
ENSG00000163235,TGFA,tumor promotion,cell proliferation,protein modification,cell migration,therapeutic target,genomic upregulation
ENSG00000124762,CDKN1A,cell cycle regulation,cyclin-dependent kinase inhibitor,genomic stability maintenance,tumor suppressor function loss,poor prognosis marker,epigenetic silencing
ENSG00000159216,RUNX1,tumor suppressor function,dna damage response,genomic stability maintenance,cellular homeostasis regulation,apoptosis regulation,transcriptional regulation
ENSG00000078900,TP73,apoptosis regulation,tumor suppressor function,p53 family member,dna repair interaction,cell survival modulation,poor prognosis marker
ENSG00000179588,ZFPM1,epigenetic regulation,dna methylation,transcriptional regulation,tumor metastasis,epithelial-to-mesenchymal transition (emt),chromatin modification
ENSG00000102145,GATA1,regulatory role,transcriptional regulation,cell differentiation,apoptosis evasion,epigenetic modifications,cell cycle progression
ENSG00000143387,CTSK,protein degradation,tumor progression,cancer aggressiveness,immune modulation,biomarker potential,therapeutic target
ENSG00000197641,SERPINB13,apoptosis regulation,cellular differentiation,tumor suppression,cell proliferation inhibition,protein-protein interactions,cancer progression inhibition
ENSG00000110092,CCND1,cell cycle progression,constitutive activation,oncogene overexpression,rapid cell proliferation,poor prognosis,therapeutic resistance
ENSG00000135446,CDK4,gain of function mutations,cell cycle progression,constitutive activation,therapeutic target,oncogene overexpression,angiogenesis promotion
ENSG00000173153,ESRRA,oncogene,cell proliferation,transcriptional regulation,apoptosis inhibition,angiogenesis promotion,prognostic marker
ENSG00000109819,PPARGC1A,**
pparγ activation,mitochondrial biogenesis suppression,glycolytic shift,oxidative stress resistance,transcriptional regulation,energy homeostasis disruption
**
ENSG00000122691,TWIST1,tumor progression,epithelial-to-mesenchymal transition,genetic amplification,molecular regulation,oncogenic signaling,apoptosis suppression
ENSG00000124813,RUNX2,transcription factor regulation,cell cycle progression,apoptosis evasion,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway modulation,tumor suppressor activity
ENSG00000109705,NKX3-2,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,dna repair mechanism,genomic stability maintenance
ENSG00000120149,MSX2,transcriptional regulation,tumor progression,epithelial-to-mesenchymal transition,cellular differentiation,apoptosis suppression,wnt/β-catenin pathway activation
ENSG00000141646,SMAD4,tgf-β signaling pathway,loss of function mutations,tumor progression,metastasis,transcriptional regulation,epigenetic modification
ENSG00000170365,SMAD1,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt),cell growth regulation,tumor progression,p53 interaction,genomic instability
ENSG00000020633,RUNX3,tumor suppressor function,cell cycle regulation,dna binding activity,apoptosis modulation,transcriptional regulation,genomic instability
ENSG00000166949,SMAD3,aberrant activation,cancer stem cell maintenance,epithelial-to-mesenchymal transition (emt),overexpression,signaling pathway dysregulation,tgf-β receptor interaction
ENSG00000198176,TFDP1,cell cycle regulation,promotes proliferation,transcriptional coactivator,overexpressed in cancer,tumorigenesis facilitation,apoptosis suppression
ENSG00000169016,E2F6,tumor suppressor function,g1 phase regulation,cell cycle progression,angiogenesis promotion,metastasis enhancement,genome instability
ENSG00000114126,TFDP2,e2f1 activation,cell cycle progression,dna replication,transcriptional regulation,oncogenic function,apoptosis suppression
ENSG00000174197,MGA,cell cycle progression,transcription factor regulation,tumor progression,oncogenic processes,apoptosis inhibition,pi3k/akt pathway activation
ENSG00000125952,MAX,transcriptional regulator,cell growth enhancement,heterodimer formation,oncogenic pathway modulation,tumor suppressor interaction,proliferation promotion
ENSG00000213246,SUPT4H1,epigenetic regulation,histone acetylation,transcriptional elongation,chromatin remodeling,oncogenic reprogramming,cell proliferation
ENSG00000196235,SUPT5H,transcriptional regulation,rna processing,cell proliferation,gene expression modulation,tumor aggressiveness,therapeutic target
ENSG00000103363,ELOB,n-glycosylation,protein modification,unfolded protein response,oncogenic pathway activation,cell survival promotion,tumor growth facilitation
ENSG00000154582,ELOC,tumor suppressor,regulation of gene transcription,transcriptional activation,elo complex component,hif-α regulation,protein stability modulation
ENSG00000125651,GTF2F1,transcriptional regulation,genome stability maintenance,chromatin remodeling,cell cycle control,apoptosis evasion,tumor growth promotion
ENSG00000188342,GTF2F2,transcription initiation,rna polymerase ii recruitment,proliferation regulation,survival signaling,metastasis facilitation,transcriptional dysregulation
ENSG00000114503,NCBP2,genomic instability,dna repair mechanisms,histone modification regulation,pre-mrna processing facilitation,onco-protein,cell proliferation enhancement
ENSG00000136937,NCBP1,rna processing,transcriptional regulation,tumor suppressor interaction,mitochondrial regulation,microrna regulation,mrna stability
ENSG00000224748,TAP1,antigen presentation,immune evasion,apoptosis regulation,cell survival pathway,tumor antigen reduction,prognostic marker
ENSG00000223481,TAP2,immune evasion,antigen presentation disruption,tumor microenvironment modulation,cancer progression facilitation,gene expression alterations,therapeutic target
ENSG00000166126,AMN,apoptosis inhibition,cell growth promotion,dna repair interaction,metabolic regulation,oncogene overexpression,protein biosynthesis enhancement
ENSG00000107611,CUBN,vitamin b12 reabsorption,imerssion deficiency anemia,renal carcinoma progression,cell signaling disruption,apoptosis impairment,pi3k/akt pathway interaction
ENSG00000146085,MMUT,genomic instability,dna damage response,mismatch repair,tumor suppressor function,cancer genome evolution,cell cycle regulation
ENSG00000151611,MMAA,mitochondrial dysfunction,tumor growth regulation,detoxification pathway,redox balance regulation,oncogenic mutation,cancer metabolism
ENSG00000117560,FASLG,apoptosis regulation,tumor progression,immune evasion,cell survival,cancer therapy resistance,genomic instability
ENSG00000026103,FAS,apoptosis regulation,tumor progression,immune evasion,cell death evasion,regulatory mechanisms,cancer immunity
ENSG00000156735,BAG4,genomic instability,tumor progression,cell cycle regulation,apoptosis inhibition,mitochondrial dysfunction,pi3k/akt pathway modulation
ENSG00000067182,TNFRSF1A,tumor suppressor function,immune modulation,apoptosis regulation,tumor growth promotion,inflammation regulation,protein-protein interaction
ENSG00000230108,TNF,tumor progression,inflammation induction,cancer promotion,apoptosis suppression,immune evasion,angiogenesis enhancement
ENSG00000106052,TAX1BP1,genomic instability,dna repair deficiency,transcriptional regulation,apoptosis inhibition,cell cycle progression,protein-protein interaction
ENSG00000118503,TNFAIP3,nf-κb pathway inhibition,oncogenic potential,apoptosis suppression,tumor progression promotion,signaling pathway modulation,pro-inflammatory response regulation
ENSG00000104689,TNFRSF10A,apoptosis regulation,cancer therapy target,death-inducing signaling complex component,programmed cell death pathway,trail receptor interaction,tumor suppressor function
ENSG00000173530,TNFRSF10D,apoptosis regulation,death receptor modulation,immune response regulation,tumor necrosis factor receptor superfamily,cancer cell survival,oncogenic process promotion
ENSG00000120889,TNFRSF10B,tnf signaling pathway,apoptosis regulation,decoy receptor function,tumor progression,poor prognosis marker,therapeutic target
ENSG00000134259,NGF,ngf,constitutive activation,angiogenesis promotion,cell proliferation enhancement,tumor progression facilitation,protein kinase activation
ENSG00000064300,NGFR,tumor-associated inflammation,immune microenvironment modulation,cell proliferation regulation,nf-κb pathway activation,t-cell activation promotion,apoptosis inhibition
ENSG00000184216,IRAK1,myd88-dependent signaling pathway,gain of function mutations,tumor progression,cell proliferation,apoptosis regulation,immune evasion
ENSG00000172936,MYD88,constitutive activation,gain of function mutations,immune signaling pathway,oncogenic driver,tumor progression,inflammation
ENSG00000109320,NFKB1,nf-κb pathway,constitutive activation,gain of function mutations,tumor progression,cell survival enhancement,inflammation regulation
ENSG00000173039,RELA,oncogenic driver,nf-κb transcription factor,aberrant activation,cell survival promotion,tumor progression,inflammation-related pathways
ENSG00000119048,UBE2B,ubiquitination pathway,overexpression,cellular stress regulation,tumor growth promotion,p53 regulation,proteasome pathway modulation
ENSG00000070950,RAD18,genomic instability,translesion synthesis,dna repair pathway,tumor progression,proliferating cell nuclear antigen interaction,therapeutic target
ENSG00000114742,WDR48,protein quality control,regulation of protein degradation,ubiquitination and proteasomal degradation,cellular trafficking and signaling,oncogenic processes,mutant protein stability
ENSG00000162607,USP1,genome stability regulation,dna damage response,deubiquitinating enzyme activity,ubiquitin-proteasome pathway,cell cycle progression,tumor suppressor function
ENSG00000009413,REV3L,genomic instability,tumor progression,dna repair pathway,lesion bypass,translesion synthesis,error-prone dna polymerase
ENSG00000116670,MAD2L2,spindle assembly checkpoint,genomic instability,aneuploidy,cell cycle regulation,tumorigenesis,biomarker potential
ENSG00000163743,RCHY1,transcriptional regulator,dna repair mechanism,cell cycle modulation,tumor overexpression,cancer driver gene candidate,genomic instability mediator
ENSG00000170734,POLH,dna damage tolerance,genomic instability,mutational burden,translesion synthesis,error-prone repair,repair of ultraviolet light-induced damage
ENSG00000121060,TRIM25,nf-κb signaling pathway regulation,oncogenic protein accumulation,immune evasion,cell growth promotion,protein degradation modulation,innate immunity regulation
ENSG00000156587,UBE2L6,ubiquitin-conjugating enzyme,cell cycle regulation,protein degradation pathway,oncogenic process activation,cell proliferation enhancement,metabolic regulation modification
ENSG00000182179,UBA7,protein ubiquitination,cell proliferation,ubiquitin-conjugating enzyme,oncogenic proteins,therapeutic target,genomic overexpression
ENSG00000187608,ISG15,mtor pathway regulation,ubiquitination pathway,oncogene activity,poor prognosis marker,cell cycle regulation,tumor aggressiveness enhancer
ENSG00000184900,SUMO3,sumoylation,cellular proliferation,protein modification,transcription regulation,tumor progression,therapeutic target
ENSG00000131944,FAAP24,genetic instability,homologous recombination,dna double-strand breaks,tumor suppressor activity,mutations in cancer,oncogenic transformation
ENSG00000187790,FANCM,genome stability maintenance,dna interstrand crosslink resolution,homologous recombination repair,tumor suppressor function,chromosomal integrity maintenance,genomic instability susceptibility
ENSG00000169689,CENPX,aneuploidy,chromosomal instability,cell proliferation enhancement,mitotic kinase activation,genomic destabilization,centrosome function alteration
ENSG00000175279,CENPS,aneuploidy,cell proliferation,chromosome segregation,genomic instability,kinetochore function,microtubule regulation
ENSG00000140525,FANCI,homologous recombination deficiency,genomic instability,dna repair pathway,cell cycle regulation,apoptosis dysregulation,tumor suppressor function
ENSG00000144554,FANCD2,dna interstrand crosslink repair,genome instability,tumor suppressor function,brca1 interaction,ubiquitination-dependent activation,chromatin modification
ENSG00000175198,PCCA,enhanced tumor growth,metabolic regulation,cellular proliferation,energy production,redox balance,cancer aggressiveness
ENSG00000114054,PCCB,extracellular matrix degradation,protein-protein interaction,tumor progression,cell invasion and migration,metastasis promotion,blood pressure regulation
ENSG00000275300,MCCC2,metabolic dysregulation,fatty acid synthesis,energy metabolism,cellular stress response,tumor progression,protein interaction
ENSG00000078070,MCCC1,metabolic regulation,energy production,tumor suppressor,cellular homeostasis,cell proliferation,signaling pathway modulation
ENSG00000175505,CLCF1,angiogenesis promotion,cancer cell proliferation,cell growth regulation,jak/stat pathway interaction,metastasis enhancement,protein cofactor function
ENSG00000006016,CRLF1,oncogene regulation,inflammation modulation,cell proliferation enhancement,cytokine receptor function,immune response dysregulation,tumor progression contribution
ENSG00000130175,PRKCSH,calcium regulation,cell proliferation,endoplasmic reticulum chaperone,apoptosis resistance,chronic kidney disease,oncogenic driver gene
ENSG00000089597,GANAB,glycosylation regulation,oncogenic signaling,cancer progression,protein modification,cell proliferation,tumor invasion
ENSG00000179218,CALR,cell signaling disruption,protein folding regulation,chaperone activity modulation,cell proliferation promotion,apoptosis inhibition,genomic stability disruption
ENSG00000283777,CANX,er chaperone function,cell growth regulation,apoptosis modulation,upr activation,protein folding regulation,cancer cell survival
ENSG00000182185,RAD51B,genomic instability,homologous recombination repair,tumor suppressor function,dna damage repair,genetic mutations,epigenetic alterations
ENSG00000243678,NME2,dna repair mechanism,oncogenic potential,genomic stability maintenance,cell survival enhancement,tumor progression association,poor prognosis marker
ENSG00000239672,NME1,tumor suppression,cell proliferation inhibition,apoptosis promotion,protein kinase activation,nucleoside diphosphate kinase activity,metabolic regulation
ENSG00000157500,APPL1,regulatory role,pi3k/akt/mtor pathway regulation,tumor suppressor function,constitutive activation,cellular differentiation,apoptosis modulation
ENSG00000187323,DCC,tumor suppressor,loss of function mutations,cell adhesion disruption,metastasis promotion,pi3k/akt pathway regulation,cell migration dysregulation
ENSG00000179222,MAGED1,pi3k/akt signaling,constitutive activation,immune evasion,tumor progression,overexpression,protein-protein interaction
ENSG00000113763,UNC5A,tumor suppressor,apoptosis regulation,angiogenesis modulation,cell cycle regulation,oncogenic process,methylation silencing
ENSG00000221823,PPP3R1,regulation of pp2a activity,p53 binding and regulation,cell cycle control and apoptosis,signaling pathway modulation,tumor suppressor function,genomic stability maintenance
ENSG00000120910,PPP3CC,cancer promoting factor,t-cell activation regulator,cell cycle regulation,apoptosis inhibitor,angiogenesis promoter,protein phosphatase activity
ENSG00000171791,BCL2,anti-apoptotic activity,cell survival promotion,oncogene function,tumor progression facilitation,apoptosis inhibition,genomic instability promotion
ENSG00000002330,BAD,apoptosis regulation,pro-apoptotic function,cell survival modulation,tumor aggressiveness,cell proliferation enhancement,bcl-2 family interaction
ENSG00000030110,BAK1,bak1 downregulation,apoptosis pathway regulation,mitochondrial outer membrane permeabilization,tumor aggressiveness,genomic instability,oncogenesis resistance
ENSG00000172115,CYCS,mitochondrial dysfunction,electron transport chain disruption,glycolysis promotion,metabolic reprogramming,pi3k/akt/mtor activation,therapeutic target
ENSG00000101966,XIAP,apoptosis suppression,oncogene overexpression,hypoxia-inducible factor 1 alpha regulation,transcriptional regulation,caspase inhibition,tumor progression
ENSG00000164305,CASP3,apoptosis regulation,cancer cell survival,tumor microenvironment,immune response modulation,genomic stability maintenance,proteolytic activity
ENSG00000165806,CASP7,apoptosis regulation,tumor growth promotion,oncogenic function,cell proliferation facilitation,dna damage response,therapeutic target
ENSG00000132906,CASP9,apoptosis regulation,dna damage response,cellular survival,proliferation regulation,tumor progression,rna interference
ENSG00000184047,DIABLO,apoptosis regulation,pro-survival function,oncogenic role,iap interaction,pi3k/akt pathway modulation,tumor progression facilitation
ENSG00000169598,DFFB,apoptosis evasion,chromatin compaction,dna degradation,genomic instability,dna repair mechanism disruption,tumor progression
ENSG00000160049,DFFA,apoptosis regulation,dna fragmentation factor,nuclear localization,genomic integrity,cellular apoptosis,proteolytic regulation
ENSG00000114030,KPNA1,nuclear transport,transcription factor binding,cell cycle progression,dna replication,genomic instability,cancer aggressiveness
ENSG00000108424,KPNB1,nuclear transport regulation,apoptosis suppression,p53 interaction,oncogenic protein import,cell cycle progression,genomic instability
ENSG00000180370,PAK2,cell cycle regulation,oncongenic pathway activation,epithelial-to-mesenchymal transition,cell migration and invasion,serine/threonine kinase activity,genomic mutations
ENSG00000071205,ARHGAP10,pi3k/akt pathway regulation,tumor suppression,rho gtpase activation inhibition,cell migration and proliferation regulation,metastasis regulation,gene expression downregulation
ENSG00000137275,RIPK1,ripk1 signaling pathway,apoptosis inhibition,tumor progression promoter,inflammatory response mediator,cell survival regulator,serine/threonine kinase activity
ENSG00000129465,RIPK3,necroptosis,tumor progression,cell survival,apoptosis resistance,therapeutic target,programmed cell death
ENSG00000131979,GCH1,angiogenesis regulation,cell proliferation modulation,dopamine synthesis alteration,iron-sulfur cluster dysregulation,metabolic reprogramming,neurotransmitter biosynthesis involvement
ENSG00000137880,GCHFR,glutathione regulation,constitutive activation,mitochondrial localization,ros modulation,oncogenic signaling,genomic instability
ENSG00000244687,UBE2V1,loss of tumor suppressor function,disrupted protein degradation pathways,tumor suppressor activity,genomic instability,promotes oncogenesis,cell cycle regulation
ENSG00000175104,TRAF6,nf-κb signaling pathway,tumor progression,immune response modulation,cell survival regulation,apoptosis modulation,prognostic marker
ENSG00000134070,IRAK2,nf-κb pathway activation,innate immune regulation,tumor growth promotion,oncogenic signaling modulation,angiogenesis enhancement,immunotherapeutic target
ENSG00000113070,HBEGF,angiogenesis promotion,cell proliferation enhancement,growth factor interaction,metastasis facilitation,tumor progression stimulation,upregulated expression levels
ENSG00000198898,CAPZA2,actin cytoskeleton regulation,cell migration promotion,protein complex component,cancer progression facilitation,cellular trafficking enhancement,metastasis promotion
ENSG00000077549,CAPZB,**

1. **cytoskeleton regulation**,2. **tumor progression**,3. **cell migration and invasion**,4. **epithelial-to-mesenchymal transition (emt)**,5. **actin filament assembly and disassembly**,6. **oncogenic role**

**
ENSG00000177938,CAPZA3,actin filament assembly regulation,cell migration enhancement,tumor progression association,apoptosis inhibition,oncogenic behavior promotion,cytoskeleton dynamics modulation
ENSG00000116489,CAPZA1,actin cytoskeleton regulation,cell migration,tumor progression,metastasis,prognosis predictor,pi3k/akt pathway interaction
ENSG00000114745,GORASP1,oncogene,membrane trafficking regulation,golgi apparatus maintenance,protein sorting disruption,tumor progression driver,cellular proliferation enhancer
ENSG00000167110,GOLGA2,alterations in golgi apparatus,cellular morphology regulation,mitotic process involvement,tumor progression influence,golgin protein function disruption,cell cycle regulation impact
ENSG00000106799,TGFBR1,constitutive activation,cell proliferation,metastasis promotion,tumor progression,epithelial-to-mesenchymal transition (emt),protein kinase regulation
ENSG00000088832,FKBP1A,loss of tumor suppressive functions,dysregulated protein stability,altered nf-κb/stat3 signaling,modulation of p53/brca1 function,enhanced cellular proliferation,regulation of hsp90/cdk interactions
ENSG00000113319,RASGRF2,activation of ras signaling,cell proliferation,dysregulation of cell growth,enhanced angiogenesis,gef function modulation,regulatory interaction with ras protein
ENSG00000058335,RASGRF1,ras signaling pathway,constitutive activation,oncogene overexpression,tumor progression,targeted therapy resistance,cell proliferation regulation
ENSG00000120251,GRIA2,ion channel regulation,neurotransmission modulation,cellular proliferation,tumor progression,synaptic plasticity,genomic instability
ENSG00000155511,GRIA1,oncogenic role,overexpression,cell proliferation,signaling pathway activation,neurotransmission regulation,tumor progression
ENSG00000105397,TYK2,immune evasion,jak-stat pathway activation,tumor growth promotion,metastasis facilitation,cancer immunotherapy resistance,signaling pathway modulation
ENSG00000142166,IFNAR1,altered expression,antitumor immune response disruption,apoptosis inhibition,angiogenesis promotion,tumor progression facilitation,immune evasion mechanism
ENSG00000162851,TFB2M,transcription regulation,dna binding,cell cycle regulation,apoptosis evasion,tumor progression,therapeutic target
ENSG00000099821,POLRMT,mitochondrial transcription,metabolic regulation,glycolytic shift,energy metabolism,transcriptional regulation,cellular respiration
ENSG00000128191,DGCR8,mirna biogenesis regulator,tumor suppressor gene modulation,cell growth promotion,apoptosis suppression,cancer cell survival,microprocessor complex component
ENSG00000113360,DROSHA,mirna biogenesis,tumor suppressor gene regulation,dysregulated expression,poor prognosis,prognostic marker,microprocessor complex
ENSG00000116918,TSNAX,tumor suppressor function,chromatin remodeling,genomic instability,apoptosis regulation,cell cycle control,loss of function mutation
ENSG00000211460,TSN,regulation of gene expression,modulation of microrna,influence on tumor progression,biomarker potential,cell migration and proliferation,prognostic significance
ENSG00000076108,BAZ2A,baz2a overexpression,chromatin remodeling,histone modification,transcriptional regulation,tumor aggressiveness,therapeutic resistance
ENSG00000119772,DNMT3A,dna methylation regulation,constitutive activation,loss or gain of function,genomic instability,tumor progression,therapeutic target
ENSG00000142182,DNMT3L,epigenetic regulation,dna methylation,tumor suppressor gene regulation,oncogene activation,prognostic marker,therapeutic target
ENSG00000088305,DNMT3B,dna methylation regulation,de novo dna methyltransferase,epigenetic regulator,mutation driver,transcriptional silencer,tumor suppressor gene inactivation
ENSG00000055130,CUL1,cellular degradation,regulatory mechanisms,oncogenic driver,tumor progression,protein stabilization,poor prognosis
ENSG00000111530,CAND1,genomic instability,cell cycle regulation,protein degradation pathway,nedd8 dissociation,ubiquitination regulation,cancer biomarker
ENSG00000072274,TFRC,iron regulation,transferrin receptor overexpression,cell proliferation enhancement,tumor progression promotion,biomarker potential,targeted therapy vulnerability
ENSG00000010704,HFE,iron metabolism,genetic alterations,cellular proliferation,tumor progression,signaling pathway interaction,hereditary disease
ENSG00000091513,TF,transcription factor regulation,tumor suppressor dysfunction,cell proliferation enhancement,gene expression modulation,apoptosis resistance,metastatic potential
ENSG00000225312,HSD17B8,steroid hormone regulation,estrogen metabolism,tumor progression,therapeutic target,cell proliferation,hormone-dependent growth
ENSG00000145439,CBR4,chromatin remodeling,tumor progression,apoptosis regulation,cell cycle control,transcriptional regulation,cancer resistance
ENSG00000157456,CCNB2,cell cycle regulation,tumor suppressor loss,anaphase-promoting complex,chromosomal instability,proliferation driver,genomic stability
ENSG00000100241,SBF1,chromatin remodeling,epigenetic regulation,dna repair,genomic stability,angiogenic activity,oncogene
ENSG00000087053,MTMR2,loss of function mutations,tumor suppressor function,pi3k/akt pathway regulation,cellular proliferation,insulin signaling regulation,genomic instability
ENSG00000003987,MTMR7,oncogene,pi3k/akt pathway,genomic instability,dephosphorylation activity,cell growth regulation,apoptosis inhibition
ENSG00000104643,MTMR9,cellular metabolism regulation,dephosphorylation activity,genomic instability contributor,mtor pathway interaction,oncogenic process regulation,phosphatase function
ENSG00000051382,PIK3CB,constitutive activation,gain of function mutations,oncogenic driver,cell signaling regulation,immune response modulation,prognostic biomarker
ENSG00000105647,PIK3R2,pi3k/akt signaling pathway regulation,dysregulated function in cancer,tumor progression contribution,oncogenic pathway modulation,therapeutic target potential,cancer biology mechanism understanding
ENSG00000171608,PIK3CD,pi3k/akt pathway disruption,tumor suppressor function loss,cellular homeostasis disruption,genomic instability,protein-protein interaction regulation,metabolic reprogramming
ENSG00000117461,PIK3R3,cellular signaling regulation,dysregulated pi3k/akt pathway,oncogenic adaptation,genomic alterations,signaling pathway modulation,regulatory subunit function
ENSG00000141506,PIK3R5,pi3k/akt pathway,enhanced cell growth,altered pi3k activity,oncogenic processes,cell survival regulation,genomic instability
ENSG00000105851,PIK3CG,pi3k signaling pathway,g-protein coupled receptor interaction,tumor progression,cell migration,oncogenic driver,genomic mutations
ENSG00000169499,PLEKHA2,pi3k/akt pathway,overexpression,tumor progression,cell proliferation,survival and migration,genomic alterations
ENSG00000163629,PTPN13,tumor suppression,tyrosine phosphatase activity,pi3k/akt pathway regulation,immune modulation,cell migration inhibition,prognostic biomarker
ENSG00000107679,PLEKHA1,cellular adhesion,oncogenic function,signaling pathway regulation,tumor progression,protein-protein interaction,cell migration
ENSG00000139505,MTMR6,mitochondrial function regulation,phosphatidylinositol 3-phosphate modulation,autophagy induction,pi3k/akt pathway impact,cellular metabolism alterations,therapeutic target potential
ENSG00000133812,SBF2,genomic instability,phosphorylation regulation,cell proliferation driver,oncogenic transformation,signaling pathway modulation,therapeutic target
ENSG00000171100,MTM1,pi3k/akt signaling suppression,tumor suppressor function,constitutive activation prevention,cell proliferation inhibition,cell survival regulation,genomic instability prevention
ENSG00000150712,MTMR12,pi3k pathway regulation,phosphoinositide metabolism modulation,oncogenic process promotion,cell proliferation regulation,biomarker for disease progression,poor prognosis indicator
ENSG00000033327,GAB2,pi3k/akt/mtor pathway,scaffolding protein function,tumor progression driver,cell growth regulator,signaling molecule interaction,oncogenic process promoter
ENSG00000150995,ITPR1,**

calcium signaling,oncogenesis,cell proliferation,apoptosis regulation,calcium homeostasis,signaling pathway modulation

**
,MRVI1,pi3k/akt signaling pathway modulation,serine/threonine kinase activity,tumor progression promoter,cell migration regulator,apoptosis inhibitor,mapk/erk signaling activation enhancer
ENSG00000111679,PTPN6,oncogene regulation,tyrosine phosphatase function,tumor suppression,cell signaling inhibition,metastatic potential,tumorigenic pathway modulation
ENSG00000261371,PECAM1,tumor progression,metastasis promotion,cell adhesion disruption,prognostic marker,signaling pathway interaction,angiogenesis regulation
ENSG00000179295,PTPN11,aberrant activation,cell proliferation,enhanced oncogenic signaling,metastasis,pi3k/akt pathway,ras/mapk pathway
ENSG00000160712,IL6R,tumor progression,immune evasion,oncogenic signaling pathway,stat3 activation,angiogenesis promotion,therapeutic target
ENSG00000136244,IL6,stat pathway activation,jak/stat signaling,angiogenesis promotion,tumor progression enhancement,inflammation mediation,growth factor activity
ENSG00000115415,STAT1,transcription factor,tumor suppression,oncogenic processes,apoptosis,cell proliferation,immune response
ENSG00000168610,STAT3,jak/stat pathway,constitutive activation,growth factor signaling,cell survival,tumor progression,immune evasion
ENSG00000128052,KDR,angiogenic signaling pathway,gain of function mutations,tumor progression,cell proliferation,vascular permeability,therapeutic target
ENSG00000113905,HRG,angiogenesis promotion,cell adhesion molecule regulation,tumor progression,therapeutic target,signaling pathway modulation,protein production overexpression
ENSG00000122194,PLG,angiogenesis promotion,metastasis facilitation,tumor progression marker,therapeutic target,cell surface protein,proteolytic function
ENSG00000182718,ANXA2,cell adhesion regulation,tumor progression,membrane trafficking regulation,cytoskeletal organization modulation,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000197747,S100A10,ecm remodeling,angiogenesis promoter,cell migration enhancer,tumor progression facilitator,cancer microenvironment modifier,protein-protein interaction hub
ENSG00000276838,SERPINF2,tumor progression,angiogenesis promotion,gene expression regulation,cell migration enhancement,tumor microenvironment modulation,protease inhibition disruption
ENSG00000122861,PLAU,tumor progression,proteolytic activation,cell invasion and migration,metastasis promotion,extracellular matrix degradation,angiogenesis enhancement
ENSG00000011422,PLAUR,cellular adhesion disruption,tumor progression facilitation,metastatic pathway activation,signaling pathway modulation,poor prognosis association,therapeutic target potential
ENSG00000165240,ATP7A,copper ion transport,tumor progression,antioxidant defense mechanisms,cell signaling modulation,chemoresistance,oxidative stress response
ENSG00000120509,PDZD11,cell adhesion disruption,oncogenic signaling pathway,protein degradation,tumor progression,cell migration enhancement,kinase regulation
ENSG00000103249,CLCN7,pi3k/akt pathway,aberrant expression,ion channel regulation,cell proliferation,oncogenic potential,electrolyte balance
ENSG00000081087,OSTM1,lysosomal dysfunction,oncogenic mutations,autophagy regulation,cancer cell survival,cellular stress response,protein-protein interaction
ENSG00000136810,TXN,thioredoxin function,redox regulation,cancer cell proliferation,tumor progression,antioxidant activity,cell survival regulation
ENSG00000265972,TXNIP,oncogenic function,metabolic reprogramming,thioredoxin inhibition,hypoxic adaptation,cellular stress response,tumor progression
ENSG00000162711,NLRP3,nalp family member,inflammasome activation,caspase recruitment,potentiates oncogenesis,tumor microenvironment modulation,immune evasion
ENSG00000103313,MEFV,pyrin function disruption,inflammatory response regulation,cell survival promotion,cytokine production modulation,apoptosis dysregulation,oncogene overexpression
ENSG00000140368,PSTPIP1,actin regulation,cytoskeleton reorganization,cell migration,signaling pathway interaction,mutation driven oncogenesis,tumor invasiveness
ENSG00000103490,PYCARD,necroptosis,aberrant activation,immune evasion,inflammatory response,tumor progression,cellular stress
ENSG00000135346,CGA,cell adhesion,epithelial-to-mesenchymal transition,immune evasion,metastasis promotion,pi3k/akt pathway regulation,tumor progression
ENSG00000104826,LHB,reproductive hormone regulation,cell signaling pathway alteration,gonadal axis modulation,hormonal influence on cell growth,gene expression regulation,tumor microenvironment interaction
ENSG00000126895,AVPR2,water reabsorption regulation,g protein-coupled receptor,x-linked disorder,kidney function modulation,antidiuretic hormone response,vasopressin signaling pathway
ENSG00000101200,AVP,overexpression,oncogenic potential,angiogenesis promotion,cell proliferation enhancement,signaling pathway activation,prognostic marker
ENSG00000115263,GCG,overexpression,oncogenic processes,tumor progression,cell proliferation,signaling pathway regulation,biomarker potential
ENSG00000215644,GCGR,metabolic regulation,cell proliferation,tumor growth,immune evasion,oncogenic signaling,g-protein coupled receptor activation
ENSG00000122679,RAMP3,adrenomedullin signaling,cellular proliferation,tumor metastasis,growth factor regulation,cancer progression,metastatic potential
ENSG00000004948,CALCR,constitutive activation,wnt/β-catenin pathway,receptor function,calcium metabolism regulation,oncogenic properties,tumor progression
ENSG00000132329,RAMP1,calcium sensing receptor modulation,oncogenic signaling pathway activation,tumor growth promotion,metastasis enhancement,wnt/β-catenin pathway interaction,poor prognosis marker
ENSG00000134200,TSHB,mapk pathway modulation,thyroid hormone regulation disruption,protein kinase activation,cell growth promotion,aggressive tumor behavior marker,poor prognosis indicator
ENSG00000179600,GPHB5,lipid metabolism regulation,cholesterol efflux pathway,cell proliferation enhancement,apoptosis inhibition,tumor progression facilitation,biomarker potential
ENSG00000149735,GPHA2,glypican 4 regulation,pi3k/akt pathway modulation,cell proliferation promotion,tumor progression association,angiogenesis regulation,poor prognosis indicator
ENSG00000064989,CALCRL,cell proliferation,g-protein coupled receptor signaling,calcium signaling pathways,tumor progression,therapeutic target,genomic profiling
ENSG00000131477,RAMP2,calcium-sensing receptor regulation,tumor growth promotion,oncogenic signaling pathway activation,cell proliferation enhancement,signaling complex formation,genetic dysregulation
ENSG00000065325,GLP2R,tumor progression,pi3k/akt/mtor pathway activation,cell proliferation,metastasis,therapeutic target,g protein-coupled receptor signaling
ENSG00000131808,FSHB,tumor microenvironment,secondary effects,cell proliferation,reproductive physiology,protein-coding gene,signaling pathways
ENSG00000138448,ITGAV,tumor progression,cell adhesion,focal adhesions,pi3k/akt pathway interaction,oncogenic role,metastasis facilitation
ENSG00000082781,ITGB5,cell migration,adhesion regulation,metastasis promotion,tumor progression,prognostic marker,gene expression profiling
ENSG00000103496,STX4,membrane fusion regulation,cancer cell proliferation,vesicle transport facilitation,protein-protein interaction,cell migration promotion,tumor aggressiveness
ENSG00000265808,SEC22B,vesicle transport regulation,tumor growth promotion,prognostic marker,poor prognosis association,cell migration facilitation,wnt/beta-catenin interaction
ENSG00000106571,GLI3,hedgehog pathway dysregulation,oncogenic transcription factor,tumor progression regulator,cell growth promoter,invasion and metastasis mediator,therapeutic target
ENSG00000185920,PTCH1,shh signaling pathway,constitutive activation,tumor progression,cell survival and growth,apoptosis regulation,therapeutic target
ENSG00000111087,GLI1,hedgehog signaling activation,transcriptional regulation,oncogenic driver,cell proliferation,tumor progression,coactivator interaction
ENSG00000074047,GLI2,hedgehog signaling,transcriptional regulation,oncogenic function,tumor progression,cell proliferation,therapeutic target
ENSG00000107882,SUFU,hedgehog signaling pathway,tumor suppressor function,loss of heterozygosity,tumor progression,therapeutic target,cell growth regulation
ENSG00000133961,NUMB,cell polarity regulation,notch signaling pathway,tumor suppressor activity,cancer stem cell maintenance,oncogene downregulation,tumorigenesis promotion
ENSG00000078747,ITCH,wnt/β-catenin pathway regulation,e3 ubiquitin ligase activity,protein degradation regulation,tumor suppressor function,cellular homeostasis maintenance,epithelial polarity regulation
ENSG00000011198,ABHD5,tumor progression,lipid metabolism modulation,fatty acid oxidation,metabolic reprogramming,cancer cell energy production regulation,dysregulation and oncogenic functions
ENSG00000166819,PLIN1,lipid metabolism regulation,oncogenic reprogramming,metabolic reprogramming,tumor growth promotion,fatty acid oxidation regulation,lipolysis facilitation
ENSG00000079435,LIPE,lipid metabolism regulation,fatty acid synthesis promotion,oncogenic process modulation,poor prognosis indicator,tumor energy provider,cellular response regulator
ENSG00000170323,FABP4,angiogenesis,tumor progression,lipid metabolism,cell survival,adipocyte differentiation,protein-protein interaction
ENSG00000153822,KCNJ16,cellular ion balance disruption,tumor progression,metabolic regulation,cell growth modulation,protein kinase interaction,transcription factor regulation
ENSG00000157551,KCNJ15,potassium channel activity,tumor progression,metastasis,biomarker,therapeutic target,cellular homeostasis
ENSG00000177807,KCNJ10,cellular homeostasis,potassium ion regulation,tumor suppression,apoptosis modulation,cell proliferation,metabolic regulation
ENSG00000161921,CXCL16,angiogenesis promotion,immune evasion,tumor invasion,tumor progression,cell migration regulation,chemokine signaling pathway
ENSG00000172215,CXCR6,cxcl16 ligand binding,pi3k/akt pathway activation,tumor growth promotion,metastasis facilitation,immune evasion,chemokine receptor function
ENSG00000197405,C5AR1,inflammatory response regulation,complement system activation,constitutive activation,tumor progression,overexpression in tumors,metastasis promotion
ENSG00000106804,C5,complement activation,inflammation mediation,angiogenesis promotion,immune evasion,cell survival enhancement,tumor progression facilitation
ENSG00000006210,CX3CL1,tumor progression,immune response regulation,oncogene potential,angiogenesis facilitation,metastasis promotion,chemokine signaling
ENSG00000168329,CX3CR1,tumor immunosuppression,immune evasion mechanisms,chemokine signaling pathway,myeloid-derived suppressor cells,epithelial-to-mesenchymal transition,immunomodulatory function
ENSG00000179002,TAS1R2,bitter taste receptor function,cellular proliferation regulation,epigenetic modification involvement,genomic instability contribution,tumor progression association,taste signaling pathway interaction
ENSG00000169962,TAS1R3,insulin receptor interaction,glucose metabolism regulation,oncogenic activation,metabolic reprogramming,tumor cell proliferation,cellular energy homeostasis
ENSG00000173662,TAS1R1,tumor progression,oncogenic potential,cell proliferation,metastasis,overexpression,signaling interaction
ENSG00000136928,GABBR2,gaba b receptor regulation,oncogenic pathway activation,metastasis promotion,poor prognosis association,pi3k/akt/mtor pathway modulation,cell proliferation enhancement
ENSG00000204681,GABBR1,gabaergic signaling pathway,downregulation,cellular homeostasis disruption,tumor progression regulation,cell proliferation modulation,apoptosis regulation
ENSG00000243646,IL10RB,inflammation regulation,cell proliferation,tumor growth promotion,immune evasion,cancer progression driver,prognostic marker
ENSG00000104064,GABPB1,transcriptional coactivation,enhancer recruitment,oncogenic signaling,cell growth regulation,protein interaction,gene expression modulation
ENSG00000154727,GABPA,transcriptional regulation,angiogenesis promotion,apoptosis resistance,metastasis enhancement,poor prognosis biomarker,protein-dna interaction
ENSG00000083312,TNPO1,nuclear transport regulation,oncogene stabilization,tumor progression promotion,poor prognosis association,metastasis facilitation,cell cycle regulation disruption
ENSG00000117245,KIF17,microtubule regulation,cell cycle progression,mitotic spindle assembly,cancer cell migration,protein-protein interactions,tumor aggressiveness
ENSG00000243955,GSTA1,detoxification process,antioxidant defense,cellular protection,dna damage response,redox regulation,oncosuppressor
ENSG00000244067,GSTA2,oncogene activity,dna damage repair,electrophilic compound detoxification,cellular oxidative stress modulation,protein-protein interactions,tumor progression
ENSG00000001084,GCLC,glutathione biosynthesis,oxidative stress regulation,antioxidant defense mechanism,redox balance modulation,cancer progression influence,therapeutic target potential
ENSG00000023909,GCLM,glutathione biosynthesis,redox regulation,antioxidant defenses,oxidative stress modulation,cell survival and proliferation enhancement,transcriptional regulation interaction
ENSG00000254647,INS,insulin signaling pathway,aberrant expression,glucose metabolism,cell proliferation,cell survival,pi3k/akt/mtor interaction
ENSG00000171105,INSR,dominant-negative inhibition,insulin-like signaling pathway,cell proliferation regulation,tumor growth promotion,metabolic regulation,structural similarity to insulin receptor
ENSG00000173208,ABCD2,cellular lipid metabolism,lipid transport regulation,oncogene overexpression,tumor progression driver,cellular membrane modulation,genetic alterations
ENSG00000101986,ABCD1,mitochondrial function regulation,tumor suppressor role,apoptosis modulation,cell cycle regulation,prognostic marker,dysregulated expression
ENSG00000117528,ABCD3,transporter function,oncogenic driver,fatty acid transport,cellular proliferation,metabolic regulation,signaling pathway interaction
ENSG00000138075,ABCG5,lipid metabolism regulation,oncogene activation,chemosensitivity modulation,tumor progression enhancement,apoptosis pathway alteration,cellular survival promotion
ENSG00000143921,ABCG8,lipid metabolism regulation,tumor suppression,cholesterol efflux transporter,abc transporters,cellular homeostasis,protein-protein interactions
ENSG00000160716,CHRNB2,nicotinic acetylcholine receptor activation,pi3k/akt pathway,cell survival,cell proliferation,cell migration,gene amplification
ENSG00000101204,CHRNA4,activation of nachr signaling,nicotinic agonist-induced oncogenesis,cell proliferation and survival,angiogenesis and emt,upregulation in cancer tissues,neurotransmission disruption
ENSG00000080644,CHRNA3,nicotinic receptor function,mir-145 target,epithelial-to-mesenchymal transition (emt),cell proliferation regulator,pi3k/akt pathway modulation,cancer metastasis promoter
ENSG00000117971,CHRNB4,ion channel function,cancer susceptibility risk factor,cellular signaling pathway modulation,proliferation regulation,survival pathway activation,nicotinic receptor activity
ENSG00000111206,FOXM1,cell proliferation,transcriptional regulation,constitutive activation,overexpression,cancer driver gene,g2/m checkpoint modulation
ENSG00000166851,PLK1,constitutive activation,cell cycle regulation,mitotic progression,tumor suppressor loss,protein kinase activity,cancer stem cell maintenance
ENSG00000117724,CENPF,genomic instability,prognostic marker,therapeutic target,tumorigenesis,centromere separation,cell cycle disruption
ENSG00000115353,TACR1,oncogene overexpression,cancer cell proliferation,tumor metastasis,neurokinin 1 receptor signaling,mapk/erk pathway activation,cell migration invasion
ENSG00000006128,TAC1,angiogenesis promotion,tumor progression driver,immune suppression,cell migration enhancement,prognostic marker overexpression,neuropeptide precursor function
ENSG00000075073,TACR2,tumor growth promotion,metastatic potential enhancement,angiogenesis stimulation,therapeutic target identification,signaling pathway activation,g-protein coupled receptor function
ENSG00000180914,OXTR,overexpression,cell growth promotion,tumor progression,angiogenesis promotion,signaling pathway activation,dysregulation association
ENSG00000101405,OXT,oxytocin regulation,cancer cell survival,apoptosis evasion,mitotic activity promotion,immunomodulation,tumor progression
ENSG00000147571,CRH,crh/hpa axis regulation,tumor progression,immune response modulation,angiogenesis promotion,metastasis facilitation,therapeutic target
ENSG00000145708,CRHBP,tumor progression,gene regulation,protein-protein interaction,signaling pathway modulation,apoptosis suppression,p53 stabilization
ENSG00000123146,ADGRE5,cell adhesion,epithelial-to-mesenchymal transition,angiogenesis promoter,tumor progression,transmembrane receptor function,signaling pathway regulation
ENSG00000196352,CD55,complement system regulation,tumor progression,cell survival evasion,oncogene function,metastasis promotion,prognostic biomarker
ENSG00000100211,CBY1,tumor suppressor function,chromatin remodeling regulation,gene expression modulation,cell growth inhibition,pi3k/akt signaling pathway interaction,poor prognosis correlation
ENSG00000168036,CTNNB1,wnt signaling pathway,canonical pathway activation,cell proliferation,tumor progression,oncogenic driver,metastasis
ENSG00000178585,CTNNBIP1,wnt/β-catenin signaling inhibition,cell proliferation regulation,protein degradation,substrate for casein kinase 1α,ubiquitin-proteasome pathway involvement,tumor suppressor activity
ENSG00000100888,CHD8,chromatin remodeling,loss of function mutations,oncogene activation,transcriptional dysregulation,tumor metastasis,aberrant cell proliferation
ENSG00000180398,MCFD2,angiogenesis facilitation,oxidative stress resistance,copper-dependent process regulation,therapeutic target,cell proliferation enhancement,metastasis promotion
ENSG00000074695,LMAN1,glycosylation process,oncogenic function,tumor aggression,metastatic potential,biomarker for cancer,cell adhesion regulation
ENSG00000170348,TMED10,cell growth regulation,protein transport regulation,tumorigenesis association,signaling pathway modulation,growth factor interaction,cell proliferation influence
ENSG00000086598,TMED2,**
tmed2's role in er stress response,cell growth promotion,oncogene activation,tumor aggressiveness,protein-protein interaction,endoplasmic reticulum modulation
**
ENSG00000010610,CD4,immune modulation,tumor immunosuppression,regulatory t-cell marker,co-receptor function,antigen presentation,immunological response
ENSG00000182866,LCK,cellular proliferation,constitutive activation,oncogenic potential,signal transduction,tyrosine kinase activity,tumor progression
ENSG00000115839,RAB3GAP1,activation of pi3k/akt pathway,cell signaling modulation,oncogenic driver,cell trafficking regulation,cell proliferation enhancement,protein-protein interaction
ENSG00000118873,RAB3GAP2,constitutive activation,loss-of-function mutation,tumor suppressor,cell proliferation,invasion,metastasis
ENSG00000148053,NTRK2,constitutive activation,cell proliferation,fusion gene,receptor tyrosine kinase,mapk/erk pathway,pi3k/akt signaling
ENSG00000176697,BDNF,tumor progression,immune evasion,metastasis promotion,cell proliferation,angiogenesis regulation,signaling pathway modulation
ENSG00000225950,NTF4,notch signaling pathway,loss of heterozygosity,tumor suppressor function,cell proliferation regulation,apoptosis inhibition,angiogenesis promotion
ENSG00000100385,IL2RB,tumor immune evasion,immune surveillance regulation,il-2 pathway dysregulation,cell proliferation inhibition,gene expression alterations,transmembrane receptor function
ENSG00000162434,JAK1,cellular processes,signaling pathways,oncogenic processes,tumor progression,therapeutic target,kinase activation
ENSG00000105639,JAK3,jak/stat pathway,constitutive activation,gain of function mutations,immune evasion,tumor progression,therapeutic target
ENSG00000147168,IL2RG,t-cell activation,severe combined immunodeficiency,immune deficiency disorder,gamma chain subunit,cytokine receptor signaling,cellular immunity dysfunction
ENSG00000120899,PTK2B,signaling pathway alteration,tumor progression,cell proliferation enhancement,oncogene overexpression,cytoskeletal modulation,protein-protein interaction
ENSG00000105246,EBI3,tumor microenvironment modulation,immune evasion,immunosuppression,potential oncogene,therapeutic target,cancer prognosis
ENSG00000197272,IL27,tumor immunity modulation,immune checkpoint regulation,cytokine production induction,cellular differentiation promotion,apoptosis enhancement,therapeutic target
ENSG00000110400,NECTIN1,cell-to-cell adhesion disruption,immune evasion,tumor aggressiveness,poor prognosis,increased metastasis risk,cell migration regulation
ENSG00000177707,NECTIN3,immunomodulation,cell-to-cell adhesion,metastasis,tumor progression,immune evasion,t-cell activation
ENSG00000143217,NECTIN4,metastasis promoter,cell adhesion molecule,tumor progression marker,oncogenic driver,epithelial-to-mesenchymal transition,angiogenesis regulator
ENSG00000130202,NECTIN2,cell adhesion regulation,oncogenic process enhancement,immunoreceptor signaling facilitation,pi3k/akt pathway activation,tumor progression promotion,poor prognosis marker
ENSG00000073008,PVR,cell adhesion,tumor metastasis,poor prognosis,advanced stage,cell migration,oncogenesis
ENSG00000113302,IL12B,heterodimeric cytokine function,tumor immunosurveillance,immune response modulation,th1 cell proliferation,cancer progression association,downregulated pathway
ENSG00000168811,IL12A,antitumor cytokine,immune evasion,pro-inflammatory cytokine,t cell activation,jak-stat pathway modulation,cancer immune microenvironment regulation
ENSG00000096996,IL12RB1,tumor immunosuppression,immune checkpoint dysfunction,cell proliferation regulation,cytokine production modulation,stat signaling activation,genetic alterations in cancer
ENSG00000081985,IL12RB2,il-12 signaling pathway,constitutive activation,loss of function mutations,tumor immune evasion,immune checkpoint blockade,immunomodulation
ENSG00000096968,JAK2,jak/stat pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000137462,TLR2,tumor-associated inflammation,promotion of oncogenic processes,recognition of pathogen-associated molecular patterns,activation of innate immune responses,regulation of epithelial-to-mesenchymal transition (emt),promotion of angiogenesis and metastasis
ENSG00000174125,TLR1,tumor progression,immune modulation,pro-inflammatory signaling,cell proliferation,cytokine production,immunosuppression
ENSG00000174130,TLR6,immune modulation,innate immunity activation,tumor microenvironment alteration,oncogenic signaling,inflammation promotion,angiogenesis enhancement
ENSG00000168214,RBPJ,notch signaling pathway,chromatin remodeling,constitutive activation,cellular proliferation,tumor progression,transcriptional regulation
ENSG00000100603,SNW1,transcriptional regulation,chromatin modification,cell proliferation,apoptosis regulation,dna repair pathway modulation,tumor suppressor gene suppression
ENSG00000148400,NOTCH1,notch signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell fate decision
ENSG00000100644,HIF1A,oncogenic transcription factor,hypoxia-induced stabilization,angiogenesis promotion,glucose metabolism regulation,cell survival enhancement,tumor growth facilitation
ENSG00000101384,JAG1,notch signaling pathway,overexpression or mutation,cell fate decisions,proliferation promotion,oncogene involvement,tumor progression facilitation
ENSG00000184916,JAG2,notch signaling,oncogenic mutations,tumor progression,cell migration,angiogenesis regulation,genomic amplification
ENSG00000110395,CBL,tumor suppressor function,ubiquitination regulation,cell signaling inhibition,oncogene regulation,metastasis promotion,therapeutic target
ENSG00000149294,NCAM1,tumor progression,metastasis,cell migration,angiogenesis,oncogenic activity,downstream signaling pathways
ENSG00000130287,NCAN,**
adhesion regulation,cell migration facilitation,metastasis promotion,angiogenesis facilitation,pi3k/akt pathway interaction,extracellular matrix modification
ENSG00000134871,COL4A2,cell proliferation regulation,extracellular matrix interaction,tumor progression facilitation,glomerular basement membrane instability,kidney disease association,basement membrane remodeling
ENSG00000187498,COL4A1,tumor progression,metastasis promotion,vascular remodeling,cell adhesion disruption,collagen assembly impairment,angiogenic pathway regulation
ENSG00000206435,HLA-C,antigen presentation,immune evasion,tumor progression,prognostic biomarker,immunosurveillance,genetic alterations
ENSG00000273686,B2M,immune evasion,mhc i downregulation,tumor progression,prognostic marker,cell survival,signaling pathway modulation
ENSG00000274739,KIR2DS5,mhc-i interaction,immune evasion,cell surface receptor,tumor surveillance,natural killer cell activation,killer cell immunoglobulin-like receptor family
ENSG00000011600,TYROBP,tumor microenvironment regulation,immune response modulation,cell survival enhancement,oncogenic process involvement,cell proliferation increase,signaling pathway activation
ENSG00000258227,CLEC5A,tumor growth promotion,immunomodulation,cell surface interaction,dap12 activation,tumor microenvironment suppression,biomarker potential
ENSG00000096264,NCR2,immune activation,cell surface receptor,ifn-gamma/jak/stat pathway,immune evasion,poor prognosis marker,tumor immunity
ENSG00000101307,SIRPB1,immune evasion,pi3k/akt pathway activation,cell surface expression,oncogene overexpression,tumor-promoting interaction,poor prognosis indicator
ENSG00000124731,TREM1,oncogenic function,immune suppression,inflammation promotion,angiogenesis enhancement,tumor growth facilitation,prognostic marker
ENSG00000095970,TREM2,immunomodulation,tumor-associated macrophage polarization,immunosuppressive microenvironment,inflammation regulation,prognostic marker,genetic alterations
ENSG00000186407,CD300E,immune evasion,modulation of nk cells,cytokine regulation,tumor growth,gene upregulation,poor prognosis
ENSG00000178789,CD300LB,tumor-associated antigen,immune checkpoint molecule,immunosuppression,poor prognosis,biomarker potential,therapeutic target
ENSG00000100351,GRAP2,src kinase regulation,oncogenic function,cell proliferation enhancement,tumor metastasis facilitation,gtpase-activating protein activity,chromosomal upregulation
ENSG00000043462,LCP2,transcriptional regulation,chromatin remodeling,oncogene overexpression,tumor progression,histone modification,nucleosome assembly
ENSG00000136158,SPRY2,tumor suppressor function,map kinase pathway inhibition,loss of inhibitory function,cell proliferation enhancement,protein interaction modulation,therapeutic target candidate
ENSG00000153071,DAB2,tumor suppression,rhoa signaling inhibition,hippo pathway regulation,metastasis promotion,epithelial-to-mesenchymal transition,angiogenesis enhancement
ENSG00000081479,LRP2,cellular regulation,tumor suppression,energy metabolism regulation,protein interaction,hypoxia response modulation,cancer progression suppression
ENSG00000124333,VAMP7,autophagy regulation,cell migration,extracellular matrix remodeling,fusion protein interaction,metastasis promotion,pi3k/akt pathway activation
ENSG00000173744,AGFG1,coat complex formation,protein sorting and transport,cargo selection and trafficking,genetic mutations,tumorigenesis promotion,therapeutic target
ENSG00000078053,AMPH,metabolic regulation,tumor progression,protein kinase activation,cellular metabolism,glycolysis regulation,energy stress response
ENSG00000136717,BIN1,pi3k/akt pathway regulation,tumor progression driver,cell survival enhancement,metastasis promotion,overexpression association,biomarker potential
ENSG00000161011,SQSTM1,autophagy regulation,dysregulated expression,prognostic biomarker,oncogene activation,metabolic reprogramming,tumor progression
ENSG00000198909,MAP3K3,mapk pathway dysregulation,oncogenic activation,amplification and overexpression,tumor aggressiveness,proliferation and survival signaling,cell migration and invasion
ENSG00000187840,EIF4EBP1,mtor pathway activation,protein synthesis regulation,tumor progression facilitation,cell survival enhancement,apoptosis resistance,genetic instability promotion
ENSG00000151247,EIF4E,oncogene activation,translation regulation,cell proliferation,cap-binding complex interaction,mrna translational control,tumor progression
ENSG00000134250,NOTCH2,cellular homeostasis disruption,oncogenic signaling activation,tumor growth promotion,cell cycle dysregulation,signaling pathway deregulation,apoptosis inhibition
ENSG00000137496,IL18BP,il-18 regulation,pro-inflammatory cytokine inhibition,tumor immune evasion,angiogenesis suppression,cancer development modulation,immune response regulation
ENSG00000150782,IL18,tumor microenvironment,constitutive activation,pro-inflammatory cytokine,oncogene,angiogenesis promotion,cell proliferation
ENSG00000115604,IL18R1,il-18 signaling pathway,tumor microenvironment modulation,aberrant expression,cell survival promotion,immune evasion,pro-inflammatory response
ENSG00000164136,IL15,jak/stat signaling pathway,angiogenesis promotion,tumor growth enhancement,metastasis facilitation,poor prognosis marker,therapeutic target
ENSG00000134470,IL15RA,il-15 signaling pathway,oncogene activation,tumor progression,cell proliferation,immunomodulation,stat3 activation
ENSG00000126456,IRF3,apoptosis inhibition,tumor suppression,nf-κb pathway interaction,immune regulation,transcriptional activation,antiviral defense
ENSG00000185507,IRF7,type i interferon regulation,tumor immunity modulation,immune checkpoint suppression,pro-inflammatory cytokine production,oncogenic process promotion,therapeutic target identification
ENSG00000005339,CREBBP,transcriptional co-activator,histone modification regulation,oncogenic driver,tumor growth promotion,epigenetic reprogramming,chromatin remodeling
ENSG00000074181,NOTCH3,notch signaling pathway,aberrant expression,cell growth promotion,vascular dysfunction mimicry,tumor cell survival,genomic instability
ENSG00000163435,ELF3,tumor progression,cell cycle regulation,metabolic reprogramming,apoptosis evasion,transcriptional regulation,therapeutic target
ENSG00000018236,CNTN1,high expression levels,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),signaling pathway activation,genetic alterations
ENSG00000110492,MDK,oncogene activity,angiogenesis promotion,cell survival enhancement,metastasis facilitation,pi3k/akt pathway modulation,mapk/erk pathway regulation
ENSG00000198719,DLL1,notch signaling pathway,aberrant expression,cell fate determination,tumor progression,transcriptional regulation,oncogenic driver
ENSG00000065978,YBX1,cellular oncogenesis,multifunctional protein,oncogene activation,transcription regulation,tumor progression,therapeutic target
ENSG00000164683,HEY1,oncogenic transcription factor,epithelial-to-mesenchymal transition,tumor suppressor gene repression,cell proliferation promotion,poor prognosis marker,chromatin remodeling interaction
ENSG00000160973,FOXH1,wnt/β-catenin signaling pathway,transcriptional regulation,cell proliferation,tumor progression,therapeutic target,epithelial-to-mesenchymal transition (emt)
ENSG00000175550,DRAP1,hif-1α inhibition,transcriptional regulation,genomic stability,angiogenesis suppression,tumor suppressor function,dna damage response
ENSG00000064309,CDON,tumor progression,cellular motility,transmembrane glycoprotein,biomarker candidate,adhesion molecule regulation,metastasis promotion
ENSG00000144857,BOC,notch receptor processing,cell survival enhancement,metastasis promotion,tumor progression,cell proliferation activation,regulatory complexity
ENSG00000110944,IL23A,il-23/il-17 axis,cancer-promoting microenvironment,tumor-promoting signals,immune evasion,pro-inflammatory cytokines,angiogenesis
ENSG00000162594,IL23R,immunomodulation,oncogenic signaling,tumor progression,therapeutic target,immune evasion,prognostic marker</end>
ENSG00000138378,STAT4,transcription factor activity,inflammation regulation,tumor progression,cell proliferation,survival signaling,jak/stat pathway interaction
ENSG00000113889,KNG1,angiogenic factor,cell migration promotion,fibrinolysis regulation,protein-protein interaction,tumor progression facilitation,vegf expression modulation
ENSG00000108561,C1QBP,cancer association,cell survival promotion,metastasis facilitation,tumor growth promotion,multifunctional protein,protein-protein interaction
ENSG00000185010,F8,coagulation pathway disruption,tumor microenvironment modulation,metastatic potential,hemostasis regulation,blood vessel interaction,proteolytic activation
ENSG00000110799,VWF,angiogenesis promotion,pro-coagulant activity,platelet aggregation facilitation,tumor growth support,blood vessel formation regulation,endothelial cell interaction
ENSG00000101981,F9,thrombin generation,angiogenesis promotion,tumor progression facilitation,coagulation pathway involvement,blood cell regulation disruption,cancer metastasis enhancement
ENSG00000143278,F13B,angiogenesis promotion,cell migration facilitation,pro-angiogenic factor overexpression,tumor progression enhancement,epithelial-to-mesenchymal transition involvement,gene expression increase
ENSG00000124491,F13A1,tumor progression,genetic instability,angiogenesis promotion,tissue remodeling,immune evasion,coagulation factor activity
ENSG00000115718,PROC,cell growth regulation,tumorigenesis driver,biomarker candidate,therapeutic target,protein processing,oncogenic behavior
ENSG00000101000,PROCR,epcr regulation,pro-coagulant activity,tumor growth promotion,angiogenesis modulation,poor prognosis marker,cell adhesion enhancement
ENSG00000154589,LY96,tumor suppressor function,immune regulation,toll-like receptor signaling,cell survival pathway,prognostic marker,tumor aggressiveness
ENSG00000136869,TLR4,damp recognition,pro-inflammatory cytokine production,immune cell recruitment,oncogene activation,tumor progression,immunotherapy target
ENSG00000163220,S100A9,tumor microenvironment modulation,oncogenic potential,immune system regulation,cell differentiation and proliferation,inflammation promotion,overexpression in cancer
ENSG00000143546,S100A8,calcium-binding protein,tumor progression,cell migration,inflammation regulation,angiogenesis promotion,immune response modulation
ENSG00000130522,JUND,regulation of cell growth,promotion of tumorigenesis,interaction with ap-1 sites,dysregulation in cancer,modulation of gene expression,cellular signal transduction
ENSG00000125740,FOSB,transcription regulation,oncogenic potential,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,signaling pathway interaction
ENSG00000242335,CFB,complement system activation,tumor growth promotion,inflammatory response modulation,immune evasion mechanisms,angiogenesis regulation,biomarker potential
ENSG00000125730,C3,overexpression,complement activation,angiogenesis promotion,tumor progression,poor prognosis,immune evasion
ENSG00000104879,CKM,cellular proliferation,energy metabolism,metabolic regulation,glycolysis promotion,anabolic processes,potential biomarker
ENSG00000166165,CKB,renin-angiotensin system regulation,blood pressure modulation,prognostic marker,tumor growth inhibition,cellular stress response,enzyme-protein interaction
ENSG00000117592,PRDX6,oxidative stress modulation,tumor progression promotion,cell survival enhancement,inflammation regulation,redox balance maintenance,anti-apoptotic activity
ENSG00000084207,GSTP1,gstp1's complex role in cancer,multifunctional enzyme,detoxification mechanism,cell survival pathway,dna repair process,genetic instability modifier
ENSG00000185122,HSF1,heat shock response,cell survival,proliferation promotion,metabolic regulation,angiogenesis promotion,genome stability maintenance
ENSG00000230989,HSBP1,cell cycle regulation,epigenetic modulation,chromatin remodeling complex,transcription factor binding,oncogenic protein expression,cancer progression driver
ENSG00000108953,YWHAE,chromatin remodeling,cell cycle regulation,apoptosis modulation,tumor progression,β-catenin interaction,therapeutic resistance
ENSG00000158941,CCAR2,cell cycle regulation,dysregulated expression,cyclin-dependent kinase interaction,oncogenic role,cell proliferation enhancement,genomic instability
ENSG00000096717,SIRT1,tumor suppressor,cell survival,epigenetic regulation,apoptosis inhibition,therapeutic target,metabolic reprogramming
ENSG00000125968,ID1,inhibitor of dna binding 1,transcriptional regulation,oncogenic potential,cell cycle progression,prognostic marker,immune evasion
ENSG00000157557,ETS2,ets2-mediated transcriptional activation,epithelial-to-mesenchymal transition (emt),amplification and overexpression,cell proliferation regulation,transcription factor activity,hypoxia response modulation
ENSG00000105722,ERF,transcription factor activity,tumor progression,cellular proliferation,oncogenic pathway activation,dna binding,protein-protein interactions
ENSG00000197442,MAP3K5,aberrant activation,apoptosis regulation,cell proliferation,jnk signaling pathway,mitogen-activated protein kinase family,tumor growth and metastasis
ENSG00000147883,CDKN2B,cell cycle regulation,tumor suppressor function,cyclin-dependent kinase inhibition,genomic stability maintenance,oncogenic transformation,pi3k/akt pathway interaction
ENSG00000172216,CEBPB,transcriptional regulation,cell proliferation,apoptosis suppression,tumor progression,oncogene activation,angiogenesis promotion
ENSG00000198178,CLEC4C,immune regulation,oncogenesis,tumor progression,cell proliferation,protein binding,cancer prognosis
ENSG00000158869,FCER1G,immune evasion,angiogenesis,oncogenic potential,tumor microenvironment modulation,pi3k/akt pathway activation,mast cell activation
ENSG00000166523,CLEC4E,immune modulation,tumor progression,pattern recognition receptor,carbohydrate binding,cancer prognosis,promoter of tumor growth
ENSG00000006062,MAP3K14,nf-κb pathway,constitutive activation,serine/threonine kinase activity,tumor progression,cellular proliferation,inflammation and immune responses
ENSG00000213341,CHUK,aberrant activation,cell survival,inflammation regulation,oncogenic driver,tumor progression,nf-κb signaling pathway
ENSG00000077150,NFKB2,nf-κb pathway activation,oncogene potential,tumor progression promotion,angiogenesis induction,metastasis facilitation,chemotherapy resistance
ENSG00000104856,RELB,tumor growth,apoptosis resistance,cell proliferation,dysregulated expression,nf-?b transcription factor,angiogenesis modulation
ENSG00000172175,MALT1,malt1 overexpression,nf-κb activation,apoptosis resistance,cell survival promotion,genomic instability regulation,cancer immunology
ENSG00000064012,CASP8,apoptosis regulation,dysregulation in cancer,extrinsic pathway,caspase activation,tumor progression,cell death evasion
ENSG00000090659,CD209,immune modulation,tumor progression,immunosuppressive microenvironment,cancer-associated gene expression,prognostic marker,signaling pathway regulation
ENSG00000108622,ICAM2,tumor progression,molecular adhesion,cell migration,angiogenesis facilitation,immune evasion,transmembrane protein
ENSG00000075218,GTSE1,cell cycle progression,chromosomal instability,centrosomal regulation,mitotic spindle checkpoint disruption,oncogenic protein interaction,tumor suppressor modulation
ENSG00000117399,CDC20,chromosome separation,cell cycle regulation,oncogenesis,protein interaction,genomic instability,therapeutic target
ENSG00000164109,MAD2L1,mitotic checkpoint regulation,spindle checkpoint activation,genomic instability,cell cycle progression,proliferation promotion,ubiquitin ligase inhibition
ENSG00000136997,MYC,constitutive activation,oncogenic driver,cell cycle regulation,transcriptional regulator,apoptosis inhibition,metabolic reprogramming
ENSG00000123374,CDK2,cyclin-dependent kinase activation,cell proliferation enhancement,uncontrolled mitosis promotion,tumor growth facilitation,cancer cell survival increase,genetic instability induction
ENSG00000105173,CCNE1,ccne1/cdk2 complex,constitutive activation,overexpression or amplification,cell cycle progression,tumor growth and metastasis,protein-protein interactions
ENSG00000112312,GMNN,g2/m phase transition,mitotic regulation,anaphase-promoting complex inhibition,cell proliferation driver,gain-of-function mutations,therapeutic target
ENSG00000167513,CDT1,cell cycle progression,dna replication,genomic instability,oncogenic driver,therapeutic target,cell proliferation
ENSG00000006634,DBF4,chromatin remodeling,cell cycle regulation,histone phosphorylation,dna repair mechanism,genomic stability,transcriptional regulation
ENSG00000097046,CDC7,replication initiation,oncogenic transformation,tumor progression,genomic instability,cell cycle regulation,dna synthesis
ENSG00000133101,CCNA1,cell cycle regulation,overexpression,genetic instability,proliferation promotion,therapeutic target,protein-protein interaction
ENSG00000145386,CCNA2,constitutive overexpression,cell proliferation regulation,oncogenic driver,cell cycle progression,tumor aggression,promoter amplification
ENSG00000139289,PHLDA1,cell cycle regulation,transcriptional repression,tumor suppressor gene,oncogenic pathway inhibition,chromatin remodeling,apoptosis suppression
ENSG00000288307,CTDNEP1,telomere regulation,nucleolar localization,dna damage response,apoptosis suppression,tumor progression driver,genomic instability marker
ENSG00000205423,CNEP1R1,cellular proliferation regulation,oncogene activation,genomic instability contribution,tumor progression association,prognostic biomarker potential,signaling pathway modulation
ENSG00000135476,ESPL1,genomic instability,chromosome condensation,mitotic regulation,tumor suppression,oncogenic mutation,cell cycle control
ENSG00000164611,PTTG1,cell cycle regulation,mitotic spindle checkpoint regulation,chromosome segregation,oncoprotein function,tumor growth promotion,therapeutic target
ENSG00000129933,MAU2,cell cycle regulation,genome stability regulation,tumor suppressor function,ubiquitination regulation,dcaf1 interaction,cancer proliferation
ENSG00000164190,NIPBL,cohesin complex regulation,genome instability,sister chromatid cohesion,cell cycle regulation,chromosome segregation,protein-protein interaction
ENSG00000112029,FBXO5,**

tumor suppressor function,cell cycle regulation,e3 ubiquitin ligase activity,protein degradation,cancer progression inhibition,pi3k/akt pathway interaction

**
ENSG00000073712,FERMT2,cell adhesion modulation,epithelial-to-mesenchymal transition,oncogene overexpression,tumor progression,metastasis regulation,protein-protein interaction
ENSG00000162458,FBLIM1,cell migration,epithelial-to-mesenchymal transition,extracellular matrix regulation,filamin-a binding,tumor metastasis,cell adhesion modulation
ENSG00000150093,ITGB1,oncogenic function,cell adhesion modulation,tumor metastasis facilitation,angiogenesis regulation,poor prognosis marker,signaling pathway interaction
ENSG00000166333,ILK,epithelial-to-mesenchymal transition (emt),oncogenic driver,integrin-linked kinase signaling,cell adhesion disruption,tumor progression and metastasis,pi3k/akt pathway activation
ENSG00000197702,PARVA,cellular adhesion,cancer progression,signaling pathway interaction,protein-protein interaction,tumor aggressiveness,oncogenic role
ENSG00000129675,ARHGEF6,rho gtpase activation,cell migration,tumor progression,cell proliferation,gef activity,signaling pathway regulation
ENSG00000188677,PARVB,heterochromatin formation,chromatin remodeling,tumor suppressor regulation,apoptosis regulation,cell cycle progression,genomic instability
ENSG00000148484,RSU1,alternative splicing,cell proliferation,oncogenic signaling,tumor progression,splicing factor regulation,pi3k/akt pathway interaction
ENSG00000169756,LIMS1,cell migration regulation,tumor progression,metastasis promotion,overexpression association,poor prognosis indicator,protein kinase activation
ENSG00000072110,ACTN1,actin filament regulation,cell adhesion disruption,oncogenic signaling,tumor progression,cell migration facilitation,cytoplasmic reorganization
ENSG00000091409,ITGA6,tumor progression,metastasis,cell adhesion,angiogenesis,extracellular matrix interaction,cancer cell migration
ENSG00000132470,ITGB4,tumor progression,metastasis driver,cell adhesion disruption,epithelial-mesenchymal transition,therapeutic target,prognostic marker
ENSG00000196776,CD47,immune evasion,overexpression,tumor progression,metastasis,therapeutic target,oncogenic function
ENSG00000198053,SIRPA,immune evasion,phagocytosis inhibition,tumor cell survival,prognostic biomarker,signaling pathway modulation,cell proliferation regulation
ENSG00000089012,SIRPG,tumor progression,immune suppression,cell survival,therapeutic target,prognostic marker,epigenetic regulation
ENSG00000161270,NPHS1,**

nephrin dysfunction,podocyte injury,epithelial-to-mesenchymal transition (emt),cell junction disruption,tumor progression,reduced permeability 
**
ENSG00000183853,KIRREL1,cell-cell adhesion disruption,tumor invasion,cell migration enhancement,polarity maintenance failure,epithelial integrity loss,protein-protein interaction dysregulation
ENSG00000118898,PPL,overexpression,tumor progression,cell proliferation,survival signaling,metastasis driver,genomic profiling
ENSG00000167880,EVPL,cell adhesion,tumor progression,molecular interaction,protein overexpression,fibrosis,cancer metastasis
ENSG00000189337,KAZN,transcriptional regulation,cell growth control,anti-apoptotic function,protein-protein interactions,chromatin remodeling complex interaction,zinc finger motif
ENSG00000167754,KLK5,**

* ecm remodeling,cell invasion
* serine protease activity,oncogenic pathways,cell proliferation
* tumor aggressiveness,prognostic marker

*,none
ENSG00000133710,SPINK5,spink5 promotes tumor progression,regulates protease activity,enhances extracellular matrix degradation,inhibits tissue repair processes,upregulation correlates with poor prognosis,modulates cellular invasion and metastasis
ENSG00000186474,KLK12,proteolytic activity,tumor invasion,metastasis driver,stat3 activation,pi3k/akt pathway regulation,ap-1 transcriptional modulation
ENSG00000178172,SPINK6,tumor progression,oncogene,angiogenesis,immune evasion,cell proliferation,proteolytic regulation
ENSG00000167759,KLK13,tumor progression,proteolytic activity,apoptosis regulation,metastasis facilitation,biomarker potential,cancer cell invasion
ENSG00000129437,KLK14,tumor progression,biomarker utility,oncogenic properties,cell cycle regulation,angiogenesis promotion,protease interaction
ENSG00000204909,SPINK9,tumor invasion,inhibition of upa activity,promotion of cell migration,metastatic potential,upregulation in kirc,cellular survival
ENSG00000077782,FGFR1,receptor tyrosine kinase,angiogenesis,cell proliferation,metastasis promotion,epithelial-to-mesenchymal transition (emt),ligand-independent activation
ENSG00000011201,ANOS1,wnt/β-catenin pathway interaction,cellular proliferation enhancement,epithelial-to-mesenchymal transition promotion,tumor suppression inhibition,poor prognosis indicator,glycoprotein secretion regulation
ENSG00000165029,ABCA1,cholesterol efflux regulation,lipid metabolism modulation,tumor aggressiveness enhancement,cellular lipid composition alteration,transcriptional regulation influence,dysregulation association with tumorigenesis
ENSG00000118137,APOA1,altered lipid metabolism,inflammation regulation,cellular differentiation promotion,cholesterol efflux facilitation,tumor growth modulation,poor prognosis marker
ENSG00000132855,ANGPTL3,angiogenesis promoter,lipid metabolism regulation,cell growth facilitation,metabolic reprogramming,tumor progression,oncogenic signaling
ENSG00000130173,ANGPTL8,enhanced fatty acid synthesis,promotes tumor growth,overexpression in tumors,interaction with cancer-related pathways,regulation of lipid metabolism,angiogenesis promotion
ENSG00000126261,UBA2,ubiquitination pathway,protein degradation regulation,tumor progression promotion,aneuploidy induction,genomic instability contribution,cell cycle control dysregulation
ENSG00000142230,SAE1,protein modification,cell cycle regulation,apoptosis inhibition,tumor aggressiveness,poor prognosis marker,therapeutic target
ENSG00000112576,CCND3,g1-s phase transition,cyclin-dependent kinase activation,cell cycle progression,tumor progression,therapeutic target,genetic alterations
ENSG00000069956,MAPK6,cell cycle regulation,tumor growth promotion,apoptosis inhibition,signaling pathway activation,oncogenic transformation,therapeutic target
ENSG00000005884,ITGA3,emt induction,metastasis promotion,cancer cell migration,cell adhesion modulation,tumor progression facilitation,microenvironment interaction
ENSG00000135424,ITGA7,integrin subunit interaction,basement membrane binding,cell adhesion modulation,tumor progression promotion,therapeutic target potential,epithelial-to-mesenchymal transition
ENSG00000164171,ITGA2,integrin subunit alpha 2,cell migration,extracellular matrix interactions,tumor microenvironment modification,cancer cell invasion,promoter of angiogenesis
ENSG00000213949,ITGA1,integrin signaling,cell adhesion,tumor progression,metastatic potential,pi3k/akt pathway,immune evasion
ENSG00000182220,ATP6AP2,altered expression,lysosomal ph regulation,v-atpase complex regulation,oncogenic process promotion,metabolic reprogramming,tumor microenvironment acidification
ENSG00000143839,REN,angiogenesis promotion,cell proliferation enhancement,tumor progression facilitation,prognostic marker upregulation,metastasis modulation via integrins,ras pathway activation
ENSG00000117481,NSUN4,ribosome biogenesis,methyltransferase activity loss,tumor suppression,cellular growth regulation,rna methylation disruption,protein synthesis dysregulation
ENSG00000122085,MTERF4,mitochondrial rna regulation,reactive oxygen species generation,cellular energy metabolism disruption,tumor promoter,apoptosis suppression,gene expression dysregulation
ENSG00000259207,ITGB3,cell adhesion,integrin signaling,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition,angiogenesis regulation
ENSG00000005961,ITGA2B,cell adhesion,integrin signaling,cell migration,extracellular matrix interaction,tumor progression,molecular targeting
ENSG00000130164,LDLR,angiogenesis,cholesterol metabolism regulation,tumor growth promotion,metastasis facilitation,cell survival enhancement,therapeutic target identification
ENSG00000169174,PCSK9,angiogenesis,lipid metabolism,tumor progression,cholesterol regulation,therapeutic target,metastasis facilitation
,TMEM173,tumor suppressor gene,cytosolic dna-sensing machinery,type i interferon production,antitumor immunity,innate immune response,genomic alterations
ENSG00000183735,TBK1,protein kinase activation,inflammatory signaling,cell survival regulation,metabolic modulation,antiviral response initiation,innate immunity regulation
ENSG00000139193,CD27,antigen presentation,t-cell activation,immunosuppression evasion,anti-tumor immune response,prognostic marker,immune checkpoint blockade
ENSG00000125726,CD70,tumor promoter,immune evasion,cell surface molecule,nf-κb activation,t-cell suppression,cancer progression
ENSG00000135960,EDAR,aberrant signaling,cell proliferation,immune response modulation,wnt/β-catenin pathway,cytokine regulation,cell survival
ENSG00000158813,EDA,cell adhesion dysregulation,tumor progression,metastasis promotion,cell migration modulation,cancer aggressiveness enhancement,signaling pathway interaction
ENSG00000131080,EDA2R,enhanced cell adhesion,cellular migration modulation,tumor cell interaction regulation,oncogenic pathway interaction,therapeutic target identification,cellular behavior modification
ENSG00000120337,TNFSF18,apoptosis regulation,immune modulation,tumor progression,biomarker potential,prognostic significance,t cell activation
ENSG00000186891,TNFRSF18,nf-κb pathway activation,gain of function mutations,overexpression in tumors,tumor cell survival,immune suppression,cell proliferation regulation
ENSG00000186827,TNFRSF4,immunosuppressive microenvironment,cell proliferation,survival,angiogenesis,therapeutic target,tumor progression
ENSG00000117586,TNFSF4,tumor growth promotion,immune evasion,metastasis facilitation,signaling pathway modulation,cellular regulation disruption,cancer immunology impact
ENSG00000215788,TNFRSF25,apoptosis regulation,tumor suppressor function,immune response modulation,cell death promotion,cancer immunology relevance,genomic instability
ENSG00000181634,TNFSF15,tumor necrosis factor superfamily,death receptor activation,immune evasion,nf-κb signaling pathway,pi3k/akt pathway regulation,cell proliferation and survival
ENSG00000106952,TNFSF8,cancer-promoting signaling,immune evasion,tumor progression,nf-κb activation,cell proliferation,oncogenic protein expression
ENSG00000120949,TNFRSF8,tumor microenvironment modulation,immunosuppression,cd4+ t-cell suppression,oncogene activation,tumor progression,immune evasion
ENSG00000125657,TNFSF9,tumor suppressor function,immune regulation,apoptosis modulation,cell proliferation,inflammation induction,metastasis promotion
ENSG00000049249,TNFRSF9,immunosuppression,t cell activation,promoter of tumor growth,upregulated in cancer,immune modulation,modulator of anti-tumor response
ENSG00000101213,PTK6,protein-tyrosine kinase activity,tumor progression,metastasis promotion,cell signaling regulation,oncogenic interaction,epithelial-to-mesenchymal transition
ENSG00000121774,KHDRBS1,alternative splicing regulation,tumor progression,oncogenic pathway interaction,splicing factor function,cell growth promotion,metastasis regulation
ENSG00000186635,ARAP1,rho gtpase regulation,cell migration and invasion,tumor suppressor function,pi3k/akt pathway interaction,genetic mutation hotspot,therapeutic target for kirc
ENSG00000142208,AKT1,akt signaling pathway,constitutive activation,gain of function mutations,tumor growth,therapeutic target,genomic profiling
ENSG00000115325,DOK1,apoptosis inhibition,cancer driver mutation,cell proliferation enhancement,cytoplasmic signaling adaptor,metastasis promotion,nf-κb pathway activation
ENSG00000196396,PTPN1,pi3k/akt pathway regulation,phosphatase activity alteration,oncogenic signaling modulation,cell proliferation promotion,metastasis enhancement,tumor progression facilitation
ENSG00000178078,STAP2,pi3k/akt signaling pathway modulation,oncogene overexpression,cell proliferation promotion,signaling pathway activation,immune evasion,gene expression regulation
ENSG00000184557,SOCS3,loss of function mutations,tumor suppressor activity,inflammation regulation,immune response modulation,cell cycle progression,apoptosis promotion
ENSG00000143127,ITGA10,cell migration,adhesion molecule function,tumor progression,metastatic behavior,therapeutic target,signaling pathway regulation
ENSG00000275931,GP6,tumor suppression,cell adhesion regulation,coagulation pathway regulation,thrombomodulin-protein c interaction,cancer association,cell migration modulation
ENSG00000132155,RAF1,constitutive activation,mapk pathway,oncogenic driver,cell growth promotion,tumor progression,therapeutic target
ENSG00000164924,YWHAZ,cellular signaling network,oncogenesis,cell proliferation,apoptosis regulation,protein-protein interaction,tumor suppressor inhibition
ENSG00000162493,PDPN,tumor progression,cell migration,lymphangiogenesis,oncogene activation,pi3k/akt signaling,metastasis promotion
ENSG00000165682,CLEC1B,tumor progression,cell adhesion,immune response modulation,cancer-associated protein,overexpression,metastasis enhancement
ENSG00000197461,PDGFA,angiogenesis,cell proliferation,constitutive activation,mutations leading to oncogenesis,tumor metastasis,cell migration
ENSG00000100311,PDGFB,angiogenesis,cell proliferation,constitutive activation,tumor growth,therapeutic target,genomic amplification
ENSG00000169896,ITGAM,immunosuppressive environment,tumor progression,immune evasion,cell adhesion modulation,gene dysregulation,biomarker value
ENSG00000160255,ITGB2,integrin-mediated adhesion,tumor progression,metastasis promotion,cell adhesion enhancement,signaling pathway activation,gene overexpression
ENSG00000154721,JAM2,angiogenesis promotion,cell adhesion disruption,focal adhesion modulation,tumor invasion facilitation,pro-angiogenic microenvironment,cell migration regulation
ENSG00000166086,JAM3,cell adhesion regulation,emt induction,oncogenic signaling pathway activation,tumor progression,migration and invasion enhancement,lymph node metastasis association
ENSG00000115232,ITGA4,cell adhesion,transmigration facilitation,oncogenic potential,tumor progression,metastatic invasion,epithelial-to-mesenchymal transition
ENSG00000005844,ITGAL,tumor progression,adhesion molecules,cell invasion,angiogenesis,immune evasion,cell signaling pathway
ENSG00000140678,ITGAX,epithelial-to-mesenchymal transition,cell adhesion disruption,signaling pathway activation,tumor progression facilitation,biomarker potential,immune response modulation
ENSG00000117091,CD48,immune modulation,tumor progression,cell activation,proliferation,cancer immune evasion,therapeutic target
ENSG00000122223,CD244,t cell regulation,nk cell activation,immune evasion mechanism,cell proliferation regulation,cancer immune evasion strategy,gene amplification related
ENSG00000116815,CD58,tumor antigen,immune evasion,cell adhesion molecule,tumor progression,therapeutic target,protein-protein interaction
ENSG00000116824,CD2,cd2 overexpression,tumor progression,cell adhesion signaling,immune response modulation,pi3k/akt pathway activation,poor prognosis biomarker
ENSG00000161638,ITGA5,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),metastatic potential,poor prognosis marker,cell migration facilitation,pi3k/akt pathway interaction
ENSG00000160593,JAML,cellular adhesion disruption,immune evasion,tumor metastasis regulation,anti-tumor immunity modulation,leukocyte migration regulation,epithelial-to-mesenchymal transition (emt) influence
ENSG00000154639,CXADR,loss of expression,tumor suppression,cell-cell interactions disruption,angiogenesis enhancement,immune response modulation,biomarker potential
ENSG00000240972,MIF,angiogenesis promotion,apoptosis inhibition,immune microenvironment regulation,proliferation enhancement,prognostic biomarker,tumor progression driver
ENSG00000019582,CD74,antigen presentation,immunosuppression,tumor microenvironment,nf-κb activation,cell proliferation,oncogenic function
ENSG00000120156,TEK,angiogenic factor,oncogene activation,amplification mutation,vegfr2 signaling,tumor microenvironment,endothelial receptor kinase
ENSG00000154188,ANGPT1,angiopoietin-1 signaling pathway,gain of function mutations,tumor angiogenesis,metastatic potential,vascular stability regulation,endothelial cell interaction
ENSG00000091879,ANGPT2,angiogenic signaling,immune evasion,tumor progression,endothelial cell migration,pro-survival pathways,immunosuppression
ENSG00000101280,ANGPT4,pi3k/akt pathway,angiogenesis promotion,tumor progression,vascular remodeling,biomarker candidate,therapeutic target
ENSG00000168918,INPP5D,pi3k/akt signaling pathway regulation,oncogenic potential,tumor progression and metastasis,cell growth and survival modulation,dephosphorylation of phosphatidylinositol 3-phosphate (pi3p),protein interaction with pi3k/akt pathway members
ENSG00000124181,PLCG1,pi3k/akt pathway,cancer progression,oncogenic activity,phospholipase c activation,protein kinase activation,tumor progression
ENSG00000172270,BSG,cell surface protein,oncogene overexpression,tumor progression promoter,metastasis facilitator,poor prognosis marker,cell adhesion regulator
ENSG00000100023,PPIL2,cellular metabolism regulation,protein folding and degradation,promotes cell survival,enhanced protein synthesis,tumor suppressor interaction,mitochondrial function alteration
ENSG00000105974,CAV1,caveolar membrane component,tumor progression,mitochondrial function regulation,cell signaling modulation,vesicular trafficking,angiogenesis promotion
ENSG00000196262,PPIA,protein folding regulation,tumor progression promotion,cancer cell survival enhancement,prognostic biomarker potential,peptidyl-prolyl cis-trans isomerase activity,cell cycle regulation
ENSG00000155465,SLC7A7,metabolic regulation,tumor growth,cellular homeostasis,amino acid transport,glycolysis,glucose metabolism
ENSG00000168003,SLC3A2,altered metabolism,cellular uptake enhancement,oncogene regulation,tumor progression driver,metabolic reprogramming,amino acid transport facilitation
ENSG00000092068,SLC7A8,mtor signaling,amino acid transport,overexpression,cancer proliferation,protein synthesis regulation,poor prognosis marker
ENSG00000021488,SLC7A9,neutral amino acid transport,tumor progression,metastasis,cell proliferation,oncogenic potential,genetic alteration
ENSG00000151012,SLC7A11,metabolic reprogramming,cellular growth promotion,tumor progression driver,therapeutic target,essential amino acid transport,oncogenic process support
ENSG00000103257,SLC7A5,cellular uptake,protein synthesis,cell proliferation,metastasis promotion,oncogenic driver,amino acid metabolism
ENSG00000130876,SLC7A10,glutamine metabolism,tumor growth and proliferation,therapeutic target,metabolic regulation,cellular nutrient uptake,oncogenic signaling pathway interaction
ENSG00000103064,SLC7A6,enhanced amino acid uptake,mtorc1 signaling activation,oncogenic function,cell proliferation,amino acid transporter regulation,tumor progression
ENSG00000136750,GAD2,glycolytic reprogramming,metabolic adaptation,oxidative stress reduction,tumor progression factor,metabolic enzyme regulation,cellular redox balance
ENSG00000128683,GAD1,altered expression,glutamate regulation,neuronal excitability modulation,immune response modulation,therapeutic target,tumor progression association
ENSG00000186090,HTR3D,serotonin receptor signaling,aberrant expression,cell proliferation,mitosis regulation,cellular interaction,ancillary role in tumorigenesis
ENSG00000166736,HTR3A,tumor progression,receptor overexpression,neurotransmission regulation,cell proliferation enhancement,apoptosis inhibition,signaling pathway interaction
ENSG00000186038,HTR3E,serotonin receptor,cell proliferation,tumor progression,cancer prognosis,neurotransmission regulation,upregulated expression
ENSG00000149305,HTR3B,serotonin receptor regulation,oncogenic process involvement,tumor progression facilitation,cellular proliferation modulation,immune microenvironment modulation,neurotransmission regulation
ENSG00000178084,HTR3C,aberrant expression,cell proliferation,immune response modulation,oncogenic processes,signaling pathway regulation,tumor microenvironment modulation
ENSG00000175387,SMAD2,tgf-?-signaling pathway,loss of tumor suppressor function,cell growth regulation,apoptosis modulation,transcriptional regulation,cancer metastasis
ENSG00000177628,GBA,lysosomal dysfunction,cellular homeostasis disruption,toxic substrate accumulation,pi3k/akt pathway activation,oncogenic process promotion,signaling pathway dysregulation
ENSG00000197746,PSAP,cell membrane regulation,biomarker candidate,glycosylphosphatidyl-inositol anchoring,sphingomyelin biosynthesis,prognostic marker,therapeutic target
ENSG00000112799,LY86,disrupted cellular adhesion,mutation-driven tumorigenesis,tumor progression,promotes metastasis,cell-cell interaction regulation,immune response modulation
ENSG00000134061,CD180,tnf receptor superfamily activation,tumor progression promotion,inflammatory response modulation,oncogenic signaling pathway,cell proliferation enhancement,upregulated expression in tumors
ENSG00000118004,COLEC11,cell surface receptor interaction,immune response regulation,tumor progression promotion,metastasis enhancement,apoptosis resistance,altered immune microenvironment
ENSG00000127241,MASP1,complement activation,cell proliferation,signaling pathway regulation,tumor progression,proteolytic activity,apoptosis suppression
ENSG00000169562,GJB1,gap junction disruption,cell migration enhancement,proliferation increase,apoptosis resistance,tumor progression driver,poor prognosis marker
ENSG00000165474,GJB2,gap junction regulation,cellular communication disruption,apoptosis regulation,therapeutic target,pi3k/akt pathway interaction,tumorigenesis promotion
ENSG00000152661,GJA1,connexin 43 expression,gap junction formation,cell proliferation enhancement,tumor progression facilitation,metastasis promotion,chemotherapy resistance development
ENSG00000277401,TJP1,tumor progression,potential oncogene,disrupted tight junctions,cellular adhesion,regulatory protein interactions,wnt/β-catenin signaling pathway
ENSG00000069869,NEDD4,protein ubiquitination,tumor suppression,pi3k/akt pathway regulation,cell proliferation inhibition,apoptosis promotion,therapeutic target
ENSG00000138032,PPM1B,mtor pathway activation,tumor suppression inhibition,cell cycle regulation,pi3k/akt signaling modulation,oncogenic pathway promotion,protein phosphatase function
ENSG00000136068,FLNB,cell adhesion disruption,cytoskeletal reorganization,gain of function mutations,invasion and metastasis,prognostic marker potential,tumor progression
ENSG00000137033,IL33,angiogenesis promotion,cancer progression facilitation,immune modulation,inflammation regulation,interleukin-33 expression,tumor microenvironment modification
ENSG00000115602,IL1RL1,inflammation regulation,tumor progression marker,immune system modulation,signaling pathway activation,adaptor molecule interaction,protein kinase activation
ENSG00000125571,IL37,tumor suppressor function,dual-role cytokine,apoptosis induction,poor prognosis marker,cancer cell growth suppression,immune response modulation
ENSG00000100368,CSF2RB,pi3k/akt signaling,angiogenesis promotion,oncogenic mutation,metastasis driver,immune evasion mechanism,signaling pathway activation
ENSG00000198223,CSF2RA,stat5 activation,il3r subunit,tumor progression,immune evasion mechanisms,receptor tyrosine kinase signaling,granulocyte-macrophage colony-stimulating factor regulation
ENSG00000164400,CSF2,angiogenesis promotion,cell proliferation stimulation,tumor progression facilitation,poor prognosis correlation,oncogene interaction,myeloid cell differentiation
ENSG00000091181,IL5RA,2. tumor growth and metastasis promotion,3. il-5/il5ra signaling pathway activation,4. stat3 regulation and transcriptional control,5. cell survival and proliferation enhancement,6. interaction with pi3k/akt/mtor pathway,7. overexpression in renal clear cell carcinoma
ENSG00000113525,IL5,angiogenesis promotion,anti-tumor immune suppression,cytokine signaling,hematopoiesis regulation,immune cell modulation,tumor growth facilitation
,TEC,oncogenic activation,constitutive phosphorylation,jak/stat pathway activation,enhanced cell survival,tumor progression driver,kinase activity regulation
ENSG00000141968,VAV1,gef activity,cytoskeletal reorganization,cell migration promotion,pi3k/akt pathway interaction,oncogenic transformation,tumor progression
ENSG00000095585,BLNK,blnk overexpression,signaling complex assembly,cell migration promotion,tumor growth enhancement,immunological synapse formation,transcriptional regulation alteration
ENSG00000077238,IL4R,il-4 signaling pathway,pro-tumorigenic effects,tumor progression,metastasis facilitation,anti-inflammatory response modulation,immunosuppression
ENSG00000131724,IL13RA1,il-13/il13ra1 axis,immune evasion,cancer progression,therapeutic target,cell proliferation,signaling pathway
ENSG00000169194,IL13,immunomodulation,angiogenesis,tumor progression,immune evasion,cytokine signaling,oncogenic driver
ENSG00000123496,IL13RA2,immune evasion,tumor progression,cell proliferation,oncogenesis,jak/stat signaling,immune modulation
ENSG00000168685,IL7R,immunosuppressive signaling,stat5 activation,oncogenic proliferation,tumor-associated macrophages,poor prognosis correlation,metastasis facilitation
ENSG00000127616,SMARCA4,swi/snf complex regulation,chromatin remodeling,tumor suppressor function,genome instability,cell cycle dysregulation,cancer susceptibility
ENSG00000185658,BRWD1,oncogenic function,regulation of transcription elongation,cell cycle progression,chromatin remodeling,g2/m phase transition,therapeutic target
ENSG00000164485,IL22RA2,il-22 signaling,dual oncogene/tumor suppressor role,stat3 activation,cell proliferation and survival regulation,tumor progression and metastasis,genomic upregulation
ENSG00000127318,IL22,immune response regulation,tumor progression,cell survival regulation,mutation frequency,genomic instability,immunomodulatory
ENSG00000185436,IFNLR1,loss-of-function mutation,tumor progression inhibition,biomarker potential,immune evasion mechanism,inflammatory response regulation,cell signaling pathway interaction
ENSG00000172349,IL16,tumor progression,immune suppression,apoptosis inhibition,pro-survival gene expression,angiogenesis promotion,biomarker potential
ENSG00000008517,IL32,apoptosis dysregulation,cell migration promotion,immune response modulation,inflammation activation,oncogenesis association,pro-inflammatory cytokine function
ENSG00000196415,PRTN3,tumor progression,metastasis regulation,cell signaling modulation,serine protease activity,cell adhesion disruption,prognostic marker
ENSG00000122025,FLT3,oncogenic activation,receptor tyrosine kinase activity,cell proliferation enhancement,apoptosis resistance,tumor progression facilitation,hematopoietic cell signaling involvement
ENSG00000090554,FLT3LG,angiogenesis promotion,constitutive activation,cytokine signaling pathway,hematopoietic cell differentiation,oncogene overexpression,tumor microenvironment interaction
ENSG00000108342,CSF3,tumor microenvironment modulation,growth factor signaling,immune suppression,myeloid-derived suppressor cells recruitment,cell proliferation enhancement,stat3 pathway activation
ENSG00000119535,CSF3R,constitutive activation,immunosuppressive microenvironment,myeloid cell development,pi3k/akt signaling,tumor associated macrophages,therapeutic target
ENSG00000084652,TXLNA,transcriptional regulation,cell signaling pathway,oncogene activation,tumor progression,cell proliferation enhancement,dna damage response modulation
ENSG00000106089,STX1A,cell proliferation regulation,pi3k/akt signaling modulation,oncogenic mutations,enhanced cell growth,resistance to apoptosis,cancer progression driver
ENSG00000112964,GHR,growth factor signaling,cell proliferation,metabolic regulation,tumor progression,oncogenic potential,signal transduction pathway
ENSG00000113494,PRLR,pi3k/akt pathway activation,constitutive signaling,cell proliferation promotion,tumor progression facilitation,stat5 interaction,mapk/erk pathway activation
ENSG00000131323,TRAF3,tumor suppressor activity,apoptosis regulation,immune response modulation,cell death pathways,ripk1 interaction,ikk interaction
ENSG00000028137,TNFRSF1B,immunomodulation,apoptosis resistance,tumor microenvironment modulation,nf-κb pathway activation,oncogene/tumor suppressor function,angiogenesis regulation
ENSG00000102245,CD40LG,cell activation,immune response regulation,tumor progression,epigenetic silencing,immunosuppression,nf-κb pathway modulation
ENSG00000101017,CD40,oncogenic signaling,cell surface receptor,tnf receptor superfamily member,immune evasion mechanisms,aberrant activation,apoptosis inhibition
ENSG00000159958,TNFRSF13C,cell proliferation,oncogenic process,immune regulation,tumorigenesis,b cell development,baff/april interaction
ENSG00000102524,TNFSF13B,cell proliferation,immune regulation,tumor progression,angiogenesis,metastasis,cancer prognosis
ENSG00000076641,PAG1,gtpase regulation,cell migration,metastasis promotion,tumor invasion,therapeutic target,gef activity
ENSG00000103653,CSK,pi3k/akt pathway modulation,tumor progression,cell signaling regulation,src kinase activation,cell adhesion disruption,metastasis promotion
ENSG00000134242,PTPN22,tumor progression,pi3k/akt signaling,immunosuppressive microenvironment,autoimmune responses,cell survival,immune regulation
ENSG00000213658,LAT,immune modulation,t-cell activation,dysregulated signaling,oncogenesis,pi3k pathway regulation,immune evasion
ENSG00000082074,FYB1,tumor suppressor function,cell proliferation regulation,pi3k/akt pathway modulation,cell signaling disruption,cytoplasmic adaptor protein,aggressive disease phenotype
ENSG00000158092,NCK1,oncogenic signaling,tumor progression,cell migration,metastasis promotion,protein-protein interaction,signal transduction modulation
ENSG00000135341,MAP3K7,nf-κb activation,cancer progression,cell proliferation,apoptosis inhibition,mapk signaling,pro-inflammatory response
ENSG00000055208,TAB2,nf-κb activation,constitutive activation,tumor growth promotion,cell survival enhancement,protein-protein interaction,oncogenic protein interaction
ENSG00000163600,ICOS,immune modulation,tumor-infiltrating lymphocyte response,co-stimulatory molecule,anti-tumor immunity,regulatory t cell modulation,prognostic marker
ENSG00000160223,ICOSLG,t-cell activation,immune checkpoint regulation,oncolytic immune response,immunotherapy target,tumor infiltration,cancer progression
ENSG00000157873,TNFRSF14,tumor progression,aberrant expression,cell survival,immune evasion,pro-invasive properties,cytokine regulation
ENSG00000186265,BTLA,immune modulation,t-cell suppression,hvem interaction,tumor immunosurveillance,oncogenesis,regulatory receptor
ENSG00000121594,CD80,tumor immune evasion,co-stimulatory signals,immune tolerance,t-cell activation,cancer cell surface expression,immune regulation
ENSG00000178562,CD28,cell surface receptor,t-cell activation,immune system regulation,adaptive immunity,costimulatory signaling,molecular interaction
ENSG00000114013,CD86,cd28 signaling pathway,immune checkpoint regulation,t-cell activation,antigen presentation,immunogenicity modulation,immune evasion mechanism
ENSG00000100906,NFKBIA,nf-kappa b signaling,constitutive activation,gain of function mutations,tumor progression,immune suppression,loss of heterozygosity
ENSG00000141367,CLTC,clathrin assembly,cell proliferation,oncogenic signaling,pi3k/akt pathway activation,endocytic machinery regulation,tumor adaptation
ENSG00000122705,CLTA,tumor progression,cell adhesion disruption,glycoprotein interaction,metastasis facilitation,pi3k/akt pathway modulation,cancer cell migration
ENSG00000242574,HLA-DMB,antigen presentation,major histocompatibility complex,peptide processing,immune modulation,tumor progression,protein-protein interaction
ENSG00000204257,HLA-DMA,immunomodulation,tumor antigen presentation,antigen-presenting cells,immune surveillance evasion,cancer cell surface expression,tumor progression regulation
ENSG00000153283,CD96,immune evasion,metastatic progression,tumor cell adhesion,cell activation,protein overexpression,tumor-promoting molecule
ENSG00000139626,ITGB7,angiogenesis promotion,cell adhesion dysregulation,immune evasion mechanism,integrin function modulation,metastasis facilitation,tumor progression driver
ENSG00000206493,HLA-E,immunosuppression,antigen presentation,nk cell evasion,tumor progression,mhc class i expression,immune surveillance
ENSG00000039068,CDH1,loss-of-function mutations,epigenetic silencing,cell-cell adhesion disruption,metastasis promotion,adherens junction complex,epithelial-to-mesenchymal transition
ENSG00000139187,KLRG1,tumor evasion,immune suppression,cancer immunology,therapeutic target,immune checkpoint modulation,evasion from immune surveillance
ENSG00000150637,CD226,tumor-associated immune responses,immunosurveillance,cell adhesion,immune checkpoint modulation,cancer immunotherapy,prognostic marker
ENSG00000091972,CD200,immunosuppressive function,tumor evasion,pro-inflammatory cytokine inhibition,immunoregulation,myeloid cell modulation,cancer progression marker
ENSG00000163606,CD200R1,immune evasion,tumor microenvironment modulation,macrophage regulation,cancer progression,prognostic marker,therapeutic target
ENSG00000235346,HLA-G,immune modulation,nk cell suppression,tumor immune evasion,oncogenic protein expression,angiogenesis promotion,pro-survival gene regulation
ENSG00000275583,KIR2DS2,immune evasion,tumor immunosuppression,nk cell suppression,killer-cell receptor function,immunoregulation,tumor immune microenvironment
ENSG00000069493,CLEC2D,immune evasion,protein-carbohydrate interaction,cell surface recognition,inflammation regulation,antigen presentation,tumor growth promotion
ENSG00000111796,KLRB1,immune regulation,leukocyte adhesion,tumor-infiltrating lymphocytes,tumor microenvironment modulation,cancer immunity,gene expression alteration
ENSG00000158125,XDH,purine metabolism,tumor growth,angiogenesis,cell survival,dysregulation,genomic instability
ENSG00000124557,BTN1A1,nf-κb pathway activation,transcriptional regulation,protein-protein interaction,nuclear localization signal,cell survival promotion,genomic amplification
ENSG00000115221,ITGB6,tumor progression,cell adhesion,metastasis induction,prognostic biomarker,therapeutic target,cancer cell migration
ENSG00000105329,TGFB1,epithelial-to-mesenchymal transition (emt),metastasis promotion,dual role in cancer,tumor progression enhancement,immunosuppression induction,cell growth inhibition
ENSG00000090006,LTBP4,aberrant tgf-β signaling,extracellular matrix remodeling,enhanced cell migration,increased protease production,immune response modulation,epithelial-to-mesenchymal transition
ENSG00000077943,ITGA8,angiogenesis promotion,cell migration facilitation,extracellular matrix degradation,hypoxia adaptation,integrin signaling pathway,tumor progression regulation
ENSG00000105855,ITGB8,angiogenic signaling,tumor progression,metastasis facilitation,cell migration enhancement,extracellular matrix interaction,vegf receptor binding
ENSG00000064692,SNCAIP,tumor progression,overexpressed in cancer,cell growth regulation,signaling pathway modulation,therapeutic target,synaptic vesicle endocytosis
ENSG00000185345,PRKN,mitochondrial quality control,apoptosis modulation,autophagy regulation,cell survival pathway,tumor suppressor function,therapeutic target
ENSG00000145335,SNCA,oncogenic driver,pi3k/akt/mtor pathway interaction,cell survival and proliferation,epithelial-to-mesenchymal transition (emt),microrna regulation,neurotransmitter delivery
ENSG00000124486,USP9X,cancer driver,oncogene,stabilization of c-myc,pi3k/akt pathway regulation,protein degradation,cell cycle regulation
ENSG00000137642,SORL1,tumor progression,endosomal sorting,oncogenic protein regulation,pi3k/akt pathway modulation,cellular proliferation enhancement,protein kinase activation
ENSG00000142192,APP,oncogenic activity,overexpression,cell proliferation,tumor progression,therapeutic target,signaling pathway interaction
ENSG00000145782,ATG12,autophagy regulation,constitutive activation,protein modification,cellular adaptation,tumor progression,potential therapeutic target
ENSG00000197548,ATG7,autophagy modulation,protein degradation pathway,cellular stress response,oncogenic potential,ubiquitin-proteasome pathway,cell survival promotion
ENSG00000152348,ATG10,autophagosome formation,tumor progression,autophagy regulation,cell survival,genomic instability,protein-protein interaction
ENSG00000057663,ATG5,autophagy dysfunction,tumor progression,cellular degradation,protein recycling,genomic instability,cellular homeostasis
ENSG00000176194,CIDEA,mitochondrial regulation,tumor aggressiveness,loss of function mutations,lipid metabolism disruption,oncogenic interactions,prognostic significance
ENSG00000187288,CIDEC,lipid metabolism,tumor progression,autophagy regulation,oncogenic signaling pathway,cell proliferation,therapeutic target
ENSG00000113721,PDGFRB,stat3 pathway activation,receptor tyrosine kinase activity,angiogenesis promotion,akt/mapk signaling enhancement,vegf upregulation,proliferation and survival promotion
ENSG00000134853,PDGFRA,pi3k/akt pathway activation,gene amplification,tyrosine kinase receptor function,cell proliferation enhancement,tumor progression,metastasis facilitation
ENSG00000163513,TGFBR2,loss-of-function mutations,tumor progression,cellular differentiation,apoptosis suppression,tgf-β pathway dysregulation,therapeutic target
ENSG00000166913,YWHAB,protein-protein interaction,apoptosis regulation,cell cycle progression,oncogenic function,tumor aggressiveness,cancer cell survival
ENSG00000126934,MAP2K2,mapk pathway activation,constitutive activation,oncogenic transformation,cell proliferation,therapeutic target,genomic alterations
ENSG00000169032,MAP2K1,aberrant signaling,constitutive activation,gain of function mutations,oncogenic transformation,raf/mek/erk pathway,therapeutic target
ENSG00000141068,KSR1,mapk signaling pathway activation,scaffolding protein function,raf kinase interaction,tumor progression,oncogenic driver,therapeutic target
ENSG00000075413,MARK3,microtubule regulation,oncogenic process,cell proliferation,survival pathway,metastasis driver,prognostic marker
ENSG00000136807,CDK9,transcriptional regulation,proliferation,apoptosis resistance,oncogenic gene expression,tumor progression,therapeutic target
ENSG00000129315,CCNT1,transcriptional regulation,cell cycle progression,oncogenic transformation,tumor progression,metastasis driver,transcription elongation
ENSG00000165898,ISCA2,mitochondrial biogenesis,electron transport chain dysfunction,reactive oxygen species production,cellular metabolism alteration,tumor progression driver,genomic instability inducer
ENSG00000135070,ISCA1,iron-sulfur cluster biogenesis,tumor progression,cancer aggressiveness,therapeutic target,cellular metabolism regulation,genomic instability
ENSG00000160703,NLRX1,tumor suppressor function,loss of expression,inhibited cell death,nf-κb pathway inhibition,apoptosis regulation,metabolic reprogramming
ENSG00000088888,MAVS,innate immune regulation,tumor suppressor function,cell death pathway modulation,antiviral signaling disruption,oncogenic pathway inhibition,apoptosis regulation
ENSG00000169855,ROBO1,slit/robo signaling,cell adhesion inhibition,tumor suppression loss,metastasis promotion,angiogenesis facilitation,pi3k/akt pathway interaction
ENSG00000145147,SLIT2,tumor suppression,cell proliferation inhibition,apoptosis promotion,epithelial maintenance,guidance cue regulation,signaling pathway modulation
ENSG00000185652,NTF3,transcriptional regulation,oncogenic function,cell proliferation,epithelial-to-mesenchymal transition (emt),transcription factor activity,cellular migration
ENSG00000179841,AKAP5,cellular signaling regulation,oncogenic transformation,apoptosis inhibition,transcriptional control,tumor progression,signaling pathway modulation
ENSG00000154134,ROBO3,tumor suppressor,rho gtpase signaling pathway inhibition,epithelial-to-mesenchymal transition regulation,cell migration suppression,angiogenesis regulation,prognostic significance
ENSG00000000971,CFH,complement system regulation,tumor progression facilitation,immune evasion enhancement,cell adhesion regulation,endothelial function modulation,inflammation response dysregulation
ENSG00000177455,CD19,b cell development,transmembrane glycoprotein,immune system activation,b cell receptor signaling,adaptor protein recruitment,cancer immunotherapy target
ENSG00000110651,CD81,epithelial-to-mesenchymal transition,overexpression,cell adhesion modulation,pi3k/akt pathway regulation,immune evasion facilitation,tumor growth promotion
ENSG00000149131,SERPING1,complement regulation,cancer progression,tumor suppressor function,immune response dysregulation,cellular process disruption,genetic mutations associated
ENSG00000182326,C1S,classical pathway activation,cell survival enhancement,complement system dysregulation,protein-protein interaction,tumor progression promotion,wound healing regulation
ENSG00000288512,C1R,classical pathway,immune evasion,complement system dysregulation,tumor growth promotion,immunoregulatory functions,cellular interaction
ENSG00000178772,CPN2,proteolytic regulation,cellular signaling pathway,aggressive disease course,poor prognosis,tumor progression,oncogenic processes
ENSG00000120054,CPN1,renin-angiotensin system regulation,peptide degradation activity,tumor growth promotion,biomarker potential,cancer cell interaction,metastasis facilitation
ENSG00000198910,L1CAM,cell migration,tumor progression,epithelial-to-mesenchymal transition,transmembrane glycoprotein,cell adhesion molecule,poor prognosis marker
ENSG00000099250,NRP1,angiogenesis promotion,vegf co-receptor,growth factor interaction,tumor microenvironment,poor prognosis marker,signaling pathway activation
ENSG00000144668,ITGA9,cell adhesion,metastasis promotion,epithelial-to-mesenchymal transition,tumor progression,signaling pathway modulation,therapeutic target
ENSG00000102882,MAPK3,enhanced cell growth,aberrant activation,cell cycle regulation,oncogenic processes,transcription factor activation,metastasis promotion
ENSG00000100030,MAPK1,ras/raf/mek/mapk signaling pathway,constitutive activation,gain of function mutations,therapeutic target,genomic amplification,cell proliferation
ENSG00000039537,C6,cellular signaling,transcriptional regulation,cell growth,chromatin remodeling,tumor progression,cell survival
ENSG00000179115,FARSA,p53 regulation,dna repair,cell proliferation,genomic instability,tumor suppressor activity,oncogenic function
ENSG00000116120,FARSB,mitochondrial dysfunction,dna damage,apoptosis modulation,cell survival enhancement,cancer progression driver,genetic instability
ENSG00000244734,HBB,energy metabolism disruption,cellular proliferation alteration,tumor growth influence,cancer susceptibility association,dna repair interaction,hemoglobin dysfunction
ENSG00000206172,HBA1,hypoxia regulation,globin protein regulation,cellular respiration,tumor adaptation,oxygen homeostasis maintenance,protein interaction
ENSG00000188536,HBA2,tumor metabolism,cell proliferation,hypoxia adaptation,angiogenesis,oxygen transport regulation,globin subunit function
ENSG00000108854,SMURF2,pi3k/akt/mtor pathway,oncogene function,ubiquitination and protein degradation,tumor progression and metastasis,cellular growth and survival regulation,ring-type e3 ubiquitin ligase activity
ENSG00000284126,SMURF1,tumor suppression,pi3k/akt pathway regulation,protein degradation,cell adhesion modulation,oncogenic substrate regulation,cancer progression modulation
ENSG00000049759,NEDD4L,tumor suppressor,protein degradation,signaling pathway regulation,cell proliferation inhibition,angiogenesis suppression,genomic stability maintenance
ENSG00000103266,STUB1,apoptosis regulation,oncogenic protein stabilization,protein degradation,tumor suppressor inhibition,cell survival enhancement,signaling pathway modulation
ENSG00000130725,UBE2M,protein degradation pathway,tumor progression,dna damage response,cell cycle regulation,oncogenic process,therapeutic target
ENSG00000285246,NEDD8,protein degradation regulation,cell cycle modulation,oncogenic process enhancement,ubiquitin-like protein function,tumor suppressor degradation,cancer aggressiveness promotion
ENSG00000155827,RNF20,histone modification regulation,oncogenic role,cell growth promotion,tumor progression marker,pi3k/akt pathway activation,epigenetic regulator
ENSG00000103549,RNF40,ubiquitin ligase activity,tumor suppressor degradation,protein degradation regulation,oncogenic pathway activation,cell cycle progression,transcriptional regulation
ENSG00000111816,FRK,oncogene overexpression,cell migration,pi3k/akt pathway interaction,emt regulation,therapeutic target,resistance to chemotherapy
ENSG00000233948,TRIM27,tumor suppression,regulates cell cycle progression,interaction with p53,protein degradation regulation,apoptosis modulation,ubiquitination pathway
ENSG00000137809,ITGA11,basal lamina interaction,cell migration facilitation,epigenetic regulation,integrin signaling pathway modulation,oncogene overexpression,tumor progression enhancement
ENSG00000156886,ITGAD,tumor progression,cell adhesion,immune modulation,biomarker potential,prognostic significance,t-cell activation
ENSG00000083457,ITGAE,tumor metastasis,cell adhesion,loss of epithelial integrity,gain of function mutations,cell migration,epithelial-mesenchymal transition
ENSG00000142798,HSPG2,angiogenesis promotion,extracellular matrix modulation,basement membrane formation,cell adhesion regulation,tumor growth facilitation,prognostic marker
ENSG00000288299,LDHA,glycolytic shift,tumor aggressiveness,energy metabolism regulation,cell proliferation enhancement,hypoxia adaptation mechanism,metabolic reprogramming
ENSG00000111716,LDHB,metabolic reprogramming,tumor glycolysis,energy metabolism,warburg effect,cellular proliferation,hypoxic response
ENSG00000163541,SUCLG1,mitochondrial function,apoptosis regulation,cancer metabolism,cell proliferation,tumor progression,therapeutic target
ENSG00000172340,SUCLG2,mitochondrial enzyme function,increased energy metabolism,glycolytic adaptation,tumor growth promotion,cellular respiration regulation,oncogenic reprogramming
ENSG00000136143,SUCLA2,energy metabolism regulation,gene amplification,tumor growth promotion,cellular homeostasis disruption,oncogenic process activation,metabolic adaptation
ENSG00000102265,TIMP1,regulation of matrix metalloproteinases,promotion of angiogenesis,suppression of apoptosis,epithelial-to-mesenchymal transition (emt),interaction with pi3k/akt pathway,prognostic marker for poor outcome
ENSG00000100985,MMP9,matrix remodeling,tumor progression,cell migration,angiogenesis,apoptosis inhibition,proteolytic activity
ENSG00000157227,MMP14,tumor progression,cellular invasion,proteolytic activity,metastasis promoter,therapeutic target,angiogenesis regulation
ENSG00000035862,TIMP2,matrix degradation inhibitor,tumor suppressor function,cell invasion restriction,s100a4 binding,tissue integrity maintenance,mmp-14 interaction
ENSG00000102054,RBBP7,chromatin remodeling,transcriptional regulation,tumor suppressor function,dna repair,cell cycle progression,apoptosis modulation
ENSG00000128708,HAT1,epigenetic regulation,chromatin structure modification,tumor suppressor regulation,oncogenic process promotion,cell cycle progression disruption,genomic stability maintenance impairment
ENSG00000135903,PAX3,proliferation promotion,emt regulation,transcriptional regulation,cell survival enhancement,oncogenic involvement,wnt/β-catenin pathway interaction
ENSG00000084676,NCOA1,nuclear receptor interaction,coactivator function,cell proliferation,oncogene activation,chromatin remodeling,tumor progression
ENSG00000163930,BAP1,dna repair pathway disruption,genomic instability,tumor suppressor loss-of-function,chromosomal alterations,oncogenic signaling activation,cell proliferation enhancement
ENSG00000172534,HCFC1,hypoxia response,transcriptional regulation,angiogenesis facilitation,metabolic reprogramming,tumor growth promotion,oncogenic adaptation
ENSG00000100324,TAB1,nf-κb activation,transcriptional coactivator activity,oncogenic signaling,cell proliferation regulation,inflammation modulation,apoptosis suppression
ENSG00000145604,SKP2,cell cycle regulation,ubiquitin ligase complex,proliferation promotion,protein degradation pathway,tumor growth facilitation,cancer development association
ENSG00000070010,UFD1,proteasome regulation,cellular degradation,tumor progression,therapeutic target,oncogenic pathway interaction,genomic instability
ENSG00000165280,VCP,genomic instability,cell cycle regulation,dna repair dysfunction,tumor progression,oncogenic pathway activation,ubiquitin-proteasome system dysregulation
ENSG00000180667,YOD1,protein deubiquitination,cell cycle progression,dna repair regulation,oncogenic potential,aggressive tumor behavior,therapeutic target
ENSG00000019995,ZRANB1,swi/snf complex,chromatin remodeling,tumor suppressor function,genomic instability,cell cycle regulation,dna repair mechanism
ENSG00000134982,APC,wnt signaling pathway,loss-of-function mutations,beta-catenin stabilization,tumor suppressor gene,cell adhesion disruption,epithelial-to-mesenchymal transition
ENSG00000066427,ATXN3,tumor progression,pi3k/akt signaling pathway activation,transcriptional regulation dysfunction,histone acetylation and chromatin remodeling,cell survival and proliferation enhancement,oncogene overexpression
ENSG00000124356,STAMBP,protein degradation regulation,tumor suppressor activity,cell proliferation regulation,anti-apoptotic pathway regulation,substrate recognition complex formation,ubiquitination mechanism modulation
ENSG00000136738,STAM,oncogenic role,endocytic vesicle regulation,pi3k/akt signaling modulation,tumor growth promotion,cell migration facilitation,protein interaction network participation
ENSG00000140538,NTRK3,constitutive activation,tumor progression,therapeutic target,fusion protein formation,cell survival promotion,kinase activation
ENSG00000105426,PTPRS,cellular signaling regulation,tumor progression promotion,oncogene interaction,pi3k/akt pathway modulation,tyrosine phosphatase activity,metastasis facilitation
ENSG00000106366,SERPINE1,tumor progression,angiogenesis promotion,oncogenic function,cell migration regulation,apoptosis suppression,metastasis facilitation
ENSG00000109072,VTN,tumor progression,cell adhesion,integrin interaction,angiogenesis facilitation,metastasis promotion,therapeutic target
ENSG00000173402,DAG1,lipid metabolism regulation,dysregulated expression,oncogenic potential,cellular signaling modulation,protein kinase c activation,altered cellular metabolism
ENSG00000188157,AGRN,tumor progression,angiogenesis,aggressive disease characteristics,prognostic marker,cell adhesion and migration,basement membrane structure
ENSG00000142867,BCL10,nf-κb signaling,overexpression,tumor progression,cell survival,epithelial-to-mesenchymal transition (emt),poor prognosis
ENSG00000187122,SLIT1,tumor suppressor,epigenetic silencing,vegf pathway regulation,cell migration inhibition,angiogenesis suppression,metastasis prevention
ENSG00000188559,RALGAPA2,ras gtpase-activating protein interaction,overexpression,ras/raf/mek/erk signaling pathway activation,microtubule dynamics regulation,cell cycle progression modulation,tumor growth promotion
ENSG00000170471,RALGAPB,rap protein regulation,gtpase activity modulation,cell proliferation promotion,oncogenic role in ccrcc,overexpression association,signaling pathway alteration
ENSG00000173230,GOLGB1,golgi apparatus modification,oncogene activation,cellular proliferation,metastasis promotion,cell cycle regulation,epigenetic modulation
ENSG00000182827,ACBD3,phospholipid regulation,mitochondrial function,oncogene potential,pi3k/akt/mtor pathway modulation,lipid metabolism dysregulation,protein-protein interaction alteration
ENSG00000100099,HPS4,autophagy regulation,lysosome biogenesis disruption,melanosome degradation,cellular stress response disruption,oncogene dysregulation,tumor suppressor loss
ENSG00000107521,HPS1,hermansky-pudlak syndrome,lysosome-related organelles,melanin production regulation,cell proliferation enhancement,oncogenesis involvement,genetic mutations association
ENSG00000163083,INHBB,cell cycle regulation,apoptosis modulation,tumor suppressor function,pi3k/akt pathway interaction,p53 interaction,cancer progression regulation
ENSG00000122641,INHBA,tgf-β signaling pathway,epithelial-to-mesenchymal transition,oncogenesis,cell proliferation,protein-protein interactions,gene expression regulation
ENSG00000108950,FAM20A,pi3k/akt/mtor pathway,tumor progression,biomarker,gene expression,cell proliferation,kinase activity
ENSG00000177706,FAM20C,cellular reprogramming,glycolytic reprogramming,pi3k/akt pathway modulation,calcium and phosphate homeostasis regulation,cell growth promotion,metabolic rewiring
ENSG00000143799,PARP1,dna damage response,synthetic lethality,homologous recombination repair,base excision repair pathway,tumor progression,therapeutic target
ENSG00000002016,RAD52,genomic instability,homologous recombination repair,dna damage tolerance,chromosomal rearrangements,genomic instability,therapeutic target
ENSG00000163961,RNF168,genomic instability,homologous recombination repair,chromatin remodeling,tumor progression,dna damage response,fanconi anemia pathway
ENSG00000067066,SP100,transcriptional regulation,apoptosis modulation,gene expression regulation,cell proliferation enhancement,cell survival promotion,oncomodulation
ENSG00000139372,TDG,dna repair mechanism,genomic instability,oxidative stress,base excision repair,therapeutic target,genetic alterations
ENSG00000165392,WRN,genomic instability,cell proliferation,replication stress resolution,dna damage response modulation,tumor progression,genetic instability
ENSG00000154767,XPC,dna repair mechanism,cellular susceptibility,genetic instability,tumor aggressiveness,apoptosis modulation,tumorigenesis promotion
ENSG00000187098,MITF,tumor progression,oncogene activation,cellular proliferation,apoptosis inhibition,hypoxia-regulated gene expression,angiogenesis promotion
ENSG00000172845,SP3,tumor progression,transcriptional regulation,angiogenesis promoter,cell proliferation,oncogenic processes,gene expression modulation
ENSG00000067369,TP53BP1,genomic instability,dna repair impairment,homologous recombination,tumor suppressor function,cancer progression,poor prognosis
ENSG00000147889,CDKN2A,p16 inhibitor,tumor suppressor function,cell cycle progression inhibition,dna damage response,genome instability prevention,cell proliferation regulation
ENSG00000177374,HIC1,transcriptional regulation,tumor suppressor function,genomic instability,apoptosis regulation,cancer progression,silencing oncogenes
ENSG00000183770,FOXL2,transcription factor regulation,oncogene overexpression,cell proliferation promotion,apoptosis inhibition,angiogenesis enhancement,wnt/β-catenin pathway interaction
ENSG00000100201,DDX17,rna helicase activity,tumor progression,multifunctional enzyme,gene regulation,rna binding protein interaction,cell migration promotion
ENSG00000182568,SATB1,satb1 overexpression,chromatin remodeling,cell proliferation regulation,tumor progression promotion,metastasis enhancement,genomic instability
ENSG00000178691,SUZ12,epigenetic regulation,histone methylation,cell proliferation,malignant transformation,tumor suppression,cell cycle regulation
ENSG00000068024,HDAC4,histone modification,tumor suppressor function,cellular proliferation,epigenetic regulation,chromatin remodeling,transcriptional repression
ENSG00000116478,HDAC1,tumor suppressor gene regulation,chromatin remodeling complex,cell cycle progression,pi3k/akt signaling pathway,oncogene overexpression,histone deacetylation
ENSG00000196591,HDAC2,tumor suppressor downregulation,cell proliferation promotion,genome instability induction,epigenetic regulation dysregulation,apoptosis inhibition,therapeutic target
ENSG00000170004,CHD3,chromatin remodeling,genome instability,transcriptional regulation,cell cycle progression,amplification in tumors,nurd complex component
ENSG00000092199,HNRNPC,alternative splicing regulation,epithelial-to-mesenchymal transition facilitation,transcription factor interaction,tumor suppressor downregulation,cancer progression promotion,chromatin modification influence
ENSG00000055044,NOP58,ribosome biogenesis,pre-rrna processing,oncogenic role,biomarker,apoptosis regulation,cell cycle progression modulation
ENSG00000198900,TOP1,dna damage,genomic instability,tumor suppressor,topoisomerase activity,chemosensitivity alteration,oncogenic transformation
ENSG00000131747,TOP2A,dna replication,genomic instability,cell proliferation,chromatin remodeling,transcriptional regulation,tumor aggressiveness
ENSG00000077097,TOP2B,dna replication,cell proliferation,genome stability,protein interaction,maintenance of genomic integrity,resistance to chemotherapy
ENSG00000143379,SETDB1,histone methylation,chromatin remodeling,oncogene regulation,cell proliferation,epigenetic changes,tumor progression
ENSG00000171681,ATF7IP,histone acetylation regulation,tumor progression regulator,cell cycle control,chromatin remodeling,transcriptional activation modulator,nuclear matrix protein
ENSG00000100462,PRMT5,methyltransferase activity,cell cycle progression,genomic instability,apoptosis evasion,oncogenic factor activation,transcriptional regulation
ENSG00000116455,WDR77,transcriptional regulation,chromatin remodeling,genomic instability,oncogene activation,cell proliferation,therapeutic resistance
ENSG00000158828,PINK1,mitochondrial dynamics,tumor suppressor function,oxidative stress regulation,mitophagy promotion,cellular metabolism regulation,energetic dysfunction
ENSG00000178568,ERBB4,oncogenic driver,receptor tyrosine kinase,signaling pathway activation,cell proliferation regulation,tumor suppressor interaction,protein phosphorylation regulation
ENSG00000189056,RELN,epithelial cell adhesion,cell migration,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition,oncogenic signaling
ENSG00000147852,VLDLR,lipid metabolism regulation,tumor growth promotion,metastasis facilitation,cell adhesion disruption,protein interaction modulation,dysregulated expression levels
ENSG00000141505,ASGR1,asgr1 overexpression,growth factor-independent proliferation,tumor cell survival,apoptosis resistance,cell growth promotion,signaling pathway activation
ENSG00000161944,ASGR2,oncogenic overexpression,epithelial-to-mesenchymal transition,mapk/erk signaling pathway,transmembrane receptor function,glycoprotein endocytosis,poor prognosis biomarker
ENSG00000120738,EGR1,cell cycle progression,transcriptional regulation,tumor promoter,metastasis,angiogenesis,poor prognosis
ENSG00000101115,SALL4,oncogene function,tumor progression,cell proliferation,immune evasion,epithelial-to-mesenchymal transition,transcription factor activity
ENSG00000179632,MAF1,genomic instability,dna repair regulation,transcriptional repressor,cell cycle checkpoint control,oncogene dysregulation,tumor suppressor function
ENSG00000160007,ARHGAP35,rho gtpase regulation,pi3k/akt signaling modulation,tumor suppressor function,oncogenic rhoa activity suppression,cell migration regulation,metastasis promotion
ENSG00000145715,RASA1,cellular adhesion regulation,tumor suppression,ras gtpase inhibition,angiogenesis regulation,cellular proliferation,apoptosis evasion
ENSG00000285460,BCAR1,pi3k/akt pathway,tumor progression,regulatory subunit,cell survival,gene overexpression,oncogenic process
ENSG00000143171,RXRG,tumor suppressor function,loss of expression,pi3k/akt pathway activation,cell proliferation regulation,apoptosis inhibition,cell cycle progression modulation
ENSG00000172819,RARG,loss of function mutations,epigenetic regulation,retinoid signaling disruption,tumor growth promotion,histone modification alteration,cellular differentiation inhibition
ENSG00000186350,RXRA,genetic regulation,tumor suppression,cell differentiation,apoptosis regulation,oncogene inhibition,dna binding protein activation
ENSG00000131759,RARA,transcription factor activity,tumor progression,cell proliferation inhibition,apoptosis regulation,wnt/β-catenin pathway interaction,notch signaling pathway interaction
ENSG00000231321,RXRB,wnt/β-catenin pathway,transcriptional regulation,apoptosis modulation,cell cycle progression,therapeutic target,nuclear receptor function
ENSG00000077092,RARB,apoptosis regulation,cell cycle progression,dysregulation of transcription,epigenetic silencing,oncogenesis promotion,transcription factor function
ENSG00000112033,PPARD,peroxisome proliferation,angiogenic factor,tumor suppressor activity,lipid metabolism regulation,nuclear receptor signaling,cell differentiation
ENSG00000118257,NRP2,vascular endothelial growth factor interaction,angiogenesis regulation,co-receptor function,tgf-β signaling modulation,oncogenic potential,cell migration and invasion
ENSG00000102755,FLT1,angiogenic pathway,tumor progression,oncogene overexpression,vegf signaling,cellular proliferation,gene amplification
ENSG00000049130,KITLG,angiogenesis stimulation,cancer progression driver,cell proliferation enhancement,cell survival promotion,immunoglobulin superfamily member,oncogene activation
ENSG00000157404,KIT,oncogene,constitutive activation,tumor progression,cell proliferation,survival pathway,therapeutic target
ENSG00000154229,PRKCA,pkcα activation,pi3k/akt pathway activation,mapk/erk pathway activation,cell proliferation enhancement,oncogenic signaling promotion,tumor growth facilitation
ENSG00000060656,PTPRU,receptor tyrosine dephosphorylation,immune modulation,signaling pathway regulation,tumor progression,oncogene and tumor suppressor potential,metastasis regulation
ENSG00000141027,NCOR1,transcriptional regulation,signaling pathway modulation,cancer cell proliferation,metastasis promotion,tumor suppressor gene suppression,therapeutic target
ENSG00000131746,TNS4,pi3k/akt signaling pathway,cell migration and invasion,metastasis and poor prognosis,biomarker for cancer recurrence,actin cytoskeleton dynamics,focal adhesion kinase interaction
ENSG00000105976,MET,tumor progression,angiogenesis,constitutive activation,gain of function mutations,onco-protein interaction,met pathway activation
ENSG00000144749,LRIG1,tumor suppression,cell proliferation inhibition,receptor tyrosine kinase regulation,apoptosis induction,angiogenesis inhibition,pi3k/akt/mtor pathway modulation
ENSG00000135473,PAN2,rna decay regulation,metastasis promotion,tumor progression driver,mrna stability modulation,cancer cell proliferation,gene expression dysregulation
ENSG00000152520,PAN3,pi3k/akt signaling,metastasis regulator,oncogene expression,tumor progression regulator,cancer cell survival enhancer,protein interaction mediator
ENSG00000009830,POMT2,impaired n-glycosylation,loss-of-function mutations,altered cell adhesion,increased aggressiveness,tumor progression,genomic instability
ENSG00000130714,POMT1,glycosylation pathway alterations,enhanced cell growth,aberrant protein anchoring,cell migration and adhesion modulation,gpi anchor synthesis,signaling pathway dysregulation
ENSG00000171155,C1GALT1C1,cell adhesion disruption,epithelial-to-mesenchymal transition,mucin-type glycoprotein modification,glycosylation pattern changes,biomarker potential,resistance to therapy
ENSG00000106392,C1GALT1,glycosylation regulation,tumor progression,metastasis facilitation,adhesion molecule regulation,poor prognosis marker,glycan modification
ENSG00000165688,PMPCA,mitochondrial protein processing,tumor suppressor dysfunction,cell proliferation regulation,autophagy modulation,cell survival pathway interaction,protein kinase activation
ENSG00000105819,PMPCB,tumor progression,cell cycle regulation,apoptosis resistance,dna repair mechanism,protein stabilization,biomarker potential
ENSG00000118217,ATF6,er stress regulation,apoptosis inhibition,cell survival promotion,tumor progression contributor,protein kinase activation,oncogenic transcription factor
ENSG00000044574,HSPA5,er stress response,tumor cell survival,resistance to apoptosis,protein folding regulation,oncogenic processes,chemotherapy resistance
ENSG00000172071,EIF2AK3,er stress response,cellular stress adaptation,protein synthesis inhibition,apoptosis induction,cancer cell proliferation,oncogenic signaling pathway
ENSG00000178607,ERN1,er stress response,unfolded protein response,cell proliferation regulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation
ENSG00000196455,PIK3R4,akt signaling,pi3k regulation,phosphoinositide interaction,oncogenic potential,cell survival enhancement,tumor suppressor regulation
ENSG00000078142,PIK3C3,regulatory subunit activation,pi3k/akt pathway,constitutive activation,tumor progression,therapeutic target,cellular growth
ENSG00000149476,TKFC,nuclear transport regulation,transcription factor interaction,cell growth promotion,genomic instability,prognostic marker,tumor aggressiveness
ENSG00000115267,IFIH1,type i interferon production,cellular stress response regulation,viral infection modulation,immune evasion,prognostic marker,therapeutic target
ENSG00000172757,CFL1,actin filament regulation,cytoskeletal reorganization,motility and invasion promotion,cellular migration enhancement,oncogenic transformation,overexpression in cancer
ENSG00000106683,LIMK1,cell migration regulation,tumor progression,gene expression regulation,oncogenic process,cytoskeleton remodeling,serine/threonine kinase activity
ENSG00000163218,PGLYRP4,pi3k/akt pathway modulation,pro-inflammatory responses,tumor cell survival,inflammation regulation,immune evasion,secreted protein
ENSG00000159527,PGLYRP3,tumor progression,immune evasion,oncogene function,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,pro-inflammatory signaling
ENSG00000132170,PPARG,metabolic reprogramming,cell proliferation,oncogene activation,tumor growth promotion,poor prognosis association,glucose metabolism regulation
ENSG00000138079,SLC3A1,cellular uptake,nutrient transport,anabolic pathway regulation,cancer metabolism,cellular proliferation,tumor progression
ENSG00000165617,DACT1,**

wnt signaling pathway,constitutive activation,loss of function mutations,tumor suppression,cellular proliferation,genomic instability 

**
ENSG00000103126,AXIN1,loss-of-function mutations,wnt/β-catenin pathway activation,scaffolding protein function,cell proliferation regulation,tumor suppressor role,prognostic biomarker status
ENSG00000082701,GSK3B,glycolytic reprogramming,cell proliferation,metabolic adaptation,oncogenic signaling,therapeutic target,tumor progression
ENSG00000067057,PFKP,glycolytic reprogramming,metabolic adaptation,tumor aggressiveness,energy production,cell proliferation,glucose utilization
ENSG00000141959,PFKL,warburg effect,metabolic reprogramming,glycolytic adaptation,tumor progression,prognostic marker,therapeutic target
ENSG00000152556,PFKM,glycolytic enzyme,increased glycolysis,prognostic marker,metabolic adaptation,therapeutic target,glucose metabolism regulation
ENSG00000084734,GCKR,glucose metabolism,overexpression,glycogen synthesis,signaling pathway regulation,tumor tissue expression,cell survival
ENSG00000106633,GCK,glucose metabolism enhancement,tumor growth promotion,energy dependency,overexpression,poor prognosis marker,cancer cell interaction
ENSG00000029534,ANK1,cytoplasmic anchoring,cell migration regulation,tumor progression,protein-protein interactions,cell survival enhancement,metastatic potential
ENSG00000091129,NRCAM,cell adhesion,signaling pathway,tumor progression,metastasis,immunoglobulin superfamily,epithelial cell interaction
ENSG00000184144,CNTN2,overexpression,metastasis promotion,epithelial disruption,cell migration enhancement,adherens junction interaction,oncogene cooperation
ENSG00000134121,CHL1,tumor suppressor function,apoptosis induction,cell adhesion regulation,metastasis suppression,pi3k/akt interaction,neural development related
ENSG00000163531,NFASC,tumor progression,metastasis,oncogene,biomarker,cell migration,angiogenesis
ENSG00000077279,DCX,microtubule interaction,epithelial-to-mesenchymal transition,oncogenic overexpression,cell cycle regulation,apoptosis evasion,tumor progression
ENSG00000137575,SDCBP,pi3k/akt signaling,overexpression,tumor progression,therapeutic target,cell proliferation,cholesterol biosynthesis
ENSG00000164050,PLXNB1,cell migration,metastasis,semaphorin binding,tumor progression,pleksin signaling pathway,rho gtpase activation
ENSG00000141736,ERBB2,erbb2 overexpression,rtk signaling,cell proliferation,tumor progression,therapeutic target,biomarker candidate
ENSG00000137076,TLN1,cell migration,tumor progression,pi3k/akt pathway,cell adhesion,metastasis,cancer metastasis
ENSG00000186111,PIP5K1C,mtor pathway regulation,type i phosphatidylinositol 4-phosphate 5-kinase activity,cell membrane trafficking regulation,cytoplasmic pi(4,5)p2 production,oncogenic signaling pathway modulation
ENSG00000004399,PLXND1,vegfr2 signaling,tumor progression,tyrosine kinase activation,metastatic dissemination,angiogenesis,poor prognosis
ENSG00000170381,SEMA3E,angiogenesis,oncogene function,tumor progression,therapeutic target,vegf regulation,cell signaling pathway
ENSG00000196189,SEMA4A,semaphorin family,cell migration,invasion regulation,plexin interaction,tumor progression,metastasis regulation
ENSG00000262418,PTPRC,decreased expression,tumor progression,loss of function mutations,tyrosine phosphorylation regulation,signaling pathway activation,biomarker potential
ENSG00000187764,SEMA4D,angiogenesis inhibition,tumor suppressor function,immune regulation,vascular development modulation,cell adhesion disruption,downregulated expression
ENSG00000137101,CD72,genomic instability,dysregulation of b-cell development,oncogene potential,cell proliferation enhancement,immune system modulation,dna repair mechanism
ENSG00000136040,PLXNC1,cellular migration,tumor progression,oncogene function,signaling pathway regulation,angiogenesis promotion,cell adhesion disruption
ENSG00000138623,SEMA7A,angiogenesis promotion,immune evasion mechanism,oncogenic signaling pathway,epithelial-to-mesenchymal transition,cell surface receptor interaction,tumor growth facilitation
ENSG00000010810,FYN,src family kinase,oncogenic transformation,tumor progression,cell growth promotion,survival pathway activation,metastasis facilitation
ENSG00000185008,ROBO2,wnt/β-catenin signaling inhibition,metastasis promotion,cell migration regulation,hippo pathway interaction,slit2 ligand binding,axon guidance disruption
ENSG00000151748,SAV1,hedgehog signaling pathway,tumor suppressor function,cell proliferation inhibition,apoptosis regulation,dna repair regulation,oncogenic mutations
ENSG00000104375,STK3,hippo signaling pathway,tumor suppressor function,loss of function mutations,cell proliferation regulation,phosphorylation-dependent regulation,protein-protein interaction
ENSG00000101109,STK4,tumor suppressor,g2/m phase transition regulation,cell cycle progression,apoptosis regulation,dna repair mechanisms interaction,loss-of-function mutations
ENSG00000119139,TJP2,tight junction disruption,epithelial-to-mesenchymal transition,cell migration enhancement,oncogenic signaling pathway modulation,angiogenesis promotion,uncontrolled cell growth
ENSG00000018408,WWTR1,hippo signaling pathway,cellular growth regulation,tumor progression,therapeutic target,transcriptional regulator,cell proliferation enhancement
ENSG00000075340,ADD2,tumor progression,loss of function mutations,gain-of-function mutations,oncogenic process,epithelial-to-mesenchymal transition (emt),cytoskeletal disruption
ENSG00000087274,ADD1,gain of function mutations,constitutive activation,cell migration,therapeutic target,oncogene,tumor progression
ENSG00000148700,ADD3,microvilli formation,cytoskeletal modulation,cell adhesion disruption,tumor progression,oncogene dysregulation,cancer cell migration
ENSG00000160862,AZGP1,cell proliferation regulation,tumor metastasis promotion,biomarker expression,pi3k/akt pathway interaction,multifunctional protein activity,zinc-dependent metalloprotease function
ENSG00000159763,PIP,pi3k/akt pathway interaction,constitutive activation,overexpression,aberrant phospholipid metabolism,oncogenic signaling,tumor progression
ENSG00000136802,LRRC8A,mechanotransduction,transmembrane protein,enhanced oncogenic activity,pi3k/akt pathway interaction,tumor progression and metastasis,genomic amplification
ENSG00000197147,LRRC8B,vrac regulation,tumor progression,cell migration,prognostic biomarker,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction
ENSG00000171017,LRRC8E,vegf secretion,tight junction disruption,ion channel dysfunction,cell polarity loss,metastasis promotion,none
ENSG00000171492,LRRC8D,mtor pathway,regulation of cell growth,aberrant activation,oncogenic process,cell survival,protein interaction
ENSG00000171488,LRRC8C,vrac function disruption,cellular proliferation,apoptosis resistance,cell cycle progression modulation,regulatory volume decrease,osmotic balance regulation
ENSG00000158402,CDC25C,constitutive activation,cell cycle regulation,g2/m checkpoint regulation,cdk activation,tumor growth promotion,p53 degradation
ENSG00000144867,SRPRB,cell signaling,oncogene potential,pi3k/akt pathway activation,tumor progression,metabolic regulation,sphingolipid biosynthesis
ENSG00000182934,SRPRA,er stress pathway,signal recognition particle complex,cellular translation regulation,oncogenic protein synthesis,therapeutic target,protein folding regulation
ENSG00000009950,MLXIPL,lipid synthesis regulation,metabolic reprogramming,cell growth promotion,transcriptional activation,oncogenic factor interaction,tumor progression driver
ENSG00000108788,MLX,transcription factor activity,tumor suppressor dysfunction,wnt/β-catenin signaling pathway,cell proliferation enhancement,transcriptional regulation modulation,max interaction
ENSG00000141526,SLC16A3,metabolic adaptation,glycolytic shift,lactate exporter,tumor metabolism,cellular energy production,proton gradient regulation
ENSG00000281917,SLC16A1,**

metabolic adaptation,constitutive activation,hypoxia-inducible factor regulation,cellular energy metabolism,tumor microenvironment modulation,glycolytic flux promotion

**
ENSG00000149269,PAK1,tumor progression,cancer metastasis,cell migration regulation,oncogenic processes activation,signaling pathway interaction,genetic instability
ENSG00000186575,NF2,genomic instability,pi3k/akt pathway activation,tumor suppressor function,loss-of-function mutations,cytoplasmic localization,cell cycle regulation
ENSG00000196924,FLNA,filamin a function,cell migration regulation,actin filament dynamics,tumor progression facilitation,cancer metastasis promotion,chromatin remodeling complex interaction
ENSG00000123143,PKN1,protein kinase regulation,cell cycle progression,apoptosis evasion,signal transduction,metastasis promotion,tumor aggressiveness
ENSG00000122966,CIT,mitochondrial function,energy metabolism,cellular respiration,krebs cycle regulation,tumor suppressor,oncogenic pathway activation
ENSG00000111276,CDKN1B,cell cycle regulation,cyclin-dependent kinase inhibition,tumor suppressor function,reduced expression in cancer,cell proliferation promotion,therapeutic target
ENSG00000001626,CFTR,ion channel dysfunction,tumor microenvironment modulation,fluid homeostasis regulation,epithelial cell membrane function,chloride ion transporter,genetic disorder contribution
ENSG00000047932,GOPC,cellular trafficking regulation,protein-protein interaction,emt regulator,src kinase activity modulation,apoptosis regulation,dna damage response
ENSG00000159593,NAE1,nuclear export,cellular proliferation,cell cycle regulation,therapeutic target,cellular stress responses,oncogenesis
ENSG00000144744,UBA3,ubiquitin activation,protein degradation regulation,tumor progression,cell cycle dysregulation,therapeutic target,genomic instability
ENSG00000184182,UBE2F,genetic instability,cell proliferation,promoter mutations,tumor suppressor degradation,dna damage response,protein degradation pathway
ENSG00000158290,CUL4B,ubiquitination pathway,constitutive activation,oncogenic driver,tumor suppressor interaction,cell cycle regulation,dna damage response
ENSG00000139842,CUL4A,tumor suppressor degradation,oncogenic substrate accumulation,cell cycle progression,dna damage response,apoptosis evasion,protein ubiquitination
ENSG00000100387,RBX1,genomic instability,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,tumor growth promotion,therapeutic target
ENSG00000112659,CUL9,protein degradation regulation,genomic instability promotion,cell cycle progression regulation,poor prognosis association,biomarker identification,pi3k/akt pathway interaction
ENSG00000116678,LEPR,tumor progression,therapeutic target,cell proliferation,angiogenesis,apoptosis regulation,metabolic regulation
ENSG00000099800,TIMM13,mitochondrial biogenesis,glycolytic metabolism,pro-apoptotic inhibition,genomic instability,oncogenic signaling,cellular proliferation
ENSG00000150779,TIMM8B,mitochondrial protein import,iron-sulfur cluster assembly,cellular metabolism regulation,oxidative stress reduction,tumor suppressor function,genomic instability prevention
ENSG00000126953,TIMM8A,mitochondrial function disruption,tumor suppressor activity,cellular respiration regulation,dna repair mechanism impairment,oxidative stress induction,genomic instability promotion
ENSG00000134809,TIMM10,mitochondrial import pathway,protein transport dysfunction,cellular metabolism alterations,oncogenic mechanisms contribution,mitochondrial integrity maintenance,cell survival enhancement
ENSG00000100575,TIMM9,mitochondrial import regulation,overexpression in tumors,enhanced cell survival,apoptosis resistance,genomic instability,cellular metabolism disruption
ENSG00000111880,RNGTT,histone deacetylation,chromatin remodeling,dna repair,cell cycle regulation,oncogenic pathway interaction,tumor suppressor function
ENSG00000101654,RNMT,trna methylation,cell proliferation,global protein synthesis regulation,protein synthesis modulation,oncogenic process promotion,tumor development and progression
ENSG00000133226,SRRM1,alternative splicing regulation,spliceosome component,rna-binding protein interaction,cell cycle regulation,apoptosis modulation,dna repair dysfunction
ENSG00000167978,SRRM2,alternative splicing,cell proliferation,dysregulated expression,enhanced metastasis,nuclear organization,oncogenic transcription
,EPRS,translation regulation,tumor progression,protein synthesis,cell proliferation,oncogenesis,translational control
ENSG00000167264,DUS2,mapk signaling,cell proliferation,protein dephosphorylation,tumor aggression,therapeutic resistance,gene overexpression
ENSG00000160193,WDR4,cell cycle regulation,chromatin remodeling,histone modification,gene expression regulation,tumor progression,protein-protein interaction
ENSG00000037897,METTL1,n6-adenosine methylation,mrna stabilization,regulatory rna modification,cell growth promotion,cancer driver gene,rna binding protein interaction
ENSG00000213339,QTRT1,mirna regulation,tumor progression,prognostic marker,cancer metastasis,molecular interaction,dna damage response
ENSG00000151576,QTRT2,tumor suppressor,cell proliferation regulation,apoptosis modulation,dna repair regulation,microrna targeting,mitochondrial function modulation
ENSG00000089195,TRMT6,trna biogenesis,mitochondrial function,cell proliferation regulation,pi3k/akt pathway interaction,cellular metabolism dysregulation,oncogenic protein interaction
ENSG00000166166,TRMT61A,mitochondrial biogenesis,regulation of energy metabolism,interaction with mitochondrial proteins,tumor progression,cell survival pathways,oncogenic mutations
ENSG00000163964,PIGX,gpi anchor synthesis alteration,cell surface protein regulation,oncogenic pathway activation,tumor progression facilitation,immune evasion modulation,metastasis promotion
ENSG00000143315,PIGM,altered glycolysis,glycosylation regulation,cell growth promotion,energy metabolism dysregulation,tumor cell proliferation,molecular interaction network
ENSG00000151665,PIGF,angiogenic factor,metastasis promotion,tumor progression marker,oncogene activation,angiopoietin-like protein interaction,vascular endothelial growth factor regulation
ENSG00000165282,PIGO,impaired ubiquitin-proteasome system,activates nf-κb pathway,tumor suppressor function,cellular stress response,increased protein damage,aggressive tumor behavior
ENSG00000174227,PIGG,aberrant glycosylation,loss of function mutations,tumor initiation,cellular proliferation,protein stability regulation,genomic instability
ENSG00000156976,EIF4A2,tumor progression,protein synthesis regulation,cell proliferation enhancement,apoptosis inhibition,oncogenic mechanism involvement,genetic amplification association
ENSG00000161960,EIF4A1,eif4a role in cap-dependent translation,overexpression in tumor tissues,translation initiation enhancement,tumor progression facilitation,oncogenic protein synthesis,cell proliferation promotion
ENSG00000080815,PSEN1,notch signaling regulation,gamma-secretase complex formation,cell cycle progression regulation,apoptosis regulation,therapeutic target potential,signaling pathway interaction
ENSG00000162736,NCSTN,notch signaling pathway,gain of function mutations,tumor progression,therapeutic target,genomic profiling,cell proliferation
ENSG00000186298,PPP1CC,pp1 dephosphorylation activity,oncogene/tumor suppressor function,cell cycle progression regulation,wnt/β-catenin pathway modulation,pi3k/akt signaling cross-talk,metastasis promotion
ENSG00000087074,PPP1R15A,cellular stress response,unfolded protein response (upr) activation,tumor progression,protein phosphatase 1 regulation,apoptosis suppression,dna damage repair modulation
ENSG00000168288,MMADHC,cellular regulation,oncogenic processes,signaling pathway disruption,cell growth promotion,gtpase activation modulation,tumor progression facilitation
ENSG00000132763,MMACHC,metabolic regulation,cellular energy homeostasis,apoptosis regulation,cell cycle progression,prognostic biomarker,therapeutic target
ENSG00000203618,GP1BB,platelet activation,vascular integrity,cell adhesion,tumor progression,genetic mutation,hematological disorder
ENSG00000185245,GP1BA,platelet adhesion,platelet aggregation,tumor progression,metastasis facilitation,cancer cell interaction,thrombosis mediation
ENSG00000232957,HLA-DOA,major histocompatibility complex (mhc) class ii molecule,antigen presentation pathway,tumor evasion,immunogenic target,adaptive immune response,cancer immunotherapy
ENSG00000243612,HLA-DOB,immunosurveillance failure,hla class i downregulation,tumor antigen presentation evasion,poor prognosis association,cancer immunology target,antigen presentation dysfunction
ENSG00000146232,NFKBIE,nf-κb pathway inhibition,tumor suppressor function,cell survival regulation,cancer progression restriction,immune response modulation,genomic instability protection
ENSG00000162924,REL,oncogene potential,dual role in cancer,transcription factor regulation,cell proliferation promotion,tumor suppressor function,chromatin remodeling
ENSG00000196781,TLE1,tle1 amplification,emt regulation,oncogene activation,apoptosis suppression,protein-protein interaction,transcriptional regulation
ENSG00000116266,STXBP3,apoptosis regulation,cell proliferation enhancement,cancer progression driver,cell survival pathway modulation,genomic overexpression,tumor cell interaction
ENSG00000147614,ATP6V0D2,ph regulation,cellular trafficking,autophagic flux modulation,glycolytic reprogramming,tumor metastasis,cancer prognosis
ENSG00000159720,ATP6V0D1,altered lysosomal ph,calcium signaling disruption,cellular proliferation enhancement,increased glycolysis,proton pump dysfunction,therapeutic target
ENSG00000115942,ORC2,chromosomal instability,genome integrity regulation,cell cycle checkpoint regulation,dna replication initiation,tumor suppression,origin recognition complex
ENSG00000125885,MCM8,genomic instability,telomere maintenance,dna damage response,homologous recombination repair,genome stability regulation,cancer development
ENSG00000172116,CD8B,**

mhc class i downregulation,immune evasion,t-cell dysfunction,antigen presentation,co-receptor function,tumor immunity 

**
ENSG00000153563,CD8A,cd8+ t cell infiltration,prognostic biomarker,cancer immunosurveillance,antigen recognition,tumor killing,immune modulation
ENSG00000198851,CD3E,t-cell receptor activation,tumor-infiltrating lymphocytes,immune regulation,adaptive immunity,cancer immunotherapy target,genetic variation
ENSG00000160654,CD3G,immune modulation,tumor suppression,cell proliferation,survival signaling,t-cell regulation,cancer immunity
ENSG00000167286,CD3D,t cell activation,immunosurveillance,t cell dysfunction,leukemia mutations,mhc class i interaction,cell surface receptor
ENSG00000138674,SEC31A,cellular trafficking,tumor suppressor activity,copii complex component,protein secretion regulation,oncogenic protein interactions,cell survival enhancement
ENSG00000157020,SEC13,er homeostasis regulation,cell proliferation promotion,misfolded protein transport,tumor progression association,prognosis indicator,therapeutic target
ENSG00000134539,KLRD1,immune surveillance,tumor suppression,leukocyte adhesion molecule,cell death regulation,immune evasion,antigen presentation
ENSG00000205809,KLRC2,immune evasion,tumor antigen recognition,cell surface expression,signaling pathway modulation,prognostic marker,ly6 superfamily member
ENSG00000136854,STXBP1,aberrant activation,cell survival,dysregulated membrane fusion,genetic mutation,oncogenic signaling,tumor microenvironment
ENSG00000168283,BMI1,cellular self-renewal,tumor suppressor inhibition,apoptosis suppression,cancer stem cell maintenance,genomic instability,polycomb repressive complex interaction
ENSG00000141582,CBX4,chromatin regulation,epigenetic silencing,polycomb complex member,tumor suppressor gene regulation,cell cycle progression,genomic stability
ENSG00000080824,HSP90AA1,overexpression,chaperone activity,protein stabilization,cell survival pathways,oncogenic protein maturation,ros production
ENSG00000077800,FKBP6,cell cycle regulation,apoptosis inhibition,protein binding,tumor progression,cancer prognosis,cell proliferation enhancement
ENSG00000123607,TTC21B,constitutive activation,tumor progression,hippo-yap signaling pathway,cell growth regulation,cilia assembly modulation,genomic instability
ENSG00000118965,WDR35,genomic instability,chromosome segregation,cell cycle regulation,aneuploidy,tumorigenesis,spindle assembly checkpoint
ENSG00000169398,PTK2,cell migration,oncogenic signaling,non-receptor tyrosine kinase,epithelial-to-mesenchymal transition (emt),pro-survival signaling,metastasis
ENSG00000204103,MAFB,oncogenic transcription factor,cell cycle progression,apoptosis evasion,tumor angiogenesis,hypoxia adaptation,genomic amplification
ENSG00000220205,VAMP2,vesicle trafficking,pro-tumorigenic cargo secretion,angiogenesis promotion,cell proliferation regulation,oncogenic signaling pathway interaction,metastasis facilitation
ENSG00000167986,DDB1,ubiquitin ligase activity,loss of function mutation,dna damage accumulation,genomic instability,cell cycle regulation disruption,oncogenic potential enhancement
ENSG00000112115,IL17A,tumor progression,immune suppression,th17 cell activation,angiogenesis promotion,pro-tumorigenic gene expression,poor prognosis marker
ENSG00000112116,IL17F,cytokine signaling,pro-inflammatory cytokines,tumor microenvironment modulation,immunosuppression evasion,inflammation regulation,nf-κb pathway activation
ENSG00000088247,KHSRP,cellular regulation,mirna-mediated repression,post-transcriptional regulation,rna processing,tumor progression,cellular metastasis
ENSG00000185630,PBX1,cellular differentiation disruption,apoptosis evasion,wnt/β-catenin pathway activation,tumor growth enhancement,prognostic marker,therapeutic target
ENSG00000160199,PKNOX1,oncogenic transcription factor,chromatin remodeling,cell proliferation regulation,tumor progression promoter,biomarker potential,angiogenesis regulator
ENSG00000082458,DLG3,tumor suppressor function,loss of function mutation,disrupted cell polarity,cell proliferation regulation,pi3k/akt pathway interaction,oncogenic process
ENSG00000132535,DLG4,synaptic plasticity regulation,cell-cell interactions modulation,tumor suppressor function,cell proliferation inhibition,protein interaction regulation,signaling pathway disruption
ENSG00000158477,CD1A,antigen presentation,immune evasion,tumor progression,mhc class i interaction,immunotherapy target,poor prognosis
ENSG00000158485,CD1B,antigen presentation,immune evasion,tumor microenvironment,lipid antigen presentation,immunosuppression,cell surface expression
ENSG00000158473,CD1D,immunosuppression,tumor progression,lipid antigen presentation,pi3k/akt signaling pathway interaction,prognostic marker,immune evasion
ENSG00000158481,CD1C,tumor progression,immune evasion,antigen presentation,lipid metabolism,prognostic marker,tumor growth
ENSG00000175097,RAG2,dna repair,genomic instability,cell proliferation,tumor development,lymphocyte maturation,v(d)j recombination
ENSG00000166349,RAG1,v(d)j recombination,chromosomal rearrangement,dna repair,tumor progression,oncogenic process,genomic instability
ENSG00000107566,ERLIN1,pi3k/akt pathway interaction,mutations leading to overexpression,cell proliferation enhancement,metabolic reprogramming,tumor progression driver,protein-protein interaction
ENSG00000147475,ERLIN2,er stress response,tumor progression,cell growth regulation,apoptosis inhibition,autophagy modulation,oncogenic protein interaction
ENSG00000140836,ZFHX3,transcriptional regulator,oncogene overexpression,epithelial-to-mesenchymal transition,tumor progression,apoptosis inhibition,cell cycle dysregulation
ENSG00000167770,OTUB1,oncogenic regulation,pi3k/akt pathway activation,deubiquitinating enzyme activity,cell cycle regulation disruption,apoptosis inhibition,immune response modulation
ENSG00000133135,RNF128,loss of e3 ubiquitin ligase activity,cellular degradation regulation,tumor suppressor protein interaction,oncogenic substrate accumulation,cell proliferation enhancement,survival pathway activation
ENSG00000072506,HSD17B10,warburg effect,metabolic regulation,energy metabolism alteration,glycolysis facilitation,nad+/nadh conversion,tumorigenesis promotion
ENSG00000174173,TRMT10C,mitochondrial regulation,thiolation process,energy production modulation,tumor suppressor potential,mitochondrial protein interaction,oncogenic pathway disruption
ENSG00000198026,ZNF335,amplification,apoptosis inhibition,dna binding,gene amplification,oncogenesis promotion,transcriptional activation
ENSG00000113300,CNOT6,mrna deadenylation,regulation of gene expression,ccr4-not complex,transcriptional regulation,tumor suppressor function,cellular proliferation
ENSG00000185002,RFX6,rfx family regulator,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor microenvironment interaction,prognostic biomarker
ENSG00000134352,IL6ST,jak/stat pathway,constitutive activation,mutations leading to oncogenesis,tumor progression,enhanced cell survival and proliferation,signal transduction modulation
ENSG00000166266,CUL5,pi3k/akt pathway modulation,cell cycle regulation,ubiquitination and degradation,tumor suppressor inhibition,apoptosis suppression,protein-protein interactions
ENSG00000036257,CUL3,cancer-related protein degradation,tumor suppressor regulation,cell cycle progression,oncogenic pathway modulation,genetic instability,ubiquitin ligase activity
ENSG00000108094,CUL2,scf complex regulation,protein degradation pathway,tumor suppressor protein degradation,cell cycle progression,oncofetal gene expression,oncogenic ubiquitination
ENSG00000215021,PHB2,apoptosis inhibition,tumor suppressor function,bax interaction,cell death regulation,genomic stability maintenance,protein-protein interactions
ENSG00000167085,PHB,mitochondrial function regulation,chromosomal instability prevention,apoptosis regulation,genomic stability maintenance,tumor suppressor activity,cell cycle regulation
ENSG00000100401,RANGAP1,genomic instability,aneuploidy,cell proliferation,spindle assembly,chromosome segregation,dna repair regulation
ENSG00000137100,DCTN3,microtubule dynamics regulation,cellular migration,motor-driven transport,cytoskeleton organization,tumor progression,genomic instability
ENSG00000175203,DCTN2,tumor progression,cell division regulation,microtubule stability,vesicle transport,oncogenic activity,cytoskeleton dynamics
ENSG00000205755,CRLF2,constitutive activation,oncogenic transformation,therapeutic target,cell proliferation,jak/stat signaling pathway,aberrant expression
ENSG00000145623,OSMR,oncostatin m receptor activation,cell proliferation enhancement,tumor progression facilitation,apoptosis resistance,signaling pathway involvement,jak/stat/mapk intersection
ENSG00000048649,RSF1,chromatin remodeling,dna repair regulation,genomic instability,oncogene activation,transcriptional dysregulation,cell cycle progression
ENSG00000137752,CASP1,inflammatory response,apoptosis regulation,cytokine activation,tumor progression,genomic instability,oncogene function
ENSG00000025434,NR1H3,nr1h3 downregulation,tumor suppressive functions,cell cycle regulation,apoptosis modulation,transcriptional activity disruption,vitamin d response element interaction
ENSG00000131408,NR1H2,pi3k/akt signaling pathway,constitutive activation,tumor progression,lipid metabolism regulation,transcriptional modulation,apoptosis inhibition
ENSG00000142655,PEX14,peroxisome biogenesis,genomic instability,oxidative stress,apoptosis regulation,cell cycle regulation,membrane protein interaction
ENSG00000162928,PEX13,peroxisomal biogenesis,cell survival,pi3k/akt signaling,cellular stress response,genetic regulation,gene expression modulation
ENSG00000176884,GRIN1,tumor progression,cell migration,neurotransmission regulation,oncogenic process,pi3k/akt pathway interaction,glutamate-gated ion channel activity
ENSG00000273079,GRIN2B,aberrant activation,cellular proliferation,driver gene,oncogenic process,pi3k/akt/mtor pathway interaction,tumor growth and metastasis
ENSG00000106299,WASL,actin cytoskeleton remodeling,cell migration enhancement,constitutive activation,gene amplification,metastasis promotion,tumor progression association
ENSG00000205726,ITSN1,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,metastasis promoter,potential prognostic marker,cytoskeletal interaction,pi3k/akt pathway interaction
ENSG00000027697,IFNGR1,immune modulation,apoptosis inhibition,tumor suppression,prognostic marker,cytokine signaling,antitumor activity
ENSG00000262795,IFNGR2,tumor immunosurveillance failure,tumor suppressor function loss,cytokine production impairment,immune evasion mechanism,cell proliferation deregulation,antiviral response dysregulation
ENSG00000134852,CLOCK,circadian rhythm regulation,transcriptional activation,cell proliferation modulation,wnt/β-catenin pathway activation,apoptosis suppression,prognostic marker
ENSG00000029153,ARNTL2,oncogenic driver,transcriptional regulation,cell proliferation enhancement,tumor metastasis promotion,apoptosis suppression,circadian rhythm disruption
ENSG00000057468,MSH4,genomic instability,tumor suppressor function,dna mismatch repair,meiotic recombination,genetic instability,mismatch repair deficiency
ENSG00000237333,MSH5,dna damage repair,genomic instability,tumor suppressor function,meiotic recombination defect,oncogenic driver mutation,poor prognosis association
ENSG00000119684,MLH3,dna mismatch repair,genomic instability,tumorigenesis,mutl complex interaction,epigenetic regulation,cancer predisposition
ENSG00000168495,POLR3D,overexpression,regulation of transcription,interaction with pi3k/akt pathway,promotion of cell growth and proliferation,poor prognosis biomarker,cancer diagnosis marker
ENSG00000058600,POLR3E,trna transcription,cellular proliferation,dna repair mechanisms,oncogene potential,genomic instability,transcriptional regulation
ENSG00000100413,POLR3H,genomic instability,dna damage repair,transcriptional regulation,tumor progression,oncogenic potential,cell proliferation
ENSG00000241258,CRCP,hypoxia adaptation,iron regulation,tumor angiogenesis,cell survival,metastasis promotion,transferrin receptor interaction
ENSG00000165168,CYBB,nadph oxidase activation,reactive oxygen species production,tumor growth promotion,oxidative stress induction,cell proliferation enhancement,angiogenesis facilitation
ENSG00000051523,CYBA,enhanced ros production,oncogenic role,therapeutic target,cell proliferation,nadph oxidase activation,protein interaction
ENSG00000083123,BCKDHB,metabolic regulation,bcaa degradation,tumor aggressiveness,therapeutic target,cell survival regulation,apoptosis modulation
ENSG00000248098,BCKDHA,branched-chain amino acid catabolism,metabolic reprogramming,glycolytic shift,energy production,tumor growth promotion,therapeutic target
ENSG00000168906,MAT2A,methylation regulation,tumor progression,mitochondrial function,cancer metabolism,cellular adaptation,poor prognosis
ENSG00000038274,MAT2B,stat3 activation,methyltransferase activity,protein kinase methylation,oncogenic signaling pathway,cell proliferation regulation,transcription factor modification
ENSG00000140505,CYP1A2,oncogene activation,oxidative stress induction,dna damage contribution,metabolic dysregulation,biomarker significance,procarcinogen bioactivation
ENSG00000127948,POR,heme biosynthesis,cellular metabolism,electron transfer,heme formation,oncogenic processes,metabolic regulation
ENSG00000165841,CYP2C19,metabolic regulation,drug metabolism,cancer susceptibility,therapeutic target,genetic variation,cellular proliferation
ENSG00000163114,PDHA2,metabolic reprogramming,tumor progression,glycolytic shift,loss-of-function mutations,energy metabolism alteration,aerobic glycolysis
ENSG00000168291,PDHB,metabolic rewiring,tumor aggressiveness,pyruvate dehydrogenase complex,cellular energy homeostasis,redox balance regulation,dysregulated metabolic pathways
ENSG00000131828,PDHA1,tumor suppressor function,metabolic regulation,energy metabolism alteration,glycolysis upregulation,oncogenic potential,cellular proliferation
ENSG00000117118,SDHB,genomic instability,ancillary signaling pathway,electron transport chain disruption,energy metabolism disruption,tumor growth promotion,pseudo-hypoxia response
ENSG00000073578,SDHA,succinate dehydrogenase activity,tumor metabolic adaptation,mitochondrial dysfunction,hypoxia-inducible factor 1 alpha activation,glycolytic shift,metabolic reprogramming
ENSG00000164951,PDP1,protein dephosphorylation,cell proliferation,oncogenic protein activation,tumor progression,poor prognosis,protein kinase regulation
ENSG00000090857,PDPR,altered expression,cell proliferation,amino acid metabolism,tumor progression,prognostic marker,pi3k/akt pathway interaction
ENSG00000105568,PPP2R1A,genetic mutations,cellular regulation,tumor suppressor function,protein phosphorylation modification,signaling pathway disruption,cell survival regulation
ENSG00000113575,PPP2CA,pi3k/akt signaling,tumor suppressor function,loss of function mutations,cellular proliferation,stabilization of oncogenes,regulatory network disruption
ENSG00000112818,MEP1A,cell growth and proliferation,genomic instability,potential therapeutic target,phosphodiesterase activity regulation,dna repair interaction,oncogene expression
ENSG00000141434,MEP1B,tumor progression,cell proliferation,extracellular matrix degradation,metalloendopeptidase activity,immune modulation,angiogenesis
ENSG00000105675,ATP4A,ph regulation,tumor microenvironment,cellular metabolism,proton pump function,ion transport alterations,genetic mutations
ENSG00000288359,ATP4B,cellular ph regulation,ion channel function,tumor metastasis,poor prognosis marker,cellular metabolism alteration,proliferation and migration signaling
ENSG00000143437,ARNT,hypoxia-inducible pathway,angiogenesis regulation,hif-alpha interaction,glucose metabolism activation,tumor progression facilitation,therapeutic target potential
ENSG00000116016,EPAS1,hypoxia-inducible factor 2-alpha subunit (hif-2α),constitutive activation,overexpression or mutation,glycolysis and angiogenesis,apoptosis suppression,tumor progression
ENSG00000169245,CXCL10,tumor microenvironment,immune cell recruitment,cancer-associated fibroblasts,chemoattractant function,antitumor immunity enhancement,prognostic marker
ENSG00000186810,CXCR3,immune cell recruitment,tumor progression,angiogenesis promotion,prognostic marker,metastasis facilitation,chemokine signaling
ENSG00000186469,GNG2,cellular signaling,pi3k/akt pathway modulation,oncogenic driver,cell proliferation regulation,metastasis promotion,signal transduction regulation
ENSG00000181104,F2R,angiogenic signaling,cell survival,coagulation pathway,metastatic potential,tumor progression,protein-protein interactions
ENSG00000164220,F2RL2,protease-activated receptor function,coagulation regulation,platelet activation,mapk/erk pathway interaction,angiogenesis promotion,tumor cell proliferation
ENSG00000070886,EPHA8,oncogenic signaling,cell migration,angiogenesis promotion,receptor tyrosine kinase activation,mapk/erk pathway regulation,tumor progression driver
ENSG00000184349,EFNA5,ephrin receptor interaction,cell migration regulation,tumor progression factor,metastasis promotion,cell adhesion modulation,signaling pathway interaction
ENSG00000033800,PIAS1,cellular proliferation,transcriptional regulation,e3 ubiquitin ligase activity,tumor suppressor inhibition,stat protein interaction,immune response modulation
ENSG00000035403,VCL,cell migration,oncogene,epithelial-to-mesenchymal transition,angiogenesis promotion,cytoskeletal reorganization,adhesion complex formation
ENSG00000072401,UBE2D1,protein stability regulation,cancer driver gene,ubiquitin ligase activity,tumor suppressor regulation,cell cycle control,oncogenic process enhancement
ENSG00000118513,MYB,tumor progression,transcription factor activity,genomic instability,cell proliferation,oncogenic signaling,apoptosis resistance
ENSG00000113580,NR3C1,metabolic reprogramming,transcriptional regulation,chromatin remodeling,apoptosis inhibition,cellular proliferation,epigenetic modification
ENSG00000140396,NCOA2,transcriptional regulation,tumor growth promotion,cell cycle progression,oncogenic pathway activation,metastatic potential enhancement,coactivator function
ENSG00000164161,HHIP,hhip regulatory mechanism,tumor suppressor function,hedgehog signaling pathway inhibition,poor prognosis indicator,transmembrane protein regulation,cancer cell proliferation suppression
ENSG00000163501,IHH,tumor progression,oncogenic signaling,cell proliferation,angiogenesis,poor prognosis,therapeutic target
ENSG00000115170,ACVR1,activin receptor type-1,cell proliferation,oncogenic processes,smad protein activation,tumor progression,tgf-β signaling pathway
ENSG00000198648,STK39,wnt/β-catenin signaling pathway,tumor suppressor function,ion channel regulation,cell cycle regulation,genomic stability maintenance,apoptosis modulation
ENSG00000065675,PRKCQ,tumor progression,overexpression,oncogenic signaling,cell proliferation,apoptosis regulation,protein kinase activation
ENSG00000106070,GRB10,tumor suppressor function,insulin receptor regulation,cell proliferation regulation,metabolic regulation,pi3k/akt pathway modulation,estrogen receptor interaction
ENSG00000101096,NFATC2,hippo/yap pathway activation,transcriptional regulation,oncogenesis,epithelial-to-mesenchymal transition (emt),angiogenesis,cell cycle progression
ENSG00000049768,FOXP3,regulatory t cell function,immune evasion,tumor microenvironment modulation,anti-tumor immunity suppression,immune homeostasis regulation,transcriptional repression
ENSG00000086758,HUWE1,p53 regulation,tumor progression,oncogene function,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis inhibition
ENSG00000107968,MAP3K8,pi3k/akt pathway,oncogenic activation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000120063,GNA13,g protein signaling,activation of rock1,cell migration and proliferation,tumor progression and metastasis,oncogenic driver mutation,therapeutic target
ENSG00000146535,GNA12,gtpase activation,ras/mapk pathway,cell proliferation,constitutive activation,tumor progression,signaling modulation
ENSG00000130396,AFDN,cell migration,epithelial-to-mesenchymal transition (emt),cytoskeletal regulation,oncogenic process,tumor progression,prognostic marker
ENSG00000197943,PLCG2,aberrant activation,pi3k/akt signaling,oncogenic driver,immune evasion,cell proliferation,metabolic reprogramming
ENSG00000254087,LYN,immunomodulation,mutation,signal transduction,tumor progression,phosphorylation,oncogenic transformation
ENSG00000180210,F2,coagulation cascade,serine protease activity,tumor progression,thrombosis and bleeding complications,hemostasis regulation,angiogenesis promotion
ENSG00000171720,HDAC3,histone deacetylation,epigenetic regulation,tumor suppressor repression,oncogene activation,cell cycle progression,apoptosis inhibition
ENSG00000164331,ANKRA2,regulation of cell proliferation,overexpression in cancer,interaction with signaling pathways,contribution to tumorigenesis,potential biomarker for diagnosis,cell cycle progression regulation
ENSG00000164867,NOS3,angiogenesis promotion,enhanced proliferation,oncogenic signaling,metastasis facilitation,vasodilation regulation,inflammation modulation
ENSG00000135966,TGFBRAP1,tgf-β signaling,aberrant activation,regulatory disruption,cell proliferation,prognostic marker,therapeutic target
ENSG00000124145,SDC4,promotes tumor progression,disrupts extracellular matrix,interaction with pi3k/akt pathway,contributes to metastasis,elevated expression in kirc,association with poor prognosis
ENSG00000274233,CCL5,tumor progression,angiogenesis promotion,immune cell recruitment,metastasis facilitation,prognostic biomarker,chemokine signaling
ENSG00000148737,TCF7L2,wnt/β-catenin signaling pathway,transcriptional regulator,tumor suppressor gene function,gene expression modulation,cell proliferation regulation,apolipoprotein regulation
ENSG00000139549,DHH,hedgehog signaling pathway,gain of function mutations,loss of ptch regulation,cell proliferation activation,tumor progression association,genomic instability induction
ENSG00000175592,FOSL1,cell proliferation,transcription factor activity,ap-1 complex member,protein-dna interaction,oncogene overexpression,mapk/erk pathway
ENSG00000180340,FZD2,wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000114251,WNT5A,non-canonical wnt signaling,epithelial-to-mesenchymal transition,cell migration,protein interaction,tumor progression,poor prognosis marker
ENSG00000028528,SNX1,egfr regulation,tumor growth promotion,endosomal trafficking,oncogenic activity,receptor tyrosine kinase activation,metastasis facilitation
ENSG00000205302,SNX2,endocytic recycling,membrane trafficking regulation,cell growth promotion,mapk signaling pathway activation,tumorigenicity increase,constitutive activation
ENSG00000080503,SMARCA2,chromatin remodeling,dna repair mechanism,cell cycle regulation,tumor suppressor function,oncogenic process regulation,genome stability maintenance
ENSG00000245848,CEBPA,tumor suppressor function,dna binding disruption,apoptosis regulation,cell cycle progression,transcriptional regulation,wnt/β-catenin pathway interaction
ENSG00000075426,FOSL2,cell cycle regulation,oncogenic transcription factor,transcriptional activation,tumor progression,genetic amplification,therapeutic target
ENSG00000090776,EFNB1,cell-cell communication,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,tumor aggressiveness,oncogenic properties,metastatic potential
ENSG00000154928,EPHB1,**

* **angiogenesis promotion**,* **cellular adhesion regulation**,* **epithelial-to-mesenchymal transition (emt)**,* **metastasis facilitation**,* **tumor progression association**,* **tyrosine kinase activation**
ENSG00000174808,BTC,bche overexpression,ester hydrolysis,cell signaling modulation,oncogenic potential,prognostic marker,tumor aggressiveness
ENSG00000100811,YY1,tumor suppressor repression,oncogenic activity,transcriptional regulation,promoter binding,cell cycle regulation,angiogenesis
ENSG00000115594,IL1R1,immune evasion,tumor microenvironment modulation,inflammation regulation,cell migration and invasion,proliferation and survival signaling,immunosuppression mediator
ENSG00000136689,IL1RN,immune evasion,inflammation regulation,oncoprotein function,cell proliferation inhibition,apoptosis modulation,tumor microenvironment alteration
ENSG00000130427,EPO,angiogenesis,cell proliferation,genomic instability,oncogenic signaling,tumor progression,vegf expression
ENSG00000187266,EPOR,aberrant signaling,angiogenesis regulation,cell proliferation,jak/stat pathway activation,oncogenic activity,tumor progression
ENSG00000198400,NTRK1,receptor tyrosine kinase activity,neural development regulation,cell proliferation driver,tumor angiogenesis,genetic fusion partner,therapeutic target
ENSG00000168040,FADD,apoptosis regulation,death receptor signaling,immune response modulation,tumor suppressor function,oncogenic potential,cell survival promotion
ENSG00000169242,EFNA1,angiogenesis promotion,cell migration facilitation,epithelial-to-mesenchymal transition,immune suppression induction,oncogene overexpression,tumor progression acceleration
ENSG00000142627,EPHA2,angiogenesis promotion,cell migration regulation,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathways,prognostic marker,receptor tyrosine kinase activity
ENSG00000151693,ASAP2,oncogenesis,metastasis promotion,tumor progression,signaling pathway activation,cell migration,prognostic biomarker
ENSG00000128917,DLL4,notch signaling,tumor progression,angiogenesis,vascular development,metastasis,oncogene
ENSG00000235396,NOTCH4,notch receptor activation,cell proliferation enhancement,angiogenesis promotion,tumor progression facilitation,oncogenic signaling pathway modulation,poor prognostic indicator
ENSG00000081059,TCF7,wnt/β-catenin signaling,constitutive activation,gene expression regulation,cell proliferation,apoptosis inhibition,epithelial-to-mesenchymal transition
ENSG00000127191,TRAF2,nf-κb activation,tumor progression,cell survival regulation,apoptosis modulation,protein-protein interaction,cancer cell maintenance
ENSG00000128602,SMO,hedgehog signaling,aberrant activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000141480,ARRB2,ap-1 complex regulation,oncogenic driver,epithelial-to-mesenchymal transition,cell proliferation enhancement,protein trafficking regulation,nf-κb pathway activation
ENSG00000196367,TRRAP,chromatin remodeling,transcriptional regulation,histone acetyltransferase activity,genomic instability,cell growth regulation,protein-protein interactions
ENSG00000108773,KAT2A,dna repair mechanisms,chromatin remodeling,histone acetylation,transcriptional regulation,oncogene regulation,tumor suppressor interaction
ENSG00000196411,EPHB4,angiogenesis promotion,cell migration regulation,oncogenic signaling pathway,pi3k/akt pathway modulation,prognostic marker,tumor progression enhancement
ENSG00000125266,EFNB2,angiogenesis,cell adhesion,epithelial-to-mesenchymal transition (emt),immune evasion,metastasis,vascular development
ENSG00000175354,PTPN2,tumor suppressor,dephosphorylation regulation,jak/stat signaling pathway modulation,protein tyrosine phosphorylation,angiogenesis promotion inhibition,poor prognosis marker
ENSG00000177425,PAWR,cell cycle regulation,apoptosis evasion,oncogenic activity,tumor progression,therapeutic target,genomic amplification
ENSG00000067606,PRKCZ,protein kinase activation,tumor progression,cell cycle regulation,apoptosis regulation,mutations leading to constitutive activation,mapk/erk signaling pathway activation
ENSG00000116809,ZBTB17,tumor suppressor,genome stability maintenance,epigenetic regulation,dna repair inhibition,cell growth inhibition,apoptosis promotion
ENSG00000140968,IRF8,tumor suppressor function,immunomodulation,immune evasion suppression,nk cell activation,t cell regulation,chromosomal location
ENSG00000160867,FGFR4,fgfr4 signaling pathway,constitutive activation,gain of function mutations,tumor progression,oncogenic processes,prognostic marker
ENSG00000138685,FGF2,fibroblast growth factor,angiogenesis promotion,tumor progression enhancement,cell proliferation stimulation,metastasis facilitation,vegf induction
ENSG00000068078,FGFR3,fgfr signaling pathway,constitutive activation,gain of function mutations,tumor progression,receptor tyrosine kinase domain,growth factor binding protein
ENSG00000066468,FGFR2,fgfr pathway activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000171223,JUNB,tumor progression,cell proliferation,transcriptional regulation,oncogenesis,prognostic marker,apoptosis suppression
ENSG00000100393,EP300,pi3k/akt signaling,enhanced transcriptional activity,cell proliferation,apoptosis inhibition,transcriptional coactivator function,metabolic regulation
ENSG00000099942,CRKL,tumor progression,cell proliferation,apoptosis resistance,cell adhesion disruption,genomic amplification,mutation hotspot
ENSG00000107263,RAPGEF1,cellular proliferation,constitutive activation,guanine nucleotide exchange factor,oncogenic driver,tumor progression,protein-protein interaction
ENSG00000157193,LRP8,cell surface receptor regulation,wnt/β-catenin signaling pathway,pi3k/akt/mtor activation,tumor progression,apoptosis evasion,cell proliferation
ENSG00000164093,PITX2,transcriptional regulation,epithelial-to-mesenchymal transition,oncogene activation,tumor progression,promoter methylation,e-cadherin downregulation
ENSG00000140992,PDPK1,phosphoinositide-dependent activation,protein kinase b (pkb/akt) activation,tumor growth promotion,cell cycle progression,apoptosis suppression,therapeutic target
ENSG00000121067,SPOP,cellular degradation,cancer driver mutation,tumor suppressor function loss,transcription factor regulation disruption,oncogenic pathway activation,protein ubiquitination regulation
ENSG00000281324,LRP6,wnt/β-catenin pathway,constitutive activation,tumor progression,cell proliferation,wnt signaling regulator,oncogenic driver
ENSG00000107984,DKK1,wnt pathway antagonist,tumor suppressor activity loss,cell growth promotion,invasion and metastasis facilitation,prognostic marker for poor outcome,overexpression associated with cancer progression
ENSG00000116288,PARK7,oncogenic potential,cellular protection,mitochondrial function,antioxidant activity,tumorigenesis,prognostic biomarker
ENSG00000063660,GPC1,heparan sulfate proteoglycan,angiogenesis promotion,growth factor modulation,tumor progression facilitation,poor prognosis association,biomarker potential
ENSG00000241186,TDGF1,cell proliferation,oncogenic process,tumor progression,therapeutic target,signaling pathway interaction,cell survival
ENSG00000138795,LEF1,wnt/β-catenin signaling,oncogene activation,transcriptional regulation,cell proliferation,survival pathways,genomic mutations
ENSG00000119630,PGF,prostaglandin biosynthesis,angiogenesis promotion,tumor metastasis enhancement,cell proliferation stimulation,inflammation induction,oncogenic pathway interaction
ENSG00000071564,TCF3,wnt/β-catenin pathway,transcriptional dysregulation,oncogenesis,cell proliferation,tumor progression,prognostic marker
ENSG00000129152,MYOD1,cell cycle disruption,epithelial-to-mesenchymal transition,oncogenic transformation,muscle differentiation regulation,transcriptional control modulation,tumor progression promotion
ENSG00000157168,NRG1,tumor progression,cell proliferation regulation,egf family member,signaling pathway activation,oncogenic driver mutation,genomic instability interaction
ENSG00000123349,PFDN5,autophagy regulation,cellular trafficking disruption,oncogenic function,protein-protein interactions,tumor progression facilitation,therapeutic target
ENSG00000153317,ASAP1,gef activity,cell migration and invasion,pi3k/akt signaling modulation,tumor progression and metastasis,protein-protein interactions,cancer-related mutations
ENSG00000113578,FGF1,angiogenesis promotion,tumor growth stimulation,cell proliferation activation,epithelial-to-mesenchymal transition facilitation,chemotherapy resistance enhancement,poor prognosis association
ENSG00000075388,FGF4,fgf/fgfr signaling pathway,tumor growth promotion,metastasis regulation,cell proliferation enhancement,anti-apoptotic effect,prognostic biomarker
ENSG00000162344,FGF19,cellular proliferation,apoptosis evasion,autocrine growth factor,therapeutic target,cell cycle progression,transcriptional regulation
ENSG00000123416,TUBA1B,microtubule stabilization,oncogenic processes,cell proliferation,survival signaling,spindle assembly checkpoint,microtubule dynamics regulation
ENSG00000112245,PTP4A1,pi3k/akt pathway interaction,oncogenic signaling,cell adhesion regulation,tumor growth promotion,metastasis facilitation,cdk14 protein interaction
ENSG00000121858,TNFSF10,apoptosis regulation,immune response modulation,tumor suppressor function,loss of heterozygosity,pro-apoptotic signaling pathway,genomic instability
ENSG00000139567,ACVRL1,tgf-β signaling,oncogene activation,angiogenesis promotion,cell proliferation enhancement,serine/threonine kinase activity,receptor tyrosine kinase regulation
ENSG00000157764,BRAF,mapk/erk pathway activation,gain-of-function mutation,tumor progression,oncogene,therapeutic target,cell proliferation regulation
ENSG00000166579,NDEL1,overexpression,cell proliferation,microtubule stabilization,apoptosis modulation,tumor progression,cell migration
ENSG00000013810,TACC3,microtubule regulation,genomic instability,protein-protein interaction,cell proliferation enhancement,amplification events,therapeutic target
ENSG00000119383,PTPA,regulation of cell signaling pathways,tyrosine phosphorylation regulation,oncogenic processes promotion,cell proliferation and migration enhancement,therapeutic target for cancer treatment,resistance to targeted therapy mechanism
ENSG00000121989,ACVR2A,tgf-beta signaling,constitutive activation,cell proliferation enhancement,apoptosis inhibition,tumor progression promotion,genomic instability association
ENSG00000133794,ARNTL,circadian rhythm regulation,cancer-promoting function,tumor progression regulator,cell cycle modulation,anti-apoptotic activity,transcriptional regulation
ENSG00000065526,SPEN,genome instability,transcriptional regulation,tumor suppressor function,cellular dna repair,oncogene inhibition,dna methylation
ENSG00000150455,TIRAP,immune modulation,oncogenesis,apoptosis inhibition,angiogenesis promotion,immune evasion,downstream signaling pathway activation
ENSG00000167393,PPP2R3B,tumor suppression,cell proliferation enhancement,apoptosis inhibition,genomic instability,regulatory subunit,phosphatase regulation
ENSG00000064490,RFXANK,chromatin remodeling,transcriptional regulation,immune evasion,tumor progression,gene expression modulation,regulatory function
ENSG00000170558,CDH2,tumor progression,cell adhesion disruption,epithelial-to-mesenchymal transition,angiogenesis promotion,cell signaling modulation,protein interaction with β-catenin
ENSG00000150760,DOCK1,gef activity,gtpase activation,oncogenic behavior,cell migration,cytokeletal reorganization,therapeutic target
ENSG00000155849,ELMO1,rac1 activation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,dendritic cell regulation,rho gtpase activation,tumor progression
ENSG00000169439,SDC2,cell adhesion disruption,oncogenic signaling pathway activation,heparan sulfate proteoglycan function,tumor cell migration facilitation,fgf2 interaction promotion,pi3k/akt pathway modulation
ENSG00000178999,AURKB,aurora kinase b regulation,chromosome alignment accuracy,cell proliferation enhancement,genomic instability induction,mitotic checkpoint modulation,spindle assembly interaction
ENSG00000173535,TNFRSF10C,pro-apoptotic function,immune evasion,tumor progression,overexpression in cancer,inflammation induction,therapeutic target
ENSG00000112592,TBP,chromatin remodeling,transcriptional regulation,cell proliferation,apoptosis suppression,oncogenesis contribution,therapeutic target
ENSG00000066336,SPI1,tumor-associated macrophages,constitutive activation,immunosuppressive microenvironment,cell proliferation,pro-inflammatory pathways,nf-κb activation
ENSG00000147443,DOK2,**

apoptosis regulation,cell adhesion disruption,egf receptor interaction,metastasis promotion,oncogenic adaptation,tumor progression facilitation

**
ENSG00000198561,CTNND1,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression marker,protein-protein interaction,signal transduction pathway,overexpression signature
ENSG00000167193,CRK,oncogenic signaling pathway,cytoskeletal reorganization,metastatic potential,angiogenesis regulation,prognostic marker,tumor progression
ENSG00000108840,HDAC5,chromatin modification,oncogene activation,cell cycle arrest suppression,tumor suppressor gene repression,histone deacetylation,prognostic marker
ENSG00000101199,ARFGAP1,oncogene activation,pi3k/akt signaling,gain of function mutations,tumor progression,therapeutic target,cell surface receptor recycling
ENSG00000105438,KDELR1,cell proliferation,tumor progression,protein folding regulation,golgi apparatus function,signaling pathway modulation,oncogene overexpression
ENSG00000094631,HDAC6,histone deacetylase regulation,cellular protein degradation,oncogenic processes,protein ubiquitination,cancer progression,therapeutic target
ENSG00000114423,CBLB,tumor suppressor dysfunction,ubiquitin ligase activity,protein degradation regulation,cellular signaling regulation,cancer-associated mutation,oncogenic properties promotion
ENSG00000157240,FZD1,wnt/β-catenin signaling,oncogenic driver,cell proliferation regulation,tumor progression promotion,cancer cell invasion enhancement,protein-protein interaction modulation
ENSG00000154342,WNT3A,wnt signaling pathway,oncogenic transformation,epithelial-to-mesenchymal transition (emt),cell migration,therapeutic resistance,genomic instability
ENSG00000163517,HDAC11,epigenetic regulation,tumor suppression,cell cycle regulation,dna damage repair,cancer prognosis,therapeutic target
ENSG00000172179,PRL,hormone regulation,cell proliferation,tumor growth,survival pathway activation,metastasis promotion,growth factor activity
ENSG00000179094,PER1,pi3k/akt signaling pathway regulation,cell cycle modulation,circadian rhythm disruption,apoptosis inhibition,tumor growth promotion,metabolic regulation
ENSG00000135144,DTX1,**

apoptosis inhibition,cell cycle regulation,gene overexpression,oncogenic transcription factor,poor prognosis,tumor growth promotion

**
ENSG00000182944,EWSR1,chimeric fusion proteins,transcriptional regulation,spliceosome assembly,tumor suppressor regulation,cell proliferation driver,oncogenic activity
ENSG00000100485,SOS2,ras-mapk signaling pathway,constitutive activation,gain of function mutations,oncogenic transformation,cell proliferation,metastasis
ENSG00000110330,BIRC2,cellular survival,apoptosis inhibition,tumor progression,metastasis promotion,nf-κb pathway interaction,therapeutic target
ENSG00000023445,BIRC3,apoptosis regulation,tumor suppressor function,caspase interaction,cell survival enhancement,tumor progression,immune evasion
ENSG00000164327,RICTOR,mtorc1 complex,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000105810,CDK6,cell cycle regulation,oncogenesis,tumor progression,apoptosis resistance,cancer stem cell maintenance,therapeutic target
ENSG00000134516,DOCK2,rho gtpase activation,dysregulated expression,cell migration facilitation,overexpressed in cancer,metastasis promotion,gef activity modulation
ENSG00000166167,BTRC,ubiquitin-proteasome pathway,protein degradation regulation,tumor progression facilitation,oncogenic pathway modulation,scf complex interaction,wnt/β-catenin signaling pathway involvement
ENSG00000126767,ELK1,mapk/erk pathway regulation,transcription factor function,cell proliferation promotion,tumorigenesis contributor,oncogenic process activation,poor prognostic marker
ENSG00000112658,SRF,transcriptional regulation,cell proliferation,oncogene activation,cytoskeletal organization,cell adhesion disruption,metastasis promotion
ENSG00000113658,SMAD5,tumor suppressor,tgf-β signaling pathway,cell growth inhibition,apoptosis promotion,epithelial-to-mesenchymal transition regulation,prognostic marker
ENSG00000105698,USF2,transcriptional regulation,oncogenic potential,cell cycle progression,metastasis,angiogenesis,poor prognosis
ENSG00000101138,CSTF1,cell cycle regulation,apoptosis evasion,tumor progression,rna processing,protein interaction,oncogenic activity
ENSG00000131462,TUBG1,microtubule stabilization,oncogenic processes,cell cycle progression,apoptosis resistance,tumor progression,genomic instability
ENSG00000101004,NINL,cell migration,cytoskeleton regulation,protein-protein interaction,tumor progression,cellular architecture,gene expression modulation
ENSG00000120693,SMAD9,loss of function,tgf-β signaling regulation,tumor suppressor function,oncogenic effects,protein interaction regulation,therapeutic target
ENSG00000158517,NCF1,nadph oxidase regulation,ros production,oxidative stress,dna damage,cellular redox balance,genetic predisposition
ENSG00000116701,NCF2,oxidative stress regulation,genomic instability,tumor progression,cancer cell survival,therapeutic resistance,nadph oxidase activity
ENSG00000137267,TUBB2A,microtubule stability,cell migration enhancement,cancer cell survival,mitosis regulation,metastasis facilitation,tumor progression
ENSG00000173273,TNKS,telomere stabilization,genomic instability,pi3k/akt pathway activation,oncogenic protein phosphorylation,cell growth promotion,metastatic gene expression
ENSG00000147601,TERF1,telomere regulation,dysregulated expression,genomic instability,chromosomal alterations,oncogenic pathway activation,tumor progression
ENSG00000095739,BAMBI,tumor progression,oncogenesis,cellular differentiation,epithelial-to-mesenchymal transition (emt),apoptosis regulation,tgf-β pathway inhibition
ENSG00000136754,ABI1,tumor suppressor,apoptosis inhibition,cell survival promotion,dna repair regulation,genomic instability facilitation,oncogenic pathway interaction
ENSG00000107643,MAPK8,genomic instability,constitutive activation,protein kinase activation,cell survival promotion,tumor progression,stress-activated signaling
ENSG00000136827,TOR1A,protein misfolding,cellular stress response,impaired protein degradation,aggregation-prone protein,neurodegenerative disease-related,cellular signaling pathway
ENSG00000108821,COL1A1,tumor progression,fibrosis and angiogenesis,metastasis promotion,angiogenic signaling,tgf-β interaction,microenvironment regulation
ENSG00000164692,COL1A2,extracellular matrix degradation,cell proliferation enhancement,angiogenesis promotion,tumor progression facilitation,oncogenic signaling pathway interaction,apoptosis inhibition
ENSG00000161800,RACGAP1,rho gtpase activation,onco-protein overexpression,tumor progression,cell migration enhancement,wnt/β-catenin pathway modulation,cytoskeleton reorganization
ENSG00000137807,KIF23,microtubule dynamics regulation,g2/m phase transition modulation,protein-protein interaction,chromosomal instability contribution,aneuploidy promotion,cell proliferation enhancement
ENSG00000078902,TOLLIP,immune regulation,tumor suppressor function,apoptosis regulation,cell cycle progression,tlr signaling pathway,protein-protein interaction
ENSG00000117748,RPA2,genomic instability,dna repair resistance,dna replication facilitation,ssdna binding affinity,oncogenic potential,therapeutic target
ENSG00000132383,RPA1,dna damage response,genomic instability,cell survival signaling,oncogenic transformation,tumor progression mechanisms,chromosomal stability
ENSG00000069702,TGFBR3,tgf-β signaling,loss-of-function mutations,angiogenesis promotion,immune evasion,epithelial-to-mesenchymal transition (emt),oncogenic transformation
ENSG00000186871,ERCC6L,dna damage response,genomic instability,transcriptional regulation,nucleotide excision repair,oncogenic function,tumor suppressor dysfunction
ENSG00000142319,SLC6A3,cellular proliferation,cell survival,tumor progression,angiogenesis,therapeutic target,signal transduction
ENSG00000169083,AR,androgen signaling pathway,aberrant activation,genomic alterations,tumor progression,cell proliferation,prognostic factor
ENSG00000196712,NF1,ras signaling pathway activation,tumor suppressor function loss,constitutive cell proliferation,angiogenesis promotion,cell survival enhancement,genetic predisposition to cancer
ENSG00000136002,ARHGEF4,rho gtpase activation,cell migration,cytoskeleton organization,tumor progression,oncogenic driver,gef activity
ENSG00000126214,KLC1,microtubule-based transport,promotes cell proliferation,contributes to tumorigenesis,kinesin motor activity,cellular compartmentalization,overexpressed in cancer
ENSG00000008294,SPAG9,cell cycle regulation,tumor antigen,oncogenic transformation,chromatin remodeling,dna repair,immunotherapeutic target
ENSG00000169429,CXCL8,angiogenesis promotion,emt induction,immune evasion,inflammation regulation,metastasis promotion,nf-κb pathway activation
ENSG00000180871,CXCR2,tumor metastasis,constitutive activation,g-protein coupled receptor signaling,immune suppression,angiogenesis promotion,therapeutic target
ENSG00000115590,IL1R2,immune regulation,inflammation suppression,cytokine modulation,tumor progression,angiogenesis stimulation,cell survival enhancement
ENSG00000115008,IL1A,inflammation promotion,tumor growth stimulation,immunosuppression induction,apoptosis inhibition,angiogenesis enhancement,cell proliferation activation
ENSG00000104312,RIPK2,necroptosis regulation,nf-κb activation,inflammatory pathway modulation,cell survival enhancement,tumor growth promotion,biomarker for disease progression
ENSG00000167207,NOD2,tumor microenvironment modulation,inflammation regulation,immune system disruption,cancer risk association,genetic variation impact,nf-κb signaling pathway activation
ENSG00000114315,HES1,oncogene,tumor progression,transcription factor,cell cycle regulation,apoptosis inhibition,protein-protein interaction
ENSG00000044524,EPHA3,angiogenesis regulation,cell adhesion disruption,metastatic potential increase,tumor progression association,ephrin receptor interaction,prognostic marker significance
ENSG00000010017,RANBP9,nuclear transport regulation,cell cycle progression,genomic instability,chromatin remodeling interaction,kinase activation,tumor growth promotion
ENSG00000156052,GNAQ,g protein signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000105443,CYTH2,cellular signaling,genomic instability,purinergic regulation,oncogenic progression,tumor microenvironment modulation,dna repair regulation
ENSG00000275338,RAB11FIP3,endocytic recycling,hippo signaling pathway,oncogenic potential,prognostic biomarker,tumor progression,cellular homeostasis
ENSG00000103769,RAB11A,**
rab gtpase function,cell cycle regulation,vesicle trafficking,membrane recycling,oncogenesis,gene expression regulation
**
ENSG00000140464,PML,tumor suppressor function,genetic mutations,loss of heterozygosity,cell cycle regulation,apoptosis regulation,angiogenesis suppression
ENSG00000205250,E2F4,cell cycle regulation,tumor suppressor activity,dual role in cancer,transcriptional regulation,apoptosis inhibition,protein-dna interaction
ENSG00000074706,IPCEF1,endocytic trafficking,regulation of cell surface receptors,ras-related gtp-binding protein rab5a interaction,genomic alterations in cancer,cancer cell proliferation regulation,protein recycling pathway involvement
ENSG00000078043,PIAS2,transcriptional regulation,tumor suppression,stat3 inhibition,cell growth repression,dual role in cancer,transcription factor interaction
ENSG00000130779,CLIP1,microtubule stability,cell division,mitosis regulation,cytoskeletal organization,chromosomal segregation,cell survival
ENSG00000007168,PAFAH1B1,genomic instability,aneuploidy,cell cycle regulation,mitotic spindle detachment,chromosome aberration,protein-protein interaction
ENSG00000125931,CITED1,transcriptional coactivator,oncogenic transcription program,cell proliferation enhancement,tumor progression facilitation,angiogenesis promotion,metastasis acceleration
ENSG00000109971,HSPA8,tumor growth,chaperone function,protein stabilization,cell survival,oncogenic transformation,cancer prognosis
,SEPT1,septin family protein,cytoskeletal organization,cell cycle progression regulation,tumor progression,oncogenesis promoter,apoptosis inhibition
ENSG00000136280,CCM2,cell proliferation,apoptosis evasion,tumor growth,angiogenesis regulation,cyclin regulation,protein interaction
ENSG00000118689,FOXO3,apoptosis induction,tumor suppression,cancer progression,cell cycle regulation,dna repair modulation,transcriptional regulation
ENSG00000070778,PTPN21,tumor suppression,cell signaling regulation,protein tyrosine phosphatase activity,dephosphorylation of oncogenic proteins,interactions with rtks and nrtks,cell growth inhibition
ENSG00000075651,PLD1,phosphatidic acid generation,cell proliferation,oncogenic transformation,tumor progression,metastasis,prognosis
ENSG00000145242,EPHA5,tumor suppression,cell adhesion regulation,gain of function mutations,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway interaction,metastasis promotion
ENSG00000152284,TCF7L1,wnt/β-catenin signaling,transcription factor regulation,dna binding activity,tumor suppressor function,cell cycle regulation,transcriptional activation
ENSG00000059728,MXD1,transcriptional regulation,tumor suppressor,cell cycle regulation,apoptosis modulation,angiogenesis inhibition,dna binding specificity
ENSG00000107295,SH3GL2,pi3k/akt/mtor pathway interaction,gain of function mutations,tumor progression enhancement,metabolic regulation alteration,cytoskeletal organization modulation,membrane trafficking regulation
ENSG00000147010,SH3KBP1,pi3k/akt modulation,constitutive activation,oncogenesis driver,scaffolding protein function,kinase regulation,cell migration enhancer
ENSG00000160999,SH2B2,stat signaling pathway regulation,cancer driver,cell proliferation enhancement,scaffold protein function,oncogenic activity,jak/stat pathway activation
ENSG00000178188,SH2B1,tyrosine kinase activation,oncogenic signaling,cell proliferation,tumor progression,scaffolding protein function,downstream signaling pathway modulation
ENSG00000196655,TRAPPC4,er-golgi transport pathway disruption,constitutive activation of downstream pathways,cellular survival enhancement,tumor progression facilitation,metabolic regulation alteration,protein aggregation promotion
ENSG00000196498,NCOR2,overexpression,tumor suppressor gene repression,nuclear receptor activation,cell cycle progression regulation,apoptosis inhibition,metastasis promotion
ENSG00000101144,BMP7,tumor suppression,cell differentiation,wnt/β-catenin pathway regulation,apoptosis induction,receptor binding,protein-protein interaction
ENSG00000171243,SOSTDC1,enhanced lipid biosynthesis,poor prognosis marker,cellular proliferation regulator,lipid metabolism regulation,steroidogenesis regulation,start domain-containing protein
ENSG00000248333,CDK11B,cell cycle progression,mitotic entry,oncogenesis,cancer progression,therapeutic target,protein-protein interaction
ENSG00000184937,WT1,wilms' tumor suppressor function,transcriptional regulation,cell proliferation,pi3k/akt pathway modulation,tumor progression association,β-catenin interaction
ENSG00000169047,IRS1,insulin/igf-1 signaling pathway,cancer cell proliferation,dysregulated expression,angiogenesis promotion,tumor aggressiveness,therapeutic target
ENSG00000071051,NCK2,immune evasion,signaling pathway activation,cell migration facilitation,tumor progression enhancement,adaptor protein function,oncogenic process promotion
ENSG00000069399,BCL3,nf-κb signaling,constitutive activation,tumor growth,epigenetic regulation,cancer driver gene,oncogenic processes
ENSG00000037280,FLT4,vegfr-3 activation,angiopoietin signaling pathway,angiogenesis promoter,tumor metastasis,lymphangiogenesis regulator,growth factor receptor
ENSG00000150630,VEGFC,angiogenesis,promoter of tumor growth,lymphangiogenesis,tumor progression,therapeutic target,cell survival pathway
ENSG00000124882,EREG,tumor progression,epidermal growth factor family,oncogenic potential,cell proliferation regulation,biomarker significance,metastasis promotion
ENSG00000131558,EXOC4,exocyst complex,epithelial-to-mesenchymal transition,overexpression,tumor aggressiveness,pro-tumorigenic factor secretion,cancer metastasis
ENSG00000180104,EXOC3,exocyst complex regulation,tumor progression,oncogenic signaling,aberrant secretion,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000151725,CENPU,kinetochores disruption,tumor proliferation,cell cycle regulation,chromosome instability,oncogenic signaling,mitotic spindle assembly
ENSG00000160691,SHC1,oncogene activation,signaling pathway regulation,cell survival promotion,tumor progression facilitation,protein-protein interaction,receptor tyrosine kinase activation
ENSG00000105701,FKBP8,tumor progression,protein folding regulation,apoptosis inhibition,cell cycle modulation,metastasis promotion,oncogenic interaction
ENSG00000185591,SP1,apoptosis resistance,cell cycle regulation,dna binding protein,gene expression modulation,oncogenic signaling pathway regulation,transcriptional activation
ENSG00000269335,IKBKG,nf-κb activation,constitutive activation,oncogenesis,cell proliferation,apoptosis resistance,prognostic significance
ENSG00000145431,PDGFC,...<end>:

<begin>
angiogenesis promotion,pdgf/pi3k/akt pathway,tumor growth and metastasis,cell proliferation and migration,fibrosis regulation,genomic overexpression
ENSG00000141052,MYOCD,cell adhesion disruption,cancer progression facilitation,cell migration promotion,cytoskeleton organization regulation,oncogenic potential,srf interaction enhancement
ENSG00000177565,TBL1XR1,transcriptional regulation,chromatin remodeling,cell cycle regulation,apoptosis modulation,tumor suppressor function,oncogenic transformation
ENSG00000101849,TBL1X,tumor suppression,wnt/β-catenin pathway modulation,transcriptional co-repressor function,cell proliferation regulation,survival pathways repression,genetic alterations associated
ENSG00000123159,GIPC1,pi3k/akt/mtor pathway,growth factor receptor interaction,cell proliferation enhancement,tumor aggressiveness,epithelial-to-mesenchymal transition,therapeutic resistance predictor
ENSG00000058272,PPP1R12A,pp1 regulation,cell cycle control,protein phosphorylation,tumor growth promotion,oncogene regulation,apoptosis suppression
ENSG00000213639,PPP1CB,dephosphorylation function,regulatory subunit,cell cycle regulation,signal transduction,transcriptional control,none
ENSG00000132604,TERF2,telomere maintenance,oncogenic driver,chromatin regulation,cell cycle progression,genomic instability,epigenetic modification
ENSG00000099956,SMARCB1,chromatin remodeling,tumor suppressor function,genomic instability,cell proliferation,dna repair,apoptosis
ENSG00000116604,MEF2D,transcription factor,oncogene activity,constitutive activation,cell proliferation regulation,epithelial-to-mesenchymal transition,genomic amplification
ENSG00000099991,CABIN1,nf-κb activation,inhibitor of calcineurin,dna damage response,cell growth regulation,apoptosis modulation,tumor suppressor function
ENSG00000162337,LRP5,wnt/β-catenin pathway activation,tumor progression,cell proliferation enhancement,epithelial-to-mesenchymal transition (emt),metastasis promotion,oncogenic driver
ENSG00000165197,VEGFD,lymphangiogenesis,angiogenic factor,pro-angiogenic gene expression,tumor growth promotion,metastasis enhancement,therapeutic target for anti-angiogenic therapy
ENSG00000147526,TACC1,microtubule regulation,centrosome dysfunction,oncogenic driver,mitotic spindle assembly,ciliogenesis,cell migration promotion
ENSG00000100592,DAAM1,wnt signaling pathway,cell proliferation,oncogenic driver,tumor growth,protein-protein interaction,cell migration
ENSG00000073584,SMARCE1,histone modification disruption,chromatin remodeling complex,loss-of-function mutations,tumor suppressor activity,gene expression regulation,swi/snf complex subunit
ENSG00000073282,TP63,angiogenesis promotion,cell growth modulation,immunosuppression evasion,cancer stem cell regulation,gene expression dysregulation,oncogenic activation
ENSG00000278114,MUC20,tumor progression,mucin family member,glycoprotein expression,immune modulation,cell migration,protein interaction
ENSG00000106991,ENG,angiogenesis,tumor progression,metastasis promotion,therapeutic target,cell signaling regulation,poor prognosis marker
ENSG00000115884,SDC1,cell adhesion regulation,tumor progression,metastasis promotion,oncogenic processes,tumor suppressor potential,heparin binding property
ENSG00000111664,GNB3,oncogenic properties,activation of pi3k/akt/mtor,regulation of cell proliferation,tumor progression and metastasis,g-protein signaling pathway,therapeutic target
ENSG00000167083,GNGT2,pi3k/akt signaling pathway,oncogenic properties,cell growth enhancement,dysregulation in cancer progression,metastasis promotion,cell survival enhancement
ENSG00000178573,MAF,cellular proliferation,transcriptional regulation,oncogene activation,tumor progression,angiogenesis promotion,metastasis enhancement
ENSG00000119335,SET,histone methyltransferase activity,dna damage response,epigenetic regulation,tumor progression marker,cell cycle regulation,protein-protein interaction
ENSG00000173801,JUP,cell-cell adhesion disruption,upregulated expression,cytoskeletal dysregulation,tumor progression,metastasis facilitation,protein-protein interactions
ENSG00000096696,DSP,desmosomal dysfunction,cell detachment,tumor metastasis,epithelial barrier disruption,cell-cell adhesion regulation,genetic mutations
ENSG00000137834,SMAD6,loss of function mutations,constitutive activation,tumor suppressor role loss,cell proliferation promotion,metastasis facilitation,apoptosis inhibition
ENSG00000183207,RUVBL2,genomic instability,dna replication regulation,oncogenic potential,tumor progression,homologous recombination repair,transcriptional regulation
ENSG00000173511,VEGFB,angiogenic factor,vascular endothelial cell proliferation,receptor activation,tumor progression,therapeutic target,prognostic marker
ENSG00000150907,FOXO1,tumor suppressor,pi3k/akt inhibition,apoptosis regulation,cell cycle control,protein-protein interaction,dna damage response
ENSG00000184371,CSF1,immunosuppression,tumor progression,monocyte differentiation,macrophage recruitment,cell proliferation,receptor activation
ENSG00000182578,CSF1R,tumor progression,metastasis promotion,protein kinase activation,ras/mapk pathway activation,pi3k/akt pathway activation,tumor growth promotion
ENSG00000166888,STAT6,stat6 signaling,constitutive activation,tumor angiogenesis,immune suppression,cell cycle progression,oncogene overexpression
ENSG00000173193,PARP14,nf-κb signaling pathway,transcriptional regulation,oncogenesis promotion,genomic instability,inflammatory response modulation,parp family member
ENSG00000137265,IRF4,immune evasion,cell proliferation,transcriptional regulation,tumor progression,oncogenic activation,apoptosis evasion
ENSG00000050748,MAPK9,constitutive activation,protein kinase activation,cell proliferation,tumor progression,signaling pathway regulation,therapeutic target
ENSG00000072736,NFATC3,nfat transcription factor regulation,cell cycle dysregulation,epithelial-to-mesenchymal transition,apoptosis resistance,tumor progression marker,genetic amplification
ENSG00000163956,LRPAP1,lrp1 regulation,oncogenic signaling,cell proliferation,metastasis promotion,wnt/β-catenin pathway involvement,endocytic cycle disruption
ENSG00000169856,ONECUT1,transcriptional regulation,cancer susceptibility,gene expression modulation,cellular differentiation,apoptosis inhibition,cell cycle progression
ENSG00000276971,TRPV6,calcium channel regulation,epithelial-to-mesenchymal transition,oncogenic potential,tumor growth promotion,metastasis facilitation,cell signaling modulation
ENSG00000109332,UBE2D3,ubiquitin-conjugating enzyme activity,tumor suppressor degradation,cell cycle progression,oncogenic pathways activation,therapeutic target identification,protein degradation regulation
ENSG00000137841,PLCB2,phospholipase activity,cell proliferation,oncogenic signaling,calcium signaling pathway,overexpression associated,therapeutic target
ENSG00000163932,PRKCD,genomic instability,dna damage response,apoptosis modulation,cell proliferation regulation,pi3k/akt pathway activation,protein kinase activity
ENSG00000116106,EPHA4,ephrin binding,overexpressed in tumor,oncogenic driver,cell migration regulation,cell adhesion modulation,epithelial-to-mesenchymal transition
ENSG00000118260,CREB1,transcription factor,cell proliferation,angiogenesis,oncogenic signaling,epithelial-to-mesenchymal transition,tumor progression
ENSG00000204628,RACK1,mapk/erk pathway activation,pi3k/akt signaling modulation,scaffolding protein function,tumor progression enhancement,cell survival promotion,prognostic significance
ENSG00000115306,SPTBN1,amplification,oncogenesis,pi3k/akt pathway activation,cytoskeletal reorganization,cell migration and invasion,protein-protein interaction modulation
ENSG00000177302,TOP3A,dna replication regulation,genomic instability,oncogenic function,protein degradation,tumor suppressor inhibition,cell cycle progression
ENSG00000197299,BLM,genomic instability,dna repair deficiency,homologous recombination,oncogenic mutations,chromosomal rearrangements,therapeutic target
ENSG00000162772,ATF3,cellular stress response,transcriptional regulation,tumor suppressor oncogene,poor prognosis indicator,apoptosis modulation,angiogenesis promotion
ENSG00000108262,GIT1,gef activity,rho gtpase regulation,cytoskeletal dynamics,cell migration,protein-protein interactions,tumor growth and metastasis
ENSG00000102606,ARHGEF7,rho gef activity,tumor progression,metastasis resistance,cell migration regulation,oncogenic signaling pathway interaction,therapeutic target
ENSG00000138039,LHCGR,cellular proliferation,receptor activation,g-protein coupled receptor,signaling pathway deregulation,immune evasion mechanisms,biomarker discovery
ENSG00000284901,RUVBL1,chromatin remodeling,genomic instability,dna replication initiation,tumor progression,cell cycle regulation,apoptosis modulation
ENSG00000183337,BCOR,chromatin regulation,tumor suppression,oncogenic processes,cell proliferation,apoptosis modulation,histone modification
ENSG00000171450,CDK5R2,cdk5 dysregulation,tumor progression,cyclin-dependent kinase activation,cell proliferation,apoptosis inhibition,aberrent cellular signaling
ENSG00000121022,COPS5,dendylyation regulation,tumor suppressor function,ubiquitination pathway,cell cycle regulation,anti-apoptotic role,cancer-related mutations
ENSG00000154473,BUB3,chromosome segregation,mitotic checkpoint,cell cycle regulation,kinetochores,spindle assembly,genomic instability
ENSG00000169679,BUB1,mitotic regulation,genomic instability,chromosomal abnormalities,cell cycle dysregulation,aneuploidy promotion,spindle checkpoint disruption
ENSG00000164342,TLR3,innate immunity,apoptosis regulation,immune evasion,tumor microenvironment modulation,oncogenic potential,nf-κb pathway activation
ENSG00000127666,TICAM1,immune modulation,toll-like receptor signaling,inflammatory response regulation,cytokine production,angiogenesis promotion,immunosuppression role
ENSG00000171552,BCL2L1,apoptosis regulation,mitochondrial function,cell survival,chemosensitivity modulation,tumor progression,genomic instability
ENSG00000069966,GNB5,g-protein coupled receptor signaling,oncogene activation,cell migration,poor prognosis,tumor progression,protein-protein interaction
ENSG00000131788,PIAS3,tumor suppression,stat3 inhibition,e3 ubiquitin ligase activity,cell growth regulation,oncogenesis prevention,transcriptional regulation
ENSG00000282130,NSMCE3,genomic instability,dna repair disruption,smc5-smc6 complex subunit,tumor progression driver,therapeutic target potential,genome stability maintenance
ENSG00000101412,E2F1,oncogenic transcription factor,constitutive activation,cell proliferation,tumor suppressor function,angiogenesis,pi3k/akt pathway regulation
ENSG00000170962,PDGFD,angiogenesis,cell proliferation,metastasis,pdgfrb signaling,platelet-derived growth factor,tumor progression
ENSG00000134954,ETS1,emt regulation,oncogene activation,tumor invasion,angiogenesis promotion,transcriptional regulation,cellular proliferation
ENSG00000161888,SPC24,nucleocytoplasmic transport,cell cycle regulation,nuclear pore complex,tumor progression,oncogenesis,genomic instability
ENSG00000080986,NDC80,genomic instability,aneuploidy,chromosome segregation,mitotic progression,dna replication errors,tumor suppressor function
ENSG00000185737,NRG3,oncogene activation,akt/mtor signaling,cell proliferation,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000182957,SPATA13,cell cycle progression,oncogenic signaling,immune regulation,centriole duplication,ciliogenesis,apoptosis modulation
ENSG00000112062,MAPK14,p38 mapk pathway,phosphorylation dependent,oncogenic processes,tumor growth,stress signaling,therapeutic target
ENSG00000131196,NFATC1,regulation of emt,enhancement of tumor progression,cell survival and migration,immune response modulation,transcriptional regulation,protein-protein interaction
ENSG00000081189,MEF2C,transcription factor regulation,oncogenic role,cell cycle progression,apoptosis evasion,pi3k/akt pathway interaction,tumor metastasis promotion
ENSG00000170289,CNGB3,calcium influx regulation,prognostic marker,potential therapeutic target,cancer risk association,tumor progression,genomic variation
ENSG00000144191,CNGA3,**

ion channel regulation,radiation resistance,epithelial-to-mesenchymal transition,calcium influx modulation,cell proliferation,signal transduction 
**
ENSG00000105221,AKT2,pi3k/akt signaling,tumor progression,cell survival,protein kinase activation,akt pathway regulation,glycolysis enhancement
ENSG00000135547,HEY2,tumor suppression,downregulation in tumors,cell proliferation regulation,apoptosis modulation,dna repair pathway interaction,tissue specificity
ENSG00000133216,EPHB2,angiogenesis promotion,mapk/erk pathway modulation,pi3k/akt signaling activation,tumor metastasis facilitation,cell migration enhancement,therapeutic target identification
ENSG00000157933,SKI,transcriptional co-activator,tgf-beta signaling pathway modulation,oncogenic transformation promotion,cell proliferation enhancement,apoptosis inhibition,cancer-related transcription factor regulation
ENSG00000150593,PDCD4,loss of tumor suppressor function,regulation of apoptosis,cellular differentiation regulation,cell growth inhibition,interaction with mdm2 and β-catenin,prognostic marker
ENSG00000196961,AP2A1,ap2a1 mediated regulatory mechanisms,tumor suppressor function,dephosphorylation activity,pp2a interaction,oncogenic pathway regulation,cancer cell aggressiveness
ENSG00000161203,AP2M1,cell surface receptor regulation,clathrin-mediated endocytosis,oncogenic signaling activation,metastasis promotion,angiogenesis enhancement,prognostic marker
ENSG00000147044,CASK,cancer-related signaling pathways,tumor growth regulation,oncogene activation,cellular process modulation,transcriptional regulation influence,synaptic plasticity dysregulation
ENSG00000158458,NRG2,egf signaling,oncogenic activation,cell proliferation enhancement,immune evasion facilitation,tumor progression,angiogenesis promotion
ENSG00000188130,MAPK12,mapk signaling pathway,oncogenic transformation,cell proliferation regulation,tumor progression driver,survival pathway activation,protein kinase activity enhancement
ENSG00000101400,SNTA1,prognostic marker,angiogenesis regulator,proliferation enhancer,tumor progression driver,metastasis associated,cell cycle regulator
ENSG00000186625,KATNA1,translation initiation,cell proliferation,chemosensitivity regulation,tumor progression,anti-cancer target,protein synthesis regulation
ENSG00000125538,IL1B,tumor microenvironment manipulation,immunosuppression facilitation,inflammation induction,cell proliferation enhancement,angiogenesis promotion,pro-inflammatory signaling pathway
ENSG00000097007,ABL1,genomic instability,kinase activity,cell proliferation,tumor suppression,phosphorylation events,oncogenic signaling
ENSG00000187555,USP7,oncogenesis,apoptosis inhibition,cell survival,tumor suppression inhibition,deubiquitination activity,transcription factor regulation
ENSG00000206279,DAXX,histone modification complex,dna repair mechanisms,genomic instability,telomere length regulation,cell cycle progression modulation,apoptosis regulation
ENSG00000061273,HDAC7,chromatin regulation,tumor suppression,cell cycle progression,apoptosis regulation,cytoplasmic localization,transcriptional repression
ENSG00000130726,TRIM28,p53 inhibition,epigenetic regulation,transcriptional repression,tumor suppressor inactivation,cell survival enhancement,chromatin remodeling
ENSG00000144485,HES6,cell cycle regulation,apoptosis modulation,emt regulation,transcriptional activation,hypoxia adaptation,metastatic promotion
ENSG00000123124,WWP1,oncogene regulation,tumor progression marker,protein degradation dysregulation,pi3k/akt/mtor pathway modulation,apoptosis inhibition,cell proliferation enhancement
ENSG00000138755,CXCL9,immune cell recruitment,tumor microenvironment modulation,chemokine signaling,cytokine regulation,pro-inflammatory activity,anti-tumor response
ENSG00000179348,GATA2,oncogenic driver,epithelial-to-mesenchymal transition (emt),transcriptional regulator,tumor growth promoter,metastasis inducer,poor prognosis marker
ENSG00000164362,TERT,telomerase activation,cancer immortality,telomere maintenance,oncogene reactivation,proliferation enhancement,cell immortalization
ENSG00000044115,CTNNA1,overexpression,tumor progression,cell migration and invasion,wnt/β-catenin pathway,adherens junction disruption,pi3k/akt signaling interaction
ENSG00000068903,SIRT2,tumor progression,epigenetic regulation,mitochondrial function,dna damage response,cell cycle regulation,therapeutic target
ENSG00000253293,HOXA10,epithelial-to-mesenchymal transition,self-renewal capacity,pro-survival signaling,tumor progression,transcriptional regulation,methylation pattern changes
ENSG00000121671,CRY2,genomic instability,pi3k/akt signaling,oncogene,cell proliferation,circadian rhythm regulation,dna damage response
ENSG00000072803,FBXW11,ubiquitin ligase activity,tumor suppression,cell cycle regulation,substrate recognition,cancer cell survival,proliferation pathway
ENSG00000184481,FOXO4,tumor suppression,apoptosis induction,cell cycle regulation,transcriptional regulation,metastasis promotion,pi3k/akt pathway interaction
ENSG00000160014,CALM3,calcium-mediated signaling pathway,cell proliferation enhancement,apoptosis inhibition,tumor progression promotion,angiogenesis regulation,protein kinase activation
ENSG00000172020,GAP43,cytoplasmic localization,cell migration regulation,cytoskeleton dynamics,mapk/erk signaling pathway,oncogene overexpression,cell proliferation enhancement
ENSG00000113712,CSNK1A1,wnt/β-catenin pathway,cell cycle regulation,protein phosphorylation,constitutive activation,transcriptional modulation,tumor metastasis
ENSG00000100567,PSMA3,proteasome regulation,ubiquitin-proteasome pathway dysregulation,tumor suppressor degradation,cell cycle progression,apoptosis resistance,therapeutic target
ENSG00000126561,STAT5A,stat transcriptional regulation,constitutive activation,growth factor signaling,cell proliferation,tumor progression,signaling pathway interaction
ENSG00000092820,EZR,cell adhesion disruption,cytoskeleton reorganization,cell migration promotion,prognostic marker upregulation,signaling pathway modulation,tumor progression facilitation
ENSG00000065717,TLE2,transcriptional regulation,cell proliferation,epithelial-to-mesenchymal transition,wnt/β-catenin signaling pathway,notch signaling pathway,chromatin remodeling
ENSG00000120798,NR2C1,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor suppressor function,genomic instability,chromatin remodeling
ENSG00000075711,DLG1,loss of function,cell adhesion disruption,tumor progression facilitation,biomarker potential,poor prognosis association,therapeutic target candidate
ENSG00000253729,PRKDC,genomic instability,dna repair mechanisms,tumor suppressor function,cell cycle regulation,protein kinase activity,chromosomal abnormalities
ENSG00000152457,DCLRE1C,genomic instability,dna damage response,tumor progression,apoptosis regulation,cell cycle checkpoint,oncogene overexpression
ENSG00000288401,CTTN,microtubule dynamics regulation,wnt/β-catenin signaling interaction,metastatic behavior association,cytoskeletal reorganization,overexpression linked to poor prognosis,centrosome modulation
ENSG00000131910,NR0B2,regulation of cell cycle,oncogenic transcription factor,apoptosis evasion,cell proliferation enhancement,metastasis promotion,pi3k/akt pathway interaction
ENSG00000185950,IRS2,pi3k/akt pathway,oncogenic process,insulin signaling disruption,tumor growth promotion,metabolic regulation,protein-protein interaction
ENSG00000140044,JDP2,tumor suppressor function,transcriptional co-repressor activity,cell differentiation regulation,ap-1 complex interaction,oncogenic process inhibition,genomic instability suppression
ENSG00000124440,HIF3A,hypoxia-inducible factor stabilization,oncogenic activation,angiogenesis promotion,cell survival enhancement,genomic instability induction,therapeutic target
ENSG00000169071,ROR2,wnt/pcp signaling pathway,constitutive activation,amplification or overexpression,cell migration and invasion,therapeutic target,genomic alterations
ENSG00000143384,MCL1,anti-apoptotic,apoptosis suppression,cell survival,malignant cell accumulation,poor prognosis marker,therapeutic target
ENSG00000079841,RIMS1,kca3.1 channel regulation,metastasis promotion,tumor progression marker,cell migration enhancement,apoptosis suppression,cell cycle regulation modulation
ENSG00000198722,UNC13B,akt regulation,cell growth promotion,kinase regulation,neurotransmitter release modulation,pi3k/akt pathway interaction,therapeutic target
ENSG00000140009,ESR2,er signaling pathway,overexpression,cell proliferation,tumor progression,therapeutic target,genomic amplification
ENSG00000131981,LGALS3,epithelial-to-mesenchymal transition,cellular invasion,pi3k/akt pathway activation,glycolysis regulation,tumor progression marker,oncogene expression
ENSG00000147099,HDAC8,histone modification,tumor growth promotion,transcriptional regulation disruption,apoptosis inhibition,angiogenesis promotion,cell cycle progression enhancement
ENSG00000198952,SMG5,nmd pathway disruption,aberrant mrna accumulation,tumor progression enhancement,cell growth promotion,survival pathway activation,genomic instability contributor
ENSG00000056558,TRAF1,nf-κb signaling pathway,apoptosis regulation,immune response modulation,cell migration promotion,oncogene activation,tumor progression facilitation
ENSG00000138964,PARVG,cell cycle disruption,dna repair dysregulation,integration into host dna,oncogene activation,pi3k/akt pathway activation,tumor formation enhancement
ENSG00000198901,PRC1,spindle checkpoint regulation,gene amplification,chromosomal instability,cell cycle progression,tumor suppressor,mitotic regulation
ENSG00000140350,ANP32A,genome instability,tumor suppressor function,chromatin regulation,dna repair mechanisms,premature chromatin condensation,oncogenic transformation
ENSG00000182636,NDN,chromatin remodeling,tumor suppressor function,cell cycle regulation,genomic instability,microtubule stability,transcriptional modulation
ENSG00000160633,SAFB,chromatin remodeling,transcriptional regulation,oncogene overexpression,tumor aggressiveness,prognostic marker,apoptosis modulation
ENSG00000089220,PEBP1,cell cycle regulation,oncogenic processes,tumor progression,therapeutic target,apoptosis inhibition,cell proliferation
ENSG00000281766,RYBP,oncogene activity,tumor suppressor function,chromatin regulation,gene silencing,e3 ubiquitin ligase complex formation,epithelial-to-mesenchymal transition (emt)
ENSG00000027869,SH2D2A,tumor suppressor function,loss of function mutation,immune response modulation,t-cell activation regulation,cancer predisposition,renal cell carcinoma association
ENSG00000169967,MAP3K2,constitutive activation,overexpression,cell proliferation,apoptosis resistance,pi3k/akt/mtor pathway interaction,poor prognosis
ENSG00000065618,COL17A1,hemidesmosome disruption,ecm interaction,cell adhesion loss,invasion facilitation,metastasis promotion,tumor progression
ENSG00000139687,RB1,cell cycle regulation,tumor suppressor function,transcriptional regulation,oncogenesis prevention,dna damage response,therapeutic target
ENSG00000118971,CCND2,g1 phase progression,constitutive activation,cancer driver,cell cycle regulation,oncogenic process,therapeutic target
ENSG00000160791,CCR5,enhanced angiogenesis,constitutive activation,pro-tumorigenic,immunomodulatory,metastatic potential,tumor microenvironment manipulation
ENSG00000197386,HTT,oncogene,unfolded protein response,tumor suppressor dysfunction,cellular stress response,protein degradation regulation,autophagy dysregulation
ENSG00000106211,HSPB1,cellular homeostasis,tumor progression,heat shock response,molecular chaperone activity,cell survival,stress tolerance
ENSG00000014216,CAPN1,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition,cell migration regulation,tumor progression association,proteolytic activity enhancement,oncogenic signaling promotion
ENSG00000126247,CAPNS1,calpain activation,cell proliferation,tumor progression,protein degradation regulation,metabolic reprogramming,genomic instability
ENSG00000184500,PROS1,tumor progression,tumor microenvironment,coagulation regulation,angiogenesis regulation,cell proliferation,vitamin k-dependent protein
ENSG00000110711,AIP,**

genetic predisposition,tumor suppressor function,ahr signaling pathway regulation,cell growth modulation,xenobiotic metabolism regulation,protein-protein interaction 

**
ENSG00000162909,CAPN2,cancer cell invasion,proteolytic activity,tumor aggressiveness,apoptosis regulation,cell adhesion modulation,oncogenic process promoter
ENSG00000141655,TNFRSF11A,nf-kappab pathway activation,osteoclast differentiation regulation,tumor microenvironment modulation,apoptosis resistance enhancement,cell cycle progression promotion,immune system evasion
ENSG00000120659,TNFSF11,tumor promotion,osteoclast differentiation,tumor microenvironment modulation,angiogenesis and lymphangiogenesis,metastasis enhancement,oncogenic signaling
ENSG00000171476,HOPX,cellular differentiation regulation,tumor suppressor function,apoptosis modulation,genetic instability,dna repair regulation,prognostic biomarker potential
ENSG00000259384,GH1,gh/igf-1 signaling,tumor progression,proliferation regulation,survival pathway,dysregulation,kinase activation
ENSG00000110934,BIN2,baf complex interaction,chromatin remodeling,cell proliferation regulation,metastasis promotion,oncogenic mutations,genomic instability
ENSG00000048052,HDAC9,epigenetic regulation,nuclear localization,chromatin compaction,transcriptional repression,tumor progression,oncogenic role
ENSG00000198821,CD247,tumor-infiltrating lymphocytes,immune evasion,tcr complex,signal-transducing component,t-cell activation,poor prognosis
ENSG00000204217,BMPR2,tumor suppressor function,constitutive activation,gain-of-function mutations,tumor progression,epigenetic regulation,pi3k/akt pathway interaction
ENSG00000107779,BMPR1A,tumor suppressor,wnt/β-catenin signaling,cell proliferation regulation,apoptosis modulation,genetic alterations,cancer development
ENSG00000140443,IGF1R,igf-1/igf-2 signaling,cell proliferation,apoptosis inhibition,pi3k/akt/mtor pathway interaction,tumor growth promotion,anti-apoptotic activity
ENSG00000136603,SKIL,wnt/β-catenin pathway regulation,oncogene activation,overexpression and amplification,tumor growth promotion,poor prognosis correlation,genomic instability
ENSG00000168398,BDKRB2,tumor progression,angiogenesis,prognostic marker,inflammation,g-protein coupled receptor,signaling pathway activation
ENSG00000170581,STAT2,stat family signaling,tumor cell proliferation,mutation/alteration,immune response regulation,interferon pathway interaction,apoptosis regulation
ENSG00000159692,CTBP1,wnt/β-catenin pathway activation,transcriptional co-repressor function,oncogenic signaling facilitation,tumor suppressor repression,prognostic marker overexpression,therapeutic target potential
ENSG00000285109,GATA4,transcriptional activator,tumor progression,metastasis,cell proliferation,survival pathway,nf-κb pathway interaction
ENSG00000183072,NKX2-5,transcriptional regulation,cardiac development related genes,apoptosis inhibition,cellular proliferation enhancement,tumor progression marker,overexpression in kirc
ENSG00000003402,CFLAR,nf-kb signaling pathway,apoptosis inhibition,tumor progression,therapeutic target,cell survival regulation,gene expression modulation
ENSG00000111348,ARHGDIB,rho gtpase regulation,oncogenic potential,cancer progression,cell motility modulation,therapeutic target,tumorigenesis
ENSG00000067560,RHOA,cell migration,cancer progression,oncogenic properties,mapk/erk pathway,gtpase activity,cytoplasmic localization
ENSG00000141456,PELP1,chromatin remodeling,cell growth regulation,steroid hormone receptor interaction,tumor suppressor function loss,oncogenic processes promotion,androgen receptor modulation
ENSG00000163599,CTLA4,tumor immune evasion,immune checkpoint inhibition,cell surface receptor,cytokine regulation,autoimmune suppression,immunotherapeutic target
ENSG00000065361,ERBB3,tumor progression,oncogenic potential,pi3k/akt signaling pathway activation,cell proliferation enhancement,angiogenesis promotion,metastasis facilitation
ENSG00000196132,MYT1,transcriptional regulation,cell proliferation,oncogene activation,apoptosis inhibition,genomic instability,therapeutic target
ENSG00000186951,PPARA,metabolic regulation,tumor suppressor function,lipid metabolism disruption,apoptosis induction,energy homeostasis dysregulation,nuclear receptor activation
ENSG00000185291,IL3RA,angiogenesis,immunosuppression,oncogene activation,tumor microenvironment modulation,signaling pathway regulation,genomic instability
ENSG00000174697,LEP,metabolic regulation,tumor progression,cell proliferation,epithelial-to-mesenchymal transition,angiogenesis,survival signaling
ENSG00000101773,RBBP8,genomic instability,homologous recombination repair,oncogene function,brca1 regulation,ubiquitination,cell cycle progression
ENSG00000135218,CD36,fatty acid uptake,tumor progression,metabolic regulation,cell adhesion,immune modulation,angiogenesis
ENSG00000128245,YWHAH,signaling pathway modulation,apoptosis regulation,scaffold protein function,cell proliferation driver,tumor suppressor dysfunction,protein-protein interaction network
ENSG00000159110,IFNAR2,interferon-alpha/beta receptor,immune evasion,tumor suppressor dysfunction,poor prognosis,antitumor immunity suppression,dysregulated signaling cascade
ENSG00000080839,RBL1,tumor suppressor function,cell cycle regulation,transcriptional regulation,cell proliferation control,protein-protein interactions,chromosomal alterations
ENSG00000116044,NFE2L2,constitutive activation,antioxidant response element,pro-apoptotic gene regulation,cell cycle regulation,oxidative stress response,transcriptional activator
ENSG00000079999,KEAP1,nrf2 signaling pathway,constitutive activation,loss-of-function mutations,cancer progression,therapeutic target,oxidative stress regulation
ENSG00000164690,SHH,shh pathway activation,tumor growth promotion,wnt/beta-catenin interaction,epithelial-to-mesenchymal transition (emt),cellular proliferation induction,microenvironment modulation
ENSG00000144891,AGTR1,agtr1 signaling pathway,oncogenic driver,cell proliferation,gene amplification,hypoxia adaptation,tumor metastasis
ENSG00000121966,CXCR4,cxcr4/cxcl12 axis,tumor progression,metastasis,cell migration,therapeutic target,epithelial-to-mesenchymal transition (emt)
ENSG00000134480,CCNH,ccnh mutations,tumor growth,transcriptional regulation,cell cycle progression,cyclin h subunit,cdk7 activation
ENSG00000134058,CDK7,cdk-activating kinase,aberrant transcription,cell cycle progression,dna repair mechanisms,genomic instability,oncogene overexpression
ENSG00000123908,AGO2,mirna regulation,dna damage response,genomic instability,tumorigenesis,cancer metastasis,biomarker potential
ENSG00000100697,DICER1,microrna regulation,oncogenesis,tumor suppressor,genomic instability,transposon-derived sirnas,piwi-pirna pathway
ENSG00000016490,CLCA1,tumor progression,cell migration,invasion,epithelial-to-mesenchymal transition,signaling pathway regulation,biomarker potential
ENSG00000164078,MST1R,oncogenic signaling pathways,receptor tyrosine kinase activity,tumor growth promotion,mutation or amplification,enhanced cellular proliferation,aberrant signaling pathway
ENSG00000168028,RPSA,ribosome biogenesis,cell proliferation,protein synthesis regulation,oncogene activity,poor prognosis marker,cell cycle regulation
ENSG00000151914,DST,autophagy regulation,lysosomal dysfunction,genomic instability,cell signaling disruption,tumor aggressiveness,therapeutic target
ENSG00000178209,PLEC,cell adhesion disruption,oncogenic signaling,apoptosis resistance,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000136238,RAC1,cell cycle regulation,cancer cell migration,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,oncogenic signaling,proliferation and survival enhancement
ENSG00000112851,ERBIN,pi3k/akt/mtor pathway,overexpression,cell proliferation,oncogenic driver,scaffolding protein,signaling modulation
ENSG00000026025,VIM,cellular structure regulation,intermediate filament protein,epithelial-to-mesenchymal transition (emt),oncogenic potential,tumor progression marker,cell adhesion modulation
ENSG00000177697,CD151,integrin interaction,cell adhesion regulation,metastasis promotion,tumor growth enhancement,molecular targeting,protein-protein interaction
ENSG00000176105,YES1,transcription regulation,genomic instability,dna repair interaction,oncogene activation,cell cycle progression,prognostic marker
ENSG00000134308,YWHAQ,cell survival,pi3k/akt pathway regulation,oncogene overexpression,tumor progression,apoptosis resistance,signaling molecule interaction
ENSG00000242372,EIF6,translation initiation,cell proliferation,oncogene expression,tumor progression,anabolic processes,translational control
ENSG00000166813,KIF7,microtubule-associated motor protein,tumor suppressor function impairment,oncogene activation,cell proliferation regulation,genomic instability contributor,signaling pathway dysregulation
ENSG00000117425,PTCH2,hedgehog pathway activation,constitutive activation,gain of function mutations,tumor progression,transmembrane receptor,cell proliferation
ENSG00000173020,GRK2,g-protein coupled receptor signaling,cell proliferation,survival pathways,pi3k/akt pathway activation,signal transduction regulation,kinase activity disruption
ENSG00000157540,DYRK1A,pi3k/akt signaling,overexpression,cell proliferation,cell survival,cyclin-dependent kinase regulation,transcription factor phosphorylation
ENSG00000163482,STK36,wnt/β-catenin pathway,kinase activation,oncogenic signaling,cell proliferation,tumor progression,genetic mutation
ENSG00000235568,NFAM1,cell cycle regulation,apoptosis modulation,oncogenic overexpression,protein-protein interaction,cell proliferation control,tumorigenesis promotion
ENSG00000115085,ZAP70,activation of downstream pathways,non-receptor tyrosine kinase function,oncogenic signaling,tumor proliferation and survival,protein-protein interactions,genomic overexpression
ENSG00000165025,SYK,tumor progression,gain of function mutations,protein kinase activation,cell proliferation,immune evasion,angiogenesis
ENSG00000111859,NEDD9,cell cycle regulation,mitotic spindle checkpoint,tumor progression,microtubule dynamics,oncogenic driver,g2/m phase transition
ENSG00000115935,WIPF1,cell migration,overexpression,oncogene,cytoskeleton regulation,actin dynamics regulation,prognostic biomarker
ENSG00000116473,RAP1A,gain of function mutations,cell migration,oncogenic processes,adhesion regulation,gtpase activation,signaling molecule interaction
ENSG00000068831,RASGRP2,rap1 activation,cell proliferation,gef activity,tumor progression,prognostic marker,genomic instability
ENSG00000110448,CD5,deregulated expression,cell proliferation,tumor metastasis,protein interaction,signaling pathway regulation,biomarker potential
ENSG00000155926,SLA,transcriptional regulation,cellular differentiation,protein interaction,tumor suppressor potential,genomic regulation,proliferation control
ENSG00000113263,ITK,t-lymphocyte activation,constitutive activation,oncogenic transformation,cell proliferation,signaling pathway modulation,immunosuppression
ENSG00000160856,FCRL3,tumor progression,immune modulation,cell migration,protein-protein interaction,signaling pathway regulation,apoptosis suppression
ENSG00000154016,GRAP,mapk/erk pathway activation,ras protein regulation,tumor suppressor function,cell proliferation regulation,oncogenic signaling,gtpase-activating activity
ENSG00000141293,SKAP1,immunomodulation,t-cell regulation,gain of function mutations,tumor progression,cell migration,immune surveillance
ENSG00000172575,RASGRP1,rap1 activation,guanine nucleotide exchange factor,cell adhesion regulation,tumor growth promotion,onco-protein interaction,pkc signaling pathway modulation
ENSG00000079805,DNM2,cell migration,mitochondrial dynamics,actin cytoskeleton regulation,tumor progression,prognostic marker,overexpression
ENSG00000198286,CARD11,nf-?b signaling pathway,pro-survival signaling,tumor progression,therapeutic target,genomic instability,immune evasion
ENSG00000139436,GIT2,gap/gef regulation,small gtpase modulation,rho gtpase pathway activation,cell migration enhancement,tumor progression promotion,prognostic marker
ENSG00000125753,VASP,cell migration,focal adhesion kinase interaction,pi3k/akt signaling pathway,actin cytoskeleton dynamics,oncogenic behavior,lamellipodia formation
ENSG00000154380,ENAH,cancer stem cell regulation,cell migration facilitation,epithelial-to-mesenchymal transition,actin cytoskeleton modulation,tumor progression enhancement,therapeutic target
ENSG00000196405,EVL,cytoplasmic protein,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression marker,cell migration promotion,cytoskeletal regulation
ENSG00000232575,TUBB,microtubule dynamics,aberrant microtubule assembly,cell migration,mitotic disruption,chemotherapy resistance,oncogenesis
ENSG00000070159,PTPN3,non-receptor protein tyrosine phosphatase,immune evasion,sh2 domain-containing phosphatase interactions,tumor progression,proliferation and survival modulation,high expression levels in cancerous tissues
ENSG00000108861,DUSP3,mapk signaling pathway,dephosphorylation activity,oncogenic function,tumor progression,apoptosis suppression,angiogenesis promotion
ENSG00000163519,TRAT1,tumorigenesis,cellular proliferation,gain-of-function mutations,apoptosis evasion,cell cycle regulation,therapeutic target
ENSG00000127947,PTPN12,tumor suppressor,cell proliferation regulation,mutation loss of function,protein tyrosine phosphatase activity,signaling pathway modulation,somatic mutation profiling
ENSG00000074966,TXK,cell proliferation,metastasis promotion,tumor progression,signaling pathway modulation,poor prognosis marker,oncogenic potential
ENSG00000185499,MUC1,immune evasion,cell signaling,tumor progression,oncogene activation,overexpression,protein-protein interaction
ENSG00000015285,WAS,arp2/3 complex activation,cell migration,cytoskeleton regulation,overexpression,poor prognosis,tumor aggressiveness
ENSG00000005020,SKAP2,apoptosis resistance,cell migration enhancer,invasion promoter,pi3k/akt pathway regulator,small gtpase activator,tumor progression mediator
ENSG00000115053,NCL,transcriptional regulator,apoptosis inhibition,tumor progression,cell cycle regulation,dna repair modulation,leucine zipper domain interaction
ENSG00000109103,UNC119,rab26 interaction,guanine nucleotide exchange factor,oncogenic signaling pathway,cell membrane trafficking,tumor aggressiveness,epithelial-to-mesenchymal transition
ENSG00000101082,SLA2,cell invasion,actin cytoskeleton regulation,metastasis regulator,biomarker candidate,tumor progression,protein-protein interaction
ENSG00000095370,SH2D3C,sh2 domain-containing protein,immune response modulation,tumor promoter,cell signaling regulation,cancer driver gene candidate,proliferation enhancement
ENSG00000107338,SHB,pi3k/akt pathway,overexpression,tyrosine kinase activation,tumor progression,cell proliferation regulation,signal transduction
ENSG00000127824,TUBA4A,microtubule dynamics,cellular structure regulation,mitotic spindle assembly,cell proliferation enhancement,cancer progression facilitation,cytoplasmic microtubules maintenance
ENSG00000134215,VAV3,gef activity,migratory pathway regulation,rho gtpase interaction,cell adhesion modulation,tumor progression enhancement,oncogenic behavior promotion
ENSG00000023892,DEF6,ubiquitin-proteasome pathway,cell proliferation,oncogenic processes,protein degradation regulation,therapeutic target,tumorigenesis
ENSG00000198087,CD2AP,cell-cell interaction,focal adhesion formation,angiogenesis promotion,cell migration regulation,oncogene function,adhesion molecule interaction
ENSG00000122188,LAX1,cellular metabolism regulation,metabolic enzyme activity,sugars degradation,tumor microenvironment interaction,genetic variation association,cancer-related expression pattern
ENSG00000080031,PTPRH,tumor aggressiveness,biomarker potential,pi3k/akt pathway regulation,tgf-β signaling modulation,cell proliferation enhancement,prognostic significance
ENSG00000113594,LIFR,lif/lifr pathway,oncogenic signaling,gain of function mutations,tumor progression,cellular proliferation,cancer metastasis
ENSG00000198793,MTOR,mtor signaling,oncogene activation,cell proliferation,protein synthesis,autophagy regulation,metabolic reprogramming
ENSG00000099985,OSM,jak/stat pathway,oncostatin m signaling,angiogenesis promotion,immune suppression,epithelial-to-mesenchymal transition,tumor progression
ENSG00000276536,HRAS,mapk/erk signaling pathway,constitutive activation,gain of function mutations,tumor progression,oncogene,cell proliferation
ENSG00000121853,GHSR,overexpression,tumor aggressiveness,cell proliferation,angiogenesis,poor prognosis,metabolic regulation
ENSG00000124089,MC3R,g protein-coupled receptor,metabolic regulation,oncogenic processes,cell proliferation,tumorigenesis,signaling pathway dysregulation
ENSG00000184845,DRD1,tumor progression,oncogenic signaling,receptor activation,g protein-coupled receptor,mutation associated cancer,cell proliferation regulation
ENSG00000147246,HTR2C,serotonin receptor activation,cell proliferation enhancement,stress response modulation,therapeutic target exploration,tumor progression facilitation,genomic profiling alterations
ENSG00000114353,GNAI2,activation of pi3k/akt pathway,signaling regulator,gain of function mutations,oncogenic driver,mapk/erk pathway regulation,cell proliferation and survival enhancement
ENSG00000157017,GHRL,cellular proliferation,energy balance regulation,growth factor activity,hormone secretion,tumor progression,metastasis promotion
ENSG00000123901,GPR83,oncogene,tumor progression,cell proliferation,apoptosis suppression,pi3k/akt/mtor pathway activation,g protein-coupled receptor signaling
ENSG00000162009,SSTR5,tumor suppression,cell cycle regulation,apoptosis induction,somatostatin signaling,proliferation inhibition,tumor metastasis inhibition
ENSG00000137486,ARRB1,regulates egfr trafficking,mitogen-activated protein kinase (mapk) pathway activation,oncogene function,cell migration promotion,tumor microenvironment modulation,prognostic marker significance
ENSG00000165119,HNRNPK,heterogeneous nuclear ribonucleoprotein,rna processing and transport,tumor suppressor regulation,cellular proliferation,apoptosis modulation,metastasis promotion
ENSG00000070190,DAPP1,focal adhesion,cell migration,protein-protein interaction,cytoplasmic structure,tumor progression,metastasis facilitation
ENSG00000101336,HCK,activates pi3k/akt pathway,immune cell regulation,resistance to therapy,tumor progression,therapeutic target,cell proliferation
ENSG00000182022,CHST15,chondroitin sulfate modification,overexpression,cell migration,metastasis promotion,integrin interaction,pi3k/akt pathway activation
ENSG00000160293,VAV2,rho gtpase activation,cancer cell migration,constitutive activation,oncogenic activity,cellular adhesion disruption,tumor progression driver
ENSG00000105369,CD79A,bcr signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,antigen receptor signaling
ENSG00000007312,CD79B,b cell development,antigen binding,signal transduction,immunoglobulin chain,cell proliferation,gene expression regulation
ENSG00000086730,LAT2,pi3k/akt pathway,constitutive activation,oncogene overexpression,tumor progression,cell proliferation,signaling molecule interaction
ENSG00000010671,BTK,apoptosis regulation,cell cycle progression,tumor metastasis,oncogenic activity,signaling pathway modulation,protein interaction
ENSG00000166908,PIP4K2C,phosphoinositide signaling pathway,oncogenic transformation,cell proliferation regulation,therapeutic target,pi3k/akt pathway modulation,metabolic reprogramming
ENSG00000276293,PIP4K2B,oncogenic signaling,phosphoinositide metabolism regulation,cell survival enhancement,tumor progression driver,cell growth promotion,apoptosis resistance
,IGHM,immunoglobulin overexpression,epigenetic regulation,aberrant expression patterns,tumor progression,oncogenic transformation,cellular proliferation
ENSG00000012124,CD22,b-cell receptor signaling,cell surface protein,glycoprotein function,immune system regulation,cancer progression mechanism,gene expression abnormality
ENSG00000143398,PIP5K1A,metabolic reprogramming,oncogenic signaling,tumor progression,cellular lipid metabolism regulation,apoptosis evasion,pi3k/akt pathway activation
ENSG00000072135,PTPN18,receptor tyrosine kinase regulation,constitutive activation,loss-of-function mutations,tumor progression,cell migration,oncogenic processes
ENSG00000035720,STAP1,slc9a3 regulation,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,negative regulation of apoptosis,sodium balance disruption
ENSG00000107242,PIP5K1B,cell membrane regulation,oncogenic signaling pathway,cell growth promotion,lipid metabolism dysregulation,protein-lipid interaction,apoptosis inhibition
ENSG00000184304,PRKD1,pi3k/akt pathway interaction,tumor progression driver,cancer signaling pathway activation,cell cycle regulation disruption,protein kinase activation,metastasis promoter
ENSG00000072694,FCGR2B,fc-gamma receptor signaling,immune checkpoint modulation,angiogenesis regulation,tumor immune evasion,poor prognosis association,overexpression implicated
ENSG00000285369,BLK,immunomodulation,oncogenic driver,poor prognosis,high expression levels,tumor microenvironment modulation,non-receptor tyrosine kinase activation
ENSG00000166501,PRKCB,pkc signaling pathway,constitutive activation,gain of function mutations,tumor progression,angiogenesis promotion,cell survival enhancement
ENSG00000263001,GTF2I,chromatin remodeling,transcriptional regulation,gene expression modulation,rna polymerase ii recruitment,cellular proliferation,protein-protein interaction
ENSG00000120088,CRHR1,cortisol regulation,hpa axis activation,mapk/erk pathway activation,pi3k/akt signaling enhancement,immune suppression,tumor growth promotion
ENSG00000087460,GNAS,constitutive activation,tumor suppressor loss,wnt/β-catenin signaling,oncogenic mutations,cell proliferation,resistance to therapy
ENSG00000088256,GNA11,gain-of-function mutations,constitutive activation,mtor pathway activation,cell growth promotion,tumor progression,oncogenic activity
ENSG00000087258,GNAO1,wnt/β-catenin pathway,constitutive activation,g protein signaling,tumor progression,therapeutic target,signaling pathway alteration
ENSG00000198055,GRK6,gpcr regulation,serine/threonine kinase activity,oncogenic signaling pathway,tumor growth promotion,cell proliferation enhancement,therapeutic target candidate
ENSG00000127955,GNAI1,g protein-coupled receptor signaling,cellular regulation disruption,tumor growth modulation,apoptosis evasion,cell cycle control dysregulation,oncogenic pathway activation
ENSG00000159069,FBXW5,apoptosis regulation,cell cycle regulation,genomic instability,oncogenic pathway suppression,protein degradation regulation,tumor suppressor function
ENSG00000070061,ELP1,aberrant transcription,chromatin remodeling,dna repair,genomic instability,oncogenic expression,transcriptional regulation
ENSG00000119414,PPP6C,cell cycle regulation,dna repair,genomic instability,oncogenic process,protein phosphatase activity,therapeutic target
ENSG00000198001,IRAK4,nf-κb activation,innate immune response modulation,tumor microenvironment modification,oncogenic signaling pathway regulation,cancer cell proliferation promotion,tumor progression enhancement
ENSG00000196083,IL1RAP,accessory receptor component,inflammation regulation,immune response modulation,cytokine signaling pathway,tumor progression,immunosuppression
ENSG00000157625,TAB3,proteasome regulation,cell cycle progression,ubiquitin-proteasome pathway,apoptosis regulation,tumor suppression,cancer progression
ENSG00000197329,PELI1,oncogenic function,immune response modulation,cell survival regulation,tumor microenvironment modulation,signaling pathway regulation,adaptor protein interaction
ENSG00000232960,CSNK2B,ck2 activation,pro-tumorigenic environment,wnt/β-catenin pathway regulation,phosphorylation and activation of targets,oncogene activation,cell cycle regulation
ENSG00000082898,XPO1,nuclear export regulation,tumor suppressor export,apoptosis suppression,cell cycle modulation,oncogenic process facilitation,tumor microenvironment modulation
ENSG00000132341,RAN,cell cycle regulation,chromosomal instability,dna repair mechanisms,aneuploidy promotion,mitotic checkpoint disruption,cytoskeleton dynamics
ENSG00000108829,LRRC59,oncogenic driver,cell adhesion disruption,cell signaling regulation,tumor progression mediator,protein-protein interaction network,tumor suppressor inactivation
ENSG00000172500,FIBP,fibroblast growth factor-binding protein,mapk/erk signaling pathway activation,oncogene upregulation,cell proliferation enhancement,tumor progression promotion,epithelial-to-mesenchymal transition regulation
ENSG00000176170,SPHK1,sphingosine-1-phosphate signaling,oncogenic growth,metastatic potential,angiogenesis promotion,chemoresistance enhancement,therapeutic target
ENSG00000230514,AGER,oncogenic potential,tumor progression,immune suppression,angiogenesis,epithelial-to-mesenchymal transition (emt),pro-inflammatory cytokines
ENSG00000147065,MSN,cancer cell migration,cell division regulation,cytoplasmic protein regulation,kinase activation modulation,oncogene function,protein phosphatase interaction
ENSG00000067900,ROCK1,cell migration,constitutive activation,phosphorylation regulation,actin cytoskeleton remodeling,tumor progression,rhoa signaling
ENSG00000173757,STAT5B,jak/stat signaling,constitutive activation,gain of function mutations,tumor growth promotion,gene expression regulation,protein interaction modulation
ENSG00000108443,RPS6KB1,phosphorylation regulation,cell cycle progression,protein synthesis enhancement,mtor pathway activation,tumor progression facilitation,therapeutic target candidacy
ENSG00000123609,NMI,rna-binding protein,pre-mrna splicing,gene regulation,tumor microenvironment modulation,oncogene involvement,therapeutic target
ENSG00000136156,ITM2B,aberrant activation,cell survival pathways,n-glycan modification,pi3k/akt pathway interaction,protein-protein interactions,tumor progression
ENSG00000134460,IL2RA,tumor immunosuppression,immune evasion,t-cell modulation,immunosurveillance failure,high-affinity receptor complex,tumor-infiltrating immune cells
ENSG00000127831,VIL1,tumor progression,oncogene function,actin filament dynamics,cell motility enhancement,epithelial-to-mesenchymal transition,poor prognostic marker
ENSG00000182511,FES,fes overexpression,oncogenic transformation,cellular proliferation,tumor progression,metastasis promotion,emt induction
ENSG00000120833,SOCS2,immune evasion,tumor progression,cancer cell growth,jak/stat pathway regulation,biomarker potential,cell proliferation suppression
ENSG00000153094,BCL2L11,apoptosis regulation,bcl-2 family interaction,mitochondrial outer membrane permeabilization,cellular homeostasis maintenance,chemotherapy resistance modulation,pro-apoptotic protein function
ENSG00000196628,TCF4,wnt signaling pathway,transcriptional regulation,cell growth and proliferation,tumor progression,apoptosis inhibition,therapeutic target
ENSG00000184502,GAST,wnt/β-catenin pathway activation,cell proliferation promotion,gastric acid secretion regulation,angiogenesis facilitation,tumor growth promotion,metastasis enhancement
ENSG00000124151,NCOA3,oncogene regulation,transcriptional coactivation,histone modification,tumor progression,poor prognosis marker,nuclear receptor interaction
ENSG00000197157,SND1,metabolic regulation,mitochondrial function,oncogenesis,cell survival,metabolic adaptation,therapeutic target
ENSG00000113520,IL4,tumor progression,angiogenesis promotion,tumor cell proliferation,immune evasion,pro-inflammatory cytokine production,jak/stat pathway modulation
ENSG00000185338,SOCS1,stat pathway activation,loss of function mutations,tumor progression,immunosuppression,cell proliferation regulation,jak/stat signaling
,HIST3H3,histone modification,chromatin remodeling,tumor suppressor function,dna repair mechanism,cell cycle regulation,genomic instability
ENSG00000124766,SOX4,transcription factor regulation,oncogenic potential,cell cycle progression,epithelial-to-mesenchymal transition,poor prognosis indicator,pi3k/akt pathway interaction
ENSG00000065559,MAP2K4,mapk/erk signaling,constitutive activation,tumor progression,cell proliferation,apoptosis resistance,dysregulated kinase activity
ENSG00000087095,NLK,cell cycle regulation,apoptosis inhibition,nf-κb pathway activation,oncogenic signaling,therapeutic target,genomic amplification
ENSG00000104432,IL7,immune checkpoint modulation,cell proliferation and survival,tumor microenvironment modulation,b-cell development and maintenance,cancer cell immune evasion,jak/stat pathway activation
ENSG00000013561,RNF14,genomic instability,cancer prognosis,biological marker,therapeutic target,ubiquitination regulation,cellular degradation
ENSG00000172531,PPP1CA,tumor growth regulation,cellular signal transduction,metabolic regulation,protein kinase activation,gene expression modulation,cancer cell survival
ENSG00000167333,TRIM68,trim68 is involved in,tumor suppressor function,loss or downregulation in cancers,ubiquitination and protein degradation regulation,cell cycle regulation,antiviral defense mechanism
ENSG00000105401,CDC37,cell cycle regulation,gene amplification,overexpression,phosphorylation activity,tumor progression,protein kinase activation
ENSG00000184895,SRY,transcription factor,sex determination,embryonic development,testis formation,cell proliferation,androgen regulation
,AES,histone modification regulation,telomere maintenance,dna repair modulation,p53 pathway regulation,cell survival promotion,apoptosis resistance
ENSG00000114166,KAT2B,p53 interaction,transcriptional regulation,chromatin remodeling,tumor suppressor modulation,oncogenic overexpression,apoptosis inhibition
ENSG00000151729,SLC25A4,mitochondrial function,energy metabolism regulation,tumor progression,cell proliferation support,therapeutic target potential,citrate transport mechanism
ENSG00000108654,DDX5,transcriptional regulation,oncogene function,cell proliferation,apoptosis inhibition,genomic instability,chromosomal rearrangement
ENSG00000160310,PRMT2,arginine methylation,cellular proliferation,oncogenic transformation,tumor progression,angiogenesis regulation,protein interaction
ENSG00000063978,RNF4,genetic instability,tumor suppressor degradation,dna repair regulation,cell proliferation enhancement,mitotic checkpoint control,ubiquitin ligase function
ENSG00000165671,NSD1,h3k36mt activity,histone modification,chromatin regulation,oncogene activation,cell proliferation,tumor progression
ENSG00000186976,EFCAB6,calcium signaling pathway,cell cycle regulation,tumor progression,proliferation regulation,cancer biology,genomic instability
ENSG00000197321,SVIL,cytoskeletal regulation,actin-binding protein,cell migration enhancement,oncogenic upregulation,tumorigenesis contribution,genomic overexpression
ENSG00000108175,ZMIZ1,chromatin remodeling,cell proliferation,dna repair,gene expression regulation,nuclear localization,transcriptional activation
ENSG00000144747,TMF1,cell cycle regulation,dna repair dysfunction,transcriptional regulation,cell proliferation enhancement,tumor growth promotion,p53 interaction
ENSG00000115641,FHL2,tumor progression,transcriptional regulation,oncogene activation,cell proliferation,apoptosis modulation,cytoskeleton organization
ENSG00000101224,CDC25B,cell cycle regulation,oncogenesis,tumor progression,cell proliferation,therapeutic target,aberrant expression
ENSG00000101158,NELFCD,transcriptional regulation,oncogenic processes,cell growth promotion,protein-protein interactions,genomic instability,tumor aggressiveness
ENSG00000109685,NSD2,histone methylation,chromatin remodeling,oncogenic transcription,genome instability,cancer driver mutation,therapeutic target
ENSG00000129514,FOXA1,foxa1 transcriptional regulation,oncogenic function,cell cycle progression,tumor progression,signaling pathway activation,transcriptional interaction
ENSG00000107077,KDM4C,histone modification,chromatin regulation,tumor suppressor gene regulation,cell proliferation promotion,oncogenic pathway regulation,epigenetic modulation
ENSG00000115548,KDM3A,histone demethylation,chromatin remodeling,tumor suppressor gene activation,gene expression regulation,oncogenic mechanism modulation,therapeutic target
ENSG00000100105,PATZ1,transcription factor activity,cell proliferation enhancement,oncogenic pathway interaction,tumor progression driver,apoptosis evasion,metastasis promoter
ENSG00000170606,HSPA4,chaperone function,cellular stress response,protein homeostasis regulation,tumor growth promotion,signaling pathway modulation,oncogenic protein accumulation
ENSG00000107262,BAG1,apoptosis inhibition,cell proliferation enhancement,cell survival promotion,oncogene activity,pi3k/akt pathway modulation,tumor growth facilitation
ENSG00000078725,BRINP1,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis suppression,epithelial-to-mesenchymal transition,signaling pathway activation
ENSG00000185247,MAGEA11,apoptosis regulation,cancer immunity,cell cycle progression,immunotherapeutic target,oncoprotein expression,tumor progression marker
ENSG00000146587,RBAK,p53-interacting protein,cell cycle regulator,genomic stability maintenance,dna repair and replication,apoptosis induction,protein kinase activation
ENSG00000135940,COX5B,mitochondrial function,oncogenic processes,tumor suppressor role,apoptosis regulation,reactive oxygen species production,electron transport chain assembly
ENSG00000122515,ZMIZ2,transcriptional coactivator,cell proliferation,protein stabilization,oncogene overexpression,poor prognosis,metastatic regulation
ENSG00000136504,KAT7,chromatin remodeling,tumor suppressor function,histone acetyltransferase activity,dna repair regulation,cell cycle progression,genomic instability mitigation
ENSG00000110768,GTF2H1,ner pathway impairment,genome instability,cell cycle dysregulation,apoptosis inhibition,transcriptional regulation,tumor suppressor function
ENSG00000266412,NCOA4,metabolic regulation,glycolysis regulation,glutaminolysis regulation,cellular proliferation,transcriptional coactivation,metabolic adaptation
ENSG00000140682,TGFB1I1,tumor suppressor function,constitutive activation,loss of function mutations,cell proliferation enhancement,metastasis promotion,smad protein interaction
ENSG00000164045,CDC25A,cdk activation,cell cycle progression,aberrant proliferation,gene expression regulation,tumor aggressiveness,therapeutic target
ENSG00000134248,LAMTOR5,mtor signaling,cell growth regulation,ragulator complex component,tumor progression driver,cell survival modulation,genomic instability contributor
ENSG00000124664,SPDEF,oncogenic function,transcriptional regulation,cell cycle modulation,apoptosis inhibition,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000147140,NONO,genomic instability,dna repair regulation,chromatin remodeling,tumor progression driver,therapeutic target,cellular proliferation
ENSG00000177426,TGIF1,cell cycle regulation,tumor suppressor activity,apoptosis pathway modulation,genomic stability maintenance,transcriptional regulation,protein-protein interaction
ENSG00000169375,SIN3A,chromatin remodeling,epigenetic regulation,tumor suppressor gene silencing,apoptosis inhibition,cell cycle progression,histone deacetylase complex component
ENSG00000132437,DDC,tyrosine kinase activation,angiogenesis promotion,tumor progression,cellular growth regulation,metastasis enhancement,dna damage response
ENSG00000126457,PRMT1,arginine methylation,epigenetic regulation,histone modification,pi3k/akt pathway modulation,oncogene activation,chromatin remodeling
ENSG00000105229,PIAS4,cellular regulation,transcriptional modulation,jak/stat pathway interaction,tumor suppressor activity,oncogene function,protein-protein interactions
ENSG00000146278,PNRC1,transcriptional regulation,promoter recognition,cell proliferation,chromatin remodeling,tumor progression,prognostic marker
ENSG00000168066,SF1,transcription factor,steroid hormone biosynthesis,cell proliferation,apoptosis inhibition,tumorigenesis driver,chromatin remodeling
ENSG00000117450,PRDX1,oxidative stress resistance,cell survival enhancement,antioxidant function,protein-protein interaction,cell signaling modulation,apoptosis regulation
ENSG00000110031,LPXN,cell adhesion disruption,metastasis promotion,signaling pathway interaction,integrin regulation,cell migration facilitation,tumor progression facilitation
ENSG00000273173,SNURF,rna splicing regulation,nuclear complex component,pre-mrna processing,cancer-related expression,tumor growth modulation,gene expression regulation
ENSG00000106546,AHR,tumor progression,immune evasion,cytochrome p450 regulation,cell proliferation,angiogenesis modulation,ligand-activated transcription factor
ENSG00000167657,DAPK3,apoptosis regulation,tumor suppressor function,cell cycle arrest,dna repair mechanism,transcriptional regulation,calcium-dependent signaling
ENSG00000169750,RAC3,gain of function mutations,constitutive activation,oncogenic transformation,cell migration,cell proliferation,tumor aggressiveness
ENSG00000137992,DBT,oxidative stress regulation,tumor initiation,biotransformation of pro-carcinogens,enzymatic activity modulation,xenobiotic metabolism,antioxidant defense influence
ENSG00000177463,NR2C2,tumor suppression,regulatory element binding,transcriptional modulation,cellular differentiation,apoptosis regulation,genomic instability
ENSG00000148180,GSN,actin-modulating protein,calcium-regulated function,cell migration promotion,cytoskeletal dynamics regulation,tumor progression facilitation,metastasis enhancement
ENSG00000083799,CYLD,nf-kappab activation,ubiquitin modification,tumor suppression,cell proliferation,metastasis promotion,oncogenic process
ENSG00000131100,ATP6V1E1,v-atpase regulation,oncogenesis,autophagy induction,tumor microenvironment acidification,metastasis promotion,protein activation by ros
ENSG00000082512,TRAF5,tnf receptor signaling pathway,oncogene,tumor progression,cell survival and proliferation,metastasis,nf-κb regulation
ENSG00000260548,IRS4,pi3k/akt pathway modulation,constitutive activation,tumor growth promotion,oncogenic potential,cell proliferation enhancement,apoptosis inhibition
ENSG00000172572,PDE3A,tumor progression,ancillary protein kinase regulation,signaling pathway dysregulation,cell proliferation enhancement,metabolic alteration,cancer prognosis marker
ENSG00000132693,CRP,chronic inflammation,systemic inflammation,immune dysregulation,tumor progression,acute-phase response,genetic instability
ENSG00000163399,ATP1A1,ion transport regulation,cell membrane polarization,cancer cell migration,tumor progression,electrochemical gradient,signal transduction
ENSG00000165409,TSHR,tumor progression,cell proliferation,growth regulation,therapeutic target,cancer biology,signal transduction
ENSG00000065135,GNAI3,g protein regulation,adenylate cyclase inhibition,cell proliferation,loss of function mutation,tumor progression,ciliogenesis regulation
ENSG00000170820,FSHR,fshr signaling,cancer progression,tumor growth promotion,angiogenesis promotion,apoptosis inhibition,cell proliferation enhancement
ENSG00000239697,TNFSF12,immune evasion,tumor growth promotion,apoptosis inhibition,pro-apoptotic signaling,angiogenesis regulation,death receptor 3 interaction
ENSG00000006327,TNFRSF12A,nf-κb pathway activation,oncogenic signaling,tumor progression driver,immune evasion mechanism,cell survival promotion,gene expression regulation
ENSG00000177575,CD163,tumor-associated macrophage polarization,inflammation regulation,immune response modulation,angiogenesis promotion,pro-tumorigenic microenvironment creation,poor prognosis correlation
ENSG00000198681,MAGEA1,nf-κb pathway interaction,oncogenic functions promotion,tumor progression association,poor prognosis correlation,apoptosis regulation,cell proliferation enhancement
ENSG00000138433,CIR1,**

microtubule stability,spindle checkpoint regulation,cell cycle checkpoints,chromosomal segregation,genomic instability,therapeutic target

**
ENSG00000022267,FHL1,fhl1 overexpression,gain of function mutations,oncogene activation,cell migration regulation,tumor progression facilitation,akt pathway interaction
ENSG00000184384,MAML2,notch signaling pathway,constitutive activation,oncogene potential,tumor progression,cell growth regulation,genomic amplification
ENSG00000196782,MAML3,notch pathway activation,transcriptional coactivator function,amplification or overexpression,oncogene activation,cell proliferation enhancement,tumor progression facilitation
ENSG00000164105,SAP30,chromatin remodeling,epigenetic regulation,cell cycle regulation,apoptosis modulation,genome stability maintenance,tumor suppressor function
ENSG00000283780,MAML1,notch signaling pathway,oncogenic transcriptional coactivator,gain of function mutations,cell proliferation and survival,tumor aggressiveness,poor prognosis
ENSG00000109670,FBXW7,tumor suppressor function,cell cycle regulation,genomic stability maintenance,ubiquitin ligase activity,signaling pathway modulation,dna repair mechanism
ENSG00000113558,SKP1,ubiquitin-proteasome pathway,scf complex,cell cycle regulation,protein turnover regulation,tumor progression,cancer driver gene
ENSG00000231115,RING1,polycomb group protein regulation,chromatin remodeling,epigenetic silencing,tumor suppressor gene repression,oncogene maintenance,dysregulated cell proliferation
ENSG00000223654,FLOT1,pi3k/akt pathway activation,cell survival promotion,membrane trafficking regulation,signaling complex formation,cancer progression facilitation,tumor aggressiveness marker
ENSG00000132589,FLOT2,cellular proliferation,apoptosis regulation,lipid metabolism modulation,signal transduction facilitation,prognostic biomarker,overexpression in cancer
ENSG00000281877,RPS6KA1,mtor pathway,oncogenic potential,cell proliferation,metabolic regulation,tumor progression,protein synthesis activation
ENSG00000071242,RPS6KA2,mtorc1 pathway,oncogenic driver,aberrant activation,cell growth regulation,protein synthesis modulation,tumor progression
ENSG00000165458,INPPL1,pi3k/akt/mtor signaling,phosphatidylinositol dephosphorylation,oncogenic pathway activation,cell growth regulation,protein-protein interaction,tumor progression modulator
ENSG00000169891,REPS2,mitotic checkpoint regulation,chromosomal instability,e3 ubiquitin ligase activation,genomic stability maintenance,cell proliferation enhancement,apoptosis evasion
ENSG00000142273,CBLC,calcium-dependent signaling,overexpression,biomarker potential,cellular proliferation,signaling pathway regulation,protein-protein interaction
ENSG00000143333,RGS16,rgs16 downregulation,tumor suppression,gpcr signaling pathway regulation,cellular response modulation,gαi protein interaction,tumorigenesis involvement
ENSG00000168374,ARF4,microtubule regulation,oncogene activation,cell migration promotion,apoptosis suppression,cell cycle progression,signaling pathway modulation
ENSG00000111057,KRT18,tumor progression,tissue integrity disruption,oncoprotein interaction,cellular morphology alteration,epithelial cell marker,signaling pathway modulation
ENSG00000149480,MTA2,histone modification,chromatin remodeling,transcriptional activation,epithelial-to-mesenchymal transition,cell migration,tumor suppressor gene suppression
ENSG00000136044,APPL2,pi3k/akt pathway interaction,tumor suppressor function,signaling pathway modulation,cell proliferation regulation,apoptosis regulation,oncogenic process inhibition
ENSG00000034152,MAP2K3,erk/mapk signaling pathway,gain of function mutations,oncogenic driver,cell proliferation regulator,anti-apoptotic function,signaling pathway activation
ENSG00000127946,HIP1,cell migration,apoptosis resistance,cytoskeletal organization,cellular trafficking,microtubule dynamics,tumor aggressiveness
ENSG00000166225,FRS2,constitutive activation,mapk pathway,oncogene,tumor progression,cell survival,adaptor protein
ENSG00000138193,PLCE1,pi3k/akt/mtor signaling pathway,ca2+ mediated signaling,gain of function mutations,oncogene,tumor growth,metastasis
ENSG00000105971,CAV2,pi3k/akt pathway modulation,cellular cholesterol transport,signaling pathway activation,tumor progression facilitation,cell growth and survival promotion,cancer gene overexpression
ENSG00000140600,SH3GL3,endocytosis regulation,tumor suppressor,pi3k/akt pathway activation,cell migration enhancement,poor prognosis marker,akt signaling modulation
ENSG00000106976,DNM1,mitochondrial dynamics,regulation of cell survival,endocytosis regulation,protein-protein interaction,cell proliferation enhancement,tumor aggressiveness
ENSG00000156508,EEF1A1,oncogenic translation,cell proliferation,protein synthesis regulation,tumor growth promotion,poor prognosis association,therapeutic target candidate
ENSG00000109917,ZPR1,chromatin remodeling,tumor suppressor function,transcriptional regulation,genomic stability maintenance,apoptosis promotion,oncogene repression
ENSG00000166484,MAPK7,oncogenic signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000153233,PTPRR,genomic alteration,pi3k/akt/mtor pathway regulation,tumor progression,oncogene function,dephosphorylation activity,cell proliferation regulation
ENSG00000017797,RALBP1,pi3k/akt pathway interaction,tumor progression driver,ubc activity,renal cancer involvement,xenobiotic transport regulation,cell survival enhancement
ENSG00000144118,RALB,aberrant activation,cancer progression,cell proliferation,cytoplasmic localization,effector protein interaction,membrane trafficking regulation
ENSG00000108946,PRKAR1A,loss of function mutations,constitutive activation,tumor suppressor function,cell proliferation regulation,mapk/erk pathway activation,prognostic significance
ENSG00000061938,TNK2,t-cell activation,serine/threonine kinase activity,oncogenic transformation,cell growth regulation,immune response modulation,protein-protein interaction
ENSG00000070831,CDC42,cell proliferation,constitutive activation,cytoskeleton regulation,cell migration,oncogenic processes,signaling pathway disruption
ENSG00000133056,PIK3C2B,regulation of cellular signaling pathways,cell growth and survival promotion,interaction with pten and vegfa regulation,oncogenic properties acquisition,tumor cell migration facilitation,angiogenesis promotion
ENSG00000144730,IL17RD,nf-κb activation,tumor growth promotion,angiogenesis enhancement,apoptosis inhibition,cancer stem cell modulation,inflammation mediation
ENSG00000116285,ERRFI1,egfr signaling pathway inhibition,tumor progression,protein-protein interaction,cell proliferation regulation,signaling cascade modulation,oncogenic driver gene expression
ENSG00000174238,PITPNA,pi3k pathway interaction,growth factor regulation,lipid metabolism dysregulation,phosphatidylserine transport,cell proliferation enhancement,tumor aggressiveness
ENSG00000065243,PKN2,akt/pkb pathway activation,cell survival enhancement,oncogenic signaling,tumor progression,therapeutic target,protein kinase regulation
ENSG00000129219,PLD2,oncogenic pathway activation,overexpression,phosphatidic acid production,cell signaling regulation,membrane trafficking dysregulation,tumor growth promotion
ENSG00000140575,IQGAP1,adhesion modulation,cell migration regulation,oncogenic transformation,tumor progression facilitation,signaling pathway interaction,metastasis promotion
ENSG00000288293,CC2D1A,centriole integrity disruption,ciliogenesis regulation,tumor suppressor function,cell growth promotion,metastasis enhancement,protein interaction network
ENSG00000133703,KRAS,gtpase activity,gain-of-function mutations,constitutive activation,tumor progression,therapeutic target,cell proliferation regulation
ENSG00000095015,MAP3K1,activation of downstream pathways,tumor progression,cell proliferation,genomic instability,epithelial-to-mesenchymal transition,oncogene activation
ENSG00000115290,GRB14,pi3k/akt pathway modulation,tumor progression driver,cell growth regulator,signaling pathway interaction,oncogenic potential,gene overexpression
ENSG00000160271,RALGDS,ras-gap regulation,tumor suppressor function,cell migration and invasion modulation,oncogenic signaling inhibition,unchecked cell growth and proliferation,growth factor response regulation
ENSG00000141738,GRB7,cell proliferation,oncogenic transformation,signal transduction pathway,receptor tyrosine kinase regulation,metastatic potential,scaffolding protein function
ENSG00000144566,RAB5A,endocytic pathway modulation,cell proliferation regulation,tumor metastasis facilitation,cell membrane trafficking regulation,cancer progression correlation,protein transportation enhancement
ENSG00000174791,RIN1,rap1 gef activity,oncogene overexpression,pi3k/akt pathway regulation,cell proliferation promotion,metastasis facilitation,extracellular matrix interaction
ENSG00000137218,FRS3,regulation of protein quality,cell survival and growth,constitutive activation,interaction with pi3k/akt pathway,cellular adaptation to stress,tumor progression
ENSG00000188313,PLSCR1,pi3k/akt interaction,cell proliferation promotion,phospholipid metabolism regulation,calcium signaling modulation,tumor metastasis facilitation,prognostic marker alteration
ENSG00000128422,KRT17,epithelial-to-mesenchymal transition,cytoplasmic intermediate filament network,microtubule stabilization,cell proliferation regulation,tumor progression facilitation,therapeutic target
ENSG00000170421,KRT8,epithelial integrity disruption,metastasis promotion,emt induction,cytoskeletal reorganization,prognostic marker,none
ENSG00000137764,MAP2K5,cell proliferation,mitogen-activated protein kinase signaling pathway,dual-specificity kinase activation,erk1/2 phosphorylation,oncogenesis,tumor progression
ENSG00000163558,PRKCI,pkc-ι signaling pathway,mutation or overexpression,tumor suppressor regulation,cell proliferation enhancement,oncogene activation,genomic instability
ENSG00000135480,KRT7,epithelial marker,tumor progression,prognostic marker,cellular structure,intermediate filament protein,cancer biomarker
ENSG00000125743,SNRPD2,**

aberrant splicing,alternative rna processing,cell growth regulation,genomic instability,mutation hotspot,oncogenic isoform formation
ENSG00000204842,ATXN2,chromatin remodeling,gain of function mutations,polyglutamine expansion,cell cycle regulation,genomic instability,protein-protein interactions
ENSG00000076201,PTPN23,overexpression,tumor suppressor function,phosphatase activity,signaling pathway regulation,cell migration regulation,apoptosis inhibition
ENSG00000145901,TNIP1,nf-κb signaling,inflammation regulation,tumor suppression,apoptosis induction,protein interaction,gene expression modulation
ENSG00000076984,MAP2K7,constitutive activation,oncogenic process,cell proliferation,tumor progression,kinase activation,signaling pathway
ENSG00000085511,MAP3K4,nf-κb activation,constitutive activation,cell proliferation,apoptosis suppression,genetic alterations,signaling pathway regulation
ENSG00000158711,ELK4,cellular proliferation,transcriptional regulation,oncogenic signaling pathways,histological characteristics,prognostic biomarkers,therapeutic targets
ENSG00000283060,ID3,oncogenic signaling,transcriptional regulation,gene silencing,tumor progression,cell cycle regulation,cancer immunity evasion
ENSG00000115738,ID2,transcription factor regulation,constitutive activation,g1 phase cell cycle arrest evasion,wnt/β-catenin pathway interaction,oncogenic driver mutation,poor prognosis biomarker
ENSG00000111145,ELK3,transcription factor regulation,oncogenic processes,cellular growth promotion,protein-protein interactions,tumor progression,cancer metastasis
ENSG00000172201,ID4,cellular proliferation,transcriptional regulation,oncogenic activity,epithelial-to-mesenchymal transition (emt),tumor suppressor gene suppression,therapeutic target
ENSG00000103479,RBL2,tumor suppressor function,loss of function mutations,cell cycle regulation,rb-e2f pathway,genomic instability,cancer driver gene
ENSG00000196092,PAX5,epigenetic regulation,transcriptional regulator,tumor progression,b-cell development,germinal center maintenance,oncogenic driver
ENSG00000159352,PSMD4,proteasome activity,tumor suppressor degradation,cell cycle progression,hyperphosphorylation,cancer metastasis,immune evasion
ENSG00000166794,PPIB,tumor suppressor modulation,apoptosis regulation,cell survival enhancement,protein folding regulation,pi3k/akt pathway interaction,genomic amplification
ENSG00000164615,CAMLG,calcium signaling,cell proliferation,oncogenic driver,tumor progression,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway activation
ENSG00000170027,YWHAG,cell cycle regulation,apoptosis suppression,protein-protein interaction,signaling pathway modulation,tumor suppressor activity,proliferation regulation
ENSG00000136098,NEK3,cell cycle regulation,tumor suppressor protein regulation,apoptosis resistance,genomic stability maintenance,oncogenic kinase activity,dna replication regulation
ENSG00000151090,THRB,cell proliferation regulation,apoptosis modulation,gene expression regulation,thyroid hormone interaction,tumor aggressiveness association,potential biomarker for disease progression
ENSG00000151849,CENPJ,centrosome amplification,cell cycle progression,genomic instability,oncogenic potential,amplified in kirc,tumor suppressor function
ENSG00000007264,MATK,oncogenic,tumor progression,cell proliferation,growth factor signaling,metastasis,therapeutic target
ENSG00000000938,FGR,mapk/erk pathway modulation,constitutive activation,oncogenic transformation promoter,therapeutic target,src family tyrosine kinase activity,cell proliferation and survival enhancer
ENSG00000166068,SPRED1,ras/mapk pathway regulation,tumor suppressor function,cellular proliferation inhibition,signaling pathway disruption,oncogenic transformation driver,protein-protein interaction dysfunction
ENSG00000198369,SPRED2,mtor pathway interaction,tumor suppressor function,loss-of-function mutations,tumor growth regulation,cell survival enhancement,growth factor inhibition
ENSG00000197323,TRIM33,tumor progression,tumor suppressor function,loss of function mutations,cell proliferation,apoptosis regulation,differentiation modulation
ENSG00000114520,SNX4,egfr pathway regulation,tumor progression,akt/mtor activation,cell survival enhancement,endosomal trafficking modulation,pten degradation
ENSG00000129515,SNX6,regulation of endosomal trafficking,signaling pathway regulation,tumor progression,cell proliferation,therapeutic target,genomic alterations
ENSG00000111424,VDR,tumor suppression,cell proliferation inhibition,immune system modulation,vitamin d signaling pathway regulation,dna repair induction,apoptosis induction
ENSG00000163877,SNIP1,nf-κb regulation,cell proliferation,apoptosis suppression,oncogenic process promotion,tumor progression,tumor suppressor downregulation
ENSG00000100614,PPM1A,pp2a regulation,tumor suppressor function,loss of function mutation,oncogenic signaling pathway activation,cell cycle progression disruption,apoptosis inhibition
ENSG00000132953,XPO4,nuclear transport regulation,tumor suppressor protein export,cell cycle disruption,oncogenic interaction,poor prognosis marker,apoptosis inhibition
ENSG00000102974,CTCF,genomic instability,chromatin remodeling,transcriptional regulation,cell cycle control,homologous recombination repair,oncogene/tumor suppressor
ENSG00000126883,NUP214,nuclear pore complex assembly,oncogene amplification,cell proliferation,signaling pathway interaction,tumor progression marker,genomic amplification
ENSG00000166887,VPS39,autophagic flux regulation,endosomal trafficking,cellular homeostasis maintenance,therapeutic resistance enhancement,pi3k/akt pathway interaction,oncogenesis promotion
ENSG00000157077,ZFYVE9,autophagic activity,gain of function mutations,endosomal trafficking regulation,multivesicular body formation,protein sorting modulation,tumor progression biomarker
ENSG00000272886,DCP1A,mrna degradation regulation,tumor suppressor mrna inhibition,cell proliferation enhancement,survival pathway activation,metastasis facilitation,therapeutic target
ENSG00000066136,NFYC,transcriptional regulation,cell cycle progression,dna replication,apoptosis suppression,tumor suppressor inactivation,genomic instability
ENSG00000120837,NFYB,ccaat box binding,oncogene upregulation,cell cycle progression,tumor growth promotion,apoptosis suppression,genome stability regulation
ENSG00000169554,ZEB2,tumor progression,metastasis driver,transcriptional regulator,e-cadherin repression,mesenchymal transition,prognostic marker
ENSG00000006125,AP2B1,**

receptor internalization,clathrin-mediated endocytosis,cell surface receptor regulation,oncogene activation,tumor growth promotion,gene expression modulation

**
ENSG00000125971,DYNLRB1,p53 regulation,ubiquitin-proteasome pathway,protein degradation,genomic instability,tumor suppressor regulation,cancer driver mutation
ENSG00000023734,STRAP,tgf-β receptor interaction,emt modulation,cell cycle regulation,scaffolding protein function,kinase/phosphatase activation,smad3 phosphorylation
ENSG00000130177,CDC16,apc complex component,cell division regulation,cell cycle progression,tumor suppressor activity loss,oncogenic process promotion,ubiquitination and degradation regulation
ENSG00000176396,EID2,nf-κb signaling pathway,overexpression,tumor growth promotion,metastasis,poor prognosis marker,none
ENSG00000004897,CDC27,cell cycle regulation,dysregulated protein degradation,cancer cell proliferation,tumor aggressiveness,genomic instability,oncogene activation
ENSG00000078399,HOXA9,hoxa9 overexpression,cell proliferation,apoptosis inhibition,angiogenesis promotion,tumor initiation,transcriptional regulation
ENSG00000221914,PPP2R2A,oncogenic signaling,loss of function mutations,tumor suppressor dysfunction,cell proliferation regulation,protein phosphatase dysregulation,cell survival enhancement
ENSG00000108984,MAP2K6,erk signaling pathway,oncogene activation,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition,genomic mutation hotspot
ENSG00000133740,E2F5,cell cycle regulation,transcriptional regulator,oncogene activation,metastasis promotion,apoptosis evasion,histone modification
ENSG00000119699,TGFB3,tgf-β signaling,epithelial-to-mesenchymal transition (emt),oncogenic activation,immune suppression,metastasis promotion,cell differentiation inhibition
ENSG00000114302,PRKAR2A,camp signaling pathway,constitutive activation,oncogenic potential,tumor progression,therapeutic target,signal transduction
ENSG00000188191,PRKAR1B,pi3k/akt interaction,constitutive activation,gain of function mutations,tumor progression,protein kinase regulation,cellular signaling pathway
ENSG00000170604,IRF2BP1,cellular proliferation,oncogene,e3 ubiquitin ligase activity,tumor suppressor inactivation,pi3k/akt pathway activation,gene expression regulation
ENSG00000101076,HNF4A,metabolic reprogramming,transcriptional regulation,tumor progression,glycolysis promotion,lipogenesis activation,prognostic biomarker
ENSG00000125398,SOX9,transcription factor function,cancer stem cell maintenance,emt and fibrosis regulation,urogenital system development,cartilage formation,mesenchymal cell expression
ENSG00000105325,FZR1,genomic instability,aneuploidy,tumor progression,cell cycle regulation,chromosome segregation,prognostic biomarker
ENSG00000026508,CD44,tumor progression,hyaluronic acid interaction,metastasis promotion,cancer stem cell regulation,angiogenesis facilitation,wnt/β-catenin pathway interaction
ENSG00000084623,EIF3I,oncogenic function,constitutive activation,protein synthesis regulation,tumor growth promotion,genomic amplification,therapeutic target
ENSG00000118046,STK11,hippo signaling pathway,tumor suppressor function,genomic instability,cell polarity regulation,dna damage response,chromosomal instability
ENSG00000144589,STK11IP,stk11 regulation,tumor suppressor inhibition,cell proliferation enhancement,oncogenic signaling promotion,poor prognosis marker,genomic instability modulation
ENSG00000001167,NFYA,oncogenic transcription,ccaat motif binding,transcriptional regulation,cell proliferation,metastasis promotion,therapeutic target
ENSG00000148516,ZEB1,transcription factor,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,immune suppression,metastasis and invasion,apoptosis resistance
ENSG00000168589,DYNLRB2,mrna degradation,cell proliferation,tumor progression,ccr4-not complex,upregulation,apoptosis resistance
ENSG00000124789,NUP153,nuclear pore complex,nucleocytoplasmic transport,tumor progression,biomarker candidate,apoptosis resistance,genomic instability
ENSG00000181191,PJA1,peptidase activity,protein-protein interactions,tumor progression,metastasis,signal transduction,transcriptional regulation
ENSG00000039319,ZFYVE16,autophagy regulation,escrt-0 complex modulation,oncogenic driver,tumor growth promotion,epithelial-to-mesenchymal transition,cancer cell stemness
ENSG00000184221,OLIG1,tumor progression,tissue-specific expression,cell cycle regulation,dna repair mechanisms,transcriptional regulator,oncogene activation
ENSG00000168556,ING2,genome stability regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,pi3k/akt pathway modulation,histone modification regulation
ENSG00000169783,LINGO1,cell proliferation,angiogenesis,immune evasion,tumor progression,metastasis,protein-protein interactions
ENSG00000134243,SORT1,genomic instability,tumor cell survival,pro-apoptotic ligand clearance,poor prognosis,cellular proliferation,endocytosis regulation
ENSG00000185634,SHC4,enhanced cell proliferation,cell migration,sustained signal transduction,phosphatidylinositol 3-kinase interaction,receptor tyrosine kinase activation,oncogenic transformation
ENSG00000073969,NSF,intracellular trafficking,aberrant protein secretion,tumor progression,metastasis,mapk/erk pathway,membrane repair
ENSG00000174804,FZD4,wnt/β-catenin signaling pathway,oncogene,tumor progression,cellular polarity disruption,therapeutic target,metastasis
ENSG00000126583,PRKCG,protein kinase activation,cellular signaling,oncogenesis,apoptosis regulation,cell cycle modulation,genomic instability
ENSG00000125084,WNT1,wnt signaling,canonical pathway,oncogenesis,cell proliferation,tumorigenesis,frizzled receptors
ENSG00000188763,FZD9,wnt/β-catenin signaling pathway,oncogene activation,tumor progression,cell proliferation regulation,metastasis promotion,gene expression modulation
ENSG00000105989,WNT2,wnt signaling pathway activation,tumor progression,oncogene overexpression,cell proliferation regulation,therapeutic target,cancer cell survival enhancement
ENSG00000164930,FZD6,wnt signaling pathway,oncogenic process,tumor progression,cell proliferation,aberrant signaling,genomic instability
ENSG00000104332,SFRP1,wnt signaling pathway inhibition,tumor suppressor function,apoptosis promotion,angiogenesis inhibition,cell growth regulation,cancer metastasis suppression
ENSG00000182968,SOX1,transcriptional regulation,cell proliferation,genomic instability,tumor progression,stemness maintenance,oncogene activation
ENSG00000107404,DVL1,wnt signaling,oncogenic driver,overexpression,tumor aggressiveness,poor prognosis,therapeutic target
ENSG00000155760,FZD7,wnt signaling pathway,oncogenic co-receptor,overexpressed in tumor tissues,planar cell polarity signaling,cell proliferation regulation,prognostic marker
ENSG00000277626,WNT3,wnt/β-catenin pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000155252,PI4K2A,regulation of phosphoinositide metabolism,constitutive activation,oncogenic signaling,cell proliferation,metastasis,lipid metabolism regulation
ENSG00000104290,FZD3,wnt signaling pathway,dysregulation,enhanced cell proliferation,cell survival and invasion,prognostic marker,therapeutic target
ENSG00000116128,BCL9,wnt/β-catenin signaling,transcriptional coactivation,overexpression in tumors,cell proliferation regulation,survival pathway activation,protein interaction modulation
ENSG00000162552,WNT4,wnt signaling pathway,overexpression in cancer,cell proliferation regulation,survival pathway activation,patterning and differentiation regulation,granulosa cell differentiation
ENSG00000123384,LRP1,tumor progression,metastasis promotion,signaling pathway regulation,multifunctional receptor activity,endocytosis and lipid metabolism regulation,poor prognosis biomarker
ENSG00000154764,WNT7A,wnt/β-catenin signaling,cell proliferation,epithelial-to-mesenchymal transition,metastasis promotion,poor prognosis association,tumor progression
ENSG00000163251,FZD5,wnt signaling pathway,canonical wnt activation,epithelial-to-mesenchymal transition (emt),cell proliferation,survival and growth,therapeutic target
ENSG00000185483,ROR1,ror1 activation,receptor tyrosine kinase activity,tumor growth promotion,cancer metastasis enhancement,cell survival and proliferation modulation,wnt5a ligand interaction
ENSG00000150764,DIXDC1,wnt/β-catenin signaling pathway,activating oncogene,tumor progression marker,cell proliferation regulator,dna damage response regulator,axin-2 interacting protein
ENSG00000096384,HSP90AB1,hsp90 chaperone function,cell proliferation,tumor growth,oncogenic signaling,therapeutic resistance,protein stability regulation
ENSG00000104365,IKBKB,nf-κb pathway,aberrant activation,tumor progression,mutation or amplification,cell survival,inflammation regulation
ENSG00000282905,NFKBIB,nf-?b inhibition,tumor suppressor function,cell proliferation regulation,apoptosis modulation,signaling pathway interaction,inflammation regulation
ENSG00000145703,IQGAP2,genomic instability,cell migration facilitation,pi3k/akt pathway interaction,cytoskeletal modulation,apoptosis inhibition,gtpase activation
ENSG00000161057,PSMC2,cell cycle regulation,proteasome activity increase,tumor growth promotion,poor prognosis association,therapeutic target,transcriptional regulation disruption
ENSG00000102871,TRADD,apoptosis regulation,caspase activation,nf-κb activation,tumor progression,oncogene involvement,inflammation pathway
ENSG00000102753,KPNA3,cell cycle progression,onco-suppressor function,nuclear import regulation,mitotic control,tumor invasion,genomic instability
ENSG00000100804,PSMB5,protein stabilization,tumor progression,poor prognosis,cellular degradation,oncogenic protein regulation,genomic instability
ENSG00000185104,FAF1,apoptosis regulation,tumor suppressor function,downregulated expression,prognostic marker,promoter hypermethylation,genetic mutations
ENSG00000100764,PSMC1,26s proteasome complex degradation,apoptosis resistance,cell cycle progression,dna repair defects,oncogenic driver,protein degradation regulator
ENSG00000137054,POLR1E,ribosomal rna synthesis,cellular metabolism regulation,genomic instability driver,transcriptional dysregulation,tumor progression mediator,protein translation enhancement
ENSG00000171453,POLR1C,transcriptional regulation,oncogenesis,ribosomal biogenesis,cell proliferation,gene expression regulation,dna-rna interaction
ENSG00000053918,KCNQ1,channel subunit,cellular proliferation,dna binding,ion channel regulation,oncogenesis,tumor progression
ENSG00000110700,RPS13,ribosomal dysfunction,anti-tumor response,protein misfolding,truncated protein production,cellular proliferation,genetic instability
ENSG00000089009,RPL6,ribosomal protein assembly,oncogenesis,cellular metabolism alteration,translation initiation complex,oncogenic protein synthesis,tumor aggressiveness
ENSG00000263528,IKBKE,nf-κb signaling pathway,oncogenic mutations,inflammation regulation,cell survival promotion,tumor progression,therapeutic target
ENSG00000136560,TANK,nf-κb pathway,inflammation regulation,ikk complex component,tumor progression,immune response modulation,cancer therapy target
ENSG00000096060,FKBP5,cellular response regulation,chaperone activity,protein stabilization,signaling pathway modulation,tumor progression,therapeutic target
ENSG00000176046,NUPR1,cell proliferation,oncogenesis,stress response,signaling pathway modulation,emt induction,chemoresistance
ENSG00000074266,EED,prc2 component,epigenetic regulation,histone modification,chromatin remodeling,cell cycle regulation,tumor suppressor dysfunction
ENSG00000103056,SMPD3,ceramide regulation,apoptosis resistance,tumor growth promotion,cell survival pathway,signaling molecule modulation,sphingomyelin metabolism dysfunction
ENSG00000025800,KPNA6,nuclear transport regulation,oncogenic signaling facilitation,tumor progression driver,genomic instability contributor,protein interaction mediator,cancer biomarker candidate
ENSG00000075391,RASAL2,negative regulator of oncogenic signaling,rasgap activity,downstream effectors activation,tumor growth promotion,metastasis facilitation,oncogenic pathway dysregulation
ENSG00000138757,G3BP2,apoptosis regulation,autophagy regulation,oncogenic protein,protein interaction network,signaling pathway modulation,stress granule assembly
ENSG00000168884,TNIP2,tumor suppression evasion,pi3k/akt pathway activation,nf-κb signaling regulation,inflammatory response modulation,cell survival enhancement,prognostic marker overexpression
ENSG00000173163,COMMD1,protein degradation regulation,tumor suppressor function,nf-κb pathway modulation,jnk signaling interaction,cancer mutation hotspot,cellular stability maintenance
ENSG00000173692,PSMD1,proteasome activation,tumor suppression degradation,oncogenic driver,cell cycle progression,apoptosis regulation,ubiquitin recognition
ENSG00000197170,PSMD12,protein degradation regulation,tumor growth promotion,metastasis facilitation,biomarker potential,apoptosis inhibition,cell cycle dysregulation
ENSG00000163636,PSMD6,proteasome subunit,ubiquitin-proteasome pathway,cell cycle regulation,tumor progression,ancillary protein targeting,angiogenesis regulation
ENSG00000076604,TRAF4,nf-κb activation,oncogenic function,tumor aggressiveness,signaling pathway regulation,cancer prognosis,epithelial-to-mesenchymal transition
ENSG00000142534,RPS11,mrna translation,cell growth,gain-of-function mutations,mtor pathway,apoptosis regulation,cell cycle control
ENSG00000173473,SMARCC1,chromatin remodeling,tumor suppressor,loss-of-function mutations,cell growth regulation,transcriptional regulation,epigenetic alterations
ENSG00000185627,PSMD13,protein degradation regulation,tumor progression promotion,cell cycle regulation,apoptosis suppression,promoter interaction,pi3k/akt pathway modulation
ENSG00000108344,PSMD3,protein degradation,ubiquitin-proteasome pathway,cell proliferation,apoptosis regulation,cancer progression,epigenetic regulation
ENSG00000184432,COPB2,protein folding regulation,cellular homeostasis maintenance,tumor suppressor function,apoptosis modulation,chaperone activity,genetic instability contribution
ENSG00000141030,COPS3,protein degradation regulation,tumor growth promotion,genome instability,cellular stress response,oncogenic potential,angiogenesis promotion
ENSG00000124602,UNC5CL,tumor suppressor function,pi3k/akt pathway regulation,cell proliferation inhibition,cell migration modulation,axon guidance disruption,metastasis inhibition
ENSG00000139613,SMARCC2,chromatin remodeling,tumor suppressor function,cell cycle regulation,dna repair mechanism disruption,swi/snf complex component,genetic instability promotion
ENSG00000104881,PPP1R13L,oncogenic signaling,dephosphorylation,tumor suppressor inhibition,cell proliferation regulation,prognostic marker,therapeutic target
ENSG00000105127,AKAP8,cell cycle regulation,mitosis regulation,pka interaction,cell proliferation enhancement,survival signaling,genomic instability promotion
ENSG00000136518,ACTL6A,chromatin remodeling,oncogene activation,epigenetic regulation,tumor progression,gene silencing,cell cycle regulation
ENSG00000161016,RPL8,overexpression,aggressive behavior,biomarker potential,regulatory role,cellular interaction,tumor progression
ENSG00000105202,FBL,cell cycle regulation,genetic instability,dna repair mechanisms,transcriptional control,nucleolar function,tumor cell survival
ENSG00000156482,RPL30,ribosome assembly,cell proliferation regulation,biomarker potential,protein synthesis modulation,stress response regulation,hypoxia adaptation
ENSG00000174444,RPL4,ribosomal regulation,tumor progression,cancer driver gene,protein synthesis enhancement,cell proliferation,signaling pathway interaction
ENSG00000133884,DPF2,dna damage response,genomic instability,gene expression regulation,tumor suppressor function,cell cycle regulation,proliferation control
ENSG00000131653,TRAF7,nf-κb activation,constitutive stabilization,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000148396,SEC16A,er organization,mitotic spindle assembly,ribosome biogenesis,copii coat complex,transport vesicle formation,growth factor secretion
ENSG00000100991,TRPC4AP,calcium channel regulation,aberrant expression,enhanced cell proliferation,store-operated calcium channels,cellular sensitivity to growth factors,mitogenic stimulation
ENSG00000126777,KTN1,tumor progression,cell adhesion regulation,metastasis promotion,oncogenic mutations,cell-cell interaction modulation,endocytic pathway regulation
ENSG00000101255,TRIB3,nf-κb pathway regulation,apoptosis suppression,oncogenic function,cell cycle progression,epithelial-to-mesenchymal transition,poor prognosis marker
ENSG00000125995,ROMO1,dna damage response,genomic instability,cell cycle regulation,protein kinase activation,oxidative demethylation,alkb family dioxygenases
ENSG00000123091,RNF11,ubiquitination regulation,tumor suppressor degradation,protein homeostasis modulation,cell cycle control,apoptosis inhibition,signaling pathway modulation
ENSG00000103035,PSMD7,protein degradation,pi3k/akt pathway interaction,cell cycle regulation,apoptosis modulation,tumor progression driver,oncoprotein accumulation
ENSG00000165916,PSMC3,protein degradation regulation,cellular proliferation enhancement,apoptosis suppression,tumor progression facilitation,oncogene activation,ubiquitin-proteasome pathway modulation
ENSG00000068654,POLR1A,genomic instability,disrupted dna repair,cell proliferation,chromatin remodeling,rna polymerase regulation,tumor progression
ENSG00000071994,PDCD2,apoptosis regulation,programmed cell death,mitochondrial outer membrane permeabilization,intrinsic apoptosis pathway,autophagy regulation,cell survival modulation
ENSG00000143256,PFDN2,autophagy regulation,protein transport disruption,pi3k/akt pathway interaction,overexpression in kirc,cellular growth modulation,adapter protein function
ENSG00000171444,MCC,methyl group transfer,cytoplasmic localization,one-carbon metabolism,cell proliferation,mutational activation,oncogenic potential
ENSG00000138095,LRPPRC,mtorc1 pathway dysregulation,autophagy regulation disruption,cell growth hyperactivation,cell proliferation enhancement,genetic mutation driver,protein interaction alteration
ENSG00000085760,MTIF2,mitochondrial protein synthesis,oncogenic role,protein overexpression,tumor progression,hypoxia adaptation,cellular homeostasis disruption
ENSG00000036672,USP2,deubiquitinating activity,oncogenic protein stabilization,mtor pathway activation,cell proliferation promotion,tumor progression facilitation,potential therapeutic target
ENSG00000106144,CASP2,apoptosis regulation,caspase activity,mitochondrial localization,cellular proliferation,tumor progression,angiogenesis
ENSG00000168067,MAP4K2,cell proliferation,apoptosis suppression,pi3k/akt activation,nf-κb signaling,epithelial-to-mesenchymal transition,overexpression
ENSG00000102226,USP11,oncogenic function,deubiquitinating enzyme activity,cell cycle regulation,protein stabilization,fbw7 interaction,tumor progression
ENSG00000090863,GLG1,warburg effect,dysregulation of glucose metabolism,glycolysis reprogramming,lactate production increase,tumor growth support,biomarker for disease progression
ENSG00000090060,PAPOLA,pi3k/akt pathway activation,mrna stability regulation,tumor growth promotion,cell proliferation enhancement,apoptosis resistance,therapeutic target
ENSG00000186184,POLR1D,ribosomal rna transcription,cell proliferation,tumor progression,gene mutation,transcriptional regulation,protein overexpression
ENSG00000135002,RFK,oncogenic signaling,pi3k/akt pathway activation,cell proliferation driver,angiogenesis regulator,tumor progression factor,therapeutic target candidate
ENSG00000175166,PSMD2,ubiquitination process,proteasome subunit,cell cycle regulation,apoptosis modulation,cell proliferation enhancement,angiogenesis support
ENSG00000215301,DDX3X,rna helicase function,transcriptional regulation,cell proliferation,oncogenic processes,tumor aggressiveness,pi3k/akt signaling pathway modulation
ENSG00000119401,TRIM32,regulation of protein stability,tumor progression,microrna regulation,e3 ubiquitin ligase activity,immune response modulation,cell proliferation enhancement
ENSG00000166508,MCM7,cell proliferation,genomic instability,dna replication,tumor aggressiveness,prognostic marker,replication machinery
ENSG00000100297,MCM5,minichromosome maintenance complex,cell proliferation,dna replication,oncogenic role,genomic instability,therapeutic target
ENSG00000163481,RNF25,p53 regulation,ubiquitin ligase activity,apoptosis inhibition,cell cycle progression,tumor suppressor degradation,protein-protein interaction
ENSG00000162551,ALPL,tumor growth,cell migration,oncogenic process,phosphatidylinositol 3-kinase pathway activation,therapeutic target,metastasis progression
ENSG00000163882,POLR2H,transcriptional regulation,oncogenesis,biomarker potential,transcription factor binding,chromatin modification,mutations in cancer
ENSG00000177700,POLR2L,transcriptional regulation,rna polymerase activity,oncogene activation,tumor suppressor function,chromatin remodeling,epigenetic modification
ENSG00000125630,POLR1B,ribosome biogenesis,nucleolar function regulation,tumor progression promotion,metastasis facilitation,therapeutic target,transcriptional regulation
ENSG00000136485,DCAF7,cell cycle regulation,e3 ubiquitin ligase activity,chromatin remodeling,dna repair mechanisms,protein degradation regulation,oncogenic process
ENSG00000072518,MARK2,cellular homeostasis disruption,constitutive activation,tumor progression,oncogenic process regulation,mitotic entry enhancement,cell cycle progression regulation
ENSG00000100784,RPS6KA5,mtor signaling,cellular growth,phosphorylation activation,tumor progression,protein synthesis regulation,poor prognosis marker
ENSG00000144802,NFKBIZ,nf-κb signaling,inflammation regulation,tumor growth promotion,epithelial-to-mesenchymal transition (emt),immune evasion,oncogene activation
ENSG00000017427,IGF1,igf1/igf1r signaling pathway,cell proliferation,tumor progression,therapeutic target,angiogenesis,metastasis
ENSG00000090020,SLC9A1,na+/h+ exchange regulation,oncogenic driver,tumor progression,cell proliferation,sodium reabsorption,signaling pathway interaction
ENSG00000169252,ADRB2,g protein-coupled receptor,tumor microenvironment modulation,angiogenesis promotion,immune response regulation,cell proliferation enhancement,adrenaline signaling pathway
ENSG00000131095,GFAP,intermediate filament assembly,cellular structure maintenance,glial cell differentiation,astrocyte function regulation,mitotic spindle formation,tumor progression potential
ENSG00000100412,ACO2,mitochondrial localization,citric acid cycle regulation,cancer metabolism modulation,tumor progression association,energy production alteration,prognostic biomarker potential
ENSG00000099995,SF3A1,disrupted rna processing,loss of function mutations,enhanced cell proliferation,resistance to apoptosis,spliceosomal complex disruption,altered gene expression profiles
ENSG00000012504,NR1H4,cholesterol metabolism regulation,tumor progression,dna repair evasion,cell cycle progression,therapeutic target,metabolic reprogramming
ENSG00000125503,PPP1R12C,pi3k/akt pathway modulation,tumor suppressor inhibition,oncogene activation,cell proliferation enhancement,apoptosis suppression,dna repair disruption
ENSG00000138802,SEC24B,endoplasmic reticulum stress regulation,oncogene,cell survival modulation,proliferation enhancement,cancer prognosis marker,protein transport facilitation
ENSG00000123240,OPTN,autophagy pathway,regulation of protein degradation,tumor suppression,cellular homeostasis,oncogenesis,ubiquitin-proteasome pathway
ENSG00000124733,MEA1,mitotic spindle assembly,constitutive overexpression,cellular proliferation,microtubule dynamics,protein-protein interactions,therapeutic target
ENSG00000270647,TAF15,rna binding,transcriptional regulation,oncogene,tumor aggressiveness,chemotherapy resistance,biomarker
ENSG00000241945,PWP2,protein-protein interaction,tumor progression,cellular proliferation,oncogene activation,prognostic marker,cell cycle regulation
ENSG00000140279,DUOX2,oxidative stress response,genomic instability,thyroid hormone regulation,ros production,dna damage response,prognostic marker
ENSG00000072062,PRKACA,pka activation,cell proliferation,anti-apoptosis,genomic instability,tumor aggressiveness,metabolic regulation
ENSG00000107485,GATA3,transcription factor,constitutive activation,oncogenic gene expression,cell cycle progression,tumor progression,epithelial-specific expression
ENSG00000186652,PRG2,complement system regulation,tumor progression marker,immune response modulation,cell proliferation regulation,apoptosis evasion,angiogenesis promotion
ENSG00000069329,VPS35,autophagy regulation,retromer complex component,tumor suppressor function,loss-of-function mutations,cellular trafficking pathway regulation,pi3k/akt signaling interaction
ENSG00000141543,EIF4A3,translation initiation complex,cellular proliferation,signaling pathway activation,ribosome scanning,mrna translation regulation,tumor progression indicator
ENSG00000121481,RNF2,chromatin remodeling,histone modification,polycomb complex recruitment,genome stability maintenance,tumorigenesis promotion,epigenetic regulation
,H3F3A,histone modification,tumor aggressiveness,chromatin remodeling,dysregulated expression,aberrant gene expression,neomorphic variants
,H3F3B,histone modification,chromatin remodeling,oncogenic driver,epigenetic regulation,cell proliferation,genetic instability
ENSG00000179583,CIITA,mhc-ii transactivation,immunogenic response,cancer progression,transcriptional regulation,prognostic marker,tumor antigens presentation
ENSG00000115840,SLC25A12,metabolic regulation,tumor progression,promotes cell proliferation,upregulated in tumors,mitochondrial dysfunction,therapeutic target
ENSG00000135047,CTSL,cellular degradation,epithelial-to-mesenchymal transition,lysosomal proteolysis,metastasis promotion,proteolytic activity,signal transduction
ENSG00000143507,DUSP10,mapk regulation,tumor progression,cell proliferation,apoptosis modulation,prognostic marker,phosphatase activity
ENSG00000100721,TCL1A,oncogenic driver,signal transduction activation,cell survival enhancement,gene expression regulation,protein-protein interaction,nf-κb pathway modulation
ENSG00000112578,BYSL,microtubule dynamics,cell division regulation,tumor progression driver,protein interaction modulation,cancer biomarker candidate,microtubule stability enhancer
ENSG00000178104,PDE4DIP,camp signaling pathway,regulation of camp levels,cell proliferation,metastasis,tumor growth,oncogenic process
ENSG00000170315,UBB,ubiquitination pathway,oncogenesis by protein stability alteration,genomic instability,cell cycle progression regulation,transcriptional regulation,protein degradation modulation
ENSG00000177971,IMP3,cellular proliferation,epithelial-to-mesenchymal transition (emt) pathway,metabolic regulation,protein-protein interactions,oncogenic potential,glycolytic reprogramming
ENSG00000133026,MYH10,actin cytoskeleton regulation,cell migration and invasion,non-muscle myosin heavy chain i,oncogenic potential,signaling pathway modulation,tumor aggressiveness enhancement
ENSG00000108771,DHX58,dna repair,tumor suppression,transcriptional regulation,cell cycle progression,apoptosis regulation,genome instability
ENSG00000105270,CLIP3,actin filament regulation,cell migration,microtubule stability,biomarker potential,tumor aggressiveness,cytoplasmic adaptor function
ENSG00000010318,PHF7,chromatin remodeling,epigenetic regulation,tumor suppressor function,tumor progression inhibition,gene regulation disruption,dna repair pathway interaction
ENSG00000269190,FBXO17,cell cycle regulation,apoptosis regulation,ubiquitin ligase activity,protein degradation pathway,microtubule dynamics regulation,mitotic progression control
ENSG00000111642,CHD4,epigenetic regulation,chromatin remodeling,histone modification,oncogenesis,tumor suppressor silencing,genome instability
ENSG00000056097,ZFR,dna repair pathway,nuclear protein function,gene expression regulation,tumor growth promotion,ran-binding interaction,genomic instability
ENSG00000100142,POLR2F,constitutive activation,gain of function mutations,transcriptional regulation,cell proliferation,angiogenesis,oncogene overexpression
ENSG00000185787,MORF4L1,chromatin remodeling,maintenance of genome integrity,nuclear receptor regulation,cell cycle progression,protein-protein interactions,tumor suppressor activity
ENSG00000071243,ING3,tumor suppressor function,cell cycle regulation,apoptosis induction,epigenetic regulation,histone modification,dna methylation
ENSG00000122026,RPL21,ribosome dysfunction,aberrant mtor signaling,genetic alterations,cellular proliferation,protein synthesis regulation,tumor aggressiveness
ENSG00000184990,SIVA1,apoptosis regulation,pro-tumor suppressor,cell cycle modulation,caspase activation,anti-apoptotic protein inhibition,tumor progression prevention
ENSG00000070495,JMJD6,histone demethylase activity,chromatin remodeling,oncogene activation,epithelial-to-mesenchymal transition,tumor progression,histone modification
ENSG00000142405,NLRP12,tumor suppression,innate immune regulation,inflammation regulation,caspase-1 activation,il-1β processing,apoptosis promotion
ENSG00000144524,COPS7B,regulation of ubiquitin-proteasome pathway,cell cycle progression regulation,dna damage response modulation,apoptosis regulation,protein degradation,interaction with cullin-ring e3 ligases
ENSG00000132970,WASF3,cell migration,actin cytoskeleton reorganization,oncogenic driver,prognostic marker,cell invasion,metastasis promotion
ENSG00000108107,RPL28,ribosome biogenesis,translation initiation,cancer driver mutations,tumor suppressor function,ribosomal protein regulation,mitochondrial function
ENSG00000109339,MAPK10,cellular stress response,apoptosis resistance,cell proliferation promotion,tumor aggressiveness,signaling pathway interaction,dna damage response
ENSG00000071082,RPL31,ribosomal regulation,tumor suppressor activity,proliferation control,protein synthesis modulation,gene expression regulation,tumorigenesis promotion
ENSG00000082153,BZW1,tumor growth,transcriptional coactivation,histone modification regulation,poor prognosis,epithelial-to-mesenchymal transition,apoptosis evasion
ENSG00000004838,ZMYND10,histone modification,transcriptional regulation,chromatin remodeling,oncogenic driver,biomarker overexpression,cellular proliferation
ENSG00000173267,SNCG,cell proliferation,oncogene,epigenetic regulation,tumor progression,chemoresistance,dna repair
ENSG00000128604,IRF5,immune evasion,apoptosis regulation,tumor microenvironment,epigenetic regulation,inflammatory response modulation,proliferation enhancement
ENSG00000130303,BST2,immune evasion,tumor progression,cell surface localization,viral restriction,prognostic marker,cancer metastasis
ENSG00000274185,LILRA4,tumor immune evasion,immune regulatory function,mhc class i-related protein interaction,cancer immunosurveillance,t-cell modulation,genomic downregulation
ENSG00000091592,NLRP1,inflammatory response,apoptosis inhibition,tumor growth promotion,oncogenic pathway activation,cytokine production,pro-inflammatory microenvironment
ENSG00000197444,OGDHL,protein degradation regulation,oncogenic potential,therapeutic target,tumor progression,ubiquitin-proteasome pathway modulation,cellular homeostasis disruption
ENSG00000178462,TUBAL3,microtubule dynamics,chromosomal instability,cellular proliferation,apoptosis resistance,pi3k/akt pathway interaction,cancer cell growth
ENSG00000106615,RHEB,rheb-rag complex,constitutive activation,gain of function mutations,tumor progression,mtor signaling pathway,cellular proliferation
ENSG00000112685,EXOC2,aberrant protein secretion,cell proliferation enhancement,dysregulated exocyst complex,increased cell survival,kinase-independent signaling pathway regulation,oncogenic protein accumulation
ENSG00000006451,RALA,oncogenic activity,mapk/erk signaling pathway,cell survival promotion,tumor progression association,cell proliferation enhancement,protein interaction modulation
ENSG00000116954,RRAGC,rag/ragulator/mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,protein synthesis regulation
ENSG00000248746,ACTN3,muscle contraction regulation,cell migration modulation,cytoskeleton remodeling,poor prognosis indicator,downregulated expression,genetic risk variant
ENSG00000166200,COPS2,ubiquitin-proteasome pathway,histone modification,de-neddylated cullin-ring ligases,protein degradation regulation,cellular response to dna damage,oncogenic signaling pathways
ENSG00000060138,YBX3,oncogene activity,transcriptional regulation,tumor progression,cell proliferation,angiogenesis promotion,p53 pathway interaction
ENSG00000092445,TYRO3,receptor tyrosine kinase activation,tumor growth promotion,immune evasion mechanisms,oncogenic signaling pathway,angiogenesis regulation,overexpression association
ENSG00000107874,CUEDC2,apoptosis regulation,dna repair modulation,genomic stability maintenance,oncogenic pathway activation,transcription factor regulation,cell proliferation enhancement
ENSG00000069667,RORA,epithelial-to-mesenchymal transition,cell cycle regulation,tumor suppression,wnt/β-catenin pathway,apoptosis regulation,transcriptional repression
ENSG00000087191,PSMC5,cellular degradation,protein quality control,apoptosis regulation,tumor progression,chaperone function,mitotic checkpoint
ENSG00000213928,IRF9,interferon-stimulated gene regulation,tumor suppression,anti-tumorigenic activity,apoptosis induction,immune modulation,transcriptional regulation
ENSG00000138814,PPP3CA,nfat pathway disruption,cellular proliferation dysregulation,apoptosis evasion,tumor progression,therapeutic target,signal transduction
ENSG00000169288,MRPL1,mitochondrial biogenesis,constitutive activation,glycolytic shift,cellular metabolism,tumor progression,myc transcriptional target
ENSG00000149273,RPS3,ribosomal regulation,cell growth promotion,translation initiation,oncogenic process facilitation,poor prognosis association,metabolic regulation
ENSG00000144028,SNRNP200,rna splicing disruption,p53 degradation,oncogenic processes,altered gene expression,microrna processing,tumor suppressor regulation
ENSG00000066044,ELAVL1,mrna stabilization,tumor progression,cell proliferation,gene expression regulation,protein-protein interaction,poor prognosis marker
ENSG00000125347,IRF1,tumor suppression,immune regulation,nf-κb signaling pathway interaction,cell proliferation inhibition,apoptosis induction,oncogenic potential
ENSG00000107201,DDX58,type i interferon signaling,rna helicase activity,immune response regulation,tumor microenvironment modulation,dna damage response,cancer development association
ENSG00000136153,LMO7,pi3k/akt pathway interaction,tumor progression facilitation,oncogenic signaling,cell survival and proliferation promotion,poor prognosis indicator,therapeutic target potential
ENSG00000082014,SMARCD3,baf60c subunit,chromatin remodeling complex component,cell proliferation enhancer,genome instability mediator,epigenetic regulator,oncogene overexpression
ENSG00000178307,TMEM11,cellular signaling,ion channel regulation,tumor progression,transmembrane protein,protein-protein interactions,genomic instability
ENSG00000087077,TRIP6,oncogenic role,pi3k/akt pathway regulation,cell proliferation promotion,cell survival enhancement,tumor progression facilitation,microrna regulation
ENSG00000103423,DNAJA3,chaperone regulation,transcriptional modulation,cellular stress response,protein folding and degradation,tumor progression and metastasis,therapeutic resistance
ENSG00000197561,ELANE,apoptosis regulation,inflammatory response modulation,neutrophil activation,oncogenic potential,proteolytic activity,tumor progression facilitation
ENSG00000158578,ALAS2,heme biosynthesis,iron metabolism,cellular proliferation,apoptosis regulation,erythropoiesis regulation,metabolic pathway regulation
ENSG00000132703,APCS,disrupted endocytic pathway,oncogenic protein interaction,cellular trafficking regulation,tumor suppressor complex subunit,cancer-related protein signaling,genetic mutation or expression alterations
ENSG00000165471,MBL2,tumor-promoting function,mannose-binding activity,immune evasion mechanism,complement system activation,inflammation regulation,cell recognition and binding pathway
ENSG00000050405,LIMA1,transcription factor activity,epithelial-to-mesenchymal transition,cancer cell proliferation,oncogene amplification,cell migration and invasion,tumor progression
ENSG00000153201,RANBP2,genetic instability,tumor suppressor protein regulation,cell cycle disruption,apoptosis regulation,nuclear transport dysfunction,ran gtpase cycle dysregulation
ENSG00000173599,PC,gluconeogenesis,metabolic adaptation,warburg effect,cancer metabolism,tumor growth promotion,amino acid metabolism
ENSG00000011304,PTBP1,alternative splicing regulation,rna processing,oncogenic isoforms expression,epithelial-to-mesenchymal transition (emt) pathway involvement,cell proliferation and survival modulation,genomic promoter hypomethylation
ENSG00000105963,ADAP1,focal adhesion disruption,tumor progression,metastasis promotion,pi3k/akt signaling modulation,cell migration facilitation,poor prognosis associated
ENSG00000100316,RPL3,ribosome biogenesis,cell proliferation,tumor growth,chemotherapy resistance,prognostic marker,oncogene upregulation
ENSG00000262406,MMP12,tumor progression,angiogenesis,cell invasion,metastasis,proteolytic activity,inflammation
ENSG00000102119,EMD,nuclear structure regulation,tumor progression,chromatin modification,protein-protein interaction,cell proliferation enhancement,gene expression regulation
ENSG00000115661,STK16,microtubule dynamics,tumor progression,pi3k/akt pathway,therapeutic target,cell division regulation,apoptosis suppression
ENSG00000198668,CALM1,calcium signaling pathway,cell proliferation,mitochondrial interaction,cancer progression,mutation hotspot,prognostic marker
ENSG00000172183,ISG20,apoptosis inhibition,cell proliferation promotion,mrna degradation,oncogenic driver,prognostic marker,tumor suppressor interaction
ENSG00000179562,GCC1,genetic instability,tumor aggressiveness,cell growth regulation,oxidative stress modulation,post-translational modification,pro-oncogenic signaling
ENSG00000128272,ATF4,endoplasmic reticulum stress,angiogenic signaling,cell survival pathways,transcriptional regulation,protein folding,apoptosis resistance
ENSG00000275796,NLRP2,innate immunity,pro-inflammatory signaling,tumor microenvironment,tumor progression,autophagy regulation,immune cell recruitment
ENSG00000132530,XAF1,tumor suppressor function,apoptosis inhibition,pi3k/akt pathway regulation,cell migration modulation,epithelial-to-mesenchymal transition (emt) regulation,xiap interaction
ENSG00000083444,PLOD1,tumor progression,cell migration,extracellular matrix remodeling,oncogene upregulation,protein-protein interaction,ecm degradation
ENSG00000221869,CEBPD,transcription factor regulation,cell proliferation modulation,tumor progression association,gene expression dysregulation,cancer prognosis marker,oncogene interaction
ENSG00000084463,WBP11,transcriptional regulation,protein-protein interactions,signal transduction,cell proliferation,tumor metastasis,gene expression modulation
ENSG00000120217,CD274,immune evasion,pd-1/pd-l1 interaction,immunotherapy target,tumor microenvironment modulation,immune checkpoint molecule,cancer immune escape
ENSG00000276977,PDCD1,immune checkpoint regulation,tumor immune evasion,immunosuppression,checkpoint protein function,cancer immunotherapy target,genetic dysregulation
ENSG00000089022,MAPKAPK5,tumor progression,cell proliferation,signaling pathway activation,therapeutic target,cell cycle regulation,dysregulated expression
ENSG00000185386,MAPK11,mapk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000106462,EZH2,oncogenic function,epigenetic regulator,histone methyltransferase,cell proliferation enhancement,microrna regulation,tumor suppressor silencing
ENSG00000034713,GABARAPL2,autophagic pathway,cellular homeostasis regulation,lipidation of lc3 protein,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000234846,NEU1,altered glycoprotein expression,epithelial-to-mesenchymal transition,cell invasion and metastasis,tumor progression,glycosylation regulation,protein degradation
ENSG00000198911,SREBF2,cellular energy homeostasis,lipid biosynthesis regulation,oncogene activation,tumor suppressor gene modulation,fatty acid synthesis enhancement,transcriptional regulation
ENSG00000184381,PLA2G6,oncogenic process,cell membrane homeostasis,lysophospholipid production,tumor progression,cell migration,therapeutic target
ENSG00000132522,GPS2,cellular proliferation,gene overexpression,protein degradation regulation,tumor progression,apoptosis inhibition,cancer prognosis
ENSG00000156265,MAP3K7CL,nf-κb pathway activation,inflammatory response modulation,tumor progression enhancement,cell survival promotion,therapeutic target identification,signaling cascade regulation
ENSG00000162889,MAPKAPK2,p38 mapk activation,cell survival,protein phosphorylation,tumor resistance,therapeutic target,cell cycle regulation
ENSG00000129167,TPH1,serotonin biosynthesis,tumor progression,immune evasion,prognostic biomarker,angiogenesis,post-translational modifications
ENSG00000110906,KCTD10,tumor suppressor or oncogene,downregulated in cancer,regulates cell cycle progression,apoptosis regulation,prognostic biomarker potential,interacts with other proteins
ENSG00000143878,RHOB,rho gtpase activity,cell cycle regulation,metastatic potential,protein-protein interactions,signaling pathway modulation,tumor progression
ENSG00000043591,ADRB1,adrb1 overexpression,cancer cell survival,cell proliferation,g protein-coupled receptor signaling,mapk/erk pathway activation,metastasis promotion
ENSG00000136541,ERMN,cellular morphology regulation,microtubule interaction,actin filament association,tumor progression factor,rho gtpase pathway interaction,cytoskeletal organization
ENSG00000107164,FUBP3,oncogene regulation,transcriptional control,cell proliferation driver,tumor progression marker,apoptosis suppression,genomic instability
ENSG00000129083,COPB1,protein folding regulation,hsp90 interaction,oncogenic signaling,tumor progression,cell proliferation enhancement,metabolic reprogramming
ENSG00000140859,KIFC3,microtubule stability,cell division regulation,genomic instability,chromosomal segregation,motor protein activity,protein-protein interaction
ENSG00000079462,PAFAH1B3,mitotic spindle disruption,chromosomal instability,genomic instability,oncogenic driver,cell proliferation enhancement,therapeutic target
ENSG00000072201,LNX1,ubiquitin ligase activity,protein degradation,tumor progression,wnt/β-catenin pathway,signaling regulation,oncogenic role
ENSG00000178952,TUFM,mitochondrial dysfunction,metabolic reprogramming,protein synthesis defects,tumor suppressor function loss,cellular energy metabolism disruption,gene expression alterations
ENSG00000130165,ELOF1,genomic instability,dna repair pathway regulation,transcriptional elongation,rna polymerase ii complex subunit,cellular response to genotoxic stress,therapeutic target
ENSG00000239732,TLR9,immune regulation,tumor microenvironment modulation,inflammatory signaling pathway activation,toll-like receptor function,innate immunity activation,upregulation of expression levels
ENSG00000052723,SIKE1,tumor progression,immunomodulation,type i interferon production,immune evasion,cell signaling regulation,viral recognition pathway
ENSG00000100453,GZMB,apoptosis induction,tumor suppressor function,caspase activation,cell death regulation,transcriptional regulation,proteolytic activity
ENSG00000174106,LEMD3,transmembrane protein,cell membrane integrity,oncogenic signaling pathway,actin cytoskeleton regulation,cell adhesion disruption,proliferation enhancement
ENSG00000152492,CCDC50,centrosome duplication,genomic instability,aneuploidy,cell proliferation,tumor aggressiveness,microtubule regulation
ENSG00000225921,NOL7,**
nucleolar protein interaction,chromosome segregation,mitotic checkpoint regulation,cell cycle control,aneuploidy induction,genetic instability
**
ENSG00000145907,G3BP1,mapk/erk pathway,overexpression,stress granule assembly,oncogenic driver,cell proliferation,tumor progression
ENSG00000117335,CD46,complement activation,tumor progression,cell survival,protein-protein interactions,immune evasion,poor prognosis
ENSG00000137309,HMGA1,oncogene overexpression,cell proliferation,chromatin remodeling,transcriptional regulation,dna damage response,tumor progression
ENSG00000130340,SNX9,epithelial-to-mesenchymal transition (emt),endosomal trafficking,phosphatidylinositol 3-kinase (pi3k) interaction,small gtpase regulation,cell migration,oncogenic potential
ENSG00000079739,PGM1,altered metabolic flux,oncogene overexpression,glycolytic reprogramming,cancer cell metabolism,tumor aggressiveness,therapeutic target
ENSG00000272804,KRTAP10-7,aberrant expression,cell proliferation,differentiation regulation,epithelial cell maintenance,keratin protein modification,type ii hair keratin family
ENSG00000164346,NSA2,dna repair mechanism,genomic stability maintenance,tumor suppressor function,cell proliferation regulation,genetic instability induction,epigenetic alteration prevention
ENSG00000111640,GAPDH,glycolytic regulation,cell proliferation enhancement,tumor progression facilitation,apoptosis evasion promotion,cell migration facilitation,energy metabolism modulation
ENSG00000085978,ATG16L1,autophagic flux dysregulation,oncogenic potential enhancement,cell survival promotion,tumor growth facilitation,protein-protein interaction,autophagy pathway modulation
ENSG00000100290,BIK,apoptosis regulation,dna damage response,mitochondrial outer membrane permeabilization,tumor progression,oncogenic process,therapeutic target
ENSG00000140379,BCL2A1,bcl-2 family regulation,apoptosis inhibition,dna repair mechanism,cancer cell survival,cell proliferation enhancement,protein-protein interaction
ENSG00000143556,S100A7,promotes metastasis,epithelial-to-mesenchymal transition,modulates kinase activity,cell cycle regulation,tumor progression,inflammatory response
ENSG00000073861,TBX21,immunomodulatory effects,tumor microenvironment regulation,pro-inflammatory cytokine production,apoptosis evasion,cell cycle progression,immune cell differentiation
ENSG00000148798,INA,chromatin remodeling,oncogenic transcriptional programs,cell proliferation,tumor progression,genetic regulation,protein-protein interactions
ENSG00000124214,STAU1,cellular regulation,mrna translation regulation,p53 interaction,stress response modulation,apoptosis regulation,tumor suppressor activity
ENSG00000115524,SF3B1,aberrant splicing,tumor suppressor function,missense mutations,enhanced splicing activity,cellular proliferation,altered gene expression
ENSG00000173327,MAP3K11,nf-κb signaling pathway,tumor progression,inflammation modulation,adapter molecule function,cell survival regulation,metastasis promotion
ENSG00000115946,PNO1,pi3k/akt pathway interaction,tumor progression,therapeutic target,cell survival regulation,mutations leading to loss of function,oncogenic process promotion
ENSG00000120616,EPC1,chromatin remodeling,histone modification regulation,cellular proliferation regulation,apoptosis inhibition,gene expression modulation,transcriptional regulation
ENSG00000117115,PADI2,protein modification,cancer progression,tumor metastasis,immune response modulation,angiogenesis promotion,gene expression regulation
ENSG00000143631,FLG,pi3k/akt signaling,cellular differentiation,loss-of-function mutations,epithelial disruption,cell proliferation regulation,tumor initiation
ENSG00000084674,APOB,cell proliferation,protein kinase activation,lipid metabolism,egfr signaling,tumor progression,biomarker
ENSG00000175197,DDIT3,transcriptional regulation,apoptosis suppression,cellular transformation,tumor progression,therapeutic target,genomic instability
ENSG00000136450,SRSF1,alternative splicing,anti-apoptotic variants,oncogenic splicing factor,cellular proliferation,rna processing regulation,apoptosis resistance
ENSG00000141570,CBX8,epigenetic regulation,histone modification recognition,oncogenic silencing,tumor suppressor gene repression,genomic instability promotion,chromatin remodeling complex interaction
ENSG00000008988,RPS20,cellular proliferation,tumor progression,oncogene,protein synthesis regulation,translation initiation complex,pi3k/akt pathway interaction
ENSG00000128973,CLN6,lipid metabolism regulation,tumor progression,ion homeostasis disruption,metastasis promotion,cancer cell interaction,signaling pathway modulation
ENSG00000058262,SEC61A1,er translocon regulation,protein trafficking dysregulation,tumor cell proliferation enhancement,cellular survival pathway modulation,cancer progression marker,anti-apoptotic function upregulation
ENSG00000130811,EIF3G,mtor pathway modulation,translation initiation factor,cell growth regulation,oncogenic process promotion,protein synthesis alteration,tumorigenesis contribution
ENSG00000162601,MYSM1,histone modification,chromatin remodeling,oncogene activation,transcription factor regulation,tumor aggressiveness,prognostic marker
ENSG00000166598,HSP90B1,proteostasis regulation,oncogenic protein stabilization,constitutive activation,tumor growth promotion,drug resistance development,chaperone-mediated protein folding
ENSG00000167987,VPS37C,tumor progression,cell proliferation,protein degradation,ubiquitination regulation,endosomal sorting,signaling pathway modulation
ENSG00000121807,CCR2,tumor microenvironment,immune suppression,cell migration,angiogenesis promotion,signaling pathway activation,chemokine receptor function
ENSG00000120438,TCP1,protein folding,chaperone activity,tumorigenesis,cell proliferation,apoptosis evasion,oncogenic protein assembly
ENSG00000171435,KSR2,mapk signaling pathway,cell proliferation,tumor progression,scaffold protein function,prognostic biomarker,signaling pathway regulation
ENSG00000113595,TRIM23,p53 regulation,proteasome degradation,oncogenic driver,cell cycle modulation,apoptosis suppression,tumor suppressor evasion
ENSG00000120896,SORBS3,cytokeletal regulation,microtubule dynamics,cell migration,epithelial-to-mesenchymal transition (emt),adhesion modulation,tumor progression
ENSG00000170482,SLC23A1,nucleotide metabolism,folate transport,dna methylation,epigenetic regulation,tumor growth,cell proliferation
ENSG00000104812,GYS1,glycolytic reprogramming,enhanced glucose uptake,tumor energy metabolism,oncogenic function,poor prognosis indicator,therapeutic target
ENSG00000150459,SAP18,pi3k/akt signaling,oncogenic transformation,tyrosine kinase activation,cell proliferation and survival,apoptosis suppression,prognostic marker
ENSG00000188529,SRSF10,pre-mrna splicing regulation,alternative splicing pattern,aberrent gene expression,cancer associated mutation,splice site recognition,cell growth regulation
ENSG00000013364,MVP,tumor suppressor function disruption,cell growth promotion,protein transport regulation,apoptosis inhibition,oncogene overexpression,cellular stress response modulation
ENSG00000162664,ZNF326,zinc finger protein,oncogene,overexpression,pi3k/akt signaling pathway,chromatin remodeling,transcriptional regulation
ENSG00000168310,IRF2,loss of function mutations,tumor suppression,cell cycle regulation,dna repair pathway,transcriptional regulation,apoptosis regulation
ENSG00000142541,RPL13A,altered glucose metabolism,constitutive activation,protein synthesis regulation,mtor pathway interaction,oncogenic transcription factor regulation,gene expression dysregulation
ENSG00000214753,HNRNPUL2,rna binding protein,oncogene activation,gene regulation,cell proliferation,metastasis promotion,poor prognosis marker
ENSG00000088833,NSFL1C,protein homeostasis disruption,ubiquitin-proteasome pathway disruption,gain-of-function mutations,genomic instability promotion,epigenetic alterations association,cellular stress response activation
ENSG00000150991,UBC,protein degradation regulation,cell cycle progression,tumor growth promotion,therapeutic target,ubiquitin transfer facilitation,dna damage response
ENSG00000164118,CEP44,centrosome dysregulation,mitotic checkpoint disruption,chromosomal instability,cellular proliferation,tumor progression,genomic destabilization
ENSG00000047315,POLR2B,increased transcription,transcriptional regulation,genomic instability,cell proliferation,rna synthesis,chromatin remodeling
ENSG00000164111,ANXA5,apoptosis regulation,cellular stress response,cancer cell migration,tumor aggressiveness,metastasis promotion,cell surface modulation
ENSG00000008438,PGLYRP1,immune evasion,molecular recognition,bacterial peptidoglycan binding,cell surface protein,patient prognosis,tumor microenvironment
ENSG00000163257,DCAF16,cancer driver gene,cell cycle regulation,tumor suppressor degradation,dna repair regulation,e3 ubiquitin ligase complex,mutational hotspot
ENSG00000130939,UBE4B,tumor suppression,apoptosis regulation,protein degradation,p53 interaction,ubiquitination pathway,oncogene overexpression
ENSG00000010278,CD9,cell adhesion modulation,oncogenesis regulation,tumor suppression,metastasis inhibition,prognostic marker,genetic alteration
ENSG00000169403,PTAFR,oncogenic driver,tumor progression,cell adhesion signaling,chemotaxis activation,erk/mapk pathway activation,pi3k/akt signaling enhancement
ENSG00000240583,AQP1,water transport,cell membrane permeability,tumor progression,biomarker,proliferation,survival
ENSG00000109906,ZBTB16,tumor suppressor,dna binding activity,cell cycle regulation,gene expression modulation,apoptosis regulation,prognostic marker
ENSG00000164877,MICALL2,microtubule regulation,mdm2/p53 pathway modulation,tumor progression correlation,cancer cell survival enhancement,prognostic biomarker potential,drug resistance association
ENSG00000077522,ACTN2,cellular adhesion,epithelial-to-mesenchymal transition (emt),cytoskeletal remodeling,tumor progression,biomarker for cancer,cell migration and invasion
ENSG00000231408,LTA,apoptosis modulation,inflammation induction,cell-mediated immunity,pro-tumorigenic microenvironment,immune evasion,cytokine signaling
ENSG00000053372,MRTO4,mtor pathway activation,agc kinase phosphorylation,cell growth promotion,tumor progression facilitation,metabolic regulation enhancement,cell survival promotion
ENSG00000134107,BHLHE40,oncogene,tumor suppressor function loss,transcriptional regulation,cell cycle progression,apoptosis resistance,metabolic regulation
ENSG00000188747,NOXA1,apoptosis regulation,protein-protein interactions,tumor progression marker,mitochondrial modulation,poor prognosis indicator,cancer cell survival
ENSG00000168135,KCNJ4,potassium channel regulation,cell proliferation modulation,ion transport regulation,cell survival promotion,pi3k/akt pathway interaction,tumorigenesis contribution
ENSG00000116711,PLA2G4A,arachidonic acid metabolism,pro-inflammatory eicosanoids,tumor growth promotion,cell membrane remodeling,signaling pathway interaction,oncogenic process facilitation
ENSG00000055332,EIF2AK2,eif2α phosphorylation,cellular stress response,protein synthesis inhibition,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000129673,AANAT,melatonin synthesis,proliferation promotion,tumor growth regulation,cell cycle progression,aggressive tumor behavior,poor patient prognosis
ENSG00000181789,COPG1,cell cycle regulation,ubiquitin-proteasome pathway,neddylation process,apoptosis inhibition,oncogenic driver,tumorigenesis promotion
ENSG00000130222,GADD45G,cell cycle regulation,dna damage response,tumor suppression,p53 pathway modulation,oncogene activation,transcriptional regulation
ENSG00000160339,FCN2,tumor microenvironment modulation,pattern recognition receptor,carbohydrate binding protein,tumor suppressor function,prognostic biomarker,cell migration inhibition
ENSG00000163661,PTX3,inflammation modulation,acute phase response regulation,tumor progression promotion,angiogenesis stimulation,poor prognosis marker,immunomodulation interaction
ENSG00000136709,WDR33,regulation of protein degradation,cell cycle progression,transcriptional regulation,apoptosis,protein stability modulation,wd40 repeat domain
ENSG00000101596,SMCHD1,heterochromatin formation,genomic instability,cellular proliferation,tumor suppression,aneuploidy,chromosomal aberrations
ENSG00000138764,CCNG2,cell cycle progression,oncogenic driver,tumor proliferation,protein interaction,cell growth regulation,therapeutic target
ENSG00000172809,RPL38,ribosomal protein function,oncogene potential,protein synthesis regulation,cell proliferation enhancement,angiogenesis facilitation,cellular stress response modification
ENSG00000170634,ACYP2,genomic instability,dna repair mechanism,oncogene overexpression,epigenetic regulation,cell cycle progression,protein-protein interactions
ENSG00000110169,HPX,heme regulation,tumor progression,oxidative stress modulation,prognostic marker,biomarker,iron metabolism regulation
ENSG00000005022,SLC25A5,mitochondrial transport,adp/atp translocation,tumor metabolism,oncogenic processes,cellular energy production,mitochondrial homeostasis
ENSG00000263465,SRSF8,tumor aggressiveness,alternative splicing regulation,nuclear localization,oncogenic processes promotion,gene expression modulation,splicing pattern changes
ENSG00000007952,NOX1,oncogenesis,genomic instability,dna damage,cell proliferation,angiogenesis,apoptosis resistance
ENSG00000106538,RARRES2,tumor suppressor function,cell differentiation regulation,apoptosis promotion,cell proliferation regulation,chemokine signaling pathway involvement,genomic instability association
ENSG00000178028,DMAP1,histone modification regulation,transcriptional control,cell proliferation promotion,apoptosis inhibition,pi3k/akt pathway interaction,oncogenic potential
ENSG00000144635,DYNC1LI1,microtubule dynamics,aneuploidy,genomic instability,cell division regulation,tumor suppressor interaction,cancer cell migration
ENSG00000149534,MS4A2,immune regulation,b cell activation,oncogenesis,tumor progression,immunoglobulin superfamily member 2,complement receptor binding
ENSG00000145649,GZMA,granule-associated protein,perforin-granule pathway activation,cytotoxic t-cell regulation,apoptosis evasion,tumor progression enhancement,immune evasion mechanism
ENSG00000173641,HSPB7,cellular chaperone,protein folding regulation,heat shock response modulation,apoptosis regulation,stress response adaptation,mapk pathway interaction
ENSG00000156711,MAPK13,tumor progression,cell proliferation,stress response pathway,inflammatory processes regulation,oncogene/tumor suppressor function,kinase activation mutation
ENSG00000065328,MCM10,cell cycle progression,genomic instability,dna helicase activity,chemosensitivity loss,tumor growth promotion,dna replication regulation
ENSG00000108578,BLMH,anti-apoptotic activity,cell migration,cell proliferation,metastasis,modulation of protease activity,prognostic marker
ENSG00000112874,NUDT12,telomere maintenance,genomic instability,dna repair,apoptosis suppression,tumor suppressor function,loss of heterozygosity
ENSG00000091732,ZC3HC1,chromatin remodeling,tumor suppressor function,epigenetic regulation,genomic instability,cell growth regulation,apoptosis regulation
ENSG00000213465,ARL2,genomic instability,microtubule stabilization,constitutive activation,dna repair pathway,tumor progression,therapeutic target
ENSG00000152795,HNRNPDL,rna regulation,oncogenic transformation,pre-mrna splicing,protein-protein interactions,cell proliferation,pi3k/akt pathway interaction
ENSG00000092067,CEBPE,cellular differentiation,transcriptional regulation,tumor suppressor pathway,protein-protein interaction,genetic alterations,cancer driver gene
ENSG00000138326,RPS24,dysregulated protein synthesis,aberrant ribosome function,cell cycle progression,cancer-specific genetic signature,dna damage response,potential therapeutic target
ENSG00000213923,CSNK1E,casein kinase 1 regulation,wnt/beta-catenin signaling pathway,oncogenic protein modulation,cell cycle progression regulation,genomic instability maintenance,apoptosis regulation
ENSG00000186847,KRT14,overexpression,aggressive tumor behavior,cell proliferation regulation,migratory and invasive capabilities,tumor microenvironment modulation,epi-genetic regulation alterations
ENSG00000158773,USF1,transcriptional regulation,oncogene activation,cell cycle progression,apoptosis inhibition,tumor growth promotion,transcription factor activity
ENSG00000116251,RPL22,ribosomal protein overexpression,cell proliferation regulation,oncogenic pathway activation,protein translation enhancement,rna processing alterations,chromatin remodeling
ENSG00000169760,NLGN1,tumor progression,metastasis promoter,cell migration enhancer,cell-cell adhesion regulation,integrin interaction,prognostic marker
ENSG00000163512,AZI2,tumor suppressor,dna repair regulation,cell cycle regulation,apoptosis induction,pi3k/akt pathway interaction,downregulated expression in cancer
,QARS,glutamine metabolism,oncogenic transformation,trna-synthetase function,cellular proliferation,dna repair mechanisms,protein synthesis regulation
ENSG00000175899,A2M,tumor progression,protease inhibition,cell signaling modulation,growth factor interaction,metastasis promotion,oncogene upregulation
ENSG00000169220,RGS14,tumor suppressor function,regulation of g-protein signaling,pi3k/akt pathway modulation,camp signaling regulation,cell proliferation regulation,gap activity for gi/o and gq/11 g-proteins
ENSG00000262845,KRT40,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),overexpression,biomarker potential,signaling pathway modulation
ENSG00000105383,CD33,tumor immune evasion,myeloid cell surface marker,cell adhesion and migration,immune modulation,cancer biomarker,cell surface protein interaction
ENSG00000122566,HNRNPA2B1,heterogeneous nuclear ribonucleoprotein family,regulatory function in mirna expression,cellular differentiation and growth,tumor progression and metastasis,pre-mrna processing and transport,overexpression in various tumors
ENSG00000134419,RPS15A,tumor progression,cell proliferation,enhanced survival,regulatory pathway interaction,metabolic regulation,protein synthesis alteration
ENSG00000104884,ERCC2,dna repair deficiency,genetic instability,oncogenic mutations,tumor suppressor function,cell cycle regulation,nucleotide excision repair
ENSG00000075856,SART3,alternative splicing,oncogene activation,transcriptional regulation,cell proliferation,spliceosome assembly,gene expression dysregulation
ENSG00000147082,CCNB3,mitotic regulation,cell cycle progression,chromosomal instability,aneuploidy promotion,cancer cell proliferation,therapeutic target
ENSG00000090924,PLEKHG2,genomic amplification,signaling pathway modulation,tumor aggressiveness,cell migration regulation,calcium signaling involvement,cytoskeletal organization
ENSG00000162511,LAPTM5,lysosomal regulation,cell trafficking modulation,tumor progression driver,metastasis promotion,cancer metastatic pathway engagement,protein-protein interaction network component
ENSG00000099204,ABLIM1,actin cytoskeleton regulation,cell migration promotion,tumor progression facilitation,prognostic biomarker potential,cancer cell invasion enhancement,adhesion modulation
ENSG00000159200,RCAN1,cellular regulation,genetic interaction,cancer progression,apoptosis modulation,tumor suppressor activity,signal transduction
ENSG00000117632,STMN1,microtubule instability,tumor aggressiveness,microtubule destabilization,cell proliferation enhancement,cancer progression facilitation,oncogene interaction
ENSG00000163694,RBM47,ribosome assembly,tumor progression,maintenance of cancer cells,mtor pathway regulation,overexpression in cancer,poor prognosis correlation
ENSG00000084093,REST,neuronal gene regulation,tumor suppressor function,epithelial-to-mesenchymal transition,stemness maintenance,dna damage response,cancer cell proliferation
ENSG00000180772,AGTR2,angiogenesis,cell migration,g protein-coupled receptor,metastasis promotion,pi3k/akt pathway activation,renin-angiotensin system interaction
ENSG00000156709,AIFM1,iron-sulfur cluster biogenesis,redox regulation,cellular stress response,apoptosis modulation,tumor aggressiveness,prognostic marker
ENSG00000143033,MTF2,transcriptional coactivator,cell proliferation regulation,androgen receptor interaction,metastasis promotion,oncogenic transformation,chromatin remodeling
ENSG00000009724,MASP2,lectin pathway activation,complement system dysregulation,tumor progression,cell migration and invasion,protein-protein interactions,poor prognosis
ENSG00000085265,FCN1,cell adhesion regulation,tumor invasion facilitation,protein-protein interaction,oncogenic process modulation,complement system activation,tumor progression promotion
ENSG00000171566,PLRG1,tgf-β signaling pathway,transcriptional regulation,cell proliferation,apoptosis regulation,biomarker potential,cancer progression
ENSG00000126581,BECN1,autophagy regulation,tumor suppressor function,genomic instability,cellular proliferation,mtor pathway interaction,oncogenic signaling
ENSG00000138642,HERC6,ubiquitination,cell proliferation,metastasis,oncogenesis,biomarker status,protein degradation
ENSG00000138641,HERC3,p53 regulation,tumor suppressor loss,cancer cell survival,proliferation promotion,cell cycle control,transcriptional regulation
ENSG00000168090,COPS6,ubiquitin-proteasome pathway,cancer-associated mutations,protein degradation regulation,cell cycle progression,dna repair modulation,oncogenic signaling alteration
ENSG00000142937,RPS8,mtor signaling pathway,overexpression,poor prognosis,ribosome biogenesis,protein synthesis enhancement,cancer biomarker
ENSG00000127152,BCL11B,cell cycle regulation,dna repair,apoptosis regulation,tumor progression,transcription factor activity,therapeutic target
ENSG00000159140,SON,ribosomal biogenesis regulation,nucleolar rna binding,early rrna transcription,protein-rna interactions,oncogene activation,cell growth modulation
ENSG00000074317,SNCB,protein misfolding,cellular stress response,signaling pathway modulation,tumor progression,oncogenic function,overexpression
ENSG00000101444,AHCY,methionine cycle regulation,homocysteine metabolism,genetic mutations leading to disease,cellular proliferation and growth regulation,tumor development and progression influence,cancer-related metabolic alterations
ENSG00000062725,APPBP2,protein trafficking regulation,cellular survival enhancement,tumor growth promotion,ubiquitination pathway dysregulation,apbb1 interaction,poor prognosis association
ENSG00000089094,KDM2B,histone modification,chromatin remodeling,cell growth promoter,epigenetic regulation,metastasis facilitator,tumor progression
ENSG00000205542,TMSB4X,cellular differentiation,tumor microenvironment modulation,metastasis promotion,angiogenesis enhancement,cell adhesion regulation,protein-protein interaction
ENSG00000166037,CEP57,cell division regulation,chromosomal instability,centrosome amplification,genomic instability,prognostic marker,gain of function mutations
ENSG00000180209,MYLPF,cellular proliferation,tumor progression,metastasis,gene amplification,protein overexpression,dysregulated cellular morphology
ENSG00000163565,IFI16,tumor suppressor function,dna repair regulation,immune response modulation,cell proliferation inhibition,prognostic marker potential,pi3k/akt pathway interaction
ENSG00000167460,TPM4,actin filament regulation,cancer cell migration,cell motility regulation,prognostic marker potential,signaling pathway modulation,tumor progression enhancement
ENSG00000198814,GK,glucose metabolism regulation,energy homeostasis maintenance,tumor growth promotion,cellular energy utilization,therapeutic target,prognostic marker
ENSG00000123358,NR4A1,overexpression,pi3k/akt pathway modulation,cell proliferation enhancement,transcriptional regulation,mapk/erk pathway interaction,cancer progression
ENSG00000214944,ARHGEF28,rho-gtpase regulation,epithelial-to-mesenchymal transition,tumor progression,metastasis promotion,cytoskeletal organization,prognostic marker
ENSG00000197647,ZNF433,tumor suppressor function,cell cycle regulation,dna binding and transcriptional repression,apoptosis modulation,oncogenic potential enhancement,tumor aggressiveness promotion
ENSG00000012779,ALOX5,leukotriene synthesis,tumor progression,metastasis,pro-inflammatory eicosanoids,cancer cell growth,survival and motility
ENSG00000116688,MFN2,**
mitochondrial dynamics,oncogenesis promotion,metabolic regulation,tumor progression,cellular metabolism,genetic overexpression 
**
ENSG00000121957,GPSM2,gpcr signaling,constitutive activation,gain of function mutations,tumor progression,prognostic marker,cell proliferation
ENSG00000106263,EIF3B,translation initiation,mtor pathway interaction,oncogenic function,protein synthesis regulation,cell proliferation promotion,therapeutic target
ENSG00000100028,SNRPD3,tumor progression,oncogenesis,promoter overexpression,splicing regulation,cellular proliferation,tumor suppressor silencing
ENSG00000019549,SNAI2,epithelial-to-mesenchymal transition,emt regulator,transcription factor activation,cell adhesion loss,metastatic potential,oncogenic interaction
ENSG00000198932,GPRASP1,hippo-yap signaling pathway,pi3k/akt/mtor pathway regulation,cancer cell survival enhancement,tumor progression promotion,cell migration facilitation,gene expression upregulation
ENSG00000169567,HINT1,genomic instability,tumor suppressor,transcriptional regulation,chromatin remodeling,dna repair,wnt/β-catenin signaling inhibition
ENSG00000166483,WEE1,genomic instability,cell cycle checkpoint,protein kinase activation,tumor suppression,proliferation inhibition,dna damage response
ENSG00000151846,PABPC3,mrna stabilization,poly(a) binding protein function,oncogenic mrna regulation,cell proliferation driver,aggressive tumor behavior,poor prognosis indicator
ENSG00000102010,BMX,cellular proliferation,mitogenic signaling,protein kinase activation,src family kinases interaction,tumor progression,metastasis
ENSG00000159176,CSRP1,cell migration,oncogenesis,protein-protein interaction,cytoskeletal regulation,cell invasion,phosphorylation event
ENSG00000125691,RPL23,ribosomal dysfunction,dysregulated protein synthesis,mtor pathway activation,tumor proliferation,cell adaptation to stress,genomic instability
ENSG00000236014,VPS52,**

escrt iii complex,membrane trafficking,protein degradation,multivesicular body pathway,cellular signaling,tumor progression
**
ENSG00000127837,AAMP,dna repair pathway,genomic instability,genetic error prevention,nucleotide metabolism regulation,tumor progression association,biomarker potential
<end>

here
ENSG00000127483,HP1BP3,chromatin remodeling,genome stability,oncogene activation,tumor growth,metastasis,poor prognosis
ENSG00000072210,ALDH3A2,tumor progression,promoter of metastasis,oncogenic role,cellular survival,ros regulation,therapeutic target
ENSG00000196218,RYR1,calcium channel dysfunction,loss of function mutations,cell proliferation enhancement,oncogenic signaling pathway activation,epithelial-to-mesenchymal transition involvement,therapeutic target for intervention
ENSG00000130402,ACTN4,**

actin filament regulation,cytoskeletal reorganization,microtubule stabilization,cell migration enhancement,tumor progression,oncogene activation

**
ENSG00000162191,UBXN1,oncogenic transformation,protein degradation regulation,cullin-ring e3 ubiquitin ligase regulation,tumor suppressor protein degradation,cell cycle progression modulation,genome stability maintenance
ENSG00000122359,ANXA11,**
anxa11 overexpression,apoptosis inhibition,calcium-dependent interactions,cell proliferation,migratory capability,tumor progression 
**
ENSG00000138180,CEP55,microtubule organization,cell cycle regulation,genomic stability,tumor progression,pi3k/akt activation,oncogene overexpression
ENSG00000102081,FMR1,loss of function mutations,epigenetic silencing,microrna regulation,cell growth regulation,rna-binding protein activity,tumor suppressive function
ENSG00000128228,SDF2L1,redox regulation,metabolic dysregulation,pi3k/akt pathway activation,sulfur metabolism alteration,oncogenic driver,cellular proliferation enhancement
ENSG00000114841,DNAH1,amplification driven,cell proliferation,ciliary function,oncogene potential,survival pathways,tumorigenesis driver
ENSG00000143851,PTPN7,rtk activation,cell proliferation,cell migration,protein phosphatase function,tumor progression,oncogenic signaling
ENSG00000173889,PHC3,chromatin regulation,oncogene driver,cell proliferation,epigenetic modification,gene expression regulation,histone methylation
ENSG00000139211,AMIGO2,tumor progression,cell proliferation,pi3k/akt pathway,epithelial-to-mesenchymal transition,oncogenic potential,cancer stem cell properties
ENSG00000141837,CACNA1A,genomic instability,regulation of cell cycle,calcium channel activation,cell migration,angiogenesis promotion,therapeutic target
ENSG00000182774,RPS17,ribosome biogenesis,cell growth regulation,proliferation driver,tumor progression,genomic instability,aberrant protein expression
ENSG00000177663,IL17RA,inflammatory cytokine signaling,immune suppression,tumor progression,metastasis promotion,angiogenesis,pro-inflammatory response
ENSG00000082516,GEMIN5,**
alternative splicing,chromatin remodeling,tumor progression,cancer-associated splice variants,spliceosome assembly,genomic instability
**
ENSG00000078114,NEBL,genomic stability regulation,mitosis regulation,microtubule dynamics,kinase activation,cell proliferation promotion,tumor progression association
ENSG00000183386,FHL3,nuclear localization,cell growth modulation,signal transduction,adaptor protein function,transcriptional regulation,tumor progression
ENSG00000125977,EIF2S2,translational regulation,stress response activation,apoptosis inhibition,cell growth promotion,autophagy modulation,protein synthesis regulation
ENSG00000002834,LASP1,actin cytoskeleton modulation,biomarker for prognosis,cell migration facilitation,emt promoter,oncogenic interactions,src kinase activation
ENSG00000136861,CDK5RAP2,centrosome duplication,cell cycle progression,dna damage repair,tumor growth,metastasis,biomarker potential
ENSG00000116641,DOCK7,gef activation,rho gtpase regulation,cell migration facilitation,metastasis promotion,co-activator role,genomic mutation hotspot
ENSG00000128609,NDUFA5,mitochondrial dysfunction,altered energy metabolism,oxidative stress,glycolytic shift,tumor metabolic reprogramming,mitochondrial complex i inactivation
ENSG00000284983,DEFA1,immune modulation,cell proliferation regulation,apoptosis induction,angiogenesis inhibition,tumor microenvironment modification,genetic instability
ENSG00000285176,DEFA1B,tumor immunity,downregulated expression,antimicrobial activity,immune evasion,oncogenic pathway modulation,cancer cell killing
ENSG00000132356,PRKAA1,mtor pathway regulation,energy homeostasis regulation,cell growth inhibition,cell proliferation suppression,tumor suppressor function,pi3k/akt pathway interaction
ENSG00000155561,NUP205,nuclear pore assembly,chromosomal instability,aneuploidy,tumor progression,tumorigenesis,genomic stress response
ENSG00000204308,RNF5,cellular ubiquitination,protein degradation,nuclear localization,tumor suppression,genomic instability,oncogenic regulation
ENSG00000164307,ERAP1,antigen presentation,immune evasion,tumor progression,cellular proliferation,pi3k/akt signaling,regulatory t-cell suppression
ENSG00000147274,RBMX,cellular proliferation,tumorigenesis,oncogenic processes,rna binding,apoptosis modulation,nuclear localization
ENSG00000240505,TNFRSF13B,baff/bcma signaling,nf-kappa b pathway activation,enhanced cell survival,tumor growth promotion,aberrant angiogenesis,genetic instability
ENSG00000121068,TBX2,genetic repressor,oncogene,tumor suppressor gene repression,cell cycle regulation,apoptosis inhibition,transcriptional modulation
ENSG00000168438,CDC40,mitotic checkpoint,genomic instability,aneuploidy induction,tumor progression,poor prognosis,cell proliferation
ENSG00000175467,SART1,altered splicing patterns,dysregulation of gene expression,alternative isoform generation,apoptosis evasion,chemo-resistance,cell cycle progression
ENSG00000132153,DHX30,tumor progression,genomic instability,transcriptional regulation,dna repair mechanism,oncogenic transcription,cell cycle checkpoint regulation
ENSG00000182287,AP1S2,cell adhesion regulation,endocytic pathway modulation,oncogenic function,substrate of cbl,tumor progression facilitation,biomarker potential
ENSG00000030066,NUP160,nuclear pore complex,nucleocytoplasmic transport,overexpression,cell proliferation,tumorigenesis,cancer progression
ENSG00000124831,LRRFIP1,oncogene activation,cell signaling disruption,tumor suppressor protein interaction,genomic instability,pathway modulation,prognostic indicator
ENSG00000080603,SRCAP,chromatin remodeling,brca1/brca2 regulation,dna repair regulation,transcriptional regulation,genomic instability,tumor aggressiveness
ENSG00000145247,OCIAD2,histone modification,epigenetic regulation,oncogene overexpression,tumor progression driver,chromatin remodeling,prognostic marker
ENSG00000165259,HDX,apoptosis inhibition,cell survival enhancement,oncogene overexpression,protein folding regulation,stress response activation,tumor progression facilitation
ENSG00000100726,TELO2,telomere maintenance,dna damage response,immortalization,cancer cell survival,therapeutic target,genotoxic stress resistance
ENSG00000100345,MYH9,tumor progression,metastasis,cell migration,cell adhesion,protein interaction,cytoskeletal regulation
ENSG00000167578,RAB4B,tumor progression,oncogenic processes,endocytic recycling,cell proliferation,growth factor receptor recycling,signaling pathway activation
ENSG00000186832,KRT16,cell proliferation,biomarker for diagnosis,tumor progression,cell survival pathways,intermediate filament regulation,cytoskeletal disruption
ENSG00000168961,LGALS9,immune evasion,tumor progression,apoptosis regulation,angiogenesis modulation,immunosuppression,biomarker potential
ENSG00000055955,ITIH4,extracellular matrix regulation,cell migration,tumor metastasis,chemoattractant function,immune cell recruitment,angiogenesis promotion
ENSG00000122565,CBX3,chromatin modification,transcriptional regulation,cell cycle progression,genomic instability,tumor suppressor repression,oncogenic function
ENSG00000135443,KRT85,tumor progression,overexpression,cytoskeletal disruption,oncogenesis,cellular regulation,biomarker candidate
ENSG00000285152,RNF31,cell cycle regulation,ubiquitination and proteasomal degradation,apoptosis modulation,tumor growth and metastasis,therapeutic target,poor prognostic marker
ENSG00000173915,ATP5MD,metabolic reprogramming,enhanced glycolysis,increased energy production,warburg effect,overexpression,cell proliferation
ENSG00000278161,TFPT,pi3k/akt pathway interaction,oncogene function,genomic instability promotion,cancer cell proliferation enhancement,tumor growth facilitation,apoptosis inhibition
ENSG00000185883,ATP6V0C,v-atpase regulation,cellular trafficking,ph homeostasis,tumor growth,oncogenic process,cell proliferation
ENSG00000197771,MCMBP,cell adhesion,cell signaling pathway,microtubule regulation,oncogene activation,tumor progression,cancer biomarker
ENSG00000145041,DCAF1,cell cycle regulation,genetic instability,protein degradation,ubiquitin-proteasome system,oncogenic signaling pathways,dna damage response
ENSG00000284881,DEFB1,inflammation mediated,immune evasion,tumor progression,metastasis promotion,antimicrobial response modulation,prognostic marker
ENSG00000137673,MMP7,ecm degradation,tumor progression,transcriptional regulation,cell migration,therapeutic target,prognostic biomarker
ENSG00000152240,HAUS1,cell cycle regulation,mitotic progression disruption,genomic instability induction,tumor growth promotion,apoptosis resistance,chromosomal instability
ENSG00000173674,EIF1AX,oncogenic mutations,aberrant protein synthesis,translation initiation regulation,loss-of-function mutation,cell cycle progression,apoptosis resistance
ENSG00000108528,SLC25A11,**

* mitochondrial transport,* oncogenic metabolism,* energy reprogramming,* tumor aggressiveness,* therapeutic resistance,* metabolic regulation 

**
ENSG00000206075,SERPINB5,apoptosis inhibition,angiogenesis regulation,cell migration promotion,emt pathway modulation,oncogene potential,proteolysis regulation disruption
ENSG00000241837,ATP5PO,mitochondrial function,energy production,cell division regulation,tumor progression,therapeutic target,genomic instability
ENSG00000114107,CEP70,centrosomal function,microtubule regulation,spindle assembly defect,genomic amplification,oncogenic transformation,cell cycle dysregulation
ENSG00000186660,ZFP91,transcriptional regulation,oncogene overexpression,tumor progression,gene expression modulation,cell survival enhancement,chemosensitivity reduction
ENSG00000108883,EFTUD2,cellular proliferation,genomic instability,rna splicing regulation,tumor suppressor activity,dna damage response,apoptosis resistance
ENSG00000137497,NUMA1,chromosomal instability,mitosis regulation,protein overexpression,kinetochore function,cell cycle disruption,tumor progression
ENSG00000115875,SRSF7,alternative splicing regulation,angiogenesis promotion,cell migration and invasion,prognosis prediction,therapeutic target,oncogenic pathway modulation
ENSG00000123268,ATF1,transcriptional regulation,constitutive activation,oncogene,tumor promotion,cell survival,signaling pathway interaction
ENSG00000100280,AP1B1,tumor progression,cell proliferation,signaling pathway interaction,mutations,genomic alteration,protein sorting and trafficking
ENSG00000198431,TXNRD1,oncogenic driver,gene amplification,redox regulation,therapeutic target,tumor progression,prognostic marker
ENSG00000023330,ALAS1,heme biosynthesis,vascular endothelial growth factor expression,hif-1α regulation,tumor aggressiveness,stemness promotion,epithelial-to-mesenchymal transition
ENSG00000104611,SH2D4A,overexpression,pi3k/akt pathway activation,cell survival promotion,tumor progression facilitation,protein-protein interaction enhancement,oncogene cooperation
ENSG00000170677,SOCS6,tumor suppressor,jak/stat pathway inhibition,cancer driver,cell proliferation regulation,apoptosis modulation,immune response regulation
ENSG00000133112,TPT1,apoptosis regulation,autophagy modulation,cell cycle regulation,protein degradation regulation,tumor cell proliferation,tumor protein family membership
ENSG00000067225,PKM,glycolytic shift,altered isoform expression,gene amplification,tumor metabolism,warburg effect,cell proliferation regulation
,HIST1H2AE,histone modification,chromatin remodeling,epigenetic regulation,tumor aggressiveness,poor prognosis,gene expression modulation
,HIST1H2AB,**

epigenetic regulation,chromatin remodeling,histone modifications,gene expression regulation,cell cycle progression,apoptosis modulation
ENSG00000196136,SERPINA3,apoptosis regulation,protease inhibition,tumor progression,microrna target,transcriptional regulation,cell proliferation
ENSG00000158859,ADAMTS4,extracellular matrix degradation,tumor invasion and metastasis,angiogenesis,cancer cell proliferation,oncogenic potential,therapeutic target
ENSG00000112559,MDFI,apoptosis regulation,cell cycle progression,oncogene activation,tumor suppressor interaction,pi3k/akt pathway modulation,cancer cell survival
ENSG00000126778,SIX1,epithelial-to-mesenchymal transition (emt),cell proliferation,transcription factor activation,tumor progression,promoter regulation,signaling pathway modulation
ENSG00000104408,EIF3E,translation regulation,protein synthesis enhancement,oncogene translation facilitation,tumor progression correlation,poor prognosis association,cancer driver role
ENSG00000185745,IFIT1,interferon response,viral replication inhibition,antiviral activity,tumor suppressor function,cell signaling regulation,immune modulation
ENSG00000057149,SERPINB3,overexpression,tumor progression,cell survival,apoptosis resistance,protease inhibition,signaling pathway modulation
ENSG00000174123,TLR10,tlr activation,inflammation induction,tumor progression association,immune evasion promotion,oncogenic signaling,endogenous ligand recognition
ENSG00000124875,CXCL6,tumor progression,angiogenesis facilitation,metastasis promotion,cell recruitment,pro-tumorigenic signaling,poor prognosis marker
ENSG00000144674,GOLGA4,golgin regulation,golgi apparatus dysregulation,tumor progression,cell proliferation,microtubule dynamics regulation,apoptosis suppression
ENSG00000254772,EEF1G,translation regulation,protein synthesis enhancement,cell proliferation promotion,tumor growth facilitation,oncogenic protein production,signaling pathway interaction
ENSG00000109061,MYH1,cell contractility regulation,cytokinesis regulation,muscle contraction interaction,cell migration facilitation,epigenetic regulation,oncogenic pathway interaction
ENSG00000163902,RPN1,apoptosis regulation,cell cycle regulation,proteasome function,tumor suppression,oncogenic pathway activation,therapeutic target resistance
ENSG00000110497,AMBRA1,autophagic regulation,mtor signaling,tumor suppressor function,oncogenic potential,cell survival regulation,cellular metabolism regulation
ENSG00000163739,CXCL1,angiogenesis promotion,cancer metastasis,cell migration,cell proliferation,constitutive activation,signaling pathway
ENSG00000162896,PIGR,glycosylation regulation,cell membrane modification,tumor progression,protein expression changes,kidney tissue specificity,membrane-bound protein function alterations
ENSG00000158856,DMTN,folate metabolism,nucleotide synthesis,cell proliferation,angiogenesis promotion,therapeutic target,cancer progression
ENSG00000029363,BCLAF1,apoptosis inhibition,tumor-initiating cells interaction,p53 regulation,transcriptional repressor function,cell cycle progression facilitation,prognostic marker for kirc
ENSG00000143621,ILF2,**
ilf2-mediated transcriptional regulation,oncogenic processes,cell proliferation,apoptosis evasion,metabolic reprogramming,immune suppression 
**
ENSG00000125970,RALY,**
raly,alternative splicing regulator,pi3k/akt pathway interaction,splice variant promoter,oncogenic splicing events,cell cycle progression modifier
**
ENSG00000117036,ETV3,etv3 involvement in emt,tumor progression driver,oncogenic transcription factor,pro-angiogenic factors regulation,poor prognosis marker,therapeutic target
ENSG00000198890,PRMT6,chromatin modification,cell cycle regulation,apoptosis inhibition,mtor pathway activation,epigenetic dysregulation,tumor progression enhancement
ENSG00000135363,LMO2,oncogene activation,cell cycle progression,transcriptional regulation,tumor progression,genomic amplification,therapeutic target
ENSG00000167552,TUBA1A,microtubule instability,cell proliferation,tumor suppressor function,mitotic spindle regulation,apoptosis suppression,kinetochore-microtubule attachment
ENSG00000118515,SGK1,cellular metabolism regulation,oncogenic properties,apoptosis resistance,proliferation promotion,ion transport regulation,protein kinase activation
ENSG00000115009,CCL20,immune cell recruitment,epithelial-to-mesenchymal transition,tumor growth promotion,metastasis facilitation,immune suppression induction,prognostic marker
ENSG00000038427,VCAN,angiogenesis promotion,cell migration facilitation,cancer stem cell association,extracellular matrix regulation,lymphangiogenesis modulation,tumor progression enhancement
ENSG00000185722,ANKFY1,cellular adhesion,motility regulation,epithelial-to-mesenchymal transition,angiogenesis facilitation,immune evasion,signal transduction
ENSG00000175906,ARL4D,mitotic regulator,gtpase activity,cell proliferation,autophagy regulation,vesicle trafficking,poor prognosis marker
ENSG00000168488,ATXN2L,chromatin remodeling,transcriptional activation,mutations associated,oncogenic pathway involvement,transcription factor regulation,gene expression dysregulation
ENSG00000168264,IRF2BP2,cell proliferation,transcriptional regulation,apoptosis evasion,chromatin remodeling,histone modification,genomic instability
ENSG00000087365,SF3B2,altered splicing patterns,alternative oncogene expression,tumorigenesis regulation,rna processing interactions,oncogenic protein expression,poor prognosis indicator
ENSG00000135046,ANXA1,cellular proliferation,signaling pathway regulation,tumor suppressor activity,lipid binding,apoptosis modulation,cell differentiation
ENSG00000143761,ARF1,cellular membrane trafficking,aberrant activation,downstream effectors interaction,tumor suppressor p53 regulation,growth factor receptor signaling,genomic instability
ENSG00000116661,FBXO2,tumor suppressor function,cell cycle regulation,ubiquitination and degradation,scf complex interaction,dna repair mechanisms,p53 protein interaction
ENSG00000140332,TLE3,wnt/β-catenin pathway,transcriptional regulation,tumor suppression,gene expression regulation,cell proliferation modulation,signaling pathway interaction
ENSG00000100448,CTSG,tumor invasion,metastasis promotion,immune evasion,cell migration regulation,biomarker potential,protein-protein interaction
ENSG00000276409,CCL14,tumor suppressor function,dual roles in cancer,cellular migration inhibition,metastasis regulation,angiogenesis modulation,inflammation response modification
ENSG00000204065,TCEAL5,p53 signaling,tumor suppression,cell cycle regulation,anti-apoptosis,angiogenesis promotion,oncogenic potential
ENSG00000111641,NOP2,rna polymerase i regulation,cell proliferation enhancement,constitutive activation,onco-protein synthesis regulator,ribosome biogenesis modulation,gene expression regulation
ENSG00000108518,PFN1,cell migration,actin dynamics regulation,tumor progression,cell survival modulation,signaling pathway interaction,protein-protein interaction
ENSG00000127334,DYRK2,tumor growth promotion,pi3k/akt pathway regulation,cancer metastasis,therapeutic target,cellular differentiation disruption,serine/threonine kinase activity
ENSG00000153048,CARHSP1,er stress modulation,autophagy regulation,calcium signaling pathway,cell proliferation enhancement,pi3k/akt/mtor pathway dysregulation,tumor growth promotion
ENSG00000153879,CEBPG,transcription factor regulation,oncogenic processes promotion,metastasis regulation,epithelial-to-mesenchymal transition (emt),therapeutic target,stemness maintenance
ENSG00000183421,RIPK4,apoptosis regulation,necroptosis pathway activation,cell cycle progression,protein kinase activation,tumor cell survival,genomic stability maintenance
ENSG00000169100,SLC25A6,mitochondrial carrier protein,energy metabolism regulation,tumor promoter,oxidative stress induction,mitochondrial dysfunction,therapeutic target
ENSG00000080561,MID2,microtubule dynamics regulation,overexpression association,oncogenesis contribution,cell division disruption,genomic instability induction,therapeutic target potential
ENSG00000167768,KRT1,aberrant expression,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),cytoskeleton disruption,proliferation enhancement,metastasis facilitation
ENSG00000111786,SRSF9,alternative splicing,apoptosis evasion,cell cycle dysregulation,metastasis promotion,prognostic marker,tumor suppressor dysfunction
ENSG00000103710,RASL12,golgi apparatus localization,ras superfamily member,cell proliferation promotion,mapk/erk pathway activation,protein secretion regulation,tumor progression association
ENSG00000179409,GEMIN4,spliceosomal snrnps,pre-mrna splicing,snrnp assembly complex,cellular regulation,protein-protein interactions,cancer progression
ENSG00000164056,SPRY1,rho gtpase signaling pathway,tumor suppressor function,cell growth inhibition,oncogenic protein regulation,apoptosis modulation,genomic instability prevention
ENSG00000164754,RAD21,chromatin remodeling,genomic instability,dna repair regulation,cohesin complex function,oncogenic driver,biomarker potential
ENSG00000083290,ULK2,autophagy regulation,cell survival enhancement,protein kinase activation,oncogenic process facilitation,therapeutic target potential,tumor progression promotion
ENSG00000175224,ATG13,autophagy regulation,cellular recycling,mtorc1 activation,pi3k/akt/mtor pathway,tumor progression,oncogenic function
ENSG00000180549,FUT7,fucosyltransferase activity,immune evasion,glycoprotein biosynthesis,tumor-immune interaction,leukocyte adhesion modulation,cancer progression
ENSG00000284832,POLR2A,transcriptional regulation,enhanced dna repair,cell proliferation,apoptosis suppression,oncogenic properties,epigenetic modulation
ENSG00000113719,ERGIC1,intra-golgi transport regulation,tumor progression,cell proliferation enhancement,glycosylation regulation,protein sorting disruption,secretion pathway modulation
ENSG00000153157,SYCP2L,genetic instability,chromosomal instability,dna damage response,homologous recombination repair,cell survival,synaptonemal complex assembly
ENSG00000167996,FTH1,ferritin assembly,iron homeostasis regulation,cellular iron accumulation,oxidative stress responses,tumor suppressor function,protein interaction network
ENSG00000063244,U2AF2,splice site mutations,aberrant splicing patterns,tumor suppressor exons,oncogenic transformation,rna processing dysregulation,poor prognosis
ENSG00000008128,CDK11A,enhanced tumor growth,cell cycle regulation,cancer driver gene,tumor aggressiveness,therapeutic target,genomic instability
ENSG00000163660,CCNL1,cell cycle regulation,gene overexpression,oncogene function,mitotic entry facilitation,chromosomal segregation,tumor progression
ENSG00000122779,TRIM24,regulation of transcription,chromatin remodeling,oncogenic signaling,cell proliferation promotion,metastasis facilitation,angiogenesis enhancement
ENSG00000183048,SLC25A10,mitochondrial function,cellular metabolism regulation,tumor growth promotion,tumorigenesis contributor,mitochondrial carrier dysfunction,ros accumulation
ENSG00000011451,WIZ,spindle checkpoint regulation,genomic stability maintenance,tumor suppression,apoptosis induction,cell proliferation inhibition,mitotic error prevention
ENSG00000280962,DUSP16,mapk pathway regulation,tumor suppressor function,oncogenic process enhancement,cell proliferation regulation,downregulated expression in cancer,potential biomarker for diagnosis and prognosis
ENSG00000132780,NASP,genomic instability,tumor progression,dysregulated expression,anti-apoptotic function,nucleosome formation regulation,apoptosis suppression
ENSG00000100065,CARD10,calcium-dependent activation,nf-κb pathway,t-cell receptor signaling,oncogenic potential,immune response regulation,autoimmune disorder association
ENSG00000113141,IK,nf-kappab signaling pathway,constitutive activation,gain of function mutations,tumor growth,apoptosis suppression,immune response modulation
ENSG00000130119,GNL3L,tumor suppressor,cell proliferation regulation,signal transduction modulation,oncogenic processes promotion,genomic instability contribution,growth factor interaction
ENSG00000143632,ACTA1,disrupted cytoskeletal integrity,loss of function mutations,tumor progression,pi3k/akt pathway involvement,metastasis,cellular migration
ENSG00000075618,FSCN1,cellular motility,actin-bundling,oncogenic processes,tumor progression,therapeutic target,genomic instability
ENSG00000185359,HGS,cellular regulation,p53 interaction,dna repair pathway,protein kinase activation,tumor suppressor function,pi3k/akt signaling modulation
ENSG00000204673,AKT1S1,akt/pi3k signaling,oncogenic regulation,genomic instability,cell proliferation,protein kinase activation,metabolic reprogramming
ENSG00000198682,PAPSS2,cancer cell proliferation,metastasis promotion,therapeutic target,redox balance regulation,cell adhesion modulation,extracellular matrix remodeling
ENSG00000196730,DAPK1,apoptosis regulation,pi3k/akt pathway modulation,tumor suppressor function,cancer-related kinase activity,cellular differentiation regulation,mitochondrial membrane permeabilization
ENSG00000125775,SDCBP2,transcriptional coactivator,oncogene,hypoxia-inducible gene expression,angiogenesis promotion,chemotherapy resistance,cell proliferation enhancement
ENSG00000012223,LTF,iron-regulating,tumor suppression,immunomodulatory,anti-angiogenic,cell proliferation regulation,apoptosis modulation
ENSG00000088986,DYNLL1,mitotic checkpoint regulation,tumor progression,cell division dysregulation,microtubule stability maintenance,centrosomal protein interaction,cancer stem cell self-renewal
ENSG00000105357,MYH14,cell migration,epithelial-to-mesenchymal transition (emt),prognostic marker,therapeutic target,cytoskeletal regulation,cell adhesion modulation
ENSG00000184922,FMNL1,cellular motility,migratory behavior,invasive potential,cytoskeleton regulation,oncogenic interaction,tumor progression
ENSG00000174516,PELI3,nf-κb signaling pathway,proteasome regulation,tumor promotion,cell proliferation,oncogenic interaction,transcriptional modulation
ENSG00000125845,BMP2,tumor progression,wnt/β-catenin signaling pathway activation,epithelial-to-mesenchymal transition (emt) promotion,angiogenesis enhancement,cellular senescence suppression,therapeutic target
ENSG00000132357,CARD6,nf-κb signaling pathway regulation,apoptosis modulation,necroptosis regulation,tumor progression influence,prognostic biomarker,metastasis enhancement
ENSG00000134970,TMED7,hypoxia response,retrograde transport regulation,growth factor secretion modulation,angiogenesis promotion,cellular interaction enhancement,poor prognosis indicator
ENSG00000102076,OPN1LW,tumor heterogeneity,cellular interaction,protein-protein interactions,gene expression modulation,regulatory mechanisms unknown,not directly related to oncogenesis
ENSG00000126351,THRA,altered expression,tumor aggressiveness,thyroid hormone regulation,transcriptional modulation,cellular differentiation,epithelial-to-mesenchymal transition
ENSG00000129654,FOXJ1,transcription factor activation,oncogene activation,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),tumor progression promoter,gene expression regulation
ENSG00000277594,DDX52,dna repair regulation,genomic instability,gene expression regulation,oncogene regulation,tumor progression promotion,poor prognosis biomarker
ENSG00000132676,DAP3,mitochondrial translation regulation,cell growth promotion,tumor suppressor dysfunction,apoptosis inhibition,proliferation enhancement,oncogene overexpression
ENSG00000158560,DYNC1I1,microtubule stability,cargo transport regulation,oncogenesis,constitutive activation,mtor pathway interaction,cell proliferation promotion
ENSG00000083750,RRAGB,mtorc1 pathway activation,constitutive activation,gaps regulation,rgs interaction,cell proliferation enhancement,tumor growth promotion
ENSG00000025039,RRAGD,gtpase activating protein,mtor pathway activation,autophagy inhibition,oncogenic signaling,cellular energy homeostasis regulation,tumor growth promotion
ENSG00000137601,NEK1,cell cycle regulation,genomic instability,oncogenic potential,protein kinase activation,therapeutic target,chromosomal abnormalities
ENSG00000118058,KMT2A,genomic instability,histone modification,cell proliferation,epigenetic regulation,oncogenic driver,chromatin remodeling
ENSG00000133895,MEN1,tumor suppressor activity,gene expression regulation,chromatin organization,cell cycle progression disruption,cancer risk factor,transcription factor interaction
ENSG00000150687,PRSS23,apoptosis regulation,cell proliferation,signaling pathway modulation,tumorigenesis contribution,serine protease function,cell survival pathway regulation
ENSG00000108679,LGALS3BP,tumor microenvironment modulation,apoptosis inhibition,cell adhesion regulation,immune response suppression,angiogenesis facilitation,glycosylation complex formation
ENSG00000174807,CD248,angiogenesis,tumor microenvironment,glycoprotein expression,endothelial cell stabilization,antigen presentation,immunotherapeutic target
ENSG00000129521,EGLN3,hypoxia-inducible factor pathway,tumor metabolism,angiogenesis regulation,hif-1α regulation,oxygen sensing,protein hydroxylation
ENSG00000171314,PGAM1,metabolic regulation,warburg effect,glycolytic pathway,tumor growth promotion,energy production,prognostic marker
ENSG00000002587,HS3ST1,glycosaminoglycan biosynthesis,heparan sulfate 3-o-sulfotransferase activity,tumor growth regulation,metastasis facilitation,angiogenesis promotion,cell signaling pathway interaction
ENSG00000128340,RAC2,cell migration,constitutive activation,gtpase activity,protein interaction,signaling pathways,tumor progression
ENSG00000136848,DAB2IP,tumor suppressor function,downregulation in cancer,cell proliferation regulation,apoptosis regulation,interaction with pten,dab2 signaling pathway interaction
ENSG00000198791,CNOT7,alternative splicing,cancer metabolism,cell proliferation,genomic instability,metastasis,tumor progression
ENSG00000132938,MTUS2,microtubule regulation,tumor suppression,ciliogenesis,gene expression regulation,cell migration,metastatic potential
ENSG00000172005,MAL,tumor progression,epithelial-to-mesenchymal transition,cell signaling pathway,transcription regulation,cell proliferation,protein transport
ENSG00000089154,GCN1,mtorc1 activation,growth factor signaling,metabolic reprogramming,cell growth regulation,nutrient sensing,protein synthesis enhancement
ENSG00000173546,CSPG4,emt regulation,tumor progression,cell migration,therapeutic target,oncogenesis driver,immune evasion mechanisms
ENSG00000167526,RPL13,ribosomal protein function,translation regulation,cell proliferation enhancement,tumor progression facilitation,oncogene potential,protein synthesis upregulation
ENSG00000137504,CREBZF,cellular regulation,gene expression modulation,dna repair,apoptosis resistance,protein interaction,tumor suppressor activity
ENSG00000104635,SLC39A14,iron regulation,metal transport,oncogenesis,tumor progression,metastasis,prognosis
ENSG00000145425,RPS3A,ribosomal protein function,oncogenic mutations,increased cell proliferation,tumor progression,poor prognosis,cellular metabolism regulation
ENSG00000120370,GORAB,golgi apparatus regulation,cellular dynamics disruption,oncogenic transformation,apoptosis resistance,cell proliferation enhancement,tumorigenesis facilitation
ENSG00000124216,SNAI1,emt driver,transcriptional repressor,metastasis promoter,prognostic marker,cell migration enhancer,epithelial plasticity regulator
ENSG00000284161,EEF2K,protein synthesis regulation,tumor growth promotion,mtor pathway interaction,cell cycle progression,kinase activity,proteostasis dysregulation
ENSG00000167658,EEF2,protein synthesis regulation,cell growth promotion,tumor progression facilitation,mtor pathway interaction,oncogene overexpression,poor prognosis indicator
ENSG00000124588,NQO2,quinone reduction,antioxidant function,cell proliferation,signal transduction,biomarker candidate,therapeutic target
ENSG00000136011,STAB2,actin cytoskeleton regulation,cell migration promotion,tumor progression facilitation,cell invasion enhancement,metastasis associated protein,genomic amplification
ENSG00000164022,AIMP1,cell survival enhancement,metabolic adaptation,pi3k/akt pathway modulation,stress response regulation,metastasis promotion,autophagy regulation
ENSG00000165629,ATP5F1C,mitochondrial biogenesis,oncogenic mutations,energy metabolism,tumor aggressiveness,glycolysis activation,therapeutic target
ENSG00000134884,ARGLU1,aberrant metabolism,arginine biosynthesis,cellular proliferation,enzyme dysregulation,glycine metabolism,poor prognosis marker
ENSG00000276111,SDCCAG8,autophagy regulation,golgi apparatus maintenance,tumor growth promotion,cellular trafficking regulation,protein synthesis modulation,poor prognosis marker
ENSG00000065534,MYLK,cell migration,cytoskeleton dynamics,constitutive activation,protein kinase activity,metastasis promotion,cell invasion
ENSG00000106049,HIBADH,**

mitochondrial function,metabolic rewiring,cellular respiration,oxidative phosphorylation,enzyme regulation,redox balance

**
ENSG00000151746,BICD1,microtubule dynamics,cellular trafficking regulation,oncogenic signaling pathway activation,cargo-specific adapter function,cell proliferation enhancement,tumor progression facilitation
ENSG00000176490,DIRAS1,pi3k/akt/mtor pathway,oncogenic driver,ras superfamily member,cell survival regulation,growth factor signaling,constitutive activation
ENSG00000114942,EEF1B2,protein synthesis initiation,cellular proliferation,apoptosis resistance,tumor progression,therapeutic target,gene expression regulation
ENSG00000047849,MAP4,microtubule dynamics regulation,tumor progression promotion,microtubule interaction,oncogene activation,cell migration facilitation,cancer metastasis association
ENSG00000198612,COPS8,protein degradation regulation,cancer susceptibility,tumor suppressor function,cellular homeostasis modulation,genetic instability contribution,oncogenic pathway interaction
ENSG00000239789,MRPS17,mitochondrial protein synthesis,cellular metabolism regulation,oncogenic process,cell proliferation enhancement,therapeutic resistance,energy production regulation
ENSG00000137806,NDUFAF1,mitochondrial dysfunction,oncogenic mutations,tumor suppressor function,energy metabolism regulation,dna damage response,glycolytic shift
ENSG00000243414,TICAM2,nf-κb signaling pathway,tumor microenvironment modulation,oncogenesis promotion,immune cell infiltration regulation,tlr4 associated molecule,prognostic biomarker
ENSG00000160710,ADAR,cell survival promotion,oncogene regulation,rna editing,tumor progression facilitation,mirna/sirna biogenesis modulation,genome instability maintenance
ENSG00000129562,DAD1,genomic instability,tumor suppressor function,apoptosis regulation,dna repair mechanism,genetic damage susceptibility,therapeutic target
ENSG00000160753,RUSC1,regulation of p53,tumor suppressor function,genome stability maintenance,pi3k/akt pathway modulation,evasion of apoptosis,protein degradation regulation
ENSG00000090376,IRAK3,nf-κb signaling,oncogenic driver,immune modulation,tumor growth promotion,angiogenesis facilitation,poor prognosis association
ENSG00000124444,ZNF576,aberrant transcription regulation,chromatin remodeling interaction,oncogene activation,poor prognosis association,cell proliferation promotion,epithelial-to-mesenchymal transition
ENSG00000086991,NOX4,reactive oxygen species,pro-tumorigenic function,mitochondrial localization,tumor progression,angiogenesis promotion,genetic instability
ENSG00000114739,ACVR2B,tgf-β signaling pathway,upregulation,epithelial-to-mesenchymal transition (emt),tumor progression,metastasis,therapeutic target
ENSG00000198836,OPA1,mitochondrial dynamics,mitochondrial dysfunction,oxidative stress regulation,apoptosis modulation,proliferation enhancement,glycolytic shift
ENSG00000180879,SSR4,er targeting,protein translation regulation,rna-binding subunit interaction,tumorigenesis implication,oncogenesis association,cellular localization role
ENSG00000153944,MSI2,polycomb repressive complex 1 component,chromatin modification,oncogenic transcriptional regulation,tumor aggressiveness marker,cancer cell proliferation promoter,metastasis enhancer
ENSG00000100266,PACSIN2,cell migration,pi3k/akt pathway,cell adhesion,actin dynamics,protein kinase activation,calmodulin-binding protein
ENSG00000046651,OFD1,genomic instability,tumor suppression,dna damage response,chromatin remodeling,mitotic checkpoint regulation,cancer predisposition
ENSG00000113140,SPARC,oncogenic driver,tumor progression,metastasis facilitation,poor prognosis marker,cell adhesion regulation,extracellular matrix modulation
ENSG00000154174,TOMM70,mitochondrial biogenesis,cellular metabolism,protein import,energy production,potential cancer driver,tumor growth regulation
ENSG00000077264,PAK3,oncogenic transformation,cell proliferation,angiogenesis promotion,metastasis facilitation,erk/mapk pathway activation,rho gtpase interaction
ENSG00000142731,PLK4,centriole biogenesis,oncogenic function,kinase activity,genomic instability,tumorigenesis,microtubule organization
ENSG00000147403,RPL10,aberrant translation,cellular growth regulation,mtor pathway interaction,oncogenic process promotion,protein synthesis regulation,ribosome assembly disruption
ENSG00000054118,THRAP3,cell proliferation,transcriptional regulation,chromatin remodeling,nuclear receptor interaction,epithelial-to-mesenchymal transition (emt),histone modification
ENSG00000182195,LDOC1,tumor suppressor function,cell growth regulation,protein-protein interaction,gene expression modulation,proliferation inhibition,cancer development modulation
ENSG00000128016,ZFP36,au-rich element binding,mrna degradation,tumor suppressor function,pro-inflammatory response modulation,cell growth regulation,gene expression regulation
ENSG00000235941,HSPA1A,protein folding regulation,stress response mechanism,cellular homeostasis maintenance,apoptosis inhibition,chemo-resistance,tumor growth promotion
ENSG00000121691,CAT,oxidative stress regulation,tumor microenvironment modulation,cellular protection mechanism,dna damage response,cancer cell metabolism,antioxidant function
ENSG00000189091,SF3B3,splicing factor regulation,altered gene expression,oncogenic driver,cancer progression,tumor suppression evasion,epithelial-to-mesenchymal transition
ENSG00000142657,PGD,metabolic reprogramming,glycolysis,glutamine metabolism,cell growth and survival,oxidative stress regulation,pentose phosphate pathway
ENSG00000136783,NIPSNAP3A,camp degradation,cancer cell proliferation,cell signaling pathway,phosphodiesterase regulation,protein kinase activation,tumor growth promotion
ENSG00000262993,KRT31,cytoarchitecture disruption,cellular disorganization,tumor progression marker,metastatic potential,epithelial cell maintenance,protein structure modification
ENSG00000004700,RECQL,**

genomic stability,dna replication,genetic instability,tumor growth,oncogenic processes,homologous recombination repair

**
ENSG00000180198,RCC1,ran gtpase regulation,cancer cell proliferation,dysregulated expression,oncogene activation,cell cycle progression,nuclear transport modulation
ENSG00000175602,CCDC85B,hedgehog signaling pathway disruption,tumor suppressor function,ciliogenesis regulation,paralog interaction,protein expression alteration,cellular growth modulation
ENSG00000176896,TCEANC,tumor microenvironment regulation,immune evasion mechanism,antigen presentation regulation,oncogenic process,genomic instability,immunological adaptation
ENSG00000117020,AKT3,constitutive activation,gain of function mutations,tumor progression,cell proliferation,metabolic regulation,protein kinase activation
ENSG00000091436,MAP3K20,cellular proliferation regulation,apoptosis induction,tumor suppressor function,signal transduction modulation,protein kinase activation,genetic alterations association
ENSG00000115109,EPB41L5,tumor migration,epithelial-to-mesenchymal transition,protein-protein interaction,cellular adhesion regulation,biomarker potential,cytoskeleton dynamics
ENSG00000165138,ANKS6,cell migration,ion channel regulation,protein-protein interaction,tumor progression,oncogenic transformation,therapeutic target
ENSG00000113448,PDE4D,camp degradation,cell proliferation regulation,signaling pathway modulation,tumor progression association,therapeutic target potential,cancer-relevant signaling
ENSG00000143190,POU2F1,transcriptional regulation,promotes oncogenesis,regulates pi3k/akt pathway,activates tumor growth,metastasis regulator,chromatin remodeling
ENSG00000169871,TRIM56,protein degradation regulation,tumor suppressor activity,cell cycle regulation,apoptosis regulation,ubiquitin-proteasome system interaction,genomic instability prevention
ENSG00000136826,KLF4,oncogene,epithelial-to-mesenchymal transition (emt),stemness regulation,tumor progression,angiogenesis,transcription factor activity
ENSG00000167601,AXL,tumor progression,oncogenic driver,receptor tyrosine kinase activation,cell migration invasion,chemoresistance immunosuppression,pi3k/akt/mtor pathway interaction
ENSG00000149948,HMGA2,regulation of transcription,epigenetic modifications,cell proliferation,oncogenic transformation,chromatin remodeling,microrna regulation
ENSG00000132842,AP3B1,epithelial-to-mesenchymal transition,oncogenic process,cell adhesion regulation,tumor progression,metastasis,therapeutic target
ENSG00000099804,CDC34,cell cycle regulation,protein degradation pathway,tumor suppressor protein suppression,ubiquitination activation,oncogenic process promotion,therapeutic target
ENSG00000108055,SMC3,genomic instability,aneuploidy,cohesin complex,chromosomal segregation,cell cycle regulation,dna damage response
ENSG00000173894,CBX2,chromatin remodeling,epigenetic silencing,oncogenic transcription,transcriptional regulation,gene silencing,prc1 complex interaction
ENSG00000174175,SELP,tumor progression,angiogenesis promotion,adhesion molecule function,oncogenic process activation,metastasis facilitation,poor prognosis association
ENSG00000090487,SPG21,er stress pathway,tumor suppressor,cell survival,protein-protein interactions,cancer susceptibility,gene regulation
ENSG00000254726,MEX3A,mirna regulation,tumor suppression,oncogenic mir-21 inhibition,biomarker potential,cell proliferation repression,metastasis prevention
ENSG00000112511,PHF1,chromatin remodeling,e3 ubiquitin ligase activity,gene regulation,tumor suppressor modulation,cell cycle regulation,dna repair dysfunction
ENSG00000135999,EPC2,regulation of emt,constitutive activation,pi3k/akt/mtor pathway,tumor growth and metastasis,transcriptional regulation,oncogenic driver
ENSG00000167088,SNRPD1,alternative splicing regulation,cancer promoter,gene expression modulation,oncogene activation,prognostic marker,tumor progression facilitator
ENSG00000120215,MLANA,melanosome transfer,oncogenesis,cell proliferation,cancer progression,gene regulation,protein interaction
ENSG00000171132,PRKCE,signaling pathway modulation,oncogenic process activation,aberrant expression,cell cycle progression,apoptosis evasion,metastasis promotion
ENSG00000171490,RSL1D1,alternative splicing,oncogenic transformation,pre-mrna processing,splice site recognition,tumor progression,gene amplification
ENSG00000135631,RAB11FIP5,cellular proliferation,endosomal recycling,genomic instability,oncogene activity,protein trafficking regulation,tumor aggressiveness
ENSG00000135930,EIF4E2,translation initiation,protein synthesis regulation,oncogene activation,tumor progression facilitation,therapeutic target identification,signaling pathway modulation
ENSG00000102580,DNAJC3,protein degradation,cell growth promotion,cell survival enhancement,apoptosis inhibition,ubiquitin-proteasome system modulation,molecular chaperone function
ENSG00000149532,CPSF7,cancer-related transcription regulation,pre-mrna processing,cell growth promotion,tumor progression facilitation,genomic instability contributor,therapeutic target candidate
ENSG00000149016,TUT1,regulatory rna modification,mirna suppression,oncogenic pathway activation,cell proliferation promotion,tumor suppressor gene silencing,poor prognosis marker
ENSG00000134452,FBH1,genomic instability,dna repair regulation,brca1 protein regulation,deubiquitinating enzyme function,tumor suppressor role,oncogenic driver mutation
ENSG00000138835,RGS3,rgs3 downregulation,g-protein signaling inhibition,tumor suppressor function,cell proliferation regulation,oncogene regulation,cancer metastasis suppression
ENSG00000120690,ELF1,genetic instability,dna repair regulation,tumor aggressiveness,proliferation enhancement,apoptosis suppression,pi3k/akt pathway modulation
ENSG00000111196,MAGOHB,mrna translation regulation,cell cycle progression disruption,tumor suppressor function loss,apoptosis inhibition,pi3k/akt pathway interaction,gene expression alteration
ENSG00000010803,SCMH1,pi3k/akt pathway dysregulation,transcription factor overexpression,tumorigenesis promotion,oncogenic process activation,cell proliferation enhancement,pi3k signaling modulation
ENSG00000101126,ADNP,oncogene,transcriptional regulator,cell proliferation,apoptosis inhibition,neuronal maintenance,tumor progression
ENSG00000164978,NUDT2,genomic instability,dna damage response,tumor suppressor function,nucleotide pool regulation,cell proliferation regulation,oncogenic mutation
ENSG00000182712,CMC4,tumor progression,cell survival,macrophage recruitment,angiogenesis enhancement,metastasis promotion,csf-1r signaling
ENSG00000033030,ZCCHC8,chromatin remodeling,dna binding,oncogenic transcription factors,wnt/β-catenin pathway,histone modification,tumor suppressor regulation
ENSG00000127914,AKAP9,wnt/β-catenin pathway,oncogenic role,subcellular localization,signaling regulation,cell proliferation,scaffold protein function
ENSG00000169900,PYDC1,pyruvate metabolism,warburg effect,glycolytic shift,tumor progression,mitochondrial dysfunction,aerobic glycolysis
ENSG00000166197,NOLC1,cell cycle regulation,oncogenic potential,ribosome biogenesis,protein-protein interactions,tumor aggressiveness,apoptosis evasion
ENSG00000164047,CAMP,signaling pathway modulation,gene expression regulation,aggressive tumor behavior,poor prognosis indicator,cell proliferation enhancement,calcium-dependent interaction
ENSG00000167965,MLST8,mtor signaling pathway,oncogene potential,cellular proliferation,protein synthesis regulation,autophagy inhibition,pi3k/akt interaction
ENSG00000265241,RBM8A,rna processing,nonsense-mediated mrna decay,tumor suppressor regulation,cell cycle progression,apoptosis modulation,dna repair pathway
ENSG00000137161,CNPY3,apoptosis resistance,cellular redox regulation,oxidative stress modulation,protein-protein interactions,cell cycle progression,signal transduction pathway
ENSG00000204099,NEU4,cell surface glycoproteins,sialic acid metabolism,glycosphingolipid hydrolysis,tumor progression,metastasis,immune modulation
ENSG00000149554,CHEK1,cell cycle regulation,tumor suppressor,checkpoint activation,dna repair mechanism,oncogenic transformation,phosphorylation and kinase activity
ENSG00000105483,CARD8,nf-?b activation inhibition,inflammatory response regulation,tumor suppressor function,autophagy modulation,cancer risk association,pro-inflammatory cytokine reduction
ENSG00000135100,HNF1A,tumor suppressor function loss,transcription factor regulation,cell proliferation promotion,apoptosis inhibition,metabolic pathway disruption,gene expression downregulation
ENSG00000109062,SLC9A3R1,tumor progression,glycolysis regulation,dysregulated ion transport,apoptosis suppression,nhe1 overexpression,cellular ph imbalance
ENSG00000103154,NECAB2,metabolic reprogramming,tumor progression,calcineurin activity regulation,immune evasion,cellular metabolism modulation,nfat signaling pathway dysregulation
ENSG00000102878,HSF4,chromatin remodeling,dna damage response,epithelial-to-mesenchymal transition (emt),heat shock protein activation,transcriptional regulation,tumor progression
ENSG00000148187,MRRF,mitochondrial function,glycolytic shift,mitochondrial fission,aerobic glycolysis,stress signaling pathways,cancer progression
ENSG00000011478,QPCTL,glycosylation regulation,tumor progression,cell signaling alteration,therapeutic target,glycoprotein modification,adhesion and migration modulation
ENSG00000213619,NDUFS3,mitochondrial dysfunction,complex i mutations,oxidative stress,energy metabolism regulation,cellular respiration modulation,electron transport chain interaction
ENSG00000139180,NDUFA9,mitochondrial function,altered energy production,tumor cell metabolism,electron transport chain,oxidative phosphorylation,rerouting of glucose metabolism
ENSG00000263012,KRT33B,cellular integrity,intermediate filament structure,tumor suppressor potential,epithelial cell specificity,renal tubular expression,keratin protein function
ENSG00000186432,KPNA4,nuclear transport,cell cycle regulation,anti-apoptotic function,oncogene overexpression,protein import complex,transcriptional regulation
ENSG00000163161,ERCC3,dna damage recognition,genomic instability,helicase activity,impaired dna repair,mutation accumulation,tumor suppressor dysfunction
ENSG00000275023,MLLT6,epigenetic regulation,chromatin remodeling,tumor suppressor function,dna repair mechanism,cell cycle regulation,oncogenic silencing
ENSG00000135018,UBQLN1,protein degradation,cellular proteostasis,oncogene role,e3 ubiquitin ligase interaction,tumor progression,cancer cell metabolism
ENSG00000102034,ELF4,transcription factor activity,oncogenic regulation,cell proliferation promotion,apoptosis evasion,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway regulation
ENSG00000101182,PSMA7,proteasome complex activation,tumor progression association,immunotherapy target,cellular stress response,ubiquitin-ligase interaction,apoptosis regulation
ENSG00000079387,SENP1,de-sumoylation,protein activation,tumor suppressor regulation,cell cycle progression,apoptosis inhibition,cancer progression
ENSG00000101871,MID1,oncogene activation,tumor aggressiveness,cell cycle progression,microtubule dynamics,protein interaction,biomarker potential
ENSG00000173581,CCDC106,pi3k/akt/mtor pathway regulation,centrosomal function disruption,chromosomal instability promotion,oncogenic signaling facilitation,dna damage response modulation,epigenetic alteration contribution
ENSG00000146223,RPL7L1,mtor signaling pathway,oncogenic activation,tumor cell proliferation,mitochondrial function regulation,ribosome biogenesis dysregulation,protein synthesis enhancement
ENSG00000015171,ZMYND11,pi3k/akt pathway interaction,cellular proliferation enhancement,chromatin remodeling role,transcriptional regulation,oncogenic protein partner,tumorigenesis driver
ENSG00000142611,PRDM16,histone modification,transcriptional regulation,oncogene activity,cell proliferation,chromatin remodeling,cancer progression
ENSG00000173372,C1QA,immune evasion,tumor progression,complement activation,protein-protein interaction,cell clearance regulation,genetic variation
ENSG00000184009,ACTG1,cytokeletal reorganization,tumor progression,epithelial-to-mesenchymal transition,cell migration invasion,therapeutic target,genomic instability
,WDYHV1,wd repeat-containing protein,protein-protein interaction,cell cycle regulation,signal transduction,tumor progression,hypothetical function
ENSG00000244405,ETV5,transcriptional regulation,oncogenic function,cell proliferation,metastasis,notch/wnt pathway interaction,chromatin remodeling
ENSG00000051108,HERPUD1,nf-?b pathway activation,cysteine protease function,tumor progression promotion,cell survival enhancement,angiogenesis regulation,i?b degradation
ENSG00000157349,DDX19B,rna helicase function,oncogenic transformation,transcriptional regulation,dna damage response,cell proliferation,genomic instability
ENSG00000143870,PDIA6,protein chaperone function,oncogenic potential,elevated expression,cell growth promotion,protein-protein interaction facilitation,cancer driver status
ENSG00000135108,FBXO21,cell proliferation regulation,dna damage repair,protein degradation pathway,tumor suppressor function,substrate recognition complex,ubiquitin-proteasome system
ENSG00000143373,ZNF687,tumor suppression,dna repair regulation,cell proliferation,transcriptional modulation,promoter recognition,zinc finger binding
ENSG00000276146,LILRB2,mhc class i binding,immune cell modulation,nk cell inhibition,tumor immune evasion,immune regulation,cell surface receptor
ENSG00000103942,HOMER2,transcriptional regulation,constitutive activation,genomic instability,cell proliferation,apoptosis inhibition,protein-protein interaction
ENSG00000149930,TAOK2,mapk/pi3k/akt pathway,oncogenic processes,tumor progression,epithelial-to-mesenchymal transition,kinase activation,cellular proliferation
ENSG00000126775,ATG14,autophagy regulation,tumor adaptation,cell survival,mtor pathway interaction,pi3k/akt signaling,constitutive activation
ENSG00000003756,RBM5,alternative splicing,apoptosis suppression,cell proliferation,chromatin remodeling,cancer cell survival,epi-genetic alterations
ENSG00000148450,MSRB2,protein repair mechanism,oxidative stress regulation,cellular homeostasis maintenance,protein oxidation resistance,cell survival enhancement,cancer progression
ENSG00000274081,PUF60,post-transcriptional regulation,tumor suppressor regulation,oncogene modulation,cell proliferation regulation,rna-binding protein function,alternative splicing involvement
ENSG00000236149,ABCF1,autophagy regulation,chromatin remodeling,apoptosis modulation,cellular transport,signal transduction,transcription factor regulation
ENSG00000128564,VGF,cell growth regulation,tumor marker candidate,signaling pathway modulation,metastasis regulation,proliferation control,protein-protein interaction
ENSG00000205356,TECPR1,autophagy regulation,protein-protein interaction,tumorigenesis association,cell proliferation,cellular stress response,metastasis modulation
ENSG00000157954,WIPI2,autophagosome formation,oncogenic processes,cell growth promotion,survival pathway activation,tumor progression,er localization
ENSG00000196363,WDR5,histone methylation regulation,chromatin remodeling complex,tumor progression correlation,poor prognosis marker,epigenetic therapy target,protein overexpression
ENSG00000163464,CXCR1,cancer-promoting,immune evasion,angiogenesis induction,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway modulation,chemokine receptor activation
ENSG00000114354,TFG,transcriptional regulation,oncogenic driver,tumor suppressor function loss,cell growth modulation,signaling pathway regulation,protein-protein interactions
ENSG00000213316,LTC4S,leukotriene synthesis,inflammation modulation,tumor progression,cancer immunotherapy,therapeutic target,metabolic regulation
ENSG00000119487,MAPKAP1,oncogenic processes,regulation of jnk signaling pathway,tumor progression,enhancement of cell survival,cell proliferation,prognosis
ENSG00000187678,SPRY4,erk/mapk pathway inhibition,loss-of-function mutation,tumor suppressor,apoptosis promotion,angiogenesis suppression,cell signaling regulation
ENSG00000160208,RRP1B,p53 pathway regulation,trna processing,cell cycle progression,apoptosis modulation,oncogene overexpression,therapeutic resistance
ENSG00000040341,STAU2,mrna regulation,oncogenic function,cell proliferation,tumor aggressiveness,prognostic marker,autophagy regulation
ENSG00000114439,BBX,chromatin remodeling,tumor promotion,cell cycle progression,histone modification,transcriptional regulation,genomic instability
ENSG00000181143,MUC16,overexpression,metastasis promotion,tumor progression,poor prognosis,glycoprotein expression,adhesion molecule function
ENSG00000100097,LGALS1,oncogenesis,cell proliferation,tumor progression,protein-protein interaction,metastasis promotion,pi3k/akt pathway modulation
ENSG00000144331,ZNF385B,dna repair regulation,apoptosis inhibition,cell cycle progression,transcriptional modulation,signaling pathway modulation,chromatin remodeling
ENSG00000204843,DCTN1,cell migration,genomic instability,centrosome separation,dynein-dependent transport,protein-protein interactions,microtubule dynamics
ENSG00000108298,RPL19,ribosomal protein function,tumor suppressor activity loss,oncogenic transformation,cellular proliferation increase,protein synthesis disruption,genomic instability contribution
ENSG00000179526,SHARPIN,linear ubiquitination,immune evasion,tumor progression,apoptosis regulation,autophagy modulation,chronic inflammation
ENSG00000125826,RBCK1,ubiquitination regulation,cell cycle progression disruption,protein degradation pathway disruption,constitutive activation of pro-survival pathways,therapeutic target,dna damage response regulation
ENSG00000160360,GPSM1,g-protein signaling modulation,tumor progression,metastasis promotion,cell growth regulation,prognostic marker,genomic overexpression
ENSG00000033122,LRRC7,tumor suppressor,cell migration,transmembrane protein,apoptosis regulation,cancer stem cell marker,prognostic biomarker
ENSG00000075292,ZNF638,overexpression,transcriptional regulation,tumor progression,apoptosis regulation,dna binding activity,zinc finger domains
ENSG00000180318,ALX1,transcription factor regulation,nuclear receptor function,cellular proliferation,apoptosis regulation,tumor progression modulation,genomic instability
ENSG00000117408,IPO13,cell cycle regulation,protein-protein interactions,apoptosis evasion,microtubule dynamics regulation,gene transcription modulation,biomarker potential
ENSG00000070961,ATP2B1,calcium signaling,cell proliferation,metastasis regulation,tumor progression,protein kinase function,gene expression alteration
ENSG00000198730,CTR9,ctr9-ubiquitin pathway disruption,tumor progression,dysregulated protein stability,oncogenic protein accumulation,cell cycle regulation,pi3k/akt signaling pathway interaction
ENSG00000265681,RPL17,cellular proliferation,ribosome dysfunction,protein synthesis regulation,oncogenic transformation,therapeutic target,genomic instability
ENSG00000134909,ARHGAP32,rho gtpase activation,cell migration,tumor progression,oncogenic signaling,gtpase regulation,adhesion modulation
ENSG00000105392,CRX,photoreceptor cell development,regulation of gene expression,oncogene potential,cell cycle regulation,epithelial cell polarity,transcriptional regulation
ENSG00000108798,ABI3,mtor pathway regulation,genomic instability,dna repair mechanism interaction,cell survival enhancement,metabolic reprogramming,oncogenic driver
ENSG00000117984,CTSD,tumor progression,antigen presentation,cell growth,proteolytic activity,lysosomal dysfunction,cell migration
ENSG00000065548,ZC3H15,transcriptional regulation,tumorigenesis driver,chromatin remodeling,oncogenic process,aggressive tumor behavior,dna repair regulation
ENSG00000185624,P4HB,redox regulation,protein folding,tumor progression,cell survival,therapeutic target,oncoprotein stabilization
ENSG00000101347,SAMHD1,oncogene activity,tumor suppressor dysfunction,genomic instability,immune evasion,cell cycle dysregulation,apoptosis resistance
ENSG00000204397,CARD16,immune response modulation,complement component interaction,tumor progression association,secreted protein function,pro-inflammatory properties,cellular stress regulation
ENSG00000089289,IGBP1,igf-1 regulation,growth factor binding,protease activation,tumor progression,mitogenic effects,biomarker expression
ENSG00000038382,TRIO,mapk pathway activation,oncogenic processes,cell proliferation enhancement,gtpase activation factor,signaling pathway regulation,cytoskeleton dynamics modulation
ENSG00000241123,KRTAP10-5,overexpression,cell growth promotion,proliferation,prognostic marker,metastasis,tumor progression
ENSG00000184060,ADAP2,cell signaling regulation,t-cell activation,transcription factor regulation,oncogenic processes,metastasis promotion,adhesion disruption
ENSG00000135441,BLOC1S1,bloc-1 complex,late endosome sorting,protein trafficking regulation,lysosomal function maintenance,cellular process disruption,cancer-related pathway interaction
ENSG00000099622,CIRBP,cancer-driving protein stabilization,cell cycle progression,tumor microenvironment modulation,angiogenesis promotion,apoptosis suppression,poor prognosis indicator
ENSG00000164548,TRA2A,regulatory protein interactions,oncogene overexpression,tumor metastasis promotion,aggressive tumor behavior,cell proliferation regulation,alternative splicing modulation
ENSG00000122068,FYTTD1,regulation of mtor pathway,tumor progression,cell survival promotion,cell migration facilitation,tissue specificity,kidney cancer association
ENSG00000014164,ZC3H3,chromatin remodeling,oncogenesis,cell cycle regulation,apoptosis suppression,pi3k/akt pathway interaction,biomarker potential
ENSG00000173120,KDM2A,histone demethylation,oncogenic pathway activation,dna damage response,chromatin remodeling,epigenetic regulation,tumor suppressor interaction
ENSG00000185129,PURA,oncogene activation,gene transcription regulation,cellular proliferation promotion,metastatic potential enhancement,transcription factor binding,tumor growth facilitation
ENSG00000167196,FBXO22,target protein degradation,ubiquitin ligase activity,cell cycle regulation,anti-oncogenic function,transcriptional repression,tumor suppressor role
ENSG00000167985,SDHAF2,sdh inhibition,energy metabolism dysregulation,tumor-promoting signaling pathway activation,hif-1α activation,angiogenesis enhancement,cell proliferation increase
ENSG00000139946,PELI2,nf-kb pathway regulation,apoptosis promotion,inflammation suppression,tumor suppressor activity,immune response modulation,cellular clearance enhancement
ENSG00000188846,RPL14,altered protein synthesis,cell proliferation,metabolic reprogramming,oncogenic functions,ribosome biogenesis,tumor progression
ENSG00000187554,TLR5,immune activation,inflammation regulation,anti-tumor response,pro-inflammatory signaling,dysregulation,tumor suppression
ENSG00000156398,SFXN2,iron-sulfur cluster assembly,cellular iron metabolism,tumor suppressor,cancer driver,oncogenic mutations,protein-protein interaction
ENSG00000121390,PSPC1,tumor progression,overexpression,cell cycle regulation,transcription factor activity,dna binding,poor prognosis
ENSG00000152402,GUCY1A2,cgmp production,cell proliferation regulation,soluble alpha-subunit function,guanylate cyclase activity,second messenger signaling,tumor suppressor potential
ENSG00000181847,TIGIT,immune suppression,tumor evasion,cd155 interaction,regulatory t-cell function,adhesion molecule,immune checkpoint
ENSG00000164338,UTP15,ribosome biogenesis,pre-rrna processing,cell growth regulation,metastasis promotion,therapeutic target,tumor progression
ENSG00000156515,HK1,glycolytic regulation,metabolic adaptation,warburg effect,overexpression,poor prognosis,therapeutic target
ENSG00000131203,IDO1,immune evasion,tryptophan depletion,kynurenine production,t-cell suppression,pd-1/pd-l1 interaction,cd47/sirpα interaction
ENSG00000129474,AJUBA,spindle checkpoint regulation,tumor progression,cell proliferation,genome instability,cytokinesis disruption,mitotic spindle stabilization
ENSG00000043093,DCUN1D1,enhanced cell proliferation,chromatin remodeling,dna repair mechanism,genomic instability,cell cycle regulation,transcriptional activation
ENSG00000172867,KRT2,cellular morphology disruption,epithelial-to-mesenchymal transition,intermediate filament protein,loss of adhesion,morphological transformation,structural stability regulation
ENSG00000147364,FBXO25,wnt/β-catenin signaling pathway,ubiquitination activity,e3 ligase function,cytoplasmic localization,cell cycle regulation,tumor suppressor protein degradation
ENSG00000135914,HTR2B,serotonin signaling pathway,overexpression in tumors,epithelial-to-mesenchymal transition,cell proliferation and survival,tumor progression and metastasis,therapeutic target
ENSG00000150753,CCT5,protein degradation regulation,tumor suppressor function,apoptosis modulation,cellular homeostasis maintenance,genomic instability promotion,therapeutic target
ENSG00000185479,KRT6B,keratin expression alteration,tumor progression,cellular structure disruption,poor prognosis,metastasis promotion,angiogenesis modulation
ENSG00000158019,BABAM2,er-associated degradation,endoplasmic reticulum stress response,substrate recognition,cellular regulation,oncogenesis,tumor progression
ENSG00000165660,ABRAXAS2,dna damage response,deubiquitinating enzyme activity,genomic instability,tumor progression,cell cycle regulation,chromosomal alterations
ENSG00000074590,NUAK1,akt signaling pathway,cell cycle progression,apoptosis inhibition,tumor promoter,protein kinase activation,stress response modulation
ENSG00000144848,ATG3,autophagy regulation,cellular recycling,dual role in tumorigenesis,metabolic regulation,prognostic marker,tumor suppressor
ENSG00000141542,RAB40B,cell survival,pi3k/akt pathway,cell migration,autophagy regulation,protein-protein interactions,genomic amplification
ENSG00000128591,FLNC,actin cytoskeleton regulation,loss-of-function mutations,tumor suppressor role,cellular invasion,increased motility,pi3k/akt pathway interaction
ENSG00000158022,TRIM63,apoptosis regulation,tumor suppressor function,protein degradation,cell cycle progression,oncogene inhibition,ubiquitination
ENSG00000082146,STRADB,apoptosis regulation,energy metabolism regulation,mtor pathway inhibition,autophagy induction,tumor suppressor function,cellular polarity regulation
ENSG00000119326,CTNNAL1,microtubule stability,cell migration,protein-protein interactions,wnt signaling pathway,oncogenic transformation,tumor growth
ENSG00000166164,BRD7,tumor suppressor,chromatin remodeling,transcriptional regulation,dna damage response,oncogenic processes,cell proliferation
ENSG00000105323,HNRNPUL1,rna binding and processing,oncogenic protein interaction,tumor progression,cell survival,gene expression regulation,protein-protein interaction
ENSG00000079385,CEACAM1,angiogenesis promotion,cell migration enhancement,metastasis facilitation,cell-cell interaction regulator,tumor progression marker,poor prognosis indicator
ENSG00000213578,CPLX3,angiogenesis promotion,immune response modulation,cell adhesion regulation,tumor progression,cancer cell proliferation,protein-protein interactions
ENSG00000006468,ETV1,etv1 overexpression,transcription factor activity,oncogenic potential,epithelial-to-mesenchymal transition,cell proliferation regulation,tumor progression
ENSG00000157554,ERG,oncogene activation,gene amplification,constitutive expression,cell cycle progression,apoptosis regulation,tumor progression
ENSG00000117595,IRF6,tumor suppression,gene expression regulation,cellular homeostasis maintenance,epithelial cell function,transcription factor activity,downregulation or mutation in cancer
ENSG00000151929,BAG3,tumor progression,oncogene activation,microtubule regulation,cell migration enhancement,apoptosis modulation,chaperone function
ENSG00000183785,TUBA8,microtubule dynamics,cell division regulation,proliferation enhancement,microtubule instability,cancer cell survival,apoptosis resistance
ENSG00000023287,RB1CC1,cancer driver gene,tumor suppressor loss,epithelial-to-mesenchymal transition,genomic instability,apoptosis resistance,cell cycle regulation
ENSG00000165527,ARF6,tumor progression,metastasis,constitutive activation,cell signaling pathway,protein-protein interaction,cytoskeleton remodeling
ENSG00000138834,MAPK8IP3,mapk/jnk signaling,apoptosis regulation,cellular stress response,tumor progression,protein-protein interactions,pi3k/akt pathway modulation
ENSG00000099783,HNRNPM,heterogenous nuclear ribonucleoprotein,splicing regulation,alternative splicing modulation,oncogenic processes,cell proliferation regulation,pi3k/akt pathway interaction
ENSG00000109255,NMU,tumor growth promotion,cell proliferation enhancement,oncogenic role,metastasis facilitation,energy metabolism regulation,neuropeptide precursor protein
ENSG00000131051,RBM39,dna repair mechanisms,transcriptional regulation,cell cycle progression,tumor suppressor,genetic instability,epigenetic modification
ENSG00000177138,FAM9B,genomic instability,dna repair pathway,prognostic biomarker,tumorigenesis promoter,atm kinase interaction,p53 regulation
ENSG00000167641,PPP1R14A,aberrant expression,cell survival regulation,cytoskeletal organization,oncogenic transformation,protein-protein interaction regulation,signaling pathway modulation
ENSG00000172243,CLEC7A,tumor microenvironment modulation,immune cell regulation,oncogenesis promotion,therapeutic target for immunotherapy,cell proliferation and migration enhancement,prognostic marker
ENSG00000162385,MAGOH,rna stabilization,mrna nuclear export,oncogenic properties,cell cycle regulation,dna repair modulation,protein stability enhancement
ENSG00000100836,PABPN1,pre-mrna splicing,translation regulation,rna-binding protein,nuclear localization,cell cycle progression,cellular proliferation
ENSG00000135766,EGLN1,tumor progression,hypoxia adaptation,hif-α stabilization,angiogenesis regulation,cell proliferation,protein modification
ENSG00000106100,NOD1,pattern recognition,apoptosis induction,tumor suppressor activity,tissue regeneration,cellular inflammation,immune response modulation
ENSG00000167553,TUBA1C,microtubule dynamics,constitutive activation,genomic instability,tumor progression,cell proliferation,protein stabilization
ENSG00000129084,PSMA1,proteasome regulation,cell cycle progression,apoptosis regulation,oncogenic transformation,proliferation and survival,tumor progression
ENSG00000171703,TCEA2,transcriptional regulation,chromatin remodeling complex,oncogene activation,tumor growth promotion,cell proliferation enhancement,metastasis facilitation
ENSG00000158796,DEDD,apoptosis regulation,cancer cell survival,promoter of oncogenesis,regulation of caspase-8,tumor progression,prognostic marker
ENSG00000160570,DEDD2,dephosphorylation,decapping complex regulation,rna stability control,tumor suppressor function,prognostic marker,genome instability modulation
ENSG00000091136,LAMB1,cellular adhesion disruption,tumor progression,metastasis promotion,gene expression alteration,biomarker potential,cancer cell proliferation
ENSG00000197619,ZNF615,krab domain binding,mutation hotspot,transcriptional regulator,chromatin remodeling,apoptosis suppression,cell cycle progression
ENSG00000107562,CXCL12,tumor-promoting,chemokine signaling,angiogenesis,metastasis,cell migration,therapeutic target
ENSG00000169925,BRD3,chromatin remodeling,tumor progression,protein-protein interaction,transcriptional regulation,therapeutic target,genomic instability
ENSG00000132275,RRP8,ribosome biogenesis,tumor suppressor function,cell proliferation regulation,mutations leading to oncogenicity,protein synthesis enhancement,mtor pathway interaction
ENSG00000140853,NLRC5,mhc class i regulation,tumor suppression,e3 ubiquitin ligase activity,immune evasion mechanisms,antigen presentation,cell surface expression regulation
ENSG00000108848,LUC7L3,pre-mrna splicing,dysregulation,gene expression regulation,rna metabolism regulation,protein isoform production,tumor progression
ENSG00000136436,CALCOCO2,protein degradation regulation,oncogenic driver,cellular interaction,apoptosis inhibition,tumor progression,genomic alterations
ENSG00000170448,NFXL1,cellular regulation,transcriptional activator/repressor,tumor suppressor/oncogene,cell proliferation/apoptosis regulation,metastasis promotion,genomic instability
ENSG00000135111,TBX3,transcription factor,oncogene,cell proliferation,cell differentiation,poor prognosis,pro-apoptotic resistance
ENSG00000275730,LILRB4,immune evasion,tumor progression,genomic alteration,nk cell inhibition,mdsc promotion,pd-1/pd-l1 axis interaction
ENSG00000213024,NUP62,nuclear pore complex regulation,cell proliferation promotion,oncogene overexpression,apoptosis resistance,tumor progression facilitation,therapeutic target
ENSG00000125864,BFSP1,intermediate filament assembly,cellular morphology regulation,cancer-related protein alterations,cellular integrity maintenance,interfilament interaction,cytoplasmic organization
ENSG00000285049,CPSF1,oncogenic mrna stabilization,proliferation enhancement,survival pathway activation,pre-mrna processing,rna polymerase ii recruitment,3' cleavage site recognition
ENSG00000188878,FBF1,apoptosis,cell cycle regulation,tumor progression,gene expression regulation,mirna processing,transcriptional control
ENSG00000162989,KCNJ3,potassium channel regulation,g protein-gated inward-rectifier potassium channels,oncogenesis,cell proliferation modulation,pi3k/akt pathway interaction,calcium signaling modulation
ENSG00000157542,KCNJ6,inward rectifier channel,cell proliferation,cell migration,tumor progression,ion balance disruption,apoptosis resistance
,HIST1H1B,histone regulation,dna repair inhibition,epigenetic modification,chromatin remodeling,transcriptional repression,cell cycle progression
,HIST3H2BB,histone modification,chromatin remodeling,cell proliferation,tumor suppressor inhibition,apoptosis regulation,epigenetic regulation
ENSG00000140740,UQCRC2,mitochondrial protein maturation,mitochondrial dysfunction,apoptosis regulation,tumor growth promotion,energy metabolism regulation,mitochondrial membrane integration
ENSG00000282853,ECH1,reduction of carbonyl groups,cellular redox regulation,metabolic reprogramming,tumor progression,therapeutic target,genomic instability
ENSG00000188042,ARL4C,oncogenic protein,cellular trafficking regulation,protein secretion modulation,tumor growth promotion,metastasis facilitation,gtpase activity
ENSG00000174137,FAM53A,ribosome regulation,p53 pathway modulation,cellular proliferation,mrna translation,cancer driver potential,genomic instability
ENSG00000169714,CNBP,tumor growth promotion,cellular proliferation regulation,oncogenic function,metastasis facilitation,genomic instability induction,therapeutic target
ENSG00000165732,DDX21,genomic instability,oncogene function,dna repair interaction,cellular proliferation,transcriptional regulation,apoptosis evasion
ENSG00000143476,DTL,mitochondrial regulation,genome stability maintenance,p53 regulation,tumor suppressor function,nucleotide synthesis promotion,cancer cell proliferation support
,WDR34,tumor suppressor function,ciliogenesis regulation,oncogenic signaling pathway activation,cell cycle progression regulation,apoptosis modulation,genomic instability
ENSG00000130826,DKC1,telomere maintenance,tumor suppressor dysfunction,ribosome biogenesis,cellular proliferation,preneoplastic lesions,therapeutic target
ENSG00000083642,PDS5B,chromatin remodeling,genome stability maintenance,sister chromatid cohesion,tumor progression promotion,transcriptional regulation dysregulation,cell division regulation
ENSG00000165637,VDAC2,cellular metabolism,oncogenic metabolic reprogramming,mitochondrial function regulation,apoptosis suppression,chemoresistance,protein interaction
ENSG00000137942,FNBP1L,cell migration,protein-protein interaction,cytoskeleton reorganization,metastasis promotion,focal adhesion kinase activation,phosphatidylinositol 3-kinase modulation
ENSG00000068366,ACSL4,fatty acid metabolism,cell proliferation,oncogenesis,poor prognosis marker,pi3k/akt pathway interaction,lipid biosynthesis regulation
ENSG00000164062,APEH,tumor progression,genomic instability,protein degradation regulation,cell signaling modulation,metabolic reprogramming,apoptosis evasion
ENSG00000182149,IST1,epithelial-to-mesenchymal transition,cell adhesion modulation,integrin interaction,immune response regulation,cancer metastasis,tumor progression
ENSG00000185187,SIGIRR,tlr signaling pathway regulation,immune system modulation,inflammation regulation,tumor progression association,oncogenic processes involvement,therapeutic target potential
ENSG00000138385,SSB,genomic instability,dna replication,oncogenesis,tumor progression,single-stranded dna binding,genome stability
ENSG00000173156,RHOD,cell migration,invasiveness,rho gtpase regulation,tumor aggressiveness,cytoskeleton modulation,therapeutic target
ENSG00000239306,RBM14,rna-binding protein,transcriptional regulation,oncogene,overexpression,cell proliferation,survival and metastasis
ENSG00000185615,PDIA2,cellular proliferation,apoptosis resistance,protein folding regulation,tumor suppressor inhibition,pi3k/akt pathway modulation,cell cycle regulation
ENSG00000277334,NCR1,cancer progression,innate immunity,tumor microenvironment,apoptosis,reactive oxygen species,dna damage
ENSG00000145912,NHP2,rna processing,cell proliferation,genomic instability,apoptosis regulation,tumor suppression,oncogenic processes
ENSG00000023902,PLEKHO1,centrosome separation,oncogenic mutations,mitotic spindle assembly,ciliogenesis regulation,microtubule dynamics,cell polarity
ENSG00000092621,PHGDH,serine biosynthesis pathway,glycolysis regulation,warburg effect,energy metabolism regulation,oncogenesis promotion,therapeutic target
ENSG00000125686,MED1,transcriptional coactivation,mediator complex component,cell cycle regulation,tumor suppressor interaction,oncogene association,cancer biomarker candidate
ENSG00000138279,ANXA7,calcium-dependent membrane binding,chromatin remodeling,cell cycle regulation,apoptosis suppression,oncogenic transformation,biomarker overexpression
ENSG00000143624,INTS3,protein degradation pathway,ubiquitin-proteasome machinery,tumor suppression mechanism,genomic instability prevention,cellular stress response regulation,cancer-related ubiquitination
ENSG00000241794,SPRR2A,cell migration,epithelial-to-mesenchymal transition,zeb1 transcriptional target,tumor promotion,cell signaling regulation,protein-protein interaction
ENSG00000187522,HSPA14,protein folding regulation,tumor aggressiveness association,cellular stress modulation,oncogene stabilization,tumor suppressor degradation,proteostasis imbalance
ENSG00000106245,BUD31,wnt/β-catenin pathway,transcriptional regulator,cell proliferation enhancer,tumor progression marker,chemotherapy resistance factor,zinc finger protein
ENSG00000100225,FBXO7,loss of function,tumor suppressor,protein degradation pathway,dna damage response,genome instability,cancer predisposition
ENSG00000107833,NPM3,oncogene activation,ribosome biogenesis,pi3k/akt pathway regulation,cell cycle dysregulation,protein-protein interactions,cancer cell proliferation
ENSG00000153406,NMRAL1,transcriptional regulation,nuclear receptor interaction,cell proliferation enhancement,oncogenic potential,apoptosis resistance,steroid hormone receptor activation
ENSG00000154277,UCHL1,protein degradation regulation,ubiquitin-proteasome pathway,26s proteasome complex association,tumor suppressor protein degradation,cell growth and survival enhancement,poor prognosis marker
ENSG00000083896,YTHDC1,m6a demethylation,gene expression regulation,oncogenic signaling pathway,tumor progression,targeted therapy potential,poor prognostic marker
ENSG00000151623,NR3C2,mineralocorticoid signaling pathway,oncogenic activity,ligand binding,gene expression regulation,cell migration,prognostic biomarker
ENSG00000165516,KLHDC2,chromatin remodeling,dna repair mechanism,tumor suppressor role,cellular proliferation,genomic instability,apoptosis regulation
ENSG00000106554,CHCHD3,mitochondrial function regulation,apoptosis resistance,tumor progression promotion,p53 regulation,pi3k/akt signaling pathway modulation,energy metabolism regulation
ENSG00000280680,HHAT,hedgehog signaling,ligand synthesis,oncogenic pathway,tumorigenesis promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000058404,CAMK2B,mtor pathway,constitutive activation,oncogenic signaling,cellular proliferation,therapeutic target,tumor microenvironment
ENSG00000138646,HERC5,pi3k/akt pathway interaction,p53 regulation,ubiquitin ligase activity,apoptosis suppression,cell cycle progression,protein degradation
ENSG00000158445,KCNB1,potassium channel regulation,cellular proliferation,metastatic potential,therapeutic target,poor prognosis indicator,genomic instability
ENSG00000175497,DPP10,cell adhesion,enhanced expression levels,mutation associated,immune response modulation,cell migration facilitation,tumor progression promotion
ENSG00000127314,RAP1B,cellular signaling,overexpression,oncogenesis,cell migration,tumor progression,therapeutic target
ENSG00000115806,GORASP2,microrna regulation,tumor suppressor degradation,oncogene activation,cell survival enhancement,pi3k/akt pathway interaction,golgi apparatus localization
ENSG00000278129,ZNF8,transcriptional regulation,tumor progression,cellular growth modulation,gene expression dysregulation,biomarker potential,zinc finger dna-binding activity
ENSG00000137171,KLC4,tumor suppressor,microtubule regulation,cell proliferation inhibition,metastasis suppression,cancer aggressiveness reduction,pi3k/akt signaling pathway modulation
ENSG00000108312,UBTF,ribosomal rna transcription,transcription factor activation,cell proliferation,protein synthesis enhancement,tumor progression facilitation,therapeutic target
ENSG00000163060,TEKT4,tekt4,genomic instability,microtubule organization,chromosomal alterations,cell cycle regulation,tumor progression
ENSG00000167858,TEKT1,apoptosis resistance,cell survival promotion,cell migration regulation,signaling pathway modulation,tumor progression,protein kinase activity
ENSG00000198382,UVRAG,autophagy regulation,genome instability,tumor suppressor function,dna repair pathway,mutational hotspot,cellular degradation
ENSG00000125676,THOC2,oncogene activation,gene overexpression,cell proliferation regulation,metastasis facilitation,nuclear export regulation,tumorigenesis promotion
ENSG00000187741,FANCA,genomic instability,dna repair mechanism,fanconi anemia pathway,cancer predisposition,genome maintenance,therapeutic target
ENSG00000113368,LMNB1,chromatin remodeling,oncogene activation,dna repair mechanisms,genome instability,nuclear structure maintenance,transcriptional regulation
ENSG00000113645,WWC1,dna double-strand break repair,homologous recombination,genomic stability maintenance,tumor suppressor function,cancer cell sensitivity,brca2 interaction
ENSG00000070371,CLTCL1,genomic instability,transcriptional activation,cell growth regulation,chromatin remodeling,dna repair mechanisms,cancer cell proliferation
ENSG00000181481,RNF135,pi3k/akt pathway modulation,oncogenic protein stabilization,cell cycle progression regulation,tumor suppressor degradation,e3 ubiquitin ligase activity,poor prognosis marker
ENSG00000120457,KCNJ5,potassium channel regulation,tumorigenic mutations,ion channel dysfunction,cellular excitability alterations,oncogenic activity enhancement,genomic instability
ENSG00000124171,PARD6B,cell migration,cell polarity regulation,overexpression,oncogenic processes,tumor progression,therapeutic target
ENSG00000161940,BCL6B,epigenetic regulation,transcriptional repression,cellular proliferation,apoptosis regulation,chromatin remodeling,protein interaction
ENSG00000160679,CHTOP,chromatin remodeling,transcription regulation,cell cycle progression,tumor suppressor function,chromodomain-helicase-dna-binding domain interaction,genomic stability maintenance
ENSG00000101844,ATG4A,autophagy regulation,cellular metabolism modulation,tumor progression contributor,protein processing and activation,lysosome biogenesis regulator,cancer cell survival factor
ENSG00000189403,HMGB1,tumor microenvironment modulation,inflammation and immune suppression,cellular survival and proliferation enhancement,angiogenesis promotion,nf-κb signaling pathway activation,cytokine and growth factor interaction
ENSG00000172236,TPSAB1,apoptosis regulation,cell death inhibition,protease inhibitor function,pi3k/akt pathway interaction,tumor growth promotion,survival pathway modulation
ENSG00000119138,KLF9,tumor progression,oncogene regulation,transcription factor activity,tumor suppressor function,epithelial-to-mesenchymal transition (emt),angiogenesis modulation
ENSG00000171346,KRT15,tumor progression,prognostic marker,cell proliferation,apoptosis suppression,malignant behavior,epithelial integrity
ENSG00000111321,LTBR,nf-κb pathway regulation,tumor growth promotion,immune evasion mechanism,tumor aggressiveness marker,cell survival enhancement,signaling pathway interaction
ENSG00000196664,TLR7,immune evasion,aberrant expression,innate immunity activation,pro-inflammatory cytokine production,type i interferon induction,dendritic cell activation
ENSG00000180182,MED14,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis suppression,tumor progression,genomic instability
ENSG00000142856,ITGB3BP,regulation of epithelial-to-mesenchymal transition (emt),oncogene function,cell adhesion modulation,tumor progression and metastasis,pi3k/akt/mtor pathway regulation,biomarker potential for cancer diagnosis and prognosis
ENSG00000170776,AKAP13,cellular regulation,oncogenic interaction,tumor progression,cell migration,signaling pathway modulation,genetic alteration
ENSG00000101460,MAP1LC3A,autophagy regulation,tumor progression,cell survival enhancement,protein modification,cellular recycling,mitochondrial function
ENSG00000146701,MDH2,metabolic reprogramming,cell proliferation,tumor energy production,therapeutic target,warburg effect,lactate production
ENSG00000143970,ASXL2,chromatin regulation,epigenetic regulator,histone modification,transcriptional silencing,loss of function mutations,oncogene upregulation
ENSG00000274651,PRPF31,wnt/beta-catenin activation,tumor suppressor dysfunction,splicing regulation,cell survival enhancement,apoptosis resistance,gene expression modulation
ENSG00000090621,PABPC4,mrna stabilization,cell proliferation,angiogenesis promotion,alternative splicing regulation,poor prognosis indicator,tumor aggressiveness enhancer
ENSG00000141522,ARHGDIA,rhogdi-alpha regulation,cytoskeleton organization,cell migration,tumor progression,metastasis driver,biomarker
ENSG00000168421,RHOH,emt activation,cell cycle regulation,metastasis promoter,oncogenic transformation,cancer progression driver,epithelial-to-mesenchymal transition
ENSG00000182670,TTC3,pi3k/akt pathway regulation,tumor suppressor activity,genomic stability maintenance,apoptosis modulation,dna repair interaction,cell proliferation control
ENSG00000103351,CLUAP1,tumor progression,metastasis facilitation,cell adhesion regulation,prognostic marker,integrin interaction,cancer cell detachment
ENSG00000105492,SIGLEC6,immune modulation,tumor progression,sialic acid binding,myleoid cell interaction,cell surface expression,cancer immunoediting
ENSG00000116663,FBXO6,regulator of protein turnover,tumor suppressor function,scf complex formation,ubiquitin-proteasome pathway regulation,cancer cell proliferation inhibition,downregulation in kirc
ENSG00000099817,POLR2E,basal transcription regulation,oncogenic potential,transcriptional enhancement,cell proliferation promotion,dna damage response modulation,cancer cell survival
ENSG00000189043,NDUFA4,mitochondrial complex i subunit,cellular respiration regulation,energy metabolism dysregulation,tumorigenic potential enhancement,ros production promotion,warburg effect induction
ENSG00000165588,OTX2,oncomarker,transcription factor,angiogenesis,tumor progression,chromatin remodeling,oncogenic transcription program
ENSG00000108604,SMARCD2,chromatin remodeling,gene expression regulation,tumor aggressiveness,cell proliferation,metabolic reprogramming,therapeutic target
ENSG00000140743,CDR2,microtubule stability,constitutive activation,protein-protein interaction,tumor progression,oncogenic transformation,cell migration
ENSG00000184743,ATL3,cell membrane dynamics,lipid signaling pathway,phospholipid metabolism regulation,oncogenic processes,therapeutic target,genomic instability
ENSG00000172346,CSDC2,cell cycle regulation,phosphorylation activity,protein degradation,dna damage response,chromatin remodeling,cell proliferation
ENSG00000119929,CUTC,disrupted protein regulation,ubiquitination pathway,tumorigenesis,cell growth regulation,therapeutic target,genomic instability
ENSG00000105829,BET1,vesicular trafficking regulation,cell proliferation enhancement,metastasis facilitation,protein secretion alteration,endosomal pathway involvement,genetic instability increase
ENSG00000179262,RAD23A,ubiquitin-proteasome pathway,oncogenic protein stabilization,tumor progression,therapeutic target,protein degradation regulation,dna damage response modulation
ENSG00000231555,HSPA1B,heat shock response,molecular chaperone function,oncogenic pathway interaction,cellular homeostasis regulation,tumor progression marker,therapeutic target potential
ENSG00000121892,PDS5A,genomic instability,overexpression,oncogenic process,wnt/β-catenin pathway activation,cell proliferation enhancement,protein-protein interaction modification
ENSG00000149187,CELF1,celf1 promotes oncogenic transformation,alternative splicing regulation,cell cycle progression,post-transcriptional control,oncogene overexpression,aberrant protein expression
ENSG00000135250,SRPK2,phosphorylation of splicing factors,epithelial-to-mesenchymal transition (emt),transcription factor regulation,cell migration and survival,cell proliferation and tumor aggressiveness,oncogenic signaling pathway modulation
ENSG00000102038,SMARCA1,chromatin remodeling,pro-tumor mutation,dna repair disruption,genomic instability,cell cycle deregulation,tumor suppressor dysfunction
ENSG00000182199,SHMT2,mitochondrial enzyme function,one-carbon metabolism regulation,cellular redox balance modulation,glycolysis promotion,genomic instability contribution,tumor growth support
ENSG00000188554,NBR1,tumor suppressor function,pi3k/akt signaling regulation,cell proliferation inhibition,autophagy promotion,immune response modulation,tumor growth suppression
ENSG00000170296,GABARAP,autophagy regulation,cell survival modulation,metabolic reprogramming,signaling pathway interaction,tumor growth promotion,prognostic marker
ENSG00000137947,GTF2B,transcriptional regulation,cell cycle progression,dna repair mechanisms,tumor microenvironment modulation,oncogenic signaling pathway involvement,genetic instability maintenance
,HIST1H2BD,histone modification,chromatin remodeling,epigenetic regulation,gene expression regulation,tumor progression,nucleosome structure
ENSG00000273575,KIR2DL4,overexpression,cell migration,apoptosis resistance,electrolyte balance regulation,ion channel function,genomic overexpression
ENSG00000115165,CYTIP,dna repair,chromatin remodeling,cell proliferation,oncogenic properties,transcription regulation,prognostic marker
ENSG00000143376,SNX27,endosomal sorting,oncogenic signaling,metastasis promotion,cell proliferation enhancement,tumor progression facilitation,receptor trafficking regulation
ENSG00000143549,TPM3,cell migration,high expression levels,oncogenic processes,regulation of cellular stress response,interactions with p53,modulation of pi3k/akt/mtor pathway
ENSG00000137767,SQOR,mtor pathway activation,tumor suppressor function,energy metabolism regulation,hypoxia adaptation,cellular respiration impairment,succinate accumulation
ENSG00000143553,SNAPIN,escrt regulation,endosomal sorting complexes,cell trafficking regulation,membrane-bound receptor degradation,altered expression patterns,cellular metabolism changes
ENSG00000124228,DDX27,oncogenic properties,rna helicase activity,dna repair regulation,transcriptional regulation,cell proliferation enhancement,apoptosis inhibition
ENSG00000237344,PBX2,co-factor for transcription factors,transcriptional regulation,tumor progression,cell proliferation,angiogenesis promotion,genomic instability
ENSG00000106785,TRIM14,regulatory mechanism,oncogenesis,tumor progression,apoptosis regulation,cell cycle modulation,protein interaction
ENSG00000112081,SRSF3,cellular proliferation,splicing factor regulation,tumorigenesis,aberrant splicing,poor prognosis,genomic instability
ENSG00000072134,EPN2,focal adhesion regulation,cell-extracellular matrix interactions,actin cytoskeleton remodeling,oncogenic progression,pi3k/akt pathway modulation,cell survival and proliferation enhancement
ENSG00000121653,MAPK8IP1,cellular signaling regulation,oncogenic signaling pathway activation,prognostic marker,therapeutic target,cell proliferation promotion,cell survival enhancement
ENSG00000173933,RBM4,rna-binding protein,apoptosis regulation,cell cycle progression,metastasis promotion,post-transcriptional regulation,tumorigenesis
ENSG00000274853,MRM1,mitochondrial localization,glycolytic reprogramming,tumor growth promotion,metabolic adaptation,therapeutic target,overexpression
ENSG00000138768,USO1,altered splicing,cancer progression,cellular signaling disruption,gene expression dysregulation,protein-protein interaction dysfunction,rna processing abnormality
ENSG00000070756,PABPC1,mrna stabilization,translation initiation,cell proliferation,oncogenic signaling,protein-protein interaction,gene regulation
ENSG00000100968,NFATC4,tumor progression,wnt/β-catenin pathway regulation,epithelial-to-mesenchymal transition (emt),cell migration,angiogenesis promotion,transcriptional regulation
ENSG00000149548,CCDC15,centrosome regulation,mitotic error,cell proliferation,chromosomal instability,microtubule dynamics,therapeutic target
ENSG00000140319,SRP14,cellular proliferation,oncogenic overexpression,protein targeting,ribosome binding,translational regulation,tumorigenesis promotion
ENSG00000139197,PEX5,protein import regulation,oncogenic signaling pathway interaction,tumor progression marker,metabolic reprogramming,peroxisomal function dysregulation,cellular survival enhancement
ENSG00000164251,F2RL1,coagulation pathway activation,apoptosis evasion,cell adhesion enhancement,tumor progression facilitation,prognostic marker status,metastasis promotion
ENSG00000152086,TUBA3E,microtubule stability,loss of function mutations,cellular proliferation,cell division regulation,cancer cell survival,tumor metastasis
ENSG00000163156,SCNM1,tumor suppressor,splice site mutation,alternative splicing,cell proliferation,survival pathway,therapeutic target
ENSG00000136147,PHF11,cell cycle regulation,chromatin remodeling,transcriptional regulation,apoptosis evasion,tumor aggressiveness,genetic instability
ENSG00000185651,UBE2L3,hif pathway activation,ubiquitination of tumor suppressors,protein stabilization,tumor progression,genomic instability,dna repair interaction
,HIST1H2AH,histone modification,chromatin remodeling,tumor progression,oncogenic processes,gene expression regulation,cell growth and proliferation
ENSG00000277956,MAPT,microtubule stabilization,apoptosis regulation,cell division dysregulation,genomic instability,protein-protein interaction,tumor progression biomarker
ENSG00000131773,KHDRBS3,oncogenic splicing,alternative exon inclusion,tumor suppressor regulation,cell proliferation and invasion,rna processing and transport,protein-protein interactions
ENSG00000055118,KCNH2,ion channel function,electrical signaling regulation,tumor microenvironment modulation,arrhythmia predisposition,voltage-gated potassium channel subunit,long qt syndrome association
ENSG00000114738,MAPKAPK3,cell survival,proliferation pathway,apoptosis regulation,cytoplasmic protein kinase activation,signal transduction adapter,oncogenic signaling axis
ENSG00000136891,TEX10,genomic instability,rna processing regulation,tumor progression marker,splicing factor overexpression,cellular proliferation enhancement,oncogenic pathway activation
ENSG00000125166,GOT2,metabolic reprogramming,upregulated expression,warburg effect activation,cell growth promotion,anabolic processes enhancement,tumor aggressiveness marker
ENSG00000116459,ATP5PB,mitochondrial dysfunction,altered energy metabolism,cellular respiration regulation,oncogenesis contribution,energy production alterations,cellular metabolism changes
ENSG00000152256,PDK1,agc kinase activation,constitutive activation,metabolic regulation,oncogenic processes,pi3k/akt pathway,tumor progression
ENSG00000116977,LGALS8,tumor progression,metastasis promotion,cell surface glycoprotein binding,signaling pathway modulation,apoptosis regulation,cell migration enhancement
ENSG00000149968,MMP3,**
matrix remodeling,proteolytic activity,tumor invasion,angiogenesis promotion,vegf release enhancement,prognostic marker
ENSG00000140564,FURIN,protein processing,tumor progression,metastasis promotion,cellular invasion,therapeutic target,poor prognosis
ENSG00000095139,ARCN1,cell adhesion modulation,gene amplification,increased proliferation,epithelial-to-mesenchymal transition,stem cell maintenance,protein-protein interaction
ENSG00000166091,CMTM5,nf-κb signaling,apoptosis induction,tumor suppressor function,angiogenesis inhibition,cancer immune modulation,cell growth regulation
ENSG00000104894,CD37,tumor progression,cell surface expression,immunomodulation,biomarker for prognosis,pi3k/akt pathway interaction,therapeutic target
ENSG00000231543,C2,complement activation,tumor progression,immune evasion,cancer cell growth,innate immunity modulation,dysregulation of complement system
ENSG00000129460,NGDN,neurotransmitter regulation,dysregulated expression,cellular migration,apoptosis modulation,autophagy regulation,ca2+ influx modulation
ENSG00000106803,SEC61B,secretion of mmps,tumor progression,interaction with pi3k/akt signaling,protein secretion into er membrane,potential biomarker for patient outcomes,oncogene role in cancer cell invasion
ENSG00000163479,SSR2,mitochondrial dynamics,apoptosis regulation,cellular metabolism,energy homeostasis,tumor progression,mitochondrial biogenesis
ENSG00000107872,FBXL15,cell cycle regulation,substrate ubiquitination,cell proliferation,oncogenic processes,protein degradation regulation,tumor suppressor interaction
ENSG00000102786,INTS6,rna processing alterations,overexpression,oncogene,gene expression regulation,dna repair pathway interaction,cell cycle control
ENSG00000169599,NFU1,mitochondrial dysfunction,altered energy metabolism,tumor growth promotion,reactive oxygen species production,apoptosis inhibition,cellular stress response modulation
ENSG00000111615,KRR1,tumor aggressiveness,microtubule dynamics regulation,oncogenic processes,cell proliferation enhancement,survival pathway activation,mitotic division disruption
ENSG00000102554,KLF5,transcriptional regulation,cellular proliferation,oncogenesis,cell survival,protein-protein interaction,gene expression modulation
ENSG00000147224,PRPS1,phosphoribosyl pyrophosphate synthesis,cell growth promotion,dna repair activation,purine nucleotide biosynthesis,oncogenic driver gene,tumor progression enhancement
ENSG00000134138,MEIS2,transcriptional regulation,wnt/β-catenin signaling activation,oncogenic function,tumor progression promoter,cellular differentiation modulator,genomic overexpression
ENSG00000105193,RPS16,ribosome biogenesis,translation initiation factor,cellular proliferation,tumor progression driver,poor prognosis marker,protein synthesis enhancement
ENSG00000126945,HNRNPH2,cell cycle regulation,mrna stability,translation regulation,prognostic marker,oncogenic role,emt regulator
ENSG00000122692,SMU1,oncogenic pathway regulation,e3 ubiquitin ligase activity,cell cycle progression,dna damage response,transcription factor activation,prognostic biomarker
ENSG00000169344,UMOD,wnt/β-catenin pathway,epithelial-to-mesenchymal transition (emt),cellular adhesion and migration,oncogenesis,glycoprotein expression,kidney development regulation
ENSG00000108061,SHOC2,hippo signaling pathway,dysregulation,constitutive activation,cell growth regulation,tumor progression,therapeutic target
ENSG00000145741,BTF3,transcriptional regulation,oncogenesis,cell proliferation,apoptosis evasion,tumor aggressiveness,therapeutic target
ENSG00000197785,ATAD3A,mitochondrial biogenesis,tumor suppressor function,chromatin regulation,dna replication modulation,glycolytic reprogramming,genomic stability maintenance
,SEPT4,cellular integrity maintenance,cytokinesis regulation,cell cycle regulation,membrane trafficking modulation,tumor progression promotion,metastasis facilitation
ENSG00000108671,PSMD11,protein degradation regulation,ubiquitin-proteasome pathway modulation,cell cycle progression regulation,apoptosis regulation,tumor progression contribution,therapeutic target potential
ENSG00000004487,KDM1A,histone demethylation,epigenetic regulation,tumor progression,metastasis promotion,chromatin remodeling,epithelial-to-mesenchymal transition
ENSG00000104756,KCTD9,**

cell cycle regulation,ubiquitination and degradation,tumor suppressor function,kinase regulation,gene expression modulation,protein-protein interaction
ENSG00000104687,GSR,detoxification process,apoptosis resistance,tumor progression,cellular survival,reactive oxygen species,metabolic regulation
ENSG00000153395,LPCAT1,cellular metabolism regulation,phospholipid biosynthesis enhancement,tumor microenvironment formation,oncogene interaction,pi3k/akt pathway activation,poor prognosis marker
ENSG00000277586,NEFL,neurofilament maintenance,cytoskeletal structure regulation,cellular adhesion modification,axonal transport influence,potential oncogenic influence,indirect contribution to tumorigenesis
ENSG00000124507,PACSIN1,cancer cell migration,cytoskeleton dynamics,enhanced invasiveness,biomarker for metastasis,poorer prognosis,therapeutic target
ENSG00000115317,HTRA2,mitochondrial function,protein ubiquitination,tumor suppressor,protein quality control,cell metabolism regulation,oncogenesis
ENSG00000282947,HNRNPL,alternative splicing,epithelial-to-mesenchymal transition (emt),oncogene activation,poor prognosis biomarker,protein-protein interaction,rna stability regulation
ENSG00000132849,PATJ,tight junction regulation,cell polarity disruption,epithelial cell adhesion,tumor progression,genetic alterations,protein interaction
ENSG00000167081,PBX3,transcription factor regulation,oncogene activity,epithelial-to-mesenchymal transition,cell cycle progression,apoptosis regulation,genetic mutation impact
ENSG00000068028,RASSF1,microtubule stabilization,apoptosis regulation,tumor suppressor function,epigenetic silencing,cancer progression,microtubule-associated protein interaction
ENSG00000139546,TARBP2,microrna-mediated gene silencing,cellular proliferation,tumor suppressor regulation,oncogenic signaling pathway,cancer stem cell maintenance,therapeutic target
ENSG00000114388,NPRL2,cell proliferation,tumor progression,metastasis,proteolytic activity,signal transduction pathway disruption,poor prognosis marker
ENSG00000106327,TFR2,iron regulation,oncogenic function,tumor growth promotion,overexpression,signaling pathway interaction,therapeutic target
ENSG00000088002,SULT2B1,sulfation regulation,cellular proliferation,apoptosis inhibition,oncogenic signaling,metabolic modulation,cancer progression
ENSG00000164114,MAP9,microtubule dynamics regulation,cell cycle progression modulation,cell proliferation promotion,tumor aggressiveness enhancement,metastatic potential enhancement,biomarker for treatment response prediction
ENSG00000096088,PGC,glycolytic regulation,metabolic adaptation,cell proliferation,tumor growth,energy metabolism,carbohydrate phosphorylation
ENSG00000177468,OLIG3,transcriptional regulation,tumor suppressor function,cell cycle progression,epigenetic regulation,histone modification,poor prognosis marker
,SEPT9,oncogene,genomic instability,cell cycle regulation,biomarker,pro-survival signaling,tumor progression
ENSG00000143614,GATAD2B,chromatin remodeling,tumor progression,cell cycle regulation,oncogenic promoter,gene expression modulation,prognostic marker
ENSG00000151923,TIAL1,regulation of translation,cellular stress response,apoptosis modulation,proliferation regulation,pi3k/akt signaling pathway,tumor suppressor function
ENSG00000112146,FBXO9,scf complex formation,cell cycle regulation,protein degradation pathway,tumor suppressor activity,apoptosis induction,oncogenic mutations
ENSG00000197540,GZMM,microtubule regulation,genomic instability,centrosome duplication,cellular proliferation,genetic mutations,tumor progression
ENSG00000124469,CEACAM8,adhesion molecule interaction,cell migration,epithelial-to-mesenchymal transition (emt),immune evasion,metastasis promotion,pi3k/akt pathway activation
ENSG00000137776,SLTM,pi3k/akt pathway regulation,cell migration and adhesion modulation,signaling pathway interaction,tumor progression promotion,adhesion molecule regulation,cancer cell invasion facilitation
ENSG00000075702,WDR62,chromosomal stability loss,spindle checkpoint regulation,genomic instability driver,mitotic error promoter,tumor suppressor role,prognostic marker potential
ENSG00000090273,NUDC,genomic instability,dna damage repair,tumor suppressor function,cell cycle regulation,nucleotide removal activity,genome maintenance
ENSG00000125257,ABCC4,cellular efflux,chemoresistance,oncogenesis,tumor progression,genomic overexpression,protein transport
ENSG00000087087,SRRT,chromatin remodeling,genomic instability,transcriptional regulation,oncogenic signaling,dna repair mechanisms,tumor progression
ENSG00000275176,ACACA,lipid metabolism,fatty acid biosynthesis,energy production,oncogenic transformation,therapeutic target,genomic instability
ENSG00000168397,ATG4B,autophagy regulation,oncogenic function,tumor progression,prognostic biomarker,cellular homeostasis,ubiquitin-proteasome system modulation
ENSG00000160214,RRP1,ribosomal protein regulation,aberrant expression,cellular metabolism modulation,oncogenic processes,protein synthesis regulation,genomic instability maintenance
ENSG00000135503,ACVR1B,tgf-β signaling pathway,epithelial-to-mesenchymal transition,constitutive activation,cell migration and invasion,prognostic biomarker,therapeutic target
ENSG00000114867,EIF4G1,oncogenic mrna translation,aberrant protein synthesis,cell proliferation driver,therapeutic target,signaling pathway regulation,protein kinase activation
ENSG00000189369,GSPT2,g2/s phase transition,cell cycle regulation,p53 stabilization,tumor suppressor,prognostic biomarker,cancer progression
ENSG00000149428,HYOU1,overexpression,protein folding regulation,cell proliferation enhancement,akt/mapk pathway activation,dna damage response modulation,chaperone activity
ENSG00000181026,AEN,lipid metabolism disruption,altered expression levels,lipid transport regulation,tumor progression association,oncogene implication,genomic instability contribution
ENSG00000162734,PEA15,pi3k/akt pathway interaction,phosphorylation regulation,tumor suppressor function loss,cell cycle progression regulation,anti-apoptotic activity enhancement,proliferation signaling influence
ENSG00000089234,BRAP,genomic instability,dna damage response,tumor suppressor function,nuclear localization,protein-protein interactions,apoptosis regulation
ENSG00000157601,MX1,epithelial-to-mesenchymal transition,signaling pathway activation,transcriptional regulation,cell proliferation promotion,oncogenesis contributor,poor prognosis biomarker
ENSG00000132313,MRPL35,cellular proliferation,apoptosis regulation,rna translation regulation,tumor progression,protein synthesis regulation,mitochondrial function
ENSG00000092969,TGFB2,tumor progression,enhanced angiogenesis,immune suppression,epithelial-to-mesenchymal transition,pro-tumorigenic signaling,metastasis facilitation
ENSG00000277359,RPS9,cellular proliferation,protein synthesis regulation,biomarker identification,tumor progression,genomic alterations,ribosomal function
ENSG00000100138,SNU13,spliceosomal assembly,pre-mrna recognition,u1 snrnp interaction,dysregulated splicing,tumor suppressor role,genomic instability
ENSG00000100650,SRSF5,splicing regulation,alternative splicing patterns,constitutive activation,tumor progression,oncogenic phenotypes,therapeutic target
ENSG00000133878,DUSP26,mapk pathway regulation,oncogenic processes,tumor suppressor function,genomic alterations,cell proliferation regulation,protein-protein interactions
ENSG00000077312,SNRPA,snrna processing,tumor progression,cellular transformation,splicing regulation,dna repair disruption,gene expression alteration
ENSG00000198099,ADH4,metabolic regulation,detoxification,antioxidant defense,tumorigenesis,epigenetic regulation,metabolic gene alterations
ENSG00000143106,PSMA5,protein degradation,ubiquitin-proteasome pathway,tumorigenesis promotion,cell cycle regulation,metastasis facilitation,apoptosis inhibition
ENSG00000107816,LZTS2,ubiquitin-proteasome pathway,cell cycle regulation,tumor suppressor function,protein degradation,poor prognosis biomarker,oncogenesis promotion
ENSG00000165169,DYNLT3,microtubule regulation,mitotic spindle stability,oncogene activation,tumor progression,cell division regulation,vesicle transport
ENSG00000197114,ZGPAT,epigenetic regulation,genome stability maintenance,tumor growth promotion,cell cycle progression regulation,apoptosis inhibition,chromatin modification
ENSG00000124535,WRNIP1,tumor suppressor function,regulation of mitotic checkpoint,g2/m phase transition regulation,dna repair regulation,genomic instability maintenance,cell cycle progression control
ENSG00000169813,HNRNPF,altered gene expression,alternative splicing,rna processing regulation,tumor suppressor modulation,cellular proliferation,protein interaction
,AARS,mitochondrial function,oxidative phosphorylation,protein synthesis regulation,cancer cell metabolism,genetic instability,cellular stress response
ENSG00000160216,AGPAT3,phosphatidic acid production,tumor progression,oncogenic process,lipid metabolism regulation,cell proliferation enhancement,therapeutic target
ENSG00000006744,ELAC2,genomic instability,promotes tumorigenesis,regulates p53 activity,dna repair regulation,cell proliferation enhancement,tumor suppressor degradation
ENSG00000008083,JARID2,epigenetic regulation,chromatin remodeling,oncogene activation,tumor suppression inhibition,cellular transformation,histone demethylation
ENSG00000160584,SIK3,pi3k/akt signaling,oncogene,tumor progression,cell cycle regulation,apoptosis suppression,protein-protein interaction
ENSG00000183010,PYCR1,metabolic reprogramming,cellular proliferation,therapeutic target,tumor aggressiveness,redox regulation,energy metabolism
ENSG00000137818,RPLP1,ribonuclease p enzyme activity,cell cycle regulation,apoptosis evasion,dna repair mechanism,protein synthesis regulation,tumor progression
ENSG00000114125,RNF7,protein degradation pathway,cell proliferation regulation,tumor suppressor dysregulation,oncogene overexpression,cancer progression,metastasis promotion
ENSG00000037474,NSUN2,genomic instability,tumor suppressor function,reduced expression levels,oncogenesis suppression,proliferation regulation,survival signaling
ENSG00000159189,C1QC,complement activation,immune surveillance,cancer progression,tumor microenvironment,cell death modulation,innate immune response
ENSG00000167208,SNX20,endosomal recycling,receptor tyrosine kinases regulation,oncogene function,cell migration promotion,tumor progression association,potential biomarker
ENSG00000176624,MEX3C,rna-binding activity,tumor promoter,apoptosis regulation,cell proliferation,oncogene regulation,genomic instability
ENSG00000131721,RHOXF2,tumor progression,oncogenic driver,cell proliferation regulation,protein-protein interaction,signal transduction modulation,genomic overexpression
ENSG00000276452,LILRB1,immune evasion,tumor immunology,fc receptor interaction,antibody-dependent cellular cytotoxicity inhibition,pd-l1 interaction,myeloid cell expression
ENSG00000071626,DAZAP1,dazap1-p53 interaction,transcriptional regulation,chromatin remodeling,cellular proliferation,poor prognosis marker,genomic instability regulator
ENSG00000196470,SIAH1,tumor suppressor degradation,oncogenic signaling,protein ubiquitination,epithelial-to-mesenchymal transition (emt),cancer cell proliferation,chemosensitivity regulation
ENSG00000084774,CAD,cellular accumulation,genomic instability,heavy metal metabolism,oxidative stress response,protein interaction,transcriptional regulation
ENSG00000135829,DHX9,dhx9 overexpression,oncogenic transcription,transcriptional regulation,dna repair mechanisms,genomic instability,cell proliferation
ENSG00000153187,HNRNPU,regulation of gene expression,cell growth regulation,apoptosis resistance,tumor progression marker,biomarker for prognosis,protein-protein interaction network
ENSG00000077235,GTF3C1,overexpression,regulation of transcription,cell proliferation,rna polymerase iii-dependent transcription,tumor progression,genetic alterations
ENSG00000071054,MAP4K4,hippo-yap1 interaction,apoptosis resistance,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,nf-κb signaling activation,genomic instability
ENSG00000012232,EXTL3,genomic instability,dna repair mechanism,homologous recombination,oncogenic mutations,prognostic biomarker,genomic amplification
ENSG00000145088,EAF2,tp53 interaction,cell cycle regulation,transcriptional activation,cell proliferation promotion,rna polymerase ii complex,genomic amplification
ENSG00000121310,ECHDC2,cellular metabolism,lipid biosynthesis,warburg effect,genomic alterations,somatic mutations,tumor growth
ENSG00000141564,RPTOR,mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000101306,MYLK2,cytoskeletal disruption,cell migration promotion,metastasis facilitation,epithelial-to-mesenchymal transition (emt) regulation,transcription factor regulation,poor prognosis marker
ENSG00000197102,DYNC1H1,microtubule regulation,cancer progression,mitotic spindle formation,vesicle transport regulation,cellular migration enhancement,oncogenic potential
ENSG00000101557,USP14,regulation of protein stability,deubiquitinating enzyme activity,cell survival and proliferation,oncogenic signaling pathway regulation,tumor suppressor protein degradation,genome integrity maintenance
ENSG00000281320,DYRK1B,cellular proliferation,dual specificity kinase activity,regulation of pi3k/akt/mtor pathway,overexpression in cancer,tumor progression,therapeutic target
ENSG00000120756,PLS1,extracellular matrix remodeling,cell adhesion modulation,tumor cell invasion,metastasis promotion,poor prognosis marker,urokinase-type plasminogen activator pathway
ENSG00000176171,BNIP3,hypoxia-inducible signaling,mitochondrial regulation,apoptosis suppression,cell survival adaptation,tumor progression marker,autophagy modulation
ENSG00000049449,RCN1,er stress modulation,calcium regulation,tumor growth promotion,metastasis facilitation,cell adhesion modification,oncogenic potential
ENSG00000128045,RASL11B,oncogene regulation,cell growth promotion,tumor progression association,prognostic marker,therapeutic target,gtpase activity
ENSG00000186716,BCR,bcr-abl fusion,constitutive tyrosine kinase activity,enhanced cell growth,oncogenic processes,signaling pathway activation,therapeutic target
ENSG00000151694,ADAM17,shedding activity,cell migration,angiogenesis promotion,tumor aggressiveness,pro-tumorigenic growth factors,immune modulation
ENSG00000064607,SUGP2,pyrimidine nucleotide metabolism,overexpression,tumor proliferation,hypoxia response,transcriptional regulation,apoptosis modulation
ENSG00000162728,KCNJ9,cellular proliferation,apoptosis regulation,pi3k/akt pathway interaction,potassium channel function,cell cycle regulation,tumor aggressiveness
ENSG00000276825,DRD4,g-protein coupled receptor,aberrant expression,signal transduction pathway,cell proliferation regulation,tumor progression,neurotransmitter interaction
ENSG00000155366,RHOC,emt driver,cytoskeleton remodeling,cell migration enhancer,oncogenic signaling,angiogenesis promoter,pro-tumorigenic factor
ENSG00000111913,RIPOR2,...<end>:

<begin>
regulation of h2s signaling pathway,oncogenic signaling pathways,tumor progression,increased cell proliferation,enhanced metastatic potential,therapeutic target
ENSG00000196839,ADA,adenosine metabolism,genomic instability,epigenetic alterations,immunomodulation,tumor microenvironment modulation,dna damage repair
ENSG00000151150,ANK3,amplified gene,oncogenic process,pi3k/akt pathway modulation,cell adhesion regulation,sodium channel regulation,tumor progression
ENSG00000119402,FBXW2,tumor suppressor regulation,protein degradation pathway disruption,cyclin-dependent kinase inhibitor regulation,ubiquitin ligase complex component,cell cycle progression modulation,apo-5 protein regulation
ENSG00000169057,MECP2,genomic instability,epigenetic regulation disruption,tumor progression modulation,cellular transformation driver,aberrant gene expression regulator,loss of function mutations
ENSG00000151466,SCLT1,overexpression,epithelial-to-mesenchymal transition,cell adhesion modulation,pi3k/akt pathway interaction,tumor progression marker,poor prognosis indicator
ENSG00000132694,ARHGEF11,rho gtpase activation,oncogenic driver,tumor progression,cell migration,invasion promotion,kinase activation
ENSG00000166670,MMP10,angiogenesis promotion,extracellular matrix degradation,cancer progression facilitation,pro-migratory pathway activation,therapeutic target,upregulated expression
ENSG00000178031,ADAMTSL1,cell migration,cell adhesion,angiogenesis promotion,metastatic suppression,prognostic marker,signaling pathway modulation
ENSG00000173914,RBM4B,microrna regulation,tumor suppression,cancer cell proliferation inhibition,anti-angiogenic effects,cellular apoptosis induction,rna-binding motif protein family member
ENSG00000170485,NPAS2,transcriptional regulation,wnt/β-catenin pathway interaction,cell cycle progression,apoptosis modulation,biomarker potential,therapeutic target
ENSG00000081154,PCNP,cell cycle regulation,apoptosis evasion,transcriptional regulation,signaling pathway modulation,biomarker potential,tumor growth promotion
ENSG00000149084,HSD17B12,steroid hormone regulation,pi3k/akt pathway activation,cell proliferation and survival,tumor progression correlation,advanced tumor stages association,poor prognosis indicator
ENSG00000092841,MYL6,pi3k/akt pathway interaction,cellular motility regulation,prognostic marker,tumor progression promotion,metastasis enhancement,poor prognosis
ENSG00000115073,ACTR1B,g-protein activation,signaling pathway dysregulation,oncogene function,tumor progression,cell proliferation regulation,cellular migration promotion
ENSG00000100823,APEX1,genomic instability,dna repair,oxidative stress response,cell cycle regulation,transcriptional control,tumor suppression
ENSG00000188229,TUBB4B,microtubule stability,cellular structure maintenance,tumor progression,cell migration regulation,cell division regulation,therapeutic target
ENSG00000104267,CA2,calcium signaling,dysregulated expression,cell cycle regulation,tumor progression,prognostic marker,apoptosis inhibition
ENSG00000113013,HSPA9,chaperone function,cell survival,tumor progression,apoptosis evasion,angiogenesis,hypoxic adaptation
ENSG00000166441,RPL27A,ribosomal component,cell proliferation enhancement,tumor growth promotion,cancer cell survival,therapeutic resistance,metabolic regulation
ENSG00000053501,USE1,nonsense-mediated mrna decay,genomic instability,cellular stress response,protein-protein interaction,post-transcriptional regulation,tumor suppressor function
ENSG00000072501,SMC1A,chromosomal instability,genomic rearrangements,cancer driver,genetic mutation,cohesin complex regulation,tumor cell growth
ENSG00000281459,PADI1,histone modification,cancer progression,tumor suppressor degradation,chromatin relaxation,oncogenic gene expression,poor prognosis marker
ENSG00000182446,NPLOC4,cell proliferation,mitotic spindle regulation,genome instability,cancer stem cell regulation,therapeutic target,prognostic biomarker
ENSG00000070087,PFN2,actin cytoskeleton regulation,cellular migration,tumor progression,protein-protein interaction,pi3k/akt signaling,oncogenic driver gene
ENSG00000134899,ERCC5,genomic instability,tumor progression,dna repair defects,cellular sensitivity,xpf endonuclease function,nucleotide excision repair
ENSG00000081181,ARG2,tumor progression,metabolic regulation,therapeutic target,genomic instability,hypoxic adaptation,cell proliferation
ENSG00000215182,MUC5AC,epithelial protection,mucin overexpression,tumor progression,lymph node metastasis,immune evasion,pi3k/akt pathway interaction
ENSG00000122852,SFTPA1,immune modulation,tumor progression,extracellular matrix remodeling,macrophage regulation,regulatory t-cell recruitment,epithelial-to-mesenchymal transition
ENSG00000154447,SH3RF1,ubiquitin-proteasome system regulation,oncogenic driver,tumor suppressor degradation,angiogenesis regulation,cell proliferation enhancement,protein degradation modulation
ENSG00000161509,GRIN2C,neurotransmission regulation,cell proliferation promotion,tumor progression association,signal transduction interaction,glutamate receptor subunit,prognostic marker significance
ENSG00000044090,CUL7,cell cycle regulation,cancer proliferation,oncogenic potential,tumor aggressiveness,protein degradation regulation,csn complex component
ENSG00000104321,TRPA1,trp channel regulation,calcium signaling pathway,inflammation modulation,tumor progression,metastasis facilitation,immune cell recruitment
ENSG00000198034,RPS4X,ribosome biogenesis,dna repair mechanism,cell growth regulation,apoptosis regulation,protein translation enhancement,gain of function mutations
ENSG00000111669,TPI1,glycolytic enzyme,enhanced glycolysis,warburg effect,tumor progression,metabolic regulation,cellular energy production
ENSG00000139722,VPS37B,autophagy regulation,escrt-0 complex subunit,tumor growth promotion,metabolic regulation alteration,protein degradation dysfunction,cancer driver mutation
ENSG00000144381,HSPD1,mitochondrial chaperone function,protein folding regulation,cancer cell survival,chemosensitivity modulation,oncogenic transformation,epithelial-to-mesenchymal transition
ENSG00000196482,ESRRG,nuclear receptor transcription factor,promotes tumor growth,regulates cell proliferation,activates angiogenesis,interacts with hnf1b/hnf4a,overexpressed in kirc
ENSG00000169297,NR0B1,pi3k/akt pathway,oncogene,tumor progression,cellular proliferation,steroidogenesis regulation,gene overexpression
ENSG00000186468,RPS23,ribosomal dysfunction,altered protein synthesis,cell growth regulation,protein kinase activation,cancer driver gene,oncogenic mutations
ENSG00000169564,PCBP1,poly(rc) binding,cell cycle regulation,oncogene function,tumorigenesis promotion,apoptosis inhibition,transcriptional regulation
ENSG00000171345,KRT19,keratin 19 upregulation,tumor progression,chemotherapy resistance,epithelial-to-mesenchymal transition,cell migration invasion,poor prognosis marker
ENSG00000182809,CRIP2,cell proliferation regulation,transcriptional regulation,nucleic acid binding,apoptosis inhibition,poor prognosis biomarker,pi3k/akt/mtor pathway interaction
ENSG00000204536,CCHCR1,genomic instability,dna repair,cell cycle checkpoint control,chromatin remodeling,genetic susceptibility,tumor aggressiveness
ENSG00000092208,GEMIN2,alternative splicing regulation,cell proliferation enhancement,gene expression dysregulation,oncogene activation,protein interaction modulation,spliceosome complex component
ENSG00000163737,PF4,angiogenesis promoter,biomarker candidate,chemokine signaling,metastasis facilitator,platelet activation factor,tumor growth supporter
ENSG00000106948,AKNA,akna dysregulation,epithelial-to-mesenchymal transition,immune evasion mechanisms,protein-protein interactions,transcriptional regulation,tumor progression
ENSG00000198931,APRT,purine metabolism,prpp overproduction,downstream signaling activation,tumorigenesis contribution,cell growth enhancement,poor prognosis association
ENSG00000154310,TNIK,wnt/β-catenin signaling,constitutive activation,protein-protein interaction,cell proliferation regulation,apoptosis resistance,cancer progression
ENSG00000188739,RBM34,polycomb repressive complex 1 (prc1),epigenetic regulation,tumor suppressor silencing,cell proliferation,oncogenic driver,microrna modulation
ENSG00000178184,PARD6G,cell polarity regulation,epithelial-to-mesenchymal transition,cell migration facilitation,tumor progression modulation,molecular interaction with par3 and apkc,cancer biology research focus
ENSG00000139218,SCAF11,histone modification regulation,chromatin remodeling,tumor suppression,oncogene activation,epigenetic regulation,prognostic marker
ENSG00000183741,CBX6,chromatin modification,epigenetic regulation,cell cycle progression,tumor growth promotion,metastasis facilitation,oncogenic pathway interaction
ENSG00000125901,MRPS26,mitochondrial translation regulation,apoptosis resistance,cell proliferation enhancement,tumor progression marker,mitochondrial biogenesis modulation,energy metabolism reprogramming
ENSG00000138100,TRIM54,mitochondrial localization,pi3k/akt pathway interaction,oncogenic potential,cell cycle regulation,apoptosis regulation,e3 ubiquitin ligase activity
ENSG00000082805,ERC1,genomic stability,apoptosis inhibition,dna repair mechanism,tumor suppressor function,cell cycle regulation,dna damage response
ENSG00000168439,STIP1,cellular stress response,protein folding regulation,therapeutic target,cellular metabolism modulation,tumor microenvironment modulation,oncogenic pathway interaction
ENSG00000115816,CEBPZ,cell cycle regulation,transcriptional activation,tumor suppressor dysfunction,tumor growth promotion,oncogene expression,mutation hotspot
ENSG00000146007,ZMAT2,transcriptional regulation,cell proliferation,apoptosis inhibition,tumor progression,co-regulatory interactions,poor prognosis
ENSG00000171860,C3AR1,tumor microenvironment regulation,immune regulation,complement system activation,anaphylatoxin binding,chemotaxis modulation,inflammation regulation
ENSG00000273562,NAP1L4,**

 histone loading complex component,chromatin remodeling,cell cycle regulation,tumor progression facilitator,transcriptional regulator,protein-protein interaction network modulator

**
ENSG00000230624,DDX39B,rna helicase function,cell proliferation regulation,mrna processing modulation,oncometabolism association,cancer driver potential,poor prognosis marker
ENSG00000130706,ADRM1,**
ubiquitin ligase activity,proteasome regulation,cellular homeostasis,cancer progression,apoptosis evasion,tumorigenesis
ENSG00000160213,CSTB,tumor suppressor function,lysosomal integrity maintenance,cellular stress induction,apoptosis modulation,cysteine protease inhibition,protein aggregation regulation
ENSG00000104852,SNRNP70,splicing defects,oncogenic driver,gain of function mutations,aberrant protein production,tumor progression,biomarker for diagnosis and prognosis
ENSG00000101916,TLR8,tlr8 signaling,immune evasion,epigenetic regulation,innate immune modulation,tumor microenvironment,pro-inflammatory cytokine production
ENSG00000100129,EIF3L,mtor pathway interaction,oncogene overexpression,tumor progression driver,cell proliferation regulation,protein synthesis enhancement,apoptosis inhibition
ENSG00000146676,PURB,ubiquitination pathway regulation,p53 degradation,cell cycle progression regulation,dna repair mechanism interaction,oncogenic potential,protein degradation function
ENSG00000086061,DNAJA1,oncogenic protein regulation,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,ubiquitin-proteasome pathway modulation,protein chaperone function
ENSG00000215271,HOMEZ,transcriptional regulation,chromatin remodeling,oncogenic potential,genomic instability,dna repair interactions,tumor suppression disruption
ENSG00000109606,DHX15,genomic instability,telomere shortening,homologous recombination,dna damage sensitivity,apoptosis induction,transcriptional regulation
ENSG00000177105,RHOG,rho gtpase activity,epithelial-to-mesenchymal transition,cell migration,cancer cell survival,tumor progression,angiogenesis regulation
ENSG00000142409,ZNF787,transcriptional regulation,oncogenic function,cell proliferation,survival mechanisms,genomic instability,epigenetic regulation
ENSG00000172301,COPRS,cellular stress response,membrane transport regulation,tumor growth modulation,oncogenic potential,cancer progression,protein-protein interaction
ENSG00000101350,KIF3B,microtubule-based transport,cell division regulation,oncogenic function,tumor progression,poor prognosis marker,protein-protein interaction
ENSG00000167792,NDUFV1,mitochondrial dysfunction,altered energy metabolism,genomic instability,rapid cell proliferation,enhanced glycolysis,oxidative stress
ENSG00000082175,PGR,ligand-activated transcription factor,nuclear hormone receptor,oncogenic processes,cell cycle progression,apoptosis regulation,hormone-dependent processes
ENSG00000168286,THAP11,tumor progression,transcription factor activity,epithelial-to-mesenchymal transition,cell proliferation regulation,dna repair modulation,genetic overexpression
ENSG00000167967,E4F1,transcriptional regulation,cell cycle progression,oncogene activation,tumor growth promotion,epigenetic modulation,apoptosis inhibition
ENSG00000117650,NEK2,genomic instability,chromosome segregation,cell cycle regulation,tumor progression,epithelial-to-mesenchymal transition,constitutive activation
ENSG00000076003,MCM6,genomic instability,cell cycle regulation,dna replication,oncogenic function,tumor aggressiveness,proliferation
ENSG00000101197,BIRC7,apoptosis inhibition,cell cycle regulation,dna damage response,epithelial-to-mesenchymal transition,nf-κb pathway modulation,pi3k/akt pathway interaction
ENSG00000228267,C4B,complement activation,immunosuppression,innate immunity,membrane attack complex,pathogen elimination,tumor microenvironment
ENSG00000233312,C4B_2,immune evasion,tumor progression,complement system regulation,pro-inflammatory response,cellular invasion,metastasis
ENSG00000146063,TRIM41,autophagy regulation,apoptosis regulation,cell cycle progression,protein degradation pathways,poor prognosis marker,tumor suppressor function
ENSG00000104388,RAB2A,oncogenic processes,tumor progression,cancer driver,cell proliferation,survival pathways,metastasis regulation
ENSG00000139990,DCAF5,genomic instability,tumor suppressor degradation,oncogene activation,cancer cell proliferation,poor prognosis indicator,pi3k/akt pathway activation
ENSG00000136111,TBC1D4,rab gtpase regulation,oncogenic process,cellular growth regulation,tumor progression,overexpression,poor prognosis
ENSG00000140299,BNIP2,mitochondrial regulation,hypoxia adaptation,tumor progression,cellular energy metabolism,oncogenic processes,hypoxic response
ENSG00000142864,SERBP1,cell proliferation,metabolic reprogramming,transcription factor activity,oncogene overexpression,tumor growth promotion,apoptosis evasion
ENSG00000229314,ORM1,aberrant expression,g-protein coupled receptor signaling,tumor aggressiveness,odorant detection,metastasis,oncogenesis
ENSG00000285258,ATXN7,chromatin modification,histone acetylation,epigenetic regulation,tumor suppressor regulation,genome instability,oncogenesis
ENSG00000111581,NUP107,genome instability,aberrant transcriptional regulation,nucleocytoplasmic transport disruption,chromatin remodeling complex interaction,mitotic checkpoint dysregulation,dna repair mechanism alteration
ENSG00000187754,SSX7,oncogene activation,cell proliferation enhancement,gene transcriptional regulation,tfe3 interaction,apoptosis suppression,genetic amplification driven
ENSG00000163736,PPBP,angiogenesis promotion,cell migration regulation,oncogenic mutations,tumor progression facilitation,protein-protein interactions,vegf regulation
ENSG00000188404,SELL,adhesion molecule regulation,decreased expression,cancer metastasis,metastatic suppressor,tumor progression,dysregulation
ENSG00000152234,ATP5F1A,mitochondrial dysfunction,metabolic reprogramming,oncogenic driver,cell proliferation,energy metabolism dysregulation,tumor progression
ENSG00000162302,RPS6KA4,mtorc1 signaling pathway,protein kinase activation,cell proliferation,cell survival,angiogenesis promotion,resistance to therapy
ENSG00000141551,CSNK1D,wnt/β-catenin pathway activation,constitutive kinase activity,tumor progression promotion,cell proliferation enhancement,poor prognosis marker,therapeutic target
ENSG00000177733,HNRNPA0,regulation of gene expression,pre-mrna splicing,rna stability,cell proliferation,survival pathways,tumor-specific genetic alterations
ENSG00000132182,NUP210,nuclear pore complex regulation,cell cycle disruption,oncogenic signaling,nuclear envelope integrity,tumor progression,therapeutic target
ENSG00000065154,OAT,cellular efflux,chemoresistance,dna synthesis regulation,nucleoside transport,signaling pathway interaction,tumor progression
ENSG00000180228,PRKRA,tumor suppression,cellular stress response,oncogenesis,phosphorylation regulation,therapeutic target,cell growth inhibition
ENSG00000177169,ULK1,autophagic process regulation,cell survival promotion,oncogenic processes facilitation,tumor progression facilitation,therapeutic target identification,genomic overexpression
ENSG00000049540,ELN,extracellular matrix remodeling,cell adhesion facilitation,tumor metastasis promotion,prognostic marker,elastic fiber formation regulation,cell migration enhancement
ENSG00000087303,NID2,tumor progression,cell migration,angiogenesis regulation,extracellular matrix interaction,immunohistochemical marker,prognostic indicator
ENSG00000165861,ZFYVE1,autophagy regulation,pi3k/akt signaling inhibition,tumor suppressor function,cell growth inhibition,apoptosis induction,protein-lipid interaction
ENSG00000139880,CDH24,loss of function mutations,tumor suppression,adhesion molecule dysfunction,cell migration and invasion,wnt signaling pathway regulation,prognostic biomarker candidate
ENSG00000118705,RPN2,protein degradation,cell cycle regulation,apoptosis inhibition,tumor suppressor regulation,dna repair modulation,ubiquitin-proteasome pathway
ENSG00000163939,PBRM1,chromatin remodeling,tumor suppressor function,loss of function mutations,cell proliferation inhibition,apoptosis promotion,epigenetic regulation
ENSG00000100220,RTCB,cellular stress response,dysregulated rna processing,oncogenic proliferation,protein interaction,enhanced tumor progression,tumor-specific regulation
ENSG00000186010,NDUFA13,mitochondrial dysfunction,electron transport chain,cellular energy metabolism,genetic alterations,cancer development,tumor growth
ENSG00000240694,PNMA2,cell signaling,cell proliferation,protein-protein interactions,oncogenesis,therapeutic target,genomic profiling
ENSG00000090054,SPTLC1,sphingolipid biosynthesis,apoptosis regulation,cancer progression modulation,biomarker identification,ceramide production increase,cell growth modulation
ENSG00000095627,TDRD1,**

cellular localization,rna-binding protein activity,tumor suppressor function,microrna regulation,nuclear complex formation,malignant transformation
ENSG00000099937,SERPIND1,inhibits mmps,matrix degradation inhibition,tumor suppressor function,biomarker for prognosis,regulates pi3k/akt pathway,proteasome interaction
ENSG00000081913,PHLPP1,pi3k/akt pathway regulation,tumor suppressor function,cellular dephosphorylation,mutations or loss of function,agc kinase inhibition,cell growth control
ENSG00000121410,A1BG,fatty acid binding,lipid metabolism,protein expression regulation,cell proliferation,tumor suppressor candidate,metabolic regulation
ENSG00000108839,ALOX12,cancer progression,angiogenesis promotion,pro-inflammatory signaling,eicosanoid biosynthesis,cell proliferation regulation,apoptosis inhibition
ENSG00000164265,SCGB3A2,**
cellular growth regulation,oncogenic potential,cellular interaction network,cell survival pathway modulation,tumor suppressor candidate,cancer biomarker 
**
ENSG00000019169,MARCO,tumor-associated macrophage regulation,immune evasion mechanism,oncogene activation,prognostic biomarker candidate,metastasis promotion,therapeutic target
ENSG00000056998,GYG2,glycosylation regulation,proliferation promotion,survival enhancement,cell division modulation,pi3k/akt/mtor interaction,tumor progression facilitation
ENSG00000074800,ENO1,glycolytic enzyme regulation,metabolic reprogramming,energy metabolism modulation,cell proliferation promotion,tumor metastasis facilitation,warburg effect support
ENSG00000167004,PDIA3,oncogene activation,protein folding regulation,er stress response,cell proliferation enhancement,therapeutic target identification,dna damage repair
ENSG00000171621,SPSB1,ubiquitin-proteasome pathway regulation,tumor growth promotion,oncogenesis involvement,cell signaling regulation,protein homeostasis disruption,cancer metastasis facilitation
ENSG00000111802,TDP2,dna repair mechanism,genome stability maintenance,top2b interaction,pi3k/akt pathway modulation,tumorigenesis driver,prognostic marker potential
ENSG00000133142,TCEAL4,tumor progression,transcription factor regulation,cellular growth regulation,apoptosis inhibition,protein-protein interactions,biomarker and potential therapeutic target
ENSG00000174255,ZNF80,transcriptional regulation,genomic instability,dna repair mechanisms,tumor suppression,cell proliferation enhancement,cancer progression factor
ENSG00000147604,RPL7,protein synthesis regulation,ribosomal subunit assembly,cell proliferation enhancement,translational control mechanisms,gene expression alteration,metabolic reprogramming
ENSG00000135625,EGR4,transcriptional regulation,tumor suppressor activity,cell cycle progression,apoptosis regulation,oncogenic potential,chromosomal deletion
ENSG00000263163,SLC27A3,fatty acid metabolism,lipid synthesis,oncogenic process,cancer cell survival,akt signaling pathway,pi3k/akt interaction
ENSG00000101856,PGRMC1,prostaglandin synthesis regulation,cell growth modulation,tumor progression association,cellular response regulation,protein-protein interaction,oncogenesis implication
ENSG00000145012,LPP,cellular proliferation,oncogenic transformation,lipid signaling pathway,phosphatase activity,metastasis promotion,protein interaction
ENSG00000153208,MERTK,apoptosis modulation,cellular clearance,downregulated expression,mitochondrial damage accumulation,oncogenic process promotion,tumor suppression
ENSG00000105197,TIMM50,mitochondrial dysfunction,energy production regulation,metabolic reprogramming,glycolysis enhancement,cell survival promotion,tumor progression driver
ENSG00000170759,KIF5B,motor protein activity,mitotic progression,chromosome segregation,oncogenic driver,tumor proliferation,cell survival regulation
ENSG00000105372,RPS19,ribosome biogenesis,tumor progression,cell growth promotion,cancer driver gene,apoptosis resistance,gene overexpression
ENSG00000067082,KLF6,genomic instability,transcriptional regulation,tumor progression,cell cycle regulation,metastasis,apoptosis inhibition
ENSG00000110107,PRPF19,spliceosome dysfunction,rna processing dysregulation,genomic instability mutations,oncogenic transformation driver,cellular processes disruption,therapeutic target candidacy
ENSG00000205937,RNPS1,ribonuclease p rna component,non-coding rna,tumor progression,cellular response regulation,oncogenic potential,precursor trna processing
ENSG00000114316,USP4,deubiquitination,pi3k/akt pathway activation,tumor progression,oncogenic transformation,protein stabilization,poor prognosis marker
ENSG00000162999,DUSP19,mapk signaling pathway regulation,tumor progression,cell proliferation enhancement,metastasis facilitation,oncogene involvement,poor prognosis marker
ENSG00000106344,RBM28,microrna regulation,gene expression modulation,cell cycle regulation,apoptosis evasion,oncogenic function,cellular proliferation
ENSG00000108651,UTP6,ribosome biogenesis,oncogenic overexpression,cell proliferation,genomic instability,chromatin remodeling,metabolic regulation
ENSG00000056736,IL17RB,il-17 signaling pathway,nf-kappab activation,inflammation promotion,tumor growth enhancement,immune evasion,pro-inflammatory cytokine regulation
ENSG00000285433,DEFB4B,tumor progression,immune evasion,innate immunity modulation,pro-inflammatory response suppression,angiogenesis promotion,oncogene function
ENSG00000285181,DEFB4A,tumor progression,immune evasion,antimicrobial activity,inflammation modulation,prognostic marker,tumor invasion
ENSG00000131437,KIF3A,mitotic spindle regulation,dysregulation of cell cycle,genomic instability,aneuploidy,tumor progression,cell proliferation
ENSG00000172943,PHF8,histone demethylase activity,chromatin remodeling,oncogenic pathway activation,tumor progression,cell cycle regulation,dna repair mechanism
ENSG00000008118,CAMK1G,cell cycle regulation,calcium/calmodulin-dependent kinase activity,apoptosis suppression,gene amplification,tumor progression,signal transduction pathway
ENSG00000157916,RER1,pi3k/akt signaling pathway interaction,tumor progression enhancement,proliferation and invasion promotion,autophagy suppression,cancer prognosis indicator,biomarker candidate for diagnosis
ENSG00000145016,RUBCN,autophagy regulation,cell death evasion,genetic alterations,metabolic reprogramming,mutations associated,tumor progression
ENSG00000197451,HNRNPAB,pre-mrna splicing,transcription regulation,nucleic acid processing,oncogenic transcription factor,tumor metastasis,gene expression modulation
ENSG00000163931,TKT,metabolic regulation,non-oxidative pentose phosphate pathway,cellular adaptation to stress,therapeutic target,cell survival pathways,prognostic biomarker
ENSG00000121741,ZMYM2,tumor suppressor,transcriptional regulation,apoptosis induction,cell proliferation inhibition,oncogenic process disruption,metastasis promotion
,HIST2H2AB,histone modification,tumor growth regulation,gene expression modulation,chromatin remodeling,transcriptional regulation,oncogenic transformation
ENSG00000177189,RPS6KA3,oncogenic driver,protein synthesis regulation,cell growth promotion,signaling pathway activation,tumor progression contributor,therapeutic target
ENSG00000212935,KRTAP10-3,intermediate filament formation,epithelial cell structural integrity,cell adhesion disruption,tumor-specific overexpression,potential biomarker,limited mechanistic insights
ENSG00000277377,SERPINA1,proteolytic inhibition,tumor microenvironment regulation,metastasis suppression,prognostic marker,cell growth regulation,cancer progression promotion
ENSG00000197694,SPTAN1,chromosomal instability,cell adhesion disruption,genomic alterations,pi3k/akt pathway interaction,tumor metastasis,cytoskeletal dysfunction
ENSG00000131504,DIAPH1,gain-of-function mutations,oncogenic processes,tumor progression,cell migration,actin cytoskeleton dynamics,rho gtpase signaling pathway
ENSG00000128739,SNRPN,spliceosome regulation,genomic instability,alternative splicing,tumor progression,therapeutic target,snrnp processing
ENSG00000105854,PON2,antioxidant properties,mitochondrial localization,tumor cell survival,apoptosis inhibition,cellular growth promotion,oncogenic processes
ENSG00000189266,PNRC2,androgen receptor regulation,chromatin remodeling complex interaction,gene expression modulation,tumor growth promotion,metastasis facilitation,signaling pathway modulation
ENSG00000134014,ELP3,transcriptional elongation,chromatin remodeling,rna polymerase ii activity,oncogenic activation,tumor progression,therapeutic target
ENSG00000125944,HNRNPR,splicing factor regulation,oncogenic isoforms,cell proliferation,survival signaling,microrna regulation,alternative splicing
ENSG00000163815,CLEC3B,oncogenic protein,tumor progression,metastasis regulation,cell adhesion molecule,signaling pathway modulation,immune response regulation
ENSG00000186395,KRT10,keratin structure,epithelial integrity,cell proliferation regulation,tumor progression marker,intermediate filament composition,aberrant expression role
ENSG00000169018,FEM1B,cell cycle regulation,genomic stability,dna repair,tumor suppression,cancer progression,protein-protein interactions
ENSG00000173812,EIF1,enhanced protein synthesis,translation initiation complex,regulatory factor,dysregulated expression,cellular proliferation,therapeutic target
ENSG00000078804,TP53INP2,p53 pathway deregulation,overexpression,tumor suppression,genomic instability,cancer progression,poor prognosis
ENSG00000128573,FOXP2,wnt/β-catenin signaling,transcriptional regulation,cell proliferation enhancement,genomic instability induction,epithelial cell differentiation disruption,oncogenic process promotion
ENSG00000096080,MRPS18A,mitochondrial translation,regulation of metabolism,warburg effect,cellular energy production,oncogenic interaction,protein complex formation
ENSG00000131507,NDFIP1,oncogenic process,tumor growth promotion,cell proliferation regulation,dysregulation associated with cancer,potential therapeutic target,aberrant gain of function mutations
ENSG00000119725,ZNF410,cell cycle regulation,transcriptional regulation,apoptosis promotion,tumor suppression,anti-proliferative function,dna damage response
ENSG00000062524,LTK,pi3k/akt pathway modulation,oncogenic signaling,gain of function mutations,cell proliferation enhancement,tumor angiogenesis promotion,immune response evasion
ENSG00000177674,AGTRAP,cellular proliferation inhibition,tumor suppressor function,protein-protein interaction regulation,angiotensin ii signaling modulation,tissue-specific expression regulation,anti-apoptotic activity suppression
ENSG00000127743,IL17B,angiogenesis promotion,pro-inflammatory cytokine,immunomodulation,metastasis facilitation,tumor growth support,immune suppression mechanism
ENSG00000142945,KIF2C,cell cycle regulation,dna replication,chromosome segregation,cancer progression,mitotic checkpoint,tumor suppressor
ENSG00000147679,UTP23,ribosome biogenesis,protein synthesis enhancement,tumor progression association,poor prognosis marker,prognostic value indicator,oncogenic potential
ENSG00000185825,BCAP31,pi3k/akt pathway modulation,apoptosis regulation,cell survival enhancement,b-cell receptor interaction,immune evasion mechanism,tumor progression facilitation
ENSG00000109107,ALDOC,warburg effect,metabolic regulation,gluconeogenesis,energy metabolism,oncogenic properties,tumor progression
ENSG00000149925,ALDOA,cellular metabolism,tumor aggressiveness,oncogene overexpression,cell proliferation regulation,metabolic reprogramming,therapeutic target
ENSG00000115825,PRKD3,cellular signaling,kinase activity,cell proliferation,apoptosis inhibition,tumor growth,oncogenic potential
ENSG00000147130,ZMYM3,chromatin remodeling,cell proliferation,oncogenesis,pi3k/akt signaling interaction,transcriptional regulation,tumor progression
ENSG00000163132,MSX1,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),gene overexpression,angiogenesis regulation,cell growth and survival regulation,none
ENSG00000276618,RAD17,genomic instability,dna damage response,replication checkpoint activation,genetic alterations accumulation,oncogenic signaling pathway activation,aneuploidy induction
ENSG00000132254,ARFIP2,cell proliferation,microtubule regulation,tumor progression,pi3k/akt pathway interaction,cancer cell survival,intracellular trafficking
ENSG00000159111,MRPL10,mitochondrial regulation,oncogenic mutations,ribosomal assembly,cellular metabolism,protein synthesis regulation,tumor progression driver
ENSG00000163221,S100A12,nf-kappa b pathway modulation,pro-inflammatory response promotion,cell proliferation facilitation,tumor microenvironment regulation,poor prognosis association,mapk signaling activation
ENSG00000181788,SIAH2,transcriptional regulation,tumor suppression inhibition,oncogenic function,protein degradation mechanism,p53 interaction,ubiquitin ligase activity
ENSG00000111247,RAD51AP1,homologous recombination repair (hrr),genomic instability,dna damage response,cell division regulation,protein-protein interactions,biomarker potential
ENSG00000197498,RPF2,cap-dependent translation,cellular stress response,growth factor activation,tumor initiation,therapeutic target,apoptosis regulation
ENSG00000117395,EBNA1BP2,epstein-barr virus latency,immune evasion mechanisms,cellular response modulation,viral replication regulation,tumorigenesis promotion,dna damage response
ENSG00000143742,SRP9,protein translocation,signal recognition particle,cellular membrane integration,protein synthesis regulation,cancer progression,metastasis
ENSG00000142168,SOD1,cellular homeostasis,oxidative stress regulation,cellular response modulation,antioxidant defense system,copper/zinc-containing enzyme,superoxide dismutation
ENSG00000152214,RIT2,ras-like gtpase activity,oncogenic signaling,cell proliferation,apoptosis inhibition,tumor growth,prognostic biomarker
ENSG00000120800,UTP20,oncogenic transcription,rna processing modulation,cellular proliferation enhancement,tumor progression facilitation,transcription regulation disruption,poor prognosis association
ENSG00000011007,ELOA,vhl pathway disruption,cell proliferation regulation,transcriptional activation,angiogenesis promotion,tumor growth facilitation,protein complex formation
ENSG00000140988,RPS2,ribosomal biogenesis,enhanced protein synthesis,tumor progression,cell proliferation,autophagy regulation,genetic cooperation
ENSG00000067596,DHX8,atp-dependent helicase activity,transcriptional regulation,cell cycle control,dna repair mechanisms,apoptosis evasion,oncogenic signaling pathways
ENSG00000176783,RUFY1,rufy1 overexpression,oncogenic processes,cell survival enhancement,tumor growth promotion,autophagy regulation,endosomal trafficking facilitation
ENSG00000107625,DDX50,tumor suppressor function,transcriptional regulation,rna metabolism regulation,helicase activity,cellular process modulation,genetic instability
ENSG00000137804,NUSAP1,microtubule regulation,aneuploidy induction,cell cycle progression,oncogenic potential,chromosome segregation error,therapeutic target
ENSG00000131018,SYNE1,cell migration,cancer progression,tumor suppression,cytoplasmic structure,protein interaction,genomic amplification
ENSG00000141644,MBD1,epigenetic regulation,tumor suppression,dna methylation,cell growth inhibition,apoptosis induction,histone modification
ENSG00000115234,SNX17,endosomal trafficking regulation,oncogenic pathway activation,co-localization with eea1,egfr/pdgfr signaling enhancement,tumor progression facilitation,kirc tumor driver
ENSG00000278741,ABR,genomic instability,cell cycle regulation,dna repair mechanisms,protein kinase activation,tumor progression,apoptosis regulation
ENSG00000165006,UBAP1,tumor suppressor function,oncogene regulation,protein degradation,receptor-mediated endocytosis,cell proliferation inhibition,endosomal trafficking regulation
ENSG00000102908,NFAT5,oncogenic transcription factor,tumor progression,cell survival and proliferation,osmostress response regulation,hypoxia-induced expression,promoter of pro-survival pathways
ENSG00000169692,AGPAT2,lipid biosynthesis regulation,dysregulated expression,cell proliferation enhancement,therapeutic target identification,protein-lipid interaction,cancer metabolism alteration
ENSG00000196581,AJAP1,tumor progression,anoikis resistance,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway activation,therapeutic target
ENSG00000108700,CCL8,tumor microenvironment modulation,immune suppressive cells recruitment,oncogenic process promotion,immunosuppression enhancement,chemokine signaling pathway regulation,cell trafficking regulation
ENSG00000175183,CSRP2,pi3k/akt pathway regulation,tumor suppression,apoptosis induction,cell cycle regulation,gene expression modulation,actin cytoskeleton dynamics
,H2AFY,histone modification,chromatin remodeling,cell proliferation,transcriptional regulation,dna damage response,oncogenic driver
ENSG00000130830,MPP1,chromatin remodeling,dna methylation,tumor suppressor gene silencing,histone modification,oncogene regulation,gene expression regulation
ENSG00000230456,DDR1,cellular proliferation,promotes tumor progression,receptor tyrosine kinase activity,tumor growth enhancement,dysregulated expression,mutation or overexpression
ENSG00000150594,ADRA2A,ros production,tumor progression,metastasis promotion,oncogenic signaling,cell survival enhancement,sympathetic nervous system modulation
ENSG00000104327,CALB1,cell adhesion disruption,calmodulin interaction,calcium signaling dysregulation,oncogenic protein binding,tumor progression facilitation,metastasis promotion
ENSG00000079332,SAR1A,genomic instability,cellular trafficking,protein transport regulation,oncogenic signaling pathways,dna repair modulation,cancer cell proliferation
ENSG00000274442,PRPF8,spliceosome component,cell growth regulation,tumor progression marker,therapeutic target,oncogene regulation,rna processing
ENSG00000196154,S100A4,emt induction,metastasis promotion,matrix metalloproteinases regulation,calcium-binding protein function,epithelial-to-mesenchymal transition,signaling pathway interaction
ENSG00000073803,MAP3K13,mapkkk activation,oncogenic potential,cell proliferation,apoptosis regulation,tumor progression,cell survival enhancement
ENSG00000130656,HBZ,transcriptional regulation,oncogenic transcription factor,chromatin remodeling,cellular transformation,cancer progression,genomic instability
ENSG00000100410,PHF5A,histone regulation,chromatin remodeling,dna repair mechanism,genome instability,therapeutic target,oncogenic protein interaction
ENSG00000102531,FNDC3A,er stress response,autophagy regulation,tumor progression,protein quality control,cellular homeostasis disruption,cancer biology relevance
ENSG00000164506,STXBP5,autophagy regulation,proteasome dysfunction,cell survival enhancement,tumor suppressor degradation,chemotherapy resistance development,cancer cell proliferation promotion
ENSG00000076944,STXBP2,upr activation,cellular stress response,chromatin remodeling,gene expression regulation,oncogenic pathway activation,tumor progression
ENSG00000198258,UBL5,cell cycle regulation,protein degradation,apoptosis inhibition,tumor suppressor function,ubiquitin-proteasome system modulation,oncogenic potential
ENSG00000102879,CORO1A,endocytic pathway,cytoskeleton reorganization,protein-protein interactions,cell proliferation,metastasis promotion,poor prognosis marker
ENSG00000120948,TARDBP,cellular proliferation,survival pathway regulation,tumor progression,oncogene activation,genetic instability,regulation of gene expression
ENSG00000148337,CIZ1,transcriptional coactivator function,oncogenic role,poor prognosis indicator,constitutive activation of pi3k/akt pathway,cell proliferation regulator,transcription factor interaction
ENSG00000103507,BCKDK,bcaa degradation,metabolic reprogramming,cellular growth promotion,constitutive activation,oncogenic mutation,therapeutic target
ENSG00000104903,LYL1,pi3k/akt pathway modulation,cell proliferation regulation,oncogene potential,tumor growth promotion,gene expression regulation,lysine-rich motif interaction
ENSG00000141127,PRPSAP2,purine biosynthesis,tumor progression,nucleotide synthesis,cell proliferation,enhanced growth,genetic mutations
ENSG00000163938,GNL3,cell cycle regulation,gene expression modulation,protein interaction,mapk/erk pathway activation,apoptosis inhibition,poor prognosis marker
ENSG00000111907,TPD52L1,cell cycle regulation,gene amplification,oncoprotein binding,tumor suppressor degradation,signaling pathway interaction,overexpression
ENSG00000108433,GOSR2,oncogenic processes,enhanced cell growth,metastasis promotion,signal transduction regulation,trafficking modulation,chemotherapy sensitivity regulation
ENSG00000269858,EGLN2,hypoxia adaptation,stability regulation of hif-α,prolyl hydroxylase activity,tumor progression facilitation,therapeutic target for rcc,hypoxia-inducible factor-alpha stabilization
ENSG00000142794,NBPF3,genomic regulation,chromatin organization,nuclear architecture,ctcf complex interaction,tad formation,oncogenesis
ENSG00000126752,SSX1,ssx1-tef3 fusion,cell proliferation,transcriptional repression,oncogene activation,pi3k/akt pathway interaction,tumor suppressor gene regulation
ENSG00000196998,WDR45,wd repeat domain 45 protein interaction,p53 tumor suppressor pathway disruption,chromatin remodeling complex involvement,dna damage repair alteration,cytoplasmic dynein-1 light chain interaction,tumorigenesis promotion through cell cycle progression
ENSG00000182901,RGS7,g-protein regulation,dysregulated signaling,cell migration,regulatory subunit,protein localization,tumor progression
ENSG00000145191,EIF2B5,regulation of protein synthesis,oncogenic functions,tumor suppressor activity,cell proliferation,chemotherapy resistance,unfolded protein response regulation
ENSG00000130037,KCNA5,ion channel regulation,pi3k/akt pathway modulation,apoptosis resistance,tumor progression,cell cycle arrest,dna damage response
ENSG00000169504,CLIC4,oncogenesis,promotes angiogenesis,proteins interaction with pi3k/akt pathway,regulates cell cycle progression,suppressed apoptosis,induces oxidative stress
ENSG00000125898,FAM110A,genomic instability,cell proliferation,tumor progression,oncogenic potential,cell migration,apoptosis suppression
ENSG00000174891,RSRC1,cell cycle regulation,apoptosis inhibition,ubiquitination regulation,tumor suppressor regulation,oncogene activation,protein degradation
ENSG00000133574,GIMAP4,apoptosis regulation,calcium signaling pathway,gtp-binding protein family,immune system modulation,lymphocyte homeostasis,tumor progression
ENSG00000119408,NEK6,genomic instability,constitutive activation,oncogenic properties,cell proliferation,aberrant expression,centrosome regulation
ENSG00000133818,RRAS2,ras signaling pathway,gain of function mutations,cell proliferation,oncogenesis,cell survival,therapeutic target
ENSG00000170748,RBMXL2,rna metabolism,post-transcriptional regulation,splicing and editing,tumor suppressor potential,oncogene or tumor suppressor,cellular regulation
ENSG00000153914,SREK1,oncogene,cell proliferation,transcriptional regulation,rna processing,protein interaction,tumorigenesis
ENSG00000166634,SERPINB12,apoptosis regulation,cell survival pathway,protease inhibition,tumor progression,protein-protein interaction,downregulated expression
ENSG00000105281,SLC1A5,tumor growth promoter,metabolic regulator,transmembrane transporter,overexpression,poor prognosis indicator,signaling pathway modulator
ENSG00000123405,NFE2,nrf2-mediated antioxidant response,transcriptional regulation,genotoxic stress resistance,chemo-resistance,tumorigenesis promoter,cell survival enhancement
ENSG00000110057,UNC93B1,immune suppression,tumor microenvironment modulation,tlr signaling dysregulation,interferon-gamma-mediated response inhibition,majeed syndrome association,tumorigenesis promotion
ENSG00000099901,RANBP1,cell cycle regulation,chromatin remodeling,tumor progression,oncoprotein function,gene expression regulation,apoptosis evasion
ENSG00000100714,MTHFD1,dna synthesis regulation,tumor growth promotion,oncogene overexpression,angiogenesis facilitation,immune evasion,folate metabolism dysregulation
ENSG00000107537,PHYH,mitochondrial dysfunction,loss of function mutations,cellular heme homeostasis,oncogenesis,chemotherapy resistance,genetic instability
ENSG00000099624,ATP5F1D,mitochondrial dysfunction,metabolic reprogramming,glycolytic shift,energy production impairment,oncogenic mutations,therapeutic target
ENSG00000157087,ATP2B2,calcium ion transport,tumor progression,cellular signaling pathway,metastasis promotion,oncogenic process,cell proliferation regulation
ENSG00000161647,MPP3,tumor progression,cell adhesion,genomic instability,transmembrane protein function,pi3k/akt pathway interaction,cellular polarity regulation
ENSG00000069275,NUCKS1,cell cycle regulation,genome instability,dna damage response,apoptosis evasion,chk2/chk1 interaction,tumor suppressor gene
ENSG00000089775,ZBTB25,tumor suppression,transcriptional regulation,chromatin remodeling,cell proliferation,dna damage response,genomic instability
ENSG00000162231,NXF1,dna repair regulation,protein-protein interaction,cellular proliferation,tumor suppressor function,mrna export regulation,genomic instability
ENSG00000145979,TBC1D7,tumor suppressor function,rab gtpase regulation,protein-protein interactions,cellular proliferation,membrane trafficking,cancer driver gene
ENSG00000134686,PHC2,epigenetic regulation,histone modification,oncogenesis,cell proliferation,apoptosis inhibition,epigenetic silencing
ENSG00000063177,RPL18,ribosomal subunit assembly,cell proliferation driver,oncogene overexpression,tumor progression marker,apoptosis inhibition,mtor pathway interaction
ENSG00000197111,PCBP2,oncogenic signaling,cell proliferation regulation,mrna stability modulation,tumor microenvironment modification,cancer cell invasion promotion,therapeutic target
ENSG00000105141,CASP14,cancer cell survival,apoptosis evasion,cell proliferation,pi3k/akt pathway activation,tumor progression,inflammation regulation
ENSG00000275700,AATF,apoptosis regulation,cell cycle progression,pi3k/akt signaling interaction,oncogenic role,transcriptional regulation,tumor suppression
ENSG00000136929,HEMGN,histone regulation,transcriptional activation,chromatin remodeling,oncogenic transformation,gene expression modulation,protein overexpression
ENSG00000160299,PCNT,centrosomal protein,genomic instability,chromosomal abnormalities,dna damage response,cell cycle progression,aneuploidy induction
ENSG00000163468,CCT3,oncoprotein degradation,protein aggregation,cell proliferation,prognostic marker,tumor progression,cancer metastasis
ENSG00000131626,PPFIA1,cytoplasmic actin assembly,cellular migration and invasion,tumor progression,poor prognosis marker,regulation of adhesion molecules,extracellular matrix modulation
ENSG00000112640,PPP2R5D,pi3k/akt signaling,tumor progression,oncogenic signaling,cellular proliferation,protein phosphatase inhibition,metastasis
ENSG00000123136,DDX39A,ddx39a's regulatory functions on rna,oncogenic mutations,cancer progression,tumor suppressor interaction,gene expression modulation,prognostic biomarker potential
ENSG00000163702,IL17RC,tumor progression,pro-inflammatory signaling,metastasis promotion,angiogenesis regulation,immune evasion,genetic interaction with stat3
ENSG00000134545,KLRC1,tumor suppressor function,impaired immune surveillance,downregulated expression,poor prognosis,antitumor immune response,immune evasion
ENSG00000147378,FATE1,metabolic regulation,cellular proliferation,tumor suppressor function,phosphatidylserine binding domain,regulatory functions,oncogenic events
,H1FX,histone modification,chromatin regulation,tumor suppressor inactivation,cell cycle progression,apoptosis regulation,transcriptional repression
ENSG00000101882,NKAP,nf-kappa b pathway dysregulation,chromatin remodeling inhibition loss,transcriptional control disruption,tumor progression promotion,prognostic biomarker,genomic instability
ENSG00000008735,MAPK8IP2,pro-survival signaling,cellular apoptosis,oncogenic mediator,cancer-related inflammation,cell proliferation,tumor progression
ENSG00000119599,DCAF4,ubiquitination regulation,cul4-ring complex interaction,cell cycle modulation,dna damage response,tumor suppressor function,oncogenic pathway disruption
ENSG00000168542,COL3A1,type iii collagen production,pro-tumorigenic effects,angiogenesis promotion,metastasis facilitation,cell adhesion regulation,tumor progression enhancement
ENSG00000083720,OXCT1,fatty acid oxidation,cellular metabolism,energy production,oncogenic processes,tumor growth,metabolic regulation
ENSG00000075415,SLC25A3,mitochondrial citrate transport,tumor energy metabolism,oncogenic promoter,therapeutic target,cell proliferation inhibition,apoptosis induction
ENSG00000138442,WDR12,ribosome biogenesis,tumor cell proliferation,enhanced metabolic rate,protein synthesis regulation,cell survival mechanisms,genetic instability mutations
ENSG00000138160,KIF11,centrosomal localization,aneuploidy induction,chromosomal instability promotion,mitotic error contributor,microtubule dynamics regulation,therapeutic target
ENSG00000017260,ATP2C1,cell proliferation,ca2+ regulation,oncogenesis,poor prognosis,therapeutic target,overexpression
ENSG00000176887,SOX11,transcriptional regulation,cell proliferation,apoptosis suppression,metastasis promotion,therapeutic target,genomic instability
ENSG00000175216,CKAP5,microtubule regulation,apoptosis modulation,autophagy induction,cell cycle progression,pi3k/akt pathway interaction,tumor suppressor protein regulation
ENSG00000120158,RCL1,chromatin remodeling,apoptosis regulation,tumor suppressor interaction,dna repair dysfunction,poor prognosis biomarker,genomic instability
ENSG00000111605,CPSF6,altered splicing,chromatin modification,cell proliferation,tumor suppressor activity,nuclear localization,rna processing dysfunction
ENSG00000214022,REPIN1,pi3k/akt pathway activation,wave complex regulation,cytoplasmic localization,tumor progression marker,cell migration facilitation,prognostic significance
ENSG00000175390,EIF3F,**
protein synthesis regulation,oncogene activation,tumor cell proliferation,cell survival enhancement,mtor pathway interaction,translation initiation factor
ENSG00000164934,DCAF13,cell cycle regulation,dna repair mechanism,e3 ubiquitin ligase activity,genomic instability,oncogenic potential,protein degradation pathway
ENSG00000197635,DPP4,pi3k/akt signaling pathway,tumor progression,metabolic regulation,angiogenesis,prognostic marker,therapeutic target
ENSG00000171385,KCND3,calcium-dependent signaling,cell cycle regulation,neuronal excitability,potassium channel function,proliferation modulation,therapeutic target
ENSG00000134365,CFHR4,regulatory interaction with factor h,aberrant expression overrepresented,promotes tumor cell survival,immune evasion mechanisms,alters complement system regulation,prognostic significance in cancer progression
ENSG00000150768,DLAT,mitochondrial dysfunction,altered energy metabolism,glycolytic shift,tumor progression,cellular respiration regulation,cancer-related metabolic reprogramming
ENSG00000078018,MAP2,microtubule stability,cancer progression,apoptosis suppression,cell migration,metastasis promotion,cytoskeleton regulation
ENSG00000183765,CHEK2,genomic instability,tumor suppressor function,cell cycle regulation,dna repair machinery,apoptosis modulation,biomarker potential
ENSG00000244038,DDOST,glycoprotein assembly,cell surface modification,tumor progression,cell adhesion disruption,unfolded protein response regulation,protein-protein interaction
ENSG00000064547,LPAR2,cellular migration,epithelial-to-mesenchymal transition (emt),growth factor regulation,signaling pathway activation,tumor invasion,lysophosphatidic acid receptor interaction
ENSG00000182134,TDRKH,alternative pre-mrna splicing,cell proliferation,oncogene overexpression,rna processing,spliceosome interaction,tumor suppressor dysregulation
ENSG00000140382,HMG20A,chromatin remodeling,oncogenic transcriptional programs,genomic instability,aggressive tumor growth,metastasis resistance,therapeutic target
ENSG00000066322,ELOVL1,lipid biosynthesis,fatty acid elongation,tumor progression,prognostic biomarker,oncogenic process,cancer aggressiveness
ENSG00000174827,PDZK1,protein scaffolding,cell signaling regulation,ion transport regulation,epithelial polarity maintenance,tumor growth promotion,cell proliferation regulation
ENSG00000280987,MATR3,gene expression regulation,chromatin organization,rna processing,tumor progression,diagnostic marker,nuclear matrix function
ENSG00000143006,DMRTB1,oncogene,promotes cell proliferation,pi3k/akt pathway activation,tumor progression,tissue invasion,poor prognosis
ENSG00000174547,MRPL11,mitochondrial ribosome assembly,oncogenic mrna translation,apoptosis resistance,energy metabolism regulation,cell growth promotion,tumor progression
ENSG00000100916,BRMS1L,genome instability,chromosomal aberration,dna repair mechanism,tumor suppressor function,homologous recombination repair,genome integrity maintenance
ENSG00000143537,ADAM15,cellular adhesion,constitutive activation,growth factor shedding,metastasis promotion,oncogenic signaling,prognostic marker
ENSG00000117139,KDM5B,epigenetic regulation,histone modification,chromatin remodeling,oncogene function,tumor growth promotion,metastasis facilitation
ENSG00000148572,NRBF2,tumor suppressor,chromatin regulation,genomic instability,cell cycle regulation,dna damage response,histone modification
,HIST1H2BB,histone modification,epigenetic regulation,tumor progression,cell proliferation enhancement,apoptosis resistance,angiogenesis promotion
ENSG00000174437,ATP2A2,calcium signaling disruption,gain of function mutations,tumor progression,therapeutic target,cell proliferation enhancement,oncogenic transformation
ENSG00000119285,HEATR1,loss-of-function mutations,aberrant cilia formation,cellular signaling disruption,proliferation promotion,tumor progression,mitotic spindle regulation
ENSG00000171953,ATPAF2,genomic instability,dna repair regulation,cell cycle progression,apoptosis dysregulation,tumor growth promotion,cancer genomic alterations
ENSG00000163625,WDFY3,tumor suppressor degradation,cell proliferation regulation,oncogenic protein interaction,cancer-promoting ubiquitination,genomic instability modulation,transcriptional control disruption
ENSG00000139112,GABARAPL1,autophagy,cellular autophagosome membrane formation,tumor suppressor function,nutrient deprivation response,lysosomal degradation regulation,protein recycling
ENSG00000113790,EHHADH,fatty acid metabolism,cellular energy homeostasis,cell proliferation,apoptosis regulation,autophagy modulation,tumor growth support
ENSG00000215375,MYL5,cell migration,tumor invasion,prognostic marker,muscle contraction regulation,cytokeletal interaction,oncogene upregulation
ENSG00000108819,PPP1R9B,regulatory subunit of protein phosphatase 1,wnt signaling pathway activation,cell cycle progression modulation,epithelial-to-mesenchymal transition regulation,androgen receptor coactivator,cancer stem cell maintenance
ENSG00000145349,CAMK2D,cellular signaling,cell cycle regulation,tumor progression,prognostic marker,oncogenic transformation,cancer driver
ENSG00000004142,POLDIP2,genomic instability,dna replication regulation,cell proliferation enhancement,poor prognosis association,tumor progression contribution,oncogenic protein interaction
ENSG00000124193,SRSF6,alternative splicing,genomic instability,oncogenic process,rna-binding protein interaction,splice site recognition,tumor aggressiveness
ENSG00000108852,MPP2,autophagy regulation,cell cycle regulation,intracellular trafficking,lysosomal enzyme sorting,multifunctional protein,tumorigenesis
ENSG00000116584,ARHGEF2,oncogenic signaling pathways,cell migration invasion,rho gtpase activation,tumor progression,genomic amplification,protein-protein interactions
ENSG00000104969,SGTA,tumor suppressor,protein degradation regulation,cell cycle regulation,dna repair regulation,apoptosis induction,chaperone function
ENSG00000175029,CTBP2,transcriptional regulation,tumor suppression,wnt/β-catenin signaling pathway,oncogene activation,prognostic biomarker,chromatin remodeling
ENSG00000178035,IMPDH2,guanine nucleotide biosynthesis,purine metabolism dysregulation,tumor progression marker,immunotherapy target,genomic instability maintenance,dna damage response
ENSG00000076928,ARHGEF1,increased cell motility,overexpression in cancer,dysregulated rho gtpase activity,promotion of oncogenic transformation,enhanced tumor progression,therapeutic target
ENSG00000007314,SCN4A,altered ion homeostasis,cellular proliferation,disrupted electrical excitability,enhanced cellular migration,metabolic reprogramming,therapeutic target
ENSG00000103222,ABCC1,drug resistance,multidrug transport,oncogenic properties,apoptosis regulation,cellular efflux,genetic overexpression
ENSG00000169727,GPS1,gpcr signaling pathway,angiogenesis regulation,cellular differentiation modulation,protein-protein interaction,tumor progression association,genomic alteration
ENSG00000100664,EIF5,translation initiation factor regulation,tumor growth promotion,cell proliferation enhancement,cancer cell migration,apoptosis suppression,promoter methylation regulation
ENSG00000115694,STK25,cell proliferation regulation,mitotic progression regulation,oncogene,dna damage response modulation,tumor progression driver,therapeutic target
ENSG00000108106,UBE2S,cancer stem cell maintenance,cell cycle regulation,dna repair pathway,oncogenic signaling,protein degradation pathway,self-renewal mechanism
ENSG00000174989,FBXW8,fbxw8-related terms,loss of tumor suppressor function,aberrant wnt/β-catenin signaling,cell cycle dysregulation,phosphorylated beta-catenin accumulation,tumor progression
ENSG00000166135,HIF1AN,hypoxia adaptation,tumor angiogenesis,metabolic regulation,cell survival pathway,gene expression regulation,oxygen-dependent degradation
ENSG00000164946,FREM1,tumor suppressor,cell migration,regulatory function,cellular morphology,adhesion regulation,focal adhesions
ENSG00000256235,SMIM3,cell growth regulation,genomic interaction,cell proliferation,limited research,unclear biological function,no established mechanisms of action
ENSG00000213585,VDAC1,apoptosis inhibition,mitochondrial function regulation,cell proliferation promotion,metabolic adaptation facilitation,energy homeostasis disruption,protein-protein interaction enhancement
ENSG00000168496,FEN1,dna replication regulation,genome stability maintenance,structure-specific endonuclease activity,tumor progression facilitation,therapeutic target potential,genomic instability contribution
ENSG00000165934,CPSF2,spliceosome assembly,alternative splicing,chromatin remodeling,transcriptional regulation,dna damage response,cancer cell survival
ENSG00000115355,CCDC88A,hippo signaling pathway,oncogene activation,cell proliferation enhancement,tumor metastasis promotion,inflammation regulation,immune response modulation
ENSG00000166681,BEX3,oncogene activation,cell proliferation promotion,apoptosis inhibition,tumor growth facilitation,poor prognosis marker,therapeutic target
ENSG00000113810,SMC4,genomic stability,chromatin organization,mitotic checkpoint regulation,tumor progression,chromosome condensation,epigenetic regulation
ENSG00000175581,MRPL48,mitochondrial ribosome component,cellular energy metabolism regulation,tumor progression promoter,cancer cell proliferation,enhanced mitochondrial biogenesis,ribosomal protein function alteration
ENSG00000021776,AQR,aquaporin function,cell proliferation,cell invasion,metastasis facilitation,tumor microenvironment modulation,protein-protein interaction
ENSG00000155974,GRIP1,glutamate receptor interaction,tumor growth promotion,cell signaling regulation,oncogenic potential,protein-protein interactions,pi3k/akt/mtor pathway activation
,SPERT,tumor suppressor,proteolytic regulation,cellular differentiation,apoptosis regulation,oncogenic process,genomic instability
ENSG00000132716,DCAF8,p53 regulation,oncogenic process promotion,protein degradation regulation,tumor suppressor protein turnover,poor prognosis association,therapeutic target candidate
ENSG00000205846,CLEC6A,tumor progression,complement activation,cell adhesion modulation,immune evasion mechanisms,lectin-like domain function,tumor associated antigen
ENSG00000166527,CLEC4D,immune recognition,cell adhesion,tumor migration,prognostic marker,therapeutic target,cellular signaling
ENSG00000160201,U2AF1,oncogenic splicing,constitutive activation,tumor progression,therapeutic target,genomic instability,cellular homeostasis disruption
ENSG00000137154,RPS6,mtor signaling pathway,overexpression,translation initiation,cell proliferation,therapeutic target,genomic instability
ENSG00000015153,YAF2,oncogene overexpression,mapk/erk pathway activation,pi3k/akt pathway modulation,cell proliferation enhancement,tumor progression facilitation,protein interaction
ENSG00000125457,MIF4GD,transcriptional regulator,gene expression regulation,dna repair mechanisms,tumor progression,oncogenic pathway modulation,cellular proliferation enhancement
ENSG00000129988,LBP,lipopolysaccharide-binding,inflammation modulation,tumor microenvironment regulation,immune system dysregulation,tumor progression facilitation,prognostic biomarker
ENSG00000123131,PRDX4,dual function,oncogenic properties,tumor suppressor activity,reactive oxygen species regulation,cell proliferation promotion,antioxidant enzyme activity
ENSG00000142748,FCN3,pattern recognition,innate immune modulation,tumor growth enhancement,cancer progression,inflammation regulation,phagocytosis augmentation
ENSG00000140632,GLYR1,glycine receptor subunit,ion homeostasis disruption,cellular signaling modulation,oncogene regulation,tumor suppressor interaction,cancer cell growth promotion
ENSG00000135404,CD63,tumor progression,metastasis regulation,cell adhesion modulation,epithelial-to-mesenchymal transition,prognostic marker,metabolic reprogramming
ENSG00000112742,TTK,genomic stability,paradoxical oncogene,cell cycle regulation,dna repair activation,kinase activation,prognostic marker
ENSG00000105404,RABAC1,pi3k/akt pathway interaction,oncogenic signaling,membrane trafficking regulation,cell proliferation enhancement,chemotherapy resistance modulation,therapeutic target candidate
ENSG00000161265,U2AF1L4,splice site recognition,genomic stability maintenance,tumorigenesis association,cell growth regulation,survival pathway modulation,pre-mrna splicing regulation
ENSG00000130816,DNMT1,epigenetic regulation,dna methylation,tumor suppressor silencing,oncogenic transformation,chemotherapy resistance,genomic instability
ENSG00000162946,DISC1,genetic instability,transcription factor regulation,cell cycle modulation,tumor progression,metastasis,signaling pathway interaction
ENSG00000100813,ACIN1,apoptosis regulation,tumor suppressor function,pro-apoptotic activity,cell growth inhibition,cancer oncogenesis,cell death pathways
ENSG00000123395,ATG101,autophagy pathway regulation,tumor progression,cell survival enhancement,genetic instability,cancer association,autophagic flux modulation
ENSG00000151651,ADAM8,cell adhesion disruption,cancer progression facilitator,metalloprotease activity,pi3k/akt pathway modulation,tumor invasion promotion,oncogenic signaling activation
ENSG00000100227,POLDIP3,chromatin association,dna replication fork progression,genomic instability,mitochondrial function,oncogenesis,polymerase interaction
ENSG00000147416,ATP6V1B2,proton gradient maintenance,cellular ph regulation,ion transport facilitation,cancer metastasis promotion,tumor growth enhancement,metabolic reprogramming
ENSG00000262327,AGK,lipid metabolism regulation,cell proliferation enhancement,signaling pathway modulation,oncogenic transformation,protein kinase activation,genomic amplification
ENSG00000165283,STOML2,tumor progression,metastasis promotion,cell proliferation facilitation,oncogenic interaction,immune evasion mechanism,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000239713,APOBEC3G,genomic instability,point mutation induction,retroviral restriction,innate immunity activation,tumor suppression disruption,oncogenic activation driver
ENSG00000155363,MOV10,oncogene,mirna regulation,rna helicase function,tumor growth promotion,proliferation and survival pathway modulation,immune evasion and tumor microenvironment regulation
ENSG00000102738,MRPS31,mitochondrial protein synthesis,cell growth regulation,translation efficiency disruption,tumor progression,therapeutic target,genomic instability
ENSG00000100450,GZMH,apoptosis induction,cellular regulation,immune modulation,tumor suppression,caspase activation,proteolytic activity
ENSG00000115414,FN1,fibronectin 1 overexpression,tumor progression,cell migration,metastasis,biomarker potential,signaling pathway modulation
ENSG00000143842,SOX13,transcriptional regulation,cell proliferation,apoptosis inhibition,tumor progression,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000124253,PCK1,gluconeogenesis regulation,energy metabolism modulation,glutamine dependence,warburg effect,tumor adaptation,metabolic enzyme interaction
ENSG00000164587,RPS14,ribosome biogenesis,protein translation regulation,oncogene amplification,tumor cell proliferation,cell survival enhancement,genetic instability
ENSG00000040199,PHLPP2,akt pathway inhibition,tumor suppressor function loss,cell proliferation regulation,phosphatase activity regulation,prognostic marker downregulation,oncogenic pathway suppression
ENSG00000148660,CAMK2G,apoptosis modulation,calcium-calmodulin pathway,cancer progression marker,cellular differentiation regulation,gene expression modification,nf-κb signaling interaction
ENSG00000134759,ELP2,transcriptional regulation,overexpression,genetic alterations,tumor growth,cell proliferation,therapeutic target
ENSG00000143412,ANXA9,pi3k/akt pathway interaction,tumor progression,immune evasion,nf-κb signaling regulation,cell growth promotion,prognostic marker
ENSG00000170542,SERPINB9,emt induction,metastasis facilitation,apoptosis regulation,cell migration promotion,prognostic marker,tumor aggressiveness enhancement
ENSG00000262145,ATP23,multidrug resistance,cellular efflux,ion transport regulation,prognostic marker,cancer progression,cellular interaction
ENSG00000005810,MYCBP2,transcriptional regulation,chromatin remodeling,cell cycle progression,tumor suppression loss,apoptosis inhibition,oncogenic activity enhancement
ENSG00000203690,TCP10,lipid biosynthesis,cellular growth,fatty acid elongation pathway,energy production,biomarker,metabolic regulation
ENSG00000147509,RGS20,gpcr signaling regulation,g-protein modulation,negative regulator function,tumor progression driver,mutation impact,signaling pathway
ENSG00000067048,DDX3Y,tumor progression,cell proliferation,regulatory rna interaction,gene expression modulation,oncogene overexpression,rna helicase function
,HIST1H3A,histone modification,chromatin regulation,epigenetic deregulation,transcriptional alteration,cancer progression,therapeutic target
,HIST1H3B,histone modification,chromatin structure,oncogenic potential,gene expression regulation,epigenetic alterations,cell proliferation
,HIST1H3C,histone modification,epigenetic regulation,chromatin remodeling,tumor suppressor gene silencing,oncogene activation,transcriptional regulation
,HIST1H3I,chromatin modification,epigenetic regulation,histone variant,cell cycle regulation,dna repair mechanism,genome stability
,HIST1H3H,**

cell cycle progression,histone modification,chromatin remodeling,transcriptional regulation,oncogenic transcription,epigenetic alteration
,HIST1H3G,histone modification,chromatin remodeling,epigenetic regulation,tumor suppressor function,gene expression regulation,dna packaging
,HIST1H3F,chromatin remodeling,histone modification,genomic stability,dna replication,tumorigenesis promotion,epigenetic regulation
,HIST1H3E,histone modification,chromatin remodeling,epigenetic regulation,tumor progression,overexpression,genomic instability
,HIST1H3J,histone regulation,epigenetic modification,chromatin remodeling,tumor proliferation,gene transcription regulation,genomic instability
,HIST1H3D,histone modification,chromatin remodeling,epigenetic regulation,tumor growth promotion,poor prognosis marker,genome instability
ENSG00000100422,CERK,protein-rna interactions,cancer cell proliferation,oncogenic protein regulation,ubiquitin-proteasome pathway modulation,cell migration and invasion,tumorigenesis driver
ENSG00000129195,PIMREG,pim kinase activation,cell cycle regulation,oncogenic transformation,therapeutic target,tumor progression,protein-protein interaction
ENSG00000137745,MMP13,matrix degradation,tumor progression,cell migration,invasion,extracellular matrix remodeling,prognostic marker
ENSG00000172059,KLF11,tumor suppressor function,loss of function mutations,cell cycle regulation,apoptosis regulation,dna repair modulation,transcriptional regulation
ENSG00000135316,SYNCRIP,oncogenic protein expression regulation,tumor progression promoter,rna-binding protein function,prognostic biomarker potential,cellular proliferation and survival enhancement,transcriptional activation role
ENSG00000095002,MSH2,genomic instability,dna mismatch repair,homologous recombination,tumor progression,microsatellite instability,lynch syndrome
ENSG00000067191,CACNB1,calcium signaling pathway,voltage-gated calcium channels,g protein-coupled receptor activation,tumor progression,cell proliferation regulation,therapeutic target
ENSG00000196504,PRPF40A,rna splicing regulation,spliceosomal complex assembly,oncogenic signaling activation,tumor progression factor,aberrant mrna production,cell proliferation and survival
,HIST1H2BC,chromatin remodeling,histone modification,cell proliferation,tumor progression,nucleosome assembly,dna packaging
,HIST1H2BE,histone modification,chromatin remodeling,gene transcription,cell growth regulation,tumor development,epigenetic alteration
,HIST1H2BG,histone modification,chromatin remodeling,epigenetic regulation,tumor suppressor modulation,cell cycle regulation,genomic stability
,HIST1H2BF,histone modification,genomic stability,cell cycle regulation,tumor progression,oncogenesis,dna packaging
,HIST1H2BI,histone modification,cell cycle regulation,chromatin structure,epigenetic regulation,genomic instability,tumor suppressor function
ENSG00000100083,GGA1,regulation of membrane trafficking,protein sorting in golgi apparatus,arf gap domain,vhs domain interaction,cell proliferation regulation,oncogenic process involvement
ENSG00000125445,MRPS7,mitochondrial dysfunction,increased protein synthesis,cell proliferation,cellular growth,energy metabolism,tumor progression
ENSG00000116560,SFPQ,rna splicing regulation,transcriptional control,cancer driver gene,tumor growth promotion,cell cycle modulation,immune evasion mechanism
ENSG00000173482,PTPRM,cellular regulation,tumor suppressor activity,dephosphorylation of tyrosine kinases,metastasis and tumor progression,cell adhesion modulation,signaling pathway regulation
ENSG00000164610,RP9,ribosomal protein function,translational regulation,tumor progression marker,protein synthesis enhancement,poor prognostic indicator,cellular proliferation promotion
ENSG00000173545,ZNF622,tumor progression,transcriptional regulation,dna-binding interactions,metastasis promotion,apoptosis inhibition,cell proliferation enhancement
ENSG00000105393,BABAM1,gap regulation,rab gtpase dysregulation,endocytic pathway disruption,tumor progression,metastasis promotion,cellular transport alteration
ENSG00000100354,TNRC6B,piwi-pirna pathway interaction,genome silencing regulation,tumor suppressor downregulation,rna-mediated process contribution,oncogenic process enhancement,kidney cancer overexpression
ENSG00000124160,NCOA5,transcriptional regulation,tumor suppressor function,dna repair mechanism,cell cycle modulation,apoptosis regulation,genomic instability
ENSG00000198755,RPL10A,ribosome assembly,increased protein synthesis,oncogenic driver,altered metabolic profile,enhanced ribosome biogenesis,cellular growth promotion
ENSG00000102931,ARL2BP,arf6 regulation,oncogene activation,tumor progression,therapeutic target,cellular trafficking regulation,pi3k/akt signaling pathway modulation
ENSG00000121058,COIL,chromatin modification,transcription regulation,cell proliferation,apoptosis resistance,tumor suppressor,genomic instability
ENSG00000160789,LMNA,chromatin remodeling,oncogenesis,cell cycle regulation,apoptosis evasion,tumor suppression,dysregulation
ENSG00000135083,CCNJL,ciliary complex regulation,mitotic spindle orientation,cell proliferation regulation,tumor suppressor function,loss-of-function mutations,centrosome function disruption
ENSG00000142186,SCYL1,regulation of protein stability,interaction with oncogenes,pi3k/akt pathway regulation,cell proliferation and invasion,prognostic marker,therapeutic target
ENSG00000119403,PHF19,h2a ubiquitination,epigenetic regulation,chromatin remodeling,tumor suppressor silencing,oncogenic processes,proliferation promotion
ENSG00000038945,MSR1,macrophage scavenger receptor 1,lipid metabolism regulation,tumor progression modulation,cell recognition and internalization,endocytosis pathway,immune response regulation
ENSG00000226033,STK19,nuclear localization,cell cycle regulation,apoptosis modulation,transcriptional regulation,tumor suppressor function,cancer-related mutations
ENSG00000198856,OSTC,cell proliferation,hippo signaling pathway,tumorigenesis,overexpression,biomarker potential,cell cycle regulation
ENSG00000107937,GTPBP4,mtor pathway,cell cycle regulation,protein translation,wnt signaling activation,oncogene overexpression,tumor progression
ENSG00000184408,KCND2,channel regulation,cell migration,therapeutic target,tumor progression,genetic alterations,ion transport regulation
ENSG00000100346,CACNA1I,calcium channel regulation,cell proliferation enhancement,voltage-gated calcium channels,cancer cell survival,aberrant calcium signaling,tumor progression
ENSG00000110429,FBXO3,protein degradation pathway,scf complex assembly,cullin interaction,p53 regulation,tumor suppressor function,transcriptional control
ENSG00000198830,HMGN2,genomic instability,chromatin remodeling,oncogene overexpression,tumor progression,dna damage response,cell proliferation
ENSG00000183751,TBL3,tumor suppressor function,dna repair regulation,cell cycle modulation,cancer driver gene candidate,gene expression regulation,proliferation inhibition
ENSG00000092847,AGO1,microrna-mediated regulation,risc complex assembly,cell proliferation,apoptosis resistance,genetic silencing,transcriptional activation
ENSG00000247077,PGAM5,metabolic reprogramming,glucose metabolism enhancement,oncogenic transformation,apoptosis resistance,glycolytic pathway modulation,tumor aggressiveness
ENSG00000134086,VHL,vhl-hif pathway disruption,tumor suppressor function loss,angiogenesis promotion,cell cycle progression,apoptosis resistance,glucose metabolism reprogramming
ENSG00000132109,TRIM21,immunomodulation,tumor microenvironment modulation,antitumor immune responses alteration,ubiquitin ligase activity,protein degradation regulation,cancer progression association
ENSG00000167283,ATP5MG,mitochondrial dysfunction,tumor growth,metabolic reprogramming,energy production,cell survival,glycolytic shift
ENSG00000088992,TESC,tumor progression,cell migration,adhesion regulation,epithelial-to-mesenchymal transition,prognostic marker,signaling pathway modulation
ENSG00000124126,PREX1,actin cytoskeleton remodeling,cell migration and invasion,gef activity for rap gtpases,tumor progression and metastasis,vhl-mtor pathway interaction,cellular processes regulation
ENSG00000197769,MAP1LC3C,autophagy regulation,microtubule stability,oncogenic potential,cell migration,protein-protein interaction,cancer prognosis
ENSG00000111445,RFC5,dna replication,oncogene overexpression,genome instability,cell proliferation,tumor progression,dna repair complex
ENSG00000104413,ESRP1,alternative splicing,cell proliferation,dna repair resistance,epithelial-to-mesenchymal transition,gene expression regulation,rna-binding protein function
ENSG00000100503,NIN,chromosome segregation,tumor suppressor,genomic instability,centrosome regulation,cell cycle control,protein-protein interaction
ENSG00000093010,COMT,catecholamine metabolism,o-methylation reaction,enzyme activity regulation,cell growth stimulation,angiogenesis promotion,metastasis facilitation
ENSG00000273772,SMN2,rna processing regulation,spinal muscular atrophy association,neuronal function maintenance,motor neuron integrity support,axonal growth promotion,cellular mrna stability
ENSG00000172062,SMN1,genomic maintenance,tumor suppression,mutation prevention,cell survival,dna repair mechanisms,genetic instability
ENSG00000156299,TIAM1,rho gtpase activation,mitogen-activated protein kinase (mapk) pathway regulation,cell migration and invasion,guanine nucleotide exchange factor function,tumor progression,ectopic expression
ENSG00000197381,ADARB1,genomic instability,cell proliferation,dna repair regulation,oncogenic mutations,therapeutic target,genome maintenance
ENSG00000124207,CSE1L,cell cycle regulation,protein export function,apoptosis dysregulation,tumor aggressiveness marker,spindle checkpoint interaction,cancer-testis antigen regulation
ENSG00000167863,ATP5PD,atp production,mitochondrial dynamics,cell growth promotion,apoptosis inhibition,tumor energy metabolism,metabolic regulation
ENSG00000136527,TRA2B,tumor growth promotion,alternative splicing regulation,rna binding protein activity,oncogenic process involvement,therapeutic target,gene expression modulation
ENSG00000114391,RPL24,60s ribosomal subunit dysregulation,cellular protein synthesis disruption,tumor suppressor p53 interaction,mtor pathway modulation,rpl24 mutation contribution to tumorigenesis,oncogenic cell growth and survival promotion
ENSG00000111752,PHC1,chromatin modification,polycomb complex component,tumor suppressor gene silencing,oncogenic potential,cell proliferation regulation,genetic instability
ENSG00000144713,RPL32,translation regulation,ribosomal subunit component,tumor progression,metastasis promotion,mtor pathway modulation,cellular growth enhancement
ENSG00000131263,RLIM,ubiquitin ligase activity,tumor suppressor function,transcriptional regulation,cell cycle arrest,apoptosis induction,gene expression modulation
ENSG00000079785,DDX1,genomic instability,transcriptional regulation,oncogene overexpression,cell proliferation enhancement,dna repair dysfunction,chemoresistance development
ENSG00000241553,ARPC4,actin polymerization,cell migration,cancer progression,therapeutic target,wasp interaction,cytoplasmic localization
ENSG00000163644,PPM1K,phosphatase activity,genomic stability,cell cycle regulation,transcription factor activation,dna repair modulation,protein phosphatase regulation
ENSG00000100519,PSMC6,proteasome degradation,ubiquitin-mediated regulation,tumor suppressor degradation,cell cycle progression,apoptosis inhibition,biomarker expression
ENSG00000152291,TGOLN2,protein trafficking regulation,tumor progression,poor prognosis biomarker,epigenetic regulation,cell growth regulation,oncogenesis driver
ENSG00000088179,PTPN4,dephosphorylation activity,tumor suppressor role,cell migration regulation,pi3k/akt pathway modulation,oncogenic transformation,signaling pathway regulation
ENSG00000108349,CASC3,chromatin remodeling,polycomb group proteins interaction,dna damage response,cell cycle regulation,tumor suppressor modulation,oncogene activation
ENSG00000124614,RPS10,ribosome biogenesis,protein synthesis regulation,tumor growth modulation,cell proliferation,genetic instability,mitotic arrest
ENSG00000114446,IFT57,cell signaling disruption,tumor suppressor function,ciliogenesis impairment,genomic instability induction,mitotic spindle regulation dysfunction,protein-protein interaction alteration
ENSG00000081320,STK17B,g2/m checkpoint regulation,cell cycle progression,tumor suppressor protein interaction,pi3k/akt pathway modulation,serine/threonine kinase activity,dna repair mechanism regulation
,HIST1H1C,histone modification,chromatin regulation,genome stability,cell cycle regulation,epigenetic dysregulation,tumor suppressor
ENSG00000005007,UPF1,nonsense-mediated mrna decay pathway,genome instability,premature stop codons,tumor progression,chemotherapy resistance,chromosomal alterations
ENSG00000125388,GRK4,tumor progression,constitutive activation,gain of function mutations,therapeutic target,phosphorylation regulation,g protein-coupled receptor signaling
ENSG00000093144,ECHDC1,metabolic reprogramming,cholesterol biosynthesis,cell membrane integrity,oncogenic processes,cellular proliferation,therapeutic resistance
ENSG00000166855,CLPX,ck2 regulation,tumor suppressor function,cell cycle regulation,phosphorylation inhibition,proliferation control,genomic stability maintenance
ENSG00000141867,BRD4,chromatin remodeling,transcriptional regulation,genomic instability,oncogenic transcription,cell cycle progression,apoptosis inhibition
ENSG00000110958,PTGES3,oncogene activation,prostaglandin production,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,therapeutic target
ENSG00000119950,MXI1,tumor suppression,transcriptional repression,p53 pathway regulation,cellular differentiation,cancer driver mutation,apoptosis induction
ENSG00000172232,AZU1,cellular proliferation,genome stability maintenance,dna damage response regulation,cell cycle progression modulation,tumor development facilitation,poor prognosis association
ENSG00000107859,PITX3,transcriptional regulation,oncogenesis,cell differentiation,epithelial cell regulation,tumor suppression,developmental regulation
ENSG00000105538,RASIP1,cell migration,ras protein regulation,oncogenic signaling,tumor progression,biomarker potential,cellular adhesion
ENSG00000213516,RBMXL1,alternative splicing regulation,nuclear rna-binding protein function,cellular proliferation modulation,apoptosis suppression,metastasis promotion,gene expression dysregulation
ENSG00000285301,BOP1,homologous recombination repair,genomic instability,apobec mutational signature,tumor suppressor function,dna damage response,cell cycle regulation
ENSG00000137193,PIM1,cell cycle regulation,constitutive activation,oncogenic potential,cell proliferation enhancement,angiogenesis promotion,tumor suppressor interaction
ENSG00000086504,MRPL28,cellular assembly,ribosomal subunit formation,oncogenic transformation,tumor progression,prognostic marker,translation regulation
ENSG00000281763,DHX36,genomic instability,chromosomal abnormalities,tumor suppressor function,dna repair disruption,cell cycle regulation,apoptosis modulation
ENSG00000165209,STRBP,androgen receptor activation,tumor progression,cell growth promotion,oncogene function,splicing regulation,microrna modulation
ENSG00000171560,FGA,angiogenesis promotion,tumor progression facilitation,blood vessel formation enhancement,metastasis support,coagulation pathway disruption,none
ENSG00000185515,BRCC3,dna damage response,genomic instability,homologous recombination,tumor suppression,e3 ubiquitin ligase activity,helicase function
ENSG00000174243,DDX23,dna repair,genomic instability,rna metabolism,chromatin remodeling,transcriptional regulation,double-strand break repair
ENSG00000179271,GADD45GIP1,tumor suppressor,apoptosis induction,cell cycle regulation,microtubule dynamics modulation,angiogenesis inhibition,therapeutic target
ENSG00000099875,MKNK2,mapk signaling pathway,protein kinase activation,oncogenic transformation,tumor progression,cell proliferation regulation,stress response modulation
,HIST2H2BE,histone modification,chromatin regulation,gene amplification,cancer driver,cell proliferation,transcriptional regulation
ENSG00000137270,GCM1,hypoxia response,oncogenic transcription,angiogenesis promotion,cellular metabolism regulation,therapeutic target,genomic upregulation
ENSG00000101695,RNF125,protein degradation regulation,ubiquitination pathway,oncogenic signaling,tumor progression,apoptosis inhibition,therapeutic target
ENSG00000170248,PDCD6IP,apoptosis inhibition,oncogenic function,pi3k/akt pathway interaction,tumor growth promotion,genomic mutation,elevated expression levels
ENSG00000127511,SIN3B,transcriptional regulation,chromatin remodeling,tumor suppressor gene silencing,oncogenic repression,epigenetic modification,cancer progression
ENSG00000089280,FUS,transcription regulation,chromatin remodeling,genomic instability,tumor progression,multifunctional protein,rna processing
,HIST1H1D,chromatin regulation,genomic instability,epigenetic changes,oncogenic processes,histone modification,tumor growth
ENSG00000173272,MZT2A,oncogenic function,cell cycle regulation,apoptosis inhibition,tumor growth promotion,gene expression regulation,zinc finger protein activity
ENSG00000166130,IKBIP,nf-kappa b signaling pathway,constitutive activation,overexpression,tumor progression,oncogene,genomic instability
ENSG00000169710,FASN,fatty acid biosynthesis,oncogenic transformation,lipid metabolism regulation,cell proliferation enhancement,chemotherapy resistance,poor prognosis marker
ENSG00000100109,TFIP11,tumor progression,constitutive activation,gain of function mutations,alternative splicing regulation,rna transport dysregulation,cell proliferation enhancement
ENSG00000074201,CLNS1A,mitochondrial dysfunction,hypoxia-inducible factor-alpha activation,oxidative stress induction,angiogenesis promotion,cell survival enhancement,energy metabolism regulation
ENSG00000000003,TSPAN6,tumor progression,apoptosis suppression,cell adhesion regulation,signal transduction modulation,angiogenesis promotion,oncogene interaction
ENSG00000189067,LITAF,tumor progression,tnf-alpha factor,inflammation modulation,immune response suppression,metastasis promotion,poor prognosis association
ENSG00000273594,EEF1D,translation initiation factor,tumor progression,cell proliferation,signal transduction,protein synthesis regulation,oncogenic potential
ENSG00000102030,NAA10,chromatin modification,cellular proliferation,protein acetylation,oncogenic protein regulation,tumor growth promotion,therapeutic target
ENSG00000172399,MYOZ2,transcriptional regulation,oncogene activation,cell proliferation,tumor progression,signaling pathway modulation,epithelial-to-mesenchymal transition (emt)
ENSG00000133398,MED10,wnt/β-catenin signaling pathway,elevated expression levels,oncogenic transcription factor regulation,cell proliferation promotion,transcriptional activation,prognostic marker
ENSG00000163811,WDR43,chromatin regulation,histone methylation,transcriptional regulation,oncogene role,rna processing,tumor progression
ENSG00000143321,HDGF,tumor progression,cell survival promotion,prognostic marker,signaling pathway interaction,angiogenesis enhancement,metastasis facilitation
ENSG00000180628,PCGF5,chromatin modification,cell proliferation,apoptosis inhibition,transcriptional regulation,overexpression,epigenetic regulation
ENSG00000198642,KLHL9,wnt/β-catenin pathway regulation,epithelial-to-mesenchymal transition modulation,protein degradation regulation,cell migration and invasion facilitation,tumor progression promotion,oncogenic protein stabilization
ENSG00000097033,SH3GLB1,cellular trafficking,protein degradation regulation,oncogenic potential,tumor progression,endocytosis regulation,signaling pathway involvement
ENSG00000176444,CLK2,gain of function mutations,constitutive activation,oncogenesis,cell proliferation,therapeutic target,aberrant splice variants
ENSG00000196975,ANXA4,dna repair facilitation,cell adhesion regulation,metastasis promotion,tumor progression enhancement,chemoresistance development,poor prognosis association
ENSG00000280908,PADI4,cancer-promoting effect,cell proliferation regulation,tumor progression association,protein modification enzyme,oncogenic pathway involvement,aggressive tumor behavior marker
ENSG00000125735,TNFSF14,overexpression,tumor progression,cell survival,apoptosis inhibition,angiogenesis promotion,metastasis enhancement
ENSG00000198373,WWP2,tumor suppressor function,downregulation in cancer,cell cycle regulation,apoptosis regulation,ubiquitination and protein degradation,ww domain-containing e3 ubiquitin ligase
ENSG00000137941,TTLL7,microtubule stabilization,tandem tudor domain-containing protein,chromosomal instability,mitotic spindle checkpoint disruption,apoptosis resistance,oncogenesis promoter
ENSG00000143164,DCAF6,ubiquitination pathway,cell cycle regulation,oncoprotein stabilization,transcriptional control,poor prognosis marker,metastasis regulator
ENSG00000060688,SNRNP40,altered gene expression,cancer progression,cell growth regulation,gene regulation,molecular mechanism,splicing aberration
ENSG00000143815,LBR,chromatin regulation,genome stability,epigenetic alterations,tumor suppression,cell cycle progression,histone modification
ENSG00000115289,PCGF1,epigenetic repression,histone modification,chromatin remodeling,tumor suppression,polycomb complex interaction,cancer cell proliferation
ENSG00000131473,ACLY,fatty acid metabolism,oncogenic processes,cell proliferation,apoptosis resistance,energy production,lipid synthesis
ENSG00000174996,KLC2,microtubule-based transport,overexpression in tumors,onconeuronal protein,biomarker for prognosis,poor patient outcome,abnormal localization
ENSG00000183943,PRKX,constitutive activation,tumor progression,serine/threonine kinase activity,signaling pathway modulation,cell cycle dysregulation,apoptosis suppression
ENSG00000132382,MYBBP1A,chromatin remodeling,tumor suppression,cell cycle regulation,dna repair,transcriptional regulation,mutation hotspot
ENSG00000134318,ROCK2,cellular morphology regulation,cytoskeleton dynamics modulation,apoptosis inhibition,tumor progression facilitation,protein kinase activation,gtpase activation
ENSG00000055917,PUM2,cell cycle regulation,apoptosis inhibition,metastasis promotion,rna binding protein,microrna interaction,tumor progression driver
ENSG00000107863,ARHGAP21,rho gtpase activation,cell migration promotion,tumor progression association,signaling pathway modulation,oncogenic activity promotion,prognostic marker role
ENSG00000109111,SUPT6H,**

supt6h overexpression,chromatin remodeling complex,transcriptional regulation,genomic instability,dna repair mechanism,oncogenic processes

**
ENSG00000186197,EDARADD,notch signaling pathway,cell-cell interactions disruption,oncogenic signaling activation,tumor progression driver,keratinocyte differentiation impairment,genomic instability association
ENSG00000187796,CARD9,immune regulation,c-type lectin receptor activity,innate immune response modulation,cell death regulation,proliferation influence,fungal pathogen recognition
ENSG00000170142,UBE2E1,protein modification,oncogenic interactions,cell cycle regulation,biomarker potential,metastatic potential,signaling pathway modulation
ENSG00000132334,PTPRE,tumor suppressor function,cell adhesion modulation,pi3k/akt pathway inhibition,metastatic potential regulation,prognostic marker candidate,loss of function oncogenesis
ENSG00000028839,TBPL1,chromatin regulation,dysregulated transcription,gain of function mutations,apoptosis resistance,proliferation enhancement,tumor suppressor loss
ENSG00000163904,SENP2,p53 de-sumoylation,tumor suppressor modulation,oncogenic protein activation,cell proliferation promotion,poor prognosis marker,sumoylation regulation
ENSG00000131469,RPL27,ribosomal function,cellular proliferation,anti-apoptotic activity,protein synthesis upregulation,tumor suppressor interaction,cell cycle regulation
ENSG00000167005,NUDT21,genomic instability,dna damage repair,metabolic regulation,cellular interaction,loss-of-function mutations,cancer progression
ENSG00000102098,SCML2,chromatin remodeling,transcriptional regulation,meiotic recombination,genetic instability,cancer biomarker,epigenetic modification
ENSG00000130935,NOL11,genomic instability,dna repair,tumor suppressor activity,cell cycle regulation,apoptosis modulation,transcriptional regulation
ENSG00000251322,SHANK3,regulatory role of hippo-yap pathway,cell migration and invasion enhancer,oncogenic protein-protein interactions,tumor progression and metastasis promoter,poor prognosis indicator,cancer-related gene expression dysregulation
ENSG00000108448,TRIM16L,tumor suppression,apoptosis induction,protein degradation regulation,cell growth inhibition,ubiquitin-proteasome pathway modulation,cancer metastasis suppression
ENSG00000133661,SFTPD,tumor progression,epithelial-to-mesenchymal transition (emt),inflammation regulation,angiogenesis modulation,immune response inhibition,tumor microenvironment modulation
ENSG00000125124,BBS2,ciliogenesis disruption,oncogenic signaling,cell proliferation,loss of function mutations,tumor suppressor dysfunction,ciliary trafficking regulation
ENSG00000131467,PSME3,cell cycle regulation,gene expression modulation,proteasome activation,promotes cell survival,apoptosis inhibition,genomic stability maintenance
ENSG00000183496,MEX3B,microrna regulation,tumor progression,cell proliferation,apoptosis inhibition,metastasis,aberrant expression
ENSG00000102837,OLFM4,cell adhesion disruption,oncogenic function,cell proliferation promotion,tumor progression association,metastasis facilitation,apoptosis inhibition
ENSG00000105245,NUMBL,protein stabilization,e3 ubiquitin ligase interaction,oncogene upregulation,tumor progression,cell proliferation,myristoylation pathway
ENSG00000101210,EEF1A2,enhanced protein synthesis,cap-dependent translation,cell growth promotion,tumor progression facilitation,angiogenesis modulation,metastasis enhancement
ENSG00000181163,NPM1,tumor progression,cell proliferation,genomic instability,dna repair dysfunction,protein mislocalization,oncogene activation
ENSG00000071655,MBD3,histone modification,dna methylation,transcriptional repression,tumor progression,chromatin regulation,oncogenesis
ENSG00000187778,MCRS1,glycosylphosphatidylinositol anchor remodeling,tumor growth regulation,protein modification,cell signaling disruption,metastasis promotion,oncogene dysregulation
ENSG00000164104,HMGB2,tumor progression,chromatin remodeling,transcriptional regulation,cell migration,angiogenesis,genomic instability
ENSG00000266472,MRPS21,mitochondrial biogenesis,mitochondrial translation,tumor suppressor function,oncogenic mutations,cellular metabolism regulation,tumorigenesis
ENSG00000063046,EIF4B,cap-dependent translation,oncogene activation,protein synthesis regulation,cell proliferation enhancement,angiogenesis promotion,metastasis facilitation
ENSG00000135945,REV1,genetic instability,dna damage response,oncogenic mutations,translesion synthesis,chromosomal instability,dna replication error
ENSG00000130758,MAP3K10,nf-κb signaling,tumor suppressor function loss,inflammation regulation,mapk pathway activation,jnk signaling modulation,apoptosis resistance
ENSG00000171873,ADRA1D,adrenergic signaling pathway,upregulation,oncogenic processes,cell survival,cell proliferation,prognostic marker
ENSG00000170525,PFKFB3,glycolytic regulation,constitutive activation,overexpression driven,poor prognosis,tumor proliferation,therapeutic target
ENSG00000119041,GTF3C3,transcriptional regulation,cell growth promotion,dna repair regulation,tumor progression enhancement,rna polymerase iii interaction,cell cycle modulation
ENSG00000196557,CACNA1H,calcium channel regulation,cell migration,intracellular signaling,proliferation enhancement,protein interaction modulation,therapeutic resistance
ENSG00000100941,PNN,tumor microenvironment modulation,cellular communication disruption,ion channel regulation,protein-protein interaction,cell death signaling enhancement,pi3k/akt pathway involvement
ENSG00000198363,ASPH,cellular proliferation,growth regulation,tumor suppression loss,genomic amplification,protein interaction,pi3k/akt/mtor pathway activation
,ASNA1,mitochondrial function,dysregulation of cell cycle,amplification in cancer,tumor cell metabolism,cellular energy production,apoptosis regulation
ENSG00000096063,SRPK1,alternative splicing regulation,cancer-related gene expression,cell proliferation enhancement,oncogenic protein interactions,phosphorylation-dependent activation,tumor aggressiveness promotion
ENSG00000104081,BMF,tumor progression,tgf-beta signaling pathway,epithelial-to-mesenchymal transition (emt),oncogenic potential,growth factor regulation,cancer stem cell maintenance
ENSG00000139921,TMX1,epigenetic regulation,cell proliferation,tumor growth,prognostic biomarker,transcriptional regulation,chromatin remodeling
,HIST1H2BM,histone modification,chromatin remodeling,tumor progression,dna repair mechanisms,epigenetic regulation,cell proliferation
ENSG00000115484,CCT4,cell cycle regulation,dna repair deficiency,oncogene overexpression,chaperone activity,cell proliferation enhancement,proliferation regulation
ENSG00000112365,ZBTB24,tumor suppressor function,loss of function mutations,cell cycle regulation,chromatin remodeling,gene repression,dna repair disruption
ENSG00000131876,SNRPA1,rna splicing dysregulation,smn complex dysfunction,oncogenic mutations,altered telomerase activity,cell immortalization,therapeutic target
ENSG00000149452,SLC22A8,ion transport,drug efflux,cellular uptake,transcriptional regulation,therapeutic target,protein interaction
ENSG00000107957,SH3PXD2A,endocytic pathway regulation,phosphoinositide binding,cell surface receptor downregulation,tumor progression,oncogenic signaling,transmembrane receptor internalization
ENSG00000215474,SKOR2,wnt/β-catenin pathway modulation,angiogenesis promotion,oncogenic transformation,tumor progression enhancement,signaling pathway regulation,cell growth modulation
ENSG00000160224,AIRE,tumor antigen presentation,autoimmune regulator gene regulation,immune tolerance modulation,tumor suppressor function,cancer-specific antigen expression,immune evasion
ENSG00000134371,CDC73,transcriptional regulation,oncogene activation,dna damage response,cell proliferation,tumor suppressor dysfunction,protein-protein interactions
ENSG00000135521,LTV1,t-box transcription factor,cell growth regulation,transcriptional regulation,oncogenic pathway involvement,poor prognosis marker,pi3k/akt pathway interaction
ENSG00000062038,CDH3,cell adhesion disruption,tumor progression,metastasis promoter,oncogenic transformation,gene expression modulation,therapeutic target
ENSG00000168763,CNNM3,mitochondrial function,metabolic regulation,tumor suppressor,reactive oxygen species production,glycolytic shift,cellular metabolism
ENSG00000149792,MRPL49,mitochondrial translation regulation,loss of mitochondrial function,cancer metabolism reprogramming,cellular growth modulation,glycolysis enhancement,therapeutic target candidate
ENSG00000010030,ETV7,etv7 overexpression,cell proliferation,tumor progression,amplification event,transcriptional regulation,prognostic marker
ENSG00000179639,FCER1A,immunomodulation,signaling pathway regulation,tumor growth modulation,gene expression alteration,therapeutic response modification,protein structure changes
ENSG00000244537,KRTAP4-2,**
keratin intermediate filaments,tumor suppressor or oncogene,cellular differentiation and proliferation,cancer cell morphology regulation,apoptosis regulation,epithelial cell integrity maintenance
**
ENSG00000185650,ZFP36L1,regulation of mrna stability,oncogenic regulation,cell survival,apoptosis inhibition,microrna regulation,tumor growth promotion
ENSG00000151702,FLI1,fli1 transcription factor,overexpression,epithelial-to-mesenchymal transition,cellular proliferation,transcriptional regulation,oncogenic signaling
ENSG00000079277,MKNK1,tumor progression,mutation-driven oncogene,mapk pathway regulation,cell proliferation,amplification/overexpression,prognostic marker
ENSG00000159023,EPB41,cell adhesion disruption,tumor progression,oncogenic potential,prognostic biomarker,cellular migration regulation,pi3k/akt pathway interaction
ENSG00000047579,DTNBP1,autophagy modulation,cancer progression driver,dystrophin-glycoprotein complex regulation,protein degradation pathway interaction,renal cell growth promotion,tumor survival enhancement
ENSG00000161970,RPL26,ribosome assembly,overexpression,cell growth regulation,proliferation enhancement,translation initiation,protein synthesis regulation
ENSG00000108669,CYTH1,tumor progression,purine metabolism regulation,mtor signaling pathway activation,cell proliferation enhancement,angiogenesis promotion,protein-protein interaction
ENSG00000129245,FXR2,alternative splicing regulation,oncogenic potential,cell proliferation modulation,rna export regulation,tumor progression influence,genetic mutation association
ENSG00000184363,PKP3,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression driver,prognostic marker candidate,cancer cell migration facilitator,signaling pathway regulator
ENSG00000120437,ACAT2,lipid biosynthesis regulation,cholesterol accumulation,tumor metastasis promotion,cell membrane integrity,mtor pathway interaction,genetic alterations leading to oncogenic processes
ENSG00000075785,RAB7A,autophagic regulation,oncogenic transformation,constitutive activation,tumor progression,receptor tyrosine kinase interaction,lysosomal formation
ENSG00000108064,TFAM,metabolic reprogramming,mitochondrial dysfunction,loss of tumor suppressor activity,cancer cell metabolism,dna replication disruption,cellular respiration impairment
ENSG00000007392,LUC7L,genomic instability,gene expression regulation,oncogenic processes,tumor progression,dna repair mechanisms,pi3k/akt pathway interaction
ENSG00000133243,BTBD2,apoptosis regulation,cell cycle control,tumor suppression,oncogenic pathway activation,genomic instability,chromatin remodeling
ENSG00000143622,RIT1,constitutive activation,ras-like gtpase activity,cell proliferation promotion,oncogenic signaling pathway regulation,genetic alterations involvement,tumor suppression interaction
ENSG00000133835,HSD17B4,steroid hormone metabolism,dysregulated expression,tumor progression,chemo-resistance,proliferation signaling,oncogenic function
ENSG00000148335,NTMT1,lysine modification,epigenetic regulation,chromatin remodeling,cancer driver,transcriptional regulation,protein function regulation
ENSG00000106397,PLOD3,tumor progression,extracellular matrix modulation,cell adhesion disruption,metastasis promotion,oncogenic expression,collagen cross-linking
ENSG00000088205,DDX18,enhanced cell proliferation,oncogenic driver,genomic instability,dna damage repair disruption,therapeutic target,overexpression
ENSG00000089818,NECAP1,endocytic trafficking,aberrant activation,regulation of cell growth,modulation of cellular responses,cell surface receptor signaling,necl-5 interaction
ENSG00000156697,UTP14A,spliceosome regulation,pre-mrna processing,nucleocytoplasmic transport,gene expression regulation,protein-protein interaction,cell cycle progression
ENSG00000130255,RPL36,ribosomal function,protein synthesis regulation,cell proliferation enhancement,tumor progression association,p53 interaction,transcriptional regulation
ENSG00000164675,IQUB,tumor progression,cell cycle regulation,apoptosis inhibition,mitotic checkpoint control,dna damage response,prognostic marker
ENSG00000138443,ABI2,tumor progression,cellular invasiveness,cell adhesion regulation,prognostic marker,src kinase interaction,oncogenic signaling
ENSG00000112282,MED23,enhanced transcriptional activity,transcriptional regulation,cell proliferation,oncogenic potential,overexpression,protein-protein interactions
ENSG00000243943,ZNF512,chromatin remodeling,tumor progression,oncogene function,transcriptional regulation,dna binding activity,zinc finger domains
ENSG00000122180,MYOG,oncogene,tumor progression,cell proliferation,promoter hypermethylation,transcriptional regulation,metastasis
ENSG00000140463,BBS4,cancer driver,genetic instability,aberrant cell signaling,cell proliferation regulation,cilia structure maintenance,protein-protein interaction
ENSG00000167306,MYO5B,oncogenic function,gain of function mutations,enhanced cell proliferation,cell migration and invasion,pi3k/akt pathway activation,therapeutic target
ENSG00000105501,SIGLEC5,cell migration,angiogenesis promotion,immune evasion,tumor progression,cell invasion,signaling pathway modulation
ENSG00000198646,NCOA6,hypoxia-inducible factor-alpha regulation,oncogenic coactivation,cell cycle progression,apoptosis inhibition,transcriptional dysregulation,chromatin remodeling
ENSG00000231370,PRRC2A,cellular signaling,cytoskeleton dynamics,metastasis promotion,tumor progression,cell migration facilitation,protein kinase activation
ENSG00000081277,PKP1,desmosomal complex regulation,cell-cell adhesion disruption,epithelial-to-mesenchymal transition inhibition,wnt/β-catenin signaling pathway interaction,immunotherapy target,tumor aggressiveness enhancement
ENSG00000145908,ZNF300,cellular regulation,tumor suppressor activity,transcriptional modulation,proliferation regulation,apoptosis modulation,clinical relevance
ENSG00000169020,ATP5ME,mitochondrial energy production,oxidative phosphorylation,energy metabolism alterations,tumor growth promotion,cell proliferation enhancement,poor prognosis marker
ENSG00000125484,GTF3C4,gtf3c/gtf2f transcriptional complex formation,tumor-promoting activity,cell proliferation enhancement,dna repair pathway interaction,apoptosis evasion facilitation,transcriptional regulation disruption
ENSG00000128951,DUT,dna damage response,genetic instability,nucleotide metabolism,therapeutic target,cell proliferation regulation,oncogenesis
ENSG00000185532,PRKG1,cell proliferation regulation,protein kinase activation,tumor progression modulation,cancer cell migration promotion,angiogenesis facilitation,genomic instability induction
ENSG00000141385,AFG3L2,protein degradation regulation,tumorigenesis driver,mutation hotspot,cellular clearance mechanism,autophagy regulation,ubiquitin-proteasome system interaction
ENSG00000169045,HNRNPH1,pre-mrna splicing regulation,oncogene activation,tumor metastasis,apoptosis inhibition,cell cycle progression,protein-protein interaction
ENSG00000177600,RPLP2,ribosomal function,translation initiation,cellular proliferation,metabolic regulation,oncogenic mrnas stability,cancer cell survival
ENSG00000067715,SYT1,chromatin remodeling,metabolic reprogramming,cellular glucose uptake,glycolysis regulation,histone modification,cell cycle progression
ENSG00000273761,DDX24,cellular proliferation,tumor progression,transcriptional regulation,mrna stability,epigenetic modification,chromatin remodeling
ENSG00000143226,FCGR2A,immune evasion,tumor progression,antibody-dependent cellular cytotoxicity,immunosuppression,fc receptor function,none
ENSG00000110876,SELPLG,angiogenesis promotion,prognostic marker,tumor progression,metastasis facilitation,vascular remodeling,cancer aggressiveness
ENSG00000143442,POGZ,chromatin remodeling,oncogenic function,epigenetic alterations,gene expression regulation,dna repair disruption,genomic instability
ENSG00000100600,LGMN,chromatin remodeling,tumor suppressor function,cell cycle regulation,nuclear morphology,genomic instability,protein-protein interaction
ENSG00000154556,SORBS2,cell migration,actin cytoskeleton regulation,metastasis promotion,tumor progression facilitation,emt regulation,oncogene activation
ENSG00000109171,SLAIN2,mitotic spindle formation,cellular proliferation,chromosome segregation,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000130956,HABP4,hyaluronic acid binding,cell adhesion modulation,oncogenic processes promotion,tumor progression facilitation,pi3k/akt signaling pathway modulation,poor prognosis indicator
ENSG00000123700,KCNJ2,increased potassium flow,regulation of cell proliferation,enhanced electrical excitability,cell survival promotion,therapeutic target,ion channel function
ENSG00000115268,RPS15,mtor pathway regulation,protein synthesis regulation,tumor progression,poor prognosis marker,cellular response modulation,oncogenic function
ENSG00000183495,EP400,chromatin remodeling,dna damage response,cell proliferation,cancer progression,therapeutic target,epigenetic regulation
ENSG00000057608,GDI2,altered expression,cell migration regulation,cell metabolism regulation,cytoskeletal organization,gtpase regulation,oncogenic transformation
ENSG00000094880,CDC23,cell cycle regulation,aneuploidy,genomic instability,mitotic checkpoint,chromosome segregation,genetic instability
ENSG00000073350,LLGL2,cell polarity disruption,oncogenic transformation,cell-cell adhesion loss,emt induction,metastasis promotion,therapeutic target
ENSG00000096433,ITPR3,regulation of calcium signaling,cell proliferation,tumor progression,oncogenic potential,cytoplasmic ca2+ regulation,cancer cell survival
ENSG00000137815,RTF1,aberrant gene expression,alternative pre-mrna splicing,cancer metastasis,cellular proliferation,constitutive activation,epithelial-to-mesenchymal transition (emt) program
ENSG00000050130,JKAMP,cell migration,prognostic marker,tumor progression,metastasis driver,oncogenic signaling,transmembrane protein
ENSG00000182952,HMGN4,chromatin regulation,tumor progression,oncogenic function,cell cycle modulation,gene expression regulation,prognostic biomarker
ENSG00000164134,NAA15,ribosomal biogenesis,cell growth promotion,tumorigenesis association,oncogenic function,cell proliferation enhancement,prognostic marker
ENSG00000244234,GMCL2,cell cycle regulation,apoptosis modulation,tumor growth promotion,oncogenic interaction,pi3k/akt pathway activation,dna repair modulation
ENSG00000103569,AQP9,glycerol transport,tumor progression,biomarker candidate,angiogenesis,cell migration,metabolic regulation
ENSG00000134001,EIF2S1,inhibition of apoptosis,integrated stress response (isr) pathway,cell proliferation promotion,protein synthesis regulation,cancer cell survival enhancement,tumor progression facilitation
ENSG00000117707,PROX1,wnt/β-catenin pathway regulation,transcriptional repression,tumor suppressor function,cell cycle arrest,proliferation inhibition,differentiation maintenance
ENSG00000124198,ARFGEF2,adp-ribosylation factor gtpases activation,cellular trafficking regulation,gef activity,membrane trafficking modulation,pi3k/akt pathway activation,tumor cell survival promotion
ENSG00000121211,MND1,mitotic checkpoint regulation,genomic stability maintenance,chromosome segregation,aneuploidy prevention,tumor progression,cancer genomics
ENSG00000123562,MORF4L2,transcriptional coactivation,gene expression regulation,oncogenic process promotion,cell cycle progression,dna repair pathway upregulation,anti-apoptotic signaling enhancement
ENSG00000108395,TRIM37,histone modification,chromatin remodeling,cell cycle regulation,tumor suppressor repression,genomic instability,protein degradation
ENSG00000116750,UCHL5,cell cycle regulation,apoptosis inhibition,tumor progression,deubiquitinating enzyme activity,mdm2 stabilization,p53 pathway disruption
ENSG00000170144,HNRNPA3,transcriptional regulation,protein-protein interaction,cell proliferation,metastasis promotion,tumor growth facilitation,biomarker potential
ENSG00000106305,AIMP2,ribosome assembly regulation,translation initiation regulation,pi3k/akt pathway interaction,genomic instability promotion,oncogene overexpression,dna repair mechanism interaction
ENSG00000138398,PPIG,cell signaling disruption,glutamine metabolism dysregulation,oncogenic behavior promotion,protein-protein interaction regulation,tumorigenesis contribution,ubiquitin-dependent proteolysis modulation
ENSG00000152936,LMNTD1,epigenetic regulation,chromatin remodeling,histone methylation,tumor suppressor silencing,oncogene activation,genomic instability
ENSG00000196408,NOXO1,ros generation,oxidative stress response,cell proliferation,tumor growth,therapeutic target,cancer progression
ENSG00000182196,ARL6IP4,endosomal trafficking,tumor suppressor,gene expression regulation,signaling pathway modulation,cancer progression,cellular homeostasis disruption
ENSG00000153207,AHCTF1,cell proliferation regulation,transcription factor activity,tumor progression facilitation,dna replication and repair modulation,apoptosis suppression,cancer cell growth promotion
ENSG00000128487,SPECC1,cell cycle progression,dna replication,genomic stability,oncogenic properties,angiogenesis promotion,cell signaling pathway interaction
ENSG00000079819,EPB41L2,signaling pathway regulation,oncogenic potential,metastasis promotion,cell adhesion disruption,tumor progression facilitation,pro-survival signaling
ENSG00000175634,RPS6KB2,mtor pathway regulation,protein synthesis activation,cell proliferation promotion,autophagy suppression,phosphorylation activity enhancement,tumor growth acceleration
ENSG00000285317,DNAJC8,protein misfolding,cellular stress response,apoptosis regulation,cancer progression,protein degradation regulation,therapeutic target
ENSG00000172465,TCEAL1,apoptosis regulation,transcriptional modulation,cell proliferation,cell cycle progression,tumor suppressor interaction,oncogenic transformation
ENSG00000105364,MRPL4,mitochondrial ribosome biogenesis,oncogene overexpression,enhanced energy metabolism,cell proliferation promotion,protein synthesis regulation,therapeutic target identification
ENSG00000139154,AEBP2,oncogene,transcriptional coactivator,cell proliferation enhancement,tumor progression facilitation,pi3k/akt pathway regulation,chromatin remodeling complex interaction
ENSG00000196547,MAN2A2,protein glycosylation regulation,tumor growth promotion,aberrant expression,cell survival enhancement,metastasis facilitation,tumor progression acceleration
ENSG00000148925,BTBD10,transcriptional regulation,tumor suppressor function,chromatin remodeling,cell cycle regulation,apoptosis regulation,dna repair mechanism
ENSG00000114416,FXR1,alternative splicing,apoptosis suppression,cell proliferation,gene expression modulation,nuclear localization,rna binding protein
ENSG00000112232,KHDRBS2,alternative splicing regulation,oncogenesis promotion,pi3k/akt pathway modulation,cell proliferation enhancement,pro-survival gene expression,cancer driver gene
ENSG00000158615,PPP1R15B,**

stress granule formation,unfolded protein response regulation,cell survival promotion,protein phosphatase 1 regulation,endoplasmic reticulum stress modulation,tumor-promoting adaptation 

**
ENSG00000143819,EPHX1,tumor progression,lipid metabolism modulation,redox balance regulation,cell proliferation enhancement,angiogenesis promotion,therapeutic target
ENSG00000126522,ASL,gag degradation,tumor microenvironment modification,glycosaminoglycan regulation,cell growth promotion,cancer progression modulation,enzyme deficiency symptoms
ENSG00000197958,RPL12,ribosome biogenesis,aberrant protein synthesis,oncogenic overexpression,tumor progression,cell proliferation,genomic instability
ENSG00000142676,RPL11,ribosomal protein regulation,tumor suppressor function,cell proliferation regulation,cancer cell metabolism modulation,translation initiation complex interaction,oncogene regulator
ENSG00000135604,STX11,mtor pathway regulation,tumor progression,membrane fusion regulation,cellular homeostasis disruption,vesicle trafficking alteration,oncogenic potential
ENSG00000112079,STK38,genomic instability,pi3k/akt pathway interaction,cell proliferation regulation,apoptosis modulation,dna repair mechanism,oncogene overexpression
ENSG00000144597,EAF1,genomic instability,aberrant protein function,chromosomal instability,oncogenic transformation,cell cycle dysregulation,tumor suppressor disruption
ENSG00000168939,SPRY3,tumor suppressor function,negative regulation of rtks,downregulation in cancer cells,cell survival inhibition,apoptosis promotion,mapk pathway modulation
ENSG00000138594,TMOD3,cell motility regulation,actin filament length control,cell invasion promotion,tumor progression,prognostic marker,cancer cell metastasis
ENSG00000063245,EPN1,cell surface adhesion,gene expression regulation,integrin-mediated signaling,actin cytoskeleton reorganization,prognostic biomarker,tumor progression mediator
ENSG00000182247,UBE2E2,ubiquitin-conjugating enzyme activity,oncogene activation,cell proliferation enhancement,tumor progression driver,protein degradation deregulation,therapeutic target
ENSG00000161542,PRPSAP1,purine biosynthesis regulation,oncogene function,nucleotide synthesis modulation,cell cycle progression regulation,dna replication regulation,metabolic reprogramming
ENSG00000249709,ZNF564,oncogenic transcriptional regulation,chromatin remodeling complex interaction,histone modification,gene expression suppression,cell cycle regulation,apoptosis regulation
ENSG00000187766,KRTAP10-8,protein misregulation,cellular differentiation disruption,oncogenic potential,tumor progression association,epithelial-to-mesenchymal transition-like behavior,kap family member expression
ENSG00000111249,CUX2,transcription factor activity,cell cycle regulation,tumor progression,oncogene activation,epithelial-to-mesenchymal transition (emt),constitutive activation
ENSG00000198945,L3MBTL3,tumor suppressor function,epigenetic regulation,chromatin remodeling,apoptosis induction,cell cycle arrest,histone modification
ENSG00000165731,RET,aberrant expression,oncogenic driver,mapk/erk signaling,cell proliferation,tumor invasion,therapeutic target
ENSG00000124191,TOX2,tumor suppressor regulation,epithelial-to-mesenchymal transition (emt),cell proliferation suppression,apoptosis inhibition,oncogene activation,cancer cell migration
ENSG00000143569,UBAP2L,autophagic regulation,endosomal trafficking,lipid metabolism regulation,cellular homeostasis maintenance,protein interaction modulation,cancer progression facilitation
ENSG00000101811,CSTF2,tumor suppressor downregulation,gene expression regulation,cell proliferation promotion,angiogenesis facilitation,oncogenic process enhancement,pro-tumorigenic factor upregulation
ENSG00000126016,AMOT,loss of function mutations,tumor suppressor activity,cell polarity regulation,adhesion molecule disruption,prognostic biomarker,rho gtpase modulation
ENSG00000148843,PDCD11,apoptosis regulation,tumor suppressor function,autophagic regulation,cell survival promotion,mitochondrial pathway disruption,protein-protein interaction
ENSG00000100842,EFS,mrna translation regulation,cell cycle progression,protein synthesis enhancement,tumor aggressiveness,proliferation factor,genomic instability
ENSG00000170819,BFSP2,epithelial cell junction maintenance,cell migration promotion,pi3k/akt pathway interaction,wnt/β-catenin pathway interaction,tumor metastasis facilitation,cancer progression marker
ENSG00000111077,TNS2,tumor aggressiveness,epithelial-to-mesenchymal transition,cell adhesion modulation,reduced expression,cancer metastasis,adherens junction regulation
ENSG00000168301,KCTD6,tumor suppressor regulation,oncogenic mutations,apoptosis inhibition,cell cycle progression,btb/poz domain interaction,transcriptional regulation
ENSG00000145919,BOD1,dna damage response,cell cycle regulation,circadian rhythm disruption,apoptosis modulation,tumor progression,prognostic marker
ENSG00000163159,VPS72,cytosolic protein accumulation,cellular sorting dysregulation,tumor progression pathway modulation,oncogenic process contribution,therapeutic target potential,cytoskeletal structure impact
ENSG00000143153,ATP1B1,na+/k+-atpase activity,sodium-potassium imbalance,tumor aggressiveness,cell migration and invasion,angiogenesis promotion,immune evasion mechanism
ENSG00000101343,CRNKL1,adapter molecule function,signaling pathway regulation,cell growth modulation,proliferation promotion,survival enhancement,cell differentiation
ENSG00000163823,CCR1,immune suppression,tumor microenvironment,chemokine signaling,cancer metastasis,tumor growth,angiogenesis
ENSG00000102007,PLP2,pro-tumorigenic mediator,regulation of phospholipid metabolism,pi3k/akt signaling pathway interaction,inflammation and angiogenesis,cell membrane dynamics regulation,lipid metabolism alteration
ENSG00000166848,TERF2IP,telomere maintenance,genomic instability,apoptosis regulation,cancer driver gene,senescence regulation,dna repair interaction
ENSG00000185619,PCGF3,histone h2a ubiquitination,polycomb repressive complex 1 (prc1),tumor suppressor gene repression,cell proliferation,metastasis,chromatin compaction
ENSG00000140416,TPM1,microtubule dynamics,cell migration,tumor progression,prognostic marker,cellular process regulation,cytoskeletal organization
ENSG00000157110,RBPMS,alternative splicing regulation,oncogene function,cell proliferation enhancement,rna processing modulation,tumor progression promotion,genomic instability induction
ENSG00000148303,RPL7A,ribosomal function,oncogenic transformation,overexpression in cancer,protein synthesis regulation,cell growth promotion,tumor aggressiveness association
ENSG00000129354,AP1M2,immunomodulation,immune evasion,tumor progression,metastasis,cell surface protein regulation,lysosomal trafficking
ENSG00000124422,USP22,cellular proliferation,epigenetic regulation,chromatin remodeling,deubiquitination,dna damage response,transcriptional activation
ENSG00000123415,SMUG1,genomic integrity maintenance,base excision repair,dna damage repair,methylpurine removal,genome stability regulation,potential oncogenic role
ENSG00000018510,AGPS,mitochondrial function,altered metabolic regulation,tumor progression,cell proliferation,oncogenic signaling pathway,dysregulated protein interactions
ENSG00000135413,LACRT,glycolysis regulation,metabolic reprogramming,angiogenesis promotion,immune evasion mechanism,tumor progression driver,cancer cell metabolism
ENSG00000182255,KCNA4,emt regulation,pi3k/akt pathway interaction,oncogenic potential,cell proliferation promotion,tumor progression facilitation,therapeutic target status
ENSG00000099381,SETD1A,epigenetic regulation,chromatin remodeling,gene expression modulation,histone methylation,oncogenic process,cellular proliferation
ENSG00000197879,MYO1C,overexpression,actin cytoskeleton interaction,tumor progression,metastasis facilitation,therapeutic target,signaling pathway regulation
ENSG00000161634,DCD,proteasomal degradation,ubiquitination pathway,oncogenic function,tumor growth promotion,cell cycle progression,transcription regulation
ENSG00000070081,NUCB2,immune microenvironment modulation,tumor progression,cell signaling regulation,gene expression dysregulation,angiogenesis facilitation,cancer biomarker
ENSG00000211455,STK38L,genomic instability,dna damage response,cell cycle regulation,centrosome separation,tumor suppressor function,kinase activation
ENSG00000149599,DUSP15,dephosphorylation regulation,mapk signaling pathway,tumor progression,apoptosis evasion,cellular proliferation enhancement,prognostic marker
ENSG00000262814,MRPL12,mitochondrial ribosome function,glycolytic reprogramming,mitochondrial dynamics alterations,cellular proliferation promotion,tumor aggressiveness enhancement,oncogenic potential contribution
ENSG00000155508,CNOT8,tumor progression,aberrant expression,microrna regulation,cancer development,cell survival,promoter methylation
ENSG00000239886,KRTAP9-2,cellular proliferation,keratin filament integrity,tumor progression,cancer biology involvement,cellular differentiation,unknown oncogenic mechanisms
ENSG00000107175,CREB3,regulatory function,transcriptional regulation,lipid metabolism,protein folding,cell survival,proliferation regulation
ENSG00000103264,FBXO31,proteasomal degradation,cell cycle regulation,dna damage response,tumor progression,ubiquitination,oncoprotein accumulation
ENSG00000277936,MRPL45,tumor suppression,mitochondrial dysfunction,impaired protein synthesis,cellular stress response,genomic instability,loss of function mutations
ENSG00000240682,ISY1,rna processing alteration,cancer biomarker,cell proliferation enhancer,poor prognosis indicator,tumor suppressor dysregulation,apoptosis inhibitor
ENSG00000086065,CHMP5,chmp5,constitutive activation,oncogene,biomarker,downstream targets,cellular processes
ENSG00000116752,BCAS2,er-alpha regulation,cancer biomarker,gene expression upregulation,oncogenic process promoter,cell growth regulator,molecular interaction partner
ENSG00000130159,ECSIT,chromatin remodeling,epigenetic regulation,tumor suppressor function,dna repair mechanism,gene expression regulation,oncogene activity
ENSG00000182872,RBM10,alternative splicing,transcriptional regulation,promotes tumorigenesis,regulates cell cycle,oncogene overexpression,apoptosis inhibition
ENSG00000137077,CCL21,angiogenesis promotion,cancer cell migration,chemotaxis regulation,immune evasion mechanism,lymph node homing,tumor microenvironment modulation
ENSG00000143337,TOR1AIP1,regulation of mtor signaling,tumor suppressor function,constitutive activation of mtor,cell growth inhibition,protein translation regulation,genetic alterations leading to loss of expression
ENSG00000198873,GRK5,cell signaling regulation,g protein-coupled receptor kinase function,promotes tumor progression,regulates egfr activity,interacts with pi3k/akt pathway,enhances cell migration
ENSG00000006638,TBXA2R,vascular remodeling,tumor angiogenesis,prognostic marker,g-protein coupled receptor,oncogenic properties,angiogenesis promotion
,H1F0,histone modification,chromatin architecture,cell cycle progression,apoptosis regulation,epigenetic regulation,biomarker potential
,SEPT5,pi3k/akt signaling pathway modulation,cell proliferation enhancement,oncogenic role identification,cellular survival promotion,cancer progression facilitation,tumor suppressor function unclear
ENSG00000182899,RPL35A,ribosome assembly,cell proliferation,protein synthesis regulation,tumor progression,increased expression levels,oncogenic activity
ENSG00000085872,CHERP,apoptosis regulation,genomic instability,homologous recombination,non-homologous end joining,tumor suppression,dna damage response
ENSG00000069011,PITX1,gain-of-function mutations,tumor progression,cell proliferation,apoptosis evasion,transcriptional regulation,angiogenesis
ENSG00000187164,SHTN1,mitochondrial dynamics regulation,metabolic reprogramming,glycolytic shift,hypoxia adaptation,protein-protein interaction,tumor progression
ENSG00000090432,MUL1,mitochondrial homeostasis,oncogenic protein degradation,tumor progression inhibition,apoptosis induction,predictive biomarker,cellular stress response
ENSG00000155256,ZFYVE27,aberrant lipid metabolism,autophagy regulation,cell proliferation enhancement,endosomal trafficking dysregulation,oncogenic potential,prognostic biomarker
ENSG00000136167,LCP1,hypoxia response,cell proliferation regulation,protein-lipid interaction,tumor progression modulation,angiogenesis inhibition,gene expression regulation
ENSG00000176619,LMNB2,nuclear lamina protein regulation,dna replication and repair,chromatin organization and remodeling,histone modification and gene expression,cellular proliferation and invasion,genomic instability and epigenetic alterations
ENSG00000072121,ZFYVE26,genomic instability,oncogenic transformation,autophagy pathway regulation,driver gene candidate,cell survival enhancement,tumor progression promotion
ENSG00000197757,HOXC6,oncogene,transcription factor regulation,tumor progression,metastasis promotion,emt activation,chromatin modification
ENSG00000103202,NME4,nucleotide phosphorylation,cell survival regulation,tumorigenesis association,energy metabolism regulation,chemoresistance modulation,apoptosis regulation
ENSG00000117601,SERPINC1,angiogenesis inhibition,coagulation regulation,dual role in tumor progression,heparan sulfate proteoglycans interaction,metastasis suppression,tumor microenvironment modulation
ENSG00000138796,HADH,mitochondrial function,fatty acid metabolism,cellular energy production,therapeutic target,tumor progression,metabolic regulation
ENSG00000182117,NOP10,cellular proliferation,genomic instability,small nucleolar rna processing,ribosomal biogenesis regulation,apoptosis modulation,dna repair interactions
ENSG00000142949,PTPRF,oncogene activation,cell adhesion modulation,signaling pathway regulation,tumor progression promotion,genomic amplification,poor prognosis marker
ENSG00000095794,CREM,regulatory element binding,oncogene activation,cell cycle progression,apoptosis inhibition,transcription factor interaction,metastasis regulation
ENSG00000055950,MRPL43,mitochondrial ribosome assembly,tumor suppressor loss,cell proliferation enhancement,genomic amplification,protein-protein interaction,oncogene activation
ENSG00000004864,SLC25A13,mitochondrial dysfunction,energy metabolism dysregulation,cellular proliferation enhancement,oxidative phosphorylation modulation,tumor progression facilitation,therapeutic target
ENSG00000281244,ADAMTS13,thrombotic microangiopathy,pancreatic cancer,protein cleavage regulation,glycoprotein binding,metastasis promoter,tumor suppressor activity
ENSG00000102921,N4BP1,apoptosis regulation,oncogene,overexpression,tumor progression,cell survival,prognostic marker
ENSG00000112530,PACRG,genomic instability,cell proliferation,apoptosis resistance,tumor progression,oncogene interaction,protein overexpression
ENSG00000109534,GAR1,nucleosome assembly,epigenetic alterations,chromatin dynamics,cell cycle progression,genomic instability,dna replication
ENSG00000145920,CPLX2,oncogenic expression,tumor aggressiveness,cell migration regulation,rho gtpase modulation,synaptic vesicle fusion regulation,tumor microenvironment modulation
ENSG00000115241,PPM1G,cellular dephosphorylation,constitutive pathway activation,tumor aggressiveness,signaling pathway dysregulation,oncogene regulation,protein kinase modulation
ENSG00000104381,GDAP1,mitochondrial function,microtubule dynamics,cell growth regulation,oncogenic mutations,axonal integrity maintenance,signaling pathway interaction
,HIST1H1E,histone modification,chromatin structure,epigenetic regulation,tumor progression,transcriptional control,gene expression
ENSG00000112096,SOD2,mitochondrial dysfunction,antioxidant defense mechanism,oxidative stress response,redox balance regulation,cancer cell metabolism,cellular antioxidant pathways
ENSG00000229524,BAG6,erad regulation,mutations associated,protein quality control,tumor suppressor degradation,cellular stress response,apoptosis resistance
,TARS,trna biosynthesis,overexpression,translation regulation,protein synthesis enhancement,cancer driver gene,cell proliferation promotion
ENSG00000112305,SMAP1,erad dysfunction,proteostasis disruption,cell proliferation,oncogene,tumor progression,therapeutic target
ENSG00000148908,RGS10,g-protein coupled receptor signaling,tumor suppressor function,cell proliferation regulation,oncogenic process modulation,cell migration inhibition,downregulated expression
ENSG00000142875,PRKACB,pka regulation,gain of function mutations,cell proliferation,glucose metabolism,tumor progression,therapeutic target
ENSG00000165512,ZNF22,zinc finger domain,transcriptional regulation,oncogene/tumor suppressor,cell growth differentiation,apoptosis regulation,dna-binding activity
ENSG00000065183,WDR3,cellular regulation,microtubule dynamics,transcriptional regulation,ubiquitination-mediated proteolysis,cancer progression,dna damage response
ENSG00000119314,PTBP3,alternative splicing regulation,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,protein kinase activation modulation,genomic instability induction
ENSG00000152217,SETBP1,h4k20 methylation pathway,oncogenic function,transcriptional coactivator,cell proliferation,tumor progression,angiogenesis and metastasis
ENSG00000131652,THOC6,transcriptional regulation,oncogene upregulation,cell proliferation,metastasis promotion,prognostic biomarker,protein-rna interactions
ENSG00000129159,KCNC1,voltage-gated potassium channel,oncogene,overexpressed in cancer,cell cycle regulation,apoptosis inhibition,neuronal differentiation
ENSG00000166407,LMO1,lymphoid development,t-cell activation,oncogene function,cell proliferation,apoptosis evasion,cancer stem cell formation
ENSG00000106080,FKBP14,oncogene,tumor progression,apoptosis inhibition,cellular stress response,protein folding regulation,angiogenesis promotion
ENSG00000145491,ROPN1L,rho gtpase pathway,constitutive activation,tumor progression,cell survival,cell migration,poor prognosis
ENSG00000180353,HCLS1,tumor suppressor function,pi3k/akt pathway regulation,apoptosis regulation,cell cycle progression,chromatin remodeling,histone modification
ENSG00000048462,TNFRSF17,tumor promotion,immune evasion,cell proliferation,inflammation regulation,poor prognosis marker,cancer progression
ENSG00000110713,NUP98,nuclear pore complex regulation,cell proliferation,gene amplification,chromosomal translocation,protein-protein interactions,therapeutic target
ENSG00000168062,BATF2,epithelial-to-mesenchymal transition (emt),oncogene,transcription factor activation,stemness,inflammation signaling,poor prognosis
ENSG00000171863,RPS7,ribosomal protein dysregulation,tumor progression,cell proliferation,signaling pathway activation,protein synthesis enhancement,cancer cell metabolism modulation
ENSG00000136155,SCEL,keratin-associated protein regulation,apoptosis regulation,cell proliferation promotion,tumor growth promotion,cell cycle regulation,mitochondrial membrane interaction
ENSG00000159166,LAD1,cell surface adhesion,epithelial-to-mesenchymal transition,signaling pathway modulation,prognostic biomarker,cancer cell invasion,therapeutic target
ENSG00000004139,SARM1,apoptosis regulation,dna damage response,mitochondrial dysfunction,necroptosis regulation,oncogenic driver,stress response modulation
ENSG00000138081,FBXO11,cell cycle regulation,genomic instability,tumor suppressor,haploinsufficiency,protein degradation,signaling pathway disruption
ENSG00000112983,BRD8,bet family interaction,chromatin remodeling,apoptosis evasion,oncogenic transcription,cell cycle disruption,transcriptional regulation
ENSG00000143013,LMO4,notch signaling regulation,oncogenic properties promotion,cell proliferation enhancement,tumor progression facilitation,transcriptional regulation modulation,genetic interaction with notch
ENSG00000104177,MYEF2,cell cycle regulation,proliferation promotion,apoptosis suppression,oncogene activation,transcriptional modulation,genomic instability
ENSG00000089157,RPLP0,ribosomal function,cellular growth regulation,protein synthesis regulation,tumor progression marker,chemotherapy resistance,pi3k/akt pathway interaction
ENSG00000175866,BAIAP2,protein degradation regulation,cell adhesion modulation,signaling pathway interaction,ovarian cancer biomarker,pi3k/akt pathway activation,tumor suppressor binding protein
ENSG00000161405,IKZF3,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition (emt),metastasis,cell migration,cell survival
ENSG00000137831,UACA,chromatin remodeling,aberrant gene expression,tumor suppressor gene silencing,dna damage response,genomic stability maintenance,therapeutic target
ENSG00000137133,HINT2,**
nuclear protein regulation,dna double-strand break repair,histone modification,homologous recombination,tumor suppressor function,oncogenic process modulation
ENSG00000161955,TNFSF13,apoptosis inhibition,immune suppression,tumor microenvironment modulation,cell surface receptor,pro-inflammatory signaling,t-cell regulation
ENSG00000065989,PDE4A,camp regulation,cell proliferation,oncogenic signaling,tumor progression,cell survival,gene expression regulation
ENSG00000155438,NIFK,transcriptional regulation,oncogenic function,pi3k/akt pathway modulation,cell growth promotion,apoptosis inhibition,tumor suppressor interaction
ENSG00000144283,PKP4,tumor progression,cell-cell adhesion disruption,desmosome regulation,loss of function mutations,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000071282,LMCD1,cell cycle regulation,dna damage response,apoptosis induction,genomic instability,poor prognosis marker,tumor progression
ENSG00000197728,RPS26,tumor suppressor function,translation regulation,protein synthesis,cellular processes,oncogenesis driver,ribosomal subunit protein
ENSG00000166477,LEO1,transcriptional regulator,chromatin remodeling,cellular proliferation,apoptosis inhibition,poor prognosis marker,epigenetic regulation
ENSG00000239264,TXNDC5,protein folding regulation,redox balance maintenance,oncogenesis promotion,cell proliferation enhancement,apoptosis suppression,nf-κb activation modulation
ENSG00000174903,RAB1B,autophagy regulation,lysosome trafficking,cell proliferation,apoptosis resistance,tumor progression,therapeutic target
ENSG00000174720,LARP7,mrna processing,regulation of translation initiation,tumorigenesis,overexpression in cancer,oncogenic mrna expression,cellular signaling pathway modulation
ENSG00000101558,VAPA,er stress regulation,autophagy modulation,cellular metabolism regulation,tumorigenesis association,oncogenic function,cancer cell survival
ENSG00000189058,APOD,phospholipid transport,cell proliferation,protein kinase activation,apoptosis inhibition,lipid metabolism modulation,oncogenic potential
ENSG00000105640,RPL18A,ribosomal protein overexpression,cellular proliferation enhancement,tumor growth promotion,apoptosis resistance,protein synthesis regulation,translational accuracy modulation
ENSG00000130734,ATG4D,autophagic flux regulation,cysteine protease function,cell growth modulation,apoptosis regulation,oncogenic potential,therapeutic target
ENSG00000171772,SYCE1,genomic instability,aneuploidy,chromosome instability,dna damage response,genome stability regulator,tumor suppressor function
ENSG00000131943,C19orf12,cellular growth regulation,protein function unknown,dna repair and replication involvement,poorly characterized gene,cell proliferation regulation,unknown oncogenic potential
ENSG00000163568,AIM2,tumor suppressor function,inflammasome activation,cell death regulation,genomic stability maintenance,immune response modulation,dna repair interaction
ENSG00000100395,L3MBTL2,histone modification,genomic instability,dna repair mechanisms,cell cycle regulation,tumor progression,therapeutic target
ENSG00000135372,NAT10,protein synthesis regulation,cell proliferation enhancement,metastasis promotion,tumor progression,genomic instability,therapeutic target
ENSG00000229117,RPL41,ribosomal subunit component,cell proliferation promotion,tumor aggressiveness marker,genomic instability contributor,protein synthesis regulation,oncogenic translation facilitator
ENSG00000183134,PTGDR2,prognostic marker,cell migration,therapeutic target,upregulated expression,signaling pathway interaction,cellular proliferation
ENSG00000168229,PTGDR,g protein-coupled receptor,cell proliferation,tumor progression,immune evasion,prostaglandin d2 binding,metastasis promotion
ENSG00000130312,MRPL34,mitochondrial protein synthesis,pyruvate dehydrogenase activation,glycolytic metabolism,cancer metabolism,tumor progression,regulatory interactions
ENSG00000160551,TAOK1,oncogenic signaling,cell cycle progression,apoptosis evasion,angiogenesis promotion,protein-protein interactions,therapeutic target
ENSG00000171262,FAM98B,microtubule stability,centrosome homeostasis,chromosomal instability,aneuploidy,kinase activity,cell cycle regulation
ENSG00000132950,ZMYM5,histone modification,chromatin regulation,epigenetic repression,tumor progression,transcriptional repressor,oncogene activation
ENSG00000107104,KANK1,cell adhesion disruption,cancer cell migration,cytoplasmic protein interaction,kirc prognosis biomarker,tumor suppressor dysregulation,oncogenic pathway facilitation
ENSG00000168092,PAFAH1B2,protein degradation,phospholipase activity,oncogenic role,cellular proliferation,signaling pathway regulation,cancer driver gene
ENSG00000177432,NAP1L5,chromatin remodeling,histone modification,dna repair mechanisms,oncogenic potential,aggressive tumor behavior,transcriptional regulation
ENSG00000133704,IPO8,pro-apoptotic inhibition,mitochondrial localization,cell cycle regulation,tumor growth promotion,poor prognosis marker,cell death modulation
ENSG00000196507,TCEAL3,transcriptional regulator,tumor promoter,prognostic marker,cell cycle regulation,genetic instability,epigenetic modulation
ENSG00000049167,ERCC8,ner complex,dna repair,genomic instability,interstrand crosslink repair,cyclobutane pyrimidine dimer repair,chemotherapy sensitivity
ENSG00000076924,XAB2,genomic instability,cell proliferation regulation,dna repair facilitation,homologous recombination repair,cyclin-dependent kinase interaction,therapeutic target
ENSG00000115275,MOGS,cell surface protein regulation,glycoprotein stability,misfolded protein accumulation,oncogenic pathway activation,protein quality control dysregulation,signaling pathway modulation
ENSG00000077420,APBB1IP,pi3k/akt signaling,tumor suppressor function,cellular metabolism regulation,chromatin remodeling,loss of heterozygosity,protein-protein interaction
ENSG00000100353,EIF3D,constitutive activation,cell growth regulation,therapeutic target,protein synthesis pathway,oncogene upregulation,tumor proliferation
ENSG00000146425,DYNLT1,microtubule stability regulation,gain of function mutations,dynein-mediated transport regulation,cellular migration regulation,cytoplasmic localization,genomic profiling
ENSG00000143575,HAX1,apoptosis resistance,mitochondrial function,dna repair,genomic stability,oncogenesis promotion,therapeutic target
ENSG00000183087,GAS6,oncogene,tumor progression,apoptosis inhibition,angiogenesis promotion,cell survival enhancement,protein-protein interaction
ENSG00000130226,DPP6,cell signaling regulation,gene expression modulation,synaptic function disruption,tumor progression driver,genetic alterations implicated,neuronal development impact
ENSG00000089199,CHGB,calcium-binding,cell growth regulation,gene expression modulation,apoptosis regulation,protein-protein interaction,cancer progression marker
ENSG00000164736,SOX17,epithelial-to-mesenchymal transition,transcriptional regulation,constitutive activation,oncogenic potential,tumor progression,proliferation and survival
ENSG00000104671,DCTN6,microtubule regulation,cell proliferation,tumor progression,mitosis meiosis regulation,signaling pathway activation,protein-protein interaction
ENSG00000124788,ATXN1,oncogenic process,pi3k/akt signaling pathway,chromatin remodeling,transcriptional regulation,cell proliferation enhancement,protein-protein interaction
ENSG00000147421,HMBOX1,transcriptional repressor,tumor suppressor function,cell cycle regulation,apoptosis regulation,genomic instability,prognostic biomarker
ENSG00000138363,ATIC,metabolic regulation,purine biosynthesis disruption,energy molecule production,cellular proliferation,oncogene activation,genomic instability
ENSG00000129824,RPS4Y1,ribosomal protein regulation,cell cycle progression,pi3k/akt pathway interaction,tumor growth promotion,apoptosis inhibition,oncogenic mutation
ENSG00000112306,RPS12,ribosomal function,protein overexpression,genomic instability,cell growth regulation,tumor progression,therapeutic target
ENSG00000136888,ATP6V1G1,v-atpase activation,tumor growth promotion,metastasis facilitation,ph homeostasis regulation,oncogenic signaling modulation,therapeutic target potential
ENSG00000160685,ZBTB7B,cellular proliferation,transcriptional regulation,oncogene/tumor suppressor,pi3k/akt signaling pathway,epithelial-to-mesenchymal transition,tumor progression
ENSG00000100239,PPP6R2,cell cycle regulation,cancer cell proliferation,apoptosis inhibition,protein phosphatase activity,tumor suppression loss,gene expression modulation
ENSG00000163918,RFC4,dna replication,gain of function mutations,cell proliferation,tumor progression,dna repair,pi3k/akt pathway
ENSG00000138074,SLC5A6,cellular uptake,glucose transport,nutrient metabolism,oncogenic process,tumor progression,therapeutic target
ENSG00000108256,NUFIP2,cellular proliferation,oncogenic role,mrna regulation,translation enhancement,apoptosis inhibition,tumorigenesis promoter
ENSG00000184905,TCEAL2,cell growth regulation,apoptosis modulation,chromatin remodeling,cell cycle control,tumor progression marker,dna damage response
ENSG00000034510,TMSB10,tumor suppressor function,downregulation in tumors,epigenetic silencing,genomic instability,apoptosis induction,cell cycle regulation
ENSG00000020426,MNAT1,mitotic spindle assembly,genomic instability,cell cycle regulation,dna damage response,biomarker potential,oncogene function
ENSG00000105402,NAPA,nucleotide metabolism,cell proliferation,overexpression,genomic stability,dna repair,cell survival
ENSG00000277564,RBFOX2,tumor suppressor function,alternative splicing regulation,cell cycle control disruption,gene expression dysregulation,proliferation promotion,apoptosis inhibition
ENSG00000130005,GAMT,tumor suppression,energy metabolism dysregulation,oxidative stress induction,dna damage accumulation,genomic instability,cellular growth modulation
ENSG00000143155,TIPRL,lipid droplet regulation,endoplasmic reticulum localization,cellular lipid metabolism,oncogenesis association,tumor progression influence,genomic alteration association
ENSG00000122218,COPA,copi regulation,protein secretion,tumorigenesis association,golgi apparatus dysfunction,cellular homeostasis disruption,mutations correlation
ENSG00000227746,C4A,complement activation,gene expression modulation,immune system regulation,mhc complex interaction,kidney disease susceptibility,renal cancer association
ENSG00000142765,SYTL1,metastasis promotion,tumor progression,oncogenic pathway regulation,cell migration modulation,prognostic marker,genomic instability
ENSG00000069974,RAB27A,tumor growth,metastasis promoter,cell signaling regulation,exocytosis regulator,vesicle trafficking,overexpression signature
ENSG00000003096,KLHL13,ubiquitin-proteasome regulation,cell cycle progression,oncogenic pathway activation,tumor suppressor function,protein degradation modulation,genetic instability
ENSG00000174748,RPL15,ribosome biogenesis,protein synthesis regulation,cell growth promotion,tumor progression,epigenetic alterations,protein-protein interactions
ENSG00000140983,RHOT2,mitochondrial dynamics regulation,oncogene overexpression,tumor growth promotion,cell migration enhancement,protein-protein interaction,stress response modulation
,H2AFY2,histone variant regulation,chromatin dynamics modulation,genome stability maintenance,gene expression regulation,dna repair interference,tumor suppressor activity
ENSG00000127329,PTPRB,inhibitory function,tumor progression,downregulation mutations,oncogenic signaling,cell migration regulation,epithelial-to-mesenchymal transition
ENSG00000080608,PUM3,cell proliferation,tumor progression,metastasis promotion,pi3k/akt pathway regulation,mapk/erk pathway activation,oncogenic mirna upregulation
ENSG00000096746,HNRNPH3,tumor progression,rna splicing regulation,cell proliferation modulation,protein-protein interaction,apoptosis regulation,oncogene overexpression
ENSG00000107796,ACTA2,aberrant expression,cell migration,dual role in cancer,epithelial-to-mesenchymal transition (emt),metastasis promoter,therapeutic target
ENSG00000128989,ARPP19,camp-dependent signaling,cell proliferation enhancement,dysregulated expression,oncogene activation,tumor progression facilitation,therapeutic target candidate
ENSG00000117751,PPP1R8,cell cycle regulation,apoptosis modulation,protein phosphatase 1 regulation,tumor progression,cell invasiveness,metastasis promotion
ENSG00000039123,MTREX,rna-binding protein,apoptosis evasion,cancer metastasis,cellular metabolism,protein-protein interactions,tumor progression
ENSG00000165264,NDUFB6,mitochondrial function,altered electron transport chain,glycolytic shift,reactive oxygen species production,apoptosis evasion,tumor progression
ENSG00000197471,SPN,angiogenesis promotion,extracellular matrix interaction,immune evasion facilitation,tumor progression driver,poor prognosis indicator,therapeutic target
ENSG00000105058,FAM32A,tumor suppressor function,regulation of cell cycle progression,apoptosis induction,cellular homeostasis maintenance,genomic instability contribution,nuclear localization
ENSG00000117505,DR1,tumor progression,cell proliferation,immune evasion,transcriptional regulation,apoptosis inhibition,nf-κb activation
ENSG00000106018,VIPR2,g-protein coupled receptor,oncogenic potential,tumor progression,metastasis regulation,cellular proliferation,signaling pathway activation
ENSG00000103024,NME3,tumor suppressor function,dna repair mechanism interaction,apoptosis regulation,cell proliferation modulation,prognostic biomarker potential,genomic instability regulation
ENSG00000109270,LAMTOR3,pi3k/akt/mtor pathway,regulatory role in autophagy,cell proliferation enhancement,tumor growth promotion,biomarker potential,apoptosis resistance
ENSG00000106992,AK1,purine metabolism,loss of function mutations,cellular proliferation,apoptosis resistance,gene expression regulation,epigenetic modifications
ENSG00000173369,C1QB,tumor progression,immune evasion,oncogenic protein,cellular interaction,molecular recognition,tissue invasion
ENSG00000156885,COX6A2,mitochondrial dysfunction,oxidative stress generation,dna damage induction,cell proliferation promotion,metastatic progression,tumor aggressiveness
ENSG00000070610,GBA2,sphingolipid metabolism,cellular proliferation,lysosomal enzyme,protein degradation pathway,tumor progression,glycosphingolipid breakdown
ENSG00000175084,DES,oncogenesis,prognostic marker,intermediate filament protein,cell structural support,tumorigenesis,metastasis regulator
ENSG00000155876,RRAGA,rag gtpase complex activation,mtorc1 hyperactivation,cellular energy dysregulation,autophagy induction,lysosomal biogenesis promotion,tumor progression driver
ENSG00000148331,ASB6,tumor suppressor regulation,e3 ubiquitin ligase interaction,protein degradation modulation,cell cycle regulation,oncoprotein stabilization,aggressive tumor behavior
ENSG00000183431,SF3A3,alternative splicing,spliceosomal complex,pre-mrna processing,tumor aggressiveness,gene expression regulation,cellular proliferation
ENSG00000242220,TCP10L,mtor pathway modulation,cellular growth regulation,protein-protein interactions,cell survival enhancement,tpr domain-containing protein,oncogenesis facilitation
ENSG00000184164,CRELD2,cell adhesion regulation,tumor progression,protein-protein interaction,cancer-related signaling pathway,cell migration regulation,kidney tissue expression
ENSG00000143947,RPS27A,ribosomal subunit assembly,cell proliferation enhancement,protein synthesis regulation,tumor growth facilitation,cell survival promotion,oncogene overexpression
ENSG00000157483,MYO1E,membrane trafficking,oncogene expression,cell migration,invasion,metastasis,actin cytoskeleton dynamics
ENSG00000066248,NGEF,rho gtpase regulation,cell migration and invasion,therapeutic target,gain of function mutations,cancer progression,signaling pathway modulation
ENSG00000125868,DSTN,oncogenic process,cell migration,actin cytoskeleton regulation,prognostic marker,therapeutic target,cell signaling pathway modulation
ENSG00000277356,KIR2DL1,oncogenic potential,cellular proliferation,ion imbalance regulation,poor prognosis,apoptosis evasion,overexpression signature
ENSG00000099797,TECR,chromatin modification,transcriptional regulation,cell proliferation enhancement,oncogenic amplifier,transcription factor activation,chromatin remodeling
ENSG00000123737,EXOSC9,tumor suppressor function,rna degradation regulation,cellular stress response modulation,apoptosis promotion,genomic integrity maintenance,oncogene regulation suppression
ENSG00000282019,GPI,overexpression,cellular adhesion modulation,tumor progression,transcription factor regulation,hypoxia response regulation,glycosylphosphatidylinositol anchoring
ENSG00000168710,AHCYL1,apoptosis regulation,chromatin remodeling,dna repair mechanisms,genomic instability,oncogenic process,protein ubiquitination
ENSG00000130254,SAFB2,chromatin remodeling,dna damage response,homologous recombination repair,transcriptional regulation,genome stability,therapeutic target
ENSG00000139343,SNRPF,rna processing,alternative splicing,protein expression regulation,cancer driver mutation,tumor suppressor function,genomic instability
ENSG00000062716,VMP1,apoptosis evasion,metabolic reprogramming,cell survival,therapeutic target,autophagy regulation,er stress response
ENSG00000104147,OIP5,pi3k/akt pathway,protein tyrosine phosphorylation,oncogenic signaling,tumorigenesis,biomarker potential,therapeutic target
ENSG00000168509,HJV,iron regulation,oncogenesis,loss-of-function mutations,tfr2 upregulation,oxidative stress resistance,cellular proliferation enhancement
ENSG00000153162,BMP6,bmp/smad signaling pathway,upregulation in cancer tissues,tumor progression,metastasis,epithelial-to-mesenchymal transition (emt),protein-protein interaction
ENSG00000186687,LYRM7,mitochondrial function alteration,energy metabolism dysregulation,cell proliferation enhancement,tumorigenesis contribution,complex i assembly disruption,oxidative stress increase
ENSG00000134222,PSRC1,chromatin remodeling,coactivator function,nuclear receptor interaction,tumor growth regulation,cancer driver mutation,genetic heterogeneity
ENSG00000213689,TREX1,dna damage response,genetic instability,tumor suppressor function,cancer predisposition,cellular stress responses,genome maintenance
ENSG00000120885,CLU,tumor suppressor function,apoptosis regulation,genomic stability maintenance,cell proliferation enhancement,oncogenic process promotion,pi3k/akt pathway modulation
ENSG00000138639,ARHGAP24,rhoa regulation,tumor suppression,gtpase activation,cell migration inhibition,metastasis suppression,epigenetic regulation
ENSG00000149091,DGKZ,cellular signaling,tumor progression,genomic instability,therapeutic target,oncogenic processes,cell growth
ENSG00000187325,TAF9B,transcriptional regulation,dna damage response,cell cycle progression,oncogenesis,enhanced cell proliferation,p53 interaction
ENSG00000102900,NUP93,nuclear envelope integrity,oncogenesis,metastasis,therapeutic resistance,cell signaling regulation,protein-protein interactions
ENSG00000143248,RGS5,g-protein coupled receptor signaling,tumor progression,cell adhesion disruption,metastasis regulation,protein interaction dysregulation,cancer therapeutic target
ENSG00000164916,FOXK1,cell cycle regulation,apoptosis inhibition,transcriptional modulation,oncogenic function,cell proliferation enhancement,epigenetic regulation
ENSG00000028277,POU2F2,transcription factor regulation,tumor suppression,cell cycle control,apoptosis regulation,genomic instability,immune response modulation
ENSG00000183763,TRAIP,p38 mapk signaling pathway,cellular stress response,tumor suppression,genomic instability,metastasis regulation,oncogenic transformation
ENSG00000100307,CBX7,chromatin remodeling,tumor suppressor,transcriptional regulation,oncogene silencing,cell cycle inhibition,dna repair regulation
ENSG00000065054,SLC9A3R2,loss of function mutations,pi3k/akt pathway regulation,cellular ph regulation loss,tumor suppressor function,cell proliferation enhancement,cell migration promotion
ENSG00000166925,TSC22D4,tumor progression,cellular regulation,transcriptional activation,angiogenesis promotion,oncogene overexpression,signaling pathway interaction
ENSG00000109079,TNFAIP1,apoptosis regulation,tumor progression,nf-κb signaling,cell proliferation,poor prognosis,oncogenic processes
ENSG00000178567,EPM2AIP1,cellular interaction,oncogene overexpression,cell proliferation,tumor progression,genomic amplification,survival signaling
ENSG00000198242,RPL23A,ribosomal protein overexpression,cellular proliferation enhancement,protein synthesis dysregulation,tumor growth promotion,oncogene activation,genomic instability increase
ENSG00000162409,PRKAA2,energy sensing,cellular metabolism regulation,tumor growth inhibition,mtor pathway modulation,cell survival promotion,oncogenic mutations
ENSG00000198467,TPM2,tumor progression,cytoskeleton regulation,actin filament dynamics,cell migration,therapeutic target,biomarker
ENSG00000110777,POU2AF1,transcriptional regulation,aberrant expression,cell proliferation promotion,oncogenic gene expression facilitation,tumorigenesis modulation,genomic landscape alteration
,HIST1H2BA,histone regulation,chromatin remodeling,dna repair mechanisms,cell cycle control,epigenetic modifications,genome stability maintenance
ENSG00000270885,RASL10B,pi3k/akt pathway,tumor progression,oncogenic processes,cell proliferation,apoptosis inhibition,dysregulation
ENSG00000164244,PRRC1,wnt/β-catenin pathway activation,chromatin modification,cell proliferation promotion,epigenetic regulation,tumor progression facilitation,transcriptional regulation
ENSG00000269404,SPIB,nf-κb pathway activation,transcriptional regulation,oncogene activation,tumor progression,metastasis driver,therapeutic target
ENSG00000237103,NCR3,nk cell activation,tumor suppression,immune recognition,cytokine production,cell signaling pathway,immune evasion
ENSG00000188211,NCR3LG1,immune modulation,tumor microenvironment regulation,cytokine regulation,natural killer cell activation,toll-like receptor signaling pathway interaction,epigenetic regulation
ENSG00000115364,MRPL19,ribosome biogenesis,cell proliferation regulation,oncogene overexpression,apoptosis resistance,mtor pathway interaction,tumor growth suppression
ENSG00000156374,PCGF6,polycomb group function,chromatin regulation,tumor suppressor role,genomic stability maintenance,cellular differentiation modulation,cancer progression facilitation
ENSG00000224379,TCF19,wnt/β-catenin pathway activation,transcriptional regulation,cell proliferation enhancement,oncogenic potential,tumor progression driver,genetic amplification
,HIST2H2AC,histone modification,chromatin remodeling,gene expression regulation,dna repair mechanisms,tumor progression,poor prognosis marker
,ADSS,tumor progression,metabolic rewiring,redox balance regulation,oncogenic phenotypes,therapeutic target,metabolic regulation
ENSG00000180818,HOXC10,oncogenic driver,transcriptional regulation,wnt/β-catenin pathway,cell proliferation,tumor progression,prognostic marker
ENSG00000104695,PPP2CB,regulatory mechanism,cell proliferation,pi3k/akt/mtor pathway,metabolic regulation,protein dephosphorylation,oncogenesis
ENSG00000069248,NUP133,nuclear pore complex regulation,cell proliferation,oncogenesis,gene expression regulation,nuclear architecture maintenance,chromatin organization
ENSG00000163874,ZC3H12A,pi3k/akt/mtor signaling,tumor suppressor pathway,genomic instability,metastasis promotion,transcriptional regulation,protein ubiquitination
ENSG00000109475,RPL34,ribosome biogenesis,cellular proliferation,prognostic biomarker,metabolic regulation,tumor progression,ancillary role in mrna translation
ENSG00000164163,ABCE1,polyadenylation regulation,oncogene upregulation,cell proliferation enhancement,dna repair modulation,tumor aggressiveness,malignant transformation
ENSG00000187051,RPS19BP1,ribosome biogenesis,rna polymerase iii transcription,cell proliferation regulation,tumor progression,oncogene potential,genomic instability
ENSG00000138778,CENPE,chromosome segregation,kinesin-like activity,mitotic progression,microtubule binding,tumor growth promotion,spindle assembly checkpoint regulation
ENSG00000135451,TROAP,chromatin remodeling,oncogene expression,histone acetylation,tumor suppressor regulation,cell cycle disruption,cancer epigenetics
ENSG00000154553,PDLIM3,pi3k/akt pathway regulation,tumor progression promotion,metastasis enhancement,apoptosis inhibition,cell migration regulation,prognostic marker
ENSG00000185303,SFTPA2,cell proliferation,pi3k/akt pathway interaction,cell survival modulation,tumor progression,kidney tissue homeostasis alteration,cancer therapy target
ENSG00000196465,MYL6B,cell migration,tumor progression,metastasis promotion,cytoplasmic regulation,signaling pathway interaction,gene overexpression
ENSG00000147166,ITGB1BP2,cell migration,signaling pathway modulation,tumor progression,metastasis regulation,aggressive disease phenotype,cancer cell invasion
ENSG00000171858,RPS21,oncogene,tumor growth promotion,cell cycle progression,ribosomal subunit function,translation efficiency enhancement,proliferation promotion
ENSG00000149557,FEZ1,microtubule regulation,cytoskeletal dynamics,microtubule association,cell migration enhancement,tumor progression,mitotic regulation
ENSG00000111725,PRKAB1,pka activation,tumor progression,metabolic regulation,cell proliferation,protein kinase interaction,genomic instability
ENSG00000196700,ZNF512B,transcriptional regulation,cell proliferation,tumorigenesis,apoptosis suppression,angiogenesis enhancement,chromatin remodeling
ENSG00000100897,DCAF11,chromatin remodeling,dna damage response,nucleotide excision repair,oncogene activity,transcriptional regulation,ubiquitin ligase adaptation
ENSG00000134283,PPHLN1,microtubule interaction,oncogenic potential,cellular morphology regulation,tumor progression association,prognostic biomarker candidate,signaling pathway modulation
ENSG00000162613,FUBP1,epigenetic regulation,oncogenic processes,cell proliferation,tumor growth,therapeutic target,transcriptional regulation
ENSG00000153140,CETN3,cell cycle regulation,cytoskeletal dynamics,cell proliferation,overexpression in cancer,apoptosis inhibition,centriole formation
ENSG00000178950,GAK,gsk-3 pathway regulation,oncogenic mutation,wnt/β-catenin signaling activation,cell proliferation enhancement,tumor progression driver,prognostic marker
ENSG00000159516,SPRR2G,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition (emt) promotion,oncogene upregulation,cellular differentiation regulation,pro-proliferative effects,mesenchymal phenotype acquisition
ENSG00000138071,ACTR2,cellular proliferation,dysregulation of pka activity,overactivation of pi3k/akt pathway,constitutive activation,apoptosis regulation,tumor growth
ENSG00000105063,PPP6R1,constitutive activation,cellular signaling regulation,protein phosphatase 2a interaction,oncogenic protein regulation,tumor progression promotion,pi3k/akt pathway modulation
ENSG00000125485,DDX31,ddx31-pten interaction,rna helicase activity,oncogenic driver,transcriptional regulation,tumor progression,overexpression
ENSG00000179059,ZFP42,tumor suppressor,transcription factor regulation,cell cycle progression,pi3k/akt signaling inhibition,genomic integrity maintenance,dna repair regulation
ENSG00000137843,PAK6,oncogenic transformation,protein kinase activation,cell migration regulation,tumor aggressiveness enhancement,rho gtpase pathway modulation,cancer progression facilitation
ENSG00000008394,MGST1,tumor suppressor,apoptosis regulation,pro-apoptotic signaling,pi3k/akt pathway suppression,cellular proliferation inhibition,therapeutic target
ENSG00000140990,NDUFB10,cellular respiration,electron transport chain,mitochondrial function,energy metabolism regulation,tumor suppressor role,loss of function mutations
ENSG00000160307,S100B,cell cycle regulation,apoptosis inhibition,prognostic marker,therapeutic target,tumor progression,calcium-binding protein
ENSG00000171773,NXNL1,mitochondrial function,cellular energy metabolism,tumor growth,apoptosis regulation,oxidative stress response,metastasis promotion
ENSG00000284571,FLII,transcription factor regulation,promotes tumor progression,angiogenesis promoter,gene expression modulation,cell proliferation enhancer,oncogene regulator
ENSG00000135387,CAPRIN1,alternative splicing regulation,sr protein interaction,oncogenic splicing,rna processing dysregulation,cancer cell proliferation,tumor metastasis promotion
ENSG00000070808,CAMK2A,pi3k/akt/mtor pathway activation,cancer cell survival and growth promotion,protein kinase activity and regulation,transcriptional regulation and gene expression modulation,cell migration and invasion enhancement,signaling pathway interaction and crosstalk
ENSG00000162641,AKNAD1,chromatin remodeling,histone modification regulation,tumor suppressor function,genomic instability modulation,apoptosis regulation,cell cycle progression control
ENSG00000125835,SNRPB,spliceosome regulation,rna processing regulation,oncogene activation,cell proliferation enhancement,tumor suppressor gene suppression,heterogenous nuclear ribonucleoprotein complex interaction
ENSG00000183684,ALYREF,aberrant mrna export,cell proliferation,mitotic checkpoint dysregulation,nuclear rna-binding protein function,tumor suppressor loss of function,genomic instability
ENSG00000152689,RASGRP3,rap1 gtpase activation,tumor progression,cell proliferation,metastasis,cell adhesion disruption,therapeutic target
ENSG00000170653,ATF7,immunosuppression,tumor microenvironment regulation,pro-inflammatory cytokine regulation,oncogene activity,tumor growth promotion,angiogenesis regulation
ENSG00000062582,MRPS24,mitochondrial translation,energy metabolism,ribosomal assembly,cellular growth,cellular survival,tumor suppressor function
ENSG00000135535,CD164,cell adhesion,tumor progression,angiogenesis,oncogene activation,microrna regulation,epithelial-to-mesenchymal transition
ENSG00000183011,NAA38,histone modification,tumor suppressor function,chromatin remodeling,eukaryotic protein regulation,n-terminal acetylation,epigenetic regulation
ENSG00000110090,CPT1A,fatty acid oxidation,mitochondrial membrane transport,cancer cell metabolism,energy production enhancement,tumor growth facilitation,ancillary metabolic regulation
ENSG00000140320,BAHD1,lipid metabolism regulation,tumor progression enhancement,cell proliferation increase,lysophospholipids acylation,pi3k/akt pathway interaction,prognostic marker potential
ENSG00000259956,RBM15B,pi3k/akt pathway,overexpression,rna-binding protein,cell proliferation,apoptosis regulation,metastasis promotion
ENSG00000169862,CTNND2,tumor suppressor activity,cell adhesion regulation,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition (emt),cancer cell migration,disruption of cell-cell interactions
ENSG00000136463,TACO1,chromatin remodeling,cell cycle regulation,transcriptional activation,oncogenesis,epigenetic modification,cancer stem cells
ENSG00000149591,TAGLN,cell adhesion,cytoplasmic organization,tumor invasion,oncogenic potential,cell migration,prognostic marker
ENSG00000235307,BRD2,transcriptional regulation,chromatin remodeling,oncogenic transcription,apoptosis evasion,cell proliferation,tumor progression
ENSG00000132305,IMMT,mitochondrial dynamics,oncogenic metabolism,tumor progression,cellular signaling,protein interaction,genetic amplification
ENSG00000170549,IRX1,epithelial-to-mesenchymal transition,transcription factor regulation,cell differentiation inhibition,oncogenic process promotion,tumor progression contributor,epithelial cell transformation
ENSG00000204071,TCEAL6,cellular growth regulation,cell cycle progression,apoptosis modulation,transcriptional regulation,t-cell differentiation,protein-protein interactions
ENSG00000145216,FIP1L1,ribosomal dna regulation,oncogenic transcription,cell proliferation,transcriptional regulation,cellular metabolism,genomic instability
ENSG00000163631,ALB,osmotic regulation,carrier protein function,blood volume maintenance,ca2+ ion binding,hormone transport,cellular homeostasis
ENSG00000169129,AFAP1L2,actin filament dynamics,apoptosis resistance,cell proliferation enhancement,dna repair impairment,genomic instability induction,pi3k/akt pathway interaction
ENSG00000128283,CDC42EP1,cell migration and invasion,cytoskeletal dynamics regulation,oncogenic role in tumor progression,metastasis promotion,cancer aggressiveness biomarker,cell proliferation and survival signaling
ENSG00000132002,DNAJB1,oncogenesis,constitutive activation,genomic instability,tumor progression,therapeutic target,protein folding regulation
ENSG00000120742,SERP1,overexpression,unfolded protein response modulation,cellular adaptation to stress,apoptosis inhibition,cancer cell proliferation enhancement,therapeutic target
ENSG00000221983,UBA52,ubiquitination regulation,tumor suppressor interaction,cell cycle disruption,oncogene activation,genomic instability,protein degradation pathway
ENSG00000166226,CCT2,chaperone function,cell proliferation,protein folding,tumor aggressiveness,poor prognosis,molecular chaperone
ENSG00000278644,PCGF2,chromatin regulation,epigenetic silencing,polycomb repressive complex 1,tumor suppressor function,loss of function mutations,chromatin organization
ENSG00000100347,SAMM50,mitochondrial integrity,mitochondrial function regulation,cell metabolism dysregulation,cancer biomarker,apoptosis evasion,cell growth promotion
ENSG00000167515,TRAPPC2L,vesicle-mediated transport regulation,cellular growth regulation,tumor growth promotion,genetic mutation implicated,endocytic pathway modulation,pi3k/akt signaling interaction
ENSG00000170145,SIK2,pi3k/akt pathway interaction,cancer cell proliferation,cell survival dysregulation,tumor progression,metabolic regulation,apoptosis resistance
ENSG00000205403,CFI,blood clotting regulation,tissue factor activation,thrombin generation,coagulation pathway modulation,hemostasis imbalance,cancer metastasis facilitation
ENSG00000112877,CEP72,oncogenesis,cell proliferation,microtubule dynamics,spindle assembly,prognostic marker,tumor progression
ENSG00000141101,NOB1,cell proliferation,transcription regulation,oncogenic potential,therapeutic target,dna repair mechanisms,pi3k/akt pathway activation
ENSG00000113761,ZNF346,tumor progression,epithelial-to-mesenchymal transition,cellular proliferation,transcription factor activity,prognostic marker,apoptosis evasion
ENSG00000105053,VRK3,cell cycle progression,apoptosis evasion,tumor growth,genomic instability,protein-protein interaction,p53 regulation
,WARS,tryptophan incorporation,genomic instability,protein synthesis deregulation,aminoacylation mechanism,oncogene function,translation fidelity disruption
ENSG00000187601,MAGEH1,epigenetic regulation,cancer-testis antigen,tumor progression,oncogene,histone modification,epigenetic reprogramming
ENSG00000111361,EIF2B1,constitutive activation,gain of function mutations,cellular proliferation,therapeutic target,protein synthesis regulation,cancer cell survival
ENSG00000109381,ELF2,transcription factor regulation,cell cycle progression,apoptosis suppression,oncogenesis promotion,tumor metastasis,prognostic indicator
ENSG00000064726,BTBD1,chromatin remodeling,tumor suppressor function,cell cycle regulation,apoptosis regulation,epigenetic regulation,molecular interaction
ENSG00000146731,CCT6A,cancer driver gene,tumor progression,tumorigenesis,cellular signaling pathways,protein synthesis regulation,oncogenic pathway activation
ENSG00000112782,CLIC5,oncogenic driver,ros regulation,cell growth promotion,tumor progression marker,prognostic indicator,redox modulation
ENSG00000105705,SUGP1,scaffold protein interaction,pi3k/akt pathway activation,cell migration enhancement,tumor progression promotion,angiogenesis regulation,genomic alteration association
ENSG00000075945,KIFAP3,chromosomal instability,genomic amplification,cell division cycle regulation,microtubule dynamics disruption,tumor suppressor activity loss,mitosis impairment
ENSG00000090520,DNAJB11,regulation of cell cycle progression,apoptosis regulation,autophagy regulation,protein folding and degradation,chromatin remodeling and epigenetic modifications,tumor development and progression
ENSG00000136146,MED4,regulation of rna polymerase ii,transcription initiation,cell cycle progression,dna repair pathways,cancer-specific gene expression,therapeutic target
ENSG00000117906,RCN2,oncogenic driver,epithelial-to-mesenchymal transition (emt),cell migration regulation,cell invasion facilitation,calcium-binding chaperone function,tumor progression enhancement
ENSG00000071127,WDR1,p53 regulation,dna repair,genomic stability,cell cycle progression,tumor suppressor interaction,oncogenesis modulation
ENSG00000179776,CDH5,ve-cadherin dysfunction,angiogenic activity,cell adhesion disruption,tumor microenvironment instability,metastatic potential increase,immune evasion mechanism enhancement
ENSG00000011243,AKAP8L,cellular proliferation regulation,pka activation,genomic instability,tumor maintenance,protein-protein interaction,oncogenic signaling
ENSG00000116544,DLGAP3,wnt/β-catenin signaling pathway,tumor progression,cell migration,adhesion complex component,signaling molecule regulation,metastasis facilitation
ENSG00000107854,TNKS2,telomere maintenance,oncogene,telomerase regulation,cell proliferation,dna repair,protein degradation
ENSG00000086827,ZW10,kinetochore regulation,tumorigenesis promotion,genomic instability,mitotic checkpoint control,chromosome segregation,cell cycle regulation
ENSG00000156304,SCAF4,telomere stabilization,genomic instability,oncogene overexpression,tumor progression,dna damage response,therapeutic target
ENSG00000137168,PPIL1,mitochondrial function,cell growth regulation,protein misfolding,apoptosis modulation,signaling pathway interaction,tumor progression driver
ENSG00000136935,GOLGA1,nuclear pore complex regulation,cell proliferation regulation,gene expression modulation,protein transport,apoptosis evasion,oncogenic signaling pathway
ENSG00000049245,VAMP3,apoptosis regulation,autophagy modulation,cellular morphology alteration,cytoplasmic trafficking regulation,cytoskeletal reorganization,protein-protein interaction
ENSG00000128596,CCDC136,microtubule stabilization,cell cycle regulation,oncogenic signaling,prognostic marker,mitosis regulation,dna damage response
ENSG00000006837,CDKL3,cell cycle regulation,aberrant kinase activation,apoptosis suppression,tumor progression driver,oncogenic transformation,genomic instability mediator
ENSG00000196793,ZNF239,tumor progression,transcriptional regulation,cellular proliferation,epigenetic modification,apoptosis inhibition,chromatin remodeling
ENSG00000182923,CEP63,oncogenic signaling,overexpression,aberrant cilia formation,chemotherapy resistance,centrosomal regulation,cell proliferation promotion
ENSG00000162408,NOL9,rna processing regulation,nuclear localization,dna damage response,oncogene activation,tumor suppressor interaction,genomic instability
ENSG00000088930,XRN2,regulation of rna turnover,genome stability maintenance,rna processing alterations,proliferation promotion,survival enhancement,metastasis facilitation
ENSG00000159461,AMFR,autophagy regulation,proteasome function modulation,cell growth promotion,oncogenic potential enhancement,ubiquitin ligase activity,poor prognosis association
ENSG00000099246,RAB18,rab18,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),microtubule stabilization,pi3k/akt pathway modulation,oncogenic transformation
ENSG00000113569,NUP155,nuclear transport regulation,aneuploidy,chromosomal instability,nucleoporin dysfunction,transcriptional regulation disruption,cell proliferation enhancement
ENSG00000072364,AFF4,transcriptional regulation,oncogene activity,cell survival pathway,tumor suppressor inhibition,prognostic marker,p-tefb complex interaction
ENSG00000198265,HELZ,genomic stability,tumor suppressor function,cell cycle regulation,dna replication,histone modification,chromatin remodeling
ENSG00000004478,FKBP4,apoptosis regulation,cell proliferation enhancement,immunophilin function,oncogene overexpression,protein degradation regulation,ubiquitin-proteasome pathway interaction
ENSG00000151239,TWF1,actin filament regulation,cytoskeletal reorganization,oncogenic progression,cell invasion,metastasis promotion,pro-oncogenic activity
ENSG00000124659,TBCC,microtubule dynamics regulation,oncogenic process contributor,chromatin remodeling,tumor progression facilitator,cancer cell growth promoter,cellular structure regulator
ENSG00000079337,RAPGEF3,rap gtpase activation,guanine nucleotide exchange factor (gef) activity,cell adhesion and migration,oncogenic signaling pathway,tumor progression and metastasis,therapeutic target for cancer treatment
ENSG00000172315,TP53RK,tumor suppressor function,genome stability regulation,apoptosis promotion,dna repair mechanism,cell cycle regulation,tumor progression inhibition
ENSG00000101361,NOP56,ribosomal rna processing,dna damage response,cellular stress response,genomic instability,transcriptional regulation,oncogenic protein interaction
ENSG00000155008,APOOL,apoptosis regulation,bcl-2 family interaction,cell cycle modulation,mitochondrial function,tumor suppressor activity,pro-apoptotic signaling
ENSG00000157106,SMG1,nonsense-mediated decay regulation,tumor suppressor function,oncogene regulation,cell cycle arrest,mrna surveillance mechanism,protein degradation pathway
ENSG00000143811,PYCR2,metabolic reprogramming,enhanced energy metabolism,anaplerotic reaction,lipid synthesis,oncogenic transcription factors,therapeutic target
ENSG00000136448,NMT1,signaling pathway activation,protein kinase regulation,cell proliferation promotion,metastasis facilitation,tumorigenesis association,cancer biomarker potential
ENSG00000067829,IDH3G,metabolic rewiring,gain of function mutations,histone modification,tumor progression,altered metabolism,oncogenic driver
ENSG00000125249,RAP2A,pi3k/akt pathway activation,oncogenic signaling,cell proliferation enhancement,apoptosis inhibition,epithelial-to-mesenchymal transition regulation,small gtp-binding protein function
ENSG00000113758,DBN1,mitochondrial function regulation,oncogene activation,genomic instability,cell survival regulation,reactive oxygen species production,calcium homeostasis disruption
ENSG00000105398,SULT2A1,tumor growth,cell proliferation,genomic instability,detoxification pathway,oncogenic activation,hormone metabolism
ENSG00000126856,PRDM7,regulatory function,epigenetic modification,gene expression regulation,tumor suppressor dysfunction,oncogenic role,immune evasion
ENSG00000152465,NMT2,cell proliferation,molecular modification,cancer progression,protein stabilization,rho gtpase activation,tumor aggressiveness
ENSG00000153814,JAZF1,gene expression regulation,chromatin modification,g2/m phase regulation,tumorigenesis,metastasis driver,cell cycle disruption
ENSG00000213463,SYNJ2BP,lipid metabolism,endocytosis regulation,cellular trafficking regulation,protein-protein interaction,tumor biology contribution,uncharacterized function
ENSG00000113356,POLR3G,genomic instability,loss-of-function mutations,transcriptional dysregulation,ribosome biogenesis,cell growth modulation,tumor suppressor dysfunction
ENSG00000132664,POLR3F,ribosome biogenesis,rna synthesis regulation,oncogene amplification,tumor growth promotion,cell proliferation enhancement,genomic instability promotion
ENSG00000136271,DDX56,oncogenic activity,cell proliferation enhancement,rna metabolism regulation,transcriptional activation,tumor aggressiveness promotion,therapeutic target identification
ENSG00000145824,CXCL14,tumor suppressor function,disrupted anti-tumor immune response,chemokine signaling,cell proliferation inhibition,apoptosis induction,therapeutic target
ENSG00000172893,DHCR7,cholesterol biosynthesis,cell growth promotion,lipid metabolism regulation,tumor progression support,mutational association,gene expression modulation
ENSG00000149485,FADS1,cellular proliferation,gene expression regulation,lipid biosynthesis regulation,prognostic biomarker,tumor aggressiveness,polyunsaturated fatty acid metabolism
ENSG00000171109,MFN1,mitochondrial fusion,megamitochondria formation,glycolytic shift,glutaminolytic adaptation,oncogenic protein overexpression,tumor suppressor gene dysregulation
ENSG00000163110,PDLIM5,tumor progression,cell migration,upregulation,cell adhesion,signaling pathway,cellular motility
ENSG00000282972,GNG4,gpcr signaling pathway,altered expression,cell membrane trafficking,signaling modulation,cancer progression,genomic instability
ENSG00000153922,CHD1,histone modification,chromatin remodeling,tumor suppressor function,genome instability,cell cycle regulation,apoptosis modulation
ENSG00000136045,PWP1,ubiquitination regulation,cell survival enhancement,protein degradation modulation,tumor progression association,hippo-yap pathway involvement,cancer cell proliferation promotion
ENSG00000197043,ANXA6,cell proliferation,calcium homeostasis regulation,signaling pathway modulation,tumor progression,epithelial-to-mesenchymal transition (emt),protein-protein interaction
ENSG00000126107,HECTD3,oncogene,cell growth promotion,protein ubiquitination,transcription factor regulation,cell cycle control disruption,tumor progression enhancement
ENSG00000108468,CBX1,chromatin remodeling,epigenetic regulation,gene silencing,heterochromatin structure,oncogenesis,polycomb repressive complex 1
ENSG00000141380,SS18,oncogenic fusion protein,transcriptional coactivation,chromatin remodeling complex member,genomic instability mediator,tumor cell proliferation driver,tumor cell survival enhancer
ENSG00000196072,BLOC1S2,lysosome biogenesis,cell growth promotion,oncogenic processes,tumor progression,protein degradation dysregulation,genetic overexpression
ENSG00000162244,RPL29,ribosomal biogenesis,translation regulation,cellular growth modulation,protein-protein interactions,genomic instability,biomarker expression
ENSG00000162521,RBBP4,dna repair,genomic instability,chromatin remodeling,transcriptional regulation,oncogenic signaling pathway,tumor aggressiveness
ENSG00000169035,KLK7,oncogenic signaling,proteolytic activation,tumor invasion,angiogenesis promotion,cell proliferation enhancement,overexpression marker
ENSG00000165912,PACSIN3,cellular proliferation,oncogenic behavior,signaling molecule interaction,transcription factor regulation,tumor growth promotion,apoptosis inhibition
ENSG00000064218,DMRT3,cellular proliferation,regulatory transcription factor,gene overexpression,tumor aggressiveness,oncogenic interaction,deregulated cellular processes
ENSG00000106605,BLVRA,dna damage repair,cell proliferation,pi3k/akt pathway interaction,genomic instability,apoptosis regulation,tumor progression
ENSG00000181852,RNF41,apoptosis regulation,cell proliferation,dna repair regulation,oncoprotein function,proteasomal degradation,tumor progression
ENSG00000087245,MMP2,tumor progression,cell migration and invasion,extracellular matrix degradation,metastasis facilitation,post-translational modification,signaling pathway regulation
ENSG00000099910,KLHL22,oncogenic regulation,tumor progression,substrate accumulation,e3 ubiquitin ligase interaction,cellular proliferation,metabolic reprogramming
ENSG00000172482,AGXT,cellular redox balance,oxidative stress regulation,tumor progression association,genetic alterations involvement,detoxification pathway interaction,metabolic regulation dysfunction
ENSG00000107581,EIF3A,translation initiation factor,cell proliferation promoter,protein synthesis regulator,oncogene activation,tumor progression driver,angiogenesis inhibitor
ENSG00000122406,RPL5,ribosome biogenesis,mutation-driven dysregulation,aberrant protein synthesis,tumor promotion,cellular proliferation,protein kinase interaction
ENSG00000196616,ADH1B,oxidative stress regulation,dna damage and mutagenesis,cell growth and proliferation,reactive oxygen species production,hydrogen peroxide generation,therapeutic target
ENSG00000188428,BLOC1S5,lysosomal dysfunction,cell survival modulation,protein degradation regulation,organelle biogenesis disruption,cancer cell adaptation,tumor aggressiveness
ENSG00000118113,MMP8,tumor progression,angiogenesis,tissue remodeling,cell migration,proliferation,apoptosis
ENSG00000173821,RNF213,microtubule dynamics,microtubule stability,aneuploidy prevention,biomarker potential,cancer cell interaction,tumor progression regulator
ENSG00000158864,NDUFS2,mitochondrial dysfunction,energy metabolism,oncogenic adaptation,tumor progression marker,prognostic significance,electron transport chain
ENSG00000166090,IL25,il-17 family member,tumor progression,immune modulation,eosinophil recruitment,immunosuppression,th2 cell activation
ENSG00000136931,NR5A1,hormone regulation,transcriptional regulation,cell proliferation,oncogenesis,tumor progression,prognostic marker
ENSG00000148346,LCN2,angiogenesis facilitation,iron homeostasis regulation,oxidative stress response,cellular senescence suppression,tumor progression promotion,biomarker potential
ENSG00000181555,SETD2,histone methyltransferase,tumor suppressor function,genomic instability,dna repair mechanism,chromatin regulation,epigenetic regulator
ENSG00000164466,SFXN1,oxidative stress,redox regulation,cellular transport,membrane trafficking,protein-protein interactions,tumorigenesis
<end>

in this summary
ENSG00000078668,VDAC3,mitochondrial regulation,metabolic adaptation,apoptosis regulation,cell survival enhancement,oncogenic potential,stress response modulation
ENSG00000177542,SLC25A22,mitochondrial function,energy production,fatty acid metabolism,cell proliferation,oxidative stress regulation,cancer metabolism
ENSG00000080293,SCTR,cellular regulation,growth factor signaling,pi3k/akt pathway,cell proliferation,tumor progression,hormone receptor activation
ENSG00000133773,CCDC59,genomic instability,telomere maintenance,cell cycle regulation,dna damage response,cancer suppressor,protein interaction network
ENSG00000170956,CEACAM3,tumor progression,metastasis,immune response modulation,cell adhesion,overexpression,prognosis
ENSG00000068308,OTUD5,nf-kappab pathway modulation,tumor suppressor function,deubiquitinating enzyme activity,antitumor protein stability regulation,cellular homeostasis maintenance,cancer-associated protein degradation
ENSG00000134245,WNT2B,wnt signaling,constitutive activation,cell proliferation,tumor progression,metastasis regulation,oncogenic process
ENSG00000106789,CORO2A,cell migration,actin dynamics regulation,tumor progression correlation,poor prognosis marker,cell invasion regulation,protein-protein interactions
ENSG00000116329,OPRD1,opioid receptor signaling,cell survival regulation,tumor progression facilitation,pain modulation pathway,therapeutic target potential,angiogenesis promotion
ENSG00000166313,APBB1,oncogene activity,tumor progression,cell proliferation,signaling pathway modulation,protein-protein interaction,therapeutic target
ENSG00000137409,MTCH1,apoptosis regulation,mitochondrial function,cell proliferation,tumor progression,mitochondrial dynamics,oncogenic interaction
ENSG00000172638,EFEMP2,tumor progression,cell migration,cell invasion,overexpression,secreted protein,egf-like domain
ENSG00000144791,LIMD1,tumor suppressor function,transcriptional regulation,apoptosis regulation,cell cycle regulation,genomic stability,protein-protein interactions
ENSG00000111667,USP5,deubiquitinating enzyme function,regulation of protein stability,influence on cell cycle progression,modulation of signaling pathways,contribution to tumorigenesis,dna repair mechanism
ENSG00000075142,SRI,pi3k/akt pathway regulation,apoptosis inhibition,cell proliferation modulation,cell migration influence,cancer progression regulator,tumor suppressor function
ENSG00000111652,COPS7A,regulation of androgen receptor signaling,protein degradation regulation,cellular homeostasis maintenance,oncogenic pathway activation,ubiquitin-proteasome pathway modulation,cancer progression facilitation
ENSG00000116218,NPHS2,glomerular filtration barrier,cell-cell adhesion,loss-of-function mutations,focal segmental glomerulosclerosis,nephrotic syndrome,actin cytoskeleton regulation
ENSG00000083845,RPS5,protein synthesis,tumor suppressor dysfunction,translation machinery regulation,cell cycle progression,apoptosis evasion,poor prognosis biomarker
ENSG00000136872,ALDOB,glycolytic metabolism,enhanced energy supply,metabolic reprogramming,hypoxic adaptation,tumor growth promotion,therapeutic target
ENSG00000109133,TMEM33,overexpression,cellular homeostasis regulation,ion channel regulation,tumor progression driver,protein-protein interactions,cellular membrane integrity
ENSG00000101057,MYBL2,cell cycle regulation,oncogenic potential,transcription factor activity,apoptosis inhibition,prognostic marker,therapeutic target
ENSG00000100029,PES1,protein synthesis pathway,constitutive activation,genomic instability,tumor progression,cell growth promotion,oncogenic interaction
ENSG00000102158,MAGT1,dna repair mechanism,tumor progression,promotes cell growth,apoptosis regulation,cellular magnesium homeostasis,magnesium transporter function
ENSG00000160305,DIP2A,histone modification,chromatin remodeling,transcriptional regulation,oncogenic process,tumor progression,therapeutic target
ENSG00000068305,MEF2A,transcription factor activation,amplification events,cell proliferation regulation,oncogene involvement,chromatin modification regulation,genetic amplification
ENSG00000076382,SPAG5,microtubule assembly,genomic instability,oncogene function,cell proliferation,protein interaction,dna repair regulation
ENSG00000101146,RAE1,mitochondrial regulation,cellular stress response,apoptosis modulation,tumor progression,genomic instability,therapeutic target
ENSG00000124713,GNMT,methionine metabolism,same activation,cell cycle regulation,dna repair alterations,oncogenic pathway activation,therapeutic target
ENSG00000147669,POLR2K,transcription elongation,rna polymerase ii complex,gene overexpression,tumor progression,cell proliferation,poor prognosis
ENSG00000124688,MAD2L1BP,mitotic checkpoint regulation,cell cycle progression modulation,dna repair mechanism regulation,oncogenic driver,tumor suppressor function loss,cancer cell proliferation facilitation
ENSG00000071539,TRIP13,genomic instability,chromatin remodeling,cell proliferation,oncogenic driver,dna replication,cell cycle regulation
ENSG00000120875,DUSP4,erk/mapk pathway regulation,apoptosis inhibition,cell proliferation,tumor progression,protein interaction,genomic amplification
ENSG00000002822,MAD1L1,spindle assembly checkpoint regulation,genomic instability driver,mitotic fidelity regulator,aneuploidy promoter,tumor suppressor loss,cell cycle regulator
ENSG00000111726,CMAS,protein modification,enzymatic activity,protein stability,cellular degradation,cancer-related gene expression,none
ENSG00000166432,ZMAT1,cell cycle regulation,transcriptional regulation,tumor suppressor gene suppression,oncogene overexpression,apoptosis inhibition,metabolic regulation
ENSG00000171497,PPID,regulation of cellular homeostasis,protein phosphatase regulation,tumor suppression function,growth factor signaling pathway,proliferation and survival regulation,metabolic regulation
ENSG00000139874,SSTR1,somatostatin receptor regulation,cell proliferation inhibition,g protein-coupled receptor signaling,tumor aggressiveness,prognosis association,mirna regulatory mechanism
ENSG00000197535,MYO5A,autophagy regulation,cellular trafficking modulation,tumor progression driver,gene expression alteration,cellular transport regulation,oncogenic signaling activation
ENSG00000196642,RABL6,cell cycle regulation,overexpression,oncogene potential,tumor progression,cell proliferation,signaling pathway interaction
ENSG00000188603,CLN3,lysosomal ph regulation,loss-of-function mutations,cellular proliferation,apoptosis resistance,tumor progression,p53 interaction
ENSG00000134824,FADS2,fatty acid biosynthesis,gene expression regulation,tumor microenvironment modulation,lipid metabolism alteration,cell membrane fluidity influence,tissue-specific expression
ENSG00000184160,ADRA2C,cellular proliferation,g protein-coupled receptor signaling,oncogenic pathway activation,metabolic regulation,tumor migration,biomarker expression
ENSG00000134046,MBD2,epigenetic regulation,constitutive activation,transcriptional repression,tumor suppressor gene silencing,oncogenic processes,histone modification
ENSG00000145220,LYAR,dna repair,genomic maintenance,oncogenic driver,transcriptional regulation,tumor progression,cell cycle regulation
ENSG00000171861,MRM3,multidrug efflux,drug resistance,substrate specificity,chemotherapy,prognosis,poor survival rates
ENSG00000113851,CRBN,protein degradation regulation,ubiquitination pathway,tumor suppressor regulation,hypoxia-inducible factor alpha regulation,angiogenesis suppression,dna damage response modulation
ENSG00000077514,POLD3,genomic instability,dna damage response,therapeutic target,biomarker significance,oncogenic potential,genetic mutations
ENSG00000125967,NECAB3,plc regulation,cell growth promotion,survival pathway activation,overexpression association,biomarker potential,genomic mutation link
ENSG00000137674,MMP20,extracellular matrix degradation,oncogenic potential,tumor progression,metastasis promotion,cell migration facilitation,cell proliferation enhancement
ENSG00000152591,DSPP,tumor suppressor,cell proliferation,oncogene activation,cell differentiation,apoptosis regulation,prognostic marker
ENSG00000135077,HAVCR2,immune checkpoint blockade,tumor immune evasion,immune regulation dysfunction,therapeutic target potential,poor prognosis indicator,advanced tumor stage marker
ENSG00000111181,SLC6A12,glutamate transport,oncogenic function,amplification mutations,tumor progression,metabolic regulation,protein interaction
ENSG00000138663,COPS4,cullin-ring e3 ligase regulation,ubiquitination process,protein degradation,cell cycle progression,tumor suppressor regulation,cancer metastasis
ENSG00000274286,ADRA2B,alpha-2a adrenergic receptor,angiogenesis promotion,apoptosis suppression,growth regulation,mapk/erk pathway modulation,tumor metastasis enhancement
ENSG00000131931,THAP1,chromatin remodeling,transcriptional repression,tumor aggressiveness,epithelial-to-mesenchymal transition,anti-apoptotic activity,genomic instability
ENSG00000162627,SNX7,pi3k/akt pathway regulation,tumor progression,protein degradation,endocytic pathway modulation,cell proliferation enhancement,apoptosis inhibition
ENSG00000159337,PLA2G4D,hydrolytic enzyme activity,calcium-independent pla2 activity,tumor growth promotion,cell migration and invasion enhancement,pi3k/akt pathway regulation,mapk/erk signaling interaction
ENSG00000105497,ZNF175,tumor suppression,dna-binding properties,transcriptional regulation,cell cycle regulation,apoptosis induction,methylated silencing
ENSG00000165271,NOL6,ribosome assembly,cell proliferation,apoptosis regulation,tumor progression,immunotherapy target,ribosome biogenesis
ENSG00000163875,MEAF6,chromatin remodeling,swi/snf complex,dna repair mechanism,tumorigenesis promotion,transcriptional regulation disruption,cell cycle control disruption
ENSG00000165702,GFI1B,pi3k/akt signaling pathway inhibition,tumor suppressor function,cell cycle regulation,apoptosis induction,angiogenesis modulation,gene expression repression
ENSG00000143933,CALM2,mapk/erk pathway,cellular signaling,calcium-dependent regulation,cancer progression,therapeutic target,aberrant expression
ENSG00000130203,APOE,lipid transport regulation,tumor progression association,phosphatidylinositol 3-kinase pathway interaction,lrp1 receptor interaction,cell survival promotion,overexpression risk factor
ENSG00000099889,ARVCF,cell adhesion disruption,epithelial-to-mesenchymal transition,metastasis promoter,cell migration enhancer,tumor progression marker,cytoskeleton regulation
ENSG00000100206,DMC1,genomic instability,tumor suppressor function,homologous recombination,dna repair mechanism,meiotic crossover regulation,somatic cell mutation
ENSG00000124702,KLHDC3,tumor promoter,cell cycle regulator,protein-protein interactions,transcriptional enhancer,genome instability,oncogenic protein expression
ENSG00000205420,KRT6A,cellular adhesion disruption,epithelial cancer association,tumor progression,oncogenic potential,overexpression in cancer,mechanical strength disruption
ENSG00000077348,EXOSC5,rna degradation,regulatory function,oncogenic potential,cellular regulation,tumor progression,metabolic reprogramming
ENSG00000124256,ZBP1,tumor microenvironment,immune cell recruitment,nf-κb activation,cell adhesion regulation,metastasis facilitation,poor prognosis marker
ENSG00000276336,SCARF1,tumor immune evasion,immune suppression,cell proliferation regulation,soluble receptor function,macrophage modulation,prognostic biomarker
ENSG00000122873,CISD1,oncogenic pathway regulation,cancer-specific mutation,mitochondrial dysfunction,tumor suppressor function,dna damage induction,genomic instability promotion
ENSG00000184056,VPS33B,autophagosome formation,cellular metabolism,endocytic trafficking,genomic instability,lysosomal function,protein-protein interaction
ENSG00000198876,DCAF12,genomic instability,cell cycle regulation,protein degradation pathway,tumor suppressor function,cancer driver mutation,e3 ubiquitin ligase complex
ENSG00000108515,ENO3,metabolic reprogramming,glycolytic enzyme function,tumor progression marker,glycolysis regulation,energy metabolism support,prognostic biomarker
ENSG00000160752,FDPS,prenylation pathway,oncogenic signaling,cholesterol biosynthesis,gain of function mutations,therapeutic target,cellular proliferation
ENSG00000164649,CDCA7L,chromatin remodeling,cell cycle regulation,mitotic progression,protein-protein interaction,cancer prognosis,tumor growth promotion
ENSG00000130589,HELZ2,dna repair pathway,genomic instability,tumor progression,oncogenic transformation,transcriptional regulation,apoptosis evasion
ENSG00000147223,RIPPLY1,wnt/β-catenin pathway activation,tumor suppressor activity loss,cell proliferation enhancement,oncogenic transcription regulation,prognostic biomarker significance,genomic instability promotion
ENSG00000130429,ARPC1B,actin cytoskeleton dynamics,cell migration,lamellipodia formation,cell invasion,therapeutic target,tumor progression
ENSG00000132300,PTCD3,cell adhesion,epithelial-to-mesenchymal transition,therapeutic target,tumor progression,cell migration,genomic expression
ENSG00000171148,TADA3,transcriptional regulation,coactivator function,tbp interaction,cellular proliferation,gene expression modulation,oncogenic mutations
ENSG00000086589,RBM22,oncogenic splicing regulation,pre-mrna processing modulation,rna-binding protein interaction,alternative splicing influence,prognostic marker potential,therapeutic target candidate
ENSG00000076685,NT5C2,cell proliferation,apoptosis regulation,cytosolic 5'-nucleotidase activity,nucleobase regulation,tumor progression,genomic instability
ENSG00000023228,NDUFS1,mitochondrial dysfunction,oncogenic metabolism,electron transport chain impairment,reduced oxidative phosphorylation,glycolytic shift,energy production compromise
ENSG00000152944,MED21,transcriptional regulation,chromatin remodeling,tumor progression,metastasis,cell proliferation,cell survival
ENSG00000214827,MTCP1,epigenetic regulation,chromatin remodeling,transcriptional regulation,apoptosis evasion,cell cycle progression,oncogene interaction
ENSG00000131023,LATS1,hippo pathway dysregulation,loss-of-function mutations,tumor progression,cell proliferation enhancement,apoptosis suppression,genomic instability
ENSG00000133063,CHIT1,ecm remodeling,tumor progression,cell migration invasion,metastasis facilitation,wnt/β-catenin signaling,protease regulation
ENSG00000105641,SLC5A5,nis mediated iodide uptake,ion transport regulation,tumor progression promotion,epithelial-to-mesenchymal transition (emt) modulation,poor prognosis association,overall survival impact
ENSG00000076662,ICAM3,altered immune responses,cellular adhesion molecule,immune modulation,tumor progression,metastasis,cancer immunotherapy
ENSG00000110321,EIF4G2,translation initiation factor regulation,growth factor pathway modulation,tumor cell proliferation,mutation-driven protein synthesis,cellular survival pathway alteration,tumor microenvironment modification
ENSG00000104442,ARMC1,cilia dysfunction,cellular proliferation,loss of function mutations,tumor suppression,pi3k/akt pathway alterations,genomic amplification
ENSG00000262788,UTP4,alternative splicing,tumor suppressor function,rna splicing regulation,cancer cell proliferation,ancillary spliceosome component,aberrant mrna production
ENSG00000117362,APH1A,gamma-secretase complex,notch signaling pathway,cellular proliferation,angiogenesis promotion,immune evasion mechanisms,epidermal growth factor receptor processing
ENSG00000189171,S100A13,tumor progression,cell adhesion disruption,calcium-dependent signaling,oncogenic protein interactions,epithelial-to-mesenchymal transition,diagnostic/prognostic marker
ENSG00000178996,SNX18,tumor promoter,endocytic recycling regulation,signaling pathway modulation,cell proliferation enhancement,cell migration facilitation,vesicular transport interaction
ENSG00000175110,MRPS22,mitochondrial ribosome biogenesis,tumor metabolism,ancillary protein,oxidative phosphorylation regulation,mitochondrial dysfunction,regulatory function
ENSG00000120075,HOXB5,oncogenic function,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell cycle progression,apoptosis resistance,angiogenesis promotion
ENSG00000111271,ACAD10,lipid metabolism modulation,oncogene activation,fatty acid oxidation regulation,cell proliferation enhancement,energy production dysregulation,tumor aggressiveness
ENSG00000115041,KCNIP3,akt/mtor pathway regulation,potassium channel modulation,oncogenesis promotion,cell proliferation enhancement,tumor progression facilitation,genomic upregulation
ENSG00000129450,SIGLEC9,cell surface recognition,immune modulation,oncogenic signaling,tumor progression,poor prognosis marker,protein-protein interaction
ENSG00000090615,GOLGA3,golgi apparatus regulation,cellular proliferation,protein-protein interaction,onco-suppressor function,tumor progression marker,cancer prognosis indicator
ENSG00000136811,ODF2,mitotic spindle assembly,dysregulation of microtubule stability,chromosomal instability,mitotic checkpoint regulation,constitutive expression,genomic stability maintenance
ENSG00000104738,MCM4,cellular proliferation,dna replication initiation,genomic instability,tumor aggressiveness,oncogene overexpression,therapeutic target
ENSG00000065357,DGKA,protein kinase c activation,phosphoinositide metabolism,cell growth regulation,tumor progression,metastasis promotion,dysregulated expression
ENSG00000001497,LAS1L,**
dna damage response,genome instability regulation,nuclear transport regulation,tumor growth suppression,cell proliferation control,protein-protein interaction
ENSG00000110075,PPP6R3,phosphatase regulation,tumor progression,oncogenic protein stabilization,cell growth modulation,signal transduction pathway,regulatory subunit interaction
ENSG00000110367,DDX6,oncogene,rna processing regulation,microrna dysregulation,tumor progression,metastasis promotion,pi3k/akt pathway interaction
ENSG00000085224,ATRX,chromatin modification,tumor suppressor function,chromosomal instability,dna repair mechanisms,histone variant regulation,epigenetic reprogramming
ENSG00000187908,DMBT1,tumor microenvironment modulation,inflammation regulation,immune surveillance disruption,epithelial-to-mesenchymal transition,cell adhesion alteration,protein-protein interaction
ENSG00000041357,PSMA4,proteasome activation,amplification,cell proliferation enhancement,therapeutic target,tumor suppressor degradation,cancer progression
ENSG00000187239,FNBP1,actin filament bundling,cell migration,wave complex interaction,arp2/3 activation,cancer progression,therapeutic target
ENSG00000169474,SPRR1A,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,chemoresistance,cell differentiation,proliferation enhancement
ENSG00000198721,ECI2,protein degradation regulation,gene overexpression,tumor suppressor protein degradation,cell cycle progression modulation,transcriptional regulation interaction,oncogenic signaling pathway modulation
ENSG00000183918,SH2D1A,regulation of t cell receptor signaling,immune response modulation,tumor microenvironment influence,antigen presentation regulation,cell activation and proliferation,passenger or potential tumor suppressor gene
ENSG00000169446,MMGT1,transcriptional regulator,apoptosis evasion,cell proliferation,cell cycle regulation,tumor progression,oncogenic activity
ENSG00000164096,C4orf3,cell cycle regulation,tumor suppression,dna damage response,cancer development,protein-protein interaction,apoptosis regulation
ENSG00000184113,CLDN5,apoptosis,cell migration,cell invasion,tumor suppressor,cell polarity,metastasis
ENSG00000177519,RPRM,rap1 gtpase activation,tumor suppressor function,cell adhesion regulation,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition regulation,cell survival and proliferation enhancement
ENSG00000163069,SGCB,pi3k/akt pathway interaction,cell adhesion disruption,metastatic progression,prognostic biomarker potential,transmembrane protein function,cancer cell invasion facilitation
ENSG00000079134,THOC1,rna export regulation,oncogene upregulation,cell proliferation promotion,tumor progression facilitation,angiogenesis enhancement,gene expression modulation
ENSG00000161526,SAP30BP,chromatin remodeling,tumor progression,metastasis facilitation,gene expression modulation,protein interaction,cellular transformation
ENSG00000120694,HSPH1,cellular stress response,molecular chaperone function,protein aggregation regulation,cell proliferation regulation,cancer progression facilitation,poor prognosis marker
ENSG00000114062,UBE3A,tumor promoter,cell growth enhancement,protein degradation disruption,substrate ubiquitination,metastasis facilitation,cancer biomarker
ENSG00000165821,SALL2,transcription factor activity,epigenetic silencing,methylated promoter regions,downregulation,tumor suppressor function,cellular differentiation disruption
ENSG00000177875,CCDC184,cell cycle progression,dna damage repair,oncogene activation,epigenetic regulation,chromosome instability,mitotic checkpoint disruption
ENSG00000111142,METAP2,tumor progression,constitutive activation,protein degradation,cell proliferation,angiogenesis,therapeutic target
ENSG00000139631,CSAD,extracellular matrix remodeling,tumor progression,cell migration,invasion,metastasis,oncogenic activity
ENSG00000167900,TK1,dna replication,proliferation marker,tumor progression marker,therapeutic target,cell cycle regulation,prognostic indicator
ENSG00000165370,GPR101,gpcr signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000164294,GPX8,cell survival promotion,antioxidant function alteration,oxidative stress resistance,tumor progression association,poor prognosis marker,signaling pathway interaction
ENSG00000164815,ORC5,cell cycle regulation,dna replication initiation,oncogene overexpression,tumor progression,cell proliferation enhancement,genomic instability
ENSG00000093009,CDC45,genomic instability,cell proliferation,oncogenic mutations,s-phase transition,dna replication initiation,replication fork progression
ENSG00000115392,FANCL,dna damage response,genomic instability,ubiquitin ligase function,interstrand crosslink repair,fa pathway regulation,tumorigenesis promotion
ENSG00000182591,KRTAP11-1,epigenetic regulation,hair follicle development,keratin-associated protein family,cellular differentiation,biomarker potential,limited cancer-related functions
ENSG00000181896,ZNF101,tumor suppressor,cell cycle regulation,apoptosis regulation,dna binding protein,krab domain-containing family,cancer prognosis modifier
ENSG00000186908,ZDHHC17,tumor progression,oncogenic pathway regulation,cell proliferation promotion,protein trafficking dysregulation,signaling molecule interaction,palmitoylation modification
ENSG00000132639,SNAP25,cell migration regulation,overexpression in cancer,protein-protein interactions,tumor progression marker,cellular adhesion modulation,signal transduction pathway modulation
ENSG00000104343,UBE2W,ubiquitination regulation,oncogenic protein stabilization,e3 ligase interaction,cell cycle dysregulation,tumor suppressor loss,protein degradation pathway disruption
ENSG00000176641,RNF152,ubiquitination,cellular degradation,oncogene activation,tumor suppressor degradation,metabolic regulation,protein stability modulation
ENSG00000095637,SORBS1,apoptosis modulation,cell cycle regulation,pi3k/akt signaling interaction,prognostic biomarker,scaffold protein function,tumor progression facilitation
ENSG00000073921,PICALM,endocytic pathway regulation,cell surface receptor turnover,lipid metabolism disruption,tumor progression,metastasis facilitation,clathrin assembly interaction
ENSG00000127922,SEM1,dna repair defects,homologous recombination deficiency,genomic instability,chromosomal alterations,oncogene activation,microsatellite instability
ENSG00000101132,PFDN4,microtubule stability,cell division,proliferation,apoptosis regulation,tumor progression,cytoskeletal organization
ENSG00000155959,VBP1,rsk activation,gene amplification,cell cycle progression,apoptosis inhibition,glucose metabolism regulation,oncogenic signaling
ENSG00000102804,TSC22D1,oncogenic properties,transcriptional regulation,cell proliferation,tumor growth and metastasis,pi3k/akt pathway interaction,overexpression in cancer
ENSG00000134376,CRB1,adherens junction disruption,epithelial-to-mesenchymal transition (emt),tumor progression,therapeutic target,cell-cell adhesion disruption,protein-protein interaction
ENSG00000133943,DGLUCY,glycolytic regulation,aerobic glycolysis promotion,glucose metabolism enhancement,tumor cell proliferation,warburg effect activation,energy metabolism disruption
ENSG00000198835,GJC2,gap junction communication,cell-cell adhesion disruption,protein overexpression,cell growth promotion,signaling molecule exchange,tumor progression facilitation
ENSG00000178623,GPR35,oncogenic driver,pi3k/akt/mtor signaling pathway,cell proliferation enhancement,immune evasion strategy,therapeutic target,adhesion gpcr family
ENSG00000124074,ENKD1,tumor suppressor function,cellular endosomal trafficking regulation,gene expression alterations,protein sorting and degradation regulation,cancer prognostic biomarker,cellular metabolism regulation
ENSG00000139579,NABP2,nuclear receptor interaction,transcriptional activation,tumor progression,cell proliferation regulation,apoptosis suppression,metastasis promotion
ENSG00000171867,PRNP,aberrant expression,cellular signaling pathway,signal transduction regulation,cell growth modulation,cell survival influence,cancer progression potential
ENSG00000181392,SYNE4,nuclear lamina structure,cell cycle regulation,chromosomal instability,tumor progression,prognostic marker,genomic integrity
ENSG00000182685,BRICD5,cellular overexpression,tumor progression,apoptosis regulation,cell cycle modulation,protein-protein interaction,signaling pathway modulation
ENSG00000139116,KIF21A,microtubule dynamics,cell division regulation,chromosome segregation,oncogenic mutations,therapeutic target,cancer metastasis
ENSG00000163072,NOSTRIN,cellular migration,morphology regulation,adherens junction formation,epithelial-to-mesenchymal transition,overexpression association,tumor aggressiveness
ENSG00000107223,EDF1,aberrant expression,cell proliferation regulation,dep domain interaction,metastasis promotion,poor prognosis association,translation initiation modulation
ENSG00000116833,NR5A2,loss of function mutations,constitutive activation,gain of function mutations,cell proliferation,epigenetic regulation,transcription factor activity
ENSG00000214253,FIS1,mitochondrial dynamics,tumor progression,cellular metabolism,oncogenesis,cell growth regulation,therapeutic target
ENSG00000100335,MIEF1,mitochondrial dynamics,regulatory function,heterodimer formation,metabolic reprogramming,cell growth regulation,apoptosis modulation
ENSG00000166689,PLEKHA7,cell signaling pathway alteration,tumor suppressor function loss,plekhin domain interaction,pkc isoform activation,pi3k regulatory subunit interaction,cell migration enhancement
,LARS,oncogenic protein synthesis,tumor progression marker,cell cycle regulation,apoptosis evasion,aminoacyl-trna synthesis dysregulation,protein homeostasis disruption
ENSG00000145888,GLRA1,cell proliferation,oncogene activation,neurotransmission regulation,ion channel function,cell growth regulation,signaling pathway modulation
ENSG00000197587,DMBX1,cell cycle regulation,transcriptional regulation,tumor suppressor function,genomic instability,dna repair interactions,akt signaling inhibition
ENSG00000100522,GNPNAT1,polyamine biosynthesis,oncogenic processes,cell growth promotion,dysregulated metabolism,key enzyme interaction,therapeutic target
ENSG00000110047,EHD1,endocytosis regulation,cell migration promotion,protein recycling facilitation,cancer stem cell maintenance,oncogenic protein interaction,tumor progression enhancement
ENSG00000131381,RBSN,mitochondrial dynamics,tumor suppressor function,apoptosis regulation,cell proliferation enhancement,mitophagy inhibition,oncogenesis promotion
ENSG00000147155,EBP,translation initiation regulation,protein synthesis dysregulation,cell growth promotion,oncogenic process driver,tumorigenesis contributor,mrna availability control
ENSG00000136052,SLC41A2,magnesium homeostasis,tumor progression,dysregulated expression,regulatory function,magnesium transport,oncogenic potential
,SEPT12,sept12 interaction,tumor suppressor function,apoptosis regulation,cell cycle modulation,cytoplasmic localization,dysregulated expression
ENSG00000082556,OPRK1,cellular signaling pathway regulation,g-protein coupled receptor function,tumor progression facilitation,cell growth enhancement,apoptosis resistance,overexpression association
ENSG00000171033,PKIA,camp-dependent signaling,cellular metabolism regulation,kinase inhibition activity,protein-protein interaction,tumor suppression,cell proliferation modulation
ENSG00000158716,DUSP23,mapk pathway regulation,tumor suppressor function,cell proliferation inhibition,erk1/2 activation,prognostic marker potential,oncogenic gene expression
ENSG00000196290,NIF3L1,p53 regulation,gene expression modulation,transcriptional activation,oncogene interaction,tumor suppressor inhibition,cancer progression promoter
ENSG00000117475,BLZF1,tumor suppressor function,transcriptional regulation,dna damage response,apoptosis induction,cell growth inhibition,pi3k/akt pathway interaction
ENSG00000075624,ACTB,actin cytoskeleton dynamics,cell migration and invasion,epithelial-to-mesenchymal transition (emt),elevated expression levels,prognostic marker,tumor progression
ENSG00000130545,CRB3,cell-cell adhesion disruption,cell migration enhancement,invasion promotion,epithelial polarity modulation,mapk/erk signaling pathway activation,pi3k/akt pathway regulation
ENSG00000120942,UBIAD1,antioxidant properties,cell survival enhancement,mitochondrial function regulation,prognostic marker association,chemotherapy resistance promotion,redox balance regulation
ENSG00000163535,SGO2,protein degradation regulation,apoptosis inhibition,ubiquitination pathway,emt marker expression,oncogenic pathway interaction,therapeutic target candidate
ENSG00000177694,NAALADL2,glutamate regulation,tumor progression,cell growth promotion,metastasis facilitation,protein interaction,oncogene overexpression
ENSG00000164082,GRM2,metabolic regulation,cell proliferation,tumor progression,metastasis,chemotherapy resistance,therapeutic target
ENSG00000145414,NAF1,genomic instability,tumor suppressor function,chromatin remodeling,cell cycle regulation,dna replication,genetic alterations
ENSG00000244362,KRTAP19-7,keratin filament assembly,cell adhesion,cell migration,protein interaction,signaling pathway modulation,tumor initiation
ENSG00000181929,PRKAG1,tumor cell metabolism,energy dysregulation,glycolysis and glutaminolysis enhancement,pi3k/akt pathway modulation,cellular energy status changes,mapk/erk signaling interaction
ENSG00000167107,ACSF2,lipid synthesis,cell growth promotion,tumorigenesis facilitation,signaling pathway modulation,protein interaction,therapeutic target
ENSG00000088682,COQ9,mitochondrial function,dysregulation of energy metabolism,role in tumorigenesis,oxidative stress,apoptosis resistance,warburg effect
ENSG00000007944,MYLIP,loss-of-function mutations,tumor suppressor function,regulation of lipid metabolism,autophagy regulation,cell growth inhibition,apoptosis induction
ENSG00000103043,VAC14,lysosome regulation,phosphoinositide metabolism,akt/mtor pathway activation,tumor growth promotion,lysosomal function maintenance,cell survival enhancement
ENSG00000159202,UBE2Z,ubiquitination pathway regulation,protein degradation modulation,cell cycle progression control,tumor development facilitation,poor prognosis indicator,therapeutic target identification
ENSG00000145358,DDIT4L,mtor pathway regulation,apoptosis inhibition,cell growth promotion,tumor progression,cell survival enhancement,protein interaction
ENSG00000204873,KRTAP9-3,cell adhesion disruption,keratin filament regulation,protein-protein interactions,hair follicle development,tumor progression association,molecular interaction
ENSG00000254997,KRTAP5-9,cell proliferation regulation,epithelial cell integrity,keratin filament interaction,prognostic biomarker potential,tumorigenesis involvement,cell growth regulation
ENSG00000158552,ZFAND2B,genomic instability,tumor suppressor function,cell cycle regulation,ubiquitination pathway,chromatin remodeling,dna damage response
ENSG00000135636,DYSF,cell membrane repair,muscle integrity maintenance,pi3k/akt pathway regulation,tumor aggressiveness promotion,cell survival enhancement,genetic mutations affecting gene expression
ENSG00000161547,SRSF2,aberrant splicing,cancer driver mutation,cell cycle regulation disruption,dna repair deficiency,oncogene activation,rna processing disorder
ENSG00000185811,IKZF1,transcriptional regulation,tumor suppressor function,epithelial-to-mesenchymal transition,cell differentiation,genomic instability,oncogene suppression
ENSG00000143156,NME7,metastasis inhibition,cell cycle regulation,dna repair,protein phosphorylation,apoptosis induction,genomic instability
ENSG00000278570,NR2E3,transcriptional regulation,cell proliferation,dna repair,nuclear receptor function,epithelial-to-mesenchymal transition,cell cycle progression
ENSG00000187175,KRTAP12-1,oncogenesis,cell proliferation regulation,cell differentiation disruption,tumor progression promotion,signaling pathway modulation,genetic overexpression alteration
ENSG00000105991,HOXA1,emt induction,gain of function mutations,transcription factor activity,cell proliferation enhancement,oncogenic pathway activation,metastasis promotion
ENSG00000126804,ZBTB1,oncogene activity,transcriptional repression,apoptosis evasion,cell growth promotion,metastasis facilitation,prognostic biomarker
ENSG00000183434,TFDP3,cell cycle regulation,transcriptional regulation,oncogene function,tumor suppressor down-regulation,cell growth promotion,poor prognosis biomarker
ENSG00000148175,STOM,cell adhesion disruption,epithelial-to-mesenchymal transition,integrin interaction,cadherin binding,protein-protein interactions,tumor progression
ENSG00000100243,CYB5R3,angiogenesis induction,cell proliferation enhancement,energy metabolism regulation,hypoxia adaptation pathway interaction,oncogenic transformation,poor prognosis marker
ENSG00000165495,PKNOX2,tumor suppression,cellular differentiation,transcriptional regulation,oncogene activation,angiogenesis promotion,metastasis enhancement
ENSG00000143079,CTTNBP2NL,cell migration,invasive behavior,oncogene,biomarker candidate,prognostic marker,poor prognosis
ENSG00000213281,NRAS,constitutive activation,guainidine-exchange activity,gain of function mutations,tumor progression,therapeutic target,cell signaling pathway
ENSG00000155833,CYLC2,lipid biosynthesis,metabolic reprogramming,oncogenic role,tumor aggressiveness,poor prognosis,cell cycle regulation
ENSG00000125409,TEKT3,centrosome localization,microtubule assembly,mitotic spindle regulation,cell proliferation,chromosome segregation,cancer cell survival
ENSG00000186930,KRTAP6-2,keratin dynamics modulation,cellular stress response,oncogenic processes,tumor progression,protein-protein interactions,cellular integrity maintenance
ENSG00000092203,TOX4,wnt/β-catenin pathway,transcriptional regulation,cell proliferation,metastasis promoter,oncogenic transcription factor,tumor suppressor gene suppression
ENSG00000115507,OTX1,transcriptional regulation,tumor progression,promoter binding,anti-apoptotic functions,cell proliferation modulation,epigenetic dysregulation
ENSG00000198089,SFI1,chromosomal instability,genomic integrity,sister chromatid cohesion,genome stability,chromatin regulation,cell cycle progression
ENSG00000147400,CETN2,microtubule regulation,ciliogenesis,cell cycle progression,oncogene overexpression,mitotic spindle assembly,tumor progression
,HIST2H3A,epigenetic regulation,histone modification,chromatin structure,gene expression modulation,tumor suppressor-like function,oncogenesis association
,HIST2H3C,histone modification,epigenetic regulation,tumor suppression,genome stability,chromatin remodeling,transcriptional regulation
,HIST2H3D,chromatin remodeling,transcriptional regulation,histone modification,oncogenic processes,tumor development,apoptosis modulation
ENSG00000105223,PLD3,phospholipid metabolism,promotes cell proliferation,mitogen-activated protein kinase activation,cell membrane fluidity modulation,kinase interaction,overexpressed in cancer
ENSG00000143786,CNIH3,cancer cell proliferation,enhanced survival signaling,phosphatidylinositol phosphorylation,g-protein coupled receptor interaction,cellular signaling pathway activation,protein kinase c activation
ENSG00000148690,FRA10AC1,lncrna regulation,chromatin remodeling,cell cycle regulation,apoptosis modulation,tumorigenesis association,epigenetic modification
ENSG00000149929,HIRIP3,chromatin remodeling,cell cycle regulation,genome instability,tumor suppressor interaction,mitotic progression,epigenetic modulation
ENSG00000168701,TMEM208,cell proliferation,mutation,pi3k/akt signaling,tumor progression,transmembrane protein,cell survival
ENSG00000262045,KRT34,pan-cancer marker,oncofetal protein,cell proliferation,epithelial-to-mesenchymal transition (emt),cytokeletal integrity,therapeutic target
ENSG00000123685,BATF3,nf-κb signaling,immunosuppression,tumor microenvironment modulation,apoptosis resistance,immune evasion,transcriptional regulation
ENSG00000204571,KRTAP5-11,cytoskeletal remodeling,tumor microenvironment,cell-cell interactions,keratin structure,cellular adhesion properties,epithelial tissue changes
ENSG00000117016,RIMS3,calcium-dependent exocytosis regulation,tumor suppressor function,pi3k/akt pathway regulation,apoptosis induction,cell proliferation inhibition,downregulated expression in tumors
ENSG00000100151,PICK1,cell proliferation regulation,oncogenic protein interaction,tumor progression promotion,endocytic pathway modulation,adaptor protein function,prognostic biomarker potential
ENSG00000171729,TMEM51,mitochondrial regulation,apoptosis induction,tumor suppression,cell cycle regulation,genomic stability maintenance,cancer progression
ENSG00000108010,GLRX3,cellular redox regulation,tumor progression,metastasis,antioxidant defense,protein folding,dna damage
ENSG00000129355,CDKN2D,cell cycle regulation,tumor suppression,cell proliferation inhibition,epigenetic modifications,pi3k/akt pathway modulation,chromatin structure alteration
ENSG00000196388,INCA1,cell cycle regulation,tumor suppressor function,genome stability maintenance,dna damage response inhibition,oncogene suppression,cdk2 interaction
ENSG00000153823,PID1,oncogene activation,cell proliferation regulation,protein degradation modulation,ubiquitination pathway interaction,tumor suppressor protein destabilization,genomic instability promotion
ENSG00000128185,DGCR6L,microrna regulation,cellular proliferation,genetic interaction,cancer development,tumor suppression,protein modulation
,HIST1H2BH,histone modification,epigenetic regulation,chromatin remodeling,dna repair mechanisms,tumor suppressor function,genome instability
ENSG00000168646,AXIN2,wnt/beta-catenin pathway disruption,oncogenic driver,cell proliferation regulation,tumor progression facilitation,genetic instability promotion,transcriptional activation enhancement
ENSG00000085382,HACE1,oncogene regulation,tumor suppression,ubiquitination degradation,cell cycle progression,apoptosis regulation,dna repair mechanism
ENSG00000149295,DRD2,increased expression,prognostic marker,angiogenesis regulation,cell migration modulation,dopamine receptor function,g protein-coupled signaling pathway disruption
ENSG00000123473,STIL,chromosomal instability,aneuploidy,cell cycle regulation,ciliogenesis disruption,mitotic error promotion,tumor aggressiveness marker
ENSG00000104412,EMC2,er membrane assembly,lipid metabolism regulation,cellular metabolism alteration,oncogenesis,prognostic marker,tumorigenesis
ENSG00000135052,GOLM1,cellular proliferation,apoptosis inhibition,tumor progression,angiogenesis promotion,signaling pathway modulation,oncogene interaction
ENSG00000143801,PSEN2,cellular growth regulation,notch signaling activation,appp processing,enhanced cell proliferation,transmembrane protein function,oncogenic process promotion
ENSG00000164896,FASTK,**
apoptosis regulation,autophagy modulation,caspase interaction,cell survival pathway,oncosuppressor function,cellular metabolism
ENSG00000181915,ADO,immune suppression,t-cell inhibition,tryptophan degradation,cell proliferation,prognostic marker,therapeutic target
ENSG00000104763,ASAH1,ceramide metabolism,apoptosis regulation,cell survival pathway,tumor progression,metastasis promotion,prognostic marker
ENSG00000280516,TMEM42,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),oncogene overexpression,pi3k/akt pathway activation,stemness properties promotion,transmembrane protein localization
ENSG00000126950,TMEM35A,intracellular trafficking,cellular transport,aberrant expression,oncogenic processes,metabolic regulation,therapeutic target
ENSG00000197976,AKAP17A,cell proliferation,protein kinase regulation,cell survival,pi3k/akt interaction,tumor overexpression,molecular anchoring
ENSG00000123154,WDR83,chromatin remodeling,oncogenic process,transcriptional regulation,genomic instability,dna repair mechanism,tumor progression
ENSG00000276644,DACH1,tumor suppressor,cell cycle regulation,transcriptional regulation,chromatin remodeling,apoptosis induction,loss-of-function mutations
ENSG00000090905,TNRC6A,microrna regulation,genetic silencing,mirisc complex formation,oncogenesis,tumor behavior,gene expression regulation
ENSG00000228964,HLA-B,immune evasion,downregulation,antigen presentation,tumor progression,mhc-i expression,loss of function mutations
ENSG00000102024,PLS3,amplification,oxidative stress,oncogene,angiogenesis,cellular proliferation,metabolic regulation
ENSG00000125356,NDUFA1,mitochondrial dysfunction,electron transport chain disruption,energy metabolism alteration,glycolytic shift,tumor progression promotion,therapeutic target potential
ENSG00000171135,JAGN1,notch signaling pathway,aberrant activation,tumor promotion,cell proliferation,genetic mutation,cancer progression
,CCDC155,microtubule instability,cilia formation disruption,mitotic spindle dysfunction,cell proliferation enhancement,genomic instability promotion,oncogenic signaling pathway dysregulation
ENSG00000143641,GALNT2,tumor progression,glycosylation modification,cell proliferation,prognostic marker,oncogene activation,signaling pathway modulation
ENSG00000117155,SSX2IP,chromatin remodeling,transcriptional regulation,cell proliferation,gene expression,apoptosis suppression,metastasis regulation
ENSG00000103018,CYB5B,electron transfer,redox regulation,cellular respiration,metabolic reprogramming,cell survival,energy production
ENSG00000155755,TMEM237,cellular homeostasis disruption,cellular membrane integrity,oncogenic transformation,therapeutic resistance,apoptosis modulation,autophagy regulation
ENSG00000100528,CNIH1,cell proliferation,calcium signaling,tumor progression,cell adhesion,signal transduction,protein interaction
ENSG00000175514,GPR152,pi3k/akt pathway,cell surface receptor,immune system modulation,tumor growth regulation,signal transduction,genetic alterations
ENSG00000166289,PLEKHF1,protein-protein interaction modulation,signaling pathway regulation,tumor progression promotion,cellular proliferation enhancement,therapeutic target potential,oncogene overexpression
ENSG00000115274,INO80B,histone modification regulation,histone acetylation,chromatin remodeling complex,oncogenic mirna upregulation,genomic instability,tumor suppressor downregulation
ENSG00000166900,STX3,cell cycle regulation,apoptosis modulation,ubiquitin-proteasome pathway interaction,biomarker potential,tumor progression,membrane fusion
ENSG00000143198,MGST3,glutathione conjugation,oxidative stress regulation,cancer progression,oncogene role,prognostic marker,detoxification pathway
ENSG00000198133,TMEM229B,cellular adhesion loss,epithelial polarity disruption,malignant transformation promotion,wnt/β-catenin pathway interaction,tumor suppressor function loss,cell migration enhancement
ENSG00000169371,SNUPN,snurportin 1 family,spliceosome assembly,snrnp transport,mrna processing regulation,cellular export machinery,gene expression modulation
ENSG00000122375,OPN4,regulation of circadian rhythm,g protein-coupled receptor function,cellular proliferation,immune response modulation,phototransduction pathway involvement,neural tissue expression
ENSG00000188021,UBQLN2,protein degradation regulation,ubiquitin-proteasome system interaction,genomic instability driver,tumor aggressiveness marker,anti-apoptotic function,p97-associated protein complex
ENSG00000164983,TMEM65,regulation of apoptosis,upregulation in cancer,cellular process regulation,autophagy modulation,therapeutic target potential,cell growth promotion
ENSG00000180532,ZSCAN4,transcription factor,cell cycle regulation,apoptosis induction,tumor suppression,dna binding motif,gene silencing
ENSG00000118402,ELOVL4,lipid metabolism alteration,cancer cell growth promotion,therapeutic target,cellular proliferation regulation,tumor aggressiveness correlation,fatty acid synthesis regulation
ENSG00000196329,GIMAP5,gtpase activity,cancer susceptibility,immune system regulation,cell growth regulation,t-cell homeostasis,genomic instability
ENSG00000197079,KRT35,keratin filament disruption,epithelial-to-mesenchymal transition (emt),tumor progression,cellular integrity compromise,cancer aggressiveness promotion,molecular mechanism complexity
ENSG00000143393,PI4KB,pi4p synthesis,cancer cell growth,dysregulated expression,protein kinase activation,metastasis and invasion,cell migration signaling
ENSG00000115307,AUP1,**

aup1
cellular stress responses,protein quality control,molecular chaperone interaction,oncogenic protein aggregation,therapeutic resistance,cell proliferation enhancement

**
ENSG00000112038,OPRM1,opioid signaling pathway,altered expression,cell proliferation regulation,apoptosis inhibition,angiogenesis promotion,pain modulation disruption
ENSG00000074319,TSG101,tumor progression,cell proliferation,protein degradation,escrt pathway,ubiquitination regulation,oncogene upregulation
ENSG00000169885,CALML6,apoptosis regulation,cell cycle modulation,microtubule stability,prognostic marker,calcium-dependent signaling,therapeutic target
ENSG00000183036,PCP4,constitutive activation,oncogenic driver mutation,cell proliferation enhancement,metastasis facilitation,protein kinase regulation,biomarker identification
ENSG00000152359,POC5,dna damage response,genomic instability,tumor suppression,genome integrity maintenance,dna repair,loss-of-function mutations
ENSG00000146592,CREB5,oncogenic transformation,tumor progression,cell survival enhancement,metabolic regulation disruption,transcriptional regulation alteration,prognostic biomarker
ENSG00000102858,MGRN1,emt regulation,protein ubiquitination,oncogenic signaling,wnt/β-catenin pathway,cell proliferation,metastasis promotion
ENSG00000087111,PIGS,cell membrane anchoring,glycosylphosphatidylinositol anchors,oncogenic potential,protein-protein interactions,tumor progression,cell proliferation
ENSG00000109654,TRIM2,pi3k/akt pathway modulation,tumor suppressor function,cell growth regulation,prognostic marker potential,oncogenic process inhibition,metastasis suppression
ENSG00000104228,TRIM35,ubiquitination pathway,e3 ligase activity,protein degradation regulation,cell cycle control,tumor suppressor function,oncogenesis modulation
ENSG00000109736,MFSD10,lipid trafficking,cellular energy regulation,fatty acid metabolism,oncogene role,pi3k/akt pathway interaction,tumor progression driver
ENSG00000121542,SEC22A,tumor suppressor function,endoplasmic reticulum-golgi network regulation,protein sorting and trafficking,cell proliferation and survival enhancement,poor prognosis marker,therapeutic target candidate
ENSG00000169217,CD2BP2,src family kinase activation,oncogene potential,cell cycle regulation disruption,overexpression in cancer cells,therapeutic target opportunity,src-src interactions role
ENSG00000152049,KCNE4,potassium channel regulation,cellular electrical properties,tumor progression,oncogenic signaling,epithelial-to-mesenchymal transition,electrogenic function
ENSG00000101161,PRPF6,aberrant splicing,biogenesis regulation,cell proliferation,gene expression regulation,mislocalized proteins,tumorigenesis association
ENSG00000162881,OXER1,oncogene activation,pi3k/akt signaling pathway modulation,gene overexpression,tumor progression,cell proliferation enhancement,apoptosis inhibition
ENSG00000213186,TRIM59,oncogene,protein degradation regulation,apoptosis inhibition,cell proliferation enhancement,tumor progression factor,biomarker for cancer
ENSG00000102934,PLLP,cell signaling pathway,increased expression,oncogenic process,tumor progression,cellular regulation disruption,growth factor binding
ENSG00000182473,EXOC7,pi3k/akt pathway modulation,rab gtpase interaction,oncogene potential,cell growth regulation,tumor progression involvement,exocyst complex component
,MARCH3,tumor suppression,apoptosis regulation,cell growth regulation,protein degradation regulation,oncogene regulation,e3 ubiquitin ligase interaction
ENSG00000284868,DHRS1,androgen receptor modulation,mitochondrial localization,steroid hormone biosynthesis,oncogenic driver,metabolic regulation,tumor growth promotion
ENSG00000169683,LRRC45,cellular interaction,protein-protein interaction,tumor progression,cancer prognosis,biomarker potential,cell migration regulation
ENSG00000179071,CCDC89,ciliogenesis disruption,cell signaling dysregulation,dysmotile cilia formation,oncogenic driver potential,therapeutic target candidate,genetic disorder connection
ENSG00000135249,RINT1,chromosomal instability,tumor suppressor function,loss of heterozygosity,dna repair mechanisms,genomic alterations,tumor progression
ENSG00000196843,ARID5A,chromatin remodeling,genomic instability,epigenetic regulation,tumor suppressor function,oncogenic signaling activation,telomere maintenance
ENSG00000152954,NRSN1,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor progression facilitation,metastasis promotion,protein expression upregulation,cancer cell migration enhancement
ENSG00000101236,RNF24,protein degradation regulator,akt pathway activation,tumor suppressor targeting,cell proliferation promoter,metastasis enhancer,ubiquitination facilitator
ENSG00000029725,RABEP1,rab5 interaction,endocytic recycling,cell migration invasion,oncogenic signaling,tumor progression marker,epithelial-to-mesenchymal transition
ENSG00000103365,GGA2,egfr signaling pathway activation,golgi apparatus function regulation,vesicular trafficking modulation,cell proliferation and survival enhancement,metastasis promotion,cancer progression contribution
ENSG00000114993,RTKN,rhoa activation,cell migration,tumor progression,pro-survival signaling,substrate for rock-1,onco-protein kinase
ENSG00000086015,MAST2,cell cycle regulation,apoptosis suppression,protein degradation regulation,substrate recognition,therapeutic target,ubiquitination machinery modulation
ENSG00000103034,NDRG4,tumor suppressor function,cell proliferation inhibition,genomic instability regulation,pi3k/akt pathway modulation,cellular response to dna damage,prognostic marker
ENSG00000127561,SYNGR3,vesicle fusion regulation,tumor progression promotion,poor prognosis association,cell migration facilitation,immune suppression role,driver gene implication
ENSG00000092607,TBX15,wnt/β-catenin pathway,overexpression,cell proliferation,migration and invasion,oncogenic role,transcriptional regulation
ENSG00000282379,DTX2,cell proliferation,apoptosis evasion,transcriptional regulation,tumor progression,cancer cell invasion,developmental regulation
ENSG00000099968,BCL2L13,anti-apoptotic activity,tumor suppressor downregulation,cell survival promotion,proteasome regulation,apoptosis inhibition,mitochondrial outer membrane permeabilization
ENSG00000170310,STX8,cell growth regulation,oncogenic potential,gene expression modulation,cell survival pathway interaction,tumor aggressiveness,protein-protein interactions
ENSG00000166833,NAV2,cellular migration,tumor progression,signaling pathway regulation,genomic amplification,protein-protein interaction,oncogenic pathway modulation
ENSG00000092010,PSME1,proteasome activation,oncogene overexpression,cell proliferation,angiogenesis promotion,apoptosis inhibition,ubiquitin-proteasome pathway regulation
ENSG00000160185,UBASH3A,pi3k/akt/mtor pathway regulation,protein degradation regulation,oncogenic process regulation,cell proliferation enhancement,tumor progression association,therapeutic target potential
ENSG00000184492,FOXD4L1,epigenetic regulation,tumor aggressiveness,cell cycle progression,transcriptional dysregulation,oncogenic driver,anti-apoptotic pathways
ENSG00000162366,PDZK1IP1,epithelial polarity regulation,tight junction organization,pi3k/akt pathway modulation,cell migration regulation,cytoplasmic adapter function,oncogenic pathway interaction
ENSG00000127774,EMC6,cellular regulation,amino acid metabolism,apoptosis modulation,gene expression changes,tumor progression,transcriptional regulation
ENSG00000111701,APOBEC1,hypermutator phenotype,gain of function mutations,tumor progression,dna deamination,oncogenesis,genomic instability
ENSG00000186977,KRTAP19-5,cell proliferation,oncogenic processes,overexpression,signaling pathway activation,tumor survival,gene expression regulation
ENSG00000020256,ZFP64,cell cycle regulation,tumor suppressor function,dna repair mechanism interaction,apoptosis regulation,genome stability maintenance,transcriptional regulation
ENSG00000141378,PTRH2,ribosome biogenesis,mtor pathway regulation,growth factor signaling,tumor progression biomarker,protein synthesis regulator,cell proliferation enhancer
ENSG00000105374,NKG7,nk cell activation,immunosurveillance evasion,cytotoxic activity enhancement,tumor immune suppression,biomarker for immunotherapy,mhc class i expression regulation
ENSG00000177842,ZNF620,tumor suppression,cell cycle progression,chromatin remodeling,transcriptional regulation,zinc finger protein,apoptosis
ENSG00000147133,TAF1,transcriptional regulation,cell cycle progression,dna repair,cell proliferation,oncogenic role,transcriptional activator complex
ENSG00000179930,ZNF648,tumor progression,tumor suppressor gene regulation,apoptosis inhibition,cell proliferation enhancement,angiogenesis promotion,protein-dna interaction
ENSG00000127993,RBM48,apoptosis resistance,cell proliferation,spliceosomal complex regulation,tumor aggressiveness,promotes metastasis,epigenetic alterations
ENSG00000100461,RBM23,rna regulation,tumor aggressiveness,pi3k/akt signaling,transcriptional regulation,mutation hotspot,cancer progression
ENSG00000163993,S100P,tumor progression,cell proliferation,cancer stem cell maintenance,signaling pathway modulation,oncogenic protein interaction,poor prognosis indicator
ENSG00000173250,GPR151,g protein-coupled receptor activation,overexpression,cellular growth,survival pathway activation,tumorigenesis regulation,protein interaction modulation
ENSG00000124103,FAM209A,cell cycle regulation,dna repair mechanisms,protein-protein interactions,altered expression,regulatory mechanism,cell proliferation
ENSG00000288427,CLSTN3,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression facilitation,protein-protein interaction enhancement,apoptosis suppression,angiogenesis regulation
ENSG00000174599,TRAM1L1,cell cycle regulation,dysregulation of cell growth,interaction with apoptosis pathways,tumor progression,genomic instability,protein-protein interaction
ENSG00000131115,ZNF227,zinc finger protein regulation,krab domain-containing family member,transcriptional repression,oncogenic potential,apoptosis suppression,cell cycle regulation
ENSG00000225998,LSM2,genomic instability,epigenetic regulation,rna splicing regulation,cell proliferation regulation,nuclear localization,cancer progression
ENSG00000100281,HMGXB4,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell growth modulation,histone modification,tumor suppression
ENSG00000102977,ACD,genomic instability,chromatin remodeling,transcriptional regulation,dna repair mechanisms,genome stability maintenance,cancer progression contributor
ENSG00000065150,IPO5,apoptosis inhibition,cell survival promotion,iap family member,nf-kb pathway interaction,oncogene overexpression,poor prognosis predictor
ENSG00000152684,PELO,cell division,chromosomal instability,mitotic regulation,oncogenic transformation,tumor aggressiveness,microtubule dynamics
ENSG00000122971,ACADS,mitochondrial enzyme,fatty acid beta-oxidation,energy metabolism regulation,cellular growth influence,cancer-related metabolic alterations,limited cancer relevance
ENSG00000263236,KRTAP4-12,cell growth regulation,tumor progression,cell survival pathways,protein-protein interactions,molecular differentiation,epithelial morphology
ENSG00000184012,TMPRSS2,transmembrane serine protease activity,cell signaling pathway modulation,oncogenic process promotion,tumor progression driver,cancer biomarker,genetic regulatory mechanism
ENSG00000163217,BMP10,tumor suppressor activity,cell cycle regulation,apoptosis induction,epithelial-to-mesenchymal transition inhibition,angiogenesis regulation,metastasis promotion
ENSG00000109099,PMP22,cell adhesion disruption,enhanced cellular migration,prognostic marker,tumor progression,metastatic potential,signal transduction pathway alteration
ENSG00000131165,CHMP1A,cell survival,metastasis promotion,lysosome regulation,autophagy regulation,endosomal trafficking,escrt-i complex
ENSG00000160318,CLDND2,epithelial polarity regulation,tight junction formation,cell growth promotion,overexpression,poor prognosis marker,therapeutic target
ENSG00000168476,REEP4,er calcium homeostasis,mitochondrial dynamics,cancer progression,stress response regulation,interaction with bag3/sod2,prognostic marker
ENSG00000115091,ACTR3,cellular migration,involved in metastasis,actin filament assembly,tumor progression,oncogenic function,regulatory mechanism
ENSG00000178951,ZBTB7A,tumor suppressor activity,transcriptional regulation,cell cycle progression inhibition,apoptosis promotion,oncogene suppression,genomic instability prevention
ENSG00000011295,TTC19,mitochondrial biogenesis,tumor suppressor function loss,genomic amplification,oncogene activation,cellular energy production,protein-protein interaction
ENSG00000163703,CRELD1,pi3k/akt signaling,tumor progression,metastasis promoter,elevated expression,biomarker for disease progression,emt regulator
ENSG00000176903,PNMA1,oncogenic signaling,overexpression,adaptor molecule,cell adhesion,epithelial-to-mesenchymal transition (emt),signaling complex
ENSG00000184402,SS18L1,transcriptional regulation,protein-protein interaction,cell growth promotion,tumor progression,cell cycle modulation,apoptosis inhibition
ENSG00000172156,CCL11,pro-tumorigenic microenvironment,immune suppression,tumor growth promotion,angiogenesis,chemokine signaling pathway,dysregulation
ENSG00000221978,CCNL2,cell cycle regulation,g1/s phase transition,cyclin family member,protein-protein interactions,tumor progression promoter,anti-apoptotic activity
ENSG00000084764,MAPRE3,microtubule stabilization,cell proliferation,oncogenic protein interaction,pi3k/akt pathway regulation,cell division facilitation,tumor promotion
ENSG00000115266,APC2,cell cycle regulation,chromosomal instability,cell proliferation,therapeutic target,ubiquitination degradation,oncogenesis
ENSG00000168412,MTNR1A,melatonin signaling pathway,regulation of apoptosis,cell proliferation regulation,g-protein coupled receptor function,pi3k/akt pathway modulation,tumor suppressor activity
ENSG00000145283,SLC10A6,nucleotide transport,cell proliferation,metastatic potential,tumor progression,prognostic biomarker,signaling pathways activation
,C16orf58,regulatory function,signaling pathway regulation,cellular localization,protein-protein interaction,wd40 repeat domain,rhogap domain
ENSG00000140941,MAP1LC3B,autophagic process,mitophagy regulation,ubiquitin conjugation system,cellular degradation,tumorigenesis association,cancer biology relevance
ENSG00000154153,RETREG1,oncogene regulation,cell differentiation disruption,tumor microenvironment modulation,cancer cell behavior influence,pi3k/akt/mtor pathway interaction,biomarker for patient outcome prediction
ENSG00000060237,WNK1,pi3k/akt/mtor pathway regulation,oncogenic driver,cell proliferation and survival modulation,signaling pathway interaction,genetic mutation association,hypertension and cardiovascular disease involvement
ENSG00000185963,BICD2,microtubule dynamics regulation,oncogene activation,genomic instability,chromosomal abnormalities,cell proliferation enhancement,protein-protein interaction
ENSG00000241595,KRTAP9-4,keratin filament network,tumor progression,cell adhesion modulation,epithelial structural changes,gene expression dysregulation,metastatic potential
ENSG00000066117,SMARCD1,chromatin remodeling,cell growth regulation,genome instability regulation,tumor progression association,prognostic marker,gene transcription modulation
ENSG00000168411,RFWD3,ubiquitin ligase activity,cell cycle regulation,dna damage response,genomic stability maintenance,protein degradation,tumor progression
ENSG00000178538,CA8,tumor progression,cell survival,oncogenic potential,angiogenesis regulation,apoptosis modulation,proliferation enhancement
ENSG00000109083,IFT20,anterograde movement,ciliary maintenance,cell division regulation,intraflagellar transport,microtubule stability,tumor progression association
ENSG00000138750,NUP54,nuclear structure maintenance,chromatin remodeling,mitotic apparatus association,prognostic marker,genomic instability,tumor progression
ENSG00000162882,HAAO,lipid metabolism,cell proliferation,energy production,fatty acid oxidation,tumor progression,pi3k/akt pathway
ENSG00000128513,POT1,telomere regulation,tumor suppressor dysregulation,oncogene activation,cell proliferation promotion,telomerase activity increase,genomic instability protection
ENSG00000106536,POU6F2,oncogenic regulation,transcriptional modulation,cell proliferation,signaling pathway regulation,tumor progression,epigenetic modification
ENSG00000101216,GMEB2,tumor progression,cell proliferation,metastasis,immune evasion,nf-κb interaction,transcriptional regulation
ENSG00000141198,TOM1L1,autophagy regulation,erad pathway modulation,cell proliferation promotion,apoptosis inhibition,tumor growth facilitation,protein quality control
ENSG00000160447,PKN3,**
overexpression,constitutive activation,cell proliferation,pi3k/akt/mtor pathway dysregulation,oncogenic driver,poor prognosis predictor
**
ENSG00000130669,PAK4,mapk/erk pathway,cell signaling pathways,oncogene,tumor progression,serine/threonine kinase activity,rho gtpase interaction
ENSG00000181885,CLDN7,epithelial-to-mesenchymal transition,upregulated expression,tumor progression,wnt/β-catenin signaling,cellular polarity disruption,cancer cell invasion
ENSG00000147123,NDUFB11,complex i dysfunction,mitochondrial reprogramming,tumor aggressiveness,oncogenic metabolic shift,mitochondrial dynamics alterations,genomic profiling alterations
ENSG00000084072,PPIE,cancer-associated overexpression,cell proliferation enhancement,metastatic potential,therapeutic target,protein folding regulation,signaling pathway modulation
ENSG00000171840,NINJ2,epigenetic regulation,tumor progression,oncogenic pathway activation,transcriptional control,chromatin remodeling,cancer driver gene
ENSG00000080345,RIF1,dna damage response,constitutive activation,genome instability,homologous recombination,tumor progression,synthetic lethality
ENSG00000160207,HSF2BP,heat shock protein regulation,tumor progression,cell proliferation,survival and metastasis,pi3k/akt pathway interaction,genomic instability
ENSG00000180448,ARHGAP45,rho gtpase regulation,cytoskeleton reorganization,cell migration,tumor progression,metastasis promotion,oncogenic activation
ENSG00000129204,USP6,deubiquitinating enzyme function,genomic amplification,oncogene overexpression,protein turnover regulation,cell proliferation promotion,dna damage response disruption
ENSG00000111245,MYL2,constitutive activation,epithelial-to-mesenchymal transition (emt),cell migration regulation,actin cytoskeleton dynamics,cell adhesion disruption,protein-protein interaction
ENSG00000166394,CYB5R2,electron transfer,mitochondrial regulation,oxidative stress,oncogenesis,poor prognosis,tumor growth enhancement
ENSG00000159289,GOLGA6A,nuclear pore complex regulation,cell proliferation suppression,transcriptional regulation,tumor progression,aberrant expression,prognostic marker
ENSG00000112837,TBX18,oncogene,cell cycle progression,apoptosis inhibition,epithelial-to-mesenchymal transition,transcription factor regulation,vascular integrity maintenance
ENSG00000198576,ARC,apoptosis modulation,tumor suppressor dysfunction,oncogenic function,therapeutic target,cell survival enhancement,mitochondrial membrane permeabilization inhibition
ENSG00000164066,INTU,**
genomic instability,premature stop codon recognition,tumor suppressor function,oncogenic mutations,splicing regulation,mrna decay
ENSG00000147459,DOCK5,rho gtpase regulation,cell invasion,cell migration,apoptosis modulation,protein-protein interactions,oncogenic driver
ENSG00000111252,SH2B3,tumor suppression,downregulation,cellular response inhibition,oncogene regulation,protein interaction,immune response modulation
ENSG00000125991,ERGIC3,protein transport regulation,tumor suppressor function,proliferation regulation,cancer cell survival enhancement,cell growth modulation,endoplasmic reticulum-golgi apparatus interaction
ENSG00000175305,CCNE2,cell cycle regulation,genomic instability,oncogenic driver,prognostic marker,therapeutic target,tumor progression
ENSG00000138668,HNRNPD,mrna stability and transport regulator,oncogenic role in cancer,cell growth and invasion facilitator,transcriptional regulation modulator,tumor suppressor gene silencer,poor prognosis biomarker
ENSG00000164949,GEM,glutathione metabolism,antioxidant capacity,cancer progression,chemoresistance,rdsscavenging,cellular metabolism regulation
ENSG00000112304,ACOT13,fatty acid metabolism,cell proliferation,metastasis promotion,pi3k/akt pathway activation,prognostic biomarker,lipid homeostasis regulation
ENSG00000122257,RBBP6,polycomb complex component,ubiquitin ligase activity,cell cycle regulation,transcriptional control,tumor suppressor dysregulation,genomic instability
ENSG00000100504,PYGL,pentose phosphate pathway activation,glycolytic flux enhancement,tumor growth promotion,cell metabolism modulation,predictive biomarker,prognostic marker
ENSG00000068976,PYGM,glycogenolysis regulation,cell proliferation promotion,energy metabolism regulation,mutations associated with cancer,oncogenic driver gene,glucose-6-phosphate production
ENSG00000130948,HSD17B3,steroid hormone regulation,dht-mediated proliferation,signaling pathway interaction,oncogene expression,androgen receptor activation,apoptosis suppression
ENSG00000050628,PTGER3,cell migration,g protein-coupled receptor family,hypoxia-inducible factor activation,metastasis promotion,oncogenic signaling pathway,tumor growth promotion
ENSG00000120699,EXOSC8,tumor suppressor rna degradation,cell proliferation enhancement,poor prognosis indicator,advanced clinical stages marker,oncogenic process facilitation,rna processing regulation
ENSG00000132510,KDM6B,histone demethylation,chromatin regulation,oncogenic driver,tumor progression,gene expression modulation,prc2 interaction
ENSG00000263341,KRTAP17-1,keratin filament assembly,cytoprotective function loss,tumor progression enhancement,cellular proliferation promotion,cancer cell migration facilitation,cytoskeleton disruption
ENSG00000114698,PLSCR4,enhanced cell migration,tumor progression,metastasis facilitation,cell survival modulation,pi3k/akt pathway interaction,phospholipid scrambling activity
ENSG00000172568,FNDC9,cell adhesion disruption,oncogenic function,tumor progression promotion,metastasis facilitation,prognostic marker,extracellular matrix interaction
ENSG00000142227,EMP3,tumor suppressor function,pi3k/akt pathway regulation,lysosome-associated membrane protein family member,cell growth and division regulation,autophagy and mitophagy modulation,prognostic biomarker potential
ENSG00000141084,RANBP10,cellular regulation,dna damage response,genome stability,nuclear transport,cell cycle progression,chromatin remodeling
ENSG00000130066,SAT1,amino acid transport,tumor growth promotion,cellular metabolism regulation,energy production enhancement,therapeutic target identification,substrate interaction
ENSG00000141504,SAT2,histone modification,epithelial-to-mesenchymal transition,chromatin remodeling,cell cycle regulation,tumor progression,metastasis promoter
ENSG00000111653,ING4,tumor suppressor,pi3k/akt pathway regulation,cancer cell growth inhibition,angiogenesis regulation,apoptosis induction,cell cycle progression
ENSG00000095951,HIVEP1,tumor microenvironment modulation,epigenetic regulation,pro-tumor transcriptional activity,angiogenesis promotion,immune evasion mechanisms,gene expression regulation
ENSG00000165630,PRPF18,cellular proliferation,spliceosome complex,mapk/erk pathway interaction,tumor progression,genomic alterations,apoptosis evasion
ENSG00000149781,FERMT3,rhoa/rac1 signaling,epithelial-to-mesenchymal transition,cytoskeletal regulation,mutation/overexpression,cancer cell migration and invasion,none
ENSG00000111837,MAK,microtubule regulation,cell migration,cytoskeleton modulation,cell proliferation,signaling pathway interaction,oncogenic driver
,ICK,cellular excitability,ion balance regulation,voltage-gated potassium channel,oncogenic process,cell proliferation enhancement,metabolic regulation
,KIF1BP,microtubule regulation,cell proliferation,genomic instability,tumor progression,cancer driver,promotes survival
ENSG00000105856,HBP1,tumor suppressor,genomic instability,cell cycle regulation,apoptosis induction,transcriptional regulation,protein-protein interactions
ENSG00000083520,DIS3,ribosomal biogenesis,nlrp3 inflammasome activation,loss of function mutation,cell proliferation driver,tumor suppressor gene,genomic instability marker
ENSG00000107371,EXOSC3,rna degradation,oncogenic signaling,cellular proliferation,transcriptional regulation,tumor progression,protein-protein interaction
ENSG00000212933,KRTAP12-4,keratin-associated protein,intermediate filament regulation,cytostructural changes,epithelial morphology regulation,tumor progression contribution,unclear tumor suppressor/oncogene relationship
ENSG00000092853,CLSPN,cellular invasion,angiogenesis promotion,tumor growth driver,biomarker candidate,dna repair regulation,transcriptional regulation enhancer
ENSG00000131966,ACTR10,protein degradation regulation,cell cycle progression regulation,oncogene overexpression,metastatic potential enhancement,therapeutic target candidate,tumor growth promotion
ENSG00000126262,FFAR2,cellular energy homeostasis,lipid metabolism regulation,g-protein coupled receptor function,oncogenic signaling pathway interaction,cell growth promotion,cell survival enhancement
ENSG00000111371,SLC38A1,amplification of slc38a1,cellular amino acid uptake,metabolic reprogramming,tumor aggressiveness,mtor signaling activation,prognostic marker
ENSG00000274352,ZNF707,zinc finger protein regulation,tumor progression,transcriptional repression,apoptosis inhibition,immune modulation,prognostic marker
ENSG00000166946,CCNDBP1,cell cycle regulation,apoptosis inhibition,transcriptional regulation,tumor progression,oncogenic processes,genomic instability
ENSG00000145029,NICN1,energy metabolism,oncogenic driver,cell proliferation,tumor progression,amino acid transport,prognostic marker
ENSG00000175691,ZNF77,chromatin remodeling,apoptosis regulation,transcriptional regulation,cellular proliferation,oncogenic activity,zinc finger binding
ENSG00000119912,IDE,ide regulation,tumor promotion,cellular degradation,metabolic modulation,pi3k/akt interaction,tumor progression
ENSG00000125207,PIWIL1,oncogenic reprogramming,microrna regulation,epigenetic dysregulation,tumor suppression,stemness maintenance,dna damage response
ENSG00000113387,SUB1,vhl-hif-1α interaction disruption,protein ubiquitination regulation,tumor suppressor degradation inhibition,angiogenesis and glycolysis enhancement,therapeutic target identification,cancer progression promotion
ENSG00000119820,YIPF4,er membrane protein regulation,autophagy regulation,oncogenic function,cell survival promotion,tumor progression marker,er lipid homeostasis
ENSG00000036565,SLC18A1,glutamate transport,neurotransmitter regulation,cancer stem cell maintenance,angiogenesis promotion,tumor aggressiveness,prognostic biomarker
ENSG00000205864,KRTAP5-6,cytoskeleton maintenance,cellular adhesion,protein expression regulation,tissue structure maintenance,keratin filament assembly,molecular chaperone interaction
ENSG00000151650,VENTX,cellular proliferation,chromatin remodeling,dna replication,oncogenic properties,transcriptional regulation,tumor progression
ENSG00000037965,HOXC8,transcriptional regulation,cell proliferation,apoptosis inhibition,metastasis promotion,tumor aggressiveness,potential oncogene
ENSG00000102144,PGK1,energy metabolism regulation,cell growth promotion,glycolytic activity increase,cancer cell proliferation,metabolic reprogramming,tumor aggressiveness indicator
ENSG00000064835,POU1F1,transcription factor activity,oncogenic effects,cell proliferation,developmental regulation,genomic instability,epigenetic modifications
ENSG00000197822,OCLN,angiogenesis,cell migration,epithelial-to-mesenchymal transition (emt),junctional regulation,permeability regulation,vascular endothelial growth factor secretion
ENSG00000196417,ZNF765,transcription factor activity,tumor suppressor function,gene expression regulation,cell cycle inhibition,oncogenic pathway interaction,epigenetic modification
ENSG00000185043,CIB1,emt regulation,oncogenesis,cell cycle progression,metastasis promotion,apoptosis inhibition,gene expression regulation
ENSG00000100348,TXN2,oncogenesis,dual function,tumor progression,cell migration,protein interaction,reactive oxygen species regulation
ENSG00000155636,RBM45,rna-binding protein,cell cycle regulation,spindle assembly regulator,mitotic checkpoint control,genomic integrity maintenance,oncogenic mrnas regulation
ENSG00000136371,MTHFS,dna damage response,genomic instability,cancer biomarker,folate metabolism alteration,tumor suppressor function,ploidy regulation
ENSG00000081386,ZNF510,dna binding,transcriptional regulation,oncogene function,cell growth regulation,tumor progression,transcription factor interaction
ENSG00000152253,SPC25,chromosomal instability,cell cycle regulation,kinetochores assembly,microtubule attachment,aneuploidy,oncogenesis
ENSG00000043143,JADE2,histone modification,chromatin remodeling,tumor suppressor gene repression,cellular proliferation enhancement,oncogenic coactivator,apoptosis evasion facilitation
ENSG00000163960,UBXN7,cell cycle regulation,protein stabilization,oncogenic processes,tumor growth,metastasis,proliferation
ENSG00000170469,SPATA24,telomerase regulation,telomere elongation,genomic instability,cell cycle dysregulation,dna repair impairment,cancer immortality
ENSG00000117394,SLC2A1,glucose uptake,energy metabolism,tumor growth,glycolysis,signaling pathway,overexpression
ENSG00000213906,LTB4R2,leukotriene b4 signaling pathway,oncogenic processes,tumor progression,cell proliferation and migration,immune response modulation,prognostic marker
ENSG00000148848,ADAM12,tumor progression,cell surface remodeling,proteolysis,cell-cell interaction,biomarker candidate,metastasis facilitation
ENSG00000188581,KRTAP1-1,cell proliferation,epithelial differentiation,tumor progression,cell survival,cytoskeletal regulation,genomic alteration
ENSG00000071203,MS4A12,cancer-associated expression,cell survival enhancement,dysregulated signaling pathways,immune response modulation,oncogenic potential,prognostic marker status
ENSG00000144063,MALL,p53 interaction,oncogene function,tumor progression,dna repair mechanism,loss of function mutation,constitutive activation
ENSG00000177238,TRIM72,tumor suppressor function,cell growth regulation,apoptosis induction,ubiquitin ligase activity,protein-protein interaction,microrna-21 target
ENSG00000140262,TCF12,wnt/β-catenin signaling pathway,transcription factor activity,tumor suppressor function,oncogene overexpression,epithelial-to-mesenchymal transition (emt),cell growth regulation
ENSG00000100652,SLC10A1,bile acid transport,nutrient stress modulation,cell proliferation regulation,oncogene potential,pi3k/akt pathway interaction,energy homeostasis disruption
ENSG00000164007,CLDN19,tumor progression,cell migration,epithelial integrity disruption,signaling pathway interaction,cell adhesion regulation,metastasis facilitation
ENSG00000147905,ZCCHC7,histone methylation,chromatin regulation,oncogenic processes,tumor progression,epigenetic dysregulation,transcriptional activation
ENSG00000137960,GIPC2,oncogenic properties,promotes cell growth,regulates wnt/β-catenin pathway,interacts with β-catenin and apc,therapeutic target,enhances cell proliferation
ENSG00000127838,PNKD,mitochondrial dynamics regulation,pi3k/akt signaling modulation,tumor progression facilitation,cellular energy metabolism enhancement,protein interaction with pink1,therapeutic target potential
ENSG00000180440,SERTM1,metastasis regulation,cell adhesion inhibition,protein-protein interaction,tumor progression,overexpression,biomarker candidate
ENSG00000197992,CLEC9A,tumor microenvironment modulation,cancer cell recognition disruption,immune evasion strategies,poor prognosis indicator,biomarker potential,cellular adhesion regulation
ENSG00000119397,CNTRL,actin cytoskeleton regulation,cell migration promotion,tumor invasion facilitation,cancer cell motility enhancement,invasiveness contributor,signaling pathway interaction
ENSG00000164440,TXLNB,erad pathway dysfunction,protein homeostasis disruption,tumor progression facilitation,cellular stress response modulation,atpase activity regulation,genomic instability association
ENSG00000116062,MSH6,genomic instability,mismatch repair deficiency,biomarker,dna damage repair,gene mutations,tumor suppressor
ENSG00000161055,SCGB3A1,tumor progression,oncogenesis,cell growth regulation,secretoglobin family protein,elevated expression levels,poor prognosis indicator
ENSG00000149823,VPS51,tumor progression,autophagy induction,cell survival enhancement,pi3k/akt pathway modulation,genomic instability,escrt pathway disruption
ENSG00000124508,BTN2A2,immune modulation,prognostic biomarker,tumor-infiltrating t cells,immunoregulatory function,cancer immunotherapy target,gene expression regulation
ENSG00000134531,EMP1,oncogenic protein,overexpression tumor suppressor,cell-cell adhesion regulation,pi3k/akt pathway modulation,angiogenesis promoter,e-cadherin suppression
ENSG00000157680,DGKI,dgk activity,cell proliferation,apoptosis modulation,protein kinase activation,cell cycle regulation,tumorigenesis driver
ENSG00000119705,SLIRP,rna-binding protein,oncogene activation,tumor progression,cancer cell survival,cell proliferation,apoptosis evasion
ENSG00000196182,STK40,cellular signaling pathways,oncogenic activation,serine/threonine kinase activity,tumor progression,cell cycle regulation,protein-protein interactions
ENSG00000079150,FKBP7,tumor progression,oncogenic signaling,cell proliferation,calcium homeostasis regulation,transcription factor regulation,prognostic biomarker
ENSG00000177427,MIEF2,mitochondrial regulation,tumor promotion,cell survival,therapeutic target,metabolic reprogramming,oncogenic function
ENSG00000008197,TFAP2D,transcriptional regulation,apoptosis suppression,cell proliferation enhancement,metastasis promotion,oncogenic driver,epigenetic modification
ENSG00000186970,KRTAP15-1,keratin filament regulation,tumor progression,cellular proliferation,epithelial cell invasion,cancer aggressiveness,aberrant expression
ENSG00000167984,NLRC3,e3 ubiquitin ligase activity,nf-κb inhibition,mtor suppression,apoptosis induction,angiogenesis regulation,tumor suppressor function
ENSG00000057019,DCBLD2,cellular adhesion,golgi apparatus regulation,epithelial-to-mesenchymal transition (emt),tumor progression,cell migration and invasion,cytoskeletal organization
ENSG00000013293,SLC7A14,amino acid transport,metabolic reprogramming,cell proliferation,tumor progression,aggressive behavior,poor prognosis
ENSG00000122877,EGR2,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor suppression,oncogene overexpression,dna binding activity
ENSG00000206053,JPT2,mitochondrial function,regulatory protein interactions,oncogenesis,cell growth regulation,energy metabolism,proliferation control
ENSG00000101438,SLC32A1,**
metabolic regulation,amino acid transport,cellular proliferation,ion balance disruption,altered expression,tumor progression 
**
ENSG00000196456,ZNF775,tumor suppression,transcriptional repression,apoptosis regulation,cancer cell cycle regulation,zinc finger protein interaction,oncogene target gene repression
ENSG00000107186,MPDZ,epithelial-to-mesenchymal transition (emt),pi3k/akt/mtor pathway regulation,tumor progression promotion,cell survival enhancement,proliferation facilitation,upregulated expression levels
ENSG00000184166,OR1D2,tumor progression,pi3k/akt pathway,cell proliferation,olfactory receptor signaling,overexpression,biomarker
ENSG00000177300,CLDN22,tumor progression,metastasis,cellular adhesion,tight junction regulation,epigenetic modification,oncogenic overexpression
ENSG00000139644,TMBIM6,apoptosis regulation,cell survival pathways,tumor suppressor function,pro-apoptotic protein inhibition,endoplasmic reticulum stress response,membrane trafficking regulation
ENSG00000170540,ARL6IP1,membrane trafficking regulation,cytoskeleton modulation,microtubule-based transport,tumor progression driver,cell migration influence,golgi apparatus localization
ENSG00000121413,ZSCAN18,epigenetic regulation,transcriptional regulation,chromatin modification,oncogenesis,tumor progression,apoptosis inhibition
ENSG00000137338,PGBD1,genomic instability,oncogenesis,dna repair pathway,non-homologous end joining (nhej),microsatellite instability (msi),chromosomal instability
ENSG00000108587,GOSR1,cellular trafficking regulation,tumor growth promotion,dysregulated signaling,protein trafficking facilitation,vesicle fusion regulation,growth factor receptor association
ENSG00000166856,GPR182,g protein-coupled receptor,cell growth regulation,metabolic stress response,tumor progression driver,poor prognosis marker,mtor pathway interaction
ENSG00000137824,RMDN3,wnt/β-catenin pathway,stability of β-catenin,aberrant activation,tumor progression,therapeutic target,biomarker
ENSG00000183733,FIGLA,**

proliferation,oncogene,metastasis,wnt/β-catenin signaling,erα interaction,mirna regulation
**
ENSG00000107187,LHX3,transcriptional regulation,cell proliferation,oncogene activation,cell cycle regulation,apoptosis evasion,tumor progression
ENSG00000147676,MAL2,tumor suppressor function,regulation of cytoskeletal dynamics,cell adhesion modulation,metastatic potential enhancement,invasive property promotion,cancer progression facilitation
ENSG00000130957,FBP2,metabolic reprogramming,tumor microenvironment adaptation,glycolytic shift,oncogenic role,cell proliferation enhancement,hypoxia-induced adaptation
ENSG00000165140,FBP1,warburg effect,glycolytic shift,glucose metabolism regulation,tumor growth promotion,transcriptional coactivation,oncogenic function
ENSG00000166261,ZNF202,tumor suppressor activity,chromatin regulation,genomic instability,apoptosis inhibition,cell proliferation enhancement,dna repair modulation
ENSG00000175294,CATSPER1,cellular proliferation,tumor progression,protein regulation,genomic instability,metastasis promotion,oncogenic function
ENSG00000196923,PDLIM7,cellular migration,epithelial-to-mesenchymal transition,oncogenic activity,prognostic marker,tumor progression,overexpression
ENSG00000189042,ZNF567,transcriptional regulation,zinc finger protein,chromatin remodeling,cell proliferation,gene expression profiling,apoptosis suppression
ENSG00000170264,FAM161A,mitochondrial dynamics regulation,genomic instability,mutagenesis prevention,protein-protein interactions,genome maintenance,tumor progression
ENSG00000095066,HOOK2,microtubule dynamics,spindle formation,cell migration,tumor growth promotion,dna damage response regulation,genomic instability
ENSG00000105185,PDCD5,apoptosis regulation,cell cycle arrest,dna damage response,protein-protein interaction,tumor suppressor function,genomic instability
,HIST2H2BF,histone modification,chromatin structure,gene expression regulation,tumor suppressor,epigenetic alteration,cell cycle control
ENSG00000033170,FUT8,oncogenic pathway activation,cell surface modification,protein glycosylation,tumor progression,cancer cell proliferation,glycoprotein modification
ENSG00000251369,ZNF550,chromatin remodeling,cancer-associated mutations,cell cycle regulation,transcriptional regulation,tumor suppressor activity,oncogenic potential
ENSG00000173207,CKS1B,cell cycle progression,overexpression,aggressive tumor behavior,substrate recognition,ubiquitin-proteasome pathway regulation,chemotherapy resistance
ENSG00000141699,RETREG3,dna damage response,tumor aggressiveness,genetic instability,apoptosis inhibition,cell survival enhancement,chromosomal alterations
ENSG00000241598,KRTAP5-4,cellular proliferation,tumor progression,genetic alteration,metastatic potential,adhesion disruption,proliferation enhancement
ENSG00000278489,KRTAP5-2,cellular adhesion disruption,epithelial cell regulation,intermediate filament assembly,keratin-associated protein function,protein-protein interaction,tumor aggressiveness enhancement
ENSG00000163206,SMCP,smooth muscle cell structure,cell motility regulation,molecular interaction,cell morphology maintenance,muscle contraction and relaxation,tumor progression impact
ENSG00000126890,CTAG2,transcriptional regulation,dysregulated expression,tumor progression,cell cycle disruption,apoptosis resistance,epigenetic regulation
ENSG00000182816,KRTAP13-2,tumor progression,metastasis,cell migration,overexpression,oncogenesis,epithelial cell integrity
ENSG00000178053,MLF1,mlf1-tsg,chromatin regulation,transcriptional repression,heterochromatic regions,cancer suppressor,apoptosis regulation
ENSG00000131016,AKAP12,pi3k/akt pathway regulation,cell proliferation modulation,apoptosis suppression,epithelial-to-mesenchymal transition (emt) promotion,protein kinase c interaction,cell migration enhancement
ENSG00000124222,STX16,membrane fusion regulation,cell proliferation enhancement,ubiquitin-proteasome system dysregulation,oncogene upregulation,tumor suppressor downregulation,pi3k/akt pathway interaction
ENSG00000168237,GLYCTK,glutathione biosynthesis,oxidative stress resistance,metabolic reprogramming,tumor growth promotion,cellular survival enhancement,apoptosis inhibition
ENSG00000262771,SSBP1,genomic instability,dna damage response,cell cycle regulation,oncogene/tumor suppressor,apoptosis modulation,single-stranded dna binding
ENSG00000124827,GCM2,pi3k/akt signaling pathway modulation,oncogene activation,cell growth regulation,tumor progression driver,genomic instability contributor,angiogenesis regulator
ENSG00000105355,PLIN3,lipid metabolism dysregulation,oncogene potential,cancer cell growth,prognostic marker,tumor progression,lipogenesis activation
ENSG00000169877,AHSP,proteostasis regulation,cellular stress response,heat shock protein interaction,genetic expression modulation,apoptosis inhibition,therapeutic target
ENSG00000049541,RFC2,genomic instability,dna damage repair,homologous recombination,non-homologous end joining,microhomology-mediated end joining,dna polymerase interaction
ENSG00000162433,AK4,ampk activation,autophagy induction,cancer progression promotion,mtor signaling inhibition,cell survival enhancement,tumor suppressor regulation
ENSG00000167670,CHAF1A,transcriptional coactivation,cell cycle progression regulation,dna replication maintenance,chromatin remodeling role,histone modification regulation,prognostic biomarker
ENSG00000198920,KIAA0753,mitochondrial dynamics regulation,tumor growth promotion,glycolysis enhancement,lactate production increase,apoptosis inhibition,mitochondrial localization
ENSG00000149115,TNKS1BP1,genomic stability,telomere maintenance,apoptosis regulation,dna repair interaction,tumor suppression,cellular senescence
ENSG00000138767,CNOT6L,mrna regulation,ccr4-not complex,deadenylation/decapping,translational control,proliferation/survival,regulatory mechanism alteration
ENSG00000179627,ZBTB42,transcriptional regulation,cancer-related transcription factor,epigenetic regulation,nuclear localization,apoptosis modulation,cell proliferation enhancement
ENSG00000205220,PSMB10,tumor progression,protein degradation,cell cycle regulation,apoptosis inhibition,ubiquitin-proteasome pathway,oncogenesis driver
ENSG00000197343,ZNF655,chromatin remodeling,oncogenic activity,transcriptional regulation,tumor progression,therapeutic target,histone modification
ENSG00000146457,WTAP,histone modification regulation,epigenetic silencing,chromatin compaction,cancer progression marker,prognostic significance,tumor suppressor dysfunction
ENSG00000162775,RBM15,transcriptional regulator,oncogene activation,cell cycle progression,ribosome biogenesis,protein synthesis regulation,tumor growth promotion
ENSG00000165156,ZHX1,tumor suppressor,transcriptional regulation,cell cycle inhibition,apoptosis induction,dna damage response,cell migration regulation
ENSG00000171307,ZDHHC16,palmitoylation pathway,aberrant expression,cell growth regulation,tumor progression,prognostic marker,therapeutic target
ENSG00000125107,CNOT1,mrna degradation regulation,oncogene expression,tumor suppressor repression,cell proliferation enhancement,tumor progression,genomic instability
ENSG00000151876,FBXO4,tumor suppressor function,cell cycle regulation,oncogenic process disruption,protein degradation pathway,mitotic error prevention,apoptosis modulation
ENSG00000117533,VAMP4,endosomal fusion,membrane trafficking regulation,tumor progression,pro-survival signaling,angiogenesis promotion,resistance to apoptosis
ENSG00000169122,FAM110B,mtor signaling pathway,oncogene overexpression,cell cycle regulation,apoptosis suppression,tumor progression,kinase activation
ENSG00000221837,KRTAP10-9,cellular structure maintenance,keratin-associated protein,cellular proliferation,cancer cell survival,tumor progression,overexpression
ENSG00000198805,PNP,purine metabolism,cell proliferation,genetic damage,biomarker potential,metabolic regulation,enzyme function
ENSG00000054523,KIF1B,mitotic spindle formation,aneuploidy promotion,genomic instability,cell proliferation regulation,cytokinesis disruption,amplified in cancer
ENSG00000288295,MCTS1,oncogenic activity,tumor progression,cell proliferation,epithelial-to-mesenchymal transition (emt),apoptosis inhibition,angiogenesis promotion
ENSG00000156261,CCT8,tumor suppressor,protein folding regulation,cellular stress response,aberrant protein accumulation,molecular chaperone function,biomarker potential
ENSG00000172354,GNB2,g-protein coupled receptors,constitutive activation,oncogenic signaling,cell proliferation,tumor growth,therapeutic target
ENSG00000013275,PSMC4,impaired protein degradation,activation of oncogenic pathways,loss of function mutation,cell proliferation,tumor progression,poor prognosis
ENSG00000101843,PSMD10,proteasome activation,cell cycle regulation,apoptosis inhibition,tumor progression,oncoprotein stabilization,protein degradation pathway
ENSG00000008323,PLEKHG6,tumor suppression,cell cycle regulation,apoptosis regulation,oncogenic process,genomic instability,protein-protein interaction
ENSG00000131791,PRKAB2,ampk pathway activation,constitutive activation,glycolysis promotion,metabolic reprogramming,tumor growth support,cell survival enhancement
ENSG00000203805,PLPP4,pi3k/akt signaling pathway modulation,overexpression in tumor tissues,enhanced cell growth and survival,increased invasion capabilities,cell proliferation regulation,phospholipid-protein phosphodiesterase activity
ENSG00000131061,ZNF341,transcriptional regulation,zinc finger protein,cell proliferation,oncogene,dna-binding activity,tumor aggressiveness
ENSG00000179335,CLK3,pi3k/akt pathway activation,cell cycle regulation,dual specificity kinase activity,phosphorylation and activation of transcription factors,tumorigenic potential,genomic instability
ENSG00000172789,HOXC5,transcriptional regulation,oncogenic function,upregulated expression,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000174307,PHLDA3,tumor suppressor function,epigenetic regulation,histone modifications,cell cycle regulation,apoptosis resistance,oncogenic pathway inhibition
ENSG00000079257,LXN,cellular adhesion disruption,epithelial-to-mesenchymal transition,cell migration facilitation,tumor progression enhancement,overexpression,metastasis promotion
ENSG00000196859,KRT39,cell adhesion,mitotic regulation,cytoskeletal integrity,keratin network regulation,protein stability maintenance,tumor progression
ENSG00000205426,KRT81,keratin dysregulation,epithelial-to-mesenchymal transition (emt),cell integrity disruption,cytoskeletal organization,poor prognosis marker,cellular differentiation alteration
ENSG00000198908,BHLHB9,cellular differentiation,transcriptional regulation,cell cycle progression,apoptosis evasion,genomic instability,therapeutic target
ENSG00000156273,BACH1,genomic instability,tumor suppressor function,dna repair regulation,cell cycle checkpoint control,transcriptional regulation,oncogenic mutations
ENSG00000278458,KANSL1,histone acetylation,chromatin relaxation,tumor suppressor function,dna repair mechanism,cell cycle regulation,genomic instability
ENSG00000114626,ABTB1,ubiquitin ligase function,regulation of cell cycle progression,dna repair regulation,oncogenic overexpression,proteasome pathway modulation,tumor proliferation
ENSG00000100815,TRIP11,telomere maintenance,genomic instability,tumor progression,therapeutic target,telomerase activity regulation,cell growth regulation
ENSG00000086967,MYBPC2,rho/rock pathway interaction,actin cytoskeleton regulation,cell migration modulation,therapeutic target,prognostic marker,genomic overexpression
ENSG00000156983,BRPF1,**

chromatin remodeling,bromodomain interaction,tumor progression,transcriptional regulation,histone acetylation,epigenetic modification

**
ENSG00000169744,LDB2,chromatin remodeling,transcriptional activation,cell cycle progression,oncogenesis,apoptosis inhibition,protein-protein interactions
ENSG00000148481,MINDY3,wnt/β-catenin pathway,oncogene,tumor growth,cell signaling,metastasis,therapeutic target
ENSG00000197714,ZNF460,tumor suppressor dysfunction,krab domain-containing protein,transcriptional regulator overexpression,oncogenesis promotion,cell growth regulation disruption,aggressive disease association
ENSG00000157212,PAXIP1,tumor progression,dna damage response,homologous recombination repair,cell cycle regulation,scaffold protein function,genomic instability
ENSG00000121057,AKAP1,oncogenic signaling,scaffolding protein function,protein kinase a regulation,microtubule stability modulation,cell cycle progression control,therapeutic target identification
ENSG00000165632,TAF3,cell cycle regulation,transcriptional regulation,chromatin remodeling,apoptosis suppression,tumor progression,coactivator interaction
ENSG00000171517,LPAR3,constitutive activation,cell proliferation,dysregulation,tumor growth,angiogenesis,signal transduction
ENSG00000215712,TMEM242,autophagy regulation,stress response modulation,tumor progression promotion,therapeutic resistance facilitation,transmembrane protein function,cellular stress interaction
ENSG00000166224,SGPL1,sphingolipid metabolism,aberrant signaling pathways,cell proliferation and survival,glycosphingolipid accumulation,tumor progression and metastasis,biological pathway regulation
ENSG00000162367,TAL1,tumor progression,cell proliferation,emt regulation,transcriptional activation,aberrant expression,oncogenic transformation
ENSG00000261934,PCDHGA9,cadherin superfamily member,cell-cell adhesion regulation,tumor suppressor function,downregulated expression,molecular interactions,neurodevelopmental role
ENSG00000175582,RAB6A,microtubule regulation,oncogenic processes,cell migration,gene expression regulation,mitotic errors prevention,tumor suppressor interaction
ENSG00000147050,KDM6A,loss of function mutations,gain-of-function mutations,epigenetic regulator,histone demethylase activity,cell cycle regulation,apoptosis suppression
ENSG00000139190,VAMP1,secretion regulation,exocytosis facilitation,cell invasion promotion,metastasis enhancement,tumor microenvironment remodeling,angiogenesis modulation
ENSG00000099365,STX1B,cell growth regulation,oncogene,pi3k/akt signaling pathway interaction,cell proliferation modulation,tumor progression association,genomic mutation frequency
ENSG00000114853,ZBTB47,cell cycle regulation,apoptosis modulation,transcriptional repression,tumor suppression,genomic amplification,protein-protein interaction
ENSG00000213672,NCKIPSD,cell adhesion regulation,pi3k/akt/mtor pathway modulation,adaptor protein interaction,tumor progression facilitation,kinase activation regulation,gene expression alteration
ENSG00000123080,CDKN2C,regulatory role in cell cycle progression,altered expression levels,pi3k/akt/mtor pathway interaction,cell proliferation enhancement,g1/s phase transition inhibition,apoptosis induction
ENSG00000109854,HTATIP2,genomic instability,tumor suppressor regulation,oncogenic potential,cell survival promotion,apoptosis suppression,dna repair interaction
ENSG00000180035,ZNF48,transcription factor activity,cell proliferation regulation,apoptosis modulation,epithelial-to-mesenchymal transition,tumor progression driver,genomic instability regulator
ENSG00000178971,CTC1,genomic instability,dna repair defects,homologous recombination,chromosomal aberrations,oncogenic mutations,tumor suppressor
ENSG00000107960,STN1,telomere maintenance,genomic instability,cellular senescence evasion,therapeutic target,cancer aggressiveness promotion,protein interaction with shelterin complex
ENSG00000077274,CAPN6,tumor progression,metastasis promotion,cell invasion regulation,apoptosis regulation,proteolytic activity,cancer metastasis
,SEPT7,mitochondrial transport,cell proliferation,oncogenic process,protein-protein interaction,wnt signaling pathway,septin family protein
ENSG00000285394,C3orf52,protein-protein interaction,cell cycle regulation,tumor progression marker,apoptosis regulation,autophagy modulation,prognostic significance
ENSG00000113845,TIMMDC1,mitochondrial dysfunction,genomic instability,ros production,dna damage,oncogenic processes,mtor pathway activation
ENSG00000196150,ZNF250,tumor suppressor function,gene silencing by promoter hypermethylation,transcriptional regulation,oncogenic properties,epigenetic modification,chromatin-modifying interactions
ENSG00000159399,HK2,glycolysis promotion,warburg effect,glucose metabolism regulation,cell proliferation enhancement,apoptosis resistance,angiogenesis promotion
ENSG00000126368,NR1D1,cancer driver,oncogene overexpression,cell proliferation enhancement,apoptosis suppression,transcriptional regulation,circadian rhythm disruption
ENSG00000127564,PKMYT1,cell cycle regulation,tumor suppressor function,genomic instability prevention,protein kinase inhibition,apoptosis regulation,cancer progression prevention
ENSG00000058799,YIPF1,erad pathway dysregulation,cellular stress resistance,tumor growth promotion,metastasis facilitation,prognosis correlation,poor disease recurrence
ENSG00000129680,MAP7D3,microtubule dynamics regulation,cell proliferation facilitation,tumor microenvironment modulation,poor prognosis marker,overexpression association,cancer cell growth promotion
ENSG00000121297,TSHZ3,cellular proliferation regulation,transcriptional repressor function,tumor suppressor gene,genomic instability,cell cycle regulation disruption,therapeutic target
ENSG00000083857,FAT1,emt regulation,cell-cell adhesion disruption,tumor suppressor function,signaling pathway modulation,wnt/β-catenin interaction,mutation or downregulation
ENSG00000073111,MCM2,dna replication regulation,genomic instability,cell cycle progression,enhanced proliferation,biomarker potential,therapeutic target
ENSG00000010282,HHATL,genomic instability,dna damage response,chromatin remodeling,transcriptional regulation,fanconi anemia pathway,tumor progression
ENSG00000148704,VAX1,oncogene function,epithelial-to-mesenchymal transition (emt),transcription factor activity,cell proliferation regulation,apoptosis inhibition,paired-like homeodomain transcription factor
ENSG00000006704,GTF2IRD1,chromatin regulation,transcriptional modulation,cell proliferation,apoptosis suppression,therapeutic target,amplification
ENSG00000170948,MBD3L1,epigenetic regulator,tumor progression,chromatin remodeling,histone modification,gene expression regulation,metastasis
ENSG00000230475,ABHD16A,lipid degradation,tumor progression,cell growth regulation,metabolic dysregulation,signaling pathway modulation,gene overexpression
ENSG00000174567,GOLT1A,glycosylation regulation,oncogene activation,cell proliferation enhancement,metastasis promotion,altered protein function,protein localization modification
ENSG00000103657,HERC1,pi3k/akt signaling modulation,tumor suppressor regulation disruption,cell cycle progression facilitation,protein degradation modulation,dna damage response,genome instability promotion
ENSG00000151967,SCHIP1,epigenetic regulation,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,metastasis suppression,cell growth regulation,transcriptional repression
ENSG00000120688,WBP4,cellular proliferation,protein regulation,ubiquitination pathway,ww domain interaction,proliferation marker,tumor progression
ENSG00000099139,PCSK5,pcsk5 overexpression,proprotein convertase activity,tumor growth promotion,genomic instability,signaling pathway activation,substrate cleavage modification
ENSG00000173898,SPTBN2,cellular structure regulation,tumor progression,biomarker expression,oncogenic activity,signaling pathway interaction,cell migration enhancement
ENSG00000151117,TMEM86A,cell growth regulation,gene expression modulation,tumorigenesis,immune response regulation,transmembrane protein interaction,cell-cell signaling
ENSG00000162735,PEX19,peroxisomal biogenesis factor,tumor suppressor function,fatty acid metabolism regulation,cellular organelle dysfunction,cancer-related pathway interaction,genetic expression downregulation
ENSG00000168958,MFF,mitochondrial fission factor,cellular energy production,oncogenic protein interaction,tumor aggressiveness,poor prognosis,cancer cell growth
ENSG00000188807,TMEM201,tumor progression,cell signaling modulation,cellular homeostasis disruption,oncogene function,cell adhesion regulation,membrane localization
ENSG00000135506,OS9,oncoprotein degradation,ubiquitin ligase regulation,tumor suppressor function,cell proliferation regulation,poor prognosis association,pi3k/akt pathway interaction
ENSG00000118200,CAMSAP2,cell migration,microtubule stabilization,cytoskeletal regulation,therapeutic target,cell invasion,tumor progression
ENSG00000163126,ANKRD23,genomic instability,chromatin organization,dna replication regulation,histone deacetylase interaction,tumor suppressor function,oncogene activation
ENSG00000262862,KRTAP2-3,cell proliferation,apoptosis inhibition,tumor progression,promising therapeutic target,antigen expression,genetic expression regulation
ENSG00000178279,TNP2,apoptosis modulation,chromatin regulation,genomic stability,tumor progression,histone interaction,dna repair association
ENSG00000127588,GNG13,mapk/erk pathway activation,g protein signaling,oncogene function,cell proliferation regulation,tumor progression facilitation,signaling pathway modulation
ENSG00000136930,PSMB7,tumor growth,tumor survival,cancer cell proliferation,ubiquitin-proteasome pathway,cellular degradation regulation,apoptosis regulation
ENSG00000006194,ZNF263,transcriptional regulation,oncogene,cell proliferation,cell survival,tumor progression,apoptosis inhibition
ENSG00000171456,ASXL1,epigenetic regulation,chromatin remodeling,oncogene activation,tumor suppressor loss,genomic instability,cooperativity with other mutations
ENSG00000126251,GPR42,gpcr activation,short-chain fatty acid sensing,cell migration and invasion,tumor progression and metastasis,therapeutic target,gut microbiota interaction
ENSG00000146859,TMEM140,er morphology regulation,gene overexpression,cellular stress induction,tumor progression correlation,therapeutic target identification,pi3k/akt pathway interaction
ENSG00000095787,WAC,dna repair,genome instability,oncogene activation,tumor suppressor interaction,cell cycle regulation,signaling pathway dysregulation
ENSG00000183640,KRTAP8-1,keratin filament disorganization,cellular transformation,epithelial-to-mesenchymal transition,chromosomal alterations,tumor invasiveness,apoptosis resistance
ENSG00000115310,RTN4,apoptosis inhibition,cell survival promotion,inflammation modulation,immune response regulation,multifunctional protein,tumor progression driver
ENSG00000086506,HBQ1,aerobic glycolysis,cellular energy metabolism,krebs cycle intermediate conversion,tumor aggressiveness,upregulated expression levels,warburg effect
ENSG00000270765,GAS2L2,cell survival pathways,oncogenic transformation,cell proliferation regulation,protein-protein interactions,akt/mtor signaling pathway modulation,genomic instability
ENSG00000109771,LRP2BP,endocytosis regulation,cell migration and invasion,signaling pathway modulation,tumor progression marker,poor prognosis indicator,overexpression association
ENSG00000125870,SNRPB2,cellular homeostasis disruption,pre-mrna splicing regulation,oncogene upregulation,tumor suppressor gene suppression,cell proliferation promotion,genomic instability induction
ENSG00000133115,STOML3,tumor suppressor function,cell proliferation regulation,actin cytoskeleton modulation,cancer progression contribution,biomarker potential,epigenetic regulation
ENSG00000156113,KCNMA1,regulation of cell growth,constitutive activation,tumor progression,oncogene function,genomic alterations,signaling pathway modulation
ENSG00000102241,HTATSF1,dna repair,genomic instability,homologous recombination,cell cycle regulation,tumor progression,poor prognosis
ENSG00000247596,TWF2,actin filament regulation,oncogene function,cell migration promotion,cytoskeleton maintenance,cancer cell survival,chemotherapy resistance
ENSG00000133627,ACTR3B,ups dysregulation,protein degradation imbalance,oncogenic protein accumulation,tumor progression enhancement,therapeutic target potential,proteasome component interaction
ENSG00000142089,IFITM3,cellular proliferation,apoptosis inhibition,immune evasion,tumor progression,oncogenic signaling,dna damage repair
ENSG00000125255,SLC10A2,bile acid transport,cell proliferation,tumorigenesis,cancer progression,potential biomarker,aberrant expression
ENSG00000135972,MRPS9,mitochondrial biogenesis,tumor suppressor regulation,cell proliferation,metabolic enhancement,dna damage response,cancer metabolism
ENSG00000144567,RETREG2,tumor progression,cell survival,telomere regulation,apoptosis modulation,senescence evasion,therapeutic target
ENSG00000123485,HJURP,centromere function regulation,genomic instability,chromosome segregation disruption,kinetochore assembly modulation,tumor progression marker,cancer prognosis indicator
ENSG00000141552,ANAPC11,genomic instability,chromosome segregation,cell cycle regulation,tumor progression,cancer driver mutations,cell proliferation
ENSG00000107758,PPP3CB,phosphatase activity,nfat activation,cell signaling pathway,oncogenic process,protein interaction,transcription factor regulation
ENSG00000112561,TFEB,autophagy regulation,tumor suppressor function,lysosome biogenesis,mtorc1 pathway activation,oncogenic activity,transcriptional regulation
ENSG00000170035,UBE2E3,cell cycle regulation,ubiquitination process,genomic stability,tumor progression,apoptosis regulation,dna repair
ENSG00000178498,DTX3,chromatin remodeling,transcriptional regulation,apoptosis inhibition,cell cycle progression,dna repair disruption,pi3k/akt pathway interaction
ENSG00000106609,TMEM248,cellular regulation,cell proliferation,tumor aggressiveness,therapeutic target,oncogene activation,signaling pathway regulation
ENSG00000204070,SYS1,glutamine metabolism,metabolic reprogramming,cell proliferation,tumor aggressiveness,prognostic marker,oncogenic process
ENSG00000187109,NAP1L1,chromatin remodeling,cell proliferation,gene expression regulation,transcriptional activation,histone modification,protein interaction
ENSG00000105255,FSD1,apoptosis regulation,mitochondrial dynamics,oncogenic promotion,cellular survival enhancement,tumorigenesis association,genomic profiling alterations
ENSG00000072609,CHFR,cell cycle regulation,dna damage response,tumor suppression,premature chromatid separation,genomic instability,g2/m checkpoint
ENSG00000101310,SEC23B,extracellular vesicle regulation,protein secretion,tumor growth promotion,metastasis facilitation,cell cycle regulation,autophagy modulation
ENSG00000124562,SNRPC,aberrant expression,genomic instability,rna splicing regulation,molecular switch,tumor progression,cell cycle regulation
ENSG00000088766,CRLS1,protein modification regulation,tumor progression,cellular homeostasis disruption,ubiquitination pathway modulation,enzyme activity regulation,proteasomal degradation enhancement
ENSG00000059145,UNKL,apoptosis regulation,chromatin remodeling,cell cycle modulation,genetic reprogramming,protein-protein interactions,cancer progression
ENSG00000090674,MCOLN1,lysosomal membrane protein,oncogenic driver,late endosomal/lysosomal localization,protein-protein interaction,cell proliferation enhancement,pi3k/akt signaling regulation
ENSG00000263296,KRTAP3-2,keratinization process,tumor progression,metastasis promotion,cancer stem cell maintenance,ancillary protein regulation,cellular adaptation enhancement
ENSG00000111450,STX2,vesicle trafficking regulation,cell proliferation enhancement,oncogenic pathway interaction,tumor progression facilitation,amplification and overexpression,metastasis promotion
ENSG00000145087,STXBP5L,apoptosis inhibition,cell proliferation,endoplasmic reticulum stress modulation,mitochondrial membrane potential regulation,oncogenesis,pi3k/akt pathway interaction
ENSG00000188566,NDOR1,hormone regulation,estrogen signaling pathway,nuclear receptor interaction,tumor growth promotion,steroid hormone activity modulation,gene expression regulation
ENSG00000236843,NRM,transcriptional regulator,mitochondrial function,oxidative stress response,tumor progression,cell growth regulation,apoptosis modulation
ENSG00000165304,MELK,cell cycle regulation,dna damage response,oncogenic kinase activity,histone phosphorylation,protein-protein interactions,cell proliferation promotion
ENSG00000171843,MLLT3,chromatin modification,epigenetic regulation,histone methylation,tumor suppression,oncogenic transformation,gene expression
ENSG00000168032,ENTPD3,extracellular atp regulation,cell signaling modulation,protein-protein interactions,tumor growth promotion,cancer progression marker,therapeutic target identification
ENSG00000167741,GGT6,glycosyltransferase activity,cell adhesion modulation,cell proliferation enhancement,oncogenic driver,metastasis promotion,protein-protein interaction
ENSG00000157985,AGAP1,cell cycle regulation,dysregulated in cancer,genomic instability,modulator of pi3k/akt pathway,oncogenic process enhancement,protein-protein interaction
ENSG00000064961,HMG20B,genomic instability,chromatin remodeling,cell proliferation,oncogenic pathway activation,transcription regulation,protein interaction
ENSG00000106628,POLD2,genomic instability,dna replication,oncogenic driver,cell proliferation,dna repair pathway,mutagenesis
ENSG00000064270,ATP2C2,calcium homeostasis disruption,ca²⁺ efflux regulation,cell proliferation enhancement,oncogenic signaling pathway activation,transcription factor regulation,cancer driver gene candidate
ENSG00000160948,VPS28,escrt pathway regulation,deregulation in cancer,tumor progression driver,prognostic marker candidate,cellular homeostasis disruption,endosomal pathway modulation
ENSG00000171056,SOX7,apoptosis regulation,epithelial-to-mesenchymal transition,tumor suppressor function,cell differentiation control,cell proliferation regulation,genomic instability association
ENSG00000197753,LHFPL5,regulation of calcium homeostasis,epithelial-to-mesenchymal transition,cell migration and invasion,cancer progression,calcineurin/nfat pathway activation,therapeutic target
ENSG00000105254,TBCB,regulation of gtpases,cell signaling pathway,rab gtpases interaction,membrane trafficking regulation,oncogenic signaling inhibition,potential biomarker
ENSG00000261609,GAN,ganglioside synthase activity,cell membrane modulation,signaling pathway regulation,apoptosis inhibition,cell proliferation promotion,protein kinase interaction
ENSG00000104237,RP1,microtubule destabilization,tumor growth promotion,cell cycle regulation,cancer driver gene,protein-protein interaction,cellular structure maintenance
ENSG00000234602,MCIDAS,chromatin remodeling,tumor suppressor activity,oncogenic potential,gene expression regulation,chromatin structure alterations,tumorigenesis
ENSG00000282956,MAGI1,epithelial-to-mesenchymal transition,cell adhesion disruption,cell proliferation enhancement,signaling pathway modulation,tumor progression,prognostic marker
ENSG00000105137,SYDE1,meiotic recombination,mitotic spindle regulation,oncogenic process,tumor progression,cell proliferation,drug resistance
ENSG00000100739,BDKRB1,g protein-coupled receptor,overexpression in tumor tissue,angiogenesis promotion,vegf expression regulation,tumor progression enhancement,apoptosis resistance mechanism
ENSG00000156970,BUB1B,mitotic checkpoint regulation,genomic instability,chromosome misalignment,aneuploidy,cell cycle progression,genetic mutation effects
ENSG00000188641,DPYD,therapeutic target,cancer metabolism,fluoropyrimidine degradation,toxicity modulation,chemosensitivity regulation,genetic polymorphism
ENSG00000249915,PDCD6,apoptosis regulation,tumor suppressor function,programmed cell death,cellular regulation,caspase activation,ripk interaction
ENSG00000179455,MKRN3,tumor suppressor,cell cycle regulator,apoptosis induction,transcriptional repressor,protein-protein interaction,growth inhibition
ENSG00000170091,NSG2,pi3k/akt signaling,wnt/β-catenin pathway,cell proliferation,oncogenesis,tumor progression,therapeutic target
ENSG00000177954,RPS27,genomic instability,ribosomal regulation,protein synthesis modulation,tumor progression,poor prognosis marker,mapk signaling interaction
ENSG00000118579,MED28,transcriptional regulation,apoptosis evasion,cell cycle progression,protein-protein interactions,chromatin remodeling,genomic instability
ENSG00000100038,TOP3B,genomic instability,dna replication,genetic mutations,cell cycle regulation,topoisomerase activity,tumorigenesis driver
ENSG00000144021,CIAO1,mitochondrial function,glycolysis regulation,cancer metabolism,aerobic glycolysis,tumor growth promotion,energy production imbalance
ENSG00000161692,DBF4B,cell cycle regulation,genomic instability,tumor aggressiveness,genome stability maintenance,cak complex activation,oncogenic processes driver
ENSG00000146112,PPP1R18,regulatory subunit,cell cycle regulation,apoptosis modulation,protein phosphorylation regulation,tumor growth promotion,cancer progression
ENSG00000134748,PRPF38A,spliceosome component,tumor suppressor loss,cellular proliferation,widespread splicing alterations,apoptosis inhibition,metastatic potential
ENSG00000118762,PKD2,cellular proliferation,disrupted signaling pathways,ion transport regulation,cancer driver mutations,therapeutic target potential,cellular homeostasis modulation
ENSG00000008710,PKD1,cellular proliferation,growth regulation,angiogenesis promotion,tumor progression,transmembrane receptor function,cancer gene target
ENSG00000127903,ZNF835,cell cycle regulation,transcriptional regulation,oncogenic protein interaction,apoptosis inhibition,dna repair dysregulation,chromatin remodeling
ENSG00000211456,SACM1L,autophagy regulation,cell cycle progression,endocytosis regulation,loss of function mutations,membrane trafficking,nedd4-2 regulation
ENSG00000116161,CACYBP,regulation of β-catenin activity,cellular proliferation,apoptosis regulation,wnt/β-catenin signaling pathway,tumor suppressor or oncogene,cell cycle control
ENSG00000157538,VPS26C,protein sorting and recycling,retromer complex component,cell proliferation and survival,oncogenic process,cancer-associated mutation,endosomal function regulation
ENSG00000149089,APIP,oncogene,cell proliferation,apoptosis inhibition,transcriptional regulation,signaling pathway modulation,tumor growth promotion
ENSG00000100577,GSTZ1,cellular detoxification,redox balance regulation,tumor chemoresistance,stem cell-like properties,poor prognosis marker,antioxidant function
ENSG00000145391,SETD7,histone methylation,oncogenic function,cell proliferation,chromatin remodeling,poor prognosis,apoptosis regulation
ENSG00000212721,KRTAP4-11,cellular adhesion,cellular structure maintenance,protein-protein interactions,cell differentiation,cell survival pathways,keratin filament formation
ENSG00000081377,CDC14B,apoptosis regulation,cell cycle checkpoint,dna repair facilitation,oncogenic pathway activation,tumor progression promotion,therapeutic target candidacy
ENSG00000138944,SHISAL1,genomic stability,tumor suppressor,dna repair mechanisms,genetic instability,oncogene regulation,protein-protein interactions
ENSG00000255112,CHMP1B,tumor progression,cell proliferation,cancer driver gene,mitotic regulation,membrane trafficking disorder,escrt complex component
ENSG00000119328,ABITRAM,tumor suppressor function,regulatory role on rho gtpases,protein-protein interaction,cell proliferation regulation,angiogenesis modulation,genomic deletion event
ENSG00000023318,ERP44,erad pathway degradation,cell proliferation regulation,protein quality control,ubq ligase interaction,tumor progression marker,upr modulation
ENSG00000162961,DPY30,chromatin remodeling,cell cycle regulation,genomic stability,tumor suppressor pathways,dna damage response,histone modification
ENSG00000166886,NAB2,transcriptional regulation,cell proliferation,chromatin remodeling,oncogenic fusion proteins,apoptosis inhibition,gene expression modulation
ENSG00000235650,RPS18,protein synthesis regulation,cell proliferation enhancement,tumor growth promotion,stress response regulation,ribosome biogenesis,hypoxia-inducible factor signaling modulation
ENSG00000150961,SEC24D,protein secretion regulation,akt pathway interaction,cell proliferation enhancement,invasion and metastasis promotion,cancer-associated gene expression,copii complex component
ENSG00000213694,S1PR3,pi3k/akt pathway activation,constitutive activation,tumor progression,cell migration regulation,protein interaction modulation,therapeutic target
ENSG00000171634,BPTF,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis inhibition,dna repair modulation,tumor suppressor dysfunction
ENSG00000173614,NMNAT1,nad+ biosynthesis,cell proliferation,increased expression,dna repair,protein-protein interactions,genomic instability
ENSG00000150433,TMEM218,apoptosis regulation,cell migration,cell proliferation,oncogenic signaling,transmembrane protein function,cell survival enhancement
ENSG00000198818,SFT2D1,er stress response,oncogene/tumor suppressor,cellular proteostasis,protein misfolding,cell survival,tumorigenesis
ENSG00000086159,AQP6,aquaporin function,cell proliferation,tumor growth promotion,water transport regulation,ion balance modulation,cancer progression
ENSG00000130559,CAMSAP1,tumor progression,microtubule stability regulation,cell migration enhancement,cytoplasmic protein function,cancer driver gene potential,cellular proliferation promotion
ENSG00000061676,NCKAP1,cell migration,cytoskeleton organization,oncogenic potential,pi3k/akt signaling,prognostic biomarker,signaling pathway regulation
ENSG00000155975,VPS37A,endosomal sorting complex regulation,oncogenic mutation,tumor growth promotion,metastasis facilitation,autophagy dysregulation,apoptosis suppression
ENSG00000249581,CLRN2,tumor progression,mechano-transduction signaling pathway,interaction with oncogenes,gene overexpression,poor prognosis indicator,stereocilia bundle maintenance
ENSG00000137078,SIT1,intracellular signaling,cell membrane transport,zinc homeostasis,apoptosis regulation,cancer association,cellular communication modulation
ENSG00000100116,GCAT,lipid biosynthesis,glycerol-3-phosphate acyltransferase activity,metabolic reprogramming,cellular energy homeostasis,lysophosphatidic acid production,tumor progression
ENSG00000170128,GPR25,tumor growth promotion,cell migration facilitation,lysophosphatidic acid binding,pi3k/akt pathway modulation,g protein-coupled receptor function,upregulated expression
ENSG00000071553,ATP6AP1,v-atpase regulation,tumor survival advantage,metastasis promotion,acidic environment maintenance,cell surface localization,genetic mutations associated
ENSG00000240432,KRTAP13-3,keratin-associated protein,sequence homology,aberrant cell signaling,kinase activation,epigenetic modifications,gene expression regulation
ENSG00000057935,MTA3,histone modification,transcriptional regulation,epigenetic regulation,cell cycle progression,invasion and metastasis,therapeutic target
ENSG00000158014,SLC30A2,cell proliferation,zinc transporter function,oncogenic process,therapeutic target,genomic profiling,cell survival
ENSG00000164756,SLC30A8,zinc transporter function,tumor growth promotion,cell signaling regulation,oncogenic processes,cell proliferation enhancement,transcription factor modulation
ENSG00000116857,TMEM9,transmembrane protein function,cell membrane regulation,oncogenic properties,tumor growth enhancement,metastatic potential increase,aberrant expression association
ENSG00000111049,MYF5,transcriptional regulator,myogenic differentiation,oncogene potential,cell proliferation,skeletal muscle development,gene expression regulation
ENSG00000176472,ZNF575,tumor suppressor function,regulatory protein interaction,modulation of pi3k/akt pathway,oncogenic potential,cell survival and growth regulation,transcriptional regulation
ENSG00000172023,REG1B,epithelial-to-mesenchymal transition,cell migration,tumor progression,microenvironment modulation,apoptosis resistance,growth factor regulation
ENSG00000090661,CERS4,lipid metabolism regulation,tumor progression,oncogenic processes,cell proliferation,fatty acid biosynthesis,genomic amplification
ENSG00000133678,TMEM254,cell migration,transmembrane regulation,genomic instability,cancer metastasis,protein-protein interaction,cell proliferation enhancement
ENSG00000129472,RAB2B,microtubule regulation,tumor progression,oncogene overexpression,cell migration,metastasis promotion,pi3k/akt pathway interaction
ENSG00000144061,NPHP1,ciliary dysfunction,chromosomal instability,aneuploidy,oncogenic signaling,genomic stability maintenance,tumor progression
ENSG00000131697,NPHP4,cilia dysfunction,cell division disruption,hippo pathway interaction,tumorigenesis driver,metastasis promoter,gene expression dysregulation
ENSG00000186141,POLR3C,tumor progression,transcriptional elongation,dna synthesis regulation,genomic stability alteration,oncogenic pathway activation,cell proliferation enhancement
ENSG00000198783,ZNF830,zinc finger protein,transcription regulation,cellular development,tumor suppressor function,dna damage response,gene expression regulation
ENSG00000061455,PRDM6,epigenetic regulation,dysregulation,tumor suppressor function,cell proliferation,transcriptional regulation,histone modification
ENSG00000151461,UPF2,genome maintenance,nonsense-mediated mrna decay,transcript degradation,premature stop codon recognition,protein quality control,cellular homeostasis
ENSG00000124098,FAM210B,tumor progression,hypoxia response,pi3k/akt pathway,oncogene activation,angiogenesis promotion,genomic profiling
ENSG00000061918,GUCY1B1,overexpression,cell proliferation,increased cgmp levels,angiogenesis promotion,metabolic regulation,signaling pathway alteration
ENSG00000164116,GUCY1A1,cellular metabolism,tumor progression,hypoxia adaptation,glycolysis regulation,electron transport chain,mitochondrial function
ENSG00000164187,LMBRD2,bcaa transport,cellular metabolism,protein synthesis,nutrient uptake regulation,tumor progression,therapeutic target
ENSG00000116830,TTF2,transcription factor regulation,epithelial-to-mesenchymal transition,tumor progression,metastasis promotion,cell cycle regulation,apoptosis suppression
ENSG00000165695,AK8,camp-dependent signaling,protein kinase regulation,cell proliferation,oncogenic potential,signaling pathway dysregulation,tumor progression
ENSG00000166199,ALKBH3,genome stability maintenance,dna demethylation,tumor-suppressive function,metabolic regulation,protein-protein interaction,epigenetic modification
ENSG00000062194,GPBP1,g-protein signaling,cellular proliferation,oncogenic signals,tumor metastasis,immune modulation,rhogtpase activation
ENSG00000096092,TMEM14A,cellular proliferation,genomic instability,ion transport regulation,oncogene potential,pi3k/akt pathway modulation,transmembrane protein interaction
ENSG00000157613,CREB3L1,tumor progression,oncogene activation,cell proliferation regulation,signaling pathway modulation,transcriptional regulation,metabolic adaptation
ENSG00000129187,DCTD,genomic instability,overexpression,dna repair,base excision repair,tumorigenesis,promoter hypermethylation
ENSG00000170860,LSM3,spliceosome assembly,oncogenic pathway interaction,cell survival promotion,mrna expression regulation,tumorigenesis contribution,dual role in cancer biology
ENSG00000111790,FGFR1OP2,fgfr1 signaling pathway,constitutive activation,tumor progression,cell proliferation,biomarker potential,genomic instability
ENSG00000185897,FFAR3,cell proliferation,g protein-coupled receptor signaling,lipid metabolism regulation,oncogenic driver,pi3k/akt pathway activation,therapeutic target
ENSG00000022840,RNF10,dna damage response,tumor suppressor function,genomic instability,ubiquitination,cell cycle regulation,apoptosis
ENSG00000137411,VARS2,trna modification,translation elongation,cell proliferation,onco-genic transformation,therapeutic target,dys-regulated metabolism
ENSG00000135365,PHF21A,chromatin regulation,genomic instability,tumor suppressor function,prognostic marker,histone modification,cell cycle progression
ENSG00000143228,NUF2,genomic instability,cell cycle checkpoint,aneuploidy promoter,chromosome segregation,dna damage response,tumor suppressor activity
ENSG00000058091,CDK14,cell cycle regulation,protein phosphorylation,oncogenic processes,tumor growth promotion,chemoresistance,poor prognosis predictor
ENSG00000170854,RIOX2,cell proliferation promotion,tumor progression association,dna repair regulation,oncogene overexpression,apoptosis inhibition,transcriptional regulation
ENSG00000158806,NPM2,**

overexpression,cellular proliferation,genomic instability,chromosomal abnormalities,tumor growth,ribosome biogenesis
ENSG00000149177,PTPRJ,pi3k/akt pathway,oncogenic driver,tumor progression,cell signaling regulation,transmembrane receptor,pi3k/mtor activation
ENSG00000159173,TNNI1,cell proliferation,cytoskeleton regulation,tumor aggressiveness,metastasis promotion,angiogenesis regulation,stress response modulation
ENSG00000160410,SHKBP1,cellular proliferation,oncogene activation,pi3k/akt/mtor pathway modulation,scaffolding protein function,tumor progression promotion,therapeutic target potential
ENSG00000169583,CLIC3,clic family signaling,oncogenic transformation,cell cycle regulation,apoptosis regulation,cell proliferation,tumor progression
ENSG00000146285,SCML4,histone methylation,cell cycle regulation,apoptosis inhibition,chromatin remodeling,tumor suppressor activity,oncogenic potential
ENSG00000149636,DSN1,dna synthesis regulation,tumor progression,cell proliferation modulation,chemosensitivity regulation,promoter region binding,replication complex assembly
ENSG00000197683,KRTAP26-1,cellular differentiation,epithelial development,intermediate filaments,protein structure,tissue integrity,mitotic regulation
ENSG00000181778,TMEM252,regulation of signaling pathways,cellular proliferation,tumorigenesis,interactions with other proteins,cellular stress response,protein expression in kidney
ENSG00000113369,ARRDC3,pi3k/akt pathway interaction,cell survival regulation,oncogenic process modulation,tumor suppressor function,endocytic pathway regulation,lipid metabolism dysregulation
ENSG00000116903,EXOC8,cell surface targeting,tumor progression,overexpression,secretion regulation,vesicle fusion regulation,pi3k/akt interaction
ENSG00000165113,GKAP1,oncogenic protein activation,scaffolding function,cellular signaling regulation,tumor growth promotion,metastasis enhancement,prognostic biomarker
ENSG00000103494,RPGRIP1L,tumor suppressor,microtubule dynamics regulation,genomic stability maintenance,cell cycle regulation disruption,dna repair pathway interaction,apoptosis inhibition
ENSG00000007255,TRAPPC6A,membrane trafficking regulation,tumor driver mutation,constitutive activation,cell proliferation promotion,autophagy regulation,tumor progression enhancement
ENSG00000276043,UHRF1,constitutive expression,epigenetic regulation,ubiquitin-proteasome pathway,tumor suppressor inactivation,cell proliferation driver,pro-survival environment
ENSG00000160961,ZNF333,zinc finger protein,transcriptional regulation,oncogene activation,cellular proliferation,epigenetic modification,tumor metastasis
ENSG00000148677,ANKRD1,akt/mtor pathway regulation,constitutive activation,cell proliferation enhancement,transcriptional regulation,epigenetic modification,metastasis promotion
ENSG00000168530,MYL1,cytoskeletal regulation,contractile apparatus component,muscle contraction regulator,cell morphology modulator,protein-protein interaction,genomic instability driver
ENSG00000141002,TCF25,wnt/β-catenin signaling pathway,tumor suppressor dysfunction,oncogene activation,cell proliferation regulation,transcriptional modulation,prognostic indicator
ENSG00000173404,INSM1,insulinoma-derived transactivator 1 function,oncogene,suppression of e-cadherin expression,wnt/β-catenin pathway regulation,tumor progression,metastasis facilitation
ENSG00000117713,ARID1A,chromatin remodeling,global chromatin relaxation,loss of function mutations,genomic instability,aneuploidy,atrx complex dysfunction
ENSG00000077454,LRCH4,chromatin remodeling,oncogenic driver,cell adhesion,leucine-rich repeats,swi/snf interaction,tumor suppressor (contrary)
ENSG00000151502,VPS26B,retrograde transport,endosomal sorting,cancer development,protein trafficking,tumor growth promotion,therapeutic target
ENSG00000134108,ARL8B,oncogenic signaling pathway,tumor progression,cellular transport regulation,autophagy modulation,cell proliferation promotion,downstream effector activation
ENSG00000137145,DENND4C,autophagy regulation,oncogenic signaling pathway activation,cell cycle progression promotion,mtor/pi3k/akt pathway interaction,protein-protein interaction facilitation,tumor progression promoter
ENSG00000159224,GIP,gip overexpression,tumor progression,angiogenesis promotion,immune microenvironment modulation,cell proliferation enhancement,pi3k/akt pathway activation
ENSG00000231377,DHX16,**
rna helicase activity,telomere maintenance,cell cycle regulation,genomic instability,oncogenic driver,nucleolar localization
**
ENSG00000183814,LIN9,transcriptional regulation,chromatin remodeling,cell cycle progression,oncogene activation,tumor progression,genomic instability
ENSG00000184708,EIF4ENIF1,mtor signaling pathway,tumor progression,cell proliferation,cap-dependent translation regulation,malignant transformation,protein synthesis enhancement
ENSG00000109686,SH3D19,epithelial-to-mesenchymal transition,oncogene,pi3k/akt signaling pathway modulation,cell proliferation enhancement,chromatin remodeling,protein-protein interaction
ENSG00000123411,IKZF4,transcriptional regulation,gene expression modulation,immune response modulation,cell cycle regulation,epigenetic modification,chromatin remodeling
ENSG00000008018,PSMB1,proteasome subunit,cellular homeostasis regulation,apoptosis inhibition,cancer progression facilitation,oncogenic process regulation,ubiquitinated protein degradation
ENSG00000152969,JAKMIP1,tumor suppression,jak-stat signaling inhibition,cell proliferation inhibition,metastasis suppression,pseudosubstrate inhibitor function,downregulated expression in cancer
ENSG00000107165,TYRP1,angiogenesis regulation,tumor cell invasion facilitation,eumelanin production,cancer prognosis marker,melanization process,protein-protein interaction modulation
ENSG00000284984,RHOU,cancer promotion,tumor growth,cell migration,protein-protein interaction,signaling pathway regulation,genomic instability
ENSG00000079432,CIC,tumor suppression,chromatin remodeling,transcriptional regulation,cell growth inhibition,genomic instability,apoptosis inhibition
ENSG00000131351,HAUS8,n-terminal acetylation regulation,loss of function mutations,tumor progression,dysregulation of centrosome duplication,aberrant cell proliferation,genomic instability
ENSG00000167625,ZNF526,zinc finger protein regulation,dna binding,tumor suppressor function,loss-of-function mutations,transcriptional modulation,genomic instability
ENSG00000133065,SLC41A1,genomic instability,cellular proliferation,chromosomal aberrations,magnesium homeostasis disruption,pi3k/akt pathway interaction,oncogenic potential
ENSG00000185046,ANKS1B,cell migration,tumor progression,protein-protein interaction,adherens junction regulation,cytoplasmic anchoring,cancer metastasis
ENSG00000196584,XRCC2,genomic instability,gain of function mutations,dna repair defects,double-strand break repair,homologous recombination,genetic predisposition
ENSG00000170260,ZNF212,oncogene activation,transcriptional regulation,cell proliferation promotion,epigenetic modulation,tumor progression driver,therapeutic target
ENSG00000140553,UNC45A,oncogene activation,cell cycle regulation,protein chaperone activity,epithelial-to-mesenchymal transition,pi3k/akt/mtor pathway interaction,tumor progression
ENSG00000197448,GSTK1,cellular redox balance,signal transduction,tumor growth and metastasis,chemo-resistance,glycolytic reprogramming,protein tyrosine kinase regulation
ENSG00000183775,KCTD16,cell cycle regulation,tumor suppressor function,apoptosis induction,pi3k/akt pathway modulation,protein-protein interaction regulation,transcriptional regulation
ENSG00000141279,NPEPPS,metastatic potential,hypoxia adaptation,pi3k/akt/mtor pathway interaction,tumor growth promotion,cell invasion facilitation,oncogenic expression regulation
ENSG00000160741,CRTC2,mammalian target of rapamycin pathway,tumor progression,transcriptional regulation,cell proliferation,energy metabolism,gene expression regulation
ENSG00000143545,RAB13,cellular trafficking,protein localization,signaling regulation,ovarian cancer associated protein,oncogenic processes,cellular proliferation
ENSG00000163884,KLF15,tumor suppressor,downregulated expression,apoptosis regulation,dna repair mechanism,cell cycle modulation,angiogenesis promotion
ENSG00000178057,NDUFAF3,mitochondrial dysfunction,cellular metabolism disruption,glycolytic shift,energy production impairment,genetic instability accumulation,therapeutic target potential
ENSG00000158825,CDA,metabolic dysregulation,homocysteine metabolism,transsulfuration pathway,methylation processes,cancer development,oncogenic process
ENSG00000165584,SSX3,oncogene,transcriptional regulation,cell proliferation,tumor progression,chromatin modification,protein interaction
ENSG00000064195,DLX3,oncogenic function,regulation of emt,cell proliferation,transcriptional regulation,signaling pathway modulation,tumor progression
ENSG00000080189,SLC35C2,glycosylation regulation,oncogenesis driver,tumor progression facilitator,cell surface protein modification,protein-protein interaction,glycoprotein biosynthesis
ENSG00000215203,GRXCR1,mitochondrial function,ros regulation,oxidative stress modulation,tumor suppressor,kidney cancer biomarker,mitochondrial redox balance
ENSG00000255690,TRIL,apoptosis resistance,cell proliferation,immune evasion,nf-κb pathway activation,tumor microenvironment modulation,adaptor protein interaction
ENSG00000163682,RPL9,ribosomal biogenesis,translation initiation,oncogenic process,tumor growth,metastasis,chemotherapy resistance
ENSG00000135486,HNRNPA1,rna processing,oncogenic properties,cell proliferation regulation,dna binding,protein interaction,tumor suppressor downregulation
ENSG00000166783,MARF1,mitochondrial involvement,oncogene role,tumor suppressor interaction,cellular stress response,altered metabolism,genomic instability
ENSG00000257923,CUX1,tumor suppressor/oncogene,transcription factor,cell proliferation regulation,apoptosis regulation,tissue patterning,prognostic marker
ENSG00000162819,BROX,transcription factor,tumor suppressor,epigenetic regulation,cell cycle regulation,apoptosis induction,chromatin modification
ENSG00000101421,CHMP4B,escrt complex regulation,mitotic progression,oncogene activation,cell cycle disruption,tumor growth promotion,apoptosis suppression
ENSG00000156256,USP16,cell cycle progression,mitotic regulation,epigenetic modulation,chromatin remodeling,apoptosis suppression,tumor growth promotion
ENSG00000072832,CRMP1,microtubule stability,regulation of pi3k/akt pathway,cell migration and invasion,oncogenic signaling,metastasis prediction,upregulation in tumors
ENSG00000125447,GGA3,oncogenic driver,tumor progression,cell growth promotion,metastasis enhancement,prognostic marker,signaling pathway regulation
ENSG00000188906,LRRK2,autophagy regulation,tumor progression,kinase activation,cell proliferation,oncogenesis,genetic mutation
ENSG00000087470,DNM1L,mitochondrial dynamics,autophagy regulation,tumor suppressor function,oxidative stress induction,oncogenic process activation,genomic instability promotion
ENSG00000266094,RASSF5,tumor suppressor,dna damage response,microtubule stability,apoptosis regulation,e3 ubiquitin ligase activity,genomic integrity maintenance
ENSG00000165792,METTL17,mrna methylation,cell growth regulation,tumor progression,therapeutic target,gene expression modulation,nuclear localization
ENSG00000061337,LZTS1,tumor suppressor,cell cycle regulation,microtubule dynamics,apoptosis regulation,genomic stability maintenance,poor prognosis marker
ENSG00000139531,SUOX,oxidative stress,tumor progression,dna damage,tumor suppression,cellular redox balance,genomic instability
ENSG00000268651,CTAG1A,dna damage response pathway,genome instability,epigenetic regulation,tumor suppression,histone modifications,cellular proliferation
ENSG00000105576,TNPO2,nuclear import regulation,cancer driver gene,oncogenic signaling pathway,protein transport modulation,transcription factor activation,genomic amplification
ENSG00000184033,CTAG1B,dna damage response,tumor suppressor function,genomic instability,chromatin remodeling,transcriptional regulation,dna repair pathways
ENSG00000127515,OR7A10,cancer driver gene,cellular response modulation,olfactory receptor family member,tumor progression association,metastasis involvement,overexpression pattern observed
ENSG00000186150,UBL4B,nf-κb signaling pathway,ubiquitination regulation,cell proliferation driver,protein degradation regulation,dna damage response,oncogenic potential
ENSG00000123297,TSFM,protein synthesis regulation,cellular proliferation,proteasome interaction,oncogene overexpression,chaperone binding,tumor aggressiveness
ENSG00000166228,PCBD1,detoxification process,oxidative stress regulation,cellular redox balance,mutational driver,tumor survival,protein overexpression
ENSG00000276194,HNF1B,transcriptional regulation,oncogenic potential,tumor suppressor activity,cell proliferation regulation,apoptosis modulation,metastasis contribution
ENSG00000154358,OBSCN,oncogenic signaling,cytoskeleton disruption,tumor progression marker,signaling pathway modulation,prognostic indicator,cellular invasion regulation
ENSG00000106153,CHCHD2,mitochondrial function regulation,cell proliferation enhancement,tumor suppression modulation,pi3k/akt pathway interaction,apoptosis regulation,oncogenic signaling pathway modulation
ENSG00000169895,SYAP1,apoptosis modulation,cell signaling pathway,immune response regulation,oncogene activation,tumor suppressor interaction,proliferation regulation
ENSG00000170037,CNTROB,cell cycle regulation,centrosome amplification,oncogenic mutations,genomic instability,tumor progression,therapeutic target
ENSG00000105939,ZC3HAV1,tumor suppressor,mrna degradation regulator,cell cycle regulation,apoptosis regulator,transcriptional regulator,protein interaction modulator
ENSG00000198271,KRTAP4-5,oncogenesis,cellular morphology modulation,regulatory mechanism uncertainty,tumor progression involvement,cancer type association,cell stress response modulation
ENSG00000244462,RBM12,splicing factor regulation,overexpression in cancer,alternative splicing events,pi3k/akt pathway modulation,cell proliferation and survival,therapeutic target
ENSG00000112182,BACH2,nf-b repression,tumor suppressor function,genomic instability modulation,epithelial-to-mesenchymal transition regulation,inflammation suppression,cell cycle progression regulation
ENSG00000198517,MAFK,cellular differentiation,transcription factor activity,tumor aggressiveness,dna repair dysregulation,programmed cell death evasion,cell proliferation enhancement
ENSG00000173991,TCAP,tumor progression,cell proliferation,transcriptional regulation,protein interaction,oncogenic potential,poor prognosis
ENSG00000169271,HSPB3,hsp20 family,heat shock protein function,cellular homeostasis regulation,protein interaction modulation,apoptosis regulation,tumor progression driver
ENSG00000144893,MED12L,histone modification regulation,chromatin remodeling interaction,transcriptional activation facilitation,epigenetic dysregulation,cell proliferation promotion,tumor suppressor gene suppression
ENSG00000040608,RTN4R,apoptosis regulation,cellular stress response,er-associated degradation,protein interaction modulation,tumor progression driver,cell survival pathway alteration
ENSG00000174483,BBS1,ift pathway dysfunction,cilia formation regulation,tumor suppressor pathway activation,cellular transport regulation,protein aggregation suppression,genetic instability promotion
ENSG00000113966,ARL6,mitotic checkpoint regulation,genomic instability,dna repair disruption,microtubule dynamics disruption,cell cycle progression,tumor progression
ENSG00000021645,NRXN3,neurexin family,transmembrane receptor,neuronal signaling,downregulation,aggressive tumor phenotype,presynaptic neurotransmitter release
ENSG00000158748,HTR6,serotonin receptor activation,g protein-coupled receptor function,cellular proliferation regulation,tumor angiogenesis promotion,pro-inflammatory cytokine secretion,chemotherapy resistance
ENSG00000067208,EVI5,rho gtpase signaling,adaptor molecule interaction,metastasis promoter,tumor suppressor loss,gene amplification,cell migration enhancer
ENSG00000147536,GINS4,cellular proliferation,dna damage response,genomic instability,protein-protein interactions,cell cycle regulation,oncogenic potential
ENSG00000131153,GINS2,**

genomic instability,dna replication,replication fork progression,chromosome segregation,cell cycle regulation,protein-protein interaction 
**
ENSG00000115145,STAM2,escrt component,tumor progression,metastasis facilitation,cell migration regulation,biomarker potential,therapeutic target
ENSG00000115762,PLEKHB2,cytoskeletal regulation,cell migration,endocytic pathway,tumor progression driver,focal adhesion modulation,protein-protein interaction
ENSG00000132781,MUTYH,**

genomic instability,dna repair dysfunction,ber pathway disruption,tumor suppressor function,oxidative stress response,cellular mutagenesis
ENSG00000166169,POLL,chromosomal instability,dna synthesis,constitutive expression,genomic alterations,cancer driver gene,cellular proliferation
ENSG00000138741,TRPC3,oncogenic properties,cell proliferation,calcium-permeable channel,cell migration,signaling pathway activation,prognostic marker
ENSG00000165120,SSMEM1,genomic instability,homologous recombination repair,dna repair,sister chromatid cohesion,cell division regulation,genetic material stability
ENSG00000143595,AQP10,tumor progression,metastasis resistance,epithelial-to-mesenchymal transition,tissue permeability regulation,cell migration promotion,upregulated expression
ENSG00000166257,SCN3B,voltage-gated sodium channel,tumor progression,cell migration,cell invasion,electrical excitability,signaling pathway modulation
ENSG00000117360,PRPF3,splicing regulation,oncogene function,gain of function mutations,alternative splicing,cancer cell proliferation,interaction with snrnp200
ENSG00000025770,NCAPH2,centrosome duplication,mitotic spindle assembly,chromosomal instability,tumor progression,cell proliferation,kinase complex interaction
ENSG00000178935,ZNF552,zinc finger dna-binding,transcriptional regulation,cell proliferation,tumor progression,overexpression,kidney development
ENSG00000034693,PEX3,peroxisomal biogenesis,cellular metabolism regulation,fatty acid ?metabolism,oxidative stress response,protein import and export,genomic stability maintenance
ENSG00000167272,POP5,spliceosome regulation,alternative splicing,rna processing,oncogenic splicing,cell proliferation,gene expression
ENSG00000156603,MED19,chromatin remodeling,transcriptional regulation,oncogene activation,cell proliferation,tumor suppressor interaction,genetic instability
ENSG00000281813,KAT6B,overexpression,transcriptional regulation,cell proliferation,tumor progression,chromatin modification,apoptosis inhibition
ENSG00000180089,TMEM86B,tumor suppressor function,cellular signaling regulation,transmembrane protein interaction,ion transport modulation,prognostic biomarker candidate,genetic alterations in tumorigenesis
ENSG00000101152,DNAJC5,cellular stress response,heat shock protein regulation,protein folding chaperone,ubiquitin-proteasome system modulation,tumor adaptation mechanism,oncogenic protein stabilization
ENSG00000155657,TTN,titin dysfunction,gene expression alterations,cellular proliferation enhancement,apoptosis suppression,protein-protein interactions disruption,tumor progression acceleration
ENSG00000121073,SLC35B1,glycosylation pathway regulation,tumor progression promotion,cell surface protein modification,signaling molecule modulation,metastasis facilitation,biomarker potential
ENSG00000083838,ZNF446,cellular localization,nuclear interactions,regulatory element binding,gene expression modulation,cancer progression marker,biomarker function
ENSG00000172466,ZNF24,cell cycle regulation,transcriptional modulation,oncogenic potential,zinc finger domain,tumor progression,apoptosis inhibition
ENSG00000130720,FIBCD1,lipid metabolism,cellular trafficking,tumor progression,protein-protein interaction,pi3k/akt pathway,cancer cell proliferation
ENSG00000176182,MYPOP,apoptosis evasion,cell cycle regulation,dysregulated transcriptional activity,g1/s transition regulation,mitotic control disruption,transcription factor activation
ENSG00000100246,DNAL4,microtubule-based motility,genomic instability,cell migration,prognostic biomarker,oncogene overexpression,tumor progression
ENSG00000184731,FAM110C,regulation of gene expression,potential protein-protein interactions,cell signaling modulation,limited research evidence,aberrant expression in cancer,structural characteristics suggesting cellular involvement
ENSG00000174099,MSRB3,oxidative stress resistance,protein repair mechanism,methionine oxidation reduction,cellular proliferation promotion,apoptosis evasion,therapeutic target for cancer treatment
ENSG00000049618,ARID1B,chromatin remodeling,tumor suppressor function,genome instability,dna replication repair,cell proliferation regulation,transcriptional regulation
ENSG00000160131,VMA21,autophagy regulation,lysosomal acidification,protein degradation regulation,cellular transport regulation,oncogenic signaling pathways activation,genomic instability promotion
ENSG00000001461,NIPAL3,**
cell proliferation,dna damage response,oncogenic signaling,pi3k/akt pathway,protein kinase activation,tumor progression 
**
ENSG00000102898,NUTF2,nuclear transport regulation,oncogene potential,overexpression,cell cycle modulation,apoptosis regulation,genomic mutation
ENSG00000134453,RBM17,pi3k/akt pathway regulation,tumor progression,oncogene function,genome stability maintenance,cell cycle regulation,apoptosis suppression
ENSG00000110171,TRIM3,p53 pathway regulation,oncogenic protein expression,cell proliferation promotion,tumor progression facilitation,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000113924,HGD,tyrosine catabolic pathway,tumor-promoting activity,oxidative stress regulation,cellular metabolism modulation,amino acid accumulation,genetic disorder association
ENSG00000186115,CYP4F2,fatty acid hydroxylation,cellular metabolism regulation,cancer cell survival,therapeutic target,genomic instability,lipid metabolism modulation
ENSG00000100867,DHRS2,oncogenic processes,cellular detoxification,tumor growth,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition,overexpression
ENSG00000173214,MFSD4B,fatty acid transport,lipid metabolism,transmembrane protein,signaling pathway regulation,tumor progression,prognostic biomarker
ENSG00000182492,BGN,tumor progression,tgf-β pathway regulation,cell adhesion modulation,cancer prognosis marker,extracellular matrix interaction,glycosaminoglycan modification
ENSG00000028116,VRK2,p53 regulation,cell cycle progression,tumor suppressor inactivation,transcription factor phosphorylation,nuclear localization,anti-apoptotic activity
ENSG00000104973,MED25,transcriptional regulation,cell proliferation,metastasis promotion,tumor progression,apoptosis inhibition,dna repair modulation
ENSG00000267796,LIN37,histone modification,epigenetic silencing,chromatin remodeling,tumor suppressor function,cancer association,gene expression regulation
ENSG00000093000,NUP50,nuclear import/export,apoptosis regulation,cell cycle progression,tumorigenesis,therapeutic target,chromatin remodeling
ENSG00000075420,FNDC3B,tumor progression,cell adhesion disruption,pi3k/akt pathway activation,oncogenic potential,prognostic marker,metastatic promotion
ENSG00000165724,ZMYND19,chromatin remodeling,dna repair defect,genomic instability,histone modification,oncogene overexpression,transcriptional regulation
ENSG00000164040,PGRMC2,cell cycle regulation,apoptosis resistance,angiogenesis promotion,protein-protein interactions,cellular differentiation,signal transduction modulation
ENSG00000135587,SMPD2,ceramide accumulation,lipid metabolism regulation,cell proliferation promotion,tumor progression enhancement,pro-survival pathway activation,biomarker potential
ENSG00000135211,TMEM60,mitochondrial dysfunction,energy metabolism regulation,reactive oxygen species production,cellular stress response,tumor progression,genomic instability
ENSG00000166069,TMCO5A,cellular response modulation,tumor progression,oncogenesis,protein interaction,cell survival,overexpression
ENSG00000135406,PRPH,tumor progression,oncogenic processes,cell migration,intermediate filament protein,cell adhesion,hypoxic response
ENSG00000171446,KRT27,epithelial integrity,structural support,tissue architecture,cell transformation,epithelial structure,regulatory functions
ENSG00000196646,ZNF136,tumor suppressor dysfunction,transcriptional regulation,oncogene activity,cell cycle progression,apoptosis inhibition,genomic instability
ENSG00000161896,IP6K3,**

phosphatidylinositol phosphorylation,oncogenic properties,cell survival,tumor progression,signaling pathway activation,gene overexpression

**
ENSG00000130741,EIF2S3,cap-dependent translation,constitutive activation,dysregulation of translation initiation,gain-of-function mutations,oncogenic signaling pathway,stress response modulation
ENSG00000171295,ZNF440,cellular proliferation,oncogenesis,transcriptional regulation,apoptosis inhibition,tumor progression,gene expression modulation
ENSG00000109445,ZNF330,cell cycle regulation,transcriptional modulation,g1 phase regulation,cyclin-dependent kinase interaction,tumor suppressor activity,therapeutic target
ENSG00000134986,NREP,epigenetic modulation,gene expression regulation,cell cycle control,tumor suppressor mechanism,dna damage response,transcriptional repression
ENSG00000181092,ADIPOQ,pro-angiogenic effects,tumor progression,cell proliferation regulation,poor prognosis marker,signaling pathway activation,metabolic regulation
ENSG00000285053,TBCE,iron-sulfur cluster assembly,tumor suppressor activity,oxidative stress response,protein-protein interactions,cellular iron regulation,signaling pathway modulation
ENSG00000111676,ATN1,**

chromatin remodeling,genomic stability,dna repair,oncogenic mutations,aberrant gene expression,cancer predisposition 

**
ENSG00000100865,CINP,mitotic spindle formation,microtubule stability,tumorigenesis contribution,cell division regulation,cytoskeletal interaction,cancer biomarker
ENSG00000137726,FXYD6,ion transport regulation,cellular signaling modulation,tumor progression,metastasis facilitation,sodium-potassium pump interaction,intracellular signaling alteration
ENSG00000142494,SLC47A1,efflux transport function,chemoresistance regulation,xenobiotic removal,multidrug resistance,cellular homeostasis maintenance,renal proximal tubule localization
ENSG00000178718,RPP25,spliceosome regulation,oncogene overexpression,aberrant pre-mrna splicing,cell proliferation enhancement,therapeutic target,genomic instability
ENSG00000143401,ANP32E,chromatin remodeling,transcriptional regulation,oncogenesis,tumor growth,cell survival,metastasis
ENSG00000142583,SLC2A5,tumor metabolism,oncogenic potential,enhanced cell survival,glucose transport facilitation,warburg effect involvement,therapeutic target candidacy
ENSG00000133103,COG6,dna repair mechanism,genome stability maintenance,cytosolic complex component,mutational impact on tumorigenesis,cellular replication regulation,potential therapeutic target
ENSG00000117862,TXNDC12,mitochondrial function,redox signaling pathway,cell proliferation,oxidative stress response,thioredoxin interaction,cell cycle regulation
ENSG00000063322,MED29,nucleosome remodeling factor complex,chromatin remodeling defect,dna repair mechanism impairment,transcription regulation disruption,genomic instability contributor,loss of function mutation
ENSG00000126603,GLIS2,transcriptional regulation,cell growth regulation,oncogene function,dna binding activity,tumor progression,signaling pathway activation
ENSG00000140854,KATNB1,microtubule dynamics regulation,chromosomal instability promotion,cellular proliferation enhancement,aneuploidy induction,therapeutic target consideration,genomic instability association
ENSG00000118523,CCN2,cell proliferation,extracellular matrix remodeling,angiogenesis promotion,epithelial-to-mesenchymal transition,tumor progression facilitation,growth factor interaction
ENSG00000188761,BCL2L15,apoptosis regulation,mitochondrial interaction,tumor suppression,cancer cell death,kircc association,cell survival modulation
ENSG00000007372,PAX6,transcription factor regulation,tumor progression,cellular homeostasis,apoptosis prevention,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction
ENSG00000169410,PTPN9,pi3k/akt signaling pathway alterations,oncogene and tumor suppressor function,substrate specificity changes,cellular proliferation and survival regulation,aggressive disease marker,genomic instability promoter
ENSG00000171992,SYNPO,actin cytoskeleton regulation,cell proliferation promotion,cancer cell growth modulation,immune response modulation,rho gtpase interaction,pi3k/akt pathway activation
ENSG00000173275,ZNF449,transcriptional regulation,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,epigenetic modification regulation,stemness gene regulation
ENSG00000105146,AURKC,cell cycle progression,chromosomal instability,oncogenic function,kinase activity,mitotic spindle checkpoint,chromosome segregation
,SEPT14,cellular processes disruption,oncogenic mechanisms,tumor progression,cytoskeleton component,microtubule interaction,cell division regulation
,SEPT2,oncogene activation,cell proliferation regulation,epithelial-to-mesenchymal transition,microtubule interaction,cell cycle regulation,growth factor pathway modulation
ENSG00000162517,PEF1,chromatin remodeling,dna replication,cell proliferation,tumor suppressor function loss,genomic instability,proliferation marker
ENSG00000135439,AGAP2,rtk recycling,oncogenic processes,tumor progression,metabolic regulation,endocytosis regulation,cell membrane trafficking
ENSG00000186207,LCE5A,cellular differentiation,apoptosis regulation,barrier function,epidermal integrity,keratinocyte interaction,regulatory mechanism
ENSG00000187180,LCE2C,**

lipid metabolism disruption,aberrant protein expression,cell membrane disruption,apoptosis resistance,pi3k/akt pathway modulation,tumor progression
ENSG00000103591,AAGAB,proteasome assembly,ubiquitin-proteasome pathway regulation,cellular stress response modulation,apoptosis regulation,protein degradation enhancement,therapeutic target potential
ENSG00000152056,AP1S3,tumor progression,cellular trafficking,metastasis promotion,cell growth regulation,apoptosis inhibition,vesicle formation
ENSG00000125878,TCF15,apoptosis regulation,tumor suppressor function,cell cycle progression,downregulation,transcriptional regulation,basic helix-loop-helix (bhlh) family
ENSG00000185475,TMEM179B,cell membrane integrity,transmembrane protein signaling,phosphoinositide phosphorylation,mitochondrial function regulation,tumor progression driver mutation,akt pathway activation
ENSG00000151778,SERP2,stat pathway regulation,gene expression modulation,tumor progression association,cellular proliferation regulation,apoptosis inhibition,metastasis facilitation
ENSG00000155229,MMS19,genomic instability,dna damage repair,oncogenic transformation,tumor progression,prognostic marker,cancer cell transformation
ENSG00000168899,VAMP5,vesicle fusion,exocytosis regulation,metastasis promotion,tumor progression,cell migration enhancement,prognostic marker
ENSG00000110025,SNX15,lysosomal function regulation,oncogenic protein expression,endocytic trafficking modulation,angiogenesis promotion,cell migration enhancement,metabolic pathway disruption
ENSG00000137074,APTX,histone modification,genomic instability,chromatin remodeling,poor prognosis,mutation hotspot,transcriptional regulation
ENSG00000183304,FAM9A,chromatin remodeling,transcriptional regulation,gene expression,overexpression,molecular interaction,genomic instability
ENSG00000148341,SH3GLB2,regulation of rtk signaling,autophagy regulation,apoptosis modulation,tumor progression,oncogene/tumor suppressor role,protein-protein interactions
ENSG00000275895,U2AF1L5,aberrant rna processing,cell proliferation,disrupted gene expression,genetic mutations,pro-survival signaling,regulatory protein interactions
ENSG00000149313,AASDHPPT,altered amino acid metabolism,enhanced cell proliferation,increased asparagine levels,oncogenic transformation,upregulated expression,dysregulation
ENSG00000134709,HOOK1,microtubule organization,protein stability regulation,cell migration and invasion,oncogenic protein modulation,tumor progression facilitation,cancer cell metastasis
,DUPD1,dna replication repair,cell cycle regulation,genomic stability modulation,tumor suppressor function,oncogenic potential,apoptosis regulation
ENSG00000108381,ASPA,protein degradation,cellular proliferation,apoptosis resistance,tumor suppressor loss,gene expression regulation,mitochondrial dysfunction
ENSG00000203786,KPRP,cellular regulation,serine protease activity,transcriptional regulation,rna processing,oncogenic interaction,therapeutic target
ENSG00000159921,GNE,cellular sialylation,tumor progression,metastatic potential,enhanced cell migration,sialic acid biosynthesis dysregulation,glycosylation pathway alteration
ENSG00000009709,PAX7,pi3k/akt pathway activation,tumor suppressor function,muscle-specific gene regulation,transcriptional repression,cell proliferation promotion,apoptosis induction
ENSG00000113552,GNPDA1,glycolytic reprogramming,oncogenic metabolism,insulin signaling pathway,metabolic regulation,cancer metabolism,therapeutic target
ENSG00000065029,ZNF76,transcriptional regulation,krab zinc finger protein family member,oncogene function,poor prognosis marker,tumor progression,cell proliferation enhancement
ENSG00000136732,GYPC,tumor suppressor function,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),poor prognosis biomarker,oncogenic signaling pathway activation,metastasis promotion
ENSG00000153060,TEKT5,tumor growth promotion,cell migration facilitation,integrin interaction,extracellular matrix remodeling,angiogenesis promotion,biomarker overexpression
ENSG00000184675,AMER1,cell cycle regulation,oncogene overexpression,genetic instability,aurora-a kinase activity,centrosome maturation,spindle formation regulation
ENSG00000172057,ORMDL3,er stress response,oncogenic driver,aberrant protein folding,unfolded protein response (upr) activation,cellular stress regulation,tumor growth promotion
ENSG00000149489,ROM1,metastasis promotion,cell migration facilitation,cytokeletal reorganization,tumor progression enhancement,cell adhesion modulation,gtpase activity regulation
ENSG00000168395,ING5,dna damage response,tumor suppressor function,cell cycle regulation,apoptosis induction,histone modification,genomic stability maintenance
ENSG00000009844,VTA1,aberrant protein trafficking,cell signaling regulation,plasma membrane integrity,tumorigenesis involvement,oncogenic process promotion,vesicular transport dysfunction
ENSG00000104490,NCALD,microtubule dynamics,overexpression,map interaction,cell migration,invasive potential,tumor progression
ENSG00000169704,GP9,platelet activation,angiogenesis promotion,tumor progression facilitation,apoptosis inhibition,protein overexpression,microenvironment modulation
ENSG00000213588,ZBTB9,tumor suppressor activity,regulation of gene expression,cell cycle regulation,apoptosis modulation,genetic alterations,epigenetic modification
ENSG00000178149,DALRD3,chromatin remodeling,dna damage response,transcriptional regulation,oncogene overexpression,cell proliferation,poor prognosis marker
ENSG00000120129,DUSP1,mapk pathway disruption,oncogenic processes promotion,tumor suppressor function,downregulation or mutation,cell proliferation suppression,constitutive activation of signaling pathways
ENSG00000127989,MTERF1,mitochondrial regulation,tumor progression,promotion of cell growth,apoptosis inhibition,prognostic marker,pi3k/akt pathway interaction
ENSG00000107140,TESK1,oncogenic signaling,cell proliferation,genetic amplification,cell migration,protein kinase activation,metastatic potential
ENSG00000070367,EXOC5,cellular invasion,cell polarity regulation,late endosome targeting,metastasis promotion,tumor progression,cancer cell migration
ENSG00000169087,HSPBAP1,microtubule stabilization,cell proliferation,protein-protein interaction,tumor growth,therapeutic target,cancer cell survival
ENSG00000105894,PTN,pi3k/akt pathway activation,cell migration and invasion,poor prognosis marker,cancer progression,heparin sulfate proteoglycans interaction,secreted glycoprotein
ENSG00000123560,PLP1,oncogenic signaling pathway disruption,tumor microenvironment modulation,overexpression in tumor tissues,cell proliferation enhancement,therapeutic target identification,pi3k/akt/mtor pathway interaction
ENSG00000164591,MYOZ3,emt modulation,glycolytic reprogramming,hif1α interaction,lipid metabolism regulation,muscle differentiation disruption,protein kinase activation
ENSG00000198081,ZBTB14,zinc finger transcription factor,tumor suppressor function,epigenetic regulator,cell cycle regulation,apoptosis inhibitor,transcriptional repression
ENSG00000173226,IQCB1,tumor suppressor,cell cycle regulation,signaling protein,phosphorylation-dependent regulation,apoptosis regulation,cytoskeleton organization
ENSG00000163093,BBS5,cilia regulation,tumor growth,polydactyly,kidney failure,renal disease,aberrant function
ENSG00000109501,WFS1,er stress response,tumor progression,cancer cell survival,clinical correlation,cellular stress regulation,dysregulated expression
ENSG00000147642,SYBU,inhibition of oncogenic pathways,cell growth regulation,tumor suppressor activity,sushi domain-containing protein,protein-protein interaction regulation,kirc susceptibility
ENSG00000182621,PLCB1,phosphoinositide hydrolysis,cell proliferation,signal transduction,metastasis promotion,mapk/erk activation,cancer progression
ENSG00000204859,ZBTB48,cell cycle regulation,oncogene activation,nuclear localization,transcriptional regulation,apoptosis inhibition,tumor suppressor interaction
ENSG00000113734,BNIP1,mitochondrial regulation,apoptosis inhibition,cell survival promotion,protein-protein interaction,tumor progression facilitation,oncogenic process contribution
ENSG00000100292,HMOX1,heme degradation,iron homeostasis,cellular redox balance,anti-inflammatory response,antioxidant defense,tumor progression
ENSG00000173110,HSPA6,tumor progression,apoptosis inhibition,cell survival enhancement,oncogenic protein stability,ubiquitin-proteasome pathway interaction,chemoresistance development
ENSG00000065882,TBC1D1,rab gtpase regulation,endoplasmic reticulum localization,gap activity towards rab35,membrane trafficking modulation,autophagy regulation,cancer association
ENSG00000196792,STRN3,pi3k/akt pathway modulation,oncogenic process promotion,tumor progression facilitation,scaffold protein function,potential therapeutic target,pi3k signaling regulation
ENSG00000151690,MFSD6,metabolic regulation,tumor growth promotion,mitochondrial function,fatty acid oxidation regulation,cellular metabolism modulation,protein-protein interaction
ENSG00000004779,NDUFAB1,mitochondrial dysfunction,apoptosis resistance,metabolic reprogramming,cellular respiration regulation,tumor progression,therapeutic target
ENSG00000144034,TPRKB,cell cycle regulation,kinase activity,signal transduction pathway,tumorigenesis driver,oncogenic process,protein-protein interaction
ENSG00000104897,SF3A2,aberrant splicing,alternative splicing regulation,cancer progression driver,splicing factor complex member,transcriptome modification,gene expression dysregulation
ENSG00000167414,GNG8,overexpression,tumor progression,signaling pathway regulation,cell survival and proliferation,camp-dependent signaling pathway,biomarker potential
ENSG00000160683,CXCR5,immune evasion,tumor progression,metastasis,cell migration,immunosuppressive microenvironment,prognostic marker
ENSG00000159082,SYNJ1,pip2 regulation,phosphoinositide dephosphorylation,cell signaling pathway,endocytosis regulation,cancer progression,tumor suppressor
ENSG00000171475,WIPF2,cellular migration,cell division regulation,oncogenesis,tumor progression,microtubule dynamics regulation,cellular stress response
ENSG00000102243,VGLL1,wnt/β-catenin signaling,transcriptional coactivator,cell proliferation,oncogene,tumor progression,signaling pathway modulation
ENSG00000128928,IVD,inflammatory response,cancer progression,immune evasion,tumor invasion,poor prognosis marker,metabolic regulation
ENSG00000063515,GSC2,wnt/β-catenin pathway,cell proliferation,transcriptional regulation,gene overexpression,tumor aggressiveness,mir-145 target
ENSG00000167123,CERCAM,chromatin remodeling,histone modification,tumor suppression,genomic instability,oncogene activation,tumor progression
ENSG00000110801,PSMD9,proteasome regulation,apoptosis modulation,cancer biomarker,cell cycle regulation,oncogene potential,tumor progression
ENSG00000128585,MKLN1,cell adhesion disruption,egfr activation,pi3k/akt pathway activation,apoptosis inhibition,mmps activation,tumor progression marker
ENSG00000143514,TP53BP2,loss of tumor suppressor function,dna repair mechanism disruption,cell cycle arrest impairment,apoptosis regulation failure,genomic instability induction,potential therapeutic target
ENSG00000108039,XPNPEP1,proteolytic enzyme activity,amino acid metabolism regulation,ubiquitin-proteasome system interaction,cell proliferation promotion,apoptosis inhibition,tumor progression support
ENSG00000103540,CCP110,centrosome overduplication,genomic instability,microtubule dynamics,spindle assembly checkpoint,cell proliferation,chromosomal instability
ENSG00000146918,NCAPG2,condensin complex,chromatin remodeling,genomic instability,aneuploidy,cell cycle regulation,metastasis driver
ENSG00000206560,ANKRD28,wnt/β-catenin pathway modulation,oncogenic function,transcriptional regulation,overexpression in tumors,cell cycle progression,chromatin remodeling
ENSG00000033050,ABCF2,chemotherapy resistance,protein folding regulation,dna repair interaction,lipid metabolism modulation,ubiquitin-proteasome pathway interaction,genomic instability maintenance
ENSG00000198162,MAN1A2,glycosylation regulation,tumor progression,potential therapeutic target,cellular growth promotion,protein processing alteration,n-glycan structure disruption
ENSG00000181541,MAB21L2,tumor suppressor function,cell cycle regulation,apoptosis modulation,loss-of-function mutations,aggressive tumor behavior,prognostic marker
ENSG00000130713,EXOSC2,genomic instability,co-amplification,rna degradation regulation,cell cycle progression,dna damage response,oncogenic signaling pathway
ENSG00000175213,ZNF408,krab domain protein,transcriptional regulator,cell proliferation enhancer,tumor growth promoter,overexpressed in cancer,genetic mutation driver
ENSG00000103995,CEP152,...<end>.

output:

<begin>
mitotic stability,cell proliferation,chromosome segregation,ciliogenesis regulation,tumor development promotion,gamma-tubulin complex formation
ENSG00000053254,FOXN3,transcriptional regulation,cell proliferation regulation,gene expression modulation,tumor suppressor potential,epithelial integrity maintenance,signal transduction pathway interaction
ENSG00000198466,ZNF587,transcriptional regulation,zinc finger protein function,tumorigenesis,gene expression modulation,cell growth and survival,transcription factor regulation
ENSG00000198315,ZKSCAN8,epigenetic regulation,zinc finger protein interaction,chromatin remodeling,apoptosis modulation,cell cycle regulation,oncogenic mutation
ENSG00000075914,EXOSC7,microrna biogenesis,oncogenic function,rna processing,cell proliferation,aggressive tumor behavior,transcriptional regulation
ENSG00000262635,TDO2,tumor growth promotion,immune suppression modulation,tryptophan degradation enzyme,kynurenine pathway regulation,immunosuppressive cell interaction,prognostic biomarker for overall survival
ENSG00000214513,NOTO,noto expression,tumor growth promotion,cell cycle regulation,transcriptional control,kidney epithelial cell involvement,wnt/β-catenin pathway interaction
ENSG00000174306,ZHX3,transcriptional regulation,cell proliferation suppression,oncogenic pathway activation,apoptosis resistance,tumor suppressor gene suppression,epigenetic modulation
ENSG00000160801,PTH1R,regulatory signaling,cellular proliferation,dysregulated expression,phosphorylation activation,oncogenic involvement,therapeutic target
ENSG00000143776,CDC42BPA,cell migration,cytoskeleton dynamics,tumorigenesis,oncogenic process,apoptosis resistance,protein interaction
ENSG00000172890,NADSYN1,nad+ synthesis,glycolytic reprogramming,metabolic rewiring,tumor growth promotion,energy metabolism dysregulation,therapeutic target
ENSG00000114850,SSR3,rna regulation,tumor suppressor,apoptosis induction,cell cycle control,genomic stability maintenance,oncogene targeting
ENSG00000197579,TOPORS,genomic instability,dna repair regulation,tumor suppressor function,cell cycle checkpoint regulation,aurora kinase inhibition,apoptosis promotion
ENSG00000188033,ZNF490,prognostic marker,tumor progression,oncogene activation,transcriptional regulation,chromatin remodeling,angiogenesis promotion
ENSG00000285248,IPO4,cell proliferation,apoptosis inhibition,nuclear import regulation,protein-protein interaction,cell cycle modulation,tumorigenesis promotion
ENSG00000162959,MEMO1,cell cycle progression,apoptosis inhibition,tumor growth promotion,poor prognosis marker,pi3k/akt pathway modulation,therapeutic target candidate
ENSG00000136003,ISCU,mitochondrial dysfunction,cellular respiration regulation,tumor growth promotion,oxidative stress induction,energy metabolism dysregulation,iron-sulfur cluster biogenesis alteration
ENSG00000147649,MTDH,oncogene,chromatin remodeling,epithelial-to-mesenchymal transition,multifunctional protein,signaling pathway regulation,cell proliferation
ENSG00000158636,EMSY,brca2 interaction,oncogene activation,dna repair disruption,chromatin remodeling,genomic instability,protein-protein interactions
ENSG00000103152,MPG,cell survival,multifunctional enzyme,oncogenesis,redox regulation,resistance to apoptosis,signaling pathway interaction
ENSG00000206505,HLA-A,tumor immunosurveillance,immune evasion mechanisms,class i histocompatibility antigen,antigen presentation pathway,peptide loading,gene expression regulation
ENSG00000175895,PLEKHF2,microtubule destabilization,cellular proliferation,mitotic regulation,protein-protein interaction,tumor suppressor dysfunction,cancer driver mutation
ENSG00000152430,BOLL,oncogenic function,cellular proliferation,dna repair mechanism,apoptosis regulation,tumor suppression,cancer progression
ENSG00000181938,GINS3,dna replication fork assembly,cell proliferation enhancer,cancer stem cell maintenance,genomic instability promoter,therapeutic resistance inducer,poor prognosis marker
ENSG00000134910,STT3A,protein synthesis regulation,translation initiation complex,cancer cell proliferation,cell survival pathways modulation,aberrant expression biomarker,therapeutic target
ENSG00000177030,DEAF1,disrupted transcriptional regulation,constitutive activation of oncogenic pathways,gain-of-function mutations,cell cycle progression,apoptosis resistance,tumor suppressor dysfunction
ENSG00000164880,INTS1,epigenetic regulation,methylation,silenced,tumor progression,cell proliferation,apoptosis
ENSG00000172073,TEX37,chromatin remodeling,transcriptional activation,oncogenesis promotion,cell proliferation,survival pathways,alternative splicing regulation
ENSG00000114279,FGF12,overexpression,oncogene,tumor progression,angiogenesis,cell proliferation,metastasis
ENSG00000103042,SLC38A7,glutamine uptake,pro-oncogenic function,tumor proliferation,cellular survival,apoptosis regulation,amino acid homeostasis
ENSG00000110218,PANX1,tumor progression,enhanced cell proliferation,inflammation modulation,cell migration and invasion,calcium signaling regulation,oxidative stress response
ENSG00000101624,CEP76,centrosome stability,microtubule dynamics,cilia assembly regulation,tumor progression,cell cycle regulation,dna damage response
ENSG00000164167,LSM6,tumor suppressor,chromatin remodeling,dna repair,cell cycle regulation,apoptosis regulation,genome stability maintenance
ENSG00000186510,CLCNKA,regulation of electrolyte balance,cellular homeostasis,oncogene potential,aberrant expression,tumor progression,cell migration
ENSG00000196459,TRAPPC2,membrane trafficking,oncogenic driver,constitutive activation,signaling pathway regulation,mtor pathway involvement,therapeutic target
ENSG00000137288,UQCC2,mitochondrial function,oncogenic mutations,enhanced oxidative phosphorylation,apoptosis evasion,cellular respiration,tumor growth promotion
ENSG00000184451,CCR10,chemokine receptor function,immune suppression recruitment,tumor progression facilitation,oncogenic role enhancement,lymph node metastasis promotion,immunotherapy target
ENSG00000116001,TIA1,oncogenic activity,stress granule regulation,cell proliferation,protein kinase activation,mrna stability,angiogenesis
ENSG00000140987,ZSCAN32,tumor suppressor function,cell cycle regulation,apoptosis modulation,cancer initiation,therapeutic target,genomic instability
ENSG00000002933,TMEM176A,akt/mtor signaling inhibition,autophagy regulation,cell survival promotion,lysosomal dysfunction,protein degradation pathway,transmembrane protein function
ENSG00000173276,ZBTB21,tumor suppressor activity,transcriptional regulation,cell cycle progression,apoptosis resistance,genomic instability,protein-protein interactions
ENSG00000100242,SUN2,chromatin regulation,cell division,genomic stability,prognostic biomarker,tumor progression,metastasis facilitation
ENSG00000002549,LAP3,autophagy regulation,lysosomal function,oncogenic processes,cell proliferation enhancement,tumor progression facilitation,therapeutic target
ENSG00000196152,ZNF79,zinc finger dna binding,tumor progression,metastasis,tumor suppressor gene repression,proto-oncogene activation,cell cycle regulation
ENSG00000176009,ASCL3,transcriptional regulator,oncogene activation,cell cycle progression,apoptosis evasion,angiogenesis promotion,tumor aggressiveness
ENSG00000128050,PAICS,dna repair mechanism,cellular proliferation,protein-protein interaction,genomic instability,nucleotide metabolism,biomarker identification
ENSG00000140265,ZSCAN29,tumor suppressor function,mtor pathway regulation,chromatin remodeling,genomic stability maintenance,cell proliferation repression,oncogene silencing
ENSG00000163346,PBXIP1,enhancer of cell cycle progression,overexpression in cancer cells,promoter of cell proliferation,transcriptional regulator,regulator of pi3k/akt signaling,cell survival pathway enhancer
ENSG00000169136,ATF5,tumor progression,tumor suppressor function loss,transcriptional regulation,cell cycle regulation,apoptosis inhibition,oncogenic transcription factor
ENSG00000154118,JPH3,calcium signaling pathway dysregulation,cellular growth regulation,apoptosis modulation,autophagy regulation,oncogenic transformation,tumor progression
ENSG00000138069,RAB1A,rab gtpase activity,apoptosis evasion,cell growth regulation,cytoskeleton organization,membrane trafficking regulation,tumor metastasis
ENSG00000265491,RNF115,ubiquitination,protein degradation,apoptosis modulation,cell cycle regulation,tumor suppressor activity,therapeutic target
ENSG00000135932,CAB39,calcium/calmodulin-dependent signaling,cell proliferation regulation,cell survival modulation,oncogenic process involvement,gene expression regulation,protein kinase activation
ENSG00000148110,MFSD14B,lipid metabolism,fatty acid transport,autophagy regulation,oncogenic mutations,cellular trafficking,lipid synthesis regulator
ENSG00000130733,YIPF2,er stress regulation,autophagy modulation,tumor suppressor function,golgi apparatus involvement,oncogenic pathway suppression,cellular homeostasis maintenance
ENSG00000129116,PALLD,**
cell motility,oncogenic behavior,cytoskeletal regulation,tumor progression,metastasis,overexpression 
**
ENSG00000120805,ARL1,tumor suppressor function loss,cell cycle progression enhancement,apoptosis suppression,membrane trafficking regulation,protein transport modulation,cancer cell survival promotion
ENSG00000120860,WASHC3,endosomal trafficking regulation,actin cytoskeleton modulation,pi3k/akt signaling modulation,tumor progression association,therapeutic target potential,none
ENSG00000166747,AP1G1,transcriptional coactivator function,oncogenic processes,cell proliferation regulation,ap-1 complex interaction,histone modification regulation,tumor progression facilitation
ENSG00000137648,TMPRSS4,tumor progression,cell migration,growth factor activation,enzymatic activity,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000005486,RHBDD2,pi3k/akt signaling,g-protein coupled receptor function,oncogene activation,cell cycle dysregulation,apoptosis inhibition,genomic amplification
ENSG00000077616,NAALAD2,enzyme regulation,cellular proliferation,therapeutic target,tumor progression,protein interaction,cell growth regulation
ENSG00000115233,PSMD14,proteasome subunit,chaperone activity,cell proliferation,apoptosis suppression,tumor aggressiveness,tumor suppressor degradation
ENSG00000107829,FBXW4,tumor suppression,dna repair regulation,cyclin degradation pathway,scf complex component,e3 ubiquitin ligase activity,cell cycle regulation
ENSG00000167604,NFKBID,nf-kappa b inhibition,oncogenic regulation,genomic instability,inflammation promotion,cell survival enhancement,tumor suppressor function
ENSG00000106688,SLC1A1,glutamate uptake,tumor growth promotion,malignant transformation,cell proliferation enhancement,aberrant overexpression,signal transduction activation
ENSG00000160877,NACC1,cellular proliferation,mutations leading to overexpression,wnt/β-catenin signaling interaction,metabolic reprogramming,protein-protein interaction,genomic instability
ENSG00000170836,PPM1D,oncogenic activation,cell cycle regulation disruption,phosphatase overactivation,cell proliferation enhancement,tumor suppressor inhibition,genomic instability promotion
ENSG00000099957,P2RX6,purinergic receptor activation,tumor microenvironment modulation,immune cell regulation,atp-mediated signaling,cancer progression promotion,cellular proliferation enhancement
ENSG00000104164,BLOC1S6,endosomal trafficking,autophagy regulation,protein degradation,cell survival,tumor progression,metabolic reprogramming
ENSG00000154710,RABGEF1,rab gtpase activation,oncogenic signaling pathway,membrane trafficking regulation,epithelial-to-mesenchymal transition (emt),cell proliferation and survival,genetic overexpression
ENSG00000170214,ADRA1B,alpha-2 adrenergic receptor subtype b,oncogene activation,tumor progression,cell proliferation regulation,angiogenesis promotion,beta-arrestin pathway interaction
ENSG00000178127,NDUFV2,mitochondrial dysfunction,energy metabolism regulation,electron transport chain disruption,oxidative stress induction,tumor progression promotion,poor prognosis marker
ENSG00000161956,SENP3,loss of deubiquitinating activity,cell cycle progression,oncogenic pathway activation,protein-protein interactions,cell proliferation,tumor suppression
ENSG00000106511,MEOX2,emt inhibition,tumor progression,cell proliferation regulation,angiogenesis promotion,metastasis facilitation,transcriptional regulation
ENSG00000102935,ZNF423,krab domain,zinc finger protein binding,gene regulation,tumorigenesis,transcriptional activation,cell proliferation
ENSG00000168209,DDIT4,mtor pathway inhibition,tumor suppressor function,cell growth regulation,apoptosis induction,metabolic regulation,pi3k/akt pathway modulation
ENSG00000173480,ZNF417,transcriptional repression,epigenetic modifications,oncogene activation,tumor suppression,metastatic progression,prognostic biomarker
ENSG00000205189,ZBTB10,oncogenic repression,tumor suppressor function,cellular differentiation,immune regulation,gene expression regulation,transcriptional repression
ENSG00000132256,TRIM5,tumor suppression,cellular proliferation regulation,protein-protein interaction,oncogene regulation,viral replication inhibition,cancer prognosis improvement
ENSG00000086548,CEACAM6,immune evasion,tumor progression,metastasis promotion,cell adhesion modulation,angiogenesis regulation,poor prognosis marker
ENSG00000177485,ZBTB33,transcriptional regulation,cell proliferation,apoptosis inhibition,oncogene potential,dna repair modulation,therapeutic target
ENSG00000136710,CCDC115,ciliary assembly,pi3k/akt pathway modulation,tumorigenesis driver,aberrant ciliogenesis,potential biomarker,therapeutic target
ENSG00000075399,VPS9D1,pi3k pathway regulation,tumor suppressor function,membrane trafficking regulation,autophagy modulation,vesicle formation control,cancer driver gene mutation
ENSG00000185379,RAD51D,dna repair mechanisms,homologous recombination,genomic instability,replication fork restart,tumor suppressor function,cancer predisposition
ENSG00000168071,CCDC88B,cellular migration,therapeutic target,tumor progression,actin cytoskeleton dynamics,epithelial-to-mesenchymal transition (emt),cell adhesion
,H2AFX,genomic stability,dna damage response,histone modification,epigenetic regulation,homologous recombination,tumor aggressiveness
ENSG00000162300,ZFPL1,zinc finger protein,transcriptional regulation,cell growth regulation,dna damage response,protein-protein interaction,gene expression modulation
ENSG00000127328,RAB3IP,rab3a activation,vesicle trafficking,cell migration,cancer cell survival,tumorigenesis,pi3k/akt signaling
ENSG00000072958,AP1M1,ap-1 activation,cellular signaling modulation,oncogenic processes,cell proliferation regulation,transcriptional regulation,nuclear translocation
ENSG00000116649,SRM,ribosome regulation,mtor pathway activation,gene mutation,protein synthesis enhancement,tumor progression driver,therapeutic target
ENSG00000147162,OGT,cell cycle regulation,glycolytic metabolism,oncogenic protein modification,transcriptional regulation,tumor metastasis,hypoxia-inducible factor 1-alpha stabilization
ENSG00000214717,ZBED1,cell proliferation,tumorigenesis,chromatin remodeling,zinc finger binding,transcriptional regulation,anti-apoptotic function
ENSG00000125863,MKKS,wnt signaling pathway,constitutive activation,amplification,cell proliferation,apoptosis inhibition,protein interaction
ENSG00000198010,DLGAP2,cell adhesion disruption,chromatin remodeling,epigenetic regulation,oncogenic signaling,tumor cell migration,proliferation enhancement
ENSG00000177917,ARL6IP6,regulation of intracellular trafficking,aberrant activation of signaling pathways,oncogenic transformation,altered cell proliferation,disrupted cellular regulation,genomic instability
ENSG00000122786,CALD1,caldesmon regulation,rho-kinase activation,cell migration promotion,tumor progression correlation,pi3k/akt pathway interaction,therapeutic target potential
,HIST1H2AM,epigenetic regulation,histone modifications,chromatin packaging,dna methylation changes,cancer predisposition,genomic instability
,HIST1H2AK,histone modification,chromatin regulation,tumor suppressor function,transcriptional regulation,dna repair mechanisms,epigenetic control
,HIST1H2AI,chromatin remodeling,histone modification,epigenetic regulation,nucleosome formation,tumor suppressor regulation,oncogene expression
,HIST1H2AL,epigenetic regulation,histone modification,gene expression regulation,chromatin structure,cell growth regulation,dna repair
,HIST1H2AG,histone regulation,tumor suppressor function,chromatin remodeling,gene expression modulation,genomic instability,cancer progression
ENSG00000264364,DYNLL2,dynein-mediated transport,microtubule stability regulation,oncogene overexpression,apoptosis resistance promotion,cell migration enhancement,therapeutic target identification
ENSG00000110079,MS4A4A,pi3k/akt signaling,cell adhesion,b-cell regulation,oncogenic activity,promoter methylation,cell migration
ENSG00000125733,TRIP10,pi3k/akt pathway interaction,cell proliferation regulation,tumor progression promotion,lipid metabolism modulation,glycolysis facilitation,therapeutic target potential
ENSG00000105677,TMEM147,ion channel regulation,transmembrane protein,cancer progression,metastasis,cellular interaction,tumor growth inhibition
ENSG00000109846,CRYAB,cell survival,epithelial-to-mesenchymal transition (emt),apoptosis resistance,chaperoning protein function,metastasis promotion,protein aggregation inhibition
ENSG00000152137,HSPB8,chaperone function,anti-apoptotic effects,protein aggregation regulation,tumor progression,cell survival enhancement,oxidative stress response
ENSG00000100526,CDKN3,cell cycle regulation,tumor suppressor function,loss of inhibitory function,mutations leading to oncogenesis,epigenetic modifications affecting expression levels,interaction with pi3k/akt pathway
ENSG00000134640,MTNR1B,mtnr1b regulation,g-protein coupled receptor function,tumor microenvironment modulation,angiogenesis regulation,immune response modulation,therapeutic target potential
ENSG00000033867,SLC4A7,cellular metabolism disruption,altered protein expression,intracellular ph regulation,oncogenic process promotion,tumor microenvironment modulation,ion transport dysfunction
ENSG00000184209,SNRNP35,alternative splicing regulation,spliceosome assembly,pre-mrna processing,tumor suppressor modulation,cancer genomic alterations,genomic instability
ENSG00000288335,TWIST2,**

twist2,epithelial-to-mesenchymal transition,e-cadherin repression,mesenchymal marker induction,wnt/β-catenin pathway activation,pi3k/akt signaling enhancement
ENSG00000104783,KCNN4,cellular excitability,ion homeostasis modulation,cell proliferation suppression,apoptosis inhibition,cell cycle regulation interaction,tumor growth promotion
ENSG00000089356,FXYD3,na+/k+-atpase regulation,ion transporter interaction,cell proliferation,tumor progression,signaling pathway modulation,protein-protein interaction
ENSG00000117625,RCOR3,tumor suppressor activity,epigenetic regulation,histone modification,transcriptional regulation,cellular homeostasis disruption,chromatin remodeling
ENSG00000147596,PRDM14,epigenetic regulation,genomic instability,cell cycle regulation,apoptosis suppression,tumor progression,poor prognosis marker
ENSG00000170266,GLB1,lysosomal degradation,glycosphingolipid metabolism,cell signaling disruption,glycolipid composition changes,metastasis promotion,oncogenic process involvement
ENSG00000138375,SMARCAL1,dna repair pathway,genomic instability,oncogenic transcription factor,protein-protein interaction,tumor progression,therapeutic target
ENSG00000183323,CCDC125,centrosomal protein regulation,microtubule dynamics,dna damage response,mitotic checkpoint control,chromosomal instability,aneuploidy promotion
ENSG00000088727,KIF9,microtubule stability,cell division regulation,mitotic spindle assembly,chromosome alignment regulation,cancer cell proliferation,genomic instability promotion
ENSG00000084731,KIF3C,kinesin-related protein activity,mitotic spindle assembly,chromosomal instability,aneuploidy,tumor progression,cell division regulation
ENSG00000163050,COQ8A,mitochondrial dysfunction,cellular bioenergetics regulation,electron transport chain maintenance,genomic instability induction,reactive oxygen species production,tumor suppressor activity loss
ENSG00000127054,INTS11,dna damage response,genomic instability,cell cycle regulation,oncogenic mutation,transcriptional regulator,integrator complex dysfunction
ENSG00000104299,INTS9,p53 regulation,dna damage response,mdm2 interaction,p53 degradation,tumor suppressor function,tumor progression marker
ENSG00000130528,HRC,mitochondrial dysfunction,altered metabolic profile,energy production defects,reactive oxygen species regulation,tumor suppressor function,oncogenic processes modulation
ENSG00000133104,SPART,tumor suppressor,genomic stability maintenance,cell cycle regulation,histone modification,dna damage response,chromatin remodeling
ENSG00000165556,CDX2,aberrant expression,cellular differentiation,epithelial regulation,homeobox transcription factor,intestinal development,tumor suppressor
ENSG00000180332,KCTD4,cell cycle regulation,transcriptional regulation,apoptosis inhibition,dna repair mechanism,tumor progression,protein-protein interaction
ENSG00000151422,FER,oncogenic driver,cell adhesion disruption,tyrosine kinase activation,tumor growth promotion,metastasis facilitation,signaling pathway modulation
ENSG00000167995,BEST1,ion channel function,tumor upregulation,cellular homeostasis disruption,oncogenic potential,cancer cell behavior alteration,genomic instability
ENSG00000100744,GSKIP,gsk3β inhibition,wnt/β-catenin signaling,cell cycle progression,apoptosis regulation,cancer driver,rna binding protein
ENSG00000107281,NPDC1,nuclear transport regulation,chromatin remodeling interaction,aberrant expression associated,apoptosis resistance linked,tumor cell growth promotion,cancer cell proliferation enhancement
ENSG00000205352,PRR13,genomic stability regulation,dna damage response regulation,tumor progression promotion,genome instability contributor,rna helicase activity,cellular stress response modulation
ENSG00000197024,ZNF398,tumor suppressor function,transcriptional repressor role,cell proliferation inhibition,apoptosis promotion,epithelial cell regulation,downregulation/mutation status
ENSG00000204946,ZNF783,transcriptional regulation,constitutive activation,oncogenic function,tumor progression,protein-dna interaction,genomic instability
ENSG00000106336,FBXO24,cellular degradation,cell cycle regulation,apoptosis suppression,pi3k/akt pathway activation,tumor suppressor targeting,poor prognosis biomarker
ENSG00000130299,GTPBP3,cellular growth regulation,signaling pathway modulation,tumor progression promotion,protein-protein interaction,pi3k/akt/mtor activation,guanine nucleotide binding
ENSG00000164707,SLC13A4,**,none,none,none,none,none
ENSG00000108255,CRYBA1,cellular structure maintenance,oncogenic transformation,cell cycle regulation,wnt signaling pathway,protein-protein interactions,tumor progression
ENSG00000168246,UBTD2,ubiquitin-dependent protein degradation,oncogene activation,pi3k/akt pathway modulation,tumor cell proliferation,cell survival enhancement,metastasis promotion
ENSG00000123636,BAZ2B,chromatin remodeling,transcriptional activation,gene expression regulation,cell proliferation,metastasis,chemoresistance
ENSG00000010932,FMO1,oxidative stress response,metabolic reprogramming,cellular detoxification,cancer cell survival,therapeutic target,genomic instability
ENSG00000167580,AQP2,disrupted water reabsorption,reduced expression levels,cell shrinkage,apoptosis resistance,tumor progression,metastatic potential
ENSG00000225697,SLC26A6,ion transport regulation,electrolyte balance disruption,cell proliferation enhancement,metabolic reprogramming,protein-protein interaction modulation,tumor cell survival promotion
ENSG00000117569,PTBP2,tumor progression,aberrant splicing events,cell migration,rna processing regulation,cellular differentiation,apoptosis inhibition
ENSG00000175575,PAAF1,polyadenylation regulation,rna processing dysregulation,oncogene activation,tumor suppressor silencing,cancer progression facilitation,therapeutic target identification
ENSG00000155660,PDIA4,protein folding regulation,tumor progression,oncogenesis,cell proliferation,cell migration,apoptosis modulation
ENSG00000170442,KRT86,epithelial cell integrity,tumor aggressiveness,biomarker for prognosis,cytoskeletal dynamics regulation,cell adhesion disruption,oncogenic processes
ENSG00000160917,CPSF4,3' end processing,alternative splicing,cancer prognosis,cell proliferation,gene expression regulation,tumor progression
ENSG00000189280,GJB5,cell-to-cell communication,gap junctions disruption,apoptosis regulation,cell proliferation,tumor progression,cancer biomarker
ENSG00000160678,S100A1,calcium signaling pathway,cell proliferation regulation,tumor progression marker,prognostic marker,apoptosis modulation,cell differentiation regulator
ENSG00000167972,ABCA3,lipid transport regulation,cancer cell membrane processes,tumor lipid metabolism,cellular signaling pathway alterations,proliferation enhancement,survival mechanisms modulation
ENSG00000078081,LAMP3,tumor microenvironment modulation,antigen presentation suppression,cytokine secretion regulation,lysosomal function regulation,biomarker significance,therapeutic target potential
ENSG00000143119,CD53,immune evasion,tumor progression,cell adhesion regulation,signaling pathway modulation,overexpression in tumors,prognostic marker
ENSG00000167656,LY6D,tumor progression,metastasis marker,cell surface expression,oncogenic function,prognostic indicator,cell migration enhancement
ENSG00000139291,TMEM19,ion transport regulation,oncogene activation,cellular homeostasis disruption,tumor progression facilitation,apoptosis resistance promotion,metastasis enhancement
ENSG00000187170,LCE4A,epithelial differentiation,cellular proliferation,apoptosis regulation,therapeutic target,dna repair modulation,genomic profiling
ENSG00000159455,LCE2B,epithelial-to-mesenchymal transition (emt),cell proliferation,gene expression regulation,protein interaction,cell migration,transcriptional regulation
ENSG00000099810,MTAP,co-amplification,cell cycle regulation,metabolic regulation,oncogene overexpression,poor prognosis indicator,hypoxia-inducible factor regulation
ENSG00000171431,KRT20,epithelial origin marker,cytoskeleton organization,protein-protein interaction,cell structure integrity,loss of expression alteration,none
ENSG00000111229,ARPC3,arp2/3 complex activation,oncogene potential,cytoskeleton regulation,cell migration enhancement,tumor progression promotion,apoptosis resistance
ENSG00000154040,CABYR,calcium-dependent regulation,cell migration,tumor progression,cell adhesion,signaling pathway modulation,gene expression regulation
ENSG00000133935,ERG28,dna repair,genomic instability,homologous recombination,oncogenic function,tumor progression,chromosomal stability
ENSG00000057294,PKP2,tumor suppressor,epithelial-to-mesenchymal transition,cell-cell adhesion disruption,loss of function mutations,signaling pathway dysregulation,cancer invasion promotion
ENSG00000163554,SPTA1,cellular stability,cell adhesion regulation,cytoskeleton maintenance,cell shape modulation,signaling pathway involvement,structural protein function
ENSG00000170523,KRT83,cellular adhesion,tumor progression,protein interaction,epithelial integrity,cell cycle regulation,cancer prognosis
ENSG00000235588,AIF1,tumor suppressor function loss,immunosuppressive effects,angiogenesis promotion,tumor microenvironment modulation,calcium signaling disruption,cell migration and invasion enhancement
ENSG00000174652,ZNF266,transcriptional regulator,tumor suppressor function,oncogenic potential,cellular differentiation regulation,gene expression modulation,genomic instability maintenance
ENSG00000105656,ELL,transcription elongation,oncogene,cell proliferation,mrna regulation,poor prognosis,therapeutic target
ENSG00000101639,CEP192,chromosomal instability,aneuploidy,mitotic checkpoint activation,cell proliferation,therapeutic resistance,kinetochores
ENSG00000277649,TIMM22,mitochondrial translocase assembly,tumor progression,apoptosis evasion,energy metabolism disruption,chemotherapy resistance,cellular transformation
ENSG00000132912,DCTN4,microtubule regulation,cell division regulation,cytoplasmic transport facilitation,oncogenic potential,cancer cell migration promotion,tumor growth enhancement
ENSG00000146054,TRIM7,cellular regulation,mitosis regulation,microtubule interaction,tumor suppression,genomic instability,oncogenic pathway modulation
ENSG00000163254,CRYGC,cellular stress response,protein homeostasis regulation,tumor progression modulation,pi3k/akt pathway interaction,oncogenic transformation potential,protein stability regulation
ENSG00000125741,OPA3,mitochondrial dysfunction,metabolic regulation,cell survival advantages,tumor growth promotion,energy metabolism disruption,cell death pathway modulation
ENSG00000280616,VPS11,retromer complex,endosomal sorting,retrograde transport,escrt-iii interaction,ablated protein trafficking,aberrant receptor degradation
ENSG00000170484,KRT74,epithelial cell morphology,tumor growth,cell adhesion changes,cancer progression,prognostic marker,biomarker expression
ENSG00000171401,KRT13,cell proliferation,epithelial integrity disruption,oncogene activation,tumor progression,metastasis promotion,poor prognosis
ENSG00000102383,ZDHHC15,palmitoylation modification,oncogenic processes,epithelial-to-mesenchymal transition,cell proliferation regulator,zinc finger domain,signaling pathway activator
ENSG00000078549,ADCYAP1R1,cellular signaling,oncogenic processes,metastasis promotion,cell survival enhancement,growth factor regulation,therapeutic target
ENSG00000140022,STON2,actin cytoskeleton regulation,cancer cell motility,epithelial-to-mesenchymal transition (emt),cell migration and invasion,tumor progression and metastasis,protein-protein interaction
ENSG00000085832,EPS15,clathrin-mediated endocytosis,constitutive activation,endosomal recycling,oncogenic processes,pi3k/akt pathway interaction,cell proliferation regulation
ENSG00000118900,UBN1,ubiquitination regulation,oncogene function,protein degradation modulation,cancer metastasis,therapeutic resistance,tumor progression
ENSG00000274137,MYOM2,non-muscle myosin,regulation of actomyosin dynamics,cell migration and invasion,oncogenic properties,aggressive tumor behavior,poor prognosis
ENSG00000164941,INTS8,genomic instability,dna repair,tumor progression,non-homologous end joining,double-strand break repair,epigenetic regulation
ENSG00000263155,MYZAP,polyamine regulation,gene expression regulation,tumor progression,aggressive tumor behavior,apoptosis modulation,cell proliferation enhancement
ENSG00000154001,PPP2R5E,altered pp2a activity,cancer cell proliferation,cellular regulation disruption,dysregulated tumor suppressor pathways,increased cancer cell survival,tumor suppressor pathway modulation
ENSG00000148734,NPFFR1,npff peptide signaling,g-protein coupled receptor function,tumor progression,cell migration enhancement,therapeutic target,cancer cell invasion
ENSG00000124678,TCP11,chaperone function,protein folding,cellular integrity maintenance,cancer prevention,tumor suppressor potential,genetic stability
ENSG00000167182,SP2,transcriptional regulation,oncogene activation,cell proliferation promotion,tumor growth facilitation,immune evasion enhancement,angiogenesis support
ENSG00000174744,BRMS1,chromatin remodeling,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis modulation,epigenetic regulation
ENSG00000133134,BEX2,apoptosis resistance,bcl-2 family regulation,cell survival promotion,mitochondrial function regulation,tumor progression facilitation,therapeutic target identification
ENSG00000008277,ADAM22,adam family member,cell surface interaction,tumor progression,epithelial-to-mesenchymal transition (emt),metastasis promoter,adhesion molecule
ENSG00000092330,TINF2,telomere maintenance,genomic instability,cell proliferation,oncogene function,epigenetic regulation,dna methylation
ENSG00000042781,USH2A,tumorigenesis,cell membrane protein,cilia morphology regulation,retina photoreceptor function,inner ear hair bundle structure,somatic mutation driver
ENSG00000006611,USH1C,cell signaling,mechanoreceptor function,protein interaction,cellular regulation,hair bundle development,inner ear function
ENSG00000158480,SPATA2,protein ubiquitination,genomic instability,cellular signaling pathway,apoptosis regulation,cell cycle control,tumor progression
ENSG00000171222,SCAND1,genomic instability,tumor suppressor function,dna repair pathway,genetic mutations,transcriptional regulation,cancer progression
ENSG00000166529,ZSCAN21,epigenetic silencing,tumor suppressor function,cell cycle regulation,apoptosis induction,dna repair regulation,genomic instability prevention
ENSG00000108691,CCL2,immune cell recruitment,monocyte/macrophage activation,immunosuppressive microenvironment,tumor progression,metastasis promotion,therapeutic target
ENSG00000181220,ZNF746,transcriptional regulation,cell cycle progression,tumor progression,pi3k/akt signaling,oncogenesis,genome instability
ENSG00000117758,STX12,membrane trafficking regulation,cell migration promotion,poor prognosis association,overexpression involvement,snare complex interaction,cellular membrane alteration
ENSG00000182544,MFSD5,lipid metabolism regulation,cellular stress modulation,chromosomal location alteration,lipid profile alterations,tumor progression driver,renal cell carcinoma association
ENSG00000232062,HLA-DQA1,immunogenicity,tumor immunosurveillance,antigen presentation,immune evasion,cancer prognosis,genetic polymorphisms
ENSG00000262156,APOBEC3A,dna deamination,genomic instability,mutator gene,tumor suppressor inactivation,oncogene activation,genetic heterogeneity
ENSG00000063854,HAGH,apoptosis regulation,cell proliferation,ion transport protein,cell membrane interaction,signal transduction pathway,genomic instability
ENSG00000189037,DUSP21,mapk pathway regulation,oncogenic signaling,tumor progression,apoptosis inhibition,overexpression,genomic instability
ENSG00000174738,NR1D2,circadian rhythm regulation,lipid metabolism regulation,tumor suppressor function,transcriptional repression,fatty acid synthesis activation,aberrent cellular energy homeostasis
ENSG00000089248,ERP29,er resident disulfide isomerases,protein folding quality control,tumor progression,oncogenic pathways,stress responses in er,cellular redox balance
ENSG00000118596,SLC16A7,glycolytic phenotype adaptation,lactate transport facilitation,tumor metabolism regulation,rapid cell proliferation support,hypoxia response modulation,metabolic regulator interaction
ENSG00000197142,ACSL5,lipid biosynthesis,cell proliferation,energy metabolism regulation,tumor progression,oncogenic role,prognostic marker
ENSG00000185880,TRIM69,e3 ubiquitin ligase activity,promoter of cellular proliferation,regulation of protein stability,driver of oncogenesis,tumor suppressor function,protein-protein interactions
ENSG00000170271,FAXDC2,cell proliferation regulation,protein-protein interactions,chromatin remodeling,transcriptional regulation,signal transduction regulation,protein-coding potential
ENSG00000011275,RNF216,p53 regulation,dna repair defects,genomic instability,oncogene activation,apoptosis inhibition,tumor suppressor dysfunction
ENSG00000097021,ACOT7,metabolic regulation,cell proliferation,oncogenic potential,fatty acid metabolism,tumor progression,therapeutic target
ENSG00000167325,RRM1,ribosome biogenesis,gene amplification,protein overexpression,therapeutic target,cancer aggressiveness,poor prognosis
ENSG00000145780,FEM1C,cell cycle regulation,tumor suppression,dna damage response,genomic instability,chromatin remodeling,apoptosis regulation
ENSG00000213145,CRIP1,cell cycle progression,tumor growth promotion,apoptosis inhibition,transcriptional regulation,prognostic marker candidate,cdk interaction
ENSG00000133800,LYVE1,lymphangiogenesis regulation,hyaluronan interaction,tumor metastasis facilitation,poor prognosis indicator,therapeutic target,cancer metastasis support
ENSG00000163472,TMEM79,lipid metabolism regulation,tumor progression promotion,lipid-raft protein interaction,cell membrane alteration,proliferation and survival enhancement,signaling pathway modulation
,PQLC1,oxidative stress regulation,dna damage response,apoptosis modulation,cell cycle regulation,tumor progression,biomarker potential
ENSG00000151490,PTPRO,pi3k/akt pathway downregulation,constitutive activation of oncogenic pathways,tumor suppression,cell signaling regulation,reduced expression in cancer tissues,protein-protein interactions
ENSG00000047936,ROS1,receptor tyrosine kinase,kinase domain mutations,therapeutic target,ras/mapk signaling pathway,pi3k/akt activation,tumor growth and survival
ENSG00000162645,GBP2,autophagy regulation,tumor suppression,immune response modulation,cancer immunotherapy target,cellular homeostasis maintenance,lysosomal membrane interaction
ENSG00000263028,TAS2R19,apoptosis regulation,cell growth modulation,cancer suppression,downstream effectors interaction,tumor suppressor function,wnt signaling pathway
ENSG00000113048,MRPS27,mitochondrial ribosome assembly,mitochondrial translation regulation,energy metabolism dysregulation,cancer cell survival advantage,protein synthesis modulation,therapeutic target identification
ENSG00000135517,MIP,cell migration,tumor progression,metastasis,prognostic marker,oncogenesis,osmoregulation
ENSG00000039560,RAI14,oncogenic function,nuclear receptor coactivator activity,cellular growth regulation,tumor progression,transcriptional regulation,histone modification interaction
ENSG00000165794,SLC39A2,zinc transporter function,cell proliferation regulation,oncogenic potential,cell migration enhancement,mapk/erk pathway interaction,tumor progression facilitation
ENSG00000179151,EDC3,cell proliferation,epigenetic silencing,metastasis,tumor suppression,histone modification,protein-protein interaction
ENSG00000197162,ZNF785,tumor suppressor,dna repair,cell cycle regulation,apoptosis regulation,genome stability maintenance,transcriptional regulation
ENSG00000003147,ICA1,ion transport,cellular metabolism,tumor progression,metastasis promotion,proton transport,biomarker potential
ENSG00000175376,EIF1AD,translation regulation,oncogenic driver,tumor progression,cellular proliferation,metabolic reprogramming,protein-protein interaction
ENSG00000171885,AQP4,aquaporin function,cell proliferation regulation,hypoxia-inducible factor-1 alpha interaction,tumor progression enhancement,water transport facilitation,cancer cell migration support
ENSG00000143862,ARL8A,cellular trafficking,gtpase activity,autophagy regulation,tumor progression,therapeutic target,survival prognosis
ENSG00000173660,UQCRH,mitochondrial electron transport chain,oxidative phosphorylation disruption,rieske iron-sulfur protein function,electron transfer regulation,cellular respiration impairment,oncogenic process contribution
ENSG00000121634,GJA8,gap junctions,cell-to-cell communication,ion channel regulation,tissue homeostasis,kidney epithelial cells,oncogenic modulation
ENSG00000015592,STMN4,microtubule dynamics regulation,tumor progression promotion,cell proliferation enhancement,metastasis facilitation,prognostic biomarker identification,genomic instability contribution
ENSG00000090989,EXOC1,membrane trafficking,exocytosis regulation,tumorigenesis promotion,cellular morphology changes,metastatic potential enhancement,protein secretion alteration
ENSG00000099203,TMED1,protein trafficking regulation,cellular homeostasis disruption,cancer progression facilitation,retrograde transport dysregulation,apoptosis evasion,therapeutic target potential
ENSG00000150787,PTS,serine biosynthesis,cell proliferation,tumor growth promotion,cell division regulation,protein synthesis enhancement,metabolic regulation alteration
ENSG00000174851,YIF1A,translation initiation factor,protein synthesis regulation,oncogene activation,tumor progression facilitation,therapeutic target identification,cellular metabolism modulation
ENSG00000145982,FARS2,iron-sulfur cluster assembly,mitochondrial function,protein modification,oncogenic processes,cell growth promotion,apoptosis inhibition
ENSG00000119782,FKBP1B,angiogenesis,cell cycle regulation,dna repair deficiency,hypoxia adaptation,metastasis promotion,transcriptional regulation
ENSG00000198626,RYR2,calcium channel dysfunction,aberrant calcium signaling,oncogenic mutations,cell proliferation enhancement,prognostic biomarker potential,pi3k/akt pathway modulation
ENSG00000169248,CXCL11,tumor progression,tissue remodeling,angiogenesis,cxcr3 interaction,immune evasion,promoter hypermethylation
ENSG00000006606,CCL26,immune suppression,tumor progression,metastatic potential,biomarker significance,chemokine signaling,inflammation regulation
ENSG00000118777,ABCG2,multidrug resistance,transporter activity,cellular efflux,oncogenesis,tumor progression,chemotherapy evasion
ENSG00000198959,TGM2,angiogenesis enhancement,apoptosis resistance,cell survival pathway modification,cross-linking enzyme activity,tumor growth promotion,protein-protein interaction
ENSG00000237508,HLA-F,tumor progression,immune evasion,mhc class i interaction,poor prognosis,cell proliferation,metastasis
ENSG00000283889,KIR3DS1,nk cell receptor,tumor surveillance,immune modulation,hla-c interaction,nk cell activation,cancer immunology
ENSG00000100055,CYTH4,tumor angiogenesis,oncogene activation,atp regulation,cell proliferation,prognostic biomarker,cell signaling pathway interaction
ENSG00000124782,RREB1,transcriptional regulator,oncogenic driver,epigenetic modifier,cell cycle progression,apoptosis inhibitor,metabolic reprogrammer
ENSG00000000457,SCYL3,er stress response,perk/eif2α pathway,cell survival promotion,oncogene,therapeutic target,protein-protein interaction
ENSG00000130684,ZNF337,cell proliferation,tumor suppressor loss,gene expression regulation,zinc finger domain,transcriptional activation,cancer cell survival
ENSG00000107249,GLIS3,wnt signaling pathway inhibition,constitutive activation,loss-of-function mutations,tumor suppressor function,cellular proliferation regulation,post-translational modifications
ENSG00000122126,OCRL,pi3k/akt pathway interaction,phosphoinositide regulation,oncogenic signaling,cell growth regulation,protein modulation,genomic instability
ENSG00000164609,SLU7,alternative splicing,spliceosome regulation,oncogenic splice variants,tumor progression,poor prognosis marker,cell cycle regulation
ENSG00000187559,FOXD4L3,epithelial-to-mesenchymal transition (emt),oncogene,transcription factor regulation,tumor progression,immune microenvironment modulation,prognostic biomarker
ENSG00000151882,CCL28,immunosuppression,tumor progression,angiogenesis promotion,prognostic marker,immune evasion,tumor microenvironment modulation
ENSG00000160796,NBEAL2,cytoplasmic protein regulation,pi3k/akt pathway interaction,autophagy regulation,cell proliferation enhancement,oncogenic process promotion,cytoskeletal dynamics modulation
ENSG00000109805,NCAPG,chromatin remodeling,chromosome condensation,cell cycle regulation,dna replication,tumor aggressiveness,prognostic marker
ENSG00000121152,NCAPH,mitotic progression,anti-apoptotic,genomic instability,chromosome segregation,cell cycle regulation,proteolytic degradation
ENSG00000119396,RAB14,egfr regulation,endocytic recycling,cell growth promotion,protein trafficking modulation,poor prognosis marker,tumor suppressor dysfunction
ENSG00000146109,ABT1,chromatin remodeling,gene silencing,tumor suppressor,mutation hotspot,epigenetic regulation,genomic instability
ENSG00000197275,RAD54B,genomic instability,homologous recombination repair,chromatin remodeling,tumor progression,dna repair deficiency,cancer susceptibility
ENSG00000147041,SYTL5,regulated exocytosis pathway,overexpression,cell migration,tumor progression,invadopodia formation,poor prognosis
ENSG00000041353,RAB27B,cellular trafficking,oncogenic protein accumulation,tumor progression,pi3k/akt signaling,cell migration,adhesion resistance
ENSG00000168993,CPLX1,wnt signaling pathway,β-catenin accumulation,proliferation and survival promotion,cellular differentiation modulation,oncogenic process activation,protein-protein interaction
ENSG00000104892,KLC3,microtubule stability,mitotic spindle assembly,kinesin-1 overexpression,cell migration and invasion,tumor progression,poor prognosis
ENSG00000118922,KLF12,emt program modulation,transcriptional repressor function,cellular differentiation regulation,proliferation promotion,survival enhancement,overexpression in cancer
ENSG00000039650,PNKP,dna repair mechanisms,genetic instability,telomere regulation,tumor progression,poor prognosis marker,genomic maintenance enzyme
ENSG00000138686,BBS7,cilia formation,cell proliferation,signaling pathway regulation,genetic disorder association,tumorigenesis contribution,oncogene potential
ENSG00000181029,TRAPPC5,oncogenic driver,cell proliferation,signaling pathway activation,protein trafficking regulation,mitotic spindle formation disruption,gene expression regulation alterations
ENSG00000164975,SNAPC3,aberrant splicing,cell cycle regulation,dysregulated protein production,gene expression modulation,malignant transformation,spliceosome assembly
ENSG00000023608,SNAPC1,genomic instability,rna processing,nuclear complex assembly,gene expression regulation,cell proliferation,tumor suppressor function
ENSG00000133318,RTN3,mitochondrial dynamics,tumor suppressor function,epithelial-to-mesenchymal transition modulation,cellular structure regulation,gene expression alteration,protein-protein interaction
ENSG00000103502,CDIPT,altered expression,cell proliferation,cell survival,dysregulated metabolism,genetic alterations,lipid metabolism regulation
ENSG00000088538,DOCK3,rho gtpase regulation,cell migration invasion,cancer progression driver,cell survival enhancement,actin cytoskeleton regulation,microtubule dynamics modulation
ENSG00000276432,RDM1,genomic instability,cellular senescence,replication fork stability,homologous recombination repair,telomere maintenance,dna repair
ENSG00000242689,CNTF,stat3 activation,growth promotion,cell survival,cytokine signaling,tumor progression,protein interaction
ENSG00000014123,UFL1,cellular homeostasis disruption,genomic instability,impaired dna repair,oncogenic process,protein quality control regulation,tumor suppressor function
ENSG00000182985,CADM1,cell adhesion regulation,tumor suppressor activity,pi3k/akt pathway modulation,cell proliferation inhibition,metastasis suppression,gene expression silencing
ENSG00000109943,CRTAM,tumor progression,poor prognosis,immunosurveillance failure,immune response modulation,protein-protein interaction,cell activation and proliferation
ENSG00000134690,CDCA8,centrosome clustering,cell proliferation,chromosomal instability,oncogenic protein interaction,tumor progression,genomic regulation
ENSG00000106069,CHN2,enhanced cell proliferation,overexpression,poor prognosis,pi3k/akt signaling interaction,chromatin remodeling,oncogene function
ENSG00000158691,ZSCAN12,transcriptional regulation,cell cycle progression,oncogene activation,wnt/β-catenin signaling pathway activation,apoptosis inhibition,tumor suppressor loss of function
ENSG00000143320,CRABP2,**
cellular retinoid metabolism regulation,oncogenic role,retinoid signaling pathway modulation,tumor progression correlation,poor prognosis association,pi3k/akt interaction
**
ENSG00000159479,MED8,histone modification,chromatin remodeling,tumor progression,cell proliferation,ubiquitin ligase activity,transcriptional regulation
ENSG00000134201,GSTM5,oxidative stress regulation,cell growth regulation,detoxification process,transcription factor modulation,apoptosis regulation,proliferation regulation
ENSG00000134202,GSTM3,regulation of cellular responses to oxidative stress,detoxification pathway activation,dna damage susceptibility,cellular protection mechanisms,tumor progression influence,genomic instability association
ENSG00000186844,LCE1A,cancer testis antigen,cell membrane protein,late cornified envelope family member,squamous cell carcinoma-related gene,tumor progression marker,cell adhesion molecule
ENSG00000196734,LCE1B,cell migration,epithelial-to-mesenchymal transition,lipid metabolism regulation,stratum corneum formation,transcriptional activation,tumor progression
ENSG00000099860,GADD45B,cellular stress response,proliferation regulation,dna repair pathway,apoptosis evasion,tumor progression promotion,p38 mapk signaling activation
ENSG00000096093,EFHC1,microtubule stabilization,epigenetic modifications,tumor progression,microtubule-associated protein interaction,cell cycle regulation,dna repair dysfunction
ENSG00000147854,UHRF2,tumor suppressor dysfunction,cell cycle progression,dna repair inhibition,ubiquitination-mediated degradation,oncogene interaction,apoptosis suppression
ENSG00000162236,STX5,vesicle trafficking,tumor progression,cellular proliferation,oncogenic signaling,regulatory mechanism,membrane fusion
ENSG00000096872,IFT74,aberrant cell cycle regulation,apoptosis inhibition,cellular stress response,defective cilia assembly,genomic instability,rna processing dysregulation
,H2AFZ,histone regulation,transcriptional modulation,chromatin remodeling,gene expression regulation,cell cycle progression,epigenetic modification
ENSG00000075089,ACTR6,tumor progression,metastasis,cell migration,actin cytoskeleton dynamics,oncogene,cancer cell migration
ENSG00000171195,MUC7,glycosylation,tumor progression,epithelial-to-mesenchymal transition (emt),biomarker candidate,metastatic potential,secretory gland expression
ENSG00000165672,PRDX3,oxidative stress regulation,mitochondrial function,antioxidant activity,cell survival and growth,genomic instability,signaling pathway interaction
ENSG00000108417,KRT37,tumor progression,oncogenesis,aberrant protein function,epithelial cell maintenance,cellular structure integrity,biomarker for diagnosis and prognosis
ENSG00000170276,HSPB2,microtubule regulation,cell survival promotion,protein interaction modulation,tumor aggressiveness enhancement,biomarker identification,potential therapeutic target
ENSG00000102362,SYTL4,vesicle trafficking,cell migration,exocytosis regulation,overexpression,cancer progression,calcium signaling
ENSG00000124164,VAPB,mtor pathway activation,cellular homeostasis disruption,autophagy promotion,oncogenic signaling enhancement,tumor aggressiveness promoter,protein trafficking regulation
ENSG00000133027,PEMT,lipid metabolism reprogramming,tumor progression,metabolic regulation,cellular membrane remodeling,therapeutic target,overexpression
ENSG00000168269,FOXI1,epithelial-to-mesenchymal transition,oncogenic transcription factor,cell adhesion regulation,apoptosis modulation,tumor progression facilitation,genomic amplification
ENSG00000213203,GIMAP1,apoptosis regulation,tumor suppressor activity,g-protein modulation,cancer development regulation,cell death pathway interaction,genetic instability
ENSG00000106004,HOXA5,hox gene family regulation,tumor suppressor function,cell proliferation regulation,anti-apoptotic signaling,downregulation in cancer,transcriptional regulation
ENSG00000096401,CDC5L,cell cycle regulation,oncogene overexpression,protein-protein interaction,tumor suppressor dysfunction,cancer cell proliferation,poor prognosis indicator
ENSG00000110955,ATP5F1B,mitochondrial function,energy production,cellular proliferation,electron transport chain,tumor growth,tumor survival
ENSG00000127603,MACF1,microtubule regulation,oncogene overexpression,cell survival and proliferation,actin cytoskeleton dynamics,epithelial-to-mesenchymal transition,tumor progression
ENSG00000119638,NEK9,mitotic regulation,genomic stability,cytokinesis regulation,chromosome segregation,cell cycle disruption,tumor suppressor function
ENSG00000137210,TMEM14B,pi3k/akt pathway,cell proliferation,cell survival,gene mutation,tumor progression,membrane dynamics
ENSG00000171403,KRT9,intermediate filament protein,tumor progression,increased cell proliferation,cellular integrity maintenance,prognostic marker candidate,signaling pathway involvement
ENSG00000180884,ZNF792,transcriptional regulation,oncogenic function,tumor growth promotion,metastasis enhancement,cellular senescence modulation,none
ENSG00000160803,UBQLN4,ubiquitin-proteasome degradation,cellular homeostasis disruption,tumor suppressor potential,autophagy regulation,apoptosis modulation,protein quality control
ENSG00000143858,SYT2,angiogenesis,epithelial-to-mesenchymal transition,immune evasion,promotes cell proliferation,oncogene overexpression,vesicle fusion regulation
ENSG00000013441,CLK1,cell cycle regulation,cak activation,g2/m phase progression,cell proliferation enhancement,tumor progression promotion,protein kinase activation
ENSG00000183091,NEB,muscle contraction regulation,actin cytoskeleton disruption,tumor invasion,cell adhesion impairment,giant protein function,protein truncation mutations
ENSG00000167371,PRRT2,cellular regulation,dysregulation of calcium channels,genetic mutations,cell proliferation,regulatory mechanism,signaling pathway activation
ENSG00000206203,TSSK2,cell cycle regulation,apoptosis inhibition,tumor growth promotion,pi3k/akt pathway interaction,cell proliferation enhancement,therapeutic target
ENSG00000198860,TSEN15,altered splicing,aberrant mrnas accumulation,alternative splicing regulation,pro-oncogenic pathway activation,tumor progression,therapeutic target
ENSG00000204104,TRAF3IP1,nf-κb pathway,inflammation regulation,oncogene/tumor suppressor,aberrant signaling,cell survival regulation,metastasis promotion
ENSG00000086288,NME8,genomic instability,oncogenic transformation,cell proliferation,signal transduction,protein-protein interaction,dna damage response
ENSG00000115947,ORC4,cell cycle regulation,dna replication initiation,gene amplification,mitotic regulatory complex,proliferation enhancement,genomic stability impairment
ENSG00000176256,HMGB4,epithelial-to-mesenchymal transition (emt),prognostic marker,cell proliferation and survival,oncogenic protein interaction,transcription regulation,chromatin remodeling
ENSG00000148308,GTF3C5,genetic instability,chromatin remodeling,transcriptional regulation,oncogenic transformation,tumor progression,dna repair dysfunction
ENSG00000159231,CBR3,oxidative stress reduction,redox regulation,cell survival enhancement,tumor progression association,protein-protein interaction,metabolic regulation
ENSG00000111737,RAB35,ras/mapk signaling,cytoskeletal reorganization,membrane trafficking regulation,tumor growth promotion,metastasis facilitation,genomic instability
ENSG00000171792,RHNO1,oncogene activation,substrate processing,cell signaling regulation,notch receptor modulation,pi3k/akt pathway interaction,tumor growth promotion
ENSG00000108179,PPIF,peptidylprolyl cis-trans isomerization,protein folding regulation,cell signaling modulation,tumor progression influence,gene expression alteration,cancer-associated protein interaction
ENSG00000155087,ODF1,cilia dysfunction,cell proliferation,therapeutic target,genomic instability,microtubule regulation,cell survival pathway
ENSG00000187742,SECISBP2,tumor suppressor,selenoprotein regulation,redox imbalance,dna damage,oxidative stress,tumor growth
ENSG00000087152,ATXN7L3,dna repair mechanism disruption,genomic instability,p53/p21 regulation,tumor suppressor protein activation,cell cycle progression modulation,apolypore function loss
ENSG00000162714,ZNF496,transcription factor,cellular proliferation,pi3k/akt pathway interaction,angiogenesis modulation,tumor progression marker,biomarker for diagnosis and prognosis
ENSG00000113739,STC2,cell proliferation,calcium homeostasis regulation,pi3k/akt signaling activation,prognostic marker,therapeutic target,phosphatase activity modulation
ENSG00000198879,SFMBT2,cell proliferation,chromatin remodeling,epigenetic regulation,histone modification,oncogenic function,tumor progression
ENSG00000174429,ABRA,mitochondrial dynamics,tumor suppressor function,regulation of mitophagy,protein-protein interaction,cellular homeostasis disruption,apoptosis prevention
ENSG00000112514,CUTA,oncogenic mutations,regulatory mechanism,cellular response regulation,transcriptional control,protein-protein interaction,tumor progression
ENSG00000176476,SGF29,chromatin remodeling,genomic instability,tumor progression,cell cycle regulation,dna repair,protein-protein interactions
ENSG00000146618,FERD3L,ferroptosis,cell survival,prognostic biomarker,tumor progression,lipid metabolism regulation,target gene expression
ENSG00000078295,ADCY2,enhanced cell proliferation,phosphorylation and activation of pka,activation of gpcr signaling pathway,modulation of camp levels,cellular metabolism regulation,ancillary protein interaction
ENSG00000091317,CMTM6,immune regulation,tumor suppression,metastasis inhibition,cancer cell growth inhibition,gene expression regulation,cellular response modulation
ENSG00000184489,PTP4A3,cancer-related phosphatase activity,oncogenic protein activation,metastasis promotion,tumor progression,overexpression in cancer cells,signaling pathway regulation
ENSG00000135324,MRAP2,melanocortin receptor regulation,overexpression in cancer cells,oncogenic signaling pathway,cell proliferation and invasion,poor prognosis biomarker,signaling interaction
ENSG00000167178,ISLR2,tumor suppressor,cell adhesion,cell migration,epithelial integrity,wnt signaling,cell polarity
ENSG00000148229,POLE3,hypermutator phenotype,genetic instability,immune checkpoint targeting,tumor progression driver,dna repair pathway dysregulation,mutagenic polymerase activity
ENSG00000115350,POLE4,mismatch repair,microsatellite instability,tumor progression,cell proliferation,genomic stability disruption,therapeutic target
ENSG00000186442,KRT3,keratin function disruption,cell morphology alteration,epithelial-to-mesenchymal transition (emt),cancer metastasis facilitation,cytoplasmic microtubule organization,therapeutic target potential
ENSG00000196236,XPNPEP3,cell growth regulation,tumor suppression,apoptosis induction,cell cycle arrest,substrate degradation,prolyl peptidase activity
ENSG00000137965,IFI44,immunogenicity,tumor progression,transcriptional regulation,poor prognosis,cell proliferation,survival rates
ENSG00000176049,JAKMIP2,cytokine receptor signaling,cell proliferation,janus kinase activation,tumor progression,metastasis promotion,genomic instability
ENSG00000116035,VAX2,transcriptional regulation,cell survival promotion,downstream target activation,genetic development regulation,cellular growth modulation,metabolic pathway involvement
ENSG00000182107,TMEM30B,mitochondrial dysfunction,apoptosis inhibition,cell survival promotion,dna damage response modulation,tumor growth enhancement,oncogenic process regulation
ENSG00000099194,SCD,fatty acid desaturation,lipid biosynthesis,energy production,cell survival pathways,metabolic reprogramming,tumor progression
ENSG00000159363,ATP13A2,ion transport dysregulation,autophagy impairment,cancer cell survival,p-type atpase function,cellular ion homeostasis disruption,redox balance modulation
ENSG00000173706,HEG1,angiogenesis promotion,constitutive expression,oncogenic transcription factor,tumor metastasis,cell survival enhancement,therapeutic target
ENSG00000001631,KRIT1,angiogenic regulation,cell migration modulation,endothelial cell survival,growth factor receptor interaction,oncogene activation,tumor vascularization
ENSG00000237110,TAAR9,regulatory mechanism,cellular behavior,indirect oncogenesis,neurotransmitter regulation,energy homeostasis,cellular signaling
ENSG00000136021,SCYL2,cellular degradation,e3 ubiquitin ligase activity,oncogenic pathway regulation,cell cycle checkpoint modulation,pi3k/akt signaling interaction,tumorigenesis association
ENSG00000153574,RPIA,tumor progression,cell proliferation,poor prognosis,dna damage response,hypoxia adaptation,ribonucleotide biosynthesis
ENSG00000165389,SPTSSA,tumor suppressor function,cell proliferation regulation,apoptosis modulation,ubiquitin-proteasome system regulation,protein degradation regulation,cancer progression
ENSG00000122557,HERPUD2,oncogenic processes,protein degradation pathways,ubiquitin ligase activity,tumor progression,cell stress responses,apoptosis regulation
ENSG00000184787,UBE2G2,ubiquitination process,dna repair modulation,cell cycle progression,oncogenic protein accumulation,tumor development driver,genomic instability
ENSG00000080819,CPOX,heme biosynthesis,warburg effect promotion,oxidative stress regulation,cancer cell proliferation,energy metabolism modulation,dna repair interaction
ENSG00000176390,CRLF3,jak/stat activation,constitutive expression,oncogenic potential,cell proliferation,survival signals,kinase activation
ENSG00000122507,BBS9,genomic instability,cilium assembly,apoptosis regulation,tumor suppressor function,cellular transport regulation,protein complex interaction
ENSG00000133169,BEX1,dna damage repair,cell cycle regulation,apoptosis modulation,rna processing regulation,genome stability maintenance,cell proliferation enhancement
ENSG00000168453,HR,constitutive activation,transcriptional regulation,hypoxia response element binding,angiogenesis,tumor growth and survival,oncogenic transcription factor
ENSG00000114638,UPK1B,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),prognostic biomarker,gene overexpression,tight junction disruption
ENSG00000221829,FANCG,genomic instability,precise dna repair mechanism,tumor progression,dna damage response pathway,genetic alterations,cell proliferation
ENSG00000101608,MYL12A,cell migration,tumor progression,non-muscle myosin function,actomyosin contractility,poor prognosis,upregulated expression
ENSG00000183726,TMEM50A,calcium signaling,cell proliferation,oncogenic function,tumor progression,overexpression mutations,therapeutic target
ENSG00000172155,LCE1D,upregulation,poor prognosis marker,tumor progression,cellular regulation modulation,protein-protein interactions,none
ENSG00000100749,VRK1,cell cycle regulation,apoptosis inhibition,tumor growth promotion,constitutively activated mutations,oncogene function,genomic instability
ENSG00000181449,SOX2,oncogene overexpression,transcription factor function,cell proliferation promotion,tumor progression driver,pluripotency maintenance disruption,wnt/β-catenin pathway interaction
ENSG00000078246,TULP3,tumor suppressor function,dna damage response,cell membrane transport,apoptosis regulation,genomic instability,metastasis promotion
ENSG00000174780,SRP72,srp complex dysfunction,tumor promoting factor,cell proliferation enhancement,protein targeting modulation,cancer cell survival enhancement,oncogenic signaling pathway interaction
ENSG00000156469,MTERF3,mitochondrial regulation,oxidative phosphorylation,tumor progression,genomic instability,rna binding protein,regulatory function
ENSG00000013503,POLR3B,oncogene activation,rna transcriptional regulation,cell cycle progression,apoptosis suppression,chemotherapy resistance,tumor growth promotion
ENSG00000089041,P2RX7,oncogene activation,tumor progression,pro-inflammatory signaling,ion channel function,cell proliferation,receptor overexpression
ENSG00000068001,HYAL2,tumor progression,enhanced metastatic potential,poor prognosis,altered expression levels,hyaluronic acid degradation,pi3k/akt signaling pathway interaction
ENSG00000135185,TMEM243,cellular regulation,tumorigenesis,protein interaction,dysregulation,overexpression,cancer aggressiveness
ENSG00000166889,PATL1,cellular proliferation enhancement,pi3k/akt pathway modulation,centrosome duplication regulation,oncogenic properties,poor prognosis association,tumorigenesis facilitation
ENSG00000083937,CHMP2B,npc assembly,chromatin remodeling,escrt-iii complex member,tumor progression,cell survival enhancement,multivesicular body formation regulation
ENSG00000214063,TSPAN4,cell adhesion,epithelial-to-mesenchymal transition,signaling pathway modulation,tumor aggressiveness,protein localization,cell surface interaction
ENSG00000178966,RMI1,genomic instability,hrr pathway interaction,sister chromatid cohesion,helicase activity,chromatin remodeling,transcriptional regulation
ENSG00000175643,RMI2,**

dna repair mechanisms,genomic instability,homologous recombination,non-homologous end joining,cell proliferation,chromatin remodeling
ENSG00000152104,PTPN14,regulation of oncogenic kinases,overexpression in cancers,pi3k/akt signaling pathway,dephosphorylation of rtks,tumor progression and metastasis,therapeutic target
ENSG00000085563,ABCB1,chemo-resistance,drug efflux,multidrug transporter,efflux pump activity,p-glycoprotein expression,chemotherapy response
ENSG00000104341,LAPTM4B,mitochondrial fusion regulation,gain of function mutations,oncogene,cellular metabolism regulation,pi3k/akt pathway activation,tumor progression enhancement
ENSG00000029364,SLC39A9,oncogenic signaling,cellular metabolism,zinc transport,metastasis promotion,tumor progression,biomarker identification
ENSG00000213996,TM6SF2,phospholipid synthesis,er stress response,lipid droplet formation,cell proliferation,lipid metabolism disruption,tumor growth promotion
ENSG00000121570,DPPA4,epithelial-to-mesenchymal transition,stem cell maintenance,tumor aggressiveness,metastatic potential,cell proliferation enhancement,signaling pathway regulation
ENSG00000176302,FOXR1,regulation of pi3k/akt pathway,oncogene activation,epithelial-to-mesenchymal transition (emt),cell proliferation promotion,dna damage response modulation,apoptosis suppression
ENSG00000137185,ZSCAN9,tumor-intrinsic regulation,therapeutic target,chromatin remodeling,immune response modulation,upstream regulator,oncogene activation
ENSG00000134198,TSPAN2,epithelial-to-mesenchymal transition,constitutive activation,gain of function mutations,tumor progression,therapeutic target potential,cell adhesion modulation
ENSG00000166448,TMEM130,endocytosis regulation,tumor progression marker,late endosome localization,membrane dynamics regulator,cell surface protein,protein-protein interaction partner
ENSG00000119522,DENND1A,endocytosis regulation,gtpase exchange facilitation,cellular trafficking modulation,tumor growth promotion,metastasis enhancement,therapeutic target candidate
ENSG00000162399,BSND,electrolyte imbalance,ion transport regulation,sodium reabsorption,potassium secretion,cellular homeostasis,transcriptional regulation
ENSG00000157978,LDLRAP1,lipid metabolism alteration,endocytosis regulation,cell growth modulation,tumor progression contributor,genomic upregulation,protein interaction mediation
ENSG00000101367,MAPRE1,microtubule organization,tumor progression,chromosome segregation dysfunction,spindle checkpoint aberration,apoptosis resistance,prognostic marker
ENSG00000128944,KNSTRN,chromosomal instability,genomic alterations,mitotic regulation,tumor aggressiveness,prognostic marker,cell cycle progression
ENSG00000221864,KRTAP12-2,biomarker potential,protein-protein interactions,aberrant expression,cell proliferation promotion,malignant progression,tumor growth regulation
ENSG00000139192,TAPBPL,mitochondrial dynamics regulation,oncogenic growth promotion,mitofusin 1 interaction,cellular survival enhancement,mitochondrial biogenesis modulation,uprmt regulation
ENSG00000110422,HIPK3,p53 regulation,apoptosis induction,tumor suppression,cell cycle regulation,dna damage response,nuclear kinase activity
ENSG00000198331,HYLS1,cilia regulation,proliferation promotion,tumor progression activation,signaling pathway involvement,genomic instability contribution,cell growth enhancement
ENSG00000187713,TMEM203,transmembrane protein,cellular signaling pathway,oncogene potential,tumor marker,epithelial-to-mesenchymal transition (emt),overexpression in cancer
ENSG00000171124,FUT3,glycosylation modification,tumor progression,cell-cell interactions,poor prognosis,immune evasion,angiogenesis modulation
ENSG00000103528,SYT17,oncogenic driver,transcriptional regulation,cell proliferation,molecular interaction,tumor progression,poor prognosis
ENSG00000100365,NCF4,oxidative stress,tumor progression,angiogenesis,dna damage response,apoptosis resistance,immunosuppression
ENSG00000177301,KCNA2,ion homeostasis,tumor progression,cell proliferation,apoptosis resistance,signaling pathway modulation,voltage-gated potassium channel activation
ENSG00000050327,ARHGEF5,cell migration,gef activity,rho gtpase regulation,oncogenic signaling,promoter of tumor aggressiveness,biomarker for prognosis
ENSG00000125818,PSMF1,tumor suppression,autophagy regulation,cell proliferation regulation,apoptosis modulation,protein degradation pathway,multifunctional protein
ENSG00000137098,SPAG8,cell cycle regulation,chromatin remodeling,dna repair,oncogenesis,tumor progression,protein-protein interaction
ENSG00000163848,ZNF148,tumor suppressor activity,transcriptional repression,cell proliferation regulation,apoptosis promotion,genomic stability maintenance,protein-protein interaction
ENSG00000146469,VIP,oncogene,tumor growth promotion,apoptosis regulation,cell proliferation inhibition,signaling pathway interaction,downregulated expression
ENSG00000136636,KCTD3,cell cycle regulation,apoptosis,tumor suppressor gene,genomic instability,dna repair mechanisms,therapeutic target
ENSG00000160471,COX6B2,mitochondrial function,metabolic regulation,cellular respiration,tumor progression,energy production,cancer biology
ENSG00000280635,PROP1,transcriptional regulation,tumor suppressor function,cell cycle regulation,genomic stability,apoptosis inhibition,dna repair interaction
ENSG00000115255,REEP6,endoplasmic reticulum maintenance,transmembrane receptor,oncogenic signaling pathway,cellular survival,genomic instability,protein-protein interactions
ENSG00000125848,FLRT3,fgfr signaling pathway,oncogene activation,cell proliferation regulation,epithelial-to-mesenchymal transition (emt) regulation,prognostic biomarker,tumor progression promotion
ENSG00000109756,RAPGEF2,cell cycle progression,apoptosis inhibition,mapk/erk pathway modulation,pi3k/akt pathway interaction,tumor progression facilitation,biomarker potential
ENSG00000148153,INIP,cellular growth regulation,pseudogene,regulatory function,lack of coding capacity,no direct biological role in cancer,none
ENSG00000183628,DGCR6,microrna biogenesis,pre-microrna processing,tumor suppressor regulation,oncogenic pathway involvement,genomic instability,cellular transformation
ENSG00000077585,GPR137B,gpcr function,overexpression,cell proliferation,mapk/erk pathway activation,pi3k/akt pathway modulation,tumor progression
ENSG00000070019,GUCY2C,mitochondrial electron transport chain,altered metabolism,increased atp synthesis,cell proliferation enhancement,apoptosis suppression,tumor aggressiveness factor
ENSG00000172367,PDZD3,oncogenic signaling,disrupted cell adhesion,promotes emt process,genomic instability,tumor progression,regulatory interactions
ENSG00000105717,PBX4,hypoxia adaptation,transcriptional regulation,cell proliferation,epithelial-to-mesenchymal transition (emt),cell migration,metastasis
ENSG00000187210,GCNT1,glycosylation regulation,signaling pathway modulation,tumor progression facilitation,cell growth promotion,therapeutic target potential,genomic profiling feature
ENSG00000177469,CAVIN1,caveolae structure regulation,tumor progression,metastasis promotion,cell proliferation enhancement,akt/pi3k signaling interaction,cell survival pathway modulation
ENSG00000149516,MS4A3,cell surface localization,immune response regulation,cancer cell growth promotion,aggressive tumor behavior,poor patient prognosis correlation,signaling pathway modulation
ENSG00000163684,RPP14,trna biogenesis,precursor rna processing,apoptosis regulation,proliferation enhancement,tumor progression driver,malignancy association
ENSG00000173141,MRPL57,mitochondrial function,cellular respiration,metabolic regulation,tumor growth,ribosomal assembly,energetic dysregulation
ENSG00000213921,LEUTX,transcriptional repression,tumor suppressor gene degradation,chromatin modification,oncogenic properties,metastasis promotion,poor prognosis marker
ENSG00000149179,C11orf49,cellular overexpression,promoter of proliferation and survival,mutation association,tumor progression,metastasis facilitation,gene upregulation
ENSG00000143319,ISG20L2,cell proliferation regulation,pi3k/akt pathway interaction,oncogenic overexpression,tumor progression,apoptosis modulation,cell cycle dysregulation
ENSG00000278062,ZNF251,cell growth regulation,tumor suppressor function,transcriptional regulation,epigenetic modifications,chromatin remodeling,oncogene activation
ENSG00000196418,ZNF124,transcriptional regulation,dna binding,zinc finger domains,cellular proliferation,oncogenesis,tumor suppressor function
ENSG00000184507,NUTM1,aberrant transcription,dna binding activity,cell proliferation,tumor progression,transcriptional regulation,oncogene overexpression
ENSG00000110680,CALCA,angiogenesis promotion,wnt/β-catenin pathway activation,oncogenic properties,tumor aggressiveness,cell proliferation regulation,metastasis enhancement
ENSG00000138190,EXOC6,exocyst complex dysregulation,pro-tumorigenic factor secretion,oncogenic signaling pathway activation,tumor suppressor pathway inhibition,cell migration and invasion facilitation,genomic instability promotion
ENSG00000158882,TOMM40L,autophagy regulation,dysregulation of cellular homeostasis,mitochondrial function regulation,tumor growth promotion,tumor cell survival enhancement,chemotherapy resistance
ENSG00000168758,SEMA4C,tumor suppressor function,epithelial-to-mesenchymal transition regulation,cell migration modulation,adhesion molecule interaction,metastasis promotion,dual-role gene behavior
ENSG00000109084,TMEM97,tumor suppressor function,cell cycle regulation,oncogenic processes,protein-protein interactions,ion transport modulation,therapeutic target
,C6orf203,overexpression,prognostic marker,rna binding regulation,cancer biomarker,rna-related regulation,kidney cancer
ENSG00000130675,MNX1,oncogenic activity,tumor progression,cell proliferation,epithelial-to-mesenchymal transition (emt),angiogenesis,vascular endothelial growth factor signaling
ENSG00000196639,HRH1,histamine signaling,tumor progression,cell proliferation,immune evasion,receptor activation,inflammatory response
ENSG00000122033,MTIF3,mitochondrial protein synthesis regulation,constitutive activation,tumor suppressor function,metabolic adaptation regulation,mtor pathway dysregulation,apoptosis inhibition
ENSG00000164741,DLC1,cell migration inhibition,tumor suppressor function,rho gtpase pathway regulation,cytoskeleton dynamics modulation,oncogenic process suppression,therapeutic target
ENSG00000131142,CCL25,tumor-associated macrophage recruitment,immune cell chemotaxis,proliferation and migration regulation,angiogenesis promotion,chemokine signaling pathway involvement,epithelial-to-mesenchymal transition facilitation
ENSG00000205323,SARNP,nuclear pore complex assembly,tumor progression,genetic instability,apoptosis regulation,proliferation enhancement,oncogene activation
ENSG00000134049,IER3IP1,irf3 inhibition,type i interferon suppression,oncogene function,cell survival regulation,tumor progression association,poor prognosis marker
ENSG00000183474,GTF2H2C,dna repair,genomic stability,transcription initiation,cell cycle regulation,nucleotide excision repair,phosphorylation of rna polymerase ii
ENSG00000101945,SUV39H1,epigenetic regulation,histone methylation,tumor suppressor gene silencing,oncogenic process facilitation,dna damage response,chromatin structure modulation
ENSG00000274675,GTF2H2C_2,dna repair,transcription regulation,tumor progression,genetic instability,protein kinase activation,cell proliferation
ENSG00000278369,KIR2DL3,genomic instability,cellular ion balance regulation,oncogenesis promotion,prognostic marker overexpression,chromosomal alteration association,tumor cell survival enhancement
ENSG00000100372,SLC25A17,mitochondrial function,cellular metabolism regulation,tumor progression association,mitochondrial transport regulation,cancer cell growth promotion,transcription factor interaction
ENSG00000145945,FAM50B,apoptosis inhibition,autophagy modulation,cellular proliferation,oncogenesis,tumor aggressiveness,protein-protein interaction
ENSG00000206538,VGLL3,cell growth regulation,promoter of oncogenesis,transcriptional co-activator,cell proliferation enhancement,apoptosis suppression,hormone-dependent processes
ENSG00000181704,YIPF6,membrane stability,tumor suppressor function,autophagy regulation,apoptosis modulation,cellular proliferation enhancement,endosomal dysfunction
ENSG00000108960,MMD,extracellular matrix remodeling,cell migration,angiogenesis promotion,integrin interaction,tumor progression facilitation,mmp regulation
ENSG00000132376,INPP5K,pi3k/akt pathway interaction,gene overexpression,tumor progression enhancement,cell proliferation regulation,phosphatidylinositol 4,5-bisphosphate hydrolysis
ENSG00000143365,RORC,enhances proliferation,regulates cytokine production,modulates immune response,promotes tumor growth,tumor suppressor role reversal,chromatin remodeling
ENSG00000189143,CLDN4,tumor progression,cell migration,oncogenesis,angiogenesis,biomarker,epithelial-to-mesenchymal transition (emt)
ENSG00000176435,CLEC14A,angiogenic factor,tumor progression,molecular chaperone function,cancer-associated protein,immune evasion,cell surface receptor
ENSG00000147465,STAR,epigenetic regulation,immunosuppression,tumor progression,chromatin remodeling,transcriptional control,rna metabolism
ENSG00000077721,UBE2A,cell cycle regulation,genomic maintenance,protein degradation,dna repair pathways,oncogenic mutations,tumor suppressor function
ENSG00000179168,GGN,chromatin remodeling,transcriptional regulation,tumor suppressor interaction,nurd complex component,epigenetic regulation,overexpression mutation
ENSG00000273899,NOL12,nucleolar protein,ribosome biogenesis,pre-rrna processing,cell proliferation regulation,oncogenic potential,cancer biomarker
ENSG00000126070,AGO3,mirna-mediated gene silencing,tumor progression,post-transcriptional regulation,cell proliferation,metabolic regulation,epithelial-to-mesenchymal transition (emt)
ENSG00000169957,ZNF768,**

transcriptional regulation,co-repressor interaction,oncogenic transformation,cell cycle control,tumor suppressor activity,krab domain function

**
ENSG00000164438,TLX3,oncogenic activation,transcriptional regulation,cellular proliferation,apoptosis suppression,tumor aggressiveness,genomic instability
ENSG00000150337,FCGR1A,fcγri receptor,tams regulation,immune suppression,pd-l1 interaction,tumor microenvironment modulation,prognostic marker
ENSG00000000005,TNMD,metabolic reprogramming,tumor cell growth,oncogenic process,energy metabolism regulation,signaling molecule interaction,therapeutic target
ENSG00000177025,C19orf18,ion transport regulation,tumor suppressor potential,cellular homeostasis regulation,kidney function regulation,upregulation in cancer,protein-protein interactions
ENSG00000169249,ZRSR2,alternative splicing regulation,cancer metastasis promotion,dysregulated expression levels,oncogene regulation,spliceosomal component recruitment,tumor suppressor gene regulation
ENSG00000106541,AGR2,overexpression,tumor progression,cell proliferation regulation,transcriptional co-activation,wnt/β-catenin pathway activation,hypoxia response gene expression
ENSG00000131748,STARD3,**

cholesterol efflux,cell proliferation,lipid metabolism regulation,pi3k/akt pathway interaction,tumor growth promotion,chemotherapy resistance
ENSG00000198887,SMC5,dna repair,genomic instability,tumor suppressor function,homologous recombination,chromosomal abnormalities,rad51 loading
,HIST1H1A,histone modification,chromatin structure,transcriptional regulation,epigenetic control,tumor growth,genome stability
ENSG00000187912,CLEC17A,cell surface receptor interaction,cancer driver gene,carbohydrate ligand binding,pi3k/akt pathway modulation,tumor growth promotion,poor prognosis marker
ENSG00000162063,CCNF,cell cycle regulation,oncogene overexpression,g1-s phase transition regulation,scf complex interaction,cell proliferation enhancement,therapeutic target potential
ENSG00000136938,ANP32B,chromatin remodeling,cell cycle progression,transcriptional regulation,oncogenic pathways,prognostic marker,tumor metastasis
ENSG00000106829,TLE4,wnt/β-catenin signaling pathway,transcriptional co-repressor function,cell cycle regulation,oncogenic process modulation,tumor progression,therapeutic target
ENSG00000111670,GNPTAB,glycosphingolipid biosynthesis,oncogenic transformation,mutations leading to overactivity,altered cellular signaling pathways,glycosphingolipid composition changes on cell surfaces,therapeutic target
ENSG00000173218,VANGL1,cellular adhesion,epithelial integrity,planar cell polarity pathway,cell migration regulation,tumor progression,pcd pathway dysregulation
ENSG00000085117,CD82,tumor suppressor,cell adhesion regulation,epithelial-to-mesenchymal transition inhibition,pi3k/akt pathway modulation,cell migration inhibition,poor prognosis indicator
ENSG00000198919,DZIP3,cellular proliferation,transcriptional regulation,nuclear localization,apoptosis regulation,dna repair,pi3k/akt/mtor pathway interaction
ENSG00000120992,LYPLA1,lipid metabolism regulation,phospholipid catabolism,cell membrane modulation,oncogenic signaling,tumor progression promotion,cancer cell proliferation
ENSG00000104131,EIF3J,protein synthesis regulation,tumor growth promotion,cell survival signaling,angiogenesis regulation,immune evasion interaction,prognostic marker
ENSG00000182183,SHISAL2A,wnt/β-catenin signaling,loss-of-function mutations,tumor suppressor,cell proliferation,oncogenic process,genomic instability
ENSG00000164627,KIF6,microtubule motor function,mitotic spindle assembly,chromosome segregation,oncogenic processes,genomic instability,signaling pathway modulation
ENSG00000152977,ZIC1,transcriptional regulation,tumor suppressor function,cell cycle progression,apoptosis regulation,dna repair pathway interaction,developmental gene expression
ENSG00000198429,ZNF69,tumor suppression,dna damage response,gene expression regulation,histone modification,chromatin remodeling,cell cycle regulation
ENSG00000066629,EML1,microtubule regulation,oncogene overexpression,cell migration facilitation,tumor progression promotion,protein-protein interaction,metastasis association
ENSG00000182040,USH1G,cell migration,epithelial-to-mesenchymal transition,cell proliferation,protein-protein interaction,oncogenic driver,tumor aggressiveness
ENSG00000130803,ZNF317,transcriptional regulation,tumor suppressor function,cell cycle progression,apoptosis regulation,dna repair,epigenetic modification
ENSG00000087086,FTL,oncogene,microfibril assembly,extracellular matrix regulation,genomic instability,tumor progression,metastasis promoter
ENSG00000120913,PDLIM2,cell migration,tumor progression,pi3k/akt pathway interaction,cytokeletal regulation,oncogene/tumor suppressor duality,adhesion molecule interaction
ENSG00000178175,ZNF366,tumor suppression,chromatin remodeling,transcriptional repression,apoptosis regulation,cancer cell survival,proliferation promotion
ENSG00000080493,SLC4A4,ion homeostasis disruption,glycolysis regulation,metabolic reprogramming,ph balance dysregulation,cell signaling modulation,tumor progression driver
ENSG00000167434,CA4,tumor growth promotion,metastasis facilitation,angiogenesis enhancement,invasion promotion,therapeutic target,protein-protein interaction
ENSG00000169188,APEX2,pi3k/akt pathway,loss of function mutations,apoptosis regulation,cell cycle progression,dna repair dysregulation,biomarker status
ENSG00000094916,CBX5,histone modification,epigenetic regulation,tumor suppression,cell cycle progression,apoptosis evasion,chromatin remodeling
ENSG00000196549,MME,**neprilysin,peptide degradation,tumor progression,oncostatic signaling,growth factor regulation,cell survival
ENSG00000275724,NDUFA3,mitochondrial function,energy metabolism adaptation,glycolytic shift,enhanced atp production,cellular respiration regulation,proton pumping activity
ENSG00000169592,INO80E,dna repair,genomic stability,chromatin remodeling,apoptosis suppression,tumor progression,gene expression regulation
ENSG00000151365,THRSP,metabolic regulation,lipid biosynthesis,glycolytic activity,tumor progression,prognostic biomarker,metabolic reprogramming
ENSG00000139767,SRRM4,aberrant splicing,cell proliferation,genomic instability,oncogenic isoforms,regulation of alternative splicing,tumor suppression
ENSG00000147573,TRIM55,tumor suppressor activity,protein degradation regulation,e3 ubiquitin ligase function,cellular process modulation,potential oncogenic role,cell growth regulation
ENSG00000126858,RHOT1,gef activity,rho gtpase regulation,cancer cell survival,proliferation and migration promotion,tumor progression,tumor suppressor dysfunction
ENSG00000125814,NAPB,cell cycle regulation,apoptosis regulation,dna repair,transcriptional regulation,chromatin remodeling,nuclear protein binding
ENSG00000105755,ETHE1,redox regulation,oxidative stress,dna damage,reactive oxygen species,therapeutic target,antioxidant defense
ENSG00000164181,ELOVL7,vlcfa synthesis,tumor progression,cell proliferation,metabolic regulation,signaling pathway modulation,oncogene interaction
ENSG00000127507,ADGRE2,cell migration and invasion,tumor progression,epithelial-to-mesenchymal transition (emt),signal transduction pathway modulation,proliferation enhancement,prognostic marker
ENSG00000100479,POLE2,dna replication,genomic instability,cell cycle regulation,therapeutic target,protein-protein interaction,constitutive activation
ENSG00000132773,TOE1,hippo-yap signaling,p53 regulation,e3 ubiquitin ligase activity,cell proliferation,tumor suppression evasion,therapeutic target
ENSG00000102683,SGCG,cell signaling modulation,tumor progression,metastasis promotion,therapeutic target,protein interaction regulation,membrane stability maintenance
ENSG00000166603,MC4R,regulation of energy balance,g protein-coupled receptor,hypothalamic expression,appetite suppression,cell proliferation regulation,metabolic regulation
ENSG00000137207,YIPF3,autophagic processes,cellular homeostasis,membrane trafficking regulation,protein-protein interactions,tumor progression,tissue-specific expression patterns
ENSG00000091844,RGS17,tumor progression,cell migration,cell invasion,oncogenic function,protein interaction,signal transduction
ENSG00000206181,ELOA2,overexpression,cell migration,actin cytoskeleton modulation,tumor aggressiveness,metastasis promotion,therapeutic target
ENSG00000276463,TAF9,chromatin remodeling,transcriptional regulation,gene expression modulation,cell proliferation promotion,tumor suppressor interaction,genomic instability
ENSG00000271605,MILR1,regulatory mechanism,tumor progression,apoptosis inhibition,cell cycle regulation,transcriptional control,oncogene overexpression
ENSG00000113303,BTNL8,immune cell activation,t-cell regulation,lipid metabolism regulation,autoimmune disease association,cancer immune evasion,tumor immunogenicity
ENSG00000110851,PRDM4,chromatin remodeling,oncogene overexpression,transcriptional regulation,p53 pathway modulation,tumor suppressor downregulation,apoptosis suppression
ENSG00000155957,TMBIM4,apoptosis inhibition,cellular homeostasis disruption,pi3k/akt pathway modulation,therapeutic target,tumor progression,biomarker for diagnosis and prognosis
ENSG00000134697,GNL2,ribosome biogenesis,mrna translation regulation,tumor progression marker,poor prognosis indicator,cell cycle alteration,apoptosis evasion
ENSG00000115750,TAF1B,transcriptional regulation,chromatin remodeling,dna repair,oncogene activation,tumorigenesis driver,gene expression modulation
ENSG00000163687,DNASE1L3,nf-κb signaling activation,cell proliferation enhancement,apoptosis inhibition,immune evasion promotion,tumor progression facilitation,genomic instability maintenance
ENSG00000125656,CLPP,altered cellular metabolism,constitutive activation,dysregulation of protein turnover,enhanced angiogenesis,mitochondrial dysfunction,oncogenic pathway activation
ENSG00000151552,QDPR,bh4-dependent enzymes,oxiative stress,oncogenic processes,metabolic reprogramming,cell survival,ros production
ENSG00000103269,RHBDL1,cellular signaling,regulatory mechanisms,protein activity modulation,dysregulated expression,cell growth promotion,survival pathway activation
ENSG00000003393,ALS2,endocytosis regulation,autophagy modulation,gtpase activation,cytoskeleton dynamics,oncogenic potential,tumor progression
ENSG00000145362,ANK2,ankyrin regulation,cell membrane structure,potassium conductance modulation,calcium homeostasis dysregulation,tumor suppressor protein interaction,cancer cell migration promotion
ENSG00000163697,APBB2,apbb2 involvement in pi3k/akt pathway,constitutive activation of downstream signaling,tumor progression and metastasis,cell growth and survival regulation,genomic instability and mutations,protein-protein interactions
ENSG00000111262,KCNA1,potassium channel regulation,cell proliferation,ion channel activity,cell migration,signaling pathway modulation,protein-protein interaction
ENSG00000115677,HDLBP,cell survival,lipid metabolism,oncogenesis,signaling pathway modulation,protein kinase activation,tumor proliferation
ENSG00000144224,UBXN4,proteasomal degradation,tumor progression,cell cycle regulation,apoptosis resistance,cancer metastasis,pi3k/akt interaction
ENSG00000147164,SNX12,egfr pathway regulation,mutation-driven oncogenesis,cell growth and survival modulation,biomarker for prognosis,tumor suppressor function,endosomal trafficking regulation
ENSG00000284017,PLCL2,amplification,cell migration,cell adhesion,cytoskeletal reorganization,protein-protein interaction,genomic amplification
ENSG00000204969,PCDHA2,cell-cell adhesion disruption,src kinase regulation,tumor suppressor function,cancer cell migration,plasma membrane-associated cytoskeleton regulation,protein kinase modulation
ENSG00000013297,CLDN11,tumor suppressor function,epithelial-to-mesenchymal transition regulation,cellular polarity maintenance,angiogenesis inhibition,adhesion molecule regulation,cancer cell migration prevention
ENSG00000066405,CLDN18,tumor progression,metastasis,angiogenesis,antibody targeting,immunotherapy,cellular polarity
ENSG00000090447,TFAP4,transcriptional regulation,cell proliferation,apoptosis evasion,oncogenic driver,metastasis promotion,cell cycle progression
ENSG00000158457,TSPAN33,cell-cell interaction,tetraspanin superfamily,cell proliferation,tumor progression,immune response regulation,signal transduction pathway
ENSG00000129691,ASH2L,chromatin remodeling,genomic instability,oncogene expression,cell growth regulation,tumor metastasis,transcriptional activation
ENSG00000122884,P4HA1,metabolic reprogramming,oncogenic function,tumor metabolism,upregulation,cell proliferation,glycolysis promotion
ENSG00000149380,P4HA3,angiogenesis promotion,cell growth enhancement,collagen stabilization,epigenetic regulation,prognostic marker,tumor progression facilitation
ENSG00000092529,CAPN3,protein degradation,tumor progression,cancer progression marker,apoptosis modulation,cell growth regulation,dna damage response
ENSG00000135318,NT5E,purinergic signaling pathway,adenosine production,angiogenesis regulation,immune suppression,metastasis promotion,tumor progression
ENSG00000061936,SFSWAP,chromatin remodeling,oncogene activation,cell cycle progression,transcriptional regulation,gene expression dysregulation,epigenetic reprogramming
ENSG00000170322,NFRKB,nf-kappa b repression,tumor suppressor function,immune evasion mechanisms,transcriptional regulation,oncogenic signaling pathway,genomic silencing
ENSG00000132485,ZRANB2,dna repair regulation,genomic instability,apoptosis inhibition,cell growth promotion,homologous recombination,chromatin remodeling
ENSG00000163630,SYNPR,cell migration,cell invasion,microtubule dynamics,overexpression,poor prognosis,cytoskeletal organization
ENSG00000175283,DOLK,glycosylation pathway,oncogenic activation,tumor progression,metabolic regulation,cell survival,phosphorylation activity
ENSG00000204197,KIFC1,microtubule dynamics,motor protein function,mitosis regulation,tumor metastasis promotion,cell migration facilitation,prognostic marker association
ENSG00000152818,UTRN,tumor progression,metastasis promotion,cancer driver gene,aggressive behavior marker,cell migration regulation,pi3k/akt pathway interaction
ENSG00000187626,ZKSCAN4,genomic instability,tumor suppression,transcriptional regulation,epigenetic control,cell proliferation inhibition,prognostic marker
ENSG00000196345,ZKSCAN7,epigenetic regulation,transcriptional repressor,chromatin remodeling,dna methylation,tumor growth,metastasis
ENSG00000184351,KRTAP19-1,keratin-associated protein function,cellular structure disruption,oncogene activation,tumor progression association,poor prognosis indicator,protein-protein interaction
ENSG00000143368,SF3B4,aberrant splicing,genomic instability,cellular proliferation,enhanced metastasis,prognostic marker,therapeutic target
ENSG00000136819,C9orf78,regulatory mechanism,protein-coding gene,cell growth regulation,gene expression alteration,oncogenesis association,unknown protein function
ENSG00000078699,CBFA2T2,chromatin remodeling,transcriptional regulation,cell proliferation,oncogenic role,microrna regulation,tumor aggressiveness
ENSG00000030582,GRN,granulin overexpression,tumor progression,cell survival promotion,angiogenesis stimulation,epithelial-to-mesenchymal transition,stemness maintenance
ENSG00000118434,SPACA1,tumor progression,cell proliferation,oncogene,metastasis,sperm-specific antigen,protein interaction
ENSG00000147027,TMEM47,tumor progression,epithelial-to-mesenchymal transition (emt),poor prognosis,pi3k/akt signaling pathway,metastasis,biomarker
ENSG00000170417,TMEM182,calcium regulation,cell growth modulation,ion channel activity,oncogenic pathway activation,tumor progression facilitation,cellular homeostasis disruption
ENSG00000136026,CKAP4,centrosome-microtubule interaction,cell migration invasion,protein localization regulation,cytoplasmic microtubule stabilization,mitotic spindle assembly function,cancer cell survival promotion
ENSG00000128271,ADORA2A,angiogenesis inhibition,adenosine signaling,cell survival enhancement,immune suppression,tumor growth promotion,overexpression involvement
ENSG00000132965,ALOX5AP,leukotriene production,tumor progression,angiogenesis promotion,cell migration enhancement,lipid metabolism regulation,oncogene expression
ENSG00000091483,FH,angiogenesis,cell migration,cell proliferation,growth factor regulation,pi3k/akt pathway activation,tumor metastasis
ENSG00000167461,RAB8A,cellular transport,oncogenic activity,epithelial-to-mesenchymal transition,cell migration,tumor metastasis,poor prognosis marker
ENSG00000178467,P4HTM,transcriptional regulation,protein stability modulation,oncoprotein stabilization,gene expression dysregulation,e3 ubiquitin ligase interaction,cell growth promotion
ENSG00000147677,EIF3H,enhanced translation,cell proliferation,protein synthesis regulation,oncogenic processes,tumorigenesis,therapeutic target
ENSG00000177963,RIC8A,g-protein signaling,oncogenic gef activity,tumor progression,amplification/mutations,biomarker potential,signaling pathway dysregulation
ENSG00000186638,KIF24,tumor suppressor function,loss of function mutations,genomic instability,microtubule dynamics regulation,mitotic spindle assembly,chromosomal instability
ENSG00000006659,LGALS14,tumor progression,cell migration,integrin interaction,focal adhesion kinase regulation,actin cytoskeleton modulation,biomarker potential
ENSG00000123119,NECAB1,**
cell migration,tumor progression,protein-protein interaction,cancer metastasis,overexpression,cell growth 
**
ENSG00000067840,PDZD4,tumor suppressor function,protein-protein interactions,cell cycle regulation,apoptosis modulation,dna repair mechanism,loss-of-function mutation
ENSG00000141252,VPS53,autophagic dysfunction,genomic instability,impaired lysosomal function,metastasis promotion,oncogenic driver,therapeutic target
ENSG00000066455,GOLGA5,golgi apparatus regulation,protein-protein interaction,cell proliferation enhancement,tumor progression promotion,apoptosis inhibition,biomarker candidate
ENSG00000152518,ZFP36L2,au-rich element binding,mrna degradation,cellular stress response,post-transcriptional regulation,tumor suppression,gene regulatory mechanism
ENSG00000091138,SLC26A3,chloride transport regulation,apoptosis resistance,ph homeostasis modulation,cellular anion balance,tumor progression driver,genetic alteration hotspot
ENSG00000107738,VSIR,autophagy regulation,cellular homeostasis maintenance,endocytosis pathway involvement,oncogenic protein degradation,therapeutic target potential,tumor progression facilitation
ENSG00000095906,NUBP2,genomic instability,dna repair mechanisms,mitochondrial dysfunction,cellular energy regulation,tumor suppressor function,cancer prognosis
ENSG00000160179,ABCG1,cellular lipid metabolism,tumor progression,cholesterol efflux regulation,transport mechanism disruption,oncogenic process promotion,therapeutic target potential
ENSG00000172164,SNTB1,cellular regulation,muscle function modulation,ion channel activity regulation,na+/k+ atpase interaction,pi3k/akt pathway influence,tumor progression driver
ENSG00000166974,MAPRE2,microtubule stabilization,cell cycle progression,oncogenic transformation,mitotic spindle formation,apoptosis regulation,protein phosphorylation
ENSG00000171970,ZNF57,transcription factor,oncogene activation,cell proliferation regulation,angiogenesis promotion,metastasis facilitation,poor prognosis marker
ENSG00000050426,LETMD1,transcriptional co-activator,cell proliferation,cell survival,e2f transcription factors,tumor development,gene expression regulation
ENSG00000176542,USF3,transcription factor activity,tumor progression,genomic instability,cell survival regulation,dna replication regulation,poor prognosis marker
ENSG00000130227,XPO7,oncoprotein export,tumor progression,therapeutic target,metastatic potential,chemosensitivity,protein transport regulation
ENSG00000228250,LY6G6C,cell adhesion regulation,prognostic marker,tumor progression,metastasis facilitation,integrin interaction,oncogenic signaling
ENSG00000167394,ZNF668,dna binding,transcriptional regulation,tumor suppression,cell proliferation,apoptosis regulation,genomic instability
ENSG00000285206,PTPMT1,tumor suppressor function,cell signaling regulation,dephosphorylation activity,oncogenic processes,apoptosis inhibition,genomic instability
ENSG00000173726,TOMM20,mitochondrial protein regulation,tumor progression,cell proliferation,apoptosis inhibition,protein-protein interaction,cancer cell survival
ENSG00000113282,CLINT1,tumor progression,angiogenesis promotion,cell migration regulation,genetic instability induction,prognostic marker,therapeutic target
ENSG00000171360,KRT38,epithelial-to-mesenchymal transition (emt),cytokeratin expression,cellular integrity,epithelial characteristics loss,tumor biomarker,potential therapeutic target
ENSG00000170545,SMAGP,er stress response regulation,autophagy modulation,pro-survival function,tumor growth promotion,cell proliferation enhancement,genetic mutation hotspot
ENSG00000100296,THOC5,rna processing and export,tumor progression,promoter of cell proliferation,regulation of dna replication,cancer prognosis marker,protein-protein interaction
ENSG00000090316,MAEA,genomic instability,homologous recombination,dna repair pathways,tumor suppressor function,chromosome segregation,meiotic recombination
ENSG00000144579,CTDSP1,brd4 interaction,transcription regulation,overexpression,poor prognosis,apoptosis suppression,microrna regulation
ENSG00000171604,CXXC5,oncogenic function,chromatin remodeling,cell proliferation,metastasis facilitation,biomarker potential,gene expression regulation
ENSG00000146670,CDCA5,genomic instability,cell cycle regulation,dna replication,g2/m phase transition,cancer progression,tumor proliferation
ENSG00000111843,TMEM14C,**

impaired iron metabolism,oxidative stress response,mitochondrial dysfunction,genomic instability,oncogenic mutations,cancer cell proliferation
ENSG00000159251,ACTC1,actin cytoskeleton regulation,cell migration,cancer cell invasion,poor prognosis,cell motility regulation,tumor aggressiveness
ENSG00000124721,DNAH8,ciliary structure,cell signaling pathways,mechanoreception,genomic instability,proliferation regulation,axoneme assembly
ENSG00000130560,UBAC1,ubiquitination pathway,protein degradation,cell cycle regulation,apoptosis modulation,tumor suppressor regulation,protein stability disruption
ENSG00000180817,PPA1,glycolysis regulation,mitochondrial localization,energy homeostasis maintenance,glycogenolysis activation,cellular metabolic shift,tumor growth promotion
ENSG00000140931,CMTM3,tumor suppression,cell migration regulation,immune response modulation,anti-angiogenic effects,biomarker potential,therapeutic target
ENSG00000288141,MRPL23,mitochondrial ribosome function,28s rrna methylation,tumor aggressiveness,energy metabolism disruption,poor prognosis,therapeutic target
ENSG00000144040,SFXN5,mitochondrial function,ros regulation,tumor progression,metabolic reprogramming,cell survival,gene expression
ENSG00000128335,APOL2,cellular membrane interaction,antimicrobial activity,tumor progression,genomic alterations,copy number variations,oncogenic signaling pathway
ENSG00000160191,PDE9A,cgmp regulation,tumor progression,renal clear cell carcinoma,pi3k/akt signaling,cancer metastasis,cell survival regulation
ENSG00000109193,SULT1E1,hormone metabolism regulation,estrogen sulfation,cell proliferation modulation,metabolic pathway alteration,cancer cell differentiation regulation,steroid hormone modification
ENSG00000139428,MMAB,one carbon metabolism,homocysteine regulation,methyl donor activity,tumor proliferation,cellular metabolism,cobalamin processing
ENSG00000141503,MINK1,mapk/erk pathway activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation regulation
ENSG00000204361,NXPE2,cell proliferation,tumor progression,genomic instability,nuclear architecture,lamin a/c dynamics,oncogenic interactions
ENSG00000284009,PLSCR3,tumor progression,phospholipid scrambling regulation,signaling pathway modulation,cell proliferation enhancement,metastasis promotion,altered phospholipid metabolism
ENSG00000177854,TMEM187,cell cycle regulation,epithelial-to-mesenchymal transition (emt),interactions with tp53,regulation of cellular transport,role in tumorigenesis,transmembrane protein function
ENSG00000164713,BRI3,tumor suppressor activity,regulation of photoreceptor cells,retinal pigment epithelium integrity,maintenance of blood-retina barrier,cancer associated alterations,renal clear cell carcinoma involvement
ENSG00000213064,SFT2D2,histone modification,epigenetic regulation,gene expression,cell proliferation,tumor progression,oncogene overexpression
ENSG00000132563,REEP2,mitochondrial dynamics,cell proliferation enhancement,oncogene role,poor prognosis association,tumor metastasis promotion,signaling pathway interaction
ENSG00000224470,ATXN1L,epigenetic regulation,genomic stability disruption,oncogene overexpression,dna damage response modulation,cell cycle regulation dysfunction,apoptosis evasion promotion
ENSG00000198326,TMEM239,calcium ion transport,cellular homeostasis,epithelial-to-mesenchymal transition (emt),oncogenic processes,metabolic regulation,transmembrane protein
ENSG00000196338,NLGN3,neuronal communication disruption,cellular adhesion regulation,tumor progression driver,signaling pathway modulation,anti-adhesive function loss,genomic alteration involvement
ENSG00000052749,RRP12,cellular proliferation,apoptosis inhibition,tumor suppressor interaction,rna processing regulation,pro-survival gene regulation,poor prognosis marker
ENSG00000198707,CEP290,ciliary dysfunction,genomic instability,cell signaling disruption,oncogenesis driver,centriole maintenance,cell polarity regulation
ENSG00000100711,ZFYVE21,rho gtpase-activating protein activity,cell migration regulation,endocytic recycling,microtubule dynamics regulation,oncogenic processes activation,therapeutic target candidate
ENSG00000196116,TDRD7,rna metabolism regulation,mir-122 expression control,tumor progression facilitation,cancer prognosis marker,cell cycle regulation modulation,microrna degradation modulation
ENSG00000143322,ABL2,abl2 overexpression,cellular proliferation modulation,tyrosine kinase activity,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition regulation,tumor progression contribution
ENSG00000185009,AP3M1,ap-3 trafficking,oncogenic protein accumulation,lysosomal regulation,tumor suppressor degradation,cell proliferation promotion,poor prognosis association
ENSG00000161202,DVL3,wnt signaling pathway,oncogenic process,protein stability mutations,cell proliferation enhancement,tumor progression,epithelial-to-mesenchymal transition (emt)
ENSG00000105176,URI1,enhanced tumor progression,constitutive activation,oncogene potential,cellular stress response modulation,dna repair regulation,pro-survival pathway activation
ENSG00000151092,NGLY1,protein deglycosylation,gain of function mutations,cellular proliferation,metabolic reprogramming,oncogenic signaling,therapeutic target
ENSG00000167565,SERTAD3,tumor suppressor interactions,transcriptional regulation,oncogenic splicing,cellular proliferation,gene silencing,genomic instability
ENSG00000091656,ZFHX4,tumor progression,transcriptional regulation,cell proliferation,genomic instability,mutation hotspot,co-regulatory protein interaction
ENSG00000277462,ZNF670,apoptosis regulation,tumor suppressor function,cell cycle control,transcriptional regulation,pro-apoptotic activity,g2/m phase inhibition
ENSG00000187024,PTRH1,histone arginine methylation,cell cycle regulation,g2/m phase transition,protein-protein interaction,oncogenic potential,epigenetic regulation
ENSG00000103194,USP10,tumor suppressor activity,apoptosis inhibition,deubiquitinating enzyme function,p53 stabilization,cell cycle regulation,protein stability modulation
ENSG00000008130,NADK,nad+/energy metabolism disruption,oncogenic pathway activation,cellular apoptosis inhibition,tumor progression association,poor prognosis marker,biosynthetic pathway regulation
ENSG00000153066,TXNDC11,redox regulation,protein folding and stability,chaperone function,cellular homeostasis modulation,tumor progression enhancement,pi3k/akt pathway interaction
ENSG00000104549,SQLE,lipid biosynthesis,cholesterol regulation,oncogenic signaling,cell proliferation,apoptosis resistance,tumor growth
ENSG00000197324,LRP10,protein-lipid interaction,oncogenic potential,tumor progression,metastasis,resistance to therapy,signaling pathway regulation
ENSG00000142082,SIRT3,tumor progression,enhanced mitochondrial function,regulation of energy metabolism,cell survival,autophagy regulation,oncogenic signaling pathway interactions
ENSG00000182318,ZSCAN22,cellular regulation,tumor suppressor function,genomic instability,chromatin remodeling,apoptosis resistance,cell cycle progression
ENSG00000181894,ZNF329,transcriptional regulation,chromatin remodeling,oncogenic driver,epigenetic modification,tumor suppressor dysfunction,protein-protein interaction
ENSG00000073670,ADAM11,tumor progression,metalloprotease activity,cancer metastasis,cell adhesion,protein-protein interaction,dysregulated expression
ENSG00000132744,ACY3,altered lipid metabolism,cell growth promotion,fatty acid oxidation regulation,mitochondrial dysfunction,oncogenic activity,tumor progression facilitation
ENSG00000116754,SRSF11,alternative splicing regulation,cellular proliferation,nuclear localization,spliceosome component recruitment,transcriptional regulation,genomic instability
ENSG00000171291,ZNF439,tumor progression,tumor suppressor dysfunction,transcriptional regulation disruption,oncogene activation,cancer driver mutation,epigenetic modification
ENSG00000161847,RAVER1,mirna regulation,constitutive expression,rna binding protein,oncogenic process,cell survival,genomic stability
ENSG00000175329,ISX,**
immunosuppression,epithelial-to-mesenchymal transition,immune evasion,tumor progression,inflammatory modulation,cell proliferation
**
ENSG00000288210,ASF1B,chromatin remodeling,dna repair,telomere maintenance,oncogene,genomic instability,cancer progression
ENSG00000186564,FOXD2,oncogene activation,transcription factor function,epithelial-to-mesenchymal transition,cell proliferation enhancement,metastasis promotion,stem cell maintenance disruption
ENSG00000138311,ZNF365,krab domain-containing zinc finger protein,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000072864,NDE1,microtubule regulation,genome stability maintenance,aneuploidy induction,cell cycle disruption,tumor suppressor function,cancer progression driver
ENSG00000170374,SP7,oncogene activation,transcriptional regulation,cell proliferation,metastasis promotion,prognostic marker,transcription factor activity
ENSG00000164488,DACT2,tumor suppressor,loss of function mutations,cell cycle regulation,genomic instability,chromatin remodeling,histone modification interaction
ENSG00000253548,PYDC2,cellular metabolism alteration,tumor progression facilitation,oncogene activation,signaling pathway modulation,protein-protein interaction,genomic overexpression
ENSG00000148688,RPP30,cell cycle regulation,nucleolar function,rna processing,ribosomal biogenesis,cell proliferation,g1 phase regulation
ENSG00000136986,DERL1,erad regulation,oncoprotein degradation,tumor progression,protein quality control,ubiquitin-proteasome system,pi3k/akt signaling pathway
ENSG00000101463,SYNDIG1,pi3k/akt signaling pathway activation,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),tumor progression,metastasis facilitation,oncogene interaction
ENSG00000167693,NXN,apoptosis regulation,cell proliferation,oncogenic protein interaction,redox balance maintenance,transcription factor inhibition,tumor progression modulation
ENSG00000112290,WASF1,actin cytoskeleton regulation,cell migration promotion,oncogenic process facilitation,metastasis enhancement,tumor progression marker,poor prognosis indicator
ENSG00000146830,GIGYF1,regulation of mrna translation,modulator of oncogenic pathways,interaction with 4e-bp1 protein,impact on pi3k/akt/mtor pathway,cellular growth and proliferation,tumorigenesis
ENSG00000105771,SMG9,regulation of nmd pathway,premature stop codon detection,truncated protein degradation,cell proliferation promotion,tumor suppression,genomic instability
ENSG00000242616,GNG10,overexpression,oncogene potential,cell proliferation regulation,survival pathway activation,tumor aggressiveness indicator,prognostic marker
ENSG00000139133,ALG10,altered glycosylation patterns,cancer progression,cellular interactions,therapeutic target,protein stability,tumor growth
ENSG00000196422,PPP1R26,mtor pathway regulation,cell cycle progression,dna repair regulation,transcriptional regulation,oncogenic signaling,cellular growth modulation
ENSG00000177239,MAN1B1,n-glycan processing,antitumor therapy target,cell survival pathway,protein folding regulation,tumorigenesis facilitation,oncogene expression
ENSG00000206395,DDAH2,ddah2 expression,nitric oxide production,cell proliferation,protein methyltransferase regulation,asymmetric dimethylarginine breakdown,apoptosis modulation
ENSG00000143570,SLC39A1,zinc homeostasis regulation,tumor progression,oncogene,genomic instability,cell proliferation regulation,apoptosis regulation
ENSG00000100209,HSCB,chromatin remodeling,epigenetic modification,genomic stability,transcriptional regulation,cellular proliferation,histone protein interaction
ENSG00000067646,ZFY,transcription factor,cell growth regulation,spermatogenesis,embryonic development,gene expression regulation,cellular differentiation pathways
ENSG00000149474,KAT14,genomic instability,transcriptional regulation,methyltransferase activity,tumor suppressor function,cell proliferation regulation,prc1 complex member
ENSG00000257218,GATC,tumor progression,transcriptional regulation,epithelial differentiation,cell proliferation,immune evasion,apoptosis resistance
ENSG00000130348,QRSL1,cellular proliferation,transcriptional regulation,nuclear receptor coactivator,tumorigenesis,oncogenic processes,therapeutic target
ENSG00000242515,UGT1A10,detoxification,metabolic regulation,cellular metabolism,substrate specificity,enzyme activity regulation,protein structure-function
ENSG00000167165,UGT1A6,metabolic regulation,xenobiotic detoxification,glucuronidation pathway,cancer treatment resistance,carcinogen metabolism,detoxification enzyme
ENSG00000196659,TTC30B,genomic instability,chaperone function,protein folding regulation,cell cycle progression,aggressive tumor behavior,metastatic potential
ENSG00000111906,HDDC2,emt regulation,pi3k/akt pathway modulation,oncoprotein stabilization,cell proliferation enhancement,protein degradation regulation,metastasis promotion
ENSG00000184575,XPOT,nuclear export protein,tumor progression,oncogenesis,cancer driver gene,cell proliferation,protein regulation
ENSG00000123106,CCDC91,centriole duplication,centrosome integrity,cell division regulation,kinase activation,protein-protein interactions,genomic instability
ENSG00000170454,KRT75,overexpression,tumor progression,cellular adhesion,epithelial cell integrity,keratin family interactions,potential biomarker
ENSG00000156928,MALSU1,chromatin remodeling,transcriptional regulation,tumor suppressor function,genome stability maintenance,cell cycle progression,apoptosis inhibition
ENSG00000146416,AIG1,proteasome regulation,oncogene activation,tumor growth promotion,cellular stress induction,metabolic reprogramming,cell cycle progression disruption
ENSG00000125629,INSIG2,cholesterol biosynthesis regulation,lipid metabolism modulation,tumor growth promotion,akt/mtor pathway activation,biomarker potential,genomic instability marker
ENSG00000170465,KRT6C,oncogenic expression,cellular integrity disruption,cell proliferation enhancement,epithelial-mesenchymal transition induction,therapeutic target,genomic instability promotion
ENSG00000079102,RUNX1T1,transcriptional regulation,apoptosis modulation,cell cycle progression,tumor progression,epigenetic modification,therapeutic target
ENSG00000185567,AHNAK2,cellular scaffold,protein complex assembly,apoptosis evasion,tumor progression,metastasis facilitation,stress response modulation
ENSG00000189114,BLOC1S3,apoptosis regulation,cell migration,oncogenic processes,cancer progression,melanogenic protein regulation,late endosome formation
ENSG00000197191,CYSRT1,cell signaling,tumor progression,protein-protein interactions,immune evasion,cancer-related pathways,cell cycle regulation
ENSG00000150457,LATS2,loss-of-function mutations,hippo signaling pathway inhibition,yap/taz activation,cell growth regulation,tumor suppressor function,genomic instability
ENSG00000198088,NUP62CL,nucleoporin interaction,long non-coding rna,cell migration invasion,apoptosis evasion,microrna recruitment,tumor aggressiveness
ENSG00000107438,PDLIM1,cell adhesion disruption,tumor progression,prognostic marker,epithelial-to-mesenchymal transition (emt),cancer cell migration,protein-protein interaction
ENSG00000008056,SYN1,cellular proliferation,protein-protein interactions,biomarker for prognosis,signaling pathway regulation,tumor progression,epithelial-to-mesenchymal transition
ENSG00000178397,FAM220A,transcriptional regulation,cell proliferation,genomic instability,epigenetic alterations,oncogenesis,poor prognosis
ENSG00000148773,MKI67,cell cycle regulation,oncogene overexpression,tumor aggressiveness,cell proliferation marker,cancer prognosis indicator,potential therapeutic target
ENSG00000280610,KIF15,mitosis regulation,chromosome segregation,kinase activity,aberrant microtubule stability,mitotic checkpoint regulation,cancer cell proliferation
ENSG00000115561,CHMP3,endosomal regulation,cellular recycling,escrt-iii complex,oncogene recycling,tumor aggressiveness,signaling pathway activation
ENSG00000171045,TSNARE1,cell migration,tumor invasion,oncogenic signaling,membrane trafficking regulation,protein-protein interaction,poor prognosis
ENSG00000175115,PACS1,ubiquitin-proteasome system regulation,oncoprotein interaction,cell proliferation enhancement,protein degradation dysregulation,tumor progression association,overexpression link
ENSG00000197081,IGF2R,igf-ii regulation,tumor suppressor function,loss-of-function mutations,cell growth promotion,growth factor interaction,epigenetic silencing
ENSG00000203985,LDLRAD1,dna damage repair,nuclear receptor coactivator,transcriptional regulation,tumor progression,metastasis,prognostic marker
ENSG00000102870,ZNF629,lncrna regulation,genetic alteration,cell proliferation,transcriptional regulator,zinc finger protein,oncogenic process
ENSG00000024048,UBR2,ubiquitin-proteasome pathway regulation,tumor progression,oncogene overexpression,cellular homeostasis disruption,protein degradation dysregulation,e3 ubiquitin ligase activity
ENSG00000170681,CAVIN4,cell proliferation,protein kinase activation,tumor growth,metastasis promotion,caveolar pathway regulation,signal transduction
ENSG00000106459,NRF1,metabolic reprogramming,oncogene activation,stress adaptation,tumor survival,therapeutic target,genomic instability
ENSG00000179044,EXOC3L1,exocyst complex regulation,tumor progression,epithelial-to-mesenchymal transition,potential oncogene,oncogenic function,cell growth promotion
ENSG00000108733,PEX12,peroxisomal biogenesis,oxidative stress regulation,mitochondrial function modulation,cellular metabolism alteration,tumor growth promotion,therapeutic target potential
ENSG00000103089,FA2H,loss-of-function mutation,cellular lipid metabolism,lipid intermediate accumulation,oncogenic process,cell growth promotion,tumor progression
ENSG00000133313,CNDP2,oncogenic potential,tumor progression,cellular proliferation,migration and invasion,antioxidant regulation,signaling pathway interaction
ENSG00000107949,BCCIP,genomic instability,tumor suppressor function,dna repair regulation,brca2 interaction,cancer predisposition,therapeutic target
ENSG00000164761,TNFRSF11B,rankl signaling pathway,tumor-promoting mutations,cell proliferation enhancement,metastasis facilitation,apoptosis resistance,osteoclast regulation
ENSG00000089177,KIF16B,**
mitotic spindle regulation,chromosomal instability,microtubule transport,oncogenic property,cell cycle progression,cellular proliferation 
**
ENSG00000163762,TM4SF18,cellular adhesion disruption,epithelial-to-mesenchymal transition,cell surface receptor interaction,gene expression upregulation,tumor metastasis promotion,malignant cell motility enhancement
ENSG00000120549,KIAA1217,mitosis regulation,cell proliferation enhancement,ciliogenesis regulation,centrosome maturation involvement,tumor progression association,protein-protein interaction modulation
ENSG00000115468,EFHD1,tumor progression,cell proliferation,oncogenic processes,cellular signaling,protein-protein interactions,apoptosis inhibition
ENSG00000164144,ARFIP1,cell migration regulation,microtubule stabilization,tumor progression promotion,apoptosis suppression,cell adhesion regulation,chemoresistance enhancement
ENSG00000144724,PTPRG,cell adhesion,down-regulation,loss of function mutation,signaling pathway disruption,tumor progression,prognostic marker
ENSG00000203896,LIME1,cellular differentiation,transcription factor regulation,oncogene activation,apoptosis suppression,tumor progression,genomic profiling
ENSG00000184210,DGAT2L6,lipid metabolism regulation,oncogenic function,altered expression,cell growth modulation,tumorigenesis involvement,genetic alteration
ENSG00000117410,ATP6V0B,altered expression,cancer stem cell maintenance,metabolic adaptation,tumor progression,ion homeostasis dysregulation,proton pump activation
ENSG00000100139,MICALL1,tumor progression,oncogenic behavior,biomarker potential,signaling pathway regulation,protein-protein interactions,cell survival promotion
ENSG00000183621,ZNF438,transcription regulation,oncogenic function,cell cycle progression,apoptosis inhibition,prognostic marker,transcription factor interaction
ENSG00000137876,RSL24D1,genomic stability,cellular senescence,dna repair mechanism,rna degradation regulation,cell cycle control interaction,therapeutic target
ENSG00000125351,UPF3B,oncogene activation,nonsense-mediated mrna decay pathway disruption,tumor suppressor loss of function,genomic instability promotion,cancer progression facilitation,mrna stabilization
ENSG00000112309,B3GAT2,cell adhesion,glycosylation process,protein modification,tumor progression,cell signaling pathway,angiogenesis
ENSG00000128266,GNAZ,constitutive activation,g-protein coupled receptor interaction,overexpression associated with poor prognosis,signal transduction pathway regulation,tumor growth promotion,cell survival enhancement
ENSG00000263101,KRTAP3-3,cytokeletal regulation,tumor progression,cancer cell proliferation,keratin-associated protein,cell differentiation modulation,tissue remodeling
ENSG00000077080,ACTL6B,chromatin remodeling,transcriptional regulation,histone modification,cell cycle regulation,proliferation modulation,tumorigenesis
ENSG00000175334,BANF1,genomic instability,tumor suppression,chromatin structure regulation,dna damage repair,cell cycle regulation,cancer driver gene
ENSG00000184486,POU3F2,transcription factor regulation,cell proliferation promotion,apoptosis suppression,tumor progression driver,genomic instability contributor,cellular differentiation regulation
ENSG00000100146,SOX10,transcription factor,cellular proliferation,tumor progression,metastasis,chemoresistance,oncogenic program
ENSG00000196531,NACA,chromatin remodeling,cell proliferation,metastasis promotion,gene expression regulation,tumor progression,histone modification
ENSG00000136279,DBNL,rna stabilization,cell cycle regulation,oncogenic signaling,cell proliferation enhancement,metastasis promotion,prognostic biomarker
ENSG00000182087,TMEM259,cellular integrity maintenance,regulatory protein interactions,tumor suppressor function,epithelial cell regulation,cellular transport modulation,signaling pathway regulation
ENSG00000108551,RASD1,ras protein activation,guanine nucleotide exchange factor (gef) activity,cell proliferation regulation,tumor progression promotion,oncogenic signaling pathway involvement,prognostic marker for cancer aggressiveness
ENSG00000128881,TTBK2,microtubule stabilization,cell cycle regulation,dna damage response,apoptosis resistance,protein kinase activation,tumor suppression pathway disruption
ENSG00000110274,CEP164,genomic instability,tumor suppressor function,centrosomal regulation,cilia formation defect,dna damage repair,apoptosis disruption
ENSG00000031081,ARHGAP31,rho-gtpase regulation,tumor suppressor function,loss of function mutations,cell proliferation inhibition,signaling pathway disruption,akt/pi3k pathway interaction
ENSG00000276234,TADA2A,chromatin remodeling,tumor suppressor function,saga complex assembly,transcriptional regulation,brg1/pbrm1 interaction,genomic instability
ENSG00000054116,TRAPPC3,protein interaction,membrane trafficking regulation,aberrant activation,oncogenic processes,cellular transport modulation,apoptosis evasion
ENSG00000256660,CLEC12B,immune modulation,tumor microenvironment,cellular interactions,cancer immunotherapy,immune evasion,protein expression alterations
ENSG00000215193,PEX26,pex26-pex5 interaction,peroxisomal biogenesis,vlcfa accumulation,tumor suppressor function,cellular signaling pathways,oncogenic processes
ENSG00000139970,RTN1,er morphology regulation,calcium homeostasis regulation,cancer driver gene,cell proliferation enhancement,therapeutic target,cellular stress response modulation
ENSG00000096070,BRPF3,chromatin remodeling,histone modification,genetic transcription regulation,oncogene activation,tumor suppressor suppression,cell growth promotion
ENSG00000119938,PPP1R3C,pp1 regulation,dysregulated activation,enhanced cell proliferation,metastasis promotion,tumor growth,aberrant protein dephosphorylation
ENSG00000132792,CTNNBL1,wnt/β-catenin pathway activation,overexpression,oncogenesis promoter,emt regulation,tumor development driver,therapeutic target
ENSG00000100219,XBP1,upr pathway,cellular stress response,apoptosis regulation,tumor progression,oncogene activation,endoplasmic reticulum homeostasis
ENSG00000281861,SLC9A3,ph regulation,cell proliferation,metabolic reprogramming,cell migration,angiogenesis,oncogenic signaling pathway
ENSG00000166927,MS4A7,immunosuppressive microenvironment,cell-cell interactions,tumor aggressiveness,metastasis,poor prognosis,overexpression
ENSG00000137875,BCL2L10,tumor suppression,apoptosis regulation,cell survival,mitochondrial outer membrane permeabilization,pro-apoptotic function,dna damage response
ENSG00000155099,PIP4P2,phosphatase activity,constitutive activation,cell growth enhancement,therapeutic resistance,prognostic marker,signaling pathway alteration
ENSG00000144451,SPAG16,microtubule dynamics,centrosome function,oncogenic overexpression,chromosomal instability,mitotic checkpoint regulation,cellular proliferation enhancement
ENSG00000139437,TCHP,chromatin remodeling,tumorigenesis,cell proliferation,gene expression regulation,transcriptional coactivation,cancer driver gene
ENSG00000184271,POU6F1,transcriptional regulation,tumor promotion,cellular proliferation,apoptosis inhibition,angiogenesis regulation,epithelial-to-mesenchymal transition
ENSG00000136451,VEZF1,tumor progression,transcription factor regulation,ectopic expression,dysregulation,epithelial-to-mesenchymal transition,microrna regulation
ENSG00000197062,ZSCAN26,transcription factor,tumor suppressor,cell cycle arrest,apoptosis induction,chromatin remodeling,genetic predisposition
ENSG00000159063,ALG8,loss-of-function mutations,oncogene activation,disrupted glycosylation patterns,aberrant protein function,tumor progression,n-glycosylation pathway dysregulation
ENSG00000163646,CLRN1,tumorigenesis,cellular homeostasis disruption,uncontrolled cell growth,cell surface receptor function,oncogenic processes,therapeutic target
ENSG00000167971,CASKIN1,camkk regulation,tumor suppression,cell cycle regulation,cell proliferation,transcriptional regulation,genomic stability
ENSG00000138175,ARL3,arl3 gtpase,constitutive activation,cellular signaling network disruption,protein secretion and trafficking regulation,tumor microenvironment modulation,cancer progression driver
ENSG00000167535,CACNB3,**

calcium channel regulation,cell proliferation,oncogenic transformation,epithelial-to-mesenchymal transition,genomic instability,neurotransmitter modulation 
**
ENSG00000115138,POMC,pi3k/akt pathway regulation,tumor progression,hormone regulation,cell growth modulation,genomic instability,immunomodulation
ENSG00000100299,ARSA,autophagy,oncogene function,pi3k/akt pathway interaction,overexpression,tumor progression,cellular growth modulation
ENSG00000250565,ATP6V1E2,ph regulation,proton pumping activity,cell invasion and metastasis,tumor growth promotion,poor prognosis indicator,v-type atpase subunit
ENSG00000182938,OTOP3,cell proliferation,overexpression,tumor suppressor,synaptic vesicle fusion,apoptosis regulation,gene expression
ENSG00000134152,KATNBL1,mitotic checkpoint regulation,genomic instability,tumor suppressor function,dna damage response,cell cycle progression,mutational hotspot
ENSG00000107560,RAB11FIP2,endocytic pathway regulation,cellular proliferation,genomic instability,oncogenic transformation,apoptosis suppression,signaling pathway activation
ENSG00000180938,ZNF572,oncogene activity,cell proliferation regulation,wnt/β-catenin pathway interaction,transcriptional elongation facilitation,chromatin structure modulation,apoptosis inhibition
ENSG00000152475,ZNF837,transcriptional regulation,dna repair mechanisms,oncogenic processes,tumor suppression,chromatin modification,nucleosome remodeling complex interaction
ENSG00000106025,TSPAN12,oncogenic function,cell adhesion regulation,cell migration facilitation,tumor progression driver,signaling pathway modulation,overexpression in cancerous tissues
ENSG00000004961,HCCS,genomic instability,dna repair regulation,tumor suppressor function,loss-of-function mutations,homologous recombination repair,base excision repair
ENSG00000198298,ZNF485,loss of function mutations,tumor suppressor activity,genomic instability,cell cycle regulation,apoptosis regulation,transcriptional regulation
ENSG00000181638,ZFP41,immune modulation,transcriptional regulation,tumor progression,gene expression alteration,cell growth regulation,proliferation pathways
ENSG00000128656,CHN1,genomic instability,dna repair mechanism,cell cycle regulation,tumor suppression,protein-dna interaction,oncogenic transformation
ENSG00000126878,AIF1L,inflammation regulation,tumor progression,immune evasion,biomarker potential,cellular regulation,prognostic marker
ENSG00000122859,NEUROG3,**
apoptosis suppression,cell proliferation enhancement,immune evasion,metastasis promotion,neural differentiation inhibition,transcriptional regulation 
**
ENSG00000085999,RAD54L,dna helicase activity,genomic stability maintenance,homologous recombination repair,chromosomal instability induction,cell cycle regulation,apoptosis modulation
ENSG00000175455,CCDC14,centrosomal regulation,loss-of-function mutation,microtubule dynamics,chromosomal instability,aneuploidy driver,signaling pathway modulation
ENSG00000107890,ANKRD26,loss of function mutations,tumor suppression,cell cycle arrest,apoptosis induction,p53 stabilization,genomic integrity maintenance
ENSG00000166860,ZBTB39,tumor suppressor function loss,epithelial-to-mesenchymal transition (emt),genomic instability,cell cycle regulation disruption,apoptosis inhibition,dna damage response impairment
ENSG00000104660,LEPROTL1,tumor suppressor function,dna repair regulation,cell growth regulation,apoptosis regulation,genetic instability,meko pathway disruption
ENSG00000172007,RAB33B,cell cycle regulation,mitotic spindle formation,gtpase activity,microtubule dynamics modulation,cancer aggressiveness correlation,signaling pathway interaction
ENSG00000198833,UBE2J1,ubiquitination regulation,cell cycle progression,protein homeostasis,tumor growth promotion,pi3k/akt pathway interaction,oncogenic protein stabilization
ENSG00000125817,CENPB,kinetochore formation,cell proliferation,tumorigenesis,chromosomal instability,dna binding,cancer progression
ENSG00000189030,VHLL,dna repair mechanism alteration,tumor development driver,apoptosis inhibition,cell cycle dysregulation,genomic instability,molecular interaction network
,HIST1H2AC,epigenetic regulation,chromatin structure modification,tumor progression,cell proliferation regulation,biomarker potential,genomic instability
ENSG00000266173,STRADA,cellular energy regulation,ampk pathway activation,metabolic reprogramming,tumor progression,therapeutic target,genomic instability
ENSG00000177602,HASPIN,kinetochore regulation,genomic instability,chromosomal segregation,spindle checkpoint activation,cell cycle regulation,therapeutic target
ENSG00000186204,CYP4F12,lipid metabolism,cell proliferation,oncogenesis,metastasis,therapeutic target,genomic overexpression
ENSG00000171219,CDC42BPG,cell cycle regulation,tumor progression,actin cytoskeleton dynamics,apoptosis inhibition,emt regulation,cancer metastasis
ENSG00000197959,DNM3,endocytosis regulation,autophagy dysregulation,oncogenic mutations,tumor suppressor function,actin dynamics modulation,pi3k/akt signaling interaction
ENSG00000182156,ENPP7,purinergic signaling,cellular homeostasis regulation,genomic instability,epigenetic modifications,pi3k/akt pathway activation,tumor growth promotion
ENSG00000143418,CERS2,ceramide biosynthesis,cell proliferation,apoptosis inhibition,angiogenesis promotion,therapeutic target,chromosomal amplification
ENSG00000128011,LRFN1,met pathway activation,tumor progression,cell adhesion disruption,prognostic marker,oncogene activation,signaling pathway modulation
ENSG00000167315,ACAA2,lipid metabolism,fatty acid synthesis,tumor aggressiveness,poor prognosis,therapeutic target,cell growth promotion
ENSG00000169981,ZNF35,tumor suppression,loss-of-function mutations,transcriptional regulation,cell proliferation inhibition,apoptosis induction,epigenetic modification
ENSG00000261857,MIA,epigenetic regulation,tumor progression,cell migration,metastasis promotion,prognostic biomarker,pi3k/akt pathway interaction
ENSG00000111596,CNOT2,mrna degradation,transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition (emt),apoptosis suppression,cell cycle progression
ENSG00000163166,IWS1,isr activation,er stress response,cell survival promotion,chemosensitivity resistance,protein synthesis regulation,tumor progression facilitation
ENSG00000147874,HAUS6,cell cycle regulation,genomic instability,nucleocytoplasmic transport,oncogenic mutations,tumor progression,biological assembly
ENSG00000137814,HAUS2,genomic instability,aneuploidy,centrosome amplification,mitotic spindle assembly,cell cycle regulation,tumor suppressor function
ENSG00000021762,OSBPL5,lipid metabolism regulation,cholesterol homeostasis disruption,oncogenic processes promotion,pi3k/akt/mtor pathway modulation,cell proliferation enhancement,autophagy dysregulation
ENSG00000138109,CYP2C9,altered expression,drug metabolism,reactive oxygen species production,cellular redox balance,hypoxic conditions adaptation,apoptosis regulation
ENSG00000115850,LCT,modulation of tumor microenvironment,alteration of immune response,inflammation and immunosuppression,cell migration and invasion,tumor progression,protein-protein interactions
ENSG00000100902,PSMA6,protein degradation,proteasome activity,oncogenic process,cellular signaling,apoptosis regulation,cell cycle progression
ENSG00000198523,PLN,calcium signaling,mitochondrial metabolism,energy regulation,cell survival,apoptosis regulation,tumor progression
ENSG00000186193,SAPCD2,sphingolipid synthesis dysregulation,oncogene activation,cell proliferation and survival,therapeutic target identification,histone deacetylase interaction,epigenetic modification regulation
ENSG00000132661,NXT1,p53 interaction,tumor suppression inhibition,nuclear transport regulation,cell proliferation promotion,apoptosis inhibition,overexpression in cancer
ENSG00000078403,MLLT10,**

histone methylation,chromatin remodeling,cell proliferation regulation,tumor suppression,oncogenic potential,genetic regulatory function
ENSG00000174796,THAP6,transcriptional regulation,oncogenic activity,cellular proliferation,tumor progression,poor prognosis,genomic instability
ENSG00000104369,JPH1,mitochondrial regulation,autophagy modulation,calcium homeostasis,oncogenic driver,tumor suppression resistance,cell survival enhancement
ENSG00000116350,SRSF4,alternative splicing,cancer driver mutations,cell growth regulation,enhanced oncogene expression,oncogenic splice variants,rna processing regulation
ENSG00000148248,SURF4,microtubule dynamics,cell cycle regulation,apoptosis evasion,tumor progression,cytoskeletal assembly,cellular proliferation
ENSG00000183258,DDX41,dna repair defects,tumor suppressor function,genomic instability drivers,rna regulation disruptions,dna damage recognition,apoptosis dysregulation
ENSG00000111291,GPRC5D,g protein-coupled receptor signaling,gain of function mutations,tumor progression,genomic profiling,cell survival pathways,pi3k/akt pathway activation
ENSG00000175489,LRRC25,cell migration,metastasis promoter,tumor progression,transmembrane protein,cell surface interaction,oncogene function
ENSG00000060339,CCAR1,cell proliferation activation,tumor progression driver,oncogene overexpression,signaling pathway regulation,transcriptional coactivation,arginine methylation activity
ENSG00000157851,DPYSL5,microtubule stability,cell division regulation,oncogene upregulation,tumor progression enhancement,chemotherapy resistance,aggressive tumor behavior
ENSG00000092964,DPYSL2,cellular migration and invasion,microtubule stability regulation,overexpression associated with poor prognosis,tumor progression driver,biomarker for disease progression,microtubule-associated protein interaction
ENSG00000116729,WLS,wnt/β-catenin pathway,constitutive activation,overexpression,cell proliferation,tumor progression,signaling regulation
ENSG00000120647,CCDC77,cell cycle regulation,dna replication inhibition,pi3k/akt pathway modulation,tumor growth promotion,apoptosis inhibition,poor prognosis association
ENSG00000145833,DDX46,ddx46 deregulation,apoptosis evasion,cell cycle regulation,gene expression modulation,microrna-mediated post-transcriptional regulation,transcriptional regulation
ENSG00000173960,UBXN2A,ubiquitination pathway,protein degradation,tumor growth,cell cycle regulation,apoptosis resistance,oncoprotein accumulation
ENSG00000067445,TRO,overexpression,constitutive activation,cellular migration,tumor progression,therapeutic target,genomic profiling
ENSG00000105605,CACNG7,oncogene,amplification and overexpression,cell migration,protein interaction with pi3k/akt pathway,therapeutic target potential,neuronal excitability regulation
ENSG00000068745,IP6K2,cellular signaling,phosphorylation regulation,tumor progression,pi3k/akt/mtor pathway,cell survival enhancement,oncogenic transformation
ENSG00000065621,GSTO2,glutathione conjugation,cell survival promotion,tumor progression facilitation,protein-protein interaction,redox balance regulation,ros induction
,WRB,copii-coated vesicles assembly,protein synthesis regulation,early secretory pathway,signal sequence recognition,ribosome integration,cancer driver gene
ENSG00000109272,PF4V1,pro-angiogenic activity,angiogenesis,vascularization,endothelial cell proliferation,growth factor interaction,biomarker
ENSG00000165685,TMEM52B,loss of function mutations,tumor progression,metastasis,cell proliferation,oncogenic potential,signaling pathway modulation
ENSG00000174453,VWC2L,cellular adhesion modulation,pi3k/akt pathway interaction,tumor progression marker,overexpression in cancer,extracellular matrix remodeling,oncogene potential
ENSG00000180872,DEFB112,antimicrobial activity,tumor suppressor function,immune modulation,anti-inflammatory properties,cytoplasmic localization,apoptosis regulation
ENSG00000166881,NEMP1,cell proliferation,oncogene function,tumor progression,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition regulation,apoptosis inhibition
ENSG00000178726,THBD,angiogenesis promotion,cell adhesion regulation,coagulation pathway modulation,oncogenic signaling interaction,tumor growth facilitation,upregulated expression
ENSG00000137812,KNL1,mitotic checkpoint regulation,chromatin remodeling complexes,genomic instability,tumor progression enhancement,kinase activity regulation,protein-protein interactions
,KCNA6,voltage-gated potassium channel regulation,potassium channel function alterations,cancer cell excitability modulation,tumorigenesis contribution,therapeutic target potential,cell signaling pathway interaction
ENSG00000166145,SPINT1,tumor suppressor,serine protease inhibitor,cellular growth regulation,wnt/β-catenin signaling pathway,cell differentiation regulation,proteolytic activity inhibition
ENSG00000126756,UXT,transcriptional regulation,cellular proliferation,oncogenic potential,metastatic promotion,gene expression modulation,cell survival enhancement
ENSG00000111237,VPS29,endosomal sorting,protein degradation,escrt-i complex component,tumor progression,cell growth regulation,signaling pathway modulation
ENSG00000006042,TMEM98,mitochondrial membrane stability,cell proliferation regulation,genomic instability,oncogenic signaling,tumor progression,therapeutic target
ENSG00000143032,BARHL2,oncogenic activity,transcriptional regulation,epithelial-to-mesenchymal transition,cell migration and invasion,tumor progression,genomic instability
ENSG00000205060,SLC35B4,glycosylation pathway regulation,proliferation enhancement,tumor progression association,apoptosis modulation,nucleotide sugar transporter function,glycosylation event promotion
ENSG00000147654,EBAG9,er chaperone function,proteasome inhibitor recycling,tumor growth promotion,er-associated degradation (erad),apoptosis inhibition,oncogenic protein expression
ENSG00000151379,MSGN1,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt),overexpression,metastasis promotion,tumor progression enhancement,cancer aggressiveness
ENSG00000179826,MRGPRX3,enhanced cell proliferation,tumor progression,therapeutic target,g protein-coupled receptor activation,genomic profiling,cell migration
ENSG00000258724,PINX1,genomic instability,tumor suppressor function,dna damage response,reactive oxygen species regulation,phosphoinositide-dependent endonuclease inhibition,cellular growth control
ENSG00000112212,TSPO2,mitochondrial transport,cholesterol regulation,fatty acid oxidation,tumor progression,immune response modulation,biomarker potential
ENSG00000176248,ANAPC2,genomic instability,cell cycle deregulation,tumor suppressor,chromosome segregation,ubiquitin ligase activity,protein-protein interactions
ENSG00000160993,ALKBH4,dna repair,genomic instability,regulation of gene expression,tumor suppression,cellular homeostasis,prognostic marker
ENSG00000123130,ACOT9,lipid metabolism modulation,gene overexpression,tumor growth promotion,energy metabolism regulation,cancer cell survival enhancement,epigenetic regulation
ENSG00000041515,MYO16,tumor progression,overexpression,cellular regulation,cancer biomarker,signaling pathway dysregulation,cytoplasmic localization
ENSG00000274829,PARN,mrna degradation,oncogenic function,tumor progression,cellular proliferation,gene regulation,nuclear enzyme activity
ENSG00000135698,MPHOSPH6,protein degradation regulation,tumor progression driver,cell cycle regulator,major oncogenic signaling,angiogenesis promoter,cancer biomarker candidate
ENSG00000171824,EXOSC10,rna degradation regulation,oncogenic process contribution,tumor growth promotion,cellular homeostasis disruption,microrna biogenesis regulation,cellular behavior modulation
ENSG00000166478,ZNF143,tumor suppressor function loss,chromatin remodeling,oncogenic transcription factor,transcriptional regulation,cell proliferation enhancement,metastatic potential increase
,SEPT10,cytokinesis regulation,cellular migration,tumor progression,metastatic potential,protein-protein interactions,cell survival
ENSG00000081041,CXCL2,tumor microenvironment creation,angiogenesis facilitation,metastasis promotion,oncogenic signaling,inflammatory response regulation,prognostic biomarker
ENSG00000153029,MR1,tumor immune evasion,immune modulation,major histocompatibility complex class i-like protein,myeloid-derived suppressor cell regulation,adenosine deaminase acting on rna 1 interaction,biomarker potential
ENSG00000101290,CDS2,genomic stability,dna repair mechanisms,cell cycle regulation,apoptosis modulation,tumor suppressor potential,genome maintenance regulation
ENSG00000158062,UBXN11,chromatin remodeling,genomic instability,oncogenic processes,protein degradation pathway,tumor suppressor regulation,cell cycle disruption
ENSG00000105509,HAS1,hyaluronic acid production,cancer cell proliferation,cell survival pathway,tumor microenvironment,biomarker potential,enzymatic activity
ENSG00000103044,HAS3,tumor progression,angiogenesis promotion,cell proliferation enhancement,biomarker potential,glycosaminoglycan synthesis regulation,tumor microenvironment modulation
ENSG00000176974,SHMT1,nucleotide biosynthesis,cell proliferation,tumor progression,one-carbon metabolism,therapeutic target,protein interaction
ENSG00000145354,CISD2,mitochondrial regulation,redox balance maintenance,cellular metabolism regulation,oncogene dysregulation,apoptosis evasion,protein-protein interactions
ENSG00000170876,TMEM43,cellular integrity disruption,oncogenic potential,cell adhesion modulation,tumor growth promotion,biomarker candidate,signaling pathway interaction
ENSG00000064655,EYA2,tumor promoter,transcription activator,epithelial-to-mesenchymal transition,cell proliferation,oncogene potential,protein-protein interaction
ENSG00000185742,C11orf87,cell growth regulation,tumor suppressor activity,protein overexpression,cell proliferation enhancement,genomic instability involvement,uncharacterized function
ENSG00000104221,BRF2,rna polymerase ii transcription,transcriptional regulation,cell cycle progression,epigenetic modification,oncogenic driver,cancer cell metabolism
ENSG00000114573,ATP6V1A,proton pump activation,lysosomal dysfunction,ion channel regulation,cell growth promotion,cancer cell metabolism,tumor progression enhancer
ENSG00000166971,AKTIP,akt signaling,oncogene activation,pi3k/akt pathway dysregulation,cell survival enhancement,tumor growth promotion,therapeutic target
ENSG00000134962,KLB,tumor progression,glycolysis regulation,gut microbiota modulation,energy metabolism dysregulation,transcriptional regulation,oncogene role
ENSG00000286112,KYAT1,epigenetic regulation,chromatin remodeling,cell proliferation,pi3k/akt signaling pathway,transcriptional activation,genomic instability
ENSG00000263160,TMEM50B,calcium signaling,endoplasmic reticulum localization,mitochondrial interaction,tumor progression,cell proliferation,therapeutic target
ENSG00000198925,ATG9A,autophagic regulation,putative oncogene,cellular homeostasis,defective autophagy,metabolic adaptation,tumor growth
ENSG00000106608,URGCP,cell cycle regulation,cell survival,mitosis progression,serine/threonine kinase activity,oncogenic potential,protein-protein interaction
ENSG00000145725,PPIP5K2,phosphoinositide signaling,pi4p phosphorylation,akt activation,cancer driver gene,cell proliferation,therapeutic target
ENSG00000154957,ZNF18,tumor suppressor function,loss of function mutation,cell proliferation inhibition,apoptosis promotion,dna repair regulation,transcriptional regulation
ENSG00000143727,ACP1,cell growth regulation,protein dephosphorylation,tumor progression,metastasis promotion,cell migration modulation,therapeutic target
ENSG00000110344,UBE4A,protein degradation dysregulation,ubiquitination pathway disruption,oncogenic signaling modulation,tumor progression facilitation,genomic instability contribution,transcriptional regulation alteration
ENSG00000005238,FAM214B,genomic instability,centrosome dysfunction,microtubule stability,chromosomal abnormalities,therapeutic target,cell cycle regulation
ENSG00000175315,CST6,loss-of-function mutations,tumor progression,metastasis promotion,cell adhesion regulation,extracellular matrix remodeling,therapeutic target
ENSG00000204381,LAYN,cell adhesion regulation,cancer progression driver,pi3k/akt pathway modulation,tumor microenvironment interaction,cell proliferation promotion,survival signaling enhancement
ENSG00000205808,PLPP6,pi3k/akt signaling,phosphatase activity,lipid metabolism regulation,cancer progression,poor prognosis marker,tumor suppressor dysfunction
ENSG00000206394,CLIC1,tumor progression,cell signaling,oncogenesis,protein interaction,therapeutic target,biomarker
ENSG00000156127,BATF,tumor progression,oncogenic potential,pro-inflammatory response,immune evasion,cell proliferation,transcriptional regulation
ENSG00000126803,HSPA2,protein folding regulation,tumor progression,cellular stress protection,apoptosis modulation,growth promotion,differentiation regulation
ENSG00000124279,FASTKD3,mitochondrial regulation,metabolic reprogramming,oncogenic process,tumor growth,glycolytic shift,energy metabolism
ENSG00000106348,IMPDH1,immunosuppression,hypoxanthine metabolism,rapid cell growth,cell survival,guanine nucleotide biosynthesis,therapeutic target
ENSG00000169951,ZNF764,transcriptional regulator,overexpression,pi3k/akt signaling,cell proliferation,molecular interaction,protein modification
ENSG00000159210,SNF8,autophagy regulation,ubiquitinated protein sorting,escrt-iii complex function,tumorigenesis regulation,protein aggregation,cellular dysfunction
ENSG00000100580,TMED8,protein processing,overexpression,cellular proliferation,aberrant protein secretion,tumor progression,metastasis
ENSG00000184752,NDUFA12,mitochondrial function,electron transport chain,cellular respiration,cancer metabolism,energy metabolism,tumor growth
ENSG00000179010,MRFAP1,microtubule dynamics,cytoskeleton modulation,cell proliferation,tumor progression,genetic alterations,signaling pathway interaction
ENSG00000217930,PAM16,chromosomal instability,oncogenic function,mitotic checkpoint regulation,cell proliferation enhancement,overexpression association,poor prognosis indicator
ENSG00000168334,XIRP1,cytoprotective function,cell migration promotion,cytoskeletal interaction,tumor suppressor loss of function,apoptosis regulation,chemosensitivity modulation
ENSG00000120265,PCMT1,protein repair and stability,cellular homeostasis,tumor progression,cancer prognosis,apoptosis regulation,genetic expression modulation
ENSG00000102970,CCL17,tumor microenvironment modulation,pro-tumorigenic effects,angiogenesis promotion,immune suppression,poor prognosis marker,therapeutic target
ENSG00000011485,PPP5C,cell cycle regulation,oncogenic transformation,protein-protein interactions,gain-of-function mutations,epigenetic modifications,akt signaling pathway
ENSG00000197601,FAR1,apoptosis regulation,cell cycle modulation,oncogene activation,protein-protein interactions,therapeutic target,cancer cell survival
ENSG00000186889,TMEM17,calcium channel regulation,cell cycle modulation,cell migration enhancement,cell proliferation increase,ion transporter interaction,prognostic biomarker
ENSG00000182979,MTA1,histone modification,chromatin remodeling,oncogenic transcription factor,tumor progression,metastasis,cell proliferation
ENSG00000185608,MRPL40,**
mitochondrial ribosome component,protein synthesis regulation,tumor suppressor potential,apoptosis modulation,metabolic regulation,gene expression control
**
ENSG00000077463,SIRT6,genomic instability,telomere maintenance,apoptosis induction,cancer suppressor function,loss-of-function mutations,parp1 interaction
ENSG00000092531,SNAP23,regulated membrane fusion,vesicle trafficking,cell migration and invasion,metastasis facilitation,tumor progression support,oncogenic process promotion
ENSG00000145911,N4BP3,protein regulation,ubiquitination modulation,oncogenic protein accumulation,tumor suppressor suppression,cell proliferation promotion,genomic instability contribution
ENSG00000134369,NAV1,ion channel regulation,cell migration,therapeutic resistance,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition modulation,sodium ion flow regulation
ENSG00000176386,CDC26,cell cycle regulation,genomic instability,tumor progression,therapeutic target,ubiquitin degradation,apc/c interaction
ENSG00000181472,ZBTB2,transcriptional regulation,oncogenic properties,cell proliferation,tumor growth,metastasis promotion,epigenetic modulation
ENSG00000126254,RBM42,mrna stability regulation,tumor progression,rna-binding protein interaction,metastasis promotion,cell proliferation enhancement,poor prognosis marker
ENSG00000171425,ZNF581,tumor progression,transcriptional regulation,cell cycle regulation,apoptosis evasion,oncogene function,genomic instability
ENSG00000101189,MRGBP,oncogene,cell growth regulation,protein stability regulation,ubiquitination pathway modulation,tumor progression driver,metastasis promoter
ENSG00000118680,MYL12B,actomyosin regulation,cytoskeleton remodeling,cell migration,metastasis promotion,oncogenic driver,therapeutic target
ENSG00000276480,MYH11,myh11 overexpression,smooth muscle contraction dysregulation,cell migration promotion,metastasis facilitation,apoptosis evasion activation,tumor growth enhancement
ENSG00000162298,SYVN1,hypoxia-inducible factor stabilization,oncogenic function,angiogenesis regulation,deubiquitinase activity,cellular homeostasis disruption,prognostic marker potential
ENSG00000176095,IP6K1,phosphoinositide regulation,cell proliferation,akt/mtor pathway activation,oncogenic processes,metabolic regulation,genomic instability
ENSG00000243067,PSMB9,cancer driver gene,protein degradation pathway,cell cycle regulation,tumor aggressiveness,rna interference,chemo-resistance
ENSG00000167840,ZNF232,zinc finger dna binding,transcriptional regulation,cell cycle progression,tumor progression,biomarker potential,genomic overexpression
ENSG00000159267,HLCS,biotin dependent enzyme regulation,metabolic reprogramming,cellular energy demand,enhanced cell proliferation,tumor aggressiveness,therapeutic target
ENSG00000134532,SOX5,transcriptional regulation,oncogene activation,cell proliferation,apoptosis evasion,tumor metastasis,therapeutic target
ENSG00000136936,XPA,genomic instability,nucleotide excision repair,dna damage accumulation,tumor formation,sensitivity to dna-damaging agents,dna repair deficiency
ENSG00000087903,RFX2,transcription factor regulation,cell proliferation enhancement,poor prognosis indicator,epithelial-to-mesenchymal transition regulator,signaling pathway modulator,cancer cell survival promoter
ENSG00000168824,NSG1,genomic integrity maintenance,tumor suppressor function,dna repair regulation,cellular response modulation,genetic instability risk,chemotherapy sensitivity
ENSG00000168000,BSCL2,lipid metabolism,altered expression,cell proliferation,oncogenic processes,cellular responses to stress,protein-protein interaction
ENSG00000205439,KRTAP12-3,intermediate filaments,cellular structure,keratin-associated proteins,epithelial cells,co-expression with keratins,dysregulated expression
ENSG00000130770,ATP5IF1,mitochondrial function,energy production,cellular metabolism,atp synthase assembly,tumor growth progression,warburg effect
ENSG00000280759,AP2A2,oncogenic function,cell cycle regulation,apoptosis inhibition,signal transduction pathway,protein phosphatase activity,tumor suppressor gene suppression
,GARS,translation initiation,trna charging,glycyl-trna synthetase activity,ribosome biogenesis,cell proliferation,cancer therapy target
ENSG00000165376,CLDN2,epithelial-to-mesenchymal transition (emt),tumor progression,upregulation,cell adhesion disruption,paracellular permeability increase,metastasis facilitation
ENSG00000112763,BTN2A1,immunomodulation,t-cell activation,cytokine regulation,immune evasion,protein interaction,cell signaling
ENSG00000154127,UBASH3B,tumor progression,cancer metabolism,protein stabilization,apoptosis inhibition,cell proliferation,ubiquitination regulation
ENSG00000141934,PLPP2,pi(3,5)p2 metabolism,lipid signaling pathway,tumor progression,therapeutic target,cell proliferation
ENSG00000136404,TM6SF1,lipid metabolism regulation,phospholipid transport modulation,lipogenic gene expression,oncogenesis promotion,cellular lipid droplet accumulation,therapeutic target
ENSG00000163466,ARPC2,actin filament formation,cell migration and invasion,constitutive activation,oncogenic protein interaction,cell proliferation regulation,therapeutic target candidate
ENSG00000155304,HSPA13,protein chaperone function,cellular stress response,oncogenic potential,cell survival enhancement,therapeutic resistance,protein homeostasis
ENSG00000180806,HOXC9,hox transcription factor,oncogenic overexpression,transcriptional regulation,enhanced cell proliferation,metastatic potential,tumor suppressor dysregulation
ENSG00000125618,PAX8,pax8 transcription factor,rcc tumorigenesis,nephrogenesis regulation,chromatin remodeling,kidney cell differentiation,transcriptional dysregulation
ENSG00000173917,HOXB2,homeobox-containing transcription factor,transcriptional regulation,cellular differentiation,epithelial-to-mesenchymal transition,oncogenic role,therapeutic target
ENSG00000131013,PPIL4,regulation of protein stability,cellular signaling pathway regulation,tumor promotion,apoptosis inhibition,e3 ubiquitin ligase complex interaction,protein folding and stabilization
ENSG00000184436,THAP7,transcriptional regulation,cell cycle progression,tumor suppression evasion,apoptosis inhibition,oncogenic processes promotion,therapeutic target
ENSG00000125888,BANF2,genomic instability,chromatin remodeling,dna repair pathway interaction,nuclear protein function,cell cycle progression regulation,protein-protein interactions
ENSG00000136942,RPL35,ribosome biogenesis,gain of function mutations,overexpression,cell growth and proliferation,genomic amplification,oncogenic processes
ENSG00000217128,FNIP1,mtor pathway regulation,tumor suppression,gene expression loss,cell proliferation regulation,oncogenic processes,interaction with folliculin
ENSG00000135823,STX6,pi3k/akt/mtor pathway,overexpression,vesicle trafficking,cell proliferation,membrane fusion,therapeutic target
ENSG00000229802,SLC39A7,zinc homeostasis,cellular uptake,metal transporters,tumor aggressiveness,transcriptional regulation,signal transduction
ENSG00000170893,TRH,hormone regulation,signaling pathway dysregulation,cellular growth modulation,thyroid function influence,metabolic regulation,potential oncogenic mechanism
ENSG00000281758,KCNIP4,regulation of potassium channels,cell proliferation,modulator of signaling pathways,potential biomarker,therapeutic target,dysregulation in cancer
ENSG00000114854,TNNC1,calcium-dependent signaling,cell proliferation enhancement,overexpression biomarker,muscle contraction regulation,protein interaction partner,tumorigenesis promoter
ENSG00000143977,SNRPG,aberrant splicing,gain of function mutations,oncogenic signaling pathway activation,tumor progression,cell proliferation regulation,overexpression
ENSG00000182004,SNRPE,splice site recognition,aberrant pre-mrna splicing,driver gene mutations,tumor progression,therapeutic target,genomic instability
ENSG00000176679,TGIF2LY,tgf-β pathway modulation,cell proliferation regulation,oncogene function,transcriptional regulation,epithelial-to-mesenchymal transition,tumor progression promotion
ENSG00000166446,CDYL2,chromatin remodeling,histone modification,transcriptional regulation,oncogenic process,cell proliferation,apoptosis suppression
,DARS,cell proliferation,onco-protein synthesis,dna repair regulation,apoptosis inhibition,tumor progression marker,genomic mutation
ENSG00000136874,STX17,pi3k/akt pathway dysregulation,extracellular matrix degradation,cell migration and invasion,autophagy regulation,membrane trafficking regulation,oncogene/tumor suppressor role
ENSG00000198728,LDB1,transcriptional regulator,chromatin remodeling,oncogenic processes,tumor suppressor silencing,epithelial-to-mesenchymal transition (emt),histone methylation
ENSG00000159556,ISL2,cellular differentiation,transcription factor,oncogene activity,tumor progression,proliferation regulation,genomic overexpression
ENSG00000165533,TTC8,oncogenic properties,cellular interactions,er stress,protein misfolding,cell cycle regulation,transcriptional control
ENSG00000131067,GGT7,glutathione metabolism,antioxidant role,oxidative stress response,cellular survival,proliferation regulation,chemotherapy resistance
ENSG00000164237,CMBL,cell cycle regulation,oncogenic potential,pi3k/akt pathway interaction,cell migration promotion,apoptosis inhibition,prognostic marker
ENSG00000185640,KRT79,intermediate filament protein,cellular differentiation,oncogenic process,protein-protein interaction,epithelial cell integrity,mitotic regulation
ENSG00000105793,GTPBP10,gtp-binding activity,cellular regulation,dna damage repair,oncogenic process,tumorigenesis,overexpression
ENSG00000185905,C16orf54,cellular overexpression,genomic amplification,cell proliferation regulation,gene expression modulation,protein interaction,molecular mechanism complexity
ENSG00000131264,CDX4,epigenetic regulation,transcription factor function,tumor suppressor suppression,cellular differentiation disruption,prognostic marker,malignant transformation promotion
ENSG00000115841,RMDN2,mitotic spindle checkpoint,chromosomal instability,aberrant cell division,tumor progression,mitosis regulation,genomic stability
ENSG00000174943,KCTD13,cellular homeostasis regulation,ion balance regulation,kirc tumorigenesis,upregulation in cancer tissues,tumor progression association,cell growth regulation
ENSG00000126067,PSMB2,cell cycle regulation,gene amplification,mutation hotspot,protein degradation pathway,tumor growth regulator,ubiquitin-proteasome complex activation
ENSG00000277791,PSMB3,proteasome regulation,tumor growth,ubiquitin-proteasome pathway,cell cycle progression,apoptosis dysregulation,nf-κb signaling
ENSG00000198853,RUSC2,chromatin modification,transcriptional regulation,cell proliferation,tumor progression,histone modification,apoptosis suppression
ENSG00000105983,LMBR1,wnt/β-catenin pathway,transcriptional regulation,tumor progression,tumorigenesis,proliferation,survival
ENSG00000196391,ZNF774,chromatin modification,transcriptional regulation,apoptosis evasion,cell cycle progression,tumor suppressor,dna binding activity
ENSG00000152147,GEMIN6,nuclear pore complex interaction,mrna export regulation,cell proliferation enhancement,oncogenic process contribution,cancer driver mutation,ribonucleoprotein complex component
ENSG00000243244,STON1,metastasis promoter,tumor progression marker,cell adhesion regulator,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,prognostic biomarker
ENSG00000134508,CABLES1,overexpression,poor prognosis,cell migration regulation,tumor progression,pi3k/akt pathway interaction,microtubule dynamics regulation
ENSG00000147262,GPR119,cell proliferation,metabolic regulation,tumor progression,g protein-coupled receptor activation,poor prognosis,overexpression
ENSG00000110324,IL10RA,il-10 signaling pathway,loss-of-function mutations,tumor microenvironment modulation,immune evasion,inflammation regulation,cancer progression
ENSG00000175445,LPL,tumor growth promotion,lipid metabolism regulation,oncogene upregulation,prognostic biomarker,cell proliferation facilitation,angiogenesis promotion
ENSG00000163735,CXCL5,angiogenesis promotion,chemokine signaling,immune suppression,oncogenic driver,prognostic marker,tumor microenvironment modulation
ENSG00000102189,EEA1,autophagy regulation,cell cycle modulation,endocytic trafficking,immunosuppressive microenvironment,tumor progression,protein recycling
ENSG00000281139,STH,glycosylation regulation,cell-cell interactions,tumor growth promotion,prognostic marker,apoptosis evasion,immune response modulation
ENSG00000197951,ZNF71,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis inhibition,epigenetic modification,oncogenic pathway activation
ENSG00000197063,MAFG,oncogenic transcription,transcriptional repression,tumor suppressor gene regulation,cell survival enhancement,angiogenesis promotion,immune evasion
ENSG00000132274,TRIM22,**

regulation of stat1 pathway,tumor suppressor activity,inhibition of cell proliferation,interaction with p53 protein,genomic stability maintenance,antiviral defense mechanism
ENSG00000069535,MAOB,mitochondrial enzyme function,tumor progression,cellular proliferation,angiogenesis facilitation,immune evasion mechanism,subcellular localization in mitochondria
ENSG00000203667,COX20,energy production,mitochondrial regulation,apoptosis regulation,tumor progression,complex formation,cellular respiration
ENSG00000087206,UIMC1,ubiquitin ligase assembly,cell cycle regulation,dna damage response,tumor suppressor function,protein degradation pathways,mitotic checkpoint control
ENSG00000136270,TBRG4,cell proliferation,transcriptional regulation,genomic instability,apoptosis resistance,signaling pathway modulation,biomarker function
ENSG00000063176,SPHK2,sphingolipid metabolism,oncogenic signaling,cell proliferation,tumor progression,therapeutic target,genomic upregulation
ENSG00000174485,DENND4A,loss-of-function mutations,disrupted regulation of crl complexes,oncogenic protein accumulation,tumor growth promotion,apoptosis suppression,cell cycle dysregulation
ENSG00000072133,RPS6KA6,phosphorylation activity,map kinase activation,tumor progression,cell survival regulation,energy metabolism reprogramming,hypoxia-induced gene expression
ENSG00000114127,XRN1,rna degradation,tumor progression,oncogenic potential,mrna stability regulation,cancer cell survival,therapeutic target
ENSG00000171806,METTL18,m6a modification,oncogenic factor regulation,cell proliferation enhancement,tumor progression facilitation,post-transcriptional regulation,potential biomarker
ENSG00000235155,B3GALT4,cell adhesion regulation,tumor progression association,oncogenic signaling pathway involvement,glycosylation process alteration,aggressive tumor behavior marker,poor prognosis indicator
ENSG00000145192,AHSG,altered calcium homeostasis,cell proliferation,overexpression,phosphate regulation,tumor biomarker,protein-protein interaction
ENSG00000204219,TCEA3,wnt/β-catenin signaling pathway,transcriptional regulation,oncogene overexpression,cell cycle progression,apoptosis suppression,genomic instability
ENSG00000004939,SLC4A1,altered expression,tumor progression,cell adhesion disruption,epithelial-to-mesenchymal transition,acid-base balance dysregulation,glycolysis modulation
ENSG00000048162,NOP16,aberrant splicing patterns,cancer driver mutations,cell growth regulation,gene expression changes,oncogenic function,pre-mrna processing
ENSG00000140830,TXNL4B,oncogenesis,tumor progression,cell proliferation,proliferation regulation,emt regulation,oxidative stress modulation
ENSG00000071967,CYBRD1,tumor progression,oncogenic signaling,cell cycle regulation,gene expression modulation,rna-binding protein,cancer development
ENSG00000160688,FLAD1,genomic instability,dna damage repair,tumor progression,apoptosis regulation,cell cycle control,enzyme dysfunction
ENSG00000146352,CLVS2,ubiquitin-proteasome pathway regulation,tumor suppressor degradation,oncogenic function,chd family member,protein binding interactions,cellular stress response modulation
ENSG00000170011,MYRIP,cell migration,tumor progression,prognostic marker,oncogenic signaling,intracellular trafficking,biomarker and therapeutic target
ENSG00000184724,KRTAP6-1,epithelial-to-mesenchymal transition,keratin filament regulation,oncogenic pathway modulation,poor prognosis marker,protein expression alteration,tumorigenesis promotion
ENSG00000144036,EXOC6B,dna repair,cell cycle regulation,pi3k/akt signaling,genomic instability,tumorigenesis,vesicle targeting
ENSG00000171116,HSFX1,cell cycle regulation,epigenetic regulation,chromatin modification,histone demethylation,tissue homeostasis,embryonic development
ENSG00000268738,HSFX2,transcription regulation,cell proliferation,apoptosis inhibition,cell cycle progression,chromatin modification,cancer driver gene
ENSG00000094841,UPRT,genomic instability,pyrimidine salvage pathway,nucleotide pool regulation,dna synthesis and repair,mutational burden,tumor progression
ENSG00000188312,CENPP,kinetochore assembly,genomic instability,oncogene function,microtubule attachment,chromosome segregation,cell cycle regulation
ENSG00000276045,ORAI1,cell proliferation,calcium channel activation,nf-κb transcriptional activity,tumor progression,therapeutic target,inflammation regulation
ENSG00000057252,SOAT1,lipid metabolism regulation,tumor growth promotion,cell proliferation enhancement,therapeutic target,biomarker potential,genomic upregulation
ENSG00000094804,CDC6,genomic instability,dna replication licensing,cell cycle progression,cancer cell proliferation,oncogenic driver,cell division regulation
ENSG00000185721,DRG1,mirna processing,apoptosis regulation,cell proliferation modulation,splicing regulation,tumor suppression deficiency,tumorigenesis promotion
ENSG00000241935,HOGA1,dna damage response,genomic stability maintenance,homologous recombination repair,telomere stability regulation,p53 modulation,aneuploidy association
ENSG00000177947,ODF3,centriole duplication,chromosomal instability,cilia formation regulation,cell cycle regulation,tumor suppressor function,genomic stability maintenance
ENSG00000122550,KLHL7,tumor suppressor,nf-κb signaling pathway,ubiquitination and degradation,cell cycle regulation,apoptosis inhibition,epigenetic silencing
ENSG00000130695,CEP85,centrosome regulation,microtubule dynamics,genomic instability,chromosomal aberrations,aneuploidy driver,mitotic spindle assembly
ENSG00000106993,CDC37L1,hsp90 interaction,protein kinase activation,cell cycle progression,tumor progression,poor prognosis biomarker,cancer cell growth inhibition
ENSG00000139329,LUM,tumor suppressor,loss of function mutations,extracellular matrix modulation,integrin-mediated signaling inhibition,angiogenesis promotion,microenvironment suppression
ENSG00000112214,FHL5,nf-κb pathway regulation,cell cycle progression modulation,transcription factor interaction,tumor growth promotion,metastasis facilitation,cancer cell proliferation enhancement
ENSG00000128610,FEZF1,oncogenic transcription factor,cell cycle regulation,epithelial-to-mesenchymal transition (emt),prognostic marker,transcriptional regulation,co-regulator interaction
ENSG00000075240,GRAMD4,angiogenesis,cell proliferation,genomic amplification,membrane fusion,oncogenic driver,pi3k/akt signaling
ENSG00000087302,RTRAF,apoptosis regulation,oncogenic processes,nf-κb pathway modulation,tumor progression,cell survival enhancement,therapeutic target
,KARS,oncogene,translation regulation,cell proliferation,tumor progression,protein synthesis,cell growth
ENSG00000189120,SP6,transcriptional regulation,cell growth regulation,oncogenic potential,ccaat-binding activity,genomic binding,tumor suppressor role
ENSG00000243489,KRTAP10-11,keratin filament regulation,epithelial-to-mesenchymal transition,cytoskeleton modulation,cell migration promotion,tumor progression marker,prognostic indicator
ENSG00000101605,MYOM1,cell migration,oncogenesis,protein interaction,cell invasion,tumor progression,muscular structure
ENSG00000102021,LUZP4,cell proliferation regulation,apoptosis modulation,tumor progression promotion,emt regulation,protein interaction,transcriptional regulation
ENSG00000183214,MICA,immune evasion,tumor-associated antigen,nkg2d receptor activation,mhc class i expression,dysregulation,overexpression
ENSG00000119878,CRIPT,calpain pathway activation,constitutive activation,cell signaling modulation,cellular stress response regulation,oncogenic process promotion,therapeutic target
ENSG00000138449,SLC40A1,iron regulation,cellular iron homeostasis,dysregulated expression,tumor growth,oncogenic signaling pathways,enhanced cell proliferation
ENSG00000186393,KRT26,keratin expression,cytokeletal reorganization,tumor progression,metastasis initiation,cell survival modulation,cancer-related biomarkers
ENSG00000083093,PALB2,genomic instability,dna damage sensitivity,tumor suppressor function,genome stability regulation,homologous recombination,genetic alterations
ENSG00000164414,SLC35A1,glycosylation regulation,nucleotide-sugar transport,cellular integrity maintenance,oncogenesis implicated,tumor cell behavior modulation,therapeutic target prospect
ENSG00000158769,F11R,coagulation cascade,gain of function mutations,protease-activated receptors,tumor progression,angiogenesis,metastasis
ENSG00000100568,VTI1B,mtor pathway activation,oncogene function,calcium signaling regulation,cell migration modulation,tumor progression,poor prognosis biomarker
ENSG00000127452,FBXL12,scf complex interaction,substrate receptor function,cell cycle regulation,protein degradation pathway,genomic stability maintenance,tumor suppressor activity
ENSG00000064703,DDX20,genomic instability,dna damage response,cell cycle regulation,tumor progression,loss of function mutations,genetic alterations
ENSG00000178741,COX5A,cellular metabolism,glycolytic shift,mitochondrial biogenesis,aerobic glycosis,proliferation rates,energy production
,RARS,tumor progression,gain of function mutations,regulation of cell cycle,activation of upr,enhancement of cell survival,interaction with stress kinases
ENSG00000010292,NCAPD2,condensin complex formation,chromosome segregation,cell proliferation,genomic instability,apoptosis inhibition,g2/m checkpoint regulation
ENSG00000141753,IGFBP4,igf binding inhibition,tumor suppression loss,cell proliferation enhancement,epigenetic silencing,therapeutic target,tumorigenesis promotion
ENSG00000084112,SSH1,chromatin remodeling,transcriptional control,oncogenic pathway modulation,cell proliferation regulation,aberrant gene expression,protein-protein interactions
ENSG00000123992,DNPEP,tumor progression,cellular proliferation,metastasis suppression,angiogenesis regulation,immune evasion,proteolytic function
ENSG00000179564,LSMEM2,cell membrane organization,oncogenic transformation,cytoplasmic vesicle transport,cancer cell migration,cell proliferation regulation,protein-protein interaction
ENSG00000163539,CLASP2,microtubule dynamics regulation,mitotic spindle checkpoint disruption,genomic instability induction,cancer cell migration enhancement,tumor progression facilitation,poor prognosis association
ENSG00000171823,FBXL14,cell cycle regulation,gene expression regulation,protein degradation pathway,apoptosis inhibition,tumor progression,oncogenic process
ENSG00000162227,TAF6L,transcriptional regulation,cell proliferation,gene expression,transcription initiation complex,tumor development,overexpression
ENSG00000092140,G2E3,oncogenic driver,biomarker,cell proliferation regulator,interaction partner,prognostic indicator,unknown protein function
ENSG00000054654,SYNE2,epithelial-to-mesenchymal transition,prognostic biomarker,nuclear-cytoplasmic interaction,cytoskeletal component,tumor aggressiveness,cellular mechanoresponsiveness
ENSG00000067167,TRAM1,er stress regulation,apoptosis inhibition,tumor suppressor function loss,cellular survival enhancement,mitochondrial dysfunction,protein-protein interaction
ENSG00000143375,CGN,genomic instability,cell cycle regulation,transcriptional regulation,tumor suppressor function,oncogenic pathway activation,chromatin modification
ENSG00000145685,LHFPL2,wnt signaling pathway,dysregulation,cell growth regulation,apoptosis modulation,tumor progression,genomic instability
ENSG00000265107,GJA5,gap junctions,cell-cell communication,tumor progression,biomarker potential,metastasis suppression,electrolyte balance
ENSG00000168818,STX18,vesicle fusion,golgi apparatus localization,snare protein interaction,oncogenic transformation,cell proliferation regulation,tumorigenesis facilitation
ENSG00000108100,CCNY,cell cycle regulation,transcriptional modulation,protein-protein interactions,tumor aggressiveness,proliferation and survival,metastasis promotion
ENSG00000102317,RBM3,mrna stability regulation,oncogenic function,cellular adaptation to hypoxia,tumor growth promotion,chemotherapy resistance,gene expression modulation
ENSG00000243927,MRPS6,mitochondrial translation regulation,tumor progression,cell proliferation enhancement,anti-apoptotic mechanisms,prognostic marker,overexpression association
ENSG00000133119,RFC3,replication initiation,dna repair mechanisms,genotoxic stress resistance,tumor progression driver,therapeutic target,cell cycle regulation
ENSG00000186081,KRT5,epithelial differentiation,cell growth regulation,cytoskeleton maintenance,biomarker expression,tumor progression,mechanical stability loss
ENSG00000130707,ASS1,metabolic reprogramming,arginine accumulation,tumor microenvironment,urea cycle dysregulation,cell proliferation enhancement,prognostic biomarker
ENSG00000115648,MLPH,cell migration and invasion,genomic instability,tumor aggressiveness,plk1 interaction,melanosome transport,cell proliferation
ENSG00000118271,TTR,tumor suppression,genomic stability,wnt/β-catenin pathway regulation,thyroid hormone transport,protein-protein interactions,altered expression levels
ENSG00000116741,RGS2,tumor suppressor function,regulator of g-protein signaling,cell proliferation regulation,pi3k/akt pathway modulation,g-protein coupled receptor interaction,poor prognosis association
ENSG00000054356,PTPRN,cell signaling modulation,tumor progression driver,pi3k/akt pathway regulation,transmembrane protein function,oncogenic pathway activation,cell survival and proliferation enhancement
ENSG00000110514,MADD,jnk signaling pathway,apoptosis regulation,cell survival mechanisms,tumor suppressor function,bh3-only protein interaction,stress response activation
ENSG00000186792,HYAL3,extracellular matrix remodeling,oncogenic role,ha degradation,cell migration facilitation,tumor progression facilitation,cancer aggressiveness promoter
ENSG00000138942,RNF185,ubiquitination regulation,tumor suppressor function,genomic instability,dna damage response,protein degradation pathway disruption,oncogenic protein stabilization
ENSG00000091428,RAPGEF4,rap gtpase activation,cell adhesion regulation,tumor progression,cancer driver gene,growth factor signaling,cell proliferation
ENSG00000120733,KDM3B,histone demethylation,chromatin regulation,cell proliferation,genome stability,malignant transformation,epigenetic modification
ENSG00000163714,U2SURP,altered gene expression,alternative splicing regulation,cancer cell proliferation,genomic instability,rna processing dysregulation,spliceosome complex interaction
ENSG00000167755,KLK6,oncogene activation,tumor invasion and metastasis,extracellular matrix degradation,pi3k/akt pathway interaction,protein-protein interaction,cellular proliferation enhancement
ENSG00000075891,PAX2,transcriptional regulation,constitutive activation,pi3k/akt pathway interaction,loss of cellular differentiation,oncogenic transformation,chromosomal instability
ENSG00000168876,ANKRD49,tumor progression,cell proliferation,transcriptional regulation,protein stabilization,biomarker potential,apoptosis evasion
ENSG00000230907,FKBPL,cellular proliferation,apoptosis inhibition,oncogene role,transcriptional regulation,mdm2 interaction,poor prognosis
ENSG00000143183,TMCO1,cell cycle regulation,dysregulated protein stability,tumor suppressor degradation,oncogenic kinase activation,protein localization modulation,mitotic progression enhancement
ENSG00000205581,HMGN1,chromatin remodeling,transcriptional regulation,oncogenic processes,histone h3 interaction,aggressive disease progression,poor prognosis
ENSG00000169908,TM4SF1,tumor progression,cell adhesion,metastasis,oncogene,prognostic marker,cell migration
ENSG00000013573,DDX11,genomic instability,chromosomal segregation,cell division regulation,oncogenic mutation,tumor aggressiveness,genomic replication
ENSG00000139926,FRMD6,actin cytoskeleton regulation,oncogenic signaling,cell invasion and metastasis,pi3k/akt pathway interaction,tumor progression,cancer cell migration
ENSG00000115593,SMYD1,histone modification,tumor progression,cell proliferation,transcriptional regulation,protein-protein interactions,therapeutic resistance
ENSG00000078140,UBE2K,regulatory function of protein stability,ubiquitination pathway modulation,protein degradation enhancement,tumor suppressor degradation,dna repair impairment,cellular response regulation
ENSG00000090104,RGS1,g-protein coupled receptor signaling,tumor suppressor function,negative regulator of g-protein signaling,cell proliferation regulation,survival pathway modulation,regulatory protein interactions
ENSG00000139625,MAP3K12,activation of nf-κb and ap-1 transcription factors,promotion of epithelial-to-mesenchymal transition (emt),regulation of cell growth,survival,and migration,interaction with downstream targets mekk4
ENSG00000205279,CTXN3,transcriptional regulation,chromatin remodeling,oncogenic driver,cell proliferation,aggressive tumor behavior,poor prognosis
ENSG00000140750,ARHGAP17,rho gtpase activation,mitochondrial localization,cancer progression,cell migration regulation,tumor growth promotion,therapeutic target
ENSG00000148943,LIN7C,cellular organization,regulation of adhesion,epithelial-to-mesenchymal transition (emt),protein-protein interaction,rho gtpase regulation,cancer progression
ENSG00000168938,PPIC,protein regulation,cellular stress response,oncogene function,cancer development,therapeutic target,genetic instability
ENSG00000108557,RAI1,tumor progression,genomic instability,transcriptional regulation,apoptosis suppression,cell proliferation enhancement,metastasis promotion
ENSG00000153046,CDYL,histone modification regulation,chromatin remodeling,epigenetic regulation,transcriptional modulation,genomic instability,cancer cell proliferation
ENSG00000266028,SRGAP2,microtubule dynamics,oncogenic properties,cell proliferation,migration regulation,cytoskeletal organization,apoptosis regulation
ENSG00000107554,DNMBP,emt process,cell adhesion regulation,mutation associated,protein-protein interaction,signaling pathway modulation,cancer progression marker
ENSG00000186487,MYT1L,transcriptional regulation,tumor suppression,cellular differentiation,apoptosis evasion,epigenetic modification,chromatin remodeling
ENSG00000215114,UBXN2B,proteostasis regulation,cell cycle progression,genome stability maintenance,tumor suppressor degradation,p97-ubxd8 complex interaction,oncogenic signaling pathway activation
ENSG00000164080,RAD54L2,genomic instability,dna repair mechanisms,homologous recombination repair,telomere maintenance,oncogenic potential,tumor progression
,MARCH2,ubiquitin ligase activity,tumor suppressor regulation,protein stabilization,oncogenic pathway modulation,cell growth regulation,apoptosis inhibition
ENSG00000168517,HEXIM2,cell cycle regulation,transcriptional repression,apoptosis evasion,protein-protein interaction,rna polymerase ii regulation,tumor suppressor function
ENSG00000068697,LAPTM4A,lipid metabolism,endocytosis regulation,tumor progression,biomarker candidate,prognostic marker,lipid signaling pathway alterations
ENSG00000087338,GMCL1,oncogenesis,cell proliferation,protein glycosylation,tumor progression,adhesion and migration,n-glycan biosynthesis
ENSG00000165553,NGB,ion homeostasis regulation,overexpression or mutation,cellular behavior changes,increased metastatic potential,therapeutic target,metabolic regulation
ENSG00000177791,MYOZ1,tumor promoter,epithelial-to-mesenchymal transition regulator,apoptosis resistance enhancer,emt pathway activator,cytoskeletal dynamics regulator,prognostic marker
ENSG00000102572,STK24,cell proliferation,tumor progression,genomic stability,spindle checkpoint,mitosis regulation,kinase activity
ENSG00000163681,SLMAP,regulation of htra1,cell growth regulation,aberrant expression,protein-protein interaction,tumor progression,cellular homeostasis
ENSG00000179456,ZBTB18,chromatin remodeling,tumor suppressor,oncogene function,cellular proliferation regulation,epigenetic regulation,pi3k/akt pathway modulation
ENSG00000151715,TMEM45B,autophagy regulation,cellular stress response,tumor suppressor function,genetic mutations,protein-protein interactions,mitochondrial dysfunction
ENSG00000108878,CACNG1,neuronal excitability,calcium influx regulation,epithelial-to-mesenchymal transition promotion,pi3k/akt pathway modulation,oncogenic mutations,cell proliferation enhancement
ENSG00000186812,ZNF397,epigenetic regulation,chromatin remodeling,tumor suppressor function,cell proliferation regulation,apoptosis modulation,transcriptional regulation
ENSG00000170832,USP32,oncoprotein regulation,cell proliferation enhancement,ubiquitin-proteasome pathway modulation,protein stability regulation,dna repair dysregulation,tumor metastasis promotion
ENSG00000105327,BBC3,tumor suppressor function,gain of function mutations,cell death regulation,p53 pathway interaction,pro-apoptotic activity,tumorigenesis suppression
ENSG00000204390,HSPA1L,cellular homeostasis,molecular chaperone function,protein quality control,cell cycle regulation,stress response pathway,autophagy regulation
ENSG00000101746,NOL4,nucleolar protein,ribosome biogenesis regulation,oncogene overexpression,cell growth promotion,rna processing modulation,tumor suppressor gene interaction
ENSG00000174446,SNAPC5,spliceosome assembly,aberrant splicing,cellular proliferation,tumor progression,therapeutic target,cancer driver gene
ENSG00000104980,TIMM44,mitochondrial dynamics,signaling pathway regulation,overexpression,energy metabolism,oncogenic mechanism,pi3k/akt interaction
ENSG00000258839,MC1R,signaling pathway deregulation,constitutive activation,cell survival enhancement,tumor growth promotion,genetic mutation association,molecular interaction modification
ENSG00000170262,MRAP,mc1r pathway regulation,oncogenic signaling,tumor progression,cellular proliferation,apoptosis resistance,signaling regulatory function
ENSG00000054938,CHRDL2,hedgehog signaling pathway,tumor suppressor function,oncogene activity,regulatory mechanism disruption,cell growth promotion,protein-protein interaction
ENSG00000137822,TUBGCP4,microtubule dynamics,chromosomal instability,aneuploidy,genomic instability,tumor progression,kinase regulation
ENSG00000170477,KRT4,keratin expression,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),cellular structure alteration,tumor aggressiveness promotion,stratified squamous epithelia marker
ENSG00000167766,ZNF83,transcriptional regulation,cellular proliferation,zinc finger domain,oncogenic function,gene overexpression,tumor progression
ENSG00000124092,CTCFL,cell cycle regulation,transcriptional activation,oncogene role,tumor growth promotion,metastasis facilitation,poor prognosis biomarker
ENSG00000178896,EXOSC4,exosome complex regulation,microrna processing,apoptosis regulation,cell cycle progression,genomic instability,oncogenic pathway activation
ENSG00000105290,APLP1,aplp1 overexpression,pi3k/akt pathway activation,tumor progression,metastasis,lipid metabolism dysregulation,calcium homeostasis disruption
ENSG00000144619,CNTN4,cell migration,tumor progression,angiogenesis,epithelial-to-mesenchymal transition,overexpression,axonal growth
ENSG00000132874,SLC14A2,altered expression,carbonic anhydrase activity,cellular metabolism,ph regulation,renal function alteration,tumor aggressiveness
ENSG00000159840,ZYX,oncogenic potential,tumor invasion,cytoskeleton dynamics,cell migration,prognostic marker,metastasis regulation
ENSG00000149257,SERPINH1,protein folding regulation,microenvironment modulation,cell proliferation enhancement,tumor invasion facilitation,pi3k/akt pathway interaction,oncogenic protein accumulation
ENSG00000206177,HBM,angiogenesis promotion,extracellular matrix degradation,growth factor regulation,tumor invasion and metastasis,poor prognosis marker,cancer progression facilitation
ENSG00000196565,HBG2,tumor metabolism,energy production,angiogenesis modulation,cell proliferation,deregulated expression,metabolic regulation
ENSG00000129250,KIF1C,centrosomal instability,chromosomal abnormalities,microtubule dynamics,cell migration,protein interaction,tumor progression
ENSG00000118518,RNF146,ubiquitin-proteasome system regulation,oncogenic protein degradation,cell cycle progression,tumor suppression,dna repair,protein-protein interaction
ENSG00000105048,TNNT1,cellular proliferation,muscle contraction regulation,skeletal muscle function,upregulation in cancer,prognostic marker potential,therapeutic target
ENSG00000133083,DCLK1,wnt/β-catenin signaling,oncogene,metastasis promoter,cell cycle regulation,microtubule dynamics,epithelial-to-mesenchymal transition
ENSG00000139514,SLC7A1,metabolic regulation,cell proliferation,tumor progression,oncogenic driver,protein-protein interaction,genomic upregulation
ENSG00000149357,LAMTOR1,mtor pathway regulation,autophagy inhibition,nutrient sensing regulation,cell growth promotion,cancer driver protein,oncogenic process enhancement
ENSG00000168765,GSTM4,oxidative stress regulation,detoxification process,cellular protection,cancer susceptibility,genetic variability,none
ENSG00000101349,PAK5,oncogenic signaling,kinase activation,cell motility regulation,nf-κb regulation,limk1/cofilin pathway activation,transcriptional modulation
ENSG00000197930,ERO1A,oncogenic potential,protein-protein interactions,endoplasmic reticulum stress,tumor progression,cell cycle regulation,mitochondrial dysfunction
ENSG00000277424,HMOX2,antioxidant defense mechanism,tumor suppressive role,cellular detoxification,oxidative stress regulation,heme metabolism,tissue-specific expression
ENSG00000131475,VPS25,escrt complex regulation,multivesicular body sorting,protein degradation dysregulation,tumorigenesis driver,cellular homeostasis disruption,endosomal trafficking modulation
ENSG00000115685,PPP1R7,cell cycle regulation,apoptosis regulation,oncogenesis,protein phosphatase regulation,substrate recognition,cytoplasmic localization
ENSG00000147533,GOLGA7,golgin protein function,mitotic spindle regulation,cellular trafficking modulation,cancer cell growth promotion,apoptosis regulation,hippo signaling pathway dysregulation
ENSG00000173542,MOB1B,hippo pathway regulation,cell survival promotion,cell proliferation enhancement,tumor aggressiveness marker,gene overexpression in kirc,apoptosis modulation
ENSG00000187514,PTMA,tumor progression,metastasis,transcriptional regulation,apoptosis regulation,cancer prognosis,promoter methylation
ENSG00000204979,MS4A13,cell surface expression,immune response modulation,upregulated expression,tumor progression association,signaling pathway interaction,oncogenic potential
ENSG00000213390,ARHGAP19,pi3k/akt pathway modulation,rho gtpase regulation,cell migration facilitation,tumor progression enhancement,overexpression association,oncogenic properties promotion
ENSG00000138785,INTS12,dna damage response,chromatin remodeling,cell cycle regulation,apoptosis modulation,tumor suppressor function,transcriptional regulation
ENSG00000181374,CCL13,tumor microenvironment modulation,angiogenesis promotion,immune suppression,cell migration regulation,prognostic marker,therapeutic target
ENSG00000108774,RAB5C,endocytic pathway regulation,oncogene activation,cell proliferation promotion,receptor-mediated endocytosis modulation,biomarker candidate,cancer progression correlation
ENSG00000138592,USP8,tumor progression,cell proliferation,akt signaling,pi3k/akt pathway,deubiquitinating enzyme,therapeutic target
ENSG00000130511,SSBP4,genomic instability,cell proliferation regulation,dna damage response,brca1/atm interaction,chromosomal instability,tumor progression
ENSG00000134323,MYCN,chromatin remodeling,tumor suppressor repression,cell growth promotion,oncogenic transformation,transcriptional regulation,epigenetic dysregulation
ENSG00000205084,TMEM231,adhesion disruption,emt regulation,invasiveness enhancement,metastasis promotion,n-cadherin/e-cadherin interaction,tumor progression marker
ENSG00000204852,TCTN1,wnt/β-catenin signaling,overexpression,poor prognosis,cell proliferation,metastasis,oncogenic driver
ENSG00000153044,CENPH,kinetochore assembly,aneuploidy,genetic instability,mitotic spindle regulation,tumor growth enhancement,chromosomal segregation dysfunction
ENSG00000083844,ZNF264,tumor suppressor function,transcriptional regulation,cell cycle progression modulation,apoptosis regulation,chromatin remodeling,histone-modifying enzyme interaction
ENSG00000116679,IVNS1ABP,cell adhesion,epithelial-to-mesenchymal transition,protein-protein interaction,cell migration,signaling pathway modulation,tumor progression
ENSG00000087076,HSD17B14,tumor progression,oncogenic processes,biomarker,lipid metabolism dysregulation,hormone regulation alteration,steroid hydroxylation enzyme activity
ENSG00000154305,MIA3,protein degradation,cell survival,apoptosis inhibition,angiogenesis promotion,metastasis,ubiquitin-proteasome pathway
ENSG00000167377,ZNF23,transcriptional repression,oncogene,dna binding,cell proliferation,genomic instability,tumor progression
ENSG00000105379,ETFB,mitochondrial function,metabolic regulation,electron transfer,glycolytic shift,warburg effect,cellular metabolism
ENSG00000078304,PPP2R5C,regulatory subunit,cell cycle regulation,apoptosis regulation,oncogenic signaling pathway,phosphatase activation,genomic instability
ENSG00000146950,SHROOM2,microtubule dynamics,cell cycle progression,pi3k/akt signaling,oncogene function,tumor aggressiveness,biomarker potential
ENSG00000186501,TMEM222,tumor progression,cell signaling modulation,overexpression,membrane-bound compartment formation,lipid raft interaction,cellular integrity maintenance
ENSG00000101150,TPD52L2,tumor suppressor function,cell cycle regulation,apoptosis modulation,mitotic spindle formation,cancer driver gene candidate,genomic instability mediator
ENSG00000124006,OBSL1,pi3k/akt pathway modulation,cell proliferation enhancement,ciliogenesis regulation,centrosome stability maintenance,metastasis promotion,oncogenic protein interaction
ENSG00000092036,HAUS4,centrosome amplification,chromosomal instability,cell cycle regulation,microtubule dynamics,oncogenesis,tumor progression
ENSG00000184515,BEX5,oncogene function,cell growth regulation,apoptosis inhibition,cell survival enhancement,protein overexpression,genomic upregulation
ENSG00000154839,SKA1,genomic instability,overexpression,prognostic marker,tumor aggressiveness,cell proliferation,mitotic regulation
ENSG00000110148,CCKBR,cholecystokinin signaling pathway,g protein-coupled receptor function,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,poor prognosis marker,therapeutic target potential
ENSG00000182667,NTM,transcriptional regulation,chromatin remodeling,cell growth regulation,oncogenic transformation,epigenetic modification,tumor progression
ENSG00000176083,ZNF683,zinc finger protein activation,transcription factor regulation,cell proliferation enhancement,gene expression modulation,oncogenesis involvement,tumor suppressor interaction
ENSG00000142920,AZIN2,genomic instability,dna repair mechanism,transcriptional regulation,chromatin remodeling,cell proliferation driver,oncogenic signaling pathway
ENSG00000143450,OAZ3,transcriptional regulation,cellular proliferation,tumor suppressor functions,mutations driving oncogenesis,cell growth regulation,therapeutic target
ENSG00000113068,PFDN1,cell cycle regulation,protein folding chaperone,oncogene overexpression,tumor progression marker,molecular chaperone function,protein aggregation prevention
ENSG00000215305,VPS16,constitutive activation,disrupted protein trafficking,enhanced cell survival,endosomal sorting dysregulation,pi3k/akt/mtor signaling cascade,autophagy modulation
ENSG00000139719,VPS33A,late endosome trafficking,tumor progression,cell survival enhancement,therapeutic target,prognostic marker,signaling pathway interaction
ENSG00000100934,SEC23A,cellular export,copii complex component,protein secretion,oncogenesis promotion,tumor progression marker,therapeutic target
ENSG00000119042,SATB2,enhancer binding,epithelial-to-mesenchymal transition,chromatin remodeling,tumor progression,gene expression regulation,overexpression
ENSG00000186814,ZSCAN30,tumor growth promotion,transcription factor regulation,cell cycle progression enhancement,apoptosis inhibition,epigenetic modification interaction,prognostic biomarker status
ENSG00000066735,KIF26A,mitotic spindle assembly,microtubule dynamics disruption,cell migration and invasion enhancement,chromosomal instability promotion,apoptosis inhibition,protein-protein interaction modulation
ENSG00000139131,YARS2,mitochondrial function,cellular metabolism,oncogenic driver,tumor growth promotion,energy metabolism disruption,tumor suppressor interaction
ENSG00000126860,EVI2A,apoptosis regulation,chromatin remodeling,oncogenic driver,cell proliferation promotion,transcriptional modulation,zinc finger protein activity
ENSG00000283727,KIR2DS4,nk cell suppression,immune evasion,tumor progression,co-expression with inhibitory receptors,signaling pathway activation,cell survival promotion
ENSG00000130544,ZNF557,transcriptional regulation,oncogenesis driver,cell proliferation enhancer,dna binding specificity,chromatin remodeling mediator,histone modification interaction
ENSG00000230900,ATP6V1G2,proton pumping,tumor progression,cell proliferation,metastasis,oncogenic driver,therapeutic target
ENSG00000178719,GRINA,rho gef activity,tumor progression,enhanced cell migration,oncogenic signaling,aberrant rac1 activation,cytoskeleton regulation
ENSG00000188243,COMMD6,cellular regulation,tumor suppressor function,protein interaction modulation,oncogenic pathway inhibition,apoptosis regulation,genetic mutation impact
ENSG00000059804,SLC2A3,glut3,glucose metabolism,oncogenic function,warburg effect,therapeutic target,tumor progression
ENSG00000046774,MAGEC2,tumor progression,cellular proliferation,transcriptional regulation,testicular expression,protein-protein interaction,oncogene upregulation
ENSG00000132603,NIP7,genome instability,tumor suppressor function,nuclear localization,cellular response to dna damage,oncogenic process promotion,dna repair regulation
ENSG00000285132,CTSB,proteolytic activity,tumor progression,lysosomal function,apoptosis regulation,immune evasion,biomarker potential
ENSG00000185862,EVI2B,transcriptional regulator,cell cycle progression,chromatin remodeling,epigenetic regulation,zinc finger protein,gene expression modulation
ENSG00000136048,DRAM1,apoptosis regulation,autophagy modulation,cellular stress response,dna repair dysregulation,genome instability,oncogenic driver
ENSG00000186925,KRTAP19-6,cellular signaling pathways,oncogene activation,overexpression,metastasis,cell proliferation,apoptosis
ENSG00000120725,SIL1,mitochondrial function regulation,tumor suppressor activity,cell proliferation regulation,antioxidant response modulation,oncogenic mutation driver,apoptosis pathway interaction
ENSG00000099795,NDUFB7,oxidative phosphorylation,electron transport chain disruption,mitochondrial function integrity,energy metabolism alteration,tumorigenesis promotion,reactive oxygen species production
ENSG00000197808,ZNF461,genomic instability,cellular stress response,transcriptional regulation,oncogenic function,protein-protein interactions,tumor progression
ENSG00000272333,KMT2B,chromatin regulation,histone modification,genome instability,tumor suppressor function,epigenetic dysregulation,oncogenic transformation
ENSG00000168002,POLR2G,transcriptional regulation,oncogenic transcription factor,cell proliferation,rna processing,therapeutic target,tumor aggressiveness
ENSG00000165795,NDRG2,dna damage response,tumor suppressor function,oxidative stress protection,pi3k/akt pathway regulation,cancer progression,genetic mutation
ENSG00000112531,QKI,tumor suppressor,alternative splicing regulation,apoptosis modulation,cell cycle regulation,dysregulated expression,kidney cancer progression
ENSG00000126003,PLAGL2,transcriptional regulation,oncogenic function,cellular metabolism modulation,proliferation promotion,tumor progression association,prognostic biomarker
ENSG00000141425,RPRD1A,genomic instability,homologous recombination repair (hrr),dna damage response,tumor progression,oncogenic transformation,genomic stability
ENSG00000130520,LSM4,genomic instability,cell proliferation regulation,apoptosis modulation,transcriptional regulation,pre-mrna splicing,proliferation factor
ENSG00000111358,GTF2H3,transcription initiation,disrupted gene regulation,tumor progression,dna repair mechanisms,kinase activity,cell cycle control
ENSG00000136824,SMC2,cell cycle regulation,chromatin organization,genomic stability,dna repair mechanisms,tumor suppressor activity,genomic instability
ENSG00000164076,CAMKV,pi3k/akt pathway regulation,cellular proliferation enhancement,tumor progression facilitation,cancer driver gene potential,cell survival pathway modulation,kinase activity maintenance
ENSG00000151353,TMEM18,cellular trafficking regulation,tumor suppressor pathway suppression,promotes tumorigenesis,enhances cell proliferation,interacts with pi3k/akt/mtor axis,regulates emt related genes
ENSG00000168314,MOBP,myelin regulation,tumor progression,metastasis regulator,cytoskeleton interaction,cell adhesion modifier,protein-protein interaction
ENSG00000188155,KRTAP10-6,hypoxia responsive,cell proliferation enhancement,epithelial-to-mesenchymal transition regulation,pi3k/akt signaling pathway modulation,poor prognosis biomarker,upregulated expression
ENSG00000114395,CYB561D2,nadph oxidase system activation,reactive oxygen species generation,cellular metabolism modulation,tumor progression promotion,apoptosis suppression,angiogenesis enhancement
ENSG00000119318,RAD23B,dna damage response,genomic instability,cell cycle regulation,protein degradation pathway,aneuploidy,homologous recombination repair
ENSG00000153130,SCOC,tumor progression,metastasis promotion,cancer-related protein interactions,sigaling pathway regulation,cell adhesion modulation,oncogenic function
ENSG00000264522,OTUD7B,ubiquitin-proteasome regulation,tumor suppressor function,cell survival enhancement,protein stability modulation,genomic integrity maintenance,stress response regulation
ENSG00000186106,ANKRD46,tumor suppression,chromosome 16q22.1 locus,cell cycle regulation,anti-apoptotic activity,dna damage response,methylated gene expression
ENSG00000112357,PEX7,peroxisome function,oncogenic pathway activation,metabolic reprogramming,cell signaling alteration,tumor growth promotion,cancer cell metabolism modification
ENSG00000105518,TMEM205,tumor suppressor function,epithelial-to-mesenchymal transition,cell-cell adhesion disruption,loss of expression,cancer progression regulation,apoptosis inhibition
ENSG00000145794,MEGF10,cellular interaction,tumor suppression,anti-proliferation mechanisms,protein-protein interactions,tissue-specific expression,survival pathway regulation
ENSG00000180530,NRIP1,regulatory imbalance,transcriptional regulation,nuclear receptor interaction,oncogenic potential,tumor progression driver,cell proliferation modulation
ENSG00000070759,TESK2,microtubule regulation,cell migration,protein kinase activity,tumor progression,cancer metastasis,cell invasion
ENSG00000144824,PHLDB2,oncogene function,transcriptional regulation,cell cycle progression,apoptosis suppression,tumor growth promotion,protein-protein interaction
ENSG00000156966,B3GNT7,n-glycosylation regulation,oncogenic potential,cell migration facilitation,glycoprotein modification,aberrant hybrid-type n-glycan production,metastatic potential enhancement
ENSG00000132718,SYT11,cellular proliferation,stress response modulation,cancer development association,signaling pathway interaction,nervous system expression,proliferation promotion
ENSG00000101883,RHOXF1,tumor progression,oncogene potential,cell proliferation,metastasis promotion,protein-protein interaction,poor prognosis marker
ENSG00000155792,DEPTOR,mtor hyperactivation,cellular proliferation,protein synthesis regulation,oncogenic process,tumor growth,metabolic dysregulation
ENSG00000138101,DTNB,cell surface protein,tumor progression,angiogenesis regulation,peptide degradation,immune evasion,cell migration
ENSG00000171522,PTGER4,**
cell migration,cell proliferation,g protein-coupled receptor,inflammation regulation,prostaglandin e2 binding,signal transduction pathway **
ENSG00000064545,TMEM161A,calcium influx modulation,cell signaling pathway regulation,apoptosis resistance,tumor progression,stress response regulation,signaling pathway interaction
ENSG00000185019,UBOX5,oncogenic function,tumor progression,protein degradation regulation,cellular stress response modulation,signaling pathway modulation,genomic overexpression
ENSG00000020181,ADGRA2,cellular signaling modulation,tumor progression,angiogenesis regulation,metastasis promotion,cancer development association,gpcr interaction
ENSG00000163395,IGFN1,igf-1 signaling pathway,oncogenic activation,overexpression-driven growth,tumor progression facilitation,metastatic potential enhancement,chemotherapy resistance promotion
ENSG00000143355,LHX9,transcriptional regulator,cell cycle progression,overexpression association,tumor aggressiveness,cell proliferation regulation,genomic disruption
ENSG00000155666,KDM8,chromatin modification,histone demethylation,transcriptional regulation,oncogenic potential,cell cycle progression,apoptosis suppression
ENSG00000169241,SLC50A1,mitochondrial function regulation,redox balance modulation,manganese ion transport,cellular proliferation enhancement,tumor microenvironment remodeling,cancer progression promotion
ENSG00000079616,KIF22,cell proliferation,genomic instability,microtubule-based transport,spindle assembly,oncogenesis,chromosome segregation
ENSG00000173559,NABP1,apoptosis regulation,chromatin remodeling,gene expression regulation,histone modification,nuclear protein binding,oncogenic driver
ENSG00000258890,CEP95,microtubule dynamics,cell proliferation,tumor progression,centrosomal regulation,microtubule stabilization,protein interaction
ENSG00000183486,MX2,wnt/β-catenin pathway,cell adhesion,tumor progression,metastasis driver,emt regulator,therapeutic target
ENSG00000164107,HAND2,cell proliferation,transcriptional activation,tumor progression,oncogenic potential,gene overexpression,poor prognosis
,SEPT11,cell cycle regulation,septin family member,mitotic progression,cancer metastasis,mitotic checkpoint regulation,gtp-binding protein activity
ENSG00000115194,SLC30A3,zinc transporter function,cellular zinc regulation,oncogenic process,tumor aggressiveness marker,metabolic regulation,transcriptional modulation
ENSG00000196586,MYO6,actin cytoskeleton regulation,motor protein activity,cell migration promotion,endocytosis regulation,pi3k/akt pathway interaction,tumor progression enhancement
ENSG00000100554,ATP6V1D,tumor progression,oncogenic role,metabolic regulation,lysosomal function,ph homeostasis disruption,genomic instability
ENSG00000204936,CD177,overexpression,pi3k/akt pathway interaction,angiogenesis promotion,metastasis facilitation,poor prognosis marker,immune modulation
ENSG00000134207,SYT6,cell migration,genomic instability,membrane trafficking regulation,oncogenic pathway interaction,tumor progression promotion,calcium-dependent exocytosis
ENSG00000172336,POP7,mitotic spindle assembly,chromosomal instability,cell division regulation,tumor progression,tumor suppressor function,aneuploidy
ENSG00000138035,PNPT1,constitutive activation,rna processing regulation,cellular proliferation,metabolic reprogramming,oncogene function,genomic dysregulation
ENSG00000163374,YY1AP1,pi3k/akt pathway modulation,tumor progression enhancement,transcription factor regulation,oncogenic process promotion,therapeutic target,cellular response dysregulation
ENSG00000281484,BTG3,apoptosis induction,cell cycle regulation,cyclin-dependent kinase inhibitor,histone modification,protein-protein interaction,tumor suppressor function
ENSG00000076321,KLHL20,regulation of e3 ubiquitin ligases,cell cycle progression,tumor suppressor function loss,transcriptional regulation,signaling pathway modulation,oncogenic mutations
ENSG00000108439,PNPO,aberrant metabolism,angiogenesis stimulation,cellular proliferation,cancer resistance,metabolic regulation,protein expression
ENSG00000181817,LSM10,spliceosome regulation,alternative splicing disruption,tumor progression marker,snrnp biogenesis,nuclear localization,protein-protein interaction
ENSG00000212901,KRTAP3-1,upregulation,oncogenic role,tumor progression,metastasis,epigenetic alteration,proliferation
ENSG00000068323,TFE3,tfe3 rearrangement,epithelial cell differentiation,transcriptional regulation,mitochondrial biogenesis,cell proliferation,autophagic flux
ENSG00000078674,PCM1,microtubule dynamics,centrosome regulation,genomic instability,tumor progression,oncogenic protein interactions,cancer therapeutic target
ENSG00000163322,ABRAXAS1,genomic instability,abraxas 1 complex,tumor suppressor function,dna damage response pathway,cell cycle regulation,brca1-a complex interaction
ENSG00000142507,PSMB6,proteasome subunit,tumor progression,apoptosis evasion,cell cycle regulation,oncogenic process,therapeutic target
ENSG00000112335,SNX3,endosomal trafficking regulation,tumor progression marker,cellular homeostasis disruption,autophagy dysregulation,apoptosis suppression,protein mislocalization
ENSG00000137501,SYTL2,overexpression,cancer progression,cell proliferation,cell migration,actin cytoskeleton regulation,calcium-dependent exocytosis
ENSG00000282175,HNRNPCL1,aberrant splicing,altered pre-mrna processing,cellular homeostasis,heterogeneous nuclear ribonucleoprotein complex (hnrnp),pre-mrna regulation,tumorigenesis
ENSG00000154548,SRSF12,aberrant splicing,cell proliferation,enhanced metastasis,oncogenic driver,rna processing regulation,splicing factor overexpression
ENSG00000111775,COX6A1,mitochondrial function,electron transport chain,warburg effect regulation,cell proliferation enhancement,prognostic biomarker,pi3k/akt pathway interaction
ENSG00000115541,HSPE1,cellular metabolism regulation,mitochondrial function maintenance,protein aggregation prevention,tumor progression promotion,therapeutic target identification,biomarker significance
ENSG00000198130,HIBCH,regulation of cellular energy metabolism,interference with autophagy,oncogenic driver gene,metabolic reprogramming,enzymatic activity,overexpression correlation
ENSG00000172667,ZMAT3,tumor suppressor activity,dna repair regulation,cell cycle progression modulation,apoptosis regulation,protein stability modulation,genome integrity maintenance
ENSG00000110917,MLEC,adam metalloprotease activity,glomerular filtration barrier maintenance,cell migration regulation,adhesion modulation,cancer cell invasion promotion,metastasis facilitation
ENSG00000163527,STT3B,protein synthesis regulation,cell proliferation driver,constitutive activation,translation initiation complex,oncogenic protein kinase,unfolded protein response
ENSG00000133422,MORC2,chromatin remodeling,telomere maintenance,dna repair,genomic stability,atpase activity,non-homologous end joining
ENSG00000116191,RALGPS2,oncogenic driver,epithelial-to-mesenchymal transition (emt),endocytic trafficking,ral gtpase regulation,metastasis promoter,autophagy regulation
ENSG00000083635,NUFIP1,tumor progression,poly(a)-binding protein interaction,mrna stabilization,cell growth regulation,oncogenic mrna regulation,cancer prognosis
ENSG00000117174,ZNHIT6,histone methylation,epigenetic silencing,oncogenic function,tumor progression,stemness maintenance,wnt/β-catenin pathway regulation
ENSG00000165643,SOHLH1,transcription factor activity,cell cycle regulation,apoptosis regulation,oncogenesis promotion,poor prognosis marker,overexpression association
ENSG00000244474,UGT1A4,glucuronidation,chemotherapy resistance,drug metabolism modulation,tumor progression correlation,enzyme-drug interaction,gene expression alteration
ENSG00000241119,UGT1A9,metabolic regulation,detoxification pathway,toxicity reduction,apoptosis modulation,cell growth regulation,xenobiotic conjugation
ENSG00000188167,TMPPE,iron metabolism regulation,hepcidin production modulation,cell growth promotion,tumor progression influence,protein interaction dysregulation,genetic mutations association
ENSG00000196313,POM121,nucleocytoplasmic transport,oncoprotein overexpression,cell proliferation enhancement,tumor progression,therapeutic resistance,prognostic significance
ENSG00000099341,PSMD8,proteasome regulation,ubiquitin-proteasome pathway,protein degradation,cellular homeostasis,oncogenic process,tumor progression
ENSG00000158234,FAIM,apoptosis regulation,pi3k/akt/mtor pathway activation,oncogenic potential,biomarker expression,cell survival enhancement,protein-protein interaction
ENSG00000142528,ZNF473,tumor progression,epigenetic regulation,transcriptional regulator,oncogene activation,cell proliferation,prognostic biomarker
ENSG00000198832,SELENOM,redox regulation,tumor growth,apoptosis resistance,oxidative stress response,selenocysteine incorporation,antioxidant defense mechanism
ENSG00000172493,AFF1,mll complex interaction,oncogene function,cell cycle regulation,histone modification,chromatin remodeling,pi3k/akt pathway involvement
ENSG00000167034,NKX3-1,transcriptional regulation,tumor suppressor function,cell proliferation regulation,apoptosis regulation,homeobox-containing gene,renal tissue specificity
ENSG00000160908,ZNF394,transcriptional regulator,epigenetic regulation,oncogene function,cell proliferation regulation,chromatin modification,prognostic biomarker
ENSG00000072080,SPP2,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),serine protease activity,cell migration enhancement,invasion promotion,prognostic biomarker
ENSG00000145244,CORIN,loss of function mutation,cell proliferation,signaling pathway activation,electrolyte balance regulation,tumor progression,metastasis
ENSG00000198324,PHETA1,chromatin regulation,tumor suppressor function,epigenetic processes,cell cycle progression,dysregulation in kirc,proliferation pathways
ENSG00000104043,ATP8B4,lipid metabolism regulation,oncogene potential,cell membrane fluidity modulation,overexpression in cancer tissues,potential therapeutic target,interaction with abc transporters and kinases
ENSG00000112697,TMEM30A,p53 regulation,tumor suppressor dysfunction,genomic instability,oncogenesis facilitation,cellular response modulation,therapeutic target exploration
ENSG00000081923,ATP8B1,efflux transporter,cellular lipid metabolism,tumor lipid regulation,lipid-dependent tumorigenesis,cholesterol homeostasis,cancer cell membrane transport
ENSG00000124406,ATP8A1,aberrant lipid metabolism,membrane trafficking,cellular membrane maintenance,therapeutic resistance,ion homeostasis regulation,overexpression
ENSG00000288146,NOC4L,chromatin regulation,dna damage response,transcriptional regulation,tumor progression,cellular proliferation,a chromatin remodeling complex
ENSG00000114023,FAM162A,cellular signaling pathway,cancer associated overexpression,protein-protein interaction,potential oncogene,tumor progression marker,cancer associated prognosis
ENSG00000288283,RFX1,tumor growth,cell proliferation,epithelial-to-mesenchymal transition,dna damage response,genomic instability,transcription factor regulation
ENSG00000285199,CIDEB,apoptosis inhibition,mitochondrial regulation,tumor progression,cell proliferation enhancement,genomic amplification,cancer promoter
ENSG00000187026,KRTAP21-2,keratin-associated protein,overexpression in cancer,tumor progression,cellular proliferation,apoptosis regulation,protein-protein interaction
ENSG00000136205,TNS3,tension family member,actin cytoskeleton regulation,cell migration and invasion,adherens junction degradation,epithelial-to-mesenchymal transition (emt),e3 ubiquitin ligase activity
ENSG00000163624,CDS1,genetic instability,dna repair mechanisms,cell proliferation checkpoint disruption,tumor progression facilitation,uncontrolled growth promotion,dna replication regulation
ENSG00000047249,ATP6V1H,v-atpase assembly,tumor growth promotion,acidic extracellular environment,cellular ph regulation,ion homeostasis modulation,angiogenesis facilitation
ENSG00000144648,ACKR2,tumor-promoting activity,immune evasion strategies,glycoprotein degradation,chemokine regulation,cellular migration and invasion,tumor microenvironment modulation
ENSG00000135436,FAM186B,protein degradation,ubiquitination pathway,cell cycle regulation,proliferation control,cancer development,oncogenic potential
ENSG00000146094,DOK3,rtk signaling pathway modulation,cell proliferation promotion,tumor progression facilitation,therapeutic target identification,oncogene function,angiogenesis regulation
ENSG00000157593,SLC35B2,glycosylation pathway regulation,tumor progression,cell proliferation,survival and migration,prognostic marker,therapeutic target
ENSG00000128578,STRIP2,apoptosis disruption,cellular trafficking regulation,golgi apparatus formation,mutations associated with tumor progression,protein expression alterations,secretory pathway dysregulation
ENSG00000154723,ATP5PF,mitochondrial biogenesis,oncogenic mutations,tumor metabolism,atp synthesis regulation,cellular energy homeostasis alteration,oxidative phosphorylation dependency
ENSG00000152455,SUV39H2,chromatin modification,histone methylation,epigenetic regulation,genome stability,apoptosis resistance,dna repair pathway interaction
ENSG00000137720,C11orf1,genomic instability,oncogene,dna repair modulation,cell survival enhancement,therapeutic target,tumorigenic potential
ENSG00000121361,KCNJ8,potassium channel regulation,ion flux disruption,cellular energy metabolism,pi3k/akt pathway interaction,oncogenic process involvement,tumor progression
ENSG00000170961,HAS2,angiogenesis,cell proliferation,glycosaminoglycan production,metastasis promotion,tumor growth enhancement,tumor progression
ENSG00000119715,ESRRB,estrogen-related receptor,transcriptional regulation,cell growth promotion,tumor progression association,prognostic marker candidate,signaling pathway modulation
ENSG00000142453,CARM1,oncogene activation,transcriptional regulation,histone modification,cell cycle progression,apoptosis suppression,metastasis promotion
ENSG00000104883,PEX11G,lipid metabolic regulation,peroxisomal biogenesis,cellular homeostasis disruption,fatty acid metabolism alteration,cancer development contribution,indirect oncogenic role
ENSG00000160932,LY6E,cell adhesion regulation,oncogene role,overexpression in tumors,tumor aggressiveness,protein-protein interactions,signal transduction modulation
ENSG00000148483,TMEM236,transmembrane protein,cellular transport regulation,altered expression in cancer,cellular ion balance regulation,potential oncogene,oncogenic pathways interaction
ENSG00000070501,POLB,genomic instability,base excision repair,dna damage response,tumor promotion,cell survival mechanism,dna polymerization
ENSG00000079263,SP140,nf-κb regulation,tumor progression,cellular proliferation,survival signaling,potential oncogene,transcriptional modulation
ENSG00000164620,RELL2,nuclear receptor coactivator,cell cycle regulation,e3 ubiquitin ligase activity,tumorigenesis driver,proteasomal degradation regulator,gene expression modulation
ENSG00000151320,AKAP6,akap-mediated anchoring,cell migration enhancement,cancer metastasis promotion,pi3k/akt pathway interaction,prognostic marker identification,signaling pathway modulation
ENSG00000214114,MYCBP,myc signaling pathway,oncogene activation,cell proliferation regulation,transcriptional modulation,tumor progression facilitation,gene expression dysregulation
ENSG00000149571,KIRREL3,cell-cell interactions,epithelial polarity,tumor suppression,cancer progression,apoptotic signaling pathways,metastasis
ENSG00000131711,MAP1B,microtubule regulation,oncogenic properties,cell proliferation promotion,apoptosis inhibition,therapeutic target,genomic amplification
ENSG00000265763,ZNF488,tumor suppressor function,dna-binding activity,transcriptional regulation,epigenetic modulation,poor prognosis association,agrresive disease behavior
ENSG00000171503,ETFDH,cellular metabolism disruption,dna replication stress,loss of function mutations,nucleotide diphosphate kinase regulation,oxidative damage,redox balance alteration
ENSG00000172602,RND1,rho family gtpase activation,microtubule dynamics regulation,tumor invasion promotion,cell migration enhancement,metastasis facilitation,cytoskeleton remodeling
ENSG00000144228,SPOPL,genomic instability,cell proliferation,oncogene overexpression,spindle formation regulation,centrosome maturation,dna damage response
ENSG00000139174,PRICKLE1,transcriptional regulation,tumorigenesis promoter,cell proliferation enhancer,apoptosis evasion,oncogenic driver interaction,poor prognosis marker
ENSG00000230034,PSMB8,apoptosis resistance,cell cycle progression,protein degradation regulation,ubiquitin-proteasome pathway,tumor development,therapeutic target
ENSG00000102309,PIN4,genomic instability,tumor suppressor dysfunction,chromosomal segregation disruption,kinase activity regulation,mitotic checkpoint regulation,cancer cell proliferation
ENSG00000088808,PPP1R13B,constitutive activation,dna damage response regulation,mutational hotspot,cell survival modulation,protein phosphatase 1 regulation,tumor progression
ENSG00000099219,ERMP1,tumor suppression,cell proliferation regulation,protein degradation regulation,vesicular transport regulation,akt/mtor pathway interaction,oncogene overexpression
ENSG00000119508,NR4A3,nr4a3 signaling pathway,tumor progression,transcriptional regulation,cancer stem cells,cell differentiation,poor prognosis
ENSG00000133315,MACROD1,macrodomain function,chromatin remodeling,genomic instability,dna repair regulation,p53 pathway modulation,cellular proliferation
ENSG00000122952,ZWINT,cell cycle regulation,tumor aggressiveness,genomic instability,mitotic checkpoint dysfunction,spindle checkpoint disruption,cancer prognosis
ENSG00000112130,RNF8,genomic instability,tumor progression,dna damage response,ubiquitination regulation,brca interaction,cell cycle control
ENSG00000256812,CAPNS2,calpain activation,protein degradation,oncogenic function,apoptosis regulation,tumor progression,cancer metastasis
ENSG00000166311,SMPD1,sphingolipid metabolism,cancer cell apoptosis,tumor progression,cell cycle regulation,therapeutic target,genomic overexpression
ENSG00000081721,DUSP12,erk1/2 activation,mapk signaling pathway,cell proliferation regulation,oncogenesis promotion,poor prognosis marker,epithelial-to-mesenchymal transition facilitation
ENSG00000262334,RPH3AL,rab gtpase regulation,vesicular transport,oncogene function,tumor growth promotion,metastasis enhancement,pi3k/akt signaling pathway interaction
ENSG00000060566,CREB3L3,er stress response,transcriptional regulation,tumorigenesis driver,cell survival pathway,protein folding regulation,chaperone function
ENSG00000215717,TMEM167B,ion transport regulation,tumor progression association,oncogenic process modulation,cellular stress response,transmembrane protein function,pi3k/akt pathway interaction
ENSG00000173113,TRMT112,polyamine biosynthesis,oncogene activation,growth promotion,therapeutic target,cell proliferation enhancement,apoptosis inhibition
ENSG00000284850,DCP1B,mrna stability regulation,cell proliferation enhancement,metabolic reprogramming,tumor progression association,prognostic marker potential,oncogenic function
ENSG00000105723,GSK3A,wnt signaling pathway,tumor suppressor activity,cell proliferation regulation,apoptosis inhibition,glycogen metabolism regulation,protein kinase activation
ENSG00000145779,TNFAIP8,tnf-alpha signaling pathway,inflammation regulation,cell proliferation,metastasis facilitation,anti-apoptotic mechanisms,chromatin modification
ENSG00000159882,ZNF230,tumor suppressor function disruption,cell proliferation regulation,apoptosis modulation,transcriptional regulation,oncogene potential,genomic instability
ENSG00000159228,CBR1,polyamine catabolism,cellular proliferation,metabolic regulation,apoptosis modulation,spermidine metabolism alteration,tumor progression
ENSG00000285302,CHMP4A,autophagy promotion,tumor progression marker,protein degradation regulation,endosomal vesicle assembly,chromatin remodeling regulation,transcriptional control enhancement
ENSG00000173457,PPP1R14B,dephosphorylation regulation,apoptosis inhibition,cell cycle progression,tumor growth promotion,oncogenic signaling,protein phosphatase regulation
ENSG00000174586,ZNF497,transcriptional regulation,chromatin modulation,apoptosis inhibition,cell proliferation enhancement,metastasis promotion,prognostic marker
ENSG00000143889,HNRNPLL,rna processing regulation,pre-mrna splicing modulation,polyadenylation and export regulation,oncogenic pathway regulation,tumor suppressor gene suppression,anti-apoptotic function enhancement
ENSG00000113811,SELENOK,redox regulation,oxidative stress protection,tumor progression involvement,genomic stability maintenance,cell growth modulation,dna damage repair interaction
ENSG00000134571,MYBPC3,oncogene overexpression,cell migration,metastasis promotion,poor prognosis,tumor progression,actin-myosin interaction
ENSG00000120049,KCNIP2,cellular regulation,oncogene function,mapk/erk pathway regulation,tumor progression promotion,prognostic marker,signaling pathway interaction
ENSG00000132879,FBXO44,tumor progression,cell cycle regulation,cul1-skp1-f-box complex interaction,protein ubiquitination,overexpression,scf e3 ligase function
ENSG00000129255,MPDU1,glycosylation pathway,altered expression,tumorigenesis,cellular proliferation,dysregulated metabolism,oncogenic changes
ENSG00000140939,NOL3,oncogene activation,overexpression,poor prognosis,rna processing,ribosome biogenesis,pi3k/akt pathway interaction
ENSG00000026652,AGPAT4,lipid biosynthesis,cell proliferation,oncogenic protein interaction,tumor progression,lipid metabolism regulation,phosphatidic acid synthesis
ENSG00000255009,UBTFL1,genomic instability,cell cycle progression,apoptosis modulation,ubiquitination pathway regulation,dna damage response regulation,tumor biomarker
ENSG00000095261,PSMD5,transcription factor stabilization,genomic instability,dna repair mechanisms,tumor progression,apoptosis regulation,proteasome function
ENSG00000105520,PLPPR2,lipid metabolism regulation,pi3k/akt pathway modulation,oncogenic potential,tumor microenvironment modulation,cell growth promotion,cancer progression facilitation
ENSG00000122862,SRGN,oncogene activity,epithelial-to-mesenchymal transition,cell adhesion molecule regulation,tumor aggressiveness,cancer cell migration,metastasis promotion
ENSG00000106258,CYP3A5,metabolism modulation,chemotherapy resistance,redox regulation,antioxidant defense,xenobiotic metabolism,drug-drug interaction
ENSG00000166347,CYB5A,mitochondrial dysfunction,electron transfer reactions,redox balance regulation,epigenetic regulation,tumor suppressor gene silencing,oncogene activation
,ZNRD1,genomic stability,deubiquitinating enzyme,cell cycle regulation,dna repair,chromatin remodeling,oncogenesis
ENSG00000182606,TRAK1,microtubule-dependent vesicle transport,cell migration,cytoskeletal dynamics,rho gtpase interaction,pi3k/akt pathway regulation,therapeutic target
ENSG00000101751,POLI,genome instability,replication error repair,dna damage response,tumor suppressor function,cell cycle regulation,defective dna polymerase activity
ENSG00000263761,GDF2,**
 oncogene/tumor suppressor,cell proliferation,angiogenesis,embryonic development,immune response regulation,apoptosis inhibition
**
ENSG00000119392,GLE1,nuclear function,mrna export regulation,protein synthesis regulation,tumor progression,cell proliferation promotion,apoptosis evasion
ENSG00000153086,ACMSD,metabolic regulation,tyrosine catabolism,homogentisic acid production,cancer metabolism,tumor growth,cell proliferation
ENSG00000147894,C9orf72,aberrant expression,oncogenesis,tumor growth,cell survival,metabolic regulation,overexpression
ENSG00000025772,TOMM34,mitochondrial function,cellular proliferation,transcriptional regulation,protein importation,cancer cell migration,mitochondrial assembly
ENSG00000143178,TBX19,transcriptional regulation,cell proliferation,t-box domain,oncogenesis,dna binding,gene expression
ENSG00000143367,TUFT1,cellular energy metabolism,mitochondrial localization,oncogenic pathway interaction,protein-protein interaction,tumor progression association,regulation of cellular proliferation
ENSG00000115956,PLEK,pleiotropic effects,amplification hotspot,cell migration regulator,metastasis promoter,tumor aggressiveness enhancer,prognostic marker
ENSG00000068383,INPP5A,phosphoinositide phosphorylation,oncogenesis,protein kinase activation,tumor suppressor function,pi3k/akt pathway regulation,cellular signaling disruption
ENSG00000283024,ATAD1,mitochondrial function regulation,genomic instability promotion,cell proliferation driver,oncogene activation,dna replication regulation,apoptosis resistance induction
ENSG00000146215,CRIP3,microtubule stabilization,cellular integrity maintenance,epithelial-to-mesenchymal transition,cancer stem cell maintenance,tumor progression facilitation,poor prognosis association
ENSG00000206527,HACD2,fatty acid metabolism regulation,oncogenic lipid synthesis,cellular proliferation promotion,apoptosis resistance,angiogenesis facilitation,signaling pathway modulation
ENSG00000144468,RHBDD1,regulation of wnt/β-catenin pathway,role in tumor progression,intramembrane serine protease function,interactions with notch receptors,cancer-associated mutations,therapeutic target
ENSG00000147383,NSDHL,histone demethylation,cell cycle progression,chromatin remodeling,apoptosis suppression,tumor aggressiveness,genomic instability
ENSG00000052802,MSMO1,detoxification,genomic instability,dna damage repair pathways,tumor suppressor activity,metabolic regulation changes,cell cycle dysregulation
ENSG00000282230,ADAM9,tumor aggressiveness,extracellular matrix degradation,cell migration,signaling pathway activation,oncogenic processes,prognostic marker
ENSG00000134775,FHOD3,transcriptional activation,tumor progression,epithelial-to-mesenchymal transition (emt),metastasis,prognostic marker,pi3k/akt pathway interaction
ENSG00000107745,MICU1,**

mitochondrial calcium regulation,enhanced glycolysis,oncogenic adaptation,cell proliferation,mitochondrial dynamics,tumor metabolism
**
ENSG00000156026,MCU,mitochondrial membrane potential,calcium homeostasis regulation,oxidative phosphorylation promotion,therapeutic target,metabolic regulation enhancement,cellular stress response modulation
ENSG00000134030,CTIF,mtor pathway regulation,translation initiation factor,cell cycle progression,oncogenic function,tumor progression,poor prognosis
ENSG00000258947,TUBB3,**

microtubule stabilization,cell proliferation enhancement,oncogenic function,chemotherapy resistance,neuronal differentiation support,tumor growth promotion

**
ENSG00000123999,INHA,inhibin regulation,fsh suppression,tumor suppression,immune modulation,reproductive hormone regulation,granulosa cell function
ENSG00000080371,RAB21,tumor progression,epithelial-to-mesenchymal transition (emt),cell invasion,dna damage response modulation,prognostic marker,cancer cell migration
ENSG00000145692,BHMT,methionine cycle regulation,cell growth promotion,one-carbon metabolism,dna methylation,tumorigenic potential alteration,mitochondrial enzyme function
ENSG00000101333,PLCB4,phospholipase c activity,protein kinase activation,signaling pathway activation,cell proliferation promotion,tumor progression association,therapeutic target
ENSG00000149100,EIF3M,eif3 complex regulation,gene amplification,protein synthesis regulation,tumor progression,metabolic reprogramming,mtor signaling pathway
ENSG00000160075,SSU72,constitutive activation,oncogene role,transcriptional regulation,cell cycle progression,apoptosis inhibition,protein-protein interaction
ENSG00000101972,STAG2,genomic instability,aneuploidy,chromosome segregation,cell division regulation,tumor suppressor function,prognostic marker
ENSG00000154930,ACSS1,histone acetylation,chromatin remodeling,loss of function mutations,epigenetic regulation,oncogene activation,cellular proliferation
ENSG00000163577,EIF5A2,**
hyperactive translation,mtor pathway activation,hif-1α regulation,poor prognosis,oncogenic driver,metastatic promotion
**
ENSG00000127884,ECHS1,mitochondrial dysfunction,altered cellular metabolism,glycolytic reprogramming,genomic instability,dna damage response,cancer cell metabolism
ENSG00000122417,ODF2L,microtubule regulation,tumor progression,therapeutic target,cellular migration,cancer prognosis,apoptosis induction
ENSG00000163209,SPRR3,overexpression,cellular proliferation,pi3k/akt pathway interaction,tumor progression,oncogene activity,biomarker potential
ENSG00000147206,NXF3,chromatin remodeling,transcription regulation,cell cycle progression,dna repair regulation,cancer development association,prognosis impact
ENSG00000101888,NXT2,cellular proliferation,genome stability regulation,rna splicing regulation,tumor progression,molecular interaction,nuclear localization
ENSG00000206280,ZBTB22,transcriptional regulation,chromatin remodeling,cell growth regulation,tumor progression,oncogene activation,transcriptional repressor
ENSG00000147586,MRPS28,mitochondrial translation,dysregulated metabolism,energy production regulation,cellular proliferation enhancement,oncogenic process activation,therapeutic target
ENSG00000132612,VPS4A,endosomal recycling pathway,escrt complex regulation,ubiquitinated protein scission,tumorigenesis associated,cellular growth modulation,protein degradation regulation
ENSG00000151413,NUBPL,nucleosome assembly,chromatin remodeling,epigenetic regulation,genomic instability,oncogenic processes,therapeutic target
ENSG00000102978,POLR2C,transcriptional regulation,constitutive activation,tumor progression,metastasis,oncogenic gene expression,chromatin modification
ENSG00000156384,SFR1,proteasome regulation,cell growth regulation,tumor suppressor regulation,oncogenic potential,cellular stress response,ubiquitin-proteasome pathway
ENSG00000005075,POLR2J,transcriptional elongation,cell proliferation,oncogenic processes,cell survival,genomic instability,poor prognosis marker
ENSG00000089169,RPH3A,cell cycle regulation,oncogenesis,protein-protein interaction,pi3k/akt pathway,cell proliferation,gtpase activity
ENSG00000255221,CARD17,necroptosis inhibition,apoptosis modulation,tumor progression,cell survival enhancement,immune evasion,protein-protein interaction
ENSG00000105649,RAB3A,endocytic pathway regulation,gtpase activity,metastasis promotion,oncogenic protein interaction,pi3k/akt pathway activation,tumor progression
ENSG00000167779,IGFBP6,igf signaling inhibition,tumor suppression,cell proliferation inhibition,apoptosis induction,angiogenesis regulation,metastasis promotion
ENSG00000142252,GEMIN7,apc/c regulation,aneuploidy,cell cycle disruption,genomic instability,oncogenic process,tumor suppressor dysfunction
ENSG00000206208,TAPBP,peptide loading,antigen presentation,immune regulation,mhc class i assembly,cell surface transport,cancer immunoediting
ENSG00000112242,E2F3,cell cycle regulation,transcriptional activation,dna replication,oncogenic driver,therapeutic target,epigenetic regulation
ENSG00000186965,KRTAP19-2,keratin filament regulation,aberrant expression,tumor progression,epithelial cell disruption,cell morphology alteration,adhesion and migration changes
ENSG00000179912,R3HDM2,tumor suppressor function,ubiquitination pathway involvement,protein-protein interaction regulation,transcriptional regulation,cellular degradation process,potential oncogenic consequences
ENSG00000168101,NUDT16L1,chromosomal instability,genomic integrity maintenance,dna repair mechanism alteration,oxidative stress regulation,biomarker potential,nucleotide metabolism regulation
ENSG00000138604,GLCE,lipid metabolism,oncogenic process,metabolic reprogramming,cellular proliferation,enzyme dysregulation,glycolytic phenotype
ENSG00000113209,PCDHB5,cell adhesion,dysregulated expression,tumor suppressor,cellular behavior regulation,signaling pathway interaction,cancer progression
ENSG00000136267,DGKB,cytosolic enzyme,detoxification pathway,tumor microenvironment,oxidative stress response,genetic regulation,variability in expression levels
ENSG00000266967,AARSD1,translation initiation enhancement,protein synthesis upregulation,ribosome biogenesis modulation,cell proliferation promotion,oncogenic potential,tumor progression association
ENSG00000108825,PTGES3L-AARSD1,tumor growth enhancement,angiogenesis promotion,metastasis facilitation,cell proliferation regulation,survival pathway modulation,transmembrane domain interaction
ENSG00000112499,SLC22A2,tumor progression,apoptosis regulation,drug resistance,cellular uptake enhancement,pi3k/akt pathway modulation,oncogenic overexpression
ENSG00000170633,RNF34,tumor suppression,ubiquitination pathway,oncogenic protein accumulation,pi3k/akt pathway regulation,wnt/β-catenin pathway modulation,nf-κb pathway activation
ENSG00000176087,SLC35A4,glycosylation regulation,tumor suppressor,overexpressed,immune evasion,nucleotide transport,poor prognosis
ENSG00000171396,KRTAP4-4,keratin-associated protein function,gain of function mutation,cell differentiation regulation,oncogenic process promotion,cell morphology alteration,biomarker potential
ENSG00000105419,MEIS3,transcriptional regulation,cell differentiation,oncogenic processes,tumor progression,angiogenesis promotion,genetic amplification
ENSG00000163125,RPRD2,tumor suppressor function,regulation of cell growth and proliferation,interaction with pi3k/akt pathway,histone modification and chromatin remodeling,reduced expression levels associated with poorer prognosis,chromatin structure regulation
ENSG00000158850,B4GALT3,cell surface protein modulation,constitutive activation,glycoprotein synthesis regulation,cell proliferation promotion,tumor aggressiveness association,therapeutic target identification
ENSG00000007237,GAS7,cytoskeleton regulation,stress granule formation,cellular morphology alteration,tumor progression,protein synthesis regulation,cell survival enhancement
ENSG00000092850,TEKT2,microtubule regulation,cell cycle modulation,autophagic flux regulation,genomic instability,mitotic progression,kinase-phosphatase interaction
ENSG00000143702,CEP170,chromosomal instability,microtubule organization,cell proliferation enhancement,apoptosis resistance,tumor growth promotion,genomic integrity maintenance
ENSG00000129295,LRRC6,oncogene,transmembrane protein,cell migration regulation,adhesion modulation,metastasis promotion,epigenetic regulation
ENSG00000117597,UTP25,spliceosomal component,alternative splicing,genetic mutations,cellular differentiation,tumor suppression,regulatory element
ENSG00000204897,KRT25,er stress response,cellular adaptation,apoptosis resistance,signaling pathway modulation,keratin overexpression,tumor progression
ENSG00000173928,SWSAP1,oncogenic properties,cell cycle regulation,tumor suppressor degradation,ubiquitination complex interaction,pi3k/akt pathway modulation,poor prognosis marker
ENSG00000214941,ZSWIM7,transcriptional regulator,overexpression,tumor progression,cell proliferation,apoptosis suppression,dna repair regulation
ENSG00000113732,ATP6V0E1,glycolysis,oncogene,metabolic regulation,therapeutic target,proton pumping,cellular ph homeostasis
ENSG00000173221,GLRX,oncogenic stress response,reactive oxygen species regulation,nf-κb pathway activation,cell proliferation enhancement,biomarker function,redox balance maintenance
ENSG00000166012,TAF1D,transcription factor regulation,genomic stability,oncogene regulation,tumor suppressor interaction,epigenetic modification,chromatin remodeling
ENSG00000107938,EDRF1,tumor suppressor function,cell growth regulation,apoptosis promotion,pi3k/akt pathway interaction,oncogene overexpression,cancer progression facilitation
ENSG00000173418,NAA20,tumor progression,cell proliferation,protein stability,apoptosis regulation,signaling pathway modulation,therapeutic target
ENSG00000236424,TSPY10,pi3k/akt signaling,chromatin remodeling,gene amplification,oncogenic function,cell proliferation enhancement,swi/snf complex interaction
ENSG00000130844,ZNF331,transcriptional regulation,epigenetic modification,tumor suppression,dna binding activity,cell cycle regulation,apoptosis regulation
ENSG00000152433,ZNF547,transcriptional regulation,cell proliferation,tumor metastasis,biomarker potential,poor prognosis,apoptosis regulation
ENSG00000204178,MACO1,mitochondrial metabolism,glycolysis reprogramming,warburg effect,cell proliferation inhibition,apoptosis induction,therapeutic target
ENSG00000146143,PRIM2,genetic instability,dna replication,biomarker potential,apoptosis regulation,tumor progression,therapeutic resistance
ENSG00000198056,PRIM1,dna replication,genomic instability,high expression levels,poor prognosis,tumor growth,potential therapeutic target
ENSG00000186226,LCE1E,lipid metabolism regulation,cell proliferation enhancement,differentiation suppression,oncogenic protein interaction,tumor progression association,biomarker potential
ENSG00000104853,CLPTM1,chromatin remodeling,transcriptional regulation,dna damage response,tumor progression,promoter binding,therapeutic target
ENSG00000244025,KRTAP19-3,keratin-associated protein,epithelial integrity,cell adhesion,epithelial-to-mesenchymal transition (emt),cellular morphology,adhesion properties
ENSG00000157741,UBN2,ubiquitination pathway regulation,tumor progression,oncogenic process,cell cycle regulation,apoptosis regulation,molecular interaction
ENSG00000100084,HIRA,dna repair regulation,transcriptional regulation,chromatin remodeling,oxidative stress response,histone modification,protein-protein interactions
ENSG00000276781,CHGA,oncogene activation,chromogranin a overexpression,cytokine secretion enhancement,growth factor regulation alteration,transcriptional regulation disruption,cellular migration promotion
ENSG00000050344,NFE2L3,transcription factor regulation,oncogenic activity,antioxidant response modulation,metabolic reprogramming,tumor progression promotion,hif-1α pathway interaction
ENSG00000101473,ACOT8,lipid metabolism regulation,gain of function mutations,constitutive activation,overexpression biomarker,cell survival promotion,pi3k/akt pathway modulation
ENSG00000197892,KIF13B,microtubule interaction,cell migration promotion,chemoresistance induction,protein kinase regulation,apoptosis evasion,cytoskeleton dynamics modulation
ENSG00000171224,FAM241B,chromatin remodeling,genome stability,cell proliferation regulation,apoptosis modulation,tumorigenesis contribution,gene expression regulation
ENSG00000165810,BTNL9,tumor suppressor function,immunomodulation,tcr signaling regulation,immune evasion,oncogenic progression,cancer immunotherapy
ENSG00000154814,OXNAD1,lipid metabolism regulation,pi3k/akt pathway activation,growth factor regulation,tumor progression,cell survival enhancement,amplification/overexpression
ENSG00000163171,CDC42EP3,cellular migration,constitutive activation,cell proliferation,cytoplasmic signaling,tumor invasion,epithelial adhesion
ENSG00000162373,BEND5,chromatin regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic stability maintenance,transcriptional regulation
ENSG00000115808,STRN,pi3k/akt signaling pathway regulation,nuclear envelope organization,cell proliferation promotion,survival enhancement,oncogenic role,signaling pathway modulation
ENSG00000164626,KCNK5,potassium channel regulation,cell proliferation modulation,apoptosis regulation,tumor growth promotion,hypoxia response,stem cell-like properties modulation
ENSG00000080845,DLGAP4,tumor progression,cell-cell adhesion disruption,metastasis facilitation,tumor suppressor function,cancer cell migration promotion,cell membrane trafficking regulation
ENSG00000003056,M6PR,lysosomal targeting,autophagy regulation,igf-ii interaction,pi3k/akt activation,tumor growth promotion,poor prognosis marker
ENSG00000163029,SMC6,genomic instability,chromosome condensation,cell cycle regulation,cohesin complex component,telomere maintenance,meiotic recombination
ENSG00000007384,RHBDF1,egfr activation,cell proliferation,oncogene function,tumor progression,phosphatidylinositol 3-kinase signaling,protein kinase b signaling
ENSG00000160218,TRAPPC10,trapp complex regulation,tumor progression,cell proliferation enhancement,autophagy activation,ubiquitin-proteasome pathway modulation,oncogenic mutation
ENSG00000099917,MED15,aberrant expression,cancer driver gene,cell proliferation,genomic instability,oncogenic potential,transcriptional regulation
ENSG00000117472,TSPAN1,tumor progression,cell migration,epithelial-to-mesenchymal transition,pi3k/akt signaling,cancer stem cells,tetraspanin function
ENSG00000126233,SLURP1,protein-lipid interaction,immune modulation,tumor progression,cell adhesion alteration,apoptosis evasion,cancer prognosis
ENSG00000179941,BBS10,ciliary dysfunction,hedgehog signaling pathway,cell polarity regulation,tumor progression,therapeutic target,genomic instability
ENSG00000283153,FRG1,oncogenesis,transcriptional regulator,overexpression,cell growth regulation,tumor progression,protein-protein interaction
ENSG00000185049,NELFA,transcriptional regulation,alternative splicing,oncogenic reprogramming,tumor suppressor gene repression,cell proliferation,apoptosis evasion
ENSG00000136630,HLX,cell cycle regulation,transcription factor activity,tumor progression,apoptosis evasion,emt facilitation,hematopoiesis regulatory function
ENSG00000132434,LANCL2,energy metabolism regulation,glycolysis enhancement,oxidative phosphorylation modulation,tumor progression promotion,cell migration facilitation,therapeutic target candidate
ENSG00000148606,POLR3A,constitutive activation,genomic instability,tumor progression,cell proliferation,transcriptional regulation,protein-protein interaction
ENSG00000032742,IFT88,ciliary dysfunction,cell growth regulation,tumor suppressor function,wnt/β-catenin pathway interaction,mitotic spindle formation,rna processing regulation
ENSG00000138002,IFT172,cilia assembly,intraflagellar transport,retrograde transport,tumor suppressor,dysregulation of cell growth,cellular stress response
ENSG00000163320,CGGBP1,cggbp1,gain-of-function mutations,telomere maintenance,genome instability,dna repair pathways,oncogenesis
ENSG00000160194,NDUFV3,mitochondrial function,electron transport chain,energy production,cell respiration,rapid growth,tumor progression
ENSG00000150347,ARID5B,transcriptional regulation,chromatin remodeling,oncogenic driver,tumor suppressor dysfunction,genomic instability,microrna regulation
ENSG00000164024,METAP1,proteolytic regulation,tumor progression,cellular invasion,metastasis promotion,therapeutic target,protein degradation
ENSG00000237155,IER3,cellular response regulation,transcriptional co-activation,oncogenic process promotion,tumor progression association,poor prognosis marker,cellular stress regulation
ENSG00000187010,RHD,tumor evasion,immune suppression,tumor progression,downregulation expression,red blood cell recognition,immune modulation
ENSG00000125148,MT2A,mitochondrial metabolism,redox balance regulation,oxidative stress protection,cell survival enhancement,metabolic reprogramming,apoptosis modulation
ENSG00000284967,FDFT1,mevalonate pathway,cell proliferation,tumor progression,cancer metabolism,therapeutic target,cholesterol biosynthesis
ENSG00000078808,SDF4,cell proliferation regulation,calcium ion homeostasis disruption,tumor progression association,metastasis promotion,oncogene function,cell survival pathway modulation
ENSG00000167791,CABP2,cell cycle progression,oncogene,transcriptional regulation,tumor progression,poor prognosis,genomic instability
ENSG00000167674,HDGFL2,dipeptidyl-peptidase activity,cell migration facilitation,metastasis promotion,protein degradation regulation,signal transduction modulation,tumor progression association
ENSG00000109118,PHF12,chromatin remodeling,transcriptional regulation,oncogene overexpression,tumor suppressor gene repression,histone modification,nuclear protein function
ENSG00000135127,BICDL1,apoptosis inhibition,tumor progression,prognostic marker,genomic amplification,anti-apoptotic pathway,cell cycle regulation
ENSG00000156738,MS4A1,oncogenic potential,tumor progression,cell proliferation enhancement,immune modulation disruption,prognostic biomarker candidate,signaling pathway regulation
ENSG00000144057,ST6GAL2,tumor-associated carbohydrate antigens (tacas),glycosylation regulation,cell adhesion modulation,enhanced metastatic potential,resistance to chemotherapy,prognostic biomarker
ENSG00000168778,TCTN2,cell migration,planar cell polarity,metastasis promoter,tumor aggressiveness,prognostic marker,cell invasion
ENSG00000065665,SEC61A2,er translocon function,protein folding regulation,tumor promotion,cell proliferation facilitation,poor prognosis marker,apoptosis inhibition
ENSG00000168724,DNAJC21,cellular chaperone,protein degradation regulation,tumor progression,apoptosis inhibition,oncoprotein stabilization,signaling pathway modulation
ENSG00000118420,UBE3D,protein degradation regulation,tumor suppressor targeting,e3 ubiquitin ligase activity,ring domain interaction,transcriptional regulation,chromatin remodeling
ENSG00000281191,KRTAP5-3,keratin filament formation,epithelial cell regulation,cancer-associated overexpression,cell growth regulation,dysregulation,epithelial-to-mesenchymal transition
ENSG00000166669,ATF7IP2,pi3k/akt signaling pathway modulation,tumor progression facilitation,gene expression regulation,transcriptional regulator function,oncogene/tumor suppressor activity,cellular proliferation promotion
ENSG00000160606,TLCD1,cell cycle regulation,apoptosis regulation,tumor suppression,dna repair mechanisms,cell growth modulation,genomic stability maintenance
ENSG00000090372,STRN4,microtubule dynamics,cell migration,metastasis,tumor progression,oncogenic process,protein-protein interaction
ENSG00000182628,SKA2,mitotic checkpoint regulation,oncogene overexpression,cell proliferation enhancement,cell survival promotion,genomic amplification,protein-protein interaction
ENSG00000239857,GET4,tumor progression,cell migration,ubiquitination regulation,molecular interaction,oncogene association,proliferation regulation
ENSG00000205155,PSENEN,gamma-secretase activity,notch signaling modulation,prognostic marker,tumor progression promoter,apoptosis regulation,cell proliferation enhancement
ENSG00000161217,PCYT1A,cell proliferation,tumor progression,genomic instability,ctp biosynthesis,cellular metabolism,oncogenic pathway interaction
ENSG00000128829,EIF2AK4,perk/eif2α/atf4 pathway,constitutive activation,cellular adaptation to stress,apoptosis resistance,protein synthesis regulation,genomic instability
ENSG00000156284,CLDN8,cellular polarity disruption,tight junction dysregulation,epithelial-to-mesenchymal transition (emt),oncogenic signaling activation,prognostic marker,cancer cell migration and invasion
,PQLC2,protein palmitoylation,cellular growth regulation,oncogenic properties,signaling pathway activation,aberrant expression mutations,regulation of cell proliferation
ENSG00000041802,LSG1,histone demethylation,chromatin remodeling,cell proliferation,tumor growth,biomarker potential,therapeutic target
ENSG00000128534,LSM8,genome instability,apoptosis regulation,splicing regulation,dna repair modulation,cell cycle regulation,tumor suppressor activity
,MARCH5,ubiquitination regulation,e3 ubiquitin ligase activity,tumor progression promoter,apoptosis modulation,cancer development associated,metastasis enhancer
ENSG00000142546,NOSIP,**

nitric oxide regulation,oncogenic driver,tumor angiogenesis,overexpression,cell proliferation,signal transduction
ENSG00000099625,CBARP,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis evasion,oncogenic activation,pro-survival signaling
ENSG00000102312,PORCN,wnt/β-catenin pathway,gain of function mutations,tumor progression,protein modification,cell proliferation,signaling pathway regulation
ENSG00000187391,MAGI2,epithelial-to-mesenchymal transition,overexpression,biomarker candidate,cell adhesion regulation,tumor suppressor protein interaction,apoptosis regulation
ENSG00000085662,AKR1B1,oxidative stress reduction,cell survival promotion,antioxidant properties,tumor growth facilitation,chemotherapy resistance contribution,redox balance modulation
ENSG00000143369,ECM1,metastasis promotion,immune evasion,epithelial-to-mesenchymal transition,cell-cell adhesion regulation,glycoprotein function,transmembrane protein interaction
ENSG00000101193,GID8,gtpase regulation,tumor progression,metastasis promotion,apoptosis resistance,cell migration,cytoskeleton reorganization
ENSG00000178982,EIF3K,eif3 regulation,oncogenic processes,protein synthesis modulation,tumor suppressor gene suppression,potential therapeutic target,enhanced translation rates
ENSG00000177479,ARIH2,cellular stress response,protein stability regulation,aberrant protein degradation,cancer cell survival,oncogenesis promotion,tumor aggressiveness
ENSG00000183230,CTNNA3,wnt/β-catenin signaling pathway,disrupted cell-cell adhesion,emt induction,loss of tumor suppressor function,cell migration and invasion,mesenchymal phenotype promotion
ENSG00000102781,KATNAL1,microtubule regulation,chromosomal instability,apoptosis induction,mitotic catastrophe,genomic profiling,cell cycle regulation
ENSG00000115423,DNAH6,genomic instability,aneuploidy,chromosomal abnormalities,mitotic regulation,dynein function,microtubule dynamics
ENSG00000165410,CFL2,tumor progression,oncogene,cell migration,actin filament regulation,cytoskeletal modulation,therapeutic target
ENSG00000109511,ANXA10,cellular homeostasis disruption,apoptosis regulation,cell cycle modulation,tumor progression facilitation,signal transduction involvement,cancer cell growth promotion
ENSG00000128833,MYO5C,cellular transport,actin-based motility,cytoplasmic protein interactions,oncogenic signaling pathways,tumor cell proliferation,metabolic regulation
ENSG00000104722,NEFM,cellular signaling pathway involvement,overexpression in cancer,tumor progression facilitation,cancer cell survival promotion,morphological disruption contribution,apoptosis evasion assistance
ENSG00000178750,STX19,cellular proliferation,tumor progression,membrane trafficking,vesicle fusion,poor prognosis,immune evasion
ENSG00000111732,AICDA,genetic instability,mutagenic activity,oncogenic transformation,somatic hypermutation,dna repair,tumor suppressor function
ENSG00000173334,TRIB1,trib1 overexpression,pi3k/akt/mtor pathway regulation,oncogene activation,cell proliferation enhancement,apoptosis inhibition,tumor progression promotion
ENSG00000145107,TM4SF19,tumor metastasis,cell migration,epithelial-to-mesenchymal transition,pi3k/akt signaling,cancer aggressiveness,transmembrane protein interaction
ENSG00000141562,NARF,chromatin regulation,oncogene activation,pi3k/akt signaling,tumor suppressor protein interaction,cell proliferation enhancement,dna repair modulation
ENSG00000106483,SFRP4,wnt pathway inhibition,tumor suppressor function,downregulation/mutation,oncogenic processes promotion,cell proliferation/survival enhancement,prognostic marker status
ENSG00000160200,CBS,metabolic regulation,transsulfuration pathway,cellular growth,tumorigenesis,prognosis,genetic dysregulation
ENSG00000163618,CADPS,calcium regulation,cell proliferation,apoptosis inhibition,kinase activation,oncogenic process,exocytosis modulation
ENSG00000051341,POLQ,genomic instability,tumor progression,chemotherapy resistance,dna repair,mutagenesis,prognostic marker
ENSG00000143105,KCNA10,cellular excitability,voltage-gated potassium channel,calcium signaling,pi3k/akt pathway,cell proliferation,tumor progression
ENSG00000110104,CCDC86,cell proliferation,survival promotion,centrosomal regulation,spindle assembly checkpoint,coiled-coil domain-containing protein,tumorigenesis promoter
ENSG00000141985,SH3GL1,egfr signaling pathway,adaptor protein function,endosomal trafficking regulation,mutation impact on cancer,tumor progression regulator,cancer therapeutic target
ENSG00000166233,ARIH1,ubiquitin ligase function,tumor suppressor activity,p53 stabilization,cell cycle regulation,apoptosis promotion,cancer progression
ENSG00000112077,RHAG,enhanced glycolysis,regulation of iron homeostasis,promotion of cell migration,angiogenesis,prognostic marker,therapeutic target
ENSG00000101160,CTSZ,cellular proliferation,tumor progression,mutation driver,transcriptional regulator,p53 interaction,oncogenic signaling
ENSG00000150672,DLG2,tumor suppressor,apoptosis regulation,cell adhesion disruption,pi3k/mapk pathway modulation,cell cycle progression regulation,genetic instability
ENSG00000089127,OAS1,apoptosis modulation,immune response regulation,tumor growth inhibition,viral rna degradation,autophagy induction,prognostic marker
ENSG00000162975,KCNF1,amplification,tumor progression,apoptosis evasion,cell proliferation,voltage-gated potassium channel,genomic profiling
ENSG00000170515,PA2G4,glutamine metabolism,mtor pathway activation,cell proliferation,cancer aggressiveness,therapeutic target,metabolic shift
ENSG00000113384,GOLPH3,oncogene,constitutive activation,cell proliferation,protein glycosylation,golgi apparatus function,metastasis
ENSG00000181409,AATK,apoptosis regulation,pi3k/akt signaling,cell cycle progression,tumor growth promotion,protein kinase activation,cell death evasion
ENSG00000108759,KRT32,type ii cytokeratin,epithelial integrity maintenance,cell adhesion regulation,cancer progression marker,tumor aggressiveness,overexpression in cancer
ENSG00000099256,PRTFDC1,apoptosis regulation,nf-κb signaling pathway modulation,tumor suppressor function loss,cell cycle progression enhancement,dna damage response interaction,genomic instability contribution
ENSG00000142178,SIK1,pi3k/akt pathway regulation,transcriptional regulation,oncogene overexpression,cell cycle progression,apoptosis inhibition,signaling pathway interaction
ENSG00000130347,RTN4IP1,cellular adhesion disruption,oncogenic signaling activation,tumor progression facilitation,metastasis promotion,therapeutic target identification,epithelial-to-mesenchymal transition regulation
ENSG00000118785,SPP1,tumor microenvironment,epithelial-to-mesenchymal transition (emt),angiogenesis promoter,oncogene activation,growth factor interaction,cytokine modulation
ENSG00000124942,AHNAK,aberrant expression,cell proliferation,oncogenic signaling,tumor microenvironment modulation,apoptosis suppression,cytoplasmic scaffold function
ENSG00000153551,CMTM7,tumor progression,pi3k/akt signaling,cell proliferation,cell migration,metastasis,biomarker
ENSG00000171928,TVP23B,p53 pathway disruption,tumor suppressor dysfunction,cell cycle dysregulation,histone modification regulation,microtubule dynamics alteration,epigenetic change promotion
ENSG00000164292,RHOBTB3,rho gtpase regulation,constitutive activation,tumor suppression,downregulation in tumors,apoptosis inhibition,oncogenic process
ENSG00000133121,STARD13,apoptosis induction,lipid metabolism regulation,tumor suppressor function,cellular proliferation inhibition,genomic instability association,protein-protein interaction modulation
ENSG00000115963,RND3,tumor suppressor,rho gtpase regulation,cell migration inhibition,cancer progression suppression,epigenetic regulation,protein-protein interaction
ENSG00000198939,ZFP2,transcriptional regulation,tumor progression,apoptosis regulation,cell growth promotion,oncogenic potential,chromatin remodeling
ENSG00000125755,SYMPK,alternative splicing,oncogenic potential,transcriptional modulation,cellular proliferation,metastasis regulation,kinase activity
ENSG00000151414,NEK7,mitotic entry regulation,chromosomal instability,oncogenic signaling,cell proliferation regulation,genomic stability disruption,tumor aggressiveness
,H2BFS,chromatin remodeling,histone variant overexpression,epigenetic regulation disruption,genome stability maintenance,cell cycle progression regulation,dna repair pathway interaction
ENSG00000130818,ZNF426,zinc finger protein regulation,tumor suppressor activity,cell cycle regulation,apoptosis induction,dna damage response,p53 interaction
ENSG00000075239,ACAT1,cholesterol metabolism,lipid accumulation,tumor growth promotion,energy metabolism regulation,lipogenesis facilitation,cellular lipid balance disruption
ENSG00000186187,ZNRF1,wnt signaling dysregulation,constitutive activation,transmembrane receptor function,tumor suppressor role,cell proliferation regulation,frizzled receptor degradation
ENSG00000161911,TREML1,tumor suppressor,immune regulation,cell signaling pathway,signal transduction,natural killer cell modulation,mitogen-activated protein kinase pathway
ENSG00000176101,SSNA1,chromatin remodeling,transcriptional activation,epigenetic alteration,cellular proliferation,genomic instability,nuclear protein interaction
ENSG00000243335,KCTD7,oncogene activation,cell proliferation enhancement,transcriptional regulation,cell cycle progression,tumor driver potential,protein-protein interaction modulation
ENSG00000072849,DERL2,protein degradation,tumor progression,cell growth,proliferation regulation,tumor suppressor degradation,therapeutic target
ENSG00000204511,MCCD1,anabolic process regulation,mitochondrial function,metabolic reprogramming,energy metabolism regulation,lipid synthesis promotion,cellular redox balance
ENSG00000120729,MYOT,cytoskeletal modulation,cell migration,epithelial-to-mesenchymal transition,oncogenic potential,tumor progression,sarcomeric protein
ENSG00000107099,DOCK8,rho gtpase activation,cell migration,cytoskeleton reorganization,tumor progression,metastasis promotion,oncogenic signaling pathway
ENSG00000163879,DNALI1,driver gene,mitotic spindle assembly,cellular transport regulation,genomic instability,microtubule stability,axonal transport disruption
ENSG00000205076,LGALS7,protein-protein interactions,tumor progression,promotes metastasis,immune response modulation,cell proliferation enhancement,apoptosis suppression
ENSG00000282902,LGALS7B,tumor microenvironment modification,immune evasion mechanisms,protein-protein interactions,cancer immunotherapy target,tumor progression marker,cellular signaling regulation
ENSG00000170577,SIX2,wnt/β-catenin pathway,epithelial-to-mesenchymal transition (emt),oncogenic transcription factor,tumor growth promotion,chemotherapy resistance,cellular differentiation
ENSG00000181754,AMIGO1,cell adhesion disruption,epithelial-to-mesenchymal transition promotion,metastasis facilitation,poor prognosis association,tumor progression promotion,prognostic biomarker candidacy
ENSG00000105486,LIG1,genomic instability,dna replication,base excision repair,oncogenesis,tumor progression,chromosomal instability
ENSG00000165802,NSMF,tumor progression,immune evasion,cell adhesion modulation,apoptosis resistance,g-protein coupled receptor function,chemotaxis regulation
ENSG00000102710,SUPT20H,chromatin remodeling,transcriptional activation,oncogenic driver,cell proliferation,genomic instability,tumor suppressor interaction
ENSG00000183668,PSG9,cellular growth,signal transduction,tumor progression,metastasis,transcriptional regulation,protein-protein interactions
ENSG00000165943,MOAP1,apoptosis regulation,oncogenic function,tumor progression,caspase modulation,prognostic biomarker,cancer cell survival
ENSG00000147872,PLIN2,lipid metabolism regulation,cellular growth promotion,fatty acid oxidation modulation,tumor aggressiveness,poor prognosis indicator,genomic overexpression
ENSG00000256061,DNAAF4,cilia assembly,dna damage response,genomic stability,cellular adaptation,oxidative stress,double-strand break repair
ENSG00000128699,ORMDL1,overexpression,sphingolipid biosynthesis regulation,ceramide levels modulation,cell growth promotion,oncogenesis activation,metastasis contribution
ENSG00000117152,RGS4,regulation of g-protein signaling,modulation of pi3k/akt pathway,tumor progression,metastasis,cell proliferation,migration
ENSG00000133019,CHRM3,tumor progression,metastasis,cell proliferation,apoptosis regulation,therapeutic target,g protein-coupled receptor
ENSG00000186834,HEXIM1,transcriptional regulation,oncogene function,tumor progression,cancer biomarker,cell cycle modulation,genome-wide gene expression
ENSG00000196101,HLA-DRB3,tumor immune evasion,immune surveillance,antigen presentation,hla class ii expression,genetic alterations,mhc function
ENSG00000132514,CLEC10A,immune modulation,tumor progression biomarker,prognostic marker,cancer immunotherapy target,cell-cell interaction,antigen presentation
ENSG00000121680,PEX16,peroxisome biogenesis,fatty acid oxidation,reactive oxygen species,genomic instability,oncogenic signaling pathway,cellular metabolism
ENSG00000198189,HSD17B11,steroid hormone regulation,oncogenic activity,cell proliferation promotion,apoptosis inhibition,metabolic pathway dysregulation,prognostic marker
ENSG00000188001,TPRG1,aberrant tyrosine kinase activity,cell proliferation,cell survival,mapk/erk pathway modulation,oncogenic signaling,tumor growth promotion
ENSG00000173908,KRT28,keratin network disruption,cellular morphology alteration,epithelial tissue disruption,tumor progression modulation,protein-protein interaction,cancer cell behavior modification
ENSG00000163071,SPATA18,genomic instability,cell cycle regulation,dna repair mechanisms,oncogenic processes,biomarker potential,tumor progression
ENSG00000163840,DTX3L,cell proliferation suppression,apoptosis regulation,transcriptional regulation,dna damage repair,cell cycle progression,chemotherapy resistance
ENSG00000008441,NFIX,transcription factor function,cell proliferation promotion,apoptosis inhibition,tumor aggressiveness enhancement,poor patient prognosis association,cell cycle progression regulation
ENSG00000176108,CHMP6,escrt-iii complex,endosomal sorting,cellular proliferation,proteasome regulation,autophagy inhibition,cancer prognosis
ENSG00000175206,NPPA,biomarker,cardiovascular function,cell proliferation,dysregulation,poor prognosis,protein interaction
ENSG00000159348,CYB5R1,electron transfer,redox regulation,proton pump function,cellular respiration,genomic instability,ros generation
ENSG00000106355,LSM5,alternative splicing regulation,chromosomal instability,oncogene overexpression,cell proliferation facilitation,tumor progression facilitation,genomic stability maintenance
ENSG00000119185,ITGB1BP1,cell adhesion disruption,oncogene or tumor suppressor,metastasis promotion,cell growth regulation,apoptosis modulation,immune evasion
ENSG00000198393,ZNF26,transcriptional regulation,cell proliferation,tumor progression,prognostic marker,chromatin remodeling,dna repair mechanism
ENSG00000135093,USP30,mitochondrial dysfunction,oxidative stress,tumor suppressor function,deubiquitination activity,protein stability regulation,brca1-associated protein interaction
ENSG00000178150,ZNF114,tumor suppression,epigenetic silencing,chromatin remodeling,gene expression regulation,cell growth regulation,oncogenic pathway activation
ENSG00000137285,TUBB2B,microtubule stabilization,genomic instability,mitotic catastrophe,cell cycle regulation,apoptosis resistance,cancer cell migration
ENSG00000257335,MGAM,glycolytic regulation,cellular metabolism,postprandial digestion,glycogen breakdown,tumor metabolism,cancer progression
ENSG00000129534,MIS18BP1,genome stability,cell proliferation,aneuploidy prevention,centromere formation,mitosis regulation,kinase regulation
ENSG00000164070,HSPA4L,tumor progression,cell survival,metastasis facilitation,protein interaction,chemoresistance enhancement,poor prognosis marker
ENSG00000185105,MYADML2,tumor suppressor function,cell cycle regulation,apoptosis modulation,prognostic marker,overexpression in tumors,gene amplification
ENSG00000151332,MBIP,mitotic progression,chromosomal instability,microtubule regulation,cell division error,genomic instability,protein-protein interaction
ENSG00000213782,DDX47,cellular stress response,heat shock protein regulation,p53 modulation,rna metabolism regulation,tumor progression facilitation,cancer driver gene potential
ENSG00000152061,RABGAP1L,rab2 gtpase regulation,cell growth promotion,oncogenic signaling,metastasis enhancement,tumor aggressiveness,epithelial-to-mesenchymal transition
ENSG00000164985,PSIP1,chromatin remodeling,epigenetic regulation,gene expression modulation,transcriptional regulation,tumor progression,metastasis driver
ENSG00000186222,BLOC1S4,lysosomal maturation,autophagy regulation,cell survival,cancer progression,apoptosis prevention,cellular homeostasis
ENSG00000132554,RGS22,g-protein coupled receptor regulation,cell proliferation regulation,tumor progression marker,signaling pathway modulation,gtpase activity facilitation,cancer associated gene expression
ENSG00000187634,SAMD11,overexpression,oncogene,cell proliferation,metastasis,chemotherapy resistance,emt regulation
ENSG00000181004,BBS12,cellular trafficking,oncogenic processes,ciliary dysfunction,tumor development,cellular proliferation,cell survival
ENSG00000217442,SYCE3,genomic instability,dna repair mechanisms,cell proliferation regulation,apoptosis inhibition,biomarker potential,synaptonemal complex component
ENSG00000197084,LCE1C,epithelial integrity maintenance,cellular differentiation regulation,stress response modulation,tissue barrier function,gene expression regulation,oncogenesis contribution
ENSG00000123353,ORMDL2,cellular stress responses,gain of function mutations,sphingolipid biosynthesis regulation,tumor progression promotion,apoptosis inhibition,cellular growth modulation
ENSG00000147439,BIN3,apoptosis regulation,cell cycle progression,tumor suppressor interaction,protein-protein interactions,cancer cell migration,poor prognosis association
ENSG00000124383,MPHOSPH10,genomic instability,chromosome segregation,tumor suppressor,cell cycle regulation,dna damage response,apokine-dependent signaling
ENSG00000182054,IDH2,idh2 mutations,2-hydroxyglutarate production,metabolic shift,epigenetic dysregulation,therapeutic target,cancer subtype
ENSG00000101489,CELF4,mrna binding,oncogene function,apoptosis resistance,cell proliferation,metastasis promotion,mirna regulation
ENSG00000134627,PIWIL4,microrna regulation,argonaute activity,tumor suppression,oncogenesis,cell proliferation regulation,dna repair
ENSG00000105993,DNAJB6,tumor suppressor function,p53 degradation,cellular stress response,protein quality control,molecular chaperone activity,cell cycle regulation
ENSG00000174132,FAM174A,14-3-3 signaling pathway,cell cycle regulation,tumor suppressor-protein interaction,oncogenic protein modulation,cancer-specific expression alteration,metastasis regulation
ENSG00000012822,CALCOCO1,p53 regulation,dna repair mechanism,apoptosis modulation,cellular stress response,tumor suppressor interaction,cancer progression hallmark
ENSG00000135090,TAOK3,pi3k/akt pathway modulation,cell cycle progression regulation,oncogene activation,genomic instability promotion,therapeutic target identification,apoptosis inhibition
ENSG00000184650,ODF4,genomic instability,chromosomal segregation,aneuploidy suppression,cell division regulation,tumor suppressor,mitosis checkpoint
ENSG00000169223,LMAN2,altered glycosylation patterns,glycoprotein transport disruption,mannose-terminal oligosaccharide recognition,cell surface localization defect,tumor progression contribution,cell signaling pathway disruption
ENSG00000187238,LCE3B,cellular adhesion regulation,epithelial integrity maintenance,oncogene activation,tumor cell migration,genetic instability,cellular differentiation
ENSG00000160472,TMEM190,autophagy regulation,cellular trafficking,lysosome formation,cancer cell survival,tumorigenesis driver,metastatic potential
ENSG00000115540,MOB4,gpcr signaling pathway,cell cycle progression,oncogenic processes,cell proliferation,mapk/erk pathway interaction,proliferation and survival mechanisms
ENSG00000120907,ADRA1A,**
cell proliferation regulation,tumor growth promotion,signaling pathway modulation,epinephrine responsiveness,g protein-coupled receptor activity,cell survival enhancement
**
ENSG00000125875,TBC1D20,regulation of gtpase activity,membrane trafficking regulation,cytoskeleton organization,cellular homeostasis maintenance,oncogene overexpression,genomic instability
ENSG00000105613,MAST1,apoptosis regulation,cell cycle progression,e3 ubiquitin ligase complex,metabolic reprogramming,nf-κb interaction,p53 modulation
ENSG00000004455,AK2,tumor growth promotion,adenosine metabolism regulation,gain of function mutations,potential therapeutic target,cancer cell survival enhancement,prognostic marker
ENSG00000134588,USP26,tumor suppressor function,deubiquitinating enzyme activity,p53 stabilization,cell cycle regulation,dna repair mechanism modulation,genomic instability promotion
ENSG00000198000,NOL8,nucleolar assembly,ribosome biogenesis,oncogene activity,promotes cell proliferation,gene overexpression,poor prognosis marker
ENSG00000121742,GJB6,oncogenic potential,tumor progression,cellular communication disruption,apoptosis regulation,interconnected cell networks,cancer-associated mutations
ENSG00000113441,LNPEP,lysophosphatidic acid regulation,dysregulated lipid phosphate signaling,proliferation promotion,cell migration enhancement,survival pathway modulation,lpa hydrolysis
ENSG00000163947,ARHGEF3,rho gtpase activation,tumor progression,cell migration,invasiveness promotion,therapeutic target,cytoplasmic localization
ENSG00000196715,VKORC1L1,oncogenic regulation,tumor progression,cellular proliferation,gene expression modulation,pseudogene function,vitamin k-dependent carboxylases
ENSG00000116771,AGMAT,increased ampd activity,enhanced adenine availability,cellular proliferation,metabolic adaptation,oncogenesis,nucleotide metabolism
ENSG00000154237,LRRK1,**
autophagy modulation,cell proliferation promotion,ciliogenesis regulation,cytoplasmic protein kinase activity,mapk/erk pathway activation,mitochondrial function regulation 
**
ENSG00000139350,NEDD1,centrosome regulation,genomic stability,cell proliferation,oncogenic pathway activation,tumor progression,therapeutic target
ENSG00000187569,DPPA3,cellular differentiation,embryonic development regulator,germ cell maintenance,oncogenic process modulation,proliferation regulation,self-renewal inhibition
ENSG00000164972,C9orf24,cellular processes regulation,protein interaction,potential biomarker,therapeutic target,unknown biological function,expression level increase
ENSG00000010219,DYRK4,genomic instability,cell proliferation,protein kinase activation,cell survival inhibition,oncogenic transformation,therapeutic target
ENSG00000240386,LCE1F,epithelial cell differentiation,cell adhesion,epidermal layer integrity,tumor progression,keratinocyte proliferation,cell migration and invasion
ENSG00000187223,LCE2D,oxidative stress response,cellular adhesion regulation,inflammation modulation,environmental stress regulation,cell-cell interaction,tissue integrity maintenance
ENSG00000171311,EXOSC1,mirna regulation,oncogene,cell proliferation,apoptosis resistance,signaling pathway modulation,tumor progression
ENSG00000275513,KIR3DL3,immunoregulation,immune evasion,nk cell activation,tumor immunity,hla class i interaction,genetic variation
ENSG00000160888,IER2,cell cycle regulation,apoptosis suppression,transcriptional regulation,dna damage response,prognostic marker,tumor progression
ENSG00000154832,CXXC1,chromatin remodeling,gene regulation,oncogene activation,tumor progression,metastasis promotion,epigenetic modification
ENSG00000146147,MLIP,mrna stabilization,cellular growth regulation,protein-protein interactions,tumor progression modulation,genetic instability,cancer prognosis
ENSG00000077063,CTTNBP2,oncogenic protein,cytoskeleton dynamics regulator,tumor progression driver,cell migration enhancer,survival pathway activator,genomic amplification associated
ENSG00000138669,PRKG2,cell proliferation,tumor progression,apoptosis regulation,ca2+/calmodulin-dependent signaling,mapk/erk pathway modulation,oncogenic protein kinase activation
ENSG00000167618,LAIR2,immune modulation,tumor progression,metastasis regulation,immune evasion,dysregulation,platelet inhibition
ENSG00000138080,EMILIN1,tumor suppressor function,angiogenesis regulation,extracellular matrix integrity,cell migration inhibition,growth factor interaction,protein-protein interaction
ENSG00000115446,UNC50,genomic instability,cell cycle progression,somatic mutations,dna damage response,putative oncogene,tumor formation
ENSG00000109519,GRPEL1,cellular differentiation,g protein coupled receptor,cell signaling pathway,oncogenic process,angiogenesis promotion,metastatic potential
ENSG00000092200,RPGRIP1,mtor pathway activation,epithelial-to-mesenchymal transition (emt) induction,cell proliferation promotion,biomarker potential,tumor growth facilitation,ciliary function regulation
ENSG00000107831,FGF8,angiogenesis promotion,tumor progression driver,cell proliferation regulator,signaling pathway interaction,oncogenic process modulation,genomic dysregulation
ENSG00000138036,DYNC2LI1,microtubule dynamics,genomic instability,mitotic spindle assembly,cell migration,chromosome segregation,cell division regulation
ENSG00000132010,ZNF20,cellular proliferation,overexpression,transcriptional regulation,metabolic reprogramming,epigenetic modification,tumor aggressiveness
ENSG00000172748,ZNF596,transcriptional regulation,chromatin remodeling,oncogenic function,tumor progression,metastasis promotion,cancer development
ENSG00000179833,SERTAD2,regulation of chromatin structure,gene expression regulation,cell proliferation modulation,transcription factor regulation,genomic instability promotion,tumor progression contribution
ENSG00000010322,NISCH,pi3k/akt pathway,epithelial-to-mesenchymal transition,overexpression,poor prognosis,apoptosis regulation,cell proliferation
ENSG00000123595,RAB9A,late endosome pathway regulation,gtpase activity,endocytic trafficking modulation,cell proliferation promotion,tumor growth enhancement,oncogene dysregulation
ENSG00000101901,ALG13,aberrant glycosylation,cell survival,dysregulated expression,enhanced proliferation,n-glycosylation pathway,tumor progression
ENSG00000121454,LHX4,tumor suppressor candidate,transcription factor function,cellular differentiation regulation,potential oncogene,genetic interaction network,epigenetic regulation impact
ENSG00000161981,SNRNP25,disrupted splicing patterns,cell cycle regulation disruption,apoptosis evasion,oncogenic gene expression,tumor growth promotion,biomarker potential
ENSG00000149503,INCENP,chromosome segregation,mitotic checkpoint regulation,genomic instability,aneuploidy promotion,cell proliferation enhancement,oncogene potential
ENSG00000164256,PRDM9,genomic instability,chromatin remodeling,epigenetic reprogramming,transcriptional regulation,meiotic recombination,histone modification
ENSG00000168679,SLC16A4,glucose metabolism,warburg effect,enhanced glycolysis,therapy resistance,cell proliferation,metabolic reprogramming
ENSG00000165633,VSTM4,immunomodulation,cytokine regulation,cellular interaction,immune evasion,genetic mutation,tumor microenvironment
ENSG00000162702,ZNF281,transcription factor activation,overexpression associated,cell cycle regulation,metastasis driver,apoptosis suppression,oncogene interaction
ENSG00000111452,ADGRD1,pi3k/akt pathway regulation,epithelial-to-mesenchymal transition (emt) modulation,oncogenic signaling,cell-cell interaction regulation,poor prognosis marker,transmembrane protein function
ENSG00000243279,PRAF2,protein kinase regulation,tumor suppressor loss,cell proliferation driver,apoptosis inhibition,genomic instability,nf-κb signaling
ENSG00000244411,KRTAP5-7,cell-cell adhesion disruption,tumor progression promotion,oncogene potential,metastasis facilitation,poor prognosis association,epithelial tissue integrity loss
ENSG00000185900,POMK,glycoprotein synthesis,mannose biosynthesis,oncogenic processes,pi3k/akt pathway,somatic mutations,glycosylation regulation
,FGFR1OP,mir-433/mir-542-3p sponge,oncogenic long non-coding rna,cancer cell proliferation,cell cycle regulation,dna repair pathways,therapeutic resistance marker
ENSG00000198937,CCDC167,cell cycle regulation,cytoskeleton organization,microtubule dynamics,genomic stability maintenance,stress response modulation,cancer driver gene
ENSG00000267467,APOC4,lipid metabolism regulation,autophagy modulation,tumor progression association,cellular homeostasis disruption,protein function alteration,metabolic regulation impact
ENSG00000106588,PSMA2,proteasome regulation,cell cycle progression,chromatin remodeling,tumor growth promotion,dna damage response,oncogenic signaling
ENSG00000276358,PLEKHM1,endosomal recycling,escrt interaction,cell migration enhancement,protein trafficking regulation,tumor metastasis promotion,oncogenic phenotype contribution
ENSG00000033627,ATP6V0A1,cellular metabolism regulation,proton gradient maintenance,tumor progression driver,gene expression regulation,poor prognosis marker,biological function alteration
ENSG00000085415,SEH1L,cell cycle regulation,chromosome segregation,proteasome targeting,genomic instability,tumorigenesis,aneuploidy
ENSG00000166123,GPT2,metabolic reprogramming,amino acid metabolism,tumor progression,cancer cell growth,poor prognosis,biomarker potential
ENSG00000138495,COX17,mitochondrial regulation,copper ion incorporation,cytochrome c oxidase assembly,energy metabolism regulation,oncogenesis promotion,biomarker potential
ENSG00000148384,INPP5E,phosphatase activity loss,cell membrane lipid composition alteration,oncogenic driver,tumor suppressor role,lipid mediator accumulation,cell adhesion disruption
ENSG00000116514,RNF19B,regulation of protein stability,tumor growth promotion,ubiquitination machinery modulation,apoptosis resistance,cell cycle regulation disruption,protein degradation enhancement
ENSG00000136319,TTC5,mitotic checkpoint disruption,tumor suppressor function,p53 signaling pathway regulation,cell cycle modulation,apoptosis regulation,genomic instability prevention
ENSG00000132436,FIGNL1,microtubule regulation,tumor progression,mitotic spindle checkpoint disruption,cell cycle modulation,protein-protein interaction,proliferation enhancement
ENSG00000102890,ELMO3,rac1 signaling pathway,cell migration,oncogenic process,prognostic biomarker,metastasis promotion,gtpase regulation
ENSG00000182585,EPGN,epigenetic regulation,chromatin remodeling,histone modification,tumor progression,prognostic biomarker,cancer development
ENSG00000187272,KRTAP9-8,keratin-associated protein,cell adhesion regulation,cell migration modulation,tumor microenvironment interactions,epithelial cell structure maintenance,intermediate filament stability
ENSG00000213741,RPS29,ribosomal protein function,cellular proliferation promotion,oncogene regulation,tumor suppressor gene interaction,cancer progression association,poor prognosis indicator
ENSG00000188895,MSL1,aberrant chromatin modification,chromatin regulation,compass complex component,gene expression dysregulation,oncogenic transformation,therapeutic target
ENSG00000180616,SSTR2,tumor suppressor,apoptosis induction,cell proliferation inhibition,hormone regulation,signaling pathway modulation,angiogenesis regulation
ENSG00000235169,SMIM1,cell survival pathways,mitochondrial dynamics,tumor growth regulation,apoptosis modulation,signaling cascade interactions,protein-protein interaction
ENSG00000181016,LSMEM1,kinetochore dysfunction,chromosomal instability,mitotic checkpoint disruption,genomic rearrangements,tumor aggressiveness,cell cycle dysregulation
ENSG00000008283,CYB561,iron regulation,reactive oxygen species regulation,cell growth promotion,tumor cell invasion,metabolic reprogramming,therapeutic target
ENSG00000161980,POLR3K,transcriptional regulation,oncogenic transcription,tumor progression,mutational hotspot,proliferation enhancement,metastasis promotion
ENSG00000176986,SEC24C,copii complex regulation,er-to-golgi transport,oncoprotein export,pi3k/akt pathway activation,tumor growth promotion,cellular proliferation enhancement
ENSG00000136352,NKX2-1,transcriptional regulator,oncogene potential,tumor progression involvement,cell proliferation regulation,metastasis promotion,thyroid development factor
ENSG00000133731,IMPA1,purine biosynthesis pathway,cell cycle regulation,tumor progression,oncogenesis,biomarker identification,therapeutic target
ENSG00000141401,IMPA2,cellular proliferation,gene amplification,nucleotide synthesis,redox regulation,antioxidant response,warburg effect
ENSG00000117448,AKR1A1,hif-1α regulation,oxidative stress response,cell survival pathway,dna damage repair,cancer cell protection,cellular detoxification
ENSG00000101191,DIDO1,**

cell proliferation enhancement,apoptosis inhibition,p53 regulation,tumor progression facilitation,protein-protein interaction,oncogenesis promotion

**
ENSG00000121766,ZCCHC17,tumor suppressor function,splicing regulation,rna processing,aberrant gene expression,apoptosis inhibition,cell cycle dysregulation
ENSG00000088356,PDRG1,cellular proliferation,tumor progression,transcriptional regulation,genomic instability,apoptosis suppression,metastasis promotion
ENSG00000092054,MYH7,cell migration,overexpression,poor prognosis,protein interaction,cytoskeleton regulation,biomarker
ENSG00000139648,KRT71,oncogenesis,cellular structure maintenance,tumor progression,epithelial tissue expression,protein overexpression,genetic dysregulation
ENSG00000148584,A1CF,alternative splicing regulation,rna-binding protein interaction,pre-mrna recognition,splice enhancer modulation,cellular proliferation regulation,genome stability maintenance
ENSG00000117868,ESYT2,er-mitochondria interaction,autophagy regulation,cancer cell proliferation,mitochondrial function regulation,lipid metabolism modulation,oncogenic signaling pathway disruption
ENSG00000139641,ESYT1,er stress response,oncogenic function,cellular autophagy,tumor progression,protein kinase activation,signaling pathway modulation
ENSG00000177108,ZDHHC22,tumor progression,oncogene activation,cell growth regulation,protein palmitoylation,aggressive tumor behavior,therapeutic target
ENSG00000272031,ANKRD34A,apoptosis modulation,cell cycle regulation,cytoplasmic localization,oncogenic pathway regulation,transcriptional control,tumor aggressiveness
ENSG00000011009,LYPLA2,lipid metabolism disruption,tumor progression facilitation,cellular microenvironment modulation,cell migration promotion,invasion enhancement,oncogenic lipid regulation
ENSG00000112655,PTK7,pi3k/akt pathway activation,receptor tyrosine kinase activity,tumor progression,therapeutic target,cell signaling modulation,upregulated expression
ENSG00000171956,FOXB1,pi3k/akt signaling pathway suppression,tumor suppressor function,epithelial tissue integrity maintenance,methylated and downregulated,cancer cell apoptosis regulation,cell cycle control modulation
ENSG00000117525,F3,tumor progression,thrombin activation,angiogenic factor,cancer metastasis,coagulation cascade,overexpression
ENSG00000189283,FHIT,cellular response modulation,dna repair mechanism regulation,genomic stability maintenance,tumor suppressor function,cell cycle regulation,proto-oncogene activation prevention
ENSG00000132963,POMP,chaperone function,protein stability modulation,tumor suppressor,ubiquitin-proteasome pathway regulation,molecular chaperone,cellular proteostasis
ENSG00000176273,SLC35G1,cell signaling alteration,glycosylation regulation,nucleotide sugar transport,tumor progression,metastasis promotion,prognostic marker
ENSG00000183864,TOB2,tumor suppression,pi3k/akt pathway inhibition,cell growth regulation,apoptosis induction,genomic stability maintenance,oncogene inhibition
ENSG00000035141,FAM136A,oncogenic signaling pathways,tumor progression,genomic profiling,cellular proliferation,protein overexpression,signaling molecule activation
ENSG00000175324,LSM1,spliceosome dysfunction,altered gene expression,chromatin remodeling,snrnp biogenesis,tumor progression,rna processing
ENSG00000158220,ESYT3,autophagy regulation,lipid metabolism modulation,oncogene activation,cell survival promotion,therapeutic resistance,tumor progression facilitation
ENSG00000055609,KMT2C,histone methylation,transcriptional regulation,oncogenesis,cell proliferation,tumor progression,chromatin remodeling
ENSG00000182173,TSEN54,trna splicing,cellular stress,protein misfolding,oncogenic driver,gene expression regulation,cell survival pathway
ENSG00000064787,BCAS1,pi3k/akt pathway activation,oncogene overexpression,cell proliferation enhancement,tumor progression correlation,therapeutic target identification,genomic biomarker
ENSG00000128908,INO80,dna replication,chromatin remodeling,genomic instability,oncogenic processes,cellular proliferation,therapeutic target
ENSG00000101442,ACTR5,cell migration,actin cytoskeleton regulation,chromatin remodeling,scaffold protein interaction,dysregulated gene expression,tumor progression
ENSG00000155090,KLF10,apoptosis regulation,cell cycle arrest,angiogenesis inhibition,tumor suppression,transcriptional regulation,downregulation in cancer
ENSG00000054598,FOXC1,transcription factor function,wnt/β-catenin signaling pathway activation,apoptosis inhibition,angiogenesis promotion,emt regulation,oncogenic pathway activation
ENSG00000159259,CHAF1B,genome instability,chromatin remodeling,cell cycle regulation,nucleosome assembly,dna replication,aggressive tumor behavior
ENSG00000198947,DMD,cell adhesion,signal transduction,muscle integrity maintenance,oncogenesis,cell proliferation regulation,extracellular matrix interaction
ENSG00000113327,GABRG2,neurotransmission regulation,cell survival promotion,tumor microenvironment modulation,signaling pathway alteration,therapeutic target,gene expression regulation
ENSG00000100814,CCNB1IP1,tumor suppressor,cell cycle regulation,ccnb1 interaction,mitotic inhibition,phosphorylation regulation,prognostic marker
ENSG00000160285,LSS,genomic instability,aneuploidy,tumor suppressor,oncogenic signaling,pi3k/akt pathway activation,mitotic spindle dysfunction
ENSG00000133059,DSTYK,cell cycle regulation,dna damage response,oncogenic driver,cell proliferation,tumor progression,therapeutic target
ENSG00000163933,RFT1,pi3k/akt pathway alteration,gtpase activity activation,cell growth promotion,endosomal sorting dysregulation,oncogenic potential enhancement,tumor aggressiveness increase
ENSG00000179532,DNHD1,cell migration,involved in oncogenesis,microtubule regulation,protein-protein interaction,tumor metastasis,therapeutic target
,COL4A3BP,genomic instability,dna repair regulation,homologous recombination repair,cellular proliferation,protein kinase activation,tumorigenesis promoter
ENSG00000133275,CSNK1G2,wnt/β-catenin pathway activation,tumor progression,therapeutic target,genomic instability,cell cycle regulation,dna repair regulation
ENSG00000139318,DUSP6,mapk pathway regulation,tumor suppressor function,erk1/2 dephosphorylation,proliferation inhibition,cell survival regulation,mitogen-activated protein kinase interaction
ENSG00000058453,CROCC,swi/snf complex,oncogenic function,chromatin remodeling,tumor progression,gene amplification,metastatic potential
ENSG00000117281,CD160,immunoglobulin superfamily member,immune modulation,tumor immunosuppression,activation of signaling pathways,overexpression in cancer,poor prognosis marker
ENSG00000113240,CLK4,alternative splicing,apoptosis resistance,cell cycle progression,cancer metastasis,metabolic regulation,tumor angiogenesis
ENSG00000213625,LEPROT,cell proliferation,oncogene activation,apoptosis inhibition,tumor growth promotion,signaling pathway regulation,dna repair interaction
ENSG00000123545,NDUFAF4,mitochondrial function regulation,metabolic reprogramming,tumor metabolism enhancement,oncogenic process promotion,interaction with pi3k/akt/mtor pathway,tumor aggressiveness promotion
ENSG00000105866,SP4,cell cycle regulation,apoptosis evasion,angiogenesis promotion,tumor progression,therapeutic target,epigenetic regulation
ENSG00000233813,MRPS18B,mitochondrial function,energy metabolism,cellular proliferation,tumor progression,apoptosis modulation,electron transport chain
ENSG00000275979,CNOT3,ccr4-not complex regulation,mrna turnover and degradation,transcriptional control,tumor progression,gene expression modulation,oncogene function
ENSG00000187173,LCE2A,epidermal barrier formation,possible tumor suppressor,tumor microenvironment regulation,cell growth modulation,proliferation and survival regulation,genomic instability susceptibility
ENSG00000114771,AADAC,metabolic reprogramming,detoxification pathway,cellular redox balance,therapeutic target,tumor aggressiveness,metabolic activation
ENSG00000134900,TPP2,altered protein degradation,disrupted cell signaling,oncogenic mutations,regulatory mechanism,cell proliferation,apoptosis regulation
ENSG00000100505,TRIM9,protein degradation regulation,cellular signaling modulation,oncogenic pathway interaction,immune response modulation,tumor immune evasion,ubiquitination pathway involvement
ENSG00000203883,SOX18,emt regulator,transcription factor,angiogenesis promoter,oncogenic factor,cellular differentiation,tumor metastasis
ENSG00000214413,BBIP1,chromosomal instability,tumor suppressor function,mitosis regulation,centrosome separation,genomic integrity maintenance,aurora kinase a inhibition
ENSG00000167916,KRT24,keratin overexpression,cytoskeleton reorganization,tumor progression,cell adhesion disruption,apoptosis resistance,protein interaction alteration
ENSG00000124275,MTRR,dna methylation regulation,cell proliferation enhancement,tumor suppressor gene silencing,genetic instability promotion,apoptosis inhibition,protein-protein interaction
ENSG00000116984,MTR,dna repair defects,folate metabolism dysfunction,genomic instability,homocysteine elevation,oncogenic processes,one-carbon metabolism disruption
ENSG00000062282,DGAT2,lipid metabolism regulation,cell growth promotion,tumor progression facilitation,energy homeostasis modulation,therapeutic target identification,protein-protein interaction enhancement
ENSG00000243509,TNFRSF6B,tumor suppression,apoptosis regulation,immune response modulation,nf-κb pathway inhibition,metastasis suppression,cell signaling regulation
ENSG00000104936,DMPK,cell cycle regulation,tumor growth promotion,apoptosis inhibition,oncogene overexpression,pi3k/akt pathway interaction,genomic instability
ENSG00000166562,SEC11C,protein degradation regulation,oncogene potential,poor prognosis marker,overexpression association,mannose trimming function,cell homeostasis disruption
ENSG00000147650,LRP12,lrp12 overexpression,tumor progression,prognostic marker,angiogenesis promotion,cell survival enhancement,therapeutic target
ENSG00000181804,SLC9A9,cell migration,epithelial-to-mesenchymal transition,metabolic adaptation,therapeutic target,wnt/β-catenin signaling,overexpression
ENSG00000023191,RNH1,genetic instability,dna damage repair,base excision repair (ber),tumor suppressor function,loss-of-function mutations,oncogenic process
ENSG00000064995,TAF11,chromatin remodeling,oncogenic gene regulation,cell proliferation,epithelial-to-mesenchymal transition (emt),transcription factor interaction,swi/snf complex association
ENSG00000281309,SURF6,cell adhesion disruption,tumor progression,proliferation promotion,invasion and metastasis facilitation,rho gtpase interaction,pi3k/akt pathway regulation
ENSG00000138587,MNS1,dna repair mechanism,genomic instability,telomere regulation,oncogenic process,homologous recombination,prognostic biomarker
ENSG00000163485,ADORA1,adenosine receptor activation,angiogenesis promotion,cell proliferation enhancement,immune evasion,metastasis facilitation,tumor progression
ENSG00000174667,OR7D4,cellular proliferation,olfactory receptor function,signaling pathway regulation,tumor progression,therapeutic target,genomic profiling
ENSG00000110887,DAO,pro-oxidative microenvironment,polyamine metabolism regulation,sirt1/prmt5 interaction,oncogenic process promotion,tumor progression facilitation,poor prognostic marker
ENSG00000105669,COPE,cell adhesion regulation,epithelial-to-mesenchymal transition,tumor growth promotion,metastasis facilitation,poor prognosis marker,therapeutic target candidate
ENSG00000138696,BMPR1B,tumor suppression,loss-of-function mutations,constitutive activation of tgf-β pathway,epithelial-to-mesenchymal transition (emt) regulation,cell growth inhibition,apoptosis promotion
ENSG00000108590,MED31,cell cycle regulation,transcriptional activation,cancer driver mutation,epigenetic regulation,chromatin remodeling,oncogenic coactivator
ENSG00000122958,VPS26A,**

1. **endosomal sorting**,2. **abnormal cell division**,3. **genome instability**,4. **cell membrane recycling**,5. **cancer cell growth**,6. **tumor progression** 

**
ENSG00000152583,SPARCL1,epithelial-to-mesenchymal transition,angiogenesis promotion,extracellular matrix interaction,cell adhesion regulation,metastasis facilitation,oncogene activity
ENSG00000065000,AP3D1,cellular trafficking,endocytosis regulation,tumor progression,signal transduction,protein sorting,genomic instability
ENSG00000099290,WASHC2A,endocytic trafficking regulation,protein homeostasis disruption,oncogenic driver mutations,vesicular transport impairment,lysosomal dysfunction,cellular recycling alteration
ENSG00000164695,CHMP4C,tumor progression,cell proliferation,endosomal sorting complex,autophagy regulation,ubiquitinated protein sorting,lysosome regulation
ENSG00000143363,PRUNE1,ubiquitination regulation,tumor suppressor pathway modulation,cell cycle progression regulation,apoptosis dysregulation,chromatin remodeling,proteasomal degradation regulation
ENSG00000104960,PTOV1,pi3k/akt signaling pathway,overexpression,phosphorylation and activation,cell proliferation and survival,angiogenesis promotion,tumor suppressor interaction
ENSG00000183813,CCR4,tumor progression,chemokine-mediated migration,immune suppression,prognostic biomarker,resistance to therapy,cell proliferation signaling
ENSG00000103932,RPAP1,ctd phosphatase regulation,e3 ubiquitin ligase activity,gene expression control,cell proliferation enhancement,tumor progression promotion,rna polymerase ii interaction
ENSG00000164162,ANAPC10,cell cycle regulation,genomic instability,oncogenesis,tumor suppressor function,prognostic biomarker,dna damage response
ENSG00000135862,LAMC1,basement membrane disruption,epithelial-to-mesenchymal transition (emt),laminin gamma 2 chain downregulation,loss of cell adhesion and migration,pi3k/akt pathway interaction,tumor progression and metastasis
ENSG00000148356,LRSAM1,trim21 interaction,mhc class i antigen presentation,ubiquitination regulation,oncogenic protein degradation,tumor suppressor modulation,gene expression regulation
ENSG00000168826,ZBTB49,transcriptional repression,oncogene regulation,apoptosis modulation,cell cycle regulation,chromatin remodeling,genetic instability
ENSG00000172795,DCP2,nonsense-mediated mrna decay,genome instability,aberrant mrna accumulation,oncogenic process promotion,tumor suppressor gene suppression,therapeutic target
ENSG00000258405,ZNF578,transcription regulation,cellular homeostasis modulation,zinc finger protein structure,tumorigenesis involvement,cell proliferation regulation,dna binding ability
ENSG00000061794,MRPS35,mitochondrial translation regulation,cellular metabolism regulation,cancer progression,aberrant protein synthesis,tumor suppressor potential,mitochondrial dynamics regulation
ENSG00000198752,CDC42BPB,rho gtpases signaling pathway,pro-oncogenic function,cdc42 activation,cytoskeleton reorganization,cell proliferation enhancement,overexpression detected
ENSG00000241233,KRTAP5-8,keratin protein regulation,cellular adhesion alteration,tumor cell morphology,therapeutic target exploration,gene expression dysregulation,malignant transformation promotion
ENSG00000085741,WNT11,wnt signaling pathway,oncogenic potential,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,signaling interaction
ENSG00000186416,NKRF,nf-κb pathway regulation,transcription factor inhibition,tumor suppressor potential,cell survival modulation,inflammation regulation,immune response modulation
ENSG00000167191,GPRC5B,receptor function,tumor suppressor dysfunction,loss of function mutations,tumor progression,metastasis regulation,calcium homeostasis disruption
ENSG00000166923,GREM1,emt inhibition,loss-of-function mutations,tumor suppressor activity,cancer cell growth,tgf-? signaling antagonist,cellular proliferation suppression
ENSG00000175745,NR2F1,tumor progression,cellular regulation,oncogene/tumor suppressor,signaling pathway modulation,epithelial-to-mesenchymal transition,metabolic regulation
ENSG00000204370,SDHD,mitochondrial dysfunction,tumor suppressor function,loss of function mutations,angiogenesis promotion,hif-dependent signaling pathway activation,energy metabolism disruption
ENSG00000154743,TSEN2,telomere maintenance,chromosomal instability,tumor progression,cellular proliferation,dna damage response,oncogene regulation
ENSG00000134548,SPX,aberrant splicing patterns,oncogenic process,alternative splicing,rna processing regulation,cell proliferation enhancement,immune evasion mechanism
ENSG00000178928,TPRX1,calcium channel activity,cellular proliferation,cancer progression,apoptosis resistance,regulatory mechanisms,prognostic marker
,MARCH6,nf-κb pathway regulation,tumor suppression,cellular homeostasis,e3 ubiquitin ligase activity,protein degradation regulation,oncogenic process modulation
ENSG00000181467,RAP2B,oncogenic transformation,overexpression,plasma membrane localization,gtp-binding activity,signaling pathway interaction,tumor progression
ENSG00000136193,SCRN1,tumor microenvironment,extracellular matrix degradation,cell migration,oncogenic potential,proteolytic activity regulation,therapeutic targeting
ENSG00000175395,ZNF25,tumor suppressor activity,dna binding,cell cycle regulation,apoptosis induction,transcriptional modulation,prognostic marker
ENSG00000084234,APLP2,cellular growth regulation,pi3k/akt pathway modulation,glycoprotein interaction,tumor suppression,oncogene function,malignant progression enhancement
ENSG00000164929,BAALC,apoptosis evasion,cell cycle progression,chromosome 8p12 amplification,increased tumor aggressiveness,oncogenic transcription factor,poor prognosis biomarker
ENSG00000111218,PRMT8,histone modification,transcriptional regulation,cell cycle control,apoptosis suppression,tumor progression,protein-protein interaction
ENSG00000162144,CYB561A3,mitochondrial function,enhanced cell survival,increased glucose metabolism,tumor progression,cell proliferation,apoptosis resistance
ENSG00000188379,IFNA2,cellular apoptosis,interferon stimulated genes,pi3k/akt signaling pathway,tumor microenvironment modulation,apoptosis induction,cell proliferation suppression
ENSG00000134602,STK26,cell polarity disruption,gain of function mutations,oncogenic signaling pathway activation,tumor progression driver mutation,protein-protein interaction,therapeutic target
ENSG00000169752,NRG4,tumor progression,cell growth regulation,angiogenesis promotion,metastasis facilitation,poor prognosis marker,emt regulation
ENSG00000135917,SLC19A3,nucleobase transport,cell proliferation,dysregulated expression,metabolic alteration,oncogenic driver,dna synthesis
ENSG00000165915,SLC39A13,zinc homeostasis disruption,cancer cell proliferation,poor prognosis association,cell survival promotion,zinc-dependent signaling,oncogenic driver gene
ENSG00000110375,UPK2,oncogene,cell proliferation,cell survival,migration,adhesion,signaling pathway
ENSG00000166452,AKIP1,**
cell proliferation,therapeutic target,signaling pathway regulation,tumor suppressor,oncogene potential,cytoplasmic localization
**
ENSG00000113504,SLC12A7,ion transport regulation,tumor aggressiveness,electrolyte imbalance,cellular proliferation,soluble protein localization,genomic instability
ENSG00000158186,MRAS,cellular proliferation,constitutive activation,oncogenesis,gtpase activity,cell migration regulation,rho pathway interaction
ENSG00000203879,GDI1,small gtpase signaling,cell growth regulation,cell migration control,tumor progression,metastasis facilitation,gdp dissociation inhibition
ENSG00000007171,NOS2,nitric oxide production,inflammation promotion,angiogenesis stimulation,cell migration enhancement,oxidative stress modulation,redox signaling pathway
ENSG00000280830,ADI1,metabolic reprogramming,mitochondrial dysfunction,cellular respiration,tumor progression,therapeutic target,protein-protein interaction
ENSG00000160460,SPTBN4,epithelial-to-mesenchymal transition,cell migration and invasion,resistance to apoptosis,altered cell adhesion,poor prognosis marker,protein-protein interaction
ENSG00000179085,DPM3,oncogenic mutations,protein modification,glycosylation regulation,tumor progression,glycans,ost complex assembly
ENSG00000105821,DNAJC2,p53 regulation,tumor suppressor dysfunction,chaperone activity hijacking,oncogenic signaling pathway activation,biomarker potential,genomic instability promotion
ENSG00000010256,UQCRC1,mitochondrial biogenesis,cellular metabolism regulation,electron transport chain function,oncogenic driver,therapeutic target potential,apoptosis modulation
,FAM84B,cellular regulation,pi3k/akt/mtor pathway,oncogenic effects,tumor progression,genetic mutation,signaling pathway modulation
ENSG00000089225,TBX5,oncogene,transcription factor,cell proliferation,apoptosis suppression,angiogenesis promotion,tumor suppressor gene regulation
ENSG00000100425,BRD1,chromatin remodeling,oncogene,histone acetylation,chromatin structure,genomic stability,dna repair
ENSG00000254986,DPP3,peptide metabolism,oncogene activation,cell growth regulation,tumor progression facilitation,pi3k/akt/mtor pathway interaction,metabolic reprogramming
ENSG00000130332,LSM7,rna splicing regulation,oncogene activation,upregulated expression,tumor growth promotion,cell survival enhancement,genomic instability
ENSG00000165175,MID1IP1,centrosome regulation,chromosomal instability,cell cycle modulation,oncogene mutation,tumor progression,mitotic spindle assembly
ENSG00000213022,KLK9,tumor growth,enzymatic activity,proteolytic regulation,cell signaling pathway,metastasis promotion,cancer cell invasion
ENSG00000135338,LCA5,spectrin superfamily,cytoskeletal protein,cellular structure maintenance,photoreceptor degeneration,leukocortin 5 protein,structural integrity disruption
ENSG00000005194,CIAPIN1,glycolytic regulation,oncogenic signaling,prognostic marker,metabolic reprogramming,cellular proliferation,therapeutic target
,MMD2,transcriptional regulation,myc interaction,cell cycle progression,apoptosis evasion,tumorigenesis correlation,chromatin remodeling
ENSG00000272047,GTF2H5,genomic instability,dna repair,tumor suppressor,apoptosis regulation,cell cycle progression,chromatin structure alteration
ENSG00000112425,EPM2A,glycogen metabolism,dual-specificity phosphatase,cell proliferation regulation,signal transduction modulation,mtor pathway interaction,oncogenesis promoter
ENSG00000187566,NHLRC1,tumor progression,antitumor protein regulation,dna damage response,tumor suppressor function,ubiquitin ligase activity,cancer cell signaling
ENSG00000183145,RIPPLY3,notch signaling pathway activation,transcriptional regulation,tumor progression enhancement,oncogenic role identification,stem cell maintenance disruption,tumor suppressor downregulation
ENSG00000114115,RBP1,tumor suppressor function,cell cycle regulation,apoptosis promotion,gene expression modulation,protein-protein interaction,loss of heterozygosity
ENSG00000099992,TBC1D10A,rab gtpase regulation,cell growth regulation,cancer driver mutation,tumor progression,cell proliferation,genomic instability
ENSG00000005812,FBXL3,ccne2 regulation,dna repair disruption,cell cycle progression,genomic instability,protein degradation pathways,homologous recombination impairment
ENSG00000057593,F7,serine protease activity,blood coagulation cascade,vitamin k-dependent enzyme,prothrombin activation,tissue factor interaction,inflammation modulation
ENSG00000243135,UGT1A3,bilirubin glucuronidation,phase ii metabolism,tumor metabolism regulation,hepatic transport regulation,drug conjugation,cytosolic enzyme activity
ENSG00000148158,SNX30,endosomal sorting,egfr pathway regulation,receptor recycling and degradation,oncogenic signaling promotion,tumor progression facilitation,cancer biology implications
ENSG00000114209,PDCD10,apoptosis inhibition,tumor suppression,cell death regulation,pro-apoptotic pathway regulation,bax interaction,poor prognosis association
ENSG00000122970,IFT81,cilia assembly,oncogenesis,prognostic biomarker,cellular proliferation,apoptosis regulation,microtubule maintenance
ENSG00000167720,SRR,rna splicing regulation,oncogenesis promotion,tumor cell proliferation,metastasis facilitation,angiogenesis induction,poor prognosis marker
ENSG00000153495,TEX29,chromatin remodeling,genome stability regulation,oncogene overexpression,tumor progression enhancement,apoptosis inhibition,prognostic biomarker
ENSG00000168172,HOOK3,microtubule stability,apoptosis modulation,cell migration promotion,tumor aggressiveness,protein-protein interaction,cancer progression
ENSG00000006712,PAF1,transcription elongation,constitutive activation,oncogenic protein,tumor progression,genomic instability,therapeutic target
ENSG00000196376,SLC35F1,glycosylation regulation,cell membrane transport,nucleotide sugar transport,oncogenic processes,tumor progression,cancer-related signaling pathways
ENSG00000183828,NUDT14,loss-of-function mutations,dna repair activation,tumor suppressor function,nucleotide regulation,oncogenic mechanism,therapeutic target
ENSG00000170873,MTSS1,cell migration,rho gtpase regulation,tumor suppression,pi3k/akt pathway inhibition,cytoskeleton organization,prognostic marker
ENSG00000080822,CLDND1,cellular homeostasis,ion channel function,tumor progression,transmembrane protein,cell volume regulation,sodium-potassium balance
ENSG00000108511,HOXB6,oncogene activation,transcriptional regulation,tumor progression,cell proliferation,metastasis promotion,poor prognosis indicator
ENSG00000140718,FTO,metabolic regulation,rna-binding protein activity,oncogene function,tumor progression,metabolic reprogramming,mrna stability
ENSG00000137492,THAP12,pi3k/akt pathway regulation,oncogenic function,cell survival enhancement,tumor progression promotion,apoptosis inhibition,transcriptional regulation
ENSG00000148985,PGAP2,pgap2 overexpression,post-translational modification,n-termini methylation,cell growth regulation,tumor progression,therapeutic target
ENSG00000196141,SPATS2L,genomic instability,oncogenic signaling,cell proliferation regulation,tumor microenvironment modulation,chromatin remodeling,gene expression regulation
ENSG00000038358,EDC4,ubiquitin-protein ligase activity,regulation of protein degradation,cullin 3-ring ubiquitin ligase complex,cellular homeostasis regulation,protein stability control,cell cycle progression modulation
ENSG00000184887,BTBD6,chromatin remodeling,transcriptional regulation,tumor suppressor function,cellular proliferation regulation,genomic stability maintenance,apoptosis modulation
ENSG00000169067,ACTBL2,cytoplasmic dynamics,cell migration,tumor aggressiveness,protein interactions,cytoskeletal regulation,genetic mutations
ENSG00000147394,ZNF185,transcriptional regulation,apoptosis inhibition,cell proliferation,metastasis promotion,tumor suppressor dysfunction,gene expression modulation
ENSG00000170423,KRT78,oncogenic potential,cytoskeletal disruption,epithelial-to-mesenchymal transition,prognostic marker,therapeutic target,cellular transformation
ENSG00000159377,PSMB4,immunoproteasome complex,protein turnover regulation,tumor growth promotion,nf-κb pathway activation,therapeutic target identification,cellular stress response modulation
ENSG00000134769,DTNA,cell adhesion disruption,pi3k/akt pathway interaction,oncogenic mutations,cell migration regulation,tumor heterogeneity,therapeutic target
ENSG00000135245,HILPDA,metabolic regulation,glycolytic switch,glutaminolytic activity,energy production modulation,pentose phosphate pathway interaction,mtor signaling pathway involvement
ENSG00000091583,APOH,tumor progression,suppression of immune response,cell migration and invasion,protease activity regulation,lipid metabolism modulation,coagulation pathway interaction
ENSG00000090971,NAT14,regulation of cell cycle,pi3k/akt pathway activation,enhanced cell proliferation,metabolic reprogramming,oncogene overexpression,genomic instability
ENSG00000198768,APCDD1L,wnt signaling pathway,gain of function mutations,tumor progression,prognostic biomarker,cellular differentiation,genetic instability
ENSG00000184205,TSPYL2,chromatin remodeling,epigenetic regulation,dna repair mechanisms,tumor aggressiveness,cell cycle progression,prognostic marker
ENSG00000223609,HBD,altered iron homeostasis,cellular metabolism disruption,hypoxia-inducible factors modulation,tumor adaptation,protein interaction,metabolic regulation
ENSG00000183049,CAMK1D,cell cycle regulation,apoptosis modulation,tumor growth promotion,metastasis facilitation,epithelial-to-mesenchymal transition,protein kinase activity
ENSG00000198586,TLK1,histone phosphorylation,chromatin remodeling,dna damage response,genomic instability,cell proliferation,therapeutic target
ENSG00000123064,DDX54,mtor pathway regulation,oncogene overexpression,cell proliferation promotion,rna stability regulation,protein-protein interaction,genome instability modulation
ENSG00000170486,KRT72,keratin overexpression,epithelial cell integrity disruption,tumor progression marker,cancer cell adhesion alteration,prognostic significance,cellular structure modification
ENSG00000132911,NMUR2,tumor growth,metastasis promoter,cellular dysregulation,g protein-coupled receptor function,therapeutic target,cancer progression
ENSG00000168917,SLC35G2,nucleotide sugar transport,cell surface protein modification,pi3k/akt pathway interaction,oncogene overexpression,cell growth promotion,kinase regulation
ENSG00000182504,CEP97,cilia formation regulation,cell signaling disruption,microtubule dynamics regulation,cell proliferation enhancement,survival pathway activation,tumorigenesis facilitation
ENSG00000185069,KRT76,cellular adhesion,mitotic regulation,tumor progression,cell migration,protein interaction,cytoskeletal structure
ENSG00000078596,ITM2A,glycosylation dysregulation,oncogenesis promotion,cellular growth modulation,tumor progression facilitation,glycoprotein modification,lipid metabolism alteration
ENSG00000112667,DNPH1,genomic instability,cellular proliferation,dna repair mechanism,tumor suppressor function,oncogenic mutation,cell cycle regulation
ENSG00000155313,USP25,genomic instability,loss of deubiquitinating activity,tumor suppressor function,pi3k/akt pathway interaction,p53 regulation,dna damage response
ENSG00000189299,FOXR2,cellular differentiation,epithelial-to-mesenchymal transition,metabolic regulation,transcription factor activation,gene expression modulation,nutrient-sensing pathway disruption
ENSG00000163719,MTMR14,cell proliferation,endocytosis regulation,autophagy modulation,signaling pathway dysregulation,metastasis promotion,overexpression association
ENSG00000171564,FGB,fibrinogen deposition,angiogenesis facilitation,cellular invasion enhancement,epithelial-to-mesenchymal transition,metastasis promotion,inflammation mediation
ENSG00000143224,PPOX,overexpression,oxidative stress,cancer driver gene,heme biosynthesis,cellular damage,protein interaction
ENSG00000126001,CEP250,aneuploidy,centrosome regulation,chromosomal instability,mitosis regulation,microtubule organization,spindle assembly dysfunction
ENSG00000155265,GOLGA7B,golgi apparatus regulation,autophagy modulation,cancer-related mutations,apoptosis dysregulation,tumor aggressiveness,cell cycle progression
ENSG00000113318,MSH3,tumor suppressor function,microsatellite instability,dna mismatch repair,genetic mutations,epigenetic alterations,cancer driver gene
ENSG00000119689,DLST,mitochondrial function,regulatory pathway modulation,dysregulation of redox balance,tumor progression,prognostic marker potential,cellular growth control pathways
ENSG00000144580,CNOT9,mrna degradation,cell proliferation,apoptosis inhibition,oncogenic process,tumor suppressor regulation,signaling pathway modulation
ENSG00000151835,SACS,cilia biogenesis,basal body formation,cellular structural integrity,aberrant cell signaling,potential oncogenic contribution,genetic instability
ENSG00000130762,ARHGEF16,oncogenic transformation,cancer progression,cell proliferation,rho gtpase activation,gef function,tumor metastasis
ENSG00000213023,SYT3,chromatin regulation,tumor progression,genomic instability,brca1 complex interaction,transcriptional modulation,oncogene overexpression
ENSG00000213967,ZNF726,transcriptional regulation,tumor progression,potential oncogene,cell proliferation,dna binding,zinc finger protein
ENSG00000068394,GPKOW,glucose metabolism regulation,glycolysis modulation,warburg effect,prognostic marker,therapeutic target,tumor microenvironment disruption
ENSG00000115183,TANC1,tumor progression,immune evasion,pi3k/akt pathway regulation,nf-κb signaling cascade activation,cell adhesion modulation,protein-protein interaction
ENSG00000134897,BIVM,transcriptional regulation,cell cycle control,oncogenic process,tumor progression,therapeutic target,dna repair
ENSG00000179922,ZNF784,transcription factor,zinc finger domain,dna binding,gene regulation,cell proliferation,tumor suppression
ENSG00000178021,TSPYL6,histone modification,transcriptional regulation,chromatin remodeling,tumor progression,protein-protein interactions,aberrant expression
ENSG00000116031,CD207,immune surveillance,antigen presentation,tumor suppression,dendritic cell regulation,anti-tumor immunity,cancer immunology
ENSG00000132768,DPH2,dna damage response,oncogene,genomic instability,prognostic marker,cell cycle regulation,apoptosis regulation
ENSG00000117298,ECE1,endothelin biosynthesis,angiogenic promotion,cell proliferation stimulation,tumor aggressiveness enhancer,vascular endothelial interaction,metastasis facilitator
ENSG00000002919,SNX11,regulation of endosomal sorting,interaction with pi3k/akt pathway,oncogene potential,cell growth modulation,survival signaling,tumor migration facilitation
ENSG00000143740,SNAP47,rab3a interaction,cell survival promotion,oncogenic potential,vesicle trafficking regulation,prognostic marker,protein-protein interaction
ENSG00000089902,RCOR1,e2f1 regulation,chromatin remodeling,cell cycle repression,tumor suppression,transcriptional control,corepressor function
ENSG00000167397,VKORC1,vitamin k-dependent protein regulation,anticoagulant target,tumor growth promotion,cell proliferation enhancement,mutational involvement in cancer,metabolic pathway disruption
ENSG00000085644,ZNF213,transcriptional regulator,tumor suppressor function,cell cycle regulation,dna repair modulation,oncogene/tumor suppressor ambiguity,genome stability maintenance
ENSG00000122008,POLK,dna repair,translesion synthesis,tumor suppressor loss,genomic instability,error-prone repair,alkylating agent resistance
ENSG00000141433,ADCYAP1,tumor progression,growth factor signaling,cellular invasion,pi3k/akt pathway activation,therapeutic target,signaling molecule overexpression
ENSG00000100095,SEZ6L,oncogenic,cell-cell adhesion disruption,emt process involvement,pi3k/akt pathway interaction,mapk/erk pathway modulation,adherens junction complex regulation
ENSG00000197008,ZNF138,tumor progression,dna binding,transcriptional regulation,cell growth modulation,oncogene function,apoptosis inhibition
ENSG00000170881,RNF139,ubiquitination regulation,tumor suppressor degradation,oncogenic process promotion,cell proliferation regulation,apoptosis inhibition,prognostic marker status
ENSG00000101294,HM13,tumor growth,oncogene function,non-coding rna regulation,gene expression modulation,cellular behavior influence,methylation-related overexpression
ENSG00000171236,LRG1,tumor progression,g protein-coupled receptor function,oncogenic potential,cell proliferation regulation,metastasis promotion,therapeutic target
ENSG00000143416,SELENBP1,tumor suppressor function,cell cycle regulation,dna repair mechanism,oxidative stress response,apoptosis promotion,genomic stability maintenance
ENSG00000035664,DAPK2,tumor suppressor,apoptosis regulation,cell survival modulation,mapk/erk pathway interaction,programmed cell death promotion,none
ENSG00000121851,POLR3GL,cell cycle regulation,transcriptional upregulation,oncogenic pathway activation,tumor progression,prognostic indicator,therapeutic target
ENSG00000223572,CKMT1A,energy metabolism regulation,potential biomarker,oncogenic function,overexpression,methylmalonyl-coa decarboxylase pathway,cellular energy homeostasis
ENSG00000237289,CKMT1B,altered cellular energy homeostasis,enhanced glycolysis,metabolic regulation,cellular proliferation,therapeutic target,oncogenic processes
ENSG00000068885,IFT80,cilia-mediated signaling,oncogenesis promotion,cell migration and invasion,tumor progression facilitation,potential biomarker,oncogenic pathway regulation
ENSG00000218891,ZNF579,regulation of gene expression,transcription factor activity,cell cycle regulation,antitumor protein interactions,apoptosis modulation,zinc finger domain structure
ENSG00000168484,SFTPC,tumor progression,proliferation regulation,cell migration,protein interaction,mapk/erk signaling,oncogenesis
ENSG00000112494,UNC93A,immune evasion,endosomal trafficking,toll-like receptor regulation,antitumor immune response,innate immune modulation,cancer immunosuppression
ENSG00000063587,ZNF275,oncogenic transcription factor,dna binding activity,cell cycle regulation,transcriptional repression,tumor progression,cancer associated gene
ENSG00000142684,ZNF593,cell cycle regulation,apoptosis evasion,transcriptional regulator,epigenetic modulation,transcription factor activity,oncoprotein function
ENSG00000132824,SERINC3,cellular proliferation inhibition,tumor suppression,lipid metabolism regulation,viral entry inhibition,apoptosis modulation,predictive biomarker
ENSG00000080298,RFX3,genomic instability,dna repair regulation,tumor suppressor regulation,cell cycle arrest,apoptosis regulation,transcriptional regulation
ENSG00000214160,ALG3,n-linked glycosylation,tumor progression,cell growth promotion,oncogenic protein regulation,apoptosis modulation,cancer metastasis enhancement
ENSG00000170369,CST2,pi3k/akt pathway,overexpression,tumor progression,metastasis,biomarker,epithelial-to-mesenchymal transition
ENSG00000186471,AKAP14,mtor pathway regulation,oncogenic signaling pathway involvement,protein kinase modulation,14-3-3 protein interaction,tumor suppressor function loss,chaperoning activity
ENSG00000173805,HAP1,chromatin remodeling,histone acetyltransferase activity,epigenetic regulation,genomic instability,tumor suppressor function,protein-protein interactions
ENSG00000111328,CDK2AP1,tumor suppressor function,cell cycle regulation,genomic instability,apoptosis induction,dna damage response,cell proliferation control
ENSG00000167767,KRT80,cellular morphology alteration,epithelial integrity disruption,intermediate filament component,keratin expression upregulation,oncogenic mutation driver,tumor cell survival promotion
ENSG00000229346,TRIM10,tumor suppressor activity,potential oncogenic mechanism,downregulation in kirc,ubiquitination and degradation,protein regulation,cellular homeostasis
ENSG00000169180,XPO6,export regulation,oncoprotein export,poor prognosis biomarker,tumor progression promoter,cell cycle regulator,apoptosis inhibitor
ENSG00000117222,RBBP5,chromatin remodeling,histone variant exchange,gene regulation,transcriptional activation,cell cycle regulation,apoptosis modulation
ENSG00000108813,DLX4,tumor progression,cell proliferation,transcriptional regulation,oncogenic pathway,metastasis,angiogenesis
ENSG00000130518,IQCN,tumor progression,cell migration,metastasis,protein interaction,gtpase regulation,calmodulin binding
ENSG00000239474,KLHL41,loss of function mutations,tumor suppression,protein aggregation,ubiquitination regulation,cell survival promotion,oncogenic pathway disruption
ENSG00000112118,MCM3,oncogene,overexpression,cell proliferation,poor prognosis,biomarker potential,tumor growth
ENSG00000135374,ELF5,transcription factor,oncogene,tumor suppressor suppression,epithelial-to-mesenchymal transition,constitutive activation,cellular metabolism reprogramming
ENSG00000053702,NRIP2,tumor suppressor,cell cycle regulation,estrogen receptor interaction,anti-apoptotic function,protein kinase activation,dna repair regulation
ENSG00000168883,USP39,pi3k/akt activation,tumor progression,dna repair regulation,ubiquitin-proteasome pathway,cell proliferation promotion,smc5-smc6 complex activation
ENSG00000078328,RBFOX1,rna binding,splicing regulation,promoter interaction,gene expression modulation,cell cycle progression,apoptosis suppression
ENSG00000167977,KCTD5,tumor suppressor function,cellular proliferation,apoptosis regulation,e3 ubiquitin ligase activity,btb/poz domain-containing protein,oncogenic protein degradation
ENSG00000106682,EIF4H,regulation of mrna translation,promotion of tumor growth,interaction with eif4e and 4e-bp1,amplification or mutation in cancer,oncogenic potential in renal cancer,facilitation of protein synthesis
ENSG00000107731,UNC5B,disrupted cellular adhesion,impaired apoptosis regulation,genetic deletion or mutation,tumor suppressor function loss,cell migration dysregulation,apoptosis resistance
ENSG00000067141,NEO1,adhesion molecule activity,cell migration promotion,epithelial-to-mesenchymal transition (emt),metastasis facilitation,signal transduction modulation,cancer progression regulation
ENSG00000105427,CNFN,cell migration,cell adhesion,actin cytoskeleton regulation,oncogenic driver,tumor progression,rho gtpase pathway
ENSG00000072682,P4HA2,angiogenesis promoter,collagen regulation,hif-1α regulator,oncogene overexpression,tumor suppressor interaction,metastasis enhancer
ENSG00000056277,ZNF280C,regulation of gene expression,transcription factor activity,oncogene overexpression,cell growth promotion,tumor progression marker,chromatin remodeling
ENSG00000282307,SERPINF1,tumor suppressor function,anti-angiogenic activity,cellular proliferation regulation,immune modulation,protease inhibition,angiogenesis suppression
ENSG00000147853,AK3,mitochondrial function,mitochondrial transport,cellular metabolism,redox balance regulation,cancer progression marker,tumor suppressor interaction
ENSG00000165801,ARHGEF40,rhoa activation,oncogene activation,cell migration enhancement,pro-migratory protein expression,tumor growth promotion,genomic instability
ENSG00000085998,POMGNT1,basement membrane component regulation,cell adhesion modulation,extracellular matrix modification,tumor growth promotion,metastasis facilitation,molecular interaction disruption
ENSG00000100036,SLC35E4,glycosylation regulation,nucleotide sugar transport,aberrant glycosylation,tumor progression,poor prognosis,oncogenic mechanism
ENSG00000196510,ANAPC7,chromosomal instability,cell cycle regulation,tumor progression,mitotic checkpoint control,ubiquitination pathway,oncogene-tumor suppressor dichotomy
ENSG00000168306,ACOX2,lipid metabolism regulation,tumor progression marker,autophagy modulation,cell survival pathways influence,fatty acid oxidation,prognostic biomarker potential
ENSG00000107736,CDH23,calcium signaling,cell migration,apoptosis regulation,oncogenic function,metastasis promotion,protein-protein interaction
ENSG00000107614,TRDMT1,methyladenosine modification,cell proliferation,oncogenic signaling,gain of function mutations,transcriptional regulation,apoptosis evasion
ENSG00000144035,NAT8,regulation of cellular metabolism,lipid biosynthesis,cell growth promotion,energy metabolism regulation,molecular interaction with acyl-coa synthetase,mtorc1 pathway activation
ENSG00000120675,DNAJC15,autophagy modulation,cancer cell survival,unfolded protein response (upr),overexpression,protein degradation regulation,tumor progression
ENSG00000116171,SCP2,cholesterol efflux,cell growth promotion,tumor progression marker,lipid metabolism regulation,sterol carrier protein function,overexpression in cancer cells
ENSG00000185231,MC2R,cellular metabolism regulation,oncogenic pathway activation,cell proliferation enhancement,pi3k/akt signaling involvement,g-protein coupled receptor function,tumor aggressiveness promotion
ENSG00000140932,CMTM2,tumor suppressor function,pi3k/akt signaling pathway,downregulation in cancer,interaction with mapk/erk pathway,cell proliferation regulation,poor prognosis association
ENSG00000101464,PIGU,cell cycle progression,constitutive activation,dna repair mechanism,oncogenic process,pi3k/akt/mtor pathway,tumor growth
ENSG00000163344,PMVK,mevalonate pathway,cell proliferation,energy metabolism,lipid biosynthesis,therapeutic resistance,oncogene overexpression
ENSG00000110011,DNAJC4,protein degradation,apoptosis regulation,tumor suppression,proliferation modulation,autophagy regulation,cellular homeostasis
ENSG00000198471,RTP2,cell growth promotion,genomic instability induction,interactions with pi3k/akt pathway,tumor aggressiveness enhancement,chromosomal alterations association,cell survival facilitation
ENSG00000106278,PTPRZ1,cell adhesion disruption,gene expression downregulation,tumor invasion,signaling pathway modulation,protein-protein interaction,oncogenesis promotion
ENSG00000163781,TOPBP1,genomic instability,dna repair,tumor progression,chemo-resistance,brca1 interaction,adaptor function
ENSG00000142675,CNKSR1,pi3k/akt pathway activation,cell proliferation enhancement,scaffolding function facilitation,akt signaling enhancement,tumor growth promotion,protein interaction modulation
ENSG00000008256,CYTH3,arf gtpase cycle regulation,metastasis promotion,cell migration facilitation,tumor progression,prognostic biomarker,gef activity
ENSG00000139405,RITA1,dna damage response pathway,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis modulation,homologous recombination repair
ENSG00000274126,C14orf180,cell proliferation,apoptosis regulation,oncogenesis,protein interaction,tumor progression,cell growth regulation
ENSG00000140374,ETFA,mitochondrial dysfunction,electron transport chain disruption,oxidative phosphorylation impairment,energy metabolism reprogramming,genomic instability induction,therapeutic target identification
ENSG00000167842,MIS12,genomic instability,chromosome segregation,mitotic checkpoint regulation,aneuploidy promotion,tumor progression facilitation,spindle checkpoint disruption
ENSG00000160783,PMF1,genomic stability,dna repair pathways,translesion synthesis,polymerase interaction,oncogenesis,genetic instability
ENSG00000141448,GATA6,gata6 transcription factor,cell cycle regulation,oncogenic function,apoptosis inhibition,epithelial-to-mesenchymal transition (emt),poor prognosis
ENSG00000169926,KLF13,klf13,kidney renal clear cell carcinoma,transcriptional regulation,tumor suppressor function,cell proliferation inhibition,apoptosis promotion
ENSG00000103051,COG4,golgi apparatus destabilization,cellular homeostasis disruption,tumor progression facilitation,aberrant glycosylation patterns,therapeutic target identification,protein modification dysregulation
ENSG00000108786,HSD17B1,steroid hormone regulation,cellular proliferation,oncogenic processes,tumor progression,metabolic regulation,hormone metabolism
ENSG00000281935,DNAH10,cilia-mediated signaling,oncogenic drivers,tumor suppressor loss,dysregulated expression,cytoskeletal regulation,cell cycle dysregulation
ENSG00000183955,KMT5A,histone modification,transcriptional regulation,chromatin remodeling,tumor growth promotion,therapeutic target,epigenetic dysregulation
ENSG00000137699,TRIM29,p53 suppression,cell proliferation enhancement,metastasis promotion,chromatin regulation,epigenetic modification,histone interaction
ENSG00000206283,PFDN6,tumor suppression,loss of function mutations,ubiquitination regulation,protein degradation pathway,cellular homeostasis disruption,genomic instability promotion
ENSG00000185869,ZNF829,transcriptional regulation,krab-domain-containing zinc finger protein,oncogene overexpression,tumorigenesis promotion,cell differentiation modulation,gene expression regulation
ENSG00000146243,IRAK1BP1,nf-κb signaling pathway inhibition,immune system modulation,tumor immunoevasion,negative regulation,cancer biology context dependence,potential oncogenic role
ENSG00000149541,B3GAT3,glycosylation regulation,cell surface modification,proteoglycan biosynthesis,cell adhesion disruption,tumor progression facilitation,gene expression alteration
ENSG00000100591,AHSA1,immune evasion,hla class i processing,protein acetylation,tumor progression,apoptosis regulation,cancer immunotherapy
ENSG00000253797,UTP14C,ribosome assembly,rna processing regulation,protein synthesis regulation,cellular metabolism,biosynthesis regulation,cancer cell growth support
ENSG00000182600,SNORC,aberrant splicing,disrupted cell cycle regulation,apoptosis evasion,chromosomal instability,tumor suppressor dysfunction,gene expression dysregulation
ENSG00000138622,HCN4,ion channel regulation,cell proliferation,tumor progression,prognostic marker,signaling pathway modulation,electrical excitability
ENSG00000169155,ZBTB43,tumor suppressor function,transcriptional regulation,cell cycle progression,apoptosis inhibition,oncogenic pathway activation,metastatic potential
ENSG00000165819,METTL3,m6a modification,rna stability regulation,oncogenic processes promotion,tumor cell proliferation enhancement,epigenetic regulation impact,genome-wide transcriptional regulation alteration
ENSG00000145388,METTL14,m6a methylation,cell proliferation,tumor progression,angiogenesis promotion,gene expression regulation,oncogene activation
ENSG00000186980,KRTAP23-1,**

cellular adhesion disruption,epithelial-to-mesenchymal transition,tumor progression,cell migration enhancement,upregulation in cancer,microenvironment modulation

**
ENSG00000179820,MYADM,regulation of p53 stability,cell cycle progression,protein degradation,apoptosis regulation,tumor suppressor modulation,therapeutic target
ENSG00000119953,SMNDC1,mrna stability regulation,tumor suppressor gene regulation,proliferation enhancement,apoptosis inhibition,tumor progression,genomic instability
ENSG00000130479,MAP1S,microtubule stabilization,mitotic spindle checkpoint regulation,cell proliferation promotion,tumor progression enhancement,oncogenic role,centrosome regulation
ENSG00000175782,SLC35E3,nucleotide sugar transport,aberrant glycosylation patterns,cell signaling disruption,tumor growth promotion,glycosylation regulation,protein-protein interaction
ENSG00000112739,PRPF4B,genome instability,spliceosome dysfunction,pi3k/akt signaling,tumor suppressor loss,oncogene activation,dna damage response
ENSG00000221926,TRIM16,e3 ubiquitin ligase activity,cellular proliferation inhibition,genomic stability maintenance,apoptosis induction,tumor suppression role,pi3k/akt pathway regulation
ENSG00000171988,JMJD1C,histone demethylation,dna repair pathway,cell cycle regulation,tumor suppressor function,brca1 interaction,metabolic regulation
ENSG00000114544,SLC41A3,tumor progression,metastasis,genomic instability,epigenetic modifications,magnesium homeostasis,oncogenesis
ENSG00000101363,MANBAL,transglutaminase activity,cell cycle regulation,oncogene function,tumor suppression,apoptosis modulation,protein modification
ENSG00000183034,OTOP2,regulation of cell proliferation,tumor progression,genomic instability,none,none,none
ENSG00000107282,APBA1,metastasis regulator,endocytosis regulation,tumor progression,cellular proliferation enhancement,protein interaction partner,apoptosis inhibition
ENSG00000188827,SLX4,genomic instability,dna repair deficiency,tumor progression,homologous recombination,metastasis promotion,synthetic lethality
ENSG00000148948,LRRC4C,cell migration,invasion,apoptosis evasion,cell cycle regulation,signaling pathway interaction,oncoprotein overexpression
ENSG00000133048,CHI3L1,tumor progression,cell migration,extracellular matrix remodeling,angiogenesis,oncogenic processes,inflammatory responses
ENSG00000130038,CRACR2A,calcium signaling pathway,gain of function mutations,tumor progression,therapeutic target,calcium channel regulation,oncogenic driver
ENSG00000159596,TMEM69,tumor suppressor function,cell adhesion disruption,e-cadherin complex interaction,epithelial polarity regulation,cancer cell invasion,cellular migration promotion
ENSG00000121769,FABP3,fatty acid transport,upregulation,cell proliferation,metabolic reprogramming,lipid oxidation,tumor growth
ENSG00000184840,TMED9,oncogenic driver,protein misfolding,protein quality control,cell signaling regulation,cancer metastasis,tumor growth promotion
ENSG00000151692,RNF144A,pi3k/akt pathway,protein degradation regulation,oncogenic function,tumor growth promotion,metastasis facilitation,signaling pathway modulation
,H3F3C,histone regulation,chromatin remodeling,gene overexpression,oncogene activation,therapeutic resistance,biomarker candidate
ENSG00000174417,TRHR,g-protein coupled receptor activation,hormone regulation,cell proliferation modulation,tumor progression association,prognostic biomarker,therapeutic target
ENSG00000146197,SCUBE3,oncogenic processes,protein-protein interactions,cellular growth regulation,tumor aggressiveness marker,biomarker for prognosis,gene expression regulation
ENSG00000159217,IGF2BP1,oncogene,cell growth promotion,translation regulation,stability of target mrnas,prognostic biomarker,tumor progression
ENSG00000183255,PTTG1IP,cell cycle regulation,genetic instability,p53 tumor suppressor inhibition,cyclin modulation,tumor progression,prognostic marker
ENSG00000178826,TMEM139,cell migration,cell invasion,transmembrane protein function,tumor progression,protein-protein interaction,cancer cell maintenance
ENSG00000243364,EFNA4,cell migration regulation,tumor progression promotion,pi3k/akt pathway activation,epithelial-to-mesenchymal transition regulation,cancer cell growth enhancement,metastasis facilitation
ENSG00000135333,EPHA7,receptor tyrosine kinase,tumor suppressor function,cell adhesion regulation,emt reversal,invasive behavior promotion,pi3k/akt pathway interaction
ENSG00000168995,SIGLEC7,cell-cell interaction,immune regulation,tumor microenvironment,cancer immunotherapy,sialic acid binding,phagocytosis modulation
ENSG00000141568,FOXK2,transcription factor activation,tumor progression facilitation,cell proliferation enhancement,apoptosis inhibition,metastasis promotion,genomic instability mediation
ENSG00000136152,COG3,n-glycosylation disruption,tumor progression,glycosylation pattern alteration,oncogenic process driver,cell growth regulation,protein misfolding
ENSG00000144560,VGLL4,wnt/β-catenin signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000115977,AAK1,cell migration,protein kinase activation,tumor progression,pi3k/akt pathway modulation,actin cytoskeleton dynamics,cell invasion
ENSG00000197912,SPG7,mitochondrial dysfunction,cellular respiration impairment,genomic instability,apoptosis regulation,oncogene activation,metabolic reprogramming
ENSG00000160202,CRYAA,aberrant protein aggregation,cell proliferation enhancement,molecular chaperone dysfunction,oncogenic signaling pathway activation,protein misfolding regulation,tumor cell survival promotion
ENSG00000118655,DCLRE1B,dna repair impairment,genomic instability,non-homologous end joining,cancer driver mutation,error-prone repair,tumor suppressor dysfunction
ENSG00000066135,KDM4A,histone demethylation,chromatin remodeling,oncogene activation,tumor progression,epigenetic regulation,prognostic marker
ENSG00000143753,DEGS1,cellular proliferation,signaling pathway regulation,therapeutic target,cellular differentiation,oncogenic signaling pathways,metastasis promotion
ENSG00000162430,SELENON,er stress response,calcium homeostasis regulation,oncogene activation,tumorigenesis promotion,metastasis facilitation,chemosensitivity reduction
ENSG00000106012,IQCE,wnt/β-catenin pathway,constitutive activation,tumor suppressor function,loss of function mutations,tumor progression,therapeutic target
ENSG00000121864,ZNF639,tumor suppressor function,transcriptional regulation,cellular proliferation,genomic instability,dna damage response,chromatin modification
ENSG00000148290,SURF1,mitochondrial dysfunction,cellular metabolism regulation,energy production disruption,tumor progression,genomic instability,protein complex assembly
ENSG00000183978,COA3,mitochondrial respiration,increased expression,genetic instability,oxidative stress,cellular metabolism,mitochondrial function
ENSG00000148841,ITPRIP,calcium regulation,cell proliferation,signaling pathway modulation,tumor progression,protein-protein interaction,cancer cell growth
ENSG00000111540,RAB5B,cancer-promoting activity,endocytic pathway regulation,tumor growth promotion,metastasis facilitation,cancer biomarker,proliferation enhancement
ENSG00000104142,VPS18,pi3k/akt interaction,tumor growth promotion,endosomal sorting regulation,lipid metabolism alteration,cellular homeostasis disruption,poor prognosis marker
ENSG00000079950,STX7,er-to-golgi trafficking,endoplasmic reticulum dysfunction,protein misfolding,cellular proliferation,tumor progression,genomic instability
ENSG00000176208,ATAD5,genomic instability,replication stress response,dna repair facilitation,oncogenic signaling pathway activation,cell survival promotion,tumor growth support
ENSG00000125450,NUP85,cellular transport regulation,nuclear pore complex assembly,apoptosis evasion,genomic instability,cell cycle dysregulation,cancer-associated mutations
ENSG00000160211,G6PD,pentose phosphate pathway,metabolic regulation,antioxidant defense,cellular homeostasis,energy production,oxidative stress
ENSG00000233927,RPS28,regulation of protein synthesis,tumor aggressiveness,enhanced cell cycle progression,ribosome assembly dysfunction,tumor suppressor activity loss,ancillary ribosomal protein function
ENSG00000095380,NANS,energy metabolism regulation,rna stability modulation,cellular growth promotion,oncogenic processes,metabolic adaptation,genomic instability
ENSG00000151503,NCAPD3,genomic instability,chromosome condensation,condensin complex dysfunction,tumor suppressor loss,dna damage response disruption,aneuploidy promotion
ENSG00000275152,CCL16,angiogenesis promotion,immune evasion,tumor microenvironment modulation,myeloid-derived suppressor cell recruitment,t regulatory cell interaction,vascular endothelial growth factor induction
ENSG00000173585,CCR9,tumor microenvironment modification,immune suppression,cell migration and invasion,therapeutic target,g-protein coupled receptor function,chemokine signaling pathway
ENSG00000227500,SCAMP4,tumor progression,tumorigenesis,cellular proliferation,anti-apoptotic functions,signaling pathway modulation,microrna regulation
ENSG00000124783,SSR1,disrupted protein targeting,cellular signal transduction,oncogenic pathway activation,tumor growth promotion,srp complex interaction,genomic instability
ENSG00000171357,LURAP1,chromatin remodeling,genome stability maintenance,dna repair,epigenetic regulation,cancer aggressiveness,oncogenic function
ENSG00000111052,LIN7A,cell junction regulation,disrupted polarity,increased invasiveness,cell adhesion disruption,prognostic marker potential,poor prognosis association
ENSG00000257727,CNPY2,tumor progression,metabolic reprogramming,protein-protein interaction,cell survival,oncogenesis,biomarker expression
ENSG00000170522,ELOVL6,lipid synthesis dysregulation,oncogenic function,fatty acid metabolism regulation,cell proliferation enhancement,pi3k/akt pathway interaction,therapeutic target
ENSG00000014641,MDH1,metabolic reprogramming,mitochondrial dysfunction,energy production dependency,glycolysis activation,tumor cell growth promotion,prognostic biomarker
ENSG00000180957,PITPNB,altered phospholipid metabolism,cell proliferation,genetic mutations,genomic instability,lipid homeostasis disruption,oncogenic processes
ENSG00000184939,ZFP90,tumor suppressor,genomic stability regulation,transcriptional regulation,immune response modulation,apoptosis resistance,cell proliferation suppression
ENSG00000070814,TCOF1,wnt/β-catenin signaling,transcriptional dysregulation,gain of function mutations,tumor driver,genomic instability,cell proliferation
ENSG00000118007,STAG1,genomic instability,cell cycle regulation,sister chromatid cohesion,centromere assembly,oncogenic function,tumor aggressiveness
ENSG00000103876,FAH,tyrosine catabolism disruption,oncogenic pathway inhibition,toxic metabolite accumulation,cellular damage and death,tumor suppressor role,metabolic enzyme dysfunction
ENSG00000164442,CITED2,transcriptional coactivator,constitutive activation,oncogenic function,cell growth regulation,dna repair regulation,genomic instability
ENSG00000166426,CRABP1,ra signaling pathway,constitutive activation,overexpression-driven oncogenesis,tumor progression and metastasis,therapeutic target,ra-dependent gene regulation
ENSG00000134020,PEBP4,phosphodiesterase regulation,oncogene overexpression,cell proliferation,tumorigenesis,signaling pathway modulation,apoptosis evasion
ENSG00000162595,DIRAS3,oncogenic gtpase,cell proliferation,gene amplification,tumor progression,therapeutic target,protein-protein interaction
ENSG00000128617,OPN1SW,oncogenic process,tumor progression,cell survival,apoptosis resistance,epithelial-to-mesenchymal transition,signaling pathway modulation
ENSG00000066027,PPP2R5A,pi3k/akt pathway regulation,protein phosphatase regulation,tumor suppressor function loss,substrate recognition and binding,cell cycle progression modulation,metabolic reprogramming
ENSG00000168591,TMUB2,emt regulation,cell trafficking regulation,tumor progression,metastasis promotion,protein interaction,signaling pathway modulation
ENSG00000242485,MRPL20,altered cellular metabolism,enhanced cell growth,increased resistance to apoptosis,mitochondrial ribosomal dysfunction,overexpression of mrpl20,tumor progression
ENSG00000180644,PRF1,tumor immunosurveillance,deficiency or mutations,immunodeficiency disorders,t-cell cytotoxicity,cytotoxic granules formation,antitumor immune response
ENSG00000149809,TM7SF2,immune evasion,apoptosis inhibition,cell proliferation regulation,tumor microenvironment modulation,protein-protein interactions,tnf receptor family member
ENSG00000180720,CHRM4,g protein-coupled receptor,muscarinic acetylcholine receptor activation,cell proliferation enhancement,apoptosis inhibition,tumor progression facilitation,phosphatidylinositol 3-kinase pathway modulation
ENSG00000241399,CD302,angiogenesis regulation,tumor progression influence,endothelial cell interaction,collagen iv binding,molecular target identification,tumor growth modulation
ENSG00000102103,PQBP1,**

rna-binding protein,cell cycle regulation,gene expression regulation,protein-protein interaction,tumor progression,oncogene overexpression

**
ENSG00000126524,SBDS,ribosome biogenesis,methyltransferase activity,cell growth promotion,tumor suppression evasion,ribosomal subunit assembly,cancer therapeutic target
ENSG00000087884,AAMDC,chromosomal instability,genomic alterations,mitotic spindle assembly,protein-protein interactions,microtubule dynamics regulation,spindle assembly checkpoint regulation
ENSG00000284096,PRKAR2B,pka signaling pathway,protein kinase activation,oncogenic driver,cellular metabolism regulation,tumor growth promotion,genomic instability modulation
ENSG00000198182,ZNF607,dna damage response,chromatin remodeling,tumor suppressor function,dna repair regulation,cell cycle control,cancer gene regulation
ENSG00000108924,HLF,cell cycle regulation,transcriptional activation,oncogenic signaling,tumor progression marker,apoptosis suppression,therapeutic target
ENSG00000167969,ECI1,genomic instability,dna repair regulation,ner pathway modulation,fanconi anemia/brca2 interaction,cell cycle control,oncogenic mutations
ENSG00000274749,KRTAP7-1,cellular structure modification,epithelial integrity regulation,tumor progression marker,genomic instability driver,pi3k/akt pathway interaction,keratin filament stabilization
ENSG00000102699,PARP4,dna repair,genomic instability,cell proliferation,metastasis regulation,angiogenesis regulation,protein-protein interaction
ENSG00000197646,PDCD1LG2,immunosuppression,tumor progression,cell signaling regulation,anti-tumor immune response inhibition,apoptosis regulation,pd-1/pd-l1 interaction
,IARS,iron-sulfur cluster assembly,cell proliferation,prognostic marker,therapeutic target,mitochondrial function,dna synthesis regulation
ENSG00000154856,APCDD1,wnt signaling pathway,constitutive activation,oncogene function,genomic driver,tumor progression,cell survival regulation
ENSG00000188488,SERPINA5,pi3k/akt pathway interaction,tumor progression and metastasis,protease regulation disruption,downregulated expression,biomarker potential,signaling pathway modulation
ENSG00000113194,FAF2,genomic instability,transcriptional dysregulation,dna repair disruption,apoptosis evasion,oncogenic transformation,cellular proliferation
ENSG00000164325,TMEM174,tumor progression,immune evasion,angiogenesis promotion,biomarker potential,metalloprotease function,regulatory mechanism dysregulation
ENSG00000074842,MYDGF,tumor progression,cell migration,genetic mutations,regulatory mechanism,transcriptional regulation,cell invasion
ENSG00000157992,KRTCAP3,keratin regulation,cellular stress response,tumor progression,epithelial cell integrity,protein stability modulation,cancer-related aberrant expression
ENSG00000137094,DNAJB5,autophagy regulation,tumor growth promotion,p53 interaction inhibition,oncogene role speculation,cellular protein degradation regulation,transcription factor regulation
ENSG00000007968,E2F2,cell cycle regulation,oncogene activation,transcriptional regulation,genomic instability,dna repair regulation,tumor suppressor gene repression
,MAATS1,emt induction,gene expression alteration,cell adhesion modification,pi3k/akt pathway interaction,prognostic marker,tumor progression enhancement
ENSG00000171509,RXFP1,pi3k/akt/mtor signaling,tumor progression,relaxin family peptides binding,cell growth regulation,metastasis promotion,therapeutic target
ENSG00000106009,BRAT1,genomic instability,homologous recombination repair,nuclear protein localization,tumor suppressor function,dna double-strand break repair,cell cycle regulation
ENSG00000280501,CEACAM7,tumor progression,metastasis,angiogenesis,cell adhesion,tumor evasion,immune suppression
ENSG00000101546,RBFA,cell cycle regulation,tumor suppressor function,loss of heterozygosity,uncontrolled cell growth,g1-s transition,cell cycle checkpoint
ENSG00000100319,ZMAT5,regulation of gene expression,zinc finger protein function,cell cycle progression,apoptosis modulation,oxidative stress response,dna damage repair
ENSG00000197279,ZNF165,tumor suppressor function,dna binding regulation,loss-of-function mutation,cell cycle progression inhibition,chromatin remodeling,transcriptional regulation
ENSG00000184517,ZFP1,tumor suppressor,transcriptional regulation,gene expression,embryonic development,cell proliferation inhibition,molecular regulation
ENSG00000132793,LPIN3,lipid biosynthesis regulation,phospholipid remodeling,tumor progression,oncogenic signaling,cellular membrane integrity,metabolic reprogramming
ENSG00000160396,HIPK4,apoptosis induction,cell proliferation inhibition,dna damage response,genomic stability maintenance,kinase activity,transcriptional regulation
ENSG00000121903,ZSCAN20,tumor suppressor activity,transcriptional regulation,apoptosis induction,cellular proliferation modulation,genomic instability prevention,protein interaction complexity
ENSG00000256977,LIMS3,transcriptional regulation,protein interactions,cellular signaling pathways,modulation of transcription,lim-only protein family,critical cellular processes
ENSG00000131370,SH3BP5,tumor progression,epithelial-to-mesenchymal transition,cell migration,oncogene overexpression,cell signaling regulation,protein-protein interaction
ENSG00000089006,SNX5,endocytic pathway regulation,oncogene activation,pi3k/akt signaling,tumor metabolism,therapeutic target,epidermal growth factor receptor recycling
ENSG00000183873,SCN5A,tumor progression,genomic upregulation,ion channel regulation,cell migration enhancement,oncogenic signaling,poor prognosis association
ENSG00000184226,PCDH9,tumor suppressor,cell-cell adhesion,epithelial-to-mesenchymal transition,apoptosis regulation,angiogenesis inhibition,prognostic biomarker
ENSG00000152779,SLC16A12,lactate transport,warburg effect,glycolytic metabolism,tumor growth promotion,poor prognosis marker,metabolic regulation
ENSG00000285069,SESN2,ampk pathway activation,mtor signaling inhibition,tumor suppression,genomic stability maintenance,autophagy promotion,cancer treatment target
ENSG00000010244,ZNF207,genomic instability,epigenetic regulation,tumor suppressor,transcriptional modulation,chromatin remodeling,apoptosis inhibition
ENSG00000154328,NEIL2,ber pathway regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic stability maintenance,dna repair enzyme activity
ENSG00000143499,SMYD2,histone modification,cell proliferation,pi3k/akt pathway modulation,oncogenic driver,tumor progression,apoptosis resistance
ENSG00000167653,PSCA,cell proliferation,enhanced migration,apoptosis resistance,tumor progression,cancer stem cells,signaling pathway interaction
ENSG00000169905,TOR1AIP2,protein-protein interaction,wd40 repeat domain,cell growth regulation,tumor progression,coiled-coil region,genomic integrity maintenance
ENSG00000162739,SLAMF6,immunosuppressive function,cell adhesion,tumor metastasis,prognostic biomarker,therapeutic target,cancer evasion
ENSG00000122756,CNTFR,cell proliferation,immune response modulation,signaling pathway activation,growth factor regulation,tumor progression marker,epi-genetic regulation
ENSG00000114978,MOB1A,hippo signaling pathway,constitutive activation,amplification or mutation,cell proliferation and survival,therapeutic target,regulatory mechanism
ENSG00000140521,POLG,mitochondrial dna replication,genomic instability,dna polymerase activity,cancer predisposition,cellular respiration dysfunction,oxidative stress accumulation
ENSG00000256525,POLG2,mitochondrial dna replication,genomic instability,oncogenic pathways activation,chemotherapy resistance,tumor growth promotion,tumorigenesis facilitation
ENSG00000182919,C11orf54,tumor progression,tumorigenesis,cell cycle regulation,apoptosis evasion,dna repair pathway,genomic instability
ENSG00000241685,ARPC1A,arpc1a function,cytoskeleton reorganization,cell migration,invasion and metastasis,cancer driver gene,tumorigenic potential
ENSG00000084733,RAB10,endocytosis,autophagy regulation,cell proliferation,tumor progression,membrane trafficking,oncogenic driver
ENSG00000178695,KCTD12,potassium channel regulation,cell proliferation,oncogenic processes,tumorigenesis,pi3k/akt interaction,mapk/erk pathway
ENSG00000149922,TBX6,tbx6 transcription factor,t-box family member,cancer driver gene candidate,kidney cell regulator,proliferation promoter,survival pathway modulator
ENSG00000074855,ANO8,calcium-activated chloride channel,oncogenic properties,cell proliferation,signaling pathway modulation,tumor progression,protein-protein interaction
ENSG00000126062,TMEM115,autophagy regulation,endocytosis facilitation,cellular homeostasis,tumor progression,therapeutic target,regulatory mechanism
ENSG00000152804,HHEX,wnt signaling pathway,tumor suppressor function,transcriptional regulation,gene expression modulation,oncogene repression,tissue development regulation
ENSG00000188986,NELFB,epigenetic regulation,chromatin remodeling,tumor suppression,gene silencing,histone modification,transcriptional regulation
ENSG00000155097,ATP6V1C1,proton transport,tumor aggressiveness,warburg effect,cellular ph regulation,apoptosis modulation,angiogenesis promotion
ENSG00000102984,ZNF821,tumor suppression,dna binding,gene repression,epigenetic regulation,cellular proliferation,transcriptional control
ENSG00000160145,KALRN,cell migration,aberrant activation,rho-gtpase signaling pathway,cytoplasmic protein regulation,tumor metastasis,poor prognosis marker
ENSG00000112367,FIG4,regulation of pi3k/akt pathway,loss-of-function mutations,tumor progression,autophagy regulation,protein-protein interaction,genomic instability
ENSG00000157657,ZNF618,transcriptional regulation,tumor progression,oncogenic driver,metastasis promotion,cellular proliferation,protein overexpression
ENSG00000187783,TMEM72,lysosomal regulation,autophagy dysfunction,cell cycle modulation,tumor suppressor,genomic instability,protein-protein interaction
ENSG00000134321,RSAD2,cellular protection,oncogenesis promotion,immune modulation,tumor progression,pro-survival activity,apoptosis resistance
ENSG00000129071,MBD4,dna repair defects,genomic instability,tumor suppressor,epigenetic alterations,mutation hotspot,prognostic biomarker
ENSG00000169826,CSGALNACT2,gag degradation pathway,tumor progression,metastasis promotion,angiogenesis regulation,cell adhesion modulation,molecular signature
ENSG00000134595,SOX3,oncogenic function,tumor progression,transcriptional regulation,pro-survival signaling,epigenetic regulation,poor prognosis
ENSG00000159445,THEM4,dna methylation,epigenetic regulation,histone modification,oncogenic transformation,signaling pathway activation,tumorigenesis
ENSG00000182885,ADGRG3,wnt/β-catenin pathway,overexpression,cell-cell interaction,metastasis,protein-protein interaction,tumor progression
ENSG00000183779,ZNF703,transcriptional repression,oncogene activation,cellular proliferation,angiogenesis promotion,apoptosis suppression,genomic amplification
ENSG00000173611,SCAI,tumor progression,cell adhesion modulation,metastasis regulation,oncogenic process,prognostic marker,signaling pathway interaction
ENSG00000144591,GMPPA,glycosylphosphatidylinositol-anchor biosynthesis,tumor aggressiveness,cellular metabolism regulation,potential biomarker,poor prognosis association,glycosylation pathway involvement
ENSG00000104517,UBR5,genomic instability,cell proliferation,dna damage response,protein degradation regulation,oncogenic substrate modification,therapeutic target
ENSG00000187147,RNF220,tumor progression,cell cycle regulation,apoptosis inhibition,dna damage repair,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction
ENSG00000187189,TSPYL4,histone modification,epigenetic regulation,cell proliferation,oncogene activation,tumor progression,genome instability
ENSG00000163913,IFT122,cilia assembly,dysregulation of cellular processes,oncogenic potential,cancer cell stemness,therapeutic resistance,tumor growth and progression
ENSG00000082397,EPB41L3,cellular migration,protein-protein interaction,tumor progression,adaptor function,metastasis promotion,hypoxia modulation
ENSG00000099260,PALMD,microtubule regulation,mitotic spindle formation,cell division,genomic stability,ploidy expansion,tumor suppressor interaction
ENSG00000173210,ABLIM3,tumor progression,metastasis promoter,cell invasion regulation,oncogene activation,pi3k/akt pathway interaction,genetic mutations
ENSG00000197713,RPE,hypoxic microenvironment,cell cycle regulation,apoptosis inhibition,melanin production,oncogenic properties,tumor progression
ENSG00000168566,SNRNP48,spliceosome assembly,rna processing regulation,tumor progression promotion,cell migration enhancement,angiogenesis facilitation,poor prognosis association
ENSG00000146733,PSPH,histone modification regulation,cancer driver gene,cell cycle regulation,proliferation promotion,tumor suppressor inhibition,epigenetic control
ENSG00000011465,DCN,tumor progression,cell adhesion regulation,growth factor modulation,proteoglycan function,cell migration promotion,signaling pathway interaction
ENSG00000134874,DZIP1,oncogenic transformation,transcription factor regulation,epithelial-to-mesenchymal transition,tumor progression,poor prognosis,cell proliferation
ENSG00000139370,SLC15A4,slc15a4,altered drug sensitivity,drug metabolism regulation,cellular transport,genomic instability,prognostic biomarker
ENSG00000110446,SLC15A3,transporter function,folate transport,cell cycle regulation,dna repair pathway interaction,genomic stability maintenance,metabolic reprogramming
ENSG00000166188,ZNF319,tumor suppressor activity,loss of function mutations,epigenetic silencing,cell cycle regulation,apoptosis induction,prognostic biomarker potential
ENSG00000187258,NPSR1,neurotransmission regulation,cancer cell proliferation,immune response modulation,g-protein coupled receptor,angiogenesis promotion,apoptosis suppression
ENSG00000129810,SGO1,golgi apparatus regulation,protein transport pathway,membrane trafficking regulation,secretory pathway modulation,cellular protein quality control,genomic instability
ENSG00000277607,VSTM1,immune evasion,tumor suppressor function,cellular differentiation regulation,protein expression regulation,proliferation control,genomic instability
ENSG00000142599,RERE,mapk/erk pathway regulation,scaffold protein function,cell signaling modulation,oncogenic signaling regulator,tumor progression driver,prognostic biomarker
ENSG00000150316,CWC15,rna processing,nuclear export,ribonucleoprotein assembly,protein-protein interactions,cancer cell metabolism,overexpression
ENSG00000164879,CA3,v-atpase complex,acidification of endosomes,tumor progression marker,proteolytic activation,extracellular matrix degradation,ph regulation
ENSG00000279486,OR2AG1,olfactory receptor function,cell migration and invasion,upregulation in cancer tissues,poor prognosis association,tumor progression,genomic instability
ENSG00000165507,DEPP1,cellular regulation,overexpression,promotes proliferation,therapeutic target,signaling pathway modulation,stress response regulation
ENSG00000134504,KCTD1,tumor suppressor,potassium channel regulation,cell signaling pathway,apoptosis regulation,genomic alterations,prognostic marker
ENSG00000169682,SPNS1,pi3k/akt pathway,metabolic regulation,tumor progression,cell proliferation,protein-protein interaction,overexpression
ENSG00000125779,PANK2,mitochondrial dysfunction,oxidative stress,cellular metabolism regulation,apoptosis regulation,genomic instability,gene expression alterations
ENSG00000126088,UROD,heme biosynthesis pathway,critical cellular process,protein function,potential tumor progression driver,genetic variation impact,none
ENSG00000152558,TMEM123,oncogenic mutations,mitochondrial dysfunction,cellular calcium homeostasis disruption,therapeutic target,cancer cell metabolism modulation,golgi apparatus localization
ENSG00000171365,CLCN5,tumor microenvironment,ion homeostasis disruption,cell signaling pathway alteration,proton transport regulation,ph level modulation,putative oncogene
ENSG00000068615,REEP1,mitochondrial dynamics,er stress response,tumor aggressiveness,cell survival,biomarker potential,er-mitochondria communication
ENSG00000089693,MLF2,amplification of mlf2,chromatin remodeling,dna repair regulation,epigenetic modification,genomic instability,tumor suppressor modulation
ENSG00000009790,TRAF3IP3,nf-kb signaling pathway,oncogene activation,cell proliferation,apoptosis inhibition,tumor progression,biomarker potential
ENSG00000095059,DHPS,folate metabolism,tetrahydrofolate synthesis,dna synthesis impairment,mutation hotspot,gene amplification,epigenetic regulation
ENSG00000132507,EIF5A,tumor progression,cellular translation regulation,oncogenic activation,protein interaction network,cancer-associated mutations,genomic instability
ENSG00000186130,ZBTB6,tumor suppressor,epigenetic regulation,cell proliferation,apoptosis inhibition,genome stability maintenance,transcriptional repression
ENSG00000131471,AOC3,hypoxia-inducible regulation,neurotransmitter biosynthesis,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,regulatory mechanism alteration
ENSG00000100321,SYNGR1,cellular heterodimerization,tumor progression,overexpression,regulatory mechanism,cell signaling pathway,transcriptional regulation
ENSG00000160113,NR2F6,transcriptional regulation,oncogenic pathway modulation,tumor progression,metastasis promotion,prognostic marker,epigenetic regulation
ENSG00000196233,LCOR,nuclear receptor signaling,transcriptional repression,chromatin modification,apoptosis regulation,cell cycle progression,tumor suppressor function
ENSG00000031823,RANBP3,ran-binding protein function,tumor progression,nuclear transport regulation,cancer cell proliferation,cell cycle control alteration,pi3k/akt pathway modulation
ENSG00000136273,HUS1,genomic instability,dna damage response,cell cycle regulation,atr/chk1 pathway activation,ubiquitin ligase recruitment,cancer predisposition
ENSG00000174607,UGT8,glucuronidation process,detoxification and metabolism,tumor overexpression,drug resistance development,prognostic marker,regulatory network modulation
ENSG00000284980,AGPAT5,lipid biosynthesis,cell proliferation,metabolic regulation,therapeutic target,glycerolipid synthesis,enzymatic activity
ENSG00000127586,CHTF18,chromatin remodeling,epigenetic regulation,tumor suppressor gene,oncogene expression,cell proliferation,genomic instability
ENSG00000164330,EBF1,transcriptional regulation,epithelial-to-mesenchymal transition,cell cycle progression,tumor metastasis,oncogene activation,cancer cell survival
ENSG00000115687,PASK,ampk signaling pathway,tumor progression,cellular metabolism,energy homeostasis,cell cycle regulation,apoptosis inhibition
ENSG00000107130,NCS1,calcium signaling,cellular regulation,gene expression modulation,neuronal excitability regulation,protein interaction,intracellular calcium regulation
ENSG00000121289,CEP89,microtubule dynamics regulation,centrosome duplication,genomic instability,chromosomal aberrations,tumor suppression,poor prognosis marker
ENSG00000101265,RASSF2,genetic instability,apoptosis resistance,cell proliferation,signaling pathway regulation,tumor suppression,promoter methylation
ENSG00000163806,SPDYA,microtubule stability,dynein motor function,cell migration,apoptosis suppression,metastatic regulation,cytoskeletal dynamics
ENSG00000198546,ZNF511,transcriptional regulation,chromatin remodeling,apoptosis regulation,differentiation control,tumor suppressor function,mutation hotspot
ENSG00000016082,ISL1,tumor progression,oncogene activation,transcriptional regulation,wnt/β-catenin signaling,cell proliferation,genetic alterations
ENSG00000010270,STARD3NL,apoptosis regulation,gene expression modulation,cell cycle progression,tumor aggressiveness,lipid metabolism disruption,protein-protein interactions
ENSG00000088876,ZNF343,genomic instability,oncogenic process,transcriptional regulation,dna repair,tumor progression,genomic interaction
ENSG00000132517,SLC52A1,folate metabolism regulation,tumor progression association,constitutive activation role,protein-protein interaction involvement,genomic profiling relevance,oncogenic function promotion
ENSG00000138030,KHK,glycolytic regulation,glucose metabolism,tumor growth support,warburg effect,metabolic enzyme,cellular homeostasis disruption
ENSG00000166619,BLCAP,**
apoptosis regulation,genomic instability,dna repair regulation,homologous recombination,tumor suppression loss,cancer progression
ENSG00000149547,EI24,cellular adhesion,cell migration,protein-protein interaction,tumor progression,genetic association,cancer cell invasion
ENSG00000080802,CNOT4,cell proliferation,mrna degradation,therapeutic target,oncogenic process,ccr4-not complex,tumorigenesis
ENSG00000162624,LHX8,oncogenic transcription factor,cell cycle regulation,apoptosis inhibition,immune suppression,tumor progression,transcriptional regulator
ENSG00000110848,CD69,tumor-associated immune suppression,immunomodulation,cell activation,proliferation regulation,t-cell differentiation,immune evasion mechanisms
ENSG00000171206,TRIM8,tumor suppressor function,apoptosis regulation,cell cycle inhibition,protein stability regulation,immune response modulation,genetic instability
ENSG00000120925,RNF170,e3 ubiquitin ligase activity,tumor suppressor gene regulation,cell cycle progression,apoptosis modulation,genomic instability,cancer-related signaling pathways
ENSG00000165996,HACD1,lipid metabolism regulation,modulator of pi3k/akt pathway,oncogene overexpression,tumor progression facilitation,cell survival enhancement,phosphoinositide phosphorylation regulation
ENSG00000102466,FGF14,cellular proliferation,metastatic potential,tumor progression,therapeutic target,signal transduction pathway,prognostic marker
ENSG00000137561,TTPA,antioxidant function,regulation of hif-1α,cellular adaptation to hypoxia,tumor progression,redox balance modulation,oxidative stress resistance
ENSG00000170290,SLN,androgen regulation,cellular transport,ion balance regulation,oncogenic pathway,protein-protein interaction,tumor overexpression
ENSG00000119574,ZBTB45,tumor suppressor function,transcriptional regulation,cell cycle regulation,apoptosis induction,dna repair modulation,epigenetic regulation
ENSG00000025156,HSF2,genomic instability,dna damage response,tumor progression,oncogenesis,apoptosis regulation,p53 pathway interaction
ENSG00000163754,GYG1,glycogen metabolism,warburg effect,oncogene,energy production,glucose uptake,lactate production
ENSG00000131779,PEX11B,cellular proliferation,peroxisomal biogenesis factor,pi3k/akt signaling pathway interaction,lipid metabolism regulation,cancer driver gene potential,tumor cell energy source
ENSG00000146857,STRA8,meiotic process,transcriptional regulator,protein-protein interaction,cell cycle regulation,chromosome pairing,gametogenesis
ENSG00000167470,MIDN,autophagy regulation,golgi apparatus function,oncogene activation,pi3k/akt pathway interaction,cell proliferation promotion,endoplasmic reticulum stress response
ENSG00000129226,CD68,tumor-associated macrophages,inflammatory process regulation,immune suppressive environment,pro-tumorigenic factor secretion,angiogenesis promotion,metastasis facilitation
ENSG00000167105,TMEM92,clear cell carcinoma promotion,cellular integrity regulation,tumor growth enhancement,metastasis facilitation,protein-protein interaction,cancer driver potential
ENSG00000099958,DERL3,erad pathway regulation,oncogene activation,tumor suppressor protein degradation,cell growth promotion,metastasis facilitation,therapeutic target identification
ENSG00000242265,PEG10,tumor progression,cell proliferation,genomic amplification,non-coding rna,oncogene activation,gene expression regulation
ENSG00000085871,MGST2,mgst2 expression,detoxification mechanism,cellular protection,apoptosis regulation,chemoresistance,genomic profiling
ENSG00000204316,MRPL38,ribosome assembly,aberrant protein synthesis,cell proliferation regulation,dna replication,metabolic reprogramming,tumor aggressiveness
ENSG00000146872,TLK2,genomic instability,dna repair mechanisms,kinase activation,cellular proliferation,chromatin remodeling,protein interaction
ENSG00000159263,SIM2,transcription factor regulation,constitutive activation,oncogene function,cell cycle progression,tumor growth promotion,genetic mutation hotspot
ENSG00000187987,ZSCAN23,cell proliferation,apoptosis inhibition,transcriptional regulation,oncogenic activity,chromatin remodeling,tumor suppressor loss
ENSG00000126749,EMG1,genomic instability,elevated expression,cell proliferation enhancement,epithelial-to-mesenchymal transition,chromosomal aberration interaction,pi3k/akt signaling pathway modulation
ENSG00000213699,SLC35F6,golgi apparatus regulation,nucleotide sugar transport,cell surface protein modification,altered glycosylation patterns,cell proliferation enhancement,metastasis promotion
ENSG00000184162,NR2C2AP,transcriptional regulation,tumor suppressor function,cell proliferation modulation,differentiation control,apoptosis evasion repression,cell cycle progression regulation
ENSG00000120333,MRPS14,mitochondrial translation,energy metabolism,oncogenesis,protein synthesis,ribosomal assembly,mitochondrial dysfunction
ENSG00000101445,PPP1R16B,**

regulation of pp1 activity,altered cell cycle progression,dysregulation of mapk signaling,cellular proliferation pathways,apoptosis modulation,tumor suppressor function
ENSG00000149596,JPH2,cell survival,enhanced proliferation,calcium homeostasis regulation,apoptosis resistance,pi3k/akt pathway interaction,prognostic marker
ENSG00000182973,CNOT10,gene expression regulation,deadenylation,rna stability,tumorigenesis,protein-protein interaction,mrna translation
ENSG00000134817,APLNR,angiogenesis promotion,g-protein coupled receptor function,pi3k/akt signaling activation,tumor growth enhancement,metastasis facilitation,cell proliferation stimulation
ENSG00000157216,SSBP3,single-stranded dna binding,genomic instability,chromosomal mutations,cell proliferation,protein-protein interactions,oncogenic potential
ENSG00000111432,FZD10,wnt signaling pathway,stabilization of beta-catenin,cell proliferation,oncogenic mutations,co-receptor function,glycosylation site
ENSG00000227460,SYNGAP1,cell migration and invasion,tumor progression,overexpression in cancer,synaptic plasticity regulation,cytoskeletal dynamics modulation,signaling pathway regulation
ENSG00000144711,IQSEC1,rho gtpase activation,cell migration,cell-cell adhesion,actin cytoskeleton regulation,gef domain interaction,tumor progression
ENSG00000161243,FBXO27,tumor suppressor function,reduced expression in tumors,cell cycle regulation,ubiquitination and degradation,scf complex component,poor prognosis associated
ENSG00000137710,RDX,emt induction,cell migration facilitation,apoptosis inhibition,tumor progression promotion,signaling pathway modulation,poor prognosis association
ENSG00000101977,MCF2,cell proliferation,protein kinase activation,tumor progression,apoptosis inhibition,signal transduction pathway,genomic amplification
ENSG00000074054,CLASP1,microtubule polymerization,overexpression in cancer,cell proliferation and survival,tumor aggressiveness and poor prognosis,cell cycle regulation disruption,prognostic biomarker potential
ENSG00000010310,GIPR,igf-1 signaling,tumor progression,cell proliferation,therapeutic target,insulin regulation,g protein coupled receptor
ENSG00000172159,FRMD3,rho gtpase regulation,hyperactivation of rhogaps,tumor progression inhibition,oncogenic mutation driver,protein-protein interaction modulation,effector molecule regulation
ENSG00000196811,CHRNG,neuromuscular junction regulation,oncogenic processes,pi3k/akt pathway interaction,tumor progression,biomarker potential,cell proliferation enhancement
ENSG00000158411,MITD1,mitochondrial translocation,oxidative stress induction,apoptosis resistance,proliferation enhancement,metabolic reprogramming,epigenetic alterations
ENSG00000130724,CHMP2A,autophagy regulation,cell growth modulation,cellular compartmentalization,endocytic pathway disruption,escrt-iii complex regulation,pi3k/akt signaling interaction
ENSG00000288505,NANOS3,cellular proliferation,oncogenic processes,regulatory mechanisms,translation regulation,tumor suppressor inhibition,protein interaction
ENSG00000111275,ALDH2,metabolic regulation,genomic instability,reactive oxygen species accumulation,cellular detoxification,oncogenic signaling pathway activation,therapeutic target
ENSG00000165092,ALDH1A1,aldh1a1 upregulation,cell proliferation enhancement,cancer stem cell marker,chemoresistance,lipid peroxidation detoxification,metabolic reprogramming
ENSG00000133997,MED6,proteasome function,protein degradation,cellular regulation,tumor suppressor,genetic instability,oncogenic transformation
ENSG00000134363,FST,extracellular regulation,cell migration,tumor progression,activin signaling inhibition,metastasis promotion,oncogenic function
ENSG00000164347,GFM2,tumor promotion,oncogenic protein translation,signaling pathway activation,cell proliferation enhancement,prognostic biomarker potential,trna charging dysregulation
ENSG00000143771,CNIH4,tumor progression,cell proliferation,oncogenic potential,potassium channel function,cell growth regulation,overexpression
ENSG00000171368,TPPP,microtubule dynamics,cellular architecture regulation,protein-protein interactions,chaperone function,tumor suppressor potential,overexpression association
ENSG00000143184,XCL1,tumor-associated immunosuppression,immune evasion,prognostic marker,immunomodulation,chemokine signaling,t cell recruitment
ENSG00000274726,ARHGEF10,rhoa activation,cancer cell migration,cell adhesion regulation,tumor progression enhancement,gef activity modulation,oncogene overexpression
ENSG00000171234,UGT2B7,phase ii metabolism,tumor resistance,chemotherapy resistance,substrate conjugation,metabolic regulation,enzyme overexpression
ENSG00000011677,GABRA3,gaba_a receptor subunit,tumor suppressor pathway modulation,neurotransmission regulation,cellular excitability control,gene expression modification,protein interaction
ENSG00000113269,RNF130,pi3k/akt pathway modulation,oncogenic process promotion,tumor growth facilitation,cell survival regulation,ubiquitination machinery modulation,genomic stability disruption
ENSG00000189334,S100A14,cell cycle regulation,calcium homeostasis regulation,epithelial-to-mesenchymal transition modulation,tumor progression enhancement,metastasis facilitation,biomarker candidate
ENSG00000174327,SLC16A13,tumor glycolysis,metabolic reprogramming,therapeutic target,prognostic marker,glycolytic metabolism,monocarboxylate transport
ENSG00000061656,SPAG4,microtubule regulation,tumor progression,proliferation regulation,antigen expression,cell motility regulation,oncogenesis
ENSG00000112378,PERP,apoptosis regulation,dna damage response,tumor suppressor function,cell survival modulation,mitochondrial pathway engagement,cancer prognosis marker
ENSG00000180053,NKX2-6,transcription factor regulation,oncogenic function,tumor progression driver,cell differentiation regulator,genomic instability promoter,chromosomal alteration mediator
ENSG00000100926,TM9SF1,amplification,lipid metabolism regulation,cell membrane trafficking,tumor growth promotion,metastasis enhancement,protein-protein interaction
ENSG00000127527,EPS15L1,clathrin-mediated endocytosis,tumor progression,metastasis regulation,cell migration regulation,signal transduction modulation,growth factor receptor interaction
ENSG00000110786,PTPN5,constitutive activation,tumor progression,phosphatase activity,oncogene activation,cell proliferation,signaling pathway modification
ENSG00000134873,CLDN10,overexpression,cell adhesion disruption,epithelial-to-mesenchymal transition regulation,tumor progression facilitation,biomarker and therapeutic target potential,genomic instability promotion
ENSG00000164270,HTR4,tumor progression,cancer driver genes,serotonin signaling,mutation or overexpression,g protein-coupled receptor,proliferation regulation
ENSG00000198042,MAK16,centrosome regulation,chromosomal instability,cell proliferation regulation,microtubule-associated protein interaction,mitotic kinase activation,aneuploidy induction
ENSG00000116213,WRAP73,genome instability,chromatin remodeling,cell proliferation,cell cycle regulation,dna replication,mcm complex interaction
ENSG00000172461,FUT9,tumor progression,glycosylation regulation,cell adhesion enhancement,metastasis promotion,tumor growth facilitation,glycoconjugate modification
ENSG00000109738,GLRB,oncogenic properties,tumor progression,cell survival,apoptosis inhibition,detoxification regulation,glutathione conjugation
ENSG00000187954,CYHR1,cellular signaling,protein stability regulation,tumorigenesis,cell growth modulation,cancer progression,stress response regulation
ENSG00000158710,TAGLN2,actin cytoskeleton remodeling,cancer cell migration,cell adhesion modulation,extracellular matrix interaction,gene expression upregulation,metastatic niche establishment
ENSG00000196812,ZSCAN16,dna repair regulation,genomic instability maintenance,transcriptional regulation,non-homologous end joining pathway interaction,cellular differentiation modulator,tumorigenesis association
ENSG00000173409,ARV1,genetic regulation,tumor suppressor activity,antioxidant response,cellular stress response,apoptosis modulation,cell cycle regulation
ENSG00000151224,MAT1A,mitochondrial function,energy metabolism regulation,cell survival promotion,glycolysis enhancement,tumor progression contributor,therapeutic target
ENSG00000078269,SYNJ2,endocytosis regulation,phosphoinositide modulation,oncogene overexpression,tumor progression driver,cell membrane trafficking alteration,vesicle interaction and trafficking
ENSG00000104154,SLC30A4,zinc export mechanism,cellular proliferation regulation,protein interaction,poor prognostic factor,tumor aggressiveness marker,metabolic regulation
ENSG00000163873,GRIK3,ionotropic glutamate receptor function,glutamate receptor modulation,cell survival pathway regulation,tumor progression,therapeutic target,genomic mutation profiling
ENSG00000233276,GPX1,glutathione peroxidase activity,oxidative stress regulation,tumor progression,metastasis promotion,chemoresistance induction,poor prognosis marker
ENSG00000163792,TCF23,constitutive activation,wnt signaling pathway,cell proliferation,transcriptional regulation,genomic amplification,tumor suppressor
ENSG00000170899,GSTA4,cell survival pathways,tumor progression,antioxidant activity,detoxification process,cancer aggressiveness,xenobiotic metabolism
ENSG00000183463,URAD,oncogenesis,cell proliferation,signaling pathway regulation,protein interaction,metastasis promotion,dysregulation
ENSG00000198807,PAX9,transcription factor activity,cell proliferation regulation,oncogene role,ectodermal tissue development,cell cycle progression,signaling pathway interaction
ENSG00000121931,LRIF1,dna repair regulation,genomic stability maintenance,tumor suppressor function,chromatin remodeling,oncogenic mutations,cancer susceptibility gene
ENSG00000152270,PDE3B,cgmp regulation,cellular signaling,tumor proliferation,apoptosis modulation,phosphodiesterase activity,oncogenic processes
ENSG00000101040,ZMYND8,chromatin regulation,histone modification,oncogenic transcription,metastasis promotion,tumor progression,genomic instability
ENSG00000203933,CXorf66,cellular regulation,pseudogene,genomic instability,epigenetic regulation,tumorigenesis,regulatory mechanism
ENSG00000177556,ATOX1,iron homeostasis regulation,cellular proliferation,oxidative stress modulation,antioxidant function,protein interaction,tumor progression
ENSG00000086289,EPDR1,cellular proliferation,epithelial development,pou domain transcription factor,tumor suppressor function,regulation of cell cycle progression,epithelial-to-mesenchymal transition
ENSG00000165655,ZNF503,cell proliferation,transcription factor function,gene regulation,oncogene activation,angiogenesis promotion,tumor progression
ENSG00000162571,TTLL10,microtubule dynamics regulation,cell division modulation,oncogenic transformation driver,therapeutic target potential,dysregulated expression implicated,mitotic spindle stabilization alteration
ENSG00000182463,TSHZ2,wnt/β-catenin pathway,transcriptional regulation,chromatin remodeling,oncogenic processes,aberrant gene expression,tumor progression
ENSG00000126264,HCST,il-6 receptor activation,inflammation pathway,immune response regulation,cell survival signaling,jak/stat pathway modulation,tumor immune evasion
ENSG00000128309,MPST,angiogenesis promotion,cell growth regulation,inflammation modulation,tumor progression enhancer,oncogene interaction modifier,prostaglandin biosynthesis
ENSG00000167395,ZNF646,zinc finger protein regulation,tumor suppression,cell proliferation repression,epigenetic modification,chromatin structure regulation,polycomb group complex interaction
ENSG00000088970,KIZ,tumor suppressor regulation,cell proliferation,wnt signaling pathway,beta-catenin stabilization,cell cycle regulation,mitotic spindle regulation
ENSG00000167491,GATAD2A,chromatin regulation,transcriptional activation,cell proliferation,oncogenesis,metastasis,therapeutic target
ENSG00000116906,GNPAT,lipid metabolism,triglyceride synthesis,cancer cell growth,oncogene overexpression,energy storage regulation,genomic amplification
ENSG00000172613,RAD9A,dna damage response,genomic instability,loss of function mutations,cell proliferation enhancement,g2/m checkpoint regulation,tumor suppressor activity
ENSG00000033178,UBA6,cell survival,apoptosis resistance,protein degradation,ubiquitination pathway,oncogenic signaling,cell proliferation
ENSG00000104472,CHRAC1,chromatin remodeling,transcription regulation,tumor progression,oncogenic gene expression,cell proliferation enhancement,metastasis facilitation
ENSG00000179051,RCC2,cell cycle regulation,chromosomal segregation,genomic instability,kinase inhibitor target,mitotic checkpoint function,oncogenic protein overexpression
ENSG00000136881,BAAT,bile acid synthesis,cellular metabolism,lipid biosynthesis,cell growth regulation,poor prognosis marker,therapeutic target
ENSG00000163347,CLDN1,wnt/β-catenin signaling pathway,glycolytic reprogramming,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,prognostic marker,tumor progression
ENSG00000081870,HSPB11,mitochondrial function,cancer promotion,tumor growth,metastasis facilitation,actin cytoskeleton regulation,signaling pathway modulation
ENSG00000198963,RORB,tumor suppressor function,epithelial-to-mesenchymal transition regulation,differentiation regulation,apoptosis induction,angiogenesis modulation,poor prognosis association
ENSG00000147548,NSD3,histone methylation,chromatin regulation,oncogenic role,genome stability,cell growth regulation,signaling pathway interaction
ENSG00000120686,UFM1,ubiquitin-fold modifier 1 conjugation,anti-proteolytic function,cell cycle regulation,oncogenic protein modification,tumor growth promotion,metastasis and therapy resistance
ENSG00000164687,FABP5,lipid metabolism regulation,tumor progression promotion,oncogenic signaling activation,cell survival enhancement,epigenetic modification involvement,cytoplasmic localization
ENSG00000139445,FOXN4,cell cycle regulation,apoptosis modulation,tumor suppressor interaction,overexpression,genomic instability,transcriptional regulation
ENSG00000011523,CEP68,microtubule regulation,cell cycle progression,tumor suppressor function,apoptosis resistance,oncogenic protein overexpression,cancer cell proliferation
ENSG00000135775,COG2,copi-coated vesicles formation,protein trafficking regulation,retrograde transport involvement,tumorigenesis contribution,oncogenic pathway modulation,aberrant protein secretion
ENSG00000124209,RAB22A,endocytic pathway regulation,tumor progression promotion,prognostic marker,oncogenic signaling activation,cell migration enhancement,metastasis facilitation
ENSG00000113272,THG1L,histone modification,chromatin remodeling,tumor suppressor regulation,cancer progression,cell proliferation,survival pathway activation
ENSG00000165704,HPRT1,genomic stability,dna repair mechanisms,purine salvage pathway,cellular proliferation,base excision repair,protein interaction
ENSG00000197901,SLC22A6,altered drug resistance,cellular uptake regulation,oncogenic process contribution,transporter function regulation,chemotherapeutic agent interaction,cellular ph regulation
ENSG00000251380,DCANP1,tumor suppression,cell adhesion regulation,protein interaction modulation,cancer progression regulation,genomic instability regulation,tissue-specific expression
ENSG00000042429,MED17,transcriptional regulation,cell cycle progression,epithelial-to-mesenchymal transition (emt),oncogenic processes,protein interaction,dysregulation
ENSG00000148297,MED22,transcriptional regulation,cell cycle progression,oncogenic processes,genetic predisposition,tumor suppressor function loss,epigenetic modifications
ENSG00000170689,HOXB9,oncogene,transcription factor,epithelial-to-mesenchymal transition (emt),tumor progression,metastasis,biomarker
ENSG00000100284,TOM1,oncogenesis,tumor progression,therapeutic target,autophagy regulation,endocytosis regulation,immune response modulation
ENSG00000039600,SOX30,loss of function mutations,tumor suppressor activity,cell cycle regulation,apoptosis modulation,transcriptional regulation,prognostic biomarker
ENSG00000111481,COPZ1,cellular growth modulation,copper transport regulation,oxidative stress response,tumor progression facilitation,signaling pathway modulation,stemness maintenance
ENSG00000243989,ACY1,glutamate metabolism,amino acid catabolism,cell survival regulation,metastasis promotion,mtor pathway modulation,mitochondrial function enhancement
ENSG00000186815,TPCN1,calcium signaling pathway,oncogenic function,tumor progression,metastasis regulation,biomarker for prognosis,cellular migration
ENSG00000162341,TPCN2,cation channel regulation,growth factor signaling,cell survival pathway,tumor adaptation,stress response modulation,channel opening mechanism
ENSG00000153896,ZNF599,transcriptional regulation,chromatin remodeling,cell proliferation,apoptosis modulation,tumor progression marker,epigenetic modification
ENSG00000167528,ZNF641,transcriptional regulation,zinc finger protein function,dna binding activity,cell growth regulation,proliferation promotion,chromatin remodeling interaction
ENSG00000134551,PRH2,cell cycle regulation,transcriptional modulation,tumor progression,apoptosis inhibition,histone modification,angiogenesis
ENSG00000258429,PDF,apoptosis regulation,cell signaling modulation,tumorigenesis association,protein interaction,oncogenic potential,genetic alteration
ENSG00000170473,PYM1,pi3k/akt signaling pathway,mitochondrial localization,cell survival and proliferation,oncogenic processes,energy metabolism regulation,ubiquitin-proteasome system regulation
ENSG00000149798,CDC42EP2,cell migration,cytoskeleton reorganization,oncogene activation,tumor progression,metastasis regulation,pi3k/akt pathway interaction
ENSG00000165804,ZNF219,cell proliferation,transcriptional regulation,oncogene,epigenetic dysregulation,tumor progression,prognostic biomarker
ENSG00000074416,MGLL,glycolytic reprogramming,mitochondrial metabolism,cell proliferation enhancement,glycating agent detoxification,oncogenic target,cancer metabolism alteration
ENSG00000135926,TMBIM1,mitochondrial dynamics,metabolic regulation,cell survival pathway,apoptosis modulation,autophagy regulation,tumor metabolism
ENSG00000162885,B3GALNT2,n-glycan branching,tumor progression,immune evasion,cell surface interaction,glycosylation regulation,protein modification
ENSG00000165502,RPL36AL,genomic instability,tumor progression,oncogene,cell proliferation,translation regulation,protein synthesis
ENSG00000066777,ARFGEF1,small gtpase activation,membrane trafficking,cell migration promotion,tumor grade correlation,oncogenic potential,genomic profiling
ENSG00000283868,ZBTB4,oncogene activity,transcription factor function,tumor growth promotion,cell cycle regulation,genomic instability,protein-protein interaction
ENSG00000276600,RAB7B,endocytic pathway regulation,oncogenic driver,gtpase activity,cancer metastasis,cell growth promotion,lysosomal trafficking
ENSG00000100360,IFT27,cancer driver gene,oncogene,cell cycle regulation,apoptosis evasion,cellular proliferation,dna repair regulation
ENSG00000204815,TTC25,cell cycle regulation,g2/m phase checkpoint activation,genomic instability,oncogenesis,protein-protein interactions,tumor suppressor-like function
ENSG00000183625,CCR3,chemokine signaling pathway,immune suppression,tumor microenvironment,g protein-coupled receptor function,oncogene interaction,angiogenesis regulation
ENSG00000188730,VWC2,oncogenic activity,cell migration,epithelial-to-mesenchymal transition,angiogenesis promotion,extracellular matrix interaction,signaling pathway regulation
ENSG00000168792,ABHD15,metabolic reprogramming,oncogenic processes,cell proliferation,fatty acid metabolism,altered expression,tumor progression
ENSG00000171049,FPR2,inflammation,tumor progression,immune response modulation,g-protein coupled receptor,angiogenesis,cell survival regulation
ENSG00000130382,MLLT1,epigenetic regulation,genomic instability,loss of function mutation,cell cycle regulation,apoptosis modulation,tumor suppressor activity
ENSG00000103966,EHD4,cell surface protein recycling,endocytosis regulation,growth factor receptor regulation,membrane trafficking modulation,oncogenic pathway activation,tumor cell migration
ENSG00000039987,BEST2,emt regulation,oncogenic function,ion channel regulation,cellular homeostasis,poor prognosis biomarker,epithelial-to-mesenchymal transition
ENSG00000156675,RAB11FIP1,rab gtpase regulation,endosomal trafficking,oncogenic signaling pathway,tumor progression,metastasis promotion,cell surface receptor recycling
ENSG00000137393,RNF144B,ubiquitination regulation,tumor suppressor regulation,apoptosis modulation,proliferation influence,angiogenesis regulation,protein degradation pathway
ENSG00000153339,TRAPPC8,endosomal sorting complex required for transport (escrt),protein synthesis regulation,cell proliferation enhancement,pi3k/akt signaling activation,metastasis promotion,tumor growth facilitation
ENSG00000135924,DNAJB2,cell cycle regulation,apoptosis resistance,genomic instability,tumor suppression modulation,protein quality control,cancer cell proliferation
ENSG00000103740,ACSBG1,dna repair,cell cycle regulation,apoptosis regulation,nuclear localization,genomic instability,prognostic marker
ENSG00000175567,UCP2,mitochondrial membrane potential,cell survival,apoptosis resistance,glycolysis enhancement,warburg effect regulation,metabolic reprogramming
ENSG00000188038,NRN1L,tumor progression,oncogene regulation,tumor suppressor modulation,cell proliferation,pi3k/akt pathway activation,chromatin remodeling
ENSG00000141956,PRDM15,tumor suppressor function,genomic instability,dna repair mechanism,cell proliferation regulation,apoptosis regulation,epigenetic regulation
ENSG00000102468,HTR2A,cellular proliferation,pi3k/akt signaling pathway,g-protein coupled receptor,tumor progression,molecular interaction,antitumor activity
ENSG00000110063,DCPS,decapping regulation,tumor progression,rna binding protein,translation regulation,mrna stability,protein interaction
ENSG00000132467,UTP3,rna helicase activity,cell cycle regulation,dna damage response,transcriptional modulation,apoptosis inhibition,oncogenic potential
ENSG00000114268,PFKFB4,glycolytic regulation,oncogenic metabolism,tumor growth promotion,poor prognosis marker,hypoxia response element,metabolic reprogramming
ENSG00000118985,ELL2,transcriptional elongation,oncogenic mutations,constitutive activation,cell proliferation,dna repair mechanism,tumor progression
ENSG00000147124,ZNF41,transcription factor activity,gene regulation,tumor suppression,carcinogenesis,cellular differentiation,apoptosis regulation
ENSG00000132837,DMGDH,methyl group transfer,redox balance regulation,oxidative stress modulation,cellular metabolism,protein overexpression,tumor proliferation
ENSG00000244476,ERVFRD-1,genomic instability,tumor promotion,dna damage repair,replication stress tolerance,proliferation regulation,survival pathway activation
ENSG00000124243,BCAS4,cell cycle regulation,chromatin remodeling,dna damage response,oncogenic potential,pi3k/akt pathway interaction,tumor proliferation
ENSG00000141971,MVB12A,endosomal sorting,escrt-0 complex interaction,multivesicular body pathway,protein degradation and recycling,tumorigenesis contribution,cell cycle regulation
ENSG00000155629,PIK3AP1,pi3k regulation,oncogenic processes,cell growth modulation,akt interaction,mtor pathway involvement,genomic instability
ENSG00000143603,KCNN3,pi3k/akt pathway modulation,cell proliferation enhancement,migration and invasion promotion,oncogenic processes involvement,voltage-gated potassium channel function,genomic overexpression
ENSG00000213397,HAUS7,cilia assembly disruption,tumor suppressor function,cellular proliferation regulation,protein-protein interaction,centriole assembly,genetic instability
ENSG00000065883,CDK13,cancer driver gene,cell proliferation,genomic instability,tumor progression,metastatic potential,epithelial-to-mesenchymal transition (emt)
ENSG00000109618,SEPSECS,cell cycle regulation,dna damage response,tumor progression,cancer driver gene,oncogenic processes,microtubule dynamics
ENSG00000163406,SLC15A2,folate transport,cellular proliferation,metabolic regulation,therapeutic target,prognostic biomarker,tumor growth
ENSG00000153234,NR4A2,oncogenic potential,constitutive activation,immune modulation,cell proliferation,tumor progression,transcriptional regulation
ENSG00000119121,TRPM6,calcium homeostasis disruption,ion channel function,cellular signaling modulation,cancer cell survival promotion,tumor progression facilitation,genetic alterations
ENSG00000115163,CENPA,chromosomal instability,gain of function mutations,centromere dysfunction,epigenetic regulation,genomic rearrangements,aneuploidy driver
ENSG00000152409,JMY,chromatin remodeling,epigenetic regulation,co-factor interaction,transcriptional activation,cell cycle progression,tumor promoter
ENSG00000134072,CAMK1,tumor progression,cell proliferation,pro-survival pathways,therapeutic target,signaling pathway regulation,genomic instability
ENSG00000109163,GNRHR,oncogenesis,cellular proliferation,g protein-coupled receptor activation,tumor progression,therapeutic target,reproductive endocrine regulation
ENSG00000197858,GPAA1,cellular regulation,apoptosis regulation,pi3k/akt pathway modulation,tumor progression,metastasis promotion,elevated expression levels
ENSG00000135437,RDH5,redox regulation,cellular metabolism,metabolic reprogramming,oxidative stress response,tumor progression,potential oncogene
ENSG00000174970,OR10AG1,olfactory receptor overexpression,cancer cell proliferation,tumor invasion,signaling pathway regulation,mapk/erk activation,pi3k/akt signaling
ENSG00000107317,PTGDS,prostaglandin synthesis,oncogenic function,angiogenesis promotion,tumor progression,cell proliferation,prognostic biomarker
ENSG00000121351,IAPP,tumor growth,metastasis promotion,immunosuppression,angiogenesis stimulation,lymphangiogenesis facilitation,tumor microenvironment modulation
ENSG00000197165,SULT1A2,hormone metabolism,detoxification enzyme,genomic alterations,oncogenesis modulation,cell growth regulation,estrogen conjugation
ENSG00000116005,PCYOX1,angiogenic factor,cell proliferation,genomic instability,oncogenesis,oxidative stress regulation,tumor progression
ENSG00000198700,IPO9,inhibitor of apoptosis,regulator of cell cycle,interaction with inositol phosphates,metabolic regulation,cell proliferation control,tumor progression facilitation
ENSG00000160282,FTCD,one-carbon metabolism pathway,tumor suppressor function,loss-of-function mutations,cell proliferation regulation,genomic stability maintenance,cancer therapeutic target
ENSG00000169621,APLF,dna damage response,genomic instability,dna repair pathway,oxidative stress resistance,tumor progression factor,cancer susceptibility gene
ENSG00000148344,PTGES,pge2 production,tumor progression,immune evasion,angiogenesis,oncogene interaction,metabolic regulation
ENSG00000156298,TSPAN7,adhesion modulation,cell migration regulation,epithelial-to-mesenchymal transition,integrin interaction,metastasis promotion,poor prognosis biomarker
ENSG00000164182,NDUFAF2,mitochondrial function,complex i assembly,energy production regulation,cellular metabolism alteration,transcriptional regulation disruption,warburg effect induction
ENSG00000169688,MT1B,regulation of reactive oxygen species,tumor progression,cell migration and invasion,apoptosis modulation,autophagy regulation,mirna regulation
ENSG00000163683,SMIM14,cell cycle regulation,apoptosis modulation,pi3k/akt pathway interaction,p53 protein interaction,tumor suppressor function,chromosomal alteration
ENSG00000154099,DNAAF1,primary ciliary function,dynein arm complex assembly,motility regulation,cilia structure maintenance,genetic disorder association,cellular sensory perception
ENSG00000171962,DRC3,autophagy regulation,beclin 1 interaction,class iii pi3k complex,cellular homeostasis,tumorigenesis promotion,prognostic marker
ENSG00000170927,PKHD1,cilia dysfunction,renal cyst formation,cell adhesion regulation,signaling pathway activation,primary cilium maintenance,fibrosis development
ENSG00000109832,DDX25,apoptosis evasion,cell cycle regulation,p53 interaction,rna metabolism regulation,tumor suppressor inhibition,poor prognosis association
ENSG00000184445,KNTC1,mitotic checkpoint regulation,genomic instability,chromosome segregation error,kinase activity disruption,spindle checkpoint dysfunction,cancer driver gene mutation
ENSG00000174442,ZWILCH,chromatin remodeling,tumor suppressor function,genomic stability maintenance,cell cycle regulation,apoptosis induction,dna damage response
ENSG00000115363,EVA1A,transcriptional regulation,chromatin remodeling,genomic stability maintenance,dna damage response interaction,testis-specific expression,potential tumor suppressor function
ENSG00000070182,SPTB,prognostic marker,tumor progression,metastasis,cell adhesion,cancer biology,spectrin expression
ENSG00000170178,HOXD12,tumor progression,metastasis driver,transcriptional regulation,promotes cell migration,contributes to tumorigenesis,cell proliferation enhancer
ENSG00000176894,PXMP2,palmitate modification,protein processing regulation,tumor growth promotion,cell proliferation regulation,mitochondrial dysfunction association,genetic instability contribution
ENSG00000244045,TMEM199,overexpression,signaling pathway modulation,tumor progression,therapeutic target,metastasis facilitation,cell survival regulation
ENSG00000143543,JTB,cell adhesion disruption,tumor progression facilitation,epithelial-to-mesenchymal transition promotion,prognostic marker,poor prognosis indicator,cancer cell invasion enhancement
ENSG00000244122,UGT1A7,drug metabolism regulation,chemotherapy resistance modulation,xenobiotic detoxification,cellular response modification,glucuronidation enzyme activity,tumor cell sensitivity alteration
ENSG00000137040,RANBP6,cell cycle regulation,apoptosis resistance,metastasis promotion,cancer cell proliferation,epithelial-to-mesenchymal transition (emt),protein-protein interaction
ENSG00000171631,P2RY6,g-protein coupled receptor,inflammation regulation,tumor growth promotion,oncogene potential,signaling pathway modulation,pro-survival signaling
ENSG00000131386,GALNT15,oncogenic function,glycosylation regulation,protein modification,tumor progression,cell proliferation,biomarker potential
ENSG00000137166,FOXP4,transcription factor regulation,tumor suppressor repression,epithelial-to-mesenchymal transition (emt),tumor progression,cell proliferation,prognostic biomarker
ENSG00000136535,TBR1,transcriptional regulation,overexpression,tumor growth promotion,apoptosis inhibition,cell cycle progression enhancement,therapeutic target
ENSG00000035499,DEPDC1B,**
mtor pathway,cell cycle regulation,apoptosis suppression,tumor promotion,cancer cell proliferation,genomic mutation 
**
ENSG00000132872,SYT4,calcium-dependent exocytosis,cancer progression,biomarker candidate,cellular proliferation,plasma membrane localization,tumor microenvironment modulation
ENSG00000165272,AQP3,aquaporin family,cellular hydration,tumor growth promotion,oncogenic processes,cellular signaling pathway alteration,metastasis facilitation
ENSG00000170017,ALCAM,tumor progression,adhesion molecule function,epithelial-to-mesenchymal transition,metastasis promotion,therapeutic target,cell migration regulation
ENSG00000013725,CD6,oncogene activation,cell proliferation enhancement,tumor progression facilitation,immune evasion promotion,angiogenesis induction,genetic mutation impact
ENSG00000072415,MPP5,tumor promotion,protein scaffolding,cell membrane complex assembly,oncogenic signaling pathway modulation,biomarker potential,apoptosis regulation
ENSG00000122696,SLC25A51,mitochondrial function,anticancer target,cellular metabolism regulation,citrate transport,tumor aggressiveness,energy homeostasis modulation
ENSG00000143167,GPA33,g-protein coupled signaling,cell proliferation,cell differentiation,signaling pathway regulation,neurological function,signal transduction
ENSG00000151612,ZNF827,dna repair mechanism,chromatin remodeling,transcriptional regulation,apoptosis induction,tumor suppressor function,homologous recombination
ENSG00000276537,TTYH1,cell migration,tumor aggressiveness,apoptosis resistance,angiogenesis regulation,prognostic marker,biomarker potential
ENSG00000108639,SYNGR2,regulation of membrane trafficking,pi3k/akt pathway activation,oncogenic signaling,cell proliferation promotion,metastasis enhancement,potential biomarker for cancer diagnosis
ENSG00000168077,SCARA3,tumor progression,metastasis promotion,cell migration enhancement,pi3k/akt pathway modulation,ligand interaction,survival regulation
ENSG00000180176,TH,antioxidant function,cell proliferation,metastasis promotion,oxidative stress reduction,tumor growth facilitation,redox regulation modulation
ENSG00000104870,FCGRT,fc-gamma receptor function,immune response modulation,tumor microenvironment influence,dysregulated immune system contribution,antibody-coated particle recognition,apoptotic cell engulfment
ENSG00000076864,RAP1GAP,rap1 inhibition,tumor suppressor function,cell proliferation regulation,signaling pathway modulation,genetic alterations,cell growth regulation
ENSG00000164902,PHAX,splicing regulation,cell cycle progression,dna repair mechanisms,oncogenic driver mutation,therapeutic target,genomic instability
ENSG00000127578,WFIKKN1,therapeutic target,tumor suppressor,ion transport regulation,apoptosis regulation,cell proliferation modulation,pi3k/akt pathway interaction
ENSG00000126458,RRAS,**
cellular proliferation,constitutive activation,gtp-binding protein activity,oncogene function,ras/raf pathway activation,signaling pathway dysregulation
ENSG00000087495,PHACTR3,cellular regulation,signaling pathway modulation,apoptosis regulation,tumor progression,metastasis regulation,genetic alteration
ENSG00000273514,FOXD4L6,oncogene,transcription factor regulation,tumor progression,tumor aggressiveness,gene overexpression,cell proliferation
ENSG00000160563,MED27,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis regulation,protein interaction,genomic instability
ENSG00000101181,MTG2,transcriptional repressor,tumor suppressor function,cellular differentiation regulation,proliferation inhibition,oncogenic transcription factor regulation,angiogenesis suppression
ENSG00000131914,LIN28A,pi3k/akt pathway regulation,oncogene activation,microrna processing repression,cell cycle progression enhancement,senescence inhibition,epithelial-to-mesenchymal transition (emt) promotion
ENSG00000135269,TES,genomic instability,oncogene activation,transcriptional regulation,cell cycle progression,dna repair mechanisms,phosphorylation-dependent regulation
ENSG00000187003,ACTL7A,microtubule dynamics,chromatin remodeling complex interactions,tumor growth promotion,cancer gene mutations,microtubule stability regulation,cell proliferation enhancement
ENSG00000182631,RXFP3,regulation of cell proliferation,oncogenic processes,cell survival pathways,tumor growth promotion,signal transduction regulation,natriuretic peptide receptor function
ENSG00000164405,UQCRQ,mitochondrial dysfunction,electron transport chain regulation,tumor aggressiveness,energy metabolism regulation,oncogenic role,therapeutic target
ENSG00000167476,JSRP1,regulation of emt,overexpression,transcriptional regulation,cell adhesion modulation,tumor progression,poor prognosis
,HIST1H4L,histone modification,chromatin remodeling,epigenetic regulation,gene expression control,tumorigenesis driver,cellular proliferation
,HIST1H4A,... <end>**

<begin>histone modification,chromatin regulation,genome instability,tumor progression,oncogenesis,epigenetic regulation
,HIST1H4J,histone modification,chromatin remodeling,genome instability,gene expression regulation,apoptosis inhibition,cell cycle progression
,HIST4H4,histone modification,epigenetic alterations,chromatin remodeling,cell cycle progression,transcriptional regulation,tumorigenesis
,HIST1H4F,histone modification,chromatin remodeling,tumor suppressor function,genomic instability,dna repair mechanisms,tumor progression
,HIST1H4C,histone regulation,dna repair mechanisms,epigenetic control,transcriptional regulation,cell cycle progression,tumor suppressor potential
,HIST2H4B,histone modification,epigenetic regulation,cell cycle regulation,genomic instability,prognostic marker,chromatin remodeling
,HIST1H4D,histone modifications,chromatin structure,gene regulation disruption,tumor suppressor silencing,genome instability,promoter hypermethylation
,HIST2H4A,histone modification,chromatin remodeling,genomic instability,cellular proliferation,apoptosis regulation,epigenetic regulation
,HIST1H4B,genomic instability,histone modification,epigenetic regulation,dna replication,chromatin structure,gene expression
,HIST1H4H,chromatin remodeling,tumor suppressor gene silencing,epigenetic regulation,histone modification,oncogenic change,genomic instability
,HIST1H4I,histone modification,chromatin remodeling,gene regulation,transcriptional modulation,cell growth regulation,genome instability
,HIST1H4K,epigenetic regulation,chromatin maintenance,histone modification,nucleosome composition,gene expression,cancer progression
,HIST1H4E,chromatin remodeling,epigenetic alterations,histone modification,gene regulation,tumor progression,nucleosome assembly
ENSG00000176410,DNAJC30,er stress response,oncogenic pathway activation,transcription factor regulation,cellular protein stability,autophagy regulation,tumor progression marker
ENSG00000107290,SETX,chromatin remodeling,dna repair regulation,transcriptional elongation,cell proliferation promotion,apoptosis suppression,genomic instability
ENSG00000062485,CS,cell migration,cytoplasmic localization,apoptosis regulation,signaling pathway interaction,tumor progression,therapeutic target
ENSG00000132670,PTPRA,cellular signaling disruption,tumor suppressor function,epithelial integrity maintenance,protein-protein interaction regulation,cellular adhesion modulation,oncogenic transformation promotion
ENSG00000092020,PPP2R3C,pi3k/akt pathway modulation,oncogene activation,tumor progression,cell proliferation regulation,signaling pathway interaction,phosphatase activity impairment
ENSG00000100427,MLC1,tumor progression,gene amplification,cytoskeletal dynamics regulation,cell proliferation promotion,microtubule stability modulation,protein interaction
ENSG00000183527,PSMG1,genomic instability,dysregulation of protein turnover,tumor suppressor function,apoptosis regulation,cancer-associated mutations,ubiquitination pathway dysregulation
ENSG00000128789,PSMG2,ubiquitin-proteasome pathway,proteolytic activity,oncogenic processes,cancer cell survival,tumor growth regulation,protein degradation
ENSG00000027075,PRKCH,cell proliferation,signaling pathway regulation,oncogenic pathway activation,tumor progression,protein kinase activation,genomic profiling
ENSG00000154114,TBCEL,er stress response,autophagy regulation,endocytosis modulation,cellular signaling,protein-protein interaction,oncogenic process
ENSG00000179304,FAM156B,dna damage response,tumor suppressor gene,genomic stability,dna repair mechanisms,protein-protein interactions,cancer prevention
ENSG00000268350,FAM156A,dna damage response,genomic instability,cell cycle regulation,chromosomal alterations,mitotic checkpoint,spindle assembly dysfunction
ENSG00000105982,RNF32,ubiquitination regulation,oncoprotein stabilization,tumor suppressor inhibition,cellular homeostasis disruption,protein degradation dysregulation,dna damage response modulation
ENSG00000076554,TPD52,oncogene activation,cell proliferation enhancement,apoptosis inhibition,poor prognosis association,tumor progression facilitation,genome instability modulation
ENSG00000140905,GCSH,glutathione synthesis,oxidative stress resistance,detoxification pathway,antioxidant function,cellular redox balance,dna damage protection
ENSG00000186185,KIF18B,chromosomal instability,aneuploidy,tumor progression,therapeutic target,mitotic spindle assembly,protein overexpression
ENSG00000008952,SEC62,er translocation,oncogene activation,tumor progression,protein transport regulation,metabolic regulation,cell proliferation enhancement
ENSG00000071575,TRIB2,activation of pi3k/akt pathway,cellular proliferation,gain of function mutations,oncogenesis,overexpression associated with poor prognosis,regulation of cell cycle progression
ENSG00000145020,AMT,glutamine regulation,cellular homoeostasis,amino acid transport,cancer cell growth,metabolic adaptation,protein interaction
ENSG00000112972,HMGCS1,warburg effect,cholesterol synthesis,metabolic reprogramming,cell proliferation promotion,tumor growth enhancement,poor prognosis marker
ENSG00000105556,MIER2,mitochondrial regulation,autophagy modulation,cellular homeostasis,therapeutic target,tumor progression,genomic instability
ENSG00000222028,PSMB11,protein degradation pathway,genomic stability maintenance,cell cycle progression,oncogenic protein stabilization,dna damage accumulation,tumor growth promotion
ENSG00000091651,ORC6,genomic instability,origin recognition complex,oncogenic function,dna replication initiation,chromatin remodeling,cell cycle progression
ENSG00000162688,AGL,glycolytic reprogramming,constitutive activation,energy metabolism alteration,tumor growth promotion,cell proliferation enhancement,metabolic adaptation
ENSG00000163281,GNPDA2,regulation of glycolysis,oncogenic processes,metabolic reprogramming,tumor growth promotion,poor prognosis marker,cancer cell metabolism
ENSG00000105122,RASAL3,ras/mapk pathway,constitutive activation,tumor suppressor gene function loss,cell proliferation regulation,apoptosis dysregulation,genomic instability promotion
ENSG00000171777,RASGRP4,constitutive activation,oncogenic transformation,mapk/erk signaling pathway,guanine nucleotide exchange factor,ras protein activation,poor prognosis marker
ENSG00000042088,TDP1,genomic instability,dna repair mechanisms,cancer progression,tumor suppressor function,cellular growth regulation,oncogene activation
ENSG00000172548,NIPAL4,chromatin remodeling,transcriptional regulation,oncogenesis,dna repair,cell cycle progression,epigenetic modulation
ENSG00000104133,SPG11,mitochondrial dysfunction,oxidative stress,pro-survival signaling,cellular metabolism,cellular proliferation,tumor progression
ENSG00000170775,GPR37,tumor progression,metastasis,prognosis marker,promotes oncogenesis,g protein-coupled receptor signaling pathway,cell proliferation
ENSG00000105373,NOP53,genomic instability,ribosomal rna processing,genome integrity regulation,dna replication regulation,therapeutic target,mutations leading to oncogenesis
ENSG00000120334,CENPL,centromere stability,chromosomal instability,kinetochores integrity,mitotic spindle regulation,genomic rearrangements,oncogenic driver
ENSG00000206418,RAB12,oncogene,overexpression,cell proliferation,tumor progression,poor prognosis,lysosomal degradation pathway
ENSG00000131375,CAPN7,proteolytic activity,tumor progression,oncogenesis,cell survival and migration,biomarker potential,interaction with pi3k/akt pathway
ENSG00000139351,SYCP3,chromatin remodeling,aneuploidy,genomic instability,tumor suppressor function,chromosome segregation error,dna repair pathway disruption
ENSG00000165730,STOX1,angiogenesis regulation,cell cycle suppression,transcriptional modulation,oncogenic transcription factor,tumor progression promotion,apoptosis inhibition
ENSG00000085377,PREP,angiogenesis,cell proliferation,protease regulation,tumor invasion,tissue remodeling,apoptosis resistance
ENSG00000129351,ILF3,aberrant gene expression,apoptosis inhibition,cell proliferation regulation,dysregulated transcription factor function,immune evasion,oncogenic driver
ENSG00000273993,PTPRK,tumor progression,constitutive activation,cell-cell adhesion disruption,immune response modulation,signaling pathway interaction,oncogenic pathway activation
ENSG00000187045,TMPRSS6,iron regulation,dna damage,cellular proliferation,predictive biomarker,tumor aggressiveness,oxidative stress
ENSG00000130208,APOC1,apoc1 overexpression,lipid metabolism regulation,lipoprotein formation modulation,tumor progression association,biomarker potential,cell signaling pathway interaction
ENSG00000179580,RNF151,oncogene activation,cell proliferation enhancement,apoptosis inhibition,pi3k/akt/mtor pathway regulation,dna repair dysfunction,ubiquitination and degradation modulation
ENSG00000135541,AHI1,disruption of dna damage response,aneuploidy,loss of function mutations,genomic instability,centrosome regulation,chromatin remodeling
ENSG00000204920,ZNF155,chromatin remodeling,transcriptional regulation,tumor suppression,cell proliferation,gene expression,zinc finger protein interactions
ENSG00000177058,SLC38A9,glutamine metabolism,cellular ph homeostasis,tumor-promoting,metabolic reprogramming,warburg effect,cancer cell survival
ENSG00000103647,CORO2B,cell migration enhancement,tumor progression correlation,epithelial-to-mesenchymal transition induction,therapeutic target potentiality,actin cytoskeleton regulation involvement,cancer cell invasion promotion
ENSG00000161860,SYCE2,autophagy regulation,apoptosis suppression,dna repair mechanism,meiotic recombination,cellular senescence evasion,tumor suppressor dysfunction
ENSG00000101745,ANKRD12,tumor suppressor,microtubule regulation,epigenetic silencing,cytoskeleton disruption,cell cycle regulation,genomic instability
ENSG00000118181,RPS25,tumor growth,promotes translation,initiates transcription,mitosis regulation,translational control,ribosomal assembly
ENSG00000136943,CTSV,tumor progression,cancer prognosis,proliferation regulation,cell invasion,metastasis,proteolytic activity
ENSG00000131015,ULBP2,immunomodulation,immune evasion,tumor progression,biomarker identification,natural killer cell activation,epithelial cell expression
ENSG00000178381,ZFAND2A,genome instability,tumor suppressor function,cell cycle regulation,dna binding,zinc finger domain,chromatin remodeling
ENSG00000196569,LAMA2,basement membrane disruption,epithelial-to-mesenchymal transition (emt),integrin interaction,tumor metastasis regulation,molecular interactions with extracellular matrix components,signaling pathway modulation
ENSG00000276856,TUBGCP5,microtubule regulation,genomic instability,chromosomal instability,cell division machinery,mitotic spindle assembly,cancer biology hallmark
ENSG00000114735,HEMK1,cell proliferation,histone methylation regulation,transcriptional regulation,pi3k/akt pathway interaction,tumor progression enhancement,therapeutic target
ENSG00000126467,TSKS,cell proliferation,mapk/erk signaling,oncogenic potential,serine/threonine kinase activity,tumor progression,cell migration
ENSG00000171700,RGS19,g-protein regulation,loss-of-function mutations,constitutive activation,cellular proliferation,tumor progression,genomic instability
ENSG00000170385,SLC30A1,zinc homeostasis regulation,tumor progression,metastasis association,pi3k/akt signaling interaction,cellular survival modulation,prognostic biomarker potential
ENSG00000156313,RPGR,genomic instability,tumor suppressor function,cellular proliferation regulation,signaling pathway interaction,gene expression regulation,protein-protein interaction
ENSG00000099617,EFNA2,ephrin type-a signaling pathway,cellular migration,angiogenesis modulation,tumor progression facilitation,oncogenic role evidence,vascular endothelial cell interaction
,HRASLS,tumor suppressor function,mapk/erk pathway regulation,ras superfamily interaction,rna expression regulation,cellular differentiation inhibition,protein-protein interaction modulator
ENSG00000125812,GZF1,transcription factor regulation,oncogene activation,tumor progression,cell cycle dysregulation,apoptosis evasion,metastasis promotion
ENSG00000106261,ZKSCAN1,transcriptional repression,tumorigenesis association,cellular proliferation,apoptosis regulation,epigenetic modification,genomic instability
ENSG00000084092,NOA1,ribosome biogenesis,oncogenic transformation,driver gene,protein synthesis,cellular proliferation,tumorigenesis
ENSG00000140365,COMMD4,protein degradation pathway,wnt/β-catenin signaling,tumor suppressor function,cell cycle regulation,ubiquitination process,transcriptional regulation
ENSG00000167850,CD300C,immune modulation,tumor immune evasion,cell adhesion molecule,cytokine production,natural killer cell activation,cancer immunotherapy target
ENSG00000105186,ANKRD27,tumor suppressor,cell cycle regulation,dna repair,genomic instability,tumor progression,cell proliferation
ENSG00000172350,ABCG4,cancer testis antigen expression,efflux pump function,lipid metabolism regulation,multidrug resistance,oncogenic protein overexpression,tumor progression enhancement
ENSG00000198398,TMEM207,**

cell migration,ion transport regulation,cellular membrane integrity,oncogenic driver,cell proliferation,therapeutic target
**
ENSG00000105607,GCDH,metabolic reprogramming,gain of function mutations,energy metabolism,cell proliferation,apoptosis regulation,therapeutic target
ENSG00000181552,EDDM3B,aberrant mrna export,cell proliferation regulation,cancer progression,metastasis facilitation,nuclear pore complex interaction,tumor suppressor deregulation
ENSG00000113083,LOX,angiogenesis promotion,crosslinking activity,tumor microenvironment modulation,extracellular matrix composition regulation,epigenetic regulation,constitutive activation
ENSG00000102003,SYP,aberrant expression,cellular trafficking regulation,oncogenic processes,vesicle fusion complex,cancer progression driver,overexpression
ENSG00000163430,FSTL1,wnt/β-catenin signaling pathway,tumor suppressor function,microrna-21 regulation,cell adhesion and migration regulation,proliferation and invasion suppression,downregulated or mutated expression
ENSG00000100429,HDAC10,histone deacetylase activity,oncogenic function,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway regulation,metastasis promoter,tumor suppressor potential
ENSG00000136231,IGF2BP3,post-transcriptional regulation,oncogenic factor,tumor progression,cell growth promotion,prognostic biomarker,therapeutic target
ENSG00000278759,TBCD,endosomal trafficking,membrane dynamics regulation,protein degradation modulation,tumor progression influence,cancer cell survival enhancement,cell membrane recycling alteration
ENSG00000085365,SCAMP1,regulation of exocytosis,cellular proliferation,microrna regulation,protein sorting,signal transduction,tumor progression
ENSG00000189129,PLAC9,tumor progression,epithelial-to-mesenchymal transition,angiogenesis promotion,immune evasion mechanism,cell proliferation regulation,signaling pathway modulation
ENSG00000165525,NEMF,nf-?b signaling pathway,protein-protein interaction,cell proliferation,tumor progression,oncogenic processes,genomic instability
ENSG00000131508,UBE2D2,**
ubiquitination,proteasomal degradation,p53 regulation,cell cycle progression,tumorigenesis,biomarker significance
**
ENSG00000004660,CAMKK1,tumor progression,cell proliferation,regulation of cellular energy metabolism,prognostic biomarker,activation of downstream targets,calcium signaling pathways
ENSG00000052850,ALX4,transcription factor regulation,cellular differentiation,tumor suppressor function,chromatin remodeling,gene expression regulation,aberrant expression mutations
ENSG00000101413,RPRD1B,rna metabolism,oncogene,gene regulation,tumorigenesis,mrna stability,cancer progression
ENSG00000288185,IL27RA,tumor microenvironment modulation,immune evasion strategy,proliferation and survival enhancement,jak/stat pathway activation,immunosuppression modulation,cancer immune evasion
ENSG00000169550,MUC15,metastasis promotion,apoptosis inhibition,tumor aggressiveness,pi3k/akt pathway modulation,cancer cell migration,overexpression biomarker
ENSG00000188822,CNR2,cb2 receptor overexpression,immune evasion,angiogenesis promotion,cell proliferation enhancement,apoptosis inhibition,pro-tumorigenic microenvironment
ENSG00000133316,WDR74,mitotic spindle assembly,cell cycle progression,chromosomal instability,kinase activation,protein-protein interaction,microtubule dynamics
ENSG00000152952,PLOD2,fibrosis,collagen deposition,oncogenesis,cell proliferation,apoptosis resistance,tumor progression
ENSG00000013016,EHD3,**

1. **protein trafficking**,2. **oncogenic driver**,3. **cell proliferation**,4. **pi3k/akt interaction**,5. **tumor progression**,6. **er-golgi regulation** 

**
ENSG00000174059,CD34,angiogenesis promotion,tumor aggressiveness marker,metastatic facilitation,hematopoietic progenitor cell expression,vascular development involvement,glycoprotein function
ENSG00000125871,MGME1,dna repair mechanisms,cell cycle regulation,oncogenic potential,atm/chk2 pathway activation,genomic instability,tumor progression
ENSG00000119866,BCL11A,transcriptional regulation,oncogene activation,cell proliferation,apoptosis inhibition,metastatic potential,tumor progression
ENSG00000120669,SOHLH2,oncogene activation,cell cycle progression,metastasis promotion,apoptosis evasion,tumor growth promotion,transcription factor activity
ENSG00000189377,CXCL17,pro-inflammatory microenvironment,immune evasion,tumor angiogenesis,epithelial-to-mesenchymal transition,chemokine signaling,vascular endothelial growth factor expression
ENSG00000123219,CENPK,centrosome amplification,chromosomal instability,aneuploidy promotion,centriole duplication regulation,cell cycle modulation,biomarker for diagnosis
ENSG00000109063,MYH3,tumor progression,cell migration,metastasis,protein kinase activation,cancer stem cell maintenance,muscle contraction regulation
ENSG00000143147,GPR161,hedgehog signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,primary cilium regulation
ENSG00000225141,PRRT1,acidification of cellular compartments,angiogenesis,cell migration,oncogenic process,prognostic marker,tumor microenvironment modification
ENSG00000213927,CCL27,tumor progression,immune evasion,pro-inflammatory signaling,chemokine activity,tumor microenvironment modulation,metastasis promotion
ENSG00000105171,POP4,nuclear transport facilitation,oncogene protein export,cellular homeostasis disruption,tumor progression enhancement,protein-protein interaction,metastasis promotion
ENSG00000104356,POP1,oncogenic mechanism,rna interference regulation,small rna processing,tumor suppressor suppression,apoptosis modulation,stem cell regulation
ENSG00000100379,KCTD17,nuclear localization,cellular response regulation,tumor suppression,dna damage repair,cell cycle regulation,protein-protein interaction
ENSG00000180785,OR51E1,olfactory receptor activity,cellular overexpression,proliferation regulation,survival pathway modulation,signaling cascade interaction,cell surface localization
ENSG00000124787,RPP40,tumor growth,metastasis,cellular translation,protein synthesis regulation,oncogenic role,poor prognosis
ENSG00000138386,NAB1,cell proliferation,transcriptional regulation,tumor progression,apoptosis inhibition,oncogenic driver,angiogenesis regulation
ENSG00000085274,MYNN,chromatin remodeling,tumor suppressor function,genomic instability,proliferation enhancement,oncogenic mutation,epigenetic regulation
ENSG00000281178,MLXIP,cell cycle regulation,apoptosis inhibition,oncogenic suppression,tumor promotion,angiogenesis enhancement,warburg effect regulation
,TMEM206,prognostic biomarker,cell growth regulation,transmembrane protein,cellular interaction,regulation of proliferation,tumor development progression
ENSG00000108405,P2RX1,oncogenic process,signaling pathway regulation,apoptosis evasion,tumor progression,cell growth regulation,metastasis promoter
ENSG00000145506,NKD2,wnt/β-catenin signaling,cell proliferation,serine/threonine kinase activity,tumor progression,oncogene activation,protein-protein interactions
ENSG00000161594,KLHL10,hypoxia-inducible factor 1 alpha,ubiquitination-mediated protein degradation,tumor suppression,protein-protein interaction,oncogenic pathway modulation,apoptosis regulation
ENSG00000181333,HEPHL1,hypoxia response regulation,tumor suppressor function,angiogenic pathway activation,vegf signaling modulation,cellular proliferation inhibition,prolyl hydroxylase activity loss
ENSG00000089486,CDIP1,homologous recombination,genetic instability,tumor suppression,cell proliferation,genomic instability,dna damage response
ENSG00000176915,ANKLE2,wnt/β-catenin signaling pathway,tumor progression,oncogene,cell migration,metastasis,therapeutic target
ENSG00000167700,MFSD3,lysosomal dysfunction,tumor progression,cellular trafficking regulation,oncogenic signaling activation,energy metabolism dysregulation,poor prognosis marker
ENSG00000240184,PCDHGC3,cell-cell adhesion,tumor progression,metastasis,prognostic marker,therapeutic target,signaling pathway regulation
ENSG00000131236,CAP1,oncogenic signaling,cell migration,tumor progression,protein kinase activation,cytoskeletal reorganization,downstream target regulation
ENSG00000139055,ERP27,er stress response,protein folding regulation,oncogene,tumor progression,cell survival,er-associated degradation
ENSG00000100196,KDELR3,er chaperone regulation,protein quality control,endoplasmic reticulum dynamics,tumor cell metabolism,cellular stress response,misfolded protein accumulation
ENSG00000102221,JADE3,hypoxia adaptation,loss-of-function mutations,tumor suppressor function,protein-protein interaction,cellular stress response regulation,oncogenic signaling pathway alteration
ENSG00000120053,GOT1,amino acid metabolism,energy production,tumor growth promotion,redox balance modulation,oncogenic role,cell proliferation support
ENSG00000132740,IGHMBP2,pi3k/akt pathway,overexpression,transcriptional regulation,chromatin remodeling,metastasis,cell proliferation
ENSG00000146909,NOM1,cell proliferation,tumor progression,ribosome biogenesis,nucleotide synthesis,cell growth promotion,tissue specificity
ENSG00000186439,TRDN,trdn overexpression,calcium signaling regulation,oncogenic proliferation,tumor progression,therapeutic target,signaling pathway activation
ENSG00000239951,IGKV3-20,b cell marker,immunoglobulin production,tumor growth promotion,overexpression association,immune dysregulation,b-cell function alteration
ENSG00000108823,SGCA,tumor progression,epithelial-to-mesenchymal transition,cell adhesion regulation,transmembrane glycoprotein,biomarker potential,cancer cell migration
ENSG00000047410,TPR,cell cycle regulation,protein-protein interactions,tumor suppressor dysfunction,dna repair mechanisms,protein homeostasis regulation,oncogenic protein binding
ENSG00000140798,ABCC12,cellular homeostasis regulation,abc transporter dysfunction,ion and water balance disruption,distal nephron expression,collecting duct function,detoxification process impairment
ENSG00000173575,CHD2,chromatin remodeling,epigenetic silencing,histone modifications,dna methylation,chromatin accessibility,transcriptional regulation
ENSG00000149932,TMEM219,cellular trafficking regulation,potential oncogene,plasma membrane localization,cell adhesion regulation,pi3k/akt pathway interaction,tumorigenesis promotion
ENSG00000100300,TSPO,tspo regulation,immune modulation,cellular metabolism,tumor microenvironment,therapeutic target,signal transduction
ENSG00000112200,ZNF451,krab domain,chromatin remodeling,transcriptional regulation,tumor suppressor suppression,cell proliferation and migration,oncogene activation
ENSG00000117280,RAB29,rab29 regulation,tumor progression,cell migration,autophagy promotion,mitochondrial dysfunction,vesicular trafficking modulation
ENSG00000064652,SNX24,modulator of pi(3)p-bound membrane dynamics,regulatory role in pi3k/akt signaling,oncogenic pathway activation,cellular growth regulator,tumor progression facilitator,biomarker for cancer diagnosis
,HIST1H4G,chromatin remodeling,histone modification,gene regulation,tumor progression,cancer epigenetics,genomic instability
ENSG00000163467,TSACC,microtubule regulation,oncogenic potential,biomarker potential,interaction with signaling pathways,cellular morphology changes,tumor progression
ENSG00000168497,CAVIN2,cellular proliferation,signaling regulation,lipid metabolism,angiogenesis promotion,tumor progression driver,metabolic adaptation
ENSG00000165678,GHITM,cellular growth regulation,tumor progression,constitutive activation,oncogene,pi3k/akt pathway interaction,glycoprotein-h6 associated with transmembrane proteins
ENSG00000174500,GCSAM,immune evasion,tumor progression,genomic instability,cell adhesion regulation,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000100605,ITPK1,ion transport regulation,intracellular signaling modulation,oncogenic transformation,protein phosphorylation regulation,cell growth modulation,therapeutic target
ENSG00000160972,PPP1R16A,pp1 regulation,tumor progression,cell cycle modulation,oncogenic process,protein phosphatase activation,biomarker potential
ENSG00000108559,NUP88,nuclear pore complex assembly,cell cycle regulation,genomic stability maintenance,protein transport regulation,tumor suppressor protein regulation,tumorigenesis promotion
ENSG00000176658,MYO1D,actin cytoskeleton regulation,enhanced cellular proliferation,microtubule stability modulation,tumor progression factor,cancer-associated gene expression,pathway interaction
ENSG00000183570,PCBP3,regulation of gene expression,oncogene function,protein-protein interaction,cell proliferation,angiogenesis promotion,biomarker potential
ENSG00000106772,PRUNE2,oncogenic transformation,mutation-driven oncogenesis,pi3k/akt signaling modulation,cell migration promotion,apoptosis inhibition,metabolic reprogramming
ENSG00000165219,GAPVD1,gapvd1 regulates gtpase activity,tumor suppressor function,pi3k/akt pathway interaction,autophagy regulation,cell growth inhibition,apoptosis induction
ENSG00000177728,TMEM94,tumor suppression,cellular polarity loss,ion transport regulation,hypoxia-inducible factor activation,epithelial integrity disruption,aggressive tumor phenotype
ENSG00000106399,RPA3,dna replication maintenance,genome instability,oncogenic pathway interaction,tumor suppressor function loss,single-strand dna binding,cell cycle regulation
ENSG00000114904,NEK4,spindle checkpoint regulation,cell cycle progression,genomic instability,tumor suppressor dysfunction,protein kinase activation,therapeutic target
ENSG00000166828,SCNN1G,enac subunit,electrolyte homeostasis disruption,tumor growth facilitation,ion transport dysregulation,oncogenic proliferation,sodium reabsorption alteration
ENSG00000276461,TCF20,oncogene activation,cell cycle regulation,transcriptional modulation,apoptosis suppression,tumor progression,therapeutic target
ENSG00000152503,TRIM36,trim family proteins,tumor suppressor function,apoptosis regulation,cell growth control,signaling pathway modulation,protein stability regulation
ENSG00000117411,B4GALT2,tumor progression,cell surface modification,biomarker identification,cancer cell resistance,cellular proliferation,glycoprotein synthesis
ENSG00000170122,FOXD4,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,biomarker for disease progression,poor prognosis associated,oncogenic transcription factor
ENSG00000197893,NRAP,cellular metabolism regulation,nuclear transport facilitation,oncogenic protein interactions,tumor progression promotion,biomarker potential,protein stability regulation
ENSG00000284290,ANKS4B,microtubule stabilization,tumor suppressor function,mitotic checkpoint regulation,cytokinesis regulation,cellular instability,genetic alterations
ENSG00000214736,TOMM6,mitochondrial translocation,protein import regulation,tumor metabolism alteration,cellular energy regulation,oncogenic pathway modulation,genetic instability exacerbation
ENSG00000153015,CWC27,alternative splicing,apoptosis regulation,cell cycle progression,rna processing,molecular regulation,tumor suppressor activity
ENSG00000196937,FAM3C,cellular proliferation,constitutive activation,dysregulation of signaling pathways,enhanced cell survival,oncogenic processes,potential tumor marker
ENSG00000068796,KIF2A,mitotic spindle formation,chromosome segregation,microtubule dynamics regulation,oncogenic potential,cell proliferation enhancement,genomic instability promotion
ENSG00000012660,ELOVL5,fatty acid biosynthesis,cell proliferation,tumor growth,metastasis,signaling pathway modulation,oncogenesis
ENSG00000156234,CXCL13,angiogenesis promotion,chemokine signaling,immune evasion,metastasis facilitation,oncogene overexpression,prognostic biomarker
ENSG00000076344,RGS11,gpcr signaling regulation,tumor suppressor function,cancer cell proliferation,g-protein modulation,dysregulated expression,rna binding protein activity
ENSG00000130940,CASZ1,chromatin remodeling,transcriptional regulation,cell growth promotion,tumor progression,therapeutic resistance,genomic amplification
ENSG00000254521,SIGLEC12,angiogenesis promotion,immune evasion facilitation,oncogenic role identification,tumor progression enhancement,inflammation regulation,apoptosis suppression
ENSG00000174792,ODAPH,genomic instability,microtubule dynamics regulation,mitotic spindle formation regulation,chromosome segregation disruption,apoptosis regulation,cell proliferation promotion
ENSG00000122133,PAEP,pi3k/akt pathway regulation,cell growth promotion,tumor progression facilitation,prognostic marker identification,oncogenesis contribution,metabolic regulation modulation
ENSG00000154027,AK5,cell proliferation,tumor progression,energy metabolism regulation,constitutive activation,signaling pathway modulation,oncogene interaction
ENSG00000109814,UGDH,metabolic reprogramming,tumor progression,warburg effect,glycolysis support,redox balance maintenance,therapeutic target
ENSG00000110693,SOX6,transcriptional regulation,oncogene function,cell cycle regulation,apoptosis suppression,tumor suppressor gene repression,protein-protein interactions
ENSG00000185960,SHOX,tumor suppression,cell growth regulation,genomic instability,apoptosis inhibition,metastasis promotion,wnt/β-catenin pathway interaction
ENSG00000167302,TEPSIN,cell proliferation enhancement,oncogene activation,proteolytic activity,tumor suppressor function,multifunctional enzyme interaction,upregulated expression levels
ENSG00000132600,PRMT7,regulatory mechanism,chromatin remodeling,tumor progression,biomarker potential,cellular proliferation,oncogene regulation
ENSG00000108219,TSPAN14,cell migration regulation,tumor suppressor dysregulation,oncogene activation,epithelial-to-mesenchymal transition (emt) promotion,cell adhesion modulation,protein-protein interaction
ENSG00000233573,TRIM31,tumor suppressor function,cell cycle regulation,apoptosis induction,protein ubiquitination,oncogenic potential,mitochondrial interaction
ENSG00000196684,HSH2D,immune evasion,tumor growth regulation,mhc class i expression,peptide presentation,cancer immunology,epigenetic regulation
ENSG00000185761,ADAMTSL5,epithelial-to-mesenchymal transition,promotes cell invasion,regulates extracellular matrix,angiogenesis regulation,cell migration facilitation,tumor progression promotion
ENSG00000166147,FBN1,elastic fiber assembly,extracellular matrix remodeling,glycoprotein function,tissue structural support,cellular migration,tumor microenvironment modulation
ENSG00000118508,RAB32,rapid cell growth,oncogenic mutations,enhanced cell survival,tumor progression,trafficking regulation,therapeutic target
ENSG00000020129,NCDN,apoptosis modulation,tumor suppressor function,cell death regulation,proliferation inhibition,prognostic biomarker,genomic instability
ENSG00000114491,UMPS,nucleotide biosynthesis,overexpression in tumors,tumor growth promotion,cell proliferation enhancement,cancer prognosis marker,cell survival pathway modulation
ENSG00000092439,TRPM7,autophagy regulation,apoptosis suppression,mg2+ ion transport,pi3k/akt pathway activation,cell proliferation enhancement,tumor growth promotion
ENSG00000163283,ALPP,cell proliferation regulation,protein interaction modulation,tumor progression association,oncogenic process contribution,epithelial differentiation role,poor prognosis marker
ENSG00000186174,BCL9L,wnt/?-catenin signaling,oncogene activation,protein-protein interaction,cellular proliferation,tumor progression,gene amplification
ENSG00000160469,BRSK1,p53 activation,tumor suppressor function,cell cycle regulation,apoptosis induction,dna repair mechanism,cancer driver gene potential
ENSG00000110243,APOA5,lipid metabolism regulation,fatty acid composition modulation,cell survival enhancement,tumor progression promotion,triglyceride regulation,cancer prognosis association
ENSG00000074276,CDHR2,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression,genomic amplification,signaling pathway modulation,poor prognosis marker
ENSG00000177613,CSTF2T,amplification,apoptosis resistance,cell cycle regulation,immune evasion,oncogene interaction,tumor progression
ENSG00000185420,SMYD3,histone methyltransferase,oncogenic signaling,gene regulation,cellular proliferation,protein interaction,tumor progression
ENSG00000163518,FCRL4,cell proliferation,immune evasion,oncogene function,prognostic marker,signaling pathway interaction,apoptosis inhibition
ENSG00000163734,CXCL3,cell migration,cxc chemokine family,pro-tumorigenic microenvironment,tumor progression,tumor microenvironment,apoptosis regulation
ENSG00000116209,TMEM59,cellular transport regulation,tumor progression,signaling pathway modulation,gene expression regulation,potential therapeutic target,cellular proliferation enhancement
ENSG00000147684,NDUFB9,mitochondrial function,overexpression,warburg effect,oncogenic potential,therapeutic target,poor prognosis
ENSG00000105388,CEACAM5,cellular adhesion,pi3k/akt signaling pathway,oncogenesis,poor prognosis,metabolic regulation,immune response modulation
ENSG00000182566,CLEC4G,tumor progression,immune modulation,cell signaling pathways,carbohydrate ligand binding,inflammation regulation,antigen presentation modification
ENSG00000275618,BFAR,apoptosis regulation,cell cycle modulation,constitutive activation,genomic instability,nuclear receptor binding,oncogenic transformation
ENSG00000197889,MEIG1,apoptosis regulation,cell proliferation,chromatin remodeling,gene expression modulation,oncogene activation,tumor progression
ENSG00000111269,CREBL2,transcriptional repression,tumor suppressor function,cell cycle progression,apoptosis regulation,protein interaction,downregulation
ENSG00000259431,THTPA,transcriptional regulation,apoptosis regulation,cell growth control,gene expression modulation,tumorigenesis association,regulatory factor interaction
ENSG00000178913,TAF7,transcription factor regulation,chromatin remodeling,cell cycle progression,apoptosis inhibition,genomic instability,oncogenic protein interaction
ENSG00000171960,PPIH,mitochondrial dysfunction,altered metabolic profiles,glycolytic shift,oncogenic mutations,energy metabolism regulation,cellular homeostasis disruption
ENSG00000170786,SDR16C5,lipid metabolism dysregulation,genetic alterations,tumor progression driver,cellular signaling modulation,metabolic regulation disruption,steroid hormone biosynthesis
ENSG00000196187,TMEM63A,tumor suppressor,cell polarity disruption,actin cytoskeleton regulation,rho gtpase activation,epithelial integrity loss,prognostic biomarker
ENSG00000167702,KIFC2,microtubule stabilization,oncogenic potential,cell proliferation,mitotic spindle assembly,cytokinesis regulation,plus-end directed transport
ENSG00000091140,DLD,pdc activity regulation,energy metabolism influence,cell proliferation enhancement,metabolic pathway regulation,therapeutic target identification,upregulated expression levels
ENSG00000131187,F12,angiogenesis promotion,coagulation cascade modulation,tumor progression enhancement,metastasis facilitation,pro-coagulant state induction,oncogenic factor
ENSG00000167118,URM1,mitochondrial regulation,oncogene potential,cellular metabolism modulation,pi3k/akt pathway interaction,tumorigenesis promotion,genetic mutation association
ENSG00000142544,CTU1,oncogene,ubiquitination regulation,e3 ubiquitin ligase complex,pi3k/akt pathway modulation,therapeutic target,genomic amplification
ENSG00000137440,FGFBP1,fibroblast growth factor regulation,tumor progression,cancer prognosis,biomarker for tumor progression,cell migration and invasion,angiogenesis facilitation
ENSG00000012171,SEMA3B,tumor suppressor,cell growth inhibition,angiogenesis promotion,metastasis facilitation,potential biomarker,repulsive signaling disruption
ENSG00000138621,PPCDC,phosphatase activity,loss of tumor suppressor function,cell cycle regulation,oncogenic kinase interaction,tumor progression,genomic instability
ENSG00000186007,LEMD1,calcium influx regulation,cellular differentiation suppression,plasma membrane localization,tumor overexpression,cancer cell proliferation enhancement,signaling pathway modulation
ENSG00000170162,VGLL2,tead transcription factor interaction,hippo signaling pathway activation,oncogenic function,cell proliferation promotion,transcriptional coactivator activity,poor prognosis indicator
ENSG00000165030,NFIL3,nfil3 transcription factor,dysregulated expression,tumor growth promotion,emt regulation,stem cell maintenance,cellular stress response
ENSG00000104872,PIH1D1,chromatin remodeling,histone modification,transcriptional regulation,epigenetic changes,cell proliferation,gene expression dysregulation
ENSG00000161920,MED11,genetic regulation,transcriptional modulation,oncogenic pathway interaction,wnt/β-catenin signaling,chromatin remodeling,therapeutic target
ENSG00000173166,RAPH1,**
regulation of rap gtpases,pi3k/akt pathway interaction,tumor growth promotion,metastasis facilitation,oncogenic kinase regulation,therapeutic target candidate
**
ENSG00000089063,TMEM230,pi3k/akt regulation,tumor progression driver,oncogenic signaling,cell proliferation modulation,therapeutic target,aberrant expression
ENSG00000135312,HTR1B,serotonin receptor activation,cell proliferation,mapk/erk signaling,g protein-coupled receptor function,cell cycle regulation,apoptosis inhibition
ENSG00000006747,SCIN,transcriptional regulation,cell cycle progression,genomic stability,dna repair,chromatin remodeling,apoptosis regulation
ENSG00000256269,HMBS,heme biosynthesis disruption,iron homeostasis deregulation,mitochondrial dysfunction,cellular respiration alterations,energy metabolism regulation,tumor progression facilitation
ENSG00000196693,ZNF33B,transcriptional regulation,oncogenic potential,cell cycle progression,apoptosis suppression,tumor proliferation,transcription factor interaction
ENSG00000109101,FOXN1,tumor progression,apoptosis inhibition,pi3k/akt signaling activation,transcriptional regulation,cell cycle promotion,immune evasion
ENSG00000119969,HELLS,genomic instability,tumor suppression,oncogenesis,rapid cell proliferation,chromosomal abnormalities,dna repair regulation
ENSG00000102172,SMS,tumor suppressor function,loss of function mutations,cell proliferation regulation,wnt/β-catenin signaling regulation,cancer metabolism regulation,tumor progression driver
ENSG00000170631,ZNF16,zinc finger binding,transcription factor activity,oncogenic properties,cell proliferation promotion,tumor suppressor gene suppression,biomarker potential
ENSG00000197961,ZNF121,transcriptional regulation,chromatin remodeling,cell cycle progression,oncogene activation,tumor aggressiveness,transcriptional coactivator
ENSG00000136870,ZNF189,transcriptional regulation,oncogene activation,cell growth promotion,apoptosis suppression,metastasis facilitation,epithelial-to-mesenchymal transition
ENSG00000158874,APOA2,hdl cholesterol regulation,cell growth regulation,oncogenic processes,poor prognosis marker,lipid metabolism regulation,cell signaling modulation
ENSG00000115216,NRBP1,oncogenic signaling pathway modulation,cell proliferation regulation,gene expression modulation,stress response regulation,rna-binding protein function,therapeutic target potential
ENSG00000183023,SLC8A1,calcium signaling pathway,oncogenesis,tumor progression,ion transport regulation,cell proliferation,aberrant expression
ENSG00000130338,TULP4,cilia maintenance,cell proliferation regulation,pi3k/akt pathway interaction,sensory reception dysregulation,tumor suppressor function loss,cancer initiation role
ENSG00000170370,EMX2,tumor progression,epithelial-to-mesenchymal transition,transcriptional regulation,oncogene activation,cell proliferation,angiogenesis modulation
ENSG00000196914,ARHGEF12,**

regulation of cytoskeletal dynamics,rho gtpase activation,cell migration and invasion,tumor progression and metastasis,oncogenic signaling pathway regulation,prognostic marker

**
ENSG00000212122,TSSK1B,cell cycle regulation,apoptosis modulation,tumor progression,oncogenesis promotion,calcium/calmodulin-dependent activation,therapeutic target
ENSG00000157191,NECAP2,mtor pathway modulation,cell proliferation regulation,oncogenic processes activation,apoptosis inhibition,autophagy modulation,tumor progression association
ENSG00000169189,NSMCE1,**

genomic instability,chromosome segregation,dna repair,homologous recombination,replication fork stability,genome maintenance

**
ENSG00000138600,SPPL2A,tumor suppressor,notch signaling pathway,cell surface regulation,cancer progression,metastasis inhibition,gene regulation
ENSG00000197385,ZNF860,krab domain-containing zinc finger protein,tumor suppressor function,transcriptional regulation,cell growth regulation,apoptosis regulation,dna repair mechanism disruption
ENSG00000132541,RIDA,genomic instability,tumor suppressor function,dna repair regulation,cell cycle regulation,apologetic regulation,replication fork stabilization
ENSG00000230124,ACBD6,lipid metabolism regulation,cellular membrane modulation,phospholipid synthesis,tumor progression enhancement,cancer cell survival,genomic upregulation
ENSG00000077152,UBE2T,chromosomal instability,mitotic progression regulation,cell survival enhancement,ubiquitination pathway,protein degradation modification,tumor growth promotion
ENSG00000187151,ANGPTL5,angiogenesis promotion,metabolic regulation dysfunction,tumor progression facilitation,therapeutic target potential,vegf upregulation contribution,pi3k/akt/mtor pathway interaction
ENSG00000161681,SHANK1,pi3k/akt pathway interaction,gene amplification,mutation,cell proliferation regulation,cytoskeleton organization,synaptic plasticity regulation
ENSG00000110244,APOA4,lipid metabolism,hdl cholesterol regulation,cellular environment modulation,indirect oncogenic mechanism,genetic dysregulation,metabolic reprogramming
ENSG00000175482,POLD4,dna polymerase epsilon,genomic instability,impaired dna repair,genome stability,cell cycle regulation,oncogenic mutations
ENSG00000155096,AZIN1,apoptosis inhibition,mitochondrial function regulation,cell cycle modulation,oncogenic activity,tumor progression,cancer metabolism adaptation
ENSG00000144366,GULP1,gdp-fucose protein modification,tumor progression,cell adhesion modulation,therapeutic resistance,glycoprotein synthesis regulation,cell invasion facilitation
ENSG00000165476,REEP3,mitochondrial regulation,er export receptor,cell survival pathways,proliferation modulation,metabolic reprogramming,therapeutic resistance
ENSG00000104859,CLASRP,cytoplasmic protein interaction,gene overexpression,cell migration enhancement,adherens junction disruption,epithelial-to-mesenchymal transition promotion,tumor progression facilitation
ENSG00000181610,MRPS23,mitochondrial ribosome regulation,energy metabolism dysregulation,glycolytic shift,tumor progression association,cellular homeostasis disruption,oncogenic translation enhancement
ENSG00000198824,CHAMP1,chromatin remodeling,oncogenic function,transcriptional repression,cell cycle progression,apoptosis inhibition,tumor aggressiveness
ENSG00000106484,MEST,cell proliferation,tumor growth,metastasis promotion,emt regulation,prognostic biomarker,therapeutic target
ENSG00000154813,DPH3,cell cycle regulation,dna repair pathway disruption,chromatin remodeling disorder,tumor suppressor function loss,oncogenic transformation,somatic mutation hotspot
ENSG00000166340,TPP1,protein degradation,genomic instability,cellular homeostasis,oncogenic processes,dna repair mechanisms,tumor progression
ENSG00000129566,TEP1,telomere maintenance,telomerase activation,cell proliferation,oncogenesis,genomic stability,prognostic marker
ENSG00000143748,NVL,cellular proliferation,transcriptional regulation,signal transduction pathway,oncogenic processes,cell growth control,aberrant expression
ENSG00000113649,TCERG1,chromatin regulation,ubiquitin ligase activity,oncogenic overexpression,cell proliferation enhancement,apoptosis inhibition,dna repair promotion
ENSG00000144852,NR1I2,nuclear receptor activity,transcriptional regulation,cell growth regulation,lipid metabolism regulation,tumor suppressor function,co-regulatory interactions
ENSG00000110719,TCIRG1,impaired antigen presentation,disrupted immune surveillance,loss-of-function mutations,calcium homeostasis regulation,lysosomal dysfunction,t-cell activation impairment
ENSG00000170791,CHCHD7,mitochondrial function,metabolic regulation,tumor suppression/oncogenesis,cellular respiration,energy metabolism,protein-protein interactions
ENSG00000108797,CNTNAP1,neurexin family,synaptic transmission regulation,cell adhesion promotion,metastasis facilitation,tumor growth enhancement,therapeutic target
,SEPT3,cell cycle regulation,septin family component,cytoskeletal organization,mitotic spindle assembly,cancer driver mutation,protein overexpression
ENSG00000074527,NTN4,cell adhesion regulation,tumor suppressor function,cell migration inhibition,pi3k/akt pathway modulation,poor prognosis association,downregulated expression levels
ENSG00000166922,SCG5,tumor suppressor candidate,cell signaling regulation,biomarker potential,prognostic indicator,oncogenesis involvement,cancer progression association
ENSG00000110435,PDHX,mitochondrial regulation,pyruvate conversion,cellular metabolism disruption,tumor progression,metabolic adaptation,oncogenic role
ENSG00000126218,F10,coagulation cascade activation,thrombin generation,angiogenesis promotion,proteolytic enzyme activity,tumor progression facilitation,poor prognosis indicator
ENSG00000113456,RAD1,dna damage response,genomic instability,nucleotide excision repair,platinum-induced damage,cell cycle regulation,tumor suppressor activity
ENSG00000046604,DSG2,tumor suppressor function,cell-cell adhesion disruption,pi3k/akt pathway interaction,cancer cell invasion,metastasis promotion,reduced expression
ENSG00000034677,RNF19A,protein degradation regulation,genomic instability,cell cycle progression regulation,apoptosis inhibition,chromatin remodeling regulation,tumor suppressor function
ENSG00000128563,PRKRIP1,tumor progression,cellular survival,protein kinase regulation,apoptosis inhibition,autophagy modulation,cancer cell metabolism
ENSG00000213983,AP1G2,protein trafficking regulation,dysregulated gene expression,oncogenic processes,tumor progression,genetic mutation,cellular metabolism
ENSG00000116981,NT5C1A,purine metabolism regulation,gene amplification,tumor progression,cell proliferation,oncogenic signaling pathway activation,nucleotide metabolism regulation
ENSG00000131778,CHD1L,epigenetic regulation,chromatin remodeling,dna repair modulation,oncogenic process driver,genomic instability promoter,therapeutic target
ENSG00000171094,ALK,alk rearrangements,constitutive activation,driver mutation,tumor progression,therapeutic target,receptor tyrosine kinase
ENSG00000106852,LHX6,regulation of cellular differentiation,transcriptional regulation,anterior-posterior axis specification,limb formation,tumor suppressor or oncogene,mutated expression
ENSG00000099331,MYO9B,pi3k/akt signaling pathway,overexpression,metastasis driver,cell migration regulation,therapeutic target,cancer biomarker
ENSG00000106665,CLIP2,microtubule dynamics regulation,cell migration regulation,cytoskeleton organization modulation,mitosis and cytokinesis regulation,aggressive tumor phenotype association,tumorigenesis driver potential
ENSG00000155890,TRIM42,oncogenic role,cellular interaction,protein-protein interaction,tumor progression,apoptosis regulation,cell cycle regulation
ENSG00000123989,CHPF,mitochondrial biogenesis,metabolic reprogramming,tumor progression,therapeutic target,oncoprotein interaction,glycolytic shift
ENSG00000178394,HTR1A,mapk/erk pathway activation,constitutive expression,cell proliferation promotion,tumor metastasis facilitation,stat3/nf-κb interaction,g protein-coupled receptor function
ENSG00000144712,CAND2,cell cycle regulation,transcriptional regulator,oncogenic driver,tumor progression marker,chromatin remodeling,cancer cell survival
ENSG00000110108,TMEM109,cellular regulation,upregulation,protein interaction,endocytosis,autophagy,tumor progression
ENSG00000111554,MDM1,tumor suppression,cell cycle regulation,apoptosis modulation,oncogenesis association,chromatin remodeling,transcriptional regulation
ENSG00000177084,POLE,genomic instability,dna mismatch repair,mutational burden,tumor recurrence,cancer driver mutation,therapeutic target
ENSG00000079112,CDH17,cell adhesion molecule,epithelial-to-mesenchymal transition,tumor progression,metastasis facilitation,angiogenesis promotion,protein interaction network
ENSG00000163510,CWC22,cleavage and polyadenylation,pre-mrna processing,rna regulation,tumor suppressor gene silencing,oncogene expression,poor prognosis marker
ENSG00000173597,SULT1B1,hormonal regulation,sulfotransferase activity,detoxification process,cell proliferation,metabolic regulation,chemotherapy modulation
ENSG00000105610,KLF1,transcription factor regulation,cell cycle regulation,pro-survival gene upregulation,angiogenesis promotion,tumor progression facilitation,therapeutic target potential
ENSG00000107807,TLX1,oncogene activation,transcription factor regulation,cell proliferation promotion,angiogenesis enhancement,tumor progression contribution,therapeutic target potential
ENSG00000283009,ZNF436,transcriptional regulation,dna damage response,proliferation,survival,prognostic marker,brca1 interaction
ENSG00000143995,MEIS1,transcriptional regulation,oncogenic function,cell proliferation,tumor progression,angiogenesis promotion,genomic amplification
ENSG00000146755,TRIM50,mitochondrial dynamics,apoptosis regulation,tumor suppression,protein-protein interaction,cellular homeostasis regulation,mitochondrial biogenesis
ENSG00000100417,PMM1,glycosylation,aberrant glycosylation patterns,pi3k/akt pathway activation,tumor progression,rna splicing regulation,protein kinase activation
ENSG00000174950,CD164L2,wnt pathway interaction,oncogene function,epithelial-to-mesenchymal transition (emt) regulation,cell adhesion modulation,tumor progression facilitation,metastatic potential enhancement
ENSG00000181444,ZNF467,cellular regulation,transcriptional regulation,oncogenic potential,pi3k/akt interaction,tumor progression,genomic instability
ENSG00000132323,ILKAP,tumor suppressor,cell adhesion regulation,akt/mtor pathway activation,oncogenic signaling,pi3k/akt pathway modulation,metastasis promotion
ENSG00000175879,HOXD8,transcription factor regulation,cell proliferation,apoptosis inhibition,metastasis promotion,biomarker identification,wnt/β-catenin pathway interaction
ENSG00000243003,LY6G6F,immunomodulation,adhesion molecule,metastatic potential,tumor progression,prognostic marker,multifunctional protein
ENSG00000123933,MXD4,tumor suppressor,cell cycle regulation,apoptosis inhibition,chromatin remodeling,transcriptional control,dna repair disruption
ENSG00000139675,HNRNPA1L2,rna processing,rna-binding protein,alternative splicing,cancer progression,gene regulation,aberrant chromatin remodeling
ENSG00000168447,SCNN1B,ion transport regulation,electrolyte balance,renal function,sodium reabsorption,cancer development,hypertension
ENSG00000174799,CEP135,**

microtubule regulation,chromosomal instability,oncogenic amplification,cell proliferation,centrosome separation,spindle formation

**
ENSG00000136758,YME1L1,mitochondrial dynamics,tumor progression,cellular metabolism regulation,potential oncogene,energetic adaptation,target for therapy
ENSG00000168118,RAB4A,endocytic recycling pathway,oncogene overexpression,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation,protein recycling
ENSG00000103994,ZNF106,zinc finger transcription factor,cell growth regulation,chromatin remodeling,nucleic acid binding,tumor progression,wnt/β-catenin signaling
ENSG00000163820,FYCO1,dna repair,genome instability,genome maintenance,cell proliferation,tumor suppression,protein-protein interactions
ENSG00000119688,ABCD4,lipid metabolism regulation,cellular homeostasis disruption,protein-protein interactions,stress response modulation,cancer-related mutation,metabolic reprogramming
ENSG00000174007,CEP19,spindle assembly checkpoint regulation,oncogene potential,prognostic biomarker,mitotic spindle stability maintenance,cell cycle progression promotion,microtubule dynamics regulation
ENSG00000051620,HEBP2,hnf-3β regulation,tumor suppressor function,loss-of-function mutations,cell growth inhibition,apoptosis promotion,p53 interaction
ENSG00000175229,GAL3ST3,gal3st3 overexpression,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,cd44 sulfation,cell adhesion modulation,glycosylation modification
ENSG00000116198,CEP104,microtubule regulation,dysregulation in tumor,centrosomal protein function,aberrant expression in cancer,cell cycle modulation,mitotic spindle dynamics
ENSG00000188171,ZNF626,oncogene,transcriptional regulator,cell proliferation,epigenetic modification,tumor aggressiveness,biomarker potential
ENSG00000100380,ST13,loss of tumor suppressive function,apoptosis regulation,mitochondrial pathway disruption,cellular stress response modulation,sef1 domain interaction,protein-protein interaction
ENSG00000172296,SPTLC3,sphingolipid biosynthesis,ceramide levels regulation,apoptosis inhibition,tumor progression,cell survival enhancement,s1p production alteration
ENSG00000007047,MARK4,microtubule regulation,tumor progression,microtubule stability,cell proliferation,protein-protein interaction,kinase activity
ENSG00000260027,HOXB7,oncogene regulation,cancer cell migration,emt induction,tumor growth promotion,anti-apoptotic function,transcriptional activation
ENSG00000065485,PDIA5,disulfide bond rearrangement,tumor progression,cell adhesion regulation,thiol-dependent oxidoreductase activity,protein folding facilitation,metastasis promotion
ENSG00000198464,ZNF480,tumor suppressor,cell cycle regulation,dna repair modulation,transcription factor activity,apoptosis induction,cancer susceptibility
,VARS,cellular metabolism,protein synthesis regulation,aminoacyl-trna synthetase function,cell growth regulation,tumor progression contribution,metabolic dysregulation
ENSG00000172497,ACOT12,mitochondrial localization,fatty acid metabolism regulation,oncogenic potential,lipid metabolism alteration,energy production modulation,overexpression correlation with poor prognosis
ENSG00000156269,NAA11,histone modification,protein n-terminal acetylation,tumorigenesis,cellular proliferation,apoptosis regulation,nuclear protein modification
ENSG00000152904,GGPS1,glutathione biosynthesis,antioxidant function,methylation reactions,oxidative stress management,cell redox balance,glutamine metabolism
ENSG00000157429,ZNF19,tumor suppressor function,transcriptional regulation disruption,apoptosis inhibition,cell cycle progression regulation,genomic instability,protein-protein interaction
ENSG00000100911,PSME2,protein degradation,cell cycle regulation,antigen presentation,tumor progression,mitotic checkpoint evasion,apoptosis suppression
ENSG00000008838,MED24,transcriptional regulation,cell proliferation,dysregulation,oncogene,genomic instability,therapeutic target
ENSG00000175221,MED16,mediator complex regulation,transcriptional activation,cell cycle progression,dna repair mechanism,apoptosis suppression,oncogenic gene expression
ENSG00000106266,SNX8,pi3k/akt/mtor pathway modulation,endosomal trafficking regulation,cell proliferation and survival enhancement,poor prognosis association,therapeutic target potential,escrt complex interaction
ENSG00000171557,FGG,angiogenesis promotion,tumor progression association,prognostic marker,signaling pathway interaction,metastasis facilitation,coagulation cascade involvement
ENSG00000072163,LIMS2,tumor progression,biomarker,cell adhesion regulation,metastasis facilitation,epithelial-to-mesenchymal transition promotion,prognostic indicator
ENSG00000137547,MRPL15,protein synthesis regulation,mitochondrial function alteration,tumor progression association,pi3k/akt pathway activation,cellular proliferation enhancement,anti-apoptotic activity promotion
ENSG00000158571,PFKFB1,increased expression,glycolytic reprogramming,enhanced glucose metabolism,cell proliferation driver,metabolic adaptation,tumor progression promoter
ENSG00000104863,LIN7B,cell migration,oncogene activation,protein-protein interaction,cell proliferation,tumor progression,biomarker for diagnosis
ENSG00000118564,FBXL5,cell cycle regulation,ubiquitination,dna repair,transcriptional control,tumor suppression,protein degradation
ENSG00000143340,FAM163A,wnt/β-catenin signaling pathway,chromatin remodeling,tumor growth promotion,biomarker for cancer,cell proliferation enhancement,transcriptional regulation modulation
ENSG00000104218,CSPP1,chromosomal instability,cell proliferation,apoptosis resistance,metabolic regulation,centrosome assembly,genomic amplification
ENSG00000087085,ACHE,acetylcholine regulation,tumor microenvironment modulation,cellular behavior alteration,signaling pathway activation,oncogenic process contribution,metastasis facilitation
ENSG00000206561,COLQ,cholinesterase regulation,cell cycle progression,apoptosis inhibition,protein-protein interaction,neuromuscular junction modulation,therapeutic target
ENSG00000167815,PRDX2,oncogenic potential,tumor suppressive function,cellular redox regulation,oxidative stress resistance,protein expression regulation,signaling pathway modulation
ENSG00000083097,DOP1A,visual cycle disruption,leber congenital amaurosis,transcriptional dysregulation,cellular signaling pathways,protein-protein interactions,retinal degeneration
ENSG00000183161,FANCF,genomic stability,dna damage repair,genetic instability,amplification/overexpression,tumor progression,therapeutic target
ENSG00000166260,COX11,metabolic reprogramming,mitochondrial function,oncogenesis,cell proliferation,protein synthesis regulation,chaperone activity
ENSG00000126432,PRDX5,peroxidase activity,antioxidant function,cell survival enhancement,tumor progression,apoptosis resistance,oxidative stress modulation
ENSG00000123739,PLA2G12A,lipid metabolism regulation,oncogenic processes promotion,cell proliferation enhancement,survival pathway activation,metastasis facilitation,cancer progression correlation
ENSG00000130717,UCK1,urea cycle regulation,ammonia detoxification,tumor progression,cellular metabolism regulation,warsburg effect,signaling pathway activation
ENSG00000139496,NUP58,chromatin remodeling,genomic instability,nucleocytoplasmic shuttling protein,overexpression in tumors,cell proliferation,transcription regulation
ENSG00000158417,EIF5B,translation regulation,gain of function mutations,cell proliferation,protein synthesis,autophagy modulation,tumor growth
ENSG00000066933,MYO9A,epithelial-to-mesenchymal transition,cell adhesion modulation,cytoskeleton regulation,metastasis promotion,tumor progression driver,protein interaction network
ENSG00000095777,MYO3A,genomic instability,actin cytoskeleton regulation,oncogene activation,enhanced cell migration,tumor progression,cell cycle modulation
ENSG00000186867,QRFPR,cellular signaling,g-protein coupled receptor,oncogenic driver,tumor suppression,loss-of-function mutation,cell proliferation regulation
ENSG00000047617,ANO2,tumor progression,metabolic adaptation,glycolytic switch,prognostic marker,bicarbonate-chloride exchange,oncogenic interaction
ENSG00000008853,RHOBTB2,cell polarity regulation,rhoa gef activity,oncogene overexpression,enhanced cell invasion,cytoskeleton remodeling,cell adhesion molecule regulation
ENSG00000166263,STXBP4,cell membrane trafficking,mutated gene expression,vesicular transport regulation,oncogenic activity enhancement,protein-protein interaction alterations,apoptosis pathway modulation
ENSG00000105835,NAMPT,nad+ biosynthesis,metabolic rewiring,cell survival,glycolytic shift,tumor progression,poor prognosis
ENSG00000125648,SLC25A23,mitochondrial carrier protein,cysteine transport,oxidative phosphorylation regulation,mtorc1 signaling activation,tumor progression,biomarker candidate
ENSG00000154978,VOPP1,autophagy regulation,tumor progression,apoptosis regulation,ubiquitin-proteasome pathway interaction,cancer development,biomarker potential
ENSG00000288485,ELP5,rna helicase activity,cancer prognosis,promoter of tumor growth,cellular rna metabolism,protein-rna interactions,tumor aggressiveness
ENSG00000187736,NHEJ1,genomic instability,dna repair pathway,non-homologous end joining,genetic mutations,cellular responses,apoptosis regulation
ENSG00000198353,HOXC4,oncogenic transcription factor,epithelial-to-mesenchymal transition,cellular proliferation,gene regulatory network,tumor stemness,signaling pathway regulation
ENSG00000161649,CD300LG,tumor progression,immune evasion,cell survival,myeloid cell regulation,tumor microenvironment modulation,ligand-receptor interaction
ENSG00000138061,CYP1B1,metabolic regulation,cell proliferation,signaling pathway activation,proliferative advantage,detoxification mechanism,tumor progression
ENSG00000166181,API5,caspase inhibition,apoptosis suppression,tumor progression factor,cell survival regulation,pi3k/akt pathway interaction,poor prognosis marker
ENSG00000133639,BTG1,genomic instability,tumor suppressor,antiproliferative effects,cell cycle regulation,cytosine methylation,apoptosis induction
ENSG00000167685,ZNF444,transcriptional regulation,tumor progression,poor prognosis,mutation associations,cell growth regulation,apoptosis modulation
ENSG00000124802,EEF1E1,protein synthesis regulation,cell proliferation enhancement,poor prognosis marker,therapeutic target,translation elongation factor,cancer cell survival
ENSG00000011590,ZBTB32,tumor suppressor function,gene regulation disruption,epithelial-to-mesenchymal transition (emt),cell cycle progression dysregulation,apoptosis inhibition,microrna regulation
ENSG00000137656,BUD13,histone regulation,tumor microenvironment modulation,dna repair mechanism,lymphocyte activation,immune evasion strategy,genome stability maintenance
ENSG00000119541,VPS4B,tumor progression,genomic instability,protein degradation,cellular response to dna damage,pi3k/akt/mtor pathway activation,endosomal trafficking regulation
ENSG00000158315,RHBDL2,wnt/β-catenin pathway regulation,oncogenic function,overexpression in cancer,cell migration and invasion facilitation,drug resistance modulation,poor prognosis association
ENSG00000144810,COL8A1,angiogenic regulation,basement membrane formation,collagen type viii alpha 1,endothelial cell function,protein-protein interaction,tumor microenvironment modulation
ENSG00000168795,ZBTB5,oncogene activation,chromatin remodeling,transcriptional repression,apoptosis suppression,tumor progression,genomic instability
ENSG00000074621,SLC24A1,transmembrane glycoprotein,cell adhesion regulation,tumor progression facilitation,immune response modulation,cell signaling pathway regulation,biomarker or therapeutic target
ENSG00000134780,DAGLA,tumor progression,cellular signaling disruption,metabolic regulation,protein kinase activation,therapeutic target,oncogenesis
ENSG00000211584,SLC48A1,ion homeostasis,proliferation enhancement,tumor growth facilitation,resistance development,prognosis correlation,cell signaling pathway interaction
ENSG00000011638,TMEM159,lysosomal regulation,oncogenic processes,mutations in tumorigenesis,overexpression in cancer cells,upregulation in cell proliferation,poor prognosis correlation
ENSG00000166928,MS4A14,immune modulation,tumor progression,apoptosis regulation,antigen presentation suppression,natural killer cell evasion,cancer immunotherapy target
ENSG00000186272,ZNF17,transcriptional regulation,tumor suppressor repression,oncogenic function,cell proliferation promotion,apoptosis inhibition,metastasis facilitation
ENSG00000144771,LRTM1,receptor internalization,oncogenesis,cell proliferation,tumor progression,cancer cell survival,therapeutic target
ENSG00000197705,KLHL14,ubiquitin ligase activity,substrate recognition,cancer progression,tumor growth,protein degradation,cell signaling
ENSG00000174021,GNG5,pi3k/akt pathway interaction,g-protein complex regulation,cell proliferation promotion,tumor progression association,oncogenic process modulation,signaling pathway activation
ENSG00000135750,KCNK1,regulation of emt,ion channel function,proliferation and migration,tumor progression,therapeutic target,genomic instability
ENSG00000136731,UGGT1,protein quality control,cell survival,oncogene activation,chemotherapy resistance,proteasome regulation,glycoprotein modification
ENSG00000073792,IGF2BP2,oncogene regulation,tumor cell proliferation,igf-1 signaling,cell survival,translational regulation,protein kinase activation
ENSG00000106648,GALNTL5,cellular modification,oncogenic driver,protein glycosylation,cancer metastasis,tumor growth regulation,signaling pathway interaction
ENSG00000187595,ZNF385C,transcriptional regulation,cell proliferation,oncogenic activity,tumor progression,pi3k/akt pathway modulation,wnt/β-catenin pathway regulation
ENSG00000159592,GPBP1L1,cell cycle regulation,oncogenesis,tumor progression,cell proliferation suppression,g2/m phase transition,genomic instability
ENSG00000042753,AP2S1,cell surface receptor downregulation,ap-2 complex regulation,mitogen-activated protein kinase pathway activation,lysosomal sorting dysfunction,ubiquitination modification,cancer cell survival enhancement
ENSG00000163950,SLBP,ribosomal rna biogenesis,cell proliferation regulation,tumor growth promotion,oncogenic processes,genetic instability,therapeutic target
ENSG00000042493,CAPG,cancer promoting,actin cytoskeleton regulation,cell migration invasion,protein-protein interaction,diagnostic biomarker,therapeutic target
ENSG00000145014,TMEM44,cell adhesion disruption,loss of function mutations,tumor progression marker,protein-protein interaction,cellular structure regulation,epithelial-mesenchymal transition
,HIST1H2BN,histone modification,chromatin remodeling,epigenetic regulation,tumor suppressor activity,cell growth regulation,protein-protein interaction
ENSG00000007923,DNAJC11,erbb2 interaction,constitutive expression,cell survival enhancement,tumor promoting signals,protein folding regulation,stress response modulation
ENSG00000110911,SLC11A2,angiogenesis promotion,immune evasion mechanism,tumor progression enhancement,cell migration facilitation,inflammation regulation,metal ion transport
ENSG00000176293,ZNF135,p53 interaction,transcriptional regulation,cell growth regulation,gene expression modulation,oncogenesis promotion,apoptosis suppression
ENSG00000136933,RABEPK,kinase activation,cell proliferation,constitutive activation,pi3k/akt pathway,membrane trafficking,oncogene mutation
ENSG00000183580,FBXL7,oncogenic pathway activation,tumor suppressor function,ubiquitination regulation,cell cycle dysregulation,genomic instability,protein degradation pathway
ENSG00000172673,THEMIS,dna damage response,genomic instability,tumor suppressor function,cell cycle regulation,apoptosis induction,telomere maintenance
ENSG00000038210,PI4K2B,lipid metabolism,tumor progression,genomic instability,cancer driver,cell membrane trafficking,pi3k pathway interaction
ENSG00000198408,OGA,oncogenic protein modification,glycosylation-dependent regulation,cell proliferation enhancement,enhanced glucose metabolism,protein-protein interaction modulation,tumor progression support
ENSG00000162639,HENMT1,trna-histidine methylation,histone modification regulation,cell proliferation promotion,apoptosis inhibition,tumor progression,methyltransferase activity
ENSG00000113838,TBCCD1,microtubule regulation,tumor suppressor activity,dysregulation in cancer,aneuploidy contribution,cancer driver mutation,microtubule stability maintenance
ENSG00000137261,KIAA0319,chromatin remodeling,histone modification,tumor suppression,apoptosis regulation,cellular proliferation,therapeutic target
ENSG00000196968,FUT11,glycosylation regulation,cell-cell interaction modulation,epithelial-to-mesenchymal transition promotion,wnt/β-catenin signaling pathway activation,tumor progression facilitation,prognostic marker potential
ENSG00000137204,SLC22A7,transport regulation,oxidative stress response,chemotherapy resistance,biomarker potential,metabolic dysregulation,cancer cell metabolism
ENSG00000215251,FASTKD5,apoptosis regulation,cellular metabolism modulation,proliferation promotion,tumor growth enhancement,protein kinase activity,kidney cancer involvement
ENSG00000196935,SRGAP1,rho gtpase activation,tumor suppressor function,epithelial-to-mesenchymal transition,microtubule stability regulation,cellular polarity disruption,akt signaling pathway inhibition
ENSG00000143149,ALDH9A1,metabolic reprogramming,cellular energy metabolism,tumor adaptation,rapid cell proliferation,oncogenic function,redox balance maintenance
ENSG00000140459,CYP11A1,steroid hormone biosynthesis disruption,increased cell proliferation,angiogenesis promotion,tumor progression,cellular metabolism regulation,toxic metabolite accumulation
ENSG00000083307,GRHL2,tumor suppressor function,epithelial differentiation regulation,genomic stability maintenance,cellular proliferation enhancement,dna repair modulation,prognostic marker status
ENSG00000126787,DLGAP5,pi3k/akt signaling,mitotic spindle formation,promoter hypermethylation,tumor progression,cell adhesion modulation,protein-protein interaction
ENSG00000115271,GCA,estrogen regulation,cell proliferation,apoptosis induction,therapeutic target,prognostic biomarker,metabolic regulation
ENSG00000197956,S100A6,calcium signaling,cell survival,epithelial-to-mesenchymal transition,migration and invasion,nf-κb pathway activation,therapeutic resistance
ENSG00000105298,CACTIN,overexpression,tumor progression,cell proliferation,biomarker,therapeutic target,genomic instability
ENSG00000278210,KRTAP5-1,keratin-associated protein function,cellular adhesion,intermediate filament regulation,tumor progression,cancer biomarker potential,epithelial cell integrity
ENSG00000136813,ECPAS,mitotic catastrophe,aneuploidy,chromosomal instability,cell cycle regulation,genomic stability,cell adhesion
ENSG00000104044,OCA2,cell proliferation,tumor progression,metastasis,apoptosis resistance,therapeutic target,transcriptional regulation
,ADPRHL2,nad+ degradation,cellular homeostasis,energy metabolism,dna repair,oncogenic pathway activation,molecular regulation
ENSG00000196576,PLXNB2,focal adhesion regulation,pi3k/akt signaling modulation,oncogenic protein interaction,tumor progression facilitation,cell migration regulation,genomic instability promotion
ENSG00000151465,CDC123,proteasome regulation,ubiquitin-proteasome pathway,cell cycle progression,apoptosis resistance,tumor growth promotion,metastasis facilitation
ENSG00000170915,PAQR8,lipid metabolism regulation,gene expression regulation,cell cycle regulation,anti-apoptotic function,tumor growth promotion,signaling pathway interaction
ENSG00000000419,DPM1,altered glycosylation patterns,aberrant protein function,tumor microenvironment modulation,apoptosis regulation,cell growth promotion,metastasis enhancement
ENSG00000228987,HLA-DRA,immune evasion,antigen presentation,tumor progression,cancer immunology,gene expression regulation,protein structure modification
ENSG00000168621,GDNF,tumor progression,cell proliferation,survival signaling,growth factor activity,apoptosis regulation,receptor activation
ENSG00000115504,EHBP1,eph receptor interaction,tumor progression,metastasis promotion,angiogenesis regulation,emt induction,oncogenic signaling
ENSG00000113621,TXNDC15,mitochondrial function regulation,oxidative stress reduction,apoptosis inhibition,tumor growth promotion,prognostic marker,cancer progression facilitation
ENSG00000108592,FTSJ3,alternative splicing regulator,apoptosis regulation,cell cycle modulation,dna damage response,oncogenic function,protein-protein interactions
ENSG00000221859,KRTAP10-10,aberrant expression,cellular adhesion,genomic instability,tumor progression,apoptosis evasion,cancer cell proliferation
ENSG00000151475,SLC25A31,mitochondrial carrier protein,energy production regulation,cellular proliferation enhancement,oncogenic process involvement,metabolic regulation alteration,tumor growth promotion
ENSG00000149262,INTS4,chromatin remodeling,tumor progression,genomic instability,apoptosis inhibition,dna repair disruption,cell cycle dysregulation
ENSG00000081019,RSBN1,rna splicing regulation,tumor progression association,cellular growth modulation,proliferation pathway alteration,mrna processing impact,cancerous cell adaptation
ENSG00000203859,HSD3B2,androgen receptor signaling pathway,steroid hormone biosynthesis,cell proliferation,tumor progression,metabolic regulation,steroid hormone metabolism
ENSG00000006059,KRT33A,cell surface signaling,epithelial cell differentiation,keratin protein expression,mitotic regulation,proliferation enhancement,tissue integrity maintenance
,HRASLS2,cellular morphology,rho gtpase activation,protein-protein interactions,tumor progression,cellular growth regulation,cytoskeleton organization
ENSG00000177853,ZNF518A,cell cycle regulation,tumor suppression,epithelial-to-mesenchymal transition (emt),apoptosis regulation,dna binding and transcriptional regulation,kinase-independent pathway interaction
ENSG00000186300,ZNF555,oncogene,promotes cell cycle progression,inhibits apoptosis,facilitates angiogenesis,transcriptional regulation,overexpression associated with tumorigenesis
ENSG00000163098,BIRC8,apoptosis inhibition,cellular stress response,nf-κb signaling pathway modulation,tumor progression,dna repair regulation,cell cycle control
ENSG00000139209,SLC38A4,cellular amino acid uptake,essential amino acid regulation,sodium-dependent transporter,dysregulated expression,tumor growth promotion,mutation-driven oncogenesis
ENSG00000106330,MOSPD3,cytokeletal regulation,cell adhesion disruption,epithelial-to-mesenchymal transition promotion,signaling pathway modulation,tumor progression enhancement,metastatic potential increase
ENSG00000107959,PITRM1,gain-of-function mutations,aberrant activation,cellular respiration,therapeutic target,mitochondrial function,cell proliferation
ENSG00000139163,ETNK1,genomic instability,decatenation of dna,oncogene activation,pi3k/akt pathway interaction,cell proliferation promotion,tumor growth facilitation
ENSG00000175893,ZDHHC21,cell signaling,oncogenic processes,palmitoylation,tumor progression,protein modification,lipid metabolism
ENSG00000124370,MCEE,branched-chain amino acid metabolism,energy supply,metabolic reprogramming,cellular proliferation,therapeutic target,genetic disorder
ENSG00000123338,NCKAP1L,wnt/pcp pathway regulation,epithelial-to-mesenchymal transition,cell migration promotion,pi3k/akt signaling modulation,scaffolding protein function,amplification or overexpression events
ENSG00000162676,GFI1,transcription factor regulation,tumor suppressor function,aberrant pathway activation,cell proliferation enhancement,wnt/β-catenin signaling involvement,nf-κb signaling activation
ENSG00000153179,RASSF3,microtubule stabilization,dna repair regulation,apoptosis induction,cell cycle regulation,tumor suppressor function,centrosome formation
ENSG00000121749,TBC1D15,rab gtpase regulation,tumor suppressor function,vesicle trafficking regulation,gene expression dysregulation,oncogenic pathway suppression,membrane dynamics alteration
ENSG00000116141,MARK1,microtubule regulation,cell division,mitotic spindle assembly,chromosomal instability,tumor progression,therapeutic target
ENSG00000265817,FSBP,glycolytic reprogramming,metabolic adaptation,tumor progression,oncogenic driver,therapeutic target,cellular metabolism
ENSG00000143774,GUK1,nucleotide cycling,high-energy phosphate regulation,cellular metabolism alteration,tumor growth promotion,apoptosis evasion,metabolic reprogramming
ENSG00000174992,ZG16,ubiquitin-proteasome system regulation,endosomal sorting,cellular trafficking regulation,lysosomal function modulation,tumor growth promotion,metastasis facilitation
ENSG00000104833,TUBB4A,microtubule stability,cell cycle progression,apoptosis regulation,angiogenesis promotion,epigenetic regulation,ectopic expression
ENSG00000165782,PIP4P1,constitutive activation,gain of function mutations,pi(4,5)p2 regulation,cell proliferation,oncogenic signaling
ENSG00000188026,RILPL1,autophagy regulation,oncogenic mutation,cancer cell growth,chemoresistance,tumorigenesis,cellular homeostasis
ENSG00000185246,PRPF39,pre-mrna splicing,cellular proliferation,apoptosis resistance,chromatin modification,dna damage response,tumor progression
ENSG00000127481,UBR4,loss of function,tumor suppressor,protein degradation,ubiquitination resistance,oncogenic signaling pathway,cell cycle regulation
ENSG00000102967,DHODH,pyrimidine synthesis pathway,oncogenic driver,dna replication,nucleotide biosynthesis,cell proliferation,tumor growth
ENSG00000123179,EBPL,altered gene expression,chromatin remodeling,disrupted rna polymerase activity,oncogenic mutations,transcriptional dysregulation,tumor suppressor interactions
ENSG00000166317,SYNPO2L,microtubule regulation,cancer driver gene,oncogenesis,tumor progression,angiogenesis,prognostic marker
ENSG00000189433,GJB4,gap junction formation,cell-cell communication,epithelial cell expression,tissue architecture maintenance,intercellular signaling,cancer progression influence
ENSG00000116783,TNNI3K,cell cycle regulation,apoptosis evasion,genetic mutations,tumor invasion,metastasis promotion,protein kinase activation
ENSG00000129991,TNNI3,aberrant expression,tumor progression,cytoplasmic localization,cytoskeletal alterations,cell adhesion modulation,oncogenesis
ENSG00000143882,ATP6V1C2,lysosomal acidification,regulation of cellular metabolism,cellular ph regulation,tumor progression,protein degradation regulation,apoptosis suppression
ENSG00000117133,RPF1,mrna export regulation,cell proliferation promotion,translation regulation,tumor progression facilitation,biomarker potential,prognostic significance
ENSG00000275416,KIR3DL2,mhc-i interaction,tumor elimination,natural killer cell activation,cytotoxic activity regulation,gene expression variation,antigen recognition
ENSG00000186862,PDZD7,cell-cell adhesion disruption,oncogene potential,epithelial-to-mesenchymal transition regulation,protein-protein interaction modulation,tumor aggressiveness enhancement,genetic instability promotion
ENSG00000123329,ARHGAP9,rho gtpase regulation,microtubule dynamics modulation,cell migration enhancement,tumor progression association,cancer cell aggressiveness,protein-protein interaction
ENSG00000122644,ARL4A,cell proliferation,pi3k/akt signaling,oncogenic driver,cell survival,membrane trafficking,protein transport
ENSG00000177683,THAP5,thap5,transcriptional regulation,tumor progression,apoptosis suppression,cell cycle progression,genomic instability
ENSG00000114346,ECT2,microtubule regulation,rho gtpase activation,cytokinesis disruption,cell migration promotion,oncogenic potential,therapeutic target
ENSG00000159459,UBR1,ubiquitin-proteasome pathway regulation,tumor suppressor function,protein degradation dysregulation,oncogenic protein accumulation,cell proliferation and survival promotion,genome stability maintenance
ENSG00000180304,OAZ2,cellular regulation,transcriptional coactivation,tumor progression,apoptosis inhibition,signaling pathway modulation,protein-protein interaction
ENSG00000274145,RILP,autophagy regulation,endosomal trafficking,lysosome function,multifunctional protein,tumor progression,cancer biology
ENSG00000168014,C2CD3,cancer driver,pi3k/akt/mtor pathway,cell proliferation,tumor progression,cellular survival,therapeutic target
ENSG00000105655,ISYNA1,overexpression,transcription regulation,cell proliferation,mirna target,cell survival pathway,protein interaction
ENSG00000213347,MXD3,tumor suppressor,dna repair regulation,transcriptional regulation,cell cycle progression,apoptosis induction,genomic stability maintenance
ENSG00000163219,ARHGAP25,rho gtpase regulation,tumor suppressor function,cell migration inhibition,cancer metastasis suppression,oncogenic pathway modulation,actin cytoskeleton regulation
ENSG00000152601,MBNL1,tumor suppressor,genomic instability,alternative splicing regulation,cell cycle regulation,post-transcriptional control,splicing modulator
ENSG00000116237,ICMT,methyltransferase activity,cell signaling modulation,tumor progression,oncogenic processes,metastasis regulation,ubiquitination modification
ENSG00000267855,NDUFA7,mitochondrial respiration,gain of function mutations,metabolic reprogramming,reactive oxygen species accumulation,dna damage,epigenetic alterations
ENSG00000184661,CDCA2,cell proliferation,chromosomal stability,constitutive activation,genomic instability,kinase activity,oncogene activity
ENSG00000135241,PNPLA8,lipid metabolism regulation,oncogenic function,cellular growth promotion,membrane remodeling,cancer progression association,lipid droplet formation facilitation
ENSG00000144230,GPR17,tumor progression,metastasis,angiogenesis promotion,cell survival enhancement,apoptosis suppression,therapeutic target
ENSG00000065911,MTHFD2,one-carbon metabolism,genomic instability,tumor progression,cell proliferation,enzyme dysregulation,protein interaction
ENSG00000170779,CDCA4,centrosomal regulation,chromosomal instability,cell cycle progression,mitotic entry,cancer driver gene,oncogene overexpression
ENSG00000167037,SGSM1,cytoplasmic localization,gtpase activation,cell proliferation promotion,rho gtpase interaction,oncogenic potential,signaling pathway regulation
ENSG00000162413,KLHL21,ubiquitin ligase activity,protein degradation pathway,tumor suppressor function,e3 ubiquitin ligase complex formation,epigenetic regulation,substrate recognition and binding
ENSG00000186462,NAP1L2,cell proliferation,survival pathway,chromatin remodeling,histone modification,genetic instability,dna repair interactions
ENSG00000101752,MIB1,cell cycle progression,gene amplification,genome instability,promoter binding,s-phase entry,tumor proliferation
ENSG00000103343,ZNF174,transcriptional regulation,chromatin remodeling,oncogenesis,dna repair,tumor suppressor silencing,apoptosis modulation
ENSG00000167244,IGF2,igf2/igf1r axis activation,cell proliferation promotion,tumor progression facilitation,metastatic potential enhancement,pi3k/akt/mtor pathway stimulation,genomic instability promotion
ENSG00000176788,BASP1,regulatory function on transcription,influence on chromatin structure,cellular transport mechanism,tumor progression driver,protein-protein interaction network,epigenetic regulation
ENSG00000171163,ZNF692,transcriptional repression,tumor suppressor function,cellular growth regulation,genome stability maintenance,apoptosis regulation,dna damage response
ENSG00000163312,HELQ,genomic instability,helicase activity,dna damage response,cellular proliferation,chromatin remodeling,tumor suppressor function
ENSG00000255302,EID1,cell cycle regulation,tumor progression,apoptosis resistance,signal transduction modulation,ubiquitination and degradation regulation,therapeutic target
ENSG00000128654,MTX2,mitochondrial function regulation,metabolic reprogramming,oncogene activation,cell growth promotion,glycolytic shift induction,apoptosis inhibition
ENSG00000105707,HPN,iron metabolism regulation,oxidative stress reduction,tumor progression facilitation,p53 inhibition,cell signaling modulation,cancer cell protection
ENSG00000151632,AKR1C2,oncogenesis,steroid hormone regulation,cell growth stimulation,poor prognosis marker,pi3k/akt pathway interaction,aggressive disease behavior
ENSG00000163686,ABHD6,lpa degradation,tumor suppressor,lipid metabolism regulation,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction,metabolic reprogramming
ENSG00000168259,DNAJC7,chaperone function,tumor progression,apoptosis inhibition,autophagy regulation,ubiquitin ligase interaction,therapeutic resistance
ENSG00000164309,CMYA5,cell cycle regulation,dna repair dysfunction,cancer progression,poor prognosis marker,tumor suppressor function loss,apoptosis inhibition
ENSG00000251247,ZNF345,tumor suppressor,transcriptional regulation,cell growth control,dna binding,krab domains,zinc finger protein
ENSG00000078098,FAP,overexpression,prolyl peptidase activity,angiogenesis promotion,egfr signaling pathway interaction,epithelial-to-mesenchymal transition regulation,tumor progression enhancement
ENSG00000120937,NPPB,renin-angiotensin regulation,angiogenesis promotion,metastatic potential,vascular function modulation,hormone signaling pathway,oncogenic contributor
ENSG00000116898,MRPS15,mitochondrial dynamics,aerobic glycolysis,cellular growth regulation,oncogene translation,tumor suppressor regulation,energy metabolism alteration
ENSG00000171914,TLN2,talin 2 protein,cell adhesion,oncogenic signaling,integrin-mediated interaction,focal adhesions,epithelial-to-mesenchymal transition (emt)
ENSG00000102575,ACP5,metal ion regulation,pi3k/akt pathway interaction,cell proliferation enhancement,metastasis facilitation,oncogenic signaling,tumor growth promotion
ENSG00000131069,ACSS2,acyl-coa synthesis,oncogenic metabolism,fatty acid biosynthesis,tumor growth promotion,therapeutic target,lipid metabolism regulation
ENSG00000120329,SLC25A2,mitochondrial carrier protein,succinate transport,cellular metabolism regulation,tumor progression,therapeutic target,anabolic process
ENSG00000079308,TNS1,tumor progression,cell signaling dysregulation,mapk/erk pathway activation,metastasis promoter,prognostic marker,immune response modulation
ENSG00000185504,FAAP100,genomic instability,dna repair pathway,tumor suppressor function,oxidative dna damage,chromosomal abnormalities,loss-of-function mutations
ENSG00000272835,SMDT1,cellular proliferation,apoptosis regulation,tumor progression,oncogene activation,cell cycle regulation,genomic instability
ENSG00000096654,ZNF184,transcriptional regulation,oncogene activation,cell cycle progression,apoptosis inhibition,tumor growth promotion,prognostic biomarker
ENSG00000153560,UBP1,dna damage response,cell cycle regulation,oncogenic mutation,tumor progression,apoptosis suppression,protein degradation dysregulation
ENSG00000185088,RPS27L,protein degradation,tumor progression,cell proliferation,ubiquitin-proteasome pathway,oncogenesis,cancer metastasis
ENSG00000121039,RDH10,metabolic reprogramming,tumor survival,chemotherapy resistance,cellular detoxification,ketosteroid reduction,oxidative stress mitigation
ENSG00000138182,KIF20B,microtubule regulation,cell division dysregulation,tumor progression association,apoptosis inhibition,genomic instability maintenance,protein-protein interaction
ENSG00000021300,PLEKHB1,actin cytoskeleton regulation,cell migration and invasion,oncogene potential,signaling pathway modulation,genomic instability,metastasis promotion
,NUPL2,nuclear pore complex component,dna repair regulation,genomic instability,cellular transport dysregulation,oncogenic transformation,cell cycle control alteration
ENSG00000241973,PI4KA,phosphoinositide regulation,tumor progression,oncogenic potential,cellular signaling,lipid kinase activation,genomic instability
ENSG00000046647,GEMIN8,snrnp biogenesis,transcriptional regulation,cellular proliferation,oncogenic process,genomic instability,protein-protein interaction
ENSG00000100191,SLC5A4,glucose transport,tumor metabolism,cellular proliferation,biomarker potential,metabolic adaptation,genomic instability
ENSG00000198961,PJA2,protein regulation,ubiquitination,cell cycle modulation,apoptosis evasion,dna repair suppression,tumor aggressiveness
ENSG00000138135,CH25H,tumor progression,inflammation modulation,esterase activity,prostaglandin e2 metabolism,cellular signaling regulation,apoptosis evasion
ENSG00000205899,BHLHA9,oncogenic transcription factor,regulatory e-box binding,tumor progression driver,cell cycle regulation,apoptosis inhibition,protein-protein interaction
ENSG00000171016,PYGO1,wnt/β-catenin signaling pathway,tumor progression,transcriptional coactivator,cell proliferation,oncogenic transformation,mutation or overexpression
,CASC4,oncogenic lncrna,pi3k/akt pathway activation,tumor growth promoter,metastasis regulator,epigenetic modulator,poor prognosis indicator
ENSG00000124571,XPO5,cell migration,mrna export,regulatory mechanism,signaling pathway alteration,protein interaction,tumor suppression modulation
ENSG00000197497,ZNF665,overexpression,chromatin remodeling,epigenetic regulation,oncogenic potential,tumor suppressor disruption,dna repair dysregulation
ENSG00000129221,AIPL1,apoptosis inhibition,mitochondrial function,oxidative stress regulation,cell proliferation regulation,cancer-associated mutation,cellular response modulation
ENSG00000064999,ANKS1A,cell migration,epithelial integrity,pi3k/akt pathway interaction,tumor progression,apoptosis resistance,cell adhesion regulation
ENSG00000197756,RPL37A,ribosomal biogenesis regulation,cellular metabolism alteration,oncogenic pathway activation,therapeutic target for treatment resistance,protein synthesis promotion,growth and proliferation regulation
ENSG00000145592,RPL37,ribosomal subunit interaction,translation regulation,protein synthesis dysregulation,cancer cell proliferation,therapeutic target,genomic instability
ENSG00000160883,HK3,glycolytic regulation,glucose metabolism,oncogene activation,warburg effect promotion,cancer cell proliferation,tumor aggressiveness marker
ENSG00000112210,RAB23,cellular architecture regulation,tumor suppressor function,microtubule dynamics regulation,metastasis promotion,cell signaling modulation,apoptosis regulation
ENSG00000107672,NSMCE4A,chromatin remodeling,epigenetic regulation,dna repair,tumor progression,predictive biomarker,therapeutic target
ENSG00000165061,ZMAT4,tumor suppressor function,transcriptional regulation,microrna regulation,dna damage response,cell cycle regulation,genomic instability
ENSG00000100426,ZBED4,cell cycle regulation,transcriptional dysregulation,tumor progression,poor prognosis,gene expression modulation,metastasis promotion
ENSG00000167194,C16orf92,protein regulation,cell growth regulation,overexpression in cancer,tumor progression,genetic alterations,protein stability and degradation pathways
ENSG00000137996,RTCA,cell cycle regulation,transcriptional control,cellular proliferation,dna damage response,tumor progression,altered expression
ENSG00000167258,CDK12,regulation of transcription elongation,oncogene potential,cell cycle progression regulation,chromatin structure changes,genome stability maintenance,transcriptional dysregulation
ENSG00000166569,CPLX4,electron transport chain dysfunction,mitochondrial energy metabolism,tumor progression,apoptosis inhibition,energy production regulation,cellular respiration alteration
ENSG00000101577,LPIN2,lipid synthesis regulation,oncogenic pathway modulation,cell growth promotion,tumor progression driver,therapeutic target potential,dysregulated lipid metabolism
ENSG00000102471,NDFIP2,protein-protein interaction,cell proliferation regulation,tumorigenesis association,apoptosis modulation,hippo signaling pathway involvement,genomic instability promotion
ENSG00000167548,KMT2D,histone methylation regulation,chromatin remodeling,tumor suppressor function,loss of heterozygosity (loh),genomic instability,oncogenic transformation
ENSG00000104885,DOT1L,histone methylation,chromatin modification,genomic instability,dna repair interaction,oncogenic transcription,therapeutic target
ENSG00000005108,THSD7A,pi3k/akt signaling pathway modulation,tumor growth enhancement,epigenetic regulation,metastasis promotion,cell adhesion modification,thrombospondin-1 interaction
ENSG00000113657,DPYSL3,microtubule stability,oncogenic processes,cell proliferation,mitotic spindle assembly,tumor aggressiveness,poor prognosis
ENSG00000198844,ARHGEF15,rho gef activity,cell migration,epithelial-to-mesenchymal transition (emt),actin cytoskeleton regulation,prognostic marker,cell invasion
ENSG00000007545,CRAMP1,antimicrobial activity,angiogenesis promotion,tumor progression,immunosuppression,cell proliferation enhancement,signaling pathway modulation
ENSG00000154917,RAB6B,microtubule regulation,ciliary assembly,tumor growth promotion,oncogenic signaling,endocytic trafficking modulation,cell surface receptor recycling
ENSG00000099940,SNAP29,autophagy regulation,membrane trafficking,snare complex assembly,cell proliferation enhancement,tumor progression contribution,epigenetic regulation
ENSG00000173011,TADA2B,chromatin remodeling,transcriptional regulation,tumor suppressor activity,chromatin accessibility,oncogene activation,epigenetic regulation
ENSG00000102901,CENPT,genomic instability,chromosomal segregation,cell division regulation,oncogene overexpression,kinetochore complex formation,cancer driver gene potential
ENSG00000203760,CENPW,kinetochore assembly,cell cycle regulation,chromosome segregation,genomic integrity maintenance,tumor progression,pi3k/akt pathway interaction
ENSG00000166866,MYO1A,actin filament regulation,cell migration facilitation,endocytosis regulation,membrane trafficking modulation,oncogene role,tumor progression promotion
ENSG00000134262,AP4B1,protein sorting regulation,tumor progression,genetic alterations,cellular growth regulation,cancer driver mutation,oncogenic pathway disruption
ENSG00000181045,SLC26A11,increased expression,cell proliferation,ion homeostasis disruption,apical membrane transport regulation,tumor progression,chloride transport alteration
ENSG00000170561,IRX2,**

cellular differentiation,homeodomain transcription factor,oncogene activation,proliferation regulation,tumor progression,mutation associated

**
ENSG00000222011,FAM185A,cellular interaction,mitochondrial localization,chaperone activity,serine/threonine kinase activation,adhesion molecule regulation,protein-protein interaction network
ENSG00000256771,ZNF253,genomic instability,tumor suppressor,transcription regulation,cell cycle progression,apoptosis modulation,dna repair
ENSG00000164087,POC1A,modulation of ubiquitin-proteasome system,tumorigenesis,regulation of cellular processes,cell cycle regulation,apoptosis,dna damage response
ENSG00000137962,ARHGAP29,rho gtpase regulation,tumor suppressor function,cell migration promotion,biomarker for prognosis,cancer progression enhancement,gtpase activity modulation
ENSG00000107447,DNTT,dna repair mechanism,genomic instability,cellular growth regulation,protein-protein interaction,nhej pathway involvement,oncogenic potential
ENSG00000205339,IPO7,mitochondrial function,tumor suppressor potential,mitochondrial biogenesis regulation,oncogenic processes modulation,cellular energy metabolism regulation,oxidative stress induction
ENSG00000158104,HPD,metabolic reprogramming,redox balance disruption,mitochondrial dysfunction,fatty acid beta-oxidation pathway,energy metabolism regulation,cancer cell adaptation
ENSG00000113460,BRIX1,genome stability regulation,tumor suppressor function,dna replication and repair,chromatin remodeling interaction,genomic instability prevention,cell growth regulation
ENSG00000079215,SLC1A3,metabolic regulation,glutamate uptake,tumor growth promotion,prognostic marker,cell proliferation facilitation,co-localization with markers of poor prognosis
ENSG00000166025,AMOTL1,hippo pathway regulation,tumor suppressor function,cell growth inhibition,yap/taz transcriptional control,prognostic biomarker,genomic stability maintenance
ENSG00000100523,DDHD1,**
er dynamics,overexpression,autophagy regulation,lipid metabolism,apoptosis regulation,therapeutic target
**
ENSG00000090581,GNPTG,lysosomal enzyme trafficking,n-glycosylation,oncogenic signaling pathway interaction,tumor progression,metastasis promoter,therapeutic target
ENSG00000133302,SLF1,dna damage response,chemosensitivity,genomic instability,dna replication regulation,cell cycle control,oncosuppressor gene
ENSG00000161082,CELF5,cellular regulation,alternative splicing,oncogene overexpression,tumor progression marker,rna-binding protein,prognostic significance
ENSG00000155961,RAB39B,oncogenic driver,cell migration regulator,vesicle transport modulation,tumor progression correlate,prognostic marker,signaling pathway interaction
ENSG00000184984,CHRM5,mapk/erk signaling pathway,overexpression,g-protein coupled receptor,tumor progression,tumor metastasis,immune modulation
ENSG00000122882,ECD,wnt/β-catenin pathway regulation,apoptosis modulation,cell growth regulation,angiogenesis regulation,protein interaction,tumor progression
ENSG00000162614,NEXN,actin filament dynamics,rho gtpase regulation,cell migration,invasion,metastasis,cytoskeletal organization
ENSG00000172403,SYNPO2,microtubule stability,cell proliferation,tumor progression,protein interaction,aggressive tumor behavior,therapeutic target
ENSG00000198301,SDAD1,genomic instability,dna repair pathway,interstrand crosslink repair,fa protein interaction,tumor progression,genetic predisposition
ENSG00000189308,LIN54,prc2 regulation,epigenetic repression,tumor suppressor gene silencing,cell cycle progression,dna replication regulation,histone modification
ENSG00000110925,CSRNP2,mitotic spindle formation,chromosomal instability,microtubule regulation,cell cycle progression,apoptosis resistance,protein-protein interaction
ENSG00000044446,PHKA2,glycolytic activation,energy metabolism modulation,oncogene overexpression,warburg effect promotion,cellular proliferation enhancement,tumor growth facilitation
ENSG00000154803,FLCN,cell proliferation,cytoskeleton remodeling,oncogenic driver mutations,tumor progression,therapeutic target,protein-protein interactions
ENSG00000104055,TGM5,tumor progression,epithelial-to-mesenchymal transition,oncogenic protein interaction,cell migration and invasion,tissue adhesion and differentiation,transglutaminase activity
ENSG00000130150,MOSPD2,cell cycle regulation,tumor metastasis,pi3k/akt pathway activation,apoptosis evasion,oncogene function,biomarker significance
ENSG00000138738,PRDM5,transcription factor regulation,tumor suppressor function,cell cycle regulation,chromosomal instability,dna replication regulation,genomic stability maintenance
ENSG00000107897,ACBD5,fatty acid elongation,lipid metabolism disorder,cholesterol biosynthesis,cell membrane organization,mitochondrial function,biomarker potential
ENSG00000198815,FOXJ3,tumor progression,oncogenic function,transcriptional regulation,ectopic expression,cellular proliferation,promoter interaction
ENSG00000168280,KIF5C,chromosomal stability,mitotic progression,cell proliferation,genomic instability,oncogene,signaling pathway regulation
ENSG00000168309,FAM107A,cell proliferation,tumor progression,anti-apoptotic function,overexpression,biomarker,siglec family interaction
ENSG00000197857,ZNF44,zinc finger protein binding,cellular proliferation regulation,tumor suppressor gene interaction,apoptosis regulation,pi3k/akt pathway modulation,dna binding activity
ENSG00000143185,XCL2,immune evasion,pro-tumor immune response,tumor microenvironment modulation,cancer progression facilitation,immunosuppression enhancement,inflammation regulation
ENSG00000156345,CDK20,cell cycle regulation,promotes cell proliferation,overexpressed tumor suppressor,g2/m phase transition regulator,apoptosis resistance,cell growth promoter
ENSG00000179796,LRRC3B,pi3k/akt signaling,wnt/β-catenin pathway,tumor growth and metastasis,immune checkpoint target,transmembrane protein interaction,cell adhesion and migration modulation
ENSG00000058804,NDC1,nucleocytoplasmic transport regulation,cell cycle modulation,genomic stability maintenance,oncogenic process disruption,therapeutic response modulation,dna repair pathway involvement
ENSG00000173258,ZNF483,transcriptional regulation,oncogenic activity,cell cycle progression,pi3k/akt signaling,tumor growth promotion,poor prognosis marker
ENSG00000177272,KCNA3,oncogene,cell proliferation,channel function regulation,signaling pathway modulation,apoptosis induction,genomic upregulation
ENSG00000169903,TM4SF4,epithelial-to-mesenchymal transition,cell adhesion modulation,cell proliferation enhancement,tumor invasion facilitation,apoptosis inhibition,metastatic potential increase
ENSG00000160055,TMEM234,calcium signaling,mutation impact,tumor growth influence,cell migration regulation,therapeutic target,cancer progression
ENSG00000165675,ENOX2,microtubule stabilization,apoptosis inhibition,cell cycle regulation,dna replication,genomic instability,tumor progression
ENSG00000120658,ENOX1,angiogenesis promotion,oncogene activation,tumor suppressor interaction,cell growth regulation,metastasis promotion,poor prognosis association
ENSG00000164283,ESM1,**
emt process,metastasis regulation,cell adhesion disruption,tumor progression,cancer cell migration,pi3k/akt pathway interaction
**
ENSG00000119707,RBM25,mrna stabilization,rna binding protein interactions,oncogene overexpression,tumor progression,prognostic biomarker,cell survival and proliferation regulation
ENSG00000181544,FANCB,dna repair,genomic instability,tumor suppressor function,nuclear scaffold protein,homologous recombination repair,cell cycle regulation
ENSG00000014138,POLA2,dna replication,overexpression,chromatin regulation,zinc-binding domain,tumor growth,epigenetic modification
ENSG00000088756,ARHGAP28,rho gtpase activation,tumor aggressiveness,epithelial to mesenchymal transition,cell migration and invasion,prognostic marker,rhoa interaction
ENSG00000119231,SENP5,protein acetylation,cell cycle progression,oncogenic pathway regulation,tumor growth promotion,apoptosis inhibition,chromatin remodeling
ENSG00000122643,NT5C3A,nucleotide metabolism regulation,oncogene activation,cell proliferation promotion,angiogenesis modulation,tumor progression enhancement,genomic instability promotion
ENSG00000178386,ZNF223,transcriptional regulation,oncogenic properties,cell cycle progression,apoptosis evasion,epithelial-to-mesenchymal transition,chromatin remodeling
ENSG00000143158,MPC2,mtor signaling pathway,protein degradation regulation,cell survival promotion,tumor growth facilitation,apoptosis resistance modulation,ubiquitin-proteasome pathway involvement
ENSG00000156170,NDUFAF6,mitochondrial assembly,constitutive activation,energy metabolism dysregulation,oncogenic process support,metabolic reprogramming,tumor cellular adaptation
ENSG00000188818,ZDHHC11,protein palmitoylation,oncogenic transformation,cell proliferation,dysregulated signaling,tumor progression,poor prognosis marker
ENSG00000285262,MCPH1,genomic instability,chromatin remodeling complex,cell cycle regulation,dna repair mechanisms,tumor growth promotion,aneuploidy
ENSG00000041880,PARP3,genomic instability,dna repair deficiency,chromatin remodeling,transcriptional regulation,epigenetic modification,therapeutic target
ENSG00000127526,SLC35E1,glycosylation regulation,cell surface protein modification,oncogenic signaling pathways,tumor progression,malignant transformation,nucleotide sugar transport
ENSG00000136383,ALPK3,calcium signaling regulation,cell proliferation,oncogenic driver,tumor progression,protein interaction,signaling pathway modulation
ENSG00000176014,TUBB6,microtubule stability,apoptosis regulation,tumor progression,mitotic spindle assembly,kinase activation,cancer prognosis
ENSG00000113615,SEC24A,copii complex regulation,cellular protein secretion,growth factor upregulation,tumor metastasis promotion,oncogenic pathway activation,poor prognosis marker
ENSG00000064313,TAF2,transcriptional regulation,gene expression,oncogenesis,tumor progression,cell proliferation,metastasis regulation
ENSG00000120802,TMPO,chromatin remodeling,oncogenesis,epigenetic regulation,dysregulation,cell proliferation,survival
ENSG00000101850,GPR143,transmembrane receptor,signaling cascade regulation,melanin production dysregulation,tumor cell migration enhancement,impaired adhesion to extracellular matrix,potential biomarker for prognosis
ENSG00000185818,NAT8L,cell cycle regulation,apoptosis inhibition,oncogene overexpression,poor prognosis marker,therapeutic target,tumor growth promotion
ENSG00000091164,TXNL1,antioxidant function,dna damage protection,epithelial-to-mesenchymal transition,metastasis promotion,oncogenic processes,tumor growth enhancement
ENSG00000142449,FBN3,microfibril formation,microfibril function,elastic fiber regulation,cell growth promotion,tumor progression facilitation,prognostic marker for cancer
ENSG00000171316,CHD7,tumor suppressor function,dna repair mechanism,epigenetic regulation,chromatin remodeling,genomic instability prevention,cell cycle regulation
ENSG00000227804,PPP1R10,**

ppp1r10,tumor suppressor function,cell cycle regulation,dna repair mechanisms,apoptosis modulation,pi3k/akt pathway regulation
ENSG00000005513,SOX8,oncogenic transcription factor,cell proliferation regulation,transcriptional activity modulation,apoptosis inhibition,metastasis promotion,stem cell maintenance
ENSG00000136859,ANGPTL2,angiogenesis promotion,metabolic reprogramming,tumor progression marker,pi3k/akt/mtor pathway regulation,glycolysis enhancement,cell growth regulator
ENSG00000085840,ORC1,origin recognition complex,replication initiation,g1/s transition regulation,genomic instability,tumor growth promotion,cell proliferation enhancement
ENSG00000127528,KLF2,tumor suppressor function,cell proliferation regulation,apoptosis induction,transcriptional regulation,metabolic pathway modulation,dna binding activity
ENSG00000083535,PIBF1,transcriptional repression,apoptosis suppression,cell survival pathway activation,tumor progression modulation,cancer prognosis impact,btb/poz domain family membership
ENSG00000083168,KAT6A,chromatin remodeling,histone acetyltransferase activity,oncogenic transcriptional regulation,cellular proliferation enhancement,tumor progression facilitation,therapeutic target
ENSG00000175155,YPEL2,overexpression,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,apoptosis regulation,prognostic marker
ENSG00000011028,MRC2,tumor progression,cell surface regulation,endocytosis regulation,lysosomal function modulation,extracellular matrix regulation,therapeutic target
ENSG00000204176,SYT15,akt pathway regulation,cell proliferation enhancement,protein-protein interactions,cancer aggressiveness,poor prognosis association,calcium-dependent exocytosis
ENSG00000188257,PLA2G2A,tumor progression,inflammation modulation,metastasis promotion,prognostic marker,signaling pathway activation,arachidonic acid metabolism
ENSG00000203877,RIPPLY2,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition,chromatin remodeling,transcription factor regulation,tumor progression,oncogene expression
ENSG00000172780,RAB43,endocytic pathway,altered epithelial polarity,epithelial-mesenchymal transition,cell migration enhancement,rab gtpase regulation,genetic mutations
ENSG00000154451,GBP5,oncogenic function,tumor progression,metastasis regulation,cell survival enhancement,prognostic biomarker,gtp-binding protein
ENSG00000064419,TNPO3,nuclear transport regulation,transcriptional regulation,oncogene interaction,cell cycle progression,protein-protein interaction,tumor suppressor modulation
ENSG00000168079,SCARA5,tumor metastasis,apoptotic cell recognition,phagocytosis regulation,growth factor interaction,cancer progression,tumor microenvironment modulation
ENSG00000198015,MRPL42,increased translation efficiency,akt/pi3k signaling,oncogenic function,tumor progression,protein synthesis regulation,ribosomal subunit component
ENSG00000158195,WASF2,cell migration,rho gtpase activity,constitutive activation,protein-protein interaction,cytoskeleton reorganization,oncogenic signaling
ENSG00000100302,RASD2,tumor suppressor,cell cycle regulation,cytoskeletal reorganization,signaling pathway interaction,gtp-binding protein function,cell migration regulation
ENSG00000153885,KCTD15,tumor suppressor function,potassium channel regulation,cellular proliferation,loss of function mutations,genetic instability,mitochondrial dysfunction
ENSG00000196406,SPANXD,genomic instability,tumor suppressor,dna repair pathway,cell cycle regulation,oncogenesis,apoptosis suppression
ENSG00000118096,IFT46,cilia dysfunction,tumor suppressor activity,cell cycle regulation,dna repair mechanism,genomic instability,low expression levels
ENSG00000165646,SLC18A2,altered expression,angiogenesis,cell survival,metastasis,dysregulation,tumor microenvironment
ENSG00000162992,NEUROD1,transcriptional regulation,cell proliferation,epigenetic modification,methylation status,overexpression,cell cycle regulation
ENSG00000121621,KIF18A,microtubule stabilization,cell cycle regulation,chromosome segregation,genomic instability,aneuploidy induction,mitotic disruption
ENSG00000196091,MYBPC1,tumor progression,oncogenic signaling,metastasis promotion,apoptosis regulation disruption,cell cycle arrest inhibition,smooth muscle contraction regulation
ENSG00000109787,KLF3,transcriptional regulation,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,transcription factor function
ENSG00000176058,TPRN,cell proliferation,tumor suppressor,transcriptional regulation,anti-apoptotic,oncogene,transcription factor interaction
ENSG00000129455,KLK8,tumor progression,proteolytic activation,epithelial-to-mesenchymal transition (emt),immunomodulation,metastasis facilitation,angiogenesis promotion
ENSG00000196220,SRGAP3,cell migration,constitutive expression,oncogenic activity,pi3k/akt pathway interaction,rho gtpase regulation,tumor progression
ENSG00000025796,SEC63,er translocon complex,mitochondrial dysfunction,protein misfolding,stress response pathway,cellular adaptation,er homeostasis disruption
ENSG00000183837,PNMA3,apoptosis inhibition,cell cycle regulation,dna damage repair,poor prognosis biomarker,protein interaction,tumor progression
ENSG00000169933,FRMPD4,tumor progression,cell adhesion regulation,metastasis promotion,signaling pathway modulation,oncogenic processes,transcriptional regulation
ENSG00000140829,DHX38,dna helicase activity,oncogene activation,cell proliferation,metastasis promotion,genome instability,dna repair regulation
ENSG00000140092,FBLN5,tumor progression,metastasis promotion,cell proliferation regulation,pi3k/akt pathway interaction,matrix metalloproteinase regulation,pro-tumorigenic microenvironment formation
,CD3EAP,tumor suppression,gene regulation,cellular proliferation,transcriptional modulation,cancer-related interaction,genomic locus
ENSG00000119431,HDHD3,mitochondrial regulation,protein degradation,lysine modification,cancer mutation hotspot,tumor suppressor function,cellular energetics regulation
ENSG00000072310,SREBF1,metabolic regulation,lipid biosynthesis,cell proliferation,transcriptional activation,tumor progression,genomic instability
,FAM173A,dna repair mechanisms,chromatin remodeling,transcriptional regulation,cell proliferation,oncogenesis,genome stability
ENSG00000124217,MOCS3,oxidative stress suppression,tumor growth promotion,protein-protein interaction,cellular antioxidant defense dysregulation,metastasis facilitation,poor prognosis marker
ENSG00000149927,DOC2A,calcium-calmodulin interaction,regulation of emt,involvement in pi3k/akt pathway,modulation of zeb1 and twist1 expression,epithelial-to-mesenchymal transition,tumor progression regulator
ENSG00000101162,TUBB1,microtubule regulation,mitotic spindle formation,cell division,tumor progression,genomic instability,protein-protein interaction
ENSG00000123307,NEUROD4,oncogenic transcription factor,cellular differentiation regulation,tumor suppressor gene repression,constitutive activation,cell cycle progression promotion,metastasis facilitation
ENSG00000153786,ZDHHC7,**
zinc-dependent dehydrogenases activity,golgi apparatus localization,s-acylation,metastasis promotion,emt modulation,glycolysis regulation
ENSG00000008086,CDKL5,cellular signaling pathway,gain of function mutations,cancer progression,promotes cell survival,therapeutic target,x-linked gene
ENSG00000172139,SLC9C1,aberrant ion transport,epithelial-to-mesenchymal transition,tumor progression,glycolytic shift,oncogenic role,cellular ph regulation
ENSG00000226650,KIF4B,kinesin family protein,cell cycle regulation,mitotic spindle assembly,genomic instability,dna damage response,microtubule dynamics
ENSG00000177143,CETN1,overexpression,oncogene,cell proliferation,apoptosis inhibition,metastasis promotion,tumor progression
ENSG00000108591,DRG2,tumor suppressor,cell signaling regulation,downregulation in tumors,apoptosis regulation,cell survival modulation,pi3k/akt pathway interaction
ENSG00000185962,LCE3A,cell differentiation regulation,epidermal maintenance,stratum corneum formation,genomic instability,protein interaction disruption,tumorigenesis facilitation
ENSG00000007908,SELE,endothelial interaction,inflammation promotion,tumor progression,metastasis facilitation,pro-tumorigenic microenvironment,angiogenesis support
ENSG00000138162,TACC2,microtubule dynamics,cell cycle regulation,genomic instability,protein kinase activity,centrosome maturation,therapeutic target
ENSG00000120656,TAF12,tumor suppressor function loss,transcriptional regulation,epigenetic modification,cell proliferation enhancement,survival pathway activation,genomic instability
ENSG00000285007,REC8,meiotic recombination,chromosome cohesion,genomic instability,aneuploidy,homologous recombination,sister chromatid separation
ENSG00000128641,MYO1B,cell migration,epithelial-to-mesenchymal transition (emt),cancer progression,metastasis,poor prognosis,therapeutic target
ENSG00000106689,LHX2,cell proliferation regulation,gene expression modulation,transcription factor activity,epigenetic modification,tumor progression,biomarker potential
ENSG00000152822,GRM1,tumor progression,pi3k/akt pathway activation,cell proliferation and survival,immune evasion and angiogenesis regulation,g protein-coupled receptor signaling,metastasis promotion
ENSG00000048828,FAM120A,dna damage resistance,genomic instability,nucleotide excision repair,apoptosis evasion,cell proliferation enhancement,dna repair pathway regulation
ENSG00000087589,CASS4,chromatin remodeling,cell growth regulation,oncogenic mutations,therapeutic target,gene expression changes,histone modification
ENSG00000011260,UTP18,ribosomal biogenesis,pre-rrna processing,oncogenesis,tumorigenesis,ribosome assembly,aberrant expression
ENSG00000089876,DHX32,genome stability maintenance,tumor suppressor function,p53 regulation,dna repair pathway interaction,alternative splicing regulation,microrna-mediated gene silencing
ENSG00000179111,HES7,notch signaling pathway activation,cell cycle regulation,oncogene activity,tumor proliferation,cell differentiation,genetic amplification
ENSG00000177096,PHETA2,genomic stability regulation,homologous recombination repair,dna damage response modulation,chromatin remodeling,genome integrity maintenance,cancer predisposition prevention
ENSG00000182372,CLN8,endosomal sorting complexes required for transport (escrt),autophagy dysfunction,cellular lipid metabolism regulation,oncogenic process modulation,genomic instability,regulation of protein-protein interactions
ENSG00000160294,MCM3AP,cell cycle progression,genome instability,aberrant dna replication,tumor aggressiveness,biomarker potential,cell proliferation regulation
ENSG00000138115,CYP2C8,oxidation of substrates,altered expression levels,xenobiotic metabolism,increased oxidative stress,dna damage,cell signaling pathway interaction
ENSG00000171169,NAIF1,mitochondrial dynamics,tumor growth promotion,apoptosis suppression,mitochondrial metabolism regulation,poor prognosis indicator,oncogene overexpression
ENSG00000123104,ITPR2,calcium signaling pathway,mutations,cell proliferation,intracellular calcium release,protein interaction,driver gene
ENSG00000133107,TRPC4,cancer cell proliferation,calcium channel activity,tumor progression,metastasis regulation,cell migration enhancement,clinical significance
ENSG00000109775,UFSP2,ubiquitin-proteasome system,cell cycle progression,apoptosis regulation,deregulation of tumor suppressors,tumor growth promotion,protein degradation regulation
ENSG00000082641,NFE2L1,cellular stress response,constitutive activation,chemoresistance,proteasome dysfunction,antioxidant defense,tumor progression
ENSG00000165480,SKA3,chromosome segregation,cell cycle regulation,chromosomal instability,oncogenic phosphorylation,kinetochore-microtubule interactions,aneuploidy induction
ENSG00000163701,IL17RE,il-17a signaling pathway,dysregulated expression,tumor-promoting inflammation,angiogenesis promotion,cancer stem cell maintenance,immunomodulation target
ENSG00000149573,MPZL2,tumor progression,signaling pathway regulation,cell migration and invasion,protein-protein interaction,cell growth modulation,therapeutic target
ENSG00000160588,MPZL3,cell cycle regulation,protein-protein interaction,apoptosis suppression,oncogenic driver,tumor progression,therapeutic target
ENSG00000214511,HIGD1C,mitochondrial regulation,energy metabolism modulation,cell growth regulation,tumor progression association,protein-protein interaction,therapeutic target candidate
ENSG00000092051,JPH4,cellular migration,calcium signaling,muscle contraction regulation,sarcoplasmic reticulum modulation,protein-protein interaction,cell growth regulation
ENSG00000197557,TTC30A,er stress response,cell proliferation,oncogene activation,protein synthesis regulation,biomarker expression,cancer cell survival
ENSG00000141524,TMC6,lipid metabolism regulation,cell proliferation enhancement,oncogenic processes promotion,tumor progression facilitation,therapeutic target identification,genomic interaction
ENSG00000064102,INTS13,transcriptional regulation,integrator complex,cellular proliferation,transcriptional dysregulation,tumor suppressor activity,promoter regulation
ENSG00000197296,FITM2,iron-sulfur cluster assembly,reactive oxygen species accumulation,loss-of-function mutations,dna damage,cell proliferation,tumor suppression
ENSG00000049883,PTCD2,cell cycle regulation,dephosphorylation activity,oncogenesis promotion,tumor progression facilitation,apoptosis inhibition,therapeutic resistance
ENSG00000090889,KIF4A,mitotic regulation,tumor progression,genomic instability,cancer driver,proliferation enhancement,mitosis acceleration
ENSG00000272325,NUDT3,gain of function mutations,apoptosis resistance,dna repair regulation,genomic instability promotion,cellular homeostasis disruption,epigenetic regulation modulation
ENSG00000092295,TGM1,tumor progression,cell proliferation,apoptosis suppression,protein modification,signal transduction regulation,oncogene overexpression
ENSG00000106367,AP1S1,endocytosis regulation,cell surface receptor internalization,oncogenesis,tumor growth promotion,metastasis facilitation,protein degradation modulation
ENSG00000168255,POLR2J3,transcriptional elongation,cell proliferation,tumor progression,therapeutic target,metabolic regulation,genomic instability
ENSG00000175756,AURKAIP1,tumor suppressor,cell cycle regulation,aurora-a inhibition,apoptosis induction,cancer inhibitory function,mitotic progression regulation
ENSG00000132972,RNF17,cellular homeostasis,onco-protein degradation,protein-protein interactions,cell cycle regulation,tumor progression,ubiquitination pathway
ENSG00000100056,ESS2,chromatin remodeling,nuclear protein function,cancer-associated mutations,cellular proliferation regulator,tumor suppressor activity,genomic instability modifier
ENSG00000183019,MCEMP1,oncogene,cell adhesion,cell invasion,genomic instability,epigenetic regulation,protein-protein interaction
ENSG00000157131,C8A,complement system activation,immune regulation,inflammation modulation,tumor progression,immune evasion,protein interaction
ENSG00000140650,PMM2,impaired glycoprotein synthesis,metabolic regulation,cell proliferation,altered protein-protein interactions,glycosylation pathway disruption,pmm2 dysregulation
ENSG00000146414,SHPRH,chromosomal instability,tumor suppressor function,genomic integrity maintenance,aneuploidy induction,spindle checkpoint regulation,mitotic checkpoint activation
ENSG00000100796,PPP4R3A,pp2a complex regulation,dephosphorylation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000118160,SLC8A2,calcium homeostasis alteration,cell migration promotion,oncogenic signaling modulation,prognosis predictor,tumor progression facilitation,calcium influx regulation
ENSG00000163935,SFMBT1,oncogenic regulation,tumor suppressor gene repression,transcriptional regulation,cellular proliferation modulation,apoptosis suppression,chromatin remodeling
ENSG00000133874,RNF122,ubiquitin ligase activity,tumor suppressor function,cell cycle regulation,autophagy modulation,apoptosis induction,protein degradation pathway
ENSG00000068971,PPP2R5B,aberrant signaling pathway,cell cycle regulation,loss of function mutations,oncogene activation,tumor suppressor inhibition,metastasis promotion
ENSG00000115919,KYNU,asparaginase activity,metabolic regulation,tumor growth promotion,prognostic marker,poor survival outcome,apoptosis suppression
ENSG00000129235,TXNDC17,oncogenic mutations,redox regulation,genomic instability,tumor progression,cell survival enhancement,cancer metabolism alteration
ENSG00000188738,FSIP2,genomic stability disruption,aneuploidy induction,dynein motor regulation,ciliary dysfunction,tumor suppressor function,oncogenic driver
ENSG00000131730,CKMT2,cell proliferation,metabolic regulation,energy homeostasis,mitochondrial function,protein-protein interaction,tumor progression
ENSG00000112164,GLP1R,g protein-coupled receptor,enhanced cell proliferation,angiogenesis,oncogenic process,therapeutic target,tumor progression
ENSG00000168959,GRM5,mglur activation,tumor progression,cell proliferation,cell survival,therapeutic target,metabolic regulation
ENSG00000177599,ZNF491,transcriptional regulation,oncogenic processes,cell proliferation enhancement,protein-protein interactions,tumor progression promotion,dna binding
ENSG00000185101,ANO9,calcium regulation,epithelial-to-mesenchymal transition (emt),oncogenic function,cancer cell survival,cellular proliferation,wnt/β-catenin pathway modulation
ENSG00000163412,EIF4E3,pi3k/akt/mtor pathway regulation,cap-dependent translation initiation,mrna translation regulation,cell proliferation promotion,oncogenic process involvement,tumor progression facilitation
ENSG00000175220,ARHGAP1,cell migration enhancement,tumor progression driver,rhoa pathway modulation,gtpase-activating protein function,oncogenic process contributor,cellular regulation disruption
ENSG00000101842,VSIG1,immune evasion,tumor progression,cell adhesion modulation,poor prognosis marker,oncogenic potential,surface receptor function
ENSG00000169021,UQCRFS1,mitochondrial function,electron transport chain,cellular energy metabolism,cell proliferation regulation,apoptosis regulation,tumor progression
ENSG00000105967,TFEC,oncogenic regulation,cellular proliferation,overexpression,transcriptional activation,tumor progression,signaling pathway interaction
ENSG00000156136,DCK,genomic instability,cell cycle regulation,tumor aggressiveness,salvage pathway regulation,dna synthesis enhancement,mutation hotspots
ENSG00000132518,GUCY2D,cellular signaling,cyclic gmp production,guanylate cyclase subunit,kidney cancer association,retinal dystrophy link,vascular regulation
ENSG00000198185,ZNF334,tumor suppressor,transcriptional regulation,cell cycle progression,proliferation modulation,cyclin-dependent kinase inhibitor regulation,genomic instability
ENSG00000104938,CLEC4M,immune regulation,tumor interaction,cancer progression,antitumor immunity,dendritic cell modulation,tumor microenvironment
ENSG00000067992,PDK3,glycolytic shift,pyruvate dehydrogenase inhibition,tumor progression,poor prognosis marker,metabolic reprogramming,kidney-specific expression
ENSG00000214274,ANG,angiogenesis promoter,constitutive activation,prognostic marker,tumor progression driver,immune suppression mediator,vascular stability regulator
ENSG00000175215,CTDSP2,cell cycle regulation,apoptosis induction,tumor suppressor function,loss-of-function mutations,transcriptional regulation,chromatin modification
ENSG00000172260,NEGR1,epithelial-to-mesenchymal transition,tumor progression,poor prognosis,signaling pathway regulation,cell growth and survival,metastasis
ENSG00000167881,SRP68,disrupted protein targeting,translational dysregulation,misfolded protein accumulation,oncogenic transformation,cellular stress response,secretory pathway disruption
ENSG00000150361,KLHL1,tumor suppressor,protein quality control,cellular regulation,cul3-dependent ubiquitination,oncoprotein regulation,kidney cancer susceptibility
ENSG00000198455,ZXDB,cellular regulation,cell cycle progression,onco-protein interaction,enhanced cell proliferation,tumor tissue overexpression,oncogenic driver gene
ENSG00000131941,RHPN2,cell migration,rho gtpase pathway activation,tumor progression,metastasis promotion,prognostic biomarker,adhesion regulation
ENSG00000131669,NINJ1,ubiquitin ligase function,genomic instability,apoptosis regulation,cell cycle modulation,tumor suppressor activity,mutation frequency
ENSG00000108641,B9D1,cell proliferation,mitotic spindle checkpoint,genomic instability,apoptosis suppression,protein interaction,poor prognosis marker
ENSG00000118194,TNNT2,troponin t function,cell signaling regulation,cancer progression association,cell adhesion modulation,tumor growth contribution,protein interaction significance
ENSG00000155846,PPARGC1B,metabolic reprogramming,aerobic glycolysis,promotes tumorigenesis,tumor progression,energy metabolism regulation,coactivator function
ENSG00000069764,PLA2G10,genomic instability,chromosomal alterations,tumor progression,inflammatory regulation,cellular lipid metabolism,protein-protein interaction
ENSG00000166582,CENPV,centromere dysfunction,genomic instability,cell division disruption,chromosome segregation error,oncogenesis contribution,tumor formation promotion
ENSG00000136449,MYCBPAP,chromatin remodeling,histone modification,oncogenic function,tumor growth promotion,myc transcription factor interaction,therapeutic target
ENSG00000125912,NCLN,apoptosis regulation,autophagy induction,cell proliferation,endoplasmic reticulum localization,tumor progression,therapeutic target
ENSG00000168955,TM4SF20,adhesion molecule regulation,cell migration enhancement,invasion promotion,tumor progression,biomarker candidate,overexpression correlation
ENSG00000105711,SCN1B,voltage-gated sodium channel regulation,cell proliferation enhancement,oncogenic protein interactions,cancer progression facilitation,upregulated expression,electrical excitability modulation
ENSG00000122481,RWDD3,chromatin remodeling,cell cycle regulation,transcriptional regulation,p53 interaction,tumor suppression,histone modification
ENSG00000146263,MMS22L,homologous recombination repair,dna damage response,genomic instability,oncogenesis,transcriptional regulation,cellular proliferation
ENSG00000166170,BAG5,tumor progression,metastasis regulator,p53-interacting protein,cell survival enhancer,genome stability maintainer,cell migration promoter
ENSG00000119787,ATL2,microtubule dynamics,cell migration,cancer progression,apoptosis regulation,protein-protein interaction,tumor growth inhibition
ENSG00000111305,GSG1,cell signaling pathway,regulatory component,tumor development,oncogenesis,cellular regulation,protein interaction
ENSG00000100034,PPM1F,tumor suppressor inactivation,phosphatase activation,oncogenic driver,dna repair regulation,cell cycle progression,protein dephosphorylation
ENSG00000181035,SLC25A42,mitochondrial carrier protein,overexpression association,cell growth promotion,tumor progression role,signaling pathway modulation,apoptosis inhibition
ENSG00000273572,CDHR5,cell adhesion disruption,metastasis promoter,epithelial-to-mesenchymal transition,overexpression biomarker,cancer aggressiveness,prognostic factor
ENSG00000139679,LPAR6,lpa signaling pathway,pi3k/akt activation,epithelial-to-mesenchymal transition,tumor progression,therapeutic target,protein kinase regulation
ENSG00000167080,B4GALNT2,tumor progression,oncogene function,cell migration regulation,glycosylation pattern alteration,immune evasion modulation,protein expression regulation
ENSG00000173137,ADCK5,mitochondrial dysfunction,gain of function mutations,tumor growth,cellular energy production,ubiquinone biosynthesis,oncogenic processes
ENSG00000186088,GSAP,cell proliferation,migratory protein,immune regulation,signaling pathway modulation,tumor microenvironment,oncogenic process
ENSG00000241878,PISD,protein folding,interaction with proteins,cellular homeostasis maintenance,indirect oncogenic roles,proteostasis regulation,stress response facilitation
ENSG00000068079,IFI35,cell cycle regulation,apoptosis inhibition,dna damage response,tumor progression,tumor growth promotion,immune modulation
ENSG00000164749,HNF4G,transcription factor activity,oncogenic metabolism,glycolysis activation,glutaminolysis regulation,lipogenesis promotion,emt process facilitation
ENSG00000143257,NR1I3,nr1i3 upregulation,constitutive expression,tumor promotion,apoptosis evasion,cell cycle progression,xenobiotic metabolism
ENSG00000159335,PTMS,genomic instability,chromosome 14q13.3,transcription regulation,protein degradation,cell proliferation,oncogene function
ENSG00000132423,COQ3,mitochondrial function,oncogene mutations,reactive oxygen species regulation,tumor progression,biomarker identification,cellular homeostasis maintenance
ENSG00000163611,SPICE1,centrosome regulation,cell division regulation,genomic instability,mitotic checkpoint modulation,tumor progression,protein-protein interactions
ENSG00000140519,RHCG,oncofetal antigen,cell migration,signaling regulation,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000197977,ELOVL2,lipid biosynthesis,oncogenic interactions,tumor suppressor function,cellular energy production,cell proliferation regulation,metabolic reprogramming
ENSG00000198040,ZNF84,transcription factor activity,cell cycle regulation,oncogenesis,protein-protein interactions,tumor progression,genomic overexpression
ENSG00000112303,VNN2,nitric oxide production,angiogenesis promotion,tumor promoter function,cellular metabolism regulation,sulfhydryl oxidase activity,antioxidant defense disruption
ENSG00000159261,CLDN14,cellular adhesion,overexpression,cancer progression,tumor invasion,tight junction disruption,biomarker potential
ENSG00000137500,CCDC90B,aneuploidy,cell cycle regulation,centrosome amplification,genomic instability,mitotic spindle formation,protein-protein interaction
ENSG00000118507,AKAP7,cellular proliferation,pi3k/akt/mtor pathway interaction,oncogenic protein kinase regulation,epigenetic dysregulation,histone modification alteration,rho gtpase family interaction
ENSG00000166963,MAP1A,microtubule stabilization,cell proliferation enhancement,oncogene overexpression,poor prognosis association,therapeutic target potential,cancer cell survival promotion
ENSG00000187607,ZNF286A,transcriptional regulation,oncogenic signaling,tumor progression,cell proliferation,epigenetic regulation,angiogenesis
ENSG00000242550,SERPINB10,tumor suppressor function,apoptosis regulation,protease inhibition,angiogenesis modulation,cell differentiation control,gene expression regulation
ENSG00000124641,MED20,mediator complex regulation,transcriptional regulation dysregulation,cell cycle progression modulation,dna repair impairment,apoptosis suppression,chromatin remodeling alteration
ENSG00000156475,PPP2R2B,tumor progression,regulatory subunit activity,inhibition of pp2a,cell cycle regulation,oncogenic pathway dysregulation,apoptosis suppression
ENSG00000197915,HRNR,chromatin silencing,genome instability,oncogene activation,retrotransposon expression,tumor proliferation,transcriptional regulation
ENSG00000140451,PIF1,genomic instability,dna replication,chromatin remodeling,genome maintenance,oncogenic mechanisms,cell proliferation
ENSG00000037241,RPL26L1,ribosomal protein synthesis,protein overexpression,cell proliferation promotion,tumorigenesis contribution,genomic instability link,cancer cell survival enhancement
ENSG00000101892,ATP1B4,ion channel regulation,cellular metabolism alteration,tumor progression driver,na+/k+-transporting atpase activity,prognostic biomarker potential,therapeutic target exploration
ENSG00000205922,ONECUT3,cell cycle regulation,transcriptional regulation,tumor suppression evasion,metastasis promotion,poor prognosis marker,immunosuppression modulation
ENSG00000116039,ATP6V1B1,lysosome acidification,proton pump activation,tumor cell growth,ion homeostasis regulation,cellular metabolism modulation,apoptosis induction
ENSG00000137106,GRHPR,tumor progression,gain of function mutations,cell proliferation,regulatory mechanism,genomic profiling,therapeutic target
ENSG00000157303,SUSD3,tumor progression,metastasis promotion,cell adhesion regulation,prognostic biomarker,transmembrane protein function,cancer cell migration
ENSG00000111845,PAK1IP1,cell migration inhibition,oncogenic signaling pathway regulation,metastasis suppression,tumor suppressor function,protein-protein interaction,cellular regulatory mechanism
ENSG00000187735,TCEA1,cellular localization,nuclear function,cell proliferation inhibition,apoptosis suppression,transcriptional regulation,therapeutic target
ENSG00000154645,CHODL,autophagy regulation,egf receptor interaction,tumor growth promotion,metastasis facilitation,poor prognosis marker,protein kinase activation
ENSG00000129353,SLC44A2,sphingosine-1-phosphate signaling,glycosphingolipid biosynthesis,cellular adhesion,tumor progression,poor prognosis,oncogenic signaling
ENSG00000173714,WFIKKN2,cellular signaling pathway,inflammatory response regulation,proteolytic enzyme activation,epithelial-to-mesenchymal transition (emt),aggressive tumor behavior,potential therapeutic target
ENSG00000134812,CBLIF,bcr/bas complex regulation,rho gtpase activity modulation,ubiquitination pathway activation,receptor tyrosine kinase regulation,tumor suppressor function,gtpase activator function
ENSG00000178921,PFAS,tumor progression,cellular proliferation,growth factor activity,angiogenesis regulation,therapeutic target,signaling pathway interaction
ENSG00000163520,FBLN2,tumor progression,metastasis promotion,elastic fiber formation,apoptosis resistance,cell migration enhancement,prognostic marker
ENSG00000164758,MED30,mediator complex regulation,transcriptional activation,oncogene overexpression,cell proliferation,tumor progression,genetic predisposition
ENSG00000065970,FOXJ2,ciliogenesis dysfunction,constitutive activation,growth and survival promotion,repression of tumor suppressors,aberrant gene expression,transcriptional regulation
ENSG00000166987,MBD6,tumor suppressor activity,epigenetic regulation,methylation-dependent gene silencing,cell cycle progression,apoptosis modulation,genomic instability
ENSG00000165521,EML5,tumor suppressor activity,genomic instability,cell cycle regulation,microtubule dynamics,mitotic spindle formation,signaling pathway modulation
ENSG00000135837,CEP350,mitotic checkpoint regulation,chromosomal stability maintenance,oncogenic driver,apoptosis evasion,angiogenesis enhancement,metastatic potential increase
ENSG00000185177,ZNF479,cell growth regulation,nuclear localization,chromatin modification,transcriptional regulation,tumor aggressiveness,protein interaction
ENSG00000144746,ARL6IP5,arl6ip5,rab gtpase regulation,tumor progression,endocytosis disruption,membrane trafficking dysregulation,cancer driver mutations
ENSG00000006607,FARP2,cell migration,rho gtpase activation,tumor progression,aggressive behavior,poor prognosis,invasion regulation
ENSG00000095209,TMEM38B,er stress regulation,apoptosis modulation,necroptosis regulation,calcium homeostasis,cell death pathways,tumor progression
ENSG00000164600,NEUROD6,transcription factor function,oncogene role,cell cycle regulation,apoptosis inhibition,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition regulation
ENSG00000114650,SCAP,cholesterol biosynthesis,lipid homeostasis regulation,srebp-2 activation,cell growth promotion,protein adaptation function,sterol regulatory role
ENSG00000167780,SOAT2,cholesterol metabolism,cancer metabolism,cellular proliferation,oncogenic signaling,tumor microenvironment,therapeutic target
ENSG00000169641,LUZP1,transcriptional regulation,cellular proliferation,metastasis,tumor progression,dna damage response,prognostic biomarker
ENSG00000144559,TAMM41,mitochondrial regulation,energy metabolism regulation,tumor progression,cell growth modulation,metastasis facilitation,driver mutation
ENSG00000115657,ABCB6,cellular transport regulation,multidrug resistance,overexpression association,tumor progression influence,biomarker potential,apoptosis modulation
ENSG00000136770,DNAJC1,er stress response,cell growth promotion,oncogene potential,autophagy regulation,protein-protein interaction,chaperone function
ENSG00000170242,USP47,deubiquitinating enzyme,oncoprotein regulation,protein stabilization,cell cycle regulation,apoptosis modulation,prognostic marker
ENSG00000136875,PRPF4,pre-mrna splicing defects,oncogenic mutations,tumor aggressiveness,cellular dysregulation,molecular mechanism disruption,poor prognosis indicator
ENSG00000241468,ATP5MF,enhanced glycolysis,high metabolic demand,mtor signaling pathway activation,tumor growth promotion,energy production regulation,cellular adaptation to energy stress
ENSG00000176692,FOXC2,oncogenic role,epithelial-to-mesenchymal transition (emt) regulation,angiogenesis promotion,transcriptional regulation,cellular proliferation enhancement,metastasis facilitation
ENSG00000196407,THEM5,pi3k/akt pathway modulation,oncogene role,apoptosis regulation,autophagy involvement,cell proliferation promotion,poor prognosis correlation
ENSG00000108826,MRPL27,mitochondrial biogenesis,energy metabolism regulation,apoptosis regulation,cell proliferation influence,autophagy modulation,ribosomal protein function
ENSG00000197362,ZNF786,transcriptional regulation,chromatin remodeling,protein-protein interactions,tumor progression,oncogenic transformation,cellular regulation
ENSG00000125846,ZNF133,transcriptional regulator,zinc finger protein,cell proliferation,dna binding,oncogenic role,apoptosis inhibition
ENSG00000085185,BCORL1,cell cycle regulation,mutation hotspot,dna damage response,epigenetic silencing,histone modification,tumor suppressor
ENSG00000188833,ENTPD8,purinergic signaling,atp hydrolysis,cell growth promotion,survival pathway regulation,protein kinase activation,tumor progression promoter
ENSG00000213015,ZNF580,transcriptional regulation,tumor progression,overexpression,chromatin remodeling,promotes metastasis,cell proliferation
ENSG00000184497,TMEM255B,er stress response,cellular homeostasis regulation,tumor suppressor activity loss,cell proliferation enhancement,apoptosis resistance,genomic instability promotion
ENSG00000037757,MRI1,microtubule regulation,spindle assembly checkpoint,genomic stability,chromosomal instability,aneuploidy promotion,cell cycle regulation
ENSG00000141485,SLC13A5,cellular metabolism,overexpression,tumor progression,cell proliferation,energy balance regulation,sodium-coupled citrate transport
ENSG00000126461,SCAF1,dna damage response pathway,genome stability maintenance,tumor progression regulator,brca2 interaction,homologous recombination repair,cell survival enhancement
ENSG00000154370,TRIM11,autophagy dysregulation,oncogene overexpression,pi3k/akt pathway activation,cell growth regulation,cellular interaction modulation,tumor progression facilitation
ENSG00000198246,SLC29A3,pyrimidine metabolism regulation,chemoresistance contribution,nucleoside transport facilitation,dna repair pathway alteration,cancer resistance mechanism,tumor suppressor gene function
ENSG00000119471,HSDL2,tumor growth,metabolic reprogramming,lipid biosynthesis,chemotherapy resistance,oncogenic processes,prognostic marker
ENSG00000129158,SERGEF,pi3k/akt pathway regulation,tumor progression promoter,cell survival enhancer,protein-protein interactions regulator,mtor complex 1 (mtorc1) activator,akt pathway upregulator
ENSG00000150048,CLEC1A,tumor microenvironment,immune modulation,angiogenesis regulation,cell adhesion and migration,prognostic marker,inflammation modulation
ENSG00000198231,DDX42,genomic instability,p53 pathway dysregulation,tumor suppressor regulation,cellular proliferation,aberrant gene expression,rna helicase activity
ENSG00000082212,ME2,mitochondrial enzyme regulation,oncogenic function,cellular metabolism alteration,tumor progression facilitation,energy production enhancement,genomic instability association
ENSG00000180767,CHST13,prognostic marker,oncogenic function,cell migration,tumor progression,signaling pathway modulation,inflammatory microenvironment modulation
ENSG00000139718,SETD1B,histone methylation,chromatin modification,cell cycle progression,apoptosis inhibition,epigenetic regulation,pi3k/akt pathway interaction
ENSG00000130414,NDUFA10,metabolic reprogramming,mitochondrial dysfunction,electron transport chain disruption,oxidative phosphorylation inhibition,reactive oxygen species production,genomic instability
ENSG00000110048,OSBP,pi3k/akt signaling pathway activation,tumor cell proliferation enhancement,apoptosis resistance promotion,lipid metabolism regulation,cancer cell survival increase,multifunctionality
ENSG00000172954,LCLAT1,lipid metabolism regulation,cell membrane remodeling,oncogenic processes,tumor progression,poor prognosis marker,phospholipid synthesis
ENSG00000179361,ARID3B,chromatin regulation,transcriptional regulator,cell cycle progression,apoptosis modulation,genomic instability,epithelial-to-mesenchymal transition
ENSG00000114988,LMAN2L,oncogenic process,overexpression,tumor progression,lipid metabolism regulation,protein-protein interaction,signal transduction pathway modification
ENSG00000185176,AQP12B,cellular signaling modulation,oncogene potential,tumor aggressiveness,hypoxia regulation,water transport,prognostic biomarker
ENSG00000103342,GSPT1,ribosome biogenesis,cell proliferation,dna damage response,therapeutic target,apoptosis resistance,pre-rrna processing
ENSG00000013374,NUB1,apoptosis induction,cell cycle regulation,dna damage repair,genomic stability maintenance,oncogene suppression,tumor suppressor function
ENSG00000159433,STARD9,dna repair regulation,oncogene activation,chromatin modification,cell cycle regulation,pi3k/akt pathway interaction,gene amplification
ENSG00000187513,GJA4,connexin 37 overexpression,gap junction communication,cell proliferation regulation,tumor progression promotion,poor patient prognosis,aggressive tumor behavior
ENSG00000186480,INSIG1,lipid biosynthesis,metabolic reprogramming,oncogene upregulation,tumorigenesis promotion,cellular lipid synthesis regulation,er membrane protein function
ENSG00000185896,LAMP1,lysosomal regulation,autophagy pathway,tumor progression,metastasis enhancement,cellular proliferation,prognostic marker
ENSG00000092108,SCFD1,cellular lipid metabolism,oncogenic process,phosphoinositide regulation,autophagy modulation,signaling pathway interaction,molecular scaffolding function
ENSG00000242173,ARHGDIG,regulation of rho gtpases,tumor growth and metastasis,actin cytoskeleton regulation,cell migration and invasion,potential therapeutic target,diagnostic marker
ENSG00000155980,KIF5A,axonal transport,microtubule stability,cell migration,invasion,oncogene,metastasis
ENSG00000146802,TMEM168,aberrant soce activity,calcium signaling dysregulation,cellular proliferation,oncogenic processes,pi3k/akt/mtor pathway regulation,tumor progression
ENSG00000162852,CNST,centrosome stability,genomic instability,aneuploidy,tumor suppressor,cell cycle regulation,protein degradation pathways
ENSG00000282725,CORO7,actin cytoskeleton regulation,metastatic potential promotion,coronin family interaction,cell migration facilitation,prognostic marker for cancer,tumor progression enhancement
ENSG00000131242,RAB11FIP4,endocytic recycling regulation,tumor progression marker,cell survival enhancement,oncogenic pathway modulation,protein-protein interaction,cancer cell proliferation
ENSG00000108469,RECQL5,genomic instability,dna replication,helicase activity,tumor suppressor function,s-phase progression,cancer driver gene
ENSG00000049769,PPP1R3F,glycogen metabolism regulation,cell proliferation enhancement,tumor progression association,therapeutic target potential,signaling pathway interaction,protein phosphatase 1 modulation
ENSG00000282752,CTDP1,genomic instability,dna repair pathways,regulatory mechanism disruption,oncogenic processes driver,transcriptional control dysregulation,rna polymerase ii regulation
ENSG00000187091,PLCD1,calcium mobilization,g-protein coupled receptor interaction,oncogene overexpression,cell proliferation regulation,protein kinase activation,tumor growth promotion
ENSG00000071794,HLTF,genomic instability,dna repair disruption,chromatin regulation,tumor suppressor function,cell cycle dysregulation,epigenetic modification
ENSG00000100100,PIK3IP1,pi3k/akt/mtor pathway,cell proliferation,angiogenesis,metastasis,oncogenic process,tumor progression
ENSG00000196365,LONP1,mitochondrial protein degradation,cellular stress response,oncogenic metabolic reprogramming,aggressive tumor phenotypes,poor prognosis indicator,protein quality control dysfunction
ENSG00000166926,MS4A6E,immune evasion,tumor progression,metastasis driver,protein-protein interaction,biomarker candidate,oncogene activity
ENSG00000176402,GJC3,cellular adhesion,gap junction formation,tumor progression,microenvironment interaction,cell migration and invasion,protein-protein interactions
ENSG00000115844,DLX2,transcriptional regulation,cell proliferation,apoptosis suppression,tumor progression,biomarker potential,regulatory element interaction
ENSG00000139515,PDX1,regulation of cell proliferation,transcriptional regulation,overexpression in tumor tissues,cell survival and metabolism,genetic mutations and epigenetic alterations,metastasis and oncogenic processes
ENSG00000100330,MTMR3,mitochondrial lipid metabolism,pi3k/akt pathway regulation,tumor suppressor function,apoptosis induction,oncogenesis modulation,lipid phosphatase activity
ENSG00000119718,EIF2B2,protein synthesis regulation,integrated stress response activation,tumor driver mutations,cellular growth promotion,translation initiation enhancement,oncogenic pathway activation
ENSG00000115211,EIF2B4,regulated protein translation,cellular homeostasis,oncogenic signaling pathway activation,tumor growth promotion,therapeutic resistance,genetic dysregulation
ENSG00000183729,NPBWR1,modulator of nuclear receptors,oncogene activation,tumor progression facilitation,cell survival promotion,genomic instability,therapeutic target
ENSG00000154783,FGD5,gain of function mutations,promotion of tumorigenesis,cell proliferation,cytoplasmic localization,signaling pathway activation,cancer cell survival
ENSG00000120915,EPHX2,epoxide metabolism,dna damage response,oxidative stress modulation,cell proliferation enhancement,apoptosis resistance,epigenetic regulation
ENSG00000163909,HEYL,wnt/β-catenin pathway regulation,transcriptional regulator activity,cell growth promotion,apoptosis inhibition,cell cycle progression regulation,poor prognosis correlation
ENSG00000197457,STMN3,cell division regulation,microtubule dynamics,oncogenesis promotion,tumor progression,protein overexpression,metastasis facilitation
ENSG00000205944,DAZ2,dna repair,genome stability,homologous recombination,cell proliferation regulation,survival pathway modulation,tumorigenesis facilitation
ENSG00000103671,TRIP4,histone modification,chromatin remodeling,cell proliferation,tumor progression,transcriptional regulation,androgen receptor interaction
ENSG00000163291,PAQR3,oncogene activity,overexpression in tumors,cell proliferation regulation,apoptosis regulation,lipid metabolism dysregulation,genomic instability modulation
ENSG00000135723,FHOD1,cellular proliferation,transcriptional regulation,epithelial-to-mesenchymal transition,transcription factor activity,cell cycle regulation,tumor progression
ENSG00000125375,DMAC2L,pi3k/akt pathway regulation,cellular signaling modulation,oncogenic mutations,cell proliferation enhancement,tumor aggressiveness,therapeutic target
ENSG00000174279,EVX2,transcription factor activation,proliferation regulation,tumor suppressor interaction,epithelial-to-mesenchymal transition (emt),poor prognosis marker,regulation of signaling pathways
ENSG00000277893,SRD5A2,aberrant expression,androgen metabolism,cell proliferation,prognostic marker,tumor aggressiveness,therapeutic target
ENSG00000196743,GM2A,lipid metabolism regulation,dysregulated expression,oncogenic potential,cell proliferation enhancement,protein interaction modulation,cancer association
ENSG00000203857,HSD3B1,androgenic hormone regulation,prognostic marker,tumor growth promotion,steroid hormone biosynthesis,cell proliferation enhancement,metabolic reprogramming
ENSG00000116199,FAM20B,phosphate metabolism regulation,cell proliferation promotion,wnt/β-catenin pathway activation,mapk/erk pathway interaction,tumor progression driver,therapeutic target candidate
ENSG00000104140,RHOV,aberrant expression,cell migration,constitutive activation,downstream effectors,oncogenic processes,poor prognosis
ENSG00000170903,MSANTD4,chromatin remodeling,epigenetic regulation,transcriptional regulation,histone modification,tumor progression,oncogenic function
ENSG00000119729,RHOQ,actin cytoskeleton reorganization,cell cycle progression,cell migration promotion,gene expression regulation,oncogenic process enhancement,serine/threonine kinase activity
ENSG00000115486,GGCX,vitamin k-dependent protein regulation,calcium metabolism alteration,cell proliferation inhibition,bone metastasis suppression,tumor progression modulation,angiogenesis regulation
ENSG00000198597,ZNF536,transcriptional regulation,tumor suppressor function,gene expression modulation,cell proliferation regulation,chromatin remodeling interaction,genomic instability
,MARS,histone modification,chromatin remodeling,transcriptional regulation,cell proliferation,oncogene activation,dna repair regulation
ENSG00000197712,FAM114A1,cellular proliferation,endoplasmic reticulum localization,calcium channel regulation,tumor aggressiveness,pi3k/akt pathway modulation,apoptosis evasion
ENSG00000167632,TRAPPC9,autophagy regulation,cellular trafficking disruption,constitutive activation,kirc tumorigenesis driver,protein-lipid interaction,mtor pathway modulation
ENSG00000130772,MED18,transcriptional regulation,cell cycle progression,oncogenic process modulation,dna repair,interaction with cul4a,therapeutic target
ENSG00000133250,ZNF414,transcriptional regulation,gene amplification,oncogene function,apoptosis evasion,cell cycle dysregulation,protein interaction
ENSG00000158486,DNAH3,ciliary motility regulation,proximal tubule cell,oncogenic signaling,cellular polarity dysregulation,tumor growth suppression,epithelial integrity maintenance
ENSG00000076770,MBNL3,rna regulation,aberrant splicing,cancer driver,oncogenic protein production,tumor resistance,cellular stress response
ENSG00000183520,UTP11,ribosome biogenesis,oncogenic processes,cellular metabolism,tumor progression,energy production pathways,apoptosis regulation
ENSG00000164329,TENT2,genomic instability,tumor suppressor function,5'-to-3' exonuclease activity,dna replication disruption,okazaki fragment processing,rna primer removal
ENSG00000128567,PODXL,role in tumor progression,upregulation,metastasis promotion,cell adhesion modulation,angiogenesis facilitation,epithelial-to-mesenchymal transition
ENSG00000106927,AMBP,tumor progression,cellular migration,protein-protein interaction,glycosphingolipid metabolism,therapeutic target,poor prognosis
,C5orf30,cancer driver,cell proliferation,apoptosis resistance,transcriptional regulation,nuclear localization,serine/threonine kinase activity
ENSG00000171443,ZNF524,transcriptional repression,c2h2-type zinc fingers,gene expression regulation,oncogenic role,tumor suppressor suppression,apoptosis regulation
ENSG00000049323,LTBP1,tumor progression,microenvironment modulation,angiogenesis facilitation,cell migration/invasion,therapeutic target,gene regulation
ENSG00000204531,POU5F1,pluripotency transcription factor,cellular differentiation regulation,stem cell maintenance,aberrant expression in cancer,tumor-initiating cell promotion,apoptosis evasion
ENSG00000130598,TNNI2,loss-of-function mutations,tumor suppressor role,cellular homeostasis regulation,cytoplasmic localization,cell cycle regulation inhibition,prognostic value
ENSG00000116586,LAMTOR2,autophagy activation,cell proliferation,lysosome regulation,mtorc1 activation,jnk signaling pathway,prognostic biomarker
ENSG00000107862,GBF1,gef activity,rhoa activation,cell migration,tumor progression,prognostic marker,oncogenic process
ENSG00000119673,ACOT2,fatty acid metabolism,lipid biosynthesis,cell survival,proliferation,oncogenic processes,metabolic reprogramming
ENSG00000161558,TMEM143,er stress response,autophagy regulation,tumor suppressor function,er-associated degradation,cancer cell growth inhibition,cellular homeostasis disruption
ENSG00000143028,SYPL2,cellular fusion regulation,exocytosis regulator,calcium-dependent signaling,tumor progression association,oncogene expression,cancer-related prognostic marker
ENSG00000118193,KIF14,mitotic progression,chromosomal stability,cell cycle regulation,oncogene overexpression,tumor aggressiveness,prognostic biomarker
ENSG00000123096,SSPN,**
nuclear envelope organization,cellular proliferation,genomic instability,chromatin remodeling,tumor progression,biomarker potential
**
ENSG00000123171,CCDC70,centrosome amplification,oncogene overexpression,cellular proliferation,genomic instability,mitotic spindle abnormalities,protein-protein interactions
ENSG00000141759,TXNL4A,apoptosis regulation,genomic instability,redox balance disruption,thiol-specific antioxidant function,tumor progression,oxidative stress response
ENSG00000129484,PARP2,dna damage response,genomic instability,tumor progression,apoptosis regulation,cell cycle modulation,mitochondrial function regulation
ENSG00000231924,PSG1,cellular stress response,innate immunity modulation,peptidoglycan recognition protein family,tumor microenvironment modulation,oncogenic processes enhancement,metastasis promotion
ENSG00000183454,GRIN2A,oncogenic mutations,cell proliferation,signaling pathway activation,cancer progression,metastasis promotion,genomic instability
ENSG00000257949,TEN1,telomere maintenance,dna damage response,genomic instability,cancer progression,oncogene overexpression,genome integrity regulation
ENSG00000125378,BMP4,bmp signaling pathway,overexpression,epithelial-to-mesenchymal transition,angiogenesis promoter,cell invasion enhancer,therapeutic target
ENSG00000164647,STEAP1,iron metabolism regulation,transcription factor activation,cellular signaling modulation,oncogenic process promotion,tumor growth facilitation,protein kinase activation
ENSG00000144736,SHQ1,chromatin remodeling,genome instability,tumor progression,oncogenic mutations,epigenetic regulation,histone modification
ENSG00000079313,REXO1,rexo1-rab6a interaction,cell proliferation,endosomal recycling,gtpase regulation,protein trafficking,vesicular transport
ENSG00000168872,DDX19A,pi3k/akt pathway interaction,genomic instability,cell proliferation regulation,mirna modulation,tumor suppressor downregulation,rna helicase activity
ENSG00000138379,MSTN,wnt/β-catenin signaling inhibition,tumor suppressor function,muscle growth regulation,cell differentiation inhibition,smad4 interaction,protein secretion pathway
ENSG00000111707,SUDS3,sumoylation regulation,cell cycle progression,protein-protein interaction,tumor suppressor function,pi3k/akt pathway modulation,transcriptional control
ENSG00000174371,EXO1,dna repair,genetic instability,tumor progression,cell proliferation,genomic integrity,protein-protein interactions
ENSG00000166479,TMX3,transcriptional coactivator,cellular differentiation regulation,oncogenic process promotion,pi3k/akt pathway interaction,cell growth regulation,tumor progression enhancement
ENSG00000123388,HOXC11,regulation of cell proliferation,interactions with p53,tumor progression marker,overexpression in cancer,pi3k/akt pathway modulation,transcriptional regulation
ENSG00000152332,UHMK1,spindle checkpoint regulation,tumor progression,genomic instability,aneuploidy,oncogene activation,mitotic regulator
ENSG00000166337,TAF10,transcriptional regulation,oncogenic transcription,cell proliferation,rna polymerase ii activity,microrna regulation,dna repair dysregulation
ENSG00000009307,CSDE1,rna regulation,oncogene activation,pi3k/akt pathway modulation,tumor progression,cell migration,invasion metastasis
ENSG00000010404,IDS,glycosaminoglycan metabolism,cellular adhesion,protein modification,enzyme function,degradation pathway,tumor progression
ENSG00000053371,AKR7A2,detoxification process,overexpression,cellular metabolism,reduction of carbonyl compounds,tumor progression,oxidative stress modulation
ENSG00000162482,AKR7A3,xenobiotic detoxification,redox regulation,cellular stress response,oxidative damage prevention,tumor progression modulation,protein-protein interaction
ENSG00000275066,SYNRG,cell migration,epithelial-to-mesenchymal transition,cytoskeletal regulation,protein-protein interaction,tumor progression,metastasis
ENSG00000129170,CSRP3,tumor progression,cell invasion,metastasis facilitation,oncogenic driver,therapeutic target,cytoskeleton regulation
ENSG00000136950,ARPC5L,tumor progression,cell migration,actin cytoskeleton regulation,metastasis promotion,prognostic marker,signaling pathway interaction
ENSG00000155868,MED7,cell cycle progression,aberrant gene expression,transcriptional regulation,cell proliferation,tumor suppressor function,oncogenic mutations
ENSG00000128595,CALU,calcium signaling pathway,cellular proliferation regulation,gene expression modulation,intracellular calcium homeostasis,tumor progression influence,cancer-related protein interactions
ENSG00000135824,RGS8,g-protein signaling,tumor suppression,regulatory function,cell proliferation,signal transduction,protein interaction
ENSG00000005893,LAMP2,lysosomal membrane protein regulation,autophagy modulation,apoptosis regulation,tumor microenvironment modulation,prognostic biomarker,promotes cell survival
ENSG00000053900,ANAPC4,genomic instability,cell cycle progression,ubiquitination pathway,cyclin b1 degradation,oncogenic potential,dna damage response
ENSG00000123191,ATP7B,copper transport regulation,proliferation promotion,akt signaling pathway,cellular invasion enhancement,overexpression association,prognostic marker
ENSG00000128805,ARHGAP22,rho gtpase regulation,tumor suppressor function,cell migration,pi3k/akt pathway modulation,constitutive activation,cytoskeleton dynamics regulation
ENSG00000110881,ASIC1,calcium channel regulation,metastasis promotion,tumor progression,potassium homeostasis alteration,cancer cell migration enhancement,sodium ion transport modulation
ENSG00000060971,ACAA1,fatty acid metabolism,upregulation,energy supply,tumor growth,metastasis,lipid synthesis
ENSG00000130540,SULT4A1,cellular redox balance,oxidative stress protection,detoxification process,prognostic marker,therapeutic target,cell signaling modulation
ENSG00000155066,PROM2,prominin 2 expression,pi3k/akt pathway interaction,cell adhesion regulation,tumor progression facilitation,stem cell-like property maintenance,prognostic marker candidate
,ACPP,overexpression,lysosomal enzyme activity,cell survival and proliferation,signaling pathway interaction,metastasis and recurrence,biomarker potential
ENSG00000157765,SLC34A2,phosphate reabsorption regulation,enhanced cell proliferation,tumor metastasis,overexpression in rcc tissues,cell invasion modulation,pi3k/akt pathway activation
ENSG00000145321,GC,glutathione regulation,cancer metabolism,oxidative stress management,antioxidant function,cellular homeostasis maintenance,protein damage repair
ENSG00000168481,LGI3,dna repair pathway,genomic instability,tumorigenesis driver,double-strand break repair,protein-dna interactions,epigenetic regulation
ENSG00000154252,GAL3ST2,sulfation activity,tumor aggressiveness,metastasis promotion,cell migration regulation,glycosylation pathway interaction,extracellular matrix modulation
ENSG00000118418,HMGN3,chromatin remodeling,oncogene upregulation,epithelial-to-mesenchymal transition (emt) regulation,histone modification,transcriptional activation,cell proliferation enhancement
ENSG00000181790,ADGRB1,gpcr signaling pathway,tumor progression,cell growth regulation,protein-protein interactions,mitogen-activated protein kinases activation,phospholipase c activation
ENSG00000152990,ADGRA3,oncogenic function,pi3k/akt pathway regulation,cell migration promotion,tumor progression facilitation,metastasis enhancement,prognostic marker status
ENSG00000139352,ASCL1,oncogenic transcription factor,tumor progression,cell cycle regulation,biomarker potential,transcriptional regulation,notch pathway interaction
ENSG00000116685,KIAA2013,apoptosis regulation,cell cycle progression,dna damage response,inhibitor of apoptosis,oncogenesis promotion,therapeutic target
ENSG00000182393,IFNL1,tumor suppression,cell proliferation inhibition,immune response modulation,apoptosis induction,epigenetic regulation,prognostic marker
ENSG00000156049,GNA14,aberrant expression,cell migration,constitutive activation,g protein signaling,mapk/erk pathway,metastasis
ENSG00000129422,MTUS1,cell cycle regulation,tumor suppressor function,microtubule dynamics regulation,apoptosis induction,cell growth inhibition,signaling pathway modulation
ENSG00000138675,FGF5,fgf signaling pathway,transcriptional regulation,cell proliferation,tumor progression,poor prognosis biomarker,epithelial-to-mesenchymal transition
ENSG00000159387,IRX6,transcriptional regulation,epithelial-to-mesenchymal transition,cell migration,tumor progression,prognostic marker,microrna regulation
ENSG00000174564,IL20RB,oncogenic signaling,tumor cell proliferation,immune evasion,angiogenesis promotion,overexpression,jak/stat pathway activation
ENSG00000168924,LETM1,mitochondrial function regulator,calcium homeostasis disruption,tumor aggressiveness marker,oncogenic process contributor,therapeutic target candidate,genomic profiling hotspot
ENSG00000177182,CLVS1,cytochrome p450 family,cellular lipid modification,gene expression regulation,tumor growth promotion,cancer metastasis,xenobiotic metabolism
ENSG00000138119,MYOF,**
cell proliferation,transcriptional regulation,muscle development,tumor progression,oncogenic potential,gene expression
**
ENSG00000018189,RUFY3,telomere maintenance,telomerase regulation,dna damage response,tumor progression,genomic stability regulation,oncogenic process driver
ENSG00000113812,ACTR8,immune evasion,antigen presentation modulation,cell proliferation enhancement,oncogenesis promotion,tumor growth support,metastasis facilitation
ENSG00000174151,CYB561D1,mitochondrial function regulation,cellular respiration modulation,tumor microenvironment modulation,cancer cell survival impact,energy production influence,redox balance modulation
ENSG00000160087,UBE2J2,ubiquitination pathway,tumor suppressor protein regulation,vhl interaction,protein stability maintenance,cancer progression facilitation,oncogenic mechanism involvement
ENSG00000005469,CROT,mitochondrial transport,cellular metabolism,energy production,altered expression levels,mitochondrial function,cellular adaptation
ENSG00000168575,SLC20A2,tumor metastasis,phosphate reabsorption regulation,cellular proliferation enhancement,prognosis biomarker,cancer aggressiveness marker,genetic expression alteration
ENSG00000120662,MTRF1,mitochondrial translation regulation,tumor suppressor dysfunction,cell growth promotion,mitochondrial biogenesis modulation,apoptosis evasion,genomic instability
ENSG00000149418,ST14,tumor progression,metastasis,oncogenic function,cell migration,extracellular matrix degradation,epithelial-to-mesenchymal transition
ENSG00000166762,CATSPER2,calcium channel regulation,cell proliferation promotion,apoptosis suppression,tumor progression,cell survival enhancement,genomic instability
ENSG00000186496,ZNF396,transcriptional repressor function,krab domain-containing zinc finger protein family,cell proliferation regulation,chromatin remodeling,epigenetic regulation,tumor suppressor function
ENSG00000006740,ARHGAP44,rhoa regulation,gtp hydrolysis,cell migration,invasion suppression,tumor progression inhibition,genomic instability
ENSG00000163288,GABRB1,gabaergic signaling,cellular proliferation,loss of function mutations,tumor progression,apoptosis regulation,ion channel activation
ENSG00000164051,CCDC51,centrosome regulation,microtubule dynamics,cell cycle progression,dna repair,oncoprotein interaction,biomarker potential
ENSG00000166405,RIC3,interferon response pathway,protein synthesis regulation,cellular stress response modulation,oncogenic potential,inhibitor function,cancer-related mutations
ENSG00000169604,ANTXR1,tumor growth promotion,metastasis enhancement,apoptosis inhibition,angiogenesis regulation,biomarker for prognosis,therapeutic target
ENSG00000143420,ENSA,cellular proliferation,oncogenic potential,gene expression regulation,chromatin remodeling,axonal targeting,neuronal development
ENSG00000059122,FLYWCH1,transcriptional regulation,cell proliferation,tumor progression,apoptosis evasion,oncogenic signaling pathways,gene expression modulation
ENSG00000197372,ZNF675,tumor progression,gene expression regulation,oncogenic activity,cell proliferation,transcription factor interaction,metastasis promoter
ENSG00000166526,ZNF3,transcriptional regulation,overexpression,tumor progression,cell proliferation,dna binding,co-regulatory interactions
ENSG00000187650,VMAC,dna replication regulation,cell cycle progression facilitation,genomic instability promotion,aneuploidy contribution,cellular growth promotion,protein-protein interaction
ENSG00000140264,SERF2,splicing regulation,rna-binding protein,oncogenic splicing,tumor aggressiveness,metastasis resistance,therapeutic target
ENSG00000067798,NAV3,oncogenesis,cell proliferation,apoptosis regulation,tumor progression,therapeutic target,oncogene overexpression
ENSG00000204822,MRPL53,mitochondrial dysfunction,metabolic reprogramming,oncogenic mutations,cell proliferation,tumor metabolism,energy production
ENSG00000065923,SLC9A7,enac-associated protein,sodium reabsorption regulation,cell survival promotion,apoptosis resistance,cell proliferation enhancement,epithelial sodium channel regulation
ENSG00000205857,NANOGNB,embryonic stem cell maintenance,pluripotency regulator,oncogene activity,transcriptional regulation,tumor growth promotion,metastasis enhancement
ENSG00000124140,SLC12A5,ion transport regulation,cell migration,tumor progression,epithelial-to-mesenchymal transition,poor prognosis,metabolic reprogramming
ENSG00000197780,TAF13,transcriptional regulation,chromatin remodeling,dna repair,cell proliferation,apoptosis suppression,cellular transformation
ENSG00000160994,CCDC105,genomic instability,overexpression,centrosomal function,mitotic spindle formation,chromosomal alterations,therapeutic target
ENSG00000188120,DAZ1,nuclear rna-binding protein,germ cell development regulator,cellular proliferation regulator,genomic stability modulator,therapeutic target candidate,gene expression regulator
ENSG00000068354,TBC1D25,endosomal regulation,rab gtpase cycle modulation,autophagy induction,oncogenic pathway activation,prognostic marker potential,therapeutic target
ENSG00000145241,CENPC,centromere regulation,chromosomal instability,oncogene function,microtubule stability,cell cycle control,genomic deregulation
ENSG00000182263,FIGN,microtubule regulation,dysregulation of cell migration,chromosomal instability,cell cycle regulation,protein-protein interactions,mitotic spindle formation
ENSG00000165349,SLC7A3,slc7a3 expression,upregulation,cell proliferation,amino acid transport,oncogenic potential,therapeutic target
ENSG00000165887,ANKRD2,cellular regulation,inhibition of oncogenic pathways,tumor suppressor function,dna damage response,transcriptional regulation,protein-protein interactions
ENSG00000167550,RHEBL1,rab8 pathway,cellular polarity disruption,gene overexpression,poor prognosis indicator,metabolic regulation,tumor growth promotion
ENSG00000167874,TMEM88,cell proliferation enhancement,tumor progression association,endocytosis regulation,cellular polarity disruption,cancer driver gene potential,metastasis promotion
ENSG00000242366,UGT1A8,detoxification pathway,glucuronidation reaction,metabolic reprogramming,chemo-resistance,drug bioavailability,tumor metabolism
ENSG00000196860,TOMM20L,mitochondrial dynamics,cellular homeostasis modulation,transmembrane protein,regulation of apoptosis,protein-protein interactions,cellular metabolism regulation
ENSG00000124177,CHD6,chromatin remodeling,genomic instability,cell cycle regulation,dna repair,tumor suppressor function,chromosomal alterations
ENSG00000062822,POLD1,genomic instability,homologous recombination repair,dna replication errors,therapeutic target,oncogenic mutations,dna polymerase activity
ENSG00000216490,IFI30,apoptosis regulation,cell cycle modulation,immune response activation,interferon-gamma induction,oncogenic process promotion,tumor growth facilitation
ENSG00000128886,ELL3,transcriptional regulation,rna metabolism,oncogenic driver,cell proliferation enhancer,apoptosis inhibitor,metastatic regulator
ENSG00000112183,RBM24,tumor progression,splicing regulation,transcriptional modulation,ancillary function,cellular growth,alternative splicing
ENSG00000147813,NAPRT,synthetic lethality,folate metabolism mutations,tumor progression,anti-apoptotic pathway activation,metabolic regulation,redox balance disruption
ENSG00000162972,MAIP1,loss of tumor suppressor function,cell proliferation regulation,metastasis promotion,p53 interaction,immune modulation,pi3k/akt/mtor pathway involvement
ENSG00000146021,KLHL3,protein degradation regulation,tumor suppressor function,cell cycle control,substrate recognition,cancer driver potential,akt signaling pathway modulation
ENSG00000140199,SLC12A6,ion transport,aberrant expression,cellular proliferation,signaling pathway modulation,tumor microenvironment regulation,ph homeostasis maintenance
ENSG00000143479,DYRK3,oncogenic driver,cell cycle regulation,apoptosis inhibition,metastatic potential,kinase activation,tumor progression
ENSG00000089048,ESF1,tumor progression,protein synthesis regulation,cell cycle regulation,oncofetal protein expression,anti-apoptotic function,translation initiation enhancement
ENSG00000168275,COA6,mitochondrial carrier dysfunction,energy metabolism impairment,genomic instability induction,reactive oxygen species generation,dna damage accumulation,epigenetic dysregulation
ENSG00000180357,ZNF609,transcriptional regulation,oncogenic driver,epigenetic modifications,tumor progression,metastasis promotion,coactivator function
ENSG00000285243,SLC39A4,copper metabolism regulation,oncogenic activity,cell proliferation enhancement,angiogenesis promotion,zinc homeostasis disruption,tumor growth facilitation
ENSG00000169764,UGP2,glycosylation,oncogenesis,cell growth,lipid biosynthesis,protein glycosylation,metabolic regulation
ENSG00000007541,PIGQ,tumor progression,cell migration,cellular signaling,angiogenesis,phosphatidylinositol glycan biosynthesis,overexpression
ENSG00000108702,CCL1,angiogenesis promotion,immune regulation,immunosuppression,tumor growth facilitation,chemokine function,poor prognosis biomarker
ENSG00000187730,GABRD,gaba receptor function,cell proliferation,dysregulated signaling,metastasis,neurotransmission regulation,tumor progression
ENSG00000171320,ESCO2,genomic instability,aneuploidy,dna repair defects,homologous recombination,non-homologous end joining,chemotherapy resistance
ENSG00000117148,ACTL8,tumor progression,pi3k/akt pathway modulation,cytokeletal regulation,cell migration and invasion,oncogene activation,biomarker potential
ENSG00000223852,ZFP57,genomic instability,transcription factor,tumor suppressor,dna methylation regulation,cell cycle regulation,epigenetic modification
ENSG00000241635,UGT1A1,ugt1a1 glucuronidation,cellular detoxification,bilirubin modulation,xenobiotic metabolism,cancer chemosensitivity,tumor progression
ENSG00000171298,GAA,lysosomal acid maltase,glycogen degradation,metabolic regulation,cellular growth,autophagy,protein-protein interactions
ENSG00000164576,SAP30L,transcriptional regulation,promotes cell proliferation,regulates epigenetic silencing,ezh2 interaction,overexpression linked to tumorigenesis,impaired apoptosis
ENSG00000186352,ANKRD37,tumor suppressor regulation,dna damage response,apoptosis regulation,cell growth modulation,pi3k/akt pathway interaction,transcriptional regulation
ENSG00000164530,PI16,cell cycle regulation,tumor suppressor function,loss-of-function mutation,genomic instability,oncogenic transformation,cell proliferation
ENSG00000274972,FRG2,cell proliferation,epithelial-to-mesenchymal transition (emt),genomic instability,angiogenesis,metastasis,poor prognosis
ENSG00000127863,TNFRSF19,nf-κb signaling pathway,immune microenvironment modulation,tumor cell proliferation,gene expression regulation,prognostic marker,therapeutic target
ENSG00000066583,ISOC1,histone modification,epigenetic regulation,tumor suppressor loss,cellular proliferation,metabolic reprogramming,oncogenic mutation
ENSG00000133872,SARAF,mitochondrial function,dysregulated mptp,tumor suppressor gene,tumorigenesis,apoptosis regulation,cellular homeostasis
ENSG00000277800,TBX22,regulatory function,t-box transcription factor,cell differentiation,tumor suppression,oncogenic potential,epithelial development
ENSG00000110328,GALNT18,cell surface modification,o-glycosylation initiation,tumor progression,oncogene overexpression,glycoprotein regulation,cell adhesion inhibition
ENSG00000147202,DIAPH2,actin dynamics regulation,rho gtpase pathway interaction,oncogenic behavior promotion,cell migration and invasion facilitation,tumorigenesis association,mutations or alterations impact
ENSG00000111962,UST,oncogenic activity,tumor promotion,cell proliferation enhancement,apoptosis suppression,metastatic potential increase,pi3k/akt pathway modulation
ENSG00000180509,KCNE1,oncogenic signaling,tumor progression,cellular regulation,overexpression marker,voltage-gated potassium channels,calcium-dependent channel modulation
ENSG00000073756,PTGS2,tumor microenvironment modulation,eicosanoid synthesis,inflammation regulation,anti-apoptotic mechanisms,cell migration enhancement,vascular remodeling
ENSG00000171067,C11orf24,transcriptional regulation,chromatin modification,cell cycle progression,tumor growth,metastasis,oncogenic processes
ENSG00000182253,SYNM,microtubule regulation,pi3k/akt pathway interaction,oncogenic function,cell migration and invasion,cytoskeletal protein,tumor metastasis
ENSG00000131503,ANKHD1,metabolic reprogramming,cell proliferation,apoptosis suppression,mitochondrial function regulation,pi3k/akt/mtor pathway interaction,mapk/erk pathway interaction
ENSG00000116761,CTH,tumor microenvironment,protein digestion regulation,growth factor interaction,apoptosis modulation,cell proliferation enhancement,angiogenesis promotion
ENSG00000099282,TSPAN15,cell-cell adhesion disruption,tumor metastasis,protein-protein interaction,signaling pathway modulation,cell invasion,cancer progression
ENSG00000174939,ASPHD1,**

chromosomal instability,genomic rearrangement,dna damage response,homologous recombination deficiency,oncogenic mutation,therapeutic target
ENSG00000118939,UCHL3,therapeutic target,deubiquitinating enzyme,oncogene,proteostasis regulation,protein degradation pathway,ubiquitination dysregulation
ENSG00000043039,BARX2,transcriptional regulator,tumor progression,metastasis promoter,epithelial-to-mesenchymal transition,cellular differentiation regulator,e-cadherin repressor
ENSG00000196502,SULT1A1,steroid hormone regulation,detoxification process,sulfation reaction,cancer development,hormone signaling pathway,metabolic regulation
ENSG00000147576,ADHFE1,oxidative stress resistance,fatty acid metabolism,aldehyde detoxification,cellular proliferation,oncogenic transformation,chemotherapy resistance
ENSG00000067248,DHX29,genomic instability,rna splicing regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,spliceosome interaction
ENSG00000283018,MRPS12,mitochondrial ribosomal subunit function,critical for mitochondrial translation,disrupts normal energy metabolism,contributes to tumorigenesis,promotes cell proliferation,tumor suppressor dysfunction
ENSG00000151292,CSNK1G3,kinase activation,oncogene function,cell proliferation,apoptosis resistance,tumor progression,genomic instability
ENSG00000118640,VAMP8,regulation of autophagy,snare complex formation,tumor cell invasion,cellular trafficking modulation,cancer driver gene potential,poor prognosis association
ENSG00000169919,GUSB,glycosaminoglycan degradation,tumor progression,extracellular matrix remodeling,angiogenesis promotion,metastasis facilitation,enzyme overexpression
ENSG00000197223,C1D,chromatin remodeling,epigenetic regulation,gene expression modulation,pro-survival pathways activation,cell cycle regulation disruption,therapeutic target
ENSG00000104435,STMN2,cell proliferation,microtubule destabilization,oncogenic potential,protein-protein interactions,cytoplasmic localization,mitotic entry
ENSG00000106477,CEP41,microtubule stabilization,pi3k/akt pathway activation,oncogenic protein-protein interactions,cell cycle regulation,tumor aggressiveness,therapeutic target
ENSG00000182389,CACNB4,calcium influx regulation,constitutive activation,cell proliferation enhancement,metastasis promotion,therapeutic resistance development,prognostic biomarker
ENSG00000139793,MBNL2,alternative splicing regulation,rna processing modulation,tumor suppressor function,oncogenic splicing suppression,genomic instability contribution,protein-rna interaction
ENSG00000285250,MSRA,oncogenic protein stabilization,hif-1α interaction,ubiquitin-proteasome pathway modulation,tumor progression promotion,therapeutic target identification,protein folding and degradation regulation
ENSG00000059573,ALDH18A1,metabolic reprogramming,oxidative stress,redox regulation,cancer cell metabolism,genomic instability,tumor aggressiveness
ENSG00000004799,PDK4,aerobic glycolysis,diversion of glucose carbon,glycolytic shift,hallmark of cancer cells,metabolic reprogramming,regulatory enzyme activity
ENSG00000134594,RAB33A,regulation of cell cycle progression,g2/m transition promoter,cell proliferation and invasion enhancer,protein trafficking regulator,microtubule interaction,therapeutic target potential
ENSG00000196814,MVB12B,protein regulation,dysregulated function,multivesicular body formation,tumor progression,cellular signaling pathways,endosomal sorting
ENSG00000124496,TRERF1,genomic instability,tumor suppressor function,dna repair regulation,prognostic biomarker potential,cellular response to dna damage,oncogenic mutation prevention
ENSG00000285493,NRL,tumor suppressor dysfunction,activation of pi3k/akt/mtor pathway,cellular proliferation regulation,metabolic reprogramming,oncogenic transcription factor,genetic regulatory element interaction
ENSG00000155761,SPAG17,**

genomic instability,oncogenic processes,cell survival,therapeutic target,dna damage response,genomic alteration
ENSG00000141458,NPC1,cholesterol transport disruption,endosomal-lysosomal dysfunction,lysosomal cholesterol accumulation,oncogenic signaling activation,pi3k/akt pathway interaction,tumor growth promotion
ENSG00000113161,HMGCR,mevalonate pathway dysregulation,isoprenoid overproduction,cholesterol synthesis enhancement,cell membrane biogenesis,oncogenic signaling support,genomic instability
ENSG00000156006,NAT2,xenobiotic metabolism,altered enzymatic activity,dna repair modulation,cellular response to stress,detoxification pathway regulation,cancer susceptibility marker
ENSG00000067334,DNTTIP2,genomic instability,chromatin remodeling,dna damage response,transcription regulation,cell proliferation,tumor progression
ENSG00000004534,RBM6,genomic instability,altered gene regulation,rna-binding motif protein family,tumor suppressor repression,enhanced cell proliferation,metastasis promotion
ENSG00000119421,NDUFA8,mitochondrial function,apoptosis regulation,tumor progression,cellular metabolism,energy production,prognostic biomarker
ENSG00000180481,GLIPR1L2,tumor progression,oncogene,pi3k/akt signaling pathway,cell proliferation regulation,apoptosis inhibition,e epithelial-to-mesenchymal transition
ENSG00000197776,KLHDC1,wnt/β-catenin signaling pathway,tumor suppressor function,negative regulation,cancer stem cells,metastatic potential,genomic instability
ENSG00000011143,MKS1,basal body formation,cilia dysfunction,cell signaling disruption,oncogenic process involvement,cellular differentiation regulation,cytoskeletal organization disorder
ENSG00000152669,CCNO,cell cycle regulation,g2/m phase transition,tumor growth promotion,cell proliferation,centriole biogenesis,cilia formation inhibition
ENSG00000187531,SIRT7,metabolic regulation,tumor suppressor activity,oncogenic potential,cellular proliferation,genetic stability maintenance,therapeutic target
ENSG00000125522,NPBWR2,transcriptional co-regulator,estrogen receptor interaction,cell growth promotion,oncogenic potential,gene expression regulation,apoptosis suppression
ENSG00000107819,SFXN3,oxidative stress regulation,cell signaling modulation,apoptosis regulation,tumor progression association,cell proliferation involvement,protein interaction mediator
ENSG00000106631,MYL7,amplification,apoptosis regulation,cell proliferation enhancement,dna replication interaction,gene expression dysregulation,muscle contraction disruption
ENSG00000027847,B4GALT7,cell adhesion disruption,glycosylation dysregulation,tumor microenvironment modulation,prognostic biomarker,metastatic potential enhancement,glycoprotein biosynthesis alteration
ENSG00000121318,TAS2R10,bitter taste receptor,cell proliferation,apoptosis regulation,tumorigenesis promotion,signaling pathway modulation,immune response modulation
ENSG00000112984,KIF20A,genomic instability,oncogene overexpression,cell cycle regulation,tumor progression,centrosome duplication,prognostic biomarker
ENSG00000204406,MBD5,histone modification,transcriptional regulation,tumor suppressor function,chromatin remodeling,dna methylation alterations,cancer prognosis association
ENSG00000110723,EXPH5,pi3k/akt pathway,cell migration and invasion,oncogenic properties,rho gtpase activation,tumor progression,prognostic marker
ENSG00000169228,RAB24,tumor progression,oncogene activation,cellular trafficking regulation,signaling pathway modulation,protein localization,genomic overexpression
ENSG00000254999,BRK1,cell proliferation,signaling pathway regulation,dysregulation,genomic instability,tumor progression,therapeutic target
ENSG00000140577,CRTC3,metabolic regulation,cell survival enhancement,transcriptional coactivation,glycolysis upregulation,oncogenic signaling modulation,apoptosis inhibition
ENSG00000152413,HOMER1,rhoa gtpase regulation,cancer cell migration,oncogenic signaling pathway modulation,cell proliferation enhancement,tumor growth promotion,pi3k/akt pathway interaction
ENSG00000184697,CLDN6,tumor aggressiveness,epithelial-to-mesenchymal transition,cell migration and invasion,poor prognosis factor,signaling pathway modulation,apoptosis regulation
ENSG00000165905,LARGE2,ribonuclease p/mrp activity,cellular proliferation,rna processing regulation,gene expression dysregulation,tumor suppressor function,oncogene mutation
ENSG00000174684,B4GAT1,n-linked glycosylation,oncogene activity,cell migration,angiogenesis promotion,glycosyltransferase function,tumor progression
ENSG00000198846,TOX,transcriptional regulation,epithelial-to-mesenchymal transition,overexpression oncogene,tumor progression,prognostic marker,genomic amplification
ENSG00000101439,CST3,oncogenic potential,tumor progression,metastasis regulation,cell growth promotion,protein-protein interactions,pi3k/akt pathway modulation
ENSG00000198208,RPS6KL1,rps6k activation,protein synthesis regulation,cell proliferation enhancement,tumor progression driver,mtor pathway interaction,constitutive phosphorylation
ENSG00000151893,CACUL1,calcium signaling pathway regulation,cell survival modulation,potential oncogene,overexpression in cancer,calpain inhibition mechanism,tumor growth promotion
ENSG00000118729,CASQ2,calreticulin regulation,calcium homeostasis regulation,apoptosis modulation,autophagy regulation,tumor progression,therapeutic target
ENSG00000188321,ZNF559,transcriptional regulation,genome stability,apoptosis regulation,cell cycle progression,tumor suppression potential,krab-containing zinc finger protein family
ENSG00000141424,SLC39A6,altered metal ion homeostasis,cancer cell survival,cellular redox balance,enhanced tumor aggressiveness,hypoxic conditions,intracellular manganese regulation
ENSG00000089335,ZNF302,tumor suppression,dna damage response,cell cycle regulation,gene expression modulation,apoptosis induction,histone modification
ENSG00000087253,LPCAT2,cell membrane regulation,oncogenic signaling,cell proliferation,tumorigenicity,metastatic potential,genomic overexpression
ENSG00000109466,KLHL2,ubiquitination pathway,protein degradation,substrate recognition,apoptosis regulation,cancer driver gene,tumor suppressor function
ENSG00000161640,SIGLEC11,immune modulation,cell adhesion and migration,tumor microenvironment regulation,increased invasive capacity and metastasis,interaction with pi3k/akt pathway,altered expression in cancer cells
ENSG00000144820,ADGRG7,adhesion receptor function,tumor progression marker,surface expression,cell adhesion regulation,pi3k/akt pathway activation,epithelial-to-mesenchymal transition involvement
ENSG00000128849,CGNL1,cell cycle regulation,genomic instability,tumor progression,oncogene activation,cell proliferation,apoptosis suppression
ENSG00000198794,SCAMP5,pi3k/akt pathway activation,cell proliferation,metastasis promotion,tumor growth facilitation,therapeutic target,protein trafficking regulation
ENSG00000165071,TMEM71,cell cycle regulation,dna damage response,genomic instability,tumor suppressor function,cellular senescence,loss-of-function mutations
ENSG00000172046,USP19,cellular ubiquitination regulation,proteasome activity modulation,tumor growth promotion,apoptosis inhibition,dna damage response,ubiquitin-proteasome pathway dysregulation
ENSG00000100075,SLC25A1,mitochondrial metabolic regulation,cell proliferation promotion,fatty acid oxidation modulation,oncogenic pathway activation,tumor aggressiveness association,poor prognosis indicator
ENSG00000002746,HECW1,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis resistance,dna damage response,cell growth promotion,protein degradation pathway
ENSG00000007933,FMO3,oxidative stress modulation,metabolic regulation,tumor microenvironment modulation,cell proliferation promotion,therapeutic target,cancer metabolism alteration
ENSG00000138136,LBX1,tumor suppressor gene regulation,epithelial-to-mesenchymal transition,transcription factor activity,cellular signaling pathway interaction,prognostic biomarker,genomic profiling
ENSG00000176925,OR51F2,tumor progression,immune evasion,epithelial-to-mesenchymal transition (emt),cell migration and invasion,oncogenic function,tumor microenvironment
ENSG00000140943,MBTPS1,transcriptional regulation,cancer progression,apoptosis modulation,cell cycle regulation,lipid metabolism,membrane trafficking
ENSG00000198892,SHISA4,hedgehog signaling suppression,tumor suppressor function,aberrant activation,cell proliferation inhibition,genetic downregulation,tissue-specific expression
ENSG00000124523,SIRT5,acetyl-lysine deacetylation,apoptosis regulation,cell cycle regulation,de novo lipogenesis,energy metabolism regulation,histone modification
ENSG00000171848,RRM2,ribonucleotide reductase activation,dna synthesis enhancement,tumor growth promotion,proliferation increase,nucleotide biosynthesis upregulation,apoptosis resistance
ENSG00000213937,CLDN9,tight junction disruption,epithelial-to-mesenchymal transition (emt),metastasis facilitation,tumor progression,overexpression association,cellular adhesion regulation
,SEPT8,septin family,tumor progression,cancer cell proliferation,microtubule stabilization,cell cycle regulation,ploidy alterations
ENSG00000257473,HLA-DQA2,immunogenicity loss,mhc class ii expression,antigen presentation defect,tumor immune evasion,prognostic marker,genetic variation
ENSG00000158055,GRHL3,cell cycle regulation,transcriptional regulation,cell proliferation promotion,apoptosis inhibition,dna repair modulation,chromatin modification interaction
ENSG00000120705,ETF1,energy metabolism,mitochondrial dysfunction,altered glycolysis,cellular respiration,tumor progression,glycolytic shift
ENSG00000130592,LSP1,oncogenic transcription factor regulation,immunosuppression,cell proliferation enhancement,apoptosis inhibition,tumor progression promotion,tumor microenvironment modulation
ENSG00000144792,ZNF660,krab domain transcriptional regulation,oncogenic function,cell cycle progression,apoptosis inhibition,chromatin remodeling,tumor suppressor gene repression
ENSG00000280618,CYFIP1,cellular proliferation,oncogenic process,tumor progression,rna binding protein,translation regulation,protein interaction
ENSG00000143294,PRCC,chromatin remodeling,oncogenic driver mutations,cell cycle progression,transcriptional regulation,genomic instability,aneuploidy
ENSG00000181195,PENK,pain regulation,tumor progression,metastasis,cell proliferation,apoptosis,angiogenesis
ENSG00000178096,BOLA1,genomic instability,tumor progression,dna repair regulation,cell proliferation regulation,apoptosis regulation,mitochondrial function disruption
ENSG00000165775,FUNDC2,autophagy regulation,mitophagy suppression,tumor cell survival,cell proliferation,glycolytic shift,apoptosis inhibition
ENSG00000182768,NGRN,ribonucleoprotein assembly,mrna processing regulation,cell proliferation modulation,rna binding activity,oncogenic transformation driver,tumor progression factor
ENSG00000213931,HBE1,genomic instability,cell proliferation,chromatin regulation,apoptosis modulation,dna damage repair,oncogenic transcription
ENSG00000116871,MAP7D1,microtubule association,tumor growth promotion,cell migration regulation,prognostic marker,chemoresistance induction,cytoskeleton modulation
ENSG00000080823,MOK,pi3k/akt/mtor pathway activation,cell proliferation promotion,apoptosis resistance,tumor progression facilitation,protein kinase activity,cell cycle regulation modulation
ENSG00000142065,ZFP14,transcriptional regulation,dna binding,zinc finger protein,cell proliferation,angiogenesis,metastasis
ENSG00000006715,VPS41,autophagic degradation,endosomal trafficking regulation,lysosome maintenance,cell survival promotion,tumor proliferation facilitation,oncogenic mutation association
ENSG00000105514,RAB3D,membrane trafficking,cellular invasion,vesicle transport,metastasis promotion,gtpase regulation,protein-protein interaction
ENSG00000163202,LCE3D,emt regulation,tumor microenvironment modulation,keratinocyte differentiation,immune evasion influence,cancer progression role,genetic expression regulation
ENSG00000177710,SLC35G5,nucleotide sugar transport,glycosylation regulation,cell membrane trafficking,protein modification,cell signaling modulation,cancer metabolism
ENSG00000173486,FKBP2,cell cycle progression,chaperone function,immunophilin family,oncogenic signaling,transcriptional regulation,protein-protein interaction
ENSG00000184292,TACSTD2,epithelial-to-mesenchymal transition,overexpression,cell migration regulation,tumor progression factor,adhesion molecule disruption,signaling pathway interaction
ENSG00000169946,ZFPM2,tumor suppressor function,transcriptional regulation,cell proliferation regulation,apoptosis modulation,genomic instability,protein-protein interaction
ENSG00000175938,ORAI3,constitutive activation,overexpression,cell proliferation,calcium signaling,oncogenic stimulus,cell survival
ENSG00000095539,SEMA4G,angiogenic regulation,tumor aggressiveness,prognostic biomarker,growth factor signaling,transmembrane receptor interaction,vegf pathway modulation
ENSG00000160190,SLC37A1,antioxidant defense,cellular detoxification,chemotherapy resistance,glutathione metabolism,intracellular sulfate transport,tumor metabolism
ENSG00000137819,PAQR5,cellular lipid metabolism regulation,oncogenic driver,tumor progression contributor,therapeutic target,overexpression,signaling pathway activation
ENSG00000003509,NDUFAF7,mitochondrial dysfunction,oxidative phosphorylation impairment,glycolysis regulation,glutaminolysis modulation,energy metabolism reprogramming,therapeutic target
ENSG00000101292,PROKR2,cell signaling,prokineticin receptor function,apoptosis suppression,tumor progression,therapeutic target,cell proliferation regulation
ENSG00000196199,MPHOSPH8,genomic stability maintenance,homologous recombination repair,dna double-strand break repair,oncogene potential,cell cycle regulation,tumor suppression
ENSG00000273607,CHCHD10,mitochondrial dynamics,apoptosis regulation,oxidative stress resistance,tumor progression,chemoresistance,metabolic regulation
ENSG00000115207,GTF3C2,cellular growth regulation,genomic instability,chromatin remodeling,transcriptional regulation,antitumor activity,apoptosis modulation
ENSG00000132466,ANKRD17,loss-of-function mutations,chromatin remodeling,nuclear receptor-binding factor,tumor suppressor function,cell cycle regulation,chromatin stability
ENSG00000116132,PRRX1,emt activation,transcriptional regulation,oncogenic potential,epithelial-mesenchymal transition,cellular differentiation,transcription factor function
ENSG00000288435,GJA10,cell-cell communication,gap junction formation,tumor progression,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,biomarker potential
ENSG00000158555,GDPD5,glycolysis,metabolic regulation,oncogenic potential,protein-protein interactions,energy metabolism,cell growth promotion
ENSG00000178860,MSC,microtubule stabilization,tau protein expression,cytoskeletal remodeling,apoptosis resistance,cell migration enhancement,oncogenic kinase regulation
ENSG00000160408,ST6GALNAC6,glycosylation process,oncogenesis,tumor progression,cell proliferation,metastasis promotion,epithelial cell regulation
,HIST1H2BL,histone modification,chromatin remodeling,genomic instability,epigenetic regulation,nucleosome assembly,transcriptional regulation
ENSG00000108509,CAMTA2,transcriptional regulation,wnt/β-catenin pathway activation,tumor progression,angiogenesis,metastasis,cell proliferation
ENSG00000067064,IDI1,oncogene activation,cell proliferation enhancement,gtpase regulation,metastasis promotion,protein stability modulation,tumor progression
ENSG00000164332,UBLCP1,cellular homeostasis,protein degradation regulation,tumor progression,oncogenic signaling,therapeutic target,ubiquitin-proteasome system dysfunction
ENSG00000153250,RBMS1,genomic instability,dna damage response,cell cycle regulation,tumor suppressor function,ubiquitination regulation,transcriptional inhibition
ENSG00000101335,MYL9,non-muscle myosin iia complex,cell adhesion disruption,genomic amplification,tumor progression driver,microtubule regulation,cancer cell migration
ENSG00000106404,CLDN15,epithelial-to-mesenchymal transition,tumor aggressiveness,cell migration invasion,prognostic biomarker,signaling pathway regulation,loss of tight junction integrity
ENSG00000204965,PCDHA5,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),methylated silencing,tumor aggressiveness,cancer cell invasion,therapeutic target
ENSG00000077380,DYNC1I2,dynein complex regulation,microtubule stability disruption,tumor progression driver,cell proliferation enhancer,oncogenic signaling pathway activator,genomic amplification hotspot
ENSG00000187097,ENTPD5,tumor microenvironment modulation,glycolytic reprogramming,oncogene overexpression,proliferation promotion,cancer progression driver,metabolic rewiring
ENSG00000074370,ATP2A3,calcium homeostasis disruption,oncogene potential,cell cycle regulation disruption,pi3k/akt pathway interaction,tumor progression association,loss of function mutation
ENSG00000111711,GOLT1B,cancer cell proliferation,glycoprotein modification,tumor progression,biomarker discovery,cell signaling regulation,protein folding defects
ENSG00000173467,AGR3,tumor promotion,cell growth regulation,wnt/β-catenin pathway interaction,epithelial cell expression,leucine-rich repeat domain,biomarker for prognosis
ENSG00000179213,SIGLECL1,tumor associated macrophage polarization,immune tolerance promotion,anti-tumor immunity suppression,nk cell activity inhibition,sialylated glycoprotein recognition,immunomodulation
ENSG00000183317,EPHA10,tumor progression,angiogenesis,cell migration,signaling pathway activation,immune response modulation,cancer metastasis
ENSG00000166189,HPS6,autophagosome formation,cellular metabolism,oncogenic signaling pathway activation,tumor growth promotion,therapeutic agent resistance,membrane trafficking regulation
ENSG00000213523,SRA1,cholesterol metabolism,gene amplification,cell proliferation regulation,lipid transfer activity,tumor aggressiveness marker,nuclear receptor interaction
ENSG00000112149,CD83,immune evasion,transmembrane glycoprotein,tumor immunology,dendritic cell maturation,toll-like receptor interaction,molecular marker
ENSG00000162444,RBP7,**

* gene regulatory mechanism,3'utr binding
* post-transcriptional processing regulation,mrna stability
* cell cycle progression influence,apoptosis evasion
* rna-binding protein function,rbm family membership
* tumorigenesis contribution,oncogenic processes

**
ENSG00000100722,ZC3H14,oncogene,transcriptional regulation,cell proliferation,ubiquitination,apoptosis,protein degradation
ENSG00000132698,RAB25,cell surface protein recycling,epithelial-to-mesenchymal transition (emt),cell adhesion modulation,metabolic regulation,protein trafficking regulation,therapeutic target
ENSG00000163530,DPPA2,pluripotency regulator,epithelial-to-mesenchymal transition,cell cycle regulation,enhanced cell survival,transcription factor modulation,cancer progression
ENSG00000273274,ZBTB8B,genetic repressor,tumor suppressor gene regulation,chromatin remodeling,apoptosis evasion,proliferation promotion,cancer prognostic marker
ENSG00000181404,WASHC1,endocytic trafficking disruption,tumor progression driver,therapeutic resistance contributor,oncogenic signaling modifier,genomic instability inducer,cellular homeostasis regulator
ENSG00000143924,EML4,alk activation,constitutive kinase activity,fusion protein formation,oncogenic signaling pathway,tumor growth regulation,tyrosine kinase activation
ENSG00000167721,TSR1,tumor suppressor,cell adhesion modulation,cytoplasmic/nuclear localization,apoptosis regulation,rac/rho gtpase interaction,epithelial-to-mesenchymal transition (emt)
ENSG00000129682,FGF13,pi3k/akt pathway activation,tumor progression,prognostic biomarker,oncogenesis,cell proliferation,overexpression
ENSG00000088826,SMOX,cell cycle regulation,chromatin remodeling,apoptosis modulation,transcriptional regulation,tumor progression,genomic instability
ENSG00000185236,RAB11B,endocytic recycling pathway,epithelial cell polarity maintenance,tumor progression driver,proliferation regulation,metastasis promotion,protein trafficking modulation
ENSG00000031691,CENPQ,aneuploidy,chromosomal instability,kinetochore-microtubule attachment,mitosis regulation,cancer cell proliferation,genomic stability maintenance
ENSG00000077942,FBLN1,tumor progression,metastasis regulation,angiogenesis facilitation,cell adhesion modulation,protein-protein interaction,genomic instability
ENSG00000175264,CHST1,tumor progression,cell proliferation,glycosylation regulation,cell migration,sulfotransferase activity,transcriptional regulation
ENSG00000205143,ARID3C,...<end>:

<begin>
chromatin remodeling,transcriptional regulation,tumor progression,cell proliferation,metastasis,therapeutic target
ENSG00000169994,MYO7B,genomic instability,dna repair mechanisms,tumor suppressor function,cell cycle regulation,apoptosis regulation,protein degradation
ENSG00000135049,AGTPBP1,oncogenic function,transcriptional regulation,cell proliferation enhancement,post-transcriptional control,metastatic suppression,protein-protein interaction
ENSG00000112186,CAP2,potassium channel regulation,tumor progression,metastasis,biomarker,cell migration,signal transduction
ENSG00000154096,THY1,immune modulation,cancer immunoevasion,cell adhesion disruption,tumor evasion,cell migration regulation,dysregulated expression
ENSG00000130433,CACNG6,regulation of calcium influx,epithelial-to-mesenchymal transition,protein interaction networks,tumor progression,promoter methylation,metastasis regulation
ENSG00000172716,SLFN11,dna damage response,tumor suppressor function,apoptosis induction,chromatin remodeling,genomic instability,therapeutic target
ENSG00000288121,MDN1,mitotic progression,spindle assembly regulation,chromosomal segregation,cell proliferation promotion,genomic instability,aberrant expression
ENSG00000198513,ATL1,cell membrane regulation,protein-protein interaction,aminophospholipid translocase complex,apoptosis evasion,lipid metabolism regulation,epithelial-to-mesenchymal transition (emt) facilitation
ENSG00000184979,USP18,tumor growth regulation,oncogenic protein stabilization,deubiquitination activity,cell survival promotion,prognostic marker identification,therapeutic target potential
ENSG00000153132,CLGN,cell adhesion disruption,tumor suppressor function,epigenetic silencing,oncogenic process regulation,cell migration dysregulation,wnt/β-catenin pathway interaction
ENSG00000117090,SLAMF1,immunomodulation,tumor progression,cell surface localization,signaling pathways regulation,poor prognosis marker,potential therapeutic target
ENSG00000095321,CRAT,lipid metabolism regulation,energy production facilitation,cellular uptake enhancement,oxidative stress suppression,acyl-coa interaction,thiolase enzyme activity
ENSG00000112651,MRPL2,mitochondrial ribosome,oncogene potential,enhanced energy metabolism,cellular growth promotion,therapeutic resistance enhancement,tumor progression facilitation
ENSG00000165526,RPUSD4,genomic instability,cell cycle progression,dna repair mechanisms,oncogenic mutation,cellular replication regulation,protein-protein interactions
ENSG00000196670,ZFP62,tumor suppressor repression,transcription regulation,cell proliferation enhancement,apoptosis inhibition,metastasis promotion,prognostic marker
ENSG00000167645,YIF1B,mitochondrial function,tumor progression,cellular respiration,mitochondrial morphology,protein translocation,oncogenic regulation
ENSG00000102780,DGKH,lipid metabolism,tumor progression,cell proliferation,therapeutic target,genomic profiling,signaling pathway activation
ENSG00000140543,DET1,chromatin remodeling,transcriptional regulation,epigenetic modification,cell proliferation,dna damage response,genomic instability
ENSG00000083099,LYRM2,apoptosis regulation,mitochondrial function,protein-protein interaction,cellular homeostasis,tumor suppressor,mitochondrial dynamics
ENSG00000090339,ICAM1,immune evasion,cell adhesion modulation,metastasis promotion,tumor microenvironment modification,signaling pathway interaction,upregulation in cancer cells
ENSG00000123810,B9D2,ciliary assembly,cell proliferation,apoptosis resistance,genomic instability,tumor metastasis,proliferation promotion
ENSG00000106268,NUDT1,dna damage repair,tumor suppressor function,cell proliferation regulation,metabolic reprogramming regulation,genome stability maintenance,apoptosis promotion
ENSG00000285482,DGAT1,triglyceride synthesis,lipid metabolism,oncogenic process,cell survival,therapeutic target,overexpression
ENSG00000164086,DUSP7,tumor suppressor,dephosphorylation of mapk,constitutive activation of mapk pathways,gene expression regulation,cell proliferation and survival signaling,prognostic biomarker
ENSG00000128594,LRRC4,cell adhesion modulation,tumor progression facilitation,signaling pathway regulation,poorly understood function,cancer-related involvement,leucine-rich repeat protein
ENSG00000162631,NTNG1,epithelial-to-mesenchymal transition,oncogene activity,cell adhesion modulation,proliferation regulation,metastasis promotion,apoptosis resistance
ENSG00000130748,TMEM160,mtor pathway modulation,oncogene role,aberrant localization,lipid metabolism regulation,tumor progression promotion,cancer cell survival enhancement
ENSG00000213398,LCAT,lipid metabolism regulation,hdl/ldl interaction,oncogenesis modulation,cholesterol esterification,lipoprotein-associated enzyme,therapeutic target
ENSG00000138315,OIT3,transcriptional regulation,cell growth regulation,zinc finger domain,genetic alterations,tumorigenesis involvement,limited research
ENSG00000242247,ARFGAP3,tumor microenvironment modulation,cell proliferation promotion,epithelial-to-mesenchymal transition regulation,extracellular matrix secretion regulation,cancer stem cell maintenance,growth factor regulation
ENSG00000164326,CARTPT,chromatin modification,oncogenic potential,histone interaction,transcriptional activation,cell proliferation,metastasis promotion
ENSG00000176401,EID2B,cell cycle regulation,cyclin a2 overexpression,tumor progression,apoptosis inhibition,transcriptional activation,therapeutic target
ENSG00000101052,IFT52,cilia assembly failure,disrupted hedgehog signaling,genomic instability,impaired intraflagellar transport,tumor suppressor function loss,hedgehog pathway dysregulation
ENSG00000125780,TGM3,apoptosis resistance,angiogenesis promotion,cell differentiation regulation,cell survival enhancement,metastasis facilitation,tumor progression marker
ENSG00000168434,COG7,protein folding regulation,mitochondrial function modulation,genomic instability contribution,cellular stress response disruption,oncogenic potential identified,cancer-related protein interactions
ENSG00000071537,SEL1L,erad pathway regulation,tumor progression,protein quality control,cellular stress response,oncogenic pathway regulation,therapeutic target
ENSG00000171617,ENC1,cell growth regulation,transcriptional regulation,leucine zipper domain,apoptosis regulation,immune response modulation,tumor progression
ENSG00000164849,GPR146,gpcr signaling pathway,promoter hypermethylation,tumor suppressor function,cell proliferation regulation,signaling molecule interaction,tissue expression alteration
ENSG00000171853,TRAPPC12,cellular regulation,disrupting endocytosis/exocytosis,enhancing tumour growth,sigaling pathway interaction,genomic profiling,none
ENSG00000134294,SLC38A2,glutamine transport,cellular metabolism regulation,tumor growth promotion,amino acid homeostasis disruption,metabolic reprogramming,oncogenic signaling
ENSG00000170745,KCNS3,potassium channel regulation,cellular excitability modulation,neurological disorders association,tumor suppressor role,pi3k/akt pathway interaction,somatically altered in cancer
ENSG00000166148,AVPR1A,angiogenesis promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition,g-protein coupled receptor signaling,increased metastasis,poor prognosis marker
ENSG00000183579,ZNRF3,wnt/β-catenin signaling,loss-of-function mutations,constitutive activation,tumor progression,negative regulator,cell signaling pathway
ENSG00000133687,TMTC1,dna repair mechanism disruption,cell cycle regulation alteration,genomic stability maintenance defect,homologous recombination impairment,protein-protein interaction dysfunction,tumor progression facilitation
ENSG00000198183,BPIFA1,cell proliferation,tumor progression,apoptosis inhibition,signaling pathway interaction,angiogenesis promotion,overexpression association
ENSG00000182557,SPNS3,pi3k/akt signaling,oncogenic function,metastasis promotion,tumor progression,chemotherapy resistance,sphingosine-1-phosphate transport
ENSG00000108370,RGS9,gpcr signaling,gαi protein regulation,cell proliferation,tumor suppression pathway disruption,apoptosis modulation,dna repair interaction
ENSG00000117500,TMED5,autophagy regulation,cellular adaptation,oncogenic pathways,protein trafficking,membrane transport,pi3k/akt signaling
ENSG00000197429,IPP,immune response modulation,cancer development contribution,cell proliferation enhancement,protein activity increase,tumor progression involvement,regulatory pathway disruption
ENSG00000135720,DYNC1LI2,dynein-1 regulation,microtubule-dependent transport,oncogenic mutations,cell proliferation enhancement,cancer metastasis,therapeutic target
ENSG00000123836,PFKFB2,cellular glycolysis regulation,glycogen metabolism dysregulation,oncogenic transformation,tumor progression driver,glucose metabolism adaptation,therapeutic target
ENSG00000137177,KIF13A,microtubule dynamics,genomic stability,chromosome segregation,cell proliferation,apoptosis resistance,tumor invasiveness
ENSG00000224654,UBD,ubiquitination regulation,genomic instability,tumor progression,dna repair disruption,protein stability modulation,oncogenic transformation
ENSG00000197037,ZSCAN25,emt induction,transcriptional regulation,chromatin remodeling,microrna regulation,pi3k/akt pathway modulation,cell proliferation promotion
ENSG00000070366,SMG6,mrna surveillance,exosome regulation,tumor suppressor function,genomic integrity maintenance,prognostic marker potential,cellular process regulation
ENSG00000172725,CORO1B,**

cell migration,actin cytoskeleton regulation,gtpase interaction,signaling pathway modulation,prognostic marker,tumor progression 
**
ENSG00000135821,GLUL,glutaminase activity,tumor progression,urea cycle regulation,metabolic reprogramming,cell proliferation enhancement,prognostic marker
ENSG00000144452,ABCA12,lipid transport regulation,cell proliferation enhancement,upregulation in tumors,cholesterol efflux modulation,detoxification function,skin barrier maintenance
ENSG00000187824,TMEM220,cellular signaling,oncogenesis,tumor progression,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),transmembrane protein function
ENSG00000118804,STBD1,chromatin remodeling,transcriptional activation,dna damage repair,pi3k/akt pathway interaction,cancer cell proliferation,tumor survival
ENSG00000184110,EIF3C,cell proliferation inhibition,tumor suppressor function,apoptosis regulation,genetic instability,metabolic adaptation,protein synthesis regulation
ENSG00000189190,ZNF600,transcriptional regulation,tumor progression,apoptosis inhibition,cell proliferation,pi3k/akt signaling,chromatin remodeling
ENSG00000119321,FKBP15,cellular regulation,apoptosis modulation,protein interaction regulation,cancer stem cell regulation,dna damage response,tumor growth promotion
ENSG00000102178,UBL4A,ubiquitin regulation,cell cycle progression,apoptosis modulation,tumor aggressiveness marker,protein stability regulation,therapeutic target
ENSG00000019991,HGF,hgf/c-met pathway,gain of function mutations,oncogenic signaling,cell survival and growth,tumor progression,angiogenesis
ENSG00000102359,SRPX2,extracellular matrix protein,oncogene potential,tumor progression promoter,cell migration enhancer,adhesion molecule regulator,prognostic marker candidate
ENSG00000188064,WNT7B,wnt/β-catenin pathway activation,cell proliferation enhancement,tumor progression,therapeutic target,cell survival promotion,signaling pathway interaction
ENSG00000164841,TMEM74,apoptosis regulation,cellular metabolism,endoplasmic reticulum stress response,protein trafficking regulation,therapeutic target,tumor progression
ENSG00000100478,AP4S1,cellular trafficking regulation,oncogenic recycling,tumor suppressor downregulation,cell proliferation modulation,signaling pathway interaction,protein sorting dysfunction
ENSG00000103510,KAT8,cell proliferation,chromatin remodeling,histone acetylation,oncogenic transcription,tumor progression,prognostic marker
ENSG00000010361,FUZ,pcp signaling pathway,constitutive activation,aberrant expression,cell migration regulation,tumor progression,therapeutic target
ENSG00000111912,NCOA7,coactivator function,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell proliferation,chromatin remodeling,histone modification
ENSG00000275544,BDH1,tumor suppression,metabolic regulation,fatty acid oxidation impairment,energy production alteration,cellular proliferation enhancement,oxidative stress response modulation
ENSG00000121716,PILRB,immune evasion,tumor microenvironment regulation,nk cell modulation,cell surface receptor function,immune checkpoint regulation,ligand-receptor interaction
ENSG00000185344,ATP6V0A2,tumor progression,metastasis regulation,proton gradient modulation,lysosomal acidification,apoptosis evasion,therapeutic target
ENSG00000183542,KLRC4,tumor immunosurveillance,evasion of tumor immunity,nk cell dysfunction,tumor microenvironment modulation,potential therapeutic target,cancer immunotherapy
ENSG00000101447,FAM83D,wnt/β-catenin signaling pathway,oncogenic driver,cell proliferation,tumor growth,signaling regulation,gene amplification
ENSG00000171951,SCG2,proteolytic processing,cellular growth regulation,tumor progression,therapeutic target,immune response modulation,ubiquitin-proteasome pathway
ENSG00000064199,SPA17,cell cycle progression,cytoplasmic localization,cell proliferation,protein interaction,cancer overexpression,tumorigenesis
ENSG00000106823,ECM2,integrin interactions,tumor progression,extracellular matrix regulation,cell adhesion modification,metastasis facilitation,biomarker potential
,IGHD,immunoglobulin expression,tumor microenvironment modulation,immune response regulation,antibody formation,gene expression alteration,rare genetic variation
ENSG00000135378,PRRG4,epithelial-to-mesenchymal transition (emt),tumor suppressor gene,tumor progression,cell-cell interactions,downregulation in cancer,proliferation regulation
ENSG00000140259,MFAP1,cell adhesion,tumor progression,metastasis,extracellular matrix remodeling,transmembrane glycoprotein,prognostic marker
ENSG00000067113,PLPP1,lipid phosphatase activity,proliferation promotion,cell cycle progression,lipid biosynthesis regulation,tumor promoter,mitochondrial function regulation
ENSG00000100170,SLC5A1,glucose metabolism,cellular uptake,glycolysis,warburg effect,tumor growth,therapeutic target
ENSG00000125149,C16orf70,genomic instability,tumor suppressor,nuclear localization,dna replication regulation,checkpoint response modulation,protein interaction with pcna and topbp1
ENSG00000103168,TAF1C,transcriptional regulation,deregulated gene expression,cell proliferation promotion,genomic instability,oncogene activation,tumor suppressor gene suppression
ENSG00000154222,CC2D1B,calcineurin regulation,dysregulation,mutations,constitutive activation,gsk3beta interaction,nfat transcription factor activation
ENSG00000135596,MICAL1,microtubule regulation,tumor progression,signaling pathway activation,oncogenic activity enhancement,cell migration promotion,epigenetic dysregulation
,H2AFV,histone variant,nucleolar localization,ribosomal rna synthesis regulation,cell cycle regulation interaction,proliferation promotion,cancer progression association
ENSG00000162695,SLC30A7,cellular proliferation,apoptosis regulation,zinc ion transport,tumor growth modulation,cell survival enhancement,protein-protein interactions
ENSG00000213759,UGT2B11,oncogene activity,pi3k/akt pathway regulation,tumor progression modulation,cellular metabolism alteration,signal transduction dysregulation,tumor microenvironment modulation
ENSG00000172292,CERS6,sphingolipid metabolism,cancer progression,cell proliferation,oncogenic processes,tumor growth,genomic instability
ENSG00000111846,GCNT2,oncogene activity,glycoprotein modification,cancer progression,cell growth promotion,tumor metastasis facilitation,genomic instability
ENSG00000090013,BLVRB,genomic instability,antioxidant defense system regulation,oxidative stress protection,cell survival promotion,angiogenesis regulation,biomarker potential
ENSG00000118363,SPCS2,oncogenic function,protein degradation,ubiquitination pathway,tumor progression,skin cancer association,poor prognosis marker
ENSG00000113722,CDX1,tumor suppressor function,cell cycle regulation,apoptosis regulation,genomic stability maintenance,differentiation regulation,kidney cancer involvement
ENSG00000084073,ZMPSTE24,prelamin a maturation,cellular senescence,apoptosis evasion,chromatin regulation,progeroid syndrome,premature aging
ENSG00000165995,CACNB2,calcium channel regulation,oncogenic activity,upregulated expression,tumor progression,cell proliferation modulation,apoptosis inhibition
ENSG00000151067,CACNA1C,l-type calcium channel activation,calcium influx regulation,cell proliferation promotion,tumor progression association,metastasis facilitation,prognostic marker status
ENSG00000102409,BEX4,tumor progression,cell migration,invasion regulation,neurodevelopmental regulation,signaling pathway interaction,oncogenesis driver
ENSG00000164303,ENPP6,atp regulation,cell survival,phosphodiesterase activity,tumor progression,metastasis promotion,cancer cell metabolism
ENSG00000008405,CRY1,dna repair,genomic instability,circadian rhythm regulation,cell cycle progression,apolypotis regulation,biomarker function
ENSG00000138347,MYPN,mlcbp function,cell migration,tumor aggressiveness,poor prognosis,muscle structure maintenance,cell adhesion regulation
ENSG00000064651,SLC12A2,sodium-chloride cotransport,epithelial-to-mesenchymal transition,cell proliferation,tumor progression,metastasis formation,prognostic marker
ENSG00000056050,HPF1,chromatin remodeling,transcriptional regulation,cell cycle progression,tumorigenesis,genomic instability,cancer development
ENSG00000011332,DPF1,**
cell cycle regulation,protein degradation,ubiquitin ligase adaptor,oncoprotein accumulation,g2/m phase transition,cul4a interaction
ENSG00000110195,FOLR1,folate receptor binding,cell proliferation enhancement,tumor growth promotion,angiogenesis facilitation,poor prognosis marker,oncogenic signaling pathway activation
ENSG00000162174,ASRGL1,oncogenesis,cell proliferation,amino acid metabolism,tumor microenvironment modulation,chemotherapy resistance,signaling pathway interaction
ENSG00000197121,PGAP1,rho gtpase regulation,gain-of-function mutations,post-translational modification,tumor progression,therapeutic target,cancer diagnosis
ENSG00000138231,DBR1,ribosome biogenesis,tumor progression,cellular growth regulation,transcriptional regulation,oncogenic mutations,gene expression modulation
ENSG00000154438,ASZ1,histone chaperone function,chromatin remodeling,dna replication regulation,genomic instability driver,oncogenic signaling pathway interaction,protein overexpression in tumors
ENSG00000111727,HCFC2,transcriptional coactivation,cell cycle regulation,dna repair mechanisms,oncogenic pathway modulation,protein-protein interactions,tumor suppressor dysfunction
ENSG00000196139,AKR1C3,steroid hormone metabolism,tumor progression,cell proliferation,oncogenic process,genomic amplification,androgen receptor interaction
ENSG00000164897,TMUB1,aberrant protein accumulation,cell surface receptor regulation,cellular homeostasis disruption,genetic instability contribution,oncogenic pathway activation,protein stability regulation
ENSG00000143436,MRPL9,mitochondrial dysfunction,antitumor activity,regulation of cell growth,tumor suppressor,cell proliferation regulation,genomic instability
ENSG00000107951,MTPAP,genomic instability,tumorigenesis,cell cycle regulation,dna repair,apoptosis regulation,metallophosphoesterase activity
ENSG00000162923,WDR26,dna damage response,cell cycle regulation,spindle checkpoint modulation,oncogenic pathway activation,tumor suppressor function,protein-protein interaction
ENSG00000167600,CYP2S1,cancer driver,cell proliferation,apoptosis regulation,tumor progression,chemotherapy resistance,antitumor therapeutic target
ENSG00000138207,RBP4,high expression,tumor progression,cell proliferation,metastasis promotion,poor prognosis,retinoid transport
ENSG00000153815,CMIP,calcium signaling,immune modulation,oncogene activation,tumor progression,metastasis facilitation,prognostic marker
ENSG00000040275,SPDL1,genomic instability,tumor suppression,dna repair regulation,cell cycle control,anti-tumor function,apoptosis regulation
,FAM129A,cell cycle regulation,transcriptional regulation,chromatin remodeling,tumor suppressor or oncogene,apoptosis regulation,mutation-driven oncogenesis
ENSG00000151500,THYN1,chromatin remodeling,transcriptional regulation,gain-of-function mutations,histone modification,epigenetic dysregulation,tumor progression
ENSG00000086619,ERO1B,er stress response,disulfide bond formation,oncogenic mutation,tumor growth,metastasis driver,protein folding homeostasis
ENSG00000198838,RYR3,calcium channel regulation,oncogenic processes,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,prognostic significance
ENSG00000086300,SNX10,tumor suppression,endosomal trafficking regulation,cell proliferation regulation,protein sorting modulation,oncogene regulation,cell survival promotion
ENSG00000121797,CCRL2,co-receptor activity,cell migration,immune evasion,apoptosis regulation,tumor progression,oncogenesis
ENSG00000285426,RNF187,ubiquitination regulation,tumor progression,apoptosis evasion,cell cycle regulation,metastasis promotion,biomarker potential
ENSG00000168491,CCDC110,**

microtubule dynamics,centrosomal regulation,mitotic spindle formation,gain-of-function mutations,oncogenic function,genomic instability 
**
ENSG00000166411,IDH3A,oncogenic mutations,gain of function alterations,metabolic reprogramming,2-hydroxyglutarate accumulation,tumor cell proliferation,somatic mutation hotspot
ENSG00000108602,ALDH3A1,angiogenesis promotion,cellular redox regulation,hypoxia-inducible gene expression,metabolic reprogramming,pro-angiogenic signaling,tumor progression enhancement
ENSG00000197971,MBP,tumor growth,cellular signaling,oncogenic processes,protein-protein interactions,cell proliferation,metastasis
ENSG00000141741,MIEN1,chromatin remodeling,cell cycle regulation,tumor suppressor loss,therapeutic target,apoptosis inhibition,dna damage response alteration
ENSG00000213020,ZNF611,tumor suppressor,apoptosis regulation,cell cycle control,transcriptional regulation,dna repair interaction,genomic stability maintenance
ENSG00000186472,PCLO,pi3k/akt pathway modulation,tumor growth promotion,cellular response regulation,genomic instability,oncogenic properties enhancement,biomarker potential
ENSG00000140612,SEC11A,protein degradation regulation,tumor growth promotion,dysregulated erad function,enhanced cell survival,poor prognosis indicator,biological stress response modulation
ENSG00000155659,VSIG4,immune evasion,apoptosis regulation,autophagy modulation,tumor progression,poor prognosis,immune suppression
ENSG00000102962,CCL22,tumor progression,angiogenesis promotion,immune suppression,cell proliferation enhancement,metastasis facilitation,prognostic marker
ENSG00000102805,CLN5,lysosomal function,autophagic regulation,protein degradation,endocytic pathway,cellular waste management,tumor suppressor
ENSG00000198734,F5,prothrombinase complex,angiogenesis promotion,coagulation pathway dysregulation,tumor metastasis enhancement,endothelial cell proliferation,vascular remodeling
ENSG00000136100,VPS36,regulation of endosomal sorting,aberrant cellular trafficking,modulation of oncogenic pathways,tumor progression,metastasis,poor prognosis
ENSG00000135334,AKIRIN2,chromatin remodeling,transcriptional regulation,overexpression in tumors,genome stability regulation,cell cycle progression modulation,biomarker potential
ENSG00000085514,PILRA,immune evasion,pattern recognition receptor activation,antiviral immunity,tumor microenvironment modulation,innate immune regulation,immunosuppressive environment creation
ENSG00000179163,FUCA1,glycosylation pathway dysregulation,tumor aggressiveness enhancement,cellular proliferation promotion,survival advantage gain,metastatic potential increase,glycoprotein metabolism disruption
ENSG00000145832,SLC25A48,metabolic regulation,mitochondrial carrier protein,oncogenic growth,redox regulation,angiogenesis activation,energy homeostasis disruption
ENSG00000143578,CREB3L4,er-localization,transcriptional regulation,cellular stress response,autophagy regulation,tumor progression,protein-protein interaction
ENSG00000141026,MED9,mediator complex interaction,transcriptional regulation,oncogenic process promotion,cell proliferation enhancement,apoptosis resistance,tumor growth facilitation
ENSG00000119596,YLPM1,actin cytoskeleton regulation,microtubule stabilization,cell migration facilitation,oncogenic process promotion,tumorigenesis driver,cell survival enhancement
ENSG00000078177,N4BP2,p53 degradation,oncogene overexpression,mdm2 interaction,tumor suppressor regulation,cell survival enhancement,dna damage response modulation
ENSG00000181458,TMEM45A,cell migration,enhanced invasion,metastasis promotion,overexpression,poor prognosis,transmembrane protein function
ENSG00000105953,OGDH,altered energy metabolism,increased glycolysis,warburg effect,dysregulated apoptosis,tumor microenvironment modulation,oxidative stress promotion
ENSG00000142669,SH3BGRL3,apoptosis evasion,cell cycle regulation,mapk signaling,proliferation enhancement,protein interaction,tumor development
ENSG00000090470,PDCD7,apoptosis regulation,cellular stress response,tumor progression,oncogenic regulation,cell survival mechanism,protein-protein interaction
ENSG00000125869,LAMP5,immune evasion,metastasis promoter,tumor progression,poor prognosis marker,immune suppression,biomarker for patient outcome
ENSG00000112039,FANCE,genomic instability,dna damage repair,chromosomal abnormalities,cellular proliferation,cancer predisposition,genetic alterations
ENSG00000251192,ZNF674,chromatin remodeling,transcriptional control,oncogenic processes,tumor progression,cell cycle regulation,apoptosis modulation
ENSG00000110717,NDUFS8,mitochondrial function disruption,oncogenic signaling pathway activation,hif-1α upregulation,glycolytic shift,tumor progression support,energy metabolism alteration
ENSG00000120253,NUP43,nuclear pore complex assembly,cell proliferation,protein transport,tumorigenesis,overexpression,signaling pathway modulation
ENSG00000104626,ERI1,eri1-trna interaction,dna damage response regulation,cell cycle progression modulation,tumor suppressor function alteration,genomic instability promotion,antitumor therapy target
ENSG00000177548,RABEP2,tumor progression,endosomal trafficking dysregulation,autophagy modulation,oncogenic protein regulation,cellular metabolism alteration,protein-protein interaction
ENSG00000152464,RPP38,ribosomal regulation,cellular proliferation,oncogene overexpression,rna processing,protein-protein interaction,tumor progression
ENSG00000089163,SIRT4,energy metabolism reprogramming,tumor growth and survival,oncometabolite,mitochondrial function regulation,glutamine synthesis promotion,cellular adaptation to hypoxia
ENSG00000077044,DGKD,cellular growth regulation,pi metabolism regulation,phosphatidic acid production,apoptosis regulation,cell signaling pathway interaction,tumor progression promotion
ENSG00000174871,CNIH2,**
calcium signaling pathway,aberrant cellular proliferation,channel regulation,tumor progression,intracellular calcium regulation,genomic instability
**
ENSG00000203880,PCMTD2,protein methylation,post-translational modification,oncogene activation,cell proliferation,apoptosis inhibition,tumor aggressiveness
ENSG00000165879,FRAT1,wnt/β-catenin signaling,dysregulation of cell growth,tumor aggressiveness,poor prognosis,overexpression mutations,cell proliferation modulation
ENSG00000188283,ZNF383,transcriptional regulator,cell proliferation enhancement,apoptosis inhibition,pi3k/akt pathway interaction,oncogenic process involvement,tumor suppressor dysfunction
ENSG00000135373,EHF,pi3k/akt pathway interaction,transcriptional regulation,oncogenic activity,cell proliferation enhancement,apoptosis suppression,tumor progression association
ENSG00000104835,SARS2,**
viral replication,rna transcription,host-virus interaction,cellular regulation,stress response modulation,indirect oncogenic influence
**
ENSG00000157911,PEX10,peroxisome biogenesis,protein importation,reactive oxygen species regulation,cellular signaling pathway alteration,cancer progression and therapy resistance,peroxisomal function disruption
ENSG00000105464,GRIN2D,nmda receptor function,overexpression in cancer,cell proliferation promotion,apoptosis induction,tumor progression contribution,ion channel regulation
ENSG00000255072,PIGY,biotin-dependent carboxylases,metabolic regulation,oncogenic processes,tumor progression,prognostic marker,enzyme activation
ENSG00000164023,SGMS2,cell proliferation,oncogenesis,apoptosis inhibition,tumor progression,therapeutic target,sphingolipid metabolism
ENSG00000249158,PCDHA11,cell adhesion disruption,gene expression alterations,prognostic marker potential,tumor progression promotion,signaling pathway interaction,cancer cell invasion modulation
ENSG00000116748,AMPD1,metabolic reprogramming,energy metabolism dysregulation,tumor growth promotion,glycolysis enhancement,anabolic processes support,tumor suppressor function
ENSG00000133805,AMPD3,energy metabolism regulation,tumor progression promoter,cell growth enhancer,adenine nucleotide metabolism,oncogenic process contributor,metabolic enzyme dysregulation
ENSG00000240344,PPIL3,cell cycle regulation,protein homeostasis modulation,oncogenic chaperone function,cdk4 interaction stabilization,proliferation enhancement,tumor adaptation facilitation
ENSG00000124839,RAB17,cellular trafficking,microtubule dynamics,cytoskeletal reorganization,oncogenic potential,metastasis promotion,prognostic biomarker
,KIAA1324,cell proliferation,tumor progression,genomic instability,microtubule regulation,akt activation,biomarker potential
ENSG00000197763,TXNRD3,oncogenic function,thioredoxin reductase activity,cell survival promotion,apoptosis inhibition,pi3k/akt pathway interaction,transcription factor regulation
ENSG00000157103,SLC6A1,sodium-dependent transport,cellular reuptake regulation,tumor growth promotion,constitutive activation of signaling pathways,oncogene potential,genomic profiling
ENSG00000156467,UQCRB,mitochondrial electron transport chain,apoptosis regulation,tumor suppressor function,metabolic reprogramming,cellular respiration regulation,oxidative stress modulation
ENSG00000148123,PLPPR1,regulation of ion transport,tumor progression marker,cell membrane integrity,downregulated expression,pi3k/akt pathway modulation,interaction with pten/akt pathway
ENSG00000257017,HP,hnf1a-dependent transcriptional activity,constitutive activation,gain of function mutations,tumor progression,therapeutic target,none
ENSG00000072571,HMMR,tumor progression,epithelial-to-mesenchymal transition (emt),metastasis,angiogenesis,cell migration,invasion
ENSG00000275499,ZNF280A,tumor suppressor,transcriptional regulation,cellular proliferation inhibition,apoptosis induction,gene expression dysregulation,prognostic marker
ENSG00000132481,TRIM47,nf-κb pathway modulation,tumor growth suppression,cancer cell interaction,protein degradation regulation,cell cycle regulation,immune response modulation
ENSG00000105664,COMP,overexpression,tumor progression,cell-cell interaction,extracellular matrix regulation,poor prognosis marker,metastasis promotion
ENSG00000151388,ADAMTS12,proteoglycan regulation,tumor suppression,angiogenesis inhibition,cell proliferation control,pi3k/akt pathway interaction,biomarker and therapeutic target potential
ENSG00000263247,PRR4,cellular regulation,innate immunity activation,tumor progression,apoptosis inhibition,autophagy modulation,genomic upregulation
ENSG00000196535,MYO18A,cell migration,constitutive activation,epithelial-to-mesenchymal transition,genomic amplification,protein interaction,tumor progression
ENSG00000103375,AQP8,oncogenic pathway interaction,cell proliferation regulation,water transport facilitation,tumor progression facilitation,protein-protein interaction,genomic overexpression
ENSG00000183914,DNAH2,cancer testis antigen,enhanced cell proliferation,disrupted ciliary function,oncogenic mutation,aberrant signaling pathway,cell cycle regulation
ENSG00000267534,S1PR2,overexpression,oncogene,constitutive activation,cell proliferation,tumor progression,pi3k/akt pathway interaction
ENSG00000164120,HPGD,angiogenesis promotion,apoptosis inhibition,cancer progression facilitation,fatty acid metabolism dysregulation,prostaglandin accumulation,tumor microenvironment modulation
ENSG00000011258,MBTD1,dna repair deficiency,genomic instability,cell cycle regulation,chromatin remodeling,apoptosis induction,tumor suppressor function
ENSG00000130827,PLXNA3,plexin/semaphorin signaling pathway,oncogenic properties,cell migration and invasion,tumor progression,overexpression in cancer cells,adhesion and cell junction regulation
ENSG00000189079,ARID2,chromatin remodeling,tumor suppressor function,dna repair regulation,cell cycle checkpoint control,epithelial-to-mesenchymal transition inhibition,metabolic pathway regulation
ENSG00000274429,DLG5,cellular polarity regulation,adherens junction disruption,wnt/β-catenin signaling modulation,tumor invasion promotion,cell-cell adhesion suppression,oncogenic protein overexpression
ENSG00000109689,STIM2,store-operated calcium entry,regulation of calcium homeostasis,cell survival modulation,tumor progression,therapeutic target,biomarker
ENSG00000100350,FOXRED2,mitochondrial complex i assembly,respiratory chain dysfunction,energy metabolism regulation,tumor cell proliferation,cellular respiration regulation,mitochondrial disorders association
ENSG00000103199,ZNF500,transcriptional regulation,chromatin remodeling,oncogenic function,tumor progression,cell cycle regulation,apoptosis evasion
ENSG00000074410,CA12,ph regulation,tumor aggressiveness,cancer progression marker,prognostic significance,tumor microenvironment modulation,cell migration and invasion
,YARS,genomic instability,aminoacyl-trna synthetase function,protein synthesis regulation,cell proliferation,therapeutic target,tumor suppression
ENSG00000175003,SLC22A1,transporter activity,drug resistance,cellular uptake,multidrug efflux,tumor progression,therapeutic target
ENSG00000163586,FABP1,**
lipid metabolism regulation,fatty acid transport,cell proliferation promotion,survival pathway activation,biomarker identification,apoptosis regulation 
**
ENSG00000278195,SSTR3,cellular regulation,g-protein coupled receptor,tumor progression,cell survival pathways,therapeutic target,downstream signaling
ENSG00000111666,CHPT1,metabolic regulation,cellular membrane biosynthesis,oncogenic processes,therapeutic target,genomic upregulation,lipid metabolism dysregulation
ENSG00000062650,WAPL,cohesin complex regulation,chromatin dynamics disruption,genomic instability,tumor progression,cell growth modulation,sister chromatid separation
ENSG00000114670,NEK11,centrosome separation,genomic instability,cell cycle regulation,spindle checkpoint dysfunction,dna repair disruption,therapeutic target
ENSG00000125482,TTF1,tumor suppressor function loss,thyroid transcription factor,transcriptional regulation,cell differentiation disruption,prognostic marker,molecular subtype classification
ENSG00000176422,SPRYD4,rtk regulation,tumor suppressor function,cell growth inhibition,cancer-associated mutations,protein-protein interaction,signaling pathway modulation
ENSG00000117594,HSD11B1,glucocorticoid regulation,oncogenic transformation,angiogenesis promotion,epithelial-to-mesenchymal transition,tumor microenvironment modulation,poor prognosis marker
ENSG00000214367,HAUS3,genomic instability,mitotic spindle regulation,cell cycle progression,centrosome duplication,aneuploidy,protein-protein interaction
ENSG00000111335,OAS2,oncogenic regulation,immune evasion,apoptosis induction,interferon-gamma signaling pathway,tumor suppressor function,autophagy regulation
ENSG00000197472,ZNF695,transcriptional regulation,zinc finger protein,cellular proliferation,tumor progression,genomic instability,apoptosis regulation
ENSG00000102893,PHKB,dna repair mechanism,genomic instability,cell migration and invasion,oncogenic effects,tumor progression,protein-protein interaction
ENSG00000149499,EML3,chromatin remodeling,tumor suppressor function,cell cycle regulation,transcriptional regulation,cancer driver gene candidate,genomic instability
ENSG00000134013,LOXL2,extracellular matrix remodeling,lysyl oxidase activity,reactive oxygen species generation,cell invasion promotion,metastatic potential enhancement,therapeutic target identification
ENSG00000175130,MARCKSL1,cellular migration,cell invasion,cytoskeletal reorganization,membrane trafficking regulation,oncogenic signaling pathway,metastatic progression
ENSG00000188295,ZNF669,transcriptional regulation,promotes cell proliferation,overexpressed in tumor tissues,involved in cellular invasion,regulates gene expression,chromatin remodeling complex interaction
ENSG00000054219,LY75,pi3k/akt signaling pathway regulation,oncogene overexpression,cell proliferation regulation,tumor interaction,prognostic marker potential,cell cycle progression control
ENSG00000135899,SP110,nf-κb pathway,transcriptional regulation,tumor suppressor function,immune response modulation,interferon signaling,oncogenic gene repression
ENSG00000076043,REXO2,genomic instability,oncogenic process,dna damage response,tumor progression,therapeutic target,genomic profiling
ENSG00000170166,HOXD4,transcription factor activation,overexpression,cell proliferation regulation,tumor progression driver,signaling pathway interaction,embryonic development gene expression
ENSG00000084070,SMAP2,genomic instability,dna repair modulation,transcriptional regulation,chromatin remodeling,nuclear protein function,tumor aggressiveness
ENSG00000129911,KLF16,loss of tumor suppressor function,tumor progression inhibition,cell cycle regulation,apoptosis induction,dna repair modulation,mtor pathway suppression
ENSG00000157827,FMNL2,actin polymerization,cell migration,cancer progression,therapeutic target,rho gtpase interaction,protein kinase regulation
ENSG00000130055,GDPD2,gdp-dimethylglycine peroxidase activity,intracellular redox balance,cell growth regulation,ros production modulation,dna repair pathway,cell cycle progression
ENSG00000131368,MRPS25,mitochondrial biogenesis,overexpression,oncogene function,tumor growth,proliferation enhancement,cell survival mechanism
ENSG00000173786,CNP,calcium regulation,cell proliferation,tumor progression,poor prognosis marker,signaling pathway modulation,protein-protein interaction
ENSG00000179958,DCTPP1,genomic instability,epigenetic alterations,cell survival,dna damage repair,tumor suppressor function,gain-of-function mutation
ENSG00000172426,RSPH9,centrosome disruption,microtubule dysregulation,ciliogenesis alterations,oncogenic driver,cell proliferation dysregulation,therapeutic target
ENSG00000085491,SLC25A24,mitochondrial transport,mtor activation,cell proliferation,aspartate regulation,metabolic adaptation,tumor progression
ENSG00000115526,CHST10,chondroitin sulfate biosynthesis,epithelial-to-mesenchymal transition (emt),cell signaling,metastasis,tumor microenvironment,glycosaminoglycan modifications
ENSG00000197863,ZNF790,transcriptional regulation,tumor suppressor,downregulation,mutation,cell growth,gene expression
ENSG00000136842,TMOD1,microtubule polymerization,tumor growth,metastasis promotion,cell migration enhancement,cytoplasmic dynein interaction,chromatin remodeling
ENSG00000174373,RALGAPA1,ras/mapk pathway,tumor progression,cell proliferation,regulatory function mutations,growth factor regulation,signaling cascade
ENSG00000108001,EBF3,tumor progression,transcription factor regulation,cell cycle progression inhibition,apoptosis suppression,emt process promotion,oncogenic transcription factor
ENSG00000119927,GPAM,glycerophospholipid biosynthesis,lysophosphatidic acid regulation,oncogene activity,pi3k/akt/mtor pathway interaction,lipid metabolism modulation,biomarker expression
ENSG00000188215,DCUN1D3,ubiquitination pathway,e3 ligase activity,protein degradation regulation,oncoprotein accumulation,tumor aggressiveness,aggressive tumor behavior
ENSG00000163666,HESX1,transcriptional regulation,cell fate decisions,embryonic development,tissue patterning,epithelial-to-mesenchymal transition (emt),tumor metastasis
ENSG00000137574,TGS1,trna charging,nucleotide biosynthesis,genomic instability,oncogenic processes,aminoacylation dysfunction,dna repair modulation
ENSG00000115419,GLS,mitochondrial function,glutamine dependency,anabolic glucose metabolism,krebs cycle regulation,tumor growth promotion,metabolic reprogramming
ENSG00000115461,IGFBP5,igf signaling pathway regulation,tumor suppressor function,biomarker potential,cellular proliferation regulation,molecular interaction modulation,tissue growth inhibition
ENSG00000166863,TAC3,neuropeptide regulation,cancer progression,signaling pathway activation,cell proliferation,metastasis promotion,angiogenesis facilitation
ENSG00000171603,CLSTN1,cell adhesion regulation,metastasis progression,epithelial-to-mesenchymal transition,biomarker potential,tumor invasion,protein-protein interaction
ENSG00000123364,HOXC13,cellular differentiation,transcriptional regulation,tumor promotion,apoptosis evasion,cell cycle progression,prognostic marker
ENSG00000137845,ADAM10,pro-tumorigenic factor release,growth factor processing,tumor progression,metalloproteinase activity,cell surface proteolysis,signaling pathway modulation
ENSG00000170043,TRAPPC1,endoplasmic reticulum-golgi apparatus transport,cellular homeostasis regulation,protein processing alteration,tumor progression contribution,antigen presentation modulation,genetic alterations
ENSG00000165322,ARHGAP12,regulation of rho gtpases,pi3k/akt/mtor pathway activation,oncogenic signaling,gain-of-function mutations,cell migration and invasion,therapeutic target
ENSG00000132825,PPP1R3D,insulin signaling pathway disruption,pp1 regulation,aberrant expression,glucose metabolism alteration,tumor growth promotion,oncogenic substrate activation
ENSG00000184117,NIPSNAP1,rho gtpase activation,cytoskeletal regulation,metastasis promotion,cell migration enhancement,tumor invasion facilitation,biomarker for cancer diagnosis
ENSG00000179934,CCR8,tumor microenvironment modulation,immune evasion mechanism,cancer stem cell maintenance,epithelial-to-mesenchymal transition,signaling pathway interaction,immunosuppressive environment creation
ENSG00000133055,MYBPH,tumor progression,cell migration,invasion pathway,oncogenic function,pi3k/akt pathway interaction,rock1 binding protein
ENSG00000073060,SCARB1,lipid trafficking,scavenger receptor function,cellular energy production,tumor progression,constitutive activation,signaling pathway interaction
ENSG00000172322,CLEC12A,tumor progression,angiogenesis promotion,myeloid cell regulation,immune evasion,cell adhesion modulation,pi3k/akt pathway interaction
ENSG00000108506,INTS2,chromatin remodeling,transcriptional regulation,oncogenic pathway,cell proliferation,nuclear localization,therapeutic target
ENSG00000132326,PER2,circadian rhythm regulation,tumor suppressor function,cell cycle control disruption,dna damage response,apoptosis regulation,molecular clock component
ENSG00000152527,PLEKHH2,cell cycle regulation,overexpression,mitogenic stimulation,oncogenic potential,unchecked cell growth,cell division
ENSG00000157796,WDR19,chromatin remodeling,genomic instability,constitutive activation,cell cycle disruption,apoptosis evasion,therapeutic target
ENSG00000125841,NRSN2,pi3k/akt signaling pathway,epithelial-to-mesenchymal transition,cell adhesion and invasion,protein-protein interactions,tumor growth and metastasis,overexpression
ENSG00000150471,ADGRL3,cell adhesion disruption,g-protein coupled receptor function,tumor progression,metastasis facilitation,angiogenesis promotion,immune evasion enhancement
ENSG00000204323,SMIM5,dna replication,cellular proliferation,oncogene activation,tumor progression,genomic instability,epigenetic regulation
ENSG00000170293,CMTM8,cell adhesion modulation,protein-protein interaction,regulatory protein binding,tumor growth promotion,apoptosis suppression,angiogenesis induction
ENSG00000079689,SCGN,calcium-binding protein,cellular secretory process regulation,tumor progression association,prognostic biomarker potential,cancer cell proliferation enhancement,promoter of cell survival and migration
ENSG00000068878,PSME4,proteasome activation,oncogenic signaling,protein stabilization,cell cycle progression,tumor aggressiveness,therapeutic resistance
ENSG00000137273,FOXF2,cell cycle regulation,apoptosis suppression,hypoxia modulation,transcriptional regulation,epigenetic modification,tumor progression
ENSG00000215790,SLC35E2A,glycosylation regulation,cellular metabolism regulation,oncogenic potential,tumor progression,metabolic reprogramming,biomarker for diagnosis
ENSG00000085063,CD59,complement system regulation,immune evasion,cell proliferation,tumor progression,biomarker,glycoprotein function
ENSG00000160808,MYL3,oncogene,cell migration,tumor progression,poor prognosis,therapeutic target,protein-protein interaction
ENSG00000131668,BARX1,tumor suppression,cellular proliferation,transcriptional regulation,wnt/β-catenin pathway,tgf-β pathway,embryonic development
ENSG00000128709,HOXD9,regulation of cell growth,overexpression,association with poor prognosis,tumor-promoting factor,involvement in cancer development,interaction with oncogenes
ENSG00000186642,PDE2A,proliferation,signaling regulation,oncogenic driver,metastasis promotion,chemoresistance,inflammatory response
ENSG00000135624,CCT7,protein folding regulation,chaperone activity enhancement,cellular adaptation,stress response modulation,oncoprotein stabilization,ubiquitin ligase interaction
ENSG00000138613,APH1B,notch signaling,dysregulation,constitutive activation,gain of function mutations,tumor progression,ubiquitination
ENSG00000051009,FAM160A2,constitutive activation,pi3k/akt/mtor pathway,gain of function mutations,tumor progression,therapeutic target,cell membrane trafficking
ENSG00000283068,IBTK,pi3k/akt pathway regulation,cell growth and proliferation,apoptosis modulation,oncogenic potential,tumorigenesis association,cellular signaling pathway regulation
ENSG00000111817,DSE,pi3k/akt pathway regulation,overexpression,cell proliferation enhancement,signaling pathway modulation,tumor progression facilitation,angiogenesis regulation
ENSG00000170006,TMEM154,cellular signaling,oncogene function,metabolic regulation,tumor progression,protein-protein interaction,genomic instability
ENSG00000091542,ALKBH5,tumor suppressor function,dna damage repair,genome stability maintenance,epigenetic regulation,prognostic marker,therapeutic target
ENSG00000035681,NSMAF,chromatin remodeling,epigenetic regulation,genome stability maintenance,tumor suppressor function,dna repair regulation,cell cycle progression control
ENSG00000122824,NUDT10,genomic stability,tumor suppressor,dna repair mechanisms,cell cycle regulation,apoptosis induction,nucleotide metabolism
ENSG00000172171,TEFM,pi3k/akt pathway regulation,oncogenic process promotion,genomic instability contribution,signaling molecule stabilization,cellular proliferation enhancement,tumor growth facilitation
ENSG00000130699,TAF4,transcriptional regulation,tata box recognition,dna binding domain,general transcription factor,rna polymerase ii,oncogenesis
ENSG00000135336,ORC3,cell cycle progression,dna replication initiation,genomic instability,cell proliferation enhancement,tumor aggressiveness increase,replication origin recognition
ENSG00000128536,CDHR3,tumor progression,cell adhesion disruption,epithelial-to-mesenchymal transition (emt) regulation,cell migration facilitation,metastasis promotion,prognostic marker
ENSG00000122783,CYREN,cellular proliferation,tumor suppressor pathway modulation,dna damage response regulation,oncogene activation,genome stability maintenance,protein-protein interactions
ENSG00000177380,PPFIA3,pi3k/akt signaling,cell migration,oncogenic function,metastasis promotion,protein interaction,gene amplification
ENSG00000184014,DENND5A,loss of function mutations,ubiquitin degradation,oncogenic activity,cellular clearance regulation,protein quality control,tumor suppressor protein degradation
ENSG00000108375,RNF43,loss-of-function mutations,wnt/β-catenin signaling pathway,tumor suppressor function,cell proliferation regulation,protein degradation role,oncogenesis driver
ENSG00000120324,PCDHB10,cell-cell adhesion disruption,transmembrane protein interaction,tumor suppressor function loss,mutation association with cancer,gene expression alteration,neurological system development
ENSG00000158786,PLA2G2F,lipid metabolism regulation,phospholipase activity,cell proliferation enhancement,signaling pathway modulation,inflammation promotion,tumor progression association
ENSG00000158747,NBL1,**

nuclear receptor coactivator function,chromatin remodeling,transcriptional activation,aberrant gene expression,oncogenic pathway activation,tumor suppressor gene suppression

**
ENSG00000169181,GSG1L,cell cycle regulation,spindle checkpoint disruption,aneuploidy,chromosome missegregation,cancer cell survival,growth advantage
ENSG00000123095,BHLHE41,tumor suppression,cell cycle regulation,transcriptional regulation,apoptosis inhibition,genetic instability,epigenetic modulation
ENSG00000151229,SLC2A13,altered energy metabolism,cellular glucose transport,dysregulated expression,metabolic reprogramming,prognostic significance,renal cell specificity
ENSG00000123352,SPATS2,tumor progression,oncogene potential,pi3k/akt pathway modulation,cell growth regulation,dna replication involvement,transcriptional regulation
ENSG00000189298,ZKSCAN3,transcriptional regulator,chromatin remodeling,tumor suppressor function,cell cycle regulation,apoptosis modulation,dna damage response
ENSG00000111300,NAA25,protein modification,oncogene potential,cell proliferation,acetyltransferase activity,tumorigenesis regulation,metastasis facilitation
ENSG00000172554,SNTG2,oncogenic signaling,receptor internalization,cancer progression,prognostic marker,sh3 domain interaction,cytoskeleton regulation
ENSG00000151364,KCTD14,**
loss of function mutations,chromosome 1p36 deletion,tumor suppressor gene,apoptosis regulation,cell cycle regulation,protein degradation pathway 
**
ENSG00000020577,SAMD4A,mitochondrial dynamics,apoptosis resistance,cellular stress response,protein-protein interaction,caspase modulation,genomic amplification
ENSG00000135968,GCC2,genomic instability,cell proliferation,dna damage,regulatory protein interaction,tumor progression,metabolic regulation
ENSG00000106565,TMEM176B,calcium signaling pathway,store-operated calcium entry,crac channel activation,cell proliferation regulation,gene expression dysregulation,cancer cell survival
ENSG00000128268,MGAT3,n-glycosylation,cell growth promotion,oncogenic processes,apoptosis evasion,protein-protein interaction modulation,glycosyltransferase function
ENSG00000138092,CENPO,chromosomal stability,genomic instability,cell division regulation,protein overexpression,tumor development,aneuploidy
ENSG00000137266,SLC22A23,transporter activity,cellular membrane transport,renal function regulation,cancer progression,prognostic biomarker,poor prognosis
ENSG00000101198,NKAIN4,cellular metabolism regulation,energy metabolism modulation,tumor promoting effects,hypoxia response regulation,kidney cell specific function,dysregulated expression levels
ENSG00000105699,LSR,mhc class i interaction,tumor progression,cell migration,oncogenic signaling,immune modulation,survival pathway
ENSG00000165416,SUGT1,chromatin remodeling,histone acetylation,oncogenesis,cell proliferation,angiogenesis,transcriptional regulation
ENSG00000157782,CABP1,tumor progression,intracellular trafficking regulation,apoptosis suppression,cell proliferation enhancement,calcium signaling modulation,genomic instability
ENSG00000100442,FKBP3,regulation of t-cell activation,calcineurin inhibition,oncogene function,tumor progression,immune response modulation,steroid hormone regulation
ENSG00000152785,BMP3,tumor suppressor function,epithelial-to-mesenchymal transition,loss-of-function mutations,pi3k/akt pathway regulation,cellular growth inhibition,metastatic suppression
ENSG00000145248,SLC10A4,bile salt transport regulation,cell growth promotion,overexpression implicated,tumor metabolism alteration,apoptosis dysregulation,dna repair impact
ENSG00000144354,CDCA7,genomic instability,chromosomal segregation,apoptosis regulation,proliferation enhancement,cell cycle modulation,dna replication
ENSG00000282854,ASAP3,mtor signaling,proliferation and migration,cellular growth regulation,rho gtpase activation,akt phosphorylation,cytoskeleton organization
ENSG00000221838,AP4M1,protein trafficking regulation,vesicle-mediated transport alteration,cell proliferation enhancement,oncogenic process contribution,metastasis promotion,genomic instability association
ENSG00000012983,MAP4K5,cell proliferation,stress response activation,tumor progression,constitutive activation,genomic instability,dna damage response
ENSG00000023572,GLRX2,glutathione reduction,tumor adaptation,hypoxia response,cancer cell survival,protein regulation,oxidative stress defense
ENSG00000074071,MRPS34,mitochondrial biogenesis,tumor suppressor regulation,apoptosis regulation,cell cycle progression,oligomeric complex formation,protein synthesis regulation
ENSG00000143093,STRIP1,genome instability,cell survival enhancement,chromosomal abnormalities,centriole regulation dysfunction,protein-protein interaction,apoptosis suppression
ENSG00000173517,PEAK1,pi3k/akt/mtor pathway,oncogenic driver,non-receptor tyrosine kinase,enhanced cell proliferation,cell survival pathway,angiogenesis promoter
ENSG00000278284,RDH13,retinoid metabolism,oncogenic potential,cell proliferation,tumor progression,redox regulation,cancer cell survival
ENSG00000181991,MRPS11,mitochondrial ribosomal biogenesis,mitochondrial translation regulation,dysregulation of energy metabolism,cell proliferation enhancement,tumor suppressor function,genomic instability association
ENSG00000078814,MYH7B,chromatin remodeling,dna replication,cell growth regulation,cell cycle progression,protein synthesis enhancement,mtor pathway activation
ENSG00000175309,PHYKPL,phosphoinositide regulation,gene amplification,tumor progression,metastasis,cell proliferation,proliferative signaling
ENSG00000198556,ZNF789,genomic instability,anti-apoptotic,epigenetic regulation,transcriptional activation,cell cycle progression,oncogene upregulation
ENSG00000134253,TRIM45,pi3k/akt pathway regulation,gene expression regulation,tumor suppressor function,cell proliferation inhibition,genomic stability maintenance,ubiquitination and protein degradation
ENSG00000163528,CHCHD4,mitochondrial function,apoptosis regulation,tumor suppression,energy metabolism regulation,oxidative stress mitigation,cell survival pathway
ENSG00000187733,AMY1C,apoptosis regulation,gene expression modulation,tumor progression,therapeutic target,cellular homeostasis,genomic stability
ENSG00000237763,AMY1A,angiogenesis promotion,apoptosis inhibition,calcium homeostasis regulation,iron metabolism regulation,metastasis facilitation,tumor growth promotion
ENSG00000174876,AMY1B,metabolic adaptation,glycolytic shift,tumor microenvironment,carbohydrate digestion,protein expression,genetic variation
ENSG00000198774,RASSF9,tumor suppressor,pi3k/akt pathway regulation,cell cycle modulation,apoptosis promotion,cancer cell proliferation inhibition,microtubule stability regulation
ENSG00000278091,ZNF85,dna binding,transcriptional regulation,oncogenic interaction,cell growth regulation,tumor progression,cancer biomarker
ENSG00000187957,DNER,emt regulation,cell adhesion molecule,notch signaling pathway,immune checkpoint target,tumor progression,transmembrane protein
ENSG00000143458,GABPB2,tumor progression,transcriptional regulation,apoptosis resistance,dna repair mechanisms,cellular proliferation,oncogenic signaling
ENSG00000175416,CLTB,cell membrane trafficking,dysregulated receptor signaling,metastasis,protein recycling,tumor growth regulation,endocytosis
ENSG00000168807,SNTB2,wnt/beta-catenin pathway modulation,signaling pathway regulation,cell proliferation promotion,apoptosis inhibition,oncogenic transformation facilitation,tumor progression enhancement
ENSG00000142687,KIAA0319L,centriole duplication,genomic instability,cell polarity regulation,ciliogenesis dysregulation,protein-protein interaction,tumor suppressor function
ENSG00000101019,UQCC1,protein degradation regulation,cell cycle regulation,oncogene activation,apoptosis evasion,tumor progression marker,therapeutic target candidate
ENSG00000177551,NHLH2,transcriptional regulation,cell cycle progression,apoptosis inhibition,angiogenesis regulation,oncogenic potential,tumor suppressor function
ENSG00000175548,ALG10B,**

oncogenic driver,cell proliferation,signaling pathway modulation,glycosylation pathway dysregulation,tumor progression,mutation hotspot
ENSG00000112319,EYA4,transcriptional regulation,oncogenic processes,pi3k/akt signaling,cell proliferation,epithelial-to-mesenchymal transition (emt),angiogenesis
ENSG00000142330,CAPN10,calcium-dependent proteolysis,cell signaling regulation,oncogenic potential,tumor progression facilitation,protein degradation modulation,apoptosis suppression
ENSG00000265354,TIMM23,mitochondrial regulation,tumor progression,cell survival,metabolic adaptation,apoptosis resistance,oncogene activation
ENSG00000165238,WNK2,tumor suppression,ion channel regulation,cellular proliferation,apoptosis regulation,metabolic reprogramming,genomic loss
ENSG00000183715,OPCML,tumor suppressor activity,reduced expression,regulation of wnt/β-catenin pathway,cell growth inhibition,apoptosis induction,protein-protein interaction
ENSG00000243156,MICAL3,actin depolymerization,cancer cell migration,cellular stress responses,cytoplasmic remodeling,er stress regulation,protein degradation pathways
ENSG00000050393,MCUR1,mitochondrial dynamics,protein folding regulation,lipid transfer function,cellular membrane integrity,tumor cell growth regulation,anti-apoptotic properties
ENSG00000076356,PLXNA2,cell migration,tumor progression,angiogenesis,signaling pathway regulation,genomic instability,aberrant expression
ENSG00000179604,CDC42EP4,rho gtpase activation,cell migration and invasion,guine nucleotide exchange factor activity,tumor metastasis,oncogenic protein interactions,cell morphology regulation
ENSG00000275003,DDT,**
mapk signaling regulation,cell cycle dysregulation,cytoplasmic localization,phosphatase activity modulation,genomic instability,therapeutic target 
**
ENSG00000118526,TCF21,chromatin remodeling,prognostic biomarker,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,transcription factor function,genome stability maintenance
ENSG00000136718,IMP4,phosphoinositide regulation,cellular proliferation,signal transduction,cancer driver gene,tumor growth,pi3k/akt pathway interaction
ENSG00000122741,DCAF10,ubiquitin ligase function,cell cycle regulation,genomic stability maintenance,substrate targeting,cell proliferation promotion,metastatic potential modulation
ENSG00000184992,BRI3BP,er stress modulation,protein-protein interactions,regulation of upr signaling,cellular homeostasis regulation,therapeutic target,genomic instability
ENSG00000171227,TMEM37,genomic instability,cell cycle regulation,dna repair,transmembrane protein function,nuclear membrane localization,mitotic checkpoint control
ENSG00000243056,EIF4EBP3,tumor suppressor function,mtorc1 pathway inhibition,cell growth regulation,apoptosis promotion,dna damage response,protein kinase activation
ENSG00000288324,ADGRL1,cell adhesion,rho gtpase regulation,tumor progression,cell migration,metastasis,adhesion molecule
ENSG00000115361,ACADL,fatty acid metabolism,tumor progression,cell survival,energetic reprogramming,lipid accumulation,genomic instability
ENSG00000141577,CEP131,centrosome integrity disruption,genomic instability,chromosomal missegregation,oncogenic protein,microtubule dynamics regulation,tumor progression promotion
ENSG00000021574,SPAST,microtubule dynamics,mitosis regulation,gain-of-function mutations,cytoskeleton organization,tumor aggressiveness,genetic instability
ENSG00000233801,NELFE,mrna degradation,cell proliferation regulation,nuclear export regulation,tumor metastasis promotion,elongin c interaction,tumor heterogeneity facilitation
ENSG00000116791,CRYZ,crystallin regulation,genomic instability,apoptosis resistance,cell proliferation,protein folding,stress response
ENSG00000076067,RBMS2,splicing regulation,rna-binding motif family,cell cycle modulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation
ENSG00000116990,MYCL,aberrant transcriptional regulator,cell proliferation enhancer,tumor progression promoter,genomic instability inducer,apoptosis suppressor,therapeutic target
ENSG00000171747,LGALS4,**
epithelial cell marker,glycoprotein binding,tumor microenvironment modulation,cell proliferation promotion,immune response regulation,transcription factor activation
**
ENSG00000118972,FGF23,overexpression,tumor progression,pi3k/akt signaling,receptor tyrosine kinase activation,poor prognosis,biomarker potential
ENSG00000169860,P2RY1,cell migration,adhesion modulation,purinergic signaling activation,prognostic biomarker,tumor progression promotion,therapeutic target
ENSG00000181830,SLC35C1,glycosylation regulation,tumor progression,oncogenic driver,aberrant protein modification,pi3k/akt pathway interaction,poor prognosis marker
ENSG00000103642,LACTB,mitochondrial dynamics,regulatory protein function,tumor progression,mitochondrial function,oncogenic processes,cancer metabolism
ENSG00000182916,TCEAL7,epithelial-to-mesenchymal transition,overexpression,oncogene function,apoptosis regulation,cell cycle modulation,tumor progression
ENSG00000135222,CSN2,e3 ubiquitin ligase regulation,cop9 signalosome complex,cell cycle progression,transcriptional regulation,dna repair,ubiquitination process disruption
ENSG00000185697,MYBL1,constitutive activation,cell cycle regulation,transcription factor activity,oncogenic potential,tumor aggressiveness,therapeutic target
ENSG00000152592,DMP1,oncogenic function,tumor progression,bone metastasis,biomarker,cell proliferation,mineral regulation
ENSG00000196110,ZNF699,transcriptional regulation,overexpression,cell migration,invasion,epithelial-to-mesenchymal transition (emt),oncogene activity
ENSG00000174938,SEZ6L2,pi3k/akt pathway interaction,calcium signaling regulation,epithelial-to-mesenchymal transition involvement,tumor growth promotion,overexpression association,poor prognosis marker
ENSG00000135114,OASL,oncogene,tumor progression,immune evasion,apoptosis regulation,cell cycle disruption,protein synthesis modulation
ENSG00000135298,ADGRB3,agpcr family,wnt/β-catenin pathway,tumor progression,cell-cell interactions,pi3k/akt/mtor signaling,prognostic marker
ENSG00000262473,GART,purine biosynthesis,cell proliferation,nucleotide synthesis,oncogenesis,prognostic biomarker,purine metabolism pathway
ENSG00000258992,TSPY1,**

genomic instability,oncogene,cell proliferation,angiogenesis,chromosomal alterations,pi3k/akt pathway interaction
ENSG00000108523,RNF167,cell cycle regulation,transcriptional control,tumor suppressor degradation,oncogenic signaling pathway,protein stability regulation,ubiquitination-mediated degradation
ENSG00000188910,GJB3,altered cell-to-cell interaction,downregulated expression,gap junction disruption,cellular communication regulation,tissue integrity maintenance,oncogenic process promotion
ENSG00000284501,MGAT4B,glycosyltransferase activity,glycan biosynthesis,tumor progression,oncogenic marker expression,immunomodulation,cell surface receptor modification
ENSG00000119977,TCTN3,wnt signaling pathway,aberrant activation,protein-protein interaction,cell proliferation regulation,apoptosis inhibition,tumor progression promotion
ENSG00000164258,NDUFS4,mitochondrial function,cellular respiration,energy metabolism,tumor growth,metabolic reprogramming,oxygen sensing
ENSG00000153904,DDAH1,nitric oxide regulation,dysregulated expression,angiogenesis promotion,tumor growth facilitation,adma hydrolysis inhibition,nitric oxide synthase inhibition
,LRMP,tumor suppressor function,regulatory mechanism disruption,cellular regulation alteration,protein-protein interaction impairment,leucine-rich repeat involvement,e3 ubiquitin ligase complex interaction
ENSG00000174013,FBXO45,cell cycle regulation,protein degradation,tumor promotion,cancer progression,e3 ubiquitin ligase activity,phosphorylation-dependent protein binding
ENSG00000159346,ADIPOR1,glucose metabolism,tumor progression,oncogenic potential,immune evasion,cell proliferation inhibition,apoptosis regulation
ENSG00000138430,OLA1,genomic instability,cell cycle regulation,tumor suppressor function,dna damage response,transcriptional activation,proliferation regulation
ENSG00000134375,TIMM17A,mitochondrial function,prognostic marker,oxidative stress regulation,cancer metabolism,cellular energy management,reactive oxygen species modulation
ENSG00000151498,ACAD8,mitochondrial metabolism,enhanced oxidative phosphorylation,altered fatty acid metabolism,increased cell proliferation,tumor metabolic reprogramming,metabolic enzyme interaction
ENSG00000183691,NOG,bmp signaling inhibition,tumor suppression,cell differentiation regulation,angiogenesis promotion,metastasis facilitation,cell proliferation regulation
ENSG00000168454,TXNDC2,redox regulation,disulfide bond formation,thioredoxin activity,tumor suppressor function,apoptosis regulation,metabolic reprogramming
ENSG00000186318,BACE1,cell survival,proteolytic activity,apoptosis resistance,tumor progression,genomic overexpression,signaling pathway modulation
ENSG00000204967,PCDHA4,tumor progression,cellular adhesion,pi3k/akt interaction,metastasis promotion,synaptic plasticity disruption,protein-protein interaction
ENSG00000105428,ZNRF4,wnt/β-catenin signaling pathway,tumor suppressor activity,ubiquitination and degradation,cellular homeostasis regulation,protein-protein interactions,oncogenic process modulation
ENSG00000188393,CLEC2A,tumor progression,tumor microenvironment modulation,immune response regulation,cancer cell adhesion,cell migration and survival pathway alteration,overexpression
ENSG00000130385,BMP15,oncogene function,cell proliferation enhancement,angiogenesis promotion,epithelial-to-mesenchymal transition,prognostic marker candidate,tumor growth promoter
ENSG00000162599,NFIA,emt regulation,hypoxia response,cellular proliferation,angiogenesis regulation,tumor progression,metastasis promotion
ENSG00000165269,AQP7,fatty acid transport,apoptosis inhibition,lipid metabolism dysregulation,tumor progression association,cellular behavior modulation,water channel function
ENSG00000262217,SLC5A8,lactate production,sodium-coupled transport,cell migration,energy metabolism,cell proliferation,warburg effect
ENSG00000198822,GRM3,constitutive activation,pi3k/akt/mtor pathway,tumor progression,cell proliferation,metastasis,protein interaction
ENSG00000135116,HRK,apoptosis regulation,tumor suppression,programmed cell death,mitochondrial membrane permeabilization,caspase activation,genomic stability maintenance
ENSG00000142552,RCN3,microtubule regulation,cell cycle progression,genomic stability,chromosome segregation,aneuploidy,therapeutic target
ENSG00000278728,CNTNAP2,overexpressed in several types of cancer,promoting epithelial-to-mesenchymal transition (emt),involved in tumor progression,interacting with notch signaling pathway,cellular adhesion and synaptic function,tumor suppressor/ oncogene ambiguity
ENSG00000176230,OR4K17,cell surface localization,olfactory receptor function,tumor progression marker,poor prognosis association,cellular proliferation influence,signaling pathway modulation
ENSG00000197415,VEPH1,veph1 overexpression,cellular proliferation regulation,tumor progression association,prognostic biomarker potential,signaling pathway interaction,genomic dysregulation
ENSG00000108599,AKAP10,pka anchoring,cell survival pathway,tumor progression,apoptosis resistance,cytoskeletal organization,cell cycle regulation
ENSG00000125510,OPRL1,opioid receptor activation,pi3k/akt pathway,cell proliferation,tumor progression,prognostic marker,g protein-coupled receptor
ENSG00000100014,SPECC1L,metastasis promotion,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,tumor progression driver,pro-survival signaling,metastatic potential enhancement
ENSG00000161914,ZNF653,tumor suppressor,genetic silencing,cell cycle regulation,pi3k/akt pathway modulation,apoptosis induction,prognostic biomarker
ENSG00000112759,SLC29A1,nucleoside transport,adenosine signaling,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,angiogenesis activation
ENSG00000151617,EDNRA,endothelin signaling,tumor progression,angiogenesis promotion,cellular proliferation,g-protein coupled receptor activation,vascular remodeling
ENSG00000141179,PCTP,cell proliferation,protein transport,lipid metabolism,tumor progression,metastasis,chemotherapy resistance
ENSG00000072195,SPEG,cell proliferation,oncogenesis,cell migration,tumor progression,protein kinase activation,signaling pathway regulation
ENSG00000099994,SUSD2,tumor suppressor function,reduced expression,cell-cell adhesion disruption,immune evasion facilitation,pi3k/akt pathway activation,biomarker potential
ENSG00000130829,DUSP9,mapk signaling,dephosphorylation of kinases,cell growth regulation,therapeutic target,oncogene activation,protein phosphatase activity
ENSG00000123472,ATPAF1,transcriptional regulation,chromatin remodeling,oncogene function,cell proliferation enhancement,dna repair mechanism,rna processing regulation
ENSG00000198093,ZNF649,transcriptional regulation,promotes oncogenesis,overexpression associated,cell cycle progression,apoptosis suppression,chromatin remodeling
ENSG00000145687,SSBP2,genomic instability,cell proliferation,oncogenic process,tumorigenesis,dna replication,potential biomarker
ENSG00000167851,CD300A,immune regulation,dysregulated expression,tumor progression,anti-tumor immunity,pd-l1 modulation,cell signaling
ENSG00000148604,RGR,pi3k/akt pathway,tumor progression,growth regulation,mutation impact,proliferation regulation,apoptosis modulation
ENSG00000125384,PTGER2,ptger2 signaling,constitutive activation,g protein-coupled receptor function,tumor progression,cell survival,pge2 response
ENSG00000224051,CPTP,proteolytic activity,signaling pathway modulation,cell invasion facilitation,oncogene overexpression,constitutive pathway activation,tumor progression promotion
ENSG00000111674,ENO2,warburg effect,oncogene,glycolytic switch,tumor progression,multifunctional enzyme,aggressive tumor behavior
ENSG00000163795,ZNF513,tumor promoter,cell proliferation activation,pi3k/akt signaling activation,oncogenic function,gene expression regulation,prognostic biomarker
ENSG00000137345,MOG,cell adhesion disruption,cell migration dysregulation,cell proliferation alteration,cell surface protein interaction,protein expression modulation,tumor progression influence
ENSG00000223802,CERS1,enhanced ceramide levels,apoptosis resistance,cell cycle regulation,signaling pathway modulation,tumor progression,sphingolipid metabolism
ENSG00000169062,UPF3A,nmd pathway,dna repair regulation,genomic integrity maintenance,tumor suppressor function,oncogenic mutation,pi3k/akt signaling interaction
ENSG00000124155,PIGT,gpi-anchor biosynthesis,overexpression in cancer,cellular proliferation,therapeutic target,tumor progression,cell migration
ENSG00000171530,TBCA,tumor progression,constitutive activation,oncogenic signaling,cell cycle regulation,protein-protein interaction,therapeutic target
ENSG00000135677,GNS,autophagy promotion,cellular stress response regulation,glycoprotein degradation enzyme function,oncogene potential,tumor suppressor interaction disruption,genomic instability contribution
ENSG00000117614,SYF2,translation regulation,oncogenic translation,cell proliferation,tumor progression,tumor suppressor/tumor promoter dual role,gene overexpression
ENSG00000163106,HPGDS,tumor suppressor,angiogenesis regulation,cell growth modulation,apoptosis induction,immune response modulation,prostaglandin metabolism
ENSG00000085719,CPNE3,cellular calcium signaling,microtubule regulation,tumor aggressiveness,biomarker identification,protein-protein interactions,cancer metastasis
ENSG00000081248,CACNA1S,cellular proliferation,calcium influx regulation,voltage-gated calcium channels,tumorigenesis promotion,poor prognosis correlation,signal transduction pathway modulation
ENSG00000176463,SLCO3A1,bile salt transport regulation,cell cycle progression,apoptosis resistance,genomic instability,tumor aggressiveness,chemotherapy resistance
ENSG00000119203,CPSF3,rna processing regulation,tumor suppressor function,genomic instability,mutation hotspot,protein-protein interaction,transcriptional regulation
ENSG00000183166,CALN1,cell proliferation,mtor pathway activation,calcium-mediated signaling,tumor progression,protein-protein interactions,cancer cell survival
ENSG00000133020,MYH8,overexpression,tumor progression,cell migration,pi3k/akt pathway interaction,therapeutic target,cytoplasmic localization
ENSG00000165060,FXN,mitochondrial dysfunction,oncogenic overexpression,epigenetic regulation,cell cycle dysregulation,tumor progression,chemotherapy resistance
ENSG00000180543,TSPYL5,tumor suppressor function,reduced expression levels,cell cycle regulation,chromatin remodeling,histone deacetylase interaction,genetic instability
ENSG00000154144,TBRG1,cell proliferation,transcriptional regulation,metabolic reprogramming,wnt/β-catenin pathway activation,pi3k/akt signaling enhancement,tumor progression driver gene
ENSG00000138083,SIX3,transcriptional regulation,cell proliferation,oncogenic activity,epigenetic modification,tumor suppressor function,embryonic development
ENSG00000075151,EIF4G3,cap-dependent translation,aberrant subcellular localization,increased protein synthesis,tumor aggressiveness,proliferation enhancement,cell survival regulation
ENSG00000135537,AFG1L,mitochondrial dynamics,regulatory mechanism of uprmt,constitutive activation of oncogenic processes,gene expression regulation,promotion of cell survival,interaction with chop/atf4
ENSG00000152578,GRIA4,ion channel regulation,glutamatergic signaling pathway,cell proliferation promotion,ionotropic neurotransmission,cell survival enhancement,neurotransmitter receptor interaction
ENSG00000047230,CTPS2,dna synthesis,nucleotide pool regulation,cell proliferation,apoptosis resistance,pi3k/akt pathway interaction,tumor suppressor dysfunction
ENSG00000104613,INTS10,genomic instability,transcriptional dysregulation,chromatin remodeling,cell cycle regulation,tumor suppressor function,cancer driver mutation
ENSG00000198203,SULT1C2,hormone regulation,tumor progression,therapeutic target,signal transduction,transcriptional control,epigenetic modification
ENSG00000181192,DHTKD1,mitochondrial function,bcaa hydroxylation,cellular energy metabolism,oxidative stress regulation,tumor progression,therapeutic target
ENSG00000141519,CCDC40,aneuploidy,tetraploidization,microtubule dynamics,centrosome dysfunction,genomic instability,oncogene activation
ENSG00000173068,BNC2,chromatin remodeling,genomic instability,tumorigenesis,transcriptional regulation,cell proliferation,somatic mutation
ENSG00000169976,SF3B5,alternative splicing regulation,tumor suppressor function,rna processing dysregulation,cancer progression driver,genetic instability contribution,spliceosome complex subunit
ENSG00000166295,ANAPC16,cell cycle regulation,chromosomal instability,gene expression dysregulation,cancer susceptibility,tumor suppressor dysfunction,s-phase progression alteration
ENSG00000137760,ALKBH8,mrna metabolism,oncogenic activity,tumor progression,cell proliferation,apoptosis inhibition,pi3k/akt signaling pathway modulation
,ARSE,androgen-regulated gene expression,cell proliferation,chromatin remodeling,gene regulation,oncogene activation,tumor aggressiveness
ENSG00000132286,TIMM10B,mitochondrial dysfunction,tumor suppressor loss,overexpression,cell cycle regulation,apoptosis induction,mitochondrial biogenesis disruption
ENSG00000244187,TMEM141,cellular polarity disruption,enhanced cell proliferation,loss of function mutations,membrane trafficking regulation,oncogenic process involvement,tumor progression facilitation
ENSG00000117228,GBP1,immune evasion,epithelial-to-mesenchymal transition (emt),cell proliferation,metastasis promotion,prognostic biomarker,tumor progression
ENSG00000079931,MOXD1,metabolic regulation,tyrosine oxidation,tumor growth,oncogenic processes,amino acid degradation,flavin-containing monooxygenase
ENSG00000161791,FMNL3,actin filament assembly,tumor invasion,mitotic spindle formation,cytoskeletal remodeling,rho gtpase activation,cell migration enhancement
ENSG00000143258,USP21,tumor suppressor inhibition,oncoprotein stabilization,genomic instability,downstream target activation,dna repair regulation,cell cycle progression
ENSG00000171723,GPHN,glutamate metabolism,oncogene potential,cell proliferation,redox balance regulation,therapeutic resistance,post-transcriptional regulation
ENSG00000007062,PROM1,cell surface expression,cell membrane integrity,cancer stem cells marker,tumor progression,protein kinase regulation,apoptosis inhibition
ENSG00000005436,GCFC2,gene regulation,tumor suppression,cell proliferation inhibition,dna repair interaction,apoptosis regulation,pi3k/akt pathway modulation
ENSG00000175591,P2RY2,angiogenesis,cancer progression,cell migration,immune response modulation,poor prognosis marker,tumor growth promotion
ENSG00000099822,HCN2,hyperpolarization-activated channel function,potassium channel regulation,oncogenic signaling pathway modulation,tumor growth promotion,metastasis facilitation,cell proliferation enhancement
ENSG00000146678,IGFBP1,igf-binding protein 1,downregulation in tumors,angiogenesis inhibitor,cell proliferation regulator,apoptosis modulator,tumor suppressor gene
ENSG00000107159,CA9,acidic extracellular environment,angiogenesis promotion,endothelial cell proliferation,hypoxia adaptation,metastasis promoter,therapeutic target
ENSG00000167216,KATNAL2,microtubule regulation,tumor progression,driver mutation,cellular proliferation,ciliogenesis disruption,therapeutic target
ENSG00000164919,COX6C,mitochondrial function,oxidative phosphorylation,electron transport chain,energy production,apoptosis resistance,cell cycle regulation
ENSG00000137868,STRA6,retinoic acid signaling,dysregulated expression,receptor function disruption,tumor progression facilitation,cellular proliferation regulation,signaling pathway dysregulation
ENSG00000176136,MC5R,g-protein coupled receptor,cell signaling pathway,hormone regulation,melanogenesis,tumor progression,genomic alteration
ENSG00000122863,CHST3,altered glycosylation,tumor progression,cell proliferation regulation,sulfated glycosaminoglycans biosynthesis,cartilage maintenance,cellular differentiation
ENSG00000103121,CMC2,**
cellular proliferation,transcriptional regulation,dna damage response,genomic instability,tumor suppressor function,oncogenic processes 
**
ENSG00000188620,HMX3,transcriptional regulation,cell growth promotion,tumor progression association,poor prognosis indicator,apoptosis inhibition,cell cycle regulation
ENSG00000168653,NDUFS5,mitochondrial dysfunction,complex i assembly defects,oxidative phosphorylation impairment,energy metabolism alteration,tumor suppressor potential,metabolic regulation interaction
ENSG00000130595,TNNT3,cellular proliferation,genetic alterations,protein interaction,tumor progression,biomarker candidate,metastasis regulation
ENSG00000174917,MICOS13,mitochondrial dynamics,oncogene activation,overexpression in cancer,pi3k/akt pathway interaction,tumor progression,therapeutic target
ENSG00000205683,DPF3,chromatin remodeling,transcriptional regulation,cell cycle regulation,apoptosis inhibition,tumor progression,oncogenic function
ENSG00000175606,TMEM70,mitochondrial function regulation,mitophagy regulation,genomic instability promotion,cellular energy production modulation,tumor aggressiveness association,mitochondrial dynamics influence
ENSG00000205981,DNAJC19,chaperone function,tumor progression,protein interaction,cell signaling modulation,poor prognosis marker,molecular chaperoning
ENSG00000087157,PGS1,lipid metabolism,prostaglandin synthesis,oncogenic potential,fatty acid regulation,hypoxia adaptation,cell survival pathway
ENSG00000163191,S100A11,tumor metastasis,cell signaling,calcium homeostasis,angiogenesis regulation,nf-κb activation,prognosis marker
ENSG00000145022,TCTA,pi3k/akt pathway interaction,oncogenic coactivator function,chromatin remodeling,transcriptional regulation,cell cycle progression,metastasis promotion
ENSG00000137842,TMEM62,regulation of cellular stress,maintenance of homeostasis,cellular interaction regulation,oncogenesis hypothesis,autophagy modulation,er stress response
ENSG00000150540,HNMT,histamine metabolism,tumor progression,genomic instability,angiogenesis,biomarker potential,dna repair regulation
ENSG00000011405,PIK3C2A,pi3k/akt signaling,constitutive activation,oncogenic mutations,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000198692,EIF1AY,regulation of translation,overexpression in tumors,association with mtor pathway,promotion of cell growth,contribution to metastasis,role in protein synthesis regulation
ENSG00000170412,GPRC5C,calcium signaling,tumor suppressor function,cell proliferation regulation,genetic alterations,oncogenic processes,transmembrane receptor
ENSG00000179195,ZNF664,zinc finger binding,transcriptional regulation,loss-of-function mutations,cell proliferation enhancement,apoptosis inhibition,protein-protein interactions
ENSG00000166211,SPIC,tumor immunosuppression,immune evasion,cell proliferation regulation,transcriptional modulation,poor prognosis marker,tumor microenvironment modulation
ENSG00000166902,MRPL16,mitochondrial translation regulation,tumor aggressiveness marker,cell proliferation regulator,metabolic reprogramming,apoptosis resistance,oncogenic interaction
ENSG00000092345,DAZL,cell cycle regulation,mrna translation modulation,proliferation promoter,apoptosis evasion,biomarker candidate,tumor progression enhancer
ENSG00000153707,PTPRD,angiogenesis inhibition,apoptosis promotion,cellular growth suppression,immune system regulation,tumor suppressor function,tumor progression suppression
ENSG00000086200,IPO11,cell cycle regulation,apoptosis modulation,tumor suppressor function,genomic stability maintenance,protein-protein interaction,cancer driver potential
ENSG00000115556,PLCD4,oncogenic,signal transduction pathway modulation,phospholipid metabolism dysregulation,cell proliferation enhancement,tumor growth promotion,metastasis facilitation
ENSG00000100228,RAB36,cell proliferation,epidermal growth factor receptor regulation,gtp-binding protein function,membrane trafficking regulation,oncogenic mutations,tumor progression
ENSG00000134278,SPIRE1,homologous recombination repair,nuclear protein function,dna damage response regulation,genome stability maintenance,tumor suppressor activity,oncogenic potential
ENSG00000127870,RNF6,tumor suppressor regulation,ubiquitin ligase activity,oncogenic process promotion,cell cycle progression,genetic instability,protein degradation dysregulation
ENSG00000166482,MFAP4,microfibril remodeling,tumor associated fibrosis,cell adhesion regulation,angiogenesis promotion,metastasis facilitation,prognostic marker
ENSG00000140945,CDH13,tumor suppressor function,downregulation/mutation,epithelial-to-mesenchymal transition regulation,adherens junction disruption,poor prognosis marker,tumor progression facilitation
ENSG00000074211,PPP2R2C,constitutive activation,gain of function mutations,regulatory subunit dysfunction,tumor progression,cell survival enhancement,histone modification alteration
,MARC1,genomic instability,dna damage response,homologous recombination repair,tumor suppressor function,cell cycle regulation,nucleic acid binding
ENSG00000129993,CBFA2T3,chromatin remodeling,transcriptional regulation,oncogenesis,cell proliferation,prognostic biomarker,transcription factor activity
ENSG00000138459,SLC35A5,nucleotide sugar transport,glycosylation regulation,tumor progression,cell proliferation,oncogenic signaling,metabolic reprogramming
ENSG00000106524,ANKMY2,mitotic spindle formation,cell cycle regulation,protein-protein interaction,tumor progression,cancer metastasis,diagnostic/prognostic marker
ENSG00000151577,DRD3,angiogenesis inhibition,cell migration,cancer progression,dopaminergic signaling,g protein-coupled receptor,metastasis promotion
ENSG00000047634,SCML1,epigenetic regulation,genomic instability,tumor suppression,dna repair,cell cycle regulation,apoptosis promotion
ENSG00000126653,NSRP1,rna splicing regulation,tumor growth promotion,rna processing modulation,cellular proliferation enhancement,transcriptional regulation impact,genomic instability contribution
ENSG00000075826,SEC31B,er export regulation,oncogene overexpression,tumor progression facilitation,angiogenesis promotion,cell migration regulation,protein secretion enhancement
ENSG00000198604,BAZ1A,chromatin remodeling,transcriptional activation,oncogene regulation,genomic instability,epigenetic modification,tumor suppressor dysfunction
ENSG00000187689,AMTN,iron metabolism regulation,tumor progression,metastasis promotion,biomarker potential,protein interaction,cellular homeostasis
ENSG00000129757,CDKN1C,tumor suppressor function,cell cycle regulation,growth inhibition,apoptosis induction,embryonic development regulation,loss of function mutation
ENSG00000135801,TAF5L,transcription regulation,proliferation promotion,cell cycle progression,oncogene regulation,transcription factor interaction,tumor suppressor evasion
ENSG00000169684,CHRNA5,nicotinic acetylcholine receptor subunit,altered expression in cancer tissues,interaction with pi3k/akt/mtor pathway,cellular proliferation regulation,tumor invasion promotion,neuronal signaling modulation
ENSG00000101846,STS,tumor progression,cell migration,extracellular matrix degradation,protein interaction,oncogenic process,cancer metastasis
ENSG00000166803,PCLAF,dna replication,overexpression,prognostic marker,tumor suppressor regulation,pcna interaction,cell cycle progression
ENSG00000152377,SPOCK1,tumor progression,epithelial-to-mesenchymal transition (emt),apoptosis inhibition,cell migration/invasion,angiogenesis promotion,secreted protein function
ENSG00000125810,CD93,tumor progression,cell migration,leukocyte adhesion,biomarker for prognosis,survival and invasion promotion,metastasis facilitation
ENSG00000021826,CPS1,ammonia production regulation,cell survival promotion,cancer cell metabolism regulation,prognostic biomarker,tumor behavior promotion,amino acid metabolism modulation
ENSG00000070404,FSTL3,tumor promotion,cell proliferation regulation,signaling pathway interaction,cell adhesion modulation,poor prognosis indicator,wnt/β-catenin pathway activation
ENSG00000198756,COLGALT2,oncogene,tumor promoter,cellular proliferation,epithelial-to-mesenchymal transition (emt),altered subcellular localization,protein-protein interaction
ENSG00000131899,LLGL1,mitotic spindle assembly,chromosomal instability,cell polarity regulation,protein-protein interactions,microtubule association,pi3k/akt signaling pathway dysregulation
ENSG00000221944,TIGD1,lipid metabolism regulation,gene expression alteration,tumor progression association,mitochondrial function influence,cell growth modulation,apoptosis regulation
ENSG00000071246,VASH1,tumor progression,transcriptional regulation,cell cycle regulation,apoptosis modulation,angiogenesis activation,oncogenic pathway activation
ENSG00000198934,MAGEE1,immune evasion,overexpression,aberrant expression,signaling pathway activation,tumor progression,gene regulation
ENSG00000173040,EVC2,genomic instability,mitotic checkpoint regulation,tumor aggressiveness,cell cycle dysregulation,chromosomal alterations,oncogenic function
ENSG00000188643,S100A16,apoptosis resistance,biomarker expression,cellular interaction,tumor metastasis,angiogenesis regulation,signaling pathway modulation
ENSG00000137713,PPP2R1B,pi3k/akt pathway dysregulation,tumor suppressor dysfunction,protein phosphatase regulation,cell survival enhancement,genetic instability promotion,oncogene overexpression
ENSG00000146426,TIAM2,rho gtpase activation,constitutive activation,gain of function mutations,cell migration promotion,tumor progression,oncogene regulation
ENSG00000112701,SENP6,oncogenic properties,deubiquitinating activity,tumor progression,therapeutic target,cell proliferation regulation,apoptosis inhibition
ENSG00000196323,ZBTB44,tumor suppressor,transcriptional regulation,cell proliferation inhibition,apoptosis promotion,dna repair regulation,cell cycle progression regulation
ENSG00000197965,MPZL1,mpzl1/muc1 interaction,gain of function mutations,tumor progression,protein modification regulation,membrane trafficking modulation,oncogenic activity enhancement
ENSG00000132359,RAP1GAP2,rap1 activation,cell proliferation,metabolic regulation,tumorigenesis promotion,negative regulatory function,gtpase-activating protein
ENSG00000112238,PRDM13,chromosomal instability,transcriptional regulator,tumor suppressor activity,dna damage response pathway,genomic alterations,biomarker potential
ENSG00000104915,STX10,cell membrane trafficking,cancer metastasis,tumor growth promotion,oncogene expression,therapeutic target,intracellular transport regulation
ENSG00000179761,PIPOX,lipid metabolism,cell proliferation,tumor progression,therapeutic target,signaling pathway,genomic alteration
ENSG00000132704,FCRL2,immune regulation,tumor progression,suppression of anti-tumor immunity,modulation of tumor-infiltrating lymphocytes,poor prognosis,transmembrane protein
ENSG00000111875,ASF1A,chromatin remodeling,apoptosis resistance,oncogenesis promotion,genomic instability,dna repair regulation,homologous recombination
ENSG00000095564,BTAF1,transcriptional regulation,amplification driven overexpression,cellular proliferation,tumor progression,oncogenic potential,genomic amplification
ENSG00000213079,SCAF8,tumor progression,tumorigenesis,genomic instability,scaffold protein function,dna repair regulation,apoptosis inhibition
ENSG00000010539,ZNF200,tumor suppression,transcriptional regulation,zinc finger protein domain,cellular proliferation,gene expression regulation,chromatin structure modulation
ENSG00000182749,PAQR7,cellular proliferation,transcription factor regulation,oncogenic signaling pathway,tumor growth promotion,prognostic biomarker,steroid hormone receptor activity
ENSG00000055163,CYFIP2,mrna translation regulation,oncogene activation,tumor progression,cell proliferation enhancement,epithelial-to-mesenchymal transition,cytoplasmic localization
ENSG00000095319,NUP188,mitotic spindle formation,dna repair regulation,gene expression regulation,nuclear pore complex component,cell cycle progression enhancement,tumor suppressor dysfunction
ENSG00000234370,GTF2H4,genomic instability,impaired dna repair,nucleotide excision repair,rna polymerase ii regulation,dna damage response,transcription regulation
ENSG00000260325,HSPB9,heat shock response,cellular stress protection,tumor growth promotion,apoptosis inhibition,metastasis facilitation,therapeutic target
ENSG00000140157,NIPA2,tumor progression,cell cycle regulation,apoptosis evasion,genetic instability,protein kinase activation,oncogenic transformation
ENSG00000122729,ACO1,metabolic reprogramming,energy metabolism,cell proliferation,atp production,mitochondrial function,tumorigenesis support
ENSG00000107954,NEURL1,transcriptional regulation,oncogene activation,cell proliferation enhancement,apoptosis inhibition,wnt/β-catenin pathway interaction,poor prognosis marker
ENSG00000076650,GPATCH1,genomic instability,dna repair mechanisms,transcriptional regulation,homologous recombination,tumor suppressor function,genome maintenance
ENSG00000072042,RDH11,genomic instability,cell proliferation,cell growth regulation,oncogenic pathway modulation,tumor progression,retinoic acid metabolism
ENSG00000163655,GMPS,biosynthetic pathway regulation,cellular metabolism modulation,protein-protein interaction,cancer biomarker,tumor adaptation,polyamine biosynthesis regulator
ENSG00000023516,AKAP11,cell proliferation,tumor progression,oncogene activation,pi3k/akt pathway interaction,apoptosis regulation,dna repair dysfunction
ENSG00000063015,SEZ6,cellular regulation,phospholipid metabolism,tumor progression,signaling pathway modulation,pi3k/akt/mtor interaction,oncogenic process activation
ENSG00000124466,LYPD3,oncogene overexpression,cell adhesion modulation,tumor progression factor,protein-protein interactions,signaling pathway dysregulation,metastasis promoter
ENSG00000121775,TMEM39B,er stress regulation,oncogenic function,cell survival enhancement,tumor progression driver,genomic amplification signature,endoplasmic reticulum modulation
ENSG00000070444,MNT,p53 pathway disruption,oncogene activation,transcription factor function,chromatin remodeling,tumor suppressor dysfunction,pi3k/akt signaling
ENSG00000163803,PLB1,pka regulation,cell cycle progression,anti-apoptotic function,tumor suppressor,protein kinase signaling,signaling pathway modulation
ENSG00000101365,IDH3B,oncogenic epigenetics,metabolic reprogramming,2-hydroxyglutarate production,tumor metabolism alterations,dysregulation of cellular respiration,histone and dna methylation regulation
ENSG00000164124,TMEM144,autophagy regulation,cell proliferation,mitochondrial dysfunction,oncogene expression,protein-protein interaction,tumor suppressor function
ENSG00000169118,CSNK1G1,wnt/β-catenin pathway activation,ck1α interaction,tumor suppressor downregulation,cell proliferation enhancement,apoptosis inhibition,dna repair regulation
ENSG00000205362,MT1A,apoptosis resistance,cell proliferation,cell survival,heavy metal detoxification,nf-kb signaling,oncogenic function
ENSG00000182450,KCNK4,oncogenic potential,cell proliferation,increased potassium flow,tumor progression,cancer-associated prognosis,channel function regulation
ENSG00000274221,CCL3,angiogenesis,immunosuppression,chemoattractant activity,tumor progression,metastasis promotion,jak/stat pathway interaction
ENSG00000135069,PSAT1,warburg effect,glycolytic reprogramming,glutamine metabolism,cancer cell survival,oncogenic driver,metabolic regulator
ENSG00000185730,ZNF696,cell cycle progression,transcriptional regulation,tumor suppressor repression,oncogene activation,apoptosis inhibition,cell proliferation promotion
ENSG00000198795,ZNF521,transcriptional regulation,oncogenic transcription factor,cell growth modulation,apoptosis evasion,dna damage response,tumor progression driver
ENSG00000205923,CEMP1,cholesterol homeostasis dysregulation,cell membrane fluidity modulation,lipid metabolism disruption,oncogenic signaling pathway activation,apoptosis resistance promotion,tumor cell survival enhancement
ENSG00000125746,EML2,chromatin remodeling,cell cycle regulation,dna repair,transcriptional control,tumor suppressor dysfunction,baf complex interaction
ENSG00000198522,GPN1,constitutive activation,metabolic regulation,tumor progression,protein kinase activation,genomic profiling,oncogenic process
ENSG00000164828,SUN1,genomic instability,nuclear envelope integrity,chromatin remodeling,dna repair mechanisms,mitotic progression regulation,tumor growth promotion
ENSG00000198914,POU3F3,transcription factor activation,cell cycle regulation,apoptosis evasion,tumor progression,prognostic marker,genomic amplification
,NARS,transcriptional regulation,oncogenic properties,cell survival,apoptosis inhibition,chromatin remodeling,rna polymerase ii activity
ENSG00000141744,PNMT,epinephrine synthesis,catecholamine metabolism,angiogenesis promotion,metastasis facilitation,protein-catalytic activity,tumor progression
ENSG00000133028,SCO1,**

mitochondrial dysfunction,electron transport chain regulation,oxidative stress,genomic instability,apoptosis resistance,iron-sulfur cluster assembly 
**
ENSG00000162419,GMEB1,wnt/β-catenin signaling pathway,transcriptional regulation,chromatin remodeling,oncogenic transcription factor,histone modification,tumor metastasis
ENSG00000008282,SYPL1,oncogene activation,cell signaling modulation,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition,poor prognosis indicator
ENSG00000182158,CREB3L2,er stress response,transcriptional regulation,cell survival,tumor progression,protein degradation,transcription factor activity
ENSG00000288369,RBP5,transcriptional regulation,chromatin modification,cell proliferation,prognostic biomarker,oncogenic activation,metastatic potential
ENSG00000138823,MTTP,lipid metabolism dysregulation,overexpression,tumor progression,oncogenic process,cellular lipid homeostasis,metabolic reprogramming
ENSG00000080546,SESN1,ampk pathway,tumor suppressor function,cell survival regulation,mtor pathway activation,pro-survival signaling,genome instability prevention
ENSG00000112855,HARS2,trna charging,histidine loading,cellular metabolism,protein synthesis regulation,oncoprotein expression,tumor progression
ENSG00000069849,ATP1B3,na+/k+-atpase regulation,ion transport disruption,cell signaling modulation,metabolic regulation,tumor progression driver,genomic instability
ENSG00000143515,ATP8B2,lipid metabolism regulation,cellular membrane homeostasis,cholestasis,progressive familial intrahepatic cholestasis (pfic),membrane fluidity regulation,tumor cell behavior
ENSG00000136695,IL36RN,anti-inflammatory action,immune suppression,tumor microenvironment modulation,nf-kb pathway regulation,pro-inflammatory cytokine inhibition,immunosuppressive environment
ENSG00000198399,ITSN2,pi3k/akt/mtor pathway regulation,constitutive activation,overexpression,cell survival enhancement,tumor progression,genomic instability
ENSG00000149133,OR5F1,metastasis promotion,pi3k/akt interaction,cell proliferation enhancement,tumor progression association,poor prognosis indicator,odorant detection function
ENSG00000198198,SZT2,pi3k/akt signaling,oncogene activity,gain of function mutations,cell proliferation regulation,constitutive activation,tumor progression driver
ENSG00000188706,ZDHHC9,palmitoylation,oncogenic processes,cell proliferation,protein modification,lipid metabolism,therapeutic target
ENSG00000162733,DDR2,**
cellular adhesion,cell cycle progression,collagen binding,epithelial-to-mesenchymal transition (emt),oncogenic transformation,phosphatidylinositol 3-kinase (pi3k) pathway interaction
ENSG00000117305,HMGCL,glycolytic switch,metabolic reprogramming,cellular energetics,prognostic biomarker,mitochondrial function,regulatory mechanism
ENSG00000106113,CRHR2,crhr2 activation,cell migration,g protein-coupled receptor,hypothalamic-pituitary-adrenal axis regulation,pi3k/akt pathway modulation,tumor progression promoter
ENSG00000004776,HSPB6,cellular protection,thermal stress resistance,protein aggregation prevention,tumor progression,apoptosis regulation,biomarker potential
ENSG00000163798,SLC4A1AP,tumor suppressor/ oncogene regulation,pi3k/akt/mtor pathway regulation,cell proliferation/survival/migration regulation,anion transport/electrolyte balance regulation,hif-1α regulation,mutations in cancer patients
ENSG00000131143,COX4I1,mitochondrial biogenesis,tumor progression,prognostic marker,therapeutic target,cellular metabolism,energy homeostasis
ENSG00000153253,SCN3A,dysregulated ion channel function,hypoxia adaptation,tumor progression,cellular metabolism alteration,oncogene upregulation,ion channel interaction
ENSG00000148120,AOPEP,pro-apoptotic function,impaired apoptosis,tumor suppression,cancer cell proliferation,cell survival enhancement,oncogene interaction
ENSG00000164631,ZNF12,tumor suppressor function,transcriptional regulation,chromatin remodeling,genomic instability,cellular proliferation,loss of function mutations
ENSG00000184857,TMEM186,calcium signaling regulation,epithelial-to-mesenchymal transition,tumor migration invasion,protein-protein interaction,cellular homeostasis modulation,oncogenic pathway activation
ENSG00000187193,MT1X,mt1x overexpression,poor prognosis marker,tumor survival promotion,angiogenesis regulation,chemo-radiation resistance,metal detoxification
ENSG00000196683,TOMM7,mitochondrial integrity,glycolytic shift,apoptosis resistance,tumor metabolism,protein translocation,cellular energetics
ENSG00000100216,TOMM22,mitochondrial translocation,cellular metabolism regulation,apoptosis resistance,protein synthesis modulation,cancer cell proliferation,therapeutic target potential
ENSG00000122484,RPAP2,protein degradation,transcriptional elongation,rna polymerase activity,gene expression regulation,transcriptional control,oncogenesis
ENSG00000170954,ZNF415,transcriptional regulation,tumor progression,cell proliferation,angiogenesis,metastasis,histone modification
ENSG00000228090,MPIG6B,ubiquitination pathway regulation,protein degradation enhancement,tumor suppressor degradation,promoter of cell proliferation,dysregulation in cancer development,poor prognosis marker
ENSG00000185551,NR2F2,tumor suppressor,transcriptional regulation,cell differentiation,genetic mutations,oncogenic driver,gene expression modulation
ENSG00000198553,KCNRG,altered cellular excitability,cellular growth promotion,cell survival inhibition,genomic instability,oncogenic pathway activation,pi3k/akt signaling alteration
ENSG00000121579,NAA50,histone modification,chromatin regulation,gene transcription regulation,cell proliferation enhancement,oncogenic potential,protein-protein interaction
ENSG00000182459,TEX19,alternative splicing regulation,cancer-related protein expression,cellular behavior modulation,mirna processing regulation,oncogenic process promotion,tumor progression association
ENSG00000167703,SLC43A2,lipid metabolism regulation,fatty acid transport,energy homeostasis modulation,cellular proliferation enhancement,oncogenic process involvement,lipid biosynthesis promotion
ENSG00000117593,DARS2,mitochondrial function,trna synthetase activity,stress response activation,energy metabolism regulation,oxidative phosphorylation impairment,cancer-related metabolic reprogramming
ENSG00000120727,PAIP2,genomic instability,poly(a)-binding protein regulation,mrna stability regulation,tumor progression promotion,cell survival enhancement,therapeutic target
ENSG00000174740,PABPC5,enhanced mrna stability,oncogenic driver,pro-survival transcript stabilization,cell cycle progression,apoptosis evasion,metastasis suppression
ENSG00000110042,DTX4,transcriptional regulation,chromatin remodeling,pi3k/akt signaling activation,cell proliferation promotion,apoptosis resistance,tumor suppressor dysfunction
ENSG00000076826,CAMSAP3,microtubule organization,cell migration,downregulation mutations,tumor progression,metastasis,cellular stress response
ENSG00000109113,RAB34,rab34 overexpression,membrane trafficking regulation,cell migration promotion,tumor progression enhancement,apoptosis regulation disruption,autophagy modulation
ENSG00000150051,MKX,myogenesis,transcriptional regulation,gene overexpression,tumor progression,cell proliferation,survival pathway
ENSG00000197217,ENTPD4,purinergic signaling,extracellular atp regulation,tumor progression,therapeutic target,tumor microenvironment remodeling,cancer cell proliferation
ENSG00000100258,LMF2,lipid metabolism regulation,transcriptional control,cellular balance maintenance,cancer association unknown,cell growth regulation,proliferation and survival pathways
ENSG00000136699,SMPD4,sphingolipid metabolism,tumor progression,apoptosis modulation,cancer metastasis,cell survival pathway activation,phosphocholine production
ENSG00000151304,SRFBP1,wnt/β-catenin signaling pathway,transcriptional co-activator function,oncogenic transformation,epigenetic regulation,cell proliferation promotion,chromatin remodeling
ENSG00000259571,BLID,mitotic regulation,cell cycle progression,anaphase-promoting complex activation,genomic instability,oncogenic driver,cancer proliferation
ENSG00000170265,ZNF282,zinc finger transcription factor,cell proliferation regulation,apoptosis suppression,myc activation,tumor suppressor gene repression,angiogenesis promotion
ENSG00000198848,CES1,drug metabolism,tumor aggressiveness,metabolic regulation,prognostic marker,therapeutic target,genomic instability
ENSG00000008513,ST3GAL1,cell surface glycosylation,oncogenic signaling,tumor growth,metastasis,prognostic marker,cell survival
ENSG00000146072,TNFRSF21,tumor microenvironment modification,immune suppression,oncogene activation,angiogenesis promotion,nf-κb signaling pathway activation,pro-inflammatory cytokine expression
ENSG00000213977,TAX1BP3,p53 pathway disruption,tumor suppressor loss,cell cycle dysregulation,dna repair impairment,genomic instability promotion,prognostic marker
ENSG00000166589,CDH16,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression,metastasis potential,prognostic marker,pi3k/akt pathway interaction
ENSG00000131482,G6PC,glucose metabolism regulation,oncogenic processes,glycolysis promotion,cell survival enhancement,energy metabolism regulation,oxidative stress contribution
ENSG00000196289,BECN2,autophagy regulation,tumor suppression,cell survival enhancement,prognostic marker,metabolic regulation,apoptosis inhibition
ENSG00000184524,CEND1,genomic instability,tumor growth,cell proliferation,mitosis regulation,centrosome duplication,protein-protein interaction
ENSG00000171115,GIMAP8,gtp-binding protein,apoptosis regulation,proliferation enhancement,migration facilitation,cancer cell survival,tumor progression promotion
ENSG00000178685,PARP10,apoptosis regulation,dna repair mechanisms,nuclear localization,genomic stability maintenance,pro-survival function,tumor aggressiveness
ENSG00000126733,DACH2,tumor suppressor function,wnt/β-catenin pathway inhibition,transcriptional regulation,cellular differentiation inhibition,chromatin remodeling,poor prognosis association
ENSG00000071189,SNX13,lysosome regulation,egf receptor internalization,tumor progression,cell migration and proliferation,pi3k/akt pathway modulation,lysosomal dysfunction
ENSG00000157823,AP3S2,lysosomal pathway regulation,protein sorting dysfunction,tumor microenvironment modulation,cell proliferation regulation,signaling pathway alteration,apoptosis evasion
ENSG00000122034,GTF3A,transcriptional regulation,dna repair pathways,tumor suppressor gene regulation,cell proliferation,genomic instability,oncogene activation
ENSG00000115761,NOL10,cell cycle regulation,oncogenesis,prognostic biomarker,immune modulation,apoptosis suppression,tumor progression
ENSG00000162616,DNAJB4,tumor progression,cell cycle regulation,oncogene activation,apoptosis inhibition,protein folding modulation,chaperone activity
ENSG00000145817,YIPF5,er membrane localization,endoplasmic reticulum structure regulation,protein transport facilitation,cancer cell proliferation,er stress modulation,tumor progression biomarker
ENSG00000115365,LANCL1,antigen presentation,oncogene,tumor progression,apoptosis resistance,cell growth promotion,immunotherapeutic target
ENSG00000158008,EXTL1,genomic instability,heparan sulfate biosynthesis,wnt/β-catenin signaling pathway,oncogenic mutations,cell proliferation regulation,extracellular matrix remodeling
ENSG00000122304,PRM2,overexpression,tumor progression,genomic instability,chromosomal alterations,cell signaling,protein regulation
ENSG00000130702,LAMA5,tumor progression,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,microenvironment modulation,extracellular matrix interaction,basement membrane formation
ENSG00000154518,ATP5MC3,mitochondrial energy production,enhanced atp production,hypoxia adaptation,oncogenic driver,tumor proliferation,cellular metabolism
ENSG00000181965,NEUROG1,neurogenic differentiation 1,promotes epithelial-to-mesenchymal transition,regulates pro-oncogenic genes,contributes to tumorigenic processes,associated with poor prognosis,potential biomarker for diagnosis
ENSG00000147081,AKAP4,cellular signaling,tumor progression,protein kinase a binding,cell proliferation,angiogenesis regulation,signal transduction modulation
ENSG00000049283,EPN3,epithelial cell polarity regulation,aberrant expression in cancer,cell adhesion disruption,rho gtpase activation,pi3k/akt pathway modulation,emt promoter
ENSG00000197555,SIPA1L1,protein stability regulation,oncogenic properties enhancement,cell proliferation promotion,apoptosis inhibition,siah2 e3 ubiquitin ligase interaction,tumor suppressor downregulation
ENSG00000274488,LY6H,immune modulation,tumor progression,cell proliferation,protein interaction,metastasis,epithelial-to-mesenchymal transition
ENSG00000273397,NDUFA6,mitochondrial dysfunction,genomic instability,oncogenic adaptation,cellular homeostasis disruption,electron transport chain disruption,glycolytic shift
ENSG00000179041,RRS1,translation regulation,ribosome recycling,protein synthesis enhancement,tumor growth promotion,oncogenic function,apoptosis evasion regulation
ENSG00000196542,SPTSSB,genomic instability,protein homeostasis disruption,apoptosis inhibition,pi3k/akt pathway interaction,tumor progression driver,cellular stress response alteration
ENSG00000134698,AGO4,mirna regulation,argonaute activity,tumor suppression,cytoplasmic localization,apoptosis inhibition,metastasis regulation
ENSG00000119509,INVS,cilium formation,microtubule stability,tumor suppressor,wnt/pcp signaling,cell migration regulation,left-right patterning
ENSG00000042813,ZPBP,zpbp expression,tumor progression,cell migration invasion,integrin interaction,adhesion signaling pathway,cell surface receptor binding
ENSG00000188092,GPR89B,g protein coupled receptor signaling,cell proliferation regulation,tumor progression promotion,downstream signaling cascade modulation,cell survival enhancement,kinase activation
ENSG00000103546,SLC6A2,oncogene,pi3k/akt pathway interaction,transporter function,cell survival,tumor progression,metabolic regulation
ENSG00000178764,ZHX2,tumor progression,therapeutic target,transcriptional regulation,cell proliferation,metabolic regulation,oncogenesis
ENSG00000154309,DISP1,protein-protein interaction,cell signaling pathway,angiogenesis regulation,tumor progression,cell migration facilitation,cancer aggressiveness marker
ENSG00000157064,NMNAT2,nad+ biosynthesis,genomic stability maintenance,tumor progression association,oncogenic interaction,sirt1 pathway activation,cell survival enhancement
ENSG00000163157,TMOD4,cell migration,actin filament regulation,oncogenic behavior,therapeutic target,cancer prognosis,tumor invasiveness
ENSG00000115128,SF3B6,spliceosomal component,gain-of-function mutations,aberrant splicing patterns,oncogenic processes,cell proliferation and survival enhancement,integrator of gene expression networks
ENSG00000205301,MGAT4D,cellular signaling pathway,oncogenic processes,cell adhesion modulation,tumor progression,protein glycosylation,metastasis promotion
ENSG00000165917,RAPSN,cell surface protein clustering,cytoskeletal organization,cell adhesion molecule function,tumor cell migration,oncogenic mutations,signaling pathway modulation
ENSG00000162368,CMPK1,mitochondrial enzyme,cellular metabolism,tumor progression,energy metabolism,iron homeostasis,biomarker
ENSG00000090238,YPEL3,p53 degradation,oncogene function,cell proliferation regulation,poor prognosis indicator,biomarker potential,protein degradation role
ENSG00000125734,GPR108,gpcr activation,adhesion-gpcr family,cell migration regulation,tumor growth promotion,metastasis facilitation,ligand binding specificity
ENSG00000231852,CYP21A2,steroid biosynthesis,cellular redox balance,oncogenesis,tumor progression,metabolic regulation,genetic expression
ENSG00000159871,LYPD5,tumor suppressor,cell adhesion regulation,immune response modulation,epithelial-to-mesenchymal transition,negative regulator pi3k/akt signaling,reduced expression associated with tumor progression
ENSG00000139977,NAA30,mitochondrial regulation,genomic instability,cellular metabolism,oxidative stress,protein synthesis regulation,aberrant expression
ENSG00000135040,NAA35,histone acetylation,chromatin remodeling,cell proliferation,tumor suppressor regulation,cancer cell maintenance,biomarker potential
ENSG00000174705,SH3PXD2B,autophagy regulation,cell migration promotion,endocytosis regulation,metastasis facilitation,pi3k/akt pathway interaction,tumor growth promotion
ENSG00000092871,RFFL,ribosome biogenesis,protein synthesis regulation,cell growth modulation,oncogenic process contributor,therapeutic target,genomic alteration
ENSG00000142025,DMRTC2,tumor suppressor function,gene expression regulation,dna damage response,cell cycle disruption,pi3k/akt signaling interaction,genomic instability maintenance
ENSG00000129194,SOX15,sox15 expression,cell cycle regulation,apoptosis resistance,emt modulation,cancer stem cell maintenance,wnt/β-catenin pathway interaction
ENSG00000158987,RAPGEF6,rap gtpase regulation,cell adhesion disruption,oncogenic signaling pathway,cell migration enhancement,cytoskeletal reorganization,tumor progression acceleration
ENSG00000150054,MPP7,cell-cell adhesion disruption,hyperactivation of pi3k/akt pathway,protein-protein interaction,tumor progression promotion,maguk family member,overexpression in cancer
ENSG00000164404,GDF9,cell proliferation,overexpression,signaling pathway activation,therapeutic target,oncogenesis,tumorigenesis
ENSG00000153037,SRP19,protein targeting,cancer driver,cell growth regulation,translation initiation,srp complex subunit,tumorigenesis promotion
ENSG00000167468,GPX4,oncogenic driver,mutation/epigenetic alteration,loss of function,cell survival resistance,tumor progression,genomic instability
ENSG00000141965,FEM1A,microtubule regulation,oncogene,cytokinesis disruption,mitotic spindle formation,cell cycle progression,protein-protein interaction
ENSG00000075407,ZNF37A,tumor suppressor function loss,genomic instability contribution,therapeutic target potential,cell proliferation promotion,anti-apoptotic regulation,pi3k/akt signaling pathway modulation
ENSG00000141905,NFIC,transcriptional regulation,oncogenic activity,coactivator function,cellular proliferation,metastasis promotion,poor prognosis marker
ENSG00000158805,ZNF276,transcriptional regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,poor prognosis marker,tumor aggressiveness promoter
ENSG00000090402,SI,apoptosis inhibition,cell survival promotion,irf activation,nf-κb signaling,innate immunity regulation,tumor progression facilitation
,HIST3H2A,**

apoptosis regulation,chromatin structure modification,epigenetic regulation,histone variant function,tumor growth promotion,gene expression dysregulation 

**
ENSG00000139219,COL2A1,angiogenesis,cell migration and invasion,collagen synthesis,tumor microenvironment remodeling,fibroblast production of pro-inflammatory cytokines,extracellular matrix degradation
ENSG00000114378,HYAL1,tumor invasion,extracellular matrix degradation,metastasis promotion,angiogenesis facilitation,glycosaminoglycan breakdown,cancer progression
ENSG00000089057,SLC23A2,urate transport,cell growth promotion,prognostic marker,therapeutic target,apoptosis inhibition,metabolic regulation
ENSG00000005882,PDK2,warburg effect,tumor progression,oncogene,cellular metabolism,energy reprogramming,therapeutic target
ENSG00000196358,NTNG2,cell-cell adhesion disruption,metastasis promoter,adhesion molecule regulation,tumor growth facilitation,signaling pathway modulation,cancer cell invasion enhancement
ENSG00000262655,SPON1,cell adhesion,overexpression,tumor progression,metastasis promotion,prognostic marker,integrin interaction
ENSG00000102547,CAB39L,camk pathway activation,cellular proliferation,apoptosis regulation,cell cycle progression,transcriptional regulation,protein interaction
ENSG00000115257,PCSK4,lipid metabolism modulation,wnt/β-catenin signaling activation,tumor progression promotion,cell proliferation enhancement,apoptosis regulation disruption,autophagy inhibition
ENSG00000157219,HTR5A,angiogenesis promotion,epithelial-to-mesenchymal transition,g protein-coupled receptor signaling,metastasis facilitation,tumor progression,predictive biomarker
ENSG00000130413,STK33,tumor progression,dna repair defects,cell division regulation,kinase activation,oncogenic mutations,prognostic biomarker
ENSG00000132196,HSD17B7,mitochondrial function,chronic oxidative stress,cellular interaction,steroid hormone regulation,genomic instability,ovarian expression
ENSG00000133742,CA1,tumor metabolism,constitutive activation,oncogenic processes,acidic environment,angiogenesis suppression,therapeutic target
ENSG00000006788,MYH13,tumor progression,cell migration,cytoskeleton organization,metastasis,therapeutic target,cytoplasmic localization
ENSG00000113946,CLDN16,tight junction regulation,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,constitutive activation,cell polarity disruption,prognostic marker
ENSG00000162512,SDC3,tumor progression,cell adhesion regulation,metastasis promotion,growth factor interaction,angiogenesis regulation,microenvironment modulation
ENSG00000196296,ATP2A1,calcium signaling pathway,oncogenic role,therapeutic target,cell survival and proliferation,interacts with pkc and plc,altered expression or activity
ENSG00000034971,MYOC,myoc mutations,cell cycle regulation,apoptosis disruption,tumor growth promotion,biomarker potential,cellular processes dysregulation
ENSG00000115457,IGFBP2,tumor progression,cell migration,metastasis promotion,apoptosis inhibition,igf signaling pathway activation,cell adhesion modulation
ENSG00000184709,LRRC26,cell migration and invasion,pi3k/akt signaling pathway,oncogenic activity,epithelial barrier breakdown,therapeutic target,cancer progression and metastasis
ENSG00000198732,SMOC1,tumor progression,metastasis facilitation,cell adhesion disruption,molecular interaction,genomic upregulation,prognostic marker
ENSG00000138760,SCARB2,lipid metabolism alteration,oncogenic overexpression,cholesterol efflux regulation,immune response modulation,tumor growth support,pi3k/akt pathway interaction
ENSG00000087842,PIR,protease inhibition,cellular regulation,tumor microenvironment,serpin family,cancer progression,immune response modulation
ENSG00000163563,MNDA,nf-κb pathway,adaptor protein function,cell proliferation regulation,inflammation modulation,tumor growth enhancement,mapk/erk signaling interaction
ENSG00000169740,ZNF32,transcriptional regulation,apoptosis suppression,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,immune evasion mechanism
ENSG00000076248,UNG,ber pathway dysfunction,dna repair defects,genomic instability,oncogenic driver mutations,tumor progression,chemotherapy resistance
ENSG00000137225,CAPN11,cell cycle regulation,proteolytic activity,tumor progression,therapeutic target,apoptosis inhibition,oncogenic processes
ENSG00000227345,PARG,parp1 inhibition,genomic instability,tumor progression,poly(adp-ribose) glycohydrolase activity,dna repair regulation,cancer cell survival
ENSG00000172273,HINFP,transcriptional repression,tumor suppression,apoptosis regulation,cell cycle progression,oncogenic gene regulation,genomic instability
ENSG00000187021,PNLIPRP1,phospholipid metabolism,oncogenic protein,tumor progression,cellular membrane composition,signaling pathway regulation,angiogenesis promotion
ENSG00000189159,JPT1,dna repair mechanisms,genomic instability,kinase activity,tumor suppressor,cellular proliferation,protein-protein interactions
ENSG00000135744,AGT,angiogenesis,tumor growth,pi3k/akt signaling,cell proliferation,vasoconstriction,protein interaction
ENSG00000171310,CHST11,tumor progression,immune evasion,oncogenic processes,cell adhesion modulation,proteoglycan regulation,glycosylation modification
ENSG00000132749,TESMIN,oncogene activation,transcriptional regulation,tumor suppression inhibition,cell proliferation promotion,survival pathway modulation,prognostic biomarker
ENSG00000109572,CLCN3,ion channel function,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,protein-protein interaction,molecular dysregulation
ENSG00000174292,TNK1,pi3k/akt pathway modulation,constitutive activation,genomic mutations,oncogenic fusion protein formation,therapeutic target,signaling pathway interaction
ENSG00000106290,TAF6,transcriptional regulation,cellular proliferation,constitutive activation,tumor progression,protein interaction,genomic instability
ENSG00000130783,CCDC62,microtubule dynamics,spindle assembly checkpoint disruption,genomic instability,aneuploidy promotion,cell cycle regulation disruption,protein-protein interactions
ENSG00000109472,CPE,tumor progression,immune evasion,cell adhesion,protein-protein interaction,cancer metastasis,poor prognosis
ENSG00000174165,ZDHHC24,pi3k/akt pathway interaction,gain of function mutation,tumor suppressor/oncogene activity,protein palmitoylation regulation,cell membrane trafficking modulation,genomic mutation hotspot in cancer
ENSG00000149308,NPAT,ribosome biogenesis,cell cycle progression,transcriptional regulation,oncogenic potential,nucleolar function maintenance,genomic stability disruption
ENSG00000135643,KCNMB4,amplification,cellular excitability,calcium-activated potassium channel,cell proliferation,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000145936,KCNMB1,downregulation,disrupted potassium channels,cell proliferation enhancement,tumor suppression loss,signaling pathway alteration,protein-protein interaction
ENSG00000179915,NRXN1,cell proliferation enhancement,signal transduction regulation,tumor suppression inhibition,apoptosis blockade,synaptic transmission alteration,signaling pathway activation
ENSG00000145555,MYO10,cell migration,actomyosin interaction,tumor progression,biomarker potential,cytoskeletal regulation,metastasis promotion
ENSG00000197530,MIB2,cell cycle regulation,cyclin-dependent kinase phosphorylation,cell proliferation,g1/s phase transition,uncontrolled cell division,tumor growth
ENSG00000244005,NFS1,iron-sulfur cluster assembly,cysteine desulfurase activity,cell growth regulation,dna repair pathway,tumor development driver,cellular metabolism modulation
ENSG00000163746,PLSCR2,phospholipid scrambling,tumor progression,cell migration,metastasis facilitation,immune evasion mechanism,therapeutic target
ENSG00000150551,LYPD1,tumor invasion,epithelial-to-mesenchymal transition (emt),transmembrane glycoprotein,cell adhesion,cancer driver gene,biomarker
ENSG00000180992,MRPL14,mitochondrial ribosomal protein,overexpression in cancer,cell proliferation regulation,pi3k/akt signaling pathway modulation,poor prognosis indicator,mtor complex 1 interaction
ENSG00000197134,ZNF257,epigenetic regulation,tumor suppressor regulation,chromatin remodeling,cell cycle progression,apoptosis modulation,oncogene regulation
ENSG00000128652,HOXD3,transcriptional regulation,cellular growth,angiogenesis modulation,tumor progression,apoptosis suppression,genomic binding sites
ENSG00000182132,KCNIP1,mtor pathway regulation,cellular proliferation modulation,apoptosis suppression,dna damage response dysregulation,tumor suppressor function alteration,genomic instability promotion
ENSG00000029639,TFB1M,26s proteasome regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,protein homeostasis maintenance,genomic instability prevention
ENSG00000197213,ZSCAN5B,overexpression,cell proliferation regulation,prognostic marker,tumor suppressor function,dna binding protein,transcriptional regulator
ENSG00000110888,CAPRIN2,enhanced cap-dependent translation,oncogenic process,mrna export facilitation,cell proliferation and survival,poor prognosis association,translation initiation regulation
ENSG00000133030,MPRIP,endocytosis,vesicle trafficking,protein-protein interaction,pi3k/akt pathway,oncogenesis,cell survival proliferation
ENSG00000104953,TLE6,transcriptional regulator,epithelial-to-mesenchymal transition,apoptosis inhibition,cell proliferation,tumor progression,therapeutic target
ENSG00000198740,ZNF652,transcriptional regulation,oncogene activity,genomic instability,cell cycle modulation,apoptosis inhibition,angiogenesis promotion
ENSG00000241343,RPL36A,enhanced protein synthesis,oncogenic process,chemotherapy resistance,cellular translation regulation,apoptosis inhibition,tumor growth promotion
ENSG00000205138,SDHAF1,mitochondrial electron transport chain regulation,metabolic reprogramming,tumor-promoting hypoxia,oncogenic mutations,genomic instability,angiogenesis driver
ENSG00000278695,GSTT2B,cellular redox regulation,detoxification processes,antioxidant enzyme activity,apoptosis modulation,tumor resistance,therapeutic target
ENSG00000110436,SLC1A2,amino acid transport,constitutive overexpression,oncogenic driver,metabolic pathway regulation,protein-protein interaction,poor prognosis marker
ENSG00000139910,NOVA1,rna-binding protein,oncogenic transformation,tumor progression,cell proliferation,post-transcriptional regulation,poor prognosis
ENSG00000102001,CACNA1F,calcium channel regulation,tumor progression,epithelial-to-mesenchymal transition,proliferation,cellular signaling,prognostic marker
ENSG00000138829,FBN2,angiogenesis promotion,cell adhesion modulation,frequent overexpression,microfibril disruption,metastasis facilitation,tgf-β pathway interaction
ENSG00000011347,SYT7,cellular trafficking,membrane fusion,oncogenic signaling,protein-protein interaction,apoptosis modulation,cell cycle regulation
ENSG00000010327,STAB1,cell surface interaction,actin cytoskeleton regulation,metastasis promotion,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,cancer cell invasion facilitation
ENSG00000149782,PLCB3,regulation of cell signaling,overexpression in cancer,activation of pi3k/akt pathway,enhanced cell proliferation,immune response modulation,tumor progression and metastasis
ENSG00000129968,ABHD17A,lipid metabolism regulation,cell proliferation promotion,tumor aggressiveness association,poor prognosis correlation,genomic overexpression,signaling pathway modulation
ENSG00000076716,GPC4,wnt/β-catenin pathway,promotes tumor growth,cell adhesion modulation,prognostic marker,therapeutic target,heparan sulfate proteoglycan
ENSG00000148824,MTG1,tumor suppressor,transcription factor regulation,cell cycle progression inhibition,apoptosis promotion,downregulated in cancer,oncogenic transcription factor inhibition
ENSG00000130024,PHF10,dna damage response,tumor suppressor function,genomic instability,e3 ubiquitin ligase activity,chromatin modification,cell cycle regulation
ENSG00000100983,GSS,mitochondrial enzyme regulation,tumor growth promotion,glycoprotein synthesis dysregulation,energy metabolism alteration,warburg effect activation,abnormal glycosylation patterns
ENSG00000118246,FASTKD2,mitochondrial protein,oncogene amplification,energy metabolism regulation,cellular respiration,apoptosis inhibition,therapeutic target
ENSG00000164398,ACSL6,fatty acid synthesis,regulatory interaction,upregulated expression,biomarker identification,poor prognosis indicator,metabolic regulation
ENSG00000230763,HLA-DPB1,immune system modulation,tumor immune evasion,major histocompatibility complex (mhc) class ii,peptide presentation,cancer immunogenomics,genetic predisposition
ENSG00000144339,TMEFF2,apoptosis regulation,cell proliferation control,cell differentiation regulation,oncogenic pathway activation,transmembrane signaling,reduced expression in kirc
ENSG00000162813,BPNT1,oncogene,cell cycle regulation,nuclear and mitochondrial localization,protein-protein interaction,genomic instability,tumor progression marker
ENSG00000106723,SPIN1,chromatin remodeling,constitutive activation,oncogenic function,transcriptional regulation,cell cycle progression,apoptosis inhibition
ENSG00000142515,KLK3,tumor aggressiveness,oncogene activation,proteolytic activity,biomarker expression,cell migration,extracellular matrix remodeling
ENSG00000114026,OGG1,ber pathway,genomic stability maintenance,oxidative dna damage repair,epigenetic regulation,tumor suppression deficiency,gene mutation association
ENSG00000144369,FAM171B,signaling pathway modulation,protein-protein interaction,transcriptional regulation,tumor suppression,oncogenesis,cellular growth
ENSG00000135097,MSI1,cell cycle regulation,chromosomal instability,oncogene function,tumor development,cell division facilitation,epigenetic regulation
ENSG00000090539,CHRD,cellular adhesion disruption,tumor progression,metastasis,epithelial cell interaction,cytoskeleton association,signal transduction regulation
ENSG00000105409,ATP1A3,ion gradient regulation,cell signaling pathway,therapeutic target,oncogenic processes,tumor progression,potassium homeostasis
ENSG00000130477,UNC13A,enhanced expression,cell proliferation,mitochondrial dynamics,vesicle fusion,signaling pathway activation,tumor progression resistance
ENSG00000107331,ABCA2,cellular efflux,cholesterol transport regulation,tumor suppressor function,lipid metabolism modulation,poor prognosis marker,therapeutic target
ENSG00000115155,OTOF,calcium-dependent signaling,cell survival promotion,intracellular regulation,molecular interaction,prognostic marker,tumor progression facilitation
ENSG00000170989,S1PR1,pro-survival signaling,cell migration,constitutive activation,tumor progression,therapeutic target,g-protein coupled receptor
ENSG00000156876,SASS6,mitotic progression,genomic instability,cell cycle regulation,dna repair mechanisms,tumor progression,tumorigenesis
ENSG00000167114,SLC27A4,fatty acid metabolism,tumor cell growth,lipid uptake regulation,cell proliferation,protein-protein interaction,genomic alteration
ENSG00000011021,CLCN6,altered ion transport,apoptosis modulation,cell proliferation,dna damage response,ion homeostasis disruption,oncogenic signaling pathway activation
ENSG00000205744,DENND1C,mtor pathway regulation,gene overexpression,tumor progression,cell survival modulation,autophagy regulation,cancer prognosis association
ENSG00000135525,MAP7,microtubule dynamics,tumor progression,oncogenesis,cell division regulation,protein overexpression,metastasis facilitation
ENSG00000093183,SEC22C,er stress response,protein folding regulation,oncogenic signaling pathway,cell survival promotion,autophagy modulation,co-chaperone activity
ENSG00000067177,PHKA1,energy metabolism regulation,cellular respiration alteration,tumor growth promotion,apoptosis inhibition,cell cycle dysregulation,mitochondrial biogenesis enhancement
ENSG00000108389,MTMR4,phosphatase activity,oncogenic potential,cell proliferation,tumor growth,dephosphorylation,cancer progression
ENSG00000089639,GMIP,tumor microenvironment modulation,immune evasion mechanisms,protein-protein interaction,cellular proliferation regulation,apoptosis regulation,genomic amplification
ENSG00000168216,LMBRD1,lysosomal dysfunction,mitochondrial transport,amino acid metabolism,cell proliferation pathway,oncogenic role,metabolic regulation
ENSG00000162407,PLPP3,mitochondrial phospholipid metabolism,altered energy production,cancer progression,poor prognosis marker,tumor suppressor interaction,genomic instability
ENSG00000170458,CD14,tumor progression,inflammation regulation,immune suppression,apoptotic cell clearance,nf-kappab pathway activation,mapk signaling modulation
ENSG00000100373,UPK3A,cellular integrity,tumor aggressiveness,loss of function,cellular invasion,pi3k/akt signaling,tight junction disruption
ENSG00000110077,MS4A6A,immune evasion,cell proliferation,prognostic marker,therapeutic target,oncogene potential,tumor progression
ENSG00000213380,COG8,oncogene activation,cell proliferation regulation,tumor progression,protein transport regulation,genomic instability,epigenetic modification
ENSG00000137413,TAF8,dna replication,constitutive activation,cell proliferation,transcriptional regulation,tumor suppression,anti-apoptotic pathway
ENSG00000116852,KIF21B,cell proliferation,mitotic spindle assembly,kinesin family protein,tumor progression,cancer cell survival,rapid cell cycle progression
ENSG00000148200,NR6A1,nr6a1,tumor progression,epithelial-to-mesenchymal transition (emt),transcription factor regulation,prognostic biomarker,cell proliferation
ENSG00000152670,DDX4,cellular proliferation,apoptosis resistance,gene expression regulation,tumor growth promotion,metastasis promotion,rna processing
ENSG00000115592,PRKAG3,metabolic reprogramming,oncogenic driver,gamma subunit function,pka activation,cell proliferation,camp signaling
ENSG00000166454,ATMIN,dna repair,genomic instability,tumor suppression,chromatin remodeling,cell cycle regulation,atm kinase interaction
ENSG00000136514,RTP4,receptor tyrosine phosphatase function,cell adhesion regulation,signaling pathway activation,mapk/erk pathway interaction,oncogenic processes promotion,dysregulated expression
ENSG00000130649,CYP2E1,metabolic regulation,dna damage,oncogenic processes,cell proliferation,signaling pathway activation,protein interaction
ENSG00000125652,ALKBH7,ber pathway regulation,genomic stability maintenance,oxidative stress response modulation,tumor suppressor activity,dna damage repair,cancer progression contribution
ENSG00000184007,PTP4A2,pi3k/akt pathway modulation,oncogene activation,tumor progression facilitation,cell proliferation enhancement,signaling molecule interaction,gene expression alteration
ENSG00000105289,TJP3,tight junction disruption,loss of function mutation,epithelial-to-mesenchymal transition,cell migration,adhesion complex disruption,metastatic potential
ENSG00000274334,VASN,extracellular matrix regulation,tgf-β signaling,cell proliferation regulation,tumor suppressor/ oncogene function,aggressive disease progression marker,poor prognosis association
ENSG00000022567,SLC45A4,emt induction,melanin synthesis regulation,cell migration promotion,pi3k/akt pathway modulation,prognostic marker,oncogene function
ENSG00000120328,PCDHB12,cell adhesion,cell migration,tumor progression,poor prognosis,metastasis,cancer biology
ENSG00000139684,ESD,cell proliferation,tumor progression,apoptosis regulation,biomarker potential,signaling pathway modulation,protein-protein interaction
ENSG00000151881,TMEM267,epithelial-to-mesenchymal transition,cell adhesion disruption,oncogenic overexpression,tumor aggressiveness,prognostic biomarker,therapeutic target
ENSG00000182150,ERCC6L2,genomic instability,dna repair defects,transcriptional regulation,nucleotide excision repair,oncogenic function,poor prognosis marker
ENSG00000162390,ACOT11,lipid metabolism regulation,oncogene function,tumor progression marker,protein-protein interactions,cell growth promotion,poor prognosis correlation
ENSG00000102910,LONP2,**

1.  **protein stability regulation**,2.  **mitochondrial function**,3.  **cell survival and proliferation**,4.  **oncogene degradation**,5.  **tumorigenesis association**
6.  **therapeutic target potential**,none
ENSG00000080709,KCNN2,**
potassium channel regulation,ion homeostasis maintenance,tumor growth promotion,cell proliferation enhancement,metastasis facilitation,oncogenic signaling pathway interaction
**
ENSG00000182512,GLRX5,cellular redox balance,cell growth regulation,iron metabolism regulation,thioredoxin domain containing protein,cell survival promotion,apoptosis inhibition
ENSG00000119514,GALNT12,glycosylation regulation,oncogenic pathway activation,cell proliferation promotion,tumor progression facilitation,metastasis enhancement,therapeutic target candidate
ENSG00000011454,RABGAP1,rab gtpase regulation,tumor suppressor function,cell membrane trafficking,endocytosis regulation,growth inhibition pathway,apoptotic response modulation
ENSG00000161798,AQP5,water transport regulation,cellular homeostasis alteration,tumor growth promotion,ion balance disruption,therapeutic target identification,genomic instability association
ENSG00000171786,NHLH1,transcription factor regulation,epithelial-to-mesenchymal transition (emt),oncogene potential,cell proliferation modulation,survival pathway regulation,metastasis promotion
ENSG00000101457,DNTTIP1,genomic instability,dna replication,cell cycle regulation,oncogenic mutations,tumor suppressor function,therapeutic target
ENSG00000109956,B3GAT1,dysregulated gag biosynthesis,tumor progression,cell proliferation,gene expression profiling,biomarker for diagnosis,prognostic significance
ENSG00000182154,MRPL41,enhanced ribosome biogenesis,translation initiation,cell growth regulation,protein synthesis,cell proliferation,tumor suppressor
ENSG00000154133,ROBO4,robo4-mediated endothelial cell regulation,tumor suppressor activity,angiogenesis inhibition,cell migration modulation,vascular development regulation,patient prognosis correlation
ENSG00000158714,SLAMF8,tumor-associated immune suppression,immune modulation,cell signaling regulation,oncogenic activity,protein-protein interactions,tumor microenvironment modification
ENSG00000243910,TUBA4B,microtubule stabilization,cell proliferation,resistance to chemotherapy,apoptosis evasion,cell division regulation,poor prognosis
ENSG00000129518,EAPP,genomic instability,tumor progression,cell cycle regulation,protein degradation,cell signaling pathway,adaptor protein activity
ENSG00000131126,TEX101,immune evasion mechanisms,tumor progression marker,nk cell suppression,transmembrane protein function,cellular interaction regulation,prognostic significance
ENSG00000181418,DDN,g1/s transition regulation,cell cycle arrest,protein phosphatase activity,dna damage response,tumor suppressor function,brca2 interaction
ENSG00000121101,TEX14,genomic instability,dna repair facilitation,protein-protein interaction,tumor progression promotion,oncogenic potential,cellular proliferation enhancement
ENSG00000065057,NTHL1,genomic instability,impaired dna repair,reduced protein expression,tumor suppressor function,biomarker potential,nuclear localization
ENSG00000169347,GP2,tumor progression,cell adhesion regulation,metastasis promotion,oncogenic process enhancement,cell migration modulation,signaling pathway interaction
ENSG00000124172,ATP5F1E,mitochondrial metabolism,energy production,tumor progression,therapeutic target,cellular transformation,protein subunit interaction
ENSG00000148795,CYP17A1,steroidogenesis,androgen production,autocrine signaling,tumor progression,therapeutic target,genomic instability
ENSG00000139620,KANSL2,genomic instability,epigenetic regulation,tumor suppression,chromatin remodeling,cell cycle control,apoptosis regulation
ENSG00000100982,PCIF1,cell cycle regulation,chromatin remodeling,transcriptional coactivation,tumor progression,apoptosis inhibition,protein-protein interaction
ENSG00000090263,MRPS33,mitochondrial ribosome function,constitutive activation of signaling pathways,g2/m cell cycle regulation,dysregulated energy production,cancer progression driver,tumor suppressor dysfunction
ENSG00000164054,SHISA5,wnt signaling regulation,tumor suppressor function,epigenetic silencing,cellular proliferation regulation,methylated gene,β-catenin interaction
ENSG00000126952,NXF5,nuclear mrna export factor,tumor growth promotion,oncogene function,gene expression regulation,cell cycle progression,poor prognosis marker
ENSG00000204577,LILRB3,immune modulation,tumor microenvironment,mhc class i binding,cytotoxic t-cell suppression,cell proliferation,cell survival
ENSG00000065609,SNAP91,mitochondrial dynamics,cancer progression,glycolytic reprogramming,tumor suppressor interaction,cell survival enhancement,mitochondrial function regulation
ENSG00000145217,SLC26A1,tumor suppressor function,epithelial ion transport regulation,cellular homeostasis disruption,oncogenic pathway activation,pi3k/akt/mtor signaling,cell survival and proliferation enhancement
ENSG00000127366,TAS2R5,bitter taste receptor,cell signaling modulation,oncogenesis contribution,immune evasion mechanisms,chemosensation regulation,protein interaction network
ENSG00000186049,KRT73,epithelial maintenance,cellular integrity,tumorigenesis association,keratin protein heterodimerization,mechanical strength modulation,adhesion property alteration
ENSG00000205364,MT1M,metal ion binding,cell proliferation,tumor progression,nf-κb pathway interaction,protein stability regulation,cysteine-rich domain
ENSG00000186967,KRTAP19-4,cellular adhesion modulation,cancer cell migration,epithelial integrity disruption,tumor progression,kap family member,cytoskeletal regulation
ENSG00000164751,PEX2,peroxisome biogenesis,cellular proliferation,tumorigenesis,oncogene potential,protein importation,genomic instability
ENSG00000136521,NDUFB5,mitochondrial dysfunction,energy metabolism alteration,glycolysis enhancement,oxidative stress induction,cellular signaling pathway disruption,potential tumor suppressor gene
ENSG00000111897,SERINC1,apoptosis regulation,tumor suppression,viral entry inhibition,membrane trafficking regulation,oncogenic process inhibition,poor prognosis association
ENSG00000116985,BMP8B,tumor suppressor,cell proliferation inhibition,apoptosis induction,dna damage response regulation,poor prognosis marker,metastasis promotion
ENSG00000115020,PIKFYVE,autophagy regulation,endocytosis promotion,lysosomal function,oncogenic signaling,pi3p metabolism,protein kinase activation
ENSG00000278165,DUSP8,aberrant mapk activation,tumor suppressor function,biomarker identification,cancer cell survival,immune response modulation,cellular differentiation
ENSG00000130176,CNN1,tumor progression,wnt/β-catenin signaling,apoptosis inhibition,cytoskeletal remodeling,e-cadherin degradation,cell migration facilitation
ENSG00000185565,LSAMP,tumor progression,cell adhesion regulation,immune modulation,oncogenic drivers,tumor suppressor function,epithelial-to-mesenchymal transition (emt)
ENSG00000183840,GPR39,overexpression,pi3k/akt signaling pathway,cell proliferation,survival and migration,wnt/β-catenin pathway interaction,therapeutic target
ENSG00000163738,MTHFD2L,...,none,none,none,none,none
ENSG00000204237,OXLD1,lipid metabolism regulation,gene expression alterations,oxidative stress management,cellular detoxification,tumor progression modulation,lipid peroxidation regulation
ENSG00000223547,ZNF844,regulation of gene expression,tumor progression,apoptosis regulation,cell cycle regulation,transcriptional modulation,zinc finger protein family
ENSG00000105085,MED26,transcriptional regulation,mediator complex function,oncogene activation,tumor growth promotion,apoptosis suppression,cell cycle regulation
ENSG00000189221,MAOA,angiogenesis,biomarker,cell invasion,metastasis,neurotransmitter regulation,tumor progression
ENSG00000132688,NES,protein regulation,transcriptional regulation,nuclear protein transport,tumor progression,therapeutic target,genomic instability
ENSG00000180660,MAB21L1,oncogene,transcription factor,tumor suppressor inhibition,cell proliferation promotion,epithelial-to-mesenchymal transition,apoptosis suppression
ENSG00000276615,KEL,pi3k/akt pathway regulation,genomic instability,tumor suppressor function,ubiquitin ligase complex formation,cell cycle regulation,dna repair interactions
ENSG00000177125,ZBTB34,tumor suppressor,transcription regulation,dna repair,apoptosis regulation,cell cycle progression,genomic instability
ENSG00000126091,ST3GAL3,sialyltransferase activity,glycan biosynthesis,cell proliferation,immune evasion,tumor progression,metastasis promotion
ENSG00000111331,OAS3,interferon-induced antiviral pathway,oncogenic potential,immune evasion,tumor progression,antiviral defense,innate immune modulation
ENSG00000166455,C16orf46,apoptosis regulation,tumor suppressor function,protein-protein interaction,cell cycle regulation,genomic stability maintenance,programmed cell death pathway
ENSG00000109758,HGFAC,cell proliferation,signal transduction,tumor progression,metastasis,cell growth regulation,protein-protein interaction
ENSG00000176920,FUT2,cellular signaling,tumor progression,epithelial-to-mesenchymal transition,glycosylation pathway,metastasis facilitation,stem-like properties
ENSG00000142512,SIGLEC10,tumor microenvironment modulation,immunosuppressive microenvironment creation,cell adhesion regulation,protein-protein interactions,immune response suppression,cell proliferation promotion
ENSG00000091640,SPAG7,p53 regulation,tumor suppressor function,chromatin remodeling,dna repair,genomic instability,prognostic marker
ENSG00000077684,JADE1,chromatin remodeling,transcriptional regulation,epithelial-to-mesenchymal transition,oncogenic potential,microrna processing,somatic mutations
ENSG00000119915,ELOVL3,vlcfa biosynthesis,cell proliferation,apoptosis inhibition,prognostic biomarker,pi3k/akt/mtor pathway activation,tumor progression
ENSG00000184185,KCNJ12,cellular ph regulation,constitutive activation,ion balance dysregulation,oncogenic transformation,tumor progression,therapeutic target
ENSG00000284039,KIR2DS3,immune evasion,nk cell activation,killer-cell immunoglobulin-like receptor,hla-c ligand interaction,tumor immune microenvironment,cancer immunity
ENSG00000128512,DOCK4,rho gtpase activation,cell migration promotion,guinea nucleotide exchange factor,lamellipodia formation regulation,tumor progression contributor,amplicon in cancer
ENSG00000166862,CACNG2,erbb4 pathway modulation,constitutive activation,gain of function mutations,tumor progression,cellular proliferation,metabolic regulation
ENSG00000166136,NDUFB8,mitochondrial electron transport,cellular energy production,metabolic reprogramming,tumor progression,oncogenic mutations,energy metabolic shift
ENSG00000175787,ZNF169,zinc finger protein regulation,transcriptional activation,cell cycle regulation,apoptosis modulation,chromatin remodeling,tumor suppressor regulation
ENSG00000079691,CARMIL1,actin cytoskeleton regulation,cell migration,metastatic potential,tumor aggressiveness,protein interaction,cancer progression
ENSG00000175348,TMEM9B,apoptosis regulation,cellular proliferation,genetic instability,tumor growth modulation,tumorigenesis contribution,stress response regulation
ENSG00000181690,PLAG1,tumor progression,gain of function mutations,transcriptional regulation,oncogene activation,pi3k/akt pathway interaction,therapeutic target
ENSG00000102384,CENPI,genomic instability,chromosomal segregation errors,tumor progression,kinetic interaction,protein phosphorylation,cell cycle regulation
ENSG00000125637,PSD4,proteasome function,cellular proliferation,apoptosis regulation,ubiquitin-proteasome system,cancer prognosis,p53 degradation
ENSG00000027001,MIPEP,energy metabolism regulation,metabolic reprogramming,cellular stress response modulation,oncogenic adaptation,tumor progression facilitation,protein-protein interaction
ENSG00000176715,ACSF3,lipid biosynthesis regulation,oncogenic lipid metabolism,tumor growth promotion,metastasis facilitation,biomarker potential,therapeutic target candidate
ENSG00000001036,FUCA2,tumor progression,cell adhesion modulation,glycoprotein breakdown,extracellular matrix regulation,metastasis facilitation,glycosidase activity
ENSG00000183077,AFMID,genetic instability,tumor progression,dna repair pathway,genomic stability,s-phase regulation,cancer driver gene
ENSG00000189046,ALKBH2,dna demethylation,tumor progression,genome instability,oxidative stress response,cellular response regulation,mutagenesis prevention
ENSG00000171989,LDHAL6B,aerobic glycolysis,warburg effect,anabolic metabolism,cell proliferation,energy metabolism regulation,therapeutic target
ENSG00000140488,CELF6,rna-binding activity,transcriptional regulation,cell proliferation,alternative splicing,metastasis,prognostic marker
ENSG00000148834,GSTO1,dna damage response,genetic instability,tumor suppressor function,cellular detoxification,apoptosis regulation,tumor progression
ENSG00000142207,URB1,ribosome assembly,rna processing regulation,tumor progression association,protein stability alteration,oncogene potential,ribosomal protein interaction
ENSG00000111863,ADTRP,regulatory protein function,transcriptional regulation,androgen receptor signaling,cell growth regulation,prognostic marker,tumor progression
ENSG00000131400,NAPSA,cellular growth regulation,signaling pathway interaction,cell proliferation control,protein processing modulation,tumor progression association,metastasis link
ENSG00000121406,ZNF549,chromatin remodeling,transcriptional regulation,proliferation enhancement,invasion promotion,cancer biomarker,therapeutic target
ENSG00000064601,CTSA,tnf-alpha processing,inflammation regulation,cancer cell invasion,therapeutic target,metalloprotease activity,prognostic marker
ENSG00000051825,MPHOSPH9,centrosome regulation,genomic stability,tumor suppressor function,mitotic checkpoint regulation,chromosomal instability prevention,aneuploidy suppression
ENSG00000100271,TTLL1,microtubule dynamics,tumor suppressor function,mitotic catastrophe,genomic instability,aberrant microtubule stabilization,angiogenesis promotion
ENSG00000174579,MSL2,histone modification regulation,chromatin remodeling,oncogene overexpression,gene expression dysregulation,cell proliferation promotion,transcriptional regulation alteration
ENSG00000158545,ZC3H18,epigenetic regulation,transcriptional control,chromatin remodeling,gene expression modulation,cell proliferation regulation,histone modification interaction
ENSG00000148672,GLUD1,glutamine metabolism,metabolic reprogramming,chemotherapy resistance,tumor growth promotion,cellular proliferation,energy production regulation
ENSG00000232616,SKIV2L,genomic instability,tumor suppressor function,rna helicase activity,transcriptional regulation,cellular growth regulation,epigenetic modification
ENSG00000100285,NEFH,neurofilament stabilization,tumor progression,microtubule regulation,cell migration,cytoskeletal organization,cancer metastasis
ENSG00000178234,GALNT11,oncogenic pathway activation,tumor progression enhancement,protein modification regulation,glycosylation initiation,cell surface receptor modulation,therapeutic target potential
ENSG00000127419,TMEM175,mitochondrial dynamics,autophagy regulation,ca2+ signaling disruption,mitofusin 2 interaction,cell death modulation,tumor suppressor function
ENSG00000110066,KMT5B,histone methyltransferase activity,oncogenic function,cell cycle progression,apoptosis inhibition,tumor aggressiveness,protein interaction regulation
ENSG00000185053,SGCZ,calcium homeostasis regulation,pi3k/akt pathway interaction,cellular metabolism modulation,epithelial-to-mesenchymal transition regulation,tumor growth promotion,metastasis facilitation
ENSG00000176024,ZNF613,krüppel c2h2 zinc finger protein,dna binding activity,transcriptional regulation,gene expression modulation,zinc finger structure,cancer-related transcription factor interaction
ENSG00000125304,TM9SF2,lipid transport regulation,membrane fluidity modulation,cholesterol metabolism dysregulation,oncogenic driver potential,tumor progression association,genomic alterations identification
ENSG00000198569,SLC34A3,genomic instability,chromosomal alterations,tumor progression,phosphate homeostasis modulation,cancer aggressiveness,cell signaling regulation
ENSG00000147799,ARHGAP39,rho gtpase regulation,tumor suppressor function,loss of function mutation,cell proliferation inhibition,oncogenic signaling pathway,cell cycle progression regulation
ENSG00000273706,LHX1,transcriptional regulation,wnt/?-catenin signaling,cell proliferation,oncogenic function,tumor progression,immune evasion
ENSG00000143457,GOLPH3L,glycosylation regulation,overexpression,cell proliferation,mtor pathway activation,tumor progression,oncogene overactivation
ENSG00000159884,CCDC107,centriolar satellite protein,mitotic spindle regulation,ciliogenesis dysfunction,cellular proliferation driver,genomic instability promoter,protein kinase substrate
ENSG00000196368,NUDT11,genomic instability,dna repair mechanism,tumor suppressor function,platinum-based drug sensitivity,cell survival promotion,apoptosis resistance
ENSG00000156076,WIF1,wnt/β-catenin pathway inhibition,tumor suppressor activity,cell proliferation regulation,cancer metastasis,cell survival modulation,genetic alterations
ENSG00000029993,HMGB3,apoptosis regulation,cell proliferation enhancement,dna repair modulation,oncogene activation,pi3k/akt pathway interaction,transcriptional regulation
ENSG00000131495,NDUFA2,mitochondrial respiratory complex,gain of function mutations,increased expression,cellular energy metabolism,tumor progression,oncogenic process
ENSG00000132591,ERAL1,rna-binding protein,oncogenic processes,cell growth promotion,metastasis enhancement,dysregulated expression,cancer progression
ENSG00000163634,THOC7,mrna export,trex-2 complex,transcriptional regulation,cellular proliferation,genetic instability,nuclear pore complex
ENSG00000276880,IFI27L1,oncogenic function,tumor progression,poor prognosis,apoptosis regulation,angiogenesis modulation,stat3/nf-κb interaction
ENSG00000178252,WDR6,chromatin remodeling,oncogene overexpression,ubiquitination regulation,cell cycle progression,tumor suppressor degradation,protein kinase activation
ENSG00000107669,ATE1,mitochondrial enzyme activity,promotes cancer cell survival,regulates cellular redox balance,hypoxia-inducible factor 1-alpha interaction,tumor progression correlate,gluconeogenesis modulation
ENSG00000171819,ANGPTL7,metabolic regulation,oncogene activation,tumor cell proliferation,survival signaling pathway,growth factor receptor interaction,lipid metabolism dysregulation
ENSG00000172380,GNG12,g-protein signaling,tumor progression,cell proliferation,angiogenesis,metastasis,oncogene activation
ENSG00000102100,SLC35A2,glycosylation pathway,prognostic marker,metastasis regulator,cell proliferation enhancer,antigen presentation,immune evasion mechanism
ENSG00000117620,SLC35A3,nucleotide sugar transporter function,glycolysis regulation,gluconeogenesis modulation,tumor growth facilitation,metabolic reprogramming,oncogenic driver mutation
ENSG00000072422,RHOBTB1,tumor suppression,apoptosis inhibition,cell growth regulation,genomic instability,nf-κb signaling pathway activation,c-myc activation
ENSG00000130158,DOCK6,cell migration and invasion,tumor progression and metastasis,gtpase activation and regulation,signaling pathway modulation,genetic alteration and mutation,cancer-related signaling cascades
ENSG00000175087,PDIK1L,cancer-related modification,tumor progression,epigenetic regulation,chromatin remodeling,biomarker potential,cellular proliferation
ENSG00000136144,RCBTB1,protein stability regulation,tumor suppressor protein degradation,oncogenic pathway activation,transcriptional regulation influence,genomic instability promotion,aneuploidy association
ENSG00000072657,TRHDE,loss of function mutations,chromatin remodeling,histone modifications,tumor suppressor function,cell cycle regulation,gene expression programs
ENSG00000131174,COX7B,cellular respiration,mitochondrial dysfunction,energy metabolism regulation,tumor progression,metabolic adaptation,oncogenic transformation
ENSG00000137714,FDX1,redox regulation,cancer driver,oncogene overexpression,cellular metabolism,electron transfer chain,antioxidant defenses
ENSG00000131055,COX4I2,mitochondrial respiration,metabolic reprogramming,electron transport chain,cytochrome c oxidase activity,oxidative phosphorylation,cellular adaptation
ENSG00000182732,RGS6,mtor pathway regulation,constitutive activation,g-protein signaling modulation,cell proliferation enhancement,tumor suppressor/tumor promoter,genomic alterations
ENSG00000155545,MIER3,cell proliferation regulation,apoptosis inhibition,chromatin remodeling,oncogenic role,cell cycle progression,tumor progression
ENSG00000151445,VIPAS39,microtubule regulation,mitotic progression,oncogenesis,cell proliferation,cellular division,biomarker potential
ENSG00000105642,KCNN1,cellular regulation,dysregulation of function,upregulation,prognostic marker,tumor progression,potential therapeutic target
ENSG00000102109,PCSK1N,cellular signaling modulation,cholesterol metabolism regulation,lipid synthesis alteration,tumor progression facilitation,overexpression association,cancer cell metabolism influence
ENSG00000109610,SOD3,oxidative stress modulation,antioxidant defense mechanism,genetic instability,cell proliferation enhancement,thiol antioxidant function,redox regulation interaction
ENSG00000135315,CEP162,centrosome amplification,genomic instability,microtubule dynamics,overexpression correlation,cancer cell resistance,therapeutic target
ENSG00000105997,HOXA3,transcriptional regulator,tumor progression driver,cell growth promotion,oncogenic process involvement,signaling pathway modulation,chromatin remodeling
ENSG00000141639,MAPK4,erk/jnk pathway regulation,cell cycle progression,apoptosis regulation,tumor growth promotion,metastasis facilitation,prognostic marker
ENSG00000135597,REPS1,cell cycle regulation,oncogene,g1/s phase transition,protein-protein interactions,apoptosis inhibition,tumor aggressiveness
ENSG00000138468,SENP7,tumor suppressor regulation,dna damage response,cellular growth control,apoptosis regulation,proteolytic activity regulation,genome stability maintenance
ENSG00000182175,RGMA,tumor progression,angiogenesis,inflammatory response,immune evasion,tumor growth,prognostic marker
ENSG00000162654,GBP4,immune evasion mechanism,cell survival pathway activation,tumor microenvironment modulation,macrophage inhibition,prognostic marker candidate,oncogene/tumor suppressor dual-function
ENSG00000136286,MYO1G,cell migration,apoptosis regulation,endoplasmic reticulum stress,cytoplasmic vesicle transport,mitotic progression,protein-protein interaction
ENSG00000042980,ADAM28,tumor progression,metastasis,cell adhesion,proteolysis,cancer biomarker,breast cancer-associated gene
ENSG00000105926,MPP6,wnt/β-catenin pathway,constitutive activation,cell survival enhancement,tumor progression driver,epithelial-to-mesenchymal transition regulation,prognostic biomarker
ENSG00000077232,DNAJC10,endoplasmic reticulum stress response,mitophagy regulation,protein chaperone function,cellular stress responses,autophagy modulation,chromosome 22q13.32 location
ENSG00000164011,ZNF691,transcriptional regulation,oncogene activation,tumor suppression,krab domain-containing family,cell proliferation,apoptosis regulation
ENSG00000138107,ACTR1A,cellular proliferation,signal transduction,heterotrimeric g-protein complex,cell cycle progression,oncogenic mutation,biomarker candidate
ENSG00000101470,TNNC2,tumor aggressiveness,overexpression,cell proliferation,poor prognosis,cell cycle regulation,apoptosis modulation
ENSG00000113971,NPHP3,ciliary dysfunction,impaired intraflagellar transport,protein-protein interaction,cell cycle regulation,tumor suppressor function,kidney development
ENSG00000182963,GJC1,gap junction communication,oncogenesis,cellular signaling modulation,tumor growth facilitation,metastasis promotion,poor prognostic marker
ENSG00000101187,SLCO4A1,efflux transporter,cellular membrane transport,tumor progression,renal cell carcinoma,kidney cell expression,chemotherapy resistance
ENSG00000126353,CCR7,tumor progression,metastasis,immune evasion,biomarker,prognostic marker,tumor microenvironment
ENSG00000106436,MYL10,cellular contraction,cell adhesion molecule,cytoskeletal regulation,gain of function mutations,oncogenesis,protein-protein interaction
ENSG00000141349,G6PC3,warburg effect,glycolytic regulation,metabolic reprogramming,tumor growth promotion,oncogene interaction,glycemic control disruption
ENSG00000155906,RMND1,mitochondrial dysfunction,loss-of-function mutations,cell proliferation,metabolic shift,oncogenic processes,cellular metabolism
ENSG00000177045,SIX5,cell cycle regulation,tumor progression,transcriptional regulation,dna repair mechanisms,genome instability,poor prognosis
ENSG00000281818,MANSC1,apoptosis regulation,cellular proliferation,protein kinase activity,tumor growth promotion,biomarker potential,genomic overexpression
ENSG00000182533,CAV3,regulatory dysfunction,loss of function mutations,mtor pathway activation,cell proliferation,oxidative stress resistance,wnt/β-catenin pathway interaction
,IMPAD1,pi3k/akt pathway activation,guanine nucleotide biosynthesis,cellular proliferation enhancement,tumor progression facilitation,therapeutic target,genomic amplification
ENSG00000206487,C6orf136,apoptosis regulation,pi3k/akt pathway interaction,cell proliferation enhancement,tumor progression association,necrosis modulation,gene expression regulation
ENSG00000106333,PCOLCE,emt pathway interaction,extracellular matrix regulation,tumor growth promotion,signaling pathway activation,collagen synthesis enhancement,metastasis facilitation
ENSG00000109674,NEIL3,genomic instability,tumor suppressor function,dna damage repair,base excision repair,oxidative stress resistance,cell cycle regulation disruption
ENSG00000124067,SLC12A4,amplified gene,electrolyte imbalance,potassium regulation,sodium reabsorption,tumor progression,ion transport dysfunction
ENSG00000171680,PLEKHG5,oncogenic driver,pi3k/akt pathway regulation,cell survival and growth enhancement,tumor progression promotion,genomic amplification,protein-protein interaction modulation
ENSG00000077157,PPP1R12B,pp1 regulation,tumor growth promotion,genomic instability,aneuploidy induction,cell cycle modulation,pi3k/akt pathway interaction
ENSG00000154655,L3MBTL4,epigenetic regulation,chromatin compaction,dna repair disruption,genomic instability,tumor suppressor gene silencing,oncogenic pathway activation
ENSG00000276747,PADI6,chromatin regulation,cell proliferation,gene expression,therapeutic target,post-translational modification,protein interaction
ENSG00000105549,THEG,cellular proliferation,transcriptional regulation,oncogene potential,apoptosis inhibition,prognostic biomarker,therapeutic target
ENSG00000277443,MARCKS,cell signaling,epithelial-to-mesenchymal transition,metastasis,oncogenic transformation,phosphorylation activity,protein kinase activation
,MARCH9,ubiquitination regulation,tumor suppressor function,protein degradation,oncoprotein targeting,cell proliferation regulation,e3 ligase interaction
ENSG00000092377,TBL1Y,transcriptional co-regulator,cell cycle regulation,apoptosis modulation,protein-dna interaction,gene expression regulation,cancer susceptibility
ENSG00000169594,BNC1,dna repair deficiency,genomic instability,cell proliferation enhancement,apoptosis suppression,tumor suppressor function,p53 pathway interaction
ENSG00000185133,INPP5J,phosphatidylinositol signaling pathway,loss of function mutations,tumor suppressor activity,cell proliferation,constitutive activation of pi3k pathway,genomic instability
ENSG00000123360,PDE1B,cancer driver mutations,regulation of camp,cgmp signaling pathway,cell proliferation,metastasis promotion,protein kinase regulation
ENSG00000241863,RPP21,ribosome biogenesis,mtor pathway activation,genomic instability,oncogene overexpression,transcriptional regulation disruption,apoptosis evasion
ENSG00000100473,COCH,tumor suppression,cell adhesion disruption,calcium signaling dysregulation,apoptosis inhibition,cell proliferation enhancement,protein interaction alterations
ENSG00000285501,AGBL2,oncogene activity,epigenetic regulation,histone modification,tumor suppressor potential,cellular proliferation,chromatin remodeling
ENSG00000196652,ZKSCAN5,tumor progression,transcriptional repression,cell cycle regulation,apoptosis suppression,angiogenesis promotion,metastasis facilitation
ENSG00000109180,OCIAD1,tumor progression,pi3k/akt pathway,lipid metabolism regulation,oncogenic signaling,epigenetic regulation,biomarker potential
ENSG00000172262,ZNF131,transcriptional regulation,tumor suppressor function,apoptosis regulation,cell growth control,nuclear localization,genomic instability
ENSG00000086102,NFX1,transcriptional regulation,cell proliferation,oncogene activation,apoptosis inhibition,transcription factor binding,cancer progression
ENSG00000124357,NAGK,n-acylated protein modification,tumor progression,protein acylation regulation,p53 pathway modulation,lipid metabolism,cell survival enhancement
ENSG00000184659,FOXD4L4,cell growth regulation,oncogenic properties,tumor progression,transcriptional regulation,protein-protein interaction,cancer stem cell maintenance
ENSG00000196911,KPNA5,nuclear transport,transcription factor regulation,cell proliferation,oncogenesis,cancer stem cells,therapeutic target
ENSG00000103174,NAGPA,glutamate biosynthesis,mitochondrial function,proliferation promotion,tumor progression,cell survival regulation,mtor pathway activation
ENSG00000142677,IL22RA1,il-22 signaling pathway,oncogenic function,aberrant expression levels,cell growth promotion,jak/stat pathway interaction,tissue repair regulation
ENSG00000197894,ADH5,metabolic regulation,oxidative stress,cell proliferation,dna damage,ros formation,aldehyde detoxification
ENSG00000221818,EBF2,emt regulation,tumor progression,mutation associated,proliferation promotion,cell migration,transcriptional regulator
ENSG00000172818,OVOL1,tumor suppressor,transcriptional repressor,epithelial-to-mesenchymal transition inhibition,cell cycle regulation,apoptosis promotion,chromatin modification
ENSG00000256683,ZNF350,chromatin remodeling,transcriptional regulation,tumor progression,cell proliferation,apoptosis regulation,oncogene activation
ENSG00000176294,OR4N2,**
olfactory receptor function,odorant detection,methylated gene,epigenetic regulation,cancer biomarker,tumor suppressor interaction
**
ENSG00000198765,SYCP1,genetic instability,oncogenic recombination,cell cycle regulation,apoptosis suppression,meiotic process interaction,protein-protein interaction
ENSG00000165233,CARD19,apoptosis regulation,cell survival pathway,oncogene potential,protein-protein interactions,signaling modulation,inflammation-related function
ENSG00000130204,TOMM40,**
mitochondrial dysfunction,cellular metabolism,reactive oxygen species generation,apoptosis resistance,tumor suppressor,mitochondrial biogenesis
ENSG00000283201,ZNF724,transcription regulation,oncogene activity,epithelial-to-mesenchymal transition,cell cycle progression,dna repair mechanisms,co-regulator interactions
ENSG00000114859,CLCN2,chloride channel regulation,tumor cell growth promotion,oncogenic process facilitation,epithelial-to-mesenchymal transition regulation,poor prognosis indicator,therapeutic target
ENSG00000172113,NME6,tumor suppressor function,cellular metabolism regulation,genomic instability prevention,signaling pathway interaction,apoptosis regulation,downregulated expression
ENSG00000059915,PSD,postsynaptic density complex,cell migration and invasion,tumor progression,signaling pathway regulation,protein-protein interactions,cancer biomarker
ENSG00000213901,SLC23A3,pyrimidine salvage pathway regulation,cell proliferation promotion,tumor progression driver,metabolic reprogramming,prognostic marker candidate,signaling molecule interaction
ENSG00000176340,COX8A,mitochondrial respiratory chain disruption,altered cellular metabolism,oxidative stress induction,glycolysis promotion,warburg effect involvement,aerobic glycolysis enhancement
ENSG00000111144,LTA4H,angiogenesis,leukotriene biosynthesis,pro-survival signaling,tumor growth promotion,metastasis,enzymatic activity
ENSG00000069188,SDK2,cellular signaling,cell proliferation regulation,potential oncogene involvement,phosphorylation activity,serine/threonine kinase function,tumor growth inhibition
ENSG00000182208,MOB2,p53 pathway regulation,apoptosis inhibition,cell cycle progression,dna repair modulation,oncogenic protein kinase activation,cancer cell survival enhancement
ENSG00000204710,SPDYC,emt regulation,stromal interaction,cell adhesion modulation,signaling pathway modulation,transcription regulation,cancer metastasis facilitation
ENSG00000136944,LMX1B,oncogene activity,proliferation regulation,apoptosis evasion,transcriptional modulation,wnt/β-catenin pathway interaction,cell cycle progression
ENSG00000173080,RXFP4,cell proliferation,signaling pathway regulation,cell survival enhancement,oncogenic processes,genomic alterations,protein-protein interaction
ENSG00000129197,RPAIN,genomic instability,dna repair defect,cell cycle regulation,therapeutic target,tumor suppressor function,oncogenic transformation
ENSG00000170325,PRDM10,chromatin regulation,tumor suppressor function,cell cycle arrest,senescence induction,dna repair pathway interaction,poor prognosis biomarker
ENSG00000156510,HKDC1,cellular stress response,oncogenic activity,tumor progression,metastasis,pi3k/akt pathway interaction,histidine kinase activity
ENSG00000011376,LARS2,cellular metabolism,energy production,poor prognosis,post-translational modifications,aminoacylation,regulatory protein translation
ENSG00000167074,TEF,transcriptional elongation,cell proliferation regulation,gene expression modulation,chromatin remodeling interaction,cell cycle control involvement,tumor suppressor function
ENSG00000135452,TSPAN31,cell adhesion regulation,tumor progression association,poor prognosis marker,epithelial-to-mesenchymal transition,overexpression in cancer,signaling pathway modulation
ENSG00000277725,KIR2DL2,potassium channel regulation,tumor growth support,cellular proliferation regulation,oncogenic pathway modulation,apoptosis resistance,electrical excitability dysregulation
ENSG00000146409,SLC18B1,glutamate transport regulation,tumor microenvironment modulation,immune response regulation,angiogenesis promotion,cell proliferation enhancement,synaptic plasticity modulation
ENSG00000107593,PKD2L1,transmembrane channel regulation,cellular proliferation enhancement,signaling pathway modulation,tumor progression facilitation,oncomorphic function association,calcium homeostasis dysregulation
ENSG00000271303,SRXN1,redox regulation,oxidative stress modulation,tumor progression,antioxidant defense mechanism,apoptosis regulation,cell survival pathway
ENSG00000163867,ZMYM6,chromatin remodeling,cell cycle regulation,dna repair,protein-protein interaction,transcriptional regulation,apoptosis inhibition
ENSG00000204548,DEFB121,epithelial cell expression,innate immunity regulation,antimicrobial activity,cell stress response,apoptosis modulation,cancer immunoediting
ENSG00000015133,CCDC88C,cellular proliferation,genomic instability,microtubule dynamics,coiled-coil domain protein,tumor suppressor function,centrosome organization
ENSG00000104112,SCG3,oncogene activity,metastasis regulation,cell migration promotion,extracellular matrix degradation,proteolytic activity enhancement,signaling pathway modulation
ENSG00000124107,SLPI,tumor microenvironment modulation,protease regulation,antibacterial activity,angiogenesis promotion,cell migration enhancement,tumor progression driver
ENSG00000119946,CNNM1,mitochondrial function regulation,cancer cell metabolism alteration,hypoxia response modulation,cellular calcium homeostasis disruption,tumor-promoting metabolic shift,enhanced cellular proliferation
ENSG00000176635,HORMAD2,**

* chromatin remodeling,* homologous recombination,* genomic instability,* aneuploidy,* tumor progression,* oncogenic driver
ENSG00000140807,NKD1,chromatin remodeling,transcriptional regulation,cellular proliferation,oncogenic driver,tumor progression,genomic instability
ENSG00000261787,TCF24,tumor suppression,epigenetic regulation,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,transcription factor activity,cell-cell adhesion
ENSG00000160949,TONSL,genomic instability,dna damage repair,cell cycle dysregulation,tumor progression,oncogene activation,cancer driver gene mutations
ENSG00000164691,TAGAP,cell adhesion disruption,immune evasion,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,tumor progression enhancement,metastasis facilitation
ENSG00000125850,OVOL2,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,cellular differentiation promotion,transcriptional regulation,apoptosis induction,therapeutic target
ENSG00000170476,MZB1,epigenetic modification,transcriptional coactivator,tumor progression,metastasis driver,chromatin remodeling,chemoresistance
ENSG00000149451,ADAM33,cellular adhesion,inflammation modulation,extracellular matrix degradation,gene expression regulation,metastatic facilitation,tumor progression
ENSG00000108799,EZH1,histone modification,tumor suppressor silencing,oncogene activation,cell proliferation regulation,epigenetic regulation,chromatin remodeling
ENSG00000187546,AGMO,lipid metabolism regulation,cell membrane interaction,apoptosis modulation,cell signaling pathway interaction,tumor suppressor or oncogene uncertain,metabolic adaptation relevant
ENSG00000172992,DCAKD,chromatin modification,epigenetic regulation,rna processing,gene expression modulation,tumor growth promotion,cell cycle progression disruption
ENSG00000085788,DDHD2,phosphoinositide biosynthesis,mitochondrial dysfunction,tumor progression,poor prognosis,cellular metabolism regulation,lipid homeostasis disruption
ENSG00000184634,MED12,genomic instability,pi3k/akt/mtor pathway activation,oncogenic transcriptional regulation,tumor suppressor dysfunction,cellular proliferation enhancement,epigenetic changes
ENSG00000177200,CHD9,genomic instability,chromatin remodeling factor,tumor suppressor function,pi3k/akt signaling pathway modulation,dna repair regulation,apoptosis regulator
ENSG00000136235,GPNMB,cell adhesion,epithelial-to-mesenchymal transition,glycoprotein regulation,metastasis promotion,transmembrane signaling,tumor progression
ENSG00000282813,ARMC10,**
chromatin remodeling,cell cycle regulation,genomic instability,oncogenic process,tumor suppressor activity,chromosome maintenance 
**
ENSG00000076555,ACACB,metabolic regulation,lipid synthesis,fatty acid biosynthesis,oncogenic processes,cancer metabolism,cell membrane biogenesis
ENSG00000114757,PEX5L,peroxysomal targeting,lipid metabolism alteration,cellular transformation driver,tumor suppressor function disruption,rapid cell growth enhancer,proliferation regulation imbalance
ENSG00000112769,LAMA4,angiogenesis promotion,cell adhesion disruption,integrin interaction,laminin receptor regulation,metastasis enhancement,oncogene overexpression
ENSG00000250361,GYPB,tumor progression,aberrant expression,cell adhesion regulation,mutation involvement,cancer development association,hemoglobin production relation
ENSG00000167771,RCOR2,chromatin remodeling,tumor suppressor function,dna repair mechanism,cell cycle regulation,epigenetic regulation,apoptosis evasion
ENSG00000172915,NBEA,cell survival,protein-protein interaction,cell proliferation,tumor growth,metastasis regulation,neuronal development
ENSG00000122386,ZNF205,zinc finger protein interaction,chromatin remodeling,oncogenic function,genome instability,dna damage response,transcriptional regulation
ENSG00000256797,KLRF2,cell adhesion disruption,metastasis promotion,epithelial-to-mesenchymal transition,oncogene overexpression,tumor progression,protein-protein interaction
ENSG00000134287,ARF3,genomic instability,tumor progression,constitutive activation,protein transport regulation,membrane trafficking modulation,biomarker potential
ENSG00000095383,TBC1D2,rab gtpase regulation,oncogenic pathway modulation,endosomal trafficking disruption,cellular protein accumulation,tumor progression facilitation,cancer driver gene status
ENSG00000099326,MZF1,transcriptional repressor,tumor microenvironment modulation,cellular differentiation regulation,epithelial-to-mesenchymal transition (emt),apoptosis suppression,angiogenesis promotion
ENSG00000205213,LGR4,wnt signaling pathway,co-receptor function,cell proliferation regulation,tumor progression driver,notch pathway interaction,apoptosis inhibition
ENSG00000105612,DNASE2,dna degradation,tumor microenvironment modulation,apoptotic cell clearance,immune response regulation,oncogenic function,upregulated expression
ENSG00000101180,HRH3,histamine regulation,g protein-coupled receptor,tumor growth promotion,angiogenesis facilitation,immune evasion support,autocrine signaling activation
ENSG00000172239,PAIP1,cell cycle regulation,mrna stability modulation,polyadenylation complex interaction,tumor suppressor function,oncogene upregulation,apoptosis inhibition
ENSG00000204962,PCDHA8,alteration in expression,cell adhesion disruption,homophilic and heterophilic interactions,signal transduction modulation,tumor suppressor activity uncertainty,none
ENSG00000133636,NTS,pi3k/akt pathway activation,angiogenesis promotion,cellular adaptation facilitation,tumor progression enhancement,therapeutic target identification,neuropeptide processing regulation
ENSG00000101188,NTSR1,neurotensin-ntsr1 signaling pathway,gain of function mutations,tumor progression,angiogenesis promotion,metastasis enhancement,immune suppression
ENSG00000063241,ISOC2,epigenetic regulation,histone modification,cell differentiation,metabolic rewiring,oxidative stress,dna methylation alterations
ENSG00000131480,AOC2,angiogenic factor secretion,biogenic amine synthesis,decarboxylation reaction,epithelial-to-mesenchymal transition,growth factor induction,metastatic potential
ENSG00000198689,SLC9A6,cellular reabsorption,glycolytic adaptation,hypoxia response element,ion channel regulation,metabolic remodeling,oncogenic transformation
ENSG00000164794,KCNV1,loss-of-function mutations,impaired potassium channel activity,increased cell proliferation,disrupted ion homeostasis,tumor growth promotion,pi3k/akt/mtor pathway activation
ENSG00000148840,PPRC1,tumor suppression,epigenetic regulation,chromatin remodeling,immune modulation,transcriptional regulation,emt process
ENSG00000130638,ATXN10,mitochondrial dysfunction,p53 regulation,cellular senescence,apoptosis inhibition,tumor suppression,polyglutamine expansion
ENSG00000155966,AFF2,gene expression regulation,cell proliferation,transcriptional activation,oncogenesis,tumor progression,genomic instability
ENSG00000167769,ACER1,pi3k/akt pathway interaction,apoptosis inhibition,angiogenesis promotion,tumor progression driver,biomarker potential,cell survival enhancement
ENSG00000134324,LPIN1,lipid metabolism regulation,oncogenic lipogenesis,cell proliferation enhancement,tumor progression facilitation,metabolic shift promotion,genomic amplification association
ENSG00000149182,ARFGAP2,autophagy regulation,gain of function mutations,overexpression,cell survival,tumor progression,signal transduction
ENSG00000116539,ASH1L,genomic instability,oncogene,epigenetic reprogramming,tumor progression,chromatin regulation,metastasis
ENSG00000124615,MOCS1,molybdenum cofactor biosynthesis,antioxidant response pathway,enhanced cell survival,oncogenic processes,tumor growth and progression,sulfur-containing compound accumulation
ENSG00000059588,TARBP1,microrna regulation,genome stability disruption,cell proliferation modulation,dna repair alteration,apoptosis suppression,tumor suppressor gene silencing
ENSG00000188778,ADRB3,lipid metabolism regulation,tumor growth promotion,cell proliferation enhancement,lipolysis regulation,thermogenesis influence,g protein-coupled receptor function
ENSG00000143314,MRPL24,ribosome biogenesis,gain of function mutations,oncogenic process,aberrant protein production,pi3k/akt pathway activation,therapeutic target
ENSG00000087008,ACOX3,metabolic rewiring,pentadecanoic acid pathway,mitochondrial enzyme,fatty acid breakdown,lipid metabolic network,oncogenic driver
ENSG00000175063,UBE2C,ubiquitination pathway,dysregulation,constitutive activation,mutations,anti-proliferative therapy target,cell cycle progression
ENSG00000070731,ST6GALNAC2,glycosyltransferase function,overexpression,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,tumor progression,prognostic marker
ENSG00000204624,DISP3,cell adhesion regulation,metastasis promotion,tumor progression,cell migration enhancement,notch-wnt signaling interaction,therapeutic target
ENSG00000203907,OOEP,cell proliferation,epigenetic regulation,metastasis,tumor progression,prognostic biomarker,cancer metastasis
ENSG00000060982,BCAT1,bcaa metabolism,tumor progression,mtor pathway activation,cell proliferation,therapeutic target,warburg effect
ENSG00000169255,B3GALNT1,altered glycosylation,overexpression,cellular proliferation,tumor progression,glycoprotein biosynthesis,cell signaling pathway
ENSG00000100403,ZC3H7B,chromatin remodeling,transcriptional regulation,pi3k/akt pathway activation,tumor progression,metastasis promotion,oncogenic mutation
ENSG00000162761,LMX1A,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor suppressor activity,emt regulation,oncogenic overexpression
ENSG00000122694,GLIPR2,tumor progression,cellular proliferation,apoptosis regulation,autophagy modulation,biomarker expression,signaling pathway regulation
ENSG00000196228,SULT1C3,steroid hormone regulation,metabolic pathway modulation,tumorigenesis association,enzymatic activity alteration,signaling pathway influence,cancer-related gene expression
ENSG00000163348,PYGO2,wnt/β-catenin signaling pathway interaction,oncogenic activation,epithelial-to-mesenchymal transition regulation,tumor cell proliferation promotion,cancer cell survival enhancement,histone modification regulation
ENSG00000141446,ESCO1,homologous recombination,genomic instability,enhanced dna repair,dna damage response,brca2 interaction,oncogenic potential
ENSG00000182400,TRAPPC6B,**

cellular trafficking,oncogenic activity,gain-of-function mutations,mtor pathway regulation,protein-protein interactions,cell proliferation enhancement

**
ENSG00000169635,HIC2,cellular proliferation,transcriptional regulation,tumor progression,prognostic marker,therapeutic target,epigenetic modification
ENSG00000100629,CEP128,centrosomal regulation,genomic instability,mitotic error,aneuploidy,cell division regulation,microtubule dynamics
ENSG00000116096,SPR,angiogenesis promotion,cell migration facilitation,tumor microenvironment interaction,integrin binding,prognostic biomarker,invasion enhancement
ENSG00000134109,EDEM1,erad pathway,constitutive overexpression,gain of function mutations,protein aggregation,therapeutic target,genomic profiling
ENSG00000163017,ACTG2,cell migration,actin filament regulation,protein-protein interaction,signaling pathway modulation,cancer progression,cytoplasmic organization
ENSG00000164344,KLKB1,tumor progression,angiogenesis,protein activation,vascular remodeling,cell migration,genomic instability
ENSG00000244057,LCE3C,**
cellular differentiation,gene expression regulation,apoptosis modulation,cell growth enhancement,skin barrier formation,tumor progression influence
**
ENSG00000100994,PYGB,glycolytic regulation,tumor metabolism,prognostic biomarker,therapeutic target,metabolic reprogramming,enzyme activity
ENSG00000164597,COG5,cog complex dysfunction,golgi apparatus maintenance,protein degradation regulation,autophagy modulation,mitochondrial function impact,tumor aggressiveness indicator
ENSG00000136240,KDELR2,protein trafficking regulation,cell growth and proliferation modulation,unfolded protein response activation,dysregulation and tumorigenesis association,kdelr2 expression correlation,upr induction
ENSG00000166451,CENPN,kinetochore complex,genomic instability,aneuploidy,cell cycle progression,cell proliferation,dna replication
ENSG00000186198,SLC51B,overexpression,tumor progression,enhanced cell survival,cell growth modulation,bile acid transport regulation,dysregulation of cellular behavior
ENSG00000140326,CDAN1,cell adhesion disruption,tumor progression promotion,epithelial-to-mesenchymal transition,cancer cell migration facilitation,poor prognosis association,therapeutic target candidacy
ENSG00000089820,ARHGAP4,rho gtpase regulation,tumor progression,cell migration,actin cytoskeleton organization,oncogenic processes,cancer driver gene
ENSG00000165434,PGM2L1,glycolytic regulation,oncogenic driver,tumor progression,metabolic adaptation,glycogen metabolism,cellular proliferation
ENSG00000183723,CMTM4,immune modulation,tumor progression,oncoprotein,biomarker,tumor microenvironment,cell cycle regulation
ENSG00000134755,DSC2,tumor progression,cell-cell adhesion disruption,epithelial-mesenchymal transition (emt),biomarker for prognosis,metastasis promotion,adhesion molecule regulation
ENSG00000075884,ARHGAP15,rhogtpase activation,cell migration,actin cytoskeleton regulation,tumor aggressiveness,signaling pathway modulation,protein-protein interaction
ENSG00000114923,SLC4A3,altered ion transport,tumor growth promotion,electrolyte regulation disruption,cell membrane alteration,overexpression association,ph balance disturbance
ENSG00000187140,FOXD3,emt activation,transcriptional regulation,epigenetic reprogramming,oncogenic transcription factor,chromatin remodeling,metastatic potential
ENSG00000168303,MPLKIP,mapk signaling inhibition,constitutive activation,tumor suppression,oncogenic transformation,cell cycle regulation,metabolic reprogramming
ENSG00000165506,DNAAF2,ciliary dysfunction,genomic instability,male infertility related mutations,mitotic spindle regulation,protein-protein interaction,wnt signaling pathway
ENSG00000117154,IGSF21,cell-cell adhesion,oncogene overexpression,angiogenesis promotion,metastasis facilitation,immune evasion,signal transduction modulation
ENSG00000070540,WIPI1,autophagy regulation,cellular homeostasis,oncogenic processes,tumor progression,prognostic marker,protein interaction
ENSG00000149256,TENM4,epithelial-to-mesenchymal transition,cell migration and invasion,transmembrane protein function,cadherin-catenin complex regulation,tumor progression and metastasis,protein-protein interaction
ENSG00000162692,VCAM1,tumor progression,angiogenesis promotion,cell adhesion modulation,immune evasion,inflammation induction,metastasis facilitation
ENSG00000175093,SPSB4,cell migration,tumor growth,epigenetic regulation,protein degradation,signal transduction pathway,transcriptional activation
ENSG00000156427,FGF18,fgf signaling pathway,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,angiogenesis inhibition,growth factor activity
ENSG00000123243,ITIH5,tumor progression,proteolytic regulation,cell survival enhancement,pathway modulation,inflammation mediator,oncogenic contribution
ENSG00000154227,CERS3,ceramide biosynthesis,tumor progression,apoptosis regulation,cell growth modulation,nf-kappa b pathway,pi3k/akt signaling
ENSG00000127463,EMC1,cell cycle regulation,cilia assembly,centriole duplication,oncogenic driver,tumor suppressor function,microtubule dynamics
ENSG00000129636,ITFG1,angiogenesis,promoter methylation,cancer metastasis,cell adhesion molecule,immune evasion,tumor progression
ENSG00000183963,SMTN,golgi apparatus regulation,microtubule stability,cell cycle regulation,apoptosis modulation,tumor progression,cancer biomarker
ENSG00000117000,RLF,cell cycle regulation,dna damage repair,apoptosis inhibition,genomic instability,transcriptional regulation,oncogene activation
ENSG00000030419,IKZF2,transcription factor activity,tumor progression,genomic instability,cell survival pathway,therapeutic target,chromosomal alteration
ENSG00000205649,HTN3,chromatin regulation,oncogenic mechanisms,cell proliferation,dna repair,histone modification,therapeutic target
ENSG00000136110,CNMD,cytoskeletal regulation,mutations leading to dysregulation,oncogenic processes,enhanced cell proliferation,cell survival regulation,therapeutic target
ENSG00000164944,VIRMA,dna repair mechanisms,genomic stability maintenance,tumor suppressor activity,cell cycle regulation,apoptosis modulation,chromatin remodeling
ENSG00000163673,DCLK3,microtubule stabilization,oncogenic potential,epithelial-to-mesenchymal transition regulation,proliferation promotion,survival enhancement,tumor aggression
ENSG00000148143,ZNF462,tumor growth,transcriptional regulation,oncogene activity,cell migration,apoptosis suppression,prognostic biomarker
ENSG00000089053,ANAPC5,genomic instability,chromosomal abnormalities,cell cycle dysregulation,mitotic progression,tumor aggressiveness,therapeutic target
ENSG00000145423,SFRP2,wnt pathway inhibition,tumor suppressor function,cell proliferation regulation,apoptosis modulation,inflammation regulation,immune system modulation
ENSG00000179528,LBX2,cellular regulation,chromatin modification,transcriptional regulation,tumor progression,cellular differentiation,aberrant expression
ENSG00000187134,AKR1C1,regulation of steroid hormone biosynthesis,cellular growth and proliferation,tumor progression,oncogene activation,metabolic regulation,gene expression upregulation
ENSG00000288118,GLUD2,metabolic reprogramming,cell proliferation,redox balance regulation,protein-protein interactions,mitochondrial function alteration,tumor aggressiveness promoter
ENSG00000054148,PHPT1,tumor progression,phosphate transport regulation,oncogenesis facilitation,cell membrane interaction,overexpression in cancer,biomarker potential
ENSG00000234514,LST1,spliceosome regulation,rna binding protein interaction,apoptosis inhibition,cell proliferation enhancement,tumor progression promoter,genomic instability mediator
ENSG00000186280,KDM4D,histone demethylation,transcriptional regulation,cell cycle progression,apoptosis suppression,metastasis facilitation,none
ENSG00000275052,PPP4R3B,genomic instability,cell cycle regulation,tumor suppressor inactivation,dephosphorylation regulation,protein phosphatase interaction,dna repair modulation
ENSG00000166473,PKD1L2,polycystin regulation,wnt/β-catenin signaling,cell proliferation regulation,voltage-dependent calcium channels,mitotic regulation,cytoskeleton organization modulation
ENSG00000160124,CCDC58,akt pathway activation,cell proliferation promotion,coiled-coil domain protein function,microtubule stability regulation,oncogenic driver potential,signal transduction modulation
ENSG00000005483,KMT2E,kmt2e overexpression,epigenetic regulation,histone methylation disruption,transcriptional dysregulation,synthetic lethality potential,cell proliferation promotion
ENSG00000183309,ZNF623,cellular regulation,chromatin remodeling,apoptosis inhibition,proliferation enhancement,tumor aggressiveness,transcriptional regulation
ENSG00000092421,SEMA6A,cell migration,pi3k/akt pathway,cell invasion,metastasis promotion,epithelial cell interaction,signal transduction regulation
ENSG00000196387,ZNF140,transcriptional regulation,krab domain-containing family,zinc finger protein,epigenetic regulation,cell cycle progression,apoptosis evasion
ENSG00000167508,MVD,genomic instability,epigenetic alterations,oncogenic transformation,tumor progression,folate metabolism,homocysteine accumulation
ENSG00000024422,EHD2,membrane recycling,endocytic trafficking,oncogenesis,tumor progression,metastasis regulation,signaling pathway modulation
ENSG00000197584,KCNMB2,cellular excitability regulation,calcium-activated potassium channel activity,oncogenic process involvement,tumor progression contribution,genomic upregulation,protein-protein interaction modulation
,HARS,translation regulation,tumor suppressor,oncogene potential,protein synthesis enhancement,trna charging,histidine metabolism alteration
ENSG00000104450,SPAG1,cellular migration,cell motility,cytokinesis regulation,mitosis regulation,tumor progression,therapeutic target
ENSG00000205277,MUC12,tumor progression,tumor metastasis,cell migration,cell proliferation,epithelial barrier maintenance,oncogenesis
,GPR21,g-protein coupled receptor activity,cell signaling pathway activation,enhanced cell growth and survival,metastatic potential increase,oncogenic pathway promotion,tumor progression association
ENSG00000144962,SPATA16,autophagy regulation,apoptosis inhibition,mtor pathway inhibition,cell survival enhancement,tumor progression correlation,oncogene function
ENSG00000277481,PKD1L3,loss-of-function mutations,oncogenic signaling,epithelial transport regulation,cellular proliferation,pi3k/akt pathway interaction,predictive biomarker
ENSG00000158296,SLC13A3,metabolic reprogramming,mitochondrial function,cell growth regulation,cancer progression,tumor metabolism,genetic upregulation
ENSG00000182795,C1orf116,mir-34 regulation,tumor suppressor function,dna damage repair modulation,pi3k/akt pathway interaction,cellular stress response regulation,oncogenic process suppression
ENSG00000146729,NIPSNAP2,**
nadph oxidase regulation,reactive oxygen species modulation,oxidative stress response,tumor progression enhancement,cellular redox balance disruption,epigenetic regulation influence
ENSG00000153820,SPHKAP,pi3k/akt/mtor pathway regulation,tumor suppressor function,sphingosine-1-phosphate metabolism,cell signaling modulation,oncogenic process inhibition,genomic instability repression
ENSG00000142484,TM4SF5,tumor progression,metastasis promotion,cell adhesion regulation,signal transduction modulation,cancer cell invasion facilitation,protein-protein interaction enhancement
ENSG00000148408,CACNA1B,calcium channel activation,tumor growth promotion,cell proliferation enhancement,survival signaling pathway,prognostic marker,therapeutic target
ENSG00000135297,MTO1,mitochondrial function regulation,glycolytic shift,apoptosis inhibition,cell proliferation enhancement,signaling pathway modulation,tumor progression driver
ENSG00000275482,EPHB6,angiogenesis inhibition,cell migration suppression,ephrin signaling pathway,genetic alterations,gene expression loss,oncogenic signaling pathway disruption
ENSG00000276582,ABCB11,bile salt export,efflux transporter function,membrane localization,drug resistance,multidrug efflux,transport process regulation
ENSG00000119922,IFIT2,ifn-induced gene regulation,tumor suppression,cell growth inhibition,apoptosis induction,emt suppression,tp53 interaction
ENSG00000159256,MORC3,genomic instability,dna damage response,cell proliferation,epigenetic regulation,chromatin remodeling,protein-protein interactions
ENSG00000182687,GALR2,oncogene,cell proliferation,tumor progression,tumor cell survival,apoptosis suppression,signaling pathway regulation
ENSG00000164128,NPY1R,angiogenesis promoter,neuropeptide y signaling,receptor activation,tumor progression,metastasis facilitator,signaling pathway modulation
ENSG00000275717,KIR3DL1,tumor immune evasion,nk cell regulation,genetic variation,immunosuppressive microenvironment,cytokine production modulation,immune checkpoint
ENSG00000185739,SRL,tumor growth,constitutive activation,pi3k/akt/mtor pathway,cell survival,metabolic regulation,tryptophan metabolism
ENSG00000169031,COL4A3,**

 basement membrane disruption,cell adhesion regulation,epithelial-to-mesenchymal transition,increased angiogenesis,tumor growth promotion,basement membrane complex
ENSG00000102385,DRP2,lipid metabolism disruption,oncogenic potential,cell membrane trafficking,tumor progression driver,protein-protein interaction,autophagy regulation
ENSG00000181631,P2RY13,purinergic signaling pathway,g protein-coupled receptor,tumor growth and metastasis,cell proliferation and survival,poor prognosis biomarker,overexpression
ENSG00000141469,SLC14A1,cellular regulation,metabolic adaptation,oncogenic potential,pro-survival mechanisms,tumor progression,phosphate transport
ENSG00000100625,SIX4,transcriptional regulation,cell differentiation,emt induction,metastasis promoter,cell growth regulator,cancer prognosis marker
ENSG00000109911,ELP4,saga complex,transcriptional regulation,chromatin remodeling,histone modification,tumor progression,cell cycle regulation
ENSG00000088367,EPB41L1,tumor suppressor function,genomic stability maintenance,cell cycle regulation,dna repair mechanism,apoptosis modulation,transcriptional repression
ENSG00000180185,FAHD1,glycolytic regulation,metabolic adaptation,energy homeostasis regulation,therapeutic target,cellular metabolism modulation,tumor aggressiveness
,HIST1H1T,histone regulation,chromatin modification,cell cycle progression,epigenetic control,transcriptional regulation,nucleosome assembly
ENSG00000100596,SPTLC2,oncogene overexpression,tumor growth promotion,dysregulated sphingolipid metabolism,cell proliferation enhancement,serine palmitoyltransferase enzyme activity,cancer driver mutation
ENSG00000114374,USP9Y,deubiquitinating enzyme,androgen receptor regulation,oncogenic protein stabilization,protein degradation modulation,y-linked gene expression,androgen receptor signaling pathway
ENSG00000170608,FOXA3,transcriptional regulation,promotes proliferation,epithelial-to-mesenchymal transition,enhances angiogenesis,tumor progression,genomic instability
ENSG00000117643,MAN1C1,er stress response,protein folding quality control,misfolding protein accumulation,cell survival promotion,apoptosis resistance,genomic instability
ENSG00000145868,FBXO38,loss of function mutations,tumor suppressor activity,cell cycle regulation,apoptosis modulation,protein stability regulation,genomic instability
ENSG00000153303,FRMD1,cell cycle regulation,genomic instability,tumor suppression,dna repair,apoptosis regulation,protein-protein interactions
ENSG00000176978,DPP7,wnt signaling pathway,cellular proliferation,protein-protein interaction,immune response modulation,oncogenesis,cell migration regulation
ENSG00000151640,DPYSL4,microtubule stabilization,wnt/β-catenin signaling,epithelial-to-mesenchymal transition,cell cycle regulation,oncogenic potential,genomic instability
ENSG00000159374,M1AP,cellular proliferation,metastasis promotion,epithelial-to-mesenchymal transition (emt),protein-protein interaction,tumor progression,cancer prognosis
ENSG00000144320,LNPK,histone demethylation,genome stability regulation,cell cycle progression,apoptosis inhibition,transcriptional regulation,protein-protein interaction
ENSG00000171051,FPR1,tumor progression,cell migration,therapeutic target,g-protein coupled receptor,metastasis,signal transduction
ENSG00000049656,CLPTM1L,dna repair regulation,cell cycle modulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation,biomarker potential
ENSG00000180245,RRH,**

microtubule stability,mitotic regulation,cell cycle progression,gtpase activation,protein-protein interaction,centrosome function
**
ENSG00000171302,CANT1,cellular chaperone,oncogenic overexpression,phosphatidylinositol 3-kinase pathway interaction,tumor progression promoter,genomic amplification driver,cellular signaling regulator
ENSG00000163975,MELTF,cell cycle regulation,apoptosis regulation,transcriptional regulation,dna repair mechanisms,tumor progression,homologous recombination
ENSG00000274205,MAPK15,oncogenic transformation,apoptosis evasion,cell cycle progression,protein phosphorylation,tumor progression,overexpression
ENSG00000174236,REP15,enhanced dna replication,oncogene activation,tumor progression,dna damage response,cell cycle regulation,protein-protein interaction
ENSG00000156218,ADAMTSL3,cell adhesion disruption,pi3k/akt pathway interaction,tumor progression facilitation,metastasis promotion,epigenetic regulation alteration,cancer cell invasion enhancement
ENSG00000134389,CFHR5,complement dysregulation,tumor progression,angiogenesis promotion,cell survival enhancement,overexpression in tumors,protein-protein interaction
ENSG00000166596,CFAP52,cilia assembly regulation,dysregulated expression,cellular proliferation enhancement,tumor progression,protein-protein interaction,centriolar satellite modulation
ENSG00000122592,HOXA7,transcriptional regulation,oncogene function,cell proliferation,tumor progression,aggressive clinical features,epithelial cell expression
ENSG00000125772,GPCPD1,glutamate metabolism,cell survival,redox state regulation,poor prognosis,overexpression,metabolic reprogramming
ENSG00000119616,FCF1,tumor suppressor,genomic stability,dna repair regulation,chromosomal instability,cellular homeostasis disruption,oncogenesis initiation
ENSG00000274803,BDP1,genomic instability,dna damage response,double-strand break repair,tumor progression,cancer cell survival,cell proliferation regulation
ENSG00000168461,RAB31,cellular trafficking regulation,gtpase activity,oncogenic signaling,epithelial-to-mesenchymal transition (emt),autophagy regulation,mitochondrial dynamics
ENSG00000178038,ALS2CL,autophagic regulation,mitochondrial function,protein-protein interaction,cellular homeostasis maintenance,tumor growth promotion,oncogenic process modulation
ENSG00000160183,TMPRSS3,tumor progression,cellular proliferation,growth factor activation,cell signaling modulation,protein interaction,overexpression
ENSG00000205758,CRYZL1,cell cycle regulation,apoptosis inhibition,oncogenic activity modulation,cell proliferation enhancement,tumor suppressor dysfunction,prognostic marker
ENSG00000073737,DHRS9,cellular proliferation,genomic instability,lipid metabolism regulation,oncogenic signaling pathway modulation,protein-protein interaction,transcriptional regulation
ENSG00000103021,CCDC113,chromosomal instability,driver gene,cell cycle regulation,microtubule dynamics,prognostic biomarker,centrosome interaction
ENSG00000175318,GRAMD2A,metabolic reprogramming,glutamate receptor activation,cell survival enhancement,oncogenesis promotion,therapeutic target identification,cell migration facilitation
ENSG00000167699,GLOD4,overexpression,tumor progression,pi3k/akt signaling pathway interaction,biomarker,cell growth regulation,cancer prognosis
ENSG00000152082,MZT2B,histone modification,epigenetic regulator,chromatin remodeling,tumor suppressor gene suppression,pi3k/akt pathway interaction,apoptosis resistance
ENSG00000124104,SNX21,tumor progression,constitutive activation,endosomal pathway modulation,protein sorting regulation,cell survival promotion,oncogenic driver gene
ENSG00000165684,SNAPC4,aberrant splicing,rna processing,cellular proliferation,enhanced survival,therapeutic target,genomic instability
ENSG00000126768,TIMM17B,mitochondrial regulation,genomic instability,oncogenic metabolic reprogramming,energy production alteration,cellular respiration modulation,therapeutic target
ENSG00000061987,MON2,ribosome biogenesis,translation initiation,oncogene overexpression,rna processing dysregulation,protein synthesis enhancement,cellular stress response regulation
ENSG00000197140,ADAM32,**
adam family protein,cell adhesion regulation,emt program modulation,metalloprotease activity,tumor progression promotion,therapeutic target 
**
ENSG00000143498,TAF1A,transcriptional regulation,gene expression modulation,cell survival enhancement,tumor progression promotion,chromatin remodeling,dna repair modulation
ENSG00000163900,TMEM41A,mitochondrial dynamics,genomic instability,mitophagy regulation,oxidative stress induction,cancer cell metabolism,therapeutic target
ENSG00000266338,NBPF15,nucleosome assembly,chromatin remodeling,genomic instability,altered gene expression,genome maintenance,dna replication
ENSG00000179364,PACS2,endosomal sorting,oncogenic protein accumulation,cellular degradation regulation,signaling pathway interaction,aberrant expression mutations,tumor progression contributor
ENSG00000141161,UNC45B,cell proliferation,chaperone function,epithelial-to-mesenchymal transition (emt),gene expression regulation,metastasis promotion,muscle cell development
ENSG00000007001,UPP2,nucleotide sugar metabolism,oncogene regulation,tumor progression,poor prognosis marker,glycolysis regulation,cell survival enhancement
ENSG00000122707,RECK,tumor suppression,mmp regulation,extracellular matrix degradation,tissue remodeling,protein-protein interaction,cancer progression
ENSG00000170703,TTLL6,microtubule regulation,dysregulated expression,oncogenic driver,tumor progression,cell proliferation regulation,cancer genome alteration
ENSG00000164674,SYTL3,regulation of membrane trafficking,tumor growth and progression,overexpression in cancer,small gtpase interaction,cellular secretion modulation,poor prognosis marker
ENSG00000241697,TMEFF1,cell adhesion regulation,metastasis promotion,biomarker potential,oncogenic pathway activation,prognostic significance,therapeutic target
ENSG00000114767,RRP9,exosome component,oncogenic rna expression,gene expression regulation,cell proliferation regulation,apoptosis modulation,signaling pathway regulation
ENSG00000006695,COX10,mitochondrial respiration,electron transport chain disruption,oxidative phosphorylation impairment,glycolytic shift,oncogenic adaptation,cancer metabolism alteration
ENSG00000170113,NIPA1,pp2a regulation,cell cycle progression,anti-apoptotic pathway,cell proliferation,tumor suppressor loss,gene expression alteration
ENSG00000171954,CYP4F22,altered lipid profile,cell growth regulation,dysregulated expression,hydroxylation activity,lipid metabolism regulation,tumor suppressor function
ENSG00000066056,TIE1,angiogenesis,tumor vasculature,receptor tyrosine kinase,vascular endothelial growth factor (vegf) signaling,poor prognosis marker,transmembrane receptor
ENSG00000128342,LIF,tumor progression,stat3 signaling,pleiotropic cytokine,immune suppression,growth factor,molecular heterogeneity
ENSG00000178343,SHISA3,tumor suppressor,epithelial-to-mesenchymal transition,cellular polarity maintenance,tight junction regulation,cell adhesion disruption,metastasis facilitation
ENSG00000148935,GAS2,tumor suppressor,cell cycle regulation,apoptosis induction,cell proliferation inhibition,dna damage response modulation,protein-protein interaction
ENSG00000137801,THBS1,angiogenic pathway modulation,cell adhesion molecule,extracellular matrix deposition,immune suppression,tumor progression marker,vascular endothelial growth factor (vegf) interaction
ENSG00000074582,BCS1L,mitochondrial dysfunction,genomic instability,oxidative stress,energy metabolism disruption,tumor progression driver,cellular stress response pathway
ENSG00000178177,LCORL,oncogenic function,overexpression,competitive endogenous rna (cerna) activity,transcriptional regulation modulation,pi3k/akt/mtor pathway activation,biomarker and therapeutic target
ENSG00000274780,PHRF1,genomic instability,chromatin remodeling,dna damage response,tumor suppressor repression,cell cycle regulation,proliferation modulation
ENSG00000284228,TMEM102,regulation of endocytosis,upregulation in tumors,pi3k/akt pathway interaction,autophagy regulation,therapeutic target,cellular homeostasis maintenance
ENSG00000185022,MAFF,**
regulation of transcription factors,cellular proliferation,tumor suppressor functions,genomic instability,nf-kb pathway interaction,jnk signaling activation
**
ENSG00000134490,TMEM241,er stress response,transmembrane protein regulation,oncogene activation,cell survival enhancement,protein folding regulation,genomic stability maintenance
ENSG00000094914,AAAS,protein stabilization,cell survival enhancement,oncogenic signaling,genomic instability,ups regulation,er stress modulation
ENSG00000106415,GLCCI1,gst activity regulation,cellular defense mechanism,cancer susceptibility,oxidative stress mitigation,dna repair enhancement,chemotherapy sensitivity
ENSG00000069345,DNAJA2,dnaj protein interactions,cell survival promotion,molecular chaperone function,tumor progression correlation,cancer signaling pathway interaction,oncogenic process regulation
ENSG00000140403,DNAJA4,molecular chaperone function,protein folding regulation,cellular proteostasis maintenance,tumor growth promotion,angiogenesis facilitation,signaling pathway modulation
ENSG00000213626,LBH,metabolic regulation,lactate production,tumor progression,cellular metabolism,warburg effect,glycolytic shift
ENSG00000158042,MRPL17,ribosomal biogenesis,mitochondrial function,cellular metabolism,tumor suppressor,cancer prognosis,protein assembly
ENSG00000123500,COL10A1,type x collagen,tumor progression,extracellular matrix regulation,cellular invasion migration,biomarker potential,apoptosis regulation
ENSG00000184792,OSBP2,lipid metabolism regulation,oncogenic potential,tumor progression contribution,protein-lipid interactions,therapeutic target consideration,genomic instability association
ENSG00000158050,DUSP2,regulation of mapk signaling,oncogene function,tumor progression,cell proliferation,metastasis promotion,prognostic marker
ENSG00000129596,CDO1,**

metabolic reprogramming,tumor progression,cellular ph regulation,carboxylate transport,ion balance modulation,mtor pathway interaction

**
ENSG00000197594,ENPP1,cell proliferation,pi3k/akt pathway,tumor metastasis,poor prognosis,chemotherapy resistance,extracellular nucleotide regulation
ENSG00000130962,PRRG1,cytoskeleton regulation,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),metastasis promotion,tumor progression,protein interaction
ENSG00000115339,GALNT3,glycosylation modulation,oncogenic activation,cell signaling regulation,tumor growth promotion,metastasis facilitation,growth factor modification
ENSG00000176222,ZNF404,tumor suppressor function,transcriptional regulation,cell cycle progression,oncogene activation,genomic instability,apoptosis modulation
ENSG00000174576,NPAS4,tumor progression,transcriptional regulation,oncogenic driver,cellular proliferation,apoptosis evasion,prognostic biomarker
ENSG00000175073,VCPIP1,proteasome function,altered expression,ubiquitin-proteasome system regulation,endoplasmic reticulum-associated degradation modulation,cancer progression driver,therapeutic target candidate
ENSG00000013588,GPRC5A,g-protein coupled receptor,cell proliferation regulation,tumor progression modulation,apoptosis regulation,therapeutic target,cell differentiation control
ENSG00000138166,DUSP5,tumor suppressor,p38 mapk inactivation,cellular stress response,oncogenic signaling,cell cycle regulation,apoptosis modulation
ENSG00000134996,OSTF1,cell cycle regulation,apoptosis evasion,tumor growth promotion,genomic instability,transcriptional dysregulation,therapeutic target
ENSG00000185670,ZBTB3,transcription factor regulation,oncogenic driver,epigenetic regulation,tumor progression,chromatin modification,cell proliferation
ENSG00000116260,QSOX1,cell proliferation,apoptosis resistance,prognostic marker,therapeutic target,redox regulation,cell signaling pathway
ENSG00000187257,RSBN1L,microtubule regulation,tumor progression,protein overexpression,cell proliferation,mitosis regulation,cancer prognosis
ENSG00000196876,SCN8A,ion channel function,voltage-gated sodium channel regulation,cellular proliferation enhancement,epithelial-to-mesenchymal transition (emt) regulation,tumor progression correlation,therapeutic target for cancer treatment
ENSG00000169218,RSPO1,wnt/β-catenin pathway,cell proliferation,survival signaling pathway,epithelial-to-mesenchymal transition,stem cell maintenance,oncogenic driver
ENSG00000187801,ZFP69B,tumor suppressor function,apoptosis regulation,cell cycle progression,dna repair mechanisms,immune response modulation,prognostic marker
ENSG00000132677,RHBG,pi3k/akt signaling pathway dysregulation,tumor progression,oncogenic process involvement,membrane transport regulation,cell proliferation enhancement,mutated in kirc tumors
ENSG00000133401,PDZD2,cellular signaling pathways,protein-protein interactions,tumor suppression,n-cadherin interaction,catenin binding,cancer cell migration
ENSG00000006453,BAIAP2L1,actin cytoskeleton regulation,dysregulated expression,tumor suppressor function,cell migration and invasion,genomic instability,stress response regulation
ENSG00000180739,S1PR5,sphingosine-1-phosphate signaling pathway,tumor invasion,g-protein coupled receptor,cell migration regulation,metastasis promotion,angiogenesis regulation
ENSG00000170624,SGCD,pi3k/akt pathway activation,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation,prognostic marker,therapeutic target
ENSG00000168757,TSPY2,oncogenic role,wnt signaling activation,cell proliferation promotion,migration and invasion enhancement,transcriptional regulation modulation,gene expression dysregulation
ENSG00000005302,MSL3,histone methylation,epigenetic regulation,chromatin remodeling,tumor progression,biomarker potential,oncogene activation
ENSG00000273859,RASSF7,cell cycle regulation,mitotic spindle checkpoint,tumor suppressor function,chromosomal instability,apoptosis induction,genomic integrity
ENSG00000138303,ASCC1,histone modification,genomic instability,epigenetic regulation,oncogenic pathway activation,cell proliferation regulation,prognostic biomarker
ENSG00000180902,D2HGDH,metabolic regulation,tumor suppression,angiogenesis regulation,iron homeostasis,cellular energy metabolism,glycolytic shift
ENSG00000134186,PRPF38B,pre-mrna splicing regulation,aberrant expression,oncogenic potential,tumor aggressiveness,poor prognosis biomarker,signaling pathway alteration
ENSG00000183648,NDUFB1,mitochondrial complex i,energy metabolism regulation,tumor progression,cell survival pathway,oncogenic driver mutation,mitochondrial dysfunction
ENSG00000187672,ERC2,genomic instability,helicase subunit,dna replication,protein overexpression,proliferation enhancement,cell survival
ENSG00000135409,AMHR2,tumor suppressor function,cell growth regulation,loss-of-function mutations,oncogenic processes,downregulation in tumors,prognostic marker
ENSG00000280094,OR1B1,cell migration and invasion,olfactory receptor function,tumor progression,poor prognosis,pi3k/akt pathway regulation,protein-protein interaction
ENSG00000107651,SEC23IP,exocyst complex regulation,cellular secretion regulation,vesicle-mediated transport,tumor aggressiveness,oncogenic driver,poor prognosis
ENSG00000124225,PMEPA1,overexpression,tumor progression,cellular proliferation,apoptosis inhibition,biomarker potential,metabolic regulation
ENSG00000172031,EPHX4,oxidative stress response,genotoxic damage modulation,cancer cell survival,tumor initiation,cellular redox balance regulation,dna integrity maintenance
ENSG00000253831,ETV3L,transcription regulation,oncogenic function,cell proliferation,apoptosis resistance,angiogenesis promotion,epithelial-to-mesenchymal transition
ENSG00000153779,TGIF2LX,transcriptional regulation,tgf-beta pathway inhibition,smad protein interaction,cell differentiation regulation,tumor growth modulation,gene expression control
ENSG00000232258,TMEM114,er stress response,apoptosis regulation,cell proliferation,tumor progression,genomic instability,protein interaction
ENSG00000196867,ZFP28,zinc finger protein regulation,tumor progression,oncogene/tumor suppressor,transcriptional modulation,apoptosis inhibition,metastasis promotion
ENSG00000163814,CDCP1,pi3k/akt pathway inhibition,tumor suppressor activity,cell-cell adhesion disruption,constitutive activation,oncogenic signaling,therapeutic target
ENSG00000138411,HECW2,ubiquitination,cell cycle regulation,apoptosis modulation,tumor growth promotion,dna repair regulation,multifunctional protein
ENSG00000091010,POU4F3,transcription factor activity,regulation of cell proliferation,cell differentiation,oncogenic potential,tumor suppression,genetic regulation
ENSG00000008300,CELSR3,notch signaling pathway,tumor progression,mutation associated,cell adhesion disruption,wnt/β-catenin pathway interaction,oncogenic driver mutation
ENSG00000156471,PTDSS1,tumor progression,constitutive activation,cell proliferation,signaling pathway activation,poor prognosis,therapeutic target
ENSG00000164068,RNF123,protein degradation,oncogenic processes,tumor progression,ubiquitination,metastasis,poor prognosis
ENSG00000059378,PARP12,cellular regulation,genomic stability maintenance,dna repair mechanism,apoptosis modulation,cell survival enhancement,oncogenic potential
ENSG00000183513,COA5,mitochondrial function,cancer metabolism,oncogenic mutations,energetic adaptation,mitochondrial biogenesis,tumor progression
ENSG00000099864,PALM,protein degradation regulation,oncogenic transformation driver,cell proliferation enhancement,tumor suppressor protein degradation,ubiquitin ligase interaction,apoptosis inhibition
ENSG00000221995,TIAF1,dna damage response,genome instability,replication stress,tumor suppressor function,cellular regulation,cancer biology
ENSG00000161533,ACOX1,fatty acid oxidation,mitochondrial enzyme,cell proliferation,energy metabolism,reactive oxygen species generation,tumor progression
ENSG00000163833,FBXO40,tumor suppressor,cell cycle regulation,dna damage response,oncogene regulation,apoptosis induction,protein ubiquitination
ENSG00000182508,LHFPL1,cell adhesion disruption,oncogenic potential,tumor progression,cell proliferation enhancement,apoptosis inhibition,lipid metabolism regulation
ENSG00000198885,ITPRIPL1,emt regulation,cell migration and invasion,cytoplasmic localization,oncogene activation,chemoresistance enhancement,actin cytoskeleton reorganization
ENSG00000129625,REEP5,mitochondrial dynamics regulation,cell proliferation activation,signaling pathway modulation,protein transport disruption,tumor progression promotion,therapeutic target potentialisation
ENSG00000120318,ARAP3,oncogenic driver,gtpase activation,cell migration regulator,tumor progression marker,epithelial-to-mesenchymal transition regulator,cancer cell proliferation enhancer
ENSG00000188037,CLCN1,ion channel regulation,tumor progression,metastasis,stemness,cellular migration,proton-assisted protein secretion
ENSG00000067704,IARS2,iron-regulatory protein 1 regulation,cellular iron metabolism dysregulation,dna damage accumulation,cell cycle progression alterations,apoptosis resistance,oxidative stress enhancement
ENSG00000203485,INF2,cellular migration,actin cytoskeleton regulation,tumor progression,metastasis,cytoskeletal protein interaction,therapeutic target
ENSG00000181061,HIGD1A,pi3k/akt pathway interaction,mutation associated cancer,cell proliferation promotion,survival pathway involvement,dna repair regulation,cancer metabolism alteration
ENSG00000148019,CEP78,microtubule dynamics regulation,gene expression regulation,chromosomal instability,cell division regulation,centrosome function disruption,tumor progression promotion
ENSG00000206237,HLA-DQB1,immune evasion,tumor antigen presentation,impaired t-cell activation,reduced mhc class ii expression,epigenetic regulation,genetic instability
ENSG00000116176,TPSG1,cell cycle regulation,microtubule dynamics,tumor cell proliferation,genomic stability,chromosomal instability,therapeutic target
ENSG00000175470,PPP2R2D,regulatory subunit,dephosphorylation activity,oncogenic signaling pathway,tumor suppressor function,cellular metabolism regulation,protein kinase activation
ENSG00000152700,SAR1B,gtpase activity,endoplasmic reticulum-golgi transport,cell proliferation enhancement,pro-tumorigenic factor secretion,poor prognosis marker,resistance to chemotherapy
ENSG00000135392,DNAJC14,genomic instability,tumor progression,cancer cell proliferation,protein degradation regulation,autophagy regulation,cell cycle control
ENSG00000197119,SLC25A29,altered metabolic profiles,mitochondrial function disruption,glycolysis and glutaminolysis regulation,warburg effect promotion,tumor progression enhancement,therapeutic target identification
ENSG00000073067,CYP2W1,tumor suppressor activity,chemo resistance,substrate degradation,cell cycle regulation,angiogenesis inhibition,transcriptional regulation
ENSG00000133111,RFXAP,histone modification regulation,chromatin remodeling,transcriptional dysregulation,cell proliferation promotion,apoptosis suppression,angiogenesis modulation
ENSG00000116205,TCEANC2,dna demethylation,epigenetic regulation,chromatin remodeling,cell proliferation,transcriptional modulation,tumor growth
ENSG00000144161,ZC3H8,transcriptional regulation,cell growth promotion,tumor progression,signal transduction modulation,gain of function mutations,therapeutic target
ENSG00000144681,STAC,dna repair mechanism,oncogenic driver,cell proliferation regulation,genomic instability,apoptosis inhibition,tumor progression
ENSG00000141447,OSBPL1A,cellular membrane dynamics,lipid metabolism modulation,oncogenic processes facilitation,pi3k/akt pathway interaction,tumor cell proliferation promotion,protein-protein interactions
ENSG00000138660,AP1AR,angiogenesis regulation,tumor growth promotion,dysregulated expression,proliferation enhancement,metastasis facilitation,transcriptional regulation
ENSG00000149124,GLYAT,gpi-anchor remodeling,tumor progression,metastasis regulator,cell signaling regulation,metallophosphoesterase activity,cancer-related adhesion
ENSG00000103067,ESRP2,altered pre-mrna splicing,cellular invasion,oncogene activation,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,metastasis promotion
ENSG00000140395,WDR61,cell cycle regulation,apoptosis inhibition,oncogenic potential,tumor progression,protein-protein interactions,cell proliferation
ENSG00000128590,DNAJB9,cellular stress response,molecular chaperone function,protein homeostasis regulation,oncogenic processes promotion,therapeutic target identification,biomarker potential
ENSG00000104904,OAZ1,rna-binding protein,deadenylation regulation,oncogenic processes,cell proliferation,tumorigenesis regulation,metastasis promotion
ENSG00000139629,GALNT6,o-glycosylation,cell growth regulation,apoptosis modulation,tumor progression,poor prognosis indicator,therapeutic target
ENSG00000070214,SLC44A1,cell surface sialylation,glycosylation regulation,biomarker potential,cellular adhesion modulation,metastasis promotion,prognostic significance
ENSG00000175538,KCNE3,kcnq/kv7 channel subunit,voltage-gated potassium channels,cell membrane excitability modulation,tumorigenesis driver gene,therapeutic target,cancer cell proliferation enhancement
ENSG00000153291,SLC25A27,mitochondrial carrier protein,energy metabolism regulation,oncogene activation,cell proliferation promotion,tumor aggressiveness association,transcriptional regulation modification
ENSG00000166503,HDGFL3,lipid metabolism dysregulation,oncogenic signaling pathway activation,tumor progression facilitation,angiogenesis enhancement,therapeutic target potential,hypoxia-inducible gene expression
ENSG00000147588,PMP2,genetic instability,disrupted cell adhesion,nuclear matrix regulation,cell proliferation enhancement,cytoplasmic intermediate filaments,transcriptional dysregulation
ENSG00000179520,SLC17A8,neurotransmitter regulation,glutamate uptake,vesicular transport,metabolic regulation,tumor suppressor,signaling pathway modulation
ENSG00000010438,PRSS3,oncogenic potential,cellular invasion,signaling pathway regulation,metastasis facilitation,timps degradation,metalloproteinase activation
ENSG00000137124,ALDH1B1,cancer stemness,dna damage,oxidative stress,cell proliferation,therapeutic target,aldehyde detoxification
ENSG00000082996,RNF13,regulation of cell cycle,apoptosis modulation,e3 ubiquitin ligase activity,tumorigenesis regulation,genomic stability maintenance,cancer target
ENSG00000135124,P2RX4,purinergic signaling,tumor growth promotion,angiogenesis regulation,immune modulation,chemotherapy resistance,prognostic marker
ENSG00000086232,EIF2AK1,cell survival,unfolded protein response,apoptosis suppression,angiogenesis promotion,therapeutic target,protein kinase activation
ENSG00000158089,GALNT14,o-linked glycosylation,cellular adhesion,mitotic regulation,cancer progression,biomarker potential,glycoprotein modification
ENSG00000163788,SNRK,pi3k/akt signaling,oncogenic properties,kinase activation,cell proliferation,transcriptional regulation,prognostic marker
ENSG00000115380,EFEMP1,tumor suppression,downregulated expression,cell-cell adhesion,extracellular matrix regulation,fibulin interaction,metastasis promotion
ENSG00000105879,CBLL1,transcriptional regulation,cell cycle progression,tumor development,oncogenic process,genome instability,chromatin remodeling
ENSG00000075336,TIMM21,mitochondrial biogenesis,energy metabolism alteration,cellular respiration regulation,tumor progression correlation,glycolytic shift promotion,protein import and assembly
ENSG00000162729,IGSF8,tumor progression,metastasis promotion,cell migration,immune evasion,therapeutic resistance,emt regulation
ENSG00000116698,SMG7,nonsense-mediated mrna decay,genomic stability,premature stop codon recognition,aberrant protein accumulation,oncometabolite production,tumor progression
ENSG00000156486,KCNS2,apoptosis modulation,cell cycle regulation,oncogene overexpression,poor prognostic marker,voltage-gated potassium channel function,tumor growth promotion
ENSG00000070785,EIF2B3,eif2b activation,oncogenic protein upregulation,cellular proliferation,tumor suppressor gene suppression,cellular stress response dysregulation,cancer therapeutic target
ENSG00000125363,AMELX,apoptosis suppression,cell cycle regulation,overexpression,angiogenesis promotion,metastasis facilitation,protein-protein interaction
ENSG00000140795,MYLK3,phosphorylation activity,cytoplasmic localization,cell migration,cytoskeleton regulation,oncogenic potential,tumor progression
ENSG00000032219,ARID4A,chromatin remodeling,transcriptional regulation,cell proliferation,tumorigenesis,dna damage response,aggressive disease behavior
ENSG00000164663,USP49,cellular stabilization,tumor progression,pi3k/akt pathway interaction,oncoprotein stabilization,prognostic marker,deubiquitinating enzyme activity
ENSG00000143390,RFX5,regulation of gene expression,oncogenic pathway regulation,tumor progression,transcription factor function,dna repair regulation,genomic instability
ENSG00000109790,KLHL5,tumor suppressor function,substrate degradation regulation,protein stability regulation,cellular homeostasis maintenance,therapeutic target,oncogenic signaling pathway regulation
ENSG00000122122,SASH3,tumor suppressor,pi3k/akt pathway regulation,cancer cell inhibition,apoptosis induction,cellular proliferation suppression,genetic downregulation
ENSG00000137857,DUOX1,ros production,pro-tumoral microenvironment,cell proliferation,dna damage,epigenetic modifications,cellular invasion
ENSG00000137474,MYO7A,actin cytoskeleton regulation,cellular trafficking modulation,malignant transformation promotion,tumor cell growth enhancement,signal transduction pathway interaction,protein overexpression and dysregulation
ENSG00000116745,RPE65,visual cycle regulation,photoreceptor maintenance,cellular growth modulation,indirect oncogenic mechanism,retinal pigment epithelium function,visual pathway disruption
ENSG00000158793,NIT1,genomic instability,base excision repair pathway,dna replication,cell survival,apoptosis regulation,tumor suppression
ENSG00000147687,TATDN1,genomic instability,homologous recombination repair,cell proliferation regulation,tumor progression,dna damage response,protein-dna interactions
ENSG00000125459,MSTO1,cell proliferation,transcriptional regulation,apoptosis suppression,tumor progression,metastasis promotion,protein-protein interaction
ENSG00000066279,ASPM,microtubule regulation,aneuploidy induction,tumor aggressiveness,proliferation enhancement,biomarker potential,genomic instability
ENSG00000156831,NSMCE2,genomic instability,dna replication,cell cycle progression,tumor progression,therapeutic target,biomarker for resistance
ENSG00000131050,BPIFA2,immunosuppression,tumor progression,cell migration,pi3k/akt pathway regulation,cancer biomarker,surface expression
ENSG00000168389,MFSD2A,metabolic regulation,cell growth promotion,nutrient uptake facilitation,cellular transport role,apoptosis modulation,therapeutic target potential
ENSG00000196705,ZNF431,transcriptional regulation,oncogene activation,epigenetic modulation,chromatin remodeling,tumor suppressor suppression,aggressive tumor behavior
ENSG00000127081,ZNF484,zinc finger protein,chromatin remodeling,transcriptional regulation,dna repair,genome stability maintenance,tumor suppressor function
ENSG00000110880,CORO1C,actin cytoskeleton regulation,cell migration and invasion,metastasis promotion,tumor progression,poor prognosis indicator,signaling pathway modulation
ENSG00000130270,ATP8B3,oncogenic process,ion transport regulation,cell survival enhancement,cellular ph homeostasis,prognostic marker potential,therapeutic target
ENSG00000144476,ACKR3,decoy receptor activity,chemokine binding,oncogenesis promotion,tumor progression facilitation,immune modulation,poor prognosis indicator
ENSG00000197360,ZNF98,transcriptional regulation,apoptosis suppression,tumor progression,angiogenesis,metastasis facilitation,zinc finger binding
ENSG00000284068,KPNA7,nuclear protein import regulation,tumor suppressor interaction,transcriptional co-regulation,protein-protein interactions,cell cycle progression,therapeutic target
ENSG00000250510,GPR162,g-protein coupled receptor,constitutive activation,cell migration,angiogenesis regulation,pi3k/akt pathway activation,protein interaction modulation
ENSG00000205336,ADGRG1,adhesion molecule regulation,g protein signaling,cell proliferation promotion,tumor invasion facilitation,metabolic regulation alteration,protein-protein interaction
ENSG00000182674,KCNB2,voltage-gated potassium channel regulation,cell proliferation promotion,tumor progression contribution,oncogenic protein interaction,pi3k/akt pathway modulation,genomic upregulation
ENSG00000248487,ABHD14A,lipid metabolism regulation,tumor progression association,cellular signaling modulation,poor prognosis marker,cancer associated expression,lipolytic activity role
ENSG00000183549,ACSM5,long-chain fatty acid synthesis,metabolic reprogramming,oncogenic process,cellular energy metabolism,therapeutic target,lipid-based metabolic adaptation
ENSG00000136634,IL10,tumor microenvironment modulation,immune evasion mechanism,dysregulated expression,poor prognosis marker,inflammation regulation,antitumoral effects
ENSG00000104093,DMXL2,cell cycle progression,chromatin modification,oncogenic interaction,apoptosis resistance,prognostic biomarker,transcriptional regulation
ENSG00000108582,CPD,loss of tumor suppressor function,cell cycle regulation,cdk inhibition,dna damage response,anti-apoptotic mechanism,tumor progression
ENSG00000152229,PSTPIP2,wnt signaling pathway,tumor-associated macrophages,immune cell regulation,actin cytoskeleton organization,inflammatory response modulation,gene expression alterations
ENSG00000198839,ZNF277,krab domain transcriptional repressor,zinc finger protein binding,gene expression regulation,apoptosis regulation,cell cycle progression,transcriptional repression
ENSG00000172889,EGFL7,endothelial cell migration,tumor progression,angiogenesis,oncogene overexpression,vascular stability regulation,interaction with nrp1
ENSG00000198417,MT1F,cell growth regulation,cancer progression promotion,apoptosis inhibition,metastasis facilitation,prognostic marker identification,tumor suppressor interaction
ENSG00000136274,NACAD,mitochondrial regulation,cellular metabolism regulation,protein modification,oncogenic function,tumor progression,genomic amplification
ENSG00000039523,RIPOR1,er stress response regulation,autophagy modulation,oncogenesis association,protein interaction,cellular homeostasis regulation,stress response dysregulation
ENSG00000154620,TMSB4Y,tumor progression,tumorigenesis,ribosome biogenesis,cell proliferation,apoptosis regulation,signaling pathway modulation
ENSG00000141316,SPACA3,genomic instability,pi3k/akt pathway activation,cell proliferation,emt process,immune suppression,spermatogenesis disruption
ENSG00000188372,ZP3,glycosylation regulation,pi3k/akt pathway interaction,cell migration facilitation,tumor progression association,oncogenic dysregulation,therapeutic target identification
ENSG00000077935,SMC1B,genomic instability,dna repair pathway disruption,homologous recombination impairment,chromosome segregation defect,tumorigenesis driver,metastasis promoter
ENSG00000157350,ST3GAL2,aberrant expression,angiogenesis,tumor progression,metastasis,cancer stem cells,sialylation modification
ENSG00000213424,KRT222,epithelial-to-mesenchymal transition,cellular signaling pathway,cellular differentiation,cancer biomarker,keratin expression regulation,tumor progression
ENSG00000108828,VAT1,calcium influx regulation,t-type calcium channel activity,oncogenic promoter,cell proliferation enhancement,apoptosis inhibition,therapeutic target candidate
ENSG00000172661,WASHC2C,endosomal tubulation,protein trafficking regulation,oncogenic transformation,cellular recycling pathway,tumor progression,therapeutic target
ENSG00000106178,CCL24,tumor progression,metastasis promotion,immunosuppression induction,inflammation regulation,angiogenesis facilitation,cell migration enhancement
ENSG00000161544,CYGB,cellular respiration,electron transport chain,energy metabolism,tumor progression,oncogenesis,therapeutic target
ENSG00000125965,GDF5,growth plate formation,tgf-beta superfamily member,bone morphogenesis regulator,cancer cell proliferation,cellular differentiation regulation,molecular signaling pathway interaction
ENSG00000213445,SIPA1,tumor aggressiveness,prognostic biomarker,pi3k/akt pathway interaction,cytoplasmic localization,cell cycle regulation,cytoskeleton organization
ENSG00000185885,IFITM1,innate immune suppression,apoptosis regulation,cell cycle modulation,signaling pathway interaction,tumor growth inhibition,viral infection response
ENSG00000277494,GPIHBP1,lipid metabolism regulation,tumor progression,cell proliferation enhancement,signaling pathway modulation,protein-protein interaction,metastasis promotion
ENSG00000164961,WASHC5,lysosome function regulation,tumor progression,rna-binding protein interaction,cancer driver gene candidate,endosomal trafficking modulation,gene mutation impact
ENSG00000143126,CELSR2,notch signaling pathway,adhesion molecule,tumor progression,metastasis,cell migration,e-cadherin interaction
ENSG00000110931,CAMKK2,ampk signaling pathway,constitutive activation,calcium-dependent regulation,cell survival enhancement,tumor growth promotion,protein kinase activation
ENSG00000135973,GPR45,cell signaling,gpcr function,tumor progression,signaling pathway dysregulation,genomic amplification,protein-protein interaction
ENSG00000274348,TRPV5,cancer cell proliferation,calcium influx regulation,oncogenic signaling pathway,cell survival mechanism,tumor progression factor,protein-protein interaction
ENSG00000101443,WFDC2,epithelial-to-mesenchymal transition,cell adhesion modulation,protein expression regulation,cancer cell migration,tumorigenesis involvement,cellular differentiation
ENSG00000066855,MTFR1,mitochondrial dynamics,apoptosis modulation,metabolic regulation,cellular stress response,glycolysis enhancement,reactive oxygen species production
ENSG00000140386,SCAPER,chromosomal instability,genomic abnormalities,cell cycle regulation,spindle checkpoint interaction,mitotic fidelity disruption,centrosome duplication regulator
ENSG00000101417,PXMP4,tumor suppressor,oxidative stress regulation,cellular protection,reactive oxygen species modulation,tumor progression inhibition,poor prognosis associated
ENSG00000196184,OR10J1,oncogenic regulation,cell proliferation,signaling pathway interaction,tumor progression,angiogenesis regulation,overexpression signature
ENSG00000118432,CNR1,tumor suppression,cell proliferation inhibition,apoptosis induction,angiogenesis regulation,pi3k/akt pathway modulation,genomic instability regulation
ENSG00000165188,RNF183,tumor progression,oncogenic activity,e3 ubiquitin ligase function,signaling pathway regulation,protein degradation modulation,therapeutic target
ENSG00000169026,SLC49A3,**

calcium homeostasis regulation,oncogene overexpression,cell proliferation modulation,protein-protein interaction,calcium channel regulation,tumorigenesis facilitation 

**
ENSG00000105583,WDR83OS,pi3k/akt pathway regulation,oncogenic function,cell proliferation promotion,tumor invasion facilitation,apoptosis inhibition,gene expression regulation
ENSG00000124212,PTGIS,vasodilator,angiogenesis,apoptosis inhibition,tumor progression,enzymatic activity,overexpression
ENSG00000186470,BTN3A2,apoptosis regulation,tumor growth modulation,poor prognosis marker,mitochondrial regulation,immunomodulation,cellular proliferation
ENSG00000004059,ARF5,endocytic pathway activation,oncogenic protein recycling,cell growth promotion,tumorigenesis contribution,cellular membrane trafficking regulation,gtpase-activating protein interaction
ENSG00000178372,CALML5,cellular differentiation,calcium-dependent signaling,oncogenic activation,cell proliferation enhancement,tumor progression,genetic mutation
ENSG00000166685,COG1,tumor suppressor function,disrupted golgi apparatus,cellular polarity loss,pi3k/akt pathway activation,gene expression alterations,cell growth regulation
,LOR,translation regulation,ribosome biogenesis,oncogenic mutations,cell proliferation enhancement,protein-protein interactions,mrna translation efficiency
ENSG00000213930,GALT,glycosylation regulation,tumor metastasis,pi3k/akt pathway interaction,glycosyltransferase activity,metabolic reprogramming,cancer cell survival
ENSG00000135749,PCNX2,tumor progression,genomic instability,cellular proliferation,selective mrna export,nuclear export factor activation,oncogenic transformation
ENSG00000087250,MT3,cellular redox regulation,metastasis promotion,transcriptional modulation,protein binding,oncogene overexpression,redox homeostasis disruption
ENSG00000100884,CPNE6,cell cycle progression,apoptosis regulation,calcium-binding protein,cancer biomarker,cell migration promotion,hypoxia adaptation
ENSG00000108510,MED13,transcriptional regulation,rnapii recruitment,cell growth promotion,mediator complex subunit,gene expression modulation,oncogenic transformation
ENSG00000283706,PRSS50,trypsin-related serine protease activity,enhanced cell proliferation,epithelial-to-mesenchymal transition regulation,cancer biomarker potential,tumor aggressiveness association,cell migration promotion
ENSG00000075188,NUP37,nuclear pore regulation,cell proliferation,tumor suppressor function,genomic instability,oncogene activity,apoptosis modulation
ENSG00000168386,FILIP1L,cell membrane dynamics,tumor progression,signaling pathway regulation,protein-protein interaction,oncogenic transformation,cancer prognosis
ENSG00000140285,FGF7,angiogenesis,oncogenic process,epithelial-to-mesenchymal transition (emt),tumor progression,growth factor receptor interaction,downstream signaling pathway activation
ENSG00000269405,NXF2,rna export,cellular proliferation,tumor progression,poor prognosis,malignant transformation,genomic instability
ENSG00000269437,NXF2B,tumor suppressor regulation,nuclear transport dysfunction,oncogenic process modulation,mrna export factor interaction,cell proliferation enhancement,prognostic marker alteration
ENSG00000182902,SLC25A18,mitochondrial carrier protein,aspartate shuttle mechanism,cellular proliferation,energy metabolism regulation,tumor progression association,oncogenic pathway involvement
ENSG00000133488,SEC14L4,phospholipid metabolism,pi3k/akt signaling,lipid trafficking,tumor progression,metabolic regulation,therapeutic target
ENSG00000156219,ART3,genomic instability,cellular response regulation,dna damage repair,genetic mutation promotion,fanconi anemia pathway interaction,tumor susceptibility factor
ENSG00000166938,DIS3L,tumor suppressor function,rrna modification regulation,enhanced cell proliferation,chemotherapy resistance,oncogenesis prevention,tumor progression
ENSG00000154719,MRPL39,mitochondrial function,ribosomal dysfunction,aberrant protein synthesis,tumor progression,metabolic regulation,energy production
ENSG00000225830,ERCC6,genomic instability,cancer predisposition,dna repair mechanism,nucleotide excision repair,cellular response to dna damage,tumor suppressor function
ENSG00000124233,SEMG1,cell migration,cytoskeleton organization,oncogene,cell adhesion,metastasis promotion,prognostic marker
ENSG00000182050,MGAT4C,aberrant glycosylation,glycosyltransferase function,oncogenic protein modification,tumor progression facilitation,poor prognosis biomarker,therapeutic target
ENSG00000285112,SLC52A2,nucleotide transport,electroneutral transporter,cellular proliferation,dna synthesis repair,nucleoside balance regulation,tumorigenesis mechanism
ENSG00000115286,NDUFS7,mitochondrial function,metabolic reprogramming,energy metabolism,cellular respiration,electron transport chain,tumor progression
ENSG00000070193,FGF10,fgf/fgfr interaction,cell proliferation,angiogenesis,epithelial-to-mesenchymal transition (emt),oncogenic signaling,prognostic biomarker
ENSG00000082126,MPP4,pi3k/akt pathway interaction,upregulation,oncogenic processes promotion,epithelial-to-mesenchymal transition (emt) induction,stemness enhancement,protein palmitoylation regulation
ENSG00000173145,NOC3L,genomic instability,cellular stress response,ribosome biogenesis,nucleolar protein regulation,cell proliferation,poor prognosis marker
ENSG00000239305,RNF103,apoptosis inhibition,cell cycle progression,dna repair regulation,e3 ubiquitin ligase activity,genomic instability facilitation,protein degradation regulation
ENSG00000136531,SCN2A,ion channel function,overexpression in cancer tissues,cellular proliferation,migration and invasion,aberrant signaling pathways,dysregulation of ion balance
ENSG00000172379,ARNT2,cellular proliferation,tumor progression,mutational driver,nrf2 pathway interaction,prognostic biomarker,oxidative stress regulation
ENSG00000104805,NUCB1,oncogene,cell proliferation,immune evasion,tumor progression,apoptosis inhibition,signal transduction
ENSG00000124587,PEX6,peroxisomal biogenesis,upregulation in cancer,cellular proliferation,lipid metabolism alterations,oxidative stress modulation,protein importation dysfunction
ENSG00000159199,ATP5MC1,mitochondrial dysfunction,cellular energy production,atp synthesis,warburg effect,glycolytic shift,regulatory mechanism alteration
ENSG00000187416,LHFPL3,lipid metabolism regulation,gene amplification,tumor progression driver,cancer cell proliferation,cell membrane integrity modulation,phospholipid composition regulation
ENSG00000163637,PRICKLE2,transcriptional regulation,cellular proliferation,apoptosis suppression,e-cadherin downregulation,emt activation,tumor progression driver
ENSG00000010295,IFFO1,ifn-mediated antitumor responses,chromatin remodeling,cell growth inhibition,apoptosis induction,inflammatory response regulation,dna repair pathway interaction
ENSG00000152642,GPD1L,mitochondrial function,fatty acid oxidation,oncogene,overexpression,poor prognosis,akt pathway interaction
ENSG00000160209,PDXK,metabolic regulation,tumor progression,cell growth,survival pathway,overexpression,cancer associated
ENSG00000182793,GSTA5,therapeutic target,cellular detoxification,tumor progression,ros detoxification,protein interaction,gene overexpression
ENSG00000170049,KCNAB3,ion channel regulation,oncogenic pathway disruption,cell migration modulation,apoptosis dysregulation,tumor progression driver,therapeutic target
ENSG00000166532,RIMKLB,microtubule regulation,tumor suppressor activity,cellular integrity maintenance,cytoskeletal dynamics modulation,mitotic spindle stabilization,cancer progression promotion
ENSG00000180535,BHLHA15,oncogene function,transcriptional regulation,tumor progression,cell proliferation,genetic instability,metastasis promotion
ENSG00000164038,SLC9B2,oncogenic driver,tumor aggressiveness,altered cellular metabolism,constitutive activation,pi3k/akt pathway,solute carrier activity
ENSG00000117400,MPL,jak/stat pathway,constitutive activation,gain of function mutations,cell proliferation,therapeutic resistance,tumor aggressiveness
ENSG00000248483,POU5F2,transcriptional regulation,oncogenesis,cellular proliferation,apoptosis evasion,co-regulatory interactions,prognostic marker
ENSG00000180964,TCEAL8,transcriptional regulation,cancer prognosis,cell proliferation,apoptosis resistance,tp53 interaction,e2f1 interaction
ENSG00000123983,ACSL3,long-chain fatty acid metabolism,metabolic reprogramming,glycolytic shift,apoptosis suppression,therapeutic target,pro-survival lipid synthesis
ENSG00000183092,BEGAIN,golgi apparatus regulation,vesicular transport modulation,cell growth regulation,tumor suppressor gene activity,protein-protein interactions,metabolic pathway modulation
ENSG00000143994,ABHD1,lipid metabolism regulation,gene amplification,cell membrane phospholipids,signaling pathway modulation,alpha/beta-hydrolase fold enzyme activity,tumorigenesis promotion
ENSG00000156110,ADK,energy metabolism regulation,oncogenic function,cell proliferation promotion,tumorigenesis contribution,atp production enhancement,downstream target activation
ENSG00000128039,SRD5A3,androgen biosynthesis,prognostic marker,tumor aggressiveness,cell proliferation,metastasis facilitation,therapeutic target
ENSG00000142347,MYO1F,actin cytoskeleton regulation,cell migration facilitation,endocytic pathway dysregulation,metastatic potential,tumor progression facilitation,cancer cell motility modulation
ENSG00000140548,ZNF710,transcription factor regulation,tumor suppressor gene downregulation,cell cycle progression,angiogenesis promotion,gene expression modulation,epigenetic regulation
ENSG00000103888,CEMIP,cell migration and invasion,oncogene activation,transcriptional regulation,tumor progression,pi3k/akt pathway interaction,therapeutic target
ENSG00000174574,AKIRIN1,wnt/β-catenin signaling pathway,oncogenic properties,transcriptional regulation,tumor progression,overexpression,poor prognosis
ENSG00000118702,GHRH,growth hormone secretion,cell proliferation,overexpression,angiogenesis,tumorigenesis,signaling pathways
ENSG00000177646,ACAD9,mitochondrial dysfunction,fatty acid oxidation regulation,cellular energy metabolism modulation,oncogenic process involvement,metabolic reprogramming influence,protein interaction modulation
ENSG00000182348,ZNF804B,oncogene function,transcription factor regulation,cell proliferation promotion,apoptosis inhibition,tumor progression association,overexpression in cancer
ENSG00000173825,TIGD3,genomic instability,dysregulated expression,tumor progression,tumor suppressor function,cell survival regulation,apoptosis modulation
ENSG00000182541,LIMK2,tumor progression,mutation,cell migration,cell proliferation,therapeutic target,signaling pathway
ENSG00000081052,COL4A4,basement membrane structure,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),gene expression profiling,oncogenic processes,tumor progression
ENSG00000105679,GAPDHS,glycolytic reprogramming,tumor metabolism,cell proliferation,oncogenic driver,metabolic adaptation,energy homeostasis
ENSG00000198205,ZXDA,zinc finger protein,transcriptional regulation,cell growth modulation,apoptosis regulation,tumor progression influence,gene expression regulation
ENSG00000139287,TPH2,vegf regulation,hif-1α regulation,angiogenesis promotion,serotonin biosynthesis,tumor progression driver,biomarker for poor prognosis
ENSG00000196850,PPTC7,tumor progression,protein metabolism regulation,angiogenesis promotion,immune suppression,oncogenic interaction,metabolic reprogramming
ENSG00000147457,CHMP7,cellular membrane dynamics,autophagy regulation,escrt-iii complex formation,oncogenic transformation,tumor progression,ubiquitination evasion
ENSG00000242802,AP5Z1,endosomal sorting,lysosome function,protein degradation,cellular trafficking,tumor suppressor regulation,oncogenic pathway
ENSG00000131148,EMC8,dna damage response,chromatin remodeling,histone phosphorylation,transcriptional regulation,genomic instability,oncogenic pathway activation
ENSG00000159788,RGS12,altered gpcr signaling,mapk/erk pathway regulation,pi3k/akt/mtor inhibition,tumor suppression,gene expression dysregulation,loss-of-function mutations
ENSG00000108688,CCL7,angiogenesis,immunosuppression,tumor progression,metastasis promotion,immune cell recruitment,cancer-associated gene expression
ENSG00000137502,RAB30,rab gtpase activation,autophagy regulation,vesicle transport,cell survival enhancement,pi3k/akt pathway modulation,prognostic marker
ENSG00000140398,NEIL1,dna repair mechanism,base excision repair,genomic integrity maintenance,tumor progression,oxidative dna damage repair,prognostic biomarker
ENSG00000188425,NANOS2,apoptosis suppression,cell cycle regulation,microrna regulation,tumor progression,autophagy regulation,oncogene activation
ENSG00000179593,ALOX15B,leukotriene synthesis,lipid metabolism dysregulation,pro-inflammatory mediator,cell proliferation regulation,tumor microenvironment modulation,therapeutic target
ENSG00000174844,DNAH12,microtubule stability,cell division regulation,dynein heavy chain function,ciliary maintenance,tumor suppressor dysfunction,kidney cancer association
ENSG00000278322,MBOAT7,lipid modification,phospholipid synthesis,cancer progression,cell membrane fluidity,therapeutic target,genomic instability
ENSG00000099954,CECR2,constitutive activation,metabolic regulation,cell growth promotion,tumor progression,immune evasion facilitation,angiogenesis promotion
ENSG00000198160,MIER1,transcriptional regulation,oncogenic processes,cell cycle progression,apoptosis evasion,dna repair dysregulation,tumor progression
ENSG00000141431,ASXL3,histone modification,chromatin remodeling,tumor suppressor function,genomic instability,epigenetic alterations,oncogenic processes
ENSG00000136108,CKAP2,microtubule regulation,cell cycle dysregulation,tumor progression,overexpression,apoptosis modulation,phosphorylation signaling
ENSG00000113430,IRX4,tumor progression,transcriptional regulation,oncogenic potential,cell proliferation,apoptosis evasion,metastasis promotion
ENSG00000152467,ZSCAN1,tumor suppressor activity,dna binding,gene regulation,apoptosis promotion,cell cycle regulation,transcription factor interaction
ENSG00000198758,EPS8L3,metastasis,cell migration,endocytosis regulation,aggressive tumor behavior,poor prognosis marker,oncogenic signaling
,MARCH8,protein degradation,immunomodulation,endocytosis regulation,tumor progression,metastasis promotion,cancer-associated protein interaction
ENSG00000281500,SLC37A4,ph regulation,sulfate transport,cellular proliferation,tumor progression,prognostic marker,therapeutic target
ENSG00000163812,ZDHHC3,oncogene activation,cell growth regulation,palmitoylation modification,protein interaction modulation,tumor progression enhancement,genomic integrity disruption
ENSG00000164219,PGGT1B,transcriptional regulation,cellular proliferation,genetic regulation,protein-protein interaction,oncogenic function,nuclear localization
ENSG00000006007,GDE1,lipid metabolism alteration,tumor growth promotion,cellular proliferation enhancement,glycogen biosynthesis regulation,signal transduction modulation,biomarker potential
ENSG00000151655,ITIH2,inflammation,tumor progression,protease inhibition,cell migration,immune evasion,angiogenesis
ENSG00000171649,ZIK1,transcriptional regulation,oncogene,enhanced cell proliferation,tumor progression,chromatin remodeling,krab domain-containing zinc finger protein family
ENSG00000162704,ARPC5,actin cytoskeleton regulation,tumor progression,cell migration and invasion,poor prognosis marker,therapeutic target candidate,oncogenic driver gene
ENSG00000160539,PLPP7,plpp7 dephosphorylates pip3,regulates pi3k/akt/mtor pathway,enhances cell proliferation,associated with tumorigenesis,tumor suppressor function,lipid metabolism regulation
ENSG00000143768,LEFTY2,tumor suppressor,downregulation in cancer,interacts with tgf-β signaling,inhibits epithelial-to-mesenchymal transition,regulates cell cycle progression,genomic downregulation
ENSG00000111058,ACSS3,fatty acid metabolism,constitutive activation,gain of function mutations,tumor progression,therapeutic target,warburg effect
ENSG00000281216,KIF26B,microtubule dynamics,cell proliferation,mitosis regulation,gene overexpression,tumor metastasis,mitotic checkpoint regulation
ENSG00000014919,COX15,mitochondrial dysfunction,oxidative stress generation,electron transport chain disruption,cellular energy metabolism alteration,genomic instability induction,tumor progression promotion
ENSG00000198380,GFPT1,glutamine-dependent hexosamine biosynthesis,udp-n-acetylglucosamine synthesis,protein glycosylation,cell proliferation,growth factor signaling,cancer metabolism
ENSG00000162706,CADM3,cell adhesion molecule,epithelial-to-mesenchymal transition,downregulation,poor prognosis,metastasis promotion,cancer progression
ENSG00000114857,NKTR,matrix metalloprotease regulation,tumor invasion and metastasis,cell proliferation and migration,oncogenic process driver,serine protease inhibitor,pi3k/akt signaling pathway interaction
ENSG00000186918,ZNF395,chromatin remodeling,transcriptional regulation,oncogene activation,cell proliferation,pi3k/akt pathway modulation,apoptosis inhibition
ENSG00000179603,GRM8,glutamate signaling,metastasis promotion,cell proliferation enhancement,mtor/pi3k/akt pathway activation,tumor progression facilitation,prognostic biomarker candidate
ENSG00000282185,PTPRN2,pi3k/akt/mtor pathway modulation,oncogenic mutations,tumor growth promotion,cell adhesion regulation,protein interaction with pi3k,signaling pathway dysregulation
ENSG00000180537,RNF182,pi3k/akt pathway,protein degradation,tumor suppressor protein degradation,cell cycle control,oncogenic process,cell proliferation
ENSG00000185527,PDE6G,camp/pka signaling pathway,tumor progression,promotes cellular proliferation,metastasis regulation,potential therapeutic target,dysregulated expression
ENSG00000108947,EFNB3,tumor suppressor function,downregulation in cancer,cell adhesion regulation,angiogenesis inhibition,metastasis suppression,ephrin receptor interaction
ENSG00000178522,AMBN,altered expression levels,tumor progression,cell adhesion regulation,protein interaction,signaling pathway modulation,oncogenesis
ENSG00000198670,LPA,angiogenesis promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition,genetic instability induction,lipid metabolism alteration,matrix metalloproteinase activation
ENSG00000138031,ADCY3,camp/pka signaling,cell proliferation,tumor progression,promoter of oncogenesis,inhibitor of apoptosis,regulation of cell growth
ENSG00000147488,ST18,tumor progression,matrix degradation,cell migration,protein interaction,oncogenesis,genomic upregulation
ENSG00000204604,ZNF468,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor microenvironment modulation,protein-protein interaction,dna repair regulation
ENSG00000171540,OTP,olfactomedin 4 overexpression,wnt/β-catenin signaling,cell migration regulation,tumor progression promotion,gene expression modulation,protein-protein interaction
ENSG00000101474,APMAP,mitochondrial-associated protein,aldehyde reduction,apoptosis regulation,redox balance modulation,cellular stress response,cellular homeostasis maintenance
ENSG00000102904,TSNAXIP1,tumor progression,oncogenic pathway activation,cell survival regulation,signaling pathway modulation,gene overexpression,protein interaction
ENSG00000185070,FLRT2,tumor progression,fgf/erk pathway regulation,cell proliferation,oncogenic processes,biomarker potential,angiogenesis promotion
ENSG00000204130,RUFY2,autophagy regulation,tumor suppressor function disruption,dna damage response,cellular survival enhancement,protein-protein interaction,genetic instability promotion
ENSG00000173976,RAX2,emt regulation,transcriptional regulation,oncogenic driver,tumor progression,metastasis promotion,angiogenesis modulation
ENSG00000172006,ZNF554,transcription factor,cell proliferation,apoptosis inhibition,epigenetic regulator,tumor growth promotion,poor prognosis marker
ENSG00000215454,KRTAP10-4,cellular differentiation,cancer progression,cell proliferation,epigenetic regulation,keratin filament stability,mechanical property modulation
ENSG00000144671,SLC22A14,altered expression,cellular ph regulation,ion transport facilitation,oncogenic process contribution,tumor progression association,upregulated expression
ENSG00000171532,NEUROD2,cellular differentiation regulator,oncogenic transcription factor,cell proliferation enhancer,apoptosis inhibitor,metastasis promoter,tumor progression driver
ENSG00000101868,POLA1,genomic instability,dna replication initiation,chromosomal abnormalities,tumor development,oncogenic mutations,cell cycle regulation
ENSG00000213366,GSTM2,oxidative stress modulation,detoxification process,xenobiotic metabolism regulation,carcinogen conjugation,dna damage repair,inflammation regulation
ENSG00000178662,CSRNP3,apoptosis regulation,dysregulated pathways,tumor progression,anti-apoptotic signaling,promoted cell survival,genomic alterations
ENSG00000162188,GNG3,pi3k/akt pathway activation,tumor progression,cell proliferation regulation,signal transduction,apoptosis modulation,protein interaction
ENSG00000255150,EID3,transcriptional regulation,cellular proliferation,apoptosis suppression,immune checkpoint,chromatin modification,genetic instability
ENSG00000118162,KPTN,proteasome regulation,p53 interaction,ubiquitin-proteasome pathway,protein degradation,cellular homeostasis,oncogenic process
ENSG00000172782,FADS6,fatty acid biosynthesis,tumor progression,cellular proliferation,upregulation in cancer,fatty acid metabolism alteration,polyunsaturated fatty acid synthesis
ENSG00000134317,GRHL1,tumor suppressor function,transcriptional regulation,wnt/β-catenin pathway interaction,cell proliferation inhibition,chromatin remodeling,oncogenic process dysregulation
ENSG00000173992,CCS,iron metabolism regulation,hypoxia response,oncogene activation,tumor progression,angiogenesis promotion,iron homeostasis disruption
ENSG00000204060,FOXO6,tumor suppressor function,cellular homeostasis regulation,transcriptional regulation,cancer cell growth inhibition,apoptosis promotion,genomic instability modulation
ENSG00000068912,ERLEC1,er stress regulation,apoptosis inhibition,cell proliferation,tumor progression,protein interaction,endoplasmic reticulum maintenance
ENSG00000197622,CDC42SE1,rho gtpase interaction,apoptosis resistance,cell migration,cell invasion,oncogenic potential,prognostic marker
ENSG00000185269,NOTUM,wnt signaling,tumor suppressor,cell migration,protein kinase regulation,cell proliferation,adhesion pathway
ENSG00000196660,SLC30A10,zinc homeostasis,oncogenic processes,cell survival regulation,therapeutic target,cell proliferation modulation,genomic profiling
ENSG00000131725,WDR44,genomic instability,chromosomal instability,mitotic checkpoint regulation,dna repair modulation,cell cycle regulation,oncogenic potential
ENSG00000046653,GPM6B,calcium influx regulation,ion channel modulation,cell growth promotion,angiogenesis induction,metastasis facilitation,poor prognosis marker
ENSG00000136867,SLC31A2,zinc metabolism regulation,tumor angiogenesis,cancer cell proliferation,metal ion transport dysregulation,cellular homeostasis disruption,autophagy modulation
ENSG00000280549,PADI3,histone modification,oncogenic function,chromatin remodeling,epigenetic regulation,transcriptional activation,genome instability
ENSG00000226430,USP17L7,ubiquitin-proteasome pathway,deubiquitinating activity,cell cycle regulation,apoptosis regulation,genomic instability,proliferation enhancement
ENSG00000156925,ZIC3,transcription factor regulation,chromatin modification,epithelial-to-mesenchymal transition,cellular proliferation,gene expression modulation,oncogenic activity
ENSG00000169918,OTUD7A,ubiquitin-proteasome pathway,cellular stress response regulation,oncogenic protein stabilization,tumor progression facilitation,deubiquitinating enzyme function,cancer-related expression alterations
ENSG00000116497,S100PBP,tumor progression,cancer biomarker,protein regulation,cell survival,immune response modulation,inflammation regulation
ENSG00000151532,VTI1A,tumor microenvironment,lysosomal regulation,cellular ph homeostasis,protein trafficking,therapeutic target,cancer progression
ENSG00000183655,KLHL25,ubiquitin-proteasome pathway,cell proliferation,tumor suppression,protein degradation regulation,genetic instability,cancer cell survival
ENSG00000066813,ACSM2B,fatty acid metabolism,oncogenic process,potential driver gene,therapeutic target,regulatory element interaction,epigenetic modification
ENSG00000168779,SHOX2,oncogene,transcription factor,epithelial-to-mesenchymal transition,tumor progression,metastasis,cell proliferation
ENSG00000104951,IL4I1,pi3k/akt/mtor signaling,cell survival and proliferation,driver gene,oncogenic process,tumor progression,tissue specificity
ENSG00000112218,GPR63,tumor metastasis,cell proliferation,signaling pathway regulation,protein-protein interaction,growth factor activation,biomarker expression
ENSG00000196511,TPK1,cellular proliferation,oncogenic signaling,protein kinase activation,cell survival pathways,phosphorylation events,kinase activity regulation
ENSG00000178814,OPLAH,aberrant glycosylation,cellular modification,glycoprotein regulation,tumorigenesis promotion,cancer cell survival,metastasis facilitation
ENSG00000171408,PDE7B,camp regulation,cellular signaling pathway,kidney tissue specificity,electrolyte balance modulation,ion channel regulation,tumor suppressor function
ENSG00000276231,PIK3R6,pi3k/akt signaling pathway regulation,tumor progression,cell growth and survival promotion,protein synthesis regulation,mtorc1 activation,dysregulated gene expression
ENSG00000198753,PLXNB3,met signaling pathway,oncogenic driver,cell migration regulator,adhesion molecule interaction,rho gtpase activation,overexpression in tumors
ENSG00000119723,COQ6,mitochondrial function,oxidative stress,electron transport chain,cellular metabolism,energy production,redox balance
ENSG00000168675,LDLRAD4,lrp1 endocytosis regulation,pi3k/akt/mtor pathway modulation,tumor progression impact,lipid metabolism regulation,cell survival influence,prognostic marker potential
ENSG00000135919,SERPINE2,angiogenic factor,tumor progression,oncogene overexpression,metastasis facilitation,poor prognosis marker,genomic amplification
ENSG00000143847,PPFIA4,epithelial-to-mesenchymal transition,akt signaling pathway activation,cell adhesion disruption,migration and invasion promotion,metastasis facilitation,therapeutic target identification
ENSG00000159409,CELF3,oncogenic regulation,cellular proliferation,upregulation in tumors,post-transcriptional regulation,stress response modulation,cell cycle progression
ENSG00000100342,APOL1,mitochondrial clearance,constitutive activation,autophagic pathways,cellular damage,therapeutic target,genomic profiling
ENSG00000147955,SIGMAR1,er stress regulation,tumor suppressor function,apoptosis modulation,cell survival pathway,protein folding regulation,signaling molecule interaction
ENSG00000144821,MYH15,non-muscle myosin iib,tumor progression,cell migration and contraction,metastasis,rho gtpase interaction,pi3k/akt pathway modulation
ENSG00000104723,TUSC3,cell cycle regulation,genomic instability,apoptosis regulation,dna damage response,tumor suppressor function,p53 signaling pathway interaction
ENSG00000164252,AGGF1,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,oncogene activation,tumor progression driver,angiogenic factor overexpression
ENSG00000100078,PLA2G3,phospholipase activity,genomic instability,pro-inflammatory signaling,dna damage,angiogenesis promotion,tumor progression marker
ENSG00000144182,LIPT1,mitochondrial function,cellular energy metabolism,glycolysis regulation,tumor growth support,lipoic acid biosynthesis regulation,ancillary enzyme activity modulation
ENSG00000120832,MTERF2,mitochondrial function,energy metabolism regulation,oncogenic processes,cellular respiration,apoptosis modulation,therapeutic target
ENSG00000002586,CD99,cell proliferation,signal transduction,tumor progression,apoptosis regulation,metastasis promotion,biomarker identification
ENSG00000137871,ZNF280D,transcriptional regulation,oncogenic properties,cell proliferation,apoptosis inhibition,epigenetic regulation,tumor progression
ENSG00000178537,SLC25A20,mitochondrial carrier protein,aspartate transport,cellular metabolism regulation,tumor growth promotion,biomarker potential,pi3k/akt pathway modulation
ENSG00000153936,HS2ST1,chromatin remodeling,histone methylation,epigenetic regulation,tumor growth,oncogene activation,tumor suppressor gene suppression
ENSG00000166869,CHP2,cell cycle regulation,dna damage response,cullin-ring ubiquitin ligase regulation,tumor suppressor function,cell proliferation,genomic instability
ENSG00000164300,SERINC5,tumor suppressor,cell proliferation restriction,reduced expression,poor prognosis marker,apoptosis modulation,cell migration regulation
ENSG00000249115,HAUS5,cilia maintenance,centrosome interface,tumor progression,metastasis promotion,cell proliferation,oncogenic process
ENSG00000275824,CCL4,tumor progression,immune suppression,angiogenesis,cytokine signaling,metastasis,gene regulation
ENSG00000173175,ADCY5,pi3k/akt signaling pathway,gain of function mutations,cell proliferation enhancement,tumor progression,metastasis promotion,signaling pathway regulation
ENSG00000198121,LPAR1,cell proliferation,signaling pathway modulation,tumor progression,g protein-coupled receptor activation,metabolic regulation,poor prognosis marker
ENSG00000116793,PHTF1,cellular proliferation,transcriptional regulation,epithelial-to-mesenchymal transition,apoptosis inhibition,genome stability,tumor progression
ENSG00000253958,CLDN23,cell-cell adhesion disruption,oncogene role,epithelial-to-mesenchymal transition promotion,tumor progression facilitation,prognostic marker,therapeutic target
ENSG00000140043,PTGR2,prostaglandin synthesis,tumor metastasis,angiogenesis promotion,immune evasion,prognostic marker,cancer progression
ENSG00000120533,ENY2,histone methylation,epigenetic regulation,chromatin remodeling,transcriptional control,oncogene activation,tumor suppressor silencing
ENSG00000152683,SLC30A6,zinc transporter regulation,tumor invasion,matrix metalloproteinase activation,tumor progression,therapeutic target,cellular stress response
ENSG00000145740,SLC30A5,zinc homeostasis regulation,cell proliferation modulation,tumor growth promotion,therapeutic target identification,biomarker potential,zinc-dependent enzyme regulation
ENSG00000147789,ZNF7,zinc finger protein interaction,transcriptional regulation,cellular transformation,epithelial-to-mesenchymal transition,poor prognosis indicator,chromatin remodeling
ENSG00000100106,TRIOBP,rho gtpase regulation,tumor progression,cell migration,prognostic biomarker,downstream signaling pathway modulation,cell invasion
ENSG00000164172,MOCS2,molybdenum cofactor (moco) biosynthesis,tumor progression,cellular metabolism regulation,redox balance disruption,sulfite oxidase activity reduction,downregulated expression
ENSG00000163297,ANTXR2,angiogenesis promotion,tumor growth facilitation,poor prognosis association,advanced tumor stages correlation,biomarker potential,therapeutic target
ENSG00000236637,IFNA4,immunomodulation,interferon signaling pathway,tumor progression,immunosuppression,antigen presentation,nk cell suppression
ENSG00000135916,ITM2C,cell proliferation,apoptosis inhibition,overexpression,oncogenic driver,therapeutic target,membrane trafficking
ENSG00000175766,EIF4E1B,oncogene,translation regulation,cell proliferation,mrna cap-dependent translation,therapeutic target,protein kinase activation
ENSG00000197044,ZNF441,transcriptional regulation,oncogenesis,cellular differentiation,tumor progression,cell survival,cell proliferation
ENSG00000072182,ASIC4,increased expression,protein-protein interaction,cell migration,calcium influx,pi3k/akt pathway activation,emt regulation
ENSG00000147117,ZNF157,oncogene activation,transcriptional regulation,cell proliferation promotion,chromatin modification interaction,tumor progression contribution,chemoresistance development
ENSG00000116133,DHCR24,steroid hormone regulation,cell migration and invasion,biomarker for kidney renal clear cell carcinoma,resistance to targeted therapies,protein-protein interactions with ar/er,signaling pathway modulation
ENSG00000130787,HIP1R,oncogenic properties,cell migration,actin cytoskeleton rearrangement,endocytosis regulation,poor prognosis association,aggressive tumor behavior
ENSG00000118473,SGIP1,gef family member,rac1 and rhoa activation,cell migration and invasion,oncogenic properties,tumor progression,endocytosis and membrane trafficking regulator
ENSG00000164010,ERMAP,epigenetic alterations,chromosomal instability,tumor progression,cell proliferation,nuclear matrix association,prognostic marker
ENSG00000183035,CYLC1,leukotriene production,angiogenesis promotion,metastasis facilitation,tumor progression,prognostic marker,inflammation regulation
ENSG00000106636,YKT6,vesicular transport regulation,proliferation promotion,akt pathway activation,metastasis facilitation,cell migration enhancement,tumor progression marker
ENSG00000132464,ENAM,overexpression,poor prognosis marker,cell proliferation regulation,tumor progression,akt pathway activation,protein-protein interaction
ENSG00000007216,SLC13A2,glutamine metabolism,amino acid transport,tumor progression,nutrient uptake,oncogenic function,cellular proliferation
ENSG00000176597,B3GNT5,chondroitin sulfate synthesis,dermatan sulfate regulation,tumor progression facilitation,extracellular matrix modification,angiogenesis promotion,metastasis enhancement
ENSG00000140297,GCNT3,glycosylation regulation,oncogenic transformation,cell surface modulation,tumor progression,therapeutic target,glycosyltransferase activity
ENSG00000115252,PDE1A,cgmp hydrolysis,cell proliferation,tumor progression,regulatory mechanisms,cell survival,cancer biology
ENSG00000148334,PTGES2,prostaglandin synthesis,inflammatory pathway,cell proliferation,angiogenesis,tumor progression,promising therapeutic target
ENSG00000197181,PIWIL2,oncogene,genomic instability regulation,tumor progression promotion,poor prognosis correlation,transposon activity suppression,apoptosis modulation
ENSG00000103037,SETD6,h3k36me2 mark regulation,genomic instability,chromatin remodeling,oncogenic processes,dna repair mechanisms,cell cycle regulation
ENSG00000127663,KDM4B,histone demethylation,oncogenic function,cell proliferation,angiogenesis,chromatin regulation,poor prognosis
ENSG00000142784,WDTC1,cellular differentiation,tumor suppressor gene,oncogene activation,epigenetic modification,transcription factor regulation,apoptosis regulation
ENSG00000158161,EYA3,apoptosis regulation,cell cycle progression,dna repair,oncogenesis contribution,transcription factor interaction,tumor suppressor dysfunction
ENSG00000197123,ZNF679,transcription factor regulation,tumor suppressor/ oncogene dualism,cell cycle progression modulation,apoptosis regulation,metastasis promotion,dna recognition motif specificity
ENSG00000177156,TALDO1,non-oxidative pentose phosphate pathway,aggressive behavior,cell proliferation,metabolic adaptation,glycolytic shift,enzymatic interaction
ENSG00000119681,LTBP2,pi3k/akt pathway,cell migration,signaling regulation,overexpression,prognostic marker,tumor progression
ENSG00000102595,UGGT2,protein homeostasis regulation,cellular stress response,oncoprotein stabilization,glycosylation facilitation,protein degradation regulation,stress response activation
ENSG00000144029,MRPS5,mitochondrial function modification,energy metabolism regulation,oncogene potential,tumor progression marker,cellular respiration modulation,prognostic indicator
ENSG00000166435,XRRA1,microtubule regulation,genomic instability,cancer driver,gene amplification,cancer hallmark,cell cycle disruption
ENSG00000134216,CHIA,chromatin remodeling,cell growth regulation,swi/snf complex interaction,p53 tumor suppressor modulation,tumor progression marker,prognostic indicator
ENSG00000077254,USP33,vhl regulation,deubiquitinating enzyme activity,tumor suppressor degradation,oncogene stabilization,angiogenesis promotion,poor prognosis marker
ENSG00000196611,MMP1,tumor progression,metastasis facilitation,extracellular matrix degradation,angiogenesis promotion,therapeutic target,genomic profiling
ENSG00000170619,COMMD5,mitotic regulation,cell cycle progression,uncontrolled proliferation,dna damage response,tumor initiator,protein-protein interaction
ENSG00000103316,CRYM,calreticulin-related function,calcium regulation,oncogenic signaling,tumor progression,cell proliferation,proapoptotic activity
ENSG00000080618,CPB2,tumor progression,metastasis regulation,cell migration,proteolytic activity,blood coagulation regulation,fibrinolysis modulation
ENSG00000137251,TINAG,transcriptional regulation,tumor suppressor interaction,cell cycle progression,dna replication,proliferation enhancement,survival pathway activation
ENSG00000171421,MRPL36,mitochondrial translation regulation,tumor progression,oncogene activation,cellular metabolism alteration,loss-of-function mutations,cancer driver gene
ENSG00000120093,HOXB3,hoxb3 transcription factor,oncogenic activity,promotes proliferation,regulates cell cycle,apoptosis evasion,epithelial-to-mesenchymal transition
,H1FOO,histone modification,chromatin remodeling,gene expression regulation,transcriptional modulation,oncogenic process facilitation,cell cycle control
ENSG00000142556,ZNF614,transcription factor regulation,oncogenic function,cell proliferation promotion,chromatin remodeling,tumor suppressor regulation,apoptosis inhibition
ENSG00000131871,SELENOS,redox regulation,thioredoxin system activation,cell proliferation promotion,migration and invasion facilitation,transcription factor regulation,nf-κb activation
ENSG00000165300,SLITRK5,metastasis induction,epithelial-to-mesenchymal transition,tumor progression,cell adhesion modulation,protein interaction partner,overexpression signature
ENSG00000178700,DHFR2,overexpression,oncogenic potential,cell proliferation support,dna synthesis support,tumor progression association,metabolic enzyme activity
ENSG00000083544,TDRD3,genomic instability,piwi-pirna complex regulation,tumor microenvironment modulation,immune response regulation,biomarker significance,prognostic indicator
ENSG00000277363,SRCIN1,regulation of cell polarity,oncogenic process promotion,cell migration and invasion regulation,interaction with src family kinases,wave complex regulation,therapeutic target candidate
ENSG00000149972,CNTN5,contactin signaling pathway,cell adhesion disruption,tumor progression,cell migration promotion,poor prognosis marker,protein-protein interactions
ENSG00000126500,FLRT1,tumor progression,notch signaling pathway interaction,oncogene activation,cell migration enhancement,fgf signaling pathway modulation,poor prognosis correlation
ENSG00000197616,MYH6,cell proliferation,tumor progression,dna damage response,genomic instability,cancer driver gene,poor prognosis marker
ENSG00000055211,GINM1,oncogenic potential,constitutive activation,cell growth regulation,protein-protein interactions,mutational hotspot,tumor-promoting activity
ENSG00000013306,SLC25A39,mitochondrial dysfunction,oxidative stress,sulfite accumulation,electron transport chain disruption,reactive oxygen species generation,cell proliferation enhancement
ENSG00000169116,PARM1,cell cycle progression,oncogene activation,g2/m phase transition,cell proliferation regulation,aurora kinase interaction,p53 tumor suppressor interaction
ENSG00000205659,LIN52,regulatory dysfunction,tumor suppressor function,dysregulated ubiquitin-proteasome pathway,cell cycle regulation,genomic instability,autophagy activation
ENSG00000198554,WDHD1,tumor suppressor function,apoptosis regulation,genomic instability,cell cycle progression,poor prognosis indicator,dna repair regulation
ENSG00000105732,ZNF574,transcriptional regulation,tumor suppressor function,target gene overexpression,cell cycle regulation,genomic stability maintenance,biomarker potential
ENSG00000119614,VSX2,cell growth regulation,transcriptional regulation,oncogenic pathway interaction,tumor progression marker,prognostic indicator,genetic overexpression
ENSG00000144218,AFF3,cell cycle regulation,transcriptional regulation,oncogene cooperation,growth factor signaling,apoptosis evasion,prognostic marker
ENSG00000102387,TAF7L,transcriptional regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,poor prognosis association,cancer progression facilitation
ENSG00000176102,CSTF3,alternative splicing regulation,apoptosis evasion,cell proliferation,genetic instability,oncogenic process modulation,tumor suppressor function disruption
ENSG00000001561,ENPP4,genetic alteration,oncogenic driver,pi3k/akt signaling,calcification process regulation,therapeutic target,cellular proliferation
ENSG00000159322,ADPGK,glycolytic regulation,gain of function mutations,metabolic reprogramming,cellular energy metabolism,therapeutic target,genomic instability
,TWISTNB,emt induction,transcriptional regulation,poor prognosis indicator,cancer stem cell maintenance,cell migration promotion,metastasis facilitation
ENSG00000133424,LARGE1,oncogene activation,rna stability modulation,cell proliferation enhancement,tumor aggressiveness,cancer development contribution,therapeutic target
ENSG00000141429,GALNT1,o-glycosylation,cell adhesion,metastasis,tumor progression,glycoprotein modification,cancer metastasis
ENSG00000152495,CAMK4,cell proliferation,promoter hypermethylation,cancer cell survival,tumor suppressor activity,transcriptional regulation,signal transduction pathway
ENSG00000112394,SLC16A10,metabolic regulation,glycolysis enhancement,cellular energy metabolism,tumor growth promotion,cancer cell survival,protein interaction
ENSG00000197106,SLC6A17,glutamate transporter,tumor progression,cellular metabolism,genomic alterations,metabolic regulation,amino acid transport
ENSG00000176399,DMRTA1,tumor progression,cell cycle regulation,oncogenic transcription factor,immune evasion,genomic instability,cell proliferation
ENSG00000160445,ZER1,transcriptional repression,oncogenesis,cell cycle regulation,metastasis,apoptosis suppression,tumor progression
ENSG00000135763,URB2,ubiquitin-like protein regulation,tumor progression,apoptosis evasion,cancer metastasis,cell cycle modulation,mdm2 interaction
ENSG00000162892,IL24,apoptosis induction,immunogenic cell death,tumor suppression,cell proliferation inhibition,signaling pathway activation,cytokine regulation
ENSG00000134153,EMC7,protein degradation pathway,tumor progression,cellular stress response,ubiquitin ligase function,apoptosis dysregulation,dna damage response
ENSG00000125675,GRIA3,ampar subunit regulation,cell proliferation enhancement,epithelial-to-mesenchymal transition,glia cell interaction,metastasis promotion,signal transduction pathway interaction
ENSG00000136378,ADAMTS7,tumor metastasis,ecm remodeling,angiogenesis regulation,cell migration facilitation,growth factor modulation,cancer progression
ENSG00000114450,GNB4,mapk/erk pathway activation,cellular proliferation,signaling cascade regulation,tumor progression,oncogene interaction,therapeutic target
ENSG00000153721,CNKSR3,cell cycle dysregulation,gain of function mutations,constitutive activation,tumor growth,therapeutic target,mitotic kinase regulation
ENSG00000116786,PLEKHM2,autophagy regulation,tumor suppressor function,cellular growth regulation,dysregulated in cancer,pleiotropic roles,genome stability maintenance
ENSG00000116747,RO60,immune suppression,tumor progression,apoptosis regulation,cell cycle modulation,dna repair interaction,prognostic marker
ENSG00000129990,SYT5,pi3k/akt pathway interaction,gain of function mutations,cell proliferation regulation,mitochondrial dysfunction contribution,tumor progression influence,energy metabolism modulation
ENSG00000197150,ABCB8,chemoresistance,cellular efflux,lipid metabolism regulation,tumor progression,prognostic marker,therapeutic target
ENSG00000047597,XK,ion channel regulation,potassium homeostasis,tumor progression,metastasis promotion,oncogenic process modulation,cellular signaling pathway interaction
ENSG00000135519,KCNH3,potassium channel regulation,tumor suppressor/oncogene,cell proliferation/migration,survival signaling pathways,mutation-driven tumorigenesis,voltage-gated potassium channels
ENSG00000160781,PAQR6,altered lipid metabolism,cell proliferation,enhanced angiogenesis,insulin resistance,metastasis promotion,nuclear receptor function
ENSG00000169251,NMD3,mitochondrial function,ribosome biogenesis,cellular proliferation,tumor progression,protein synthesis regulation,oncogenic interaction
ENSG00000173918,C1QTNF1,tumor suppression,metastasis regulation,cell adhesion modulation,biomarker potential,immune response regulation,epithelial-to-mesenchymal transition
ENSG00000133466,C1QTNF6,tumor suppressor function,cell growth regulation,disrupted function mutations,apoptosis modulation,cancer progression,immune evasion
ENSG00000122585,NPY,tumor progression,angiogenesis,metastasis promotion,immune modulation,cell proliferation enhancement,vasoconstriction
ENSG00000176209,SMIM19,cellular homeostasis regulation,intracellular signaling modulation,potential tumor suppressor,limited cancer-related studies,altered expression levels,cellular process maintenance
ENSG00000188991,SLC15A5,oncogene,cellular metabolism regulation,transporter function,glycolysis modulation,cell cycle progression,apoptosis evasion
ENSG00000161904,LEMD2,pi3k/akt pathway interactions,oncogene activity,cell proliferation promotion,membrane dynamics regulation,overexpression association,tumor progression contribution
ENSG00000103449,SALL1,tumor suppressor,embryonic kidney formation regulation,transcriptional regulation disruption,cell growth inhibition loss,oncogenesis involvement,cell cycle regulation alteration
ENSG00000102393,GLA,dysregulated lipid metabolism,lysosomal dysfunction,cell growth regulation,metabolic reprogramming,toxic metabolite accumulation,aggressive tumor behavior
ENSG00000066827,ZFAT,wnt/beta-catenin pathway activation,transcriptional regulation,oncogenic pathway activation,cell growth promotion,tumor progression driver,chromatin modification interaction
ENSG00000117477,CCDC181,cilia dysfunction,cell proliferation,apoptosis regulation,tumor progression,oncogenic driver,genomic instability
ENSG00000156521,TYSND1,mitochondrial function modulation,oxidative stress response,cellular homeostasis regulation,tumor progression driver,apoptosis resistance,genetic instability promotion
ENSG00000147912,FBXO10,loss of tumor suppressor function,pi3k/akt pathway activation,downregulation or mutation,cell proliferation promotion,apoptosis inhibition,ubiquitin-proteasome pathway interaction
ENSG00000129151,BBOX1,chromatin remodeling,histone demethylation,tumor suppressor regulation,cell growth regulation,protein-protein interactions,transcriptional activation
ENSG00000148219,ASTN2,cell-cell adhesion disruption,tumor progression driver,metastasis enhancer,apoptosis resistance,angiogenesis promotion,therapeutic target
ENSG00000182983,ZNF662,transcriptional regulation,cell cycle progression,apoptosis evasion,metastasis promotion,oncogene overexpression,chromatin remodeling
ENSG00000130558,OLFM1,epithelial integrity disruption,metastasis promotion,epithelial-to-mesenchymal transition,cell adhesion modulation,tumor suppressor function,signaling pathway regulation
ENSG00000132681,ATP1A4,ion transport regulation,cellular membrane maintenance,electrochemical gradient modulation,cancer cell resistance,oncogenic signaling pathway alteration,tumor progression enhancement
ENSG00000126545,CSN1S1,tumor suppressor degradation,proteasome regulation,cell proliferation enhancement,oncogenic process facilitation,apoptosis evasion,aggressive disease progression
ENSG00000018625,ATP1A2,na+/k+-atpase function,loss-of-function mutations,gain of novel functions,cell survival enhancement,proliferation regulation,tumor suppressor/oncofunction
ENSG00000163923,RPL39L,ribosomal regulation,cancer associated gene,pseudogene,cellular proliferation,growth modulation,protein synthesis
ENSG00000126217,MCF2L,oncogenic driver,amplification,cell migration,cell invasion,cell survival,guanine nucleotide exchange factor
ENSG00000160991,ORAI2,calcium influx regulation,tumor progression,oncogenic signaling,immune response modulation,prognostic marker,therapeutic target
ENSG00000141873,SLC39A3,metabolic reprogramming,zinc transporter function,cellular proliferation,tumor progression,cancer stem cell maintenance,glycolytic shift
ENSG00000168944,CEP120,microtubule dynamics,centrosomal regulation,chromosomal instability,genomic alterations,aneuploidy,protein-protein interactions
ENSG00000105136,ZNF419,zinc finger binding,transcriptional regulation,dna-binding activity,oncogenic signaling,cellular growth,tumor suppressor interaction
ENSG00000067533,RRP15,ribosome regulation,rna processing,oncogenic driver,cellular proliferation,tumor progression,therapeutic target
ENSG00000129128,SPCS3,regulation of protein turnover,cell cycle progression,dna damage response,oncogenic processes,ubiquitination pathway,cancer biology
ENSG00000145075,CCDC39,microtubule regulation,dysregulated cilia formation,microtubule assembly alterations,oncogenic mutations,cellular proliferation promotion,apoptosis inhibition
ENSG00000172766,NAA16,nuclear rna-binding protein,cell proliferation,mrna regulation,protein synthesis,cell survival,translation efficiency
ENSG00000182759,MAFA,metabolic reprogramming,glycolytic shift,transcriptional regulation,oncogenesis,metastasis promotion,poor prognosis
ENSG00000128394,APOBEC3F,hypermutation,dna deamination,tumor suppressor inactivation,therapeutic resistance,oncogenic pathway activation,cancer therapy evasion
ENSG00000066926,FECH,heme biosynthesis,reactive oxygen species (ros),iron metabolism,cell cycle progression,apoptosis regulation,therapeutic target
ENSG00000156531,PHF6,chromatin remodeling,aneuploidy,genomic instability,transcriptional regulation,tumor suppressor function,cell cycle progression
ENSG00000164742,ADCY1,camp regulation,protein kinase activation,oncogenic signaling,tumor aggressiveness,cell proliferation,cellular interaction
ENSG00000198092,TMPRSS11F,glycosylation regulation,cell surface modulation,signal transduction,growth factor regulation,cancer cell invasion,aggressive behavior
ENSG00000183576,SETD3,histone modification,chromatin regulation,tumor suppressor gene regulation,dna repair,cell proliferation,apoptosis inhibition
ENSG00000130881,LRP3,lrp3-lipoprotein interaction,tumor angiogenesis,metastatic potential,cellular growth regulation,survival signaling,aberrant receptor activation
ENSG00000186684,CYP27C1,cholesterol metabolism,hypoxia response,lipid homeostasis regulation,oxidative stress modulation,tumor survival adaptation,genetic regulation of lipid transport
ENSG00000205358,MT1H,oxidative stress regulation,cellular damage response,redox balance modulation,tumorigenesis association,protein-protein interaction,heavy metal detoxification
ENSG00000134825,TMEM258,er stress response,autophagy pathway,genomic instability,oncogenic pathway interaction,tumor progression correlation,therapeutic target
ENSG00000112294,ALDH5A1,oncogenesis,epigenetic regulation,metabolic regulation,cell survival,detoxification process,poor prognosis
ENSG00000056291,NPFFR2,g-protein coupled receptor,tumor progression,oncogene activation,cell proliferation,metastasis promotion,signaling pathway interaction
ENSG00000130700,GATA5,transcription factor activity,oncogene function,cell cycle regulation,tumor growth promotion,metastasis induction,therapeutic target candidate
ENSG00000148498,PARD3,microtubule stability regulation,cell migration promotion,epithelial junction disruption,par complex component,prognostic marker candidate,tumor progression driver
ENSG00000166557,TMED3,protein quality control,er-associated degradation,molecular chaperone interactions,oncogenic signaling pathway activation,cell proliferation enhancement,tumorigenesis promotion
ENSG00000198924,DCLRE1A,genomic instability,dna damage response,tumor suppressor function,impaired dna repair,cell cycle regulation disruption,apoptosis modulation
ENSG00000253710,ALG11,dol synthesis pathway,alpha-1,2-glucosyltransferase activity,glycosylation dysregulation,tumor progression,protein function modulation
ENSG00000129038,LOXL1,extracellular matrix remodeling,cell invasion,growth factor receptor modulation,tgf-β signaling regulation,protein cross-linking,cancer progression
ENSG00000143536,CRNN,tumor progression,metastasis induction,immune evasion,chemokine regulation,receptor activation,oncogenic potential
ENSG00000261456,TUBB8,microtubule assembly,aberrant splicing,oncogenic process,cell proliferation,predictive marker,microtubule stability
ENSG00000168802,CHTF8,epigenetic regulation,chromatin remodeling,cell proliferation,oncogenic mutations,tumor aggressiveness,genomic instability
ENSG00000110841,PPFIBP1,pi3k/akt pathway,constitutive activation,pten binding,mutations or amplifications,tumor suppressor interaction,protein-protein interactions
ENSG00000112053,SLC26A8,ion transport regulation,bicarbonate reabsorption,renal epithelial function,oncogenic potential,electrolyte imbalance,ph homeostasis
ENSG00000175832,ETV4,tumor suppressor regulation,epithelial-to-mesenchymal transition,transcriptional activation,cell cycle progression,apoptosis evasion,poor prognosis
ENSG00000101638,ST8SIA5,glycosylation process,cell proliferation,tumor growth,angiogenesis,prognostic marker,oncogenic properties
ENSG00000111199,TRPV4,cellular proliferation,hyperphosphaturia,mechanical stress response,potassium channel regulation,tumor formation,tissue injury signaling
ENSG00000198829,SUCNR1,g-protein coupled receptor,oncogenic role,tumor growth promotion,cell migration enhancement,angiogenesis regulation,macrophage modulation
ENSG00000214872,SMTNL1,rhoa activation,cell proliferation,metabolic adaptation,tumor progression,signaling pathway regulation,protein stability modulation
ENSG00000168734,PKIG,cellular regulation,apoptosis modulation,cell cycle progression,tissue specificity,gene expression alteration,potential oncogenic role
ENSG00000188290,HES4,cellular differentiation,dna damage response,epithelial-to-mesenchymal transition (emt),notch signaling inhibition,oncogenic transcription factor,prognostic biomarker
ENSG00000141200,KIF2B,microtubule dynamics,cell cycle regulation,p53 degradation,oncogenesis,tumor progression,metastasis
ENSG00000181019,NQO1,apoptosis regulation,cell proliferation enhancement,oxidative stress response,dna repair mechanism,therapeutic target potential,genetic overexpression marker
ENSG00000161671,EMC10,mitochondrial biogenesis,cell energy homeostasis,mitochondrial dynamics,tumorigenesis driver,cellular metabolism regulation,mitochondrial interaction protein
ENSG00000255529,POLR2M,transcriptional elongation,overexpression,oncogenic potential,chromatin remodeling,cell proliferation,gene expression regulation
ENSG00000183773,AIFM3,mitochondrial metabolic regulation,apoptosis inhibition,cellular proliferation promotion,oxidative stress modulation,energy metabolism regulation,fatty acid synthesis alteration
ENSG00000002726,AOC1,cell proliferation,oncogenic protein association,sulfur-containing amino acid metabolism,tumor progression,therapeutic target,apoptosis regulation
ENSG00000197721,CR1L,cancer progression,metastasis promotion,cell survival,immune evasion,tumor cell recognition,inflammation regulation
ENSG00000114805,PLCH1,calcium signaling pathway,pi3k/akt activation,cell proliferation regulation,oncogenic function,metastasis promotion,biomarker candidate
ENSG00000196214,ZNF766,transcription factor activity,gene expression regulation,zinc finger motif binding,apoptosis modulation,cellular differentiation regulation,tumor suppressor function
ENSG00000196967,ZNF585A,oncogene,transcriptional regulation,cell cycle disruption,overexpression,tumor growth,metastasis
ENSG00000123594,ATXN3L,**

chromatin regulation,gene expression modulation,protein-protein interaction,transcriptional regulation,cellular process regulation,homologous protein function
ENSG00000198551,ZNF627,histone modification regulation,tumor suppressor function,epigenetic regulation,cell cycle regulation,apoptosis regulation,tumor progression marker
ENSG00000151151,IPMK,phosphoinositide signaling,tumor progression,oncogenic process,cell proliferation,apoptosis evasion,therapeutic target
ENSG00000107815,TWNK,mitochondrial function,mtdna instability,oncogenic process,cancer cell metabolism,dna replication,cellular energy metabolism
ENSG00000142279,WTIP,cellular adhesion,maintenance of cellular structure,tumor progression regulation,p53 interaction,cancer associated protein,apoptosis regulation
ENSG00000230797,YY2,tumor progression,alternative splicing regulation,oncogenic gene expression,cell proliferation enhancement,transcriptional co-activation,poor prognosis marker
ENSG00000255974,CYP2A6,metabolic reprogramming,substrate metabolism,redox balance regulation,energy production alteration,cancer drug resistance,tumor growth promotion
ENSG00000158435,CNOT11,cccr4-not complex regulation,driver mutations,gene expression modulation,tumor progression,cell cycle regulation,apoptosis inhibition
ENSG00000163394,CCKAR,g-protein coupled receptor,cell proliferation,mapk/erk pathway activation,tumor progression,oncogene expression,gastrointestinal hormone regulation
ENSG00000160602,NEK8,**
centrosome amplification,genomic instability,oncogene overexpression,cell proliferation,protein-protein interaction,kinase activity 
**
ENSG00000135974,C2orf49,autophagy regulation,gain-of-function mutations,poor prognosis marker,oncogenic process modulator,metabolic reprogramming regulator,tumor progression associated
ENSG00000183044,ABAT,cell proliferation enhancement,metabolic reprogramming,tumor microenvironment modification,oxidative stress modulation,energy metabolism regulation,therapeutic target identification
ENSG00000176153,GPX2,antioxidant function,oxidative stress response,cell signaling pathway interaction,tumor progression promotion,metastasis facilitation,cancer-related redox imbalance
ENSG00000032444,PNPLA6,mtor signaling pathway activation,lipid metabolism regulation,cellular autophagy enhancement,tumor progression facilitation,therapeutic target identification,genomic instability association
ENSG00000140835,CHST4,gag modification,cell adhesion disruption,tumor progression facilitation,angiogenesis regulation,extracellular matrix remodeling,pi3k/akt pathway modulation
ENSG00000196090,PTPRT,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway regulation,tumor suppressor function,cell migration and invasion,protein tyrosine phosphatase activity,mapk/erk signaling pathway regulation
ENSG00000166743,ACSM1,lipid synthesis regulation,cancer metabolism alteration,tumor growth promotion,energy homeostasis regulation,fatty acid transport involvement,oncogenic process contribution
ENSG00000100852,ARHGAP5,rho gtpase regulation,tumor progression,cell migration,actin cytoskeleton remodeling,signaling pathway interaction,cellular morphology maintenance
ENSG00000116014,KISS1R,tumor progression,cell proliferation,cell migration,survival pathway activation,g-protein coupled receptor function,oncogenic process promotion
ENSG00000123505,AMD1,histone chaperoning,chromatin remodeling,epigenetic regulation,genome instability,tumor suppressor function,cell cycle regulation
ENSG00000104313,EYA1,transcriptional activator,oncogene function,cell growth promotion,metabolic regulation,apoptosis inhibition,prognostic biomarker
ENSG00000228628,ATF6B,protein folding regulation,cell cycle progression,apoptosis inhibition,therapeutic target,transcriptional regulation,endoplasmic reticulum stress response
ENSG00000186517,ARHGAP30,rhogtpase activation,tumor suppressor function,cell migration regulation,protein interaction network,gtp hydrolysis activity,cancer biomarker status
ENSG00000110921,MVK,mevalonate pathway regulation,lipid biosynthesis dysregulation,cell growth promotion,therapeutic target potential,oncogenic signaling activation,genetic mutation implications
ENSG00000048740,CELF2,cellular proliferation,overexpression,post-transcriptional regulation,rna-binding protein activity,oncogenic signaling,epithelial-to-mesenchymal transition
ENSG00000146192,FGD2,rho/rac gtpase activation,constitutive activation,cell migration promotion,emt induction,cancer metastasis enhancement,pi3k/akt pathway interaction
ENSG00000053747,LAMA3,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,tumor progression facilitation,metastasis promotion,poor prognosis marker,extracellular matrix component
ENSG00000163207,IVL,tumor progression,epithelial-to-mesenchymal transition,cell-cell adhesion disruption,oncogenic signaling,protein-protein interactions,cellular proliferation
ENSG00000275718,CCL15,immune recruitment,tumor progression,epithelial-to-mesenchymal transition,immunosuppression,poor prognosis marker,metastasis promotion
ENSG00000167862,MRPL58,mitochondrial translation,oncogene overexpression,poor prognosis marker,tumor progression regulator,apoptosis inhibition,chemoresistance development
ENSG00000158623,COPG2,protein degradation,ubiquitin-proteasome pathway,oncogenic mutations,tumor progression,cell cycle regulation,apoptosis suppression
ENSG00000011426,ANLN,cell division regulation,actin dynamics modulation,cytoskeleton stabilization,tumor progression promotion,therapeutic target,overexpression correlation
ENSG00000143341,HMCN1,cell adhesion disruption,tumor suppression,adherens junctions regulation,cellular migration,invasion promotion,gene expression downregulation
ENSG00000181619,GPR135,g protein-coupled receptor,cell proliferation,signaling pathway activation,tumor progression,prognostic marker,oncogene overexpression
ENSG00000185085,INTS5,cell growth regulation,transcriptional activation,rna splicing regulation,tumorigenesis contribution,cancer biomarker potential,prognostic significance
ENSG00000077147,TM9SF3,nonsense-mediated mrna decay,oncogenic signaling,cell cycle progression,apoptosis evasion,therapeutic target,genomic instability
ENSG00000143494,VASH2,immune evasion,tumor microenvironment modulation,cell adhesion regulation,oncogenic potential,cancer immune response modulation,epithelial-leukocyte interaction
ENSG00000162998,FRZB,prognostic biomarker,cell-cell interaction regulation,overexpression,poor prognosis association,tumor growth promotion,metastasis facilitation
ENSG00000111046,MYF6,cell cycle regulation,muscle differentiation,transcriptional regulation,oncogenic process,tumor progression,apoptosis inhibition
ENSG00000058063,ATP11B,cell membrane remodeling,genomic instability,lipid metabolism reprogramming,metastatic potential,phospholipid transport activation,tumor aggressiveness
ENSG00000113196,HAND1,oncogenic activity,promotes cell proliferation,enhances tumor aggressiveness,dysregulation of cellular processes,transcriptional regulation,cell cycle regulation
ENSG00000143252,SDHC,mitochondrial electron transport chain,energy production,succinate accumulation,hif-alpha activation,oncogenic processes,metabolic reprogramming
ENSG00000130529,TRPM4,calcium channel regulation,pi3k/akt pathway modulation,oncogenic signaling,tumor progression,cell proliferation enhancement,metastasis promotion
ENSG00000102230,PCYT1B,pyrimidine biosynthesis,cell growth promotion,protein-protein interactions,dna repair regulation,genomic stability maintenance,therapeutic target
ENSG00000005206,SPPL2B,cell migration,angiogenesis promotion,tumor progression facilitation,protease activation,cellular invasion enhancement,pi3k/akt pathway interaction
ENSG00000177666,PNPLA2,mitochondrial dysfunction,lipid metabolism regulation,oncogenic process modulation,cancer cell survival enhancement,therapeutic resistance promotion,tumor progression driver
ENSG00000071859,FAM50A,ribosome biogenesis regulation,pre-rrna processing complex,cellular homeostasis disruption,tumor suppressor or oncogene potential,ribosome dysregulation,protein synthesis modulation
ENSG00000128242,GAL3ST1,glycosylation regulation,cell adhesion modulation,angiogenesis influence,tumor growth enhancement,metastasis promotion,oncogene/tumor suppressor role
ENSG00000262860,LSM14A,mrna metabolism regulation,cell growth regulation,tumor progression,oncogenic processes,gene expression regulation,metastasis
ENSG00000074603,DPP8,oncogenic function,cell survival promotion,prognostic marker,therapeutic target,regulation of cellular homeostasis,metalloprotease activity
ENSG00000181072,CHRM2,pi3k/akt pathway,oncogenic signaling,cell proliferation,angiogenesis,tumor progression,therapeutic target
ENSG00000149021,SCGB1A1,cellular homeostasis disruption,oxidative stress protection,anti-inflammatory properties,immunomodulation,immune evasion,tumor cell behavior modulation
ENSG00000160326,SLC2A6,glucose metabolism regulation,tumor energy production,enhanced glycolytic activity,glycolytic switch activation,cellular redox balance,genomic amplification
ENSG00000171865,RNASEH1,rna processing,cancer driver,microrna regulation,proofreading dysfunction,tumorigenesis trigger,oncogenic mutation
ENSG00000143157,POGK,genomic instability,dna replication,replication fork progression,tumorigenesis,prognostic marker,therapeutic target
ENSG00000170615,SLC26A5,ion channel regulation,cell proliferation,signaling pathway activation,cellular metabolism,tumor microenvironment modulation,oncogenic processes
ENSG00000166847,DCTN5,cellular architecture disruption,mitotic regulation,oncogenic processes,cell migration modulation,microtubule interaction,protein complex assembly
ENSG00000043355,ZIC2,oncogene activation,tumor promoter,cell proliferation enhancer,apoptosis inhibitor,poor prognosis marker,transcriptional regulator
ENSG00000181652,ATG9B,autophagy regulation,oncogenic potential,tumor cell survival,cellular homeostasis disruption,nutrient deprivation adaptation,protein-protein interactions
ENSG00000163914,RHO,rho gtpase,constitutive activation,cell migration,tumor progression,cell invasion,therapeutic target
ENSG00000168538,TRAPPC11,tumor progression,oncogene activation,cell proliferation,genomic amplification,protein transport,membrane trafficking
ENSG00000111319,SCNN1A,enac activation,pi3k/akt pathway activation,metastasis promotion,cell proliferation enhancement,angiogenesis facilitation,tumor microenvironment modulation
ENSG00000163995,ABLIM2,rhoa activation,actomyosin contractility,cell migration enhancement,cytoskeletal regulation,prognostic marker,oncogenic function
ENSG00000136051,WASHC4,tumor growth,aberrant expression,cell migration,endocytic recycling,autophagy regulation,therapeutic target
ENSG00000140263,SORD,glycolysis regulation,ros regulation,tumor growth promotion,poor prognosis marker,warburg effect,dna damage tolerance
ENSG00000152439,ZNF773,transcription factor activity,gene regulation,tumor growth promotion,apoptosis suppression,dna binding motifs,cell proliferation modulation
ENSG00000129951,PLPPR3,lipid metabolism regulation,cellular signaling modulation,pi3k/akt pathway interaction,tumor progression promotion,lipid phospholipase activity regulation,cancer-related lipid metabolism modification
ENSG00000179751,SYCN,apoptosis evasion,angiogenesis promoter,cell proliferation regulator,oncogenic driver,tumor metastasis facilitator,cell cycle progression mediator
ENSG00000187714,SLC18A3,transporter function,angiogenesis promotion,cell proliferation enhancement,tumor growth facilitation,poor prognosis marker,metastasis association
ENSG00000165383,LRRC18,tumor progression,epithelial-to-mesenchymal transition,prognostic marker,plasma membrane localization,cell adhesion modulation,metastatic potential enhancement
ENSG00000049246,PER3,circadian rhythm regulation,cell cycle progression,dna repair,apoptosis inhibition,tumor suppressor function,pi3k/akt pathway interaction
ENSG00000129657,SEC14L1,lipid signaling,membrane trafficking,oncogenic potential,cell proliferation,metastatic processes,dysregulated expression
ENSG00000275013,PRAME,immunogenic antigen,poor prognosis,epigenetic regulation,antitumor immunity,cancer-testis antigen,tumor progression
ENSG00000130643,CALY,epigenetic regulation,oncogene activation,pi3k/akt pathway interaction,cellular proliferation modulation,gene expression regulation,tumor progression promotion
ENSG00000031003,FAM13B,oncogene activation,cell proliferation enhancement,signaling pathway modulation,apoptosis inhibition,tumor aggressiveness increase,prognostic marker
ENSG00000110675,ELMOD1,cell migration,rho gtpase activation,pi3k/akt signaling,tumor growth,therapeutic target,cytoskeleton regulation
ENSG00000148600,CDHR1,pi3k/akt signaling,epithelial-to-mesenchymal transition (emt),cell-cell adhesion disruption,oncogene overexpression,tumor progression,biomarker potential
ENSG00000082515,MRPL22,mitochondrial translation,oncogene or tumor suppressor,regulation of mitochondrial biogenesis,alterations in cellular metabolism,mitochondrial dysfunction,tumor progression
ENSG00000282891,STATH,stat protein activation,tumor growth promotion,biomarker for poor prognosis,cell proliferation enhancement,angiogenesis facilitation,cell survival augmentation
ENSG00000076258,FMO4,tumor suppressor,apoptosis induction,detoxification process,cellular metabolism regulation,genome stability maintenance,prognostic marker
ENSG00000197565,COL4A6,basement membrane disruption,tumor suppressor function,cellular adhesion loss,genomic instability,aggressive tumor behavior,poor prognosis
ENSG00000133247,KMT5C,histone modification,tumor suppressor loss,apoptosis suppression,metastasis promotion,cancer stem cell maintenance,genome instability
ENSG00000177106,EPS8L2,actin cytoskeleton regulation,mitotic spindle assembly,cell adhesion regulation,tumor progression marker,cell migration facilitation,cancer cell motility enhancement
ENSG00000157734,SNX22,rtk signaling,membrane trafficking,oncogenic signaling,genomic stability,apoptosis regulation,protein interaction
ENSG00000162630,B3GALT2,glycosylation,metastasis promotion,tumor progression,cell adhesion modulation,glycoconjugate synthesis,epigenetic regulation
ENSG00000128710,HOXD10,tumor suppressor,epithelial-to-mesenchymal transition (emt) inhibition,transcription factor regulation,cellular differentiation inhibition,chromatin remodeling complex interaction,genomic instability prevention
ENSG00000105808,RASA4,ras gtpase regulation,tumor suppressor function,cell proliferation modulation,downstream signaling pathway interaction,genomic instability contribution,gtpase activity alteration
ENSG00000173436,MICOS10,mitochondrial function,dysregulated cell survival,energy metabolism regulation,enhanced cellular proliferation,epithelial-to-mesenchymal transition (emt),oncogenic reprogramming
ENSG00000168564,CDKN2AIP,cdk4/6 inhibition,tumor suppressor function,cell cycle regulation,genetic alterations,cancer development,therapeutic target
ENSG00000151474,FRMD4A,oncogenic driver,actin cytoskeleton regulation,cell migration and invasion,pi3k/akt pathway modulation,biomarker potential,genomic amplification
ENSG00000134313,KIDINS220,cellular migration,epithelial-to-mesenchymal transition,microtubule regulation,oncogenesis,protein-protein interaction,regulation of cell morphology
ENSG00000136715,SAP130,chromatin modification,histone acetylation,transcriptional regulation,oncogenic transformation,cell proliferation,therapeutic target
ENSG00000130821,SLC6A8,cellular metabolism,energy homeostasis disruption,tumor suppressor function,metabolic reprogramming,pi3k/akt pathway interaction,dysregulated energy sensing
ENSG00000167588,GPD1,glycolytic reprogramming,metabolic regulation,redox balance disruption,oncogenic processes enhancement,tumor growth support,therapeutic target potential
ENSG00000166676,TVP23A,genomic instability,tumor suppressor function,histone modification regulation,cell cycle regulation,apoptosis induction,dna repair mechanism
ENSG00000134644,PUM1,genomic instability,post-transcriptional regulation,rna-binding activity,oncogenic mrnas repression,tumor progression facilitation,cellular differentiation inhibition
ENSG00000139151,PLCZ1,pi3k/akt/mtor activation,phospholipase activity,cell proliferation regulation,tumor progression,genomic upregulation,signaling pathway interaction
ENSG00000111254,AKAP3,pka anchoring,cellular signaling regulation,tumor metastasis promotion,oncogenic processes modulation,cell proliferation regulation,protein phosphorylation facilitation
ENSG00000005471,ABCB4,lipid transport,multidrug resistance,oncogenesis,cellular homeostasis disruption,protein-protein interaction,epigenetic regulation
ENSG00000048405,ZNF800,transcriptional regulation,dna binding,oncogene,cell cycle regulation,apoptosis modulation,zinc finger protein
ENSG00000165566,AMER2,metastasis promotion,cell adhesion disruption,tumor microenvironment modulation,apoptosis regulation,angiogenesis regulation,therapeutic target
ENSG00000138801,PAPSS1,sulfate conjugation,oncogenic potential,tumor growth,cell proliferation,poor prognosis,protein interaction
ENSG00000236177,HLA-DPA1,immunosuppressive microenvironment,antigen presentation,mhc class i expression,tumor progression,immune evasion,cell signaling pathways
ENSG00000242114,MTFP1,mtf1 regulation,metal homeostasis disruption,oxidative stress response,cell growth promotion,iron metabolism alteration,transcriptional regulation
ENSG00000103150,MLYCD,fatty acid metabolism,malonyl-coa decarboxylation,lipid biosynthesis,cellular energy production,oncogenic processes,metabolic pathway interaction
ENSG00000180613,GSX2,transcription factor regulation,cancer cell proliferation,apoptosis resistance,tumor growth promotion,cell cycle progression,oncomodulator
ENSG00000172586,CHCHD1,mitochondrial function regulation,cell cycle progression disruption,oncogenic transformation driver,tumorigenesis contributor,therapeutic target,genomic instability induction
ENSG00000203926,SPANXA2,oncogene,driver gene,cell proliferation regulation,tumor progression promoter,gene amplification,signaling pathway modulation
ENSG00000198021,SPANXA1,cell signaling modulation,tgf-β pathway dysregulation,oncogenic processes,cell proliferation regulation,therapeutic target,gene expression upregulation
ENSG00000284938,FAM180B,homologous recombination,genomic instability,dna repair defects,oncogene dysregulation,cancer cell dependency,therapeutic target
ENSG00000165733,BMS1,ribosome assembly,aberrant expression,cell proliferation,aggressive tumor behavior,protein synthesis regulation,cancer cell survival
ENSG00000176165,FOXG1,transcription factor regulation,oncogenic transformation,cell proliferation enhancement,metastasis promotion,apoptosis inhibition,cell cycle dysregulation
ENSG00000171201,SMR3B,tumor progression,oncogene activation,cellular proliferation,protein translocation,apoptosis resistance,pi3k/akt signaling
ENSG00000179774,ATOH7,oncogenic activity,epithelial-to-mesenchymal transition,transcriptional regulation,cell invasion,metastasis,immune evasion
ENSG00000196604,POTEF,glycosylation regulation,cell proliferation,oncogenic transformation,tumor progression,wnt/β-catenin signaling pathway,protein interaction
ENSG00000205927,OLIG2,oncogene activation,cell cycle regulation,apoptosis inhibition,metastasis facilitation,transcriptional repression,tumor suppressor gene regulation
ENSG00000026751,SLAMF7,nk-cell activation,tumor microenvironment modulation,immune system regulation,cancer prognosis impact,immunotherapeutic target,cell adhesion and proliferation
ENSG00000175768,TOMM5,mitochondrial function regulation,oncogenic process,cell proliferation,metabolic reprogramming,loss-of-function mutation,energy metabolism disruption
ENSG00000112041,TULP1,tumor suppressor function,loss of function mutations,genomic instability,dna repair regulation,cell growth regulation,p53 pathway disruption
ENSG00000197562,RAB40C,ras superfamily signaling,gtpase activity,tumor progression,cell migration,metastasis,protein-protein interaction
ENSG00000161036,LRWD1,tumor suppression,cell cycle regulation,dna repair modulation,p53 degradation,genomic instability prevention,cancer progression facilitation
ENSG00000116254,CHD5,chromatin remodeling,double-strand break repair,tumor suppressor function,genomic instability,gene expression regulation,poor prognosis marker
ENSG00000147251,DOCK11,rac gtpase activation,cell migration facilitation,ciliogenesis regulation,oncogenic process promotion,tumor cell survival enhancement,metastasis promoter
ENSG00000176076,KCNE5,cell proliferation regulation,overexpression,kinase activation,signaling pathway modulation,genomic instability,proliferation enhancement
ENSG00000084090,STARD7,lipid metabolism regulation,oncogene function,tumor growth promotion,pi3k/akt pathway interaction,lipid droplet formation modulation,cellular signaling pathway regulation
,HIST1H2BO,histone modification,chromatin regulation,transcriptional regulation,cellular proliferation,genomic instability,oncogene/tumor suppressor
ENSG00000130313,PGLS,glycolytic activity,warburg effect,metabolic regulation,tumor growth,glucose metabolism,pentose phosphate pathway
ENSG00000063601,MTMR1,pi3k/akt pathway dysregulation,cell growth and survival enhancement,tumor suppressor or oncogene function,mutations contributing to tumorigenesis,pi3k/akt pathway interaction,gene expression regulation complexity
ENSG00000035928,RFC1,genomic instability,cell cycle regulation,dna replication,oncogenesis,tumor development,protein interaction
ENSG00000149970,CNKSR2,cell signaling modulation,tumor progression,integrin-mediated signaling,epithelial-to-mesenchymal transition (emt),prognostic marker,therapeutic target
ENSG00000171606,ZNF274,zinc finger-mediated transcriptional regulation,epigenetic dysregulation,cell proliferation promotion,tumor suppressor gene repression,oncogenic function,chromatin remodeling
ENSG00000112679,DUSP22,erk/mapk pathway regulation,oncogenic process,cell proliferation promotion,apoptosis inhibition,protein kinase activation,signaling pathway modulation
ENSG00000138346,DNA2,genomic instability,tumor progression,ddr pathway activation,phosphorylation of atm/chk1/chk2 kinases,loss-of-function mutations,dna damage response
ENSG00000143486,EIF2D,translation regulation,tumor growth modulation,cellular stress response,hypoxia adaptation,protein synthesis control,cancer biomarker candidate
ENSG00000180263,FGD6,rho gtpase regulation,actin cytoskeleton remodeling,cell proliferation enhancement,guainine nucleotide exchange factor activity,tumor progression promotion,cancer cell migration and invasion facilitation
ENSG00000124784,RIOK1,genomic stability,kinetochore assembly,spindle checkpoint activity,tumor progression,cancer driver mutation,cell cycle regulation
ENSG00000073536,NLE1,chromatin remodeling,cellular proliferation,transcriptional regulation,histone modification,oncogenic signaling,dna damage response
ENSG00000183426,NPIPA1,genomic instability,chromatin remodeling,transcriptional regulation,dna repair,chromosomal alterations,therapeutic target
ENSG00000182903,ZNF721,cellular regulation,transcriptional modulation,genomic instability,tumorigenic potential,protein-dna interaction,oncogenic pathway activation
ENSG00000175426,PCSK1,protein processing,tumor progression,cell proliferation,inflammation regulation,cancer biomarker,biological pathway modulation
ENSG00000274671,MARVELD2,ion channel regulation,tumor growth promotion,metastasis facilitation,overexpression correlation,cellular communication modulation,protein family member
ENSG00000016391,CHDH,oncogene,chromatin remodeling,genomic instability,tumor progression,epithelial-to-mesenchymal transition,dna repair mechanism
ENSG00000177076,ACER2,angiogenic signaling pathway,vegf regulation,oxidative stress response,neurotransmitter regulation,amine oxidase activity,tumor progression
ENSG00000156642,NPTN,vegf signaling pathway,angiogenesis promoter,tumor progression marker,poor prognostic indicator,immune modulation,endothelial cell survival
ENSG00000138161,CUZD1,cell adhesion regulation,tumor growth promotion,focal adhesion kinase interaction,epithelial-to-mesenchymal transition modulation,poor prognosis marker,therapeutic target
ENSG00000132702,HAPLN2,heparan sulfate proteoglycans,glycosaminoglycan regulation,oncogenic signaling pathways,cell adhesion and migration,tumor progression and metastasis,epithelial-to-mesenchymal transition
ENSG00000064933,PMS1,genomic stability,dna mismatch repair pathway,tumor suppressor function,genomic instability,mutagenesis prevention,cancer suppression
ENSG00000130517,PGPEP1,oncogenic process,cell proliferation,signaling pathway activation,tumor metastasis,therapeutic target,gene overexpression
ENSG00000054796,SPO11,meiotic initiation,genomic instability,homologous recombination,dna repair mechanism,chromosome segregation,cancer predisposition
ENSG00000185024,BRF1,brf1 overexpression,tumor progression,genomic instability,dna repair dysregulation,cell growth promotion,protein synthesis regulation
ENSG00000159450,TCHH,trna modification,histidine charging,oncogenesis,cell proliferation,protein synthesis regulation,gene expression dysregulation
ENSG00000196188,CTSE,cathepsin e overexpression,angiogenesis promotion,epithelial-to-mesenchymal transition,proteolytic activity enhancement,metastasis facilitation,lysosomal dysfunction
ENSG00000275313,CCL4L2,immune evasion,tumor microenvironment modulation,angiogenesis promotion,metastasis facilitation,poor prognosis association,cancer-related pathway interaction
ENSG00000278259,MYO19,cell migration,invasiveness regulation,oncogenic activity,cellular motility regulation,mitotic spindle organization,gene overexpression
ENSG00000136213,CHST12,glycosaminoglycan modification,tumor progression,cellular migration,proteoglycan regulation,metastasis facilitation,therapeutic target
ENSG00000103047,TANGO6,rna modification,mitochondrial dysfunction,rna degradation,protein misfolding,cancer initiation,pseudouridylation
ENSG00000174233,ADCY6,camp signaling pathway,cell proliferation,pi3k/akt pathway interaction,ca2+ channel regulation,malignant tumor growth,biomarker significance
ENSG00000114547,ROPN1B,microtubule stability,cell proliferation,cilia formation,apoptosis inhibition,therapeutic target,prognostic marker
ENSG00000204899,MZT1,dna repair,chromatin regulation,cell proliferation,cell cycle regulation,metabolic activity,genomic instability
ENSG00000151726,ACSL1,cellular lipid metabolism,oncogenic processes,fatty acid oxidation,cancer cell energy demands,tumor progression,poor prognosis
ENSG00000135778,NTPCR,genomic instability,telomere regulation,dna replication repair,nucleotide excision repair,base excision repair,telomerase activation
ENSG00000110844,PRPF40B,aberrant splicing,cellular transformation,oncogenic signaling,spliceosome assembly,pre-mrna processing,tumor progression
ENSG00000168827,GFM1,mitochondrial dynamics regulation,tumor progression,cell migration and invasion regulation,metabolic reprogramming,therapeutic target,genomic instability
ENSG00000205835,GMNC,ras/raf/mapk pathway,oncogenic driver,tumor progression,protein-protein interaction,cell proliferation regulation,guanine nucleotide exchange
ENSG00000090266,NDUFB2,mitochondrial complex i dysfunction,gain-of-function mutations,electron transport chain disruption,reactive oxygen species production,tumor metabolic reprogramming,oncogenic signaling pathway activation
ENSG00000126550,HTN1,hnrnp function,pre-mrna splicing regulation,rna stability modulation,protein-rna interaction,chromatin modification influence,cellular gene expression regulation
ENSG00000123454,DBH,metabolic regulation,oxidative stress,tumor progression,cellular damage,signaling pathway interaction,genomic instability
ENSG00000122299,ZC3H7A,zinc finger domain,transcription regulation,cell proliferation,apoptosis modulation,tumor suppressor interaction,emt regulation
ENSG00000145757,SPATA9,smc family protein,genome instability,dna repair mechanism,oncogenic signaling,cell proliferation,tumor progression
ENSG00000117226,GBP3,tumor growth,cell proliferation,therapeutic target,immune response modulation,microtubule dynamics,protein-protein interaction
ENSG00000114480,GBE1,gbe1_overexpression,cell proliferation,sphingolipid metabolism,oncogene potential,ceramide regulation,metabolic dysregulation
ENSG00000173253,DMRT2,regulation of cell proliferation,pi3k/akt signaling pathway regulation,transcriptional regulation,cell survival pathways activation,epithelial-to-mesenchymal transition (emt) regulation,tumor progression
ENSG00000154646,TMPRSS15,tumor progression,cell invasion,extracellular matrix degradation,protein processing,angiogenesis regulation,immune evasion mechanism
ENSG00000236221,TNXB,tumor progression,extracellular matrix regulation,cell migration,angiogenesis promotion,therapeutic target,epigenetic regulation
ENSG00000161381,PLXDC1,endocytic trafficking,cellular signaling,oncogenic properties,tumor growth promotion,increased cell proliferation,signaling pathway modulation
ENSG00000102996,MMP15,ecm remodeling,cancer invasion,mmp family member,tumor progression,angiogenesis regulation,cancer cell migration
ENSG00000149196,HIKESHI,genomic instability,dna repair deficiency,homologous recombination,chromosomal abnormalities,tumor suppressor function,cell cycle regulation
ENSG00000071909,MYO3B,cell migration,intracellular trafficking,vesicle transport,cytoskeletal reorganization,tumor progression,gene overexpression
ENSG00000138688,KIAA1109,set domain,epigenetic regulation,chromatin modification,genomic instability,pan-cancer driver gene,cell proliferation
ENSG00000274276,CBSL,transsulfuration pathway,metabolic regulation,homocysteine metabolism,pseudogene function,cellular metabolism,genetic variation
ENSG00000115318,LOXL3,tumor progression,cell migration,extracellular matrix remodeling,oxidative stress response,signaling pathway modulation,cancer cell invasion
ENSG00000138772,ANXA3,tumor progression,cell proliferation,angiogenesis,apoptosis evasion,metastasis regulation,calcium signaling
ENSG00000143473,KCNH1,pi3k/akt signaling,oncogenic potential,tumor suppressor activity,cell proliferation regulation,apoptosis modulation,therapeutic target
ENSG00000134240,HMGCS2,metabolic reprogramming,lipogenesis,tumor growth,cell proliferation,oncogenic role,fatty acid synthesis
ENSG00000065320,NTN1,cell adhesion regulation,tumor progression facilitation,poor prognosis indicator,immunoglobulin-like domain containing protein,cell migration modulation,pi3k/akt pathway interaction
ENSG00000162490,DRAXIN,pi3k/akt pathway inhibition,tumor suppressor function,cell migration regulation,semaphorin 3f inhibition,axon guidance modulation,egfr/notch pathway interaction
ENSG00000156502,SUPV3L1,ribosome biogenesis,cell proliferation,oncogenic processes,cell survival,protein translation,biomarker potential
ENSG00000135838,NPL,oncogene activation,transcriptional regulation,tumor progression,cell proliferation,apoptosis suppression,genomic instability
ENSG00000176842,IRX5,irx-binding sites,oncogene activity,transcriptional regulation,wnt/β-catenin signaling,cell proliferation,chromosomal instability
ENSG00000103485,QPRT,pyrimidine regulation,cell proliferation,methionine cycle regulation,enzyme overexpression,nucleotide metabolism interaction,chemotherapeutic resistance
ENSG00000078618,NRDC,nuclear receptor regulation,cell growth regulation,tumor suppressor function,chromatin modulation,histone deacetylase interaction,transcriptional regulation
ENSG00000188820,CALHM6,cellular regulation,calcium channel modulation,apoptosis induction,tumor suppression hypothesis,cancer subtype specificity,cell cycle control
ENSG00000122420,PTGFR,tumor progression,pi3k/akt pathway activation,receptor overexpression,cell proliferation promotion,metastasis enhancement,wnt/β-catenin pathway interaction
ENSG00000139651,ZNF740,oncogenic function,tumor suppressor protein degradation,cell proliferation,apoptosis inhibition,cancer-promoting transcription,genetic instability
ENSG00000242252,BGLAP,tumor suppression,downregulation in tumors,calcium binding protein,cell proliferation inhibition,apoptosis promotion,angiogenesis suppression
ENSG00000163453,IGFBP7,igf system regulation,cell proliferation inhibition,tumor suppression,apoptosis induction,pi3k/akt pathway interaction,genomic instability
ENSG00000187048,CYP4A11,metabolic reprogramming,altered expression levels,xenobiotic metabolism,mitochondrial enzyme activity,cancer progression,tumor tissue specificity
ENSG00000116731,PRDM2,chromatin regulation,histone modification,tumor suppression,cell cycle arrest,apoptosis regulation,gene expression repression
ENSG00000138777,PPA2,regulatory subunit,tumor suppressor function,pi3k/akt pathway regulation,cell cycle regulation,protein stability modulation,oncogenic protein regulation
ENSG00000122042,UBL3,proteasome regulation,altered protein homeostasis,tumor progression,mutations leading to oncogenesis,stress response modulation,aberrant expression
ENSG00000171611,PTCRA,tumor progression,immune evasion,cell cycle regulation,apoptosis dysregulation,transcription factor activation,therapeutic target
ENSG00000188997,KCTD21,wnt signaling regulation,cellular growth control,tumor suppressor function,kinase activity regulation,gene expression modulation,cancer susceptibility genomics
ENSG00000148835,TAF5,transcriptional regulation,increased cell proliferation,dna damage response,oncogenesis,cell growth regulation,cancer biomarker
ENSG00000188921,HACD4,fatty acid synthesis,lipid biosynthesis,cell proliferation,energy production,therapeutic target,aberrant activation
ENSG00000176953,NFATC2IP,tumor suppressor,nfat transcriptional regulation,apoptosis induction,angiogenesis inhibition,cell cycle regulation,oncogenic pathway suppression
ENSG00000134255,CEPT1,microtubule dynamics,genomic instability,centrosome dysfunction,chromosomal instability,aneuploidy,protein overexpression
ENSG00000177283,FZD8,wnt signaling pathway,oncogene,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,biomarker
ENSG00000112031,MTRF1L,mitochondrial translation regulation,tumor suppressor function,genomic instability,epigenetic alterations,energy metabolism dysregulation,cellular respiration impairment
ENSG00000140367,UBE2Q2,mdm2 ubiquitination,cell proliferation,apoptosis induction,protein degradation regulation,tumor progression marker,cancer-specific interactions
ENSG00000125492,BARHL1,transcriptional regulation,cell proliferation,oncogene activation,genomic instability,tumor progression,therapeutic target
ENSG00000198355,PIM3,cell cycle regulation,protein kinase activation,mapk/erk pathway activation,pi3k/akt signaling,oncogenesis promotion,cancer cell survival enhancement
ENSG00000197841,ZNF181,chromatin remodeling,transcriptional regulation,cell cycle progression,tumor suppressor function,genomic instability,oncogenic mutation
ENSG00000133789,SWAP70,b-cell receptor signaling,cell proliferation,immune response modulation,oncogenic process facilitation,tumor growth promotion,phosphorylation-dependent regulation
ENSG00000136720,HS6ST1,heparan sulfate modification,tumor growth promotion,signaling pathway activation,cell migration regulation,biomarker potential,angiogenesis induction
ENSG00000187775,DNAH17,ciliary dysfunction,motor protein function,intracellular transport regulation,cell proliferation enhancement,metastasis facilitation,oncogenesis association
ENSG00000146233,CYP39A1,lipid metabolism disruption,constitutive activation,oncogenesis promotion,cholesterol regulation,protein kinase modulation,tumor growth progression
ENSG00000131238,PPT1,late endosomal trafficking,autophagy regulation,protein palmitoylation,oncogenic processes,cell growth promotion,protein-protein interaction
ENSG00000242389,RBMY1E,rna-binding protein,epigenetic regulation,dysregulation,gene expression modulation,tumorigenesis,rna translation regulation
ENSG00000120254,MTHFD1L,increased expression,dna synthesis regulation,one-carbon metabolism involvement,cell proliferation promotion,cancer cell survival enhancement,tumorigenesis association
ENSG00000116221,MRPL37,mitochondrial ribosomal function,cellular energy metabolism,translation regulation,oxidative phosphorylation,mitochondrial dysfunction,genomic instability
ENSG00000132958,TPTE2,pi3k/akt pathway,apoptosis regulation,mutations associated,tumor progression,cancer metastasis,tissue invasion
ENSG00000170802,FOXN2,oncogenic transcription factor,cell proliferation enhancement,tumor progression driver,metastasis facilitation,angiogenesis regulation,therapeutic target
ENSG00000144136,SLC20A1,protein transport,cellular proliferation,metabolic regulation,kidney function,genomic instability,oncogenesis
ENSG00000145494,NDUFS6,mitochondrial dysfunction,energy metabolism adaptation,oncogenic process driver,tumor metabolic reprogramming,cellular survival regulation,genetic mutations
ENSG00000168874,ATOH8,transcription factor regulation,cell differentiation inhibition,apoptosis suppression,tumor aggressiveness marker,prognostic indicator,gene expression modulation
ENSG00000242612,DECR2,pentose phosphate pathway,cellular redox state,glycolysis regulation,metabolic rewiring,transcriptional regulation,energy metabolism
ENSG00000114812,VIPR1,cellular signaling,dysregulated expression,immune modulation,proliferation regulation,tumor progression,tissue invasion
ENSG00000225614,ZNF469,cell proliferation modulation,chromatin regulation,constitutive activation,transcriptional regulation,tumor suppressor function,apoptosis modulation
ENSG00000171189,GRIK1,glur5 subunit,ampar function,synaptic plasticity,tumor growth promotion,apoptosis regulation,angiogenesis modulation
ENSG00000146399,TAAR1,gpcr signaling pathway,tumor progression,autocrine signaling,cellular proliferation,mutation,overexpression
ENSG00000105447,GRWD1,chromatin regulation,dna repair,epigenetic modification,tumor suppressor modulation,oncogene interaction,cell survival promotion
ENSG00000173653,RCE1,oncogene,chromatin remodeling,histone acetylation,gene expression regulation,cell proliferation,tumorigenesis
ENSG00000163104,SMARCAD1,genomic instability,chromatin remodeling,dna repair regulation,tumor suppressor function,cellular proliferation modulation,epigenetic regulation
ENSG00000073614,KDM5A,chromatin remodeling,histone modification,cell proliferation,oncogenic mutation,tumor progression,therapeutic target
ENSG00000198300,PEG3,loss-of-function mutations,tumor suppressor function,cell growth regulation,apoptosis induction,protein-protein interaction,biomarker candidate
ENSG00000220201,ZGLP1,transcription factor regulation,oncogenic function,cell proliferation,apoptosis inhibition,epigenetic modulation,tumor progression
ENSG00000258315,C17orf49,tumor progression,cellular regulation,metastasis promotion,oncogene involvement,protein interaction,uncharacterized protein function
ENSG00000102401,ARMCX3,genomic instability,transcriptional activation,chromatin remodeling,oncogene upregulation,tumor progression,prognostic marker
ENSG00000136908,DPM2,secretory pathway disruption,glycosylation alterations,oncogenic signaling pathway,cellular homeostasis disruption,protein modification,cancer cell growth
ENSG00000069122,ADGRF5,adgrf family member,oncogenic function,g-protein coupled receptor interaction,cell proliferation regulation,tumor progression promotion,cell cycle regulation
ENSG00000087269,NOP14,ribosome biogenesis,overexpression,cell proliferation,survival promotion,tumor resistance,apolypotosis regulation
ENSG00000166920,C15orf48,tumor suppressor function,cell proliferation regulation,pi3k/akt signaling pathway interaction,genomic stability maintenance,biomarker potential,oncogenic process inhibition
ENSG00000196632,WNK3,ion transport regulation,osmotic stress response,cellular osmoregulation,electrolyte imbalance disturbances,wnk kinase activity,tumor progression modulation
ENSG00000185842,DNAH14,microtubule organization,cilia formation,cellular motility,protein-protein interactions,cytoskeletal regulation,dysregulation and tumorigenesis
ENSG00000188153,COL4A5,tumor progression,cell adhesion disruption,extracellular matrix interaction,angiogenesis facilitation,metastasis promotion,altered basement membrane architecture
ENSG00000148339,SLC25A25,mitochondrial metabolism,glycolysis enhancement,cellular energy production,ancillary protein regulation,tumor microenvironment modulation,apoptosis suppression
ENSG00000060558,GNA15,g-protein signaling,mutation hotspot,mapk/erk pathway,cell proliferation regulation,signaling pathway dysregulation,oncogene mutation
ENSG00000140474,ULK3,autophagy dysregulation,pi3k/akt/mtor pathway interaction,cancer cell proliferation,cell survival enhancement,tumor suppressor function loss,genetic mutations impact
ENSG00000150403,TMCO3,mitochondrial function regulation,gene amplification,cellular proliferation,oncogenic role,apoptosis regulation,tumor suppression
ENSG00000198858,R3HDM4,pi3k/akt signaling pathway,genomic instability,tumor suppressor function,apoptosis regulation,dna damage response,cancer progression
ENSG00000115902,SLC1A4,metabolic reprogramming,energy metabolism,oncogenic process,tumor progression,aerobic glycolysis,transmembrane transporter
ENSG00000081803,CADPS2,calcium regulation,cellular signaling,dysregulated expression,cancer progression,prognostic biomarker,tumor growth
ENSG00000138078,PREPL,pro-survival signaling,tumor progression,cell growth regulation,drug resistance modulation,oncogene interaction,pro-hormone processing
ENSG00000104888,SLC17A7,altered expression,biomarker potential,cell migration regulation,glutamatergic neurotransmission regulation,sodium-dependent transport function,tumor progression association
ENSG00000118997,DNAH7,ciliary structure,cilia assembly,male infertility,primary ciliary dyskinesia,situs inversus,oncogenesis
ENSG00000186897,C1QL4,immune evasion,cellular proliferation,complement pathway regulation,tumor progression,dysregulated expression,prognostic marker
ENSG00000131620,ANO1,ion transport regulation,cell migration enhancement,tumor progression facilitation,oncogene potential,therapeutic target possibility,signaling pathway modulation
ENSG00000185610,DBX2,cell proliferation,malignant progression,tumor suppressor loss,transcription factor regulation,metastasis promotion,cell differentiation loss
ENSG00000174695,TMEM167A,ion channel regulation,dysregulation,cell membrane integrity,signaling pathway interaction,hypoxia response modification,protein structure alteration
ENSG00000121446,RGSL1,tumor suppressor,g-protein coupled receptor signaling,oncogenic pathway modulation,cellular growth regulation,protein modification,genomic alteration
ENSG00000021461,CYP3A43,steroid hormone regulation,cellular growth modulation,tumor progression influence,pharmaceutical metabolism,detoxification of carcinogens,hormone level modulation
ENSG00000235194,PPP1R3E,glycogen regulation,pp1 regulation,cell signaling,metabolic regulation,tumor metabolism,regulatory subunit
ENSG00000151014,NOCT,tumor suppressor function,apoptosis induction,cell cycle regulation,genomic stability maintenance,transcriptional coactivation,nf-κb pathway modulation
ENSG00000115652,UXS1,pyrimidine biosynthesis,proliferation enhancement,tumor growth support,nucleotide synthesis acceleration,metabolic adaptation,cancer proliferation boost
ENSG00000177303,CASKIN2,cell death regulation,apoptosis inhibition,oncogenic protein interaction,tumor progression,therapeutic target,autophagy regulation
ENSG00000159733,ZFYVE28,oncogenic regulation,protein trafficking dysregulation,cellular stress response modulation,tumor aggressiveness correlation,endosomal pathway involvement,genomic instability maintenance
ENSG00000116147,TNR,apoptosis regulation,tnf/tnfr interactions,cell survival pathways,immune responses modulation,pro-inflammatory cytokine receptor,cancer progression driver
ENSG00000139155,SLCO1C1,transporter function,resistance to chemotherapy,cellular uptake regulation,drug sensitivity modulation,bile acid metabolism alteration,stem-like cell formation
ENSG00000066032,CTNNA2,cancer-related function,cadherin interaction,signaling pathway activation,cell migration and invasion,tumor progression,therapeutic target
ENSG00000260314,MRC1,tumor-associated macrophage recruitment,angiogenesis facilitation,nutrient and growth factor uptake,immune evasion mechanism,poor prognostic marker,cellular phagocytosis regulation
ENSG00000188487,INSC,sialoglycoprotein internalization,pi3k/akt pathway interaction,tumor cell proliferation,cell survival enhancement,metabolic regulation alteration,sialic acid binding protein function
ENSG00000130921,C12orf65,mitochondrial biogenesis,energy metabolism regulation,cell survival enhancement,apoptosis resistance,cell growth promotion,unclear protein function
ENSG00000097096,SYDE2,meiotic spindle formation,chromosomal instability,microtubule stability disruption,aneuploidy induction,tumor suppressor function,cell cycle regulation
ENSG00000196268,ZNF493,transcriptional regulation,tumor progression,apoptosis suppression,cell cycle modulation,gene overexpression,oncogenic driver
ENSG00000114349,GNAT1,g-protein signaling,aberrant cellular proliferation,cell survival enhancement,tumor progression modulation,sigaling pathway dysregulation,protein-protein interactions
ENSG00000175970,UNC119B,rab22a activation,gef activity,recycling pathway regulation,cell proliferation promotion,metastasis facilitation,cancer prognosis correlation
ENSG00000095574,IKZF5,transcriptional regulation,cell cycle dysregulation,tumor suppressor function,apoptosis inhibition,cell proliferation enhancement,genomic instability promotion
ENSG00000154845,PPP4R1,regulatory subunit,aberrant activation,tumor growth,dna repair,genome instability,apoptosis inhibition
,SARS,mtor signaling pathway,constitutive activation,loss-of-function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000151023,ENKUR,cell growth regulation,protein-protein interactions,ankyrin repeat domains,cell signaling modulation,cellular regulation,genome-wide analysis
ENSG00000186971,KRTAP13-4,pi3k/akt pathway,gain of function mutations,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000163870,TPRA1,transcriptional regulator,gene expression modulation,cell cycle progression regulation,proliferation promotion,cancer progression,chromatin remodeling
ENSG00000154079,SDHAF4,energy metabolism regulation,tumor progression,loss of function mutation,mitochondrial dysfunction,succinate accumulation,angiogenesis promotion
ENSG00000188994,ZNF292,transcriptional regulation,dna binding specificity,tumorigenesis association,apoptosis modulation,cellular proliferation control,prognostic marker potential
ENSG00000196620,UGT2B15,loss of function mutations,downregulation,tumor suppressor,regulatory protein interaction,cellular growth regulation,metabolic dysregulation
ENSG00000074964,ARHGEF10L,rho gtpase signaling pathway,tumor growth,apoptosis regulation,cell cycle progression,mutations,aberrant activation
ENSG00000172724,CCL19,immune modulation,chemokine signaling,tumor progression,immunosuppression,angiogenesis promotion,cell migration facilitation
ENSG00000172830,SSH3,cell migration,spectrin superfamily,cell membrane dynamics,protein-protein interaction,cell motility enhancement,tumor progression facilitation
ENSG00000162104,ADCY9,camp signaling pathway,constitutive activation,gain of function mutations,tumor progression,oncogenic signaling,metabolic regulation
ENSG00000167130,DOLPP1,lipid metabolism regulation,protein processing and folding,cellular homeostasis maintenance,cancer-related alterations,cell signaling modulation,tumorigenesis contribution
ENSG00000171794,UTF1,transcriptional regulation,cell proliferation,dna replication,oncogenic process,embryonic development,gene expression
ENSG00000103160,HSDL1,redox regulation,dna repair,genomic stability,cellular detoxification,cancer progression,oncogenic transformation
ENSG00000175646,PRM1,serine protease inhibitor,epithelial-to-mesenchymal transition regulation,pi3k/akt pathway activation,tumor invasion and metastasis,cellular regulation disruption,oncogenic transformation
,ADSSL1,actin-cytoskeleton regulation,cell migration enhancement,tumor progression facilitation,oncogenic mutation involvement,metastasis promotion,cancer cell invasion support
ENSG00000092758,COL9A3,cell adhesion,extracellular matrix interaction,tumor progression,metastasis promotion,aggressive disease behavior,poor prognosis
ENSG00000132819,RBM38,oncogenic regulation,overexpression,cell proliferation,genomic instability,apoptosis evasion,transcriptional regulation
ENSG00000166592,RRAD,cytoskeletal regulation,cell survival signaling,tumor progression driver,aberrant gtpase activity,genomic instability mediator,protein-protein interaction hotspot
ENSG00000119685,TTLL5,microtubule regulation,cilia formation,cellular structure regulation,growth factor regulation,tumor progression modulation,therapeutic target
ENSG00000037042,TUBG2,microtubule stabilization,tumor progression,cell proliferation,dna damage response,microtubule assembly,gene mutation
ENSG00000138073,PREB,pi3k/akt pathway,oncogene,cellular metabolism regulation,intracellular calcium regulation,therapeutic target,glycolysis regulation
ENSG00000081307,UBA5,ubiquitination pathway,tumor progression,promotes cell proliferation,dysregulation of protein degradation,interaction with cell cycle regulators,genomic instability
ENSG00000105737,GRIK5,genomic alterations,cell proliferation modulation,signaling pathway interaction,tumor microenvironment modulation,apoptosis regulation,cell cycle influence
ENSG00000092096,SLC22A17,drug efflux pump,chemotherapy resistance,multidrug resistance,prognostic marker,tumor aggressiveness,cellular transport mechanism
ENSG00000102218,RP2,ciliary dysfunction,genomic instability,tumor progression,protein-protein interactions,cellular transport regulation,oncogene activation
ENSG00000197177,ADGRA1,adhesion g-protein coupled receptor function,tumor progression,epithelial-to-mesenchymal transition,signaling pathway interaction,cell migration regulation,cancer metastasis
ENSG00000161091,MFSD12,lipid transport regulation,cellular homeostasis maintenance,tumor progression influence,oncogenic lipid metabolism,cancer cell proliferation enhancement,genomic instability association
ENSG00000127954,STEAP4,iron metabolism regulation,tumor growth promotion,oxidative stress resistance,mitochondrial homeostasis maintenance,ferroptotic cell death prevention,hypoxia-inducible factor pathway activation
ENSG00000081014,AP4E1,late endosomal sorting,escrt machinery interaction,oncogenic potential,trafficking pathway disruption,cellular homeostasis alterations,adaptor complex component
ENSG00000167772,ANGPTL4,lipid metabolism suppression,fatty acid oxidation inhibition,oncogenic driver,tumor growth promotion,metastasis facilitation,pi3k/akt pathway interaction
ENSG00000163507,CIP2A,pp2a inhibition,cell proliferation activation,oncogenesis promotion,tumor suppression inhibition,genomic instability induction,protein kinase activation
ENSG00000176890,TYMS,dna synthesis,oncogene activation,cell proliferation enhancement,resistance to therapy,therapeutic target,genetic instability
ENSG00000177508,IRX3,loss of function mutations,tumor suppressor,epigenetic regulation,chromatin remodeling,cell differentiation,apoptosis regulation
ENSG00000170340,B3GNT2,egfr activation,glycosylation modification,tumor progression,therapeutic target,cell proliferation,prognostic biomarker
ENSG00000177191,B3GNT8,oncogene overexpression,altered glycosylation patterns,cell proliferation enhancement,tumor aggressiveness,chemotherapy resistance,metastasis promotion
ENSG00000263309,KRT23,**

keratin expression,epithelial differentiation,cellular structure maintenance,intermediate filament assembly,mechanical stability,tumor marker 

**
ENSG00000140479,PCSK6,oncogenic role,tumor progression,proprotein convertase activity,cell proliferation,pi3k/akt signaling,angiogenesis promotion
ENSG00000173200,PARP15,genomic stability regulation,homologous recombination repair (hrr),dna repair efficiency increase,tumor resistance promotion,protein interaction facilitation,brca2 binding enhancement
ENSG00000108474,PIGL,gpi-anchor modification,tumor suppressor function potential,cell surface protein regulation,cancer-related mutations unknown,protein modification pathway,cellular regulation influence
ENSG00000138615,CILP,oncogenic functions,tumor progression,cell adhesion and migration,signaling pathway regulation,biomarker potential,therapeutic target
ENSG00000078124,ACER3,regulated cellular processes,serine protease inhibition,overexpressed in cancer,tumor progression,tumor aggressiveness,cellular interactions
ENSG00000175161,CADM2,tumor suppressor,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway interaction,cell adhesion disruption,apoptosis regulation failure,gene expression loss
ENSG00000103274,NUBP1,cellular energy metabolism,genomic instability,oncogenic pathway activation,tumor growth promotion,metabolic regulation disruption,cell proliferation enhancement
ENSG00000162572,SCNN1D,enac complex formation,constitutive activation,oncogenic processes,sodium reabsorption,cell proliferation,ion transport regulation
ENSG00000156875,MFSD14A,lipid transport regulation,cell growth modulation,tumor progression contribution,therapeutic target potential,cancer metabolism hallmark,protein-protein interaction
ENSG00000064687,ABCA7,cholesterol efflux regulation,metastasis promotion,tumor progression,signaling pathway modulation,biomarker potential,lipid transport regulation
ENSG00000241360,PDXP,mitochondrial beta-oxidation,energy metabolism regulation,cell growth modulation,tumor progression correlation,therapeutic target potential,metabolic reprogramming hallmark
ENSG00000173762,CD7,tumor progression,oncogene overexpression,immunosuppressive environment,cell surface antigen expression,t cell development,cancer stem cell maintenance
ENSG00000147481,SNTG1,protein translation regulation,cell proliferation enhancement,tumor progression promotion,apoptosis inhibition,biomarker potential,poor prognosis association
ENSG00000188937,NYX,cell cycle regulation,circadian rhythm disruption,tumor progression,therapeutic target,apoptosis suppression,mitotic regulation
ENSG00000119411,BSPRY,**
overexpression,chromatin remodeling,transcriptional regulation,oncogene,cell cycle progression,apoptosis inhibition
**
ENSG00000168010,ATG16L2,autophagy dysregulation,cellular homeostasis disruption,protein-protein interaction,cell growth promotion,tumor suppressor function,genetic mutation impact
ENSG00000103310,ZP2,tumor progression,cell proliferation,aberrant expression,metastasis,oncogenesis,glycoprotein layer formation
ENSG00000280641,CDH4,cell adhesion disruption,tumor progression,metastasis regulation,wnt/β-catenin pathway modulation,epithelial polarity disruption,biomarker significance
ENSG00000254415,SIGLEC14,siglec family member,immunoregulatory function,cell adhesion molecule,tumor microenvironment modulation,immune suppression promotion,altered expression in kirc
ENSG00000263014,ATP6V1G3,v-atpase complex regulation,oncogenic processes support,metastasis promotion,energy supply increase,cancer driver potential,cellular pathway interaction
ENSG00000105516,DBP,cell proliferation,energy homeostasis,lipid metabolism,nuclear hormone receptor,oncogenesis,thyroid hormone response
ENSG00000145384,FABP2,lipid metabolism,cell proliferation,energy supply,tumor progression,biomarker potential,pi3k/akt/mtor interaction
ENSG00000256060,TRAPPC2B,cellular trafficking regulation,gene amplification,tumor suppressor function,akt pathway interaction,vesicle formation regulation,cancer driver gene
ENSG00000128694,OSGEPL1,lipid metabolism regulation,oncogenic cell growth,pi3k/akt/mtor pathway modulation,tumor progression,prognostic marker,genomic alterations
ENSG00000137877,SPTBN5,cancer driver gene,pi3k/akt pathway interaction,cellular invasion promotion,tumor growth enhancement,metastasis facilitation,erm protein interaction
ENSG00000127920,GNG11,**
g-protein coupled receptor signaling,cell proliferation regulation,signaling pathway modulation,cell survival enhancement,tumor progression support,gene expression alteration
**
ENSG00000164715,LMTK2,cell cycle regulation,aneuploidy,genomic instability,tumor progression,microtubule dynamics,centrosomal localization
ENSG00000102897,LYRM1,tumor progression,cellular respiration regulation,mitochondrial function regulation,glycolysis enhancement,energy metabolism modulation,biomarker expression
ENSG00000083814,ZNF671,cell cycle regulation,transcriptional regulation,tumor aggressiveness,poor prognosis,metastasis promotion,target gene regulation
ENSG00000188690,UROS,heme biosynthesis pathway,gain of function mutations,oxidative stress,iron homeostasis,dna damage,tumor progression
ENSG00000160868,CYP3A4,**

* drug metabolism,alteration
* pharmacokinetics modulation,interaction
* endogenous compound oxidation,lipid metabolism
* chemotherapy efficacy modification,toxicity regulation
* oncogenic potential contribution,tumor progression facilitation
* therapeutic target consideration
ENSG00000138131,LOXL4,tumor progression,oncogenic potential,cell migration,angiogenesis,collagen cross-linking,hypoxia response
ENSG00000118707,TGIF2,tumor suppressor function,loss of function mutations,genomic instability,chromatin regulation,apoptosis regulation,cell cycle progression
ENSG00000112333,NR2E1,nuclear receptor regulation,tumor suppressor function,retinoic acid signaling,cell cycle regulation,apoptosis modulation,dna repair pathway
ENSG00000205707,ETFRF1,ecm remodeling,tumor progression,overexpression,cell invasion,protein-protein interaction,signaling pathway regulation
ENSG00000282003,TUBGCP3,microtubule nucleation,genomic instability,centrosome regulation,protein kinase activation,oncogenesis,cell proliferation
ENSG00000146216,TTBK1,microtubule stabilization,cell proliferation enhancement,hippo signaling pathway regulation,kinase activation gain-of-function,tumor aggressiveness promotion,chromosomal instability prevention
ENSG00000171763,SPATA5L1,genomic instability,cellular stress survival,apoptosis evasion,chromatin remodeling,dna repair regulation,cell cycle progression
ENSG00000129103,SUMF2,glycosphingolipid metabolism regulation,cellular proliferation promotion,protein-protein interaction regulation,post-translational modification facilitation,tumor progression contribution,therapeutic target potential
ENSG00000110245,APOC3,angiogenesis promotion,lipid accumulation,metabolic regulation,inflammation induction,tumor growth facilitation,immune evasion enhancement
ENSG00000186912,P2RY4,purinergic signaling,cell migration,receptor overexpression,tumor progression,metastasis promotion,calcium mobilization
ENSG00000185340,GAS2L1,cell migration,gtpase activation,cytoskeletal organization,tumor progression,metastasis promotion,cellular morphology disruption
ENSG00000183153,GJD3,gap junction formation,cell proliferation enhancement,tumor progression facilitation,signaling pathway regulation,metabolic regulation modulation,cancer cell survival promotion
ENSG00000138821,SLC39A8,altered zinc homeostasis,dysregulation of cell proliferation,overexpression,tumor progression,biomarker for prognosis,protein-protein interactions
ENSG00000140497,SCAMP2,regulation of exocytosis,overexpression,cell growth regulation,tumor progression marker,cancer cell survival,cell cycle modulation
ENSG00000137731,FXYD2,ion transport regulation,tumor aggressiveness,prognostic marker,cell signaling modulation,na+/k+-atpase interaction,cancer progression
ENSG00000075790,BCAP29,cell proliferation,pi3k/akt pathway activation,oncogene potential,cell survival promotion,b-cell receptor signaling regulation,tumor tissue overexpression
ENSG00000138271,GPR87,g protein-coupled receptor,acid-sensing mechanism,tumor progression marker,cell migration regulator,prognostic indicator,receptor interaction partner
ENSG00000163607,GTPBP8,translation initiation,cell proliferation regulation,ribosome biogenesis,protein translation regulation,oncogenic signaling pathway modulation,cell cycle progression disruption
ENSG00000132330,SCLY,sulfite oxidase activity,oxidative stress reduction,dna damage prevention,tumor suppressor function,metabolic regulation,cell growth inhibition
ENSG00000153487,ING1,genomic instability,tumor suppressor function,epigenetic silencing,cell cycle regulation,apoptosis regulation,signaling pathway modulation
ENSG00000063761,ADCK1,mitochondrial complex assembly,cellular proliferation enhancement,apoptosis inhibition,signaling pathway activation,tumor progression promotion,energy metabolism disruption
ENSG00000142892,PIGK,cell membrane attachment,oncogenic transformation,tumor progression,cell migration,cell proliferation,adhesion regulation
ENSG00000006576,PHTF2,chromatin remodeling,apoptosis suppression,cell cycle regulation,dna damage response,tumor progression,genomic instability
ENSG00000155463,OXA1L,mitochondrial dynamics,oxidative stress response,cellular respiration,apoptosis regulation,energy metabolism modulation,protein-protein interaction
ENSG00000006534,ALDH3B1,aldehyde detoxification,cellular redox balance,oxidative stress protection,tumor progression modulation,therapeutic resistance,metabolic regulation
ENSG00000120094,HOXB1,hoxb1 overexpression,transcription factor activity,cellular differentiation regulation,oncogenic processes enhancement,epithelial-to-mesenchymal transition regulation,therapeutic target potential
ENSG00000130052,STARD8,phospholipid metabolism,lipid signaling pathways,cellular homeostasis modulation,oncogenic function,tumor progression facilitation,metabolic adaptation regulation
ENSG00000178732,GP5,serine protease inhibitor activity,tumor progression regulation,matrix metalloproteinase modulation,cellular invasion promotion,inflammation regulation,coagulation pathway interaction
ENSG00000159713,TPPP3,**

cellular survival,constitutive activation,dysregulated mitochondrial function,increased cell proliferation,mitochondrial chaperone activity,therapeutic target

**
ENSG00000139323,POC1B,genomic instability,pikk family regulation,dna damage response,chromatin remodeling,histone modification,cell cycle regulation
ENSG00000117697,NSL1,epigenetic regulation,chromatin remodeling,gene expression,histone acetylation,oncogenesis,prognostic biomarker
ENSG00000172590,MRPL52,**

mitochondrial ribosome,disrupted mitochondrial function,cell proliferation,tumor progression,prognostic marker,genomic instability 
**
ENSG00000067842,ATP2B3,calcium homeostasis disruption,cell proliferation enhancement,oncogenic signaling pathway activation,metabolic regulation alteration,protein interaction modulation,tumor progression promotion
ENSG00000179772,FOXS1,cell cycle regulation,transcriptional regulation,tumor suppressor function,cancer cell proliferation,pi3k/akt signaling interaction,chromatin remodeling
ENSG00000086712,TXLNG,regulation of cellular growth,pi3k/akt pathway modulation,oncogenic process driver,cell proliferation regulation,tumorigenesis contributor,survival signaling pathway regulator
ENSG00000104447,TRPS1,oncogenic transformation,gain of function mutations,tumor progression,angiogenesis inhibition,cell cycle regulation,transcriptional dysregulation
ENSG00000127980,PEX1,peroxisome biogenesis,vlcfa accumulation,neurodegenerative disorder,cellular metabolism,peroxisomal function,x-linked inheritance
ENSG00000138722,MMRN1,tumor aggressiveness,cell cycle regulation,apoptosis inhibition,oncogenic function,protein-protein interaction,m6a rna modification
ENSG00000182180,MRPS16,mitochondrial translation regulation,tumor suppressor,cellular metabolism modulation,oncogenic potential,energy production enhancement,mitochondrial dysfunction association
ENSG00000176383,B3GNT4,tumor progression,overexpression,cell proliferation,glycosylation modification,signaling pathway activation,therapeutic target
ENSG00000181722,ZBTB20,transcription factor function,cellular differentiation,apoptosis regulation,tumor suppression,histone modification,cell cycle regulation
ENSG00000139508,SLC46A3,folate metabolism,transporter activity,cell proliferation,oncogenic potential,tumor progression,clinical correlation
ENSG00000176428,VPS37D,escrt-0 complex regulation,endosomal sorting and trafficking,tumor progression and metastasis,pi3k/akt pathway interaction,autophagy and apoptosis regulation,cell migration and invasion modulation
ENSG00000102125,TAZ,hippo pathway,overexpression,cell growth,transcriptional coactivator,constitutive activation,emt regulation
ENSG00000127990,SGCE,cytoskeleton regulation,mutation-associated disorder,protein assembly,cell proliferation,upregulated gene,cancer cell migration
ENSG00000102302,FGD1,fgd1 overexpression,cellular proliferation,pi3k/akt pathway interaction,tumor progression,mutation contribution,glycoprotein synthesis
ENSG00000187118,CMC1,mitochondrial carrier function,tumor cell metabolism,warburg effect modulation,energy metabolism regulation,cell growth promotion,prognostic marker status
ENSG00000009335,UBE3C,**

cell cycle regulation,apoptosis inhibition,dna damage response,ubiquitin ligase activity,oncoprotein stabilization,prognostic marker
ENSG00000234906,APOC2,lipid metabolism regulation,triglyceride hydrolysis facilitation,hdl/ldl cholesterol regulation,gene expression influence,disease progression contribution,therapeutic target potential
ENSG00000180447,GAS1,apoptosis induction,tumor suppressor function,p53 interaction,cellular stress response,dna damage repair,proteolytic regulation
ENSG00000178403,NEUROG2,wnt/β-catenin pathway,transcription factor activity,cell proliferation,apoptosis inhibition,signaling pathway activation,tumor progression
ENSG00000117054,ACADM,increased lipid metabolism,metabolic reprogramming,poor prognosis marker,tumor aggressiveness,cell proliferation regulation,energy homeostasis modulation
ENSG00000137414,FAM8A1,cellular degradation regulation,oncogenic processes,tumor cell growth promotion,cancer aggressiveness factor,protein interaction modulation,genomic mutation association
ENSG00000140391,TSPAN3,overexpression,cell migration,immune evasion,metastasis promotion,poor prognosis,signaling pathway modulation
ENSG00000163359,COL6A3,ecm organization,dysregulation,tumor progression,metastasis,epithelial-to-mesenchymal transition (emt),integrin signaling activation
ENSG00000005381,MPO,pro-tumorigenic effects,hypochlorous acid production,dna damage,oxidative stress,genomic instability,epigenetic regulation
ENSG00000109065,NAT9,myristate transferase activity,oncogenic signaling,pi3k/akt pathway modulation,cell proliferation enhancement,tumor aggressiveness promotion,genomic instability maintenance
ENSG00000152580,IGSF10,cellular adhesion,tumor progression,neurodevelopmental regulation,dysregulated expression,immunoglobulin superfamily member,microenvironment modulation
ENSG00000006071,ABCC8,chemoresistance,metabolic reprogramming,tumor progression,enhanced growth,cellular homeostasis disruption,genomic instability
ENSG00000275111,ZNF2,zinc finger protein,transcription factor activity,epithelial-to-mesenchymal transition (emt) regulation,chromatin remodeling,gene expression regulation,cell proliferation promotion
ENSG00000016602,CLCA4,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway activation,chloride ion transport regulation,tumor progression,metastasis promotion,therapeutic target
ENSG00000151834,GABRA2,gaba receptor regulation,tumor suppressor activity,cell proliferation inhibition,silent mutation impact,neurotransmission modulation,cancer progression alteration
ENSG00000254004,ZNF260,zinc finger protein,transcription factor,cell cycle regulation,apoptosis modulation,tumor suppressor function,dna binding
ENSG00000275385,CCL18,angiogenesis promotion,regulatory t cell recruitment,epithelial-to-mesenchymal transition (emt),tumor progression facilitation,immune suppression enhancement,cancer-associated inflammation
ENSG00000171130,ATP6V0E2,v-atpase regulation,tumor growth promotion,metastasis facilitation,cellular ph regulation,extracellular matrix degradation,therapeutic target identification
ENSG00000145214,DGKQ,cellular proliferation,protein kinase c activation,signaling pathway regulation,apoptosis suppression,tumor progression,biomarker potential
ENSG00000140937,CDH11,cell-cell adhesion disruption,oncogene activity,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway interaction,promotes tumor progression,metastasis associated
ENSG00000140284,SLC27A2,lipid metabolism modulation,long-chain fatty acid transport,oncogenesis promotion,cell proliferation enhancement,metastasis facilitation,apoptosis resistance
ENSG00000102195,GPR50,nuclear orphan receptor,transcriptional regulation,cellular growth modulation,g protein-coupled receptor family,potential oncogenic involvement,signaling pathway interaction
ENSG00000183856,IQGAP3,tumor progression,cell migration,oncogenic protein regulation,cytoskeleton regulation,metastasis facilitation,poor prognosis marker
,TMEM246,regulatory role in membrane trafficking,interaction with oncogenic proteins,gain of function mutations,cellular signaling pathway regulation,tumor progression influence,transmembrane protein functionality
ENSG00000203747,FCGR3A,adcc mechanism,immunotherapy target,tumor elimination,oncogenic process,immune regulation,cancer prognosis
ENSG00000188266,HYKK,pi3k/akt pathway activation,apoptosis inhibition,cell cycle dysregulation,dna repair involvement,oncogene/tumor suppressor role,cell growth regulation
ENSG00000165609,NUDT5,disrupts cellular metabolism,regulates parp1 activity,enhances nicotinamide production,modulates gene expression,tumor progression,therapeutic target
ENSG00000059377,TBXAS1,thromboxane synthesis,coagulation activity,platelet aggregation,angiogenesis promotion,oncogene potential,tumor microenvironment interaction
ENSG00000119013,NDUFB3,mitochondrial dysfunction,tumor-promoting mutations,oncogenic protein stabilization,altered metabolism,rapid cell proliferation,mitochondrial respiratory chain impairment
ENSG00000086205,FOLH1,pi3k/akt interaction,metastatic potential,cell proliferation,folate metabolism alteration,oncogenic driver,prognostic marker
,TSTA3,pi3k/akt pathway regulation,tumor suppressor function,immune response modulation,cellular proliferation inhibition,genomic profiling alterations,therapeutic target potential
ENSG00000145736,GTF2H2,genomic instability,dna repair mechanism disruption,oncogenic signaling pathway activation,transcriptional dysregulation,genome stability maintenance,biomarker potential
ENSG00000100678,SLC8A3,apoptosis resistance,calcium homeostasis regulation,cancer cell proliferation,intracellular ca2+ signaling pathway,oncogenic processes promotion,therapeutic target for cancer treatment
ENSG00000240303,ACAD11,mitochondrial function,fatty acid oxidation,cellular energy metabolism,tumor progression,energy homeostasis disruption,metabolic reprogramming
ENSG00000054983,GALC,lysosomal degradation,galactosylceramidase activity,cell proliferation regulation,apoptosis modulation,metabolic regulation,protein-protein interaction
ENSG00000288399,KCTD11,regulation of e3 ubiquitin ligase complex,overexpression associated with tumor progression,inhibition of protein degradation pathways,contribution to epithelial-to-mesenchymal transition (emt),poor prognosis marker,protein-protein interaction critical for cancer biology
ENSG00000126391,FRMD8,actin cytoskeleton regulation,tumor suppressor function,cell migration and invasion,potential oncogene activation,genomic instability,protein degradation regulation
ENSG00000284752,GMPR2,purinergic signaling,guanine nucleotide regulation,cellular proliferation,metabolic reprogramming,nucleoside transport,tumor suppressor activity
ENSG00000144895,EIF2A,protein synthesis regulation,integrated stress response (isr),cell growth modulation,stress-activated kinase perk interaction,autophagy regulation,cell survival enhancement
ENSG00000148634,HERC4,genomic instability,ubiquitination regulation,protein degradation machinery,cell signaling pathways,tumor progression,dna damage response
ENSG00000182362,YBEY,ribosomal assembly,cellular growth,proliferation pathway,protein synthesis regulation,tumorigenesis implication,cancer biology alteration
ENSG00000197724,PHF2,chromatin remodeling,tumor suppressor function,histone modification regulation,cell cycle regulation disruption,dna repair pathway alteration,genomic instability promoter
ENSG00000103066,PLA2G15,pla2 enzyme activity,overexpression in cancer,tumor progression,chemoresistance modulation,pi3k/akt pathway interaction,prognostic marker
ENSG00000244274,DBNDD2,cell proliferation,microtubule stability,cytoskeletal dynamics regulation,protein-protein interaction,oncogenic process involvement,cell migration promotion
ENSG00000088881,EBF4,transcriptional regulation,oncogenesis,chromatin remodeling,tumor progression,cell proliferation,overexpression
ENSG00000185480,PARPBP,parp1 interaction,cell cycle regulation,dna repair modulation,oncogenic process promotion,therapeutic target potential,genome stability regulation
ENSG00000240021,TEX35,transcriptional regulation,chromatin modification,epigenetic regulation,dna methylation,oncogene expression,proliferation
ENSG00000157388,CACNA1D,calcium channel function,voltage-gated calcium channels,cell excitability,tumor growth,angiogenesis promotion,metastasis facilitation
ENSG00000256223,ZNF10,tumor suppressor,transcriptional regulation,genomic stability,cell cycle progression,apoptosis regulation,p53 interaction
ENSG00000134575,ACP2,calcium homeostasis regulation,energy metabolism modulation,cellular proliferation promotion,tumor progression facilitation,protein phosphorylation regulation,metabolic reprogramming
ENSG00000013563,DNASE1L1,dna degradation,apoptosis,genomic instability,tumor progression,therapeutic target,cell death
ENSG00000101958,GLRA2,glycine receptor regulation,chloride channel activation,cell migration promotion,tumor growth enhancement,metastasis facilitation,oncogenic protein interaction
ENSG00000167522,ANKRD11,chromatin remodeling,tumor suppressor function,cell proliferation regulation,genomic stability disruption,transcriptional regulation modulation,epigenetic modification alteration
ENSG00000157869,RAB28,rab gtpase activity,cell migration,epithelial-to-mesenchymal transition,overexpression,tumor progression,protein-protein interaction
ENSG00000134716,CYP2J2,cancer progression,apoptosis suppression,tumor metastasis,anti-inflammatory response,cytochrome p450 activity,arachidonic acid metabolism
ENSG00000137563,GGH,dna repair mechanisms,glutathione metabolism regulation,cell cycle progression,apoptosis modulation,prognostic marker,therapeutic target
ENSG00000172172,MRPL13,ribosomal protein function,translation regulation,cellular proliferation,tumorigenesis association,genetic mutation impact,cellular metabolism alteration
ENSG00000152782,PANK1,metabolic reprogramming,mitochondrial function disruption,iron homeostasis deregulation,tumor cell proliferation enhancement,cell survival pathway activation,genomic instability induction
ENSG00000198918,RPL39,ribosome function,protein synthesis regulation,cellular proliferation,genomic instability,tumor progression,translation initiation
ENSG00000184005,ST6GALNAC3,tumor-associated glycosylation,oncogenic modification,glycoprotein regulation,wnt/β-catenin signaling,tumor progression,immunoevasion
ENSG00000131096,PYY,regulatory role in tumor growth,angiogenic signaling pathway modulation,microenvironment regulation,tumor metastasis facilitation,wnt/β-catenin pathway interaction,pi3k/akt/mtor pathway modulation
,HIST1H2BJ,histone modification,chromatin remodeling,epigenetic regulation,dna packaging,gene expression,tumor progression
ENSG00000170275,CRTAP,collagen modification,ecm integrity disruption,cellular response modulation,tumor progression facilitation,post-translational modification regulator,protein interaction partner
ENSG00000174840,PDE12,cgmp regulation,cell proliferation,somatic mutations,protein kinase activation,kidney cell regulation,renal function modulation
ENSG00000163508,EOMES,tumor suppression,immune regulation,apoptosis promotion,emt inhibition,transcriptional modulation,cell cycle arrest
ENSG00000169490,TM2D2,wnt signaling pathway disruption,oncogenic mutations,chromatin remodeling regulation,cell proliferation enhancement,ubiquitin ligase interaction,adaptor molecule function
ENSG00000109158,GABRA4,ion channel regulation,neurotransmission disruption,tumor promotion,cell proliferation regulation,survival pathway modulation,cancer-associated mutation
ENSG00000107020,PLGRKT,overexpression,tumor progression,cell adhesion regulation,metastasis promotion,biomarker potential,signaling pathway modulation
ENSG00000176720,BOK,apoptosis regulation,cancer cell survival,mitochondrial membrane permeabilization,calcium signaling pathway,therapeutic target,serine/threonine kinase activity
ENSG00000006377,DLX6,wnt/β-catenin pathway interaction,cell proliferation,overexpression,tumor initiation and progression,transcriptional regulation,cancer biomarker
ENSG00000215045,GRID2IP,calcium signaling disruption,oncogenic mutations,ip3 receptor interaction,cell proliferation enhancement,intracellular calcium regulation,signaling pathway dysregulation
ENSG00000143443,C1orf56,mitochondrial regulation,apoptosis inhibition,cell proliferation promotion,oncogenic signaling modulation,tumor suppressor function disruption,genetic instability contribution
ENSG00000135870,RC3H1,oncogenic regulation,ubiquitination activity,cell survival signaling,protein stability modulation,tumor suppressor interaction,amplification event
ENSG00000160746,ANO10,calcium signaling pathway,akt activation,cell migration,apoptosis regulation,cancer progression marker,tumor suppression
ENSG00000250722,SELENOP,tumor suppressor function,redox regulation,oxidative stress modulation,genome stability maintenance,selenium-dependent protein biosynthesis,cancer progression inhibition
ENSG00000237693,IRGM,pi3k/akt pathway modulation,autophagy regulation,tumor microenvironment influence,dna damage induction,genomic instability promoter,oxidative stress mediator
ENSG00000179431,FJX1,cellular regulation,transmembrane protein function,tumor suppression mechanism,pi3k/akt pathway modulation,kidney cancer association,oncogene activation prevention
ENSG00000104901,DKKL1,wnt/β-catenin pathway inhibition,tumor progression,oncogenic driver,therapeutic target,cell growth regulation,epithelial-to-mesenchymal transition
ENSG00000125414,MYH2,chromatin remodeling,cellular proliferation,signaling pathway regulation,gene expression modulation,cytoskeletal dynamics regulation,oncogenic process promotion
ENSG00000112486,CCR6,immune system modulation,tumor progression,metastasis promotion,cell migration regulation,ligand interaction,cancer signaling pathway activation
ENSG00000183778,B3GALT5,cell adhesion,tumor microenvironment,glycosylation regulation,proteoglycan biosynthesis,metastasis,poor prognosis
ENSG00000198342,ZNF442,transcriptional regulation,oncogenic pathway activation,tumor suppressor gene suppression,cell proliferation promotion,apoptosis inhibition,protein-protein interaction modulation
ENSG00000165496,RPL10L,ribosomal biogenesis,mtor pathway activation,oncogenic process,cell growth promotion,protein synthesis enhancement,tumorigenesis promotion
ENSG00000095596,CYP26A1,retinoic acid regulation,cell proliferation inhibition,oncogenic function,enzymatic activity,gene expression modulation,rar interaction
ENSG00000173848,NET1,cell migration,actin cytoskeleton remodeling,prognostic marker,tumor invasion,microtubule stability,therapeutic target
ENSG00000158604,TMED4,ribosome biogenesis,overexpression in cancer,chaperone function,protein synthesis regulation,tumor progression driver,signaling pathway activation
ENSG00000108306,FBXL20,e3 ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,dna repair regulation,tumor suppressor pathway interaction,proteasomal degradation
ENSG00000140534,TICRR,pi3k/akt pathway regulation,chromatin remodeling,cell cycle progression,dna repair modulation,transcriptional regulation,genomic instability
ENSG00000105672,ETV2,etv2 mediated transcriptional regulation,oncogene activation,epithelial-to-mesenchymal transition,cell proliferation enhancement,wnt/β-catenin pathway activation,apoptosis suppression
ENSG00000147408,CSGALNACT1,cellular adhesion,glycosaminoglycan biosynthesis,tumor progression,metastasis,cell proliferation,biomarker
ENSG00000277354,CRIM1,complement regulation,immune modulation,tumor suppression,cancer progression,tissue homeostasis,mutation impact
ENSG00000265203,RBP3,retinoid transport,cellular retinoid storage,oxidative stress response,angiogenic promoter,cancer metabolism,cell survival signaling
ENSG00000166111,SVOP,protein-protein interaction,cell signaling regulation,immune response modulation,signaling pathway modulation,cell growth regulation,cancer progression influence
ENSG00000124767,GLO1,glycolytic reprogramming,cell survival enhancement,therapeutic target,metabolic adaptation,oxidative stress mitigation,genetic dysregulation
ENSG00000103460,TOX3,transcription factor activity,oncogene overexpression,cell proliferation enhancement,apoptosis inhibition,epigenetic regulation modulation,poor prognosis marker
ENSG00000075673,ATP12A,cancer-related,cell membrane transport,copper homeostasis regulation,oxidative stress induction,pro-oncogenic,dna damage response modulation
ENSG00000176533,GNG7,oncogene,g-protein coupled receptor signaling,cell migration and invasion,rho gtpase activation,signal transduction pathway modulation,tumorigenesis regulation
ENSG00000104368,PLAT,overexpression,oncogenic signaling pathway,calcium signaling regulation,cell proliferation,prognostic biomarker,protein kinase activation
ENSG00000136856,SLC2A8,glucose transporter function,oncogenic driver,warburg effect,metabolic regulation,cellular glucose uptake,cancer prognosis
ENSG00000273494,PANK4,iron-sulfur cluster assembly,oxidative stress response,therapeutic target,cellular redox balance,tumor growth promotion,metabolic regulation
ENSG00000166272,WBP1L,hippo signaling pathway,tumor progression,cell growth regulation,oncogene interaction,transcriptional regulation,cell proliferation modulation
ENSG00000162520,SYNC,cell migration,intermediate filament protein,overexpression,poor prognosis,apoptosis regulation,metastasis promotion
ENSG00000141540,TTYH2,centrosome amplification,mitotic spindle checkpoint disruption,apoptosis resistance,cell proliferation enhancement,overexpression,genomic instability
ENSG00000180090,OR3A1,pi3k/akt pathway modulation,cell proliferation regulation,tumor progression association,poor prognosis marker,protein interaction influence,intracellular signaling regulation
ENSG00000100997,ABHD12,cellular regulation,sphingolipid metabolism,apoptosis modulation,cell proliferation regulation,lipid metabolism regulation,none
ENSG00000184903,IMMP2L,tumor progression,cell adhesion regulation,epithelial-to-mesenchymal transition,signaling pathway modulation,cancer cell invasion,metastasis driver gene
ENSG00000070669,ASNS,cellular proliferation,oncogenic function,anabolic processes,metabolic regulation,nutrient sensing pathway,therapeutic target
ENSG00000122482,ZNF644,tumor aggressiveness,epigenetic regulation,androgen receptor coactivator,prognostic marker,oncogene regulation,wnt/β-catenin pathway interaction
ENSG00000131373,HACL1,histone deacetylation,chromatin remodeling,tumor suppressor regulation,cell proliferation enhancer,apoptosis inhibition,oncogene expression
ENSG00000113805,CNTN3,cellular adhesion disruption,tumor progression marker,glycoprotein signaling,molecular biomarker,axonal outgrowth regulation,neurodevelopmental gene expression
ENSG00000089050,RBBP9,chromatin regulation,cell cycle progression,genome stability maintenance,dna repair mechanisms,transcriptional regulation,protein-protein interactions
ENSG00000203797,DDO,thyroid hormone regulation,oncogenic driver,angiogenesis promotion,tumor progression marker,cell proliferation modulation,apoptosis inhibition
ENSG00000072840,EVC,elastic fiber formation,cell proliferation regulation,protein-protein interaction,tumor progression involvement,therapeutic target potential,genetic disorder association
ENSG00000170468,RIOX1,chromatin remodeling,transcription regulation,histone modification,prognostic marker,tumor progression,genetic instability
ENSG00000130294,KIF1A,mitotic checkpoint regulation,centrosome separation,motor protein function,microtubule dynamics,cell division control,tumor suppressor dysfunction
ENSG00000123213,NLN,oncogene activation,transcriptional regulation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,pi3k/akt signaling modulation
ENSG00000205863,C1QTNF9B,cell proliferation,tumor suppressor activity,apoptosis regulation,protein-protein interactions,cell differentiation,cancer-related gene expression
,ELMSAN1,mitotic regulation,aneuploidy promotion,chromosomal instability,genomic alterations,tumor suppressor candidate,cell cycle control
ENSG00000135164,DMTF1,epigenetic regulation,tumor suppressor downregulation,cellular proliferation,invasion and metastasis,epigenetic regulators interaction,poor prognosis indicator
ENSG00000065613,SLK,phosphorylation regulation,pi3k/akt pathway modulation,cell survival enhancement,tumor progression driver,protein kinase activation,metastasis promotion
,HIST1H2AA,histone modification,chromatin remodeling,dna packaging,epigenetic regulation,gene expression modulation,transcriptional activation
ENSG00000119844,AFTPH,transcription coactivator,oncogene,chromatin remodeling,tumor progression,cell proliferation,survival pathway
ENSG00000126773,PCNX4,nucleosome reorganization,chromatin remodeling,dna repair,genome stability,prognostic marker,cancer cell survival
ENSG00000160182,TFF1,tumor progression,proliferation and survival,oncogene,prognostic marker,signaling pathway modulation,epithelial integrity regulation
ENSG00000121904,CSMD2,tumor suppressor function,cell growth regulation,loss of function mutations,immune evasion mechanism,protein-protein interaction,apoptosis regulation
ENSG00000187240,DYNC2H1,microtubule interaction,motor function dysregulation,cell migration promotion,tumor invasion enhancement,proliferation facilitation,poor prognostic marker
ENSG00000214021,TTLL3,microtubule dynamics,tumor progression,tubulin modification,dysregulated function,cellular homeostasis disruption,mutation hotspot
ENSG00000108576,SLC6A4,serotonin signaling,tumor progression,prognostic marker,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway interaction,overexpression
ENSG00000167549,CORO6,actin dynamics regulation,cell migration promotion,prognostic marker,tumor progression facilitation,metastasis enhancement,oncogenic role
ENSG00000186310,NAP1L3,chromatin remodeling,oncogenic function,cell proliferation,apoptosis regulation,signaling pathway modulation,tumor progression
ENSG00000100626,GALNT16,glycosylation regulation,oncogenic protein expression,tumor progression,metastasis facilitation,cellular proliferation,prognostic marker
ENSG00000166716,ZNF592,tumor suppressor/oncogene,transcriptional regulation,cell proliferation/survival,apoptosis modulation,cell cycle progression,therapeutic target
ENSG00000184428,TOP1MT,genomic instability,cell cycle regulation,dna replication,tumor progression,oncogenesis,mitochondrial function
ENSG00000142973,CYP4B1,oncogenic role,overexpression,lipid peroxidation,oxidative stress,angiogenesis modulation,dna damage repair
ENSG00000197629,MPEG1,autophagic regulation,endocytic pathway modulation,lysosomal dysfunction,tumor microenvironment remodeling,oncogenic signaling pathway disruption,mitochondrial dysfunction
ENSG00000278767,SERPINA10,protease inhibition,cell migration regulation,tumor progression modulation,cancer cell invasion,tumor behavior influence,therapeutic target exploration
ENSG00000084636,COL16A1,collagen biosynthesis,tumor progression,extracellular matrix remodeling,cell adhesion modulation,invasion facilitation,matrix metalloproteinase interaction
ENSG00000122674,CCZ1,chromatin remodeling,tumor suppressor activity,loss of function mutations,cancer cell proliferation,dna repair dysregulation,apoptosis evasion
ENSG00000174669,SLC29A2,transporter function,overexpression in ccrcc,cell survival promotion,resistance to apoptosis,therapeutic target,signaling pathway regulation
ENSG00000144026,ZNF514,transcriptional regulator,cell growth regulation,zinc finger protein,dna binding activity,gene expression modulation,potential tumor suppressor
ENSG00000135390,ATP5MC2,mitochondrial energy metabolism,oncogenesis,electron transport chain regulation,tumor growth promotion,energy production enhancement,cell proliferation acceleration
ENSG00000147862,NFIB,transcription factor regulation,mutant allele association,cell proliferation promotion,gene expression alteration,tumor progression facilitation,therapeutic target potential
ENSG00000188338,SLC38A3,glutamine homeostasis,cellular energy metabolism,increased expression,cell proliferation,therapeutic target,metabolic reprogramming
ENSG00000144231,POLR2D,transcriptional regulation,oncogenic function,cell proliferation,apoptosis resistance,epigenetic modification,therapeutic target
ENSG00000164308,ERAP2,antigen processing and presentation,immune evasion,oncogene activation,tumor progression,poor prognosis,elevated expression
ENSG00000213047,DENND1B,autophagic pathway regulation,tumor suppressor function,membrane trafficking regulation,cellular homeostasis maintenance,protein secretion modulation,cancer cell survival enhancement
ENSG00000219438,TAFA5,cellular proliferation,transcription regulation,chromatin remodeling,protein interaction,genomic instability,oncogene activation
ENSG00000168393,DTYMK,ditp-transferase activity,overexpression,cell signaling modulation,nucleotide metabolism regulation,tumor progression contribution,cell survival enhancement
ENSG00000174177,CTU2,epigenetic regulation,histone h3 lysine 9 trimethylation (h3k9me3),chromatin remodeling,tumor progression,genomic instability,dysregulation of gene expression
ENSG00000123612,ACVR1C,tumor suppression,epithelial-to-mesenchymal transition,growth factor regulation,oncogene function,signal transduction,extracellular matrix production
ENSG00000131446,MGAT1,glycosylation regulation,cell growth promotion,signaling pathway modulation,pi3k/akt activation,protein function stabilization,tumor progression correlate
ENSG00000257446,ZNF878,dna damage response,tumor suppressor function,cellular transcription regulation,protein-dna interaction,genomic stability maintenance,apoptosis induction
ENSG00000076706,MCAM,cell adhesion disruption,metastatic promotion,tumor progression facilitation,signaling pathway interaction,oncogenic role,angiogenesis enhancement
ENSG00000180113,TDRD6,mirna regulation,oncogenesis,tumor suppressor gene regulation,protein-rna interaction,cellular survival,gene expression control
ENSG00000178201,VN1R1,tumor progression,genomic instability,overexpression,cellular proliferation,metastasis,signaling pathway modulation
ENSG00000174915,PTDSS2,lipid biosynthesis regulation,oncogenic pathway modulation,cell growth promotion,tumor progression driver,overexpression implicated,therapeutic target potential
ENSG00000182141,ZNF708,zinc finger protein regulation,transcriptional modulation,cell cycle progression,apoptosis evasion,tumor suppression,genomic instability
ENSG00000278608,MAMDC2,tumor progression,chromatin regulation,cell cycle regulation,transcriptional regulator,gene overexpression,oncogenic potential
ENSG00000164299,SPZ1,tumor suppressor/oncogene dual role,pi3k/akt pathway interaction,cell cycle regulation,apoptosis inhibition,microrna regulation,tumor aggressiveness predictor
ENSG00000154240,CEP112,cilia formation,wnt/β-catenin pathway modulation,centriole duplication regulation,oncogenic process,aneuploidy and genomic instability,therapeutic target
ENSG00000122574,WIPF3,actin cytoskeleton regulation,cell migration,rho gtpase activation,aggressive tumor behavior,overexpression,metastatic potential
ENSG00000187446,CHP1,chromatin remodeling,genomic instability,aneuploidy,cell cycle regulation,tumor progression,biomarker potential
ENSG00000138756,BMP2K,enhanced cell survival,gene expression dysregulation,pi3k/akt signaling pathway modulation,tumor progression promotion,therapeutic target,cell proliferation regulation
ENSG00000106331,PAX4,oncogene activation,transcriptional regulation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,poor prognosis marker
ENSG00000085721,RRN3,ribosomal rna processing,cellular growth regulation,tumor progression,poor prognosis,cancer biology interaction,genomic instability
ENSG00000108242,CYP2C18,regulation of cell proliferation,modulation of angiogenesis,interaction with other proteins,biotransformation of substrates,cellular response modulation,tumorigenesis association
ENSG00000159164,SV2A,angiogenesis facilitation,immune evasion,pro-oncogenic gene regulation,tumor growth promotion,vesicle fusion machinery interaction,immunotherapy target
ENSG00000105552,BCAT2,metabolic reprogramming,oncogenic potential,redox regulation,energy metabolism enhancement,tumor aggressiveness promotion,therapeutic target
ENSG00000205307,SAP25,cellular regulation,proliferation and survival,protein-protein interactions,signaling pathway modulation,oncogenic processes,tumor progression
ENSG00000152595,MEPE,phosphatonin activity,tumor progression,cell proliferation,pi3k/akt pathway activation,mineralization regulation,protein interaction
ENSG00000167930,FAM234A,regulation of cell proliferation,potential biomarker,driver mutation,interaction with pi3k/akt pathway,aberrant protein processing,er stress response
ENSG00000101825,MXRA5,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition,tumor suppressor regulation,cell cycle progression,apoptosis suppression,proliferation promotion
ENSG00000137672,TRPC6,calcium signaling,oncogenic signaling pathway,metastasis,angiogenesis,cell migration,epithelial-to-mesenchymal transition
ENSG00000166821,PEX11A,altered lipid metabolism,autophagy regulation,peroxisomal biogenesis,lipid synthesis modulation,cellular stress response,tumor suppressor protein interaction
ENSG00000151892,GFRA1,gdnf/ret signaling pathway,cell survival and proliferation,tumor development and progression,cellular motility,ret tyrosine kinase activation,glial-derived neurotrophic factor binding
ENSG00000166401,SERPINB8,tumor growth promotion,apoptosis inhibition,protease inhibition,metastasis facilitation,cancer cell survival,signaling pathway interaction
ENSG00000275181,GPR20,gain of function mutations,oncogenic transformation,cellular proliferation,cell migration and invasion,g protein-coupled receptor signaling,constitutive activation
ENSG00000177225,GATD1,mtor pathway activation,cell proliferation regulation,protein synthesis dysregulation,dna repair regulation,tumor progression contribution,oncogene overexpression
ENSG00000168300,PCMTD1,tumor suppressor,cell cycle regulation,genomic instability,apoptosis regulation,protein-protein interactions,dna repair pathway interaction
ENSG00000147257,GPC3,gpc3 overexpression,cell surface proteoglycan,growth factor binding,oncogenesis promotion,prognostic marker,tumor aggressiveness
ENSG00000162931,TRIM17,tumor suppressor,cell cycle regulation,apoptosis regulation,pi3k/akt pathway modulation,ubiquitination and degradation regulation,immune response modulation
ENSG00000177951,BET1L,cellular trafficking regulation,intracellular signaling modulation,oncogenic behavior promotion,protein-protein interaction facilitation,tumor growth factor regulation,gene expression alteration
ENSG00000146904,EPHA1,tumor progression,constitutive activation,metastasis promotion,angiogenesis regulation,cell migration enhancement,receptor tyrosine kinase activity
ENSG00000106617,PRKAG2,cellular signaling pathway,regulatory subunit mutations,energy metabolism reprogramming,oncogenic process promotion,pka activation,proliferation and survival enhancement
ENSG00000006283,CACNA1G,calcium influx regulation,electrolyte imbalance,cell proliferation,tumor progression,genomic alterations,ion channel dysfunction
ENSG00000120500,ARR3,mitochondrial function regulation,oncogene activation,p53 pathway interaction,cell proliferation enhancement,glycolytic shift promotion,protein interaction modulation
,GUCA1A,wnt/β-catenin pathway,regulation of cell growth,cell proliferation,poor prognosis marker,calcium-binding protein function,tumor progression
ENSG00000019505,SYT13,**
chromatin remodeling,oncogenic potential,histone-modifying interactions,tumor progression,biomarker,genomic instability 
**
ENSG00000155287,SLC25A28,mitochondrial transport,energy metabolism regulation,tumor suppressor function,oncogenic potential,epigenetic regulation interaction,metabolic disruption
ENSG00000136643,RPS6KC1,**
protein synthesis regulation,growth factor signaling,cell survival pathway,tumor progression driver,kinase activity regulation,metastasis promoter **
ENSG00000139725,RHOF,epithelial-to-mesenchymal transition,actin cytoskeleton regulation,rho gtpase interaction,tumor aggressiveness,cell migration,signaling pathway modulation
ENSG00000170364,SETMAR,telomere regulation,dna repair pathways,oncogene activation,cell proliferation,genome stability disruption,chromatin modification
ENSG00000204963,PCDHA7,cell-cell interaction,neural adhesion,signal transduction pathways,epithelial-to-mesenchymal transition (emt),tumor aggressiveness modulation,cellular adhesion regulation
ENSG00000172269,DPAGT1,n-glycosylation disruption,cellular metabolism alteration,glycan biosynthesis enzyme,protein stability modulation,tumor suppressor loss,genetic mutation hotspot
ENSG00000139083,ETV6,oncogenic fusion protein,chromosomal translocation,epithelial-to-mesenchymal transition,tumor progression driver,transcription factor regulation,cell signaling pathway interaction
ENSG00000095752,IL11,tumor growth promotion,angiogenesis stimulation,metastasis enhancement,apoptosis suppression,tumor microenvironment modulation,oncogenic signaling pathway interaction
ENSG00000112110,MRPL18,mitochondrial ribosome assembly,cell survival enhancement,tumor progression facilitation,prognostic marker,poor prognosis indicator,cancer cell resistance to therapy
ENSG00000169418,NPR1,natriuretic peptide signaling pathway,cell growth regulation,apoptosis induction,tumor progression,guanylyl cyclase activation,cancer therapy target
ENSG00000105258,POLR2I,transcriptional regulation,oncogenic pathway activation,cell proliferation enhancement,tumor growth promotion,dna repair modulation,genome stability maintenance
ENSG00000048544,MRPS10,mitochondrial ribosome assembly,tumor suppressor activity,loss of function mutations,cellular respiration regulation,oncogenic transformation,genomic instability
ENSG00000115607,IL18RAP,il-18 signaling pathway,angiogenesis promotion,prognostic marker,tumor microenvironment modulation,pi3k/akt pathway regulation,mapk/erk pathway activation
ENSG00000183878,UTY,histone modification,chromatin remodeling,oncogene activation,tumor suppressor silencing,epiigenetic regulation,cell proliferation
ENSG00000160957,RECQL4,genome instability,dna repair dysfunction,oncogenesis promotion,chromosomal alterations,therapeutic target,helicase activity disruption
ENSG00000111241,FGF6,fibroblast growth factor signaling,mitogenic activity,tumor progression promoter,growth factor regulation,oncogenic potential,cellular proliferation enhancer
ENSG00000153107,ANAPC1,cell cycle regulation,dysregulated protein degradation,genomic instability,apoptosis induction,cancer driver gene,chromosome segregation error
ENSG00000196284,SUPT3H,chromatin remodeling,genomic instability,transcriptional regulation,epigenetic modifications,tumor suppression loss,gene expression dysregulation
ENSG00000136492,BRIP1,homologous recombination repair,dna double-strand break repair,genomic instability,tumor suppressor function,gain-of-function mutations,oncogenic potential
ENSG00000168487,BMP1,protease activation,epithelial-to-mesenchymal transition,angiogenesis facilitation,tumor microenvironment modulation,signaling pathway regulation,cellular differentiation regulation
ENSG00000144827,ABHD10,lipid metabolism regulation,cell growth regulation,tumor suppressor function,poor prognosis marker,potential biomarker,oncogenic role
ENSG00000120242,IFNA8,tumor progression,pro-inflammatory cytokine induction,immune evasion mechanisms,stat1/irf9 pathway activation,apoptosis regulation,cytokine signaling
ENSG00000113600,C9,regulatory mechanisms,exosome complex component,rna degradation,oncogenic process,tumorigenesis,aberrant metabolism
,HIST1H2BK,histone modification,chromatin assembly,transcriptional regulation,tumor suppressor function,genomic stability,epigenetic regulation
ENSG00000233816,IFNA13,immune modulation,tumor microenvironment regulation,apoptosis induction,angiogenesis suppression,dysregulated expression,poor prognosis indicator
ENSG00000197919,IFNA1,tumor-promoting,cell proliferation,immune modulation,stat1/stat2 activation,akt/mtor signaling,proliferation enhancement
ENSG00000075213,SEMA3A,tumor suppressor function,angiogenesis regulation,apoptosis induction,patient survival association,therapeutic target,genomic profiling
ENSG00000167186,COQ7,mitochondrial function,energy metabolism regulation,reactive oxygen species production,oxidative stress response modulation,cell survival enhancement,tumor suppressor dysfunction
ENSG00000104976,SNAPC2,spliceosome assembly,pre-mrna processing,aberrant splicing patterns,oncogenic signaling pathways,cellular processes disruption,tumor progression
ENSG00000036828,CASR,cell proliferation regulation,oncogenesis promotion,tumor metastasis modulation,calcium homeostasis disruption,biomarker for cancer diagnosis,g-protein coupled receptor interaction
ENSG00000204086,RPA4,dna replication,genomic stability,single-stranded dna binding,tumor progression,poor prognosis,therapeutic target
ENSG00000110200,ANAPC15,chromosomal instability,g2/m phase regulation,mitotic checkpoint control,loss-of-function mutations,ubiquitination dysregulation,cyclin b1 degradation
ENSG00000145839,IL9,il9/il9r pathway,tumor-promoting cytokine,immunomodulation,angiogenesis enhancement,epithelial-to-mesenchymal transition,ectopic lymphoid structure formation
ENSG00000124334,IL9R,oncogene activation,stat3 pathway activation,cell proliferation enhancement,angiogenesis promotion,t-cell regulation,immune evasion mechanism
ENSG00000102678,FGF9,fgf signaling pathway,oncogenic potential,cell proliferation promotion,metastasis facilitation,tumor progression enhancement,therapeutic target identification
ENSG00000129055,ANAPC13,genetic instability,cell cycle regulation,tumor aggressiveness,poor prognosis,proliferation regulation,apoptosis suppression
ENSG00000147873,IFNA5,immune modulation,interferon-stimulated genes (isgs),antiviral state,immunosuppression,tumor progression,genomic instability
ENSG00000171855,IFNB1,type i interferon signaling,immune evasion,tumor suppression,tumor microenvironment modulation,angiogenesis inhibition,apoptosis induction
ENSG00000186895,FGF3,angiogenesis promotion,cellular proliferation,oncogenic processes,signaling pathway activation,tumor growth facilitation,tumor metastasis enhancement
ENSG00000114861,FOXP1,oncogene,cellular proliferation,tumor progression,therapeutic target,genomic profiling,apoptosis regulation
ENSG00000081026,MAGI3,epithelial-to-mesenchymal transition,oncogene activation,tumor progression,metastasis promotion,cell adhesion regulation,signaling pathway modulation
ENSG00000105287,PRKD2,cellular proliferation,protein kinase activation,constitutive activation,tumor growth promotion,apoptosis resistance,cell signaling regulation
ENSG00000119973,PRLHR,tumor progression,cell proliferation,jak/stat signaling pathway,metastasis,prognostic marker,proliferation and migration
ENSG00000144596,GRIP2,pi3k/akt pathway interaction,growth regulation,oncogenic potential,apoptosis inhibition,mutation association,cancer progression
ENSG00000069020,MAST4,microtubule stability,aurora kinase regulation,cell division,mitotic checkpoint,protein-protein interaction,tumor progression
ENSG00000183479,TREX2,chromatin remodeling,genomic instability,transcriptional dysregulation,dna repair impairment,cell cycle progression,protein truncation
ENSG00000175175,PPM1E,phosphatase regulation,cell cycle modulation,tumor suppressor function,apoptosis evasion,cell migration enhancement,tumorigenesis promotion
ENSG00000144455,SUMF1,post-translational modification regulation,tumor progression,cell proliferation enhancement,prognostic biomarker,therapeutic target,sulfatase activation
ENSG00000198964,SGMS1,ceramide regulation,oncogene,sphingomyelin synthase activity,sphingolipid signaling,apoptosis resistance,cell proliferation enhancement
ENSG00000261150,EPPK1,cellular regulation,protein kinase activation,tumor suppressor activity,dna repair mechanisms,apoptosis regulation,genetic instability
ENSG00000125844,RRBP1,rna-binding protein,oncogenic function,cellular proliferation,pi3k/akt pathway interaction,metastasis promotion,epithelial-to-mesenchymal transition regulation
ENSG00000144407,PTH2R,pi3k/akt signaling,cell proliferation,receptor activation,tumor metastasis,bone metabolism regulation,epithelial-to-mesenchymal transition
ENSG00000113396,SLC27A6,fatty acid transport,metabolic reprogramming,cell signaling,lipid metabolism regulation,oncogenic potential,therapeutic target
ENSG00000185238,PRMT3,regulation of gene expression,cellular signaling pathways,pi3k/akt pathway regulation,tumor progression,protein-protein interactions,cancer cell survival
ENSG00000183291,SELENOF,cellular antioxidant,dna damage response,oxidative stress modulation,redox regulation,tumor promoter,genomic instability
ENSG00000144048,DUSP11,oncogenic activity,mapk pathway regulation,cell proliferation enhancement,tumor progression promotion,biomarker potential,signaling molecule interaction
ENSG00000079393,DUSP13,anti-apoptotic function,tumor progression,cell proliferation enhancement,map kinase signaling regulation,jnk1/2 interaction,bcl-2 upregulation
ENSG00000284835,DEFA3,immune system regulation,antimicrobial defense,tumor microenvironment modulation,prognostic marker,oncogenic driver,therapeutic target
ENSG00000130640,TUBGCP2,microtubule stabilization,oncogenic processes,cell proliferation,apoptosis resistance,cancer driver gene,microtubule polymerization
ENSG00000183638,RP1L1,cellular proliferation,chromosomal instability,mitotic checkpoint regulation,overexpression associated,poor prognosis indicator,transcriptional regulator interaction
ENSG00000130234,ACE2,renin-angiotensin system modulation,angiogenesis promoter,tumor progression facilitator,metastasis enhancer,cell surface expression,biomarker candidate
ENSG00000266200,PNLIPRP2,lipid metabolism regulation,tumor progression,cellular signaling activation,cancer driver gene,oncogenic pathway modulation,genomic instability
ENSG00000114113,RBP2,tumor suppressor function,regulation of chromatin remodeling,transcriptional co-repressor activity,e3 ubiquitin ligase activity,cell cycle regulation inhibition,oncogenic overexpression
ENSG00000121207,LRAT,lipid metabolism reprogramming,cellular differentiation regulation,tumor proliferation enhancement,cancer lipid pathway involvement,genomic instability association,oncogenic potential marker
ENSG00000171864,PRND,cell growth regulation,cellular proliferation regulation,oncogenic process contribution,signaling pathway modulation,neuropeptide processing,potential tumor expression
ENSG00000183395,PMCH,regulatory mechanism,iron metabolism regulation,hepcidin expression,oncogenesis association,cell proliferation modulation,genomic instability
ENSG00000125851,PCSK2,cell proliferation,metastasis promotion,protein processing,signaling pathway interaction,tumor growth facilitation,cancer progression
ENSG00000130635,COL5A1,ecm remodeling,cell invasion,metastasis promotion,oncogene expression,collagen fibril formation,tumor progression enhancement
ENSG00000170743,SYT9,apoptosis regulation,autophagy modulation,cell proliferation enhancement,cancer progression facilitation,mutational activation,signaling pathway interaction
ENSG00000168952,STXBP6,cellular proliferation,membrane fusion regulation,tumor progression facilitation,signaling pathway modulation,overexpression,poor prognosis marker
ENSG00000021852,C8B,complement activation,cellular lysis,pore formation,tumor microenvironment modulation,cancer immunosurveillance,genetic dysregulation
ENSG00000266964,FXYD1,oncogenic potential,ion transport regulation,cellular metabolism enhancement,tumor progression,cell proliferation,na+/k+-atpase pump interaction
ENSG00000203710,CR1,immune evasion,complement activation,tumor microenvironment modulation,angiogenesis regulation,metastasis facilitation,immune surveillance evasion
ENSG00000204983,PRSS1,proteolytic activity,cell signaling regulation,tumor progression,growth factor activation,metastatic potential,oncogenic process
ENSG00000088926,F11,coagulation cascade,tumor progression,metastasis,angiogenesis,blood clotting,thrombin formation
ENSG00000106624,AEBP1,epigenetic regulation,chromatin remodeling,oncogene activation,tumor progression,transcriptional regulation,apoptosis suppression
ENSG00000070748,CHAT,tumor growth,oncogenic processes,metastasis promotion,akt pathway activation,cell survival mechanisms,acetylcholine biosynthesis
ENSG00000128791,TWSG1,wnt signaling pathway regulation,epithelial-to-mesenchymal transition promotion,cell migration enhancement,tumor invasion facilitation,prognostic biomarker overexpression,cancer cell aggressiveness association
ENSG00000159723,AGRP,oncogenic function,cell proliferation regulation,angiogenesis promotion,tumor progression facilitation,therapeutic target identification,signaling pathway modulation
ENSG00000165195,PIGA,glycosylation dysregulation,gpi anchor synthesis impairment,immune evasion mechanism,metabolic alteration contribution,therapeutic target potential,biomarker significance
ENSG00000100564,PIGH,glycolytic enzyme regulation,glycerol-3-phosphate metabolism,cell growth and proliferation,metabolic adaptation,insulin/igf-1 signaling pathway,tumor growth and survival
ENSG00000127129,EDN2,angiogenesis,tumor progression,vasoconstriction,oncogenic processes,protein processing,signaling pathway interaction
ENSG00000092009,CMA1,autophagy regulation,protein aggregation,cancer cell survival,tumor progression,genomic instability,mtor pathway interaction
ENSG00000132561,MATN2,cell adhesion disruption,metastasis promotion,wnt/β-catenin pathway interaction,tumor suppressor function,cell migration enhancement,glycoprotein expression dysregulation
ENSG00000167103,PIP5KL1,cellular phosphoinositide regulation,tumor progression,constitutive activation,oncogenic processes,cell survival enhancement,proliferation facilitation
ENSG00000134247,PTGFRN,tumor progression,cell proliferation,metastasis,therapeutic target,prostaglandin signaling,upregulated expression
ENSG00000134489,HRH4,immune modulation,cell migration,proliferation regulation,tumor microenvironment modulation,g-protein coupled receptor,oncogenic potential
ENSG00000150681,RGS18,overexpression,cell proliferation,g-protein regulation,oncogenic potential,tumor progression,metastasis promotion
ENSG00000107518,ATRNL1,genomic instability,cell cycle regulation,dna repair,tumor growth,brca2 complex,atm/atr kinase interaction
ENSG00000117322,CR2,cr2 expression,immune suppression,complement component interaction,tumor progression,poor prognosis marker,immune evasion mechanism
ENSG00000036473,OTC,genomic instability,oxidative damage,reactive oxygen species,metabolic reprogramming,tumor microenvironment modulation,dna mutation
ENSG00000129910,CDH15,cell adhesion regulation,tumor metastasis,epithelial-to-mesenchymal transition,cancer progression,cell migration modulation,cytoplasmic dynein interaction
ENSG00000204262,COL5A2,pro-tumorigenic extracellular matrix,tumor growth promotion,metastasis facilitation,biomarker potential,cell adhesion modulation,extracellular matrix degradation
ENSG00000003436,TFPI,angiogenesis modulation,cell signaling regulation,metastasis promotion,apoptosis inhibition,tumor progression driver,extracellular matrix remodeling
ENSG00000139610,CELA1,fatty acid metabolism alteration,lipid accumulation,oncogenic signaling,metabolic reprogramming,enzymatic activity dysregulation,cancer cell growth promotion
ENSG00000124159,MATN4,cell adhesion disruption,epithelial-to-mesenchymal transition,cell migration regulation,poor prognosis indicator,potential therapeutic target,biomarker upregulation
ENSG00000132031,MATN3,tumor progression,cell migration,metastasis,protein interaction,signaling pathway regulation,cell adhesion
ENSG00000108963,DPH1,tumor suppressor function,loss of heterozygosity,genomic instability,cell cycle regulation,transcriptional regulation,poor prognosis
ENSG00000004468,CD38,calcium signaling,adp-ribosyltransferase (art),second messenger,cell adhesion,enzyme dysregulation,tumor progression
ENSG00000127311,HELB,genomic instability,oncogene,rna processing regulation,cell proliferation enhancement,apoptosis suppression,protein-protein interaction
ENSG00000135074,ADAM19,wnt/β-catenin pathway,cell adhesion disruption,metastasis promotion,prognostic marker,tumor progression,adhesive molecule activation
ENSG00000172238,ATOH1,cellular differentiation regulation,tumor suppressor function,transcriptional regulation,loss-of-function mutations,epithelial cell integrity maintenance,reduced expression in tumors
ENSG00000101680,LAMA1,basement membrane structure,cellular adhesion,integrin interaction,laminin subunit assembly,metastatic suppression,tumor aggressiveness
ENSG00000242441,GTF2A1L,transcriptional regulation,chromatin remodeling,rna polymerase ii activity,gene expression modulation,cell proliferation pathways,tumor suppressor activity
ENSG00000113100,CDH9,cell-cell interaction,tumor progression,prognostic marker,overexpression,cancer metastasis,epithelial cell adhesion
ENSG00000223496,EXOSC6,exosome regulation,rna degradation,tumor progression,cell proliferation,genomic instability,dna repair mechanisms
ENSG00000146938,NLGN4X,cellular proliferation,tumor growth regulation,apoptosis regulation,dysregulated expression,oncogene potential,tumor suppressor interaction
ENSG00000211896,IGHG1,tumor microenvironment modulation,immune response regulation,immunoglobulin expression alteration,oncogenic potential association,tumor progression impact,adaptive immune response component
ENSG00000176406,RIMS2,oncogene activity,signaling pathway regulation,cell growth modulation,tumor suppressor function,synaptic plasticity regulation,neurotransmitter release control
ENSG00000073849,ST6GAL1,tumor progression,cell adhesion,immune evasion,surface antigen sialylation,metastatic potential,immunotherapeutic target
ENSG00000081138,CDH7,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression facilitation,oncogenic role,signaling pathway modulation,metastasis promotion
ENSG00000113361,CDH6,cell adhesion disruption,metastasis facilitation,tumor progression,oncogene potential,pi3k/akt pathway regulation,cell migration and invasion
ENSG00000023839,ABCC2,multidrug resistance,tumor progression,cellular transport,detoxification pathways,xenobiotic efflux,breast cancer resistance protein expression
ENSG00000185252,ZNF74,transcriptional regulation,zinc finger protein,krab domain-containing,cell cycle progression,apoptosis suppression,oncogenic activity
ENSG00000143196,DPT,tumor aggressiveness,cell proliferation regulation,prognostic biomarker,oncogenic properties,hypoxia adaptation,cancer metastasis promotion
ENSG00000198785,GRIN3A,nmda receptor function,cell migration and invasion,tumor growth and metastasis,apoptosis evasion,cell cycle regulation,therapeutic target
ENSG00000131183,SLC34A1,phosphate transport regulation,cellular proliferation,apoptosis inhibition,tumor aggressiveness,poor prognosis,cell cycle dysregulation
ENSG00000161513,FDXR,redox regulation,iron-sulfur cluster assembly,dna damage response,cell cycle modulation,apoptosis evasion,tumor aggressiveness
ENSG00000197467,COL13A1,cellular structure disruption,disrupted tissue architecture,basement membrane degradation,tumor progression,cell migration,genomic instability
ENSG00000122367,LDB3,chromatin remodeling,epithelial-to-mesenchymal transition (emt),glycolytic shift,oncogenic transcription factor,gene expression regulation,cell cycle progression
ENSG00000196371,FUT4,fucosylation,epithelial-to-mesenchymal transition,cell migration,angiogenesis,tumor progression,glycoprotein modification
ENSG00000142185,TRPM2,trp channel regulation,oncogenic signaling,reactive oxygen species production,cell proliferation enhancement,survival pathway modulation,protein kinase activation
ENSG00000164574,GALNT10,o-glcnac transferase activity,cellular signaling pathway modulation,post-translational modification regulation,tumor progression facilitation,therapeutic target identification,protein modification influence
ENSG00000087237,CETP,cancer metastasis,lipid metabolism regulation,cell membrane composition,tumor progression,oncogenic role,lipoprotein exchange
ENSG00000205916,DAZ4,oncogenic overexpression,regulation of cell proliferation,dysregulation of dna repair,enhanced genomic instability,overexpression in tumor tissues,therapeutic target
ENSG00000112234,FBXL4,fbxl4 ubiquitination,pi3k/akt signaling regulation,tumor suppressor function,cell proliferation regulation,genomic instability,apoptosis impairment
ENSG00000040731,CDH10,loss of cell-cell adhesion,tumor suppressor function,altered expression profiles,cellular migration and invasion,poor prognosis,signaling pathway regulation
ENSG00000167642,SPINT2,tumor suppressor,loss of function mutations,cell migration and invasion,protease inhibition regulation,egf receptor interaction,tgf-β pathway modulation
ENSG00000114270,COL7A1,cellular migration,epithelial-mesenchymal transition,anchoring fibril disruption,tumor progression,metastasis facilitation,loss of function mutation
ENSG00000148702,HABP2,cell cycle regulation,epigenetic regulation,tumor progression,apoptosis evasion,metastasis promotion,signaling pathway modulation
ENSG00000134760,DSG1,cell-to-cell adhesion disruption,cell polarity loss,prognostic biomarker,cell migration regulation,pkcζ interaction,β-catenin complex formation
ENSG00000099769,IGFALS,igf-i regulation,tumor progression,angiogenesis promotion,metastasis enhancement,prognostic marker,cell growth stimulation
ENSG00000186340,THBS2,tumor-promoting signaling pathways,angiogenesis regulation,cellular migration,proteolytic activity modulation,extracellular matrix interaction,growth factor binding
ENSG00000010818,HIVEP2,gene expression regulation,tumor progression,immune response suppression,cell proliferation enhancement,survival pathway activation,transcription factor activity
ENSG00000159496,RGL4,tumor suppressor,cell cycle regulation,apoptosis promotion,dna repair modulation,cancer biomarker potential,tumor growth inhibition
ENSG00000100060,MFNG,notch signaling pathway,aberrant activation,amplification or mutation,cell proliferation and survival,tumor progression,biomarker potential
ENSG00000106003,LFNG,tumor progression,cell migration,extracellular matrix modulation,signaling pathway regulation,glycosyltransferase activity,cell adhesion
ENSG00000130988,RGN,pi3k/akt signaling,genomic instability,tumor progression,cell proliferation,cell migration,signaling pathway activation
,FAM57A,altered expression,apoptosis regulation,cancer susceptibility,cell proliferation regulation,gene amplification,potential oncogene
ENSG00000010072,SPRTN,genomic instability,tumor suppressor,cellular dna replication,oncogenesis,genomic integrity maintenance,loss-of-function mutation
ENSG00000182240,BACE2,oncogene,notch signaling,angiogenesis regulation,anti-apoptotic function,cell growth promotion,tumor progression
ENSG00000111785,RIC8B,gef function,ras/mapk pathway modulation,g protein signaling regulation,cell proliferation enhancement,tumor growth facilitation,oncogenic potential demonstration
ENSG00000103495,MAZ,transcriptional regulation,tumor promotion,angiogenesis modulation,cell proliferation,coactivator function,biomarker potential
ENSG00000149575,SCN2B,ion channel regulation,cellular proliferation,tumor progression,prognostic biomarker,neuronal excitability,electrical signaling
ENSG00000166947,EPB42,cytoplasmic actin binding,oncogenic potential,cell migration regulation,tumor metastasis,biomarker potential,prognostic indicator
ENSG00000120903,CHRNA2,cancer progression,tumor aggressiveness,oncogenic signaling,upregulated expression,cell proliferation,metastasis
ENSG00000221946,FXYD7,ion channel regulation,cellular proliferation,prognostic marker,tumor aggressiveness,epithelial cell survival,renal cancer development
ENSG00000282049,PRSS2,genomic instability,oncogenic activation,tumor progression,cell proliferation,serine protease activity,cancer driver gene
ENSG00000196526,AFAP1,afap1 overexpression,cell migration,cell invasion,microtubule dynamics,oncogenic protein interaction,tumor progression
ENSG00000197614,MFAP5,microfibril-associated protein,extracellular matrix regulation,epithelial-to-mesenchymal transition (emt),growth factor signaling modulation,metastasis promotion,prognostic marker
ENSG00000058085,LAMC2,cell adhesion disruption,metastasis promotion,tumor progression association,poor prognosis marker,signaling pathway interaction,basement membrane component
ENSG00000048028,USP28,**

1. **tumor progression**,2. **oncoprotein stabilization**,3. **deubiquitinating enzyme activity**,4. **pi3k/akt signaling pathway regulation**,5. **protein stability modulation**,6. **cellular proliferation enhancement**.

**
ENSG00000126746,ZNF384,transcription factor activation,cell proliferation,dna binding,oncogene function,epigenetic regulation,tumor aggressiveness
ENSG00000177103,DSCAML1,immune evasion,tumor immunomodulation,cell adhesion molecules,antigen presentation,immune cell recruitment,cancer immune therapy
ENSG00000116962,NID1,chromatin remodeling,aberrant expression,tumor progression,cell proliferation,genomic instability,apoptosis resistance
ENSG00000146276,GABRR1,overexpression,cell proliferation,survival promotion,tumor progression,promoter activation,signaling pathway regulation
ENSG00000186583,SPATC1,cell cycle regulation,dna replication initiation,gain-of-function mutations,oncogenic transformation,protein-protein interactions,tumor progression
ENSG00000204084,INPP5B,cell proliferation,tumor progression,genomic instability,phosphoinositide regulation,akt/mtor pathway interaction,oncogenic drivers
ENSG00000108830,RND2,epithelial-to-mesenchymal transition,cell migration,microtubule stability,protein-protein interaction,cancer cell motility,oncogenic processes
ENSG00000042832,TG,iron transport,cell growth regulation,cellular proliferation,metabolic regulation,protein-protein interaction,signal transduction pathway
ENSG00000107789,MINPP1,mapk signaling pathway activation,oncogene function,dual specificity phosphatase activity,cell proliferation regulation,protein kinase activation,tumor progression promotion
ENSG00000277445,CPEB1,**
cell cycle regulation,post-transcriptional regulation,tumor growth promotion,oncogene overexpression,cell survival enhancement,microrna regulation 
**
ENSG00000197375,SLC22A5,regulation of drug resistance,transport mechanism alteration,cellular transport regulation,tumor growth modulation,apoptosis evasion,genomic instability
ENSG00000197208,SLC22A4,multidrug resistance,drug transport,organic cation transport,xenobiotic accumulation,nucleoside analog transport,poor prognosis association
ENSG00000084453,SLCO1A2,transporter function,chemotherapy resistance,multidrug resistance,cellular homeostasis,detoxification processes,tumor progression
ENSG00000064205,CCN5,cell proliferation,genomic instability,therapeutic target,tumor progression,signaling pathway modulation,immune response regulation
ENSG00000160349,LCN1,hypoxia response,iron regulation,tumor progression,multifunctional protein,immune modulation,poor prognosis marker
ENSG00000090382,LYZ,tumor microenvironment,cell invasion,metastasis promotion,extracellular matrix degradation,tumor progression,immune evasion
ENSG00000100031,GGT1,redox regulation,dna damage response,cellular proliferation,oxidative stress resistance,apoptosis evasion,genomic instability
ENSG00000077984,CST7,proteolytic regulation,cathepsin l processing,antigen presentation,lysosomal function,apoptosis modulation,cell signaling
ENSG00000196104,SPOCK3,epithelial-to-mesenchymal transition (emt),extracellular matrix regulation,cell adhesion and migration,angiogenesis modulation,fibrosis and angiogenesis,prognostic biomarker
ENSG00000107742,SPOCK2,tumor progression,ecm remodeling,cell invasion,aggressive behavior,proteolytic activity,signaling pathway modulation
ENSG00000160963,COL26A1,cellular adhesion disruption,loss of heterozygosity,invasion promotion,metastasis facilitation,tumor progression contribution,epithelial cell differentiation regulation
ENSG00000186998,EMID1,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis modulation,tumor aggressiveness,therapeutic target
ENSG00000126562,WNK4,ion channel regulation,tumor suppressor function,cell polarity disruption,hippo pathway activation,yap/taz regulation,loss-of-function mutations
ENSG00000070915,SLC12A3,ion transport regulation,tumor aggressiveness,cell signaling modulation,epithelial-to-mesenchymal transition,cellular stress response,kidney function disruption
ENSG00000050438,SLC4A8,electrolyte balance,tissue-specific expression,cellular ion regulation,dysregulation of metabolism,functional dysplasia,proliferative disorder
ENSG00000109861,CTSC,tumor metastasis,immunosuppression,cancer cell invasion,lysosomal function,molecular regulation,proteolytic activity
ENSG00000115386,REG1A,oncogenic activity,promotes tumor growth,cell proliferation regulation,apoptosis inhibition,signaling pathway activation,transcriptional regulation
ENSG00000172016,REG3A,cell proliferation,tumor progression,therapeutic target,cellular differentiation,oncogenic properties,metastasis
ENSG00000179403,VWA1,tumor progression,cell adhesion,integrin binding,growth factor regulation,metastasis promotion,poor prognosis
ENSG00000148926,ADM,hypotensive effects,vasodilatory actions,cell growth promotion,metastasis enhancement,angiogenesis modulation,biomarker potential
ENSG00000078401,EDN1,endothelin-1,angiogenesis promotion,vasoconstriction regulation,cellular proliferation,signaling cascade activation,tumor microenvironment modulation
ENSG00000173171,MTX1,proteolysis,invasion,metastasis,poor prognosis,dysregulation,signaling pathways
ENSG00000145730,PAM,coenzyme a biosynthesis,gene overexpression,metabolic regulation,proliferation promotion,protein kinase activation,therapeutic target
ENSG00000121236,TRIM6,e3 ubiquitin ligase activity,pi3k/akt pathway regulation,tumor suppressor function,oncogenic processes,cell growth regulation,poor prognosis marker
ENSG00000125834,STK35,genomic instability,loss-of-function mutations,tumor suppressor role,cell proliferation,apoptosis regulation,metabolic regulation
ENSG00000104415,CCN4,angiogenesis promotion,immune evasion mechanisms,tumor progression factor,cell adhesion regulator,integrin interaction,metastasis facilitation
ENSG00000142156,COL6A1,col6 network regulation,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,angiogenesis promotion,extracellular matrix remodeling,pro-angiogenic factor upregulation
ENSG00000162510,MATN1,extracellular matrix regulation,tumor progression,cell invasion and migration,epithelial-to-mesenchymal transition (emt),prognostic marker,gene expression alteration
ENSG00000030304,MUSK,tumor suppressor function,cell signaling pathway modulation,apoptosis regulation,cell cycle control,gene expression alterations,mutational hotspot
ENSG00000170498,KISS1,tumor progression,oncogenic process,prognostic biomarker,cellular interaction,reproductive function disruption,energy balance regulation
ENSG00000105880,DLX5,transcriptional regulation,tumor progression,cell proliferation,metastasis,invasion,overexpression
ENSG00000128872,TMOD2,microtubule regulation,oncogene activation,tumor growth promotion,metastasis facilitation,therapeutic target identification,genomic biomarker
ENSG00000171199,OPRPN,opioid signaling pathway,tumor progression,cell migration regulation,cancer biomarker,overexpression in cancer,prognostic marker
ENSG00000121552,CSTA,tumor progression,cell proliferation,apoptosis inhibition,biomarker potential,epigenetic regulation,prognostic indicator
ENSG00000140465,CYP1A1,cellular proliferation,genetic instability,chemotherapy resistance,protein binding,enzymatic activity,inducible expression
ENSG00000171533,MAP6,microtubule regulation,promotes cell proliferation,microtubule stability,cell division abnormality,chromosomal instability,protein-protein interaction
ENSG00000145864,GABRB2,gaba receptor regulation,cellular proliferation,apoptosis regulation,protein-protein interactions,downregulated expression levels,neurotransmitter modulation
ENSG00000115993,TRAK2,pi3k/akt signaling pathway interaction,gain of function mutations,cell proliferation regulation,tumor progression promotion,endocytosis regulation,cell polarity maintenance
ENSG00000182256,GABRG3,gaba receptor function disruption,cell survival enhancement,tumor progression facilitation,apoptosis evasion,signaling pathway modulation,neurotransmission dysregulation
ENSG00000131089,ARHGEF9,rhoa activation,guanine nucleotide exchange factor,tumor suppressor regulation,oncogenic signaling pathway,cell migration and invasion,poor prognosis marker
ENSG00000187955,COL14A1,cellular adhesion,extracellular matrix regulation,mutation associated,prognostic marker,tumor progression,overexpression of
ENSG00000196767,POU3F4,transcriptional regulation,apoptosis inhibition,cell proliferation enhancement,metastasis promotion,tumor progression driver,protein-protein interaction
ENSG00000157152,SYN2,cell survival,oncogenesis,synaptic vesicle fusion,therapeutic target,tumor progression,protein interaction
ENSG00000185666,SYN3,cell proliferation,protein interaction,pi3k/akt pathway,cell migration,epigenetic regulation,dna methylation
ENSG00000159197,KCNE2,ion channel regulation,tumor progression,cell survival,oncogene,apoptosis modulation,angiogenesis promotion
ENSG00000188783,PRELP,cell adhesion regulation,metastasis promotion,extracellular matrix interaction,growth factor receptor modulation,oncogenic signaling pathway activation,tumor progression facilitation
ENSG00000151704,KCNJ1,ion channel dysfunction,cell proliferation,tumor progression,electrolyte imbalance,oncogenic signaling,epigenetic regulation
ENSG00000054967,RELT,angiogenesis promotion,cancer cell migration,neurodevelopmental disorder association,tumor progression enhancement,cell signaling regulation,metastasis facilitation
ENSG00000198502,HLA-DRB5,tumor immunoevasion,immune dysfunction,class ii mhc antigen presentation,impaired antigen processing,immune suppression,prognostic marker
ENSG00000167635,ZNF146,transcriptional regulation,gene expression modulation,tumor progression driver,cell cycle control,dna repair pathways,apoptosis modulation
ENSG00000080573,COL5A3,cellular proliferation,tumor progression,extracellular matrix regulation,genomic instability,therapeutic target,tissue invasion
ENSG00000109471,IL2,immune response modulation,t cell activation,proliferation and differentiation,anti-tumor immune responses,cancer progression promotion,immune microenvironment regulation
ENSG00000087494,PTHLH,tumor progression,cell proliferation,oncogene,cell migration,signaling pathway activation,wnt/β-catenin interaction
ENSG00000027644,INSRR,insulin-like growth factor signaling,cell proliferation enhancement,tumor development facilitation,metabolic regulation modification,cancer driver gene association,cell survival pathway activation
ENSG00000132692,BCAN,emt-related,apoptosis inhibition,genomic instability,cell cycle dysregulation,protein-protein interactions,signal transduction activation
ENSG00000263290,SCAMP3,pi3k/akt pathway,cell growth regulation,metastasis modulation,protein-protein interaction,apoptosis regulation,angiogenesis involvement
ENSG00000171209,CSN3,genomic instability,cancer driver gene,protein degradation pathway,cell cycle checkpoint control,tumor suppressor activity,oncogenic signaling pathway
ENSG00000169676,DRD5,g protein-coupled receptor activation,overexpression in cancer,cell proliferation promotion,tumor progression,signal transduction modulation,angiogenesis regulation
ENSG00000099866,MADCAM1,tumor progression,angiogenesis,lymphangiogenesis,immune evasion,metastasis promotion,cell adhesion molecule function
ENSG00000261701,HPR,**

cellular regulation,tumor progression,metastasis promotion,cell adhesion modulation,oncogenic processes,protein-protein interactions 

**
ENSG00000088320,REM1,receptor tyrosine kinase activity,cell proliferation regulation,plasma membrane localization,ligand interaction,upregulated expression,tumorigenesis involvement
ENSG00000143590,EFNA3,tumor promotion,epithelial-to-mesenchymal transition,resistance to therapy,cell migration and invasion,poor prognosis biomarker,anti-angiogenic resistance
ENSG00000159640,ACE,tumor angiogenesis,immunosuppressive microenvironment,angiogenic factor,poor prognosis,renin-angiotensin system regulation,immune evasion
ENSG00000120708,TGFBI,extracellular matrix remodeling,cell adhesion disruption,tumor progression facilitation,cell migration promotion,oncogenic property association,signaling pathway regulation
ENSG00000163141,BNIPL,microtubule regulation,cell cycle progression,tumor suppressor function,genetic instability,therapeutic target,cancer progression
ENSG00000104537,ANXA13,epithelial-to-mesenchymal transition,overexpression,cell migration,actin cytoskeleton regulation,chemotherapy resistance,apoptosis evasion
ENSG00000175564,UCP3,mitochondrial function regulation,energy metabolism alteration,tumor growth enhancement,metabolic reprogramming,oxidative stress modulation,therapeutic target
,C1orf61,trim family protein,regulation of p53 pathway,cell proliferation enhancement,tumor suppressor modulation,oncogene activation,genomic instability
ENSG00000041982,TNC,angiogenesis,cell adhesion,cell migration,extracellular matrix interaction,glycoprotein expression,tumor microenvironment modulation
ENSG00000164588,HCN1,hcn channel regulation,cell proliferation,tumor progression,ion channel function,signaling pathway modulation,cell migration
ENSG00000123066,MED13L,tumor progression,cancer driver,cell proliferation,gene transcription regulation,chromatin remodeling,transcriptional activation
ENSG00000176909,MAMSTR,mitotic spindle assembly,tumor suppressor activity,genomic instability,aneuploidy induction,protein-protein interaction,cell cycle regulation
ENSG00000187688,TRPV2,oncogenesis,cellular stress response,gene expression regulation,ca2+ influx modulation,signaling pathway interaction,tumor progression
ENSG00000196689,TRPV1,tumor progression,cell proliferation,oncogenic process,tumor microenvironment modulation,angiogenesis facilitation,immune evasion mechanism
ENSG00000164117,FBXO8,protein degradation,cell cycle regulation,oncogenesis,apoptosis regulation,tumor progression,potential biomarker
ENSG00000141665,FBXO15,f-box protein regulation,apoptosis pathway regulation,cell cycle checkpoint control,tumor suppressor interaction,cancer progression mechanism,therapeutic target for cancer
ENSG00000147255,IGSF1,cell adhesion,protein interaction,tumor growth,metastasis,poor prognosis,integrin regulation
ENSG00000156671,SAMD8,ubiquitin proteasome pathway,protein degradation regulation,tumor suppressor modulation,cell growth promotion,deubiquitinating enzyme activity,cancer mutation association
ENSG00000206073,SERPINB4,tumor suppression,protease inhibition,cathepsin b regulation,cellular stress response,inflammation modulation,oncogene modulator
ENSG00000163131,CTSS,tumor progression,protein degradation,cell signaling,extracellular matrix degradation,metastasis promotion,lysosomal function
ENSG00000126838,PZP,cell adhesion disruption,pi3k/akt pathway regulation,tumor growth promotion,angiogenesis facilitation,cell migration enhancement,gene expression modulation
ENSG00000182742,HOXB4,homeobox transcription factor,overexpressed in tumors,tumor progression,cell proliferation regulation,dysregulated expression,poor prognosis biomarker
ENSG00000285121,MTCH2,mitochondrial dynamics,glycolytic metabolism,warburg effect,apoptosis regulation,mitochondrial biogenesis inhibition,tumor progression driver
ENSG00000272398,CD24,tumor progression,cell adhesion disruption,apoptosis inhibition,metastasis promotion,angiogenesis facilitation,cancer stem cell enrichment
ENSG00000177879,AP3S1,ap-3 complex,cellular trafficking,gene expression regulation,immune response modulation,mutations driving oncogenesis,protein sorting disruption
ENSG00000105376,ICAM5,cell adhesion,epithelial-to-mesenchymal transition (emt),immune response modulation,metastasis regulation,neurological signaling,pi3k/akt pathway interaction
ENSG00000112280,COL9A1,cell adhesion disruption,collagen degradation,extracellular matrix remodeling,tumor invasion facilitation,type ix collagen regulation,cell migration promotion
ENSG00000160013,PTGIR,angiogenesis promotion,tumor microenvironment modulation,protein-protein interaction,cell proliferation enhancement,metastasis facilitation,oncogene overexpression
ENSG00000276613,MUC4,aberrant glycosylation,cell proliferation,glycoprotein function,initiation and maintenance,oncogenic processes,signaling pathway modulation
ENSG00000073754,CD5L,apoptosis regulation,immune modulation,tumor microenvironment modification,cancer progression association,mitochondrial outer membrane permeabilization regulation,cellular proliferation influence
ENSG00000136381,IREB2,tumorigenesis,regulation of iron homeostasis,cell cycle regulation,mutation and overexpression,prognostic biomarker,interaction with cdks and other proteins
ENSG00000178473,UCN3,energy metabolism regulation,mapk/erk signaling activation,tumor progression enhancement,cell proliferation promotion,prognostic biomarker status,cancer cell migration facilitation
ENSG00000198252,STYX,chromatin remodeling,epigenetic regulation,histone modification,genomic instability,dna damage response,tumor suppressor regulation
ENSG00000126759,CFP,tumor growth regulation,cell proliferation enhancement,calcium signaling regulation,pi3k/akt pathway interaction,gene expression modulation,therapeutic target
ENSG00000082258,CCNT2,proliferation regulation,oncogene activation,cell cycle progression,transcriptional activation,therapeutic target,genomic instability
ENSG00000169131,ZNF354A,tumor suppressor function,pi3k/akt pathway regulation,cell proliferation inhibition,dna damage response regulation,chromatin modification interaction,oncogene potential
ENSG00000134765,DSC1,loss of adhesion,tumor progression,cell migration,cell signaling modulation,dysregulation in tumors,tissue architecture disruption
ENSG00000138769,CDKL2,cell cycle regulation,cell proliferation,oncogene activation,tumor progression,cell growth enhancement,genomic amplification
ENSG00000116353,MECR,mitochondrial dna translation regulation,apoptosis evasion,oncogenic driver potential,cell cycle dysregulation,therapeutic resistance induction,energy metabolism alterations
ENSG00000152208,GRID2,calcium channel regulation,tumor suppressor function,ion channel dysregulation,cell signaling pathways,cancer cell growth,neurotransmitter release modulation
ENSG00000105929,ATP6V0A4,cellular ph regulation,metabolic reprogramming,proton pumping,cancer metastasis,oncogenic signaling,cell membrane interaction
ENSG00000105825,TFPI2,cell invasion,tumor aggressiveness,metastasis promotion,biomarker,oncogenic properties,apoptosis evasion
ENSG00000187848,P2RX2,oncogenic signaling,cell proliferation,gene expression regulation,tumor progression,calcium influx signaling,ligand-gated ion channel
ENSG00000179142,CYP11B2,oncogene,tumor progression,metabolic regulation,cell survival,angiogenesis promotion,therapeutic target
ENSG00000241484,ARHGAP8,rho gtpase regulation,tumor progression,cell invasion,metastasis promotion,cytoskeleton remodeling,cell polarity disruption
ENSG00000100234,TIMP3,tumor suppressor function,mmp inhibition,cell adhesion regulation,apoptosis induction,integrin modulation,growth factor interaction
ENSG00000116183,PAPPA2,igf signaling pathway disruption,metastasis promoter,tumor progression,cell growth regulation,protein degradation,poor prognosis indicator
ENSG00000117122,MFAP2,mfap2 upregulation,tumor progression,angiogenesis promotion,immune evasion,cell migration facilitation,ecm assembly regulation
ENSG00000166402,TUB,microtubule stability,genomic instability,cell proliferation,tumor aggressiveness,metastasis promotion,chemotherapy resistance
ENSG00000182752,PAPPA,igf-i regulation,cell proliferation,tumor progression,insulin-like growth factor binding protein-4,pregnancy-associated plasma protein a proteolysis,cancer prognosis
ENSG00000169213,RAB3B,rab3b overexpression,tumor progression,cell migration and invasion,epithelial-to-mesenchymal transition (emt),signaling pathway regulation,oncoprotein interaction
ENSG00000280706,REXO4,mirna regulation,tumor suppressor function,cellular proliferation,apoptosis regulation,gene expression dysregulation,rna processing
ENSG00000116117,PARD3B,disruption of cell polarity,loss of epithelial characteristics,tumor progression,promoter of metastasis,signaling pathway activation,cell adhesion regulation
ENSG00000144355,DLX1,cell proliferation enhancement,tumor progression facilitation,transcriptional regulation,signaling pathway modulation,apoptosis inhibition,genomic instability promotion
ENSG00000103811,CTSH,chromatin remodeling,tumor suppressor function,cell proliferation enhancement,metastasis promotion,dna damage response disruption,apoptosis inhibition
ENSG00000168539,CHRM1,oncogenic signaling,g protein-coupled receptor activation,cell proliferation regulation,immune evasion modulation,tumor microenvironment influence,phosphorylation-dependent pathway activation
ENSG00000185668,POU3F1,transcriptional regulator,oncogene function,tumor progression driver,cell cycle regulation,apoptosis evasion,epigenetic regulation
ENSG00000170430,MGMT,base excision repair,genomic stability,dna repair,o6-methylguanine-dna methyltransferase,chemosensitivity,epigenetic regulation
ENSG00000111783,RFX4,characteristic words,none,none,none,none,none
ENSG00000105695,MAG,cell adhesion,oncogene activation,integrin interaction,pi3k/akt pathway modulation,emt regulation,glycoprotein function
ENSG00000138496,PARP9,parp pathway,loss of function mutations,genomic instability,tumor progression,dna repair dysfunction,chromosomal abnormalities
ENSG00000112599,GUCA1B,oncogenic process,cellular proliferation,genetic alteration,cyclic gmp regulation,smooth muscle relaxation,gene expression regulation
ENSG00000203668,CHML,immune regulation,tumor suppression,cancer immunity,protein-protein interaction,cell surface molecule,downregulation in cancer
ENSG00000108961,RANGRF,ran gtpase regulation,cell proliferation,oncogene function,cell cycle modulation,nucleocytoplasmic transport,therapeutic target
ENSG00000166816,LDHD,metabolic reprogramming,oncogenic signaling,tumor progression,energy production,redox balance,cellular growth
ENSG00000100979,PLTP,pi3k/akt signaling pathway modulation,oncogene activity,tumor aggressiveness promotion,cell proliferation regulation,metabolic reprogramming,protein-protein interaction enhancement
ENSG00000141086,CTRL,genomic instability,cell proliferation,microtubule organization,centriole duplication,oncogenic process,tumorigenesis
ENSG00000105371,ICAM4,adhesion molecule function,tumor progression,metastatic potential,cell migration regulation,extracellular matrix interaction,oncogenic upregulation
ENSG00000213918,DNASE1,dna repair mechanisms,dysregulation of,genomic instability,cell proliferation,apoptosis modulation,lysosomal function
ENSG00000187244,BCAM,upregulation,tumor progression,metastasis,cell migration,epithelial-to-mesenchymal transition (emt),adhesion molecule function
ENSG00000135622,SEMA4F,tumor suppressor function,cell adhesion regulation,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition (emt) modulation,tumor microenvironment alteration,prognostic biomarker potential
ENSG00000174611,KY,nk cell activation,tumor immune evasion,immune surveillance,pseudogene,hla class i interaction,cancer immunity modulation
ENSG00000274619,CFD,complement system regulation,immune modulation,tumor progression,angiogenesis promotion,cell survival impact,genetic variability
ENSG00000185313,SCN10A,neural signaling,regulatory pathway,pain modulation,tumor progression,immune evasion,cancer stem cell regulation
ENSG00000155897,ADCY8,tumor growth,cell proliferation,energy metabolism regulation,oncogenic pathway modulation,therapeutic target,camp signaling
ENSG00000072315,TRPC5,calcium channel function,oncogenic signaling pathway,cellular proliferation,aggressive tumor behavior,potential therapeutic target,overexpression in cancer
ENSG00000240771,ARHGEF25,rho gtpase activation,cell migration facilitation,invasive cell behavior promotion,tumor progression enhancement,therapeutic target identification,signaling pathway modulation
ENSG00000104880,ARHGEF18,rho gtpase regulation,constitutive activation,cell migration driver,metastasis promotion,prognostic marker,cancer cell invasion
ENSG00000145681,HAPLN1,heparan sulfate proteoglycan binding,cell adhesion regulation,tumor progression facilitation,cancer cell invasion modulation,signaling pathway regulation,extracellular matrix interactions
ENSG00000163888,CAMK2N2,calcium/calmodulin-dependent regulation,constitutive activation,neuronal excitability modulation,cell proliferation enhancement,genetic instability induction,signaling pathway dysregulation
ENSG00000168263,KCNV2,ion channel regulation,cell cycle progression,apoptosis modulation,angiogenesis promotion,prognostic biomarker,tumor growth facilitation
ENSG00000062598,ELMO2,cell migration,actin cytoskeleton reorganization,rac1 gtpase activation,tumor progression,metastasis promotion,biomarker potential
ENSG00000069424,KCNAB2,constitutive activation,akt signaling pathway,tumor progression,potassium channel regulation,cell proliferation,kvlqt1 interaction
ENSG00000169282,KCNAB1,voltage-gated potassium channel regulation,oncogenic transformation,ion channel activity modulation,cellular proliferation regulation,tumor progression association,genomic profiling alterations
ENSG00000170890,PLA2G1B,arachidonic acid release,pro-inflammatory eicosanoid production,tumor progression,cell proliferation enhancement,pi3k/akt pathway interaction,lipid metabolism regulation
ENSG00000173432,SAA1,acute phase response,angiogenesis promotion,cancer metastasis,cell proliferation regulation,immune evasion,inflammation promotion
ENSG00000137872,SEMA6D,pi3k/akt signaling,tumor suppressor gene,cell migration regulation,cytoskeletal dynamics modulation,metastasis promoter,plexinb2 interaction
ENSG00000114554,PLXNA1,overexpression,tumor progression,cell adhesion molecule,signaling pathway activation,metastatic potential,therapeutic target
ENSG00000118263,KLF7,tumor suppressor function,dna binding activity,cell proliferation inhibition,oncogenic pathway regulation,genomic stability maintenance,prognostic marker
ENSG00000123843,C4BPB,complement system regulation,cell surface modulation,inflammatory response,tumor progression,therapeutic target,protein interaction
ENSG00000005243,COPZ2,protein degradation regulation,cell cycle progression,ubiquitination regulation,tumorigenesis,poor prognosis marker,oncoprotein accumulation
ENSG00000131771,PPP1R1B,pp1 regulation,oncogenic signaling pathway,cell proliferation inhibition,apoptosis suppression,tumor suppressor function,regulatory subunit interaction
ENSG00000285456,LTB4R,ltb4 signaling pathway,tumor growth promotion,inflammation regulation,immune suppression,angiogenesis modulation,tumor microenvironment remodeling
ENSG00000198049,AVPR1B,overexpression in tumor,g-protein coupled receptor,cell proliferation,cell migration invasion,pi3k/akt pathway activation,oncogene role
ENSG00000165462,PHOX2A,transcription factor regulation,oncogenic processes,cellular differentiation,tumorigenesis involvement,therapeutic target potential,dysregulated expression
ENSG00000103145,HCFC1R1,transcriptional regulation,chromatin remodeling,cell proliferation,signaling pathway activation,apoptosis inhibition,epithelial-to-mesenchymal transition
ENSG00000196517,SLC6A9,neurotransmitter transport regulation,cancer progression,cell proliferation regulation,dysregulation in cancer,transcription factor interaction,gaba transport modulation
ENSG00000111886,GABRR2,disrupted cellular function,gene mutation,tumor progression,signaling pathway interaction,cell growth regulation,oncogenic involvement
ENSG00000188419,CHM,cellular signaling,gain of function mutations,tumor progression,oncogenesis,cell proliferation,therapeutic target
ENSG00000158985,CDC42SE2,rho gtpase activation,oncogenic processes,cytoskeletal dynamics,cell migration regulation,chemoresistance,tumor aggressiveness
ENSG00000137103,TMEM8B,calcium regulation,dysregulated expression,cell proliferation,tumor progression,signaling pathway modulation,cancer cell invasion
,GRASP,neurotransmitter regulation,synaptic plasticity modulation,protein-protein interaction,signal transduction regulation,cancer metastasis facilitation,gene expression modulation
ENSG00000186795,KCNK18,potassium channel regulation,cell proliferation,ion balance regulation,tumorigenic potential,metastatic marker,cancer associated protein
ENSG00000182771,GRID1,mitochondrial dynamics,apoptosis resistance,energy metabolism regulation,warburg effect association,tumor progression marker,prognostic biomarker
ENSG00000114646,CSPG5,....<end>:

<begin>
cell adhesion,wnt signaling pathway,epithelial-to-mesenchymal transition (emt),tumor progression,overexpression,poor prognosis
ENSG00000134184,GSTM1,genetic detoxification,reactive oxygen species,glutathione conjugation,tumor suppressor function,oxidative stress mitigation,dna damage accumulation
ENSG00000129214,SHBG,hormone regulation,tumor progression,sex hormone binding,protein transport,cell growth,overexpression
ENSG00000167749,KLK4,proteolytic activity,apoptosis inhibition,tumor invasion,angiogenesis promotion,cell proliferation enhancement,mmp activation
ENSG00000145526,CDH18,cdh18 downregulation,loss of cell-cell adhesion,wnt/β-catenin pathway interaction,tumor progression,poor prognosis,cellular proliferation
ENSG00000071991,CDH19,tumor suppressor,downregulated expression,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,increased cellular migration,signaling pathway regulation
ENSG00000063438,AHRR,xenobiotic metabolism regulation,transcriptional regulation,cellular stress response,tumor suppression,environmental toxin response,cancer progression inhibition
ENSG00000110697,PITPNM1,pi3k/akt pathway,signaling regulation,metabolic regulation,tumor progression,therapeutic target,cellular membrane dynamics
ENSG00000285346,CTRB1,immune modulation,complement system activation,disease susceptibility,kidney disorder association,tumor progression modulation,protein interaction
ENSG00000164418,GRIK2,glutamatergic signaling,oncogenic protein interaction,tumor progression,metastasis promotion,cell proliferation enhancement,therapeutic target
ENSG00000005421,PON1,lipid metabolism regulation,oxidative stress modulation,tumor suppressor function,cancer progression inhibition,lipid peroxidation prevention,antioxidant defense enhancement
ENSG00000134757,DSG3,cell adhesion disruption,emt regulation,pi3k/akt pathway activation,prognostic marker,tumor aggressiveness,biomarker for poor prognosis
ENSG00000141298,SSH2,genome instability,cell cycle progression,tumor suppressor function,dna damage response pathway,oncogenic process regulation,helicase activity
ENSG00000162461,SLC25A34,mitochondrial carrier protein,upregulated expression,enhanced energy metabolism,cell survival,therapeutic target,genomic profiling
ENSG00000175920,DOK7,rtk signaling pathway,oncogenic driver,protein-protein interaction,cell proliferation enhancement,apoptosis resistance,signal transduction mediator
ENSG00000124102,PI3,regulatory subunit,pi3k/akt pathway,tumor suppressor,cell proliferation,loss-of-function mutations,genomic stability
ENSG00000187682,ERAS,amplification,cell proliferation,signaling pathway modulation,tumor progression,therapeutic target,genomic profiling
ENSG00000113249,HAVCR1,**

immune evasion,tumor progression,apoptotic cell recognition,immunosuppression,prognostic biomarker,cell surface expression
ENSG00000154330,PGM5,glycogen metabolism,oncogene potential,warburg effect promotion,cell proliferation enhancement,therapeutic target,tumor growth facilitation
ENSG00000164816,DEFA5,antimicrobial activity,immune regulation,kidney epithelial protection,inflammation modulation,tumor growth inhibition,cancer metastasis suppression
ENSG00000171303,KCNK3,ion channel regulation,cell proliferation modulation,tumorigenesis involvement,ion homeostasis disruption,signaling pathway interaction,oxidative stress response modification
ENSG00000166035,LIPC,lipid metabolism regulation,tumor progression association,cell growth modulation,fatty acid synthesis regulation,protein-protein interaction regulation,subcellular localization dysregulation
ENSG00000150281,CTF1,genomic instability,dna replication regulation,tumor suppressor function,cell cycle progression,apoptosis regulation,transcriptional control
ENSG00000158815,FGF17,fgf signaling pathway,tumor progression,oncogenic processes,angiogenesis regulation,mapk/erk pathway interaction,therapeutic target
ENSG00000182871,COL18A1,prognostic biomarker,angiogenesis promotion,extracellular matrix disruption,tumor progression facilitation,vascular endothelial growth factor regulation,colagen xviii expression reduction
ENSG00000170502,NUDT9,dna replication regulation,genome instability,helicase activation modulation,oncogenesis association,rtel1 interaction,tumor suppressor function
ENSG00000154080,CHST9,wnt/beta-catenin pathway activation,cell proliferation enhancement,tumor progression promotion,cancer prognosis prediction,protein-protein interaction modulation,biosynthesis regulation
ENSG00000145777,TSLP,pro-inflammatory cytokine production,angiogenesis promotion,immune suppression modulation,oncogene activation,cancer cell invasion enhancement,tumor microenvironment regulation
ENSG00000054179,ENTPD2,purinergic signaling,tumor aggressiveness,poor prognosis,nucleotide degradation,cancer progression,cell proliferation
ENSG00000006652,IFRD1,tumor suppressor,cell growth regulation,antiviral defense,immune modulation,inflammation regulation,genomic stability maintenance
ENSG00000162747,FCGR3B,immunoregulation,tumor progression,immune evasion,dysregulation,therapeutic target,prognostic biomarker
ENSG00000112936,C7,colony-stimulating factor 7,oncogene,tumor progression,cell proliferation,angiogenesis,pro-survival signaling
ENSG00000169836,TACR3,cell proliferation,metastasis regulation,tumor growth,immune response modulation,signal transduction,inflammation
ENSG00000168056,LTBP3,tgf-β signaling,dysregulated expression,cell migration regulation,angiogenesis promotion,metastasis facilitation,extracellular matrix production
ENSG00000169385,RNASE2,regulation of tumor growth,modulation of signaling pathways,aberrant expression,immune evasion mechanisms,tumor progression biomarker,rna degradation activity
ENSG00000138435,CHRNA1,tumor progression,gene expression regulation,signaling pathway activation,cell proliferation,apoptosis modulation,oncogenic transformation
ENSG00000164619,BMPER,bmp receptor antagonist,tumor suppressor,cell proliferation regulation,angiogenesis inhibition,apoptosis promotion,metastasis modulation
ENSG00000014824,SLC30A9,cellular proliferation regulation,metabolic regulation,apoptosis modulation,genomic mutational hotspot,oncogenic pathway interaction,zinc homeostasis maintenance
ENSG00000124157,SEMG2,cytoplasmic accumulation,cell migration enhancement,cytoskeleton dysregulation,metastasis promotion,tumor progression driver,genomic amplification
ENSG00000146477,SLC22A3,drug resistance,cell proliferation,oncogene,multidrug resistance,energy metabolism,protein-protein interactions
ENSG00000154734,ADAMTS1,tumor suppression,cell adhesion modulation,pi3k/akt pathway regulation,angiogenesis inhibition,extracellular matrix interaction,biomarker potential
ENSG00000038295,TLL1,transcription factor function,tumor progression,oncogenic properties,constitutive activation,cell survival enhancement,gene expression modulation
ENSG00000111341,MGP,angiogenesis promotion,apoptosis inhibition,tumor growth regulation,metastasis facilitation,genetic interaction,mineralization regulation
ENSG00000163536,SERPINI1,cellular proliferation,tumor progression,apoptosis resistance,protease inhibition,pi3k/akt pathway interaction,genomic upregulation
ENSG00000095303,PTGS1,angiogenesis promotion,tumor growth modulation,inflammation regulation,immune response modulation,poor prognosis marker,therapeutic target
ENSG00000106031,HOXA13,tumor progression,tissue patterning regulation,gene expression regulation,apoptosis evasion,cell cycle progression,cancer metastasis
ENSG00000128714,HOXD13,cell growth regulation,tumorigenesis suppression,hox gene family,embryonic development,maintenance of cellular homeostasis,oncogenic activity
,MARCH4,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,protein degradation regulation,pi3k/akt pathway interaction,poor prognosis association
ENSG00000183696,UPP1,nucleotide metabolism,apoptosis regulation,mitochondrial function,cell growth control,oxidative stress response,dna repair regulation
ENSG00000118520,ARG1,oncogene activation,metabolic reprogramming,glutamine dependence,mtor suppression,cell proliferation enhancement,hif-1α interaction
ENSG00000155858,LSM11,aberrant splicing,snrnp component,tumor suppressor,rna processing regulation,spliceosome function,genetic instability
ENSG00000176020,AMIGO3,wnt/β-catenin pathway regulation,cell migration promotion,tumor growth facilitation,prognostic marker for disease severity,adhesion complex disruption,metastasis enhancement
ENSG00000127533,F2RL3,tumor cell growth,regulation of coagulation,receptor function,pro-tumorigenic microenvironment,angiogenesis,metastasis
ENSG00000171587,DSCAM,met pathway interaction,metastatic promoter,prognostic marker,oncogenic signaling,tumor progression,stem cell maintenance
ENSG00000184588,PDE4B,camp regulation,cell proliferation,cell survival,oncogenic signaling,transcription factor regulation,poor prognosis marker
ENSG00000169306,IL1RAPL1,nf-κb pathway activation,oncogene overexpression,angiogenesis promotion,metastasis enhancement,tumor growth regulation,immune modulation
ENSG00000163064,EN1,transcriptional regulation,cell proliferation regulation,developmental processes regulation,signaling cascade modulation,tumor progression involvement,cancer driver potential
ENSG00000135845,PIGC,glycosylphosphatidylinositol anchor biosynthesis,tumor suppressor function,apoptosis regulation,lipid metabolism regulation,cellular stress response modulation,dysregulated expression
ENSG00000102924,CBLN1,pi3k/akt pathway modulation,wnt/β-catenin signaling regulation,cell adhesion and migration regulation,tumor invasion and metastasis promotion,oncogene-tsg interaction,cancer cell proliferation enhancement
ENSG00000139899,CBLN3,overexpression,tumor progression,cell migration,extracellular matrix regulation,synaptic plasticity dysregulation,breast cancer metastasis
ENSG00000047457,CP,oxidative stress response,detoxification mechanism,endoplasmic reticulum localization,metabolic regulation,cellular proliferation,genetic alteration
ENSG00000110756,HPS5,autophagy regulation,lysosomal biogenesis,oncogenic processes,tumor microenvironment remodeling,therapeutic resistance,immune evasion
ENSG00000179862,CITED4,cellular proliferation,transcriptional regulation,oncogenesis,angiogenesis promoter,glucose metabolism regulator,tumor progression
ENSG00000175189,INHBC,igf-1 signaling pathway,overexpression,tumor growth promotion,poor prognosis,cell proliferation regulation,insulin-like growth factor binding protein interaction
ENSG00000185972,CCIN,cell cycle regulation,g2/m phase transition,tumor progression,cancer driver,protein degradation,scf complex interaction
ENSG00000184156,KCNQ3,voltage-gated potassium channel regulation,apoptosis resistance,glycolysis regulation,cellular proliferation enhancement,ion balance disruption,signaling pathway modulation
ENSG00000117013,KCNQ4,ion channel regulation,voltage-gated potassium channels,cellular excitability,electrical properties modulation,tumor growth influence,therapeutic target
ENSG00000126266,FFAR1,metabolic regulation,cell survival,hypoxia adaptation,g protein-coupled receptor signaling,tumor progression,therapeutic target
ENSG00000136816,TOR1B,mtorc1 regulation,cellular growth promotion,protein synthesis dysregulation,tumor progression driver,therapeutic target potential,kinase activation
ENSG00000168878,SFTPB,cell proliferation enhancement,overexpression,oncogenic process promotion,tumor progression,adhesion and survival mechanism promotion,potential biomarker
ENSG00000160613,PCSK7,golgi apparatus localization,tumor progression,metastasis promotion,cell survival enhancement,proprotein convertase activity,overexpression association
ENSG00000168065,SLC22A11,transport regulation,chemoresistance,tumor suppression,cell membrane localization,organic cation transporter,carcinogen uptake
ENSG00000001617,SEMA3F,cell migration,tumor suppressor function,angiogenesis inhibition,signaling pathway regulation,gene expression downregulation,protein-protein interaction
ENSG00000164889,SLC4A2,slc4a2 anion transport,ion homeostasis disruption,cellular metabolism dysregulation,tumor cell survival enhancement,protein-protein interaction alterations,therapeutic target potential
ENSG00000169902,TPST1,oncogenic function,tumor progression,cell signaling regulation,protein modification,therapeutic target,genomic overexpression
ENSG00000174600,CMKLR1,tumor microenvironment manipulation,chemokine binding,immune response modulation,cell migration promotion,metastasis facilitation,prognostic biomarker potential
ENSG00000128294,TPST2,hif1a transcriptional regulation,redox balance modulation,cellular invasion promotion,apoptosis suppression,glycolysis enhancement,type ii transsulfuratase activity
ENSG00000156103,MMP16,gelatinolytic activity,tumor progression,cell invasion,metastasis facilitation,protein interaction,signaling pathway regulation
ENSG00000143669,LYST,autophagy regulation,tumor growth promotion,lysosomal dysfunction,pi3k/akt pathway interaction,cancer driver mutation,cellular signaling regulation
ENSG00000254550,OMP,oncogenic regulation,tumor suppressor modulation,poor prognosis marker,cellular proliferation regulation,apoptosis resistance,transcriptional control
ENSG00000175336,APOF,lipid metabolism regulation,cellular proliferation promotion,apoptosis resistance enhancement,angiogenesis promotion,cell survival pathway regulation,tumor progression facilitation
ENSG00000282291,SLC39A11,metal ion transport,tumor progression,cellular redox balance,dna repair mechanisms,signaling pathway regulation,angiogenesis modulation
ENSG00000276858,FCAR,lectin pathway activation,immune regulation,innate immunity modulation,complement activation,ficolin interaction,autoimmune associations
ENSG00000278533,OSCAR,rhoa gtpase pathway activation,sialylated glycopeptide cleavage,cell surface receptor regulation,tumor aggressiveness modulation,growth factor receptor signaling,protein-protein interaction
ENSG00000160882,CYP11B1,tumor growth promotion,metastatic potential enhancement,steroid hormone biosynthesis regulation,apoptosis modulation,cell cycle progression regulation,emt induction
ENSG00000119669,IRF2BPL,tumor suppressor inhibition,cell cycle regulation,apoptosis suppression,p53 interaction,oncogene activation,genomic instability
ENSG00000151164,RAD9B,dna damage response,genomic instability,homologous recombination,tumor suppression,cell cycle checkpoint activation,hrr facilitation
,CARS,angiogenesis induction,oxidative stress promotion,metabolic regulation disruption,tumor progression facilitation,cell proliferation enhancement,proteostatic imbalance
ENSG00000166206,GABRB3,tumor progression,cellular modulation,proliferation regulation,signaling pathway alterations,dysregulation,genetic alterations
ENSG00000203722,RAET1G,tumor promotion,immune response regulation,cell proliferation enhancement,apoptosis inhibition,tumor microenvironment modulation,protein interaction regulation
ENSG00000111981,ULBP1,immune evasion,nk-cell inhibition,cell surface protein,tumor progression,immune modulation,poor prognosis
ENSG00000077327,SPAG6,dynein complex activation,ciliogenesis disruption,oncogenic signaling pathway,cell proliferation enhancement,prognostic biomarker candidate,apoptosis suppression
ENSG00000125910,S1PR4,sphingolipid signaling pathway,constitutive activation,cell migration,oncogenic signaling,tumor progression,therapeutic target
ENSG00000148154,UGCG,n-glycan biosynthesis,cell metabolism regulation,tumor progression,metastasis promotion,glucose utilization,glycoprotein synthesis
ENSG00000083807,SLC27A5,fatty acid metabolism,cell survival,protein-protein interaction,lipid signaling pathway,cancer cell proliferation,tumor progression
ENSG00000121743,GJA3,gap junction communication,oncogenesis,tumor suppression,cell cycle regulation,pi3k/akt pathway interaction,chemotherapy resistance
ENSG00000119888,EPCAM,loss of cell adhesion,enhanced cell motility,regulation of wnt/β-catenin signaling,tumor progression,cancer stem cell maintenance,epithelial-to-mesenchymal transition
ENSG00000121764,HCRTR1,hormone receptor function,tumor angiogenesis,cell proliferation regulation,oncogenic signaling pathway,vegf signaling activation,therapeutic target identification
ENSG00000111537,IFNG,immune evasion,tumor progression,cytokine signaling,genetic silencing,pro-inflammatory response,anti-tumor effects
ENSG00000099953,MMP11,tumor progression,extracellular matrix degradation,angiogenesis regulation,proteolytic cascade activation,metastasis promotion,cancer aggressiveness
ENSG00000163431,LMOD1,lmod1 overexpression,constitutive activation,cell proliferation,transcription factor activity,tumor progression,emt regulation
ENSG00000143162,CREG1,hypoxia-inducible gene expression,angiogenesis,cell proliferation,tumor progression,metastasis,vascular endothelial growth factor interaction
ENSG00000196878,LAMB3,laminin beta 3,cell adhesion disruption,basement membrane degradation,tumor invasion promotion,integrin interaction activation,cancer cell migration facilitation
ENSG00000163794,UCN,protein regulation,cell growth promotion,apoptosis resistance,tumor progression,metastasis enhancement,therapeutic target
ENSG00000125966,MMP24,tumor progression,extracellular matrix degradation,metastasis promotion,angiogenesis facilitation,transcriptional regulation,proteolytic activity enhancement
ENSG00000106086,PLEKHA8,pi3k/akt pathway activation,cell adhesion dysregulation,gain of function mutations,tumor progression correlation,therapeutic target,genomic overexpression
ENSG00000115159,GPD2,glycerol-3-phosphate dehydrogenase,redox balance,metabolic reprogramming,oncogene potential,antioxidant defense,cellular proliferation
ENSG00000162437,RAVER2,alternative pre-mrna splicing,cell proliferation,apoptosis inhibition,tumorigenesis driver,biomarker potential,gene amplification/mutation
ENSG00000160321,ZNF208,transcription factor regulation,cell cycle progression,apoptosis suppression,tumor promoter,genomic instability,overexpression
ENSG00000022355,GABRA1,gaba receptor dysfunction,cell proliferation regulation,tumor suppressor function,synaptic transmission modulation,apoptosis evasion,genomic instability
ENSG00000179546,HTR1D,cellular proliferation,constitutive activation,oncogene overexpression,tumor progression,angiogenesis promotion,apoptosis regulation
ENSG00000165215,CLDN3,tumor suppressor function,epithelial integrity disruption,paracellular transport dysregulation,cell adhesion impairment,metastasis facilitation,early detection biomarker
ENSG00000164284,GRPEL2,mitochondrial dysfunction,cellular stress response regulation,oxidative stress induction,cell survival enhancement,tumor progression contribution,genomic instability link
ENSG00000170367,CST5,chromatin remodeling,transcriptional regulation,oncogenic processes,tumor progression,cell proliferation,metastasis promotion
ENSG00000274542,CHRNA7,disrupted signaling pathways,downregulation in tumors,nicotinic acetylcholine receptor function,cell proliferation regulation,oncogenesis,apoptosis evasion
ENSG00000124570,SERPINB6,apoptosis inhibition,cell proliferation enhancement,oncogenic process promotion,poor prognosis marker,protein degradation regulation,tumor progression facilitation
ENSG00000050767,COL23A1,tumor progression,biomarker,cell adhesion and migration regulation,promotes cell growth and survival,tumor initiation and progression,altered expression levels
ENSG00000116996,ZP4,fertilization,cellular adhesion,epithelial-to-mesenchymal transition,tumor microenvironment alteration,cancer metastasis,potential therapeutic target
ENSG00000101246,ARFRP1,gtp-binding domain,oncogene overexpression,cell signaling disruption,vesicle transport regulation,apoptosis inhibition,cell cycle dysregulation
ENSG00000144278,GALNT13,oncogene function,wnt/beta-catenin pathway interaction,tumor progression marker,cell proliferation enhancement,glycosylation regulation,prognostic indicator
ENSG00000139574,NPFF,overexpression,pain modulation,stress response,oncogenic functions,cellular proliferation,survival and metastasis pathways
ENSG00000073711,PPP2R3A,pp2a regulation,pi3k/akt pathway interaction,tumor suppressor function,oncogenic potential,cell signaling modulation,genomic instability
ENSG00000139220,PPFIA2,cell adhesion regulation,tumor progression,metastasis promotion,cell migration enhancement,signaling pathway modulation,potential therapeutic target
ENSG00000196277,GRM7,cell proliferation,dysregulated expression,g-protein coupled receptor,metastasis promotion,oncogenic pathway activation,tumor progression
ENSG00000124493,GRM4,constitutive activation,gain of function mutations,oncogenic driver,pi3k/akt pathway,tumor progression,therapeutic target
ENSG00000113262,GRM6,glutamate signaling,tumor progression,oncogenic processes,cell proliferation,therapeutic target,signaling pathway modulation
ENSG00000185974,GRK1,gpcr signaling pathway regulation,oncogene activation,tumor progression facilitation,apoptosis dysregulation,cancer-related gene interaction,cell survival and proliferation enhancement
ENSG00000038002,AGA,chromatin remodeling,epigenetic regulation,histone modification,oncogene potential,cell proliferation enhancement,genomic instability promotion
ENSG00000092929,UNC13D,vesicle priming regulation,cell proliferation,protein localization aberration,genomic instability,oncogene potential,cell signaling alteration
ENSG00000163286,ALPG,altered gag metabolism,glycosylation dysregulation,tumor progression driver,cancer cell adhesion modification,immune evasion facilitation,loss of function mutations
ENSG00000135740,SLC9A5,nhe4 regulation,cell proliferation,tumor invasion,ion balance,upregulated expression,cancer progression
ENSG00000136160,EDNRB,et-1/etbr signaling pathway,constitutive activation,tumor progression,angiogenesis promotion,cell proliferation enhancement,pi3k/akt pathway interaction
ENSG00000158528,PPP1R9A,cell cycle regulation,oncogenic transformation,g2/m phase arrest,cell proliferation enhancement,tumor growth promotion,metastasis facilitation
ENSG00000272636,DOC2B,cellular vesicle trafficking,calcium-dependent regulation,oncogenic signaling modulation,tumor progression correlation,poor prognosis association,therapeutic target potential
ENSG00000187961,KLHL17,cellular regulation,oncogenic mechanism,tumor suppression evasion,protein degradation pathway,adaptor protein function,e3 ubiquitin ligase complex interaction
ENSG00000162139,NEU3,tumor progression,pi3k/akt pathway activation,glycosylation regulation,signaling pathway modulation,cellular metabolism dysregulation,protein stability alteration
ENSG00000182346,DAOA,glutaminase activation,amino acid metabolism regulation,enzyme regulation,tumor metabolism modulation,biomarker candidate,therapeutic target potential
ENSG00000167346,MMP26,tumor progression,substrate specificity,regulatory pathways,cell migration,apoptosis modulation,proteolytic activity
ENSG00000274129,TSEN34,apoptotic regulation,cancer driver gene,cell death evasion,genomic instability,nonsense-mediated mrna decay,pre-mrna splicing
ENSG00000213199,ASIC3,proton-gated sodium channel,tumor growth,metastasis promotion,poor prognosis,cell proliferation regulation,angiogenesis facilitation
ENSG00000276068,NAIP,apoptosis regulation,tumor suppressor potential,cell survival pathway modulation,protein-protein interaction,oncogenic role ambiguity,therapeutic target candidacy
ENSG00000169992,NLGN2,nlgn2-kir2.1 interaction,egfr pathway activation,oncogenic function,cell proliferation enhancement,apoptosis resistance,tumor tissue overexpression
ENSG00000116774,OLFML3,oncogene,cell migration and invasion,tumor progression,apoptosis resistance,protein-protein interactions,plasma membrane localization
ENSG00000100883,SRP54,protein synthesis regulation,cell proliferation enhancement,tumor microenvironment modulation,aberrant translation,pro-oncogenic gene expression,cell cycle progression
ENSG00000122224,LY9,tumor progression,immune response modulation,cell surface receptor interaction,oncogene or oncosuppressor role,apoptosis regulation,cancer cell proliferation enhancement
ENSG00000131269,ABCB7,mitochondrial integrity,tumor suppressor function,cellular iron regulation,genomic instability,potential oncogene role,apoptosis regulation
ENSG00000116032,GRIN3B,overexpression,cell proliferation,synaptic plasticity,ca2+ influx,tumor progression,therapeutic target
ENSG00000133937,GSC,ubiquitination pathway,tumor suppressor function,loss of function mutations,cell cycle regulation,proteasome complex interaction,cancer progression
ENSG00000100359,SGSM3,pi3k/akt signaling,protein-protein interaction,tumor progression,cell proliferation regulation,autophagy modulation,apoptosis regulation
ENSG00000137709,POU2F3,emt regulation,metastasis promoter,dna repair regulation,gene expression modulation,tumor progression,cancer correlation
ENSG00000124568,SLC17A1,vesicular nucleotide transport,cellular proliferation,transmembrane protein function,osmoregulation,neurotransmission regulation,tumor cell survival enhancement
ENSG00000213402,PTPRCAP,cell signaling regulation,tumor progression,metastasis,protein-protein interaction,epithelial-to-mesenchymal transition,pi3k/akt pathway activation
ENSG00000132205,EMILIN2,cell adhesion regulation,tumor suppression,angiogenesis inhibition,metastasis regulation,genomic instability,tissue architecture disruption
ENSG00000159212,CLIC6,chloride channels,epithelial-to-mesenchymal transition,cell migration,apoptosis regulation,tumor progression,calcium signaling
ENSG00000122735,DNAI1,aneuploidy,chromosomal instability,microtubule dynamics,oncogenic process,spindle checkpoint regulation,epigenetic modification
ENSG00000197632,SERPINB2,inhibits protease activity,overexpression,cell proliferation,apoptosis inhibition,angiogenesis promotion,tumor progression
ENSG00000169575,VPREB1,cell cycle regulation,tumor suppressor function,dna damage response,transcriptional activation,genomic instability,onco-protein interaction
ENSG00000163581,SLC2A2,glucose metabolism regulation,tumor metabolic reprogramming,glycolysis activation,cell proliferation promotion,therapeutic target identification,molecular biomarker candidate
ENSG00000079335,CDC14A,genomic instability,tumor growth promotion,cell proliferation enhancement,oncogenic pathway interaction,prognostic marker,therapeutic target
ENSG00000115616,SLC9A2,ph regulation,tumor progression,metastasis,cell migration,invasion,therapeutic target
ENSG00000171126,KCNG3,voltage-gated potassium channels,cell proliferation,migration and invasion,epithelial-to-mesenchymal transition,chemoresistance,cell survival
ENSG00000049089,COL9A2,type ii collagen expression,overexpression in tumors,promotes metastasis,cell adhesion modulation,oncogenic potential,extracellular matrix interaction
ENSG00000115596,WNT6,wnt/β-catenin signaling,oncogenesis,aberrant activation,cell proliferation,tumor growth,metastasis
ENSG00000168418,KCNG4,cellular excitability modulation,voltage-gated potassium channels,ion channel dysfunction,tumor progression,oncogene overexpression,electrical signal regulation
ENSG00000108684,ASIC2,ion channel regulation,tumor progression,cellular proliferation,ion flux regulation,metabolic adaptation,therapeutic target
ENSG00000086848,ALG9,n-glycosylation dysregulation,oncogenic process,overexpression,poor prognosis,glycoprotein modification,cell growth promotion
ENSG00000146070,PLA2G7,lpa production,cell proliferation,mitogen activity,oncogenic signaling pathway,genomic overexpression,phospholipase activity
ENSG00000198691,ABCA4,lipid metabolism,genomic stability,cell proliferation,apoptosis regulation,cholesterol efflux,tumor development
ENSG00000122176,FMOD,ecm remodeling,angiogenesis promotion,tumor progression,metastasis facilitation,immune suppression,cell adhesion modulation
ENSG00000143869,GDF7,tumor progression,growth factor activity,cell proliferation regulation,poor prognosis biomarker,signaling pathway modulation,metastasis promotion
ENSG00000105668,UPK1A,overexpression,tumor progression,cell migration,chemoresistance,adhesion disruption,epithelial-to-mesenchymal transition
ENSG00000115112,TFCP2L1,tumor suppressor function,apoptosis regulation,cell cycle regulation,transcriptional regulation,gene expression modulation,poor prognosis marker
ENSG00000144837,PLA1A,phospholipid hydrolysis,cell proliferation,signaling regulation,lysophospholipid production,membrane trafficking,metastasis promotion
ENSG00000103723,AP3B2,lysosomal dysfunction,protein trafficking regulation,cellular metabolism alteration,tumor progression contribution,genetic alterations implication,oncogenic pathway regulation
ENSG00000135617,PRADC1,mitochondrial function regulation,tumor energy metabolism modulation,cellular fusion and fission,oncogenic signaling pathway activation,cancer cell energy source enhancement,tumor progression facilitation
ENSG00000196954,CASP4,apoptosis inhibition,cancer progression,inflammation regulation,immune evasion,tumor microenvironment modulation,proteolytic activity alteration
ENSG00000095397,WHRN,adherens junction regulation,actin cytoskeleton interaction,mechanosensory stereocilia maintenance,cytoskeletal reorganization,tumor suppressor activity,cell migration modulation
ENSG00000185437,SH3BGR,signaling pathway regulation,protein-protein interaction modulation,tumor suppression,cellular homeostasis maintenance,pi3k/akt pathway regulation,cancer suppressor function
ENSG00000153246,PLA2R1,autoantigen,immune response modulation,tumor antigen presentation,renal pathology involvement,cancer progression association,immunotherapy target
ENSG00000169340,PDILT,protein folding regulation,tumor suppressor interaction,oncogenic driver,poor prognosis marker,aggressive disease progression,cancer cell survival
ENSG00000142173,COL6A2,tumor progression,metastasis promotion,oncogene activation,extracellular matrix component,cell migration enhancement,therapeutic target
ENSG00000165970,SLC6A5,tumor progression,energy metabolism regulation,cell proliferation promotion,therapeutic target,metabolic reprogramming,upregulated expression
ENSG00000164953,TMEM67,primary cilium dysregulation,oncogene activation,cell proliferation enhancement,apoptosis resistance,genomic instability induction,wnt/β-catenin signaling pathway disruption
ENSG00000163285,GABRG1,gaba receptor modulation,immune suppression,tumor microenvironment modification,metastasis promotion,oncogenic signaling pathway alteration,poor prognosis marker
ENSG00000152932,RAB3C,rab3c regulation,gain of function mutations,increased membrane trafficking,altered pi3k/akt signaling,enhanced cell proliferation,therapeutic target
ENSG00000157150,TIMP4,timp4 downregulation,loss of function mutations,ecm remodeling,tumor invasion,therapeutic target,genomic profiling
ENSG00000064666,CNN2,calcium homeostasis regulation,cell proliferation promotion,metabolic reprogramming,tumor progression facilitation,protein interaction with pi3k/akt pathway,overexpression in kirc cancer cells
ENSG00000120068,HOXB8,wnt/β-catenin pathway regulation,transcription factor activity,cell proliferation enhancement,tumor aggressiveness marker,apoptosis suppression,oncogenic behavior promotion
ENSG00000106341,PPP1R17,pp1 pathway regulation,cell cycle regulation,protein phosphatase activation,tumor progression,biomarker potential,signaling pathway modulation
ENSG00000060718,COL11A1,cell adhesion disruption,extracellular matrix regulation,tumor progression,metastasis driver,collagen family member,cell migration modulation
ENSG00000179914,ITLN1,tumor progression,inflammation regulation,cancer promotion,potential biomarker,tumor growth,immune response modulation
ENSG00000124257,NEURL2,loss-of-function mutations,tumor suppressor function,cell proliferation promotion,apoptosis suppression,dna repair pathway dysregulation,transcriptional repressor activity
ENSG00000150394,CDH8,cadherin function disruption,cell migration enhancement,epithelial-to-mesenchymal transition disruption,metastasis promotion,therapeutic target consideration,signaling pathway interaction
ENSG00000105996,HOXA2,pro-tumorigenic microenvironment,gene overexpression,tumor progression,cell proliferation,apoptosis resistance,angiogenic potential
ENSG00000005073,HOXA11,oncogenic transcription factor,overexpression in cancer,cell proliferation regulation,apoptosis evasion,epithelial-to-mesenchymal transition,angiogenesis promotion
ENSG00000264424,MYH4,cancer progression,cell migration invasion,pi3k/akt signaling,epigenetic regulation,tumor aggressiveness,metastasis promotion
ENSG00000133454,MYO18B,actin cytoskeleton regulation,cell migration modulation,cytokinesis dysregulation,intracellular trafficking disruption,microtubule stability alteration,oncogene overexpression
ENSG00000109424,UCP1,mitochondrial uncoupling,angiogenic regulation,glycolytic enhancement,oxidative stress resistance,cancer metastasis,therapeutic target
ENSG00000123838,C4BPA,complement regulation,tumor progression,immune evasion,cancer prognosis,metastasis facilitation,cell adhesion
ENSG00000166033,HTRA1,protease regulation,cellular stress response,p53 modulation,pi3k/akt pathway interaction,tumor suppressor disruption,metastasis promotion
ENSG00000170425,ADORA2B,angiogenesis promotion,cell proliferation enhancement,immune suppression,metastasis facilitation,prognostic marker,signaling pathway modulation
ENSG00000125798,FOXA2,transcription factor regulation,pi3k/akt pathway activation,cell growth promotion,tumor aggressiveness enhancement,chromatin remodeling involvement,biomarker potential
ENSG00000164778,EN2,oncogene,cell proliferation,transcription factor activity,epithelial-to-mesenchymal transition (emt),metastasis,poor prognosis
ENSG00000081842,PCDHA6,altered cell adhesion,disrupted epithelial barriers,cell migration regulation,signaling pathway interaction,tumor progression contribution,mutational alteration
ENSG00000104899,AMH,tumor suppressor,cell proliferation inhibition,tgf-β signaling pathway,metastatic suppression,angiogenesis regulation,cell differentiation modulation
ENSG00000163382,NAXE,protein degradation regulation,oncogene involvement,aberrant expression,cell growth modulation,apoptosis resistance,protein homeostasis
ENSG00000112293,GPLD1,cell surface glycoprotein regulation,tumor progression,metastasis facilitation,pi3k/akt pathway modulation,wnt/β-catenin signaling activation,chemoresistance promotion
ENSG00000147437,GNRH1,angiogenesis,cell cycle regulation,epithelial-to-mesenchymal transition (emt),hormone regulation,oncogenic signaling,reproductive axis modulation
ENSG00000134443,GRP,transcriptional regulation,oncogene activation,cell proliferation,apoptosis resistance,angiogenesis modulation,nuclear matrix association
,ELOA3,oncogenic potential,lipid metabolism regulation,aggressive tumor behavior,pi3k/akt/mtor pathway modulation,cell growth promotion,energy production enhancement for cancer cells
ENSG00000104918,RETN,inflammation regulation,tumor microenvironment modulation,cancer-immune cell interaction,secreted protein function,immunosuppression promotion,cell signaling pathway modulation
ENSG00000164061,BSN,metabolic regulation,tumor growth promotion,pi3k/akt pathway activation,cellular process modulation,apoptosis inhibition,angiogenesis regulation
ENSG00000134265,NAPG,chromatin assembly,cell cycle progression,apoptosis inhibition,tumor progression,proliferation regulation,therapeutic target
ENSG00000135902,CHRND,cellular interaction,metastasis,protein expression,biomarker,signaling pathway,tumor progression
ENSG00000129744,ART1,upr regulation,tumor promotion,oncogenic function,cellular stress response,mutation implicated,pro-survival signaling
ENSG00000280477,RASA3,ras protein regulation,hyperactivated signaling pathways,oncogenic mutations,tumor progression,therapeutic target,endothelial dysfunction
ENSG00000127472,PLA2G5,arachidonic acid pathway,cell migration,epithelial-to-mesenchymal transition,lipid metabolism regulation,oncogenic signaling,pro-inflammatory eicosanoid production
ENSG00000114200,BCHE,acetylcholine hydrolysis,oncogenic processes,tumor progression,cell survival pathways,immune regulation,neurotransmitter signaling
ENSG00000281151,KCNQ2,cellular proliferation regulation,ion channel modulation,signaling pathway interaction,regulation of cell excitability,kinase activity alteration,renal tissue expression
ENSG00000278444,CDC42EP5,cell migration regulation,guanine nucleotide exchange factor activity,gtpase activation,cancer metastasis promoter,tumor progression,epithelial-to-mesenchymal transition (emt)
ENSG00000111186,WNT5B,wnt signaling pathway,cell migration,epithelial-to-mesenchymal transition,tumor progression,protein-protein interaction,β-catenin-independent signaling
ENSG00000116703,PDC,apoptosis dysregulation,tumor suppression loss,aggressive disease progression,poor prognosis association,cell growth regulation,apoptotic pathway interaction
ENSG00000128713,HOXD11,hox gene regulation,transcriptional control,cell migration,tumor suppressor function,embryonic patterning,chromatin remodeling
ENSG00000102854,MSLN,cell-cell interaction,immune evasion,tumor progression,glycoprotein function,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000177098,SCN4B,sodium channel regulation,tumor aggressiveness,poor prognosis,protein-protein interaction,pi3k/akt pathway modulation,mapk/erk signaling activation
ENSG00000168267,PTF1A,transcriptional regulation,oncogenic function,cell proliferation,constitutive activation,apoptosis inhibition,genomic instability
ENSG00000197891,SLC22A12,chemotherapy resistance,cellular uptake regulation,metabolite transport,kidney function regulation,oncogene potential,drug response modulation
ENSG00000079482,OPHN1,tumor suppressor,cell adhesion regulation,axon guidance regulation,oncogenesis inhibition,pi3k/akt pathway suppression,metastasis prevention
ENSG00000173702,MUC13,tumor progression,oncogenesis,tumor growth promotion,angiogenesis,biomarker potential,prognostic significance
ENSG00000132424,PNISR,gpcr regulation,rgs inhibition,cell proliferation,phosphodiesterase activity,cell survival,genomic instability
ENSG00000177946,CENPBD1,chromatin binding,centromere regulation,kinetochore assembly,microtubule attachment,chromosomal segregation,tumor suppressor function
ENSG00000115425,PECR,pi3k/akt pathway activation,tumor progression,phosphoinositide metabolism,cell survival enhancement,metastasis facilitation,therapeutic target
ENSG00000112541,PDE10A,constitutive activation,oncogenic processes,cell proliferation,tumor progression,metabolic regulation,pi3k/akt/mtor pathway
ENSG00000189180,ZNF33A,krab domain transcription factor,tumor suppressor function,genome instability regulation,apoptosis induction,cellular senescence modulation,prognostic marker potential
ENSG00000125861,GFRA4,gdnf/ret/mapk signaling pathway,oncogenic process,tumor progression,cell survival,genomic profiling,therapeutic target
ENSG00000125650,PSPN,cellular signaling,epithelial-to-mesenchymal transition,overexpression,tumor progression,signaling pathway regulation,serine protease activity
ENSG00000184956,MUC6,tumor progression,cell proliferation,signaling pathway activation,epithelial surface protection,glycosylation dysregulation,cell migration
ENSG00000138356,AOX1,metabolic reprogramming,redox balance regulation,oxidative stress modulation,aldehyde oxidation,energy metabolism regulation,tumor microenvironment interaction
ENSG00000169231,THBS3,angiogenesis,vegf interaction,cell adhesion modulation,mutation-driven overexpression,tumor microenvironment regulation,pro-angiogenic signaling
ENSG00000154478,GPR26,wnt/β-catenin signaling pathway,gain of function mutations,tumor progression,therapeutic target,cell proliferation regulation,aberrant activation
ENSG00000012174,MBTPS2,lipid metabolism regulation,cholesterol transport,cell growth promotion,metabolic adaptation,transcriptional regulation,oncogenic potential
ENSG00000185760,KCNQ5,voltage-gated potassium channels,cell cycle progression,constitutive activation,tumor progression,therapeutic target,electrical homeostasis
ENSG00000137975,CLCA2,calcium-activated chloride channels,tumor progression,cell migration,ion homeostasis,biomarker expression,genomic instability
ENSG00000171812,COL8A2,type viii collagen expression,tumor progression,metastasis promotion,extracellular matrix degradation,cancer cell migration,oncogenic potential
ENSG00000086189,DIMT1,protein stability regulation,cellular interaction,ubiquitination and degradation,cancer biology link,cellular process regulation,metabolic pathway involvement
ENSG00000086062,B4GALT1,glycosylation modulation,tumor cell proliferation,cell surface glycoproteins,angiogenesis promotion,metastasis facilitation,biomarker identification
ENSG00000169427,KCNK9,overexpression,potassium channel function,electrolyte balance regulation,tumor progression marker,malignancy correlation,poor prognosis
ENSG00000148965,SAA4,inflammation induced,lipid transport regulation,tumor microenvironment modulation,metastasis promotion,tumor progression marker,acute phase response
ENSG00000115665,SLC5A7,metabolic reprogramming,tumor proliferation,glucose transport,sodium-glucose cotransporter,overexpression,cancer metabolism
ENSG00000160951,PTGER1,ep4 signaling pathway,prostaglandin e2 activation,growth factor regulation,angiogenesis promotion,apoptosis inhibition,tumor metastasis
ENSG00000198598,MMP17,extracellular matrix remodeling,tumor progression,cell migration and invasion,oncogene potential,mapk/erk pathway interaction,cytoplasmic expression and secretion
ENSG00000143199,ADCY10,**
camp signaling,adenylate cyclase activity,oncogenic growth promotion,cell proliferation enhancement,tumor progression association,genomic amplification 
**
ENSG00000179097,HTR1F,serotonin receptor regulation,tumor progression,cell differentiation regulation,apoptosis regulation,angiogenesis promotion,oncogenic signaling pathway modulation
ENSG00000134438,RAX,transcriptional regulator,oncogenic promoter activity,cell proliferation enhancement,therapeutic target candidate,neural tube formation regulation,anterior neural development gene
ENSG00000101346,POFUT1,notch receptor modification,o-glycosylation process,cell proliferation regulation,tumor progression marker,protein interaction,enzymatic activity modulation
ENSG00000188517,COL25A1,tumor progression,cell migration,extracellular matrix regulation,protein-protein interaction,gene upregulation,cancer aggressiveness
ENSG00000167748,KLK1,genomic instability,oncogenic potential,overexpression,proteolytic activity,epithelial-to-mesenchymal transition,poor prognosis
ENSG00000109743,BST1,tumor progression,immune evasion,metastasis facilitation,cellular adhesion modulation,inflammatory response regulation,protein shedding activity
ENSG00000101938,CHRDL1,bmp signaling regulation,dysregulation of growth factors,cellular proliferation,tumor progression,protein-protein interaction,genomic overexpression
ENSG00000121281,ADCY7,camp accumulation,oncogenic effect,cell proliferation,metabolic regulation,signaling pathway alteration,protein-protein interaction
ENSG00000197093,GAL3ST4,cell proliferation enhancement,oncogene activation,signaling pathway modulation,tumor progression marker,cell survival regulation,metabolic modification
ENSG00000175785,PRIMA1,apoptosis inhibition,tumor suppressor function,dna damage response,cell cycle regulation,genomic instability,transcriptional modulation
ENSG00000101190,TCFL5,wnt/β-catenin signaling pathway,transcriptional activation,amplifications or mutations,cell proliferation,therapeutic target,genomic profiling
ENSG00000168743,NPNT,tumor progression,metastasis promoter,cell adhesion,epithelial-to-mesenchymal transition,biomarker candidate,transmembrane protein
ENSG00000137221,TJAP1,tight junction regulation,cellular adhesion modulation,protein-protein interactions,tumor progression promotion,therapeutic target potential,cancer cell invasion facilitation
ENSG00000116675,DNAJC6,mitochondrial dysfunction,chaperone functions,apoptosis regulation,cancer cell proliferation,tumor growth enhancement,cellular stress response
ENSG00000154162,CDH12,reduced adhesion,epithelial-to-mesenchymal transition (emt),stem-like cell population,pi3k/akt pathway regulation,cell migration and invasion,loss of cellular function
ENSG00000187017,ESPN,genome instability,nuclear architecture regulation,chromatin remodeling,cell cycle progression,dna repair interaction,genomic profiling
ENSG00000139269,INHBE,tumor suppressor,cell growth regulation,apoptosis induction,smad signaling modulation,follicle-stimulating hormone inhibition,cancer cell proliferation
ENSG00000126231,PROZ,hypoxia-inducible factor alpha stabilization,angiogenesis promotion,metabolic reprogramming,glycolytic switch,tumor progression enhancement,oncogenic signaling pathway activation
ENSG00000179091,CYC1,electron transport chain,mitochondrial respiration,cellular metabolism,tumor aggressiveness,energy production,cancer cell survival
ENSG00000100665,SERPINA4,tumor suppression,cellular regulation,protease inhibition,matrix metalloproteinase regulation,pi3k/akt pathway interaction,cancer progression
ENSG00000177511,ST8SIA3,cell surface modification,oncogenic process modulation,tumor microenvironment remodeling,metastatic potential enhancement,immune response evasion,cell adhesion modulation
ENSG00000113532,ST8SIA4,cell migration,glycoprotein modification,tumor progression,metastasis,angiogenesis,therapeutic target
ENSG00000140557,ST8SIA2,glycosylation regulation,oncogenic signaling pathway interaction,tumor progression promoter,cell surface modification,gene expression regulation,metastasis enhancement
ENSG00000162545,CAMK2N1,nf-κb pathway activation,cell proliferation regulation,tumor metastasis promotion,cancer progression,protein kinase interaction,mutation-driven oncogenesis
ENSG00000184302,SIX6,transcriptional regulation,oncogenic driver,cell proliferation,metastasis promotion,apoptosis suppression,angiogenesis regulation
ENSG00000110080,ST3GAL4,sialylation regulation,tumor progression,metastasis promotion,glycosylation modification,cell adhesion modulation,signaling pathway interaction
ENSG00000125813,PAX1,tumor suppressor function,transcriptional regulation,cellular proliferation,apoptosis regulation,wnt/β-catenin pathway interaction,kidney development patterning
ENSG00000163785,RYK,wnt signaling pathway activation,tumor metastasis promotion,cell migration regulation,angiogenesis facilitation,prognostic biomarker candidate,tyrosine kinase activity
ENSG00000135678,CPM,brca2 interaction,genetic instability,dna repair disruption,transcriptional regulation,cell growth promotion,oncogenic signaling pathway
ENSG00000185033,SEMA4B,pi3k/akt signaling pathway regulation,tumor suppressor activity,angiogenesis inhibition,immune response modulation,cell migration and adhesion regulation,secreted protein expression
ENSG00000182580,EPHB3,cell adhesion disruption,pi3k/akt/mtor pathway regulation,angiogenesis promotion,tumor progression driver,biomarker potential,receptor tyrosine kinase activity
ENSG00000141574,SECTM1,cell surface regulation,tumor progression,oncogenic processes,upregulated expression,prognostic marker,cell adhesion modulation
ENSG00000112249,ASCC3,histone modification,chromatin remodeling,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,apoptosis inhibition
ENSG00000127074,RGS13,pi3k/akt pathway regulation,oncogenic process promotion,tumor progression inhibition,cell growth modulation,g-protein coupled receptor signaling,tumor suppressor function
ENSG00000180875,GREM2,wnt/β-catenin pathway modulation,oncogene activation,tgf-β signaling suppression,epithelial-to-mesenchymal transition inhibition,tumor progression facilitation,cell survival enhancement
ENSG00000114982,KANSL3,chromatin remodeling,histone methylation,transcriptional regulation,oncogenic pathway activation,genome instability,tumor suppressor gene silencing
ENSG00000169313,P2RY12,platelet activation,tumor progression,vascular homeostasis,angiogenesis,cancer-related thrombosis,purinergic signaling pathway
ENSG00000172009,THOP1,centrosome regulation,genomic instability,kinetochore interaction,mitotic spindle assembly,microtubule dynamics,cell proliferation
ENSG00000104921,FCER2,tumor microenvironment,mast cell activation,immune system modulation,signaling pathway dysregulation,cell proliferation enhancement,angiogenesis promotion
ENSG00000205810,KLRC3,immune evasion,t-cell dysfunction,nk cell modulation,cytokine regulation,antigen presentation,oncogenic transformation
ENSG00000133116,KL,cell proliferation,protease activity,serine protease,tumor progression,angiogenesis,pi3k/akt interaction
ENSG00000096006,CRISP3,crispr-mediated regulation,tumor progression,promoter methylation,serine protease activation,inflammation modulation,cancer progression
ENSG00000186074,CD300LF,tumor growth promotion,immune regulation,poor prognosis indicator,cancer biomarker,metastasis promotion,therapeutic target potential
ENSG00000275099,GGNBP2,gpcr activation,hippo-yap pathway regulation,tumor promotion,cellular proliferation regulation,g-protein coupling,signaling transduction
ENSG00000172794,RAB37,oncogenic potential,gtpase activity,tumor progression,metastasis facilitation,cell surface trafficking,prognostic marker
ENSG00000152266,PTH,bone metastasis,pth signaling pathway,calcium regulation,osteoblast activation,angiogenesis promotion,wnt/β-catenin pathway activation
ENSG00000127124,HIVEP3,immune regulation,transcriptional regulator,tumor growth promotion,oncogenic driver,immune evasion mechanism,genomic overexpression
ENSG00000164035,EMCN,angiogenic factor,prognostic biomarker,tumor progression,endothelial cell marker,growth factor binding,cell migration
ENSG00000114631,PODXL2,oncogenic potential,glycocalyx maintenance,cell migration and invasion,signaling pathway interaction,tumor progression and metastasis,prognostic significance
ENSG00000105472,CLEC11A,tumor-associated macrophage regulation,immunosuppressive microenvironment modulation,innate immunity regulation,cytokine and chemokine regulation,transmembrane protein function,immune cell recruitment
ENSG00000101890,GUCY2F,cgmp pathway regulation,tumor growth promotion,angiogenesis enhancement,metastasis facilitation,therapeutic target potential,oncogenic mechanism involvement
ENSG00000158887,MPZ,altered expression,cell adhesion regulation,migration and invasion,pi3k/akt pathway modulation,protein-protein interactions,tumor progression support
ENSG00000244486,SCARF2,**
cellular adhesion,signal transduction,tumor progression,cytoplasmic localization,apoptosis resistance,cell migration
**
ENSG00000134258,VTCN1,tumor suppressor function,immune evasion,cell adhesion regulation,metastasis suppression,diagnostic marker,cancer stem cell maintenance
ENSG00000088827,SIGLEC1,immunosuppressive microenvironment,tumor-associated immune responses,overexpression in tumors,interaction with pd-l1,oncogenic properties,myeloid-derived suppressor cells activation
ENSG00000119523,ALG2,cellular stress response,endoplasmic reticulum stress,unfolded protein response activation,oncogene overexpression,protein modification regulation,tumor growth promotion
ENSG00000170175,CHRNB1,cell proliferation,metastasis,cell migration,prognostic marker,epigenetic regulation,tumor progression
ENSG00000104755,ADAM2,adam family,angiogenesis,cell adhesion regulation,extracellular matrix degradation,metastasis facilitation,tumor progression enhancement
ENSG00000074803,SLC12A1,nkcc1 function,cell proliferation,ion transport regulation,tumor progression,metastasis promotion,biomarker potential
ENSG00000139998,RAB15,gtpase activity,cell proliferation,constitutive activation,membrane trafficking,oncogenic driver,effector protein interaction
ENSG00000105697,HAMP,iron regulation,angiogenesis promotion,prognostic marker,tumor progression support,immune evasion facilitation,therapeutic target potential
ENSG00000109991,P2RX3,neurotransmission regulation,pain signaling modulation,cell proliferation enhancement,migration and invasion promotion,tumor progression facilitation,therapeutic target potential
ENSG00000141527,CARD14,nf-κb pathway,constitutive activation,gain of function mutations,tumor progression,inflammation regulation,immune evasion
ENSG00000134762,DSC3,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression correlation,overexpression in cancer,poor prognosis association,signaling pathway interaction
ENSG00000160111,CPAMD8,cancer metabolism,nutrient transport,cell proliferation,mutations implicated,oncogenic processes,transporter function
ENSG00000187094,CCK,tumor growth,cell proliferation,signaling pathway activation,gastrointestinal hormone function,cell migration and survival,oncogenic process involvement
ENSG00000185149,NPY2R,oncogenic signaling,angiogenesis promotion,tumor aggressiveness,cell migration,poor prognosis marker,g-protein coupled receptor activation
ENSG00000075223,SEMA3C,tumor suppression,angiogenesis regulation,vegf signaling pathway interaction,metastasis promotion,gene expression dysregulation,kidney cancer progression
ENSG00000165949,IFI27,rna-binding protein,tumor suppressor gene,apoptosis regulation,cell cycle progression,poor prognosis marker,cancer development pathway
ENSG00000115705,TPO,tpo-related thyroid hormone regulation,cell growth enhancement,metabolic reprogramming,tumor progression facilitation,genomic instability association,selenocysteine-containing enzyme activity
ENSG00000161298,ZNF382,epigenetic regulation,chromatin remodeling,tumor suppressor function,cell proliferation inhibition,apolipoprotein interaction,genomic stability maintenance
ENSG00000164509,IL31RA,tumor-promoting effects,cancer-related inflammation,immune evasion,cell proliferation enhancement,therapeutic target,signaling pathway dysregulation
ENSG00000091536,MYO15A,cancer cell invasion,actin filament organization,cell migration regulation,signaling pathway interaction,protein-protein interactions,tumor progression
ENSG00000166825,ANPEP,altered expression,angiogenesis promotion,amino acid regulation,protein degradation pathway,cell invasion facilitation,tumor growth enhancement
ENSG00000183607,GKN2,glycoprotein regulation,cellular detachment,metastasis facilitation,wnt signaling dysregulation,epithelial integrity loss,tumor progression association
ENSG00000125820,NKX2-2,transcriptional repressor,tumor suppressor,cell proliferation regulation,cancer progression disruption,tissue-specific gene regulation,lineage-specific regulator
ENSG00000136982,DSCC1,emt process,cell adhesion disruption,wnt/β-catenin pathway activation,stemness and drug resistance,poor prognosis marker,tumor progression facilitation
ENSG00000122678,POLM,cell cycle regulation,chromosomal instability,genomic instability,tumor promoter,spindle checkpoint regulation,mitotic entry and exit
ENSG00000183671,GPR1,g protein-coupled receptor activation,tumor progression,metastasis promotion,prognostic marker,signaling pathway regulation,dysregulation in tumorigenesis
ENSG00000116785,CFHR3,complement regulation,tumor progression,metastasis regulation,cell proliferation,poor prognosis,immunomodulation
ENSG00000138771,SHROOM3,actin cytoskeleton regulation,cell adhesion disruption,oncogenic properties,prognostic biomarker,cancer progression,poor prognosis
ENSG00000128322,IGLL1,immunoglobulin assembly,oncogenic properties,cell proliferation,genomic instability,chromosomal rearrangement,protein-protein interaction
ENSG00000108091,CCDC6,**
microtubule stability,centrosome duplication,oncogene activation,chromosomal instability,aneuploidy induction,protein-protein interaction
ENSG00000008516,MMP25,tumor invasion,extracellular matrix degradation,proteolytic activity,metastasis promotion,cell migration enhancement,biomarker potential
ENSG00000139132,FGD4,gef activity,pi3k/akt signaling,actin cytoskeleton regulation,cancer progression,protein-protein interactions,tumor metastasis
ENSG00000164266,SPINK1,apoptosis regulation,oncogene function,tumor progression,protease inhibition,pi3k/akt interaction,poor prognosis marker
ENSG00000147647,DPYS,pyrimidine catabolism,genomic instability,dna damage accumulation,cell proliferation,oncogenic processes,poor prognosis marker
ENSG00000197696,NMB,oncogenic signaling,tumor growth promotion,angiogenesis regulation,metastasis facilitation,poor prognosis marker,protein interaction
ENSG00000179943,FIZ1,wnt signaling pathway,cell migration,tumor progression,metastasis regulation,prognostic marker,transcriptional modulation
ENSG00000006116,CACNG3,**

calcium channel regulation,cell proliferation,neuronal excitability,synaptic transmission,tumor progression,metastasis
ENSG00000185559,DLK1,oncogenic signaling,tumor progression,cell proliferation,angiogenesis,prognostic marker,genomic amplification
ENSG00000168702,LRP1B,cellular metabolism regulation,oncogenic pathway inhibition,tumor suppressor function,cell proliferation regulation,cellular migration inhibition,poor prognosis association
ENSG00000238289,MICB,apoptosis regulation,immune evasion,tumor cell survival,cell proliferation modulation,mhc class i antigen presentation,dysregulation in tumorigenesis
ENSG00000136457,CHAD,metabolic regulation,cellular homeostasis,ion transport,phi regulation,tumor development,glycolysis promotion
ENSG00000243480,AMY2A,cell proliferation,survival mechanisms,prognostic marker,therapeutic target,metabolic regulation,tumor progression
ENSG00000021355,SERPINB1,tumor suppression,proteolytic regulation,cell invasion inhibition,cancer progression,therapeutic target,gene expression downregulation
ENSG00000054803,CBLN4,tumor suppression,cell cycle regulation,cell proliferation,neuronal function modulation,synaptic transmission regulation,molecular interaction
ENSG00000026559,KCNG1,tumor progression,cellular proliferation,ion channel function,voltage-gated potassium channel,overexpression,metastasis
ENSG00000178342,KCNG2,voltage-gated potassium channel,cellular excitability modulation,ion channel regulation,cancer cell proliferation,oncogenic process involvement,tumor tissue overexpression
ENSG00000177981,ASB8,tumor suppressor function,genomic instability regulation,ubiquitin-proteasome pathway regulation,oncogenic process suppression,protein degradation regulation,cancer progression association
ENSG00000100312,ACR,aquaporin function,cellular water transport,growth regulation,epithelial-to-mesenchymal transition,cancer metastasis,genomic expression
ENSG00000257594,GALNT4,glycosylation regulation,tumor progression,cell proliferation regulation,apoptosis inhibition,metastasis promotion,prognostic marker
ENSG00000108556,CHRNE,cellular regulation,genetic mutation,chromosomal location,signal transduction,protein interaction,mutation-induced oncogenesis
ENSG00000138792,ENPEP,constitutive activation,gain of function mutations,tumor progression,cell proliferation regulator,protein-protein interaction,genomic amplification
ENSG00000112246,SIM1,stat3 activation,oncogenic properties,cell proliferation regulation,transcriptional regulation,apoptosis inhibition,genetic alterations
ENSG00000139178,C1RL,tumor progression,prognostic biomarker,therapeutic target,complement activation,angiogenesis promotion,immune response modulation
ENSG00000110721,CHKA,akt signaling pathway,tumor progression,cell growth regulation,lipid metabolism alteration,choline kinase activity,cancer cell proliferation driver
ENSG00000124205,EDN3,angiogenesis stimulation,autocrine growth factor,biomarker potential,cell proliferation enhancement,immune response modulation,vascular regulation dysfunction
ENSG00000112619,PRPH2,disrupted protein interaction,ancillary subunit function,amplification and overexpression,oncogenic potential,tumor progression marker,poor prognosis indicator
ENSG00000149403,GRIK4,neurotransmission regulation,cell proliferation,oncogene activation,pi3k/akt signaling,tumor growth promotion,upregulated expression
ENSG00000159307,SCUBE1,angiogenesis promotion,tumor progression association,vegf signaling interaction,cell growth regulation,poor prognosis marker,metastasis facilitation
ENSG00000175356,SCUBE2,cell-cell adhesion regulation,notch signaling pathway,tumor progression,metastasis,protein-protein interaction,wnt/β-catenin pathway
ENSG00000156853,ZNF689,**
cell cycle regulation,apoptosis inhibition,transcriptional regulation,zinc finger domain,dna binding protein,tumor progression 
**
ENSG00000118733,OLFM3,tumor suppressor function,loss of adhesion,cell migration,metastasis promotion,wnt/β-catenin pathway interaction,prognostic marker
ENSG00000188613,NANOS1,chromatin remodeling,mirna-mediated repression,apoptosis evasion,cancer stem cell maintenance,cellular proliferation enhancement,tumor progression
,DAZ3,chromatin remodeling,transcriptional regulation,dna repair,genomic instability,cell proliferation,none
ENSG00000171246,NPTX1,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition regulation,cell survival enhancement,cell proliferation promotion,metastasis facilitation,synaptic function dysregulation
ENSG00000124374,PAIP2B,regulation of cell proliferation,rna-binding protein interaction,mrna stability regulation,apoptosis inhibition,cell cycle progression,tumor growth promotion
ENSG00000159184,HOXB13,transcription factor regulation,oncogenic activity,tumor progression,epithelial-to-mesenchymal transition,angiogenesis,cell proliferation
ENSG00000241563,CORT,tumor growth,angiogenesis promotion,wnt/β-catenin signaling activation,tumor metastasis facilitation,poor prognosis marker,metabolic regulation
ENSG00000183067,IGSF5,cell adhesion modulation,tumor progression,metastasis facilitation,oncogenic potential,cell migration enhancement,protein-protein interaction
ENSG00000028203,VEZT,vezt overexpression,cellular proliferation,protein stabilization,oncogenic processes,tumor progression,ubiquitin ligase complex
ENSG00000132465,JCHAIN,aberrant expression,cell surface modification,immune modulation,mucosal barrier function,protein transport,tumor microenvironment
ENSG00000158488,CD1E,immune suppression,tumor evasion,lipid metabolism,cell adhesion,prognostic marker,antigen presentation pathway
ENSG00000115598,IL1RL2,il-1r signaling,tumor growth promotion,inflammation regulation,poor prognosis association,therapeutic target potential,metastasis enhancement
ENSG00000140015,KCNH5,oncogenic signaling,cell proliferation,altered ion balance,voltage-gated potassium channel function,dysregulated expression,proliferation and survival enhancement
ENSG00000102539,MLNR,mitochondrial dynamics,regulatory protein,tumor suppressor,cellular metabolism,energy production regulation,genomic stability
ENSG00000106128,GHRHR,growth factor regulation,receptor signaling pathway,tumor progression,metastasis promoter,poor prognosis biomarker,cell proliferation enhancer
ENSG00000136487,GH2,protein processing,endoplasmic reticulum localization,glycosylation regulation,cellular maturation,substrate specificity,enzymatic activity
ENSG00000136697,IL1F10,tumor suppressor function,inflammation regulation,nf-κb signaling inhibition,apoptosis induction,stat3 pathway modulation,pi3k/akt pathway interaction
ENSG00000227357,HLA-DRB4,immune evasion,antigen presentation,major histocompatibility complex (mhc),class ii mhc molecule,t-cell activation,inflammatory responses
ENSG00000176919,C8G,apoptosis regulation,cell differentiation,lipid transport,cell proliferation,genetic association,protein interaction
ENSG00000137252,HCRTR2,angiogenesis,promotes oncogenic processes,upregulated expression,g-protein coupled receptor function,interacts with mapk/erk pathway,tumor progression and metastasis
ENSG00000244414,CFHR1,complement system regulation,tumor growth promotion,angiogenesis facilitation,poor prognosis marker,therapeutic target,genomic dysregulation
ENSG00000154736,ADAMTS5,angiogenic switch,tumor metastasis,proteoglycan degradation,growth factor regulation,apoptosis suppression,extracellular matrix remodeling
ENSG00000185518,SV2B,overexpression,cellular proliferation,oncogenic pathways,cell survival,neurotransmitter release regulation,potential therapeutic target
ENSG00000102349,KLF8,transcriptional regulation,gene expression modulation,proliferation promotion,anti-apoptotic signaling,tumor suppressor interaction,dysregulation in tumorigenesis
ENSG00000184470,TXNRD2,antioxidant activity,cell proliferation,oncogenic potential,mitochondrial function,electron transport chain interaction,therapeutic target
ENSG00000162267,ITIH3,anti-apoptotic properties,angiogenesis promotion,epithelial-to-mesenchymal transition (emt),inflammation regulation,pi3k/akt pathway interaction,serpin family member
ENSG00000177311,ZBTB38,chromatin remodeling,tumor suppressor function,wnt/β-catenin pathway regulation,cell proliferation inhibition,gene expression repression,apoptosis regulation
ENSG00000077498,TYR,melanogenesis,tumor progression,oxidative stress resistance,cell survival enhancement,metastasis promotion,melanoma association
ENSG00000126709,IFI6,ifn-alpha-inducible protein,inflammation modulation,tumor microenvironment,immune response regulation,poor prognosis marker,biomarker for disease severity
ENSG00000155903,RASA2,ras gtpase regulation,tumor suppressor function,cellular adhesion regulation,mutation hotspot,protein-protein interaction,ras pathway modulation
ENSG00000167157,PRRX2,epithelial-to-mesenchymal transition (emt),transcription factor activity,genomic instability,dna repair,cell proliferation,poor prognosis
ENSG00000172840,PDP2,phosphatase activity,cell cycle regulation,oncogenic signaling,dephosphorylation of substrates,pi3k/akt pathway modulation,therapeutic target
ENSG00000174080,CTSF,mtor pathway activation,cellular growth promotion,oncogenic process enhancement,protein interaction modulation,cysteine accumulation,poor prognosis correlation
ENSG00000181826,RELL1,genomic instability,tumor suppressor function,homologous recombination repair,dna damage response,fanconi anemia pathway,genetic mutations
ENSG00000141384,TAF4B,transcriptional regulation,oncogene activation,tumor growth promotion,cell cycle dysregulation,chromatin remodeling,epigenetic modulation
ENSG00000242950,ERVW-1,genomic instability,transposable element,tumor promoter,pi3k/akt signaling,cell proliferation,poor prognosis
ENSG00000164776,PHKG1,glycogen metabolism regulation,oncogenic activation,tumor growth promotion,enhanced glycolysis,cell proliferation increase,apoptosis evasion
ENSG00000126861,OMG,mitochondrial function regulation,tumor progression promotion,cell proliferation enhancement,oncogenic properties,signaling pathway activation,potential biomarker
ENSG00000185924,RTN4RL1,tumor suppressor function,apoptosis induction,cell cycle regulation,pi3k/akt pathway inhibition,wnt/β-catenin signaling modulation,genomic instability
ENSG00000111729,CLEC4A,tumor progression,immune evasion,metastasis,biomarker,cell migration,signaling modulation
ENSG00000135709,KIAA0513,chromatin remodeling,genomic instability,histone modification,tumor progression,cell cycle regulation,epigenetic dysregulation
ENSG00000186326,RGS9BP,g-protein regulation,oncogenic signaling,aberrant expression,cell proliferation,metabolic dysregulation,protein stability regulation
ENSG00000103226,NOMO3,chromatin remodeling,transcriptional regulation,genome instability,dna repair suppression,tumorigenesis suppression,cell cycle regulation
ENSG00000101425,BPI,cellular proliferation,apoptosis regulation,tumor progression,angiogenesis promotion,immune evasion,prognostic marker
ENSG00000163590,PPM1L,tumor suppression,pathway regulation,cell metabolism regulation,cell growth inhibition,protein interaction,phosphatase activity
ENSG00000276836,ARHGAP27,rho gtpase regulation,tumor progression,cell migration,oncogenic transformation,cancer metastasis,cytoplasmic signaling
ENSG00000140545,MFGE8,efferocytosis,immune evasion,tumor progression,apoptotic cell uptake,metastasis facilitation,angiogenesis promotion
ENSG00000164532,TBX20,tbx20 regulates emt,constitutive activation of tbx20,promotes tumor progression,disrupts cell-cell adhesion,interacts with pi3k/akt pathway,tumor metastasis enhancer
ENSG00000064225,ST3GAL6,sialylation,cell adhesion,glycosphingolipid biosynthesis,oncogenic properties,therapeutic target,cell migration
ENSG00000178199,ZC3H12D,tumor suppressor function,represses oncogene transcription,disrupts dna repair pathways,alters cell cycle regulation,contributes to vhl gene mutations,involved in kirc tumorigenesis
ENSG00000156232,WHAMM,microtubule regulation,genomic instability,cell migration,oncogenic process,tumor progression,cancer metastasis
ENSG00000141756,FKBP10,hsp90 complex regulation,protein degradation regulation,tumor growth promotion,cell cycle modulation,apoptosis inhibition,therapeutic target
ENSG00000221866,PLXNA4,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),rac1 activation,met interaction,hippo signaling pathway dysregulation
ENSG00000168282,MGAT2,tumor progression,cell proliferation,altered glycosylation,oncogenic regulation,dysregulated expression,immune evasion
ENSG00000048342,CC2D2A,cilia dysfunction,oncogenic transformation,genome instability,aneuploidy prevention,cell signaling regulation,protein-protein interaction
ENSG00000125744,RTN2,protein-protein interactions,tumor progression,cell survival,signal transduction,overexpression marker,cell migration
ENSG00000182264,IZUMO1,tumor progression,molecular signature alteration,cell adhesion modulation,protein-protein interaction,cancer metastasis,overexpression
ENSG00000129749,CHRNA10,nicotinic acetylcholine receptor subunit alpha-10,oncogenesis,pi3k/akt pathway activation,tumor growth promotion,immunosuppression,epithelial-mesenchymal transition
ENSG00000174343,CHRNA9,alpha subunit,cell proliferation,dysregulated expression,ion channel function,ligand-gated receptor,neurotransmission regulation
ENSG00000152127,MGAT5,glycosylation regulation,tumor growth promotion,cell signaling modulation,angiogenesis and metastasis,therapeutic target,overexpression
ENSG00000052795,FNIP2,mtor pathway regulation,tumor suppressor function,loss of function mutations,tumor progression,cell survival promotion,protein-protein interaction
ENSG00000122012,SV2C,tumor progression,promoter,neurotransmitter regulation,cell membrane trafficking,protein interaction,signaling pathway disruption
ENSG00000158158,CNNM4,magnesium transport regulation,cellular homeostasis disruption,tumor growth promotion,potential tumor suppressor function,microrna regulation interaction,gene expression dysregulation
ENSG00000162836,ACP6,modulation of cell cycle,disruption of apoptosis,regulation of phosphodiester bonds,prognostic marker potential,therapeutic target candidate,signaling pathway interaction
ENSG00000167210,LOXHD1,genomic instability,oncogene regulation,homologous recombination,dna repair mechanism,tumor suppressor function,genomic profiling
ENSG00000126267,COX6B1,mitochondrial respiration,energy metabolism alteration,cellular proliferation support,therapeutic target,genomic instability association,metabolic regulation adaptation
ENSG00000236279,CLEC2L,tumor microenvironment modulation,immune response regulation,cell adhesion influence,protein-protein interaction,immune surveillance recognition,cancer cell behavior modulation
ENSG00000213934,HBG1,altered oxygen transport,cellular adaptation,dna repair interaction,energy metabolism alteration,hypoxia response,tumor microenvironment modification
ENSG00000183734,ASCL2,epithelial-to-mesenchymal transition,cancer stem cell maintenance,oncogenesis promotion,poor prognosis association,therapeutic target potential,transcription factor regulation
ENSG00000237123,CDSN,loss of adhesion,cell-cell interaction,tumor progression,metastasis,oncogenic function,adhesive properties
ENSG00000135272,MDFIC,apoptosis regulation,cell cycle progression,gene expression modulation,multifunctional protein,oncogenic properties,protein-protein interaction
ENSG00000263324,HCN3,tumor progression,cell proliferation,ion channel function,signaling pathway modulation,metastatic potential,prognostic marker
ENSG00000184571,PIWIL3,rna-mediated silencing,suppression of tumor suppressors,oncogene activation,tumor progression,therapeutic target,epigenetic regulation
ENSG00000167531,LALBA,cellular regulation,protein synthesis pathway,molecular chaperone function,dysregulation of oncogenesis,altered cell survival,tumor microenvironment alteration
ENSG00000166006,KCNC2,calcium-activated potassium channel,epithelial-to-mesenchymal transition,proliferation promoter,metastasis enhancer,pi3k/akt pathway regulator,tumor suppressor downregulation
ENSG00000151657,KIN,cellular proliferation,oncogenic driver,aberrant signaling,receptor tyrosine kinase activation,metastatic potential,angiogenesis promotion
ENSG00000171940,ZNF217,oncogenic transcription factor,chromatin remodeling complex regulation,transcriptional regulator of cell proliferation,tumor growth promoter,genomic amplification associated,cancer-specific microrna regulator
ENSG00000108231,LGI1,tumor suppressor,downregulated expression,pi3k/akt pathway regulation,apoptosis regulation,cell cycle regulation,synaptic plasticity regulation
ENSG00000165059,PRKACG,pkc activation,mapk/erk signaling,phosphorylation regulation,oncogenic pathway activation,tumor progression,cellular proliferation
ENSG00000214415,GNAT3,gnat3 involvement,g protein signaling regulation,pi3k/akt pathway modulation,cell growth enhancement,transcription factor interaction,oncogenic mutation
ENSG00000069018,TRPC7,calcium channel activation,oncogenic processes,tumor growth promotion,cell proliferation regulation,metastasis facilitation,therapeutic target
ENSG00000185808,PIGP,pig-linked proteins,oncogenesis,cell proliferation,migration invasion,prognostic biomarker,therapeutic target
ENSG00000171759,PAH,amino acid metabolism,mtor signaling,altered cellular behavior,oncogenic potential,tumor growth promotion,genetic interaction
ENSG00000143627,PKLR,enhanced glycolysis,tumor growth,energy metabolism,dysregulation,overexpression,glycolytic flux
ENSG00000141012,GALNS,tumor progression,extracellular matrix degradation,lysosomal storage disorder,glycosaminoglycan metabolism,cell migration and invasion,enzyme regulation
ENSG00000105499,PLA2G4C,phospholipase activity,lipid metabolism regulation,tumor progression,oncogenic pathway activation,prognostic marker,metastasis enhancement
ENSG00000132141,CCT6B,protein chaperone function,cell cycle regulation,cellular stress response,tumorigenesis driver,mutation associated,chaperone-protein interaction
ENSG00000144285,SCN1A,voltage-gated sodium channel regulation,cell proliferation enhancement,migration and invasion promotion,poor prognosis association,overexpression involvement,signaling pathway modulation
ENSG00000169857,AVEN,aurora b kinase activation,apoptosis regulation,cell cycle control,tumor suppressor function,dna repair modulation,genomic instability
ENSG00000117983,MUC5B,hypoxic niche formation,oncogenic processes,cell proliferation enhancement,metastasis promotion,signaling pathway modulation,tumor progression
ENSG00000152382,TADA1,genomic instability,dna repair regulation,chromatin remodeling,transcriptional dysregulation,cellular proliferation,protein interaction
ENSG00000119760,SUPT7L,histone modification,chromatin remodeling,oncogene regulation,gene expression modulation,cell growth regulation,tumor suppression
ENSG00000104325,DECR1,rna degradation,antitumor immunity,immunomodulation,oncogenic response,tumor regression,gene expression modulation
ENSG00000168781,PPIP5K1,phosphatidylinositol-4-phosphate 5-kinase activity,pi3k/akt pathway regulation,cell growth and survival signaling,oncogenic mutations,phosphoinositide metabolism,tumorigenesis driver
ENSG00000136295,TTYH3,microtubule regulation,cell migration,apoptosis evasion,tumor growth promotion,metastasis facilitation,prognostic biomarker
ENSG00000164197,RNF180,ubiquitin ligase activity,cell cycle regulation,apoptosis suppression,oncogenic signaling pathway activation,dna repair interaction,protein-protein interaction
ENSG00000140455,USP3,cell cycle regulation,ubiquitination and proteasomal degradation,apoptosis evasion,tumor suppressor protein interaction,oncogenic activity,prognostic marker
ENSG00000066923,STAG3,chromatin remodeling,cooperative interaction,genome instability,cellular transformation,tumor suppressor function,therapeutic target
ENSG00000164091,WDR82,oncogenic transcription factor regulation,mrna stability modulation,ccr4-not complex subunit,epigenetic modification regulator,transcriptional program regulator,poor prognosis marker
ENSG00000143867,OSR1,insulin signaling,oncogenic process,cell proliferation,kinase activation,tumor progression,pi3k/akt pathway
ENSG00000198168,SVIP,tumor suppressor function,cell proliferation inhibition,cell migration inhibition,protein-protein interaction,downregulated expression,regulatory mechanism
ENSG00000121440,PDZRN3,loss of function mutations,tumor suppression,apoptosis regulation,cell cycle arrest,pi3k/akt pathway interaction,dna repair dysfunction
ENSG00000196177,ACADSB,metabolic regulation,tumor suppressor,bcaa metabolism,warburg effect,energetic shift,cellular proliferation
ENSG00000055483,USP36,protein degradation,deubiquitination activity,apoptosis regulation,dna repair modulation,tumor suppressor interaction,therapeutic target
ENSG00000239900,ADSL,tumor metabolism,amp synthesis,nucleotide balance regulation,cell growth regulation,mtor pathway interaction,dna repair regulation
ENSG00000135913,USP37,gain of function mutations,apoptosis inhibition,cell cycle progression,dna repair regulation,prognostic biomarker,therapeutic target
ENSG00000136014,USP44,tumor progression,cancer cell survival,genome instability,dna repair regulation,kinase activity regulation,tumor suppressor inactivation
ENSG00000178445,GLDC,oncogenic mutation,altered metabolic function,energy metabolism regulation,redox balance disruption,rapid cell proliferation,cellular energy production
ENSG00000141404,GNAL,gnal mutations,cancer cell proliferation,akt/mtor activation,g protein signaling dysregulation,cell survival promotion,constitutive g protein activity
ENSG00000140986,RPL3L,ribosomal subunit component,alters protein synthesis,overexpression associated with poor prognosis,tumor growth promotion,pseudogene expression,cellular proliferation enhancement
ENSG00000223443,USP17L2,oncogenic activation,cell proliferation enhancement,genomic instability promotion,therapeutic target identification,ubiquitination regulation disruption,tumor progression association
ENSG00000186866,POFUT2,notch signaling,cellular proliferation,cell migration,tumor aggressiveness,glycosyltransferase activity,o-fucose modification
ENSG00000109016,DHRS7B,cellular regulation,oncogene potential,metabolic regulation,protein-protein interaction,pi3k/akt pathway involvement,tumor progression driver
ENSG00000005100,DHX33,transcriptional regulation,genome stability maintenance,dna repair facilitation,oncogene/tumor suppressor role,cell proliferation enhancement,subcellular localization alterations
,FAM129B,pi3k/akt/mtor pathway regulation,immune evasion,tumor progression,metastasis promotion,cell surface receptor regulation,oncogenic signaling
ENSG00000115368,WDR75,homologous recombination repair,telomere maintenance,cell cycle regulation,dna damage response,chromatin remodeling,genomic stability
ENSG00000183605,SFXN4,genomic instability,mitochondrial dysfunction,iron-sulfur cluster assembly,dna damage repair,oncogenic driver,tumor progression
ENSG00000163584,RPL22L1,ribosomal protein expression,tumor progression marker,overexpression in cancer,cell proliferation regulation,apoptosis modulation,genomic instability
ENSG00000165097,KDM1B,histone demethylation,epigenetic regulation,cell differentiation,apoptosis inhibition,proliferation regulation,tumor suppressor activity
ENSG00000187772,LIN28B,oncogenesis,promotes proliferation,cellular self-renewal,pluripotency regulation,let-7 microrna regulation,tumor progression
ENSG00000143493,INTS7,chromatin remodeling,tumor suppressor,cell cycle progression,dna damage response,transcriptional regulation,genomic stability maintenance
ENSG00000111231,GPN3,glycosylation dysregulation,tumor progression,metabolic reprogramming,cell survival enhancement,genetic instability promotion,oncogenic pathway activation
ENSG00000182521,TBPL2,cellular proliferation,genetic dysregulation,oncogenic signaling,tumor progression,transcriptional regulation,apoptosis suppression
ENSG00000112992,NNT,nad+ kinase activity,disrupted cellular energy homeostasis,increased oxidative stress,activation of pi3k/akt pathway,tumor progression,metabolic regulation
ENSG00000156011,PSD3,epigenetic regulator,chromatin remodeling,transcriptional regulation,oncogene function,cell proliferation driver,genome stability maintainer
ENSG00000198690,FAN1,dna repair mechanism,genomic instability,cancer resistance,oncogenesis,prognostic marker,cellular damage response
ENSG00000188322,SBK1,oncogenic signaling,pro-tumorigenic effects,overexpression,promotes tumorigenesis,tumor progression,apoptosis regulation
ENSG00000155115,GTF3C6,transcriptional regulation,rna polymerase iii,tfiiic complex,gene expression,cellular proliferation,tumor suppressor function
ENSG00000241476,SSX2,oncogenic activity,transcriptional regulation,brca1 interaction,cell proliferation,genomic instability,apoptosis suppression
ENSG00000268447,SSX2B,chromatin remodeling,oncogene expression,tumor suppressor interaction,cell proliferation driver,histone modification regulation,prognostic biomarker
ENSG00000119547,ONECUT2,cell cycle regulation,transcriptional regulation,tumor suppressor repression,oncogene overexpression,apoptosis inhibition,chromatin remodeling
ENSG00000115827,DCAF17,ubiquitination regulation,tumor suppressor dysregulation,cancer prognosis marker,chromatin remodeling complex component,e3 ubiquitin ligase interaction,oncogenic role
ENSG00000180233,ZNRF2,wnt signaling regulation,gene mutations,oncogenic pathway activation,loss-of-function mutations,tumor suppressor function,cancer therapeutic target
ENSG00000258659,TRIM34,oncogene activation,p53 regulation,cell survival promotion,pi3k/akt pathway interaction,dna damage response modulation,ubiquitination and proteasomal degradation
ENSG00000163564,PYHIN1,tumor suppression,tumor microenvironment modulation,immune evasion,dna repair mechanisms,cell cycle regulation,apoptosis induction
ENSG00000125703,ATG4C,autophagy regulation,protein degradation pathway disruption,tumor growth promotion,cell survival enhancement,therapeutic target for chemotherapy resistance,signaling pathway modulation
ENSG00000099814,CEP170B,centrosome amplification,genomic instability,cell proliferation,oncogenic signaling,microtubule dynamics,antibody target
ENSG00000162396,PARS2,genomic stability regulation,tumor progression,parp1 activation,cell proliferation,angiogenesis enhancement,prognostic marker
ENSG00000066084,DIP2B,histone h3k4me3 degradation,epigenetic regulation disruption,chromatin remodeling,cell proliferation enhancement,tumor progression promotion,epi-drug target
ENSG00000189195,BTBD8,chromatin remodeling,dna repair mechanism,tumor suppressor function,oncogenic transformation,transcriptional regulation,genomic instability
ENSG00000105662,CRTC1,cellular proliferation,transcriptional coactivation,oncogenic transformation,mtor signaling pathway,metabolic regulation,tumor progression
ENSG00000175121,WFDC5,wnt/β-catenin pathway,tumor progression,oncogene,cellular proliferation regulation,dysregulation,protein interactions
ENSG00000111704,NANOG,cancer stem cell maintenance,cell cycle regulation,tumor progression,apoptosis suppression,therapeutic target,oncogenic transcription factor
ENSG00000267680,ZNF224,genetic regulation,tumor progression,cellular proliferation,potential oncogene,gene expression modulation,zinc finger domain interaction
ENSG00000124459,ZNF45,transcriptional repressor function,cell cycle regulation,tumor progression,dna repair pathways,apoptosis evasion,therapeutic target
ENSG00000167380,ZNF226,transcription regulation,nuclear localization,oncogene overexpression,tumor progression,metastasis promotion,prognostic marker
ENSG00000146757,ZNF92,cell growth regulation,transcriptional repression,dna repair regulation,tumor progression,apoptosis inhibition,genomic instability modulation
ENSG00000235109,ZSCAN31,tumor suppressor function,transcriptional regulation,cell cycle modulation,apoptosis induction,genetic repressor activity,cancer prevention target
ENSG00000135638,EMX1,transcription factor regulation,cell cycle progression,tumor suppressor function,loss of expression,mutation accumulation,apoptosis inhibition
ENSG00000128645,HOXD1,hox gene regulation,cancer cell proliferation,tumor growth promotion,cell cycle progression modulation,metastasis facilitation,transcription factor interaction
ENSG00000169989,TIGD4,genomic instability,pi3k/akt pathway activation,oncogene function,cell proliferation promotion,dna damage response disruption,tumor progression enhancement
ENSG00000165583,SSX5,chromatin remodeling,t-box transcription factor interaction,oncogenic protein cooperation,cell proliferation enhancement,survival pathway modulation,poor prognosis association
ENSG00000115421,PAPOLG,mrna regulation,cell proliferation,protein overexpression,cell survival,tumor progression,altered expression
ENSG00000005801,ZNF195,krab domain,transcriptional regulation,oncogene upregulation,cell proliferation,apoptosis inhibition,tumor suppression
ENSG00000151240,DIP2C,microtubule dynamics regulation,cellular proliferation,metastasis promotion,epithelial-to-mesenchymal transition (emt),tumor growth facilitation,therapeutic target
ENSG00000160352,ZNF714,transcriptional regulation,tumor growth promotion,cell cycle progression,dna repair modulation,zinc finger protein structure,oncogenic gene expression
ENSG00000215421,ZNF407,transcriptional regulation,tumor suppressor activity,cell proliferation modulation,apoptosis regulation,dna damage response,potential oncogene
ENSG00000198039,ZNF273,zinc finger transcription factor,oncogenic function,cell proliferation regulation,apoptosis inhibition,tumor progression promoter,poor prognosis marker
ENSG00000164651,SP8,transcriptional regulation,oncogene activity,cell cycle modulation,chromatin remodeling,apoptosis evasion,tumor suppressor interaction
ENSG00000172000,ZNF556,transcriptional regulation,chromatin remodeling,dna binding,oncogenic transcription,cell growth promotion,tumorigenesis driver
ENSG00000175322,ZNF519,gata transcription factor,transcriptional regulation,cell cycle progression,oncogenic changes,epigenetic regulation,prognostic biomarker
ENSG00000171467,ZNF318,zinc finger protein regulation,tumor suppressor function,transcriptional regulation,chromatin remodeling,gene expression modulation,oncogenic role
ENSG00000185669,SNAI3,emt induction,epithelial-to-mesenchymal transition,cell migration and invasion,transcriptional regulation,oncogenic driver,metastatic progression
ENSG00000081665,ZNF506,dna-binding,transcriptional regulation,epigenetic modification,gene expression suppression,oncogene activation,tumorigenesis promotion
ENSG00000111639,MRPL51,mtor signaling pathway,mitochondrial function,cell proliferation,enhanced tumorigenesis,poor prognosis,translation regulation
,H2BFM,histone modification,chromatin remodeling,tumor suppressor activity,genomic instability,cell cycle regulation,anti-apoptotic function
ENSG00000176387,HSD11B2,mineralocorticoid regulation,dysregulation in cancer,tumor microenvironment modulation,epithelial-to-mesenchymal transition (emt),apoptosis resistance,wnt/β-catenin pathway interaction
ENSG00000204335,SP5,transcriptional regulation,oncogene activation,cell proliferation,transcription factor activity,gene expression modulation,cell growth promotion
ENSG00000269058,CALR3,calcium homeostasis regulation,cellular signaling modulation,tumor progression enhancement,proliferation promotion,survival pathway activation,genomic instability driver
ENSG00000167136,ENDOG,angiogenesis promotion,tgf-β pathway interaction,cellular differentiation inhibition,oncogene potential,prognostic marker,vascular endothelial growth factor interaction
ENSG00000188786,MTF1,mtf1-binding sites,oxidative stress regulation,metal homeostasis,transcriptional activation,tumor growth promotion,poor prognosis association
ENSG00000101493,ZNF516,tumor suppressor function,transcriptional regulation,chromatin remodeling,histone modification,dna binding activity,cell cycle progression
ENSG00000108423,TUBD1,cell cycle regulation,genomic stability,dna repair mechanisms,deubiquitinating enzyme activity,homologous recombination,tumor suppressor function
ENSG00000145476,CYP4V2,lipid metabolism regulation,detoxification process involvement,prognostic marker,therapeutic target,oncogene interaction,tumor growth influence
ENSG00000125520,SLC2A4RG,glucose metabolism regulation,cell growth modulation,oncogenic potential,metabolic reprogramming,pi3k/akt pathway interaction,cancer-related metabolic alterations
ENSG00000153391,INO80C,genomic instability,chromatin remodeling,dna replication repair,tumor suppressor regulation,oncogenic mutations,tumor aggressiveness
ENSG00000283510,INO80D,genomic stability,cell growth regulation,dna repair,chromatin remodeling,tumor suppressor regulation,tumor progression
ENSG00000100601,ALKBH1,dna damage response,genome stability maintenance,tumor progression driver,cell survival enhancement,epigenetic regulation,stress adaptation mechanism
ENSG00000130997,POLN,genomic stability,dna replication,tumor progression,metastasis promotion,oncogenic process,cell cycle regulation
ENSG00000118245,TNP1,cell cycle regulation,apoptosis resistance,dna repair mechanism,tumor growth promotion,cell proliferation enhancement,protein-protein interaction
ENSG00000100162,CENPM,genomic instability,aneuploidy,cell proliferation,tumor progression,chromosomal abnormalities,dna damage response
,HIST1H2AD,histone modification,epigenetic regulation,chromatin remodeling,gene expression alteration,tumor growth promotion,cell proliferation enhancement
ENSG00000130304,SLC27A1,lipid metabolism,cancer cell energy,fatty acid activation,oncogenesis,tumor progression,therapeutic target
ENSG00000155307,SAMSN1,apoptosis regulation,tumor suppression,caspase inhibition,cell death evasion,protein interaction,genomic instability
ENSG00000147180,ZNF711,zinc finger protein,transcriptional regulation,oncogenic properties,cell proliferation,dna repair mechanism,tumor growth promotion
ENSG00000184735,DDX53,genomic instability,dna damage response,loss of function mutation,tumor suppressor,cellular regulation,apoptosis modulation
ENSG00000187821,HELT,dna replication regulation,genomic instability,helicase activity disruption,oncogene expression,transcriptional dysregulation,tumor suppression
ENSG00000184058,TBX1,transcription regulation,gene expression modulation,tumor progression,oncogene activation,cell proliferation regulation,dysregulation associated with tumorigenesis
ENSG00000050030,NEXMIF,transcriptional regulation,g1/s transition phase,cell proliferation,survival pathways,metastasis promotion,apoptosis evasion
ENSG00000263141,PAXBP1,transcriptional regulation,constitutive activation,oncogenic processes,cell proliferation,tumor suppressor genes,microrna regulation
ENSG00000284869,EEFSEC,mrna translation regulation,tumor progression,cell proliferation,protein-protein interactions,biomarker potential,translation initiation phase
ENSG00000008311,AASS,bh4 biosynthesis,cellular metabolism,disrupted redox balance,glycolytic regulation,mitochondrial dysfunction,oxidative stress response
ENSG00000176623,RMDN1,p53 regulation,e3 ubiquitin ligase activity,dna damage response,genomic stability maintenance,cell cycle regulation,apo-5 ubiquitination
ENSG00000168297,PXK,pi3k/akt pathway regulation,cell cycle progression regulation,apoptosis evasion,tumor progression promotion,signaling molecule interaction,protein phosphorylation
ENSG00000154493,C10orf90,cell cycle progression,mitotic checkpoint,serine/threonine kinase activity,oncogenic process,tumor aggressiveness,kinase regulation
ENSG00000125246,CLYBL,mitochondrial function,redox state regulation,cellular metabolism,apoptosis resistance,protein folding,mitochondrial dynamics
ENSG00000103855,CD276,tumor necrosis factor receptor superfamily,oncogene function,immune evasion,tl1a ligand activation,cell proliferation enhancement,tumor metastasis promotion
ENSG00000075275,CELSR1,wnt/β-catenin pathway,transmembrane receptor function,cell adhesion regulation,tumor metastasis,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000150893,FREM2,pi3k/akt pathway,cell adhesion disruption,extracellular matrix interaction,tumor migration facilitation,gene expression alteration,oncogenic signaling modulation
ENSG00000148842,CNNM2,calcium homeostasis disruption,cellular metabolism regulation,cancer cell proliferation enhancement,endoplasmic reticulum localization,oncogenic process involvement,prognostic marker significance
ENSG00000196159,FAT4,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,tumor suppressor function,cellular adhesion regulation,cancer stem cell inhibition,poor prognosis marker
ENSG00000166341,DCHS1,cell-cell adhesion,tumor suppression,cell proliferation,adhesion molecule regulation,cancer progression,cell migration
ENSG00000169851,PCDH7,cell adhesion disruption,oncogene activation,protein-protein interaction,signaling pathway modulation,cancer progression driver,tumor suppressor function loss
ENSG00000280165,PCDH20,tumor suppression,cell adhesion regulation,epithelial-to-mesenchymal transition inhibition,protein-protein interaction,cell communication disruption,metastasis prevention
ENSG00000253873,PCDHGA11,cell adhesion disruption,tumor suppressor function,loss of expression,epithelial-to-mesenchymal transition (emt) regulation,pi3k/akt pathway interaction,cancer cell proliferation and invasion
ENSG00000165323,FAT3,altered lipid metabolism,cell proliferation,oncogenic mutation,fatty acid transport,pi3k/akt pathway interaction,metastasis promotion
ENSG00000203972,GLYATL3,pi3k/akt/mtor pathway,oncogene,cellular proliferation,tumor progression,epigenetic regulation,long non-coding rna
ENSG00000263243,KRT12,cell adhesion,cell migration,resistance to therapy,tumor progression,biomarker for prognosis,ectopic expression
ENSG00000072778,ACADVL,altered cellular metabolism,decreased enzyme activity,contribution to tumorigenesis,potential therapeutic target,impact on gene expression,disruption of normal cellular processes
ENSG00000136010,ALDH1L2,tumor progression,detoxification processes,cellular redox balance,reactive oxygen species regulation,metabolic modulation,prognostic biomarker
ENSG00000157184,CPT2,mitochondrial beta-oxidation pathway,fatty acid breakdown,cardiomyopathy risk,oxidative stress modulation,cellular energy production,mitochondrial dysfunction
ENSG00000069998,HDHD5,lipid metabolism regulation,methyltransferase activity,tumorigenesis involvement,oncogenic potential,cell growth modulation,protein stability regulation
ENSG00000182810,DDX28,cell cycle regulation,oncogene activation,pi3k/akt pathway interaction,constitutive activation,rna helicase function,metastatic potential
ENSG00000132463,GRSF1,rna regulation,cell proliferation,oncogenic translation,tumor suppressor modulation,apoptosis resistance,protein interaction
ENSG00000100294,MCAT,constitutive activation,protein-protein interaction,cellular membrane trafficking,biomarker potential,oncogenic pathway activation,genomic profiling
ENSG00000114686,MRPL3,oncogenic function,metabolic reprogramming,protein synthesis regulation,mitochondrial function regulation,cell survival enhancement,tumor progression acceleration
ENSG00000106591,MRPL32,mitochondrial translation,glycolytic adaptation,tumor aggressiveness,poor prognosis marker,energy metabolism dysregulation,ribosomal protein interaction
ENSG00000136897,MRPL50,mitochondrial ribosomal function,regulatory mechanisms,cellular metabolism adaptation,tumor aggressiveness predictor,oncogenic processes driver,genomic instability mediator
ENSG00000183617,MRPL54,aberrant protein synthesis,mitochondrial dysfunction,cancer progression,enhanced tumor growth,chemotherapy resistance,cellular metabolism regulation
ENSG00000162910,MRPL55,mitochondrial ribosomal function,oncogenic transformation,cell proliferation,metastasis,translation efficiency,tumor progression
ENSG00000122140,MRPS2,mitochondrial biogenesis dysfunction,altered translation efficiency,metabolic reprogramming,tumor progression marker,regulatory mechanism dysregulation,e3 ubiquitin ligase interaction
ENSG00000112996,MRPS30,mitochondrial translation,regulatory function,tumor suppressor activity,cellular proliferation,energy metabolism,apoptosis resistance
ENSG00000177192,PUS1,rna splicing regulation,cellular proliferation,oncogenic processes,gene expression regulation,tumorigenesis,pre-mrna maturation
ENSG00000143374,TARS2,genomic instability,protein synthesis dysregulation,translation factors interaction,cell cycle progression,transcriptional regulation modulation,oncogenic signaling pathway activation
ENSG00000112941,TENT4A,alternative splicing regulation,protein processing regulation,microrna-mediated gene expression,cellular proliferation enhancement,rna metabolism disruption,oncogenic function modulation
,MARCH1,march1 function,ubiquitin-proteasome pathway,cellular proliferation,tumor suppressor,protein degradation,apo-1/fas signaling
ENSG00000108479,GALK1,glycolysis promotion,tumor growth support,cell proliferation enhancer,oncogenic process contributor,prognostic marker,metabolic regulation
ENSG00000180855,ZNF443,zinc finger protein regulation,tumor suppressor activity,transcriptional regulation,cellular differentiation,proliferation regulation,apoptosis inhibition
ENSG00000007174,DNAH9,ciliary dysfunction,cell division regulation,genomic instability,cancer susceptibility,mitotic spindle assembly,somatic mutations
ENSG00000141696,P3H4,collagen regulation,tumor microenvironment modulation,angiogenesis promotion,cancer progression contributor,cellular stress response regulation,protein interaction partner
ENSG00000185432,METTL7A,m6a regulation,cell proliferation enhancement,rna stability modulation,oncogenic process promotion,therapeutic target potential,genomic instability influence
ENSG00000065518,NDUFB4,mitochondrial function,tumor metabolism,oncogenic mutations,energy production,electron transport chain,cellular respiration
ENSG00000155962,CLIC2,ion channel regulation,tumor progression,apoptosis modulation,cellular transformation,emt process regulation,protein-protein interaction
ENSG00000114124,GRK7,gpcr desensitization,g-protein coupled receptor signaling pathway,oncogenesis,cell proliferation regulation,tumor development promoter,cellular migration
ENSG00000204977,TRIM13,immune evasion,tumor proliferation,apoptosis resistance,cell cycle regulation,protein-protein interactions,genetic instability
ENSG00000120008,WDR11,chromatin remodeling,transcriptional regulation,cell cycle control,dysregulation,aggressive tumor behavior,genome instability
ENSG00000284807,DHRS4,cellular redox balance regulation,cell proliferation promotion,tumor suppressor protein interaction,apoptosis inhibition,metabolic regulation,protein kinase activation
ENSG00000168546,GFRA2,gdnf signaling,ras/mapk pathway activation,cell proliferation,metastasis,poor prognosis,oncogenic driver
ENSG00000211448,DIO2,thyroid hormone axis,mapk/erk signaling,proliferation suppression,apoptosis inhibition,oncogenic pathway activation,tumor aggressiveness
ENSG00000181873,IBA57,tumor suppressor activity,protein synthesis regulation,dna damage response,cellular stress response,genome stability maintenance,oncogenic protein accumulation
ENSG00000100226,GTPBP1,mitochondrial regulation,oncogenic signaling,tumor growth promotion,poor prognosis association,cell cycle modulation,angiogenesis regulation
ENSG00000123684,LPGAT1,lipid metabolic pathway,cell membrane homeostasis,tumor progression,fatty acid synthesis,phospholipid synthesis,biomarker for disease aggressiveness
ENSG00000197563,PIGN,pig anchor biosynthesis,mutational activation,glycosylphosphatidylinositol modifications,enhanced protein expression,cell signaling regulation,tumor growth promotion
ENSG00000196458,ZNF605,oncogene,pi3k/akt signaling,cell proliferation,genomic instability,dna damage,transcriptional regulation
ENSG00000213221,DNLZ,atp-dependent rna helicase activity,chromatin remodeling,dna damage response,genomic instability,transcriptional regulation,none
ENSG00000130309,COLGALT1,intracellular ph regulation,cell migration,tumor progression,extracellular matrix degradation,proteoglycan synthesis,hypoxic response
ENSG00000053438,NNAT,cell proliferation,growth factor regulation,tumor progression,cell survival,gene expression regulation,metastasis
ENSG00000166796,LDHC,glycolytic shift,oncogenic function,metabolic adaptation,cell proliferation,tumor progression,therapeutic resistance
ENSG00000106038,EVX1,wnt/beta-catenin signaling,chromatin remodeling,epithelial-to-mesenchymal transition,cell cycle progression,transcription factor regulation,oncogenic protein interaction
ENSG00000186017,ZNF566,krüppel-associated box domain,chromatin remodeling,transcriptional repression,overexpression in cancer,epithelial-to-mesenchymal transition,cancer stem cell maintenance
ENSG00000083812,ZNF324,zinc finger protein regulation,tumor suppressor gene suppression,oncogenic pathway promotion,cell proliferation enhancement,metastasis facilitation,pi3k/akt signaling pathway regulation
ENSG00000159917,ZNF235,oncogenic transcription factor,cell cycle regulation,apoptosis inhibition,genomic instability,protein-protein interaction,tumor progression marker
ENSG00000137573,SULF1,sulfation of heparan sulfate,tumor progression,cell migration and invasion,growth factor activation,therapeutic resistance,signaling molecule interaction
ENSG00000138336,TET1,dna demethylation,epigenetic regulator,tumor suppressor function,genome stability maintenance,dysregulated expression,target for therapy
ENSG00000263310,SALL3,transcription factor regulation,oncogenic mutation,embryonic development,cell growth repression,tumor driver,gene amplification
ENSG00000163872,YEATS2,chromatin regulation,histone modification recognition,tumor suppressor function,oncogenic processes promotion,gene expression regulation,transcriptional repression
,H2AFJ,cellular proliferation,chromatin structure disruption,dna damage response inhibition,genomic instability promotion,histone modification regulation,oncogene activation
ENSG00000178449,COX14,mitochondrial biogenesis,metabolic reprogramming,electron transport chain,tumor growth promotion,mitochondrial metabolism alteration,proliferation enhancement
ENSG00000051596,THOC3,transcription elongation,mrna export,oncogene expression,cell proliferation,metastasis facilitation,nuclear export regulation
ENSG00000234438,KBTBD13,tumor suppressor modulation,gene overexpression,tumor progression,apoptosis regulation,cancer driver gene,protein degradation
,H2AFB1,chromatin remodeling,dna repair,genome stability maintenance,histone modification regulation,nucleoplasmic localization,transcriptional activation modulation
ENSG00000112699,GMDS,microtubule stabilization,cell proliferation enhancement,apoptosis inhibition,oncogenic process promotion,golgi apparatus regulation,cell growth promotion
ENSG00000153933,DGKE,cell proliferation,promotes tumor growth,resistance to apoptosis,pi3k/akt pathway regulation,phosphatidic acid metabolism,overexpression in tumors
ENSG00000058866,DGKG,enhanced lipid metabolism,activation of pi3k/akt signaling,overexpression implicated,tumor progression associated,epithelial-to-mesenchymal transition,metabolic regulation critical
ENSG00000091704,CPA1,cellular proteolysis,peptide breakdown,tumor growth promotion,metastasis enhancement,angiogenesis facilitation,oncogenic process activation
ENSG00000180138,CSNK1A1L,cell cycle regulation,epigenetic regulation,pi3k/akt/mtor pathway activation,protein phosphorylation and signaling,tumor progression promotion,apoptosis modulation
ENSG00000066422,ZBTB11,tumor suppressor,genome stability,cell cycle regulation,dna damage response,apoptosis induction,transcriptional regulation
ENSG00000288503,DDX51,telomere maintenance,dna repair mechanism,genomic stability regulation,cancer prognosis marker,replication stress response,prognostic value
ENSG00000138380,CARF,rna processing regulation,oncogene activation,epigenetic silencing,tumor progression,cell survival adaptation,transcriptional regulation
ENSG00000112695,COX7A2,mitochondrial dysfunction,altered cellular metabolism,energy production disruption,increased ros generation,dna damage induction,tumor progression acceleration
ENSG00000169515,CCDC8,amplification,cell signaling pathway interaction,cilia dysfunction,oncogenic driver,tumor aggressiveness,cancer prognosis
ENSG00000101003,GINS1,genomic instability,cell division regulation,dna replication synthesis,oncogenesis association,poor prognosis marker,apoptosis regulation
ENSG00000124479,NDP,wnt/β-catenin signaling pathway,angiogenesis promotion,biomarker potential,tumor progression facilitation,cell proliferation enhancement,poor prognosis association
ENSG00000141314,RHBDL3,apoptosis inhibition,cell survival enhancement,tumor progression promotion,protein-protein interaction regulation,kidney cancer association,cell death regulation
ENSG00000196275,GTF2IRD2,transcriptional regulation,epithelial-to-mesenchymal transition,oncogenic processes,cell proliferation,apoptosis modulation,metastasis regulation
ENSG00000075461,CACNG4,calcium channel function,cell proliferation enhancement,oncogenic interaction,tumor progression facilitation,genomic amplification,electrical signal modulation
ENSG00000133256,PDE6B,aberrant signaling pathway,cellular proliferation,cancer progression,gene mutation,photoreceptor regulation,signal transduction
ENSG00000181588,MEX3D,microrna regulation,oncogenic function,tumor microenvironment interaction,cellular proliferation promotion,prognostic marker,post-transcriptional regulation
ENSG00000180011,ZADH2,glycolytic shift,metabolic adaptation,oncogenic potential,tumor hypoxia,lactate production,energy metabolism
ENSG00000175193,PARL,cell survival resistance,mitochondrial regulation,apoptotic pathway inhibition,oncogenic protein stabilization,energy metabolism regulation,cancer cell proliferation promotion
ENSG00000180901,KCTD2,tumor suppression,tumor progression,proliferation regulation,apoptosis modulation,mutation hotspot,diagnostic marker
ENSG00000112078,KCTD20,cellular signaling modulation,protein-protein interaction,oncogenic role,cell proliferation regulation,tumor aggressiveness marker,poor prognosis indicator
ENSG00000102271,KLHL4,tumor suppressor function,dna damage response regulation,chromatin remodeling,cell cycle progression control,e3 ubiquitin ligase activity,genotoxic stress modulation
ENSG00000155729,KCTD18,tumor suppressor function,ion channel regulation,cell survival promotion,protein-protein interaction,cancer aggressiveness association,potassium homeostasis modulation
ENSG00000137200,CMTR1,mitochondrial function,ca2+ signaling pathway,oncogene potential,apoptosis regulation,cellular proliferation,calcium homeostasis
ENSG00000197345,MRPL21,mitochondrial protein synthesis,cellular metabolism regulation,tumor growth promotion,cell proliferation enhancement,oncogenic factor interaction,metabolic reprogramming
ENSG00000258366,RTEL1,telomerase activity,genomic instability,dna helicase function,homologous recombination repair,tumor progression,chromosomal stability
ENSG00000121940,CLCC1,chloride transport regulation,cellular homeostasis disruption,apoptosis resistance,epithelial-to-mesenchymal transition,tumor progression,ion balance alterations
ENSG00000131043,AAR2,40s ribosomal subunit assembly,autophagy regulation,cellular proliferation,overexpression,protein degradation regulation,tumor progression
ENSG00000112584,FAM120B,cell cycle regulation,chromatin remodeling,epigenetic regulation,genome stability maintenance,interactions with brca1,bcl3 pathways activation
ENSG00000131459,GFPT2,hexosamine biosynthetic pathway,glycosylation regulation,oncogenic properties,tumor progression,protein kinase activation,cell proliferation
ENSG00000134744,TUT4,enhanced mrna stability,increased oncogene expression,oncogenic role,nuclear localization,cell proliferation promotion,therapeutic target
ENSG00000138413,IDH1,epigenetic regulation,metabolic reprogramming,oncogenic transformation,tumor suppressor mutation,altered histone modification,epigenetic silencing
ENSG00000253506,NACA2,transcriptional coactivator,overexpressed in cancer,promotes oncogenic transcription,chaperone function,rna polymerase ii regulation,biomarker for disease progression
ENSG00000153093,ACOXL,regulation of lipid metabolism,fatty acid oxidation pathway,metabolic reprogramming,peroxisomal enzyme function,cellular redox state modulation,hypoxic response regulation
ENSG00000140876,NUDT7,dna damage response,homologous recombination repair,genomic instability,base excision repair,dna repair regulation,nucleotide metabolism
ENSG00000130584,ZBTB46,tumor suppressor function,cell cycle regulation,dna binding activity,oncogenesis inhibition,chromatin modification,epigenetic regulation
ENSG00000165487,MICU2,calcium signaling,mitochondrial function,cell survival pathways,tumor suppressor function,cellular stress response,calcium regulation
ENSG00000188573,FBLL1,tumor suppressor function,cell cycle regulation,protein degradation regulation,apoptosis regulation,cancer-related mutations,cell proliferation modulation
ENSG00000126249,PDCD2L,apoptosis regulation,cell death pathway modulation,tumor growth inhibition,cancer therapy target,protein interaction,stress response regulation
ENSG00000180098,TRNAU1AP,trna pseudouridylation,nucleolar localization,transfer rna modification,oncogenic potential,cellular proliferation,cancer biology
ENSG00000172469,MANEA,cellular regulation,protein-protein interactions,cytoplasmic localization,cell growth regulation,potential oncogene,none
ENSG00000119655,NPC2,npc2-npc1 complex dysfunction,lipid metabolism alteration,cholesterol regulation disruption,tumor suppressor gene function,protein trafficking impairment,cellular homeostasis disruption
ENSG00000156282,CLDN17,tumor suppressor dysfunction,epithelial-to-mesenchymal transition,egfr pathway activation,cell growth promotion,overexpression biomarker,poor prognosis indicator
ENSG00000257008,GPR142,metabolic reprogramming,glycolysis enhancement,lipid metabolism regulation,tumor growth promotion,biomarker potential,oncogenic function
ENSG00000047648,ARHGAP6,rho gtpase regulation,cancer progression,cell migration,tumor suppressor loss,oncogenic signaling,therapeutic target
ENSG00000263238,CTSO,lysosomal degradation,apoptosis evasion,proteolytic activity,cancer progression,immune suppression,metastatic potential
ENSG00000186479,RGS7BP,regulation of g-protein signaling,cell surface receptor regulation,signal transduction,cancer progression,overexpression,cell survival
ENSG00000203780,FANK1,microtubule regulation,tumor suppression,cell proliferation,apoptosis resistance,metastasis inhibition,pro-oncogenic pathway regulation
ENSG00000198216,CACNA1E,calcium influx modulation,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,therapeutic target identification,ion channel dysregulation
ENSG00000142910,TINAGL1,cytoskeletal regulation,epithelial-to-mesenchymal transition,cell migration and invasion,oncogene overexpression,tumor progression and metastasis,therapeutic target for cancer treatment
ENSG00000125831,CST11,genomic instability,cancer cell proliferation,apoptosis inhibition,tumor growth promotion,cell cycle regulation,protein-protein interaction
ENSG00000152454,ZNF256,tumor suppression,pi3k/akt pathway inhibition,transcriptional regulation,apoptosis induction,cellular senescence modulation,gene expression modification
ENSG00000112379,ARFGEF3,membrane trafficking,arf1 regulation,gene overexpression,tumor cell proliferation,secretion pathway dysregulation,cancer biomarker
ENSG00000170255,MRGPRX1,overexpression,tumor progression,cancer prognosis,promotes angiogenesis,g protein signaling pathway,immune response modulation
ENSG00000114796,KLHL24,protein degradation,oncogenic protein accumulation,cell cycle regulation,tumor suppression,apoptosis regulation,ubiquitin ligase complex interaction
ENSG00000142634,EFHD2,pi3k/akt pathway regulation,tumor suppression,transcription factor regulation,cell cycle regulation,apoptosis modulation,genetic dysregulation
ENSG00000188158,NHS,iron regulation dysregulation,hypoxia response modulation,cellular metabolism alteration,tumor progression facilitation,apoptosis resistance,angiogenesis promotion
ENSG00000152784,PRDM8,chromatin remodeling,histone modification,transcriptional regulation,tumor suppressor function,apoptosis regulation,cell cycle control
ENSG00000119125,GDA,rab gtpase regulation,cellular vesicle transport,tumor growth promotion,therapeutic target,oncogenic pathway modulation,protein-protein interactions
ENSG00000169154,GOT1L1,metabolic regulation,cell growth regulation,amino acid metabolism,tumor progression,oxidative stress response,energy production
ENSG00000025708,TYMP,angiogenesis,oncogene,nucleotide metabolism,tumor growth,metastasis promoter,dna synthesis regulator
ENSG00000255346,NOX5,angiogenesis enhancement,cancer stem cell maintenance,epithelial-to-mesenchymal transition (emt),oncogenic processes promotion,reactive oxygen species production,signaling pathway activation
ENSG00000173626,TRAPPC3L,cellular proliferation,apoptosis inhibition,tumor growth promotion,protein transport regulation,endoplasmic reticulum-to-golgi transport,cancer cell survival enhancement
ENSG00000128159,TUBGCP6,mitotic spindle assembly,oncogene overexpression,cell division regulation,microtubule stability,chemotherapy resistance,cell cycle progression
ENSG00000175854,SWI5,dna repair dysregulation,genomic instability promotion,tumor progression facilitation,homologous recombination involvement,overexpression association,poor prognosis indicator
ENSG00000127084,FGD3,rho gtpase activation,gef activity,tumor progression,cytoskeletal reorganization,cell migration and invasion,signaling pathway interaction
ENSG00000108784,NAGLU,lysosomal degradation,angiogenesis promotion,cell growth enhancement,tumor metastasis facilitation,glycosaminoglycan metabolism dysfunction,protein-protein interaction modulation
ENSG00000137509,PRCP,cell surface expression,cysteine protease regulation,metalloprotease activity,oncogenic role,prognostic marker,tumor progression
ENSG00000116406,EDEM3,erad pathway,protein misfolding,tumor progression,oncogenic potential,cell survival,apoptosis regulation
ENSG00000181523,SGSH,altered cell adhesion,mucopolysaccharidosis,sulfatase activity,glycosaminoglycan regulation,cell proliferation regulation,apoptosis modulation
ENSG00000164039,BDH2,glyoxylate cycle regulation,fatty acid oxidation modulation,lipid metabolism dysregulation,tumor growth promotion,oncogenic potential enhancement,metabolic adaptation facilitation
ENSG00000170088,TMEM192,cellular proliferation,constitutive activation,overexpression,tumor progression,therapeutic target,stress response modulation
ENSG00000198171,DDRGK1,genomic instability,oncogenic process,dna damage response,homologous recombination,brca2 interaction,amplification event
ENSG00000100802,C14orf93,transcription factor activity,oncogene,zinc finger domain,cell cycle progression,apoptosis inhibition,protein-protein interaction
ENSG00000165046,LETM2,mitochondrial function,cellular energy metabolism,tumor progression,therapeutic target,regulation of mptp,interaction with mfn1
ENSG00000185404,SP140L,oncogene,transcriptional regulator,tumor growth promoter,metastasis enhancer,nuclear function regulator,therapeutic target
ENSG00000140522,RLBP1,cellular proliferation,apoptosis resistance,tumor progression marker,biomarker for diagnosis,therapeutic target,genomic instability associated
,C22orf46,wnt/β-catenin signaling pathway,cell proliferation regulation,tumor progression association,potential biomarker,oncogenic process promotion,molecular interaction modulation
ENSG00000137491,SLCO2B1,drug resistance,cell membrane transport,overexpression,tumor progression,bile acid transport,chemotherapy efficacy
ENSG00000247626,MARS2,mitochondrial localization,protein synthesis regulation,cellular respiration modulation,tumor progression association,energy metabolism alteration,oncogene overexpression
ENSG00000121316,PLBD1,tumor progression,apoptosis regulation,proteolytic activity enhancement,matrix metalloproteinase activation,cell migration facilitation,extracellular matrix degradation
ENSG00000100889,PCK2,gluconeogenesis,glycolytic flux,glycolytic activity,oncogenic processes,cellular ph regulation,transcriptional regulation
ENSG00000111536,IL26,immunosuppressive microenvironment,tumor-promoting cytokine,pro-inflammatory response,immune evasion mechanisms,oncogenic signaling pathway activation,metastasis enhancement
ENSG00000110002,VWA5A,wnt-activated kinase complex,cell cycle regulation,oncogene activation,tumor suppressor interaction,growth factor signaling,proliferation and survival driver
ENSG00000134183,GNAT2,cellular proliferation,oncogenic activation,tumor progression,metabolic regulation,protein kinase interaction,cellular migration
ENSG00000132840,BHMT2,bhmt2 overexpression,cellular metabolism regulation,homocysteine levels modulation,methionine metabolism,oncogenesis promotion,one-carbon metabolism interaction
ENSG00000163377,TAFA4,regulatory mechanism,transcriptional regulator,oncogene potential,tumor progression,cell cycle modulation,apoptosis regulation
ENSG00000174370,C11orf45,immune response modulation,tradd interaction,cell survival regulation,poor prognosis association,oncogenic potential,overexpression marker
ENSG00000163378,EOGT,cell proliferation,chromatin remodeling,immune regulation,oncogene overexpression,protein-protein interactions,tumor growth
ENSG00000117308,GALE,pi3k/akt pathway interaction,constitutive activation mutations,tumor progression promotion,therapeutic target identification,cellular growth regulation,signaling pathway modulation
ENSG00000116874,WARS2,protein synthesis regulation,tumor growth promotion,oncogene activation,cell proliferation enhancement,translation modulation,genomic amplification
ENSG00000141580,WDR45B,ubiquitin-proteasome pathway disruption,mutant p53 accumulation,cell cycle regulation,glycolytic shift,tumor suppressor function loss,aerobic respiration enhancement
ENSG00000114956,DGUOK,mitochondrial dysfunction,cell proliferation,oncogenic pathway activation,epigenetic modification,metabolic regulation,dna replication
ENSG00000103707,MTFMT,mitochondrial function disruption,genomic instability promotion,fatty acid oxidation impairment,metabolic reprogramming,cancer cell growth enhancement,tumor suppressor dysfunction
ENSG00000042445,RETSAT,transcriptional regulation,dna-binding protein,chromatin remodeling,cell proliferation,oncogenic pathway activation,genomic instability
ENSG00000282074,MPV17L,mitochondrial dysfunction,mtdna instability,oncogenic process,cell death regulation,protein-protein interaction,nuclear-encoded mitochondrial protein
ENSG00000144647,POMGNT2,enhanced glycosylation,glycoprotein modification,oncogenic pathway activation,cell adhesion regulation,metastatic potential,pi3k/akt signaling involvement
ENSG00000285136,DEFA6,antimicrobial activity,pro-inflammatory response,angiogenesis promotion,tumor aggressiveness,immune modulation,overexpression
ENSG00000122335,SERAC1,lipid metabolism regulation,endoplasmic reticulum localization,cellular stress responses,oncogenic mutations,tumor progression,poor prognosis marker
ENSG00000158270,COLEC12,tumor microenvironment modulation,immune evasion mechanisms,prognostic marker,cancer cell aggressiveness,mutations leading to tumorigenesis,cellular defense mechanisms
ENSG00000152611,CAPSL,mrna cleavage,oncogenic regulation,epigenetic modulation,prognostic biomarker,cell growth regulation,cancer driver gene
ENSG00000073605,GSDMB,pyroptosis,inflammasome regulation,tumor suppression,cell death regulation,killer protein interaction,apoptotic pathway modulation
ENSG00000101074,R3HDML,dna repair regulation,homologous recombination,genomic instability,tumor suppressor function,protein-protein interactions,nuclear localization
ENSG00000106537,TSPAN13,cell adhesion disruption,metastasis promotion,tumor progression,genomic instability,cancer stem cell maintenance,epithelial-to-mesenchymal transition
ENSG00000124232,RBPJL,notch signaling dysregulation,oncogenic activity,transcriptional regulation,gene expression modulation,cell cycle progression alterations,dna repair mechanism disruption
ENSG00000139914,FITM1,iron metabolism regulation,tumor progression,angiogenesis promotion,therapeutic target,poor prognosis marker,cancer-associated gene
ENSG00000124449,IRGC,...,<end> format,sorted by importance:

<begin>
calcium signaling,oncogenic processes,tumor progression,metastasis
ENSG00000163521,GLB1L,glycogen metabolism regulation,tumor suppressor function loss,glycolytic intermediate accumulation,autophagy modulation,apoptosis dysregulation,mtor pathway interaction
ENSG00000177830,CHID1,chloride channel regulation,genomic instability,cell cycle progression,tumor growth,metastasis promotion,dna repair mechanism disruption
ENSG00000006625,GGCT,glycoprotein biosynthesis,glycosyltransferase activity,cell signaling modulation,cell-cell interactions regulation,tissue development influence,oncogenic process contribution
ENSG00000169738,DCXR,cellular signaling pathway,organic anion transport,transmembrane protein function,tumor aggressiveness,cancer biomarker potential,protein-protein interaction regulation
ENSG00000173464,RNASE11,cell death regulation,tumor aggressiveness,apoptosis sensitivity,prognostic marker,overexpression status,cancer interaction
ENSG00000080910,CFHR2,complement regulation,immune evasion,tumor progression,cell proliferation,signaling pathway modulation,genomic dysregulation
ENSG00000119899,SLC17A5,nucleoside transport,pi3k/akt pathway activation,oncogenic signaling,cell proliferation and survival,genomic instability,therapeutic target
ENSG00000129480,DTD2,dttp/dntp balance,dna mismatch repair,oncogenesis,tumor growth,resistance to apoptosis,cell proliferation
ENSG00000144815,NXPE3,cell cycle regulation,gene expression modulation,oncogenic role,protein-protein interactions,tumor progression,apoptosis suppression
ENSG00000106384,MOGAT3,lipid metabolism,dysregulation of energy homeostasis,interaction with oncogenic proteins,metabolic reprogramming,cellular proliferation,therapeutic target
ENSG00000197406,DIO3,cellular proliferation inhibition,thyroid hormone regulation,oncogenic process,tumor progression driver,metabolic reprogramming,enzyme activity alteration
ENSG00000143919,CAMKMT,oncogene function,mutation/alteration,genomic instability,cell cycle regulation,apoptosis modulation,tumor progression
ENSG00000150656,CNDP1,cysteine catabolism,cellular redox balance,reactive oxygen species regulation,oncogenic potential,therapeutic targeting opportunity,antioxidant enzyme interaction
ENSG00000166049,PASD1,tumor suppressor function loss,genetic instability,cell cycle disruption,mitotic checkpoint dysregulation,signaling pathway alteration,onco-proliferation driver
ENSG00000101327,PDYN,oncogenesis,pi3k/akt pathway activation,cell proliferation regulation,apoptosis resistance,protein-protein interaction,neurotransmitter regulation
ENSG00000154122,ANKH,increased ppi efflux,osteomalacia susceptibility,cell migration promotion,bone mineralization disruption,protein-protein interaction,cell proliferation enhancement
ENSG00000186283,TOR3A,aberrant mtor activation,oncogene,tumor suppressor loss of function mutations,cell proliferation regulation,metabolic reprogramming,cancer therapeutic target
ENSG00000127540,UQCR11,mitochondrial electron transport chain,oxidative phosphorylation,cellular energy homeostasis,metabolic regulation,apoptosis modulation,electron transfer pathway
ENSG00000136522,MRPL47,mitochondrial protein synthesis,cell proliferation,oncogenic role,tumor aggressiveness,prognostic marker,therapeutic target
ENSG00000139168,ZCRB1,cell growth regulation,dna damage response,chromatin remodeling,ran-gtpase interaction,tumor suppressor function,genomic instability
ENSG00000128524,ATP6V1F,vacuolar h+-atpase function,cellular ph regulation,proton transport activity,tumor microenvironment modulation,cancer cell migration,targeted therapy resistance
ENSG00000103335,PIEZO1,mechanical activation,metastatic potential,cell migration regulation,ion channel dysregulation,signaling pathway modulation,mechanosensing disruption
ENSG00000116580,GON4L,mitotic regulation,cell cycle progression,aneuploidy suppression,dna damage response,protein interaction,tumor aggressiveness
ENSG00000104774,MAN2B1,pi lipid metabolism,pi3k/akt pathway,cell survival,tumor growth,oncogenesis,mtor interaction
ENSG00000152620,NADK2,cellular energy metabolism,tumor progression,cell proliferation,dna repair,therapeutic target,metabolic reprogramming
ENSG00000131171,SH3BGRL,cell migration,cell invasion,protein kinase regulation,signaling pathway modulation,tumor growth promotion,therapeutic target potential
ENSG00000128311,TST,extracellular matrix remodeling,angiogenesis promotion,cell migration facilitation,tumor progression support,immune response modulation,emt regulation
ENSG00000104889,RNASEH2A,dna repair deficiency,genomic instability,tumor progression driver,mutational burden increase,base excision repair pathway disruption,none
ENSG00000172922,RNASEH2C,genomic instability,dna strand breaks,alternative dna repair pathways,genetic hypermutability,dna repair mechanisms,ribonuclease h2 enzyme
ENSG00000136104,RNASEH2B,genomic instability,telomere maintenance,cellular aging,cancer predisposition,genetic mutations,enzyme activity alteration
ENSG00000122965,RBM19,altered splicing regulation,cell proliferation enhancement,oncogenic potential,metastatic potential enhancement,translational regulation,tumor aggressiveness promotion
ENSG00000171202,TMEM126A,histone modification regulation,transcriptional modulation,chromatin structure regulation,cell growth promotion,epigenetic dysregulation,tumor suppression
ENSG00000174982,OR4S2,cell adhesion disruption,olfactory receptor function,oncogenic signaling,cell proliferation enhancement,protein-protein interaction modulation,tumor progression facilitation
ENSG00000091009,RBM27,tumor suppressor gene dysfunction,nuclear export regulation,oncogenic mrna expression,rna-protein interaction,alternative splicing modulation,prognostic marker
ENSG00000165661,QSOX2,disulfide bond formation,redox regulation,cell proliferation,epithelial-to-mesenchymal transition,oncogenic driver,tumor progression
ENSG00000115204,MPV17,mitochondrial protein import,genomic instability,oxidative stress induction,tumor progression driver,therapeutic target,genetic mutation hotspot
ENSG00000206256,PPT2,protein modification,thiol protease activity,potential oncogene,upregulated in tumors,cellular signaling pathways,modulator of protein function
ENSG00000151176,PLBD2,chromatin remodeling,histone modification,transcriptional regulation,cell proliferation,apoptosis resistance,therapeutic target
ENSG00000090686,USP48,tumor progression,protein stabilization,oncogenic protein regulation,cell proliferation,apoptosis resistance,therapeutic target
ENSG00000144120,TMEM177,lipid metabolism regulation,hypoxia-inducible factor signaling modulation,tumor progression promotion,therapeutic target identification,cellular membrane dynamics regulation,cancer cell proliferation enhancement
ENSG00000184076,UQCR10,mitochondrial electron transport chain,oncogenic signaling pathway,energy metabolism regulation,reactive oxygen species production,complex iii subunit,oxidative phosphorylation dysfunction
ENSG00000166704,ZNF606,transcriptional regulation,cell cycle control,telomerase activity,zinc finger protein,dna damage response,cancer suppressor
ENSG00000132915,PDE6A,gtpase regulation,tumor progression,phosphodiesterase activity,cell proliferation,visual transduction pathway,rgs4 interaction
ENSG00000178187,ZNF454,**
zinc finger protein,oncogene role,transcriptional regulator,cell cycle progression,tumor growth promotion,apoptosis inhibition 
**
ENSG00000085449,WDFY1,rho gtpase signaling pathway,cell migration,cytoskeleton regulation,tumor progression,metastasis promoter,gene expression regulation
ENSG00000283085,TPBG,tumor angiogenesis,regulatory mechanism,cell survival pathways,oncogenic properties,angiogenesis regulation,therapeutic target
ENSG00000135776,ABCB10,multidrug resistance,tumor progression,efflux pump function,chemoresistance,cancer cell survival,transport regulation
ENSG00000198729,PPP1R14C,akt/mtor signaling,pp2a regulatory function loss,tumor progression,oncogenic pathways activation,cell growth regulation,serine/threonine phosphatase regulation
ENSG00000100558,PLEK2,pi3k/akt pathway activation,oncogene overexpression,cell migration promotion,tumor aggressiveness enhancement,prognostic biomarker potential,mapk/erk pathway interaction
ENSG00000184227,ACOT1,therapeutic target,lipid metabolism regulation,tumor progression facilitation,cellular energy homeostasis disruption,oncogenic pathway activation,protein-protein interaction
ENSG00000115944,COX7A2L,mitochondrial regulation,oxidative phosphorylation,electron transport chain interaction,cellular respiration modification,cancer-related mutations,energy production alteration
ENSG00000112893,MAN2A1,protein glycosylation,aberrant expression,cell surface expression,tumor progression,metastasis,post-translational modification
ENSG00000277656,GSTT1,detoxification function,glutathione conjugation,oxidative stress resistance,chemotherapy resistance,dna damage sensitivity,antioxidant defense mechanism
ENSG00000254685,FPGT,glycolytic regulation,tumor progression,oncogenic adaptation,glycolysis enhancement,mitochondrial function alteration,genomic instability promotion
ENSG00000148719,DNAJB12,chaperone-mediated autophagy,cellular stress response disruption,genetic mutations in cancer,apoptosis regulation disruption,protein misfolding prevention,autophagic flux regulation
ENSG00000196449,YRDC,rna regulation,mutation in cancer,cell cycle control,tumor progression,rna processing,oncogenic processes
ENSG00000101079,NDRG3,tumor suppressor,cell migration inhibition,angiogenesis suppression,metastasis regulator,pi3k/akt pathway regulation,gene expression alteration
ENSG00000204764,RANBP17,nuclear transport regulation,gene expression modulation,cell cycle progression,aberrant protein interactions,tumor suppressor interaction,genomic instability
ENSG00000127080,IPPK,enhanced nucleotide synthesis,purine biosynthesis pathway,cancer driver mutation,nucleotide metabolism regulation,cellular growth promotion,dna replication enhancement
ENSG00000101337,TM9SF4,endocytic pathway,lipid metabolism,oncogenic transformation,cell membrane regulation,tumor progression,metabolic reprogramming
ENSG00000173905,GOLIM4,protein trafficking disruption,therapeutic target,endocytic pathway regulation,tumor aggressiveness,cellular homeostasis disruption,oncogenic potential
ENSG00000099974,DDTL,dna mismatch repair,genetic instability,tumor suppressor function,dna replication regulation,cell cycle control,genome maintenance
ENSG00000205903,ZNF316,krab domain-containing protein,transcriptional regulation,pi3k/akt pathway modulation,oncogenic processes,apoptosis modulation,genomic instability
ENSG00000125877,ITPA,purine metabolism alteration,genome instability,dna damage response,cell cycle regulation,apoptosis evasion,nucleotide biosynthesis
ENSG00000169299,PGM2,metabolic regulation,glycogen metabolism disruption,warburg effect promotion,cell growth enhancement,protein-protein interaction modulation,oncogenic role
ENSG00000134056,MRPS36,mitochondrial biogenesis,disrupted energy metabolism,tumor progression,proliferation regulation,mitochondrial function,regulatory mechanism
ENSG00000160785,SLC25A44,mitochondrial carrier protein,succinate transport regulation,cellular metabolism regulation,oncogenic pathway activation,tumor growth promotion,therapeutic target candidate
ENSG00000106853,PTGR1,tumor progression,tumor cell proliferation,angiogenesis,vascular endothelial growth factor interaction,prostaglandin synthesis regulation,oncogenic function
ENSG00000155850,SLC26A2,cellular transport regulation,ion homeostasis disruption,epithelial-to-mesenchymal transition,therapeutic target,tumor microenvironment modulation,cellular adhesion alteration
ENSG00000166800,LDHAL6A,lactate dehydrogenase regulation,cellular metabolism modulation,cancer glycolysis enhancement,tumor progression support,therapeutic target potential,metabolic adaptation
ENSG00000153956,CACNA2D1,oncogenic processes,angiogenesis promotion,calcium channel regulation,tumor growth enhancement,metastasis facilitation,poor prognosis marker
ENSG00000117143,UAP1,mtor complex activation,cell proliferation enhancement,angiogenesis promotion,tumor growth facilitation,ubiquitination pathway dysregulation,protein stability disruption
ENSG00000205544,TMEM256,tumor suppressor,differentially expressed,cell proliferation regulation,apoptosis regulation,signaling pathway modulation,transmembrane protein function
ENSG00000166965,RCCD1,apc regulator,tumor suppressor,cell cycle regulation,pi3k/akt pathway inhibition,dna damage response,cell proliferation enhancement
ENSG00000178802,MPI,tumor growth promotion,angiogenesis facilitation,prostaglandin biosynthesis,cell proliferation enhancement,apoptosis inhibition,cell signaling pathway interaction
ENSG00000173262,SLC2A14,glycolytic reprogramming,glucose uptake enhancement,metabolic rewiring,cell survival promotion,prognostic marker association,therapeutic target potential
,PALM2,mitochondrial dynamics,protein processing,metabolic regulation,apoptosis regulation,cellular signaling,none
ENSG00000198478,SH3BGRL2,pi3k/akt pathway interaction,constitutive activation,gain of function mutations,oncogenic signaling,cell proliferation regulation,signaling molecule interaction
ENSG00000164933,SLC25A32,mitochondrial transport,oncogenic metabolism,energy production,protein interaction,metabolic reprogramming,cancer stem cell maintenance
ENSG00000185414,MRPL30,ribosomal regulation,tumor progression,cell proliferation,protein synthesis regulation,signaling pathway activation,biomarker status
ENSG00000072756,TRNT1,trnt1 overexpression,cell proliferation enhancement,pi3k/akt pathway activation,trna modification regulation,p53 suppression,transcriptional regulation
ENSG00000163389,POGLUT1,o-glcnacylation,cell proliferation,signaling protein modulation,cancer stem cell maintenance,poor prognosis,pi3k/akt pathway regulation
ENSG00000213965,NUDT19,dna repair mechanism,tumor progression,genomic instability,cell proliferation enhancement,therapeutic target,biomarker
ENSG00000113273,ARSB,apoptosis regulation,extracellular matrix degradation,glycosaminoglycan metabolism,inflammatory response modulation,pi3k/akt pathway interaction,tumor progression facilitation
ENSG00000054793,ATP9A,ion transport regulation,potassium-sodium exchange,cancer progression,cell signaling alteration,tumor suppressor interaction,lysosomal acidification
ENSG00000157014,TATDN2,protein degradation regulation,aberrant protein accumulation,tumor progression,roles in apoptosis,cancer biology involvement,ubiquitin-proteasome pathway modulation
ENSG00000044459,CNTLN,cell adhesion regulation,epithelial-to-mesenchymal transition,emt program promotion,wnt/β-catenin pathway interaction,oncogenic process promotion,metastasis facilitation
ENSG00000122687,MRM2,mrna stability regulation,oncogenesis facilitation,cell cycle modulation,apoptosis inhibition,angiogenesis promotion,microrna regulation
ENSG00000116127,ALMS1,cancer-promoting mutations,cellular processes regulation,dna damage response disruption,apoptosis inhibition,pi3k/akt pathway interaction,tumor suppressor function loss
ENSG00000163319,MRPS18C,mitochondrial biogenesis,glycolytic shift,energy metabolism regulation,oncogenic mutations,tumor proliferation,pyruvate kinase interaction
ENSG00000243147,MRPL33,mitochondrial biogenesis,oxidative phosphorylation regulation,tumor progression marker,prognostic indicator,energy metabolism alteration,cellular respiration modulation
ENSG00000275004,ZNF280B,transcriptional regulation,zinc finger protein function,cell proliferation influence,apoptosis modulation,tumor suppression potential,cancer biology involvement
ENSG00000198453,ZNF568,enhanced cell proliferation,tumor progression,transcriptional regulation,oncogenic potential,overexpression in tumors,zinc finger protein interactions
ENSG00000257591,ZNF625,epigenetic regulation,oncogene function,tumor suppressor silencing,transcriptional activation,cell proliferation driver,chromatin modification
ENSG00000196437,ZNF569,wnt/β-catenin signaling pathway,transcriptional regulation,oncogenic properties,cell proliferation,apoptosis regulation,biomarker potential
ENSG00000249471,ZNF324B,transcriptional regulation,chromatin remodeling,tumor progression,epigenetic modification,zinc finger protein function,aberrant gene expression
ENSG00000245680,ZNF585B,epigenetic regulation,tumor suppressor function,transcriptional repression,cell cycle regulation,genetic instability,chromatin remodeling
ENSG00000181007,ZFP82,genomic instability,oncogene function,transcriptional regulation,cellular proliferation,dna damage response,chromosomal alterations
ENSG00000275723,NAPEPLD,lipid metabolism regulation,cancer progression driver,overexpression,cell survival enhancement,proliferation promotion,angiogenesis induction
ENSG00000182111,ZNF716,androgen receptor target,epigenetic regulation,c2h2 zinc finger motif,chromatin modification,tumor progression,transcriptional regulation
ENSG00000274195,ZNF705G,zinc finger protein regulation,epigenetic modification,oncogene activation,transcriptional upregulation,cell proliferation enhancement,metastasis promotion
ENSG00000170920,OR7G3,tumor progression,metastasis promotion,cell adhesion modulation,oncogene expression,genomic upregulation,signaling pathway interaction
ENSG00000185013,NT5C1B,homologous recombination,cell growth regulation,dna repair mechanism,cell migration invasion,signaling pathway interaction,pi3k/akt pathway activation
ENSG00000145194,ECE2,tumor growth,angiogenesis,endothelin signaling,vascular permeability,tumor invasion,prognostic marker
ENSG00000137976,DNASE2B,genomic instability,dna degradation,apoptosis regulation,tumor suppression,programmed cell death,cellular response
ENSG00000169814,BTD,dna repair mechanisms,tumor suppressor function,genomic instability,dna damage repair,biotin metabolism regulation,cancer-related genomic alterations
ENSG00000196344,ADH7,aldehyde oxidation,cytosolic localization,detoxification regulation,oxidative stress modulation,protein-protein interaction,biomarker potential
ENSG00000148513,ANKRD30A,cellular proliferation,tumor metastasis,transcriptional regulation,chromatin remodeling,apoptosis modulation,transcription factor interaction
ENSG00000219481,NBPF1,neurodevelopmental regulation,cellular overexpression,tumor progression marker,poor prognosis indicator,proliferation regulator,survival pathway activator
ENSG00000100578,KIAA0586,transcriptional regulation,chromatin remodeling,cellular responses,poorly defined functions,tumor progression,limited information
ENSG00000128059,PPAT,phosphatidylserine cycle regulation,tumor progression,enzymatic activity alteration,metastasis promotion,cell signaling pathway modulation,cancer-related protein overexpression
ENSG00000172663,TMEM134,apoptosis regulation,autophagy modulation,cell membrane integrity,oncogenic driver,prognostic biomarker,tumor growth promotion
ENSG00000165490,DDIAS,apoptosis regulation,cell cycle modulation,phosphatase activity,tumor suppressor function,signaling pathway modulation,oncogenic transformation
ENSG00000243749,TMEM35B,cell polarity regulation,modulator of pi3k/akt pathway,tumor progression,oncogenic transformation,apoptosis regulation,cell cycle modulation
ENSG00000124780,KCNK17,pi3k/akt pathway modulation,cell cycle progression enhancement,apoptosis inhibition,tumor growth promotion,kcnk17 overexpression association,poor prognosis biomarker
ENSG00000156453,PCDH1,cell adhesion regulation,tumor suppressor function,metastasis suppression,loss of expression,biomarker potential,cell-cell interaction
ENSG00000242110,AMACR,mitochondrial lipid metabolism,tumor aggressiveness,lipid peroxidation,oncogenic properties,poor prognosis,diagnostic marker
ENSG00000101323,HAO1,antioxidant activity,anti-inflammatory response,oncogene activation,tumor progression,angiogenesis promotion,cell survival enhancement
ENSG00000116882,HAO2,angiogenesis,cellular antioxidant defense,endothelial cell proliferation,vasodilation,cell migration and invasion,potent vasodilator
ENSG00000148832,PAOX,fatty acid oxidation,lipid biosynthesis,mitochondrial function,cancer metabolism,therapeutic target,peroxisomal regulation
ENSG00000177465,ACOT4,lipid metabolism regulation,overexpression,cell survival promotion,tumor growth facilitation,fatty acid degradation,energy-rich molecule production
ENSG00000118454,ANKRD13C,microtubule stability,cell proliferation,oncogenic pathway activation,tumorigenesis regulation,biomarker expression,dysregulation in cancer
ENSG00000137948,BRDT,regulates chromatin structure,facilitates transcriptional elongation,essential for mitosis progression,interacts with cdk1 and plk1,promotes oncogenic processes,therapeutic target in cancer treatment
ENSG00000172594,SMPDL3A,sphingomyelin regulation,apoptosis suppression,cell survival enhancement,therapeutic resistance,tumor progression,protein interaction
,IGHG2,immunoglobulin function,antibody production,adaptive immune response,immune evasion,tumor microenvironment modulation,oncogene-independent
ENSG00000100288,CHKB,lipid metabolism,cell growth,therapeutic target,oncogenic properties,resistance to apoptosis,signaling pathway activation
ENSG00000055957,ITIH1,tumor progression,angiogenesis promotion,metastasis facilitation,poor prognosis marker,cellular inflammatory regulation,fibrinolysis modulation
ENSG00000168907,PLA2G4F,arachidonic acid regulation,gene expression modulation,tumor progression,proliferation enhancement,cell survival pathway regulation,pkc interaction
ENSG00000198336,MYL4,cell migration,invasion and metastasis,tumor progression,poor prognosis marker,non-muscle myosin regulation,cytoskeleton dynamics modulation
ENSG00000103489,XYLT1,tumor progression,cellular growth,extracellular matrix degradation,glycosaminoglycan biosynthesis,molecular interactions,oncogenic activity
ENSG00000178878,APOLD1,tumor suppression,loss-of-function mutations,dna damage response,cell cycle arrest,apoptosis regulation,genomic instability
ENSG00000128918,ALDH1A2,cellular detoxification,redox regulation,oncogenic signaling,cancer stem cell properties,tumor progression,therapeutic target
ENSG00000153558,FBXL2,cell cycle progression,apoptosis suppression,ubiquitination pathway,genomic instability,therapeutic target,protein degradation
ENSG00000172476,RAB40A,cellular trafficking,oncogenic processes,gtpase activity,endocytic pathway regulation,poor prognosis,therapeutic target
ENSG00000119682,AREL1,rna-binding protein,mrna stability regulation,cell proliferation promotion,tumor progression facilitation,pi3k/akt pathway modulation,oncogene activation
ENSG00000196109,ZNF676,tumor progression,oncogenic function,transcriptional regulation,cell proliferation,apoptosis inhibition,pi3k/akt pathway activation
ENSG00000125821,DTD1,extracellular matrix degradation,tumor progression,metastasis facilitation,proteolytic function,cell migration enhancement,poor prognosis marker
ENSG00000282966,CYP2D6,drug metabolism,pharmacokinetics influence,genetic variations impact,oxidation reactions catalysis,enzyme expression alterations,personalized medicine significance
ENSG00000139160,ETFBKMT,epigenetic regulation,histone methylation,tumorigenesis,oncogene activation,cell proliferation,therapeutic target
ENSG00000123427,EEF1AKMT3,protein synthesis inhibition,cellular stress adaptation,metabolic regulation,tumor progression promotion,cell growth regulation,eukaryotic translation initiation factor 2 alpha modification
ENSG00000181038,METTL23,tumor progression,epigenetic regulation,dna methylation,biomarker potential,oncogenic function,prognostic value
ENSG00000128915,ICE2,downregulation,oncogene,tumor suppression,cdk4/6 inhibition,p53 regulation,dna damage repair
ENSG00000237172,B3GNT9,aberrant glycosylation,cellular invasiveness,immune evasion,oncogenic processes,tumor progression,biomarker
ENSG00000166930,MS4A5,immune modulation,cell-cell interaction signaling pathway,tumor progression,metastasis promotion,cell survival enhancement,potential immunotherapy target
ENSG00000198157,HMGN5,hmgn5 overexpression,chromatin remodeling,transcriptional regulation,cell proliferation,apoptosis suppression,oncogene function
ENSG00000120322,PCDHB8,tumor suppressor,cell-cell adhesion,epithelial-to-mesenchymal transition,metastasis progression,wnt/β-catenin signaling,notch pathway interaction
ENSG00000033011,ALG1,n-glycosylation pathway,aberrant glycoproteins formation,tumor progression driver,cell surface recognition modification,oncogene candidate,glycan structure alteration
ENSG00000171551,ECEL1,endothelin-1 processing,vascular smooth muscle cell proliferation,angiogenesis regulation,cell growth modulation,tumor progression,metastasis
ENSG00000228474,OST4,oligosaccharyltransferase complex,n-glycosylation,cell surface receptors modification,tumor progression,protein-protein interactions,sigaling pathway regulation
ENSG00000068650,ATP11A,phospholipid metabolism,ion transport,oncogenic driver,cell growth regulation,apoptosis modulation,therapeutic target
ENSG00000101974,ATP11C,atpase activity,phospholipid transport,autophagy regulation,tumor progression,constitutive activation,therapeutic target
ENSG00000103227,LMF1,cell proliferation,oncogene overexpression,rna-binding protein,metastatic potential,apoptosis suppression,hypoxia response
ENSG00000147256,ARHGAP36,rho gtpase regulation,tumor suppressor function,microtubule dynamics disruption,cell cycle dysregulation,oncogenic driver,genomic instability promoter
ENSG00000072786,STK10,pi3k/akt pathway regulation,loss of function mutations,tumor suppressor activity,cancer therapy target,cell cycle progression regulation,apoptosis induction
ENSG00000161929,SCIMP,immune evasion,apoptosis suppression,tumor microenvironment modulation,cancer progression marker,pro-tumorigenic factor,poor prognosis indicator
ENSG00000140254,DUOXA1,thyroid hormone regulation,dual oxidase activity,cellular damage,oxidative stress,protein interaction,cancer progression
ENSG00000258484,SPESP1,pi3k signaling,proliferation enhancement,tumor progression,oncogenic interaction,cell survival regulation,phosphoinositide modification
ENSG00000113088,GZMK,apoptosis regulation,caspase activation,serine protease function,cell death pathway,tumor suppression,prognostic biomarker
ENSG00000254709,IGLL5,immunoglobulin assembly,tumor suppressor function,genomic instability,ubiquitination pathway,protein turnover regulation,dna repair impairment
ENSG00000170099,SERPINA6,cellular proliferation,tumor progression,serine protease inhibition,metastasis promotion,poor prognosis indicator,signaling pathway regulation
ENSG00000123561,SERPINA7,overexpression,apoptosis inhibition,tumor growth promotion,angiogenesis enhancement,pi3k/akt pathway regulation,protease inhibition
ENSG00000120539,MASTL,microtubule regulation,g2/m checkpoint disruption,proliferation enhancement,tumor progression association,biomarker potential,therapeutic target
ENSG00000176371,ZSCAN2,tumor suppressor,cell cycle regulation,apoptosis induction,dna repair mechanism,pi3k/akt pathway modulation,cancer progression prevention
ENSG00000288504,YBX2,transcriptional regulation,dna repair,cancer cell proliferation,cell cycle progression,protein-protein interaction,chemosensitivity
ENSG00000227642,AGPAT1,lipid signaling,cell proliferation,fatty acid metabolism,cell migration,genomic amplification,tumor progression
ENSG00000198610,AKR1C4,metabolic reprogramming,steroid hormone regulation,oncogenesis,cell adhesion regulation,protein-protein interaction,therapeutic target
,APOPT1,apoptosis regulation,programmed cell death,tumor suppressor function,caspase activation,protein-protein interaction,genomic instability
ENSG00000147145,LPAR4,lysophosphatidic acid signaling pathway,cell proliferation,tumor progression,therapeutic target,g protein-coupled receptor function,metastasis promotion
ENSG00000174156,GSTA3,hypoxia response,oxidative stress resistance,tumor progression,biomarker potential,prognostic indicator,therapeutic target
ENSG00000060642,PIGV,tumor progression,metastasis promotion,cell surface protein modification,prognostic marker,therapeutic target,glycoprotein degradation
ENSG00000169906,S100G,tumor progression,calcium signaling disruption,protein kinase activation,cell proliferation regulation,gene expression modulation,microrna regulation
ENSG00000184602,SNN,amino acid transport,oncogene activation,metabolic regulation,cell proliferation,protein synthesis regulation,tumor progression
ENSG00000136840,ST6GALNAC4,tumor progression,cell migration,invasion enhancement,poor prognosis marker,glycoprotein regulation,protein interaction modulation
ENSG00000130300,PLVAP,platelet adhesion,tumor progression,metastasis,angiogenesis,immune evasion,prognostic marker
ENSG00000178828,RNF186,protein degradation regulation,genomic instability prevention,cell cycle progression,oncogene overexpression,therapeutic target,ubiquitin ligase activity
ENSG00000196151,WDSUB1,genomic instability,dna repair mechanism,chromosomal alterations,cell proliferation regulation,tumor suppressor function,oncogene activation
ENSG00000174502,SLC26A9,tumor suppressor,chloride transport regulation,oncogenic transformation prevention,cellular homeostasis maintenance,wnt/β-catenin pathway interaction,microrna regulation
ENSG00000166788,SAAL1,alternative splicing regulation,gene expression modulation,oncogenic driver,aggressive tumor behavior,prognostic marker,tumor progression promoter
ENSG00000130193,THEM6,mitochondrial function,energy production regulation,cell proliferation enhancement,tumor cell survival promotion,therapeutic target identification,oncogenic protein overexpression
ENSG00000142197,DOP1B,dopamine biosynthesis,oncogenic process,tumor progression,cell survival enhancement,angiogenesis promotion,therapeutic target
ENSG00000158669,GPAT4,lipid biosynthesis,tumor progression,mtor pathway activation,cell survival promotion,anabolic metabolism regulation,autophagy suppression
ENSG00000050555,LAMC3,emt induction,gene amplification,immune evasion,prognostic marker,angiogenesis promotion,cell adhesion regulation
ENSG00000117479,SLC19A2,nucleotide metabolism,oncogenic signaling,cell proliferation,genomic instability,dna synthesis regulation,therapeutic target
ENSG00000140107,SLC25A47,mitochondrial carrier protein,succinate transport,cellular metabolism regulation,oncogenic pathway activation,metabolic vulnerability target,energy homeostasis regulation
ENSG00000159423,ALDH4A1,tumor progression,cellular proliferation,metabolic regulation,protein interaction,apoptosis regulation,poor prognosis
ENSG00000178301,AQP11,hydration regulation,water transport,cellular ion balance,protein-protein interaction,aquaporin function,tumorigenesis modulation
ENSG00000182858,ALG12,altered glycosylation patterns,cell proliferation enhancement,dysregulated expression,enhanced oncogenic protein glycosylation,tumor progression facilitation,upregulated expression
ENSG00000113492,AGXT2,mitochondrial dysfunction,oxidative stress,metabolic reprogramming,tumor suppressor,genomic instability,biomarker
ENSG00000197859,ADAMTSL2,protease regulation,cell adhesion modulation,extracellular matrix interaction,tumor suppressor function,metastasis promotion,oncogenesis contribution
ENSG00000187758,ADH1A,cellular redox balance,roles in metabolic regulation,oxidative stress modulation,aldehyde dehydrogenase interaction,ros detoxification pathway,tumor growth inhibition
ENSG00000091262,ABCC6,tumor suppressor function,genomic instability,oxidative stress modulation,dna damage response,cellular calcium regulation,abc transporter activity
ENSG00000085465,OVGP1,metastasis promotion,cell adhesion modulation,surface expression,tumor progression marker,mucin family member,glycoprotein interaction
ENSG00000114770,ABCC5,multidrug resistance,platinum-based drug transport,cancer chemoresistance,cellular survival,protein overexpression,drug efflux mechanism
ENSG00000171766,GATM,metabolic reprogramming,hypoxia adaptation,cellular metabolism regulation,tumor growth promotion,therapeutic target,transcriptional regulation
ENSG00000111713,GYS2,glycogen synthesis regulation,glucose metabolism alteration,tumor progression marker,energy metabolism dysregulation,cell proliferation support,apoptosis inhibition
ENSG00000119711,ALDH6A1,reactive oxygen species regulation,glutaryl-coa catabolism,epigenetic alteration,genomic instability,cell proliferation enhancement,branched-chain amino acid metabolism
ENSG00000135929,CYP27A1,cholesterol regulation,oncogenic role,lipid metabolism regulation,bile acid synthesis,cellular apoptosis suppression,tumor progression promotion
ENSG00000154265,ABCA5,lipid metabolism regulation,oncogene upregulation,tumor growth promotion,lipid accumulation support,cancer cell survival enhancement,cellular lipid transport modulation
ENSG00000197417,SHPK,lipid metabolism,oncogenic driver,rapid cell growth,dysregulated signaling pathways,tumor microenvironment modification,fatty acid regulation
ENSG00000166741,NNMT,tumor progression,akt signaling activation,one-carbon metabolism regulation,epigenetic modification,therapeutic target,metabolic reprogramming
ENSG00000086544,ITPKC,calcium signaling,constitutive activation,gain of function mutations,tumor growth,pi3k/akt pathway interaction,cellular regulation
ENSG00000167676,PLIN4,lipid droplet formation,tumor progression,lipolysis regulation,fatty acid oxidation,metabolic reprogramming,prognostic marker
ENSG00000170949,ZNF160,transcriptional repression,tumor suppressor function,loss of heterozygosity,chromatin remodeling,epigenetic regulation,oncogenic transformation
ENSG00000182327,GLTPD2,lipid raft formation,cell membrane integrity,glycolysis regulation,oncogenic signaling,protein interaction network,metabolic reprogramming
ENSG00000070526,ST6GALNAC1,sialylation,oncogenic potential,tumor progression,glycosylation modulation,cell adhesion,pi3k/akt activation
ENSG00000153976,HS3ST3A1,tumor progression,metastasis facilitation,prognosis association,therapeutic target,extracellular matrix modification,cell migration promotion
ENSG00000176022,B3GALT6,glycosylation regulation,cell adhesion modulation,tumor progression association,metastasis correlation,proteoglycan synthesis involvement,golgi apparatus localization
ENSG00000198715,GLMP,oncogenic driver,glycolysis promotion,metabolic adaptation,glutamine uptake regulation,tumor growth support,therapeutic target candidate
ENSG00000181666,ZNF875,krab domain interaction,co-repressor binding,transcriptional regulation,cancer cell proliferation,gene silencing,kap1 interaction
ENSG00000185947,ZNF267,aberrant expression,oncogene activation,cell proliferation,apoptosis inhibition,epithelial-to-mesenchymal transition (emt),transcriptional regulation
ENSG00000100490,CDKL1,g2/m phase regulation,cyclin-dependent kinase activity,dna damage response,cell cycle progression,oncogenic signaling pathway,tumor suppressor interaction
ENSG00000168661,ZNF30,tumor suppression,krab domain-containing zinc finger protein,transcriptional regulation,cell cycle progression,apoptosis regulation,tumor metastasis inhibition
ENSG00000007038,PRSS21,tumor progression,cell proliferation,extracellular matrix degradation,overexpression,therapeutic target,microenvironment modulation
ENSG00000109323,MANBA,lysosomal enzyme,alpha-mannosidase activity,glycoprotein degradation,tumor progression,mitochondrial dysfunction,ancillary cellular functions
ENSG00000143324,XPR1,tumor progression,immune evasion,cellular transport regulation,prognostic marker,leukocyte extravasation,transcriptional regulation
ENSG00000166004,CEP295,centrosomal protein overexpression,chromosomal instability,cell proliferation enhancement,microtubule dynamics regulation,genomic stability maintenance disruption,tumor progression facilitation
ENSG00000162039,MEIOB,androgen receptor regulation,proliferation enhancement,migration promotion,survival pathway activation,oncogenic driver status,genomic amplification
ENSG00000136868,SLC31A1,cellular copper homeostasis disruption,copper transport dysfunction,dna synthesis enhancement,oncogenic process activation,tumor growth promotion,resistance to chemotherapy
ENSG00000167914,GSDMA,tumor progression,cell survival,signaling pathway modulation,nf-κb pathway activation,overexpression,prognostic marker
ENSG00000148218,ALAD,iron homeostasis,tumor growth,oxidative stress regulation,angiogenesis promotion,protein-protein interaction,cellular metabolism regulation
ENSG00000147471,PLPBP,cell signaling regulation,cancer cell survival,protein chaperone activity,genomic instability,gene expression regulation,chaperone-mediated protein folding
ENSG00000065833,ME1,tumor progression,metabolic reprogramming,apoptosis regulation,energy production,nadph generation,cancer metabolism
ENSG00000142002,DPP9,dysregulation,immune suppression,tumor progression,cell signaling regulation,protein interaction,cancer prognosis
ENSG00000122642,FKBP9,mtor pathway regulation,protein-protein interaction,oncogene activation,tumor progression facilitation,cell growth promotion,transcriptional regulation modulation
ENSG00000172037,LAMB2,tumor progression,epithelial-to-mesenchymal transition,metastasis,altered expression,biomarker potential,cell adhesion disruption
ENSG00000111344,RASAL1,ras gtpase activation,epigenetic silencing,loss-of-function mutations,mapk pathway activation,pi3k/akt signaling,tumor progression
ENSG00000121064,SCPEP1,immune modulation,tumor immune evasion,cellular stress response,metastasis promotion,therapeutic target,inflammation regulation
ENSG00000088899,LZTS3,cell cycle regulation,tumor suppressor function,g2/m phase transition inhibition,ccnb1 degradation,cdk2 interaction,cancer association
ENSG00000206557,TRIM71,tumor suppressor function,cell proliferation regulation,apoptosis induction,cyclin-dependent kinase regulation,tumor suppressor interactions,oncogene modulation
ENSG00000119698,PPP4R4,pp4 regulation,oncogene activation,cell survival promotion,apoptosis resistance,genomic stability maintenance,signaling pathway modulation
ENSG00000274391,TPTE,microtubule dynamics,tumor suppressor function,cell growth regulation,oncogenic protein inhibition,gene expression regulation,protein stability modulation
ENSG00000015520,NPC1L1,lipid metabolism,signaling pathway modulation,cell growth promotion,tumor cell proliferation,cancer cell survival,protein interaction
ENSG00000107443,CCNJ,calcium channel regulation,oncogenic signaling pathway activation,tumor progression marker,cell proliferation enhancement,apoptosis inhibition,metastatic potential increase
ENSG00000185736,ADARB2,rna editing,alternative splicing,oncogene regulation,tumor progression,therapeutic target,genomic instability
ENSG00000149657,LSM14B,mirna regulation,cell proliferation,apoptosis regulation,pre-mirna processing,poor prognosis marker,tumorigenesis promotion
ENSG00000197483,ZNF628,regulation of gene expression,oncogene activity,cell cycle progression,apoptosis resistance,pi3k/akt pathway interaction,mapk/erk pathway modulation
ENSG00000123728,RAP2C,overexpression,oncogene function,signal transduction pathway,apoptosis regulation,cell proliferation promotion,biomarker utility
ENSG00000276130,SLC22A18,tumor metabolism,chemo-resistance,drug efflux transporter,organic cation transport,substrate uptake regulation,gene expression alteration
ENSG00000167644,C19orf33,glycolytic reprogramming,pi3k/akt pathway activation,tumor aggressiveness enhancement,metastasis promotion,poor prognosis association,therapeutic target potential
ENSG00000148411,NACC2,microtubule dynamics,mitotic spindle formation,cell proliferation,epithelial-to-mesenchymal transition,protein-protein interaction,apoptosis suppression
ENSG00000176160,HSF5,cellular homeostasis regulation,oncogenic process promotion,transcriptional regulation,cell survival enhancement,tumorigenesis facilitation,metastasis augmentation
ENSG00000143194,MAEL,cell cycle regulation,tumor progression,apoptosis suppression,mitotic checkpoint regulation,spindle assembly modulation,oncogenic pathway activation
ENSG00000005379,TSPOAP1,mitochondrial function,protein-protein interaction,cell survival regulation,tumor aggressiveness marker,overexpression in tumors,energy metabolism modulation
ENSG00000151322,NPAS3,cell cycle regulation,transcriptional control,oncogene function,chromatin remodeling complex interaction,target gene modulation,tumor progression driver
ENSG00000167889,MGAT5B,aberrant glycosylation,aggressive tumor behavior,cancer progression,glycosyltransferase activity,immune evasion,tumor microenvironment
ENSG00000153266,FEZF2,fezf2 overexpression,tumor progression,oncogenic function,transcriptional regulation,cellular proliferation,epithelial-to-mesenchymal transition
ENSG00000111911,HINT3,tumor progression,gene expression regulation,cell proliferation,oncogenic potential,transcriptional regulation,chromatin dynamics
ENSG00000110237,ARHGEF17,rho gtpase activation,tumor progression,metastasis promotion,cell migration enhancement,cancer driver gene,transcriptional regulation
ENSG00000156414,TDRD9,chromatin modification,tumor progression,genome instability,oncogene activation,piwi-pirna pathway,epigenetic regulation
ENSG00000110871,COQ5,mitochondrial function,coenzyme q10 regulation,energy metabolism regulation,oxidative stress induction,cellular respiration impairment,tumor progression facilitation
ENSG00000167113,COQ4,mitochondrial dysfunction,redox imbalance,tumor progression,cancer cell metabolism,mitochondrial biogenesis,coenzyme q biosynthesis
ENSG00000136960,ENPP2,cell growth regulation,calcium phosphate homeostasis disruption,pi3k/akt pathway interaction,tumor progression association,extracellular nucleotide regulation,bone mineralization alteration
ENSG00000100027,YPEL1,cellular regulation,genome stability maintenance,oncogene function,tumor progression driver,apoptosis resistance,cell cycle regulation
ENSG00000178295,GEN1,genomic instability,dna replication regulation,genetic mutations promoter,therapeutic target,genome integrity maintenance,protein interaction
ENSG00000169894,MUC3A,epithelial-to-mesenchymal transition,immune evasion strategies,tumor suppressor function,glycosylation regulation,mucin expression modulation,cell migration promotion
ENSG00000167895,TMC8,cell signaling,genomic instability,protein-protein interaction,apoptosis regulation,oncogenic driver gene,dna repair enzyme
ENSG00000243284,VSIG8,wnt/β-catenin pathway inhibition,tumor suppressor function,epithelial-to-mesenchymal transition suppression,metastasis regulation,cell cycle progression control,genomic instability prevention
ENSG00000267673,FDX2,fumarate accumulation,genetic instability,cellular metabolism regulation,oncogenic signaling activation,dna damage induction,mitochondrial dysfunction
ENSG00000141376,BCAS3,oncogenesis,cell proliferation,apoptosis regulation,tumor progression,biomarker potential,protein-protein interaction
ENSG00000215455,KRTAP10-1,keratin filament assembly,ancillary function,cellular migration,epithelial differentiation,tumor microenvironment modulation,poor prognosis indicator
ENSG00000126460,PRRG2,oncogene,cell proliferation,tumor progression,protein-protein interaction,poor prognosis marker,apoptosis regulation
ENSG00000141391,PRELID3A,genomic instability,cell cycle regulation,apoptosis modulation,tumor progression,pi3k/akt pathway interaction,clinical biomarker
ENSG00000160767,FAM189B,genomic instability,proliferation,akt signaling pathway activation,survival and metastasis,tumor progression marker,pi3k/akt interaction
ENSG00000198390,KRTAP13-1,cellular adhesion,epithelial-to-mesenchymal transition,tumor progression,cell proliferation,gene dysregulation,therapeutic target
ENSG00000196378,ZNF34,chromatin remodeling,tumor suppressor function,transcriptional regulation,gene expression modulation,cancer progression suppression,tumor suppressor activity disruption
ENSG00000205476,CCDC85C,pi3k/akt pathway modulation,protein-protein interaction regulation,oncogenic process promotion,cell growth control,signaling molecule activation,therapeutic target potential
ENSG00000196263,ZNF471,zinc finger protein activation,cell proliferation modulation,chromatin remodeling,transcriptional regulation disruption,apoptosis resistance,tumor progression
ENSG00000154889,MPPE1,cell cycle regulation,apoptosis evasion,heme biosynthesis regulation,tumor progression,epigenetic modification,metastasis promotion
ENSG00000120451,SNX19,endosomal recycling,membrane trafficking regulation,cellular growth modulation,tumor progression,metastasis facilitation,therapeutic target candidate
ENSG00000143452,HORMAD1,genomic instability,chromosomal alterations,dna damage response,oncogenic driver,brca1 interaction,mitotic stability
ENSG00000109132,PHOX2B,oncogenic transcription factor,regulation of neuronal differentiation,homeobox gene family,cell proliferation regulation,tumor aggressiveness,potential therapeutic target
ENSG00000105877,DNAH11,cilia-mediated signaling,oncogenesis,cell signaling disruption,aberrant expression,mutations,signaling pathway dysregulation
ENSG00000188766,SPRED3,vegf pathway regulation,angiogenesis modulation,cell proliferation inhibition,immune response modulation,mtor/pi3k/akt signaling,tumor growth suppression
ENSG00000124541,RRP36,ribosome biogenesis,translation initiation,tumor progression,oncogenic processes,metastasis,altered protein synthesis
ENSG00000113593,PPWD1,genomic instability,dna damage response,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor growth promotion
ENSG00000124608,AARS2,altered expression,cell proliferation,tumor progression,protein synthesis dysregulation,amino acid metabolism,possible interaction with dna repair pathways
ENSG00000149212,SESN3,mtor pathway regulation,apoptosis inhibition,autophagy modulation,stress response regulation,cell growth promotion,cancer driver candidate
ENSG00000132581,SDF2,cellular transport regulation,metabolic modulation,tumor progression contribution,lipid biosynthesis involvement,protein-protein interaction,upregulation in cancer
ENSG00000185127,C6orf120,apoptosis regulation,cell cycle modulation,oncosuppressor function,tumor suppressor role,uncharacterized protein,cancer progression association
ENSG00000087301,TXNDC16,disulfide bond formation,protein stabilization,cell growth regulation,proliferation enhancement,cancer progression facilitation,unfolded protein response regulation
ENSG00000134882,UBAC2,protein degradation regulation,tumor progression,autophagy dysregulation,cell proliferation enhancement,oncomitogenesis association,ubiquitination pathway disruption
ENSG00000128463,EMC4,rnase p complex,oncogenic mutations,rna processing dysregulation,aggressive tumor phenotype,poor prognosis,tumor suppressor function
ENSG00000197056,ZMYM1,myc interaction,epithelial-to-mesenchymal transition (emt),zinc finger domain,transcriptional activation,cell proliferation,tumor progression
ENSG00000169715,MT1E,cellular proliferation,metal-responsive transcription factor family,regulation of gene expression,tumor progression,oncogenic potential,chromatin remodeling interactions
ENSG00000177558,FAM187B,pi3k/akt signaling pathway modulation,cell growth regulation,tumor progression association,oncogenic process involvement,protein-protein interaction,cellular stress response modulation
ENSG00000100263,RHBDD3,cell cycle regulation,dysregulated expression,loss of function mutations,tumor suppressor activity,transcriptional regulation,protein-protein interactions
ENSG00000168830,HTR1E,serotonin signaling pathway,cell proliferation,tumor progression,g protein-coupled receptor,apoptosis regulation,angiogenesis modulation
ENSG00000121577,POPDC2,epithelial-to-mesenchymal transition,tumor progression,metastasis regulation,prognostic marker,transcription factor activity,cell proliferation promotion
ENSG00000177119,ANO6,ion transport regulation,metastasis promotion,emt regulation,therapeutic target,pi3k/akt signaling pathway regulation,poor prognosis
ENSG00000146828,SLC12A9,ion transport regulation,pi3k/akt pathway interaction,tumor progression promotion,metastasis facilitation,poor prognosis marker,therapeutic target candidate
ENSG00000197136,PCNX3,wnt/β-catenin signaling pathway,cellular response regulation,tumor progression influence,protein interaction modulation,oncogenic process contribution,cell growth regulation
ENSG00000169762,TAPT1,ion channel regulation,transport modulation,dysregulated expression,cancer cell survival,cellular homeostasis disruption,therapeutic target
ENSG00000087502,ERGIC2,endoplasmic reticulum regulation,overexpression,cell migration enhancement,metastasis promotion,therapeutic target,golgi apparatus interaction
ENSG00000004866,ST7,t-box transcription factor,oncogene function,tumor progression,cell proliferation regulation,embryonic development,chromatin remodeling
ENSG00000124532,MRS2,cellular regulation,magnesium homeostasis,dysregulation,energy metabolism,cancer development,proliferation and survival
ENSG00000103550,KNOP1,genome stability maintenance,tumor suppressor function disruption,cell cycle progression regulation,dna repair modulation,transcriptional regulation disruption,protein degradation dysregulation
ENSG00000187792,ZNF70,oncogenic properties,transcriptional regulation,chromatin remodeling,apoptosis inhibition,cell cycle progression,prognostic marker
ENSG00000179965,ZNF771,cell cycle regulation,transcriptional repression,apoptosis inhibition,histone modification,tumor progression,overexpression
ENSG00000101247,NDUFAF5,mitochondrial dysfunction,tumor suppressor,oncogenesis,cellular respiration,energy production,genomic instability
ENSG00000198146,ZNF770,oncogene function,transcriptional regulation,tumor progression,cell proliferation,poor prognosis marker,overexpression in tumors
ENSG00000282608,ADORA3,adenosine receptor activation,cell proliferation regulation,oncogenic process promotion,pro-survival signaling pathway activation,tumor progression contribution,therapeutic target potential
ENSG00000284400,TBC1D9B,endocytic regulation,rab gtpase modulation,autophagic pathway involvement,tumor suppression,cellular trafficking disruption,lysosomal function regulation
ENSG00000260916,CCPG1,transcriptional regulation,tumor progression,cell proliferation,poor prognosis,dna repair interaction,oncogenic properties
ENSG00000184277,TM2D3,genomic instability,dna damage response,base excision repair,tumor suppressor function,loss-of-function mutations,apoptosis regulation
ENSG00000169230,PRELID1,chromatin remodeling,epigenetic regulation,oncogene or tumor suppressor,cell cycle regulation,apoptosis dysregulation,tumor progression
ENSG00000243130,PSG11,tumor microenvironment modification,gene expression regulation,immune response modulation,cell proliferation enhancement,pro-tumorigenic effects,oncogenic protein interaction
ENSG00000243137,PSG4,proteolytic activity,tumor invasion,cell proliferation,overexpression,poor prognosis,complex regulatory networks
ENSG00000114902,SPCS1,er-associated degradation,lipid biosynthesis regulation,oncogene activation,tumor progression,protein modification dysregulation,cellular growth enhancement
ENSG00000141219,C17orf80,mitochondrial localization,energy metabolism regulation,cellular respiration modulation,tumor progression association,poor prognosis indicator,cancer biomarker potential
ENSG00000198482,ZNF808,oncogenic potential,transcriptional regulator,apoptosis suppression,genomic instability,signaling pathway interaction,tumor overexpression
ENSG00000197566,ZNF624,transcriptional regulation,dna binding activity,zinc finger motifs,oncogenic potential,cell proliferation,metastasis
ENSG00000177150,FAM210A,**

mitochondrial function regulation,oncogenic mutation,metabolic reprogramming,tumorigenesis association,prognostic marker,cellular metabolism modulation
**
ENSG00000133983,COX16,mitochondrial biogenesis,oncogene activation,tumor progression,glycolytic shift,cell proliferation,energy metabolism
ENSG00000156535,CD109,pi3k/akt pathway regulation,transmembrane glycoprotein function,wnt/β-catenin pathway modulation,cell adhesion and migration regulation,tumor progression and metastasis facilitation,prognostic marker correlation
ENSG00000155275,TRMT44,mitochondrial translation regulation,mitochondrial function modulation,genomic instability promotion,cellular energy metabolism increase,apoptosis inhibition,tumorigenesis facilitation
ENSG00000232629,HLA-DQB2,immune evasion,antigen presentation,histocompatibility complex,tumor progression,immune response modulation,gene expression regulation
ENSG00000163864,NMNAT3,cellular metabolism,energy metabolism,nad+ homeostasis,promoter of cell proliferation,sirtuin interaction,therapeutic target
ENSG00000141627,DYM,microtubule stabilization,aneuploidy,mitotic stability,genomic instability,cellular transport regulation,protein-protein interaction
ENSG00000102763,VWA8,cell adhesion disruption,metastasis promotion,tumor progression,protein-protein interaction,overexpression in cancer,signaling pathway regulation
ENSG00000148377,IDI2,mitochondrial enzyme function,protein repair maintenance,redox regulation modulation,oncogene activation,signaling pathway activation,tumor progression enhancement
ENSG00000262664,OVCA2,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis regulation,dna repair pathway interaction,transcriptional regulation
ENSG00000130032,PRRG3,pi3k/akt pathway interaction,tumor progression promoter,cell proliferation enhancement,metastasis facilitation,poor prognosis indicator,epithelial-to-mesenchymal transition regulation
ENSG00000163162,RNF149,e3 ubiquitin ligase activity,pi3k/akt pathway regulation,cellular proliferation enhancement,tumor growth promotion,protein degradation dysregulation,poor prognosis association
ENSG00000173451,THAP2,chromatin remodeling,overexpression,poor prognosis,tumor progression,cell proliferation,epigenetic regulation
ENSG00000176988,FMR1NB,microtubule regulation,cell migration enhancement,tumor growth promotion,overexpression in cancer cells,cytoplasmic localization,prognostic marker
ENSG00000119777,TMEM214,regulates cellular processes,endoplasmic reticulum stress response,modulator of autophagy,mitochondrial function regulation,lipid metabolism regulator,cell growth regulator
ENSG00000164073,MFSD8,mitochondrial dynamics,autophagy regulation,mitophagy pathway,cellular homeostasis disruption,aberrant metabolic function,tumor progression facilitation
ENSG00000121210,TMEM131L,cellular endocytosis disruption,transmembrane protein function,genomic instability induction,signaling pathway alterations,dna repair mechanism disruption,tumor growth promotion
ENSG00000171208,NETO2,microtubule regulation,cancer progression,oncogenic function,tumor metastasis,cell migration,therapeutic target
ENSG00000122912,SLC25A16,mitochondrial carrier,energy metabolism regulation,cellular proliferation promotion,tumor progression associated,biomarker potential,genomic instability modulation
ENSG00000106714,CNTNAP3,cell adhesion disruption,oncogenic potential,tumor progression facilitation,cell migration regulation,signaling pathway modulation,overexpression marker
ENSG00000126243,LRFN3,cell adhesion disruption,oncogenic signaling,tumor progression,therapeutic target,emt regulation,overexpression correlation
ENSG00000167757,KLK11,tumor progression,metastasis,proteolytic cascade activation,cell migration facilitation,ubiquitin-proteasome pathway regulation,oncogenic signaling pathway activation
ENSG00000138759,FRAS1,loss of function mutations,tumor suppression,cell adhesion disruption,epithelial-to-mesenchymal transition,poor prognosis,protein-protein interaction
ENSG00000182575,NXPH3,cell adhesion,transmembrane protein,epithelial-to-mesenchymal transition (emt),cell growth regulation,signaling pathway modulation,cancer progression
ENSG00000083067,TRPM3,ion channel regulation,oncogenic signaling,apoptosis resistance,tumor progression,therapeutic target,calcium influx
ENSG00000144642,RBMS3,cellular proliferation,oncogene function,regulatory mechanisms,cellular interaction,phosphorylation regulation,tumor progression
ENSG00000181240,SLC25A41,mitochondrial transport,metabolic reprogramming,cellular metabolism,energy production,tumorigenesis,poor prognosis
ENSG00000137513,NARS2,protein modification,cellular proliferation,regulatory mechanisms,metabolic regulation,oncogenic processes,tumor progression
ENSG00000131378,RFTN1,cellular trafficking modulation,oncogenic signaling pathway regulation,protein secretion enhancement,tumor suppressor gene suppression,metastasis promotion,cell proliferation upregulation
ENSG00000177054,ZDHHC13,tumor suppressor function,regulation of s-acylation,interaction with akt/mtor pathway,autophagy modulation,cell growth regulation,oncogenic signaling regulation
ENSG00000001630,CYP51A1,mevalonate pathway,aberrant lipid metabolism,prenylation of proteins,cellular proliferation,therapeutic target,protein-protein interaction
ENSG00000120697,ALG5,protein glycosylation,aberrant expression,tumor progression,cellular interaction,glycoprotein biosynthesis,apoptosis evasion
ENSG00000164081,TEX264,chromatin remodeling,nuclear organization,dna replication,genome stability maintenance,tumor suppressor function,prognostic marker
ENSG00000164535,DAGLB,phospholipid metabolism,cell signaling regulation,tumor progression,cell proliferation regulation,cancer biology implicated,cell survival modulation
ENSG00000128203,ASPHD2,mitotic spindle checkpoint,chromosomal instability,genomic alterations,kinetochore function,dysregulation of mitosis,cancer progression
ENSG00000167775,CD320,genomic instability,cell proliferation,survival signaling,angiogenesis regulation,tumor microenvironment modification,vitamin b12 receptor function
ENSG00000119537,KDSR,microtubule regulation,tumor progression,cell division,metastasis,oncogene,mitotic spindle
ENSG00000099904,ZDHHC8,glycosylation regulation,oncogene activation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,signaling pathway modulation
ENSG00000156599,ZDHHC5,mtor signaling,cell proliferation,s-palmitoylation,cell survival,protein activation,oncogenic process
ENSG00000121578,B4GALT4,tumor progression,glycosylation modulation,cell adhesion disruption,metastasis promotion,poor prognosis marker,therapeutic target
ENSG00000132026,RTBDN,tumorigenesis,cell growth regulation,transcription factor interaction,apoptosis inhibition,prognostic marker,nuclear receptor function
ENSG00000186787,SPIN2B,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis modulation,signaling pathway interaction,oncogenic process promotion
ENSG00000168813,ZNF507,transcriptional regulation,tumor suppressor activity,cell growth inhibition,apoptosis promotion,dna binding specificity,gene expression modulation
ENSG00000248496,ZBED9,pi3k/akt signaling,oncogene activity,cell proliferation,emt regulation,tumor suppressor interaction,metastasis promotion
ENSG00000170324,FRMPD2,cell adhesion regulation,cancer driver mutations,cell proliferation enhancement,tumor metastasis promotion,signaling pathway modulation,cell migration regulation
ENSG00000157637,SLC38A10,glucose metabolism,tumor progression,anabolic process,glutamine uptake,cell proliferation,metabolic regulation
ENSG00000164465,DCBLD1,cell surface receptor interaction,extracellular matrix remodeling,protein kinase activation,tumor progression,oncogenic signaling,metastasis promotion
ENSG00000106692,FKTN,glycosylation regulation,signaling pathway modulation,tumor progression contribution,protein modification aberration,cellular proliferation enhancement,signal transduction activation
ENSG00000131019,ULBP3,nkg2d ligand,immune evasion,transmembrane glycoprotein,cancer cell survival,tumor progression,overexpression
ENSG00000125430,HS3ST3B1,heparan sulfate biosynthesis,angiogenesis promotion,tumor microenvironment regulation,metastatic potential enhancement,poor prognosis biomarker,pro-tumorigenic role in cancer progression
ENSG00000131873,CHSY1,bmp signaling,cell proliferation,apoptosis regulation,oncogenic properties,tumor growth enhancement,metastasis promotion
ENSG00000102743,SLC25A15,mitochondrial function,tumor aggressiveness,metabolic reprogramming,cell survival,energy production,ornithine metabolism
ENSG00000138678,GPAT3,lipid biosynthesis regulation,cell membrane fluidity modulation,oncogenic protein-lipid interaction,tumor progression promotion,lipid metabolic reprogramming,therapeutic target identification
ENSG00000188883,KLRG2,immunosuppressive microenvironment,tumor evasion mechanisms,regulation of immune cell activity,cell surface molecule binding,oncogenic processes promotion,poor prognosis marker
ENSG00000181027,FKRP,o-glcnac modification,cell proliferation,glycosyltransferase activity,muscle integrity disruption,tumor microenvironment modulation,muscle wasting regulation
ENSG00000158470,B4GALT5,glycosylation regulation,cell adhesion disruption,tumor progression facilitation,metastasis promotion,apoptosis resistance,therapeutic target
ENSG00000161682,FAM171A2,genomic instability,constitutive activation,dna damage response regulation,tumor suppression defect,protein overexpression,poor prognosis biomarker
ENSG00000114487,MORC1,genomic instability,chromatin remodeling complex member,tumor suppressor function,oncogenic transcriptional regulation,cell proliferation enhancement,dna repair disruption
ENSG00000145861,C1QTNF2,tumor progression,cell adhesion,epithelial-to-mesenchymal transition,cell migration,signaling pathways,prognostic marker
ENSG00000166321,NUDT13,genomic instability,oncogene activation,therapeutic target,biomarker candidate,cell proliferation regulator,dna repair mechanism disruption
ENSG00000120256,LRP11,angiogenic signaling,tumor progression,oncogene overexpression,cell proliferation,metastasis regulation,epithelial-to-mesenchymal transition
ENSG00000170571,EMB,tumor progression,signaling pathway modulation,kinase regulation,cell migration and invasion,therapeutic target,oncogenesis
ENSG00000084444,FAM234B,autophagy regulation,cellular stress response,protein interaction,tumor suppressor function,genomic instability,therapeutic target
ENSG00000164169,PRMT9,regulation of chromatin,oncogenic signaling pathway,histone methylation,tumor promotion,gene expression regulation,therapeutic target
ENSG00000007402,CACNA2D2,calcium channel regulation,cell proliferation enhancement,apoptosis inhibition,immune evasion mechanism,signaling pathway modulation,electrolyte balance disruption
ENSG00000109586,GALNT7,glycosylation regulation,oncogenic protein modification,tumor progression enhancement,cell proliferation promotion,apoptosis inhibition,signaling pathway modulation
ENSG00000166507,NDST2,enhanced angiogenesis,tumor progression,cell migration and invasion,glycosaminoglycan biosynthesis,cell surface proteoglycans modification,heparan sulfate regulation
ENSG00000070614,NDST1,hepran sulfate biosynthesis,overexpression,epithelial-to-mesenchymal transition (emt),growth factor signaling,poor prognosis biomarker,tumor microenvironment modification
ENSG00000187676,B3GLCT,glycosylation regulation,cell surface modification,tumor progression,cell migration,signaling pathway interaction,therapeutic target
ENSG00000139263,LRIG3,pi3k/akt/mtor pathway regulation,tumor suppressor function,rtk signaling inhibition,epithelial-to-mesenchymal transition (emt) modulation,prognostic marker potential,cellular homeostasis maintenance
ENSG00000063180,CA11,angiogenesis,cell proliferation,acid-base regulation,tumor growth promotion,metastasis facilitation,chemo-resistance
ENSG00000186446,ZNF501,transcriptional regulation,tumor development,cell growth modulation,apoptosis suppression,kidney cancer association,zinc finger protein function
ENSG00000147869,CER1,ceramide biosynthesis,apoptosis inhibition,cell proliferation enhancement,oncogenic process contributor,therapeutic target,poor prognosis marker
ENSG00000184613,NELL2,oncogenic role,tumor progression,cell proliferation,regulatory function,poor prognosis marker,neurofilament family
ENSG00000165644,COMTD1,metabolic reprogramming,energy production,fatty acid oxidation,lipid metabolism,cell survival,tumor aggressiveness
ENSG00000180488,MIGA1,mitochondrial dna maintenance,tumor progression,cell metabolic regulation,oxidative stress reduction,prognostic marker,therapeutic target
ENSG00000139278,GLIPR1,immune evasion,apoptosis regulation,tumor suppression,cell proliferation modulation,immune surveillance,protein-protein interaction
ENSG00000103544,VPS35L,autophagic regulation,cellular trafficking,endolysosomal sorting,gene expression regulation,protein-protein interactions,receptor recycling
ENSG00000174928,C3orf33,apoptosis regulation,autophagy modulation,tumor suppression function,genomic stability maintenance,signaling pathway regulation,therapeutic target potential
ENSG00000138399,FASTKD1,mitochondrial transcription,genomic instability,tumor suppression,cell proliferation,apoptosis inhibition,energy metabolism regulation
ENSG00000103356,EARS2,constitutive activation,disrupted dna repair,chemotherapy resistance,altered trna charging,oncogenic signaling,tumor progression
ENSG00000174032,SLC25A30,mitochondrial carrier protein,succinate transport,oncogenic metabolic reprogramming,energy metabolism regulation,biomarker potential,prognostic marker
ENSG00000136444,RSAD1,tumor progression,oncogene,cell proliferation,gtp-binding protein,apoptosis regulation,inflammatory response modulation
ENSG00000105696,TMEM59L,pi3k/akt pathway regulation,cell adhesion modulation,tumor growth promotion,oncogene/tumor suppressor potential,prognostic marker,cellular signaling interaction
ENSG00000135454,B4GALNT1,mucin-type o-glycosylation,glycoprotein modification,cell surface remodeling,tumor progression,immune evasion,cancer cell survival
ENSG00000104497,SNX16,endosomal sorting,receptor-mediated endocytosis,tumor progression,enhanced metastasis,immune evasion,cell survival
ENSG00000144227,NXPH2,calcium channel regulation,oncogene overexpression,tumor progression,ion channel interaction,cell proliferation enhancement,signaling pathway modulation
ENSG00000280969,RPS4Y2,ribosomal protein overexpression,cell proliferation enhancement,tumor growth promotion,translation efficiency increase,oncogene activation,cancer progression acceleration
ENSG00000174749,FAM241A,pi3k/akt/mtor pathway regulation,oncogenic potential,tumor progression facilitation,cell growth regulation,signaling pathway modulation,genomic amplification
ENSG00000157570,TSPAN18,cell adhesion regulation,integrin interaction,tumor progression facilitation,metastasis promotion,overexpression association,cell-cell interaction modulation
ENSG00000168785,TSPAN5,tumor progression,oncogene,cell adhesion regulation,metastasis promotion,immune evasion,protein-protein interaction
ENSG00000103978,TMEM87A,er stress response,upr signaling,transmembrane protein function,tumor progression,cancer prognosis,proliferation regulation
ENSG00000153982,GDPD1,glycosylation modification,redox balance modulation,cell proliferation enhancement,tumor progression facilitation,biomarker potential,cancer cell survival promotion
ENSG00000003989,SLC7A2,glutamine metabolism regulation,tumor growth facilitation,redox status modulation,angiogenesis promotion,pi3k/akt signaling interaction,gene expression alteration
ENSG00000109929,SC5D,pi3k/akt pathway,cell growth regulation,cell cycle progression,sulfation enzyme activity,tumor aggressiveness,therapeutic target
ENSG00000023041,ZDHHC6,cell signaling,protein activation,palmitoylation,cell growth,metastasis,lipid modification
ENSG00000175106,TVP23C,tpr domain-containing protein,tumor suppressor regulation,cell cycle regulation,genomic stability maintenance,p53 modulation,oncogenic mutation
ENSG00000215704,CELA2B,wnt/β-catenin signaling,carboxylesterase activity,cancer progression,metabolism regulation,prognostic marker,tumor suppression
ENSG00000150625,GPM6A,pi3k/akt pathway interaction,cell proliferation promotion,oncogene activity,neuronal development regulation,transmembrane glycoprotein function,synaptic plasticity modulation
ENSG00000204160,ZDHHC18,protein modification,cellular signaling,lipid metabolism,membrane trafficking,oncogene/tumor suppressor,tumor behavior regulation
ENSG00000185090,MANEAL,autophagy regulation,tumor suppressor function,downregulation,genomic instability,oxidative stress,cellular homeostasis
ENSG00000258102,MAP1LC3B2,autophagic regulation,cell survival enhancement,chemotherapy resistance,cancer progression,protein-protein interaction,tumor recurrence
ENSG00000102128,RAB40AL,rab40al overexpression,pi3k/akt pathway activation,cellular autophagy regulation,oncogene function,tumor cell growth promotion,genetic mutation impact
ENSG00000285281,SGPP1,sphingolipid metabolism,oncogenic process,cell survival,tumor progression,metastasis regulation,signal transduction
ENSG00000214113,LYRM4,mitochondrial function regulation,antitumor activity,tumor suppressor function,mitochondrial dynamics regulation,apoptosis promotion,cancer metabolism reprogramming
ENSG00000177000,MTHFR,genomic instability,epigenetic modifications,dna synthesis,one-carbon metabolism,therapeutic target,methyltransferase activity
ENSG00000130508,PXDN,pi3k/akt pathway interaction,constitutive activation,redox regulation,gene amplification,tumor progression correlation,cellular proliferation enhancement
ENSG00000137269,LRRC1,cellular invasion,tumor aggressiveness,chemotherapy resistance,epithelial-to-mesenchymal transition,adherens junction regulation,cancer cell migration
ENSG00000282830,CALB2,calcium-dependent signaling,tumor progression,cellular response modulation,prognostic marker,overexpression,stress response regulation
ENSG00000053770,AP5M1,ap-5 complex regulation,cellular trafficking disruption,tumor progression,therapeutic target,oncogenic cell growth,metabolic dysregulation
ENSG00000143502,SUSD4,tumor suppressor,cell surface receptor interaction,pi3k/akt pathway regulation,metastasis inhibition,cancer progression driver,proliferation and invasion regulation
ENSG00000169629,RGPD8,rhogdi regulation,tumor progression,cell migration regulation,aberrant activation,metastasis modulation,prognostic marker
ENSG00000112276,BVES,tumor suppressor,adherens junction regulation,metastasis promotion,vegf secretion enhancement,cell proliferation inhibition,apoptosis induction
ENSG00000151366,NDUFC2,electron transport chain dysfunction,mitochondrial metabolism alteration,oxidative phosphorylation disruption,cellular energy production impairment,cancer cell growth promotion,redox state dysregulation
ENSG00000101452,DHX35,dna damage repair,genomic instability,telomere maintenance,cell survival enhancement,oncogenic transcription factor regulation,helicase activity modulation
ENSG00000125827,TMX4,tumor progression,metastasis promotion,cell migration,epithelial-to-mesenchymal transition,angiogenesis regulation,prognostic marker
ENSG00000129244,ATP1B2,disrupted ion transport,na+/k+ pump dysfunction,cell membrane potential regulation,cellular signaling disruption,hypertension association,kidney disease relation
ENSG00000180730,SHISA2,shisa2 downregulation,tumor suppression,wnt/β-catenin pathway inhibition,plasma membrane localization,signaling molecule modulation,cellular proliferation regulation
ENSG00000282739,SLC25A26,oncogene,metabolic alterations,mitochondrial carrier,warburg effect,cellular metabolism,tumor aggressiveness
ENSG00000165115,KIF27,chromosomal stability,mitotic spindle formation,cell cycle progression,cytokinesis regulation,post-translational modification,tumor suppressor function
ENSG00000278565,CEACAM21,adhesion modulation,pi3k/akt pathway regulation,oncogene or tumor suppressor,cell migration and invasion,wnt/β-catenin signaling interaction,prognostic marker
ENSG00000170426,SDR9C7,metabolite degradation regulation,cellular homeostasis maintenance,genomic instability association,oncogenesis impact,stress response regulation,tumorigenesis link
ENSG00000148090,AUH,regulation of protein synthesis,tumor progression,post-transcriptional regulation,cellular responses,mitochondrial function,rna-binding activity
ENSG00000244444,EGFL8,angiogenesis,cell proliferation,tumor progression,immune suppression,vascularization,mutation hotspot
ENSG00000164898,FMC1,microtubule regulation,cell proliferation,chromatin remodeling,tumor suppressor role,mitotic spindle assembly,cytoskeletal organization
ENSG00000139324,TMTC3,tumor progression,cell signaling pathway,protein interactions,biomarker identification,oncogene overexpression,cancer cell migration
ENSG00000125247,TMTC4,pi3k/akt pathway modulation,cancer cell migration and invasion,epithelial-to-mesenchymal transition (emt),chromatin remodeling and epigenetic regulation,tumor progression and metastasis,therapeutic target
ENSG00000137216,TMEM63B,tumor progression,regulation of calcium channels,cell proliferation,oncogenic properties,mtor pathway activation,prognostic marker
ENSG00000146433,TMEM181,tumor suppressor activity,calcium channel regulation,oncogenic process promotion,apoptosis suppression,transcription factor modulation,ion channel function
ENSG00000157600,TMEM164,autophagy regulation,apoptosis inhibition,endoplasmic reticulum stress response modulation,cell survival promotion,proliferation enhancement,transmembrane protein function
ENSG00000106809,OGN,dna damage repair,cell growth regulation,genomic stability maintenance,tumor suppressor activity,oncogene overexpression,cell cycle regulation
ENSG00000064763,FAR2,epithelial-to-mesenchymal transition,elevated expression in tumors,fibroblast activation protein complex,integrin interaction,pi3k/akt/mtor pathway activation,tumor progression
,MARC2,apoptosis regulation,bcl-2 family protein,cell cycle modulation,dna damage response,oncogenic upregulation,tumor progression
ENSG00000179598,PLD6,phospholipase d activity,akt/mtor pathway activation,oncogenic potential,tumor progression,cell signaling regulation,genomic overexpression
ENSG00000147119,CHST7,glycosaminoglycan biosynthesis,epithelial-to-mesenchymal transition,cell adhesion regulation,metastasis promotion,poor prognosis marker,wnt/β-catenin pathway interaction
ENSG00000116273,PHF13,chromatin remodeling,transcriptional regulation,epigenetic modulation,histone modification,tumorigenesis,oncogenic transcription
ENSG00000183032,SLC25A21,mitochondrial transport,metabolic reprogramming,oncogenic process,energy production,interactions with pdc/kgdhc,altered glycolysis/glutaminolysis
ENSG00000113583,C5orf15,long non-coding rna function,regulation of pi3k/akt pathway,tumor progression,cellular growth modulation,oncogene involvement,therapeutic target
ENSG00000037749,MFAP3,extracellular matrix regulation,microfibril-associated protein function,cell adhesion modulation,tumor invasion promotion,biomarker significance,prognostic indicator
ENSG00000084110,HAL,apoptosis regulation,cell cycle modulation,tumor suppressor interaction,signaling pathway dysregulation,halogenated compound degradation,cancer development promotion
ENSG00000198276,UCKL1,**
actin cytoskeleton modulation,microtubule stability regulation,cell migration promotion,tumor progression enhancement,oncogenic interaction network formation,genomic amplification 
**
ENSG00000183066,WBP2NL,tumor progression,cell proliferation,protein degradation regulation,metastasis promotion,oncogenic protein regulation,poor prognosis association
ENSG00000186075,ZPBP2,apoptosis regulation,programmed cell death induction,stress response modulation,tumor cell viability regulation,chemotherapy resistance,cellular stress adaptation
ENSG00000104760,FGL1,immune evasion,tumor microenvironment modulation,cell adhesion regulation,angiogenesis promotion,thrombosis dysregulation,fibrinogen expression regulation
ENSG00000113391,FAM172A,genomic instability,tumor suppression,proliferation regulation,apoptosis modulation,pi3k/akt pathway regulation,cellular response regulation
ENSG00000110811,P3H3,hypoxia-induced stabilization,angiogenic signaling,cell proliferation,transcriptional regulation,protein modification,metastatic potential
ENSG00000133612,AGAP3,cell migration regulation,gtpase activation,tumor progression,cell proliferation promotion,protein interaction modulation,cytoskeleton reorganization
ENSG00000122787,AKR1D1,oncogene activation,epigenetic regulation,cell cycle progression,metabolic dysregulation,prognostic marker,therapeutic target
ENSG00000135898,GPR55,g-protein coupled receptor activation,metastasis promotion,cell migration regulation,tumor progression driver,therapeutic target,apoptosis inhibition
ENSG00000158764,ITLN2,tumor growth promotion,glycoprotein interaction,signaling pathway activation,cell proliferation enhancement,metastasis facilitation,prognosis marker
ENSG00000055732,MCOLN3,calcium signaling,overexpression in cancer,tumor progression,oncogenic process,cell proliferation regulation,autophagy modulation
ENSG00000135317,SNX14,regulation of endocytosis,cell survival pathways,tumor promotion,autophagy regulation,biomarker candidate,protein trafficking modulation
ENSG00000106603,COA1,mitochondrial dysfunction,metabolic regulation,cellular respiration,energy metabolism,oxidative stress,tumor growth
ENSG00000153898,MCOLN2,cellular homeostasis disruption,tumor promotion,programmed necrosis regulation,ripk3 interaction,pseudokinase function,prognostic marker
ENSG00000156162,DPY19L4,cellular proliferation,genomic instability,cell division regulation,mitotic spindle assembly,centrosome stability,tumor progression
ENSG00000007341,ST7L,**

genomic instability,pi3k/akt pathway,tumor suppressor activity,cell cycle regulation,oncogenic potential,apoptosis regulation 
**
ENSG00000278889,OR2S2,olfactory receptor,cellular proliferation,tumor progression,metastasis promotion,cancer metastasis,overexpression marker
ENSG00000121377,TAS2R7,tumor progression,cellular signaling pathway regulation,gene expression alteration,tumor growth modulation,cancer development influence,dysregulation of chemoresistance
ENSG00000157111,TMEM171,calcium homeostasis regulation,cell membrane integrity,oncogene overexpression,tumor growth promotion,apoptosis inhibition,metastasis facilitation
ENSG00000244617,ASPRV1,ribosomal assembly,translation regulation,overexpression,tumorigenesis,metastasis,genetic mutations
ENSG00000172061,LRRC15,oncogenic driver,cell cycle regulation,phosphorylation,gene expression regulation,pi3k/akt/mtor pathway activation,metabolic enhancement
ENSG00000164318,EGFLAM,angiogenesis promoter,tumor progression factor,vegf signaling pathway interaction,endothelial cell regulator,vascular homeostasis disruption,therapeutic target
ENSG00000183098,GPC6,cellular adhesion,epithelial-to-mesenchymal transition,glycosylphosphatidylinositol-anchored protein,cell migration,cell survival,tumor progression
ENSG00000054690,PLEKHH1,microtubule dynamics,tumor progression,constitutive activation,oncogenic transformation,gene amplification,cellular proliferation
ENSG00000126259,KIRREL2,wnt/β-catenin pathway regulation,cell-cell adhesion disruption,tumor suppressor function,epithelial integrity maintenance,adherens junction interaction,oncogenic pathway dysregulation
ENSG00000165828,PRAP1,genomic instability,aneuploidy,cell cycle regulation,mitotic checkpoint regulation,therapeutic target,prognostic marker
ENSG00000162769,FLVCR1,angiogenesis promotion,cell proliferation,endothelial interaction,genomic instability,iron export regulation,tumor progression
ENSG00000072041,SLC6A15,amplification,amino acid transport,cell proliferation,glycolytic shift,metabolic reprogramming,tumor progression
ENSG00000147100,SLC16A2,tumor growth promotion,metabolic reprogramming,oncogene potential,biomarker significance,poor prognosis marker,lactate transport function
ENSG00000176142,TMEM39A,lipid metabolism regulation,ceramide levels modulation,tumor progression association,poor prognosis marker,cell membrane composition regulation,pi3k/akt pathway interaction
ENSG00000125434,SLC25A35,mitochondrial carrier protein,metabolic regulation,succinate transport,citric acid cycle modulation,oncogenic pathway activation,prognostic marker
ENSG00000164291,ARSK,pre-mrna splicing regulation,genome stability maintenance,cellular growth promotion,tumorigenesis contribution,mutation-induced aberrancy,apoptosis resistance facilitation
ENSG00000184374,COLEC10,immune response,inflammation regulation,cell signaling modulation,tumor microenvironment interaction,prognostic marker potential,cancer immunology
ENSG00000025423,HSD17B6,**
estrogen-dependent growth,hormone regulation,metabolic reprogramming,cell proliferation,protein-protein interactions,steroidogenesis **
ENSG00000171936,OR10H3,olfactory receptor function,cellular response modulation,tumor detection,proliferation regulation,survival enhancement,signaling pathway interaction
ENSG00000151093,OXSM,mitochondrial function,oxidative stress regulation,cellular protection,tumor suppressor/ oncogene,cancer progression,metabolic regulation
ENSG00000175065,DSG4,cell adhesion disruption,tumor suppressor function,loss of expression,metastatic potential,aggressive tumor behavior,pi3k/akt pathway regulation
ENSG00000184635,ZNF93,tumor suppression,transcriptional regulation,dna damage response,cell proliferation inhibition,apoptosis promotion,genomic instability prevention
ENSG00000118620,ZNF430,transcriptional regulation,cellular proliferation,angiogenesis promotion,tumor progression,tissue specificity,epigenetic regulation
ENSG00000136877,FPGS,folate metabolism,cell proliferation,tumor progression,enzyme activity,polyglutamate synthesis,cancer cell growth
ENSG00000095981,KCNK16,cellular excitability,ion flow regulation,tumor cell proliferation,signal transduction modulation,oncogenic process activation,potassium channel function alteration
ENSG00000173621,LRFN4,cellular signaling pathway disruption,epithelial-to-mesenchymal transition facilitation,oncogene potential,tumor progression promotion,cellular survival enhancement,resistance mechanism regulation
ENSG00000143061,IGSF3,cell-cell adhesion disruption,oncogene activation,pi3k/akt/mtor pathway interaction,epithelial-to-mesenchymal transition promotion,tumor suppressor protein pten regulation,gain of function mutations
ENSG00000138617,PARP16,er-mediated gene expression,overexpression,regulation of cell growth,cellular dna repair,transcriptional regulation,protein-protein interactions
ENSG00000115539,PDCL3,tumor growth promotion,cell cycle regulation,apoptosis inhibition,dna repair modulation,cancer prognosis indicator,therapeutic target
ENSG00000161395,PGAP3,glycosylphosphatidylinositol (gpi) anchoring,cell-to-cell communication,cellular signaling,protein modification,tumor progression,cancer biology
ENSG00000213413,PVRIG,immune evasion,immunosuppressive microenvironment,t-cell inhibition,overexpression association,prognostic marker,cancer immunotherapy target
ENSG00000116138,DNAJC16,cellular chaperone function,oncogene activation,protein-protein interactions,apoptosis regulation,cell cycle progression,tumor suppressor inactivation
ENSG00000185561,TLCD2,nuclear protein interaction,transcriptional regulation,tetratricopeptide repeat domain,protein stability modulation,oncogenesis,cancer progression
ENSG00000120594,PLXDC2,pi3k/akt pathway interaction,receptor recycling and reuse,oncogenic driver function,tumor growth and invasion enhancement,cell surface receptor internalization,signaling pathway regulation
ENSG00000070413,DGCR2,microrna processing,oncogenic micrornas,tumor progression,cellular regulation,gene expression modulation,post-transcriptional regulation
ENSG00000048140,TSPAN17,tetraspanin-enriched microdomains,epithelial-to-mesenchymal transition (emt),oncogenic processes,apoptosis suppression,cell-cell interactions modulation,prognostic biomarker
ENSG00000019102,VSIG2,tumor suppressor function,cell adhesion,apoptosis regulation,pi3k/akt signaling,proliferation promotion,immune modulation
ENSG00000171004,HS6ST2,sulfotransferase activity,tumor progression,protein modification,cell adhesion regulation,angiogenesis promotion,poor prognosis marker
ENSG00000178904,DPY19L3,genomic instability,oncogene activation,histone modification,dna repair,tumor progression,poor prognosis
ENSG00000177034,MTX3,cellular proliferation,zinc-dependent signaling,signaling pathway modulation,epigenetic modification regulation,tumor progression marker,cancer-related gene expression
ENSG00000106560,GIMAP2,regulation of t-cell function,modulation of immune microenvironment,immune system regulation,tumor microenvironment interaction,genetic dysregulation,none
,KIAA0391,autophagy regulation,cell cycle modulation,mitotic spindle formation,protein function alteration,tumor development impact,cancer research relevance
ENSG00000284120,KIR2DS1,immune modulation,immune evasion,tumor progression,natural killer cell regulation,prognostic marker,genomic expression changes
ENSG00000133317,LGALS12,tumor progression,nf-κb signaling pathway,oncogene activation,cell proliferation regulation,biomarker discovery,protein-carbohydrate interaction
ENSG00000172551,MUCL1,tumor progression,metastasis facilitation,epithelial-to-mesenchymal transition,signaling pathway modulation,cell migration regulation,overexpression in cancer
ENSG00000174944,P2RY14,tumor microenvironment,immune evasion,angiogenesis promotion,chronic inflammation,cancer metastasis,poor prognosis marker
ENSG00000198108,CHSY3,glycosylation pathway,angiogenesis,tumor progression,immune evasion,therapeutic resistance,cell adhesion modification
ENSG00000111885,MAN1A1,protein modification,tumor progression,cell survival,signaling pathway modulation,extracellular matrix regulation,poor prognosis
ENSG00000183798,EMILIN3,tumor progression,cell-ecm interaction,biomarker potential,extracellular matrix remodeling,integrin interaction,adhesion molecule function
ENSG00000145882,PCYOX1L,redox balance regulation,genomic instability promotion,dna repair interaction,cell cycle regulation,tumor suppressor function,oxidative stress induction
ENSG00000149577,SIDT2,mitochondrial dynamics regulation,small molecule transport,cell proliferation promotion,oncogenic pathway activation,loss of function mutation,tumor cell survival enhancement
ENSG00000198743,SLC5A3,tumor progression,lactate production,glycolysis enhancement,oncogene activation,metabolic regulation,cellular proliferation
ENSG00000117069,ST6GALNAC5,biomarker for cancer diagnosis,enzymatic activity in glycosylation,cell migration and invasion,chemoresistance modification,protein kinase activation modulation,increased cell proliferation
ENSG00000102078,SLC25A14,tumor growth,metabolic reprogramming,mitochondrial function,cellular homeostasis,therapeutic target,metabolic regulation
ENSG00000111801,BTN3A3,apoptosis modulation,cell adhesion regulation,immune regulation disruption,pi3k/akt pathway modulation,tumor progression enhancement,upregulated expression
ENSG00000026950,BTN3A1,immune modulation,cell proliferation,antigen presentation,t-cell activation,tumor microenvironment,immune landscape
ENSG00000240654,C1QTNF9,cellular adhesion,epithelial-to-mesenchymal transition,tumor progression,metastatic potential,cell migration,integrin interaction
ENSG00000118298,CA14,oxidative stress regulation,cell survival enhancement,pi3k/akt pathway activation,glucose metabolism increase,therapeutic target identification,cancer cell metabolism modulation
ENSG00000128274,A4GALT,altered glycosylation,cellular processes disruption,dysregulated protein stability,glycosylation pathway interactions,kidney cancer progression,oncogenic potential
ENSG00000166997,CNPY4,cytosolic superoxide dismutase regulation,cellular redox balance modulation,oxidative stress protection,dna damage response,genomic instability contribution,intracellular copper regulation
ENSG00000256453,DND1,genomic maintenance,dna damage response,chromosomal instability,cell proliferation,oncogenic mutations,tumor progression
ENSG00000141933,TPGS1,lipid metabolism regulation,tumor growth promotion,warburg effect enhancement,fatty acid modulation,transcriptional regulator role,genomic instability contribution
ENSG00000137821,LRRC49,cell migration,prognostic marker,leucine-rich repeat domain,tumor progression,aggressive behavior,cell adhesion
ENSG00000172339,ALG14,n-glycosylation disruption,dysregulated expression,tumor growth promotion,cell cycle regulation,genetic instability,therapeutic target
ENSG00000005059,MCUB,tumor progression,metalloprotease regulation,extracellular matrix degradation,cell invasion,metastasis,therapeutic target
ENSG00000248144,ADH1C,metabolic regulation,alcohol metabolism,tumor progression,dna damage repair,oxidative stress modulation,cellular growth regulation
ENSG00000102287,GABRE,inhibitory neurotransmission,ion channel regulation,synaptic plasticity modulation,cellular excitability disruption,oncogenic pathway modulation,tumor suppressor function loss
ENSG00000137198,GMPR,cellular migration,metastasis promotion,genomic instability,tumor progression,pi3k/akt pathway interaction,cytoskeleton regulation
ENSG00000169508,GPR183,lipid metabolism regulation,constitutive activation,oncogenic processes,tumor progression,immune evasion,metabolic regulation
ENSG00000203737,GPR52,cell proliferation,oncogenic processes,inflammatory response modulation,tumor microenvironment modification,poor prognosis marker,g protein signaling
ENSG00000135912,TTLL4,microtubule dynamics,overexpression,oncogenic role,driver gene,microtubule stability,signaling pathways
ENSG00000165799,RNASE7,tumor suppression,immune response regulation,ribonuclease activity,viral rna degradation,cell growth inhibition,downregulated expression
ENSG00000179913,B3GNT3,proteoglycan biosynthesis,cell migration,integrin interaction,growth factor regulation,tumor invasion,adhesion molecule function
ENSG00000106526,ACTR3C,**
mitotic regulation,centrosomal function,chromosomal instability,oncogenic driver,cell cycle progression,spindle assembly 
**
ENSG00000164048,ZNF589,oncogene,tumor suppressor degradation,cell proliferation enhancement,metastasis promotion,prognostic marker,pi3k/akt pathway modulation
ENSG00000090612,ZNF268,transcriptional regulation,tumor progression,oncogenesis,krab domain-containing zinc finger protein family,chromatin remodeling complexes,metastasis
ENSG00000169258,GPRIN1,mapk/erk signaling pathway,g protein regulation,cell proliferation,tumor growth and metastasis,amplification and mutation,poor prognosis marker
ENSG00000103241,FOXF1,hypoxia-inducible factor signaling pathway,interaction with hif-1α,tumor adaptation,angiogenesis regulation,metabolic regulation,cellular survival
ENSG00000076351,SLC46A1,dna synthesis regulation,nucleobase transport disruption,genomic instability modulation,tumor progression association,cellular response regulation,protein-protein interaction
ENSG00000143612,C1orf43,cellular regulation,constitutive activation,genomic amplification,oncogene potential,protein-protein interaction,tumor progression
ENSG00000162600,OMA1,mitochondrial function regulation,apoptosis resistance,cellular metabolism modulation,tumor suppression,protein homeostasis maintenance,cell survival pathway interaction
ENSG00000275600,PIGW,gpi anchor biosynthesis,cell adhesion disruption,metastasis driver,tumor aggressiveness,oncogenic potential enhancement,protein-protein interaction
ENSG00000141437,SLC25A52,mitochondrial function regulation,energy metabolism modulation,cellular energy homeostasis disruption,oncogenic transformation promotion,biomarker potential,tumor growth support
ENSG00000283034,ZNF445,transcriptional regulation,tumor suppressor activity,ccnd1 repression,p53 interaction,genomic stability maintenance,zinc finger motifs
ENSG00000161905,ALOX15,metabolic regulation,pro-inflammatory lipid production,tumor progression,angiogenesis promotion,apoptosis suppression,biomarker potential
ENSG00000166396,SERPINB7,apoptosis inhibition,cell proliferation,oncogene role,stat3 interaction,p65 interaction,protease inhibitor activity
ENSG00000118017,A4GNT,glycoprotein modification,cell surface receptor regulation,protein kinase activation,tumor aggressiveness,poor prognosis biomarker,pi3k/akt/mtor pathway interaction
ENSG00000198792,TMEM184B,ion transport regulation,cell homeostasis maintenance,ion channel activity,cellular membrane association,signaling pathway involvement,protein expression regulation
ENSG00000111684,LPCAT3,lysophospholipid remodeling,metabolic regulation,cell membrane fluidity,oncogenic transformation,tumor growth and metastasis,phospholipid metabolism
ENSG00000167332,OR51E2,olfactory receptor function,cellular regulation,signaling pathway modulation,tumor behavior influence,cell growth promotion,aberrant expression
ENSG00000164180,TMEM161B,calcium signaling disruption,proliferation enhancement,mitochondrial regulation,tumor cell migration,anti-apoptotic function,cell membrane protein
ENSG00000139624,CERS5,cancer cell proliferation,cell survival,tumor progression,lipid metabolism regulation,oncogenic protein interaction,poor prognosis marker
ENSG00000181396,OGFOD3,tumor suppression degradation,cell growth promotion,protein processing regulation,pi3k/akt pathway interaction,apoptosis inhibition,tumor progression driver
ENSG00000149582,TMEM25,pi3k/akt signaling,promoter hypermethylation,cell proliferation modulation,gene amplification,signaling pathway regulation,tumor progression promotion
ENSG00000176454,LPCAT4,lipid remodeling,tumor progression,cell signaling modulation,biomarker expression,prognostic significance,genomic amplification
ENSG00000197586,ENTPD6,tumor suppressor,regulation of purinergic signaling,cell proliferation regulation,apoptosis modulation,biomarker potential,prognostic significance
ENSG00000178752,ERFE,epithelial-to-mesenchymal transition,elevated expression,metastasis promotion,tumor aggressiveness,poor prognosis,transcription factor activity
ENSG00000170801,HTRA3,apoptosis inhibition,angiogenesis promotion,bcl-2 regulation,cell survival enhancement,dna damage response modulation,protein quality control
ENSG00000185621,LMLN,overexpression,tumor progression,cell survival,cell proliferation,signaling pathway regulation,molecular interaction
ENSG00000120820,GLT8D2,cell growth regulation,glutamyl cyclization modification,cellular interaction,protein degradation facilitation,oncogenic pathway activation,tumor progression promotion
ENSG00000173852,DPY19L1,cell cycle dysregulation,dna repair disruption,genomic instability driver,oncogenic cell growth,tumor progression marker,co-amplification with other genes
ENSG00000164976,MYORG,cellular migration,cytoskeleton dynamics,intracellular transport,motor protein function,tumor progression,adhesion regulation
ENSG00000144959,NCEH1,**

cholesterol efflux,lipid metabolism regulation,tumor progression,cellular cholesterol reduction,pi3k pathway interaction,genomic instability
ENSG00000106771,TMEM245,cellular homeostasis,tumor suppressor,transmembrane protein,apoptosis regulation,autophagy modulation,cell cycle regulation
ENSG00000169379,ARL13B,ciliary dysfunction,oncogenic processes,disrupted cellular polarity,reduced expression levels,ciliary assembly maintenance,protein-protein interactions
ENSG00000182162,P2RY8,purinergic signaling,platelet activation,tumor progression,metastasis promotion,poor prognosis,thrombosis regulation
ENSG00000133657,ATP13A3,iron regulation,oxidative stress response,metal ion transport,autophagy dysregulation,oncogenic pathway disruption,tumor aggressiveness
ENSG00000115828,QPCT,glutathione regulation,oxidative stress modulation,cellular homeostasis,protein degradation,antioxidant defense regulation,tumor aggressiveness enhancement
ENSG00000198018,ENTPD7,tumor microenvironment modulation,cell surface localization,glycosylphosphatidylinositol-anchored enzyme,immune response regulation,cell survival and proliferation pathways,altered expression levels
,TMEM8A,er stress response,calcium homeostasis regulation,protein expression modulation,tumor cell growth promotion,cellular differentiation disruption,apoptosis suppression
ENSG00000146282,RARS2,aberrant translation,cellular proliferation,genomic instability,oncogenic mutations,protein synthesis regulation,tumor suppression loss
ENSG00000069943,PIGB,glycosylphosphatidylinositol anchor,cell adhesion disruption,metastasis promotion,cell proliferation enhancement,survival pathway modulation,glycosylation process alteration
ENSG00000163755,HPS3,hps complex regulation,albinism,immunodeficiency,lysosome biogenesis disorder,cellular trafficking defect,tumor aggressiveness marker
ENSG00000111728,ST8SIA1,cell proliferation,microenvironment modulation,tumor progression,glycosylation regulation,immune evasion,therapeutic target
ENSG00000269556,TMEM185A,tumor suppressor function,immune response modulation,cell signaling regulation,nf-κb pathway interaction,transmembrane protein expression,downregulated in tumors
ENSG00000226479,TMEM185B,pi3k/akt pathway activation,oncogene function,tumor progression,gain of function mutations,cell proliferation regulation,transmembrane protein expression
ENSG00000143653,SCCPDH,oncoprotein overexpression,tumor progression,apoptosis inhibition,cell cycle dysregulation,cancer cell survival,biomarker potential
ENSG00000115488,NEU2,cell surface modulation,oncogenic signaling,epithelial-to-mesenchymal transition (emt),metastasis-related gene expression,tumor progression,biomarker for prognosis
ENSG00000196950,SLC39A10,zinc transport,tumor progression,poor prognosis,protein-protein interactions,dna damage repair,apoptosis prevention
ENSG00000112195,TREML2,immune activation,tumor microenvironment modulation,tumor progression influence,therapeutic target,immune cell regulation,pathogen recognition
ENSG00000153214,TMEM87B,epithelial-to-mesenchymal transition,tumor progression,cell signaling,oncogenic driver,ion transport regulation,transmembrane protein function
ENSG00000086696,HSD17B2,steroid metabolism regulation,tumor suppressor activity,oncogene regulator role,cell proliferation modulation,metastasis suppression influence,epigenetic regulation alteration
ENSG00000090530,P3H2,tumor progression,cell migration,biomarker potential,extracellular matrix organization,collagen binding,signaling pathway modulation
ENSG00000206072,SERPINB11,apoptosis suppression,tumor suppressor function,cell migration modulation,protease inhibition,onco-suppression,cell adhesion regulation
ENSG00000152749,GPR180,gpcr function,constitutive activation,tumor progression,pi3k/akt pathway interaction,increased expression,potential therapeutic target
ENSG00000115525,ST3GAL5,glycan modification,pi3k/akt pathway modulation,apoptosis resistance,cell adhesion enhancement,sialic acid addition,glycosylation regulation
ENSG00000243449,C4orf48,genomic amplification,tumor suppressor function,cell cycle regulation,oncogenic processes,protein interaction,genomic instability
ENSG00000169884,WNT10B,wnt signaling pathway,epithelial-to-mesenchymal transition (emt),stem cell-like properties,cell proliferation and survival,aberrant expression,pro-invasive capabilities
ENSG00000070718,AP3M2,tumor microenvironment modulation,cell migration facilitation,lysosomal trafficking regulation,cancer cell invasion enhancement,immune response regulation disruption,protein complex subunit function
,FUK,dna repair mechanism,genomic instability prevention,tumor suppressor function,cell cycle regulation,replication intermediate processing,dna damage response
ENSG00000145309,CABS1,cell cycle regulation,protein-protein interaction,oncogenic potential,apoptosis regulation,transcriptional control,cellular stress response
ENSG00000122778,KIAA1549,cell cycle regulation,microtubule dynamics regulation,tumor progression,oncogene overexpression,emt regulation,signaling pathway activation
ENSG00000110975,SYT10,chromatin remodeling,oncogene overexpression,cell cycle regulation,epigenetic modification,apoptosis suppression,co-expression networks
ENSG00000184330,S100A7A,epithelial-to-mesenchymal transition,cell signaling regulation,protein-protein interaction,oncogenic function,tumor progression,apoptosis inhibition
ENSG00000172888,ZNF621,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor aggressiveness marker,cell proliferation promotion,zinc finger domain containing
ENSG00000149328,GLB1L2,glycoprotein regulation,golgi apparatus function,cellular trafficking regulation,oncogenesis implication,cell signaling modulation,genomic instability association
ENSG00000169105,CHST14,tumor progression,cell adhesion and migration,oncogene activation,genomic amplification,protein-protein interactions,cancer metastasis
ENSG00000196562,SULF2,heparan sulfate regulation,tumor progression,growth factor modulation,cell proliferation,angiogenesis,therapeutic target
ENSG00000088812,ATRN,genomic instability,cell cycle regulation,dna damage response,tumor suppressor function,checkpoint activation,replication stress sensitivity
ENSG00000144357,UBR3,tumor suppression,dna damage response,protein stability regulation,genomic instability,ubiquitination pathway interaction,loss-of-function mutation
ENSG00000106868,SUSD1,tumor suppressor function,loss of function mutations,pi3k/akt pathway modulation,cell adhesion and migration regulation,immune response modulation,therapeutic target
ENSG00000146833,TRIM4,microrna regulation,apoptosis regulation,e3 ubiquitin ligase activity,tumor suppressor function,nf-κb pathway modulation,pi3k/akt signaling pathway interaction
ENSG00000100276,RASL10A,cell proliferation,ras superfamily member,signaling pathway component,cytoskeletal regulation,growth factor activation,tumor progression marker
ENSG00000168528,SERINC2,ceramide biosynthesis,tumor suppressor function,cancer cell proliferation regulation,s1p/ceramide signaling pathway disruption,apoptosis inhibition,loss-of-function mutations
ENSG00000110013,SIAE,immune modulation,metastasis promotion,tumor microenvironment regulation,leukocyte adhesion regulation,biomarker potential,cancer cell behavior modification
ENSG00000138744,NAAA,tumor progression,metabolic regulation,apoptosis regulation,cell survival modulation,lipid metabolism influence,therapeutic target
ENSG00000013288,MAN2B2,glycosylation pathway,oncogenic potential,tumor progression,metastasis,angiogenesis,immune evasion
ENSG00000140993,TIGD7,tumor suppressor,transcriptional regulation,apoptosis modulation,cell cycle regulation,genomic instability,protein interaction
ENSG00000147432,CHRNB3,nicotinic acetylcholine receptors,cellular proliferation,signaling pathway activation,gene expression regulation,tumor progression,receptor dimerization
ENSG00000174428,GTF2IRD2B,transcription regulation,chromatin remodeling,cancer promoter,gene expression modulation,cell proliferation,aberrant splicing
ENSG00000112761,CCN6,cell proliferation promotion,tumor progression enhancement,oncogenic protein interaction,apoptosis regulation disruption,genomic instability induction,signaling pathway activation
ENSG00000167261,DPEP2,oncogenic activity,cell proliferation,therapeutic target,tumor progression,protein synthesis regulation,ph regulation
ENSG00000033100,CHPF2,centriole biogenesis,hippo-yap signaling pathway,cilia formation regulation,cellular proliferation,chromosomal stability modulation,oncogenic driver gene
ENSG00000168569,TMEM223,cellular integrity,apoptosis regulation,proliferation regulation,tumor progression,metastasis enhancement,pi3k/akt pathway interaction
ENSG00000145990,GFOD1,glutamine metabolism,tumor growth modulation,mitochondrial function regulation,cellular energy production,metabolic reprogramming,cancer progression
ENSG00000141098,GFOD2,er stress response,cellular homeostasis,energy metabolism regulation,protein folding regulation,mitochondrial function support,tumor progression susceptibility
ENSG00000162694,EXTL2,microtubule dynamics,cell cycle regulation,genomic stability,chromosome segregation,cell survival,protein overexpression
ENSG00000139572,GPR84,mapk/erk pathway activation,oncogenic function,tumor progression,immune response modulation,aggressive tumor behavior,poor prognosis
ENSG00000188095,MESP2,oncogenic function,transcriptional regulation,cellular differentiation,proliferation promotion,survival pathway activation,epigenetic modification
ENSG00000157617,C2CD2,spindle checkpoint,cell cycle regulation,genomic instability,aneuploidy,tumor suppression,mitotic checkpoint dysfunction
ENSG00000095203,EPB41L4B,rna-binding protein function,oncogenic promoter,tumor growth promotion,cell migration regulation,protein translation enhancement,genomic amplification marker
ENSG00000161714,PLCD3,pi3k/akt pathway regulation,metastasis progression,cell proliferation enhancement,tumor growth promotion,ca2+ signaling modulation,e-cadherin interaction
ENSG00000288508,ISLR,cell-cell interaction,immunoglobulin superfamily member,tumor progression,cell proliferation,survival pathway,immune response regulation
ENSG00000170848,PSG6,cellular proliferation,epithelial expression,protein-protein interaction,tumor progression,cancer-associated protein,oncogenic signaling pathway
ENSG00000204941,PSG5,cell adhesion disruption,tumor progression,emt modulation,proteolytic activity enhancement,tumor aggressiveness promotion,metastasis facilitation
ENSG00000221826,PSG3,apoptosis regulation,cell growth inhibition,epithelial expression,kidney tissue involvement,protein homeostasis regulation,tumor suppression
ENSG00000129667,RHBDF2,notch signaling pathway activation,dysregulation of cellular differentiation,aberrant protein processing,increased tumor growth and metastasis,chemotherapy resistance modulation,elevated pro-tumorigenic gene expression
ENSG00000139344,AMDHD1,mtor activation,cellular ph regulation,amino acid metabolism,oncogenic transformation,protein synthesis enhancement,tumor growth promotion
ENSG00000159579,RSPRY1,apoptosis regulation,cell cycle progression,dna damage response,genomic instability,rna-binding protein function,tumorigenesis modulation
ENSG00000187054,TMPRSS11A,**
cell surface receptor cleavage,epithelial-to-mesenchymal transition (emt),signaling pathway activation,overexpression,oncogenic processes,vascular endothelial growth factor (vegf) regulation
**
ENSG00000166682,TMPRSS5,**
protein processing,cell signaling,angiogenesis,epithelial-to-mesenchymal transition,transmembrane protease activity,tumor progression 
**
ENSG00000134779,TPGS2,xenobiotic metabolism,glucuronidation process,bilirubin conjugation,liver and kidney expression,pharmacokinetic changes,drug interactions
ENSG00000186919,ZACN,tumor suppressor function loss,transcriptional regulator dysfunction,cell cycle dysregulation,genomic instability promotion,apoptosis inhibition,dna repair mechanism disruption
ENSG00000149150,SLC43A1,lipid metabolism regulation,fatty acid transport,cellular energy production,tumor progression promotion,therapeutic target identification,genomic alteration implication
ENSG00000171466,ZNF562,cell cycle regulation,apoptosis inhibition,transcriptional regulation,nuclear localization,dna binding activity,chromatin remodeling
ENSG00000171469,ZNF561,transcription factor regulation,cell proliferation enhancement,oncogenic function,tumor tissue overexpression,cell growth regulation,zinc finger motif dna binding
ENSG00000167981,ZNF597,oncogenic role,transcriptional regulation,chromatin remodeling,apoptosis inhibition,cell cycle progression,overexpression marker
ENSG00000124302,CHST8,cell adhesion,glycosylation regulation,oncogenic potential,prognostic marker,tumor progression,cell migration
ENSG00000087299,L2HGDH,metabolic regulation,energy production,tumor progression,oncogenic potential,genetic mutations,cellular metabolism
ENSG00000276175,LILRA3,immune modulation,leukocyte activation,tumor infiltration,immunotherapy target,cancer immunity,immune evasion mechanism
ENSG00000277398,LILRA1,leukocyte interaction,immunomodulation,tumor microenvironment alteration,chemotaxis regulation,phagocytosis modulation,tumor progression facilitation
ENSG00000149054,ZNF215,brca1 interaction,dna damage response,genomic instability,oncogenic function,transcriptional regulation,zinc finger protein
ENSG00000166979,EVA1C,cellular stress response,gain of function mutations,signaling pathway regulation,cell growth modulation,metabolic adaptation,oncogenic process promotion
ENSG00000125355,TMEM255A,plasma membrane localization,cell proliferation regulation,oncogenic mutations,cell migration promotion,protein-protein interaction,tumor progression enhancement
ENSG00000115226,FNDC4,cellular adhesion,metastasis promotion,extracellular matrix interaction,prognostic marker,tumor progression,cell migration
ENSG00000122986,HVCN1,ion channel regulation,immune response modulation,tumor progression,cell migration enhancement,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000118242,MREG,genomic instability,epigenetic regulation,dna methylation,tumor suppressor gene silencing,oncogene activation,poor prognosis biomarker
ENSG00000177181,RIMKLA,camk activation,cell cycle regulation,metastasis promotion,microtubule dynamics regulation,cancer cell proliferation,therapeutic target
ENSG00000188352,FOCAD,fatty acid regulation,lipid metabolism modulation,mitochondrial dynamics regulation,tumor cell survival enhancement,cancer progression facilitation,cellular lipid degradation pathway alteration
ENSG00000072954,TMEM38A,tumor progression,oncogene activation,increased cell proliferation,genomic instability,apoptosis resistance,cell migration enhancement
ENSG00000151806,GUF1,cell proliferation,genomic instability,oncogenic process,dna replication,apoptosis resistance,cell cycle regulation
ENSG00000188175,HEPACAM2,tumor progression,extracellular matrix interaction,metastasis promotion,cell adhesion modulation,protein-protein interaction,oncogenic processes
ENSG00000068137,PLEKHH3,microtubule dynamics regulation,oncogenic pathway activation,tumor growth promotion,cancer therapy target,poor prognosis marker,cell proliferation enhancement
ENSG00000168671,UGT3A2,glucuronidation,pharmacokinetic modulation,chemotherapy resistance,detoxification process,oncosuppression,genotoxic stress
ENSG00000163898,LIPH,cellular proliferation,lysophosphatidic acid signaling,metabolic dysregulation,tumor growth promotion,prognostic biomarker,pi3k/akt/mtor pathway activation
ENSG00000087116,ADAMTS2,tumor progression,metastasis regulation,proteolytic processing,extracellular matrix remodeling,tumor microenvironment modulation,growth factor regulation
ENSG00000214456,PLIN5,lipid metabolism reprogramming,tumor growth promotion,mtor pathway interaction,oncogenic potential,poor prognosis marker,energy metabolism dysregulation
ENSG00000100344,PNPLA3,lipid metabolism,prognostic marker,tumor growth progression,oncogenesis,lipid homeostasis disruption,cancer cell survival pathways
ENSG00000139974,SLC38A6,glutamine metabolism,amino acid transport,mtor pathway activation,cell growth promotion,cancer cell survival,oncogenic protein interaction
ENSG00000281919,SLC45A2,transmembrane protein,promotes tumor cell proliferation,interacts with cell cycle regulators,contributes to oncogenesis,survival factor in cancer cells,dysregulated expression
ENSG00000140675,SLC5A2,**

regulatory dysfunction,electrolyte imbalance,sodium-chloride cotransporter function,cell proliferation enhancement,tumor suppressor loss-of-function mutations,renal tubular acidosis association
ENSG00000113296,THBS4,tumor progression,angiogenesis regulation,protein-protein interactions,cell adhesion modulation,extracellular matrix regulation,biomarker potential
ENSG00000205268,PDE7A,regulatory function,signal transduction pathway,overexpression,cellular responses modification,cancer progression,tumor modulation
ENSG00000188782,CATSPER4,calcium channel regulation,sperm cell function,fertilization process,oncogenic mutation,tumor growth promotion,genomic dysregulation
ENSG00000170464,DNAJC18,dna damage response,cellular survival,tumor aggressiveness,apoptosis regulation,molecular chaperone function,prognostic biomarker
ENSG00000103196,CRISPLD2,cellular regulation,tumor suppression,oncogenic inhibition,tumor progression,metastasis,prognostic marker
ENSG00000164176,EDIL3,emt program,epithelial-to-mesenchymal transition,angiogenesis promotion,oncogene overexpression,tumor growth enhancement,prognostic marker
ENSG00000136883,KIF12,mitotic progression,oncogene overexpression,microtubule dynamics regulation,cell cycle regulation enhancement,genomic instability promotion,therapeutic target potential
ENSG00000146006,LRRTM2,overexpression,oncogene role,cell proliferation,tumor progression,poor prognosis,pi3k/akt pathway interaction
ENSG00000198754,OXCT2,mitochondrial transport,energy metabolism regulation,glutamine metabolism dysregulation,oncogenic pathway activation,tumor suppressor function impairment,metabolic reprogramming
ENSG00000094975,SUCO,energy metabolism regulation,mitochondrial function,cellular proliferation,metabolic reprogramming,overexpression in cancer,none
ENSG00000163053,SLC16A14,glucose uptake regulation,monocarboxylate transport,lactate export regulation,tumor growth promotion,cellular metabolism modulation,energy production enhancement
ENSG00000138111,MFSD13A,cellular metabolism regulation,tumor growth promotion,metabolic reprogramming,oncogene overexpression,autophagy modulation,glycolysis enhancement
ENSG00000186377,CYP4X1,tumor progression,biomarker,cell proliferation,apoptosis modulation,lipid metabolism regulation,oncogenesis promotion
ENSG00000196636,SDHAF3,mitochondrial dysfunction,cellular metabolism reprogramming,tumor progression driver,hif-α stabilization,angiogenesis promotion,glycolysis upregulation
ENSG00000276114,CCL23,immunosuppression,angiogenesis,promotes metastasis,tumor progression,prognostic biomarker,aberrant expression
ENSG00000173638,SLC19A1,cellular growth regulation,folate metabolism regulation,resistance to apoptosis,proliferation promotion,dna synthesis facilitation,tumor progression
ENSG00000148950,IMMP1L,primary cilium maintenance,intraflagellar transport component,retrograde transport mechanism,sensory organelle dysfunction,tumor progression modifier,cancer susceptibility gene
ENSG00000248099,INSL3,oncogenic overexpression,tumor progression,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,protein-protein interaction
ENSG00000150045,KLRF1,nf-κb pathway modulation,cancer cell survival,cell-cell interactions,tumor suppressor function,immune response regulation,signaling pathway interaction
ENSG00000206150,RNASE13,rna degradation,genomic stability,cellular homeostasis,oncogenesis,tumorigenesis,proliferation
ENSG00000177202,SPACA4,chromatin remodeling,meiotic process,spermatogenesis regulator,nuclear localization,tumor expression upregulation,cancer research focus
ENSG00000134905,CARS2,cellular metabolism integration,methionine cysteine biosynthesis pathway,anabolic processes support,oncogenic driver gene,poor prognosis indicator,cancer cell proliferation
ENSG00000164494,PDSS2,mitochondrial function,prenylation pathway,ubiquinone biosynthesis,oxidative stress,energetic metabolism,cellular transformation
ENSG00000204140,CLPSL1,calcium homeostasis disruption,cell proliferation enhancement,cancer aggressiveness promoter,protein-protein interactions,metabolic regulation alteration,apoptosis inhibition
ENSG00000188811,NHLRC3,genetic instability,apoptosis regulation,proteasomal degradation,tumor suppressor function,p53 pathway regulation,ubiquitination complex formation
ENSG00000228083,IFNA14,ifna14's tumor suppressor function,anti-tumor immunity,apoptosis induction,angiogenesis inhibition,cancer cell regulation,dna damage response pathway
ENSG00000234829,IFNA17,tumor-suppressive effect,type i interferon signaling,apoptosis induction,proliferation inhibition,stat1 activation,angiogenesis promotion
ENSG00000138308,PLA2G12B,apoptosis regulation,cell signaling pathway,cancer cell survival,lipid metabolism regulation,metastasis promotion,prostaglandin synthesis
ENSG00000263961,RHEX,tumor progression,enhanced cell proliferation,metastasis promotion,cell cycle regulation,tumor growth facilitation,prognostic marker
ENSG00000173947,PIFO,cell cycle regulation,tumor suppressor function,mutation associated,epigenetic silencing,apoptosis inhibition,cell proliferation
ENSG00000109762,SNX25,escrt pathway regulation,tumor progression,cellular proliferation,protein recycling,oncogenic interaction,genomic amplification
ENSG00000090975,PITPNM2,overexpression,regulation of cellular membrane dynamics,cell proliferation,enhanced metastasis,poor prognosis,phosphoinositide transfer
ENSG00000148343,MIGA2,microtubule stabilization,cell proliferation,tumor progression,oncogenic driver,therapeutic target,mitotic spindle regulation
ENSG00000205111,CDKL4,tumor growth promotion,cell cycle regulation,genomic instability,mitotic index increase,oncogenic processes,therapeutic target
ENSG00000185838,GNB1L,mapk/erk pathway,overexpression,oncogenic process,tumor progression,poor prognosis,regulatory protein
ENSG00000176204,LRRTM4,cell adhesion regulation,tumor progression,oncogenic mutations,cell surface interaction,signaling pathway modulation,metastasis promotion
ENSG00000139044,B4GALNT3,glycosylation,tumor growth promotion,metastasis enhancement,cell proliferation modulation,aberrant protein production,signaling pathway interaction
ENSG00000182272,B4GALNT4,cell surface glycosylation,oncogenic signaling,tumor aggressiveness,glycan biosynthesis,aberrant glycans,pi3k/akt activation
ENSG00000198799,LRIG2,rtk regulation,oncogene/tumor suppressor,cell migration/proliferation,egfr signaling inhibition,tumor growth/metastasis,biomarker/prognostic marker
ENSG00000146530,VWDE,cellular communication,extracellular matrix regulation,tumor progression,proteoglycan breakdown,collagen degradation,angiogenesis modulation
ENSG00000119900,OGFRL1,cell growth regulation,tumor progression,pro-survival signaling,pi3k/akt pathway activation,metastasis promotion,ligand interaction
ENSG00000113119,TMCO6,mitotic regulation,chromosomal instability,aurora kinase interaction,cell cycle control,protein degradation regulation,cancer prognosis
ENSG00000171595,DNAI2,dynein axonemal intermediate chain function,aneuploidy facilitation,cell proliferation promotion,cilia and flagella formation,mitotic spindle assembly regulation,centrosome separation interaction
ENSG00000101448,EPPIN,angiogenesis inhibition,tumor suppressor activity,extracellular matrix interaction,cell adhesion regulation,glycoprotein function,binding to upa
ENSG00000249139,EPPIN-WFDC6,tumor suppression,serine protease regulation,cellular adhesion,cell migration inhibition,protein function disruption,oncogenic potential
ENSG00000187800,PEAR1,angiogenesis promotion,cell adhesion regulation,immune response modulation,integrin interaction,metastasis facilitation,pi3k/akt pathway activation
ENSG00000180626,ZNF594,krab domain transcription factor,overexpressed in cancer,tumor progression,cell proliferation regulation,apoptosis inhibition,chromatin modification
ENSG00000154415,PPP1R3A,glycolytic regulation,metabolic reprogramming,protein phosphatase activity,tumor suppressor function,insulin signaling pathway,cell proliferation enhancement
ENSG00000139292,LGR5,cell proliferation enhancement,tumor initiation promotion,emt facilitation,cancer stem cell maintenance,oncogene expression,signaling pathway activation
ENSG00000173114,LRRN3,leucine-rich repeat-containing protein,apoptosis regulation,cell migration facilitation,epithelial-to-mesenchymal transition promotion,axonal guidance disruption,rna-binding protein activity
ENSG00000182168,UNC5C,apoptosis regulation,cell migration facilitation,netrin-1 binding,tumor suppressor interaction,prognostic marker,genomic instability
ENSG00000148468,FAM171A1,tumor progression,genomic instability,cellular proliferation,oncogenic processes,protein interaction,dysregulated expression
ENSG00000152767,FARP1,gef activity,cell migration,tumor progression,oncogenic pathway activation,angiogenesis regulation,rho gtpase activation
ENSG00000224940,PRRT4,signaling pathway modulation,tumor progression,cell migration and invasion,oncogene function,therapeutic target,prognostic marker
ENSG00000113205,PCDHB3,cell adhesion regulation,immune evasion mechanisms,tumor progression driver,therapeutic target,prognostic biomarker,oncogenic signaling pathway activation
ENSG00000117114,ADGRL2,cell-cell interaction alteration,cellular signaling pathway modulation,cancer progression contribution,tumor aggressiveness association,prognosis impact,genomic alteration link
ENSG00000081760,AACS,lipid metabolism regulation,oncogenic function,metabolic reprogramming,fatty acid degradation,enzyme activation,tumor progression
ENSG00000108846,ABCC3,apoptosis resistance,cell proliferation,drug efflux mechanism,metabolic regulation,nf-κb pathway interaction,substrate transport function
ENSG00000112812,PRSS16,cellular differentiation,enzymatic activity,high expression levels,oncogenic process,poor prognosis,proliferation pathway
ENSG00000151005,TKTL2,warburg effect,pyrimidine biosynthesis,energy metabolism reprogramming,tumor growth promotion,biomarker potential,therapeutic target
ENSG00000170950,PGK2,glycolytic pathway activation,tumor proliferation,metabolic regulation,cell survival,therapeutic target,genomic amplification
ENSG00000164434,FABP7,lipid metabolism regulation,cell proliferation enhancement,metastasis promotion,tumor microenvironment modulation,cell migration facilitation,protein-protein interaction facilitation
ENSG00000047365,ARAP2,regulation of pi3k/akt/mtor pathway,tumor suppression,cell growth regulation,mitochondrial dynamics modulation,hippo signaling pathway interaction,yap/taz transcriptional coactivation
ENSG00000143891,GALM,glyoxalase system regulation,cellular detoxification,reactive carbonyl compound metabolism,oxidative stress reduction,tumorigenesis association,cancer therapy target
ENSG00000101311,FERMT1,actin cytoskeleton regulation,cell migration enhancement,oncogenic overexpression,poor prognosis association,cell proliferation increase,metastasis promotion
ENSG00000100033,PRODH,mtor pathway activation,gain of function mutations,tumor growth promotion,biomarker,cell proliferation enhancement,apoptosis regulation
ENSG00000253626,EIF5AL1,translation regulation,metabolic regulation,cell proliferation,promoter methylation,tumor suppressor function,genomic instability
ENSG00000134398,ERN2,regulation of unfolded protein response,modulation of cellular stress responses,interaction with pi3k/akt/mtor pathway,altered expression in cancer cells,role in cellular proliferation and apoptosis,regulation by transcription factors
ENSG00000156958,GALK2,glycolytic enzyme regulation,hypoxia adaptation,oncogenic signaling,tumor growth promotion,metabolic rewiring,poor prognosis marker
ENSG00000183208,GDPGP1,glycolytic regulation,metabolic adaptation,oncogene overexpression,angiogenic promotion,glycogen phosphorylation,cellular energy homeostasis
ENSG00000196475,GK2,pi3k/akt signaling,cellular proliferation,tumor progression,signaling pathway modulation,apoptosis regulation,angiogenesis promotion
ENSG00000099984,GSTT2,glutathione conjugation,detoxification process,xenobiotic metabolism,oxidative stress regulation,cancer susceptibility,antioxidant defense mechanism
ENSG00000107902,LHPP,lysine-histidine transport,tumor suppressor function,cellular proliferation,disrupted regulation,cdk4/cyclin d1 interaction,genomic deletion
ENSG00000198951,NAGA,metabolic reprogramming,cellular proliferation,glutaminolysis enhancement,glycolytic shift,protein synthesis modulation,amino acid regulation
ENSG00000185792,NLRP9,inflammation regulation,apoptosis modulation,tumor metastasis,cell death pathway,immune microenvironment modulation,oncogenic potential
ENSG00000215440,NPEPL1,regulatory mechanism,cellular signaling pathways,tumor progression,protein turnover regulation,oncogene potential,immune system modulation
ENSG00000157045,NTAN1,tumor suppressor regulation,protein degradation pathway,cellular stress response,ubiquitin-proteasome system dysfunction,cancer prognosis marker,oncogenic protein stabilization
ENSG00000218823,PAPOLB,oncogene activation,overexpression,tumor progression,cell proliferation,hormone regulation,protein-protein interaction
ENSG00000127125,PPCS,phosphatase activity,cell cycle regulation,protein-protein interactions,tumor progression,therapeutic target,pi3k/akt pathway modulation
ENSG00000185164,NOMO2,nuclear mitotic apparatus protein 2,chromosomal instability,cell survival signaling,pro-survival pathways,kinetochore component,mitosis regulator
ENSG00000013583,HEBP1,angiogenesis facilitation,cell proliferation modulation,coactivator function,hypoxia response regulation,metabolic pathway interaction,oncogenic transcriptional activation
ENSG00000145284,SCD5,fatty acid metabolism,lipid biosynthesis,pi3k/akt pathway,cell proliferation,metabolic regulation,oncogenesis
ENSG00000100092,SH3BP1,oncogenic activation,endocytosis regulation,tumor progression,cell migration invasion,signaling molecule interaction,cytoplasmic reorganization
ENSG00000171612,SLC25A33,mitochondrial function,energy metabolism,lipid biosynthesis,carnitine transport,fatty acid oxidation,glycolytic shift
ENSG00000114779,ABHD14B,phospholipid metabolism,cellular signaling pathway,oncogenic role,pi3k/akt pathway modulation,tumor suppressor interaction,lipid regulation
ENSG00000109667,SLC2A9,glucose transporter function,metabolic reprogramming,glycolytic shift,oncogenic potential,tumor microenvironment adaptation,pi3k/akt pathway interaction
ENSG00000142871,CCN1,tumor progression,cell survival signaling,oncogene activation,angiogenesis promotion,metastasis facilitation,apoptosis inhibition
ENSG00000167962,ZNF598,genomic instability,transcriptional regulation,apoptosis modulation,tumor suppressor interaction,cell cycle progression,rna-binding protein
ENSG00000214338,SOGA3,mitochondrial function,cancer metabolism,autophagy regulation,cellular signaling pathways,biomarker potential,protein synthesis modulation
ENSG00000176393,RNPEP,protein degradation pathway,oncogenic signaling,pi3k/akt activation,tumor progression,metastasis promotion,poor prognosis marker
ENSG00000105778,AVL9,p53 degradation inhibitor,ubiquitination pathway regulator,cell cycle progression,tumor suppressor interaction,genomic instability mediator,malignant transformation
ENSG00000254656,RTL1,microtubule regulation,cancer progression,tumor aggressiveness,cellular organization,motor protein interaction,prognostic biomarker
ENSG00000172318,B3GALT1,tumor progression,glycoprotein synthesis,cellular adhesion,immune evasion,prognostic marker,epithelial-to-mesenchymal transition
ENSG00000172733,PURG,pseudogene,dna repair,replication regulation,cell cycle control,gene regulatory element,evolutionary remnant
ENSG00000106034,CPED1,enhanced oncogenic activity,interaction with pi3k/akt pathway,angiogenesis promotion,cell proliferation and survival,anti-apoptotic protein expression,overexpression
ENSG00000154165,GPR15,tumor growth,immune evasion,cell migration,signaling pathway regulation,metastasis,overexpression
ENSG00000181827,RFX7,cell cycle regulation,chromatin remodeling,transcriptional regulation,oncogene overexpression,tumor progression,dna repair regulation
ENSG00000121075,TBX4,**

tbx4 overexpression,cell proliferation,genetic alterations,t-box transcription factor,morphogenesis regulation,kidney development dysfunction

**
ENSG00000248905,FMN1,oxidative stress regulation,metabolic regulation,cell proliferation modulation,tumor growth promotion,antioxidant enzyme function,dna damage response alteration
ENSG00000160094,ZNF362,transcription factor activation,epithelial-to-mesenchymal transition,cell proliferation regulation,migratory behavior promotion,cancer stem cell maintenance,oncogenic overexpression
ENSG00000156787,TBC1D31,regulation of rab7 gtpase,disruption of endocytosis and autophagy,tumor progression,cellular growth and survival regulation,oncogenic pathway activation,lysosomal dysfunction
ENSG00000104983,CCDC61,cell cycle progression,oncogenic function,transcriptional regulation,apoptosis evasion,angiogenesis modulation,coiled-coil domain interaction
ENSG00000277848,MEGF11,cellular differentiation,apoptosis regulation,oncogenic potential,tumor progression,metastasis promotion,cellular stress response
ENSG00000143971,ETAA1,chromatin remodeling,transcriptional regulation,cell growth promotion,oncogenic processes,cancer driver gene,histone modification
ENSG00000196074,SYCP2,cell cycle regulation,dna damage response,epithelial-to-mesenchymal transition,homologous chromosome pairing,meiotic process,oncoprotein overexpression
ENSG00000263002,ZNF234,transcriptional regulation,cell proliferation,tumor progression,epigenetic modification,overexpression,transcription factor
ENSG00000186020,ZNF529,oncogenic regulation,transcriptional activation,cell proliferation promotion,apoptosis inhibition,chromatin remodeling,cancer overexpression
ENSG00000204611,ZNF616,tumor suppressor,krab domain,c2h2-type zinc fingers,downregulated expression,cell cycle regulation,genomic stability
ENSG00000244588,RAD21L1,chromosomal instability,cohesin complex disruption,genomic aberrations,tumor progression,oncogene regulation,transcriptional repression
,FOPNL,cellular growth regulation,dysregulation,cytoplasmic protein interaction,cell migration modulation,genomic instability marker,biological process alteration
ENSG00000169607,CKAP2L,tumor progression,oncogene function,cell cycle regulation,chromatin remodeling,nuclear pore complex interaction,pi3k/akt signaling pathway
ENSG00000133739,LRRCC1,microtubule regulation,cell cycle control,adaptor molecule function,centrosome localization,protein-protein interaction,tumorigenesis link
ENSG00000169359,SLC33A1,glycosphingolipid metabolism,cellular homeostasis regulation,protein phosphorylation modulation,tumor progression,oncogenic transformation,signaling pathway interaction
ENSG00000006831,ADIPOR2,metabolic regulation,tumor progression,cell growth and survival signaling pathway interaction,oncogenic processes,epithelial-to-mesenchymal transition,biomarker potential
ENSG00000138018,SELENOI,cancer driver gene,oncogenic function,protein-protein interaction,cell survival promotion,antioxidant defense system,overexpression in tumors
ENSG00000164168,TMEM184C,tumor suppressor,ion transport regulation,epithelial polarity maintenance,cellular homeostasis regulator,kidney cancer association,membrane protein interaction
ENSG00000146842,TMEM209,autophagy regulation,tumor progression,therapeutic target,genomic profiling,constitutive activation,dysregulation
ENSG00000166471,TMEM41B,er stress regulation,unfolded protein response,cellular proliferation,tumor progression,metastasis promotion,chaperone activation
ENSG00000175274,TP53I11,apoptosis regulator,dna damage response,cellular senescence,tumor suppressor function,genetic instability,pro-apoptotic protein
ENSG00000139636,LMBR1L,**

lmbr1 family member,epigenetic regulator,chromatin remodeling,transcriptional modulator,oncogenesis promoter,tumor progression driver
ENSG00000143797,MBOAT2,sphingolipid metabolism,tumor progression,cell proliferation inhibition,apoptosis suppression,prognostic biomarker,therapeutic target
ENSG00000111860,CEP85L,centrosome function,microtubule dynamics,chromosomal instability,genomic alterations,cell division regulation,aneuploidy prevention
ENSG00000170390,DCLK2,microtubule dynamics,oncogenic transformation,cell proliferation,kinase activation,signaling pathway modulation,poor prognosis marker
ENSG00000100147,CCDC134,cell cycle regulation,mitotic spindle assembly,chromosomal instability,aneuploidy,aberrant centrosome formation,tumor progression
ENSG00000158966,CACHD1,genomic instability,tumor suppressor function,cell cycle regulation,dna repair mechanisms,chromatin remodeling,epigenetic modification
ENSG00000148358,GPR107,regulation of electrolyte balance,overexpression in ccrcc,g protein-coupled receptor function,kidney-specific expression,cell growth and survival pathways,tumor marker or therapeutic target
ENSG00000176018,LYSMD3,loss of cell adhesion,oncogenic properties,cytoplasmic localization,cell-cell interaction regulation,adherens junction modulation,cytoskeletal dynamics regulation
ENSG00000124786,SLC35B3,heparan sulfate biosynthesis,nucleotide sugar transporter,glycosaminoglycan synthesis,cell growth regulation,tumor cell maintenance,pi3k/akt pathway interaction
ENSG00000131389,SLC6A6,neurotransmitter transporter function,cellular metabolism regulation,oncogene overexpression,cancer cell growth promotion,apoptosis inhibition,signaling pathway interaction
ENSG00000149483,TMEM138,ion channel regulation,dysregulated expression,genomic mutation,cellular homeostasis disruption,tumor microenvironment alteration,cancer driver gene candidate
ENSG00000180776,ZDHHC20,tumor invasion,cancer progression,cell growth modulation,promoter of cell proliferation,stat3 transcription factor interaction,palmitoylation regulation of e-cadherin
ENSG00000163704,PRRT3,pi3k/akt pathway activation,oncogenic processes promotion,cell proliferation facilitation,tumor progression enhancement,prognostic biomarker potential,transmembrane protein function
ENSG00000173930,SLCO4C1,transport of bile acids and bilirubin glucuronides,tumor progression,membrane transport regulation,kidney tissue specificity,gene expression alteration,cancer biology implication
ENSG00000187049,TMEM216,mitochondrial function,autophagy regulation,tumor suppressor activity,cellular stress response,pi3k/akt pathway interaction,mtor activation
ENSG00000116396,KCNC4,potassium channel regulation,cellular excitability,tumorigenesis,oncogenic processes,cellular proliferation,protein interaction
ENSG00000103061,SLC7A6OS,oncogene overexpression,gene amplification,tumor progression,cell survival enhancement,metabolic regulation,prognostic marker
ENSG00000164403,SHROOM1,microtubule regulation,actin filament interaction,oncogenic potential,cell migration enhancement,epithelial-to-mesenchymal transition (emt) regulation,pi3k/akt/mtor pathway interaction
ENSG00000100124,ANKRD54,chromatin remodeling,tumor growth enhancement,transcriptional regulation modification,histone mark alteration,oncogene activation,cellular differentiation disruption
ENSG00000114541,FRMD4B,tumor suppressor function,pi3k/akt pathway regulation,cellular migration and invasion regulation,chromosomal location at 14q32.33,biomarker potential,oncogenic process enhancement
,KIAA0556,wnt/β-catenin pathway activation,cell proliferation enhancement,oncogenic mutation,biomarker overexpression,signaling pathway dysregulation,cancer cell growth promotion
ENSG00000148459,PDSS1,mitochondrial regulation,prenylation pathway,cellular proliferation,tumor growth promotion,oncogene overexpression,signaling pathway activation
ENSG00000019186,CYP24A1,vitamin d degradation,calcium metabolism disruption,cell proliferation promotion,apoptosis inhibition,tumor microenvironment modulation,genomic instability driver
ENSG00000174886,NDUFA11,mitochondrial function,energy production,metabolic reprogramming,cellular respiration,atp synthesis,tumor metabolism
ENSG00000110074,FOXRED1,mitochondrial respiratory chain dysfunction,oncogenic metabolism,cellular respiration regulation,transcriptional regulator function,tumor growth promotion,metabolic adaptation
ENSG00000144406,UNC80,intracellular chloride regulation,tumor growth inhibition,cell migration modulation,therapeutic target identification,apoptosis induction,wnt/β-catenin pathway interaction
ENSG00000164296,TIGD6,nf-κb pathway regulation,inflammatory response modulation,tumor progression association,cell survival enhancement,protein interaction influence,genomic instability connection
ENSG00000004848,ARX,tumor suppressor function,dna repair regulation,cell differentiation regulation,genomic stability maintenance,transcriptional regulation disruption,apoptosis suppression
ENSG00000172197,MBOAT1,lipid metabolism regulation,oncogenic function,lipid accumulation,cell membrane composition,tumor progression,poor prognosis marker
ENSG00000171487,NLRP5,pi3k/akt signaling pathway,oncogene function,cell proliferation,survival regulation,tumor progression,metastasis promotion
ENSG00000183340,JRKL,regulation of cell growth,signaling pathway regulation,tumor progression,cellular stress response,protein phosphorylation,mapk pathway activation
ENSG00000167701,GPT,tumor metabolism,cell proliferation,protein interaction,overexpression,metabolic regulation,cancer progression
ENSG00000131848,ZSCAN5A,tumor suppressor,transcriptional regulation,cell cycle progression,apoptosis inhibition,genomic instability,prognostic biomarker
ENSG00000113248,PCDHB15,metastasis,cell adhesion,upregulation,prognosis,cell migration,tumor progression
ENSG00000166548,TK2,mitochondrial localization,gain of function phenotype,nucleotide salvage pathway,dna synthesis,cellular proliferation,pyrimidine metabolism
ENSG00000274538,PHLDA2,loss of function mutations,tumor suppressor function,cell proliferation regulation,apoptosis inhibition,genomic instability,transcriptional repression
ENSG00000005889,ZFX,epigenetic regulation,transcriptional regulation,dna binding,x-linked gene,genome stability,histone modification
ENSG00000164099,PRSS12,protease activation,tumor progression,pro-survival signaling,cell proliferation regulation,wnt/β-catenin pathway modulation,serine protease function
ENSG00000275568,ARHGAP11A,rho gtpase activation,cell proliferation regulation,tumor progression facilitation,cytoskeletal remodeling,metastasis promotion,oncogenic signaling enhancement
ENSG00000138640,FAM13A,oncogene activation,tumor progression promoter,cancer-related signaling pathway regulator,cell proliferation enhancer,genomic overexpression associate,proliferation and survival mediator
ENSG00000173083,HPSE,tumor progression,extracellular matrix degradation,angiogenesis promotion,metastasis facilitation,epithelial-to-mesenchymal transition,cell migration and invasion
ENSG00000134802,SLC43A3,lipid metabolism,lipid transport,oncogenic driver,tumor progression,poor prognosis,therapeutic target
ENSG00000111696,NT5DC3,metabolic regulation,nucleotide levels,cellular proliferation,apoptosis regulation,dysregulation in cancer,biomarker potential
ENSG00000056586,RC3H2,p53 regulation,oncogenic potential,ubiquitination degradation pathway,cell survival proliferation,genomic instability tumor suppression,therapeutic target
ENSG00000074657,ZNF532,transcription factor regulation,dna binding activity,cell proliferation promotion,tumor progression involvement,genomic instability mediator,chromatin remodeling
ENSG00000024526,DEPDC1,pi3k/akt signaling,oncogene activation,cell proliferation,resistance to apoptosis,biomarker significance,protein-protein interactions
ENSG00000125454,SLC25A19,mitochondrial carrier protein,succinate transport,cellular metabolism regulation,tumorigenesis association,energy production alteration,therapeutic response modification
ENSG00000134343,ANO3,ion channel regulation,epithelial-to-mesenchymal transition,cell proliferation enhancement,ion transport activity,tumor progression,cancer aggressiveness
ENSG00000123600,METTL8,m6a modification,proliferation enhancement,tumor progression,metabolic reprogramming,gene expression regulation,cancer cell migration
ENSG00000091622,PITPNM3,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000204991,SPIRE2,microrna regulation,genomic instability,dna damage response,rna metabolism,oncogene regulation,tumor suppressor regulation
ENSG00000186001,LRCH3,pi3k/akt/mtor pathway regulation,genomic instability,epithelial-to-mesenchymal transition (emt),prognostic marker,chromosomal rearrangements,tumor progression and metastasis
ENSG00000213799,ZNF845,cellular transformation,dna binding activity,oncogenic transformation,transcriptional regulation,gene expression modulation,apoptosis evasion
ENSG00000017483,SLC38A5,cellular proliferation,ammonia detoxification,glutamine uptake,oncogenic transformation,plasma membrane localization,amino acid transport
ENSG00000203705,TATDN3,genome maintenance,epigenetic regulation,cytosine targeting,dna methylation,epigenomic alterations,tumor suppressor regulation
ENSG00000123165,ACTRT1,cell proliferation,wnt/β-catenin pathway activation,cytokeletal dynamics regulation,protein interaction,oncogene overexpression,biomarker significance
ENSG00000180346,TIGD2,regulation of energy metabolism,oncogenic factor,overexpression associated with poor prognosis,tumor growth promotion,interaction with other proteins,cell proliferation facilitation
ENSG00000173681,BCLAF3,tumor suppressor,cell survival,transcriptional regulation,chromatin remodeling,genomic instability,apoptosis inhibition
ENSG00000277972,CISD3,calcium regulation,mitochondrial dynamics,oncogenic potential,cellular stress responses,protein interaction,cancer resistance
ENSG00000185189,NRBP2,rna binding,translational regulation,cell cycle progression,apoptosis inhibition,mrna stability,therapeutic target
ENSG00000257315,ZBED6,transcriptional regulation,tumor suppressor function,cell cycle progression regulation,apoptosis modulation,chromatin remodeling involvement,metastasis influence
ENSG00000070601,FRMPD1,cell migration,oncogenic process,biomarker expression,protein interaction,signaling pathway regulation,cancer progression
ENSG00000163623,NKX6-1,**
apoptosis regulation,cell cycle progression,oncogenic transcription factor,tumor suppression dysfunction,transcriptional activation,cancer driver gene 
**
ENSG00000104967,NOVA2,rna splicing regulation,oncogene regulation,tumor progression,cell cycle regulation,anti-apoptotic function,transcriptional control
ENSG00000184677,ZBTB40,tumor suppressor activity,downregulation in tumors,cell cycle regulation,apoptosis inhibition,angiogenesis promotion,genomic mutations
ENSG00000251493,FOXD1,transcriptional regulation,apoptosis evasion,cell cycle progression,epithelial-to-mesenchymal transition (emt),microrna regulation,oncogenic transcription factor
ENSG00000178919,FOXE1,tumor suppressor,epigenetic regulation,promoter methylation,cell proliferation,dna repair,tumor progression
ENSG00000186766,FOXI2,transcription regulation,cellular differentiation,epithelial-to-mesenchymal transition,proliferation modulation,therapeutic target,none
ENSG00000179981,TSHZ1,transcriptional regulation,cell proliferation,tumor suppressor suppression,apoptosis inhibition,oncogene activation,prognostic marker
ENSG00000176678,FOXL1,cellular differentiation regulation,gene expression modulation,oncogenesis promotion,apoptosis pathway regulation,proliferation enhancement,metastasis influence
ENSG00000164379,FOXQ1,transcription factor activity,oncogenic driver,epithelial-to-mesenchymal transition,cell proliferation regulation,apoptosis resistance,metastasis promotion
ENSG00000267728,KRTAP9-9,keratin filament assembly,intermediate filament stability,cell morphology regulation,cytoskeletal support,structural integrity modulation,mechanical support provision
ENSG00000180386,KRTAP9-7,intermediate filament maintenance,cell migration enhancement,cell adhesion complex disruption,tumor aggressiveness promotion,cytoskeleton stability impairment,protein structure modulation
ENSG00000240542,KRTAP9-1,tumor differentiation regulation,cellular proliferation modulation,signaling pathway interaction,oncogenic potential,biomarker candidate,cell survival regulation
ENSG00000162782,TDRD5,tumor suppressor function,post-transcriptional regulation,rna stability regulation,cellular growth enhancement,mutational events,genomic instability
ENSG00000227140,USP17L5,pi3k/akt pathway regulation,deubiquitinating activity,cancer cell survival,tumor progression,cell proliferation enhancement,ubiquitin-proteasome system interaction
ENSG00000230549,USP17L1,ubiquitin-specific protease activity,cell cycle regulation,apoptosis modulation,tumor growth promotion,chemotherapy resistance,protein degradation regulation
ENSG00000144659,SLC25A38,mitochondrial carrier protein,cancer cell metabolism,energy production regulation,krebs cycle regulation,warburg effect induction,tumor growth promotion
ENSG00000188452,CERKL,ceramide metabolism,apoptosis regulation,cell growth modulation,constitutive activation,tumor aggressiveness,oncogene dysregulation
ENSG00000176567,OR4X1,odorant receptor function,overexpression,tumor progression,metastasis,transcriptional regulation,biomarker potential
ENSG00000214435,AS3MT,oxidative stress modulation,epigenetic regulation,dna damage response,arsenic methylation,kidney disease risk,cancer cell survival
ENSG00000196917,HCAR1,tumor growth promotion,immune modulation,inflammatory signaling,pro-tumorigenic microenvironment,cell surface interaction,immunosuppression facilitation
ENSG00000184347,SLIT3,robo receptor modulation,tumor suppressor/oncogene dual role,cell migration/adhesion regulation,molecular interaction with pi3k/akt pathway,prognostic significance,poor prognosis marker
ENSG00000165973,NELL1,pi3k/akt signaling modulation,nuclear protein overexpression,tumor suppressor gene suppression,poor prognosis indicator,cellular proliferation enhancement,therapeutic target potential
ENSG00000171714,ANO5,mitochondrial dysfunction,chloride transport disruption,calcium signaling dysregulation,cell growth stimulation,tumor progression enhancement,metastasis facilitation
ENSG00000170613,FAM71B,apoptosis modulation,cell survival promotion,chromatin remodeling,genome stability maintenance,protein-protein interaction,histone modification regulation
ENSG00000261221,ZNF865,transcriptional regulation,oncogenesis,tumor progression,metastasis,protein interaction,gene expression modulation
ENSG00000139800,ZIC5,overexpression,transcription factor activity,cell proliferation,apoptosis evasion,cell cycle progression,prognostic marker
ENSG00000224877,NDUFAF8,mitochondrial dysfunction,oxidative stress generation,complex i assembly defect,cellular respiration impairment,tumor progression,therapeutic target
ENSG00000240857,RDH14,retinoid biosynthesis,tumor suppression,cellular differentiation,apoptosis regulation,metabolic regulation,protein-protein interaction
ENSG00000101166,PRELID3B,pi3k/akt signaling,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,genomic instability,apoptosis resistance,cancer cell migration
ENSG00000127184,COX7C,tumor suppressor function,energy metabolism regulation,oncogenic mutations,increased oxygen consumption,enhanced glycolysis,potential therapeutic target
ENSG00000240230,COX19,mitochondrial biogenesis,electron transport chain regulation,tumor suppressor function,oxidative stress induction,genomic instability promotion,cox assembly regulation
ENSG00000123815,COQ8B,mitochondrial integrity,coenzyme q8 assembly,cellular metabolism regulation,tumorigenesis modulation,electron transport chain maintenance,redox state regulation
ENSG00000135469,COQ10A,coenzyme q synthesis,mitochondrial dysfunction,oxidative damage accumulation,cellular respiration regulation,tumor growth promotion,therapeutic target identification
ENSG00000173085,COQ2,impaired mitochondrial function,loss-of-function mutations,decreased coq10 levels,tumor progression,cellular stress,oncogenesis
ENSG00000167799,NUDT8,metabolic regulation,cell proliferation,therapeutic target,genetic mutation,nad+/nadh ratio,glycolytic rate
ENSG00000165443,PHYHIPL,apoptosis resistance,cellular homeostasis disruption,cell cycle regulation,metastatic potential enhancement,oncogene function,pro-survival signaling pathway involvement
ENSG00000115520,COQ10B,mitochondrial function alteration,coenzyme q10 biosynthesis pathway amplification,enhanced anabolic metabolism,cell survival enhancement,resistance to apoptosis,genetic driver gene
ENSG00000185973,TMLHE,**

regulation of histone modification,alteration of chromatin structure,disruption of cell cycle regulation,oncogenic pathway activation,constitutive enzyme activity,genomic instability

**
ENSG00000006282,SPATA20,genomic instability,dna repair,homologous recombination,cell cycle regulation,nuclear protein function,tumor aggressiveness
ENSG00000146250,PRSS35,**

vegf activation,type ii transmembrane serine protease,tumor progression,angiogenesis promotion,growth factor processing,cellular proliferation regulation

**
ENSG00000184831,APOO,apoptosis induction,cell cycle regulation,lipid metabolism modulation,tumor suppressor function,phosphatidylinositol 3-kinase pathway interaction,casparse activation inhibition
ENSG00000144481,TRPM8,trp channel activation,calcium influx regulation,cell migration enhancement,cancer stem cell maintenance,tumor progression facilitation,gene expression modulation
ENSG00000198771,RCSD1,ubiquitin-proteasome system regulation,cellular homeostasis modulation,protein degradation regulation,oncogenic potential,apoptosis regulation,cancer progression correlation
ENSG00000276776,TC2N,wnt/β-catenin pathway,transcriptional regulation,gain of function mutations,tumor progression,therapeutic target,signaling pathway activation
ENSG00000163608,NEPRO,driver of cell proliferation and survival,interaction with cancer-related genes and pathways,role in tumor progression and aggressiveness,constitutive activation of signaling pathways,potential oncogene,tumor suppressor gene dysregulation
ENSG00000174990,CA5A,tumor progression,anti-tumor therapy target,proton production,cell migration,angiogenesis,cancer metabolism
ENSG00000167800,TBX10,loss-of-function mutations,tumor suppressor function,transcription regulation,cell cycle control,apoptosis induction,dna damage response
ENSG00000235608,NKX1-1,tumor suppressor function,pi3k/akt pathway inhibition,proliferation regulation,cell differentiation modulation,apoptosis induction,anti-oncogenic activity
ENSG00000131845,ZNF304,zinc finger regulation,cell cycle modulation,tumor suppressor function,apoptosis regulation,chromatin remodeling,transcriptional regulation
ENSG00000105467,SYNGR4,cellular proliferation,metastasis promotion,synaptic vesicle regulation,tumor progression,gene expression upregulation,signal transduction pathway interaction
ENSG00000213853,EMP2,tumor progression,metastatic potential,cell adhesion modulation,signaling pathway interaction,oncogenic driver,prognostic marker
ENSG00000132294,EFR3A,lipid metabolism,er function,oncogenic driver,biomarker candidate,pi3k/akt pathway activation,lipid synthesis regulation
ENSG00000165757,JCAD,promotes tumor invasion,regulates cell adhesion,contributes to oncogenesis,interacts with e-cadherin,involved in metastasis,increases cell migration
ENSG00000165959,CLMN,calmodulin regulation,actin cytoskeleton remodeling,epithelial cell integrity maintenance,tumor growth promotion,cell migration enhancement,adhesion molecule interaction
ENSG00000115459,ELMOD3,cell signaling regulation,tumor progression,pi3k/akt pathway modulation,lipid metabolism dysregulation,cell proliferation promotion,protein-protein interaction
ENSG00000166897,ELFN2,oncogene activation,transcriptional regulation,cell proliferation,apoptosis suppression,genomic instability,wnt/β-catenin pathway interaction
ENSG00000288318,PALM3,regulation of actin cytoskeleton,cell migration,invadopodia formation,tumor progression,prognostic marker,rho gtpase signaling
ENSG00000215252,GOLGA8B,altered golgi function,cellular proliferation,cargo sorting regulation,oncogenic signaling,tumor growth promotion,protein processing regulation
ENSG00000116157,GPX7,oxidative stress regulation,cell survival promotion,redox balance maintenance,antioxidant activity,tumor-promoting role,apoptosis resistance
ENSG00000212657,KRTAP16-1,keratin filament organization,cellular structure maintenance,cancer-related gene expression,trichohyalin family protein,keratin-associated proteins,epithelial tissue differentiation
ENSG00000170667,RASA4B,**
rho gtpase regulation,epithelial cell expression,tumor suppressor function,cell adhesion modulation,oncogenic process enhancement,cytoskeletal integrity disruption
**
ENSG00000284965,OR2F2,olfactory receptor function,tumor progression,metastasis involvement,pi3k/akt pathway interaction,cancer driver gene potential,aggressive tumor behavior association
ENSG00000130368,MAS1,cellular differentiation,apoptosis regulation,tumor progression,tumor suppressor function,transcriptional regulation,angiogenesis modulation
ENSG00000154678,PDE1C,camp signaling,oncogenic functions,protein kinase regulation,cell proliferation modulation,chemotherapy resistance,poor prognosis marker
ENSG00000188107,EYS,cancer driver,genetic instability,tumor suppressor,proliferation regulation,cilia dysfunction,cellular integrity maintenance
ENSG00000172824,CES4A,tumor progression,drug metabolism modulation,chemotherapy sensitization,cell proliferation regulation,signaling pathway modulation,cancer cell sensitivity
ENSG00000214595,EML6,microtubule dynamics disruption,aneuploidy contributor,cell proliferation enhancer,genomic instability inducer,therapeutic target,mitotic spindle regulator
ENSG00000238243,OR2W3,olfactory receptor function,g-protein coupled signaling,cellular expression,tumor association,immune regulation,genomic expression
,PRSS42,trypsin family,extracellular protease,cell migration regulation,cancer progression facilitation,epithelial-to-mesenchymal transition,proteolytic activity enhancement
126231,ZNF573,transcription factor regulation,genomic stability,cell cycle progression,apoptosis modulation,co-regulatory interactions,oncogenic potential
ENSG00000102043,MTMR8,mitochondrial dynamics regulation,phosphatase activity modification,apoptosis regulation,cell cycle modulation,stress response regulation,mitochondrial localization
ENSG00000189108,IL1RAPL2,immune regulation,tumor progression,metastasis,aggressive behavior,prognosis marker,oncogenic process
ENSG00000254245,PCDHGA3,cell-cell adhesion disruption,oncogenesis promotion,tumor growth facilitation,metastasis enhancement,protein-protein interaction,epigenetic regulation
ENSG00000174948,GPR149,g protein-coupled receptor function,tumor progression,cell proliferation regulation,signaling pathway activation,prognostic marker,overexpression
ENSG00000167065,DUSP18,mapk signaling inhibition,cell proliferation regulation,tumor suppressor candidate,erk1/2 phosphorylation regulation,cancer-related gene expression alteration,mitogen-activated protein kinase pathway modulation
ENSG00000156194,PPEF2,pp1 modulation,cell cycle progression,protein phosphorylation regulation,oncogene activation,tumor growth promotion,metabolic dysregulation
ENSG00000203867,RBM20,tumor suppressor dysfunction,aberrant splicing patterns,cell proliferation promotion,metastasis facilitation,poor prognosis marker,therapeutic target
ENSG00000167861,HID1,dna repair,genomic instability,helicase activity,mutations leading to tumorigenesis,genome integrity maintenance,none
ENSG00000198585,NUDT16,genomic instability,dna damage response,cell proliferation,therapeutic target,prognostic marker,apoptosis regulation
ENSG00000213973,ZNF99,**

cellular regulation,tumor suppression,dna binding activity,transcriptional repression,apoptosis induction,prognostic marker 
**
ENSG00000263464,PPIAL4C,protein processing,ubiquitin-proteasome pathway,cellular degradation,protein regulation,tumor suppression potential,metabolic regulation
ENSG00000137080,IFNA21,antitumor effects,immune modulation,apoptosis regulation,tumor suppressor function,immune response induction,cytokine signaling pathway
ENSG00000174482,LINGO2,inflammation regulation,immune evasion mechanisms,tumor progression promotion,poor prognosis association,cellular growth regulation,pi3k/akt signaling interaction
ENSG00000197479,PCDHB11,cell adhesion disruption,tumor invasion enhancement,poor prognosis marker,therapeutic target,cell proliferation regulation,apoptosis resistance modulation
ENSG00000250120,PCDHA10,metastasis inhibition,tumor suppression,cell adhesion,pi3k/akt/mtor regulation,poor prognosis,signaling pathways
ENSG00000211679,IGLC3,t-cell activation,immune evasion,co-stimulatory molecules,b7 family,immunosuppression,therapeutic target
ENSG00000253910,PCDHGB2,cell adhesion disruption,metastatic potential,pi3k/akt pathway modulation,tumor progression,cell migration,genomic instability
ENSG00000254221,PCDHGB1,cell adhesion inhibition,epithelial-to-mesenchymal transition,tumor suppression,tumor progression,genetic instability,regulatory networks
ENSG00000248383,PCDHAC1,tumor suppressor function,cell-cell adhesion disruption,loss of heterozygosity,reduced expression levels,oncogenic processes,tumor microenvironment modification
ENSG00000198077,CYP2A7,oxidative stress,cellular metabolism regulation,xenobiotic detoxification,enzymatic activity,cytochrome p450 family member,gene expression alterations
ENSG00000186190,BPIFB3,cell proliferation,pi3k/akt pathway interaction,lipid metabolism regulation,oncogenic driver,tumor progression,protein-protein interactions
ENSG00000165246,NLGN4Y,cell adhesion disruption,epithelial integrity loss,tumor progression modulation,neuronal communication dysfunction,altered expression,genomic instability
ENSG00000236334,PPIAL4G,**
protein folding regulation,cell cycle progression disruption,cancer mutation association,misfolded protein accumulation,cellular stress induction,proteostasis dysregulation 
**
ENSG00000131398,KCNC3,voltage-gated potassium channels,oncogene overexpression,cell proliferation,cell signaling modulation,tumor progression,electrical properties regulation
ENSG00000272674,PCDHB16,cell adhesion disruption,tumor progression influence,mutation impact,neurological function loss,cancer cell migration enhancement,synaptic plasticity regulation
ENSG00000251664,PCDHA12,tumor suppression,cell adhesion modulation,wnt/β-catenin pathway inhibition,overexpression association,plasma membrane localization,signaling pathway regulation
,IGLC2,immune modulation,tumor microenvironment,immunotherapeutic target,cell activation,proliferation regulation,genomic instability
ENSG00000187372,PCDHB13,adhesion regulation,tumor progression,metastasis modulation,cell migration enhancement,dysregulated expression,protein interaction
ENSG00000255408,PCDHA3,cell migration suppression,anoikis inhibition,cell adhesion regulation,overexpression in cancer,tumor progression facilitation,neuronal function association
ENSG00000162365,CYP4A22,cellular metabolism,tumor progression,oncogene overexpression,gene expression regulation,cell growth modulation,metabolic pathway disruption
ENSG00000239389,PCDHA13,cell adhesion disruption,signaling pathway activation,cell migration and invasion,synaptic plasticity alteration,tumor progression involvement,transmembrane receptor function
ENSG00000204961,PCDHA9,altered adhesion properties,aberrant signaling pathways,cell migration regulation,carcinogenesis driver,tumor progression association,synaptic plasticity alteration
ENSG00000160870,CYP3A7,cytochrome p450 superfamily,drug metabolism regulation,resistance to chemotherapy,transporter protein interaction,multidrug resistance,xenobiotic metabolism
ENSG00000186526,CYP4F8,arachidonic acid metabolism,cellular lipid regulation,tumor progression,metabolic reprogramming,cell cycle modulation,apoptosis resistance
ENSG00000276547,PCDHGB5,cell-cell adhesion disruption,metastatic processes promotion,tumor progression facilitation,oncogenic signaling events,epithelial-to-mesenchymal transition (emt),transmembrane protein interaction
ENSG00000253953,PCDHGB4,cell adhesion disruption,metastasis promotion,emt regulation,pi3k/akt pathway activation,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000166173,LARP6,ribosomal rna regulation,oncogenic mutation,nuclear localization,constitutive activation,therapeutic target,cell proliferation
ENSG00000284810,CTRB2,overexpression,cell adhesion modification,wnt/β-catenin pathway activation,ectopic protein expression,cellular proliferation enhancement,tumor progression facilitation
ENSG00000100012,SEC14L3,autophagy regulation,biomarker potential,cell survival enhancement,lipid metabolism modulation,membrane trafficking regulation,oncogenic signaling pathway interaction
ENSG00000253485,PCDHGA5,immune evasion,tumor progression,cell-cell adhesion,integrin regulation,metastasis,cancer biology
ENSG00000197838,CYP2A13,phase i enzyme activity,substrate oxidation,xenobiotic metabolism,cell proliferation,apoptosis inhibition,angiogenesis regulation
ENSG00000105889,STEAP1B,iron metabolism regulation,tumor aggressiveness promoter,metabolic adaptation driver,angiogenic pathway activation,cell growth regulator,therapeutic target
ENSG00000051128,HOMER3,oncogenic activity,angiogenesis promotion,apoptosis inhibition,cell migration enhancement,proliferation modulation,tumor progression facilitation
ENSG00000262209,PCDHGB3,cell adhesion disruption,epithelial-to-mesenchymal transition,glycosylation dependent interactions,tumor progression marker,pi3k/akt signaling activation,cellular migration facilitation
ENSG00000214042,IFNA7,ifn-α7 signaling,jak-stat pathway,tumor suppression,immune modulation,tumor microenvironment regulation,cancer immunotherapy target
ENSG00000243709,LEFTY1,tumor suppressor,loss of function mutation,wnt/β-catenin signaling inhibition,cellular differentiation regulation,epithelial-to-mesenchymal transition promotion,biomarker potential
ENSG00000124467,PSG8,immune evasion,tumor suppression,epithelial expression,innate immune response,pattern recognition receptor,nf-κb signaling
ENSG00000071073,MGAT4A,glycosylation initiation,oncogenic potential,n-glycan synthesis,protein modification,tumor metastasis,cell growth regulation
ENSG00000130751,NPAS1,p53 regulation,cell cycle dysregulation,prognostic marker,apoptosis modulation,circadian rhythm disruption,tumor suppression
ENSG00000095587,TLL2,wnt/β-catenin pathway activation,serine protease activity,oncogenic signaling,tumor growth promotion,metastasis facilitation,biomarker potential
ENSG00000163295,ALPI,tumor progression,mineralization process,regulation of osteoblasts,phosphatase activity,cell migration and invasion,therapeutic target
ENSG00000059691,GATB,calcium regulation,store-operated calcium entry,tumor suppressor function,cellular proliferation regulation,apoptosis modulation,transmembrane protein interaction
ENSG00000004809,SLC22A16,metabolic reprogramming,cellular transport,tumor progression,nutrient uptake,protein-protein interaction,cancer metabolism
ENSG00000113212,PCDHB7,cell adhesion disruption,oncogenic role,transmembrane protein,tumor progression,metastasis facilitation,aberrant expression
ENSG00000204970,PCDHA1,cell migration,tumor progression,metastasis regulation,angiogenesis modulation,cell-cell adhesion disruption,synaptic plasticity involvement
ENSG00000131409,LRRC4B,cell adhesion regulation,extracellular matrix modulation,integrin interaction,pdgf receptor signaling,prognostic marker,cell invasion promotion
ENSG00000198131,ZNF544,tumor suppressor function,transcriptional regulation,chromatin remodeling,cell proliferation inhibition,apoptosis promotion,wnt/β-catenin pathway regulation
ENSG00000186297,GABRA5,ion channel regulation,cell migration,tumor microenvironment modulation,neuronal development,synaptic transmission,prognostic marker
ENSG00000174348,PODN,angiogenesis,cell survival,immune response modulation,phagocytosis regulation,protein-protein interaction,tumor progression
ENSG00000189184,PCDH18,amplification,cell proliferation,emt regulation,metastasis promotion,oncogenic signaling,transcriptional regulation
ENSG00000242419,PCDHGC4,disruption of adhesion,cell migration enhancement,tumor progression facilitation,protein-protein interaction alteration,signaling pathway modulation,gene expression dysregulation
ENSG00000100003,SEC14L2,phospholipid biosynthesis,membrane trafficking,cytoskeleton organization,signal transduction pathway disruption,lipid metabolism alteration,tumor growth promotion
ENSG00000112852,PCDHB2,cell-cell adhesion disruption,tumor progression,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction,overexpression correlation with cancer aggressiveness,poor prognosis association
ENSG00000111799,COL12A1,basement membrane formation,cell adhesion,epithelial-to-mesenchymal transition,growth factor regulation,protein-protein interaction,tumor progression
ENSG00000213512,GBP7,autophagy regulation,cellular proliferation,immune response modulation,protein-protein interactions,signaling pathway regulation,tumor growth promotion
ENSG00000228278,ORM2,endoplasmic reticulum stress,unfolded protein response activation,potential oncogene,cell proliferation enhancement,apoptosis regulation disruption,er protein folding modulation
ENSG00000185674,LYG2,immune evasion,tumor-infiltrating lymphocytes,impaired t-cell function,g protein-coupled receptor,immune suppression,prognostic marker
ENSG00000134249,ADAM30,tumor progression,cell adhesion regulation,oncogene function,epithelial-to-mesenchymal transition (emt),cell migration modulation,protein expression regulation
ENSG00000015413,DPEP1,glutathione degradation,tumor progression,cell migration,epithelial-to-mesenchymal transition,oxidative stress regulation,poor prognosis marker
ENSG00000139200,PIANP,chromatin remodeling,cell cycle regulation,apoptosis inhibition,oncogene overexpression,transcriptional regulation,protein-protein interactions
ENSG00000141096,DPEP3,type ii transmembrane serine protease,proteolytic activity,tumor progression,aggressive behavior,poor prognosis,overexpression
ENSG00000113211,PCDHB6,cell adhesion disruption,enhanced cell migration,pi3k/akt pathway activation,epithelial-to-mesenchymal transition,prognostic biomarker,signaling receptor interaction
ENSG00000138650,PCDH10,tumor suppressor function,pi3k/akt pathway regulation,cell adhesion disruption,apoptosis induction,biomarker potential,genetic downregulation
ENSG00000118946,PCDH17,tumor suppression,epithelial-to-mesenchymal transition (emt),cell-cell adhesion,wnt/β-catenin pathway regulation,signaling pathway modulation,downregulated expression
ENSG00000167740,CYB5D2,mitochondrial function,cellular metabolism,electron transfer,oxidative stress resistance,tumorigenesis promotion,redox reaction regulation
ENSG00000158467,AHCYL2,chromatin remodeling,constitutive activation,dna damage response,histone acetylation,mapk pathway activation,p53 regulation
ENSG00000074935,TUBE1,microtubule destabilization,oncogenic process,cell cycle progression,mitotic regulation,chromosome segregation,cancer therapy target
ENSG00000165105,RASEF,pi3k/akt pathway interaction,oncogene overexpression,cell signaling regulation,tumor progression role,cytoplasmic protein localization,metastasis facilitation
ENSG00000221968,FADS3,fatty acid metabolism,dysregulation of fatty acids,warburg effect,promotion of cancer cell proliferation,resistance to therapy,inflammation regulation
ENSG00000136478,TEX2,rna export,cell proliferation,transmembrane protein,regulatory mechanism,nuclear transport,genomic alterations
ENSG00000170373,CST1,histone modification regulation,chromatin structural domain protein family,cell growth and survival modulation,onco-suppressor function,tumor suppressor activity,genomic instability promotion
ENSG00000101441,CST4,cysteine protease inhibitor,apoptosis resistance,cell survival promotion,tumor progression,proteolytic regulation,anti-proteolytic function
ENSG00000057704,TMCC3,adhesion complex disruption,cancer cell migration,cell-cell interaction regulation,epithelial-to-mesenchymal transition (emt),metastatic promotion,tumor progression facilitation
ENSG00000179104,TMTC2,tumor suppressor function,cellular differentiation regulation,kidney development regulation,mutations contributing to oncogenesis,genomic instability driver,protein-protein interaction domain containing
ENSG00000166450,PRTG,cell cycle regulation,mitotic checkpoint,tumor progression,oncogenic signaling,potential therapeutic target,genomic instability
ENSG00000113555,PCDH12,cell-cell adhesion disruption,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,pi3k/akt pathway regulation,cell proliferation and migration promotion,gene expression regulation
ENSG00000198538,ZNF28,transcriptional regulation,tumor progression,poor prognosis biomarker,cellular proliferation,apoptosis evasion,metastasis promotion
ENSG00000253537,PCDHGA7,loss of cell polarity,downregulation in cancer,epithelial-to-mesenchymal transition,angiogenesis regulation,cell adhesion disruption,tumor suppressor activity
ENSG00000168515,SCGB1D1,tumor suppressor,epithelial cell integrity,cellular differentiation regulation,genomic stability maintenance,epithelial-to-mesenchymal transition regulation,cancer cell migration inhibition
ENSG00000162877,PM20D1,apoptosis regulation,mitochondrial function modulation,oncogene overexpression,cellular proliferation regulation,therapeutic target potential,energy metabolism involvement
ENSG00000167904,TMEM68,cellular membrane regulation,apoptosis modulation,autophagy regulation,cancer progression,oncogenesis,therapeutic resistance
ENSG00000103742,IGDCC4,**
regulation of gene expression,mtor activation,rna-binding protein function,cell proliferation,protein-protein interaction,overexpression 
**
ENSG00000165023,DIRAS2,pi3k/akt pathway activation,constitutive signaling,oncogenic transformation,tumor growth promotion,angiogenesis induction,cell proliferation enhancement
ENSG00000185909,KLHDC8B,wnt/β-catenin pathway regulation,cell adhesion modulation,tumor progression,prognostic biomarker,oncogenic role,cell migration regulation
ENSG00000177047,IFNW1,antitumor activity,regulation of cell growth,immune modulation,interferon signaling pathway,apoptosis induction,tumor microenvironment modification
ENSG00000134533,RERG,tumor suppressor,cell proliferation inhibition,mapk/erk pathway regulation,apoptosis induction,pi3k/akt signaling inhibition,cancer progression suppression
ENSG00000127418,FGFRL1,fgf/fgfr signaling disruption,tumor suppressor function,cell growth regulation,apoptosis inhibition,cell adhesion modulation,prognostic biomarker
ENSG00000156150,ALX3,transcription factor activity,cellular development,regulation of gene expression,developmental patterning,disrupted cellular regulation,tumor progression
ENSG00000139330,KERA,keratin-associated protein regulation,cell proliferation enhancement,epithelial-to-mesenchymal transition promotion,cell differentiation maintenance,tumor progression association,prognostic marker potential
ENSG00000274349,ZNF658,transcriptional regulation,cellular differentiation,aberrant expression,chromatin modification,protein-dna interaction,zinc finger domain
ENSG00000178163,ZNF518B,tumor suppressor,cell cycle regulation,apoptosis modulation,transcriptional regulation,zinc finger domain,cancer progression
ENSG00000175697,GPR156,g protein-coupled receptor signaling,oncogenic processes,tumor progression,metastasis promotion,poor prognosis marker,therapeutic target
ENSG00000221890,NPTXR,cell proliferation,pi3k/akt pathway interaction,oncogenic activity,tumor progression,therapeutic target,signaling pathway regulation
ENSG00000159618,ADGRG5,cell migration,proliferation regulation,tumor progression,adhesion g protein-coupled receptor,pi3k/akt pathway modulation,cancer cell invasion
ENSG00000172878,METAP1D,mitochondrial trna processing,metabolic reprogramming,cellular metabolism regulation,oxidative stress resistance,anticancer therapy target,poor prognosis marker
ENSG00000136169,SETDB2,tumor suppressor dysfunction,histone methylation,chromatin compaction,oncogenic potential,epigenetic regulation,cancer progression
ENSG00000174326,SLC16A11,metabolic reprogramming,glycolytic shift,warburg effect promotion,lactate transport facilitation,cell proliferation enhancement,prognostic marker
ENSG00000062370,ZNF112,dna repair regulation,chromatin remodeling,cell proliferation enhancement,genomic instability promotion,tumor growth facilitation,therapeutic target
ENSG00000197363,ZNF517,transcriptional regulation,chromatin remodeling,oncogene activation,tumor progression,poor prognosis association,gene expression reprogramming
ENSG00000198759,EGFL6,angiogenic factor,tumor progression,vascularization,endothelial cell migration,integrin interaction,driver gene
ENSG00000278216,UGT2A3,glucuronidation,tumor progression,xenobiotic metabolism,bilirubin metabolism,chemotherapy resistance,cancer treatment modification
ENSG00000173227,SYT12,amplification,cell proliferation,oncogenic pathway activation,phosphoinositide regulation,pten interaction,tumor growth
ENSG00000173391,OLR1,lipid metabolism regulation,oncogenic properties,angiogenesis promotion,tumor growth promotion,cell adhesion regulation,metastasis facilitation
ENSG00000160161,CILP2,cell adhesion disruption,glycosylphosphatidylinositol-anchored protein,immune suppression,angiogenesis promotion,tumor progression facilitation,metastasis enhancement
ENSG00000166535,A2ML1,tumor microenvironment,proteolytic enzyme regulation,cellular invasion,metastasis promotion,apoptosis inhibition,angiogenesis regulation
ENSG00000122254,HS3ST2,tumor aggressiveness,cancer progression,biomarker expression,oncogenic modification,cell adhesion regulation,signaling pathway modulation
ENSG00000149742,SLC22A9,drug efflux,organic anion transport,multidrug resistance,p-glycoprotein interaction,tumor progression,cancer therapy response
ENSG00000164451,CALHM4,calcium signaling pathway,gene expression regulation,cell proliferation,tumor progression,metastasis,protein interaction
ENSG00000170044,ZPLD1,transcription factor,oncogenic driver,tumor progression,epigenetic regulation,cell migration,immune suppression
ENSG00000140511,HAPLN3,tumor progression,metastasis promotion,ecm remodeling,ha binding regulation,cell migration facilitation,prognostic marker
ENSG00000168903,BTNL3,antigen presentation,immune regulation,tumor progression,therapeutic target,cellular activation,molecular interaction
ENSG00000149218,ENDOD1,transcriptional regulation,oncogene function,cell proliferation promotion,cell survival enhancement,tumor suppressor interaction,genomic overexpression
ENSG00000100416,TRMU,trna biosynthesis,mitochondrial function,cellular metabolism,oncogenic processes,protein synthesis regulation,energy production dysregulation
ENSG00000167992,VWCE,ubiquitin ligase activity,genomic instability,cell cycle regulation,tumor progression,protein degradation,oncometabolite regulation
ENSG00000075429,CACNG5,neural adhesion,cell migration,tumor progression,calcium channel regulation,cancer cell invasion,protein-protein interactions
ENSG00000110900,TSPAN11,tumor aggressiveness,cell migration,epithelial-to-mesenchymal transition (emt),immune suppression,overexpression,cellular proliferation
ENSG00000120519,SLC10A7,bile salt transport,cell survival,oncogenic signaling,metabolic regulation,cellular homeostasis,protein interaction
ENSG00000205359,SLCO6A1,bile acid metabolism,transport regulation,cellular growth promotion,oncogenic processes,therapeutic target,genomic alterations
ENSG00000145863,GABRA6,overexpression,apoptosis regulation,cell cycle progression,metastasis promotion,tumor growth regulation,biomarker potential
ENSG00000185664,PMEL,melanoma antigen recognized by t cells 1,tumor progression,mutations associated with cancer,protein trafficking regulation,dysregulated expression in cancer,cell migration facilitation
ENSG00000122711,SPINK4,tumor suppressor activity,cell proliferation regulation,apoptosis inhibition,extracellular protease inhibitor,oncogenic overexpression,cell growth promotion
ENSG00000164411,GJB7,gap junction disruption,cell-cell communication impairment,increased cell proliferation,overexpression in tumors,prognostic marker,tumor progression enhancement
ENSG00000119004,CYP20A1,oxidative stress regulation,apoptosis inhibition,cell proliferation promotion,inflammation modulation,immune system regulation,tumor progression promotion
ENSG00000180432,CYP8B1,lipid metabolism regulation,altered lipid profiles,indirectly implicated in oncogenesis,cell proliferation enhancement,potential therapeutic target,genomic instability
ENSG00000163626,COX18,mitochondrial biogenesis,energy metabolism enhancement,oncogenic pathway activation,tumor aggressiveness promotion,poor prognosis association,cellular interaction facilitation
ENSG00000197020,ZNF100,oncogene overexpression,zinc finger protein binding,cell proliferation promotion,epithelial-to-mesenchymal transition regulation,tumor progression association,signal transduction modulation
ENSG00000065308,TRAM2,pi3k/akt pathway regulation,endocytosis dysregulation,oncogenic potential,tumor progression promotion,metastasis facilitation,poor prognosis association
ENSG00000112337,SLC17A2,purinergic signaling,ectopic enzyme function,tumor progression,cellular regulation,adenosine efflux,extracellular adenosine levels
ENSG00000157693,TMEM268,cell membrane trafficking regulation,oncogene overexpression,signaling pathway interaction,poor prognosis association,mutations and copy number variations,rab protein interaction
ENSG00000117151,CTBS,angiogenesis promotion,tumor growth regulation,vegf signaling activation,poor prognosis marker,metastatic potential enhancement,chemoresistance induction
ENSG00000139540,SLC39A5,zinc ion transport,oxidative stress resistance,cell proliferation enhancement,tumor growth promotion,therapeutic target identification,metallothionein interaction
ENSG00000167280,ENGASE,glycosylation regulation,tumor growth promotion,cellular adhesion modulation,emt regulation,oncogenic signaling enhancement,biomarker potential
ENSG00000172828,CES3,cell proliferation,metabolic regulation,tumor progression,protein kinase activation,microrna regulation,oncogenesis
ENSG00000095713,CRTAC1,**
cell cycle regulation,chromatin remodeling,oncogene amplification,tumor progression,pi3k/akt pathway interaction,cyclin-dependent kinase inhibition
**
ENSG00000148482,SLC39A12,apoptosis inhibition,cell growth promotion,homeostatic regulation failure,increased ros production,oncogenic signaling pathway interaction,zinc transporter dysfunction
ENSG00000134193,REG4,cell proliferation regulation,oncogenic function,cell cycle progression,apoptosis inhibition,tumor progression,biomarker expression
ENSG00000124785,NRN1,transcriptional coactivation,oncogenic signaling pathway,tumor progression,metastasis regulation,cell proliferation enhancement,overexpression in cancer
ENSG00000164520,RAET1E,immune modulation,oncogenesis,immunosuppression,tumor microenvironment,antigen presentation,cancer immunity
ENSG00000103260,METRN,hypoxia adaptation,genomic stability maintenance,cell cycle regulation,tumor angiogenesis,tumor growth promotion,cellular adaptation
ENSG00000198797,BRINP2,oncogene activity,apoptosis inhibition,pi3k/akt pathway interaction,tumor progression driver,poor prognosis marker,cell survival enhancement
ENSG00000162670,BRINP3,tumor suppressor role,chromosomal instability,genetic mutations,dna damage repair,brca1 interaction,cell cycle regulation
ENSG00000182986,ZNF320,transcriptional regulation,tumor progression,cell cycle regulation,apoptosis regulation,oncogene overexpression,epithelial-to-mesenchymal transition (emt)
ENSG00000232143,GNL1,ribosome biogenesis,cellular proliferation,protein-protein interaction,tumor aggressiveness,oncogenic driver,nuclear transport regulation
ENSG00000186777,ZNF732,tumor progression,transcriptional regulation,chromatin remodeling,cell proliferation,oncogenic processes,epigenetic regulators
ENSG00000165953,SERPINA12,proteolytic regulation,tumor suppressor function,apoptosis modulation,cellular stress response,angiogenesis regulation,tissue remodeling
ENSG00000162687,KCNT2,altered potassium fluxes,cell cycle dysregulation,oncogenic pathway activation,epithelial-to-mesenchymal transition,therapeutic target,genomic instability
ENSG00000162086,ZNF75A,tumor progression,epithelial-to-mesenchymal transition,cell cycle regulation,oncogenic signaling pathways,therapeutic target,transcription factor modulation
ENSG00000162944,RFTN2,tumor progression,metabolic regulation,cell proliferation,therapeutic target,signaling pathway modulation,genomic overexpression
ENSG00000186803,IFNA10,interferon-induced response,constitutive activation,angiogenesis promotion,jak-stat pathway regulation,tumor growth modulation,cell cycle regulation
ENSG00000185873,TMPRSS11B,activation of pro-proteinases,cell proliferation,immune suppressive environment,metastasis regulation,oncogenic function,protease-activated receptors
ENSG00000183196,CHST6,chondroitin sulfate sulfotransferase function,glycosaminoglycan modification,tumor progression,cell surface interaction,wnt/β-catenin pathway modulation,pi3k/akt signaling regulation
ENSG00000243232,PCDHAC2,emt program dysregulation,cell adhesion disruption,signaling pathway modulation,biomarker expression,prognostic significance,cancer cell migration
ENSG00000162496,DHRS3,tumor aggressiveness,cell survival signaling,oncogenic lipid metabolism,therapeutic target,prognostic marker,genomic instability
ENSG00000178502,KLHL11,mitochondrial regulation,oxidative stress,nf-κb activation,tumor suppression,protein degradation,ubiquitination regulation
ENSG00000145103,ILDR1,immune modulation,cytokine production,signaling pathway regulation,cellular homeostasis,transcriptional regulation,tumor microenvironment modulation
ENSG00000253767,PCDHGA8,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,pro-oncogenic pathway activation,tumor progression,metastasis promotion,cell proliferation regulation
ENSG00000180423,HARBI1,overexpression,oncogene,genomic stability,transcriptional regulation,apoptosis resistance,cell cycle progression
ENSG00000133069,TMCC2,p53 tumor suppressor interaction,apoptosis regulation,tumor suppression loss,cell cycle regulation,dna damage response,prognostic significance
ENSG00000183979,NPB,cell adhesion,epithelial to mesenchymal transition,cancer cell proliferation,extracellular matrix component,tumor progression marker,overexpression in cancer
ENSG00000160233,LRRC3,tumor progression,immune system modulation,cellular recognition,protein-protein interaction,oncogenesis,tissue specificity
ENSG00000146453,PNLDC1,tumor progression,gene amplification,oncogenic driver,tumor aggressiveness,cell cycle regulation,angiogenesis
ENSG00000186452,TMPRSS12,tumor progression,extracellular matrix degradation,malignant phenotype,oncogenic process,therapeutic target,cellular signaling
,IGHA2,immune evasion,tumor progression,oncogenesis,aberrant expression,immunoglobulin gene,immune response modulation
ENSG00000197745,SCGB1D4,cell growth regulation,tumor suppressor activity,cell cycle modulation,proteasome interaction,secreted protein function,poor prognosis biomarker
ENSG00000141337,ARSG,heparan sulfate degradation,tumor progression,metastasis promotion,angiogenesis regulation,cell invasion facilitation,biomarker potential
ENSG00000182612,TSPAN10,tumor progression,cell migration,metastasis promotion,oncogene activation,epithelial-to-mesenchymal transition regulation,pi3k/akt pathway modulation
ENSG00000170382,LRRN2,microtubule stability,cytoskeleton dynamics regulation,oncogenic function,pi3k/akt pathway interaction,tumor cell proliferation,cell survival enhancement
ENSG00000101203,COL20A1,extracellular matrix,tumor progression,metastasis,cell adhesion,basement membranes,collagen family
ENSG00000283934,IGSF6,cell migration,angiogenesis promotion,tumor metastasis,tumor progression,immune modulation,cell adhesion
ENSG00000162951,LRRTM1,tumor progression,cell-cell interactions,oncogene function,prognostic marker,angiogenesis promotion,pi3k/akt pathway interaction
ENSG00000133597,ADCK2,mitochondrial biogenesis,tumor microenvironment adaptation,mitochondrial dysfunction,tumor progression,energy metabolism modulation,cellular stress response
ENSG00000171462,DLK2,pi3k/akt signaling pathway regulation,tumor growth enhancement,oncogenic pathway activation,genomic instability induction,cellular proliferation promotion,protein kinase activity
ENSG00000203697,CAPN8,**

cellular migration,oncogenic activity,cell proliferation,apoptosis regulation,pancreatic beta-cell function,calcium-dependent proteolysis
ENSG00000150967,ABCB9,mdr phenotype,cellular efflux,substrate transport,multidrug resistance,poor prognosis,chemotherapy response
ENSG00000166118,SPATA19,mitochondrial regulation,oncogenic role,apoptosis evasion,cell proliferation,genomic instability,protein-protein interaction
ENSG00000126010,GRPR,enhanced cell proliferation,therapeutic target,g protein-coupled receptor activation,cell survival promotion,tumorigenesis facilitation,neuropeptide signaling
ENSG00000137507,LRRC32,recycling endocytic pathway,tumor progression,cell proliferation,cell invasion,signaling molecule interaction,protein internalization
ENSG00000169955,ZNF747,cellular regulation,transcriptional modulation,dna damage response,cell growth regulation,genomic stability,tumor suppression
ENSG00000151033,LYZL2,cellular migration,oncogenic properties,extracellular matrix modification,protein-protein interactions,signaling pathway regulation,tumor progression
ENSG00000115084,SLC35F5,glycosylation regulation,cell surface modification,aberrant expression,poor prognosis,therapeutic target,nucleotide sugar transport
ENSG00000146411,SLC2A12,glucose transporter,increased expression,warburg effect,cell proliferation,tumor progression,metabolic reprogramming
ENSG00000135407,AVIL,cytoskeleton interaction,rho gtpase activation,oncogenic protein interaction,cell migration regulation,pi3k/akt pathway modulation,amplification associated cancer progression
ENSG00000253159,PCDHGA12,epithelial-to-mesenchymal transition,oncogenic potential,prognostic marker,cell adhesion disruption,signaling pathway interaction,tumor progression
ENSG00000137968,SLC44A5,glycosphingolipid metabolism,tumor progression,proliferation,cell membrane integrity,glycosylation,signaling pathway modulation
ENSG00000135697,BCO1,oncogene regulation,therapeutic target,cell metabolism modulation,redox balance disruption,tumor progression promotion,chemosensitivity alteration
,C12orf49,cell cycle regulation,growth promotion,tumor progression,proliferation enhancement,cell division regulation,oncogenic potential
ENSG00000157214,STEAP2,angiogenesis promotion,iron homeostasis regulation,oncogenic potential,tumor progression facilitation,cell migration enhancement,prognostic significance
,KIAA1324L,genomic integrity maintenance,dna repair regulation,non-homologous end joining pathway,tumor suppressor function,pi3k/akt pathway regulation,genetic instability prevention
ENSG00000077713,SLC25A43,mitochondrial carrier function,energy metabolism regulation,metabolic reprogramming,tumor aggressiveness,poor prognosis marker,cancer-related metabolic alterations
ENSG00000050165,DKK3,wnt antagonist,overexpression,tumor progression,epithelial-to-mesenchymal transition (emt),cell adhesion and migration,prognostic marker
ENSG00000137869,CYP19A1,estrogen-mediated growth,tumor progression,therapeutic target,enhanced proliferation,metastasis promotion,resistance to therapy
ENSG00000204524,ZNF805,tumor suppressor function,transcriptional regulation,dna repair regulation,cell cycle progression,apoptosis regulation,p53 interaction
ENSG00000197408,CYP2B6,chemoresistance,redox balance regulation,detoxification process,apoptosis regulation,cell survival pathway modulation,xenobiotic metabolism
ENSG00000164484,TMEM200A,telomere maintenance,chromosomal instability,tumor suppressor function,apoptosis regulation,autophagy modulation,genomic stability regulation
ENSG00000164855,TMEM184A,tumor suppressor function,pi3k/akt/mtor pathway activation,cell proliferation enhancement,calcium signaling dysregulation,cell invasion promotion,angiogenesis facilitation
ENSG00000016402,IL20RA,il-10 family signaling,tumor progression enhancement,angiogenesis promotion,cell proliferation regulation,immune evasion mechanism,pro-inflammatory response modulation
ENSG00000184254,ALDH1A3,retinoic acid synthesis,oxidative stress tolerance,cell differentiation regulation,chemoresistance induction,renal tissue development,cancer stem cell maintenance
ENSG00000177932,ZNF354C,oncogenic function,transcriptional regulation,cell cycle progression,dna repair disruption,zinc finger protein interaction,tumor promoter
ENSG00000121417,ZNF211,transcriptional regulation,epithelial-to-mesenchymal transition,cell proliferation,genomic amplification,prognostic marker,metastasis promotion
ENSG00000160097,FNDC5,tumor progression,oncogenic function,metastasis,cell migration,angiogenesis,pi3k/akt pathway activation
ENSG00000155970,MICU3,mitochondrial calcium regulation,tumorigenesis promotion,metabolic reprogramming,oncogenic interaction,p53 pathway modulation,bcl2 interaction
ENSG00000174951,FUT1,fucosylation process,tumor progression,epithelial-to-mesenchymal transition (emt),therapeutic target,gene amplification,molecular interaction
ENSG00000186026,ZNF284,tumor suppressor,cell cycle regulation,apoptosis promotion,pi3k/akt pathway modulation,gene expression regulation,transcriptional repression
ENSG00000091490,SEL1L3,erad regulation,ubiquitination pathway,oncogene function,tumor suppressor degradation,cellular homeostasis disruption,protein quality control
ENSG00000184599,TAFA3,**
chromatin remodeling,histone modification,transcriptional regulation,oncogenic processes,cancer progression,prognostic marker 
**
ENSG00000157315,TMED6,er stress response,retrotranslocation regulation,protein degradation pathway,cellular adaptation,tumor progression marker,genetic instability
ENSG00000180257,ZNF816,tumor suppressor function,transcription factor regulation,cell cycle disruption,dna repair mechanisms,epithelial-to-mesenchymal transition (emt),apoptosis regulation
ENSG00000174514,MFSD4A,autophagy regulation,cholesterol metabolism,lysosomal function,oncogenic mutations,protein expression alterations,tumor suppressor loss
ENSG00000106328,FSCN3,fascin polymerization,mitotic spindle stabilization,cytoskeletal reorganization,metastasis promotion,prognostic biomarker,tumor aggressiveness
ENSG00000149050,ZNF214,tumor aggressiveness,cell cycle regulation,chromatin remodeling,transcriptional activation,overexpression,prognostic marker
ENSG00000139985,ADAM21,cell adhesion,tumor progression,metastasis,cell signaling,overexpression,tumor growth
ENSG00000166509,CLEC3A,immunosuppressive microenvironment,carbohydrate recognition,cell adhesion regulation,tumor progression factor,pi3k/akt pathway interaction,biomarker potential
ENSG00000189050,RNFT1,cellular proliferation,tumor growth regulation,transcriptional regulation,protein interaction,oncogene potential,biomarker utility
ENSG00000187037,GPR141,cell proliferation,ligand-independent activation,tumor progression,poor prognosis,signaling pathway modulation,g protein-coupled receptor function
ENSG00000105852,PON3,lipid metabolism modification,detoxification process,cancer-associated gene,liver expression,xenobiotic hydrolysis,growth regulation
ENSG00000165194,PCDH19,plexin-c1 signaling pathway,adhesion molecule function,cell-cell interaction regulation,synaptic plasticity regulation,epigenetic modification regulation,tumor suppressor potential
ENSG00000124574,ABCC10,transporter function,drug efflux,detoxification pathway,cellular membrane regulation,multidrug resistance,cancer therapeutic target
ENSG00000174842,GLMN,tumor suppressor,actin cytoskeleton regulation,cytoskeletal organization disruption,loss-of-function mutations,laminin-binding protein interaction,microtubule stability modulation
ENSG00000218336,TENM3,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway,oncogenesis,tumor progression,cell adhesion modulation,metastasis promoter
ENSG00000198346,ZNF813,tumor suppressor,chromatin modification regulation,dna repair disruption,cell cycle regulation,apoptosis induction,genomic stability maintenance
ENSG00000213096,ZNF254,zinc finger protein regulation,krab domain-containing family,transcriptional modulation,oncogenic overexpression,chromatin remodeling involvement,signaling pathway interaction
ENSG00000165475,CRYL1,oncogene,cell proliferation,overexpression,tumor progression,protein interaction,cell cycle regulation
ENSG00000162078,ZG16B,transcriptional regulation,protein-protein interactions,cell cycle progression,apoptosis modulation,tumor suppressor potential,genomic instability
ENSG00000183569,SERHL2,histone methylation,chromatin regulation,transcriptional regulation,oncogenic pathway modulation,tumor progression,genomic instability
ENSG00000135953,MFSD9,cellular transport,lipid metabolism regulation,transmembrane protein function,tumor progression,cancer biology dysregulation,therapeutic target
ENSG00000175928,LRRN1,apoptosis regulation,cell cycle modulation,mapk pathway interaction,oncogenic potential,protein-protein interactions,tumor progression
ENSG00000172687,ZNF738,transcriptional regulation,chromatin modification,cell proliferation,tumor progression,gene overexpression,signaling pathway modulation
ENSG00000144045,DQX1,gef activity,gtpase regulation,cell proliferation,potential oncogene,tumor maintenance,signaling pathways
ENSG00000120563,LYZL1,tgf-β signaling pathway,cell proliferation,collagen modification,oncogenesis,extracellular matrix interaction,prognostic marker
ENSG00000125900,SIRPD,cd47 interaction,biomarker potential,tumor growth promotion,metastasis facilitation,apoptosis resistance,immune response regulation
ENSG00000182489,XKRX,microtubule regulation,oncogene overexpression,cell migration,apoptosis resistance,kinesin superfamily,mir-101 target
ENSG00000005189,REXO5,genomic instability,cell proliferation,dna repair,exonuclease activity,oncogene,genetic mutation
ENSG00000146066,HIGD2A,mitochondrial transport,succinate regulation,metabolic reprogramming,oncogenic adaptation,tumor growth,therapeutic target
ENSG00000174109,C16orf91,overexpression,cell cycle regulation,anti-apoptotic activity,pi3k/akt pathway interaction,uncharacterized protein function,cancer-related overexpression
ENSG00000273111,LYPD4,tumor progression,cell migration,integrin signaling,cell adhesion,protein-protein interaction,biomarker potential
ENSG00000172940,SLC22A13,organic cation transporter,disrupted cellular transport,altered pharmacokinetics,tumorigenesis contribution,cellular efflux regulation,proximal tubule expression
ENSG00000169758,TMEM266,apoptosis regulation,autophagy modulation,epithelial-to-mesenchymal transition,overexpression association,poor prognosis indicator,cellular integrity maintenance
ENSG00000113108,APBB3,akt pathway regulation,cell survival promotion,oncogenic signaling,tumor promoter role,signaling pathway modulation,nf-κb transcription factor interaction
ENSG00000107362,ABHD17B,pld2 pathway modulation,tumor progression,lipid metabolism regulation,cell migration and invasion enhancement,oncogenic protein interaction,epigenetic regulation
ENSG00000237814,SFTA2,overexpression,cell proliferation,poor prognosis,signaling pathway regulation,cell survival,tumor growth
ENSG00000157837,SPPL3,notch signaling pathway,oncogene activation,wnt protein processing,tumor progression,cell proliferation,signaling molecule regulation
ENSG00000275031,METRNL,oxidative stress resistance,tumor suppressor interaction,cell cycle regulation,apoptosis modulation,biomarker potential,protein repair function
ENSG00000136237,RAPGEF5,rap1 gtpase activation,oncogenic signaling pathway,cell migration regulation,erk/mtor signaling,tumor progression,therapeutic target
ENSG00000105088,OLFM2,emt regulation,cell adhesion modulation,nf-κb pathway activation,pi3k/akt signaling enhancement,tumor progression facilitation,pro-survival gene upregulation
ENSG00000166575,TMEM135,cellular transport regulation,signaling pathway modulation,epithelial-to-mesenchymal transition (emt),metabolic regulation,protein-protein interaction,biomarker potential
ENSG00000182534,MXRA7,max/mis dimerization protein family,tumor suppressor function,transcriptional regulation,apoptosis promotion,cell cycle progression control,p53 interaction
ENSG00000119686,FLVCR2,iron metabolism regulation,tumor growth promotion,cellular proliferation enhancement,metastasis facilitation,prognostic marker potential,heme biosynthesis role
ENSG00000188467,SLC24A5,overexpression,tumor microenvironment interaction,melanogenesis regulation,cancer progression,cell signaling pathway,gene amplification
ENSG00000158516,CPA2,cell proliferation,metastasis promotion,oncogene role,cancer progression,enzymatic activity,tumor growth
ENSG00000163959,SLC51A,cell membrane modulation,oncogenic properties,tumor progression,cell proliferation,apoptosis resistance,transporter function
ENSG00000128040,SPINK2,oncogene role,tumor progression,metastasis facilitation,serine protease inhibition,pi3k/akt pathway interaction,poor prognosis marker
ENSG00000083454,P2RX5,tumor progression,mutation,immune modulation,cell migration,purinergic receptor function,pi3k/akt pathway interaction
ENSG00000205669,ACOT6,oncogenic lipid metabolism,interaction with pi3k/akt pathway,tumor progression and metastasis,chemoresistance and targeted therapy evasion,biomarker for poor prognosis,upregulation in kirc
ENSG00000180479,ZNF571,dna repair mechanisms,tumor suppressor function,chromatin remodeling,cell proliferation regulation,gene transcription modulation,mitotic checkpoint regulation
ENSG00000173875,ZNF791,dna binding,chromatin remodeling,tumor progression,biomarker candidate,transcriptional regulation,genomic instability
ENSG00000159905,ZNF221,transcription factor regulation,oncogene involvement,cell proliferation promotion,apoptosis suppression,zinc finger domain presence,dna-binding activity
ENSG00000256294,ZNF225,transcriptional regulation,tumor suppressor modulation,apoptosis regulation,cell cycle progression,mutation associated oncogene,dna binding protein
ENSG00000163328,GPR155,hedgehog signaling,tumor suppressor,oncogenesis,cell proliferation,survival pathways,genomic instability
ENSG00000173950,XXYLT1,heparan sulfate proteoglycan biosynthesis,cell surface regulation,metastasis promotion,epithelial-to-mesenchymal transition,matrix metalloproteinase expression,chemotherapy resistance
ENSG00000124935,SCGB1D2,oncogene activity,epithelial cell modulation,stress response regulation,tumor aggressiveness enhancer,emt regulator,transcriptional control via notch pathway
ENSG00000235589,ZNF311,transcriptional regulation,cellular response,chromatin remodeling,apoptosis modulation,therapeutic target,genomic instability
ENSG00000145451,GLRA3,ion channel regulation,tumor progression,cellular proliferation,protein-protein interactions,signal transduction,metastasis
ENSG00000141449,GREB1L,chromatin remodeling,transcriptional regulation,androgen receptor interaction,oncogene expression,genomic instability,cancer progression
ENSG00000144043,TEX261,transcriptional regulation,chromatin remodeling,oncogene upregulation,tumor cell proliferation,epithelial-to-mesenchymal transition,angiogenesis promotion
ENSG00000172817,CYP7B1,bile acid biosynthesis,lipid metabolism regulation,cell growth modulation,cancer driver gene,poor prognosis marker,cholesterol homeostasis
ENSG00000151948,GLT1D1,onco-protein interaction,metabolic regulation,tumor progression,genomic instability,oncogene activation,cellular proliferation
ENSG00000104499,GML,glutamate regulation,apoptosis inhibition,cell proliferation promotion,oncogenic protein interaction,tumor progression facilitation,glutamine metabolism modulation
ENSG00000269743,SLC25A53,mitochondrial carrier protein function,metabolic regulation,glycolysis regulation,glutaminolysis enhancement,cancer cell proliferation,therapeutic target
ENSG00000139433,GLTP,mtor pathway regulation,phospholipid transfer activity,lipid raft formation,cell survival and proliferation,protein synthesis upregulation,autophagy inhibition
ENSG00000172986,GXYLT2,cell proliferation,tumor progression,oncogene,therapeutic target,glycosyltransferase function,wnt/β-catenin pathway interaction
ENSG00000151233,GXYLT1,glycosylation pathway,cellular proliferation,tumor progression,epithelial-to-mesenchymal transition,microenvironment modulation,protein-carbohydrate interaction
ENSG00000099998,GGT5,cell cycle regulation,dna repair interactions,tumor growth promotion,apoptosis inhibition,protein homeostasis maintenance,chaperone activity
ENSG00000124490,CRISP2,cell migration enhancement,apoptosis regulation,immune response modulation,cancer progression promotion,biomarker potential,tumor aggressiveness enhancement
ENSG00000099999,RNF215,e3 ubiquitin ligase activity,protein degradation regulation,cell cycle progression,dna damage response,transcriptional regulation,immune system modulation
ENSG00000158156,XKR8,nf-kappa b regulation,cell cycle progression,protein degradation,ubiquitination regulation,tumor growth promotion,oncogenic potential
ENSG00000115649,CNPPD1,nucleotide regulation,toxic metabolite accumulation,cell death induction,tumorigenesis link,metabolic pathway interaction,apoptosis promotion
ENSG00000163710,PCOLCE2,...,none,none,none,none,none
ENSG00000103355,PRSS33,prss33 activation,mapk/erk pathway,cell proliferation,protease activity,tumor growth,metastasis regulation
ENSG00000131781,FMO5,oxidative stress response,pro-oxidant enzyme regulation,tumorigenesis,cellular metabolism modulation,therapeutic target,poor prognosis indicator
ENSG00000131044,TTLL9,tumor progression,cell migration,microtubule regulation,protein-protein interaction,cell proliferation,ubiquitination-dependent regulation
ENSG00000124251,TP53TG5,genomic instability,apoptosis regulation,cell cycle progression,tumor suppression,p53 pathway modulation,dna repair mechanisms
ENSG00000167562,ZNF701,tumor suppressor function,gene expression regulation,cell proliferation regulation,chromatin remodeling interaction,apoptosis evasion,dna repair pathway
ENSG00000169397,RNASE3,tumor progression,inflammation induction,apoptosis regulation,cell cycle modulation,angiogenesis promotion,cancer immune evasion
ENSG00000080166,DCT,divalent cation transport,cellular proliferation,oncogenic processes,genetic alterations,pi3k/akt pathway,therapeutic target
ENSG00000213085,CFAP45,centrosomal regulation,cilia formation and maintenance,tumor progression marker,oncogenic pathway activation,biomarker identification,genomic stability disruption
ENSG00000184995,IFNE,epigenetic silencing,tumor suppression,antiviral activity,cell proliferation inhibition,apoptosis induction,immune modulation
ENSG00000078795,PKD2L2,**
cellular ion transport,cilia-dependent signaling,genetic alterations,metastasis promotion,oncogenic pathway activation,protein-protein interaction
**
ENSG00000176782,DEFB104A,tumor microenvironment modulation,immune response regulation,oncogenic potential,antimicrobial peptide expression,cellular infiltration modulation,cancer progression facilitation
ENSG00000277006,DEFB104B,tumor aggressiveness,apoptosis regulation,cellular proliferation,immune modulation,antimicrobial activity,innate immunity
ENSG00000101670,LIPG,enhanced lipid metabolism,fatty acid oxidation,prognostic marker,tumor proliferation,survival pathway regulation,cancer cell metabolism
ENSG00000125458,NT5C,ampk signaling pathway,cellular energy status regulation,nucleotidase activity,tumor cell metabolism modulation,glycolysis enhancement,energy production promotion
ENSG00000143297,FCRL5,immune checkpoint modulation,cell surface protein,immune response regulation,apoptosis evasion,tumor immune microenvironment,pro-survival signaling
ENSG00000007350,TKTL1,metabolic regulation,energy production,cell survival,tumor progression,glucose metabolism,hypoxia adaptation
ENSG00000165076,PRSS37,serine protease function,cell migration enhancement,tumor progression facilitation,extracellular matrix degradation,protein interaction regulation,mapk/erk pathway modulation
ENSG00000118276,B4GALT6,tumor progression,cell proliferation,immune modulation,glycosylation modification,cancer metastasis,prognostic marker
ENSG00000183709,IFNL2,antiviral activity,immune response modulation,apoptosis promotion,cell proliferation inhibition,jak/stat pathway activation,downregulated expression
ENSG00000104804,TULP2,microtubule binding,oncogenesis,cell proliferation,epigenetic regulation,gene expression,protein-protein interaction
ENSG00000134538,SLCO1B1,transporter activity,cellular uptake regulation,chemotherapy response modulation,cancer progression facilitation,substrate transport specificity,tissue-specific expression pattern
ENSG00000117009,KMO,metabolic reprogramming,oncogenic processes,hypoxia-inducible factor-1 alpha regulation,reactive oxygen species production,prognostic biomarker,therapeutic target
ENSG00000167543,TP53I13,genomic instability,tumor suppressor dysfunction,apoptosis inhibition,cell cycle disruption,protein-protein interaction,oncogenic mutation
ENSG00000198812,LRRC10,cellular proliferation,apoptosis inhibition,cell cycle regulation,oncogenic mutation,tumor progression,protein-protein interaction
ENSG00000142694,EVA1B,alternative splicing regulation,dysregulated protein expression,increased cell proliferation,oncogenic potential,rna processing modulation,tumor progression
ENSG00000186334,SLC36A3,nutrient uptake regulation,cell proliferation enhancement,glutamine/arginine transport,amino acid metabolism modulation,tumor progression promotion,protein expression dysregulation
ENSG00000109576,AADAT,amino acid metabolism,tumor suppressor function,kirc,metabolic reprogramming,cellular proliferation,transamination reaction
ENSG00000145879,SPINK7,oncogene,cell proliferation,tumor progression,therapeutic target,pi3k/akt signaling pathway modulation,epithelial-to-mesenchymal transition regulation
ENSG00000138463,SLC49A4,**
calcium ion transport regulation,pi3k/akt signaling pathway,cellular homeostasis disruption,tumor aggressiveness promotion,poor prognosis association,calcium-related oncogenesis
ENSG00000166250,CLMP,cell-to-cell adhesion regulation,tumor progression promotion,ectodomain shedding mediator,migratory behavior facilitation,transmembrane protein expression,promotes epithelial-to-mesenchymal transition
ENSG00000144908,ALDH1L1,oxidative stress response,aldehyde detoxification,tumor adaptation,therapeutic resistance,cellular survival,enzymatic activity
ENSG00000158865,SLC5A11,altered sodium/myo-inositol transport,cellular metabolism disruption,energetic pathway modulation,epigenetic modifications,protein interaction alterations,tumor growth promotion
ENSG00000172728,FUT10,cell adhesion modulation,glycosylation process,tumor progression promoter,oncogenic gene expression,cellular migration facilitation,signaling pathway regulation
ENSG00000002745,WNT16,wnt signaling pathway,dysregulated expression,tumor progression promotion,cell proliferation enhancement,survival signal activation,cancer stem cell maintenance
ENSG00000004846,ABCB5,tumor microenvironment modulation,epithelial-to-mesenchymal transition,stem cell-like properties,drug resistance,cell cycle regulation,apoptosis modulation
ENSG00000167536,DHRS13,steroid reduction,cell proliferation regulation,tumor progression driver,therapeutic target,detoxification pathway modulation,anti-apoptotic function
ENSG00000155893,PXYLP1,pi3k/akt signaling pathway regulation,oncogene activity,tumor progression facilitation,cellular interaction modulation,apoptosis suppression,signaling pathway modulation
ENSG00000174562,KLK15,metastasis,tumor progression,proteolytic activity,cell migration,epithelial-to-mesenchymal transition (emt),serine protease activity
ENSG00000254402,LRRC24,tumor progression marker,cell adhesion disruption,overexpression in tumors,cancer metastasis,soluble protein structure,mitochondrial targeting protein
ENSG00000168890,TMEM150A,pi3k/akt signaling pathway interaction,gene amplification,tumor progression association,cancer biomarker potential,cellular membrane regulation,oncogenic properties
ENSG00000179954,SSC5D,glycosaminoglycan synthesis,sulfate uptake,cell migration,extracellular matrix production,tumor growth promotion,overexpression
ENSG00000205221,VIT,vitamin k-dependent blood coagulation pathway,cellular growth regulation,cell proliferation,tumor progression,therapeutic target,genomic instability
ENSG00000134285,FKBP11,tumor progression,oncogene,pi3k/akt signaling interaction,poor prognosis,apoptosis regulation,cell cycle modulation
ENSG00000157800,SLC37A3,redox regulation,antioxidant defense mechanism,sulfur amino acid transport,oncogenic process,cellular proliferation,metastasis promotion
ENSG00000149564,ESAM,tumor suppressor,angiogenesis inhibition,endothelial cell regulation,protein-protein interaction,metastasis suppression,cell adhesion modulation
ENSG00000156574,NODAL,nodal overexpression,tgf-β signaling,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,poor prognosis marker,therapeutic target
ENSG00000016864,GLT8D1,cellular transport regulation,aberrant expression,oncogenic behavior,metabolic modulation,tumorigenesis driver,glutamate transport
ENSG00000167941,SOST,wnt/β-catenin pathway,osteoblast differentiation,cell proliferation regulation,tumor growth modulation,genomic alteration,signaling pathway disruption
ENSG00000083817,ZNF416,oncogenic pathway,epigenetic regulator,transcriptional activator,tumor progression,metastasis,prognostic marker
ENSG00000158525,CPA5,cellular homeostasis regulation,oncogene activation,cell proliferation promotion,pi3k/akt pathway modulation,tumor progression driver,cellular invasion facilitation
ENSG00000217555,CKLF,overexpression,oncogene,cell migration,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),biomarker
ENSG00000169239,CA5B,tumor progression,cell proliferation,acidic tumor microenvironment,cancer metastasis,tumor growth,protein interaction
ENSG00000198663,C6orf89,wd40 repeat domain,coiled-coil protein interactions,tumor growth regulation,cellular signaling pathways,cancer biomarker potential,protein-protein interactions
ENSG00000171161,ZNF672,transcriptional regulation,zinc finger protein function,tumor suppressor role,cellular proliferation,genetic mutation hotspot,oncogenic transformation
ENSG00000214128,TMEM213,tmem213 overexpression,promoter of metastasis,cross-talk with pi3k/akt,cell membrane regulation,tumor progression marker,genomic instability
ENSG00000167311,ART5,tumor progression,immune suppression,cell proliferation,poor prognosis,therapeutic target,antimicrobial defense
ENSG00000183876,ARSI,iron metabolism,tumor progression,cellular stress response,therapeutic target,protein-protein interaction,oncogenesis
ENSG00000280568,ZNF780A,oncogenesis,transcriptional regulation,cellular proliferation,apoptosis inhibition,tumor suppressor activity loss,chromatin remodeling
ENSG00000224290,APOM,lipid transport regulation,cancer metastasis suppression,apolipoprotein binding,cellular stress response modulation,renal function regulation,tumor suppressor function
ENSG00000117010,ZNF684,tumor progression,dna binding activity,transcriptional regulation,apoptosis inhibition,cell proliferation enhancement,potential biomarker
ENSG00000094963,FMO2,oxidation reactions,detoxification process,cellular damage,gene expression changes,cell signaling disruption,tumor progression
ENSG00000105767,CADM4,cellular adhesion disruption,metastatic potential increase,epithelial-to-mesenchymal transition regulation,tumor suppressor function,protein interaction modulation,downregulated expression
ENSG00000186765,FSCN2,actin filament dynamics,cell migration promotion,emt regulation,invasion enhancement,metastasis facilitation,protein overexpression
ENSG00000118094,TREH,glucose metabolism,tumor metabolism,cell growth regulation,glycolytic shift,oncogenesis promotion,metabolic adaptation
ENSG00000078579,FGF20,angiogenesis,cell migration,tumor progression,oncogene,signaling pathway modulation,metastasis driver
ENSG00000254858,MPV17L2,mitochondrial dysfunction,genomic instability,oncogenic mutations,cell cycle regulation,apoptosis modulation,dna replication
ENSG00000256087,ZNF432,oncogenic behavior,tumor suppressor activity,cell cycle regulation,apoptosis regulation,dna binding activity,zinc finger protein family
ENSG00000204922,UQCC3,mitochondrial biogenesis,metabolic reprogramming,energy metabolism regulation,cellular respiration modulation,tumor cell survival,therapeutic target
ENSG00000140873,ADAMTS18,extracellular matrix regulation,cell adhesion molecule shedding,proteoglycan processing,oncogenic signaling,tumor progression,metastasis facilitation
ENSG00000146360,GPR6,g-protein coupled receptor,cell migration and adhesion,pi3k/akt pathway interaction,tumor growth and progression,epithelial-to-mesenchymal transition (emt),oncogenic signaling
ENSG00000173264,GPR137,cell adhesion regulation,signaling pathway modulation,tumor growth promotion,metastasis enhancement,therapeutic target identification,cancer cell migration facilitation
ENSG00000197110,IFNL3,immunomodulation,immune evasion,oncolytic potential,interferon production,tumor-infiltrating lymphocytes,antiviral response
ENSG00000143552,NUP210L,cellular transport,chromatin organization,tumor progression,genome instability,prognostic marker,therapeutic target
ENSG00000164088,PPM1M,cellular regulation,genomic integrity maintenance,tumor suppressor function,pi3k/akt/mtor pathway modulation,cancer biomarker potential,dna repair mechanism regulation
ENSG00000120057,SFRP5,wnt pathway dysregulation,tumor suppressor function,cellular growth regulation,oncogenic process promotion,poor prognostic marker,signaling pathway antagonist
ENSG00000118557,PMFBP1,tumor suppressor,regulatory role in cell growth,interaction with transcription factors,genomic stability maintenance,apoptosis regulation,cell cycle control
ENSG00000213088,ACKR1,immune modulation,tumor progression facilitation,receptor function,chemokine regulation,leukocyte trafficking regulation,prognostic significance
ENSG00000100632,ERH,cell cycle regulation,oncogenic process,cell proliferation,protein interaction,transcriptional regulation,rna stability
ENSG00000198573,SPANXC,cell proliferation,gene transcription regulation,oncogenesis,apoptosis inhibition,protein expression regulation,tumor development
ENSG00000155254,MARVELD1,disrupted cell polarity,cell-cell communication disruption,tissue integrity maintenance,epithelial integrity regulator,signaling pathway modulation,membrane-associated protein interaction
ENSG00000215695,RSC1A1,chromatin remodeling,transcriptional regulation,histone modification,oncogenic processes,epigenetic reprogramming,tumor progression
ENSG00000174136,RGMB,adhesion molecule,cancer driver gene,cell migration signaling,immunoglobulin superfamily member,integrin interaction,tumor progression marker
ENSG00000131686,CA6,prognostic marker,tumor progression,cell adhesion modulation,metastasis facilitation,therapeutic target,acid-base balance regulation
ENSG00000125999,BPIFB1,oncogenic signaling,membrane regulation,lipid-binding protein function,apoptosis resistance,tumor progression,therapeutic target
ENSG00000121270,ABCC11,constitutive activation,multidrug resistance,protein overexpression,tumor progression,cancer metastasis,oncogenic pathway
ENSG00000198113,TOR4A,tsc2 associated protein,loss of function mutations,mtor pathway dysregulation,cell proliferation driver,angiogenesis promoter,metabolic reprogramming
ENSG00000088726,TMEM40,mitochondrial function regulation,cell proliferation modulation,energy metabolism regulation,oxidative stress prevention,tumor suppressor activity,genomic instability maintenance
ENSG00000134851,TMEM165,lipid metabolism,aberrant expression,vesicular transport,cancer progression,metastasis,cellular behavior
ENSG00000108018,SORCS1,endocytic regulation,cell migration modulation,pi3k/akt pathway regulation,tumor progression facilitation,receptor binding activity,protein sorting modification
ENSG00000183128,CALHM3,calcium regulation,mitochondrial function,cell proliferation,apoptosis regulation,tumor progression,genomic instability
ENSG00000174332,GLIS1,gli family transcription factor,hedgehog pathway activation,transcriptional regulation,cell proliferation,tumor progression,oncogenic potential
ENSG00000137449,CPEB2,cell cycle regulation,mtor pathway activation,oncogenic transformation,protein synthesis regulation,tumor growth promotion,translational control
ENSG00000174885,NLRP6,inflammatory response regulation,immune system modulation,tumor suppression,cancer cell inhibition,apoptosis promotion,genomic instability prevention
ENSG00000169469,SPRR1B,oncogenic role,cell proliferation,metastasis promotion,dna damage response modulation,epithelial cell differentiation regulation,tumor progression
ENSG00000181450,ZNF678,epigenetic regulation,oncogenic function,cell proliferation,transcriptional regulation,protein-dna interaction,metastasis promotion
ENSG00000130035,GALNT8,oncogenic glycosylation,cellular transformation,poor prognosis marker,enhanced receptor activation,glycoprotein modification,tumor progression facilitation
ENSG00000180592,SKIDA1,epigenetic regulation,chromatin remodeling,oncogene upregulation,cell proliferation enhancement,transcriptional activation,histone modification alteration
ENSG00000203785,SPRR2E,epithelial-to-mesenchymal transition (emt),metastatic potential,cell proliferation regulation,stress signaling pathway interaction,dna damage response,poor prognosis marker
ENSG00000166143,PPP1R14D,enhanced cell migration,constitutive activation of pi3k/akt/mtor pathway,oncogenic protein phosphorylation,protein-protein interaction,therapeutic target,prognostic marker
ENSG00000105738,SIPA1L3,regulatory role in endocytosis,enhanced cell survival,increased membrane trafficking,prognostic biomarker candidate,cell proliferation regulation,therapeutic target
ENSG00000134758,RNF138,oncogenesis,promoter activity,ubiquitin ligase function,tumor suppressor degradation,cell cycle progression,protein interaction network
ENSG00000175764,TTLL11,microtubule regulation,tumor suppressor function,cell growth inhibition,apoptosis induction,microtubule stabilization,protein-protein interaction
ENSG00000196169,KIF19,microtubule-based motility,chromosomal instability,aneuploidy,cell proliferation enhancement,mitotic spindle assembly,protein-protein interaction regulation
ENSG00000018869,ZNF582,cellular regulation,transcriptional modulation,tumor progression,metastasis driver,genomic instability,dna-binding protein
ENSG00000141946,ZIM3,chromatin remodeling,transcriptional regulation,tumor growth promotion,angiogenesis regulation,cell survival enhancement,oncogenic protein interaction
ENSG00000267041,ZNF850,transcriptional regulation,krab domain interaction,cell proliferation regulation,apoptosis evasion,tumorigenesis promotion,genomic profiling
ENSG00000204519,ZNF551,cell cycle regulation,apoptosis modulation,tumor progression,oncogenic potential,transcriptional control,genomic instability
ENSG00000281448,ZNF502,transcriptional regulation,oncogene function,tumor progression,cell proliferation,dna binding activity,protein interaction networks
ENSG00000181315,ZNF322,1. transcriptional regulation,2. tumor progression,3. epithelial-to-mesenchymal transition,4. cancer stem cell maintenance,5. cell differentiation,6. gene expression
ENSG00000167637,ZNF283,oncogene overexpression,cell cycle regulation,transcriptional repression,poor prognosis marker,cell growth modulation,co-regulator interaction
ENSG00000136866,ZFP37,tumor progression,promoter hypermethylation,zinc finger protein function,dna-binding activity,transcriptional regulation,tumor suppressor protein interaction
ENSG00000250571,GLI4,hedgehog pathway activation,transcriptional regulation,cell proliferation promotion,tumor progression association,poor prognosis indicator,genomic amplification event
ENSG00000146839,ZAN,genomic instability,dna repair regulation,transcriptional modulation,cellular proliferation,cancer susceptibility,oncogenic potential
ENSG00000221880,KRTAP1-3,keratin-associated protein family,epithelial-to-mesenchymal transition,tumor progression,cell differentiation,regulatory role,oncogenesis
ENSG00000102181,CD99L2,tumor progression,cell adhesion disruption,poor prognosis predictor,metastasis promoter,cell migration regulator,overexpression marker
ENSG00000117480,FAAH,endocannabinoid system regulation,pain modulation,oncogenic signaling pathway interaction,tumor growth promotion,cancer cell proliferation enhancement,metabolic regulation alteration
ENSG00000215186,GOLGA6B,cellular regulation,chromatin remodeling,nucleus function,gene expression regulation,cell cycle progression,oncogenesis
ENSG00000228049,POLR2J2,transcriptional regulation,pseudogene expression,genomic instability,tumor progression,epigenetic alterations,genetic mutations
ENSG00000206306,HLA-DRB1,mhc class ii,antigen presentation,immunogenic peptides,t-cell activation,gene polymorphism,immune surveillance
ENSG00000070388,FGF22,tumor progression,fgfr interaction,oncogene activation,angiogenesis promotion,metastasis facilitation,proliferation enhancement
ENSG00000176239,OR51B6,olfactory receptor signaling,g-protein coupled receptor interactions,cellular differentiation,proliferation regulation,gip modulation,odorant detection
ENSG00000112139,MDGA1,cell adhesion modulation,tumor progression,signaling pathway regulation,glycosylation and lipid metabolism,met promoter mutations,cancer metastasis
ENSG00000161610,HCRT,angiogenesis promotion,oncogenic function,cell proliferation enhancement,immune system modulation,stress response regulation,therapeutic target
ENSG00000109390,NDUFC1,mitochondrial function,complex i assembly,mitochondrial dynamics regulation,energy metabolism alterations,cell survival enhancement,therapeutic target for metabolic disruption
ENSG00000178235,SLITRK1,slit family member,tumor suppressor function,cell migration regulation,angiogenesis modulation,wnt/β-catenin pathway interaction,poor prognosis associated with downregulation
ENSG00000165379,LRFN5,amplification,oncogenic properties,cell adhesion modulation,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000157766,ACAN,cell adhesion disruption,extracellular matrix modulation,oncogenic signaling pathway interaction,tumor progression facilitation,apoptosis resistance promotion,cell migration enhancement
ENSG00000112562,SMOC2,**
 smoc2 expression,tumor progression,angiogenesis promotion,signaling pathway activation,cell proliferation facilitation,vegf interaction
ENSG00000136488,CSH1,tumor progression,oncogenesis,cell proliferation,therapeutic target,aberrant transcriptional programs,smad protein interaction
ENSG00000179399,GPC5,cellular differentiation,metastasis facilitation,tumor microenvironment modulation,oncogene activation,therapeutic target identification,growth factor regulation
ENSG00000197054,ZNF763,cellular proliferation regulation,transcription factor function,metastasis promotion,epithelial-to-mesenchymal transition modulation,pi3k/akt pathway interaction,tumor progression association
ENSG00000150275,PCDH15,cellular adhesion disruption,tumor progression,hippo pathway modulation,cell migration enhancement,poor prognosis association,therapeutic target candidate
ENSG00000110427,KIAA1549L,microtubule stability,cell proliferation,oncogenesis,tumor aggressiveness,poor prognosis,mitosis regulation
ENSG00000213420,GPC2,glycosylphosphatidylinositol-anchored mucin,cell surface expression,oncogenesis,tumor progression,immune suppression,enhanced cell proliferation
ENSG00000112414,ADGRG6,cell adhesion disruption,overexpression,tumor progression,proliferation enhancement,survival promotion,prognostic biomarker
ENSG00000276053,LAIR1,immune regulation,tumor immunity suppression,prognostic marker,therapeutic target,apoptosis regulation,cell growth modulation
ENSG00000134256,CD101,cell adhesion,immunosuppression,tumor progression,prognostic marker,therapeutic target,adaptive immunity
ENSG00000182035,ADIG,redox regulation,cellular detoxification,oncogenic properties,cell proliferation,signaling pathway modulation,protein interaction
ENSG00000163273,NPPC,vip/neuropeptide k signaling pathway,vasoactive intestinal peptide,tumor progression,apoptosis inhibition,angiogenesis promotion,biomarker potential for rcc diagnosis and treatment
ENSG00000196209,SIRPB2,immune modulation,cellular adhesion,signal transduction,tumor microenvironment,none,none
ENSG00000154269,ENPP3,cellular proliferation,metabolic regulation,cell migration,atp hydrolysis,tumor microenvironment,energy metabolism
ENSG00000145850,TIMD4,immune regulation,tumor progression,treg modulation,oncogenesis,metastasis promotion,prognostic marker
ENSG00000158292,GPR153,g protein-coupled receptor activation,constitutive wnt/β-catenin signaling,enhanced cell proliferation,immune evasion mechanisms,tumor angiogenesis promotion,oncogenic pathway activation
ENSG00000140287,HDC,histamine-mediated signaling pathways,tumor microenvironment modulation,angiogenesis promotion,immune response regulation,epigenetic regulation,prognostic marker
ENSG00000183117,CSMD1,pi3k/akt pathway,cell adhesion disruption,tumor aggressiveness,epithelial-to-mesenchymal transition (emt),biomarker potential,complement system regulation
ENSG00000180828,BHLHE22,cellular regulation,dysregulation,loss-of-function mutations,tumor progression,transcriptional modulation,cancer biology
ENSG00000169618,PROKR1,prokineticin receptor signaling,tumor growth promotion,cell survival activation,angiogenesis enhancement,metastasis facilitation,poor prognosis association
